Citrus Sinensis ID: 020085
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 331 | 2.2.26 [Sep-21-2011] | |||||||
| Q55GU0 | 916 | Probable serine/threonine | yes | no | 0.712 | 0.257 | 0.429 | 1e-54 | |
| Q54H46 | 642 | Probable serine/threonine | no | no | 0.652 | 0.336 | 0.472 | 1e-54 | |
| Q2MHE4 | 390 | Serine/threonine-protein | no | no | 0.658 | 0.558 | 0.439 | 2e-54 | |
| Q05609 | 821 | Serine/threonine-protein | no | no | 0.722 | 0.291 | 0.437 | 3e-52 | |
| Q54H45 | 690 | Probable serine/threonine | no | no | 0.652 | 0.313 | 0.450 | 5e-52 | |
| Q9FPR3 | 933 | Serine/threonine-protein | no | no | 0.655 | 0.232 | 0.468 | 2e-51 | |
| Q7T6Y2 | 1624 | Putative serine/threonine | N/A | no | 0.652 | 0.133 | 0.441 | 6e-47 | |
| Q7T6X2 | 1657 | Putative serine/threonine | N/A | no | 0.661 | 0.132 | 0.418 | 7e-46 | |
| Q54TM7 | 1288 | Probable serine/threonine | no | no | 0.646 | 0.166 | 0.419 | 8e-46 | |
| P11345 | 648 | RAF proto-oncogene serine | yes | no | 0.634 | 0.324 | 0.422 | 4e-45 |
| >sp|Q55GU0|Y9955_DICDI Probable serine/threonine-protein kinase DDB_G0267514 OS=Dictyostelium discoideum GN=DDB_G0267514 PE=3 SV=1 | Back alignment and function desciption |
|---|
Score = 213 bits (543), Expect = 1e-54, Method: Compositional matrix adjust.
Identities = 103/240 (42%), Positives = 162/240 (67%), Gaps = 4/240 (1%)
Query: 87 LIESSPNCIEIPTDGTDVW---EIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLK- 142
++++S + +E P+ + EI +LKI K+ G++G +YKG + VAIK +K
Sbjct: 634 ILKNSGSVVEPPSQQQQYFSDIEISFSELKISSKLGEGTFGVVYKGLWRGSSVAIKQIKI 693
Query: 143 PECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK 202
E VN ++L+EF +E+ I+ ++RH N+V + ACT PPNLC +TE++ GS+YD LH +K
Sbjct: 694 NEDVNNQVLEEFRKELTILSRLRHPNIVLLMAACTAPPNLCFITEYLPGGSLYDALHSKK 753
Query: 203 GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262
+ K+AI +++GMNYLH + +IHRD+K+ NLL+DE+ VK+ DFG+++++++S
Sbjct: 754 IKMNMQLYKKLAIQIAQGMNYLHLSGVIHRDIKSLNLLLDEHMNVKICDFGLSKLKSKST 813
Query: 263 VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK 322
MT G+ WM+PE++ + Y K DV++FGI LWEL TGELPY+GL +Q A+ V K
Sbjct: 814 EMTKSIGSPIWMSPELLMGEDYTEKVDVYAFGIILWELGTGELPYSGLDSVQLALAVTTK 873
|
Dictyostelium discoideum (taxid: 44689) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q54H46|DRKA_DICDI Probable serine/threonine-protein kinase drkA OS=Dictyostelium discoideum GN=drkA PE=3 SV=1 | Back alignment and function description |
|---|
Score = 213 bits (543), Expect = 1e-54, Method: Compositional matrix adjust.
Identities = 105/222 (47%), Positives = 147/222 (66%), Gaps = 6/222 (2%)
Query: 100 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVY 159
DG D ID Q+KI ++ G+YG++Y GT+ +VA+K L +N +LKEF +E+
Sbjct: 365 DGKD---IDIHQIKIGVRIGKGNYGEVYLGTWRGSQVAVKKLPAHNINENILKEFHREIN 421
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
+M+ +RH NV+QF+G+C PP++CI TE+M RGS+Y LH Q Q + L+K+ ID +K
Sbjct: 422 LMKNLRHPNVIQFLGSCLIPPDICICTEYMPRGSLYSILHDQALQLQWSLLIKMMIDAAK 481
Query: 220 GMNYLHQNN--IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPE 277
G+ YLH + I+HRDLK+ NLL+DEN VKVADFG++ ++ Q MTA GT W +PE
Sbjct: 482 GVIYLHNSTPVILHRDLKSHNLLVDENWKVKVADFGLSTIEQQGATMTA-CGTPCWTSPE 540
Query: 278 VIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGV 319
V+ + Y KADV+SFGI LWE T + PY G+ P Q V
Sbjct: 541 VLRSQRYTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAV 582
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2MHE4|HT1_ARATH Serine/threonine-protein kinase HT1 OS=Arabidopsis thaliana GN=HT1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 213 bits (542), Expect = 2e-54, Method: Compositional matrix adjust.
Identities = 98/223 (43%), Positives = 150/223 (67%), Gaps = 5/223 (2%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLK----PECVNTEMLKEFSQEVYI 160
W D QL I K ASG++ +Y+G Y + VA+K+++ E ++ ++F EV +
Sbjct: 79 WTADLSQLFIGNKFASGAHSRIYRGIYKQRAVAVKMVRIPTHKEETRAKLEQQFKSEVAL 138
Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSK 219
+ ++ H N+VQFI AC +PP CI+TE+M++G++ +L+K++ + ++L++A+D+S+
Sbjct: 139 LSRLFHPNIVQFIAACKKPPVYCIITEYMSQGNLRMYLNKKEPYSLSIETVLRLALDISR 198
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVI 279
GM YLH +IHRDLK+ NLL+++ VKVADFG + ++ Q GTYRWMAPE+I
Sbjct: 199 GMEYLHSQGVIHRDLKSNNLLLNDEMRVKVADFGTSCLETQCREAKGNMGTYRWMAPEMI 258
Query: 280 EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK 322
+ KPY K DV+SFGI LWEL T LP+ G+TP+QAA V +K
Sbjct: 259 KEKPYTRKVDVYSFGIVLWELTTALLPFQGMTPVQAAFAVAEK 301
|
Serine/threonine kinase involved in the control of stomatal movement in response to CO(2). Shows a reduced response to ABA or light compared to CO(2). Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q05609|CTR1_ARATH Serine/threonine-protein kinase CTR1 OS=Arabidopsis thaliana GN=CTR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 205 bits (522), Expect = 3e-52, Method: Compositional matrix adjust.
Identities = 109/249 (43%), Positives = 163/249 (65%), Gaps = 10/249 (4%)
Query: 79 GVPMHSKLLIESSPNCI--EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEV 136
PM++ + + PN E+ DG D+ +I L I+ K+ +GS+G +++ + +V
Sbjct: 517 AAPMNAPPISQPVPNRANRELGLDGDDM-DIPWCDLNIKEKIGAGSFGTVHRAEWHGSDV 575
Query: 137 AIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYD 196
A+K+L + + E + EF +EV IM+++RH N+V F+GA T+PPNL IVTE+++RGS+Y
Sbjct: 576 AVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYR 635
Query: 197 FLHKQKGVFQL--TSLLKVAIDVSKGMNYLHQNN--IIHRDLKTANLLMDENGVVKVADF 252
LHK QL L +A DV+KGMNYLH N I+HRDLK+ NLL+D+ VKV DF
Sbjct: 636 LLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDF 695
Query: 253 GVARVQAQSGVMT-AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLT 311
G++R++A + + + + GT WMAPEV+ +P + K+DV+SFG+ LWEL T + P+ L
Sbjct: 696 GLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLN 755
Query: 312 PLQ--AAVG 318
P Q AAVG
Sbjct: 756 PAQVVAAVG 764
|
Acts as a negative regulator in the ethylene response pathway. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54H45|DRKB_DICDI Probable serine/threonine-protein kinase drkB OS=Dictyostelium discoideum GN=drkB PE=3 SV=1 | Back alignment and function description |
|---|
Score = 204 bits (520), Expect = 5e-52, Method: Compositional matrix adjust.
Identities = 100/222 (45%), Positives = 146/222 (65%), Gaps = 6/222 (2%)
Query: 100 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVY 159
DG D ID +Q+KI ++ G++G++Y GT+ +VA+K L +N +LKEF +E+
Sbjct: 382 DGKD---IDTQQIKIGVRIGKGNFGEVYLGTWRGSQVAVKKLPAHNINENILKEFHREIN 438
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
+M+ +RH NV+QF+G+C P++CI TE+M RGS+Y LH +K + + ++ ID +K
Sbjct: 439 LMKNLRHPNVIQFLGSCLISPDICICTEYMPRGSLYSILHNEKIKISWSLVKRMMIDAAK 498
Query: 220 GMNYLHQNN--IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPE 277
G+ YLH + I+HRDLK+ NLL+DEN VKVADFG++ ++ Q MTA GT W +PE
Sbjct: 499 GIIYLHGSTPVILHRDLKSHNLLVDENWKVKVADFGLSTIEQQGATMTA-CGTPCWTSPE 557
Query: 278 VIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGV 319
V+ + Y KADV+SFGI LWE T + PY G+ P Q V
Sbjct: 558 VLRSQRYTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAV 599
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FPR3|EDR1_ARATH Serine/threonine-protein kinase EDR1 OS=Arabidopsis thaliana GN=EDR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 203 bits (516), Expect = 2e-51, Method: Compositional matrix adjust.
Identities = 104/222 (46%), Positives = 142/222 (63%), Gaps = 5/222 (2%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR 165
EI L I ++ GSYG++Y + EVA+K + + L EF EV IMR++R
Sbjct: 663 EIPWNDLVIAERIGLGSYGEVYHADWHGTEVAVKKFLDQDFSGAALAEFRSEVRIMRRLR 722
Query: 166 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 225
H NVV F+GA TRPPNL IVTEF+ RGS+Y LH+ K +K+A+DV+ GMN LH
Sbjct: 723 HPNVVFFLGAVTRPPNLSIVTEFLPRGSLYRILHRPKSHIDERRRIKMALDVAMGMNCLH 782
Query: 226 QN--NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET-GTYRWMAPEVIEHK 282
+ I+HRDLKT NLL+D N VKV DFG++R++ + + + T GT WMAPEV+ ++
Sbjct: 783 TSTPTIVHRDLKTPNLLVDNNWNVKVGDFGLSRLKHNTFLSSKSTAGTPEWMAPEVLRNE 842
Query: 283 PYDYKADVFSFGIALWELLTGELPYAGLTPLQ--AAVGVVQK 322
P + K DV+SFG+ LWEL T LP+ G+ P+Q AVG +
Sbjct: 843 PSNEKCDVYSFGVILWELATLRLPWRGMNPMQVVGAVGFQNR 884
|
MAPKKK serine/threonine-protein kinase involved in the regulation of a MAP kinase cascade (probably including MPK3 and MPK6) that negatively regulates salicylic acid- (SA-) dependent defense responses, abscisic acid (ABA) signaling, and ethylene-induced senescence. Modulates also stress response (e.g. drought) signaling and cell death, in an ORE9-dependent manner. Functions at a point of cross talk between ethylene, ABA and SA signaling that impinges on senescence and cell death. In another hand, confers sensitivity to various pathogens such as the fungus Erysiphe cichoracearum, the oomycete Hyaloperonospora parasitica and the bacteria Pseudomonas syringae pv. tomato DC3000. Required for the resistance to some hemibiotrophic/necrotrophic fungal pathogens (e.g. Colletotrichum gloeosporioides, Colletotrichum higginsianum and Alternaria brassicicola) through the induction of defensins expression, probably by repressing MYC2, an inhibitor of defensin genes (PDFs). Together with KEG, may regulate endocytic trafficking and/or the formation of signaling complexes on trans-Golgi network (TGN)/ early endosome (EE) vesicles during stress responses. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T6Y2|YR831_MIMIV Putative serine/threonine-protein kinase/receptor R831 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R831 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 187 bits (476), Expect = 6e-47, Method: Compositional matrix adjust.
Identities = 99/224 (44%), Positives = 145/224 (64%), Gaps = 8/224 (3%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI 164
WEID +L+I + +G YG++YK + EVA+K++ + V+ +M + F +EV IM +
Sbjct: 779 WEIDFSELEIGETLGTGGYGEVYKSIWKGTEVAVKLISSKHVSKDMERSFFEEVKIMTSL 838
Query: 165 RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKV--AIDVSKGMN 222
RH NVV F+ A T+ PN+CIV EFM+ GS+YD L + + ++ LK+ A SKGM+
Sbjct: 839 RHPNVVLFMAASTKSPNMCIVMEFMSLGSLYDLLGNEL-IPEIPYALKIKMAYQASKGMH 897
Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE---TGTYRWMAPEVI 279
+LH + I+HRDLK+ NLL+D VKV+DFG+ +V+++ GT W+APE++
Sbjct: 898 FLHSSGIVHRDLKSLNLLLDSKWNVKVSDFGLTKVKSELDKKKTNDNIIGTIHWIAPEIL 957
Query: 280 -EHKPYDY-KADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321
+ DY ADV+SFGI LWELLT E PY G+TP AV V++
Sbjct: 958 NDSTEVDYILADVYSFGIILWELLTREQPYKGMTPAAIAVSVIR 1001
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q7T6X2|YR826_MIMIV Putative serine/threonine-protein kinase/receptor R826 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R826 PE=4 SV=2 | Back alignment and function description |
|---|
Score = 184 bits (467), Expect = 7e-46, Method: Compositional matrix adjust.
Identities = 95/227 (41%), Positives = 150/227 (66%), Gaps = 8/227 (3%)
Query: 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPE-CVNTEMLKEFSQEVYI 160
+D WEID +L++ ++ +G++G+++KGT+ EVA+K++ P+ + ++ + F EV +
Sbjct: 776 SDDWEIDFHELELGEQLGTGAFGEVHKGTWRGTEVAVKMISPDKTITKDIERNFKDEVRV 835
Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI--DVS 218
M +RH NVV F+ A T+PP +CIV EFMA GS++D L K + + + LKV I S
Sbjct: 836 MTTLRHPNVVLFMAASTKPPKMCIVMEFMALGSLHDLL-KNELIPDIPFALKVKIAYQAS 894
Query: 219 KGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE--TGTYRWMAP 276
KGM++LH + I HRDLK+ NLL+D VKV+DFG+ + ++ + E GT +W AP
Sbjct: 895 KGMHFLHSSGITHRDLKSLNLLLDIKWNVKVSDFGLTKFKSDVKSINPEKFAGTIQWTAP 954
Query: 277 EVI-EHKPYDY-KADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321
E++ E + DY +DV+SFGI +WEL+T + PY G++P AV V++
Sbjct: 955 EILSEDREVDYILSDVYSFGIIMWELITRDQPYFGMSPAAIAVSVIR 1001
|
Acanthamoeba polyphaga (taxid: 5757) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q54TM7|DRKD_DICDI Probable serine/threonine-protein kinase drkD OS=Dictyostelium discoideum GN=drkD PE=2 SV=1 | Back alignment and function description |
|---|
Score = 184 bits (467), Expect = 8e-46, Method: Compositional matrix adjust.
Identities = 91/217 (41%), Positives = 140/217 (64%), Gaps = 3/217 (1%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI 164
WE+ ++ I ++ G YG +++G++ EVA+K+L + VN +++ + +EV ++ K+
Sbjct: 844 WEVPLSEIAIGARIGRGGYGQVFRGSWRGTEVAVKMLFNDNVNLKLISDLRKEVDLLCKL 903
Query: 165 RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 224
RH N+V F+GACT P + CIVTE+++RGS+ + L + L++ D ++GM YL
Sbjct: 904 RHPNIVLFMGACTEPSSPCIVTEYLSRGSLANILLDESIEMDWGLRLQLGFDCARGMTYL 963
Query: 225 HQNN--IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHK 282
H N IIHRDLKT NLL+D++ VKVADFG+A V++ + T GT W+APEV+ +
Sbjct: 964 HSRNPIIIHRDLKTDNLLVDDSWQVKVADFGLATVKSHTFAKTM-CGTTGWVAPEVLAEE 1022
Query: 283 PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGV 319
Y KADV+S+ I LWELLT +PYAG +Q +
Sbjct: 1023 GYTEKADVYSYAIVLWELLTRLIPYAGKNTMQVVRSI 1059
|
Dictyostelium discoideum (taxid: 44689) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P11345|RAF1_RAT RAF proto-oncogene serine/threonine-protein kinase OS=Rattus norvegicus GN=Raf1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 182 bits (461), Expect = 4e-45, Method: Compositional matrix adjust.
Identities = 92/218 (42%), Positives = 144/218 (66%), Gaps = 8/218 (3%)
Query: 100 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVY 159
D + WEI+A ++ + ++ SGS+G +YKG + +VA+K+LK E L+ F EV
Sbjct: 337 DSSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQLQAFRNEVA 395
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
++RK RH N++ F+G T+ NL IVT++ S+Y LH Q+ FQ+ L+ +A ++
Sbjct: 396 VLRKTRHVNILLFMGYMTKD-NLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQ 454
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAE--TGTYRWMAP 276
GM+YLH NIIHRD+K+ N+ + E VK+ DFG+A V+++ SG E TG+ WMAP
Sbjct: 455 GMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAP 514
Query: 277 EVI---EHKPYDYKADVFSFGIALWELLTGELPYAGLT 311
EVI ++ P+ +++DV+S+GI L+EL+TGELPY+ +
Sbjct: 515 EVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHIN 552
|
Serine/threonine-protein kinase that acts as a regulatory link between the membrane-associated Ras GTPases and the MAPK/ERK cascade, and this critical regulatory link functions as a switch determining cell fate decisions including proliferation, differentiation, apoptosis, survival and oncogenic transformation. RAF1 activation initiates a mitogen-activated protein kinase (MAPK) cascade that comprises a sequential phosphorylation of the dual-specific MAPK kinases (MAP2K1/MEK1 and MAP2K2/MEK2) and the extracellular signal-regulated kinases (MAPK3/ERK1 and MAPK1/ERK2). The phosphorylated form of RAF1 (on residues Ser-338 and Ser-339, by PAK1) phosphorylates BAD/Bcl2-antagonist of cell death at 'Ser-75'. Phosphorylates adenylyl cyclases: ADCY2, ADCY5 and ADCY6, resulting in their activation. Phosphorylates PPP1R12A resulting in inhibition of the phosphatase activity. Can promote NF-kB activation and inhibit signal transducers involved in motility (ROCK2), apoptosis (MAP3K5/ASK1 and STK3/MST2), proliferation and angiogenesis (RB1). Can protect cells from apoptosis also by translocating to the mitochondria where it binds BCL2 and displaces BAD/Bcl2-antagonist of cell death. Regulates Rho signaling and migration, and is required for normal wound healing. Plays a role in the oncogenic transformation of epithelial cells via repression of the TJ protein, occludin (OCLN) by inducing the up-regulation of a transcriptional repressor SNAI2/SLUG, which induces down-regulation of OCLN. Restricts caspase activation in response to selected stimuli, notably Fas stimulation, pathogen-mediated macrophage apoptosis, and erythroid differentiation (By similarity). Phosphorylates TNNT2/cardiac muscle troponin T. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 331 | ||||||
| 449456851 | 579 | PREDICTED: mitogen-activated protein kin | 0.942 | 0.538 | 0.794 | 1e-151 | |
| 449495086 | 579 | PREDICTED: mitogen-activated protein kin | 0.942 | 0.538 | 0.794 | 1e-151 | |
| 356538347 | 571 | PREDICTED: serine/threonine-protein kina | 0.942 | 0.546 | 0.798 | 1e-147 | |
| 357483963 | 574 | Dual specificity protein kinase pyk2 [Me | 0.942 | 0.543 | 0.807 | 1e-147 | |
| 217074650 | 538 | unknown [Medicago truncatula] | 0.942 | 0.579 | 0.807 | 1e-147 | |
| 356496589 | 571 | PREDICTED: serine/threonine-protein kina | 0.942 | 0.546 | 0.798 | 1e-146 | |
| 224117232 | 587 | predicted protein [Populus trichocarpa] | 0.942 | 0.531 | 0.807 | 1e-146 | |
| 297798344 | 570 | kinase family protein [Arabidopsis lyrat | 0.939 | 0.545 | 0.801 | 1e-145 | |
| 22329194 | 570 | ACT-like protein tyrosine kinase family | 0.939 | 0.545 | 0.801 | 1e-145 | |
| 116643258 | 581 | flag-tagged protein kinase domain of put | 0.939 | 0.535 | 0.801 | 1e-145 |
| >gi|449456851|ref|XP_004146162.1| PREDICTED: mitogen-activated protein kinase kinase kinase 10-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 540 bits (1390), Expect = e-151, Method: Compositional matrix adjust.
Identities = 248/312 (79%), Positives = 284/312 (91%)
Query: 11 VGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILKSKDQS 70
+ +LTSLL ++GLNIQEAHAFS+VDGFSLDVFV+DGWPY+ETE+LK VL KEIL K+Q
Sbjct: 196 LSQLTSLLADVGLNIQEAHAFSSVDGFSLDVFVIDGWPYEETEELKRVLEKEILNFKEQC 255
Query: 71 CSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGT 130
S++QP+ + H++ +ES P+C+ IPTDGTDVWE+D QLK E KV SGS+GDLY+GT
Sbjct: 256 WSEKQPSSALGKHNQNRVESFPSCVGIPTDGTDVWEMDISQLKFENKVGSGSFGDLYRGT 315
Query: 131 YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMA 190
YCSQEVAIKVL+PE +N EMLKEFSQEVYIMRK+RHKNVVQF+GACT+PPNLCIVTEFM+
Sbjct: 316 YCSQEVAIKVLRPERINEEMLKEFSQEVYIMRKVRHKNVVQFLGACTKPPNLCIVTEFMS 375
Query: 191 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
RGS+YDFLHKQ+GVF L SLLKVAI++S+GMNYLHQNNIIHRDLKTANLLMDEN VVKVA
Sbjct: 376 RGSVYDFLHKQRGVFNLPSLLKVAINISRGMNYLHQNNIIHRDLKTANLLMDENMVVKVA 435
Query: 251 DFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL 310
DFGVARVQ QSGVMTAETGTYRWMAPEVIEHKPYD+KADVFSFGIALWELLTGE+PY+ +
Sbjct: 436 DFGVARVQTQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIALWELLTGEIPYSSM 495
Query: 311 TPLQAAVGVVQK 322
TPLQAAVGVVQK
Sbjct: 496 TPLQAAVGVVQK 507
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449495086|ref|XP_004159730.1| PREDICTED: mitogen-activated protein kinase kinase kinase 10-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 540 bits (1390), Expect = e-151, Method: Compositional matrix adjust.
Identities = 248/312 (79%), Positives = 284/312 (91%)
Query: 11 VGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILKSKDQS 70
+ +LTSLL ++GLNIQEAHAFS+VDGFSLDVFV+DGWPY+ETE+LK VL KEIL K+Q
Sbjct: 196 LSQLTSLLADVGLNIQEAHAFSSVDGFSLDVFVIDGWPYEETEELKRVLEKEILNFKEQC 255
Query: 71 CSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGT 130
S++QP+ + H++ +ES P+C+ IPTDGTDVWE+D QLK E KV SGS+GDLY+GT
Sbjct: 256 WSEKQPSSALGKHNQNRVESFPSCVGIPTDGTDVWEMDISQLKFENKVGSGSFGDLYRGT 315
Query: 131 YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMA 190
YCSQEVAIKVL+PE +N EMLKEFSQEVYIMRK+RHKNVVQF+GACT+PPNLCIVTEFM+
Sbjct: 316 YCSQEVAIKVLRPERINEEMLKEFSQEVYIMRKVRHKNVVQFLGACTKPPNLCIVTEFMS 375
Query: 191 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
RGS+YDFLHKQ+GVF L SLLKVAI++S+GMNYLHQNNIIHRDLKTANLLMDEN VVKVA
Sbjct: 376 RGSVYDFLHKQRGVFNLPSLLKVAINISRGMNYLHQNNIIHRDLKTANLLMDENMVVKVA 435
Query: 251 DFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL 310
DFGVARVQ QSGVMTAETGTYRWMAPEVIEHKPYD+KADVFSFGIALWELLTGE+PY+ +
Sbjct: 436 DFGVARVQTQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIALWELLTGEIPYSSM 495
Query: 311 TPLQAAVGVVQK 322
TPLQAAVGVVQK
Sbjct: 496 TPLQAAVGVVQK 507
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356538347|ref|XP_003537665.1| PREDICTED: serine/threonine-protein kinase CTR1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 527 bits (1358), Expect = e-147, Method: Compositional matrix adjust.
Identities = 249/312 (79%), Positives = 278/312 (89%)
Query: 11 VGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILKSKDQS 70
+ +LT++LGE+GLNIQEAHAFST DGFSLDVFVV+GWP +ETE+LK VL KEI K K+Q+
Sbjct: 194 LSQLTAILGEMGLNIQEAHAFSTTDGFSLDVFVVEGWPNEETEELKGVLEKEIFKVKEQN 253
Query: 71 CSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGT 130
S + + +E SP+CI+IP+DG DVWEID QLK E KV SGS+GDLY+GT
Sbjct: 254 LSNQGIHYATNEQYQARMEPSPHCIQIPSDGADVWEIDTNQLKYENKVGSGSFGDLYRGT 313
Query: 131 YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMA 190
YCSQ+VAIKVLKPE ++T+ML+EF+QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFM+
Sbjct: 314 YCSQDVAIKVLKPERISTDMLREFAQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMS 373
Query: 191 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
RGS+YDFLHKQ+GVF+L SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN VVKVA
Sbjct: 374 RGSLYDFLHKQRGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENEVVKVA 433
Query: 251 DFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL 310
DFGVARVQ QSGVMTAETGTYRWMAPEVIEHKPYD KADVFSFGIALWELLTGELPY+ L
Sbjct: 434 DFGVARVQTQSGVMTAETGTYRWMAPEVIEHKPYDQKADVFSFGIALWELLTGELPYSCL 493
Query: 311 TPLQAAVGVVQK 322
TPLQAAVGVVQK
Sbjct: 494 TPLQAAVGVVQK 505
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357483963|ref|XP_003612268.1| Dual specificity protein kinase pyk2 [Medicago truncatula] gi|355513603|gb|AES95226.1| Dual specificity protein kinase pyk2 [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 527 bits (1358), Expect = e-147, Method: Compositional matrix adjust.
Identities = 252/312 (80%), Positives = 278/312 (89%)
Query: 11 VGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILKSKDQS 70
+ +LTS+LGEIGLNIQEAHAFST DGFSLDVFVV+GWP +ETE+LK VL KEILK KDQ
Sbjct: 194 LSQLTSILGEIGLNIQEAHAFSTSDGFSLDVFVVEGWPNEETEELKGVLEKEILKVKDQY 253
Query: 71 CSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGT 130
S + + +ESSP+CI+IP DG DVWEID QLK E KV SGS+GDL++G+
Sbjct: 254 LSNQGTLYSSNDQYQTRMESSPDCIQIPFDGADVWEIDPSQLKYENKVGSGSFGDLFRGS 313
Query: 131 YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMA 190
YCSQ+VAIKVLKPE ++T+MLKEF+QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFM+
Sbjct: 314 YCSQDVAIKVLKPERISTDMLKEFAQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMS 373
Query: 191 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
RGS+YDFLH+QKGVF+L SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN +VKVA
Sbjct: 374 RGSLYDFLHRQKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENELVKVA 433
Query: 251 DFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL 310
DFGVARVQ QSGVMTAETGTYRWMAPEVIEHKPYD KADVFSFGIALWELLTGELPY+ L
Sbjct: 434 DFGVARVQTQSGVMTAETGTYRWMAPEVIEHKPYDQKADVFSFGIALWELLTGELPYSYL 493
Query: 311 TPLQAAVGVVQK 322
TPLQAAVGVVQK
Sbjct: 494 TPLQAAVGVVQK 505
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|217074650|gb|ACJ85685.1| unknown [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 527 bits (1358), Expect = e-147, Method: Compositional matrix adjust.
Identities = 252/312 (80%), Positives = 278/312 (89%)
Query: 11 VGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILKSKDQS 70
+ +LTS+LGEIGLNIQEAHAFST DGFSLDVFVV+GWP +ETE+LK VL KEILK KDQ
Sbjct: 194 LSQLTSILGEIGLNIQEAHAFSTSDGFSLDVFVVEGWPNEETEELKGVLEKEILKVKDQY 253
Query: 71 CSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGT 130
S + + +ESSP+CI+IP DG DVWEID QLK E KV SGS+GDL++G+
Sbjct: 254 LSNQGTLYSSNDQYQTRMESSPDCIQIPFDGADVWEIDPSQLKYENKVGSGSFGDLFRGS 313
Query: 131 YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMA 190
YCSQ+VAIKVLKPE ++T+MLKEF+QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFM+
Sbjct: 314 YCSQDVAIKVLKPERISTDMLKEFAQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMS 373
Query: 191 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
RGS+YDFLH+QKGVF+L SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN +VKVA
Sbjct: 374 RGSLYDFLHRQKGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENELVKVA 433
Query: 251 DFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL 310
DFGVARVQ QSGVMTAETGTYRWMAPEVIEHKPYD KADVFSFGIALWELLTGELPY+ L
Sbjct: 434 DFGVARVQTQSGVMTAETGTYRWMAPEVIEHKPYDQKADVFSFGIALWELLTGELPYSYL 493
Query: 311 TPLQAAVGVVQK 322
TPLQAAVGVVQK
Sbjct: 494 TPLQAAVGVVQK 505
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356496589|ref|XP_003517149.1| PREDICTED: serine/threonine-protein kinase CTR1-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 524 bits (1350), Expect = e-146, Method: Compositional matrix adjust.
Identities = 249/312 (79%), Positives = 277/312 (88%)
Query: 11 VGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILKSKDQS 70
+ +LT++LGE+GLNIQEAHAFST DGFSLDVFVV+GWP +ETE+LK VL KEI K K+Q+
Sbjct: 194 LSQLTAILGEMGLNIQEAHAFSTTDGFSLDVFVVEGWPNEETEELKGVLEKEIFKVKEQN 253
Query: 71 CSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGT 130
S + + +E SP+CI IP+DG DVWEID QLK E KV SGS+GDLY+GT
Sbjct: 254 MSNQGIHYATNEQYQARMEPSPHCILIPSDGADVWEIDTNQLKYENKVGSGSFGDLYRGT 313
Query: 131 YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMA 190
YCSQ+VAIKVLKPE ++T+ML+EF+QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFM+
Sbjct: 314 YCSQDVAIKVLKPERISTDMLREFAQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMS 373
Query: 191 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
RGS+YDFLHKQ+GVF+L SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN VVKVA
Sbjct: 374 RGSLYDFLHKQRGVFKLPSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENEVVKVA 433
Query: 251 DFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL 310
DFGVARVQ QSGVMTAETGTYRWMAPEVIEHKPYD KADVFSFGIALWELLTGELPY+ L
Sbjct: 434 DFGVARVQTQSGVMTAETGTYRWMAPEVIEHKPYDQKADVFSFGIALWELLTGELPYSCL 493
Query: 311 TPLQAAVGVVQK 322
TPLQAAVGVVQK
Sbjct: 494 TPLQAAVGVVQK 505
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224117232|ref|XP_002331754.1| predicted protein [Populus trichocarpa] gi|222874451|gb|EEF11582.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 523 bits (1348), Expect = e-146, Method: Compositional matrix adjust.
Identities = 252/312 (80%), Positives = 278/312 (89%)
Query: 11 VGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILKSKDQS 70
+ +LTSLL EIGLNIQEAHAFSTVDGFSLDVFVVDGW +ETE+L+N L KEILKSK+Q
Sbjct: 205 LSQLTSLLAEIGLNIQEAHAFSTVDGFSLDVFVVDGWLREETEELRNALEKEILKSKEQC 264
Query: 71 CSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGT 130
SK+ V +K +ES P+C+EIP+DGTDVWEID LK+E KVASGSYGDLY+GT
Sbjct: 265 FSKQLSVSLVGEQNKTGVESLPDCVEIPSDGTDVWEIDTSLLKVENKVASGSYGDLYRGT 324
Query: 131 YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMA 190
YCSQEVAIKVLKPE V+ EML+EFS+EVYIMRK+RHKNVVQFIGAC R PNLCIVTEFMA
Sbjct: 325 YCSQEVAIKVLKPERVSGEMLREFSREVYIMRKVRHKNVVQFIGACDRSPNLCIVTEFMA 384
Query: 191 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
+GS+Y+FLHKQKGVF+L L+KVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN VVKVA
Sbjct: 385 KGSLYNFLHKQKGVFKLPCLIKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENEVVKVA 444
Query: 251 DFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL 310
DFGVARVQ QSGVMTAETGTYRWMAPEVIEHKPYD+KADVFSFGI WELLTGELPY+ L
Sbjct: 445 DFGVARVQTQSGVMTAETGTYRWMAPEVIEHKPYDHKADVFSFGIVAWELLTGELPYSYL 504
Query: 311 TPLQAAVGVVQK 322
TPLQAAVGVV+K
Sbjct: 505 TPLQAAVGVVRK 516
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297798344|ref|XP_002867056.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297312892|gb|EFH43315.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 521 bits (1341), Expect = e-145, Method: Compositional matrix adjust.
Identities = 250/312 (80%), Positives = 274/312 (87%), Gaps = 1/312 (0%)
Query: 11 VGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILKSKDQS 70
+ +LTS+LGE+GLNIQEAHAFST DGFSLDVFVVDGW +ETE LK+ L KEI K KDQ
Sbjct: 192 LSQLTSMLGELGLNIQEAHAFSTADGFSLDVFVVDGWSQEETEGLKDALTKEIRKLKDQP 251
Query: 71 CSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGT 130
CSK Q ++ H K E P C+EIPTDGTD WEID KQLKIE KVA GSYG+L++GT
Sbjct: 252 CSK-QKSITFFEHDKSTNELLPACVEIPTDGTDEWEIDMKQLKIEKKVACGSYGELFRGT 310
Query: 131 YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMA 190
YCSQEVAIK+LKPE VN EML+EFSQEVYIMRK+RHKNVVQFIGACTR PNLCIVTEFM
Sbjct: 311 YCSQEVAIKILKPERVNAEMLREFSQEVYIMRKVRHKNVVQFIGACTRSPNLCIVTEFMT 370
Query: 191 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
RGSIYDFLHK KGVF++ SLLKVA+DVSKGMNYLHQNNIIHRDLKTANLLMDE+ VVKVA
Sbjct: 371 RGSIYDFLHKHKGVFKIQSLLKVALDVSKGMNYLHQNNIIHRDLKTANLLMDEHEVVKVA 430
Query: 251 DFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL 310
DFGVARVQ +SGVMTAETGTYRWMAPEVIEHKPYD++ADVFS+ I LWELLTGELPY+ L
Sbjct: 431 DFGVARVQTESGVMTAETGTYRWMAPEVIEHKPYDHRADVFSYAIVLWELLTGELPYSYL 490
Query: 311 TPLQAAVGVVQK 322
TPLQAAVGVVQK
Sbjct: 491 TPLQAAVGVVQK 502
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|22329194|ref|NP_195303.2| ACT-like protein tyrosine kinase family protein [Arabidopsis thaliana] gi|20260236|gb|AAM13016.1| putative protein [Arabidopsis thaliana] gi|22136520|gb|AAM91338.1| putative protein [Arabidopsis thaliana] gi|332661163|gb|AEE86563.1| ACT-like protein tyrosine kinase family protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 520 bits (1340), Expect = e-145, Method: Compositional matrix adjust.
Identities = 250/312 (80%), Positives = 274/312 (87%), Gaps = 1/312 (0%)
Query: 11 VGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILKSKDQS 70
+ +LTS+LGE+GLNIQEAHAFST DGFSLDVFVVDGW +ETE LK+ L KEI K KDQ
Sbjct: 192 LSQLTSMLGELGLNIQEAHAFSTADGFSLDVFVVDGWSQEETEGLKDALKKEIRKFKDQP 251
Query: 71 CSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGT 130
CSK Q ++ H K E P C+EIPTDGTD WEID KQLKIE KVA GSYG+L++GT
Sbjct: 252 CSK-QKSITFFEHDKSTNELLPACVEIPTDGTDEWEIDMKQLKIEKKVACGSYGELFRGT 310
Query: 131 YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMA 190
YCSQEVAIK+LKPE VN EML+EFSQEVYIMRK+RHKNVVQFIGACTR PNLCIVTEFM
Sbjct: 311 YCSQEVAIKILKPERVNAEMLREFSQEVYIMRKVRHKNVVQFIGACTRSPNLCIVTEFMT 370
Query: 191 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
RGSIYDFLHK KGVF++ SLLKVA+DVSKGMNYLHQNNIIHRDLKTANLLMDE+ VVKVA
Sbjct: 371 RGSIYDFLHKHKGVFKIQSLLKVALDVSKGMNYLHQNNIIHRDLKTANLLMDEHEVVKVA 430
Query: 251 DFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL 310
DFGVARVQ +SGVMTAETGTYRWMAPEVIEHKPYD++ADVFS+ I LWELLTGELPY+ L
Sbjct: 431 DFGVARVQTESGVMTAETGTYRWMAPEVIEHKPYDHRADVFSYAIVLWELLTGELPYSYL 490
Query: 311 TPLQAAVGVVQK 322
TPLQAAVGVVQK
Sbjct: 491 TPLQAAVGVVQK 502
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|116643258|gb|ABK06437.1| flag-tagged protein kinase domain of putative mitogen-activated protein kinase kinase kinase [synthetic construct] | Back alignment and taxonomy information |
|---|
Score = 520 bits (1339), Expect = e-145, Method: Compositional matrix adjust.
Identities = 250/312 (80%), Positives = 274/312 (87%), Gaps = 1/312 (0%)
Query: 11 VGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILKSKDQS 70
+ +LTS+LGE+GLNIQEAHAFST DGFSLDVFVVDGW +ETE LK+ L KEI K KDQ
Sbjct: 192 LSQLTSMLGELGLNIQEAHAFSTADGFSLDVFVVDGWSQEETEGLKDALKKEIRKFKDQP 251
Query: 71 CSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGT 130
CSK Q ++ H K E P C+EIPTDGTD WEID KQLKIE KVA GSYG+L++GT
Sbjct: 252 CSK-QKSITFFEHDKSTNELLPACVEIPTDGTDEWEIDMKQLKIEKKVACGSYGELFRGT 310
Query: 131 YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMA 190
YCSQEVAIK+LKPE VN EML+EFSQEVYIMRK+RHKNVVQFIGACTR PNLCIVTEFM
Sbjct: 311 YCSQEVAIKILKPERVNAEMLREFSQEVYIMRKVRHKNVVQFIGACTRSPNLCIVTEFMT 370
Query: 191 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
RGSIYDFLHK KGVF++ SLLKVA+DVSKGMNYLHQNNIIHRDLKTANLLMDE+ VVKVA
Sbjct: 371 RGSIYDFLHKHKGVFKIQSLLKVALDVSKGMNYLHQNNIIHRDLKTANLLMDEHEVVKVA 430
Query: 251 DFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL 310
DFGVARVQ +SGVMTAETGTYRWMAPEVIEHKPYD++ADVFS+ I LWELLTGELPY+ L
Sbjct: 431 DFGVARVQTESGVMTAETGTYRWMAPEVIEHKPYDHRADVFSYAIVLWELLTGELPYSYL 490
Query: 311 TPLQAAVGVVQK 322
TPLQAAVGVVQK
Sbjct: 491 TPLQAAVGVVQK 502
|
Source: synthetic construct Species: synthetic construct Genus: N/A Family: N/A Order: N/A Class: N/A Phylum: N/A Superkingdom: |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 331 | ||||||
| TAIR|locus:2128043 | 570 | STY17 "serine/threonine/tyrosi | 0.939 | 0.545 | 0.801 | 2.1e-132 | |
| TAIR|locus:2827943 | 546 | STY8 "serine/threonine/tyrosin | 0.939 | 0.569 | 0.785 | 4e-129 | |
| TAIR|locus:2121154 | 575 | STY46 "serine/threonine/tyrosi | 0.933 | 0.537 | 0.732 | 7.7e-119 | |
| TAIR|locus:2061092 | 411 | AT2G24360 [Arabidopsis thalian | 0.679 | 0.547 | 0.484 | 2.3e-55 | |
| TAIR|locus:2126311 | 412 | AT4G31170 [Arabidopsis thalian | 0.679 | 0.546 | 0.476 | 1.3e-54 | |
| DICTYBASE|DDB_G0289791 | 642 | drkA "DRK subfamily protein ki | 0.649 | 0.334 | 0.479 | 4.4e-52 | |
| DICTYBASE|DDB_G0267514 | 916 | DDB_G0267514 "protein kinase, | 0.712 | 0.257 | 0.429 | 2.4e-51 | |
| DICTYBASE|DDB_G0289709 | 690 | drkB "DRK subfamily protein ki | 0.649 | 0.311 | 0.457 | 9.5e-50 | |
| TAIR|locus:2144613 | 821 | CTR1 "CONSTITUTIVE TRIPLE RESP | 0.716 | 0.288 | 0.441 | 5.6e-49 | |
| TAIR|locus:2027794 | 1030 | AT1G73660 [Arabidopsis thalian | 0.679 | 0.218 | 0.440 | 7.3e-49 |
| TAIR|locus:2128043 STY17 "serine/threonine/tyrosine kinase 17" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1298 (462.0 bits), Expect = 2.1e-132, P = 2.1e-132
Identities = 250/312 (80%), Positives = 274/312 (87%)
Query: 11 VGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILKSKDQS 70
+ +LTS+LGE+GLNIQEAHAFST DGFSLDVFVVDGW +ETE LK+ L KEI K KDQ
Sbjct: 192 LSQLTSMLGELGLNIQEAHAFSTADGFSLDVFVVDGWSQEETEGLKDALKKEIRKFKDQP 251
Query: 71 CSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGT 130
CSK Q ++ H K E P C+EIPTDGTD WEID KQLKIE KVA GSYG+L++GT
Sbjct: 252 CSK-QKSITFFEHDKSTNELLPACVEIPTDGTDEWEIDMKQLKIEKKVACGSYGELFRGT 310
Query: 131 YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMA 190
YCSQEVAIK+LKPE VN EML+EFSQEVYIMRK+RHKNVVQFIGACTR PNLCIVTEFM
Sbjct: 311 YCSQEVAIKILKPERVNAEMLREFSQEVYIMRKVRHKNVVQFIGACTRSPNLCIVTEFMT 370
Query: 191 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
RGSIYDFLHK KGVF++ SLLKVA+DVSKGMNYLHQNNIIHRDLKTANLLMDE+ VVKVA
Sbjct: 371 RGSIYDFLHKHKGVFKIQSLLKVALDVSKGMNYLHQNNIIHRDLKTANLLMDEHEVVKVA 430
Query: 251 DFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL 310
DFGVARVQ +SGVMTAETGTYRWMAPEVIEHKPYD++ADVFS+ I LWELLTGELPY+ L
Sbjct: 431 DFGVARVQTESGVMTAETGTYRWMAPEVIEHKPYDHRADVFSYAIVLWELLTGELPYSYL 490
Query: 311 TPLQAAVGVVQK 322
TPLQAAVGVVQK
Sbjct: 491 TPLQAAVGVVQK 502
|
|
| TAIR|locus:2827943 STY8 "serine/threonine/tyrosine kinase 8" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1267 (451.1 bits), Expect = 4.0e-129, P = 4.0e-129
Identities = 245/312 (78%), Positives = 275/312 (88%)
Query: 11 VGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILKSKDQS 70
+ +LTSLLGE+GLNIQEAHAFSTVDGFSLDVFVVDGW +ET+ L++ L+KEILK KDQ
Sbjct: 186 LSQLTSLLGELGLNIQEAHAFSTVDGFSLDVFVVDGWSQEETDGLRDALSKEILKLKDQP 245
Query: 71 CSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGT 130
SK Q ++ H K E P CIEIPTDGTD WEID QLKIE KVASGSYGDL++GT
Sbjct: 246 GSK-QKSISFFEHDKSSNELIPACIEIPTDGTDEWEIDVTQLKIEKKVASGSYGDLHRGT 304
Query: 131 YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMA 190
YCSQEVAIK LKP+ VN EML+EFSQEV+IMRK+RHKNVVQF+GACTR P LCIVTEFMA
Sbjct: 305 YCSQEVAIKFLKPDRVNNEMLREFSQEVFIMRKVRHKNVVQFLGACTRSPTLCIVTEFMA 364
Query: 191 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
RGSIYDFLHKQK F+L +LLKVA+DV+KGM+YLHQNNIIHRDLKTANLLMDE+G+VKVA
Sbjct: 365 RGSIYDFLHKQKCAFKLQTLLKVALDVAKGMSYLHQNNIIHRDLKTANLLMDEHGLVKVA 424
Query: 251 DFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL 310
DFGVARVQ +SGVMTAETGTYRWMAPEVIEHKPY++KADVFS+ I LWELLTG++PYA L
Sbjct: 425 DFGVARVQIESGVMTAETGTYRWMAPEVIEHKPYNHKADVFSYAIVLWELLTGDIPYAFL 484
Query: 311 TPLQAAVGVVQK 322
TPLQAAVGVVQK
Sbjct: 485 TPLQAAVGVVQK 496
|
|
| TAIR|locus:2121154 STY46 "serine/threonine/tyrosine kinase 46" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1170 (416.9 bits), Expect = 7.7e-119, P = 7.7e-119
Identities = 227/310 (73%), Positives = 261/310 (84%)
Query: 13 ELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILKSKDQSCS 72
+LT+LL E+GLNIQEAHAFST DG+SLDVFVVDGWPY+ETE L+ L KE K + QS S
Sbjct: 192 QLTALLAELGLNIQEAHAFSTTDGYSLDVFVVDGWPYEETERLRISLEKEAAKIELQSQS 251
Query: 73 KRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYC 132
P + + + IP DGTDVWEI+ K LK K+ASGSYGDLYKGTYC
Sbjct: 252 WPMQQSFSPEKENGQTGARTH-VPIPNDGTDVWEINLKHLKFGHKIASGSYGDLYKGTYC 310
Query: 133 SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARG 192
SQEVAIKVLKPE +++++ KEF+QEV+IMRK+RHKNVVQFIGACT+PP+LCIVTEFM G
Sbjct: 311 SQEVAIKVLKPERLDSDLEKEFAQEVFIMRKVRHKNVVQFIGACTKPPHLCIVTEFMPGG 370
Query: 193 SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADF 252
S+YD+LHKQKGVF+L +L KVAID+ KGM+YLHQNNIIHRDLK ANLLMDEN VVKVADF
Sbjct: 371 SVYDYLHKQKGVFKLPTLFKVAIDICKGMSYLHQNNIIHRDLKAANLLMDENEVVKVADF 430
Query: 253 GVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTP 312
GVARV+AQ+GVMTAETGTYRWMAPEVIEHKPYD+KADVFS+GI LWELLTG+LPY +TP
Sbjct: 431 GVARVKAQTGVMTAETGTYRWMAPEVIEHKPYDHKADVFSYGIVLWELLTGKLPYEYMTP 490
Query: 313 LQAAVGVVQK 322
LQAAVGVVQK
Sbjct: 491 LQAAVGVVQK 500
|
|
| TAIR|locus:2061092 AT2G24360 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 571 (206.1 bits), Expect = 2.3e-55, P = 2.3e-55
Identities = 113/233 (48%), Positives = 159/233 (68%)
Query: 98 PTDGT---DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVL-KPECVNTE---M 150
PT+G D W ID ++L + A G++G LYKGTY ++VAIK+L +PE + M
Sbjct: 113 PTEGLTNYDEWTIDLRKLNMGPAFAQGAFGKLYKGTYNGEDVAIKILERPENSPEKAQFM 172
Query: 151 LKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL-HKQKGVFQLTS 209
++F QEV ++ ++H N+V+FIGAC +P CIVTE+ GS+ FL +Q L
Sbjct: 173 EQQFQQEVSMLANLKHPNIVRFIGACRKPMVWCIVTEYAKGGSVRQFLTRRQNRAVPLKL 232
Query: 210 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETG 269
+K A+DV++GM Y+H N IHRDLK+ NLL+ + +K+ADFGVAR++ Q+ MT ETG
Sbjct: 233 AVKQALDVARGMAYVHGRNFIHRDLKSDNLLISADKSIKIADFGVARIEVQTEGMTPETG 292
Query: 270 TYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK 322
TYRWMAPE+I+H+ Y+ K DV+SFGI LWEL+TG LP+ +T +QAA VV +
Sbjct: 293 TYRWMAPEMIQHRAYNQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNR 345
|
|
| TAIR|locus:2126311 AT4G31170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 564 (203.6 bits), Expect = 1.3e-54, P = 1.3e-54
Identities = 111/233 (47%), Positives = 158/233 (67%)
Query: 98 PTDGT---DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTE----M 150
PT+G + W ID ++L + A G++G LY+GTY ++VAIK+L+ N E +
Sbjct: 114 PTEGLVNYEEWTIDLRKLHMGPAFAQGAFGKLYRGTYNGEDVAIKLLERSDSNPEKAQAL 173
Query: 151 LKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK-QKGVFQLTS 209
++F QEV ++ ++H N+V+FIGAC +P CIVTE+ GS+ FL K Q L
Sbjct: 174 EQQFQQEVSMLAFLKHPNIVRFIGACIKPMVWCIVTEYAKGGSVRQFLTKRQNRAVPLKL 233
Query: 210 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETG 269
+ A+DV++GM Y+H+ N IHRDLK+ NLL+ + +K+ADFGVAR++ Q+ MT ETG
Sbjct: 234 AVMQALDVARGMAYVHERNFIHRDLKSDNLLISADRSIKIADFGVARIEVQTEGMTPETG 293
Query: 270 TYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK 322
TYRWMAPE+I+H+PY K DV+SFGI LWEL+TG LP+ +T +QAA VV +
Sbjct: 294 TYRWMAPEMIQHRPYTQKVDVYSFGIVLWELITGLLPFQNMTAVQAAFAVVNR 346
|
|
| DICTYBASE|DDB_G0289791 drkA "DRK subfamily protein kinase" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 540 (195.1 bits), Expect = 4.4e-52, P = 4.4e-52
Identities = 107/223 (47%), Positives = 149/223 (66%)
Query: 100 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVY 159
DG D ID Q+KI ++ G+YG++Y GT+ +VA+K L +N +LKEF +E+
Sbjct: 365 DGKD---IDIHQIKIGVRIGKGNYGEVYLGTWRGSQVAVKKLPAHNINENILKEFHREIN 421
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
+M+ +RH NV+QF+G+C PP++CI TE+M RGS+Y LH Q Q + L+K+ ID +K
Sbjct: 422 LMKNLRHPNVIQFLGSCLIPPDICICTEYMPRGSLYSILHDQALQLQWSLLIKMMIDAAK 481
Query: 220 GMNYLHQNN--IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPE 277
G+ YLH + I+HRDLK+ NLL+DEN VKVADFG++ ++ Q MTA GT W +PE
Sbjct: 482 GVIYLHNSTPVILHRDLKSHNLLVDENWKVKVADFGLSTIEQQGATMTA-CGTPCWTSPE 540
Query: 278 VIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQA--AVG 318
V+ + Y KADV+SFGI LWE T + PY G+ P Q AVG
Sbjct: 541 VLRSQRYTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAVG 583
|
|
| DICTYBASE|DDB_G0267514 DDB_G0267514 "protein kinase, TKL group" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 540 (195.1 bits), Expect = 2.4e-51, P = 2.4e-51
Identities = 103/240 (42%), Positives = 162/240 (67%)
Query: 87 LIESSPNCIEIPTDGTDVW---EIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLK- 142
++++S + +E P+ + EI +LKI K+ G++G +YKG + VAIK +K
Sbjct: 634 ILKNSGSVVEPPSQQQQYFSDIEISFSELKISSKLGEGTFGVVYKGLWRGSSVAIKQIKI 693
Query: 143 PECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK 202
E VN ++L+EF +E+ I+ ++RH N+V + ACT PPNLC +TE++ GS+YD LH +K
Sbjct: 694 NEDVNNQVLEEFRKELTILSRLRHPNIVLLMAACTAPPNLCFITEYLPGGSLYDALHSKK 753
Query: 203 GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262
+ K+AI +++GMNYLH + +IHRD+K+ NLL+DE+ VK+ DFG+++++++S
Sbjct: 754 IKMNMQLYKKLAIQIAQGMNYLHLSGVIHRDIKSLNLLLDEHMNVKICDFGLSKLKSKST 813
Query: 263 VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK 322
MT G+ WM+PE++ + Y K DV++FGI LWEL TGELPY+GL +Q A+ V K
Sbjct: 814 EMTKSIGSPIWMSPELLMGEDYTEKVDVYAFGIILWELGTGELPYSGLDSVQLALAVTTK 873
|
|
| DICTYBASE|DDB_G0289709 drkB "DRK subfamily protein kinase" [Dictyostelium discoideum (taxid:44689)] | Back alignment and assigned GO terms |
|---|
Score = 518 (187.4 bits), Expect = 9.5e-50, P = 9.5e-50
Identities = 102/223 (45%), Positives = 148/223 (66%)
Query: 100 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVY 159
DG D ID +Q+KI ++ G++G++Y GT+ +VA+K L +N +LKEF +E+
Sbjct: 382 DGKD---IDTQQIKIGVRIGKGNFGEVYLGTWRGSQVAVKKLPAHNINENILKEFHREIN 438
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
+M+ +RH NV+QF+G+C P++CI TE+M RGS+Y LH +K + + ++ ID +K
Sbjct: 439 LMKNLRHPNVIQFLGSCLISPDICICTEYMPRGSLYSILHNEKIKISWSLVKRMMIDAAK 498
Query: 220 GMNYLHQNN--IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPE 277
G+ YLH + I+HRDLK+ NLL+DEN VKVADFG++ ++ Q MTA GT W +PE
Sbjct: 499 GIIYLHGSTPVILHRDLKSHNLLVDENWKVKVADFGLSTIEQQGATMTA-CGTPCWTSPE 557
Query: 278 VIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQA--AVG 318
V+ + Y KADV+SFGI LWE T + PY G+ P Q AVG
Sbjct: 558 VLRSQRYTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAVG 600
|
|
| TAIR|locus:2144613 CTR1 "CONSTITUTIVE TRIPLE RESPONSE 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 516 (186.7 bits), Expect = 5.6e-49, P = 5.6e-49
Identities = 109/247 (44%), Positives = 163/247 (65%)
Query: 81 PMHSKLLIESSPNCI--EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAI 138
PM++ + + PN E+ DG D+ +I L I+ K+ +GS+G +++ + +VA+
Sbjct: 519 PMNAPPISQPVPNRANRELGLDGDDM-DIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAV 577
Query: 139 KVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL 198
K+L + + E + EF +EV IM+++RH N+V F+GA T+PPNL IVTE+++RGS+Y L
Sbjct: 578 KILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLL 637
Query: 199 HKQKGVFQLTSL--LKVAIDVSKGMNYLHQNN--IIHRDLKTANLLMDENGVVKVADFGV 254
HK QL L +A DV+KGMNYLH N I+HRDLK+ NLL+D+ VKV DFG+
Sbjct: 638 HKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGL 697
Query: 255 ARVQAQSGVMT-AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPL 313
+R++A + + + + GT WMAPEV+ +P + K+DV+SFG+ LWEL T + P+ L P
Sbjct: 698 SRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPA 757
Query: 314 Q--AAVG 318
Q AAVG
Sbjct: 758 QVVAAVG 764
|
|
| TAIR|locus:2027794 AT1G73660 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 519 (187.8 bits), Expect = 7.3e-49, P = 7.3e-49
Identities = 103/234 (44%), Positives = 155/234 (66%)
Query: 90 SSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTE 149
S +C ++ +D +WE ++ + ++ GSYG++Y+G + EVA+K + + E
Sbjct: 731 SKSDCDDV-SDCEILWE----EITVGERIGLGSYGEVYRGDWHGTEVAVKKFLDQDLTGE 785
Query: 150 MLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTS 209
L+EF EV IM+K+RH N+V F+GA TRPPNL IVTEF+ RGS+Y +H+
Sbjct: 786 ALEEFRSEVRIMKKLRHPNIVLFMGAVTRPPNLSIVTEFLPRGSLYRLIHRPNNQLDERR 845
Query: 210 LLKVAIDVSKGMNYLHQNN--IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE 267
L++A+D ++GMNYLH N I+HRDLK+ NLL+D+N VVKV DFG++R++ + + +
Sbjct: 846 RLRMALDAARGMNYLHSCNPMIVHRDLKSPNLLVDKNWVVKVCDFGLSRMKHSTYLSSKS 905
Query: 268 T-GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320
T GT WMAPEV+ ++P D K DV+S+G+ LWEL T + P+ + P+Q VG V
Sbjct: 906 TAGTAEWMAPEVLRNEPADEKCDVYSYGVILWELFTLQQPWGKMNPMQV-VGAV 958
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 331 | |||
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-76 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-74 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-73 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-67 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 3e-66 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 4e-65 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-60 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-59 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 4e-57 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 7e-57 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-54 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 6e-54 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 7e-53 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-52 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-50 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-50 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-49 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-48 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-48 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-47 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 3e-47 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-46 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 9e-46 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 1e-45 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-45 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-45 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-44 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 1e-44 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 7e-44 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 7e-44 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 1e-43 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-43 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 2e-43 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-43 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 6e-43 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-41 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-41 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 3e-41 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 8e-41 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 9e-41 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-40 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 8e-40 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 9e-40 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-39 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-39 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-39 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-38 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 3e-37 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 6e-37 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-36 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 2e-36 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-36 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-36 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-35 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-35 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 3e-35 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-35 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 4e-35 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 8e-35 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 8e-35 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-34 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 1e-34 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-34 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-34 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-34 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-34 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 2e-34 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 2e-34 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 4e-33 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 1e-32 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-32 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-32 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 2e-32 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-32 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 7e-32 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 8e-32 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 8e-32 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-31 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-31 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-31 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-31 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 7e-31 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 8e-31 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-30 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 1e-30 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 1e-30 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-30 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 5e-30 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 6e-30 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 6e-30 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 1e-29 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 1e-29 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 1e-29 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-29 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 2e-29 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 2e-29 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-29 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-29 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 3e-29 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 3e-29 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-29 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 4e-29 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-29 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 5e-29 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 6e-29 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 9e-29 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 9e-29 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-28 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-28 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-28 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-28 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 3e-28 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-28 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 5e-28 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 7e-28 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 7e-28 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-27 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 1e-27 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 1e-27 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-27 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-27 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-27 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-27 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 3e-27 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 3e-27 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-27 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-27 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 6e-27 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 8e-27 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 8e-27 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 9e-27 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 9e-27 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 1e-26 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-26 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-26 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-26 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-26 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 3e-26 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 3e-26 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-26 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 3e-26 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-26 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-26 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 5e-26 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-26 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 8e-26 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 1e-25 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-25 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-25 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 2e-25 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-25 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 5e-25 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 6e-25 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 1e-24 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-24 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 4e-24 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 4e-24 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-23 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-23 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-23 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 4e-23 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 6e-23 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 8e-23 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-22 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-22 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-22 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-22 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-22 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 8e-22 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 9e-22 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-21 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 9e-21 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-20 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-20 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 2e-20 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-20 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 3e-20 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 6e-20 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-20 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 1e-19 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 1e-19 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-19 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 2e-19 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-19 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 2e-19 | |
| cd04928 | 68 | cd04928, ACT_TyrKc, Uncharacterized, N-terminal AC | 2e-19 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-19 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 3e-19 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-19 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 3e-19 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 4e-19 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-19 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 5e-19 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 5e-19 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 5e-19 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 6e-19 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 7e-19 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 9e-19 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 9e-19 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-18 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-18 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-18 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 2e-18 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 2e-18 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 2e-18 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-18 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-18 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-18 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-18 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-18 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-18 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-18 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 3e-18 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-18 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 4e-18 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 4e-18 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 5e-18 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 9e-18 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-17 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 2e-17 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-17 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-17 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-17 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-17 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-17 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 5e-17 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 5e-17 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-16 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 1e-16 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-16 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 1e-16 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 2e-16 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 2e-16 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-16 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-16 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-16 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-16 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-16 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-16 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-16 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 5e-16 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 6e-16 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-16 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 6e-16 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 7e-16 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 8e-16 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 8e-16 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 8e-16 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 8e-16 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 9e-16 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-15 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-15 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-15 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 1e-15 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-15 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-15 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 4e-15 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 6e-15 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 6e-15 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 7e-15 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 9e-15 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 9e-15 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 9e-15 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-14 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-14 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 2e-14 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-14 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 3e-14 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-14 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 4e-14 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 5e-14 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-14 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 5e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-14 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-13 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-13 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 3e-13 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 4e-13 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 5e-13 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 8e-13 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-12 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-12 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-12 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 1e-12 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 3e-12 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-12 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 5e-12 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 7e-12 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 1e-11 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 2e-11 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 2e-11 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-11 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-11 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 5e-11 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 8e-11 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-10 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 3e-10 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 5e-10 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 7e-10 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 8e-10 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 8e-10 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 1e-09 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-09 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-09 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 3e-09 | |
| cd04900 | 73 | cd04900, ACT_UUR-like_1, ACT domain family, ACT_UU | 5e-09 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-08 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 6e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-07 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 4e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 4e-06 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 2e-05 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 3e-05 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 4e-05 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-04 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 2e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 6e-04 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 8e-04 | |
| cd04873 | 70 | cd04873, ACT_UUR-ACR-like, ACT domains of the bact | 0.003 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 233 bits (598), Expect = 4e-76
Identities = 83/214 (38%), Positives = 125/214 (58%), Gaps = 11/214 (5%)
Query: 112 LKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR 165
L++ K+ G++G++YKGT +VA+K LK E +EF +E IM+K+
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASE-EEREEFLEEASIMKKLS 59
Query: 166 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 225
H N+V+ +G CT+ L IVTE+M G + DFL K L LL++A+ ++KGM YL
Sbjct: 60 HPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLE 119
Query: 226 QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY---RWMAPEVIEHK 282
N +HRDL N L+ EN VVK++DFG++R + G +WMAPE ++
Sbjct: 120 SKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDG 179
Query: 283 PYDYKADVFSFGIALWELLT-GELPYAGLTPLQA 315
+ K+DV+SFG+ LWE+ T GE PY G++ +
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEV 213
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 230 bits (588), Expect = 1e-74
Identities = 83/221 (37%), Positives = 126/221 (57%), Gaps = 14/221 (6%)
Query: 112 LKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR 165
L + K+ G++G++YKG EVA+K LK + + + ++EF +E IMRK+
Sbjct: 1 LTLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDA-SEQQIEEFLREARIMRKLD 59
Query: 166 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 225
H NVV+ +G CT L IV E+M G + +L K + L+ LL A+ +++GM YL
Sbjct: 60 HPNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLE 119
Query: 226 QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETG--TYRWMAPEVIEHKP 283
N IHRDL N L+ EN VVK++DFG++R G RWMAPE ++
Sbjct: 120 SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGK 179
Query: 284 YDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKV 323
+ K+DV+SFG+ LWE+ T GE PY G++ + V++ +
Sbjct: 180 FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEE----VLEYL 216
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 225 bits (576), Expect = 7e-73
Identities = 83/214 (38%), Positives = 124/214 (57%), Gaps = 11/214 (5%)
Query: 112 LKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR 165
L + K+ G++G++YKGT EVA+K LK + + + ++EF +E IMRK+
Sbjct: 1 LTLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDA-SEQQIEEFLREARIMRKLD 59
Query: 166 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTS-LLKVAIDVSKGMNYL 224
H N+V+ +G CT L IV E+M G + D+L K + S LL A+ +++GM YL
Sbjct: 60 HPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYL 119
Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETG--TYRWMAPEVIEHK 282
N IHRDL N L+ EN VVK++DFG++R + G RWMAPE ++
Sbjct: 120 ESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKEG 179
Query: 283 PYDYKADVFSFGIALWELLT-GELPYAGLTPLQA 315
+ K+DV+SFG+ LWE+ T GE PY G++ +
Sbjct: 180 KFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEV 213
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 212 bits (542), Expect = 1e-67
Identities = 81/212 (38%), Positives = 119/212 (56%), Gaps = 18/212 (8%)
Query: 120 SGSYGDLYKGTY-----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
G++G++YKG + EVA+K LK E + E K+F +E +M+K+ H NVV+ +G
Sbjct: 5 EGAFGEVYKGKLKGKDGKTTEVAVKTLK-EDASEEERKDFLKEARVMKKLGHPNVVRLLG 63
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTS--------LLKVAIDVSKGMNYLHQ 226
CT L +V E+M G + D+L K + VF LL AI ++KGM YL
Sbjct: 64 VCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS 123
Query: 227 NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY---RWMAPEVIEHKP 283
+HRDL N L+ E+ VVK++DFG++R +TG RWMAPE ++
Sbjct: 124 KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGI 183
Query: 284 YDYKADVFSFGIALWELLT-GELPYAGLTPLQ 314
+ K+DV+SFG+ LWE+ T G PY GL+ +
Sbjct: 184 FTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE 215
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 208 bits (532), Expect = 3e-66
Identities = 79/201 (39%), Positives = 123/201 (61%), Gaps = 5/201 (2%)
Query: 117 KVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
K+ SGS+G +YK + + VA+K+LK ++ + +E+ I+R++ H N+V+ I
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLID 65
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
A +L +V E+ G ++D+L + G K+A+ + +G+ YLH N IIHRDL
Sbjct: 66 AFEDKDHLYLVMEYCEGGDLFDYLSR-GGPLSEDEAKKIALQILRGLEYLHSNGIIHRDL 124
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSG-VMTAETGTYRWMAPEVI-EHKPYDYKADVFS 292
K N+L+DENGVVK+ADFG+A+ +S +T GT +MAPEV+ Y K DV+S
Sbjct: 125 KPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWS 184
Query: 293 FGIALWELLTGELPYAGLTPL 313
G+ L+ELLTG+ P++G L
Sbjct: 185 LGVILYELLTGKPPFSGENIL 205
|
Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 205 bits (525), Expect = 4e-65
Identities = 70/205 (34%), Positives = 109/205 (53%), Gaps = 4/205 (1%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
+I K+ GS+G +Y + VAIKV+K + + + +E+ I++K++H N+V
Sbjct: 2 EILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKK-KIKKDRERILREIKILKKLKHPNIV 60
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 230
+ L +V E+ G ++D L K +G + + YLH I+
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLLKK-RGRLSEDEARFYLRQILSALEYLHSKGIV 119
Query: 231 HRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADV 290
HRDLK N+L+DE+G VK+ADFG+AR +T GT +MAPEV+ K Y D+
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDI 179
Query: 291 FSFGIALWELLTGELPYAGLTPLQA 315
+S G+ L+ELLTG+ P+ G L
Sbjct: 180 WSLGVILYELLTGKPPFPGDDQLLE 204
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 193 bits (494), Expect = 1e-60
Identities = 80/201 (39%), Positives = 121/201 (60%), Gaps = 4/201 (1%)
Query: 117 KVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
K+ G +G++YK + +EVAIKV+K E + E ++ E+ I++K +H N+V++ G
Sbjct: 7 KIGKGGFGEVYKARHKRTGKEVAIKVIKLE--SKEKKEKIINEIQILKKCKHPNIVKYYG 64
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
+ + L IV EF + GS+ D L + + V ++ KG+ YLH N IIHRD+
Sbjct: 65 SYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDI 124
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 294
K AN+L+ +G VK+ DFG++ + + GT WMAPEVI KPYDYKAD++S G
Sbjct: 125 KAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLG 184
Query: 295 IALWELLTGELPYAGLTPLQA 315
I EL G+ PY+ L P++A
Sbjct: 185 ITAIELAEGKPPYSELPPMKA 205
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 190 bits (485), Expect = 1e-59
Identities = 66/186 (35%), Positives = 113/186 (60%), Gaps = 6/186 (3%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
G +G +Y ++VAIK++K E ++ +L+E +E+ I++K+ H N+V+ G
Sbjct: 3 EGGFGTVYLARDKKTGKKVAIKIIKKE-DSSSLLEELLREIEILKKLNHPNIVKLYGVFE 61
Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 237
+L +V E+ GS+ D L + +G +L++ + + +G+ YLH N IIHRDLK
Sbjct: 62 DENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPE 121
Query: 238 NLLMDE-NGVVKVADFGVAR-VQAQSGVMTAETGTYRWMAPEVIEHKP-YDYKADVFSFG 294
N+L+D NG VK+ADFG+++ + + ++ GT +MAPEV+ K Y K+D++S G
Sbjct: 122 NILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLG 181
Query: 295 IALWEL 300
+ L+EL
Sbjct: 182 VILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 185 bits (471), Expect = 4e-57
Identities = 68/214 (31%), Positives = 112/214 (52%), Gaps = 8/214 (3%)
Query: 111 QLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN 168
+ + GS+G +Y + +A+K ++ + E L+ +E+ I+ ++H N
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 169 VVQFIGAC-TRPPN-LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ 226
+V++ G+ N L I E+++ GS+ L K G + K + +G+ YLH
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKK-FGKLPEPVIRKYTRQILEGLAYLHS 119
Query: 227 NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET---GTYRWMAPEVIEHKP 283
N I+HRD+K AN+L+D +GVVK+ADFG A+ GT WMAPEVI +
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179
Query: 284 YDYKADVFSFGIALWELLTGELPYAGLTPLQAAV 317
Y AD++S G + E+ TG+ P++ L AA+
Sbjct: 180 YGRAADIWSLGCTVIEMATGKPPWSELGNPMAAL 213
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 184 bits (470), Expect = 7e-57
Identities = 86/225 (38%), Positives = 130/225 (57%), Gaps = 14/225 (6%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRK 163
WEID +++ K+ +G +G++++G + + VA+K LKP T K+F E IM+K
Sbjct: 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKP---GTMDPKDFLAEAQIMKK 57
Query: 164 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGMN 222
+RH ++Q CT + IVTE M GS+ ++L G +L L+ +A V+ GM
Sbjct: 58 LRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMA 117
Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEVI 279
YL N IHRDL N+L+ EN + KVADFG+ARV + + A G +W APE
Sbjct: 118 YLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKED-IYEAREGAKFPIKWTAPEAA 176
Query: 280 EHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKV 323
+ + K+DV+SFGI L E++T G +PY G+T + V+Q+V
Sbjct: 177 LYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE----VLQQV 217
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 179 bits (455), Expect = 1e-54
Identities = 87/213 (40%), Positives = 130/213 (61%), Gaps = 10/213 (4%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRK 163
WEI + LK+E K+ +G +G+++ GT+ + +VA+K LKP ++ E F QE IM+K
Sbjct: 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMSPE---AFLQEAQIMKK 57
Query: 164 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ-LTSLLKVAIDVSKGMN 222
+RH +VQ C+ + IVTE+M++GS+ DFL +G L L+ +A +++GM
Sbjct: 58 LRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMA 117
Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEVI 279
YL N IHRDL N+L+ EN V K+ADFG+AR+ TA G +W APE
Sbjct: 118 YLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD-EYTAREGAKFPIKWTAPEAA 176
Query: 280 EHKPYDYKADVFSFGIALWELLT-GELPYAGLT 311
+ + K+DV+SFGI L E++T G +PY G+T
Sbjct: 177 NYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMT 209
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 176 bits (449), Expect = 6e-54
Identities = 87/222 (39%), Positives = 134/222 (60%), Gaps = 12/222 (5%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI 164
W I++K+LK+ + G +GD+ G Y Q+VA+K LK ++ + F E +M +
Sbjct: 1 WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKD---DSTAAQAFLAEASVMTTL 57
Query: 165 RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLH-KQKGVFQLTSLLKVAIDVSKGMNY 223
RH N+VQ +G + L IVTE+MA+GS+ D+L + + V L L A+DV +GM Y
Sbjct: 58 RHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEY 117
Query: 224 LHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEVIEH 281
L + N +HRDL N+L+ E+ V KV+DFG+A+ +A G ++G +W APE +
Sbjct: 118 LEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAK-EASQGQ---DSGKLPVKWTAPEALRE 173
Query: 282 KPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQK 322
K + K+DV+SFGI LWE+ + G +PY + PL+ V V+K
Sbjct: 174 KKFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPHVEK 214
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 174 bits (442), Expect = 7e-53
Identities = 80/225 (35%), Positives = 131/225 (58%), Gaps = 17/225 (7%)
Query: 107 IDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIMRKIR 165
ID +L ++ SG +G ++ G + + +VAIK+++ ++ + +F +E +M K+
Sbjct: 1 IDPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSED---DFIEEAKVMMKLS 57
Query: 166 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 225
H N+VQ G CT+ + IVTE+MA G + ++L ++KG LL + DV + M YL
Sbjct: 58 HPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLE 117
Query: 226 QNNIIHRDLKTANLLMDENGVVKVADFGVAR--VQAQSGVMTAETGT---YRWMAPEVIE 280
N IHRDL N L+ E+ VVKV+DFG+AR + Q T+ GT +W PEV +
Sbjct: 118 SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQ---YTSSQGTKFPVKWAPPEVFD 174
Query: 281 HKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVS 324
+ + K+DV+SFG+ +WE+ + G++PY + + VV+ VS
Sbjct: 175 YSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE----VVESVS 215
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 173 bits (439), Expect = 2e-52
Identities = 77/211 (36%), Positives = 131/211 (62%), Gaps = 6/211 (2%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRK 163
WE ++ +E K+ SG +G++++G + VAIK+LK + + ++F +EV +++
Sbjct: 1 WERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSD--DLLKQQDFQKEVQALKR 58
Query: 164 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGMN 222
+RHK+++ C+ + I+TE M +GS+ FL +G V + SL+ +A V++GM
Sbjct: 59 LRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMA 118
Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT-YRWMAPEVIEH 281
YL + N IHRDL N+L+ E+ V KVADFG+AR+ + ++++ Y+W APE H
Sbjct: 119 YLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASH 178
Query: 282 KPYDYKADVFSFGIALWELLT-GELPYAGLT 311
+ K+DV+SFGI L+E+ T G++PY G+
Sbjct: 179 GTFSTKSDVWSFGILLYEMFTYGQVPYPGMN 209
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 168 bits (427), Expect = 2e-50
Identities = 82/213 (38%), Positives = 127/213 (59%), Gaps = 11/213 (5%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMR 162
WE++ + ++ K+ G YG++Y+G + S VA+K LK + T ++EF +E +M+
Sbjct: 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMK 57
Query: 163 KIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK-QKGVFQLTSLLKVAIDVSKGM 221
+I+H N+VQ +G CTR P I+TEFM G++ D+L + + LL +A +S M
Sbjct: 58 EIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 117
Query: 222 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEV 278
YL + N IHRDL N L+ EN +VKVADFG++R+ TA G +W APE
Sbjct: 118 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGDTYTAHAGAKFPIKWTAPES 176
Query: 279 IEHKPYDYKADVFSFGIALWELLT-GELPYAGL 310
+ + + K+DV++FG+ LWE+ T G PY G+
Sbjct: 177 LAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 209
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 167 bits (425), Expect = 2e-50
Identities = 80/215 (37%), Positives = 124/215 (57%), Gaps = 6/215 (2%)
Query: 111 QLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN 168
++ + G++G +YKG VAIK + E + E LK QE+ +++ ++H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 169 VVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQN 227
+V++IG+ +L I+ E+ GS+ + K+ G F SL+ V + V +G+ YLH+
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQII-KKFGPFP-ESLVAVYVYQVLQGLAYLHEQ 118
Query: 228 NIIHRDLKTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDY 286
+IHRD+K AN+L ++GVVK+ADFGVA ++ S + GT WMAPEVIE
Sbjct: 119 GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGAST 178
Query: 287 KADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321
+D++S G + ELLTG PY L P+ A +VQ
Sbjct: 179 ASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQ 213
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 2e-49
Identities = 75/209 (35%), Positives = 115/209 (55%), Gaps = 15/209 (7%)
Query: 114 IECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQ 171
I K+ GSYG +YK + Q VAIKV+ E E++KE S I+++ +V+
Sbjct: 7 ILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEIS----ILKQCDSPYIVK 62
Query: 172 FIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF---QLTSLLKVAIDVSKGMNYLHQNN 228
+ G+ + +L IV E+ GS+ D + ++ ++L KG+ YLH N
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILY---QTLKGLEYLHSNK 119
Query: 229 IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYDY 286
IHRD+K N+L++E G K+ADFGV+ Q + T GT WMAPEVI+ Y+
Sbjct: 120 KIHRDIKAGNILLNEEGQAKLADFGVSG-QLTDTMAKRNTVIGTPFWMAPEVIQEIGYNN 178
Query: 287 KADVFSFGIALWELLTGELPYAGLTPLQA 315
KAD++S GI E+ G+ PY+ + P++A
Sbjct: 179 KADIWSLGITAIEMAEGKPPYSDIHPMRA 207
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 163 bits (414), Expect = 1e-48
Identities = 78/206 (37%), Positives = 121/206 (58%), Gaps = 9/206 (4%)
Query: 107 IDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIMRKIR 165
I +L + ++ SG +G ++ G + + +VAIK ++ ++ E +F +E +M K+
Sbjct: 1 IHPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSEE---DFIEEAQVMMKLS 57
Query: 166 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 225
H +VQ G CT +C+V EFM G + D+L Q+G F +LL + +DV +GM YL
Sbjct: 58 HPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLE 117
Query: 226 QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEVIEHK 282
+N+IHRDL N L+ EN VVKV+DFG+ R T+ TGT +W +PEV
Sbjct: 118 SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ-YTSSTGTKFPVKWSSPEVFSFS 176
Query: 283 PYDYKADVFSFGIALWELLT-GELPY 307
Y K+DV+SFG+ +WE+ + G+ PY
Sbjct: 177 KYSSKSDVWSFGVLMWEVFSEGKTPY 202
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 163 bits (416), Expect = 1e-48
Identities = 75/215 (34%), Positives = 114/215 (53%), Gaps = 18/215 (8%)
Query: 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHK 167
+ + + GS+G++YK +Q VAIKV+ E E+ ++ QE+ + + R
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEI-EDIQQEIQFLSQCRSP 59
Query: 168 NVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN 227
+ ++ G+ + L I+ E+ GS D L + G T + + +V G+ YLH+
Sbjct: 60 YITKYYGSFLKGSKLWIIMEYCGGGSCLDLL--KPGKLDETYIAFILREVLLGLEYLHEE 117
Query: 228 NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET-------GTYRWMAPEVIE 280
IHRD+K AN+L+ E G VK+ADFGV SG +T+ GT WMAPEVI+
Sbjct: 118 GKIHRDIKAANILLSEEGDVKLADFGV------SGQLTSTMSKRNTFVGTPFWMAPEVIK 171
Query: 281 HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQA 315
YD KAD++S GI EL GE P + L P++
Sbjct: 172 QSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRV 206
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 161 bits (409), Expect = 2e-47
Identities = 73/203 (35%), Positives = 112/203 (55%), Gaps = 8/203 (3%)
Query: 117 KVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
K+ G+ G++YK T + +EVAIK ++ N E++ E+ IM+ +H N+V +
Sbjct: 26 KIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELII---NEILIMKDCKHPNIVDYYD 82
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
+ L +V E+M GS+ D + + + V +V +G+ YLH N+IHRD+
Sbjct: 83 SYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDI 142
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYDYKADVFS 292
K+ N+L+ ++G VK+ADFG A Q + GT WMAPEVI+ K Y K D++S
Sbjct: 143 KSDNILLSKDGSVKLADFGFA-AQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWS 201
Query: 293 FGIALWELLTGELPYAGLTPLQA 315
GI E+ GE PY PL+A
Sbjct: 202 LGIMCIEMAEGEPPYLREPPLRA 224
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 159 bits (404), Expect = 3e-47
Identities = 74/205 (36%), Positives = 120/205 (58%), Gaps = 8/205 (3%)
Query: 117 KVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
K+ G++GD+YKG EVA+K + ++ ++F QE I+++ H N+V+ IG
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGV 60
Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 235
C + + IV E + GS+ FL K+K + LL++++D + GM YL N IHRDL
Sbjct: 61 CVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLA 120
Query: 236 TANLLMDENGVVKVADFGVARVQAQSGVMTAETGT----YRWMAPEVIEHKPYDYKADVF 291
N L+ EN V+K++DFG++R + + G+ T G +W APE + + Y ++DV+
Sbjct: 121 ARNCLVGENNVLKISDFGMSR-EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVW 179
Query: 292 SFGIALWELLT-GELPYAGLTPLQA 315
S+GI LWE + G+ PY G++ Q
Sbjct: 180 SYGILLWETFSLGDTPYPGMSNQQT 204
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 156 bits (397), Expect = 5e-46
Identities = 58/200 (29%), Positives = 112/200 (56%), Gaps = 8/200 (4%)
Query: 117 KVASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
++ GS+G L + + +K + ++ + ++ EV I++K+ H N++++
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTS---LLKVAIDVSKGMNYLHQNNIIH 231
+ LCIV E+ G + + KQK + +L + + + YLH I+H
Sbjct: 67 SFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILH 126
Query: 232 RDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYDYKAD 289
RD+K N+ + NG+VK+ DFG+++V + + + A+T GT +++PE+ ++KPY+YK+D
Sbjct: 127 RDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL-AKTVVGTPYYLSPELCQNKPYNYKSD 185
Query: 290 VFSFGIALWELLTGELPYAG 309
++S G L+EL T + P+ G
Sbjct: 186 IWSLGCVLYELCTLKHPFEG 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 155 bits (395), Expect = 9e-46
Identities = 74/214 (34%), Positives = 119/214 (55%), Gaps = 10/214 (4%)
Query: 107 IDAKQLKIECKVASGSYGDLYKGTY---CSQE--VAIKVLKPECVNTEMLKEFSQEVYIM 161
ID + IE + G +G++ +G +E VAIK LK + + L +F E IM
Sbjct: 1 IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRL-DFLTEASIM 59
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
+ H N+++ G T+ + I+TE+M GS+ FL + G F + L+ + ++ GM
Sbjct: 60 GQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGM 119
Query: 222 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTAETG--TYRWMAPEV 278
YL + N +HRDL N+L++ N V KV+DFG++R S T + G RW APE
Sbjct: 120 KYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEA 179
Query: 279 IEHKPYDYKADVFSFGIALWELLT-GELPYAGLT 311
I ++ + +DV+SFGI +WE+++ GE PY ++
Sbjct: 180 IAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS 213
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 1e-45
Identities = 86/212 (40%), Positives = 132/212 (62%), Gaps = 11/212 (5%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRK 163
WEI + L++E K+ G +G+++ GT+ + VAIK LKP ++ E F QE +M+K
Sbjct: 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AFLQEAQVMKK 57
Query: 164 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF-QLTSLLKVAIDVSKGMN 222
+RH+ +VQ + P + IVTE+M++GS+ DFL + G + +L L+ +A ++ GM
Sbjct: 58 LRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMA 116
Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEVI 279
Y+ + N +HRDL+ AN+L+ EN V KVADFG+AR+ + TA G +W APE
Sbjct: 117 YVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPEAA 175
Query: 280 EHKPYDYKADVFSFGIALWELLT-GELPYAGL 310
+ + K+DV+SFGI L EL T G +PY G+
Sbjct: 176 LYGRFTIKSDVWSFGILLTELTTKGRVPYPGM 207
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 155 bits (393), Expect = 2e-45
Identities = 76/224 (33%), Positives = 117/224 (52%), Gaps = 13/224 (5%)
Query: 110 KQLKIECKVASGSYGDLYKGTYC---SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH 166
++ + G+ +Y C +++VAIK + E T + E +EV M + H
Sbjct: 1 DDYELIEVIGVGATAVVYAA-ICLPNNEKVAIKRIDLEKCQTSV-DELRKEVQAMSQCNH 58
Query: 167 KNVVQFIGACTRPPNLCIVTEFMARGSIYDFL-HK-QKGVFQLTSLLKVAIDVSKGMNYL 224
NVV++ + L +V +++ GS+ D + +G + V +V KG+ YL
Sbjct: 59 PNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYL 118
Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET-----GTYRWMAPEVI 279
H N IHRD+K N+L+ E+G VK+ADFGV+ A G T + GT WMAPEV+
Sbjct: 119 HSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVM 178
Query: 280 E-HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK 322
E YD+KAD++SFGI EL TG PY+ P++ + +Q
Sbjct: 179 EQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN 222
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 155 bits (394), Expect = 2e-45
Identities = 61/205 (29%), Positives = 105/205 (51%), Gaps = 13/205 (6%)
Query: 110 KQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVYIMRK 163
+ LK ++ G +G + Y +VA+K L +F +E+ I+R
Sbjct: 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHR-SDFEREIEILRT 62
Query: 164 IRHKNVVQFIGACTRP--PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
+ H+N+V++ G C +P +L ++ E++ GS+ D+L + + L LL + + KGM
Sbjct: 63 LDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGM 122
Query: 222 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG----VMTAETGTYRWMAPE 277
+YL IHRDL N+L++ +VK++DFG+A+V + V W APE
Sbjct: 123 DYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPE 182
Query: 278 VIEHKPYDYKADVFSFGIALWELLT 302
+ + +DV+SFG+ L+EL T
Sbjct: 183 CLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 153 bits (387), Expect = 1e-44
Identities = 75/212 (35%), Positives = 127/212 (59%), Gaps = 9/212 (4%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRK 163
WE+ + LK+ K+ +G +G+++ G Y +VAIK LK ++ E F E +M++
Sbjct: 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMSPE---AFLAEANLMKQ 57
Query: 164 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKGMN 222
++H +V+ T+ P + I+TE+M GS+ DFL +G+ + L+ +A +++GM
Sbjct: 58 LQHPRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMA 116
Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEVIE 280
++ + N IHRDL+ AN+L+ E K+ADFG+AR+ + E + +W APE I
Sbjct: 117 FIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAIN 176
Query: 281 HKPYDYKADVFSFGIALWELLT-GELPYAGLT 311
+ + K+DV+SFGI L E++T G +PY G+T
Sbjct: 177 YGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT 208
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 1e-44
Identities = 84/221 (38%), Positives = 129/221 (58%), Gaps = 10/221 (4%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI 164
W ++ K+LK+ + G +GD+ G Y +VA+K +K N + F E +M ++
Sbjct: 1 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK----NDATAQAFLAEASVMTQL 56
Query: 165 RHKNVVQFIGACTRPP-NLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMN 222
RH N+VQ +G L IVTE+MA+GS+ D+L + + V LLK ++DV + M
Sbjct: 57 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 116
Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHK 282
YL NN +HRDL N+L+ E+ V KV+DFG+ + +A S T + +W APE + K
Sbjct: 117 YLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTK-EASSTQDTGKLPV-KWTAPEALREK 174
Query: 283 PYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQK 322
+ K+DV+SFGI LWE+ + G +PY + PL+ V V+K
Sbjct: 175 KFSTKSDVWSFGILLWEIYSFGRVPYPRI-PLKDVVPRVEK 214
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 151 bits (383), Expect = 7e-44
Identities = 75/205 (36%), Positives = 113/205 (55%), Gaps = 8/205 (3%)
Query: 117 KVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
++ SG+YGD+YK + VAIKV+K E + + QE+ ++++ RH N+V + G
Sbjct: 10 RIGSGTYGDVYKARDIATGELVAIKVIKLE--PGDDFEIIQQEISMLKECRHPNIVAYFG 67
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
+ R L IV E+ GS+ D +G + V + KG+ YLH+ IHRD+
Sbjct: 68 SYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDI 127
Query: 235 KTANLLMDENGVVKVADFGV-ARVQAQSGVMTAETGTYRWMAPEVIEHK---PYDYKADV 290
K AN+L+ E+G VK+ADFGV A++ A + GT WMAPEV + YD K D+
Sbjct: 128 KGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDI 187
Query: 291 FSFGIALWELLTGELPYAGLTPLQA 315
++ GI EL + P L P++A
Sbjct: 188 WALGITAIELAELQPPMFDLHPMRA 212
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 150 bits (381), Expect = 7e-44
Identities = 86/212 (40%), Positives = 131/212 (61%), Gaps = 11/212 (5%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRK 163
WEI + L+++ K+ G +G+++ GT+ + +VAIK LKP T M + F QE IM+K
Sbjct: 1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKP---GTMMPEAFLQEAQIMKK 57
Query: 164 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF-QLTSLLKVAIDVSKGMN 222
+RH +V + P + IVTEFM +GS+ DFL + G + +L L+ +A ++ GM
Sbjct: 58 LRHDKLVPLYAVVSEEP-IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMA 116
Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEVI 279
Y+ + N IHRDL+ AN+L+ +N V K+ADFG+AR+ + TA G +W APE
Sbjct: 117 YIERMNYIHRDLRAANILVGDNLVCKIADFGLARL-IEDNEYTARQGAKFPIKWTAPEAA 175
Query: 280 EHKPYDYKADVFSFGIALWELLT-GELPYAGL 310
+ + K+DV+SFGI L EL+T G +PY G+
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGRVPYPGM 207
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 1e-43
Identities = 77/212 (36%), Positives = 131/212 (61%), Gaps = 8/212 (3%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRK 163
WEI + +K+ K+ +G +G+++ G Y S +VA+K LKP T ++ F +E +M+
Sbjct: 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKP---GTMSVQAFLEEANLMKT 57
Query: 164 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKGMN 222
++H +V+ T+ + I+TE+MA+GS+ DFL +G L L+ + +++GM
Sbjct: 58 LQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMA 117
Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEVIE 280
Y+ + N IHRDL+ AN+L+ E+ + K+ADFG+ARV + E + +W APE I
Sbjct: 118 YIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN 177
Query: 281 HKPYDYKADVFSFGIALWELLT-GELPYAGLT 311
+ K+DV+SFGI L+E++T G++PY G++
Sbjct: 178 FGSFTIKSDVWSFGILLYEIVTYGKIPYPGMS 209
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 150 bits (380), Expect = 1e-43
Identities = 83/212 (39%), Positives = 133/212 (62%), Gaps = 11/212 (5%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRK 163
WEI + L++ K+ +G +G+++ GT+ + +VA+K LKP ++ E F +E IM+K
Sbjct: 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSPE---SFLEEAQIMKK 57
Query: 164 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGMN 222
+RH +VQ + P + IVTE+M++GS+ DFL +G +L +L+ +A V+ GM
Sbjct: 58 LRHDKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMA 116
Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEVI 279
Y+ + N IHRDL++AN+L+ + V K+ADFG+AR+ + TA G +W APE
Sbjct: 117 YIERMNYIHRDLRSANILVGDGLVCKIADFGLARL-IEDNEYTARQGAKFPIKWTAPEAA 175
Query: 280 EHKPYDYKADVFSFGIALWELLT-GELPYAGL 310
+ + K+DV+SFGI L EL+T G +PY G+
Sbjct: 176 LYGRFTIKSDVWSFGILLTELVTKGRVPYPGM 207
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 150 bits (379), Expect = 2e-43
Identities = 76/222 (34%), Positives = 124/222 (55%), Gaps = 11/222 (4%)
Query: 107 IDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIMRKIR 165
I+ +L ++ SG +G ++ G + +Q +VAIK + ++ E +F +E +M K+
Sbjct: 1 INPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEE---DFIEEAKVMMKLS 57
Query: 166 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 225
H +VQ G CT+ L IVTEFM G + ++L +++G LL + DV +GM YL
Sbjct: 58 HPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLE 117
Query: 226 QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEVIEHKP 283
+N+ IHRDL N L+ GVVKV+DFG+ R ++ + +W PEV
Sbjct: 118 RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSK 177
Query: 284 YDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVS 324
Y K+DV+SFG+ +WE+ T G++P+ + + VV+ +S
Sbjct: 178 YSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE----VVEMIS 215
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 149 bits (376), Expect = 5e-43
Identities = 79/212 (37%), Positives = 128/212 (60%), Gaps = 9/212 (4%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIMRK 163
WEI + LK+E K+ +G +G+++ TY +VA+K +KP ++ E F E +M+
Sbjct: 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSVE---AFLAEANVMKT 57
Query: 164 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGMN 222
++H +V+ T+ P + I+TEFMA+GS+ DFL +G L L+ + +++GM
Sbjct: 58 LQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMA 116
Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEVIE 280
++ Q N IHRDL+ AN+L+ + V K+ADFG+ARV + E + +W APE I
Sbjct: 117 FIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAIN 176
Query: 281 HKPYDYKADVFSFGIALWELLT-GELPYAGLT 311
+ K+DV+SFGI L E++T G +PY G++
Sbjct: 177 FGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS 208
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 148 bits (375), Expect = 6e-43
Identities = 74/209 (35%), Positives = 129/209 (61%), Gaps = 9/209 (4%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI 164
W ++ ++L + + G +G + +G Y Q+VA+K +K C T + F +E +M K+
Sbjct: 1 WLLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIK--CDVTA--QAFLEETAVMTKL 56
Query: 165 RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNY 223
HKN+V+ +G L IV E M++G++ +FL + + + + LL+ ++DV++GM Y
Sbjct: 57 HHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEY 115
Query: 224 LHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKP 283
L ++HRDL N+L+ E+GV KV+DFG+ARV + GV ++ +W APE ++HK
Sbjct: 116 LESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSM-GVDNSKLPV-KWTAPEALKHKK 173
Query: 284 YDYKADVFSFGIALWELLT-GELPYAGLT 311
+ K+DV+S+G+ LWE+ + G PY ++
Sbjct: 174 FSSKSDVWSYGVLLWEVFSYGRAPYPKMS 202
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 2e-41
Identities = 76/220 (34%), Positives = 125/220 (56%), Gaps = 9/220 (4%)
Query: 107 IDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIMRKIR 165
ID K L ++ +G +G + G + Q +VAIK++K ++ + EF +E +M K+
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMKLS 57
Query: 166 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 225
H+ +VQ G CT+ + IVTE+M+ G + ++L + FQ + LL++ DV +GM YL
Sbjct: 58 HEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLE 117
Query: 226 QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEVIEHK 282
IHRDL N L+D+ G VKV+DFG++R T+ G+ RW PEV+ +
Sbjct: 118 SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLLYS 176
Query: 283 PYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQ 321
+ K+DV++FG+ +WE+ + G++PY + V Q
Sbjct: 177 KFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQ 216
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 2e-41
Identities = 66/201 (32%), Positives = 107/201 (53%), Gaps = 6/201 (2%)
Query: 112 LKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNV 169
L+ + GS G +YK + + A+K + + E K+ +E+ +R V
Sbjct: 3 LERVKVLGQGSSGVVYKVRHKPTGKIYALKKIH-VDGDEEFRKQLLRELKTLRSCESPYV 61
Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN-N 228
V+ GA + + IV E+M GS+ D L K+ G L +A + KG++YLH +
Sbjct: 62 VKCYGAFYKEGEISIVLEYMDGGSLAD-LLKKVGKIPEPVLAYIARQILKGLDYLHTKRH 120
Query: 229 IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYK 287
IIHRD+K +NLL++ G VK+ADFG+++V + GT +M+PE I+ + Y Y
Sbjct: 121 IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYA 180
Query: 288 ADVFSFGIALWELLTGELPYA 308
AD++S G+ L E G+ P+
Sbjct: 181 ADIWSLGLTLLECALGKFPFL 201
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 3e-41
Identities = 72/210 (34%), Positives = 112/210 (53%), Gaps = 16/210 (7%)
Query: 118 VASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQ---EVYIMRKIRHKNV 169
+ G++G +Y C +E+A+K + + + E KE + E+ +++ ++H+ +
Sbjct: 10 LGQGAFGRVY---LCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERI 66
Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
VQ+ G L I E+M GS+ D L K G T K + +G+ YLH N I
Sbjct: 67 VQYYGCLRDDETLSIFMEYMPGGSVKDQL-KAYGALTETVTRKYTRQILEGVEYLHSNMI 125
Query: 230 IHRDLKTANLLMDENGVVKVADFGVA-RVQA---QSGVMTAETGTYRWMAPEVIEHKPYD 285
+HRD+K AN+L D G VK+ DFG + R+Q M + TGT WM+PEVI + Y
Sbjct: 126 VHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYG 185
Query: 286 YKADVFSFGIALWELLTGELPYAGLTPLQA 315
KADV+S G + E+LT + P+A + A
Sbjct: 186 RKADVWSVGCTVVEMLTEKPPWAEFEAMAA 215
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (363), Expect = 8e-41
Identities = 70/201 (34%), Positives = 113/201 (56%), Gaps = 12/201 (5%)
Query: 120 SGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFI 173
SG++G +YKG + + VAIKVL+ E + + KE E Y+M + H +VV+ +
Sbjct: 17 SGAFGTVYKGVWIPEGEKVKIPVAIKVLR-EETSPKANKEILDEAYVMASVDHPHVVRLL 75
Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
G C + ++T+ M G + D++ K LL + ++KGM+YL + ++HRD
Sbjct: 76 GICL-SSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRD 134
Query: 234 LKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAPEVIEHKPYDYKADV 290
L N+L+ VK+ DFG+A+ + AE G +WMA E I H+ Y +K+DV
Sbjct: 135 LAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDV 194
Query: 291 FSFGIALWELLT-GELPYAGL 310
+S+G+ +WEL+T G PY G+
Sbjct: 195 WSYGVTVWELMTFGAKPYEGI 215
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 9e-41
Identities = 70/209 (33%), Positives = 115/209 (55%), Gaps = 13/209 (6%)
Query: 117 KVASGSYGDLYKGTYCSQ-----EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQ 171
K+ GS+G + +G + + VA+K LK + + ++++ +F +E IM + H+N+++
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKL-SDIMDDFLKEAAIMHSLDHENLIR 60
Query: 172 FIGACTRPPNLCIVTEFMARGSIYDFLHK-QKGVFQLTSLLKVAIDVSKGMNYLHQNNII 230
G P L +VTE GS+ D L K G F +++L A+ ++ GM YL I
Sbjct: 61 LYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFI 119
Query: 231 HRDLKTANLLMDENGVVKVADFGVARVQAQSG---VMTAETGT-YRWMAPEVIEHKPYDY 286
HRDL N+L+ + VK+ DFG+ R Q+ VM + W APE + + + +
Sbjct: 120 HRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSH 179
Query: 287 KADVFSFGIALWELLT-GELPYAGLTPLQ 314
+DV+ FG+ LWE+ T GE P+AGL+ Q
Sbjct: 180 ASDVWMFGVTLWEMFTYGEEPWAGLSGSQ 208
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 1e-40
Identities = 71/204 (34%), Positives = 111/204 (54%), Gaps = 7/204 (3%)
Query: 118 VASGSYGDLYKGTYCSQE--VAIKV--LKPECVNT-EMLKEFSQEVYIMRKIRHKNVVQF 172
+ SGS+G +Y+G A+K L + E +K+ QE+ ++ K++H N+VQ+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 173 IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHR 232
+G NL I E + GS+ L K G F + + G+ YLH N +HR
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEYLHDRNTVHR 126
Query: 233 DLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHK-PYDYKADVF 291
D+K AN+L+D NGVVK+ADFG+A+ + + G+ WMAPEVI + Y AD++
Sbjct: 127 DIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIW 186
Query: 292 SFGIALWELLTGELPYAGLTPLQA 315
S G + E+ TG+ P++ L + A
Sbjct: 187 SLGCTVLEMATGKPPWSQLEGVAA 210
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 8e-40
Identities = 65/205 (31%), Positives = 115/205 (56%), Gaps = 10/205 (4%)
Query: 118 VASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH---KNVVQF 172
+ G+YG +Y+G + + VA+K++ + + + + + +EV ++ ++R N+ ++
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDD-VSDIQREVALLSQLRQSQPPNITKY 67
Query: 173 IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHR 232
G+ + P L I+ E+ GS+ + + S+ + +V + Y+H+ +IHR
Sbjct: 68 YGSYLKGPRLWIIMEYAEGGSVRTLMKAGPIAEKYISV--IIREVLVALKYIHKVGVIHR 125
Query: 233 DLKTANLLMDENGVVKVADFGV-ARVQAQSGVMTAETGTYRWMAPEVI-EHKPYDYKADV 290
D+K AN+L+ G VK+ DFGV A + S + GT WMAPEVI E K YD KAD+
Sbjct: 126 DIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADI 185
Query: 291 FSFGIALWELLTGELPYAGLTPLQA 315
+S GI ++E+ TG PY+ + +A
Sbjct: 186 WSLGITIYEMATGNPPYSDVDAFRA 210
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 9e-40
Identities = 68/234 (29%), Positives = 113/234 (48%), Gaps = 35/234 (14%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQE 157
WE+ +++ + ++ GS+G +Y+G VAIK + E + EF E
Sbjct: 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERI-EFLNE 59
Query: 158 VYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK---------GVFQLT 208
+M++ +VV+ +G + +V E MA+G + +L ++ G L
Sbjct: 60 ASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQ 119
Query: 209 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET 268
+++A +++ GM YL +HRDL N ++ E+ VK+ DFG+ R ET
Sbjct: 120 KFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTR-------DIYET 172
Query: 269 GTY----------RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLT 311
Y RWMAPE ++ + K+DV+SFG+ LWE+ T E PY GL+
Sbjct: 173 DYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS 226
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 139 bits (352), Expect = 1e-39
Identities = 75/203 (36%), Positives = 118/203 (58%), Gaps = 7/203 (3%)
Query: 118 VASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC 176
+ G++G+++KGT + VA+K K E + E+ +F E I+++ H N+V+ IG C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCK-EDLPQELKIKFLSEARILKQYDHPNIVKLIGVC 61
Query: 177 TRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKT 236
T+ + IV E + G FL K+K + L+K A+D + GM YL N IHRDL
Sbjct: 62 TQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAA 121
Query: 237 ANLLMDENGVVKVADFGVARVQAQSGVMTA---ETGTYRWMAPEVIEHKPYDYKADVFSF 293
N L+ EN V+K++DFG++R Q G+ ++ + +W APE + + Y ++DV+S+
Sbjct: 122 RNCLVGENNVLKISDFGMSR-QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSY 180
Query: 294 GIALWELLT-GELPYAGLTPLQA 315
GI LWE + G PY G+T QA
Sbjct: 181 GILLWETFSLGVCPYPGMTNQQA 203
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 2e-39
Identities = 69/215 (32%), Positives = 107/215 (49%), Gaps = 10/215 (4%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQEVY 159
+EI + + + + G +GD+Y+G Y S E VA+K K + K F QE Y
Sbjct: 1 YEIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREK-FLQEAY 59
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
IMR+ H ++V+ IG T P + IV E G + +L K L SL+ + +S
Sbjct: 60 IMRQFDHPHIVKLIGVITENP-VWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLST 118
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPE 277
+ YL +HRD+ N+L+ VK+ DFG++R A G +WMAPE
Sbjct: 119 ALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPE 178
Query: 278 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLT 311
I + + +DV+ FG+ +WE+L G P+ G+
Sbjct: 179 SINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVK 213
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 138 bits (350), Expect = 3e-39
Identities = 67/202 (33%), Positives = 107/202 (52%), Gaps = 13/202 (6%)
Query: 120 SGSYGDLYKGTYCSQ-----EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
G++G + KG Y + EVA+K LK E + KEF +E +M ++ H +V+ IG
Sbjct: 5 HGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGK-KEFLREASVMAQLDHPCIVRLIG 63
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
C P L +V E G + +L K++ ++ L ++A V+ GM YL + +HRDL
Sbjct: 64 VCKGEP-LMLVMELAPLGPLLKYL-KKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDL 121
Query: 235 KTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETG---TYRWMAPEVIEHKPYDYKADV 290
N+L+ K++DFG++R + A S A T +W APE I + + K+DV
Sbjct: 122 AARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDV 181
Query: 291 FSFGIALWELLT-GELPYAGLT 311
+S+G+ LWE + G PY +
Sbjct: 182 WSYGVTLWEAFSYGAKPYGEMK 203
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 5e-38
Identities = 74/241 (30%), Positives = 124/241 (51%), Gaps = 30/241 (12%)
Query: 97 IPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTE 149
+P D WE+ +L + + G++G + K + VA+K+LK + +
Sbjct: 1 LPLD--PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKD 58
Query: 150 MLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLT 208
L + E+ +M+ I +HKN++ +G CT+ L +V E+ A G++ DFL ++ +
Sbjct: 59 -LSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYA 117
Query: 209 S---------------LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFG 253
S L+ A V++GM +L IHRDL N+L+ E+ V+K+ADFG
Sbjct: 118 SPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFG 177
Query: 254 VAR-VQAQSGVMTAETG--TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAG 309
+AR + G +WMAPE + + Y +++DV+SFG+ LWE+ T G PY G
Sbjct: 178 LARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 237
Query: 310 L 310
+
Sbjct: 238 I 238
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 3e-37
Identities = 66/193 (34%), Positives = 108/193 (55%), Gaps = 5/193 (2%)
Query: 120 SGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
+G+ G + K + + +A+K ++ E +N + K+ +E+ I+ K +V F GA
Sbjct: 11 AGNSGVVSKVLHRPTGKIMAVKTIRLE-INEAIQKQILRELDILHKCNSPYIVGFYGAFY 69
Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH-QNNIIHRDLKT 236
++ I E+M GS+ L + +G L K+A+ V KG+ YLH ++ IIHRD+K
Sbjct: 70 NNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKP 129
Query: 237 ANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIA 296
+N+L++ G +K+ DFGV+ S T GT +MAPE I+ Y K+D++S G++
Sbjct: 130 SNILVNSRGQIKLCDFGVSGQLVNSLAKT-FVGTSSYMAPERIQGNDYSVKSDIWSLGLS 188
Query: 297 LWELLTGELPYAG 309
L EL TG PY
Sbjct: 189 LIELATGRFPYPP 201
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (336), Expect = 6e-37
Identities = 71/224 (31%), Positives = 117/224 (52%), Gaps = 17/224 (7%)
Query: 99 TDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQ 156
+ D+WEI + + G++G +YK + A K+++ E + E L++F
Sbjct: 1 VNPNDIWEIIGE-------LGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMV 51
Query: 157 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAID 216
E+ I+ + +H N+V A L I+ EF G++ + + + + V
Sbjct: 52 EIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQ 111
Query: 217 VSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV-ARVQAQSGVMTAETGTYRWMA 275
+ + +N+LH + +IHRDLK N+L+ +G VK+ADFGV A+ ++ GT WMA
Sbjct: 112 MLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMA 171
Query: 276 PEVI-----EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ 314
PEV+ + PYDYKAD++S GI L EL E P+ L P++
Sbjct: 172 PEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR 215
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 132 bits (332), Expect = 2e-36
Identities = 71/201 (35%), Positives = 115/201 (57%), Gaps = 6/201 (2%)
Query: 117 KVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
++ GS+G++YKG + VAIK++ E E +++ QE+ ++ + + ++ G
Sbjct: 11 RIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYITRYYG 69
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
+ + L I+ E++ GS D L + G + T + + ++ KG++YLH IHRD+
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLL--KPGPLEETYIATILREILKGLDYLHSERKIHRDI 127
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVM-TAETGTYRWMAPEVIEHKPYDYKADVFSF 293
K AN+L+ E G VK+ADFGVA + + GT WMAPEVI+ YD+KAD++S
Sbjct: 128 KAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSL 187
Query: 294 GIALWELLTGELPYAGLTPLQ 314
GI EL GE P + L P++
Sbjct: 188 GITAIELAKGEPPNSDLHPMR 208
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (333), Expect = 2e-36
Identities = 78/238 (32%), Positives = 121/238 (50%), Gaps = 36/238 (15%)
Query: 100 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQE 157
D T ++E+ +++ + G+YG +YK + Q VAIK++ + +E +E
Sbjct: 3 DPTGIFEL----VEV---IGEGTYGKVYKARHKKTGQLVAIKIMDII---EDEEEEIKEE 52
Query: 158 VYIMRKI-RHKNVVQFIGA------CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSL 210
I+RK H N+ F GA L +V E GS+ D + KG+ +
Sbjct: 53 YNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLV---KGLRKKGKR 109
Query: 211 LKVAI------DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM 264
LK + +G+ YLH+N +IHRD+K N+L+ +N VK+ DFGV+ Q S +
Sbjct: 110 LKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA-QLDSTLG 168
Query: 265 TAET--GTYRWMAPEVI--EHKP---YDYKADVFSFGIALWELLTGELPYAGLTPLQA 315
T GT WMAPEVI + +P YD ++DV+S GI EL G+ P + P++A
Sbjct: 169 RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRA 226
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 2e-36
Identities = 70/213 (32%), Positives = 113/213 (53%), Gaps = 13/213 (6%)
Query: 107 IDAKQLKIECKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
ID +KIE + +G +G++ +G VAIK LK + ++F E IM
Sbjct: 1 IDVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEASIM 59
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
+ H N++ G T+ + I+TEFM G++ FL + G F + L+ + ++ GM
Sbjct: 60 GQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGM 119
Query: 222 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY------RWMA 275
YL + N +HRDL N+L++ N V KV+DFG++R T + RW A
Sbjct: 120 KYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTA 179
Query: 276 PEVIEHKPYDYKADVFSFGIALWELLT-GELPY 307
PE I ++ + +DV+S+GI +WE+++ GE PY
Sbjct: 180 PEAIAYRKFTSASDVWSYGIVMWEVMSYGERPY 212
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 134 bits (337), Expect = 3e-36
Identities = 69/228 (30%), Positives = 116/228 (50%), Gaps = 16/228 (7%)
Query: 113 KIECKVASGSYGDLYKGTYCSQEVAIKVLKPE-CVNTEMLKEFSQEVYIMRKIRH-KNVV 170
+I K+ GS+G++Y + VA+KVL + ++ ++ F +E+ I+ + H N+V
Sbjct: 3 RILRKLGEGSFGEVYLA-RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIV 61
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHK--QKGVFQLTSLLKVAIDVSKGMNYLHQNN 228
+ +L +V E++ GS+ D L K +KG + L + + + YLH
Sbjct: 62 KLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG 121
Query: 229 IIHRDLKTANLLMDENG-VVKVADFGVARVQAQSGV-------MTAETGTYRWMAPEVIE 280
IIHRD+K N+L+D +G VVK+ DFG+A++ G + GT +MAPEV+
Sbjct: 122 IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLL 181
Query: 281 HK---PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSI 325
+D++S GI L+ELLTG P+ G A ++ +
Sbjct: 182 GLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILE 229
|
Length = 384 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 3e-35
Identities = 74/215 (34%), Positives = 114/215 (53%), Gaps = 11/215 (5%)
Query: 107 IDAKQLKIECKVASGSYGDLYKGTYCSQ-----EVAIKVLKPECVNTEMLKEFSQEVYIM 161
IDA +KIE + +G +G++ G VAIK LK + ++F E IM
Sbjct: 1 IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQR-RDFLSEASIM 59
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
+ H N++ G T+ + IVTE+M GS+ FL K G F + L+ + ++ GM
Sbjct: 60 GQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGM 119
Query: 222 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSGVMTAETGT--YRWMAPE 277
YL +HRDL N+L++ N V KV+DFG++RV T G RW APE
Sbjct: 120 KYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPE 179
Query: 278 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLT 311
I ++ + +DV+S+GI +WE+++ GE PY ++
Sbjct: 180 AIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMS 214
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 3e-35
Identities = 68/216 (31%), Positives = 119/216 (55%), Gaps = 9/216 (4%)
Query: 117 KVASGSYGDLYKGTYCSQE--VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
++ G++G+++ G + VA+K + E + ++ +F QE I+++ H N+V+ IG
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCR-ETLPPDLKAKFLQEARILKQYSHPNIVRLIG 60
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
CT+ + IV E + G FL + ++ L+++ + + GM YL + IHRDL
Sbjct: 61 VCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDL 120
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT----YRWMAPEVIEHKPYDYKADV 290
N L+ E V+K++DFG++R + + GV + G +W APE + + Y ++DV
Sbjct: 121 AARNCLVTEKNVLKISDFGMSR-EEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDV 179
Query: 291 FSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSI 325
+SFGI LWE + G +PYA L+ Q + Q V +
Sbjct: 180 WSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRL 215
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 3e-35
Identities = 69/207 (33%), Positives = 110/207 (53%), Gaps = 13/207 (6%)
Query: 121 GSYGDLYKG-TYCSQEVAIK--VLKPECVNT--EMLKEFSQEVYIMRKIRHKNVVQFIGA 175
G+YG +Y G T Q +A+K L V + ++ +EV +++ ++H N+VQ++G
Sbjct: 11 GAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGT 70
Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 235
C + I EF+ GSI L + G K + G+ YLH N ++HRD+K
Sbjct: 71 CLDDNTISIFMEFVPGGSISSIL-NRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIK 129
Query: 236 TANLLMDENGVVKVADFGVARVQA-------QSGVMTAETGTYRWMAPEVIEHKPYDYKA 288
N+++ NG++K+ DFG AR A S ++ + GT WMAPEVI Y K+
Sbjct: 130 GNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKS 189
Query: 289 DVFSFGIALWELLTGELPYAGLTPLQA 315
D++S G ++E+ TG+ P A + L A
Sbjct: 190 DIWSIGCTVFEMATGKPPLASMDRLAA 216
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 128 bits (322), Expect = 4e-35
Identities = 57/199 (28%), Positives = 105/199 (52%), Gaps = 6/199 (3%)
Query: 114 IECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQ 171
I K+ GS+G ++K + + A+K + +N +E E ++ K+ +++
Sbjct: 4 ILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIR 63
Query: 172 FIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKGMNYLHQNNII 230
+ + L IV E+ G ++ L Q+G + + I + G+ +LH I+
Sbjct: 64 YYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKIL 123
Query: 231 HRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYDYKA 288
HRD+K+ NL +D VK+ D GVA++ + + A T GT +++PE+ E KPY+ K+
Sbjct: 124 HRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF-ANTIVGTPYYLSPELCEDKPYNEKS 182
Query: 289 DVFSFGIALWELLTGELPY 307
DV++ G+ L+E TG+ P+
Sbjct: 183 DVWALGVVLYECCTGKHPF 201
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 4e-35
Identities = 73/223 (32%), Positives = 127/223 (56%), Gaps = 17/223 (7%)
Query: 118 VASGSYGDLYKGTYCS--QEVAIKVLKPECVNTE-------MLKEFSQEVYIMRKIRHKN 168
+ SGS+G +Y G S + +A+K ++ V+ ML ++E+ ++++++H+N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 169 VVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNN 228
+VQ++G+ +L I E++ GS+ L+ G F+ T + + KG+NYLH
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLN-NYGAFEETLVRNFVRQILKGLNYLHNRG 126
Query: 229 IIHRDLKTANLLMDENGVVKVADFGVA-RVQAQSGVMTAET------GTYRWMAPEVIEH 281
IIHRD+K AN+L+D G +K++DFG++ +++A S G+ WMAPEV++
Sbjct: 127 IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQ 186
Query: 282 KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVS 324
Y KAD++S G + E+LTG+ P+ T LQA + + S
Sbjct: 187 TSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENAS 229
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 8e-35
Identities = 70/221 (31%), Positives = 114/221 (51%), Gaps = 39/221 (17%)
Query: 121 GSYGDLYKG-------TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFI 173
G++G +YKG + VAIK LK E ++ +EF QE +M ++H N+V +
Sbjct: 16 GAFGKVYKGELTGPNERLSATSVAIKTLK-ENAEPKVQQEFRQEAELMSDLQHPNIVCLL 74
Query: 174 GACTRPPNLCIVTEFMARGSIYDFL---------------HKQKGVFQLTSLLKVAIDVS 218
G CT+ C++ E++A G +++FL K + L +AI ++
Sbjct: 75 GVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIA 134
Query: 219 KGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR---------VQAQSGVMTAETG 269
GM YL ++ +HRDL N L+ E VK++DFG++R VQ++S +
Sbjct: 135 AGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLL------ 188
Query: 270 TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAG 309
RWM PE I + + ++D++SFG+ LWE+ + G PY G
Sbjct: 189 PVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYG 229
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 8e-35
Identities = 72/219 (32%), Positives = 116/219 (52%), Gaps = 14/219 (6%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQE 157
WE L + +G++G + + T +VA+K+LKP ++E S E
Sbjct: 30 WEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMS-E 88
Query: 158 VYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF-QLTSLLKVAI 215
+ IM + H+N+V +GACT + ++TE+ G + +FL +++ F L LL +
Sbjct: 89 LKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSY 148
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY---R 272
V+KGM +L N IHRDL N+L+ +VK+ DFG+AR + +
Sbjct: 149 QVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVK 208
Query: 273 WMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGL 310
WMAPE I + Y +++DV+S+GI LWE+ + G PY G+
Sbjct: 209 WMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGM 247
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 1e-34
Identities = 75/203 (36%), Positives = 116/203 (57%), Gaps = 10/203 (4%)
Query: 117 KVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
++ GS+G+++KG Q VAIK++ E E +++ QE+ ++ + V ++ G
Sbjct: 11 RIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYVTKYYG 69
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
+ + L I+ E++ GS D L FQ+ ++LK ++ KG++YLH IHRD
Sbjct: 70 SYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIATMLK---EILKGLDYLHSEKKIHRD 126
Query: 234 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYDYKADVF 291
+K AN+L+ E G VK+ADFGVA Q + T GT WMAPEVI+ YD KAD++
Sbjct: 127 IKAANVLLSEQGDVKLADFGVAG-QLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIW 185
Query: 292 SFGIALWELLTGELPYAGLTPLQ 314
S GI EL GE P + + P++
Sbjct: 186 SLGITAIELAKGEPPNSDMHPMR 208
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 127 bits (322), Expect = 1e-34
Identities = 66/199 (33%), Positives = 102/199 (51%), Gaps = 32/199 (16%)
Query: 136 VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY 195
VA+KVL+P+ + ++F +EV I+ ++ N+ + +G CT P LC++ E+M G +
Sbjct: 49 VAVKVLRPD-ASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLN 107
Query: 196 DFLHKQKGVFQLTS----------LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG 245
FL K + LL +A ++ GM YL N +HRDL T N L+ +N
Sbjct: 108 QFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNY 167
Query: 246 VVKVADFGVARVQAQSGVMTAETGTY-----------RWMAPEVIEHKPYDYKADVFSFG 294
+K+ADFG++R + Y RWMA E + + K+DV++FG
Sbjct: 168 TIKIADFGMSR--------NLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFG 219
Query: 295 IALWELLT--GELPYAGLT 311
+ LWE+LT E PY LT
Sbjct: 220 VTLWEILTLCREQPYEHLT 238
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 127 bits (319), Expect = 1e-34
Identities = 72/201 (35%), Positives = 115/201 (57%), Gaps = 6/201 (2%)
Query: 117 KVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
K+ GS+G+++KG + VAIK++ E E +++ QE+ ++ + V ++ G
Sbjct: 11 KIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYVTKYYG 69
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
+ + L I+ E++ GS D L + G T + + ++ KG++YLH IHRD+
Sbjct: 70 SYLKDTKLWIIMEYLGGGSALDLL--EPGPLDETQIATILREILKGLDYLHSEKKIHRDI 127
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKADVFSF 293
K AN+L+ E+G VK+ADFGVA + + GT WMAPEVI+ YD KAD++S
Sbjct: 128 KAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSL 187
Query: 294 GIALWELLTGELPYAGLTPLQ 314
GI EL GE P++ L P++
Sbjct: 188 GITAIELAKGEPPHSELHPMK 208
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 127 bits (320), Expect = 1e-34
Identities = 74/225 (32%), Positives = 116/225 (51%), Gaps = 39/225 (17%)
Query: 118 VASGSYGDLYKGTYCSQE-------VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
+ G++G ++ G E VA+K LK N + K+F +E ++ +H+N+V
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASN-DARKDFEREAELLTNFQHENIV 71
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFL--HKQKGVF---------QLT--SLLKVAIDV 217
+F G CT +V E+M G + FL H F +LT LL++A+ +
Sbjct: 72 KFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQI 131
Query: 218 SKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY------ 271
+ GM YL + +HRDL T N L+ + VVK+ DFG++R V T T Y
Sbjct: 132 ASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR-----DVYT--TDYYRVGGHT 184
Query: 272 ----RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLT 311
RWM PE I ++ + ++DV+SFG+ LWE+ T G+ P+ GL+
Sbjct: 185 MLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS 229
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 2e-34
Identities = 62/206 (30%), Positives = 111/206 (53%), Gaps = 6/206 (2%)
Query: 111 QLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN 168
K+ K+ GSYG +YK S Q A+K + ++ + ++ E+ I+ + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 169 VVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV---FQLTSLLKVAIDVSKGMNYLH 225
++ + A LCIV E+ G + + K+K + ++ I + +G+ LH
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120
Query: 226 QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYD 285
+ I+HRDLK+AN+L+ N +VK+ D G+++V + + + GT +MAPEV + +PY
Sbjct: 121 EQKILHRDLKSANILLVANDLVKIGDLGISKV-LKKNMAKTQIGTPHYMAPEVWKGRPYS 179
Query: 286 YKADVFSFGIALWELLTGELPYAGLT 311
YK+D++S G L+E+ T P+ +
Sbjct: 180 YKSDIWSLGCLLYEMATFAPPFEARS 205
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 2e-34
Identities = 74/220 (33%), Positives = 112/220 (50%), Gaps = 24/220 (10%)
Query: 118 VASGSYGDLYKGTYCS--------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNV 169
+ SG++G++Y+GT VA+K L+ + E KEF +E ++M H N+
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEK-KEFLKEAHLMSNFNHPNI 61
Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK------GVFQLTSLLKVAIDVSKGMNY 223
V+ +G C I+ E M G + +L + + L LL + +DV+KG Y
Sbjct: 62 VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121
Query: 224 LHQNNIIHRDLKTANLLMDENG-----VVKVADFGVARVQAQSGVMTAETG---TYRWMA 275
L Q + IHRDL N L+ E G VVK+ DFG+AR +S E RWMA
Sbjct: 122 LEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMA 181
Query: 276 PEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQ 314
PE + + ++DV+SFG+ +WE+LT G+ PY L +
Sbjct: 182 PESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE 221
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 2e-34
Identities = 69/212 (32%), Positives = 111/212 (52%), Gaps = 11/212 (5%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTY-----CSQEVAIKVLKPECVNTEMLKEFSQEVYI 160
EI + + + +G +G++++G VAIK LKP + ++F E I
Sbjct: 1 EIHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQR-QDFLSEASI 59
Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 220
M + H N+++ G T+ I+TE+M G++ +L G F L+ + ++ G
Sbjct: 60 MGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAG 119
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ--SGVMTAETGT--YRWMAP 276
M YL N +HRDL N+L++ N KV+DFG++RV G T G RW AP
Sbjct: 120 MKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAP 179
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPY 307
E I ++ + +DV+SFGI +WE+++ GE PY
Sbjct: 180 EAIAYRKFTSASDVWSFGIVMWEVMSFGERPY 211
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 2e-34
Identities = 59/166 (35%), Positives = 90/166 (54%), Gaps = 6/166 (3%)
Query: 147 NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP--NLCIVTEFMARGS---IYDFLHKQ 201
N ++ K+ +E+ I + + +V++ GA ++ I E+ GS IY + K+
Sbjct: 39 NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKR 98
Query: 202 KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261
G L K+A V KG++YLH IIHRD+K +N+L+ G VK+ DFGV+ S
Sbjct: 99 GGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158
Query: 262 GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 307
T TGT +MAPE I+ KPY +DV+S G+ L E+ P+
Sbjct: 159 LAGTF-TGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPF 203
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 4e-33
Identities = 73/227 (32%), Positives = 126/227 (55%), Gaps = 16/227 (7%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 159
E + K++K+ + SG++G +YKG + + VAIK L+ E + + KE E Y
Sbjct: 6 ETEFKKIKV---LGSGAFGTVYKGLWIPEGEKVKIPVAIKELR-EATSPKANKEILDEAY 61
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
+M + + +V + +G C + ++T+ M G + D++ + K LL + ++K
Sbjct: 62 VMASVDNPHVCRLLGICL-TSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAK 120
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 276
GMNYL + ++HRDL N+L+ VK+ DFG+A+ + A AE G +WMA
Sbjct: 121 GMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMAL 180
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQK 322
E I H+ Y +++DV+S+G+ +WEL+T G PY G+ P +++K
Sbjct: 181 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI-PASEISSILEK 226
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 122 bits (308), Expect = 1e-32
Identities = 66/201 (32%), Positives = 106/201 (52%), Gaps = 26/201 (12%)
Query: 136 VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY 195
VA+K+LK E + +M +F +E +M + H N+V+ +G C +C++ E+MA G +
Sbjct: 38 VAVKMLKEE-ASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLN 96
Query: 196 DFLHKQ--KGVFQL-------------------TSLLKVAIDVSKGMNYLHQNNIIHRDL 234
+FL + + L T L +A V+ GM YL + +HRDL
Sbjct: 97 EFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDL 156
Query: 235 KTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAPEVIEHKPYDYKADVF 291
T N L+ EN VVK+ADFG++R + + +E RWM PE I + Y ++DV+
Sbjct: 157 ATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVW 216
Query: 292 SFGIALWELLT-GELPYAGLT 311
++G+ LWE+ + G PY G+
Sbjct: 217 AYGVVLWEIFSYGMQPYYGMA 237
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 1e-32
Identities = 67/220 (30%), Positives = 108/220 (49%), Gaps = 21/220 (9%)
Query: 118 VASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF 172
+ G +G +Y GT + A+K L + E +++F +E IM+ H NV+
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLN-RITDLEEVEQFLKEGIIMKDFSHPNVLSL 61
Query: 173 IGACTRPPNL-CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIH 231
+G C +V +M G + +F+ + + L+ + V+KGM YL +H
Sbjct: 62 LGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVH 121
Query: 232 RDLKTANLLMDENGVVKVADFGVAR---------VQAQSGVMTAETGTYRWMAPEVIEHK 282
RDL N ++DE+ VKVADFG+AR V +G +WMA E ++ +
Sbjct: 122 RDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLP----VKWMALESLQTQ 177
Query: 283 PYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQ 321
+ K+DV+SFG+ LWEL+T G PY + V ++Q
Sbjct: 178 KFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ 217
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 1e-32
Identities = 71/215 (33%), Positives = 121/215 (56%), Gaps = 15/215 (6%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 159
E + K++K+ + SG++G +YKG + + VAIK+L E + EF E
Sbjct: 6 ETELKRVKV---LGSGAFGTVYKGIWVPEGETVKIPVAIKILN-ETTGPKANVEFMDEAL 61
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
IM + H ++V+ +G C P + +VT+ M G + D++H+ K LL + ++K
Sbjct: 62 IMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAK 120
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 276
GM YL + ++HRDL N+L+ VK+ DFG+AR ++ A+ G +WMA
Sbjct: 121 GMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMAL 180
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGL 310
E I ++ + +++DV+S+G+ +WEL+T G PY G+
Sbjct: 181 ECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI 215
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 122 bits (306), Expect = 2e-32
Identities = 72/245 (29%), Positives = 123/245 (50%), Gaps = 41/245 (16%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYCSQE-------------------VAIKVLKPECV 146
E +QL+++ K+ G +G+++ C E VA+K+L+ + V
Sbjct: 1 EFPRQQLRLKEKLGEGQFGEVH---LCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD-V 56
Query: 147 NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ 206
+F +E+ IM ++++ N+++ +G C LC++TE+M G + FL +++
Sbjct: 57 TKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIEST 116
Query: 207 LT-----------SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA 255
T +LL +A+ ++ GM YL N +HRDL T N L+ + +K+ADFG++
Sbjct: 117 FTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMS 176
Query: 256 RVQAQSGVMTAETG----TYRWMAPEVIEHKPYDYKADVFSFGIALWEL--LTGELPYAG 309
R SG G RWMA E I + +DV++FG+ LWE+ L E PY+
Sbjct: 177 R-NLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235
Query: 310 LTPLQ 314
L+ Q
Sbjct: 236 LSDEQ 240
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 2e-32
Identities = 59/206 (28%), Positives = 106/206 (51%), Gaps = 26/206 (12%)
Query: 113 KIECKVASGSYGDLYKGT--YCSQEVAIKVLKPECVNTEMLKE-FSQ----EVYIMRKIR 165
K+E K+ G+YG +YK + VA+K ++ + +E E+ ++++++
Sbjct: 3 KLE-KLGEGTYGVVYKARDKKTGEIVALKKIR-----LDNEEEGIPSTALREISLLKELK 56
Query: 166 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 225
H N+V+ + L +V E+ + +L K+ G + + + +G+ Y H
Sbjct: 57 HPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCH 115
Query: 226 QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV----MTAETGT--YRWMAPEVI 279
+ I+HRDLK N+L++ +GV+K+ADFG+AR G+ T E T YR APE++
Sbjct: 116 SHRILHRDLKPQNILINRDGVLKLADFGLAR---AFGIPLRTYTHEVVTLWYR--APEIL 170
Query: 280 -EHKPYDYKADVFSFGIALWELLTGE 304
K Y D++S G E++TG+
Sbjct: 171 LGSKHYSTAVDIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 120 bits (301), Expect = 7e-32
Identities = 73/214 (34%), Positives = 116/214 (54%), Gaps = 19/214 (8%)
Query: 118 VASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIG 174
V +G+YG +YKG + Q AIKV+ V + +E E+ +++K H+N+ + G
Sbjct: 24 VGNGTYGQVYKGRHVKTGQLAAIKVMD---VTEDEEEEIKLEINMLKKYSHHRNIATYYG 80
Query: 175 ACTR--PP----NLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGMNYLHQN 227
A + PP L +V EF GS+ D + KG + + + ++ +G+ +LH +
Sbjct: 81 AFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH 140
Query: 228 NIIHRDLKTANLLMDENGVVKVADFGV-ARVQAQSGVMTAETGTYRWMAPEVI--EHKP- 283
+IHRD+K N+L+ EN VK+ DFGV A++ G GT WMAPEVI + P
Sbjct: 141 KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPD 200
Query: 284 --YDYKADVFSFGIALWELLTGELPYAGLTPLQA 315
YDY++D++S GI E+ G P + P++A
Sbjct: 201 ATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA 234
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 8e-32
Identities = 75/218 (34%), Positives = 107/218 (49%), Gaps = 35/218 (16%)
Query: 121 GSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFI 173
G++G++Y+G Y +VA+K L PE + + +F E IM K H+N+V+ I
Sbjct: 17 GAFGEVYEGLYRGRDGDAVELQVAVKTL-PESCSEQDESDFLMEALIMSKFNHQNIVRLI 75
Query: 174 GACTRPPNLCIVTEFMARGSIYDFLH----KQKGVFQLT--SLLKVAIDVSKGMNYLHQN 227
G I+ E MA G + FL + + LT LL A DV+KG YL +N
Sbjct: 76 GVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN 135
Query: 228 NIIHRDLKTANLLMDENG---VVKVADFGVARVQAQSGVMTAETGTYR----------WM 274
+ IHRD+ N L+ G V K+ADFG+AR ++ YR WM
Sbjct: 136 HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASY-------YRKGGRAMLPIKWM 188
Query: 275 APEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLT 311
PE + K DV+SFG+ LWE+ + G +PY G T
Sbjct: 189 PPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT 226
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 8e-32
Identities = 64/218 (29%), Positives = 104/218 (47%), Gaps = 36/218 (16%)
Query: 121 GSYGDLYKGTY-----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
G +G + +G +VA+K +K + ++EF E M+ H NV++ IG
Sbjct: 10 GEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGV 69
Query: 176 C------TRPPNLCIVTEFMARGSIYDFL-----HKQKGVFQLTSLLKVAIDVSKGMNYL 224
C + P ++ FM G ++ FL L +LLK +D++ GM YL
Sbjct: 70 CFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYL 129
Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY-----------RW 273
N IHRDL N ++ E+ V VADFG+++ +G Y +W
Sbjct: 130 SNRNFIHRDLAARNCMLREDMTVCVADFGLSK--------KIYSGDYYRQGRIAKMPVKW 181
Query: 274 MAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGL 310
+A E + + Y K+DV++FG+ +WE+ T G+ PY G+
Sbjct: 182 IAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGV 219
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 119 bits (299), Expect = 1e-31
Identities = 75/214 (35%), Positives = 119/214 (55%), Gaps = 19/214 (8%)
Query: 118 VASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIG 174
V +G+YG +YKG + Q AIKV+ V + +E QE+ +++K H+N+ + G
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEEIKQEINMLKKYSHHRNIATYYG 70
Query: 175 ACTR--PP----NLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGMNYLHQN 227
A + PP L +V EF GS+ D + KG + + + ++ +G+++LHQ+
Sbjct: 71 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH 130
Query: 228 NIIHRDLKTANLLMDENGVVKVADFGV-ARVQAQSGVMTAETGTYRWMAPEVI--EHKP- 283
+IHRD+K N+L+ EN VK+ DFGV A++ G GT WMAPEVI + P
Sbjct: 131 KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPD 190
Query: 284 --YDYKADVFSFGIALWELLTGELPYAGLTPLQA 315
YD+K+D++S GI E+ G P + P++A
Sbjct: 191 ATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA 224
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 2e-31
Identities = 55/165 (33%), Positives = 93/165 (56%), Gaps = 7/165 (4%)
Query: 149 EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLT 208
E+++ +E+ +M ++ H ++++ +GA + + E+MA GS+ L K G F+
Sbjct: 45 EVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKY-GAFKEA 103
Query: 209 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG-VVKVADFGVARVQAQSGVMTAE 267
++ + +G++YLH+N IIHRD+K ANLL+D G +++ADFG A A G E
Sbjct: 104 VIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGE 163
Query: 268 -----TGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 307
GT +MAPEV+ + Y DV+S G + E+ T + P+
Sbjct: 164 FQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPW 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 2e-31
Identities = 56/204 (27%), Positives = 106/204 (51%), Gaps = 11/204 (5%)
Query: 117 KVASGSYGDLYKG-TYCSQEV-AIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
K+ G++G +Y + E+ A+K ++ + + + +KE + E+ ++ ++H N+V++ G
Sbjct: 7 KIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG 66
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
+ I E+ + G++ + L + + + + +G+ YLH + I+HRD+
Sbjct: 67 VEVHREKVYIFMEYCSGGTLEELLE-HGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDI 125
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAE-----TGTYRWMAPEVIEHKPYDYK-- 287
K AN+ +D NGV+K+ DFG A + E GT +MAPEVI
Sbjct: 126 KPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGR 185
Query: 288 -ADVFSFGIALWELLTGELPYAGL 310
AD++S G + E+ TG+ P++ L
Sbjct: 186 AADIWSLGCVVLEMATGKRPWSEL 209
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 5e-31
Identities = 67/215 (31%), Positives = 117/215 (54%), Gaps = 6/215 (2%)
Query: 121 GSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180
G+YG +Y S +V I + + ++ ++ +E+ + ++H+N+VQ++G+ +
Sbjct: 19 GTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENG 78
Query: 181 NLCIVTEFMARGSIYDFLHKQKGVFQL--TSLLKVAIDVSKGMNYLHQNNIIHRDLKTAN 238
I E + GS+ L + G + +++ + +G+ YLH N I+HRD+K N
Sbjct: 79 FFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDN 138
Query: 239 LLMDE-NGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDY--KADVFSFG 294
+L++ +GVVK++DFG ++ A T TGT ++MAPEVI+ P Y AD++S G
Sbjct: 139 VLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLG 198
Query: 295 IALWELLTGELPYAGLTPLQAAVGVVQKVSIHSII 329
+ E+ TG+ P+ L QAA+ V IH I
Sbjct: 199 CTIVEMATGKPPFIELGEPQAAMFKVGMFKIHPEI 233
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 7e-31
Identities = 76/228 (33%), Positives = 116/228 (50%), Gaps = 26/228 (11%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYI 160
WE +K E + G++G + + AIK+LK E + ++F+ E+ +
Sbjct: 1 WE----DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLK-EFASENDHRDFAGELEV 55
Query: 161 MRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK-------------GVFQ 206
+ K+ H N++ +GAC L I E+ G++ DFL K +
Sbjct: 56 LCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTAST 115
Query: 207 LTS--LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM 264
LTS LL+ A DV+ GM YL + IHRDL N+L+ EN K+ADFG++R +
Sbjct: 116 LTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKK 175
Query: 265 TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLT 311
T RWMA E + + Y K+DV+SFG+ LWE+++ G PY G+T
Sbjct: 176 TMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT 223
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 117 bits (293), Expect = 8e-31
Identities = 74/205 (36%), Positives = 112/205 (54%), Gaps = 9/205 (4%)
Query: 117 KVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
++ SG+YGD+YK + + AIKV+K E E QE+ +M+ +H N+V + G
Sbjct: 16 RIGSGTYGDVYKARNVNTGELAAIKVIKLE--PGEDFAVVQQEIIMMKDCKHSNIVAYFG 73
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
+ R L I EF GS+ D H G + + V+ + +G+ YLH +HRD+
Sbjct: 74 SYLRRDKLWICMEFCGGGSLQDIYH-VTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDI 132
Query: 235 KTANLLMDENGVVKVADFGV-ARVQAQSGVMTAETGTYRWMAPEV--IEHK-PYDYKADV 290
K AN+L+ +NG VK+ADFGV A++ A + GT WMAPEV +E K Y+ D+
Sbjct: 133 KGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDI 192
Query: 291 FSFGIALWELLTGELPYAGLTPLQA 315
++ GI EL + P L P++A
Sbjct: 193 WAVGITAIELAELQPPMFDLHPMRA 217
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 1e-30
Identities = 70/226 (30%), Positives = 115/226 (50%), Gaps = 22/226 (9%)
Query: 107 IDAKQLKIECKVASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMR 162
++ +K + + G++G + K + AIK +K E + + ++F+ E+ ++
Sbjct: 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLC 62
Query: 163 KI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK---------------GVFQ 206
K+ H N++ +GAC L + E+ G++ DFL K +
Sbjct: 63 KLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS 122
Query: 207 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 266
LL A DV++GM+YL Q IHRDL N+L+ EN V K+ADFG++R Q T
Sbjct: 123 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTM 182
Query: 267 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLT 311
RWMA E + + Y +DV+S+G+ LWE+++ G PY G+T
Sbjct: 183 GRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 228
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 1e-30
Identities = 60/173 (34%), Positives = 94/173 (54%), Gaps = 8/173 (4%)
Query: 136 VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--PNLCIVTEFMARGS 193
VA+K L+ E L++F +E+ I++ ++H N+V++ G C NL +V E++ GS
Sbjct: 36 VAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGS 93
Query: 194 IYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFG 253
+ D+L K + LL A + KGM YL +HRDL T N+L++ VK+ DFG
Sbjct: 94 LRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFG 153
Query: 254 VARV--QAQSGVMTAETGTYR--WMAPEVIEHKPYDYKADVFSFGIALWELLT 302
+ +V Q + E G W APE + + +DV+SFG+ L+EL T
Sbjct: 154 LTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 1e-30
Identities = 59/181 (32%), Positives = 98/181 (54%), Gaps = 7/181 (3%)
Query: 128 KGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI--V 185
+G ++VA+K LKPE + + +E+ I+R + H+N+V++ G CT I +
Sbjct: 28 EGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLI 86
Query: 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG 245
EF+ GS+ ++L + K L LK A+ + KGM+YL +HRDL N+L++
Sbjct: 87 MEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEH 146
Query: 246 VVKVADFGVAR-VQAQSGVMTAE---TGTYRWMAPEVIEHKPYDYKADVFSFGIALWELL 301
VK+ DFG+ + ++ T + W APE + + +DV+SFG+ L+ELL
Sbjct: 147 QVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELL 206
Query: 302 T 302
T
Sbjct: 207 T 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 3e-30
Identities = 65/193 (33%), Positives = 108/193 (55%), Gaps = 17/193 (8%)
Query: 134 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG------ACTRPPNLCIVTE 187
Q+VA+K+LK + ++ ++EF +E M++ H NV++ IG A R P ++
Sbjct: 28 QKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILP 87
Query: 188 FMARGSIYDFL-----HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD 242
FM G ++ FL ++ L +L++ ID++ GM YL N IHRDL N +++
Sbjct: 88 FMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLN 147
Query: 243 ENGVVKVADFGVARVQAQSGVM----TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALW 298
EN V VADFG+++ + SG A +W+A E + Y +DV++FG+ +W
Sbjct: 148 ENMTVCVADFGLSK-KIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMW 206
Query: 299 ELLT-GELPYAGL 310
E++T G+ PYAG+
Sbjct: 207 EIMTRGQTPYAGV 219
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 5e-30
Identities = 71/244 (29%), Positives = 122/244 (50%), Gaps = 32/244 (13%)
Query: 96 EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS---------QEVAIKVLKPECV 146
E+P D WE+ +L + + G +G + +VA+K+LK +
Sbjct: 6 ELPEDPR--WEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT 63
Query: 147 NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK--- 202
+ L + E+ +M+ I +HKN++ +GACT+ L ++ E+ ++G++ ++L ++
Sbjct: 64 EKD-LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 122
Query: 203 ------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
L+ A V++GM YL IHRDL N+L+ E+ V+K+A
Sbjct: 123 MEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIA 182
Query: 251 DFGVARVQAQSGVMTAETG---TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELP 306
DFG+AR T +WMAPE + + Y +++DV+SFG+ LWE+ T G P
Sbjct: 183 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 242
Query: 307 YAGL 310
Y G+
Sbjct: 243 YPGV 246
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 6e-30
Identities = 63/214 (29%), Positives = 104/214 (48%), Gaps = 18/214 (8%)
Query: 118 VASGSYGDLYKGTYCSQEVAIKVLKPECVNTE----------MLKEFSQEVYIMRKIRHK 167
+ G+YG +Y + + V + E T M+K E+ ++ + H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 168 NVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN 227
N+VQ++G T L I E++ GSI L G F+ + V +G+ YLH
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSK 127
Query: 228 NIIHRDLKTANLLMDENGVVKVADFGVAR----VQAQSGVMTAETGTYRWMAPEVIE--H 281
I+HRDLK NLL+D +G+ K++DFG+++ + M+ + G+ WMAPEVI
Sbjct: 128 GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQ-GSVFWMAPEVIHSYS 186
Query: 282 KPYDYKADVFSFGIALWELLTGELPYAGLTPLQA 315
+ Y K D++S G + E+ G P++ + A
Sbjct: 187 QGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAA 220
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 6e-30
Identities = 63/195 (32%), Positives = 105/195 (53%), Gaps = 21/195 (10%)
Query: 136 VAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSI 194
VA+K+LK + + L + E+ +M+ I +HKN++ +G CT+ L ++ E+ A+G++
Sbjct: 47 VAVKMLKDNATDKD-LADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNL 105
Query: 195 YDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANL 239
+FL ++ L+ A V++GM YL IHRDL N+
Sbjct: 106 REFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNV 165
Query: 240 LMDENGVVKVADFGVARVQAQSGVMTAETG---TYRWMAPEVIEHKPYDYKADVFSFGIA 296
L+ E+ V+K+ADFG+AR + +WMAPE + + Y +++DV+SFGI
Sbjct: 166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGIL 225
Query: 297 LWELLT-GELPYAGL 310
+WE+ T G PY G+
Sbjct: 226 MWEIFTLGGSPYPGI 240
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 1e-29
Identities = 64/210 (30%), Positives = 110/210 (52%), Gaps = 9/210 (4%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTY---CSQE--VAIKVLKPECVNTEMLKEFSQEVYI 160
E+D K +KIE + +G +G+L +G +E VAI L+ C + + F E
Sbjct: 1 ELDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRG-FLAEALT 59
Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 220
+ + H N+V+ G TR + IVTE+M+ G++ FL K +G L+ + ++ G
Sbjct: 60 LGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASG 119
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETG--TYRWMAPEV 278
M YL + +H+ L +L++ + V K++ F + + T +G W APE
Sbjct: 120 MKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEA 179
Query: 279 IEHKPYDYKADVFSFGIALWELLT-GELPY 307
I++ + +DV+SFGI +WE+++ GE PY
Sbjct: 180 IQYHHFSSASDVWSFGIVMWEVMSYGERPY 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 1e-29
Identities = 68/212 (32%), Positives = 112/212 (52%), Gaps = 10/212 (4%)
Query: 108 DAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFS-QEVYIMRKI 164
K + E K+ G+ G +Y + QEVAIK + + + KE E+ +MR+
Sbjct: 18 KKKYTRFE-KIGQGASGTVYTAIDVATGQEVAIKQMN---LQQQPKKELIINEILVMREN 73
Query: 165 RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 224
+H N+V ++ + L +V E++A GS+ D + + + V + + + +L
Sbjct: 74 KHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFL 131
Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFG-VARVQAQSGVMTAETGTYRWMAPEVIEHKP 283
H N +IHRD+K+ N+L+ +G VK+ DFG A++ + + GT WMAPEV+ K
Sbjct: 132 HSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA 191
Query: 284 YDYKADVFSFGIALWELLTGELPYAGLTPLQA 315
Y K D++S GI E++ GE PY PL+A
Sbjct: 192 YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA 223
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 1e-29
Identities = 74/243 (30%), Positives = 127/243 (52%), Gaps = 32/243 (13%)
Query: 97 IPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE---------VAIKVLKPECVN 147
+P D WE+ +L + + G +G + + VA+K+LK + +
Sbjct: 1 LPADPK--WELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATD 58
Query: 148 TEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK--GV 204
+ L + E+ +M+ I +HKN++ +GACT+ L ++ E+ ++G++ ++L ++ G+
Sbjct: 59 KD-LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGM 117
Query: 205 -----------FQLT--SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 251
QLT L+ A V++GM YL IHRDL N+L+ E+ V+K+AD
Sbjct: 118 DYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIAD 177
Query: 252 FGVARVQAQSGVMTAETG---TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPY 307
FG+AR T +WMAPE + + Y +++DV+SFG+ LWE+ T G PY
Sbjct: 178 FGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY 237
Query: 308 AGL 310
G+
Sbjct: 238 PGI 240
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 1e-29
Identities = 61/205 (29%), Positives = 95/205 (46%), Gaps = 13/205 (6%)
Query: 120 SGSYGDLY--KGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC 176
G+YG ++ K AIKV+ K + + + + E I+ + + VV+ +
Sbjct: 3 KGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF 62
Query: 177 TRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKT 236
NL +V E++ G + L G ++ + YLH N IIHRDLK
Sbjct: 63 QGKKNLYLVMEYLPGGDLASLLE-NVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKP 121
Query: 237 ANLLMDENGVVKVADFGVARV-----QAQSGVMTAET----GTYRWMAPEVIEHKPYDYK 287
N+L+D NG +K+ DFG+++V Q E GT ++APEVI + +
Sbjct: 122 DNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKT 181
Query: 288 ADVFSFGIALWELLTGELPYAGLTP 312
D +S G L+E L G P+ G TP
Sbjct: 182 VDWWSLGCILYEFLVGIPPFHGETP 206
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 2e-29
Identities = 67/227 (29%), Positives = 115/227 (50%), Gaps = 28/227 (12%)
Query: 122 SYGDLYKGTYC------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
++G +YKG +Q VAIK LK + N + EF QE +M ++ H N+V +G
Sbjct: 17 AFGKIYKGHLYLPGMDHAQLVAIKTLK-DINNPQQWGEFQQEASLMAELHHPNIVCLLGV 75
Query: 176 CTRPPNLCIVTEFMARGSIYDFL-----HKQ-----------KGVFQLTSLLKVAIDVSK 219
T+ +C++ E++ +G +++FL H K L +AI ++
Sbjct: 76 VTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAA 135
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY---RWMAP 276
GM YL + +H+DL N+L+ E VK++D G++R + + + RWM P
Sbjct: 136 GMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPP 195
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQK 322
E I + + +D++SFG+ LWE+ + G PY G + Q + +V+K
Sbjct: 196 EAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSN-QEVIEMVRK 241
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 2e-29
Identities = 62/196 (31%), Positives = 101/196 (51%), Gaps = 11/196 (5%)
Query: 121 GSYGDLY----KGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
GS+G + K T + A+KVL K + + + ++ E I+ +I H +V+ A
Sbjct: 4 GSFGKVLLVRKKDT--GKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYA 61
Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 235
L +V E+ G ++ L K+ G F A ++ + YLH II+RDLK
Sbjct: 62 FQTEEKLYLVLEYAPGGELFSHLSKE-GRFSEERARFYAAEIVLALEYLHSLGIIYRDLK 120
Query: 236 TANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYDYKADVFSF 293
N+L+D +G +K+ DFG+A+ + S T GT ++APEV+ K Y D +S
Sbjct: 121 PENILLDADGHIKLTDFGLAK-ELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSL 179
Query: 294 GIALWELLTGELPYAG 309
G+ L+E+LTG+ P+
Sbjct: 180 GVLLYEMLTGKPPFYA 195
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 2e-29
Identities = 70/244 (28%), Positives = 120/244 (49%), Gaps = 32/244 (13%)
Query: 96 EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYC---------SQEVAIKVLKPECV 146
E+P D WE +L + + G +G + + VA+K+LK +
Sbjct: 3 ELPED--PRWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT 60
Query: 147 NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV- 204
+ L + E+ +M+ I +HKN++ +GACT+ L ++ E+ ++G++ ++L ++
Sbjct: 61 EKD-LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 119
Query: 205 --------------FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
L+ V++GM YL IHRDL N+L+ EN V+K+A
Sbjct: 120 MEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIA 179
Query: 251 DFGVARVQAQSGVMTAETG---TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELP 306
DFG+AR T +WMAPE + + Y +++DV+SFG+ +WE+ T G P
Sbjct: 180 DFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 239
Query: 307 YAGL 310
Y G+
Sbjct: 240 YPGI 243
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 113 bits (283), Expect = 3e-29
Identities = 70/215 (32%), Positives = 118/215 (54%), Gaps = 15/215 (6%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVY 159
E + K++K+ + SG++G +YKG + VAIKVL+ E + + KE E Y
Sbjct: 6 ETELKKVKV---LGSGAFGTVYKGIWIPDGENVKIPVAIKVLR-ENTSPKANKEILDEAY 61
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
+M + V + +G C + +VT+ M G + D++ + K LL + ++K
Sbjct: 62 VMAGVGSPYVCRLLGICL-TSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAK 120
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAP 276
GM+YL + ++HRDL N+L+ VK+ DFG+AR + A+ G +WMA
Sbjct: 121 GMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMAL 180
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGL 310
E I H+ + +++DV+S+G+ +WEL+T G PY G+
Sbjct: 181 ESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI 215
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 3e-29
Identities = 59/210 (28%), Positives = 116/210 (55%), Gaps = 6/210 (2%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
+ G++G+ LY+ T V K + ++ + ++ E+ I+ ++H N++ +
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
L I E+ G++YD + +QKG +F+ +L + ++Y+H+ I+HRD+
Sbjct: 68 FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDI 127
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYDYKADVFS 292
KT N+ + + G++K+ DFG++++ M AET GT +M+PE+ + Y++K+D+++
Sbjct: 128 KTLNIFLTKAGLIKLGDFGISKILGSEYSM-AETVVGTPYYMSPELCQGVKYNFKSDIWA 186
Query: 293 FGIALWELLTGELPYAGLTPLQAAVGVVQK 322
G L+ELLT + + PL V +VQ
Sbjct: 187 LGCVLYELLTLKRTFDATNPLNLVVKIVQG 216
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 3e-29
Identities = 75/210 (35%), Positives = 116/210 (55%), Gaps = 14/210 (6%)
Query: 118 VASGSYGDLY--KGTYCSQEVAIKVLKPECVNTEMLKEFSQ---EVYIMRKIRHKNVVQF 172
+ G++G +Y +E+A K ++ + + E KE S E+ +++ ++H+ +VQ+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 173 IGACTR---PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
G C R L I E+M GS+ D L K G + K + +GM+YLH N I
Sbjct: 70 YG-CLRDRAEKTLTIFMEYMPGGSVKDQL-KAYGALTESVTRKYTRQILEGMSYLHSNMI 127
Query: 230 IHRDLKTANLLMDENGVVKVADFGVA-RVQA--QSGV-MTAETGTYRWMAPEVIEHKPYD 285
+HRD+K AN+L D G VK+ DFG + R+Q SG + + TGT WM+PEVI + Y
Sbjct: 128 VHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYG 187
Query: 286 YKADVFSFGIALWELLTGELPYAGLTPLQA 315
KADV+S G + E+LT + P+A + A
Sbjct: 188 RKADVWSLGCTVVEMLTEKPPWAEYEAMAA 217
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 4e-29
Identities = 57/160 (35%), Positives = 90/160 (56%), Gaps = 3/160 (1%)
Query: 157 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAID 216
EV IMR +H N+V+ + L +V EF+ G++ D + + + V +
Sbjct: 66 EVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTR--MNEEQIATVCLA 123
Query: 217 VSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFG-VARVQAQSGVMTAETGTYRWMA 275
V K +++LH +IHRD+K+ ++L+ +G VK++DFG A+V + + GT WMA
Sbjct: 124 VLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMA 183
Query: 276 PEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQA 315
PEVI PY + D++S GI + E++ GE PY PLQA
Sbjct: 184 PEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQA 223
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 4e-29
Identities = 60/163 (36%), Positives = 98/163 (60%), Gaps = 7/163 (4%)
Query: 149 EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLT 208
+ K+ +E+ IM + R +V F GA N+C+ EFM GS+ D ++K+ G +
Sbjct: 45 SVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSL-DRIYKKGGPIPVE 103
Query: 209 SLLKVAIDVSKGMNYLH-QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE 267
L K+A+ V +G+ YL+ + I+HRD+K +N+L++ G +K+ DFGV+ S A+
Sbjct: 104 ILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS---IAD 160
Query: 268 T--GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYA 308
T GT +M+PE I+ Y K+DV+S GI++ EL G+ P+A
Sbjct: 161 TFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFA 203
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 5e-29
Identities = 58/191 (30%), Positives = 110/191 (57%), Gaps = 6/191 (3%)
Query: 117 KVASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
K+ GS+G L K ++ IK + ++ + +E +EV ++ ++H N+VQ+
Sbjct: 7 KIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQE 66
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
+ NL IV ++ G +Y ++ Q+GV F +L + + + ++H I+HRD
Sbjct: 67 SFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRD 126
Query: 234 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYDYKADVF 291
+K+ N+ + ++G +K+ DFG+ARV S V A T GT +++PE+ E++PY+ K+D++
Sbjct: 127 IKSQNIFLTKDGTIKLGDFGIARV-LNSTVELARTCIGTPYYLSPEICENRPYNNKSDIW 185
Query: 292 SFGIALWELLT 302
+ G L+E+ T
Sbjct: 186 ALGCVLYEMCT 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 5e-29
Identities = 65/215 (30%), Positives = 104/215 (48%), Gaps = 36/215 (16%)
Query: 116 CKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFI 173
++ G+YG +YK + VA+K ++ E +E+ +++K+RH N+V+
Sbjct: 5 AQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLK 64
Query: 174 GACTRPPNLCIVTEFMARGSIY--------DF--LHKQKGV-F---QLTSLLKVAIDVSK 219
IVT +GSIY D L V F Q+ +K + +
Sbjct: 65 ---------EIVTS-KGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLL---E 111
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA--QSGVMTAETGT--YRWMA 275
G+ YLH N I+HRD+K +N+L++ +GV+K+ADFG+AR S T T YR
Sbjct: 112 GLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYR--P 169
Query: 276 PEVIEH-KPYDYKADVFSFGIALWELLTGELPYAG 309
PE++ Y + D++S G L EL G+ + G
Sbjct: 170 PELLLGATRYGPEVDMWSVGCILAELFLGKPIFQG 204
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 6e-29
Identities = 66/205 (32%), Positives = 104/205 (50%), Gaps = 36/205 (17%)
Query: 136 VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY 195
VA+K+L+P+ N +F +EV I+ +++ N+++ +G C LC++TE+M G +
Sbjct: 49 VAVKILRPD-ANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLN 107
Query: 196 DFLHK------------------QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 237
FL +SLL VA+ ++ GM YL N +HRDL T
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATR 167
Query: 238 NLLMDENGVVKVADFGVA---------RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKA 288
N L+ EN +K+ADFG++ R+Q ++ + RWMA E I + +
Sbjct: 168 NCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVL------PIRWMAWECILMGKFTTAS 221
Query: 289 DVFSFGIALWELLT--GELPYAGLT 311
DV++FG+ LWE+L E PY LT
Sbjct: 222 DVWAFGVTLWEILMLCKEQPYGELT 246
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 9e-29
Identities = 69/215 (32%), Positives = 110/215 (51%), Gaps = 22/215 (10%)
Query: 118 VASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQF 172
+ G++G + K + AIK +K E + + ++F+ E+ ++ K+ H N++
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAGELEVLCKLGHHPNIINL 61
Query: 173 IGACTRPPNLCIVTEFMARGSIYDFLHKQK---------------GVFQLTSLLKVAIDV 217
+GAC L + E+ G++ DFL K + LL A DV
Sbjct: 62 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 121
Query: 218 SKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPE 277
++GM+YL Q IHRDL N+L+ EN V K+ADFG++R Q T RWMA E
Sbjct: 122 ARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIE 181
Query: 278 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLT 311
+ + Y +DV+S+G+ LWE+++ G PY G+T
Sbjct: 182 SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 216
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 9e-29
Identities = 56/192 (29%), Positives = 98/192 (51%), Gaps = 7/192 (3%)
Query: 117 KVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
K+ G+YG +YK + VAIK +K + + K +E+ +++++ H N+++ +
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
+L +V EFM +Y + ++ + + + +G+ + H + I+HRDL
Sbjct: 66 VFRHKGDLYLVFEFM-DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDL 124
Query: 235 KTANLLMDENGVVKVADFGVARVQA-QSGVMTAETGTYRWM-APEVI-EHKPYDYKADVF 291
K NLL++ GV+K+ADFG+AR T T RW APE++ K Y D++
Sbjct: 125 KPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVT-RWYRAPELLLGDKGYSTPVDIW 183
Query: 292 SFGIALWELLTG 303
S G ELL+
Sbjct: 184 SVGCIFAELLSR 195
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 2e-28
Identities = 73/207 (35%), Positives = 113/207 (54%), Gaps = 14/207 (6%)
Query: 121 GSYGDLY--KGTYCSQEVAIKVL--KPECVNT-EMLKEFSQEVYIMRKIRHKNVVQFIGA 175
G++G++Y +E+A+K + P+ T + + E+ +++ +RH +VQ+ G
Sbjct: 13 GAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYG- 71
Query: 176 CTRPP---NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHR 232
C R P L I E+M GSI D L K G + + +G++YLH N I+HR
Sbjct: 72 CLRDPEEKKLSIFVEYMPGGSIKDQL-KAYGALTENVTRRYTRQILQGVSYLHSNMIVHR 130
Query: 233 DLKTANLLMDENGVVKVADFGVA-RVQA--QSGV-MTAETGTYRWMAPEVIEHKPYDYKA 288
D+K AN+L D G VK+ DFG + R+Q SG + + TGT WM+PEVI + Y KA
Sbjct: 131 DIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKA 190
Query: 289 DVFSFGIALWELLTGELPYAGLTPLQA 315
DV+S + E+LT + P+A + A
Sbjct: 191 DVWSVACTVVEMLTEKPPWAEYEAMAA 217
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-28
Identities = 61/173 (35%), Positives = 98/173 (56%), Gaps = 9/173 (5%)
Query: 136 VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--PNLCIVTEFMARGS 193
VA+K LK EC + + +E+ I++ + H+N+V++ G C+ L ++ E++ GS
Sbjct: 36 VAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGS 94
Query: 194 IYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFG 253
+ D+L K K L LL A + +GM YLH + IHRDL N+L+D + +VK+ DFG
Sbjct: 95 LRDYLPKHK--LNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFG 152
Query: 254 VARV--QAQSGVMTAETGTYR--WMAPEVIEHKPYDYKADVFSFGIALWELLT 302
+A+ + E G W A E ++ + Y +DV+SFG+ L+ELLT
Sbjct: 153 LAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-28
Identities = 73/227 (32%), Positives = 119/227 (52%), Gaps = 17/227 (7%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEV--AIKVLKPECVNTEMLKEFSQEVYI 160
+ WEI + + G++G +YK V A KV+ + + E L+++ E+ I
Sbjct: 5 EFWEIIGE-------LGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDI 55
Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 220
+ H N+V+ + A NL I+ EF A G++ + + + + V +
Sbjct: 56 LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEA 115
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTAETGTYRWMAPEVI 279
+NYLH+N IIHRDLK N+L +G +K+ADFGV+ ++ + GT WMAPEV+
Sbjct: 116 LNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVV 175
Query: 280 -----EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321
+ +PYDYKADV+S GI L E+ E P+ L P++ + + +
Sbjct: 176 MCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAK 222
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 2e-28
Identities = 61/218 (27%), Positives = 118/218 (54%), Gaps = 17/218 (7%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNT-------EMLKEFSQEV 158
E + ++LK+ + SG +G ++KG + + +IK+ P + T + +E + +
Sbjct: 6 ETELRKLKL---LGSGVFGTVHKGIWIPEGDSIKI--PVAIKTIQDRSGRQTFQEITDHM 60
Query: 159 YIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVS 218
M + H +V+ +G C +L +VT+ GS+ D + + + LL + ++
Sbjct: 61 LAMGSLDHAYIVRLLGICP-GASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIA 119
Query: 219 KGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV---QAQSGVMTAETGTYRWMA 275
KGM YL ++ ++HR+L N+L+ + +V++ADFGVA + + + +WMA
Sbjct: 120 KGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMA 179
Query: 276 PEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTP 312
E I Y +++DV+S+G+ +WE+++ G PYAG+ P
Sbjct: 180 LESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRP 217
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 110 bits (275), Expect = 3e-28
Identities = 73/209 (34%), Positives = 113/209 (54%), Gaps = 12/209 (5%)
Query: 118 VASGSYGDLY--KGTYCSQEVAIKVLKPECVNTEMLKEFSQ---EVYIMRKIRHKNVVQF 172
+ G++G +Y +E+A+K ++ + + E KE + E+ +++ + H+ +VQ+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 173 IGACTRPP--NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 230
G P L I E M GSI D L K G K + +G++YLH N I+
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGSIKDQL-KSYGALTENVTRKYTRQILEGVSYLHSNMIV 128
Query: 231 HRDLKTANLLMDENGVVKVADFGVA-RVQA--QSGV-MTAETGTYRWMAPEVIEHKPYDY 286
HRD+K AN+L D G VK+ DFG + R+Q SG M + TGT WM+PEVI + Y
Sbjct: 129 HRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGR 188
Query: 287 KADVFSFGIALWELLTGELPYAGLTPLQA 315
KAD++S G + E+LT + P+A + A
Sbjct: 189 KADIWSVGCTVVEMLTEKPPWAEFEAMAA 217
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 3e-28
Identities = 63/199 (31%), Positives = 113/199 (56%), Gaps = 7/199 (3%)
Query: 117 KVASGSYGDLY--KGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
K+ GS+G +Y K S+ IK + + + + +EV ++ K++H N+V F
Sbjct: 7 KIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFA 66
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
+ L IV E+ G + +++Q+GV F +L + +S G+ ++H I+HRD
Sbjct: 67 SFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRD 126
Query: 234 LKTANLLMDENGVV-KVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYDYKADV 290
+K+ N+ + +NG+V K+ DFG+AR S + A T GT +++PE+ +++PY+ K D+
Sbjct: 127 IKSQNIFLSKNGMVAKLGDFGIARQLNDS-MELAYTCVGTPYYLSPEICQNRPYNNKTDI 185
Query: 291 FSFGIALWELLTGELPYAG 309
+S G L+EL T + P+ G
Sbjct: 186 WSLGCVLYELCTLKHPFEG 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 5e-28
Identities = 63/195 (32%), Positives = 105/195 (53%), Gaps = 18/195 (9%)
Query: 136 VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY 195
VA+K+L+ + N +F +E+ IM +++ N+++ + C LC++TE+M G +
Sbjct: 49 VAVKMLRED-ANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107
Query: 196 DFL--HKQKG--------VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG 245
FL H+ + ++L+ +A ++ GM YL N +HRDL T N L+ +N
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNY 167
Query: 246 VVKVADFGVARVQAQSGVMTAETG----TYRWMAPEVIEHKPYDYKADVFSFGIALWELL 301
+K+ADFG++R SG G RWM+ E I + +DV++FG+ LWE+L
Sbjct: 168 TIKIADFGMSR-NLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEIL 226
Query: 302 T--GELPYAGLTPLQ 314
T E PY+ L+ Q
Sbjct: 227 TLCKEQPYSQLSDEQ 241
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 7e-28
Identities = 68/203 (33%), Positives = 110/203 (54%), Gaps = 9/203 (4%)
Query: 117 KVASGSYGDLYKGT--YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
K+ GS G + T + ++VA+K K + + + EV IMR H+NVV
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVK--KMDLRKQQRRELLFNEVVIMRDYHHENVVDMYN 86
Query: 175 ACTRPPNLCIVTEFMARGSIYDFL-HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
+ L +V EF+ G++ D + H + Q+ + V + V + ++YLH +IHRD
Sbjct: 87 SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT---VCLSVLRALSYLHNQGVIHRD 143
Query: 234 LKTANLLMDENGVVKVADFG-VARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFS 292
+K+ ++L+ +G +K++DFG A+V + + GT WMAPEVI PY + D++S
Sbjct: 144 IKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWS 203
Query: 293 FGIALWELLTGELPYAGLTPLQA 315
GI + E++ GE PY PLQA
Sbjct: 204 LGIMVIEMIDGEPPYFNEPPLQA 226
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 7e-28
Identities = 65/203 (32%), Positives = 110/203 (54%), Gaps = 17/203 (8%)
Query: 117 KVASGSYGDLYKGTYCSQ----EVAIKVLKPE---CVNTEMLKEFSQEVYIMRKIRHKNV 169
++ SG++G + KG Y + +VAIKVLK E V EM++E IM ++ + +
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMRE----AEIMHQLDNPYI 57
Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
V+ IG C L +V E + G + FL +K +++++++ VS GM YL N
Sbjct: 58 VRMIGVC-EAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNF 116
Query: 230 IHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETG---TYRWMAPEVIEHKPYD 285
+HRDL N+L+ K++DFG+++ + A A + +W APE I + +
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS 176
Query: 286 YKADVFSFGIALWELLT-GELPY 307
++DV+S+GI +WE + G+ PY
Sbjct: 177 SRSDVWSYGITMWEAFSYGQKPY 199
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-27
Identities = 62/204 (30%), Positives = 104/204 (50%), Gaps = 20/204 (9%)
Query: 136 VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY 195
VA+K LK + ++F +E ++ ++H+++V+F G CT L +V E+M G +
Sbjct: 38 VAVKALKE--ASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLN 95
Query: 196 DFLHKQK--------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM 241
FL G L +L +A ++ GM YL + +HRDL T N L+
Sbjct: 96 RFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLV 155
Query: 242 DENGVVKVADFGVARVQAQSGVMTAETGTY---RWMAPEVIEHKPYDYKADVFSFGIALW 298
+ VVK+ DFG++R + T RWM PE I ++ + ++D++SFG+ LW
Sbjct: 156 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLW 215
Query: 299 ELLT-GELPYAGLTPLQAAVGVVQ 321
E+ T G+ P+ L+ +A + Q
Sbjct: 216 EIFTYGKQPWYQLSNTEAIECITQ 239
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 1e-27
Identities = 62/196 (31%), Positives = 101/196 (51%), Gaps = 21/196 (10%)
Query: 136 VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY 195
VA+K LK K+F +E ++ ++H+++V+F G C L +V E+M G +
Sbjct: 38 VAVKALKDP--TLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLN 95
Query: 196 DFLH---------------KQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL 240
FL + KG L+ +L +A ++ GM YL + +HRDL T N L
Sbjct: 96 KFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCL 155
Query: 241 MDENGVVKVADFGVARVQAQSGVMTAETGTY---RWMAPEVIEHKPYDYKADVFSFGIAL 297
+ N +VK+ DFG++R + T RWM PE I ++ + ++DV+SFG+ L
Sbjct: 156 VGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVIL 215
Query: 298 WELLT-GELPYAGLTP 312
WE+ T G+ P+ L+
Sbjct: 216 WEIFTYGKQPWFQLSN 231
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 1e-27
Identities = 67/213 (31%), Positives = 107/213 (50%), Gaps = 34/213 (15%)
Query: 116 CKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQ-EVYIMRKIRHKNV 169
V G+YG + K C + VAIK K E + E +K+ + EV ++R++RH+N+
Sbjct: 7 GVVGEGAYGVVLK---CRNKATGEIVAIKKFK-ESEDDEDVKKTALREVKVLRQLRHENI 62
Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG----------VFQLTSLLKVAIDVSK 219
V A R L +V E++ R ++ + L G ++QL +
Sbjct: 63 VNLKEAFRRKGRLYLVFEYVER-TLLELLEASPGGLPPDAVRSYIWQLL----------Q 111
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTYRWM-APE 277
+ Y H +NIIHRD+K N+L+ E+GV+K+ DFG AR ++A+ + RW APE
Sbjct: 112 AIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPE 171
Query: 278 V-IEHKPYDYKADVFSFGIALWELLTGELPYAG 309
+ + Y DV++ G + ELL GE + G
Sbjct: 172 LLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPG 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-27
Identities = 64/197 (32%), Positives = 100/197 (50%), Gaps = 8/197 (4%)
Query: 118 VASGSYGDLYKGTYCSQEV--AIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
+ G +G + S+ A+K + K V T + E I+ + H +V+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVF-QLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
+ ++ E+ G ++ L +G+F + T+ +A V YLH II+RD
Sbjct: 61 TFKDKKYIYMLMEYCLGGELWTILRD-RGLFDEYTARFYIACVVL-AFEYLHNRGIIYRD 118
Query: 234 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKADVFS 292
LK NLL+D NG VK+ DFG A+ + +SG T GT ++APE+I +K YD+ D +S
Sbjct: 119 LKPENLLLDSNGYVKLVDFGFAK-KLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWS 177
Query: 293 FGIALWELLTGELPYAG 309
GI L+ELLTG P+
Sbjct: 178 LGILLYELLTGRPPFGE 194
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 2e-27
Identities = 63/208 (30%), Positives = 103/208 (49%), Gaps = 32/208 (15%)
Query: 113 KIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKE---FS--QEVYIMRKIR 165
+ K+ G+Y +YK + VAIK +K + K+ F+ +E+ ++++++
Sbjct: 3 EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLG--ERKEAKDGINFTALREIKLLQELK 60
Query: 166 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVS------- 218
H N++ + N+ +V EFM D + V + S++ D+
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFME----TDL----EKVIKDKSIVLTPADIKSYMLMTL 112
Query: 219 KGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAETGTYRWM-AP 276
+G+ YLH N I+HRDLK NLL+ +GV+K+ADFG+AR MT + T RW AP
Sbjct: 113 RGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVT-RWYRAP 171
Query: 277 EVI---EHKPYDYKADVFSFGIALWELL 301
E++ H Y D++S G ELL
Sbjct: 172 ELLFGARH--YGVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 2e-27
Identities = 64/203 (31%), Positives = 110/203 (54%), Gaps = 9/203 (4%)
Query: 117 KVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFS-QEVYIMRKIRHKNVVQFI 173
K+ G+ G ++ + QEVAIK + + + KE E+ +M+++++ N+V F+
Sbjct: 26 KIGQGASGTVFTAIDVATGQEVAIKQIN---LQKQPKKELIINEILVMKELKNPNIVNFL 82
Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
+ L +V E++A GS+ D + + + V + + + +LH N +IHRD
Sbjct: 83 DSFLVGDELFVVMEYLAGGSLTDVV--TETCMDEAQIAAVCRECLQALEFLHANQVIHRD 140
Query: 234 LKTANLLMDENGVVKVADFG-VARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFS 292
+K+ N+L+ +G VK+ DFG A++ + + GT WMAPEV+ K Y K D++S
Sbjct: 141 IKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWS 200
Query: 293 FGIALWELLTGELPYAGLTPLQA 315
GI E++ GE PY PL+A
Sbjct: 201 LGIMAIEMVEGEPPYLNENPLRA 223
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 2e-27
Identities = 65/236 (27%), Positives = 116/236 (49%), Gaps = 35/236 (14%)
Query: 111 QLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQEVYIMRK 163
L + + G +G + K T VA+K+LK E ++ L++ E ++++
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLK-ENASSSELRDLLSEFNLLKQ 59
Query: 164 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV------------------- 204
+ H +V++ GAC++ L ++ E+ GS+ FL + + V
Sbjct: 60 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNP 119
Query: 205 ----FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQA 259
+ L+ A +S+GM YL + ++HRDL N+L+ E +K++DFG++R V
Sbjct: 120 DERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYE 179
Query: 260 QSGVMTAETG--TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTP 312
+ + G +WMA E + Y ++DV+SFG+ LWE++T G PY G+ P
Sbjct: 180 EDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP 235
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 108 bits (270), Expect = 3e-27
Identities = 65/203 (32%), Positives = 109/203 (53%), Gaps = 9/203 (4%)
Query: 117 KVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFS-QEVYIMRKIRHKNVVQFI 173
K+ G+ G +Y QEVAIK + + + KE E+ +MR+ ++ N+V ++
Sbjct: 26 KIGQGASGTVYTAIDIATGQEVAIKQMN---LQQQPKKELIINEILVMRENKNPNIVNYL 82
Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
+ L +V E++A GS+ D + + + V + + +++LH N +IHRD
Sbjct: 83 DSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALDFLHSNQVIHRD 140
Query: 234 LKTANLLMDENGVVKVADFG-VARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFS 292
+K+ N+L+ +G VK+ DFG A++ + + GT WMAPEV+ K Y K D++S
Sbjct: 141 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWS 200
Query: 293 FGIALWELLTGELPYAGLTPLQA 315
GI E++ GE PY PL+A
Sbjct: 201 LGIMAIEMVEGEPPYLNENPLRA 223
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 3e-27
Identities = 68/205 (33%), Positives = 113/205 (55%), Gaps = 9/205 (4%)
Query: 117 KVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
+V SG+YGD+YK + + A+K++K E + L QE++++++ +H N+V + G
Sbjct: 16 RVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSL--IQQEIFMVKECKHCNIVAYFG 73
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
+ L I E+ GS+ D H + +L + V + +G+ YLH +HRD+
Sbjct: 74 SYLSREKLWICMEYCGGGSLQDIYHVTGPLSEL-QIAYVCRETLQGLAYLHSKGKMHRDI 132
Query: 235 KTANLLMDENGVVKVADFGV-ARVQAQSGVMTAETGTYRWMAPEVI---EHKPYDYKADV 290
K AN+L+ +NG VK+ADFGV A++ A + GT WMAPEV ++ Y+ D+
Sbjct: 133 KGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDI 192
Query: 291 FSFGIALWELLTGELPYAGLTPLQA 315
++ GI EL + P L P++A
Sbjct: 193 WAVGITAIELAELQPPMFDLHPMRA 217
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 5e-27
Identities = 75/224 (33%), Positives = 115/224 (51%), Gaps = 12/224 (5%)
Query: 112 LKIECKVASGSYGDLYKGTYCSQEVAIKVLK-PECVNTEMLKEFSQEVYI-MRKIRHKNV 169
L++ ++ G+YG + K + + V + VN++ K ++ I MR +
Sbjct: 3 LEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYT 62
Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHK--QKGVFQLTSLL-KVAIDVSKGMNYLHQ 226
V F GA R ++ I E M S+ F K KG+ +L K+A+ + K + YLH
Sbjct: 63 VTFYGALFREGDVWICMEVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS 121
Query: 227 N-NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVI----EH 281
++IHRD+K +N+L++ NG VK+ DFG++ S T + G +MAPE I
Sbjct: 122 KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQ 181
Query: 282 KPYDYKADVFSFGIALWELLTGELPYAGL-TPLQAAVGVVQKVS 324
K YD K+DV+S GI + EL TG PY TP Q VV++ S
Sbjct: 182 KGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPS 225
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 6e-27
Identities = 75/252 (29%), Positives = 127/252 (50%), Gaps = 29/252 (11%)
Query: 73 KRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQL----KIECKVASGSYGDLYK 128
+R P+L VP+ L SS + + + AK L ++ ++ SG+ G +YK
Sbjct: 36 QRDPSLAVPL--PLPPPSSSSSSSSSSSASGSAPSAAKSLSELERVN-RIGSGAGGTVYK 92
Query: 129 GTY--CSQEVAIKVLKPECVNTE--MLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI 184
+ + A+KV+ N E + ++ +E+ I+R + H NVV+ + +
Sbjct: 93 VIHRPTGRLYALKVIYG---NHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQV 149
Query: 185 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN 244
+ EFM GS+ + + L VA + G+ YLH+ +I+HRD+K +NLL++
Sbjct: 150 LLEFMDGGSL-----EGTHIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSA 204
Query: 245 GVVKVADFGVARVQAQSGVM---TAETGTYRWMAPEVI----EHKPYD-YKADVFSFGIA 296
VK+ADFGV+R+ AQ+ M + GT +M+PE I H YD Y D++S G++
Sbjct: 205 KNVKIADFGVSRILAQT--MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVS 262
Query: 297 LWELLTGELPYA 308
+ E G P+
Sbjct: 263 ILEFYLGRFPFG 274
|
Length = 353 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 6e-27
Identities = 63/203 (31%), Positives = 113/203 (55%), Gaps = 11/203 (5%)
Query: 117 KVASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF 172
++ SG++G + KG Y + VA+K+LK + + + E +E +M+++ + +V+
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 173 IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHR 232
IG C + +V E G + FL K K V + ++ ++ VS GM YL + N +HR
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFLQKNKHVTE-KNITELVHQVSMGMKYLEETNFVHR 119
Query: 233 DLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAET-GTY--RWMAPEVIEHKPYDYKA 288
DL N+L+ K++DFG+++ + A A+T G + +W APE + + + K+
Sbjct: 120 DLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKS 179
Query: 289 DVFSFGIALWELLT-GELPYAGL 310
DV+SFG+ +WE + G+ PY G+
Sbjct: 180 DVWSFGVLMWEAFSYGQKPYKGM 202
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 8e-27
Identities = 64/214 (29%), Positives = 106/214 (49%), Gaps = 12/214 (5%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLK-PECVNTEMLKEFSQEVYIMRK 163
+ D L+ ++ SG+ G +YK + + V + N E K ++ ++ K
Sbjct: 10 YPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLK 69
Query: 164 IRH--KNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKG 220
H +V+ G ++ I E M+ + D L K+ +G L K+ + + K
Sbjct: 70 -SHDCPYIVKCYGYFITDSDVFICMELMS--TCLDKLLKRIQGPIPEDILGKMTVAIVKA 126
Query: 221 MNYLHQN-NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVI 279
++YL + +IHRD+K +N+L+D +G VK+ DFG++ S T G +MAPE I
Sbjct: 127 LHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERI 186
Query: 280 EHKP----YDYKADVFSFGIALWELLTGELPYAG 309
+ YD +ADV+S GI+L EL TG+ PY
Sbjct: 187 DPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 8e-27
Identities = 66/201 (32%), Positives = 107/201 (53%), Gaps = 5/201 (2%)
Query: 117 KVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC 176
K+ GS G + T S + V K + + + EV IMR +H+NVV+ +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 177 TRPPNLCIVTEFMARGSIYDFL-HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 235
L +V EF+ G++ D + H + Q+ + V + V K ++ LH +IHRD+K
Sbjct: 87 LVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA---VCLAVLKALSVLHAQGVIHRDIK 143
Query: 236 TANLLMDENGVVKVADFG-VARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 294
+ ++L+ +G VK++DFG A+V + + GT WMAPE+I PY + D++S G
Sbjct: 144 SDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLG 203
Query: 295 IALWELLTGELPYAGLTPLQA 315
I + E++ GE PY PL+A
Sbjct: 204 IMVIEMVDGEPPYFNEPPLKA 224
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 9e-27
Identities = 69/223 (30%), Positives = 112/223 (50%), Gaps = 17/223 (7%)
Query: 100 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEV--AIKVLKPECVNTEMLKEFSQE 157
D +VWEI + + G++G +YK A KV+ E + E L+++ E
Sbjct: 9 DPNEVWEIIGE-------LGDGAFGKVYKAKNKETGALAAAKVI--ETKSEEELEDYMVE 59
Query: 158 VYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDV 217
+ I+ H +V+ +GA L I+ EF G++ + + + + +
Sbjct: 60 IEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQM 119
Query: 218 SKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTAETGTYRWMAP 276
+ + YLH IIHRDLK N+L+ +G +K+ADFGV+ ++ + GT WMAP
Sbjct: 120 LEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAP 179
Query: 277 EVI-----EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ 314
EV+ + PYDYKAD++S GI L E+ E P+ L P++
Sbjct: 180 EVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR 222
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 9e-27
Identities = 63/203 (31%), Positives = 103/203 (50%), Gaps = 11/203 (5%)
Query: 121 GSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEV-YIMRKIRHKNVVQFIGACT 177
G++G + K + +A+K ++ E K ++ +MR +V+F GA
Sbjct: 15 GAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQ-KRLLMDLDVVMRSSDCPYIVKFYGALF 73
Query: 178 RPPNLCIVTEFM--ARGSIYDFLH-KQKGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRD 233
R + I E M + Y +++ K V L K+A+ K +NYL + IIHRD
Sbjct: 74 REGDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRD 133
Query: 234 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE---HKPYDYKADV 290
+K +N+L+D NG +K+ DFG++ S T + G +MAPE I+ YD ++DV
Sbjct: 134 VKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDV 193
Query: 291 FSFGIALWELLTGELPYAGLTPL 313
+S GI L+E+ TG+ PY +
Sbjct: 194 WSLGITLYEVATGKFPYPKWNSV 216
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 1e-26
Identities = 64/203 (31%), Positives = 108/203 (53%), Gaps = 9/203 (4%)
Query: 117 KVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFS-QEVYIMRKIRHKNVVQFI 173
K+ G+ G +Y QEVAI+ + + + KE E+ +MR+ ++ N+V ++
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYL 83
Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
+ L +V E++A GS+ D + + + V + + + +LH N +IHRD
Sbjct: 84 DSYLVGDELWVVMEYLAGGSLTDVV--TETCMDEGQIAAVCRECLQALEFLHSNQVIHRD 141
Query: 234 LKTANLLMDENGVVKVADFG-VARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFS 292
+K+ N+L+ +G VK+ DFG A++ + + GT WMAPEV+ K Y K D++S
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWS 201
Query: 293 FGIALWELLTGELPYAGLTPLQA 315
GI E++ GE PY PL+A
Sbjct: 202 LGIMAIEMIEGEPPYLNENPLRA 224
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 2e-26
Identities = 59/190 (31%), Positives = 104/190 (54%), Gaps = 5/190 (2%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
V GSYG+ L + ++ IK L + K QE ++ +++H N+V + +
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 176 CTRPPN-LCIVTEFMARGSIYDFLHKQKGVFQLTS-LLKVAIDVSKGMNYLHQNNIIHRD 233
L IV F G +Y L +QKG + +++ + ++ + YLH+ +I+HRD
Sbjct: 68 WEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRD 127
Query: 234 LKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFS 292
LKT N+ + ++KV D G+ARV + Q + + GT +M+PE+ +KPY+YK+DV++
Sbjct: 128 LKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWA 187
Query: 293 FGIALWELLT 302
G ++E+ T
Sbjct: 188 LGCCVYEMAT 197
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 105 bits (265), Expect = 2e-26
Identities = 55/239 (23%), Positives = 101/239 (42%), Gaps = 36/239 (15%)
Query: 113 KIECKVASGSYGDLYKGT--YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-----R 165
K + GS+ + ++E AIK+L + E K + V I +++
Sbjct: 4 KFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEK-KV--KYVKIEKEVLTRLNG 60
Query: 166 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 225
H +++ NL V E+ G + ++ K G A ++ + YLH
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKY-GSLDEKCTRFYAAEILLALEYLH 119
Query: 226 QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET----------------- 268
IIHRDLK N+L+D++ +K+ DFG A+V + +
Sbjct: 120 SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRF 179
Query: 269 ----GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKV 323
GT +++PE++ KP +D+++ G ++++LTG+ P+ G QK+
Sbjct: 180 ASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL----TFQKI 234
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-26
Identities = 62/214 (28%), Positives = 105/214 (49%), Gaps = 29/214 (13%)
Query: 121 GSYGDLY----KGTYCSQE---VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFI 173
G +G+++ KG V +K L+ + EF +E+ + RK+ HKNVV+ +
Sbjct: 16 GEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDE-NLQSEFRRELDMFRKLSHKNVVRLL 74
Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ------LTSLLKVAI--DVSKGMNYLH 225
G C ++ E+ G + FL K + L++ KVA+ ++ GM++L
Sbjct: 75 GLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLS 134
Query: 226 QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY-------RWMAPEV 278
+HRDL N L+ VKV+ +++ V +E RW+APE
Sbjct: 135 NARFVHRDLAARNCLVSSQREVKVSLLSLSK-----DVYNSEYYKLRNALIPLRWLAPEA 189
Query: 279 IEHKPYDYKADVFSFGIALWELLT-GELPYAGLT 311
++ + K+DV+SFG+ +WE+ T GELP+ GL+
Sbjct: 190 VQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS 223
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 63/200 (31%), Positives = 105/200 (52%), Gaps = 10/200 (5%)
Query: 120 SGSYGD----LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
+GS+G +KG+ + A+K+L K + V + ++ E I++ IRH +V G
Sbjct: 11 TGSFGRVMLVRHKGSG--KYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYG 68
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
+ NL +V E++ G ++ L ++ G F A V + YLH +I++RDL
Sbjct: 69 SFQDDSNLYLVMEYVPGGELFSHL-RKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDL 127
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 294
K NLL+D +G +K+ DFG A+ + T GT ++APE+I K Y D ++ G
Sbjct: 128 KPENLLLDSDGYIKITDFGFAKR-VKGRTYTL-CGTPEYLAPEIILSKGYGKAVDWWALG 185
Query: 295 IALWELLTGELPYAGLTPLQ 314
I ++E+L G P+ P+Q
Sbjct: 186 ILIYEMLAGYPPFFDDNPIQ 205
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-26
Identities = 48/189 (25%), Positives = 103/189 (54%), Gaps = 4/189 (2%)
Query: 118 VASGSYGDLY--KGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
V G++G ++ + + V IK + E + + E +++ + H N++++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
L IV E+ G++ +++ K+ + ++L + + ++++H I+HRDL
Sbjct: 68 FLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDL 127
Query: 235 KTANLLMDENG-VVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
KT N+L+D++ VVK+ DFG++++ + GT +++PE+ E KPY+ K+D+++
Sbjct: 128 KTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWAL 187
Query: 294 GIALWELLT 302
G L+EL +
Sbjct: 188 GCVLYELAS 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 3e-26
Identities = 65/218 (29%), Positives = 107/218 (49%), Gaps = 31/218 (14%)
Query: 118 VASGSYGDLYKGTYCSQE----VAIKVLKPE-CVNTEMLKEFSQEVYIMRKIRHKNVVQF 172
+ G +G + +G + VA+K +K C +EM ++F E M++ H NV++
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEM-EDFLSEAVCMKEFDHPNVMRL 65
Query: 173 IGACTRP------PNLCIVTEFMARGSIYDFL-----HKQKGVFQLTSLLKVAIDVSKGM 221
IG C + P+ ++ FM G ++ FL L+K D++ GM
Sbjct: 66 IGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGM 125
Query: 222 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--------QAQSGVMTAETGTYRW 273
YL + IHRDL N +++EN V VADFG+++ Q + M +W
Sbjct: 126 EYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPV-----KW 180
Query: 274 MAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGL 310
+A E + + Y K+DV+SFG+ +WE+ T G+ PY G+
Sbjct: 181 IAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGV 218
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 3e-26
Identities = 69/213 (32%), Positives = 106/213 (49%), Gaps = 14/213 (6%)
Query: 117 KVASGSYGDLY--KGTYCSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFI 173
++ GS+G +Y + ++ VAIK + + E ++ +EV ++++RH N +++
Sbjct: 22 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYK 81
Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
G R +V E+ GS D L K Q + + +G+ YLH + IHRD
Sbjct: 82 GCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRD 140
Query: 234 LKTANLLMDENGVVKVADFGVARVQ--AQSGVMTAETGTYRWMAPEVI---EHKPYDYKA 288
+K N+L+ E G VK+ADFG A + A S V GT WMAPEVI + YD K
Sbjct: 141 IKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEVILAMDEGQYDGKV 195
Query: 289 DVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321
DV+S GI EL + P + + A + Q
Sbjct: 196 DVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 228
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 3e-26
Identities = 64/218 (29%), Positives = 110/218 (50%), Gaps = 12/218 (5%)
Query: 114 IECKVASGSYGDLY--KGTYCSQEVAIKVLKPECV---NTEMLKEFSQEVYIMRKIRHKN 168
++ ++ GS+G +Y K E +KVLK V N + +QE ++ K+ H
Sbjct: 4 LQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPA 63
Query: 169 VVQFIGACTRPPNLCIVTEFMARGSIYDF----LHKQKGVFQLTSLLKVAIDVSKGMNYL 224
+V+F + CI+TE+ G D L + + I + G++Y+
Sbjct: 64 IVKFHASFLERDAFCIITEY-CEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYM 122
Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTAETGTYRWMAPEVIEHKP 283
HQ I+HRDLK N+ + N ++K+ DFGV+R+ S + T TGT +M+PE ++H+
Sbjct: 123 HQRRILHRDLKAKNIFLKNN-LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQG 181
Query: 284 YDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321
YD K+D++S G L+E+ + G L + +V+
Sbjct: 182 YDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 4e-26
Identities = 67/218 (30%), Positives = 113/218 (51%), Gaps = 25/218 (11%)
Query: 117 KVASGSYGDLYKG---TYCSQE----VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNV 169
++ G++G ++ C ++ VA+K LK N K+F +E ++ ++H+++
Sbjct: 12 ELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNAR--KDFHREAELLTNLQHEHI 69
Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFL--HKQKGVF--------QLTS--LLKVAIDV 217
V+F G C L +V E+M G + FL H V +LT +L +A +
Sbjct: 70 VKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129
Query: 218 SKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY---RWM 274
+ GM YL + +HRDL T N L+ EN +VK+ DFG++R + T RWM
Sbjct: 130 AAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189
Query: 275 APEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLT 311
PE I ++ + ++DV+S G+ LWE+ T G+ P+ L+
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS 227
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 4e-26
Identities = 59/215 (27%), Positives = 102/215 (47%), Gaps = 21/215 (9%)
Query: 117 KVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQ---EVYIMRKIRHKNVVQ 171
+ GS+G + K S + + K + + KE Q EV I+R+++H N+V+
Sbjct: 7 TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTE---KEKQQLVSEVNILRELKHPNIVR 63
Query: 172 FIGACTRPPN--LCIVTEFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLH- 225
+ N L IV E+ G + + K ++ + + ++ + + H
Sbjct: 64 YYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123
Query: 226 ----QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVI 279
N ++HRDLK AN+ +D N VK+ DFG+A++ A+T GT +M+PE +
Sbjct: 124 RSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI-LGHDSSFAKTYVGTPYYMSPEQL 182
Query: 280 EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ 314
H YD K+D++S G ++EL P+ LQ
Sbjct: 183 NHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ 217
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 5e-26
Identities = 60/221 (27%), Positives = 105/221 (47%), Gaps = 23/221 (10%)
Query: 116 CKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNV 169
+ G++G ++ G +EV +K +K + + QE ++ + H+N+
Sbjct: 12 DLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQ-VTLLLQESCLLYGLSHQNI 70
Query: 170 VQFIGACTR---PPNLCIVTEFMARGSIYDFL----HKQKGVFQLTS---LLKVAIDVSK 219
+ + C PP + +M G++ FL + Q S L+ +AI ++
Sbjct: 71 LPILHVCIEDGEPPFVLY--PYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIAC 128
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYR---WMAP 276
GM+YLH+ +IH+D+ N ++DE VK+ D ++R R WMA
Sbjct: 129 GMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMAL 188
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAA 316
E + +K Y +DV+SFG+ LWEL+T G+ PY + P + A
Sbjct: 189 ESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMA 229
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 5e-26
Identities = 72/214 (33%), Positives = 108/214 (50%), Gaps = 10/214 (4%)
Query: 117 KVASGSYGDLY--KGTYCSQEVAIKVLKPECVNT-EMLKEFSQEVYIMRKIRHKNVVQFI 173
++ GS+G +Y + S+ VAIK + + E ++ +EV ++K+RH N +Q+
Sbjct: 22 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
G R +V E+ GS D L K Q + V +G+ YLH +N+IHRD
Sbjct: 82 GCYLREHTAWLVMEY-CLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRD 140
Query: 234 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVI---EHKPYDYKADV 290
+K N+L+ E G+VK+ DFG A + A + GT WMAPEVI + YD K DV
Sbjct: 141 VKAGNILLSEPGLVKLGDFGSASIMAPANXF---VGTPYWMAPEVILAMDEGQYDGKVDV 197
Query: 291 FSFGIALWELLTGELPYAGLTPLQAAVGVVQKVS 324
+S GI EL + P + + A + Q S
Sbjct: 198 WSLGITCIELAERKPPLFNMNAMSALYHIAQNES 231
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 8e-26
Identities = 65/237 (27%), Positives = 115/237 (48%), Gaps = 35/237 (14%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQE 157
WE+ +++ + ++ GS+G +Y+G VAIK + E + EF E
Sbjct: 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERI-EFLNE 59
Query: 158 VYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ---------LT 208
+M++ +VV+ +G ++ ++ E M RG + +L + + L
Sbjct: 60 ASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLK 119
Query: 209 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET 268
++++A +++ GM YL+ N +HRDL N ++ E+ VK+ DFG+ R ET
Sbjct: 120 KMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR-------DIYET 172
Query: 269 GTY----------RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQ 314
Y RWM+PE ++ + +DV+SFG+ LWE+ T E PY G++ Q
Sbjct: 173 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ 229
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 104 bits (259), Expect = 1e-25
Identities = 68/214 (31%), Positives = 108/214 (50%), Gaps = 10/214 (4%)
Query: 117 KVASGSYGDLY--KGTYCSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFI 173
++ GS+G +Y + ++ VAIK + + E ++ +EV +++I+H N +++
Sbjct: 32 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYK 91
Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
G R +V E+ GS D L K Q + + +G+ YLH +N+IHRD
Sbjct: 92 GCYLREHTAWLVMEY-CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRD 150
Query: 234 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVI---EHKPYDYKADV 290
+K N+L+ E G VK+ADFG A + + + GT WMAPEVI + YD K DV
Sbjct: 151 IKAGNILLTEPGQVKLADFGSASIASPANSF---VGTPYWMAPEVILAMDEGQYDGKVDV 207
Query: 291 FSFGIALWELLTGELPYAGLTPLQAAVGVVQKVS 324
+S GI EL + P + + A + Q S
Sbjct: 208 WSLGITCIELAERKPPLFNMNAMSALYHIAQNES 241
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 2e-25
Identities = 61/188 (32%), Positives = 89/188 (47%), Gaps = 9/188 (4%)
Query: 127 YKGTYCSQEVAIKVLKPECV----NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL 182
YK T + AIK LK + E L + RH +V ++
Sbjct: 20 YKKT--GELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHV 77
Query: 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD 242
C V E+ A G + +H VF + A V G+ YLH+N I++RDLK NLL+D
Sbjct: 78 CFVMEYAAGGDL--MMHIHTDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLD 135
Query: 243 ENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKADVFSFGIALWELL 301
G VK+ADFG+ + G T+ GT ++APEV+ Y D + G+ ++E+L
Sbjct: 136 TEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEML 195
Query: 302 TGELPYAG 309
GE P+ G
Sbjct: 196 VGESPFPG 203
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 2e-25
Identities = 65/196 (33%), Positives = 106/196 (54%), Gaps = 13/196 (6%)
Query: 117 KVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFS-QEVYIMRKIRHKNVV 170
V GSYG + K C Q VAIK E + +M+K+ + +E+ +++++RH+N+V
Sbjct: 8 LVGEGSYGMVMK---CKHKETGQIVAIKKFL-ESEDDKMVKKIAMREIRMLKQLRHENLV 63
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 230
I R L +V EF+ ++ D L K + + K + +G+ + H +NII
Sbjct: 64 NLIEVFRRKKRLYLVFEFVDH-TVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNII 122
Query: 231 HRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWM-APEVIEHKP-YDYKA 288
HRD+K N+L+ ++GVVK+ DFG AR A G + + RW APE++ Y
Sbjct: 123 HRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAV 182
Query: 289 DVFSFGIALWELLTGE 304
D+++ G + E+LTGE
Sbjct: 183 DIWAVGCLVTEMLTGE 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-25
Identities = 63/203 (31%), Positives = 110/203 (54%), Gaps = 9/203 (4%)
Query: 117 KVASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEF-SQEVYIMRKIRHKNVVQFI 173
K+ GS G + + + ++VA+K++ + + +E EV IMR +H+NVV+
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMRDYQHQNVVEMY 84
Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
+ L ++ EF+ G++ D + + + + V V + + YLH +IHRD
Sbjct: 85 KSYLVGEELWVLMEFLQGGALTDIVSQTR--LNEEQIATVCESVLQALCYLHSQGVIHRD 142
Query: 234 LKTANLLMDENGVVKVADFG-VARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFS 292
+K+ ++L+ +G VK++DFG A++ + GT WMAPEVI PY + D++S
Sbjct: 143 IKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWS 202
Query: 293 FGIALWELLTGELPYAGLTPLQA 315
GI + E++ GE PY +P+QA
Sbjct: 203 LGIMVIEMVDGEPPYFSDSPVQA 225
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 5e-25
Identities = 50/168 (29%), Positives = 83/168 (49%), Gaps = 1/168 (0%)
Query: 142 KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQ 201
K +CV ++ E I++++ H +V + N+ +V + + G + L Q
Sbjct: 35 KQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHL-SQ 93
Query: 202 KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261
K F + ++ + YLH IIHRD+K N+L+DE G V + DF +A
Sbjct: 94 KVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPD 153
Query: 262 GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAG 309
+ T+ +GT +MAPEV+ + Y D +S G+ +E L G+ PY G
Sbjct: 154 TLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRG 201
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 101 bits (255), Expect = 5e-25
Identities = 48/177 (27%), Positives = 88/177 (49%), Gaps = 12/177 (6%)
Query: 134 QEVAIKVL----KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFM 189
+ VA+K + + + L+E + ++ +H VV+ + +V E+M
Sbjct: 26 ETVALKKVALRRLEGGIPNQALRE----IKALQACQHPYVVKLLDVFPHGSGFVLVMEYM 81
Query: 190 ARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKV 249
+ + L ++ + + KG+ Y+H N I+HRDLK ANLL+ +GV+K+
Sbjct: 82 PS-DLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKI 140
Query: 250 ADFGVARVQA--QSGVMTAETGTYRWMAPEVIEHKP-YDYKADVFSFGIALWELLTG 303
ADFG+AR+ + + + + + T + APE++ YD D+++ G ELL G
Sbjct: 141 ADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNG 197
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 6e-25
Identities = 67/214 (31%), Positives = 108/214 (50%), Gaps = 10/214 (4%)
Query: 117 KVASGSYGDLYKGT--YCSQEVAIKVLKPECVNT-EMLKEFSQEVYIMRKIRHKNVVQFI 173
++ GS+G +Y T + ++ VA+K + T E ++ +EV +++++H N +++
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
G + +V E+ GS D L K Q + + +G+ YLH +N+IHRD
Sbjct: 88 GCYLKEHTAWLVMEY-CLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRD 146
Query: 234 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVI---EHKPYDYKADV 290
+K N+L+ E G VK+ADFG A + + GT WMAPEVI + YD K DV
Sbjct: 147 IKAGNILLTEPGQVKLADFGSASKSSPANSF---VGTPYWMAPEVILAMDEGQYDGKVDV 203
Query: 291 FSFGIALWELLTGELPYAGLTPLQAAVGVVQKVS 324
+S GI EL + P + + A + Q S
Sbjct: 204 WSLGITCIELAERKPPLFNMNAMSALYHIAQNDS 237
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 1e-24
Identities = 56/205 (27%), Positives = 108/205 (52%), Gaps = 9/205 (4%)
Query: 113 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKP-ECVNTEMLKEFSQEVYIMRKIRHKNV 169
KIE K+ G + +YK + VA+K ++ E ++ + ++ +E+ +++++ H NV
Sbjct: 5 KIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNV 64
Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFL---HKQKGVFQLTSLLKVAIDVSKGMNYLHQ 226
++++ + L IV E G + + KQK + ++ K + + + ++H
Sbjct: 65 IKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHS 124
Query: 227 NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPY 284
I+HRD+K AN+ + GVVK+ D G+ R S A + GT +M+PE I Y
Sbjct: 125 KRIMHRDIKPANVFITATGVVKLGDLGLGR-FFSSKTTAAHSLVGTPYYMSPERIHENGY 183
Query: 285 DYKADVFSFGIALWELLTGELPYAG 309
++K+D++S G L+E+ + P+ G
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 3e-24
Identities = 58/200 (29%), Positives = 91/200 (45%), Gaps = 10/200 (5%)
Query: 118 VASGSYGDLY--KGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHK-NVVQFI 173
++ G++G +Y K AIKVL K + + + E IM V +
Sbjct: 4 ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63
Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
+ L +V E++ G + K G + +V G+ LHQ IIHRD
Sbjct: 64 YSFQSKDYLYLVMEYLNGGDCASLI-KTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRD 122
Query: 234 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKADVFS 292
+K NLL+D+ G +K+ DFG++R G+ + GT ++APE I D +D +S
Sbjct: 123 IKPENLLIDQTGHLKLTDFGLSRN----GLENKKFVGTPDYLAPETILGVGDDKMSDWWS 178
Query: 293 FGIALWELLTGELPYAGLTP 312
G ++E L G P+ TP
Sbjct: 179 LGCVIFEFLFGYPPFHAETP 198
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 99.2 bits (247), Expect = 4e-24
Identities = 68/203 (33%), Positives = 104/203 (51%), Gaps = 16/203 (7%)
Query: 121 GSYGDLYKGTYCSQE--VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR 178
G+ G +YK + +A+KV+ P + E+ K+ E+ I+ K ++ F GA
Sbjct: 12 GNGGTVYKAYHLLTRRILAVKVI-PLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFV 70
Query: 179 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTAN 238
+ I TEFM GS+ + + V L ++A+ V KG+ YL I+HRD+K +N
Sbjct: 71 ENRISICTEFMDGGSLDVYRKIPEHV-----LGRIAVAVVKGLTYLWSLKILHRDVKPSN 125
Query: 239 LLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALW 298
+L++ G VK+ DFGV+ Q + + GT +MAPE I + Y +DV+S GI+
Sbjct: 126 MLVNTRGQVKLCDFGVST-QLVNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFM 184
Query: 299 ELLTGELPY-------AGLTPLQ 314
EL G PY L PLQ
Sbjct: 185 ELALGRFPYPQIQKNQGSLMPLQ 207
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 4e-24
Identities = 57/199 (28%), Positives = 101/199 (50%), Gaps = 16/199 (8%)
Query: 121 GSYGDL----YKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-----RHKNVVQ 171
GS+G + KGT + A+KVLK + + + E + +++ +H + Q
Sbjct: 6 GSFGKVLLAELKGT--DELYAVKVLKKDVILQDDDVECTM---TEKRVLALAGKHPFLTQ 60
Query: 172 FIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIH 231
L V E++ G + + + G F A ++ G+ +LH+ II+
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFLHERGIIY 119
Query: 232 RDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKADV 290
RDLK N+L+D G +K+ADFG+ + GV T+ GT ++APE++ ++PY D
Sbjct: 120 RDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDW 179
Query: 291 FSFGIALWELLTGELPYAG 309
++ G+ L+E+L G+ P+ G
Sbjct: 180 WALGVLLYEMLAGQSPFEG 198
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 1e-23
Identities = 80/237 (33%), Positives = 115/237 (48%), Gaps = 35/237 (14%)
Query: 100 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQE 157
D TD WEI IE + G+YG +YK T A+K+L P +++ +E E
Sbjct: 19 DPTDTWEI------IE-TIGKGTYGKVYKVTNKKDGSLAAVKILDPI---SDVDEEIEAE 68
Query: 158 VYIMRKI-RHKNVVQFIGACTRPPN-----LCIVTEFMARGSIYDFLHKQKGVFQLTSLL 211
I++ + H NVV+F G + L +V E GS+ + + KG+ L
Sbjct: 69 YNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV---KGLLICGQRL 125
Query: 212 KVAI------DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT 265
A+ G+ +LH N IIHRD+K N+L+ G VK+ DFGV+ Q S +
Sbjct: 126 DEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVS-AQLTSTRLR 184
Query: 266 AET--GTYRWMAPEVIE-HKPYDY----KADVFSFGIALWELLTGELPYAGLTPLQA 315
T GT WMAPEVI + YDY + DV+S GI EL G+ P + P++
Sbjct: 185 RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT 241
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 97.3 bits (242), Expect = 2e-23
Identities = 65/213 (30%), Positives = 109/213 (51%), Gaps = 17/213 (7%)
Query: 124 GDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183
G+ ++G ++ V +K L+ E L F QEV R++ H NV+Q +G C
Sbjct: 14 GEAHRGMSKAR-VVVKELRASATPDEQL-LFLQEVQPYRELNHPNVLQCLGQCIESIPYL 71
Query: 184 IVTEFMARGSIYDFLHKQKGVF----QLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANL 239
+V EF G + ++L +G+ Q L ++A +V+ G+ +LHQ + IH DL N
Sbjct: 72 LVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNC 131
Query: 240 LMDENGVVKVADFGVARVQ-AQSGVMTAETGTY--RWMAPEVIEH-----KPYDY--KAD 289
+ + VK+ D+G+A Q + +T + RW+APE++E P D K++
Sbjct: 132 QLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSN 191
Query: 290 VFSFGIALWELLT-GELPYAGLTPLQAAVGVVQ 321
++S G+ +WEL T + PY L+ Q VV+
Sbjct: 192 IWSLGVTMWELFTAADQPYPDLSDEQVLKQVVR 224
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 3e-23
Identities = 46/152 (30%), Positives = 80/152 (52%), Gaps = 1/152 (0%)
Query: 157 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI-YDFLHKQKGVFQLTSLLKVAI 215
E I+ K+ + +V A +LC+V M G + Y + + F + A
Sbjct: 43 EKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAA 102
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
+ G+ +LHQ I++RDLK N+L+D++G V+++D G+A + GT +MA
Sbjct: 103 QIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMA 162
Query: 276 PEVIEHKPYDYKADVFSFGIALWELLTGELPY 307
PEV++ + YD+ D F+ G L+E++ G P+
Sbjct: 163 PEVLQGEVYDFSVDWFALGCTLYEMIAGRSPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 96.6 bits (240), Expect = 4e-23
Identities = 63/237 (26%), Positives = 112/237 (47%), Gaps = 35/237 (14%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQE 157
WE+ +++ + ++ GS+G +Y+G VA+K + E + EF E
Sbjct: 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI-EFLNE 59
Query: 158 VYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ---------LT 208
+M+ +VV+ +G ++ +V E MA G + +L + + L
Sbjct: 60 ASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQ 119
Query: 209 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET 268
++++A +++ GM YL+ +HRDL N ++ + VK+ DFG+ R ET
Sbjct: 120 EMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR-------DIYET 172
Query: 269 GTYR----------WMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQ 314
YR WMAPE ++ + +D++SFG+ LWE+ + E PY GL+ Q
Sbjct: 173 DYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ 229
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 6e-23
Identities = 76/236 (32%), Positives = 113/236 (47%), Gaps = 33/236 (13%)
Query: 100 DGTDVWEIDAKQLKIECKVASGSYGDLYK--GTYCSQEVAIKVLKPECVNTEMLKEFSQE 157
D +D WEI IE + G+YG ++K + A+K+L P ++ +E E
Sbjct: 15 DPSDTWEI------IE-TIGKGTYGKVFKVLNKKNGSKAAVKILDPI---HDIDEEIEAE 64
Query: 158 VYIMRKIR-HKNVVQFIGACTRPP-----NLCIVTEFMARGSIYDFLHKQKGVFQLTSLL 211
I++ + H NVV+F G + L +V E GS+ D + KG + +
Sbjct: 65 YNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLV---KGFLKRGERM 121
Query: 212 KVAI------DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV-ARVQAQSGVM 264
+ I + G+ +LH N IHRD+K N+L+ G VK+ DFGV A++ +
Sbjct: 122 EEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR 181
Query: 265 TAETGTYRWMAPEVIE-----HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQA 315
GT WMAPEVI YD + DV+S GI EL G+ P A L P++A
Sbjct: 182 NTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA 237
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 8e-23
Identities = 64/223 (28%), Positives = 100/223 (44%), Gaps = 48/223 (21%)
Query: 113 KIECKVASGSYGDLYKGTY--CSQEVAIKVLK------PECVNTEMLKEFSQEVYIMRKI 164
K+ ++ G++G +Y + VAIK +K EC+N L+E V +RK+
Sbjct: 2 KVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMN---LRE----VKSLRKL 54
Query: 165 -RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG-----------VFQLTSLLK 212
H N+V+ L V E+M G++Y + +KG ++Q+
Sbjct: 55 NEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQ--- 110
Query: 213 VAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYR 272
G+ ++H++ HRDLK NLL+ VVK+ADFG+AR T T R
Sbjct: 111 -------GLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVST-R 162
Query: 273 WM-APEVIEHKP-YDYKADVFSFGIALWELLTGELPYAGLTPL 313
W APE++ Y D+++ G + EL T L PL
Sbjct: 163 WYRAPEILLRSTSYSSPVDIWALGCIMAELYT-------LRPL 198
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 2e-22
Identities = 56/194 (28%), Positives = 109/194 (56%), Gaps = 5/194 (2%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
V GS+G L + Q+ A+K ++ ++ +++ +E ++ K++H N+V F +
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLP-KSSSAVEDSRKEAVLLAKMKHPNIVAFKES 66
Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
+L IV E+ G + + Q+G +F ++L+ + + G+ ++H+ ++HRD+
Sbjct: 67 FEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDI 126
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKADVFSF 293
K+ N+ + +NG VK+ DFG AR+ G GT ++ PE+ E+ PY+ K+D++S
Sbjct: 127 KSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSL 186
Query: 294 GIALWELLTGELPY 307
G L+EL T + P+
Sbjct: 187 GCILYELCTLKHPF 200
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 2e-22
Identities = 53/206 (25%), Positives = 112/206 (54%), Gaps = 9/206 (4%)
Query: 112 LKIECKVASGSYGDLYKGTYC---SQEVAIKVLKP-ECVNTEMLKEFSQEVYIMRKIRHK 167
+IE K+ G + ++Y+ T C + VA+K ++ E ++ + ++ +E+ +++++ H
Sbjct: 4 FQIEKKIGRGQFSEVYRAT-CLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 168 NVVQFIGACTRPPNLCIVTEFMARGSIYD---FLHKQKGVFQLTSLLKVAIDVSKGMNYL 224
NV++++ + L IV E G + + KQK + ++ K + + + ++
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122
Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTYRWMAPEVIEHKP 283
H ++HRD+K AN+ + GVVK+ D G+ R +++ + GT +M+PE I
Sbjct: 123 HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENG 182
Query: 284 YDYKADVFSFGIALWELLTGELPYAG 309
Y++K+D++S G L+E+ + P+ G
Sbjct: 183 YNFKSDIWSLGCLLYEMAALQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.4 bits (235), Expect = 2e-22
Identities = 55/226 (24%), Positives = 115/226 (50%), Gaps = 20/226 (8%)
Query: 111 QLKIECKVASGSYGDLYK------GTYCSQEVAIKVLK-PECVNTEMLKEFSQEVYIMRK 163
L+ V +G++G ++ Y A+KV+ PE + + + E ++++
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYY----ALKVMAIPEVIRLKQEQHVHNEKRVLKE 57
Query: 164 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNY 223
+ H +++ L ++ E++ G ++ +L + G F ++ L A ++ + Y
Sbjct: 58 VSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYL-RNSGRFSNSTGLFYASEIVCALEY 116
Query: 224 LHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTYRWMAPEVIEHK 282
LH I++RDLK N+L+D+ G +K+ DFG A+ ++ ++ + GT ++APEVI+ K
Sbjct: 117 LHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTL---CGTPEYLAPEVIQSK 173
Query: 283 PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIHSI 328
++ D ++ GI ++E+L G P+ P G+ +K+ +
Sbjct: 174 GHNKAVDWWALGILIYEMLVGYPPFFDDNPF----GIYEKILAGKL 215
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 3e-22
Identities = 50/205 (24%), Positives = 106/205 (51%), Gaps = 7/205 (3%)
Query: 112 LKIECKVASGSYGDLYKGTYCSQEVAIKVLKPEC---VNTEMLKEFSQEVYIMRKIRHKN 168
+IE K+ G + ++Y+ T V + + K + ++ + + +E+ +++++ H N
Sbjct: 4 FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63
Query: 169 VVQFIGACTRPPNLCIVTEFMARGSIYDFLH---KQKGVFQLTSLLKVAIDVSKGMNYLH 225
V+++ + L IV E G + + KQK + ++ K + + + ++H
Sbjct: 64 VIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMH 123
Query: 226 QNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTYRWMAPEVIEHKPY 284
++HRD+K AN+ + GVVK+ D G+ R +++ + GT +M+PE I Y
Sbjct: 124 SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGY 183
Query: 285 DYKADVFSFGIALWELLTGELPYAG 309
++K+D++S G L+E+ + P+ G
Sbjct: 184 NFKSDIWSLGCLLYEMAALQSPFYG 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 3e-22
Identities = 59/232 (25%), Positives = 113/232 (48%), Gaps = 27/232 (11%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEV 158
EI+ ++ ++ +G +YKG +Q VAIK LK + + +EF E
Sbjct: 1 EINLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDK-AEGPLREEFKHEA 59
Query: 159 YIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL-----HKQ----------KG 203
+ +++H N+V +G T+ L ++ + + +++FL H K
Sbjct: 60 MMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS 119
Query: 204 VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQS- 261
+ + + ++ GM +L ++++H+DL T N+L+ + VK++D G+ R V A
Sbjct: 120 TLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADY 179
Query: 262 -GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLT 311
+M RWM+PE I + + +D++S+G+ LWE+ + G PY G +
Sbjct: 180 YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS 231
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 8e-22
Identities = 58/196 (29%), Positives = 104/196 (53%), Gaps = 9/196 (4%)
Query: 121 GSYGDLY-----KGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
GS+G ++ G Q A+KVLK + E I+ ++ H +V+ A
Sbjct: 7 GSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYA 66
Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 235
L ++ +F+ G ++ L K+ +F + +++ +++LH II+RDLK
Sbjct: 67 FQTEGKLYLILDFLRGGDLFTRLSKEV-MFTEEDVKFYLAELALALDHLHSLGIIYRDLK 125
Query: 236 TANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYDYKADVFSF 293
N+L+DE G +K+ DFG+++ ++ A + GT +MAPEV+ + + AD +SF
Sbjct: 126 PENILLDEEGHIKLTDFGLSK-ESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSF 184
Query: 294 GIALWELLTGELPYAG 309
G+ ++E+LTG LP+ G
Sbjct: 185 GVLMFEMLTGSLPFQG 200
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 94.2 bits (234), Expect = 9e-22
Identities = 41/145 (28%), Positives = 71/145 (48%), Gaps = 1/145 (0%)
Query: 157 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAID 216
E +++ + H +V++ C+V +Y +L K+ + L +
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHY-SSDLYTYLTKRSRPLPIDQALIIEKQ 165
Query: 217 VSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAP 276
+ +G+ YLH IIHRD+KT N+ +++ V + D G A+ + GT AP
Sbjct: 166 ILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAP 225
Query: 277 EVIEHKPYDYKADVFSFGIALWELL 301
EV+ Y+ KAD++S GI L+E+L
Sbjct: 226 EVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 3e-21
Identities = 59/202 (29%), Positives = 104/202 (51%), Gaps = 22/202 (10%)
Query: 121 GSYGDLY----KGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-----RHKNVVQ 171
GS+G + KGT ++ AIK LK + V + + + + R++ H +
Sbjct: 6 GSFGKVMLAELKGT--NEFFAIKALKKDVV---LEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 172 FIGACTRPPNLCIVTEFMARGSIYDFLH--KQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
+L V E++ G D + + G F A ++ G+ +LH+ I
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGG---DLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGI 117
Query: 230 IHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYDYK 287
I+RDLK N+L+D++G +K+ADFG+ + +G A T GT ++APE+++ + Y+
Sbjct: 118 IYRDLKLDNVLLDKDGHIKIADFGMCKENM-NGEGKASTFCGTPDYIAPEILKGQKYNES 176
Query: 288 ADVFSFGIALWELLTGELPYAG 309
D +SFG+ L+E+L G+ P+ G
Sbjct: 177 VDWWSFGVLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 9e-21
Identities = 62/225 (27%), Positives = 106/225 (47%), Gaps = 37/225 (16%)
Query: 113 KIECKVASGSYGDLYKG----TYCSQEVAIKVLKPECVNTEMLKEFSQ----EVYIMRKI 164
+IE + G+YG +YK +E AIK K + SQ E+ ++R++
Sbjct: 3 EIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYT---GISQSACREIALLREL 59
Query: 165 RHKNVVQFIGACTRPPNLCI--VTEFMARGSIYDFL-----HKQKGVFQL-TSLLKVAI- 215
+H+NVV + + + + ++ + +D H+Q + S++K +
Sbjct: 60 KHENVVSLVEVFLEHADKSVYLLFDY----AEHDLWQIIKFHRQAKRVSIPPSMVKSLLW 115
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLM----DENGVVKVADFGVARV-QAQSGVMTAETG- 269
+ G++YLH N ++HRDLK AN+L+ E GVVK+ D G+AR+ A +
Sbjct: 116 QILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPV 175
Query: 270 --TYRWMAPEVI---EHKPYDYKADVFSFGIALWELLTGELPYAG 309
T + APE++ H Y D+++ G ELLT E + G
Sbjct: 176 VVTIWYRAPELLLGARH--YTKAIDIWAIGCIFAELLTLEPIFKG 218
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 1e-20
Identities = 63/211 (29%), Positives = 105/211 (49%), Gaps = 28/211 (13%)
Query: 118 VASGSYGDL----YKGTYCSQEVAIKVLKP-ECVNTEMLKEFSQEVYIMRKIRHKNVVQF 172
+ +GS+G + +KGT + AIK LK E + + ++ +QE I+ ++ H +V
Sbjct: 26 LGTGSFGRVRIAKHKGT--GEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNM 83
Query: 173 IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK--------GMNYL 224
+ + + + EF+ G ++ L K + DV+K YL
Sbjct: 84 MCSFQDENRVYFLLEFVVGGELFTHLRKAG---------RFPNDVAKFYHAELVLAFEYL 134
Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKP 283
H +II+RDLK NLL+D G VKV DFG A +V ++ + GT ++APEVI+ K
Sbjct: 135 HSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTL---CGTPEYLAPEVIQSKG 191
Query: 284 YDYKADVFSFGIALWELLTGELPYAGLTPLQ 314
+ D ++ G+ L+E + G P+ TP +
Sbjct: 192 HGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR 222
|
Length = 329 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 1e-20
Identities = 44/113 (38%), Positives = 63/113 (55%), Gaps = 14/113 (12%)
Query: 207 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR--------VQ 258
L L+ + V++GM +L IHRDL N+L+ EN VVK+ DFG+AR V+
Sbjct: 172 LEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR 231
Query: 259 AQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGL 310
+ +WMAPE I K Y ++DV+SFG+ LWE+ + G PY G+
Sbjct: 232 KGDARL-----PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGV 279
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 2e-20
Identities = 57/220 (25%), Positives = 110/220 (50%), Gaps = 16/220 (7%)
Query: 120 SGSYGDLYKGTYCSQEVAIKVLK------PECVNTEMLKEFS-----QEVYIMRK-IRHK 167
SG++G +YK + + LK P + ++ S EV I+++ +RH
Sbjct: 10 SGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHP 69
Query: 168 NVVQFIGACTRPPNLCIVTEFMARGSIYDF---LHKQKGVFQLTSLLKVAIDVSKGMNYL 224
N+V++ L IV + + + + L ++K F + + + + + YL
Sbjct: 70 NIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYL 129
Query: 225 H-QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKP 283
H + I+HRDL N+++ E+ V + DFG+A+ + +T+ GT + PE+++++P
Sbjct: 130 HKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEP 189
Query: 284 YDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKV 323
Y KADV++FG L+++ T + P+ L A +V+ V
Sbjct: 190 YGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAV 229
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 88.8 bits (220), Expect = 2e-20
Identities = 46/133 (34%), Positives = 73/133 (54%), Gaps = 3/133 (2%)
Query: 179 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTAN 238
P L + + M G ++ L Q GVF + A ++ G+ ++H +++RDLK AN
Sbjct: 69 PDKLSFILDLMNGGDLHYHL-SQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPAN 127
Query: 239 LLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIAL 297
+L+DE+G V+++D G+A A GT+ +MAPEV++ YD AD FS G L
Sbjct: 128 ILLDEHGHVRISDLGLA-CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCML 186
Query: 298 WELLTGELPYAGL 310
++LL G P+
Sbjct: 187 FKLLRGHSPFRQH 199
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 89.4 bits (221), Expect = 3e-20
Identities = 50/194 (25%), Positives = 97/194 (50%), Gaps = 5/194 (2%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
+ G++G L + + A+K+LK E + + + E +++ RH +
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
+ LC V E++ G ++ L +++ VF ++ ++YLH I++RDL
Sbjct: 63 SFQTKDRLCFVMEYVNGGELFFHLSRER-VFSEDRTRFYGAEIVSALDYLHSGKIVYRDL 121
Query: 235 KTANLLMDENGVVKVADFGVARVQ-AQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
K NL++D++G +K+ DFG+ + + M GT ++APEV+E Y D +
Sbjct: 122 KLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGL 181
Query: 294 GIALWELLTGELPY 307
G+ ++E++ G LP+
Sbjct: 182 GVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 6e-20
Identities = 54/198 (27%), Positives = 101/198 (51%), Gaps = 15/198 (7%)
Query: 117 KVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF-- 172
++ G+YG +Y+ T + VA+K ++ + + +E+ ++ +RH N+V+
Sbjct: 14 RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKE 73
Query: 173 IGACTRPPNLCIVTEF----MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNN 228
+ ++ +V E+ +A L F + + + + + +G+ YLH+N
Sbjct: 74 VVVGKHLDSIFLVMEYCEQDLAS-----LLDNMPTPFSESQVKCLMLQLLRGLQYLHENF 128
Query: 229 IIHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVI-EHKPYDY 286
IIHRDLK +NLL+ + G +K+ADFG+AR + MT + T + APE++ Y
Sbjct: 129 IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTT 188
Query: 287 KADVFSFGIALWELLTGE 304
D+++ G L ELL +
Sbjct: 189 AIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 6e-20
Identities = 60/200 (30%), Positives = 99/200 (49%), Gaps = 15/200 (7%)
Query: 118 VASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVY-----IMRKIRHKNVVQF 172
+ G +G++Y C + K+ +C++ + +K E IM + F
Sbjct: 2 IGRGGFGEVYG---CRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 58
Query: 173 IGACT----RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNN 228
I T P LC + + M G ++ L Q GVF + A ++ G+ ++H
Sbjct: 59 IVCMTYAFHTPDKLCFILDLMNGGDLHYHL-SQHGVFSEKEMRFYATEIILGLEHMHNRF 117
Query: 229 IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEH-KPYDYK 287
+++RDLK AN+L+DE+G V+++D G+A A GT+ +MAPEV++ YD
Sbjct: 118 VVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHASVGTHGYMAPEVLQKGTAYDSS 176
Query: 288 ADVFSFGIALWELLTGELPY 307
AD FS G L++LL G P+
Sbjct: 177 ADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 1e-19
Identities = 63/220 (28%), Positives = 104/220 (47%), Gaps = 34/220 (15%)
Query: 110 KQLKIECKVASGSYGDLY----KGTYCSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKI 164
K +I +V G YG ++ K T + VA+K +K + ++ E I+
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDT--GEIVALKRMKKSLLFKLNEVRHVLTERDILTTT 58
Query: 165 RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDF---------LHKQKGVFQLTSLLKVAI 215
+ + +V+ + A L + E++ G DF L + F + + A+
Sbjct: 59 KSEWLVKLLYAFQDDEYLYLAMEYVPGG---DFRTLLNNLGVLSEDHARFYMAEMF-EAV 114
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT---AETGTYR 272
D LH+ IHRDLK N L+D +G +K+ DFG++ G++T + G+
Sbjct: 115 DA------LHELGYIHRDLKPENFLIDASGHIKLTDFGLS-----KGIVTYANSVVGSPD 163
Query: 273 WMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTP 312
+MAPEV+ K YD+ D +S G L+E L G P++G TP
Sbjct: 164 YMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP 203
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 1e-19
Identities = 64/198 (32%), Positives = 101/198 (51%), Gaps = 10/198 (5%)
Query: 112 LKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNV 169
KIE K+ G+YG +YKG Q VA+K ++ E + +E+ ++++++H N+
Sbjct: 3 TKIE-KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNI 61
Query: 170 VQFIGACTRPPNLCIVTEF--MARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQ 226
V + L ++ EF M D L KG + L+K + + +G+ + H
Sbjct: 62 VCLQDVLMQESRLYLIFEFLSMDLKKYLDSL--PKGQYMDAELVKSYLYQILQGILFCHS 119
Query: 227 NNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTYRWMAPEVIEHKP-Y 284
++HRDLK NLL+D GV+K+ADFG+AR V T E T + APEV+ P Y
Sbjct: 120 RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRY 179
Query: 285 DYKADVFSFGIALWELLT 302
D++S G E+ T
Sbjct: 180 STPVDIWSIGTIFAEMAT 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 2e-19
Identities = 59/210 (28%), Positives = 102/210 (48%), Gaps = 33/210 (15%)
Query: 117 KVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKE-FS----QEVYIMRKIRHKNV 169
K+ G++G+++K Q VA+K V E KE F +E+ I++ ++H+NV
Sbjct: 19 KIGQGTFGEVFKARHKKTKQIVALKK-----VLMENEKEGFPITALREIKILQLLKHENV 73
Query: 170 VQFIGACTRPPNLCIVTEFMARGSIY---DF--------LHKQKGVFQLTSLLKVAIDVS 218
V I C +GS Y +F L + F L+ + KV +
Sbjct: 74 VNLIEICRTKAT----PYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLL 129
Query: 219 KGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV-----QAQSGVMTAETGTYRW 273
G+ Y+H+N I+HRD+K AN+L+ ++G++K+ADFG+AR ++ T T +
Sbjct: 130 NGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWY 189
Query: 274 MAPEV-IEHKPYDYKADVFSFGIALWELLT 302
PE+ + + Y D++ G + E+ T
Sbjct: 190 RPPELLLGERDYGPPIDMWGAGCIMAEMWT 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 2e-19
Identities = 45/129 (34%), Positives = 77/129 (59%), Gaps = 2/129 (1%)
Query: 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM 241
L V E++ G + + +Q G F+ + A +++ G+ +LH II+RDLK N+++
Sbjct: 76 LYFVMEYVNGGDLM-YQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML 134
Query: 242 DENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKADVFSFGIALWEL 300
D G +K+ADFG+ + GV T GT ++APE+I ++PY D ++FG+ L+E+
Sbjct: 135 DSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEM 194
Query: 301 LTGELPYAG 309
L G+ P+ G
Sbjct: 195 LAGQAPFEG 203
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 2e-19
Identities = 63/216 (29%), Positives = 106/216 (49%), Gaps = 27/216 (12%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
VWE+ + + V SG+YG + T ++VAIK L + K +E+ ++
Sbjct: 10 VWEVPDRYQNLS-PVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLL 68
Query: 162 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQK-----GVFQLTSL 210
+ + H+NV+ + T +L +VT M + + + QK F + +
Sbjct: 69 KHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGA-DLNNIVKCQKLSDDHIQFLVYQI 127
Query: 211 LKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT 270
L+ G+ Y+H IIHRDLK +N+ ++E+ +K+ DFG+AR MT T
Sbjct: 128 LR-------GLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR-HTDDE-MTGYVAT 178
Query: 271 YRW-MAPEVIEHK-PYDYKADVFSFGIALWELLTGE 304
RW APE++ + Y+ D++S G + ELLTG+
Sbjct: 179 -RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 2e-19
Identities = 48/157 (30%), Positives = 82/157 (52%), Gaps = 8/157 (5%)
Query: 157 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGS----IYDFLHKQKGVFQLTSLLK 212
E I+ K+ + +V A +LC+V M G IY+ + G F
Sbjct: 43 EKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPG-FPEPRACF 101
Query: 213 VAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE--TGT 270
+ G+ +LHQ II+RDLK N+L+D +G V+++D G+A V+ + G + GT
Sbjct: 102 YTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLA-VELKDGQSKTKGYAGT 160
Query: 271 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 307
+MAPE+++ + YD+ D F+ G+ L+E++ P+
Sbjct: 161 PGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPF 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|153200 cd04928, ACT_TyrKc, Uncharacterized, N-terminal ACT domain of an Arabidopsis/Oryza predicted tyrosine kinase and other related ACT domains | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 2e-19
Identities = 32/52 (61%), Positives = 39/52 (75%)
Query: 13 ELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEIL 64
+L+SLLG++GLNI EAHAFST DG +LD+FVV GW ET L + L KEI
Sbjct: 17 QLSSLLGDLGLNIAEAHAFSTDDGLALDIFVVTGWKRGETAALGHALQKEID 68
|
This CD includes a novel, yet uncharacterized, N-terminal ACT domain of an Arabidopsis/Oryza predicted tyrosine kinase and other related ACT domains. Members of this CD belong to the superfamily of ACT regulatory domains. Length = 68 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 86.6 bits (215), Expect = 2e-19
Identities = 55/174 (31%), Positives = 83/174 (47%), Gaps = 34/174 (19%)
Query: 157 EVYIMRKIRHKNVVQFIG-ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLL---K 212
E+ I++K++H NVV I A RP RGS+Y L+ LL
Sbjct: 57 EIKILKKLKHPNVVPLIDMAVERPDK-----SKRKRGSVYMVTPYM--DHDLSGLLENPS 109
Query: 213 VAIDVSK----------GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV----- 257
V + S+ G+NYLH+N+I+HRD+K AN+L+D G++K+ADFG+AR
Sbjct: 110 VKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPP 169
Query: 258 ---QAQSGVMTAE-TG--TYRWM-APEVIEH-KPYDYKADVFSFGIALWELLTG 303
+ G T + T RW PE++ + Y D++ G E+ T
Sbjct: 170 PNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR 223
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 3e-19
Identities = 52/190 (27%), Positives = 93/190 (48%), Gaps = 21/190 (11%)
Query: 135 EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI 194
V +KVL + ++ F + +M ++ HK++V+ G C R N+ +V E++ G +
Sbjct: 32 SVVLKVLGSDHRDSL---AFFETASLMSQLSHKHLVKLYGVCVRDENI-MVEEYVKFGPL 87
Query: 195 YDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV-------V 247
FLH++K L L VA ++ ++YL ++H ++ N+L+ G+ +
Sbjct: 88 DVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFI 147
Query: 248 KVADFGVARVQAQSGVMTAETGTYR--WMAPEVIE--HKPYDYKADVFSFGIALWELLT- 302
K++D G+ V++ E R W+APE I AD +SFG L E+ +
Sbjct: 148 KLSDPGIPI-----TVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSN 202
Query: 303 GELPYAGLTP 312
GE P + L+
Sbjct: 203 GEEPLSTLSS 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 3e-19
Identities = 43/153 (28%), Positives = 86/153 (56%), Gaps = 3/153 (1%)
Query: 157 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI-YDFLHKQKGVFQLTSLLKVAI 215
E I+ K+ +V A +LC+V M G + Y + + ++ ++ +
Sbjct: 43 EKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSA 102
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAETGTYRWM 274
++ G+ +LH +I++RD+K N+L+D+ G +++D G+A V+ + G +T GT +M
Sbjct: 103 QITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLA-VELKDGKTITQRAGTNGYM 161
Query: 275 APEVIEHKPYDYKADVFSFGIALWELLTGELPY 307
APE+++ +PY Y D F+ G +++E++ G P+
Sbjct: 162 APEILKEEPYSYPVDWFAMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 3e-19
Identities = 45/129 (34%), Positives = 78/129 (60%), Gaps = 2/129 (1%)
Query: 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM 241
L V E++ G + + +Q G F+ + A ++S G+ +LH+ II+RDLK N+++
Sbjct: 76 LYFVMEYVNGGDLMYHI-QQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVML 134
Query: 242 DENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKADVFSFGIALWEL 300
D G +K+ADFG+ + GV T GT ++APE+I ++PY D +++G+ L+E+
Sbjct: 135 DSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEM 194
Query: 301 LTGELPYAG 309
L G+ P+ G
Sbjct: 195 LAGQPPFDG 203
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 4e-19
Identities = 50/195 (25%), Positives = 101/195 (51%), Gaps = 6/195 (3%)
Query: 118 VASGSYGDLYKGTYCSQEV--AIKVLKPECV--NTEMLKEFSQEVYIMRKIRHKNVVQFI 173
+ GS+G + + ++E A+KVL+ + + E S+ +++ ++H +V
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
+ L V +++ G ++ L +++ + + A +++ + YLH NI++RD
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAA-EIASALGYLHSLNIVYRD 121
Query: 234 LKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAETGTYRWMAPEVIEHKPYDYKADVFS 292
LK N+L+D G + + DFG+ + + +G + GT ++APEV+ +PYD D +
Sbjct: 122 LKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWC 181
Query: 293 FGIALWELLTGELPY 307
G L+E+L G P+
Sbjct: 182 LGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 4e-19
Identities = 46/113 (40%), Positives = 65/113 (57%), Gaps = 4/113 (3%)
Query: 202 KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR--VQA 259
K V L L+ + V+KGM +L IHRDL N+L+ EN VVK+ DFG+AR +
Sbjct: 173 KKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKD 232
Query: 260 QSGVMTAETG-TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGL 310
V + +WMAPE I + Y ++DV+SFG+ LWE+ + G PY G+
Sbjct: 233 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 285
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 5e-19
Identities = 58/225 (25%), Positives = 110/225 (48%), Gaps = 20/225 (8%)
Query: 117 KVASGSYGDLYKGT----YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF 172
++ +G +G + G Y +V +K L+ E +K F +E R ++H N++Q
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMK-FLEEAQPYRSLQHSNLLQC 60
Query: 173 IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLT----SLLKVAIDVSKGMNYLHQNN 228
+G CT +V EF G + +L + +T +L ++A +++ G+ +LH+NN
Sbjct: 61 LGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN 120
Query: 229 IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY---RWMAPEVIEHKPYD 285
IH DL N L+ + VK+ D+G++ + + + RW+APE+++ +
Sbjct: 121 FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGN 180
Query: 286 Y-------KADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQK 322
+++V+S G+ +WEL G PY L+ Q V++
Sbjct: 181 LLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVRE 225
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 5e-19
Identities = 44/129 (34%), Positives = 76/129 (58%), Gaps = 2/129 (1%)
Query: 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM 241
L V E++ G + + +Q G F+ + A +++ G+ +LH II+RDLK N+++
Sbjct: 76 LYFVMEYVNGGDLM-YHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML 134
Query: 242 DENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKADVFSFGIALWEL 300
D G +K+ADFG+ + G T GT ++APE+I ++PY D ++FG+ L+E+
Sbjct: 135 DAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEM 194
Query: 301 LTGELPYAG 309
L G+ P+ G
Sbjct: 195 LAGQPPFDG 203
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 5e-19
Identities = 53/204 (25%), Positives = 96/204 (47%), Gaps = 19/204 (9%)
Query: 126 LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV 185
L K + VA+K + + + E LK QE+ R+++H N++ ++ + L +V
Sbjct: 18 LAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVV 77
Query: 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAI-----DVSKGMNYLHQNNIIHRDLKTANLL 240
+ MA GS D L K F L ++AI DV ++Y+H IHR +K +++L
Sbjct: 78 SPLMAYGSCEDLL---KTHFP-EGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHIL 133
Query: 241 MDENGVVKVADFGVARVQAQSGVMTA--------ETGTYRWMAPEVIEH--KPYDYKADV 290
+ +G V ++ + + G W++PEV++ + Y+ K+D+
Sbjct: 134 LSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDI 193
Query: 291 FSFGIALWELLTGELPYAGLTPLQ 314
+S GI EL G +P+ + Q
Sbjct: 194 YSVGITACELANGHVPFKDMPATQ 217
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 6e-19
Identities = 46/173 (26%), Positives = 88/173 (50%), Gaps = 3/173 (1%)
Query: 137 AIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY 195
A+K+L+ E + + + E +++ RH + A LC V E+ G ++
Sbjct: 24 AMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELF 83
Query: 196 DFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA 255
L +++ VF ++ + YLH ++++RD+K NL++D++G +K+ DFG+
Sbjct: 84 FHLSRER-VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLC 142
Query: 256 RVQAQSG-VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 307
+ G M GT ++APEV+E Y D + G+ ++E++ G LP+
Sbjct: 143 KEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 85.5 bits (212), Expect = 7e-19
Identities = 65/223 (29%), Positives = 105/223 (47%), Gaps = 42/223 (18%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQEV 158
E+D K + I+ + G+YG CS ++VAIK + N K +E+
Sbjct: 2 EVDTKYVPIKP-IGRGAYG-----IVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREI 55
Query: 159 YIMRKIRHKNVVQFIGACTRPPN------LCIVTEFMARGSIYDFL---------HKQKG 203
++R + H+NV+ I PP+ + IV E M ++ + H Q
Sbjct: 56 KLLRHLDHENVIA-IKDIMPPPHREAFNDVYIVYELMDT-DLHQIIRSSQTLSDDHCQYF 113
Query: 204 VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG- 262
++QL +G+ Y+H N++HRDLK +NLL++ N +K+ DFG+AR ++ G
Sbjct: 114 LYQLL----------RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD 163
Query: 263 VMTAETGTYRWMAPEVI-EHKPYDYKADVFSFGIALWELLTGE 304
MT T + APE++ Y DV+S G ELL +
Sbjct: 164 FMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 9e-19
Identities = 58/231 (25%), Positives = 108/231 (46%), Gaps = 27/231 (11%)
Query: 113 KIECKVASGSYGDLYK------GTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR- 165
KI K+ G++ ++ K G Y AIK +K + E + E+ +R++
Sbjct: 2 KILGKIGEGTFSEVLKAQSRKTGKY----YAIKCMKKHFKSLEQVNNLR-EIQALRRLSP 56
Query: 166 HKNVVQFIGACTRPPN--LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNY 223
H N+++ I L +V E M ++Y+ + +K + + K +++
Sbjct: 57 HPNILRLIEVLFDRKTGRLALVFELM-DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDH 115
Query: 224 LHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWM-APE-VIEH 281
+H+N I HRD+K N+L+ ++ ++K+ADFG R T T RW APE ++
Sbjct: 116 MHRNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYIST-RWYRAPECLLTD 173
Query: 282 KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVS-IHSIILT 331
Y K D+++ G +E+L+ L PL + +++ IH ++ T
Sbjct: 174 GYYGPKMDIWAVGCVFFEILS-------LFPLFPGTNELDQIAKIHDVLGT 217
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 9e-19
Identities = 44/152 (28%), Positives = 82/152 (53%), Gaps = 1/152 (0%)
Query: 157 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI-YDFLHKQKGVFQLTSLLKVAI 215
E I+ K+ + VV A LC+V M G + + H + F+ + A
Sbjct: 50 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAA 109
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
++ G+ LHQ I++RDLK N+L+D++G ++++D G+A + + GT +MA
Sbjct: 110 EICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMA 169
Query: 276 PEVIEHKPYDYKADVFSFGIALWELLTGELPY 307
PEV++++ Y + D ++ G L+E++ G+ P+
Sbjct: 170 PEVVKNERYTFSPDWWALGCLLYEMIAGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 84.6 bits (209), Expect = 1e-18
Identities = 47/131 (35%), Positives = 77/131 (58%), Gaps = 4/131 (3%)
Query: 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL 240
+L V EF+ G + F + KG F L A ++ G+ +LH II+RDLK N++
Sbjct: 70 HLFFVMEFLNGGDLM-FHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVM 128
Query: 241 MDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYDYKADVFSFGIALW 298
+D +G +K+ADFG+ + + G A T GT ++APE+++ Y + D +SFG+ L+
Sbjct: 129 LDRDGHIKIADFGMCK-ENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLY 187
Query: 299 ELLTGELPYAG 309
E+L G+ P+ G
Sbjct: 188 EMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 1e-18
Identities = 41/105 (39%), Positives = 63/105 (60%), Gaps = 4/105 (3%)
Query: 210 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAET 268
LL + V+KGM++L N IHRDL N+L+ + K+ DFG+AR ++ S +
Sbjct: 216 LLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGN 275
Query: 269 GTY--RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGL 310
+WMAPE I + Y +++DV+S+GI LWE+ + G PY G+
Sbjct: 276 ARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGM 320
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 1e-18
Identities = 49/194 (25%), Positives = 98/194 (50%), Gaps = 11/194 (5%)
Query: 126 LYKGTYCSQEVAIKVLKPECVNTEMLKE-FSQEVYIMRKIRHKNVVQ----FIGACTRPP 180
+YKG + ++EV I+ K ++L + E+ +R+I N+++ I P
Sbjct: 36 IYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLP 95
Query: 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANL 239
L ++ E+ RG + + L K+K + + L +AID KG+ L++ N +++L + +
Sbjct: 96 RLSLILEYCTRGYLREVLDKEKDL-SFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSF 154
Query: 240 LMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEH--KPYDYKADVFSFGIAL 297
L+ EN +K+ G+ ++ + Y + +++ Y K D++S G+ L
Sbjct: 155 LVTENYKLKIICHGLEKILSSPPFKNVNFMVYF--SYKMLNDIFSEYTIKDDIYSLGVVL 212
Query: 298 WELLTGELPYAGLT 311
WE+ TG++P+ LT
Sbjct: 213 WEIFTGKIPFENLT 226
|
Length = 283 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 84.5 bits (210), Expect = 2e-18
Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 36/209 (17%)
Query: 118 VASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
+ SG+YG + ++VAIK + + K +E+ ++R +RH+N++ +
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDI 67
Query: 176 CTRPP------NLCIVTEFMA--------RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
RPP ++ IVTE M H Q ++Q+ +G+
Sbjct: 68 -LRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQIL----------RGL 116
Query: 222 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ----AQSGVMTAETGT--YRWMA 275
YLH N+IHRDLK +N+L++ N +K+ DFG+AR + G +T T YR A
Sbjct: 117 KYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYR--A 174
Query: 276 PEVI-EHKPYDYKADVFSFGIALWELLTG 303
PE++ Y D++S G ELLT
Sbjct: 175 PELLLSSSRYTKAIDIWSVGCIFAELLTR 203
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 2e-18
Identities = 57/223 (25%), Positives = 96/223 (43%), Gaps = 52/223 (23%)
Query: 121 GSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFS----------------QEVYIMR 162
G+YG + K T + VAIK +K E+ + + +E+ IM
Sbjct: 20 GTYGKVEKAYDTLTGKIVAIKKVK----IIEISNDVTKDRQLVGMCGIHFTTLRELKIMN 75
Query: 163 KIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVA------ID 216
+I+H+N++ + + +V + MA D K V L + +
Sbjct: 76 EIKHENIMGLVDVYVEGDFINLVMDIMA----SDL----KKVVDRKIRLTESQVKCILLQ 127
Query: 217 VSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV------------- 263
+ G+N LH+ +HRDL AN+ ++ G+ K+ADFG+AR
Sbjct: 128 ILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRR 187
Query: 264 --MTAETGTYRWMAPEVI-EHKPYDYKADVFSFGIALWELLTG 303
MT++ T + APE++ + Y + D++S G ELLTG
Sbjct: 188 EEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTG 230
|
Length = 335 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 2e-18
Identities = 44/113 (38%), Positives = 64/113 (56%), Gaps = 14/113 (12%)
Query: 207 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR--------VQ 258
+ L+ + V++GM +L IHRDL N+L+ EN VVK+ DFG+AR V+
Sbjct: 173 MEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVR 232
Query: 259 AQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGL 310
S + +WMAPE I K Y ++DV+SFG+ LWE+ + G PY G+
Sbjct: 233 KGSARL-----PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGV 280
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 2e-18
Identities = 53/195 (27%), Positives = 99/195 (50%), Gaps = 6/195 (3%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
+ G++G L K + A+K+LK E V + + E +++ RH +
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH-QNNIIHRD 233
+ LC V E+ G ++ L +++ VF ++ ++YLH + N+++RD
Sbjct: 63 SFQTHDRLCFVMEYANGGELFFHLSRER-VFSEDRARFYGAEIVSALDYLHSEKNVVYRD 121
Query: 234 LKTANLLMDENGVVKVADFGVARVQAQSG-VMTAETGTYRWMAPEVIEHKPYDYKADVFS 292
LK NL++D++G +K+ DFG+ + + G M GT ++APEV+E Y D +
Sbjct: 122 LKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWG 181
Query: 293 FGIALWELLTGELPY 307
G+ ++E++ G LP+
Sbjct: 182 LGVVMYEMMCGRLPF 196
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 2e-18
Identities = 47/173 (27%), Positives = 87/173 (50%), Gaps = 3/173 (1%)
Query: 137 AIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY 195
A+K+LK E + + + E +++ RH + + LC V E+ G ++
Sbjct: 24 AMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELF 83
Query: 196 DFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA 255
L ++ VF ++ + YLH ++++RDLK NL++D++G +K+ DFG+
Sbjct: 84 FHLSRE-RVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLC 142
Query: 256 RVQAQSG-VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 307
+ G M GT ++APEV+E Y D + G+ ++E++ G LP+
Sbjct: 143 KEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 3e-18
Identities = 57/195 (29%), Positives = 99/195 (50%), Gaps = 6/195 (3%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECV--NTEMLKEFSQEVYIMRKIRHKNVVQFI 173
+ GS+G L K + A+KVL+ + V E ++ +++ ++H +V
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
+ L V +F+ G ++ L +++ + + A +++ + YLH NI++RD
Sbjct: 63 YSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLHSINIVYRD 121
Query: 234 LKTANLLMDENGVVKVADFGVARVQ-AQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFS 292
LK N+L+D G V + DFG+ + AQS T GT ++APEVI +PYD D +
Sbjct: 122 LKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWC 181
Query: 293 FGIALWELLTGELPY 307
G L+E+L G P+
Sbjct: 182 LGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 3e-18
Identities = 59/200 (29%), Positives = 103/200 (51%), Gaps = 19/200 (9%)
Query: 116 CKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTE---MLKEFS-QEVYIMRKIRH 166
K+ GSYG ++K C Q VAIK + V +E ++K+ + +E+ ++++++H
Sbjct: 7 SKIGEGSYGVVFK---CRNRETGQIVAIK----KFVESEDDPVIKKIALREIRMLKQLKH 59
Query: 167 KNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ 226
N+V I R L +V E+ + + +GV + + K+ + +N+ H+
Sbjct: 60 PNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEH-LIKKIIWQTLQAVNFCHK 118
Query: 227 NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWM-APEVI-EHKPY 284
+N IHRD+K N+L+ + G +K+ DFG AR+ G + RW APE++ Y
Sbjct: 119 HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQY 178
Query: 285 DYKADVFSFGIALWELLTGE 304
DV++ G ELLTG+
Sbjct: 179 GPPVDVWAIGCVFAELLTGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 3e-18
Identities = 61/206 (29%), Positives = 102/206 (49%), Gaps = 19/206 (9%)
Query: 118 VASGSYGDLYKGTYCSQE---VAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFI 173
+ +GS+G + TY +++ VAIK K + + + + E I+ I H V
Sbjct: 38 LGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLY 97
Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQK------GVFQLTSLLKVAIDVSKGMNYLHQN 227
G+ L +V EF+ G + FL + K G F ++ + YL
Sbjct: 98 GSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLI-------FEYLQSL 150
Query: 228 NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYK 287
NI++RDLK NLL+D++G +K+ DFG A+V + T GT ++APE++ + +
Sbjct: 151 NIVYRDLKPENLLLDKDGFIKMTDFGFAKV-VDTRTYTL-CGTPEYIAPEILLNVGHGKA 208
Query: 288 ADVFSFGIALWELLTGELPYAGLTPL 313
AD ++ GI ++E+L G P+ PL
Sbjct: 209 ADWWTLGIFIYEILVGCPPFYANEPL 234
|
Length = 340 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 3e-18
Identities = 43/154 (27%), Positives = 78/154 (50%), Gaps = 1/154 (0%)
Query: 157 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI-YDFLHKQKGVFQLTSLLKVAI 215
E I+ K+ + VV A LC+V M G + + + F+ L A
Sbjct: 50 EKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAA 109
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
++ G+ LH+ N ++RDLK N+L+D+ G ++++D G+A + + GT +MA
Sbjct: 110 EILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMA 169
Query: 276 PEVIEHKPYDYKADVFSFGIALWELLTGELPYAG 309
PEV+ ++ Y D + G ++E++ G+ P+ G
Sbjct: 170 PEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRG 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 3e-18
Identities = 59/206 (28%), Positives = 106/206 (51%), Gaps = 24/206 (11%)
Query: 118 VASGSYGDLY----KGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-----RHKN 168
+ GS+G ++ KGT +Q AIK LK + V ++ + + + +++ H
Sbjct: 3 LGKGSFGKVFLAELKGT--NQFFAIKALKKDVV---LMDDDVECTMVEKRVLSLAWEHPF 57
Query: 169 VVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQN 227
+ NL V E++ G + H Q F L A ++ G+ +LH
Sbjct: 58 LTHLYCTFQTKENLFFVMEYLNGGDL--MFHIQSCHKFDLPRATFYAAEIICGLQFLHSK 115
Query: 228 NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET----GTYRWMAPEVIEHKP 283
I++RDLK N+L+D +G +K+ADFG+ + ++ + A+T GT ++APE++ +
Sbjct: 116 GIVYRDLKLDNILLDTDGHIKIADFGMCK---ENMLGDAKTCTFCGTPDYIAPEILLGQK 172
Query: 284 YDYKADVFSFGIALWELLTGELPYAG 309
Y+ D +SFG+ L+E+L G+ P+ G
Sbjct: 173 YNTSVDWWSFGVLLYEMLIGQSPFHG 198
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 3e-18
Identities = 41/98 (41%), Positives = 65/98 (66%), Gaps = 3/98 (3%)
Query: 215 IDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS---GVMTAETGTY 271
I V ++++H ++IHRD+K+AN+L+ NG+VK+ DFG +++ A + V GT
Sbjct: 150 IQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTP 209
Query: 272 RWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAG 309
++APE+ KPY KAD+FS G+ L+ELLT + P+ G
Sbjct: 210 YYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDG 247
|
Length = 496 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 83.3 bits (206), Expect = 3e-18
Identities = 50/181 (27%), Positives = 91/181 (50%), Gaps = 11/181 (6%)
Query: 133 SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP-PNLCIVTEFMAR 191
Q VAIK + + K +E+ +++ +RH+N++ P ++ VTE +
Sbjct: 35 GQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELLGT 94
Query: 192 GSIYDFLHK--QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKV 249
LH+ + + + +G+ Y+H ++HRDLK +N+L++EN +K+
Sbjct: 95 D-----LHRLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKI 149
Query: 250 ADFGVARVQAQSGVMTAETGTYRWMAPEV-IEHKPYDYKADVFSFGIALWELLTGELPYA 308
DFG+AR+Q MT T + APE+ + + YD + D++S G E+L G+ +
Sbjct: 150 CDFGLARIQDPQ--MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFP 207
Query: 309 G 309
G
Sbjct: 208 G 208
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.5 bits (207), Expect = 4e-18
Identities = 63/218 (28%), Positives = 104/218 (47%), Gaps = 36/218 (16%)
Query: 109 AKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH 166
+ + + G+YG + T+ +VAIK + P T + +E+ I+R+ +H
Sbjct: 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTL-REIKILRRFKH 62
Query: 167 KNVVQFIGACTRPPNLC------IVTEFMARGSIYDFL--------HKQKGVFQLTSLLK 212
+N++ I RPP+ IV E M +Y + H Q ++Q+ LK
Sbjct: 63 ENIIG-ILDIIRPPSFESFNDVYIVQELM-ETDLYKLIKTQHLSNDHIQYFLYQILRGLK 120
Query: 213 VAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ----SGVMTAET 268
Y+H N++HRDLK +NLL++ N +K+ DFG+AR+ +G +T
Sbjct: 121 ----------YIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYV 170
Query: 269 GTYRWM-APEV-IEHKPYDYKADVFSFGIALWELLTGE 304
T RW APE+ + K Y D++S G L E+L+
Sbjct: 171 AT-RWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 4e-18
Identities = 58/203 (28%), Positives = 99/203 (48%), Gaps = 25/203 (12%)
Query: 117 KVASGSYGDLYKGTYCSQE--VAIKVLKPECVNTEMLKEFS-------QEVYIMRKIRHK 167
++ G+YG +Y+ VA+K LK M KE +E+ I+ K++H
Sbjct: 12 RIEEGTYGVVYRARDKKTGEIVALKKLK-------MEKEKEGFPITSLREINILLKLQHP 64
Query: 168 NVVQF--IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 225
N+V + + + +V E++ + + K F + + + + + G+ +LH
Sbjct: 65 NIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLH 123
Query: 226 QNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGT--YRWMAPEVIEHK 282
N I+HRDLKT+NLL++ G++K+ DFG+AR + T T YR APE++
Sbjct: 124 DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYR--APELLLGA 181
Query: 283 P-YDYKADVFSFGIALWELLTGE 304
Y D++S G ELLT +
Sbjct: 182 KEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 5e-18
Identities = 42/105 (40%), Positives = 61/105 (58%), Gaps = 4/105 (3%)
Query: 210 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETG 269
L+ + V+ GM +L N +HRDL N+L+ E +VK+ DFG+AR + ++
Sbjct: 241 LVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGS 300
Query: 270 TY---RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGL 310
T+ +WMAPE I + Y +DV+SFGI LWE+ T G PY L
Sbjct: 301 TFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPEL 345
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 82.1 bits (203), Expect = 9e-18
Identities = 47/162 (29%), Positives = 87/162 (53%), Gaps = 3/162 (1%)
Query: 146 VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF 205
+ + + +E+ ++ + +V F GA + I E M GS+ D + K+ G
Sbjct: 38 IKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRI 96
Query: 206 QLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM 264
L K++I V +G+ YL + I+HRD+K +N+L++ G +K+ DFGV+ Q +
Sbjct: 97 PENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-QLIDSMA 155
Query: 265 TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELP 306
+ GT +M+PE ++ Y ++D++S G++L E+ G P
Sbjct: 156 NSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 1e-17
Identities = 40/108 (37%), Positives = 60/108 (55%), Gaps = 4/108 (3%)
Query: 207 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 266
LL V++GM +L N +HRDL N+L+ + +VK+ DFG+AR +
Sbjct: 236 TLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVS 295
Query: 267 ETGTY---RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGL 310
+ T+ +WMAPE I Y +DV+S+GI LWE+ + G PY G+
Sbjct: 296 KGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGM 343
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 2e-17
Identities = 58/210 (27%), Positives = 106/210 (50%), Gaps = 6/210 (2%)
Query: 118 VASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
V G+YG + K + + VAIK K N E+ + +E+ ++R ++ +N+V+ A
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 235
R L +V E++ + ++ + L + + + K +++ H+N+I+HRD+K
Sbjct: 69 FRRRGKLYLVFEYVEK-NMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIK 127
Query: 236 TANLLMDENGVVKVADFGVAR--VQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
NLL+ N V+K+ DFG AR + + T T + +PE++ PY D++S
Sbjct: 128 PENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSV 187
Query: 294 GIALWELLTGELPYAGLTPLQAAVGVVQKV 323
G L EL G+ + G + + +QKV
Sbjct: 188 GCILGELSDGQPLFPGESEIDQLF-TIQKV 216
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 2e-17
Identities = 56/199 (28%), Positives = 98/199 (49%), Gaps = 14/199 (7%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECV--NTEMLKEFSQEVYIMRKIRHKNVVQFI 173
+ GS+G L K A+KVL+ + + E ++ +++ ++H +V
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
+ L V +++ G ++ L +++ + + A +V+ + YLH NII+RD
Sbjct: 63 YSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAA-EVASAIGYLHSLNIIYRD 121
Query: 234 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAET-----GTYRWMAPEVIEHKPYDYKA 288
LK N+L+D G V + DFG+ + GV ET GT ++APEV+ +PYD
Sbjct: 122 LKPENILLDSQGHVVLTDFGLCK----EGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTV 177
Query: 289 DVFSFGIALWELLTGELPY 307
D + G L+E+L G P+
Sbjct: 178 DWWCLGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 3e-17
Identities = 50/195 (25%), Positives = 98/195 (50%), Gaps = 6/195 (3%)
Query: 118 VASGSYGDLYKGTYCSQEV--AIKVLKPECV--NTEMLKEFSQEVYIMRKIRHKNVVQFI 173
+ GS+G + + + A+KVL+ + + E ++ +++ ++H +V
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
+ L V +++ G ++ L +++ + + A +++ + YLH NII+RD
Sbjct: 63 YSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAA-EIASALGYLHSLNIIYRD 121
Query: 234 LKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAETGTYRWMAPEVIEHKPYDYKADVFS 292
LK N+L+D G V + DFG+ + + S + GT ++APEV+ +PYD D +
Sbjct: 122 LKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWC 181
Query: 293 FGIALWELLTGELPY 307
G L+E+L G P+
Sbjct: 182 LGAVLYEMLYGLPPF 196
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 3e-17
Identities = 45/150 (30%), Positives = 76/150 (50%), Gaps = 4/150 (2%)
Query: 157 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAID 216
E +I+R I H +++Q G T C++ + +Y +L ++ + + +L +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILP-RYKTDLYCYLAAKRNI-AICDILAIERS 190
Query: 217 VSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA--RVQAQSGVMTAETGTYRWM 274
V + + YLH+N IIHRD+K N+ ++ G V + DFG A V + GT
Sbjct: 191 VLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATN 250
Query: 275 APEVIEHKPYDYKADVFSFGIALWELLTGE 304
APE++ PY D++S GI L+E+ T
Sbjct: 251 APELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 4e-17
Identities = 47/174 (27%), Positives = 98/174 (56%), Gaps = 4/174 (2%)
Query: 137 AIKVLKPECVNTEMLKEFSQ-EVYIMRKIRHKNVVQFIGACTRPPN-LCIVTEFMARGSI 194
A+KV+K E VN + ++ Q E ++ + + + + +C + + L V E++ G +
Sbjct: 24 AMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 83
Query: 195 YDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV 254
+ +Q+ + + + A ++S +NYLH+ II+RDLK N+L+D G +K+ D+G+
Sbjct: 84 MFHMQRQRKLPEEHARFYSA-EISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGM 142
Query: 255 ARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 307
+ + G T+ GT ++APE++ + Y + D ++ G+ ++E++ G P+
Sbjct: 143 CKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 4e-17
Identities = 60/213 (28%), Positives = 108/213 (50%), Gaps = 21/213 (9%)
Query: 110 KQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLK---PECVNTEMLKEFSQEVYIMRKI 164
KQL+ K+ G+Y +YKG + VA+K + E + ++E S +M+++
Sbjct: 3 KQLE---KLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREIS----LMKEL 55
Query: 165 RHKNVVQFIGACTRPPNLCIVTEFMARG-SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNY 223
+H+N+V+ L +V E+M + Y H +G ++ + KG+ +
Sbjct: 56 KHENIVRLHDVIHTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAF 115
Query: 224 LHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV----MTAETGTYRWMAPEVI 279
H+N ++HRDLK NLL+++ G +K+ADFG+AR G+ + E T + AP+V+
Sbjct: 116 CHENRVLHRDLKPQNLLINKRGELKLADFGLARA---FGIPVNTFSNEVVTLWYRAPDVL 172
Query: 280 -EHKPYDYKADVFSFGIALWELLTGELPYAGLT 311
+ Y D++S G + E++TG + G
Sbjct: 173 LGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTN 205
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 5e-17
Identities = 49/152 (32%), Positives = 85/152 (55%), Gaps = 3/152 (1%)
Query: 156 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
+E+ ++ + +V F GA + I E M GS+ D + K+ G L KV+I
Sbjct: 52 RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-DQVLKKAGRIPEQILGKVSI 110
Query: 216 DVSKGMNYLHQNN-IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWM 274
V KG+ YL + + I+HRD+K +N+L++ G +K+ DFGV+ Q + + GT +M
Sbjct: 111 AVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-QLIDSMANSFVGTRSYM 169
Query: 275 APEVIEHKPYDYKADVFSFGIALWELLTGELP 306
+PE ++ Y ++D++S G++L E+ G P
Sbjct: 170 SPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 5e-17
Identities = 57/198 (28%), Positives = 101/198 (51%), Gaps = 11/198 (5%)
Query: 121 GSYGDLYK-----GTYCSQEVAIKVLKPECV--NTEMLKEFSQEVYIMRKIRHKNVVQFI 173
G YG +++ G + A+KVLK + N + E I+ ++H +V I
Sbjct: 7 GGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLI 66
Query: 174 GACTRPPNLCIVTEFMARGSIYDFLH-KQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHR 232
A L ++ E+++ G + F+H +++G+F + ++S + +LHQ II+R
Sbjct: 67 YAFQTGGKLYLILEYLSGGEL--FMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYR 124
Query: 233 DLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKADVF 291
DLK N+L+D G VK+ DFG+ + G +T GT +MAPE++ + D +
Sbjct: 125 DLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWW 184
Query: 292 SFGIALWELLTGELPYAG 309
S G ++++LTG P+
Sbjct: 185 SLGALMYDMLTGAPPFTA 202
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 1e-16
Identities = 48/152 (31%), Positives = 85/152 (55%), Gaps = 3/152 (1%)
Query: 156 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
+E+ ++ + +V F GA + I E M GS+ L + K + + L KV+I
Sbjct: 52 RELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPE-EILGKVSI 110
Query: 216 DVSKGMNYLHQ-NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWM 274
V +G+ YL + + I+HRD+K +N+L++ G +K+ DFGV+ Q + + GT +M
Sbjct: 111 AVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSG-QLIDSMANSFVGTRSYM 169
Query: 275 APEVIEHKPYDYKADVFSFGIALWELLTGELP 306
+PE ++ Y ++D++S G++L EL G P
Sbjct: 170 SPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 1e-16
Identities = 54/196 (27%), Positives = 95/196 (48%), Gaps = 17/196 (8%)
Query: 126 LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV 185
L + T V +++ E E LK EV + RH N++ T L ++
Sbjct: 18 LARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVI 77
Query: 186 TEFMARGSIYDFL--HKQKGVFQ--LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM 241
+ FMA GS L + +G+ + + ++L A+ +G+NYLHQN IHR++K +++L+
Sbjct: 78 SPFMAYGSANSLLKTYFPEGMSEALIGNILFGAL---RGLNYLHQNGYIHRNIKASHILI 134
Query: 242 DENGVVKVADFGVARVQAQSGVMTA--------ETGTYRWMAPEVIEHKPYDY--KADVF 291
+G+V ++ ++G T W++PE++ Y Y K+D++
Sbjct: 135 SGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIY 194
Query: 292 SFGIALWELLTGELPY 307
S GI EL TG +P+
Sbjct: 195 SVGITACELATGRVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.7 bits (194), Expect = 1e-16
Identities = 43/155 (27%), Positives = 81/155 (52%), Gaps = 3/155 (1%)
Query: 157 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI-YDFLHKQKGVFQLTSLLKVAI 215
E I+ K+ + VV A LC+V M G + + + F + A
Sbjct: 50 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAA 109
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAETGTYRWM 274
+++ G+ LH+ I++RDLK N+L+D+ G ++++D G+A V+ G + GT +M
Sbjct: 110 EITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLA-VEIPEGETIRGRVGTVGYM 168
Query: 275 APEVIEHKPYDYKADVFSFGIALWELLTGELPYAG 309
APEV++++ Y + D + G ++E++ G+ P+
Sbjct: 169 APEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQ 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 1e-16
Identities = 43/110 (39%), Positives = 65/110 (59%), Gaps = 8/110 (7%)
Query: 207 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMT 265
L LL+ + V++GM++L N IHRD+ N+L+ + V K+ DFG+AR + S +
Sbjct: 211 LDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVV 270
Query: 266 AETGTYR----WMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGL 310
G R WMAPE I Y ++DV+S+GI LWE+ + G+ PY G+
Sbjct: 271 --KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGI 318
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 2e-16
Identities = 56/205 (27%), Positives = 104/205 (50%), Gaps = 15/205 (7%)
Query: 110 KQLKIECKVASGSYGDLYKG---TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR- 165
+Q + ++ G+YG ++K + VA+K ++ + M +EV ++R +
Sbjct: 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 60
Query: 166 --HKNVVQFIGACT-----RPPNLCIVTEFMARGSIYDFLHK--QKGVFQLTSLLKVAID 216
H NVV+ CT R L +V E + + + +L K + GV T + +
Sbjct: 61 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTET-IKDMMFQ 118
Query: 217 VSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAP 276
+ +G+++LH + ++HRDLK N+L+ +G +K+ADFG+AR+ + +T+ T + AP
Sbjct: 119 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 178
Query: 277 EVIEHKPYDYKADVFSFGIALWELL 301
EV+ Y D++S G E+
Sbjct: 179 EVLLQSSYATPVDLWSVGCIFAEMF 203
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 2e-16
Identities = 53/183 (28%), Positives = 94/183 (51%), Gaps = 18/183 (9%)
Query: 135 EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI 194
+V +KVL P + ++ F + +MR++ HK++V G C R +V EF+ G +
Sbjct: 34 KVILKVLDPS--HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPL 91
Query: 195 YDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV-------V 247
F+H++ V KVA ++ ++YL +++H ++ T N+L+ G+ +
Sbjct: 92 DLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFI 151
Query: 248 KVADFGVARVQAQSGVMTAETGTYR--WMAPEVIE-HKPYDYKADVFSFGIALWEL-LTG 303
K++D G+ V++ + R W+APE +E K AD +SFG LWE+ G
Sbjct: 152 KLSDPGIPIT-----VLSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNG 206
Query: 304 ELP 306
E+P
Sbjct: 207 EIP 209
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 3e-16
Identities = 54/216 (25%), Positives = 105/216 (48%), Gaps = 24/216 (11%)
Query: 124 GDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183
++Y T ++ V +K LK + E EF Q+ R ++H N++Q +G C
Sbjct: 14 SEIYTDTGVARVV-VKELKANASSKEQ-NEFLQQGDPYRILQHPNILQCLGQCVEAIPYL 71
Query: 184 IVTEFMARGSIYDFLHKQKGVF---QLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL 240
+V E+ G + +L +++ QL L ++A +++ G+ ++H++N +H DL N
Sbjct: 72 LVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCF 131
Query: 241 MDENGVVKVADFGVARVQAQSGVMTAETGTY---RWMAPEVI-----------EHKPYDY 286
+ + VKV D+G+ + + + E RW+APE++ + KP
Sbjct: 132 LTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKP--- 188
Query: 287 KADVFSFGIALWELL-TGELPYAGLTPLQAAVGVVQ 321
++V++ G+ LWEL PY+ L+ + V++
Sbjct: 189 -SNVWALGVTLWELFENAAQPYSHLSDREVLNHVIK 223
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 3e-16
Identities = 38/99 (38%), Positives = 58/99 (58%), Gaps = 3/99 (3%)
Query: 219 KGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA--QSGVMTAETGTYRWMAP 276
+G+ YLH I+HRD+K NLL++ N V+K+ DFG+ARV+ +S MT E T + AP
Sbjct: 114 RGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAP 173
Query: 277 EVIEHKP-YDYKADVFSFGIALWELLTGELPYAGLTPLQ 314
E++ Y D++S G ELL + + +P+Q
Sbjct: 174 EILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQ 212
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 3e-16
Identities = 59/199 (29%), Positives = 102/199 (51%), Gaps = 15/199 (7%)
Query: 121 GSYGDLYKGTYCSQEV--AIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR 178
G+YG +YK + V A+K ++ E ++ + E+ I+ K +V F GA
Sbjct: 12 GNYGSVYKVLHRPTGVTMAMKEIRLE-LDESKFNQIIMELDILHKAVSPYIVDFYGAFFI 70
Query: 179 PPNLCIVTEFMARGS---IYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL-HQNNIIHRDL 234
+ + E+M GS +Y +G+ + L ++ V KG+ +L ++NIIHRD+
Sbjct: 71 EGAVYMCMEYMDAGSLDKLYAGGVATEGIPE-DVLRRITYAVVKGLKFLKEEHNIIHRDV 129
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVI------EHKPYDYKA 288
K N+L++ NG VK+ DFGV+ + + G +MAPE I ++ Y ++
Sbjct: 130 KPTNVLVNGNGQVKLCDFGVSG-NLVASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQS 188
Query: 289 DVFSFGIALWELLTGELPY 307
DV+S G+++ E+ G PY
Sbjct: 189 DVWSLGLSILEMALGRYPY 207
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 3e-16
Identities = 58/201 (28%), Positives = 104/201 (51%), Gaps = 19/201 (9%)
Query: 113 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFS---QEVYIMRKIRHK 167
K+E K+ G+YG +YK + VA+K ++ ++TE S +E+ +++++ H
Sbjct: 4 KVE-KIGEGTYGVVYKARNKLTGEVVALKKIR---LDTETEGVPSTAIREISLLKELNHP 59
Query: 168 NVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQ 226
N+V+ + L +V EF+ + + F+ L+K + + +G+ + H
Sbjct: 60 NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHS 118
Query: 227 NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV----MTAETGTYRWMAPEV-IEH 281
+ ++HRDLK NLL++ G +K+ADFG+AR GV T E T + APE+ +
Sbjct: 119 HRVLHRDLKPQNLLINTEGAIKLADFGLARA---FGVPVRTYTHEVVTLWYRAPEILLGC 175
Query: 282 KPYDYKADVFSFGIALWELLT 302
K Y D++S G E++T
Sbjct: 176 KYYSTAVDIWSLGCIFAEMVT 196
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 4e-16
Identities = 54/186 (29%), Positives = 85/186 (45%), Gaps = 18/186 (9%)
Query: 134 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL------CIVTE 187
Q VAIK L N K +E+ +M+ + HKN++ + T +L +V E
Sbjct: 42 QNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVME 101
Query: 188 FMARGSI----YDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE 243
M D H++ L G+ +LH IIHRDLK +N+++
Sbjct: 102 LMDANLCQVIQMDLDHERMSYLLYQMLC--------GIKHLHSAGIIHRDLKPSNIVVKS 153
Query: 244 NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTG 303
+ +K+ DFG+AR S +MT T + APEVI Y D++S G + E++ G
Sbjct: 154 DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRG 213
Query: 304 ELPYAG 309
+ + G
Sbjct: 214 TVLFPG 219
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 76.4 bits (189), Expect = 5e-16
Identities = 48/208 (23%), Positives = 96/208 (46%), Gaps = 25/208 (12%)
Query: 110 KQLKIEC--KVASGSYG--DLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVY---IMR 162
K +I K+ G +G + K + K++K + N + E +M+
Sbjct: 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFN-------AIEPMVHQLMK 66
Query: 163 KIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLL--KVAIDVSKG 220
+ N ++ + T ++ +++ G ++D L K+ +L+ K+ + +
Sbjct: 67 D--NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG---KLSEAEVKKIIRQLVEA 121
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGV-VKVADFGVARVQAQSGVMTAETGTYRWMAPEVI 279
+N LH++NIIH D+K N+L D + + D+G+ ++ GT + +PE I
Sbjct: 122 LNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD---GTLDYFSPEKI 178
Query: 280 EHKPYDYKADVFSFGIALWELLTGELPY 307
+ YD D ++ G+ +ELLTG+ P+
Sbjct: 179 KGHNYDVSFDWWAVGVLTYELLTGKHPF 206
|
Length = 267 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 5e-16
Identities = 40/131 (30%), Positives = 71/131 (54%), Gaps = 5/131 (3%)
Query: 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM 241
L ++ +++ G ++ L+ Q+ F + + ++ +++LHQ II+RD+K N+L+
Sbjct: 80 LHLILDYVNGGELFTHLY-QREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILL 138
Query: 242 DENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKP--YDYKADVFSFGIAL 297
D G V + DFG+++ A + GT +MAPEVI +D D +S G+
Sbjct: 139 DSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLT 198
Query: 298 WELLTGELPYA 308
+ELLTG P+
Sbjct: 199 FELLTGASPFT 209
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 5e-16
Identities = 55/204 (26%), Positives = 102/204 (50%), Gaps = 10/204 (4%)
Query: 117 KVASGSYGDLYKGT--YCSQEVAIKVLKPECVNTEMLKEFS--QEVYIMRKIRHKNVVQF 172
K+ GSY +YKG + VA+KV++ + E F+ +E +++ ++H N+V
Sbjct: 12 KLGEGSYATVYKGKSKVNGKLVALKVIR---LQEEEGTPFTAIREASLLKGLKHANIVLL 68
Query: 173 IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHR 232
L +V E++ + ++ K G ++ + +G++Y+HQ I+HR
Sbjct: 69 HDIIHTKETLTLVFEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHR 127
Query: 233 DLKTANLLMDENGVVKVADFGVARVQA-QSGVMTAETGTYRWMAPEV-IEHKPYDYKADV 290
DLK NLL+ + G +K+ADFG+AR ++ S + E T + P+V + Y D+
Sbjct: 128 DLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDM 187
Query: 291 FSFGIALWELLTGELPYAGLTPLQ 314
+ G E++ G + G+ +Q
Sbjct: 188 WGVGCIFVEMIQGVAAFPGMKDIQ 211
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 6e-16
Identities = 68/224 (30%), Positives = 111/224 (49%), Gaps = 33/224 (14%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-------EVAIKVLKPECVNTEMLKEFSQ 156
+WE+ + ++ +V SG+YG T CS +VAIK L + K +
Sbjct: 10 IWEVPDRYRDLK-QVGSGAYG-----TVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR 63
Query: 157 EVYIMRKIRHKNVVQFIGACTRPPNL------CIVTEFMAR--GSI--YDFLHKQKGVFQ 206
E+ +++ ++H+NV+ + T +L +V FM G + ++ L + + F
Sbjct: 64 ELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFL 123
Query: 207 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 266
+ +LK G+ Y+H IIHRDLK NL ++E+ +K+ DFG+AR Q S MT
Sbjct: 124 VYQMLK-------GLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR-QTDSE-MTG 174
Query: 267 ETGTYRWMAPEVI-EHKPYDYKADVFSFGIALWELLTGELPYAG 309
T + APEVI Y D++S G + E+LTG+ + G
Sbjct: 175 YVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKG 218
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 6e-16
Identities = 62/221 (28%), Positives = 104/221 (47%), Gaps = 28/221 (12%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQ 156
VWE+ + + +V SG+YG + CS ++VAIK L + K +
Sbjct: 10 VWELPERYTSL-KQVGSGAYGSV-----CSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYR 63
Query: 157 EVYIMRKIRHKNVVQFIGACTRPP------NLCIVTEFMARGSIYDFLHKQKGV-FQLTS 209
E+ +++ ++H+NV+ + T + +V +M L K G
Sbjct: 64 ELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTD-----LQKIMGHPLSEDK 118
Query: 210 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETG 269
+ + + G+ Y+H IIHRDLK NL ++E+ +K+ DFG+AR MT
Sbjct: 119 VQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR--HADAEMTGYVV 176
Query: 270 TYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAG 309
T + APEVI + Y+ D++S G + E+LTG+ + G
Sbjct: 177 TRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 217
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 76.9 bits (189), Expect = 6e-16
Identities = 57/197 (28%), Positives = 93/197 (47%), Gaps = 16/197 (8%)
Query: 121 GSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRK------IRHKNVVQF 172
GS+G L + + A+KVLK + + L++ E + K H + Q
Sbjct: 6 GSFGKVMLARLKESGRLYAVKVLKKDVI----LQDDDVECTMTEKRILSLARNHPFLTQL 61
Query: 173 IGACTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKGMNYLHQNNIIH 231
P L V EF+ G + H QK F A +++ + +LH II+
Sbjct: 62 YCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIY 119
Query: 232 RDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKADV 290
RDLK N+L+D G K+ADFG+ + +G T+ GT ++APE+++ Y D
Sbjct: 120 RDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDW 179
Query: 291 FSFGIALWELLTGELPY 307
++ G+ L+E+L G P+
Sbjct: 180 WAMGVLLYEMLCGHAPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 7e-16
Identities = 61/215 (28%), Positives = 103/215 (47%), Gaps = 15/215 (6%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
+WE+ + + V SG+YG + T VA+K L + K +E+ ++
Sbjct: 12 IWEVPERYQNLS-PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 70
Query: 162 RKIRHKNVVQFIGACTRPPNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
+ ++H+NV+ + T +L +VT M + + + QK L I
Sbjct: 71 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMG-ADLNNIVKCQKLTDDHVQFLIYQI 129
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
+G+ Y+H +IIHRDLK +NL ++E+ +K+ DFG+AR MT T + A
Sbjct: 130 --LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRA 185
Query: 276 PEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 309
PE+ + Y+ D++S G + ELLTG + G
Sbjct: 186 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 220
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 76.6 bits (189), Expect = 8e-16
Identities = 62/214 (28%), Positives = 102/214 (47%), Gaps = 40/214 (18%)
Query: 113 KIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR 165
K + SG+YG CS ++VAIK + + K +E+ I+R +
Sbjct: 8 KPIENIGSGAYG-----VVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFK 62
Query: 166 HKNVVQFIGACTRPP-----NLCIVTEFMARGSIYDFLHKQKGV------FQLTSLLKVA 214
H N++ I RPP ++ +V + M ++ +H + + + L LL+
Sbjct: 63 HDNIIA-IRDILRPPGADFKDVYVVMDLM-ESDLHHIIHSDQPLTEEHIRYFLYQLLR-- 118
Query: 215 IDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-----GVMTAETG 269
G+ Y+H N+IHRDLK +NLL++E+ +++ DFG+AR + S MT
Sbjct: 119 -----GLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVA 173
Query: 270 TYRWM-APEVIEHKP-YDYKADVFSFGIALWELL 301
T RW APE++ P Y D++S G E+L
Sbjct: 174 T-RWYRAPELLLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 8e-16
Identities = 51/192 (26%), Positives = 89/192 (46%), Gaps = 14/192 (7%)
Query: 133 SQEVAIKVLKPECVNTEML-KEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI-VTEFMA 190
EVAIK+L+ + E F +E + ++ H N+V + + PP L V E++
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 191 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV---V 247
++ + L G ++ + V + H I+HRDLK N+++ + GV
Sbjct: 63 GRTLREVLAAD-GALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHA 121
Query: 248 KVADFGVARV-----QAQSGVMTAET---GTYRWMAPEVIEHKPYDYKADVFSFGIALWE 299
KV DFG+ + A +T T GT + APE + +P +D++++G+ E
Sbjct: 122 KVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLE 181
Query: 300 LLTGELPYAGLT 311
LTG+ G +
Sbjct: 182 CLTGQRVVQGAS 193
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 8e-16
Identities = 63/222 (28%), Positives = 104/222 (46%), Gaps = 36/222 (16%)
Query: 118 VASGSYGDLY--KGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI----RHKNVVQ 171
+++G+YG +Y + Q A+K + +L+ Q+V++ R I + VV
Sbjct: 9 ISNGAYGAVYLVRHKETRQRFAMKKI---NKQNLILRNQIQQVFVERDILTFAENPFVVS 65
Query: 172 FIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQL-TSLLKVAIDVSKGMNYLHQNNII 230
+ +LC+V E++ G L K G + + + A V + YLH I+
Sbjct: 66 MFCSFETKRHLCMVMEYVEGGDCATLL-KNIGALPVDMARMYFAETVL-ALEYLHNYGIV 123
Query: 231 HRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--------------------GT 270
HRDLK NLL+ G +K+ DFG++++ G+M+ T GT
Sbjct: 124 HRDLKPDNLLITSMGHIKLTDFGLSKI----GLMSLTTNLYEGHIEKDTREFLDKQVCGT 179
Query: 271 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTP 312
++APEVI + Y D ++ GI L+E L G +P+ G TP
Sbjct: 180 PEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP 221
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 8e-16
Identities = 32/95 (33%), Positives = 60/95 (63%), Gaps = 1/95 (1%)
Query: 214 AIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYR 272
A +V+ + +LH++ +I+RDLK N+L+D G K+ADFG+ + +GV T GT
Sbjct: 102 AAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPD 161
Query: 273 WMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 307
++APE+++ Y D ++ G+ ++E++ G+ P+
Sbjct: 162 YIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPF 196
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 9e-16
Identities = 51/195 (26%), Positives = 105/195 (53%), Gaps = 6/195 (3%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ-EVYIMRKIRHKNVVQFIG 174
+ GSY L + + A+KV+K E VN + ++ Q E ++ + + +
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 175 ACTRPPN-LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
+C + + L V EF++ G + + +Q+ + + + A ++S +N+LH+ II+RD
Sbjct: 63 SCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSA-EISLALNFLHERGIIYRD 121
Query: 234 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKADVFS 292
LK N+L+D G +K+ D+G+ + + G T+ GT ++APE++ + Y + D ++
Sbjct: 122 LKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWA 181
Query: 293 FGIALWELLTGELPY 307
G+ ++E++ G P+
Sbjct: 182 LGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 1e-15
Identities = 56/201 (27%), Positives = 100/201 (49%), Gaps = 10/201 (4%)
Query: 117 KVASGSYGDLYKGT--YCSQEVAIKVLKPECVNTEMLKEFS--QEVYIMRKIRHKNVVQF 172
K+ GSY +YKG Q VA+KV+ + TE F+ +E +++ ++H N+V
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVIS---MKTEEGVPFTAIREASLLKGLKHANIVLL 68
Query: 173 IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHR 232
L V E+M + ++ + G ++ + +G+ Y+H +I+HR
Sbjct: 69 HDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHR 127
Query: 233 DLKTANLLMDENGVVKVADFGVARVQA-QSGVMTAETGTYRWMAPEVI-EHKPYDYKADV 290
DLK NLL+ G +K+ADFG+AR ++ S ++E T + P+V+ Y D+
Sbjct: 128 DLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDI 187
Query: 291 FSFGIALWELLTGELPYAGLT 311
+ G E+L G+ + G++
Sbjct: 188 WGAGCIFIEMLQGQPAFPGVS 208
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 1e-15
Identities = 52/199 (26%), Positives = 101/199 (50%), Gaps = 27/199 (13%)
Query: 132 CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF--------------IGACT 177
C + VA+K K + + +K +E+ I+R++ H N+V+ +G+ T
Sbjct: 29 CDKRVAVK--KIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLT 86
Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 237
++ IV E+M + + L + + L + +G+ Y+H N++HRDLK A
Sbjct: 87 ELNSVYIVQEYM-ETDLANVLEQGPLSEEHARLF--MYQLLRGLKYIHSANVLHRDLKPA 143
Query: 238 NLLMD-ENGVVKVADFGVARV----QAQSGVMTAETGTYRWMAPEVIEHKPYDYK--ADV 290
N+ ++ E+ V+K+ DFG+AR+ + G ++ T + +P ++ P +Y D+
Sbjct: 144 NVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLS-PNNYTKAIDM 202
Query: 291 FSFGIALWELLTGELPYAG 309
++ G E+LTG+ +AG
Sbjct: 203 WAAGCIFAEMLTGKPLFAG 221
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 1e-15
Identities = 44/159 (27%), Positives = 79/159 (49%), Gaps = 15/159 (9%)
Query: 157 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGS----IYDF----LHKQKGVFQLT 208
E I+ K+ + VV A LC+V M G IY+ +Q+ +F
Sbjct: 50 EKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIF--- 106
Query: 209 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET 268
A ++ G+ L + I++RDLK N+L+D+ G ++++D G+A + +
Sbjct: 107 ----YAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRV 162
Query: 269 GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 307
GT +MAPEVI ++ Y + D + G ++E++ G+ P+
Sbjct: 163 GTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPF 201
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 75.2 bits (185), Expect = 1e-15
Identities = 60/212 (28%), Positives = 103/212 (48%), Gaps = 34/212 (16%)
Query: 113 KIECKVASGSYGDLYKGT--YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
K+E K+ G+YG ++K + VA+K ++ + + + +E+ ++++++HKN+V
Sbjct: 4 KLE-KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIV 62
Query: 171 QFIGACTRPPNLCIVTEFM----------ARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 220
+ L +V E+ G I D + +FQL KG
Sbjct: 63 RLYDVLHSDKKLTLVFEYCDQDLKKYFDSCNGDI-DPEIVKSFMFQLL----------KG 111
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-----VQAQSGVMTAETGTYRWMA 275
+ + H +N++HRDLK NLL+++NG +K+ADFG+AR V+ S AE T +
Sbjct: 112 LAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYS----AEVVTLWYRP 167
Query: 276 PEVI-EHKPYDYKADVFSFGIALWELLTGELP 306
P+V+ K Y D++S G EL P
Sbjct: 168 PDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 2e-15
Identities = 50/199 (25%), Positives = 106/199 (53%), Gaps = 6/199 (3%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ-EVYIMRKIRHKNVVQFIG 174
+ GSY L + Q A+KV+K E V+ + ++ Q E ++ + + +
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 175 ACTRPPN-LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
+C + + L +V E++ G + + +Q+ + + + A ++ +N+LH+ II+RD
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAA-EICIALNFLHERGIIYRD 121
Query: 234 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEVIEHKPYDYKADVFS 292
LK N+L+D +G +K+ D+G+ + G T+ GT ++APE++ + Y + D ++
Sbjct: 122 LKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWA 181
Query: 293 FGIALWELLTGELPYAGLT 311
G+ ++E++ G P+ +T
Sbjct: 182 LGVLMFEMMAGRSPFDIIT 200
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 75.9 bits (186), Expect = 2e-15
Identities = 53/182 (29%), Positives = 90/182 (49%), Gaps = 10/182 (5%)
Query: 134 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL------CIVTE 187
+ VAIK L N K +E+ +M+ + HKN++ + T +L IV E
Sbjct: 50 RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109
Query: 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVV 247
M ++ + + +++ LL + G+ +LH IIHRDLK +N+++ + +
Sbjct: 110 LM-DANLCQVIQMELDHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTL 165
Query: 248 KVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 307
K+ DFG+AR S +MT T + APEVI Y D++S G + E++ G + +
Sbjct: 166 KILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLF 225
Query: 308 AG 309
G
Sbjct: 226 PG 227
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 4e-15
Identities = 51/199 (25%), Positives = 100/199 (50%), Gaps = 6/199 (3%)
Query: 117 KVASGSYGDLYKGTYCSQE--VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
K+ G+Y +YKG + VA+K ++ E +EV +++ ++H N+V
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAI-REVSLLKDLKHANIVTLHD 71
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
+L +V E++ + + +L + ++ + +G+NY H+ ++HRDL
Sbjct: 72 IIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDL 130
Query: 235 KTANLLMDENGVVKVADFGVARVQA-QSGVMTAETGTYRWMAPEV-IEHKPYDYKADVFS 292
K NLL++E G +K+ADFG+AR ++ + + E T + P++ + Y + D++
Sbjct: 131 KPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWG 190
Query: 293 FGIALWELLTGELPYAGLT 311
G +E+ TG + G T
Sbjct: 191 VGCIFYEMSTGRPLFPGST 209
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 6e-15
Identities = 35/92 (38%), Positives = 59/92 (64%), Gaps = 3/92 (3%)
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS---GVMTAETGTYRWMAPE 277
++ +H ++HRDLK+AN+ + G++K+ DFG ++ + S V ++ GT ++APE
Sbjct: 182 LDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPE 241
Query: 278 VIEHKPYDYKADVFSFGIALWELLTGELPYAG 309
+ E K Y KAD++S G+ L+ELLT P+ G
Sbjct: 242 LWERKRYSKKADMWSLGVILYELLTLHRPFKG 273
|
Length = 478 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.5 bits (181), Expect = 6e-15
Identities = 60/207 (28%), Positives = 100/207 (48%), Gaps = 31/207 (14%)
Query: 113 KIECKVASGSYGDLYKG--TYCSQEVAIKVLK----PECVNTEMLKEFSQEVYIMRKIRH 166
K+E K+ G+YG +YK + VA+K ++ E V + ++E S +++++ H
Sbjct: 3 KVE-KIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREIS----LLKELNH 57
Query: 167 KNVVQFIGACTRPPNLCIVTEFMARGSIYDF-LHK---QKGVFQLTSLL--KVAIDVSKG 220
N+V+ + L +V EF+ D L K + L L + +G
Sbjct: 58 PNIVRLLDVVHSENKLYLVFEFL------DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQG 111
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV----MTAETGTYRWMAP 276
+ Y H + ++HRDLK NLL+D G +K+ADFG+AR GV T E T + AP
Sbjct: 112 IAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARA---FGVPVRTYTHEVVTLWYRAP 168
Query: 277 EV-IEHKPYDYKADVFSFGIALWELLT 302
E+ + + Y D++S G E++
Sbjct: 169 EILLGSRQYSTPVDIWSIGCIFAEMVN 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 7e-15
Identities = 51/180 (28%), Positives = 90/180 (50%), Gaps = 10/180 (5%)
Query: 136 VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL------CIVTEFM 189
VA+K L N K +E+ +++ + HKN++ + T +L +V E M
Sbjct: 49 VAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELM 108
Query: 190 ARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKV 249
++ +H + +++ LL + G+ +LH IIHRDLK +N+++ + +K+
Sbjct: 109 -DANLCQVIHMELDHERMSYLL---YQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKI 164
Query: 250 ADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAG 309
DFG+AR + +MT T + APEVI Y D++S G + EL+ G + + G
Sbjct: 165 LDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQG 224
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 9e-15
Identities = 69/244 (28%), Positives = 115/244 (47%), Gaps = 40/244 (16%)
Query: 108 DAKQLKIECKVASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKE-----FSQEVYI 160
D +K+ + G++G+ L + Q A+K+L EM+K F +E I
Sbjct: 44 DFDVIKV---IGRGAFGEVQLVRHKSSKQVYAMKLLS----KFEMIKRSDSAFFWEERDI 96
Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI------YDFLHKQKGVFQLTSLLKVA 214
M + +VQ A L +V E+M G + YD K + T+ + +A
Sbjct: 97 MAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFY--TAEVVLA 154
Query: 215 IDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYR 272
+D +H IHRD+K N+L+D++G +K+ADFG +G++ +T GT
Sbjct: 155 LDA------IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPD 208
Query: 273 WMAPEVIE----HKPYDYKADVFSFGIALWELLTGELP-YAGLTPLQAAVGVVQKVSIHS 327
+++PEV++ Y + D +S G+ L+E+L G+ P YA + VG K+ H
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYA-----DSLVGTYSKIMDHK 263
Query: 328 IILT 331
LT
Sbjct: 264 NSLT 267
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 9e-15
Identities = 40/132 (30%), Positives = 71/132 (53%), Gaps = 5/132 (3%)
Query: 179 PPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 237
+L +VT++M+ G + F H QK G F ++ + +LH+ +I++RDLK
Sbjct: 68 DSDLYLVTDYMSGGEL--FWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPE 125
Query: 238 NLLMDENGVVKVADFGVARVQAQSGVMTAE-TGTYRWMAPEV-IEHKPYDYKADVFSFGI 295
N+L+D G + + DFG+++ T GT ++APEV ++ K Y D +S G+
Sbjct: 126 NILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGV 185
Query: 296 ALWELLTGELPY 307
++E+ G P+
Sbjct: 186 LVFEMCCGWSPF 197
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 9e-15
Identities = 60/206 (29%), Positives = 101/206 (49%), Gaps = 36/206 (17%)
Query: 118 VASGSYGDLYKG--TYCSQEVAIK-VLKPEC---VNTEMLKEFSQEVYIMRKIR---HKN 168
+ G+YG +YK + VA+K V P + L+E + +++++ H N
Sbjct: 7 IGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIA----LLKQLESFEHPN 62
Query: 169 VVQFIGACTRPPN-----LCIVTEFMARGSIYDFLHK--QKGVFQLTSLLKVAI-DVSK- 219
+V+ + C P L +V E + + + +L K + G L I D+ +
Sbjct: 63 IVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPG------LPPETIKDLMRQ 115
Query: 220 ---GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT--YRWM 274
G+++LH + I+HRDLK N+L+ +G VK+ADFG+AR+ + +T+ T YR
Sbjct: 116 LLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYR-- 173
Query: 275 APEVIEHKPYDYKADVFSFGIALWEL 300
APEV+ Y D++S G EL
Sbjct: 174 APEVLLQSSYATPVDMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 1e-14
Identities = 53/209 (25%), Positives = 99/209 (47%), Gaps = 24/209 (11%)
Query: 116 CKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
+ G YG+L+K EV +KVL + + + F + +M ++ HK++V G
Sbjct: 15 IRREVGDYGELHK-----TEVLLKVL--DKSHRNYSESFFEAASMMSQLSHKHLVLNYGV 67
Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 235
C +V E++ GS+ +L K K + ++ L+VA ++ +++L + H ++
Sbjct: 68 CVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVC 127
Query: 236 TANLLMDENG--------VVKVADFGVARVQAQSGVMTAETGTYR--WMAPEVIEH-KPY 284
N+L+ +K++D G++ V+ E R W+ PE IE+ +
Sbjct: 128 AKNVLLIREEDRKTGNPPFIKLSDPGISIT-----VLPKEILLERIPWVPPECIENPQNL 182
Query: 285 DYKADVFSFGIALWELLTG-ELPYAGLTP 312
AD +SFG LWE+ +G + P + L
Sbjct: 183 SLAADKWSFGTTLWEIFSGGDKPLSALDS 211
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 2e-14
Identities = 58/208 (27%), Positives = 99/208 (47%), Gaps = 24/208 (11%)
Query: 117 KVASGSYGDLYKGTYCSQE--VAIKVLKPE------CVNTEMLKEFSQEVYIMRKIRHKN 168
K+ G+Y ++KG E VA+K ++ E C +EV +++ ++H N
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-------REVSLLKNLKHAN 64
Query: 169 VVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI---DVSKGMNYLH 225
+V L +V E++ D L S+ V I + +G++Y H
Sbjct: 65 IVTLHDIIHTERCLTLVFEYLDS----DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCH 120
Query: 226 QNNIIHRDLKTANLLMDENGVVKVADFGVARVQA-QSGVMTAETGTYRWMAPEV-IEHKP 283
+ I+HRDLK NLL++E G +K+ADFG+AR ++ + + E T + P+V +
Sbjct: 121 KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTE 180
Query: 284 YDYKADVFSFGIALWELLTGELPYAGLT 311
Y D++ G L+E+ TG + G T
Sbjct: 181 YSTPIDMWGVGCILYEMATGRPMFPGST 208
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 2e-14
Identities = 51/205 (24%), Positives = 96/205 (46%), Gaps = 17/205 (8%)
Query: 127 YKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186
YK T + V ++ + E EM+ E+++ + H N+V + L +VT
Sbjct: 21 YKPT--GEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVT 78
Query: 187 EFMARGSIYDFL--HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN 244
FMA GS D + H G+ +L + + V K ++Y+H +HR +K +++L+ +
Sbjct: 79 SFMAYGSAKDLICTHFMDGMSELA-IAYILQGVLKALDYIHHMGYVHRSVKASHILISVD 137
Query: 245 GVVKV----ADFGVARVQAQSGVMTAETGTYR-----WMAPEVIEH--KPYDYKADVFSF 293
G V + ++ + Q + + Y W++PEV++ + YD K+D++S
Sbjct: 138 GKVYLSGLRSNLSMIN-HGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSV 196
Query: 294 GIALWELLTGELPYAGLTPLQAAVG 318
GI EL G +P+ + Q +
Sbjct: 197 GITACELANGHVPFKDMPATQMLLE 221
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 2e-14
Identities = 61/222 (27%), Positives = 107/222 (48%), Gaps = 29/222 (13%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
VWE+ + + V SG+YG + T Q+VA+K L + + +E+ ++
Sbjct: 10 VWEVPERYQNLT-PVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLL 68
Query: 162 RKIRHKNVVQFIGACTRPPNL------CIVTEFMAR--GSIYDFL-----HKQKGVFQLT 208
+ ++H+NV+ + T ++ +VT M +I H Q ++QL
Sbjct: 69 KHMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLL 128
Query: 209 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET 268
+G+ Y+H IIHRDLK +N+ ++E+ +++ DFG+AR QA MT
Sbjct: 129 ----------RGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR-QADDE-MTGYV 176
Query: 269 GTYRWMAPEV-IEHKPYDYKADVFSFGIALWELLTGELPYAG 309
T + APE+ + Y+ D++S G + ELL G+ + G
Sbjct: 177 ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPG 218
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 3e-14
Identities = 50/186 (26%), Positives = 89/186 (47%), Gaps = 18/186 (9%)
Query: 134 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGS 193
+ VAIK L N K +E+ +M+ + HKN++ + T +L EF
Sbjct: 43 RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSL---EEFQDVYL 99
Query: 194 IYDFLHKQKGVFQLTSLLKVAIDVSK----------GMNYLHQNNIIHRDLKTANLLMDE 243
+ + + L ++++ +D + G+ +LH IIHRDLK +N+++
Sbjct: 100 VMELMDAN-----LCQVIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKS 154
Query: 244 NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTG 303
+ +K+ DFG+AR S +MT T + APEVI Y D++S G + E++
Sbjct: 155 DCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRH 214
Query: 304 ELPYAG 309
++ + G
Sbjct: 215 KILFPG 220
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 4e-14
Identities = 62/286 (21%), Positives = 105/286 (36%), Gaps = 38/286 (13%)
Query: 48 PYDETEDLKNV----LAKEILKSKDQSCSKRQPALGVPMHSKLLIESSPNCIEIPTDG-- 101
Y+ L +K+ K C + + V + ++ + TD
Sbjct: 18 GYEAIFSLTGGTDTSDSKDTTGDKFDDCDELGDSDDVTHATD--YDADEESLSPQTDVCQ 75
Query: 102 --------TDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKE 153
+D + Q I + GS G+++ T E KV+ K
Sbjct: 76 EPCETTSSSDPASVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG---KT 132
Query: 154 FSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKV 213
+E+ I++ I H+ ++ I A +C+V D L L+
Sbjct: 133 PGREIDILKTISHRAIINLIHAYRWKSTVCMVM----PKYKCDLFTYVDRSGPLP--LEQ 186
Query: 214 AIDVSKGM----NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETG 269
AI + + + YLH IIHRD+KT N+ +DE + DFG A +
Sbjct: 187 AITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAA---CKLDAHPDTPQ 243
Query: 270 TYRWM------APEVIEHKPYDYKADVFSFGIALWELLTGELPYAG 309
Y W +PE++ PY K D++S G+ L+E+ + G
Sbjct: 244 CYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFG 289
|
Length = 392 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 4e-14
Identities = 52/199 (26%), Positives = 98/199 (49%), Gaps = 18/199 (9%)
Query: 117 KVASGSYGDLYKGT--YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR---HKNVVQ 171
++ G+YG +YK + VA+K ++ + + +EV +++++ H N+V+
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 172 FIGACT-----RPPNLCIVTEFMARGSIYDFLHKQKG----VFQLTSLLKVAIDVSKGMN 222
+ C R + +V E + + + +L K + L++ + +G++
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFL---RGLD 122
Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHK 282
+LH N I+HRDLK N+L+ G VK+ADFG+AR+ + +T T + APEV+
Sbjct: 123 FLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQS 182
Query: 283 PYDYKADVFSFGIALWELL 301
Y D++S G E+
Sbjct: 183 TYATPVDMWSVGCIFAEMF 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 5e-14
Identities = 51/204 (25%), Positives = 104/204 (50%), Gaps = 7/204 (3%)
Query: 112 LKIECKVASGSYGDLYKGTYCSQE--VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNV 169
+K+E K+ G+Y ++KG E VA+K ++ E +EV +++ ++H N+
Sbjct: 9 IKLE-KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAI-REVSLLKDLKHANI 66
Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
V +L +V E++ + + ++ + + ++ + +G+ Y H+ +
Sbjct: 67 VTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKV 125
Query: 230 IHRDLKTANLLMDENGVVKVADFGVARVQA-QSGVMTAETGTYRWMAPEV-IEHKPYDYK 287
+HRDLK NLL++E G +K+ADFG+AR ++ + + E T + P+V + Y +
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQ 185
Query: 288 ADVFSFGIALWELLTGELPYAGLT 311
D++ G +E+ +G + G T
Sbjct: 186 IDMWGVGCIFFEMASGRPLFPGST 209
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 5e-14
Identities = 63/228 (27%), Positives = 110/228 (48%), Gaps = 35/228 (15%)
Query: 118 VASGSYGDLYKGTY-CSQEV-AIKVLKPECVNTEMLKE-----FSQEVYIMRKIRHKNVV 170
+ G++G++ + SQ+V A+K+L EM+K F +E IM VV
Sbjct: 51 IGRGAFGEVQLVRHKSSQKVYAMKLLS----KFEMIKRSDSAFFWEERDIMAFANSPWVV 106
Query: 171 QFIGACTRPPNLCIVTEFMARGSI------YDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 224
Q A L +V E+M G + YD K + +L ++ +
Sbjct: 107 QLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEVVL--------ALDAI 158
Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHK 282
H +IHRD+K N+L+D++G +K+ADFG ++G++ +T GT +++PEV++ +
Sbjct: 159 HSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQ 218
Query: 283 P----YDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIH 326
Y + D +S G+ L+E+L G+ P+ + VG K+ H
Sbjct: 219 GGDGYYGRECDWWSVGVFLFEMLVGDTPFYA----DSLVGTYSKIMDH 262
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 5e-14
Identities = 63/231 (27%), Positives = 110/231 (47%), Gaps = 31/231 (13%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKE-----FSQEVYIMRKIRHKNVV 170
+ G++G+ L + + A+K+L EM+K F +E IM VV
Sbjct: 51 IGRGAFGEVQLVRHKSTRKVYAMKLLS----KFEMIKRSDSAFFWEERDIMAFANSPWVV 106
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHK----QKGVFQLTSLLKVAIDVSKGMNYLHQ 226
Q A L +V E+M G + + + +K T+ + +A+D +H
Sbjct: 107 QLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEVVLALDA------IHS 160
Query: 227 NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKP- 283
IHRD+K N+L+D++G +K+ADFG + G++ +T GT +++PEV++ +
Sbjct: 161 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGG 220
Query: 284 ---YDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIHSIILT 331
Y + D +S G+ L+E+L G+ P+ + VG K+ H LT
Sbjct: 221 DGYYGRECDWWSVGVFLYEMLVGDTPFYA----DSLVGTYSKIMNHKNSLT 267
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 71.0 bits (174), Expect = 6e-14
Identities = 64/221 (28%), Positives = 102/221 (46%), Gaps = 58/221 (26%)
Query: 118 VASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKE-FS----QEVYIMRKIRHKNVV 170
+ G+YG +YK + VA+K V + KE F +E+ I+R++ H+N+V
Sbjct: 15 IGEGTYGQVYKARDKDTGELVALKK-----VRLDNEKEGFPITAIREIKILRQLNHRNIV 69
Query: 171 QFIGACTRPPNLC-IVTEFMARGSIYDFLHKQKGVF------------------------ 205
NL IVT+ + DF K KG F
Sbjct: 70 ----------NLKEIVTD---KQDALDFK-KDKGAFYLVFEYMDHDLMGLLESGLVHFSE 115
Query: 206 -QLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSG 262
+ S +K ++ G+NY H+ N +HRD+K +N+L++ G +K+ADFG+AR+ +S
Sbjct: 116 DHIKSFMKQLLE---GLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESR 172
Query: 263 VMTAETGTYRWMAPE-VIEHKPYDYKADVFSFGIALWELLT 302
T + T + PE ++ + Y DV+S G L EL T
Sbjct: 173 PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFT 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 69.8 bits (171), Expect = 2e-13
Identities = 52/194 (26%), Positives = 88/194 (45%), Gaps = 18/194 (9%)
Query: 124 GDLYKGTYCSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL 182
GD+Y A+KV+K + E + F +E I+ + Q A NL
Sbjct: 26 GDIY---------AMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNL 76
Query: 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD 242
+V E+ G + L++ + F ++ ++ +HQ +HRD+K N+L+D
Sbjct: 77 YLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLID 136
Query: 243 ENGVVKVADFG-VARVQAQSGVM-TAETGTYRWMAPEVIE------HKPYDYKADVFSFG 294
G +K+ADFG AR+ A V GT ++APEV+ Y + D +S G
Sbjct: 137 RTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLG 196
Query: 295 IALWELLTGELPYA 308
+ +E++ G P+
Sbjct: 197 VIAYEMIYGRSPFH 210
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 69.5 bits (171), Expect = 2e-13
Identities = 63/227 (27%), Positives = 108/227 (47%), Gaps = 57/227 (25%)
Query: 110 KQLKIECKVASGSYGDLYKGT--YCSQEVAIKVLKPECVNTEMLKEF--------SQ--- 156
++ +I K+ G+YG ++K + VA+K K F +Q
Sbjct: 7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALK------------KIFDAFRNATDAQRTF 54
Query: 157 -EVYIMRKIR-HKNVVQFIGACTRPPN---LCIVTEFMA-------RGSIYDFLHKQKGV 204
E+ ++++ H N+V+ + + N + +V E+M R +I + +HK+ +
Sbjct: 55 REIMFLQELGDHPNIVKLL-NVIKAENDKDIYLVFEYMETDLHAVIRANILEDVHKRYIM 113
Query: 205 FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-- 262
+QL LK Y+H N+IHRDLK +N+L++ + VK+ADFG+AR ++
Sbjct: 114 YQLLKALK----------YIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEEN 163
Query: 263 ----VMTAETGTYRWM-APEV-IEHKPYDYKADVFSFGIALWELLTG 303
V+T T RW APE+ + Y D++S G L E+L G
Sbjct: 164 PENPVLTDYVAT-RWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLG 209
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 70.2 bits (171), Expect = 3e-13
Identities = 57/232 (24%), Positives = 111/232 (47%), Gaps = 49/232 (21%)
Query: 117 KVASGSYGDLY----KGT---YCSQEVAIKVLKPECVNTEMLKEFSQ---EVYIMRKIRH 166
K+ +G +G+++ K T +C + ++ + LK +E SQ EV +MR+++H
Sbjct: 20 KIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKE--------REKSQLVIEVNVMRELKH 71
Query: 167 KNVVQFIGACTRPPN--LCIVTEFMARGSIYDFL---HKQKGVFQLTSLLKVAIDVSKGM 221
KN+V++I N L I+ EF G + + +K G + +++ + + +
Sbjct: 72 KNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHAL 131
Query: 222 NYLHQ-------NNIIHRDLKTANLLMDE---------------NG--VVKVADFGVARV 257
Y H ++HRDLK N+ + NG + K+ DFG+++
Sbjct: 132 AYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKN 191
Query: 258 QAQSGVMTAETGTYRWMAPEVIEH--KPYDYKADVFSFGIALWELLTGELPY 307
+ + GT + +PE++ H K YD K+D+++ G ++EL +G+ P+
Sbjct: 192 IGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243
|
Length = 1021 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 4e-13
Identities = 59/218 (27%), Positives = 99/218 (45%), Gaps = 27/218 (12%)
Query: 111 QLKIECKVASGSYGDL--YKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN 168
+ KI+ + GSYG + T+ ++VAIK + + +E+ ++R +RH +
Sbjct: 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPD 60
Query: 169 VVQFIGACTRPPN------LCIVTEFMARG-----SIYDFLHKQKGVFQLTSLLKVAIDV 217
+V+ I PP+ + +V E M D L + F L LL+
Sbjct: 61 IVE-IKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLR----- 114
Query: 218 SKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV---QAQSGVMTAETGTYRWM 274
+ Y+H N+ HRDLK N+L + + +K+ DFG+ARV + + + RW
Sbjct: 115 --ALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWY 172
Query: 275 -APEVIE--HKPYDYKADVFSFGIALWELLTGELPYAG 309
APE+ Y D++S G E+LTG+ + G
Sbjct: 173 RAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPG 210
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 5e-13
Identities = 61/230 (26%), Positives = 105/230 (45%), Gaps = 43/230 (18%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVN----------TEMLKEFSQEVYI 160
K+E K+ G+YG +YK + + VA+K + E +L+ S+ +YI
Sbjct: 5 KLE-KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYI 63
Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFM-----------ARGSIYDFLHK--QKGVFQL 207
+R + ++V + G P+L +V E++ RG K + ++QL
Sbjct: 64 VRLLDVEHVEEKNGK----PSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119
Query: 208 TSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD-ENGVVKVADFGVARV-QAQSGVMT 265
KG+ + H++ ++HRDLK NLL+D + G++K+AD G+ R T
Sbjct: 120 L----------KGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYT 169
Query: 266 AETGTYRWMAPEV-IEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ 314
E T + APEV + Y D++S G E+ + + G + LQ
Sbjct: 170 HEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ 219
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 8e-13
Identities = 58/211 (27%), Positives = 97/211 (45%), Gaps = 28/211 (13%)
Query: 116 CKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFS--QEVYIMRKIRHKNVVQ 171
K+ GSY +YKG Q VA+K ++ + E F+ +E +++ ++H N+V
Sbjct: 11 DKLGEGSYATVYKGRSKLTGQLVALKEIR---LEHEEGAPFTAIREASLLKDLKHANIVT 67
Query: 172 FIGACTRPPNLCIVTEFMAR---------GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMN 222
L +V E++ G + + +FQL +G+
Sbjct: 68 LHDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLL----------RGLA 117
Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA-QSGVMTAETGTYRWMAPEVI-E 280
Y HQ ++HRDLK NLL+ E G +K+ADFG+AR ++ S + E T + P+V+
Sbjct: 118 YCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLG 177
Query: 281 HKPYDYKADVFSFGIALWELLTGELPYAGLT 311
Y D++ G +E+ TG + G T
Sbjct: 178 STEYSTSLDMWGVGCIFYEMATGRPLFPGST 208
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 67.4 bits (165), Expect = 1e-12
Identities = 36/91 (39%), Positives = 51/91 (56%), Gaps = 8/91 (8%)
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-----VQAQSGVMTAETGTYRWM 274
G+ Y+H N++HRDLK NLL++ + +K+ DFG+AR +G MT T RW
Sbjct: 117 GLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVAT-RWY 175
Query: 275 -APEV-IEHKPYDYKADVFSFGIALWELLTG 303
APE+ + + Y DV+S G L ELL
Sbjct: 176 RAPEIMLSFQSYTKAIDVWSVGCILAELLGR 206
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 1e-12
Identities = 38/130 (29%), Positives = 68/130 (52%), Gaps = 2/130 (1%)
Query: 179 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTAN 238
P L +V F+ G ++ L ++ G F L+ ++ + LH+ N+I+RDLK N
Sbjct: 65 PEKLYLVLAFINGGELFHHLQRE-GRFDLSRARFYTAELLCALENLHKFNVIYRDLKPEN 123
Query: 239 LLMDENGVVKVADFGVARVQ-AQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIAL 297
+L+D G + + DFG+ ++ GT ++APE++ Y D ++ G+ L
Sbjct: 124 ILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLL 183
Query: 298 WELLTGELPY 307
+E+LTG P+
Sbjct: 184 YEMLTGLPPF 193
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 1e-12
Identities = 49/205 (23%), Positives = 83/205 (40%), Gaps = 32/205 (15%)
Query: 137 AIKVLKPECVNTE-MLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY 195
A+KVL + + +K E I+ + H + + LC+V ++ G ++
Sbjct: 30 ALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELF 89
Query: 196 DFLHKQKG-VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADF-- 252
L +Q G A +V + YLH I++RDLK N+L+ E+G + ++DF
Sbjct: 90 RLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDL 149
Query: 253 -------GVARVQAQSG-------------VMTAET--------GTYRWMAPEVIEHKPY 284
+A + E GT ++APEVI +
Sbjct: 150 SKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGH 209
Query: 285 DYKADVFSFGIALWELLTGELPYAG 309
D ++ GI L+E+L G P+ G
Sbjct: 210 GSAVDWWTLGILLYEMLYGTTPFKG 234
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 1e-12
Identities = 60/240 (25%), Positives = 102/240 (42%), Gaps = 54/240 (22%)
Query: 118 VASGSYGD--LYKGTYCSQEVAIKVLKPECVNTEMLKE-----FSQEVYIMRKIRHKNVV 170
+ G++G+ L + Q A+KVL+ +M+K E I+ +V
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVLRKS----DMIKRNQIAHVRAERDILADADSPWIV 64
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ------LTSLLKVAIDVSKGMNYL 224
+ + +L +V E+M G + + L + K VF + L +A+D +
Sbjct: 65 KLYYSFQDEEHLYLVMEYMPGGDLMNLLIR-KDVFPEETARFYIAELVLALD------SV 117
Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVA----------------------------- 255
H+ IHRD+K N+L+D +G +K+ADFG+
Sbjct: 118 HKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRR 177
Query: 256 RVQAQSGVMT-AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ 314
R Q V + GT ++APEV+ PY + D +S G+ L+E+L G P+ T +
Sbjct: 178 RDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQE 237
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 66.1 bits (161), Expect = 3e-12
Identities = 54/201 (26%), Positives = 102/201 (50%), Gaps = 12/201 (5%)
Query: 118 VASGSYGDLY-----KGTYCSQEVAIKVL-KPECVNTEMLKEFSQ-EVYIMRKIRHKN-V 169
+ +G+YG ++ G + A+KVL K V E ++ E ++ +R +
Sbjct: 8 LGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFL 67
Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
V A L ++ ++++ G ++ L+ Q+ F + + ++ + +LH+ I
Sbjct: 68 VTLHYAFQTEAKLHLILDYVSGGEMFTHLY-QRDNFSEDEVRFYSGEIILALEHLHKLGI 126
Query: 230 IHRDLKTANLLMDENGVVKVADFGVAR--VQAQSGVMTAETGTYRWMAPEVIEHKPYDYK 287
++RD+K N+L+D G V + DFG+++ + + + GT +MAPE+I K K
Sbjct: 127 VYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGK 186
Query: 288 A-DVFSFGIALWELLTGELPY 307
A D +S GI ++ELLTG P+
Sbjct: 187 AVDWWSLGILIFELLTGASPF 207
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 3e-12
Identities = 56/221 (25%), Positives = 101/221 (45%), Gaps = 58/221 (26%)
Query: 113 KIECKVASGSYGDLYKGT--YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
K+E K+ G+YG +YK ++ +A+K ++ E + + +E+ ++++++H N+V
Sbjct: 6 KVE-KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIV 64
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG---VFQLTSL-LKVAIDVS-------- 218
+ + D +H +K VF+ L LK +D S
Sbjct: 65 R----------------------LQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPR 102
Query: 219 ----------KGMNYLHQNNIIHRDLKTANLLMDE-NGVVKVADFGVAR-----VQAQSG 262
+G+ Y H + ++HRDLK NLL+D +K+ADFG+AR V+
Sbjct: 103 LIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT--- 159
Query: 263 VMTAETGTYRWMAPEV-IEHKPYDYKADVFSFGIALWELLT 302
T E T + APE+ + + Y D++S G E++
Sbjct: 160 -FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVN 199
|
Length = 294 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 64.9 bits (158), Expect = 5e-12
Identities = 50/188 (26%), Positives = 88/188 (46%), Gaps = 18/188 (9%)
Query: 136 VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY 195
V +KVL P + ++ F + +M ++ H ++ G C R +V EF+ G +
Sbjct: 47 VVLKVLDPS--HRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLD 104
Query: 196 DFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV-------VK 248
L K+KG + + VA ++ ++YL N++H ++ N+L+ G+ +K
Sbjct: 105 VCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIK 164
Query: 249 VADFGVARVQAQSGVMTAETGTYR--WMAPEVIEH-KPYDYKADVFSFGIALWEL-LTGE 304
++D GV+ ++ E R W+APE + AD +SFG L E+ GE
Sbjct: 165 LSDPGVS-----FTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGE 219
Query: 305 LPYAGLTP 312
+P TP
Sbjct: 220 VPLKERTP 227
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 7e-12
Identities = 52/202 (25%), Positives = 101/202 (50%), Gaps = 13/202 (6%)
Query: 118 VASGSYGDLY-----KGTYCSQEVAIKVLKPECV--NTEMLKEFSQEVYIMRKIRHKN-V 169
+ +G+YG ++ G + A+KVLK + + + E ++ IR +
Sbjct: 8 LGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFL 67
Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
V A L ++ +++ G ++ L Q+ F+ + + ++ + +LH+ I
Sbjct: 68 VTLHYAFQTDTKLHLILDYINGGELFTHL-SQRERFKEQEVQIYSGEIVLALEHLHKLGI 126
Query: 230 IHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIE--HKPYD 285
I+RD+K N+L+D NG V + DFG+++ + V A + GT +MAP+++ +D
Sbjct: 127 IYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHD 186
Query: 286 YKADVFSFGIALWELLTGELPY 307
D +S G+ ++ELLTG P+
Sbjct: 187 KAVDWWSMGVLMYELLTGASPF 208
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 1e-11
Identities = 60/244 (24%), Positives = 104/244 (42%), Gaps = 43/244 (17%)
Query: 108 DAKQLKIECKVASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKI 164
D + LK+ + G++G+ L + A+K+L K + + E + E I+ +
Sbjct: 2 DFESLKV---IGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEA 58
Query: 165 RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 224
VV+ + NL ++ EF+ G + L K+ + + + +A + ++ +
Sbjct: 59 DSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIA-ETVLAIDSI 117
Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVA-----------------------RVQAQS 261
HQ IHRD+K NLL+D G VK++DFG+ Q +
Sbjct: 118 HQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMN 177
Query: 262 GVMTAET-------------GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYA 308
AET GT ++APEV Y+ D +S G+ ++E+L G P+
Sbjct: 178 SKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237
Query: 309 GLTP 312
TP
Sbjct: 238 SETP 241
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 34/215 (15%)
Query: 116 CKVASGSYGDLYKGTYC----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQ 171
CKV G+YG +YK +E A+K ++ T + +E+ ++R+++H NV+
Sbjct: 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIE----GTGISMSACREIALLRELKHPNVIA 62
Query: 172 ----FIGACTRP---------PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVS 218
F+ R +L + +F R S + Q + SLL +D
Sbjct: 63 LQKVFLSHSDRKVWLLFDYAEHDLWHIIKFH-RASKANKKPMQLPRSMVKSLLYQILD-- 119
Query: 219 KGMNYLHQNNIIHRDLKTANLLM----DENGVVKVADFGVARVQAQSGVMTAETG----T 270
G++YLH N ++HRDLK AN+L+ E G VK+AD G AR+ A+ T
Sbjct: 120 -GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 178
Query: 271 YRWMAPE-VIEHKPYDYKADVFSFGIALWELLTGE 304
+ + APE ++ + Y D+++ G ELLT E
Sbjct: 179 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 2e-11
Identities = 61/244 (25%), Positives = 104/244 (42%), Gaps = 43/244 (17%)
Query: 108 DAKQLKIECKVASGSYGD--LYKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKI 164
D + LK+ + G++G+ L + A+K+L K + + E + E I+ +
Sbjct: 2 DFESLKV---IGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEA 58
Query: 165 RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 224
VV+ + NL ++ EF+ G + L K+ + + + +A V ++ +
Sbjct: 59 DGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVL-AIDAI 117
Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVA-----------------------RVQAQS 261
HQ IHRD+K NLL+D G VK++DFG+ Q +
Sbjct: 118 HQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177
Query: 262 GVMTAET-------------GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYA 308
AET GT ++APEV Y+ D +S G+ ++E+L G P+
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237
Query: 309 GLTP 312
TP
Sbjct: 238 SETP 241
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 2e-11
Identities = 54/211 (25%), Positives = 99/211 (46%), Gaps = 32/211 (15%)
Query: 118 VASGSYGDL--YKGTYCSQEVAIKVLKPECVNTEMLKE-----FSQEVYIMRKIRHKNVV 170
+ G++G++ K + A+K+L EMLK F +E ++ ++ +
Sbjct: 9 IGRGAFGEVAVVKLKNADKVFAMKILN----KWEMLKRAETACFREERDVLVNGDNQWIT 64
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHK-------QKGVFQLTSLLKVAIDVSKGMNY 223
A NL +V ++ G + L K F L ++ +AID
Sbjct: 65 TLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMV-IAIDS------ 117
Query: 224 LHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM--TAETGTYRWMAPEVIEH 281
+HQ + +HRD+K N+LMD NG +++ADFG + G + + GT +++PE+++
Sbjct: 118 VHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 177
Query: 282 KP-----YDYKADVFSFGIALWELLTGELPY 307
Y + D +S G+ ++E+L GE P+
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-11
Identities = 41/143 (28%), Positives = 76/143 (53%), Gaps = 4/143 (2%)
Query: 118 VASGSYGDLYKG--TYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
++ G++G +Y G S+ A+KV+ K + +N M+ + E + + +V
Sbjct: 12 ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY 71
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
+ N+ +V E++ G + LH G F +K +V+ ++YLH++ IIHRDL
Sbjct: 72 SLQSANNVYLVMEYLIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDYLHRHGIIHRDL 130
Query: 235 KTANLLMDENGVVKVADFGVARV 257
K N+L+ G +K+ DFG+++V
Sbjct: 131 KPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 5e-11
Identities = 62/215 (28%), Positives = 102/215 (47%), Gaps = 34/215 (15%)
Query: 116 CKVASGSYGDLYKGTYCS----QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQ 171
CKV G+YG +YK ++ A+K ++ T + +E+ ++R+++H NV+
Sbjct: 7 CKVGRGTYGHVYKAKRKDGKDDRDYALKQIE----GTGISMSACREIALLRELKHPNVIS 62
Query: 172 ----FIGACTRP---------PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVS 218
F+ R +L + +F R S + Q + SLL +D
Sbjct: 63 LQKVFLSHADRKVWLLFDYAEHDLWHIIKFH-RASKANKKPVQLPRGMVKSLLYQILD-- 119
Query: 219 KGMNYLHQNNIIHRDLKTANLLM----DENGVVKVADFGVARVQAQSGVMTAETG----T 270
G++YLH N ++HRDLK AN+L+ E G VK+AD G AR+ A+ T
Sbjct: 120 -GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVT 178
Query: 271 YRWMAPE-VIEHKPYDYKADVFSFGIALWELLTGE 304
+ + APE ++ + Y D+++ G ELLT E
Sbjct: 179 FWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 8e-11
Identities = 44/184 (23%), Positives = 75/184 (40%), Gaps = 57/184 (30%)
Query: 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNIIHRDLKTANL 239
NL V +++ G + L + G+F+ L + I +++ + +H+ IHRD+K N+
Sbjct: 75 NLYFVMDYIPGGDMMSLL-IRLGIFE-EDLARFYIAELTCAIESVHKMGFIHRDIKPDNI 132
Query: 240 LMDENGVVKVADFGVA-------------------------------------------- 255
L+D +G +K+ DFG+
Sbjct: 133 LIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRR 192
Query: 256 -----RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL 310
R A S V GT ++APEV+ Y D +S G+ L+E+L G+ P+
Sbjct: 193 KRQHQRCLAHSLV-----GTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAD 247
Query: 311 TPLQ 314
TP +
Sbjct: 248 TPAE 251
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 1e-10
Identities = 30/95 (31%), Positives = 56/95 (58%), Gaps = 7/95 (7%)
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM--TAETGTYRWMAPE 277
++ +HQ + +HRD+K N+L+D NG +++ADFG Q G + + GT +++PE
Sbjct: 114 AIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPE 173
Query: 278 VIEHK-----PYDYKADVFSFGIALWELLTGELPY 307
+++ Y + D +S G+ ++E+L GE P+
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 3e-10
Identities = 63/232 (27%), Positives = 112/232 (48%), Gaps = 32/232 (13%)
Query: 110 KQLKIECKVASGSYGDLYKGTYC---SQEVAIK-VLK-PECVNTEMLKEFSQEVYIMRKI 164
K K+ + +GS+G +Y+ C S++VAIK VL+ P+ N E+L IM+ +
Sbjct: 66 KSYKLGNIIGNGSFGVVYEAI-CIDTSEKVAIKKVLQDPQYKNRELL--------IMKNL 116
Query: 165 RHKNVV----QFIGACTRPPN----LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI- 215
H N++ + C + L +V EF+ + +++ ++ L V +
Sbjct: 117 NHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLY 175
Query: 216 --DVSKGMNYLHQNNIIHRDLKTANLLMDENG-VVKVADFGVAR--VQAQSGVMTAETGT 270
+ + + Y+H I HRDLK NLL+D N +K+ DFG A+ + Q V +
Sbjct: 176 SYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRF 235
Query: 271 YRWMAPEV-IEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321
YR APE+ + Y D++S G + E++ G ++G + + V ++Q
Sbjct: 236 YR--APELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQ 285
|
Length = 440 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 5e-10
Identities = 43/153 (28%), Positives = 71/153 (46%), Gaps = 14/153 (9%)
Query: 155 SQEVYIMRKIRHKNV-----VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTS 209
E ++R++ H V V+ +G T C+V R +Y +L + L
Sbjct: 208 VHEARLLRRLSHPAVLALLDVRVVGGLT-----CLVLP-KYRSDLYTYLGARLRPLGLAQ 261
Query: 210 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA---RVQAQSGVMTA 266
+ VA + ++Y+H IIHRD+KT N+L++ + + DFG A R +
Sbjct: 262 VTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYG 321
Query: 267 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWE 299
GT APEV+ PY D++S G+ ++E
Sbjct: 322 IAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 7e-10
Identities = 49/200 (24%), Positives = 84/200 (42%), Gaps = 19/200 (9%)
Query: 112 LKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQ 171
LK E ++ G G YKG + V + VN+ E + M K++H N+V+
Sbjct: 692 LKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD----MGKLQHPNIVK 747
Query: 172 FIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN---N 228
IG C ++ E++ ++ + L K+AI ++K + +LH
Sbjct: 748 LIGLCRSEKGAYLIHEYIEGKNLSEVLRN----LSWERRRKIAIGIAKALRFLHCRCSPA 803
Query: 229 IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYR--WMAPEVIEHKPYDY 286
++ L E ++ D R+ + T ++APE E K
Sbjct: 804 VV------VGNLSPEKIIIDGKDEPHLRLSLPGLLCTDTKCFISSAYVAPETRETKDITE 857
Query: 287 KADVFSFGIALWELLTGELP 306
K+D++ FG+ L ELLTG+ P
Sbjct: 858 KSDIYGFGLILIELLTGKSP 877
|
Length = 968 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 59.2 bits (143), Expect = 8e-10
Identities = 47/196 (23%), Positives = 83/196 (42%), Gaps = 52/196 (26%)
Query: 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI-DVSKGMNYLHQNNIIHRDLKTANL 239
NL V +++ G + L + G+F L + I +++ + +H+ IHRD+K N+
Sbjct: 75 NLYFVMDYIPGGDMMSLLIRM-GIFP-EDLARFYIAELTCAVESVHKMGFIHRDIKPDNI 132
Query: 240 LMDENGVVKVADFGV--------------------------------------------- 254
L+D +G +K+ DFG+
Sbjct: 133 LIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPL 192
Query: 255 ---ARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLT 311
A Q Q + + GT ++APEV+ Y D +S G+ L+E+L G+ P+ T
Sbjct: 193 ERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQT 252
Query: 312 PLQAAVGVVQ-KVSIH 326
PL+ + V+ + S+H
Sbjct: 253 PLETQMKVINWQTSLH 268
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 59.8 bits (145), Expect = 8e-10
Identities = 53/226 (23%), Positives = 91/226 (40%), Gaps = 38/226 (16%)
Query: 117 KVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKE-FSQEVYIMRKIRHKNVVQFI 173
+ G G++Y CS+ VA+K ++ + +LK+ F +E I + H +V
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSL-------------LKVAIDVSKG 220
C+ V M Y K V+Q SL L + +
Sbjct: 69 SICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICAT 125
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ------------AQSGVMTAE- 267
+ Y+H ++HRDLK N+L+ G V + D+G A + + + +
Sbjct: 126 IEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSM 185
Query: 268 ------TGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 307
GT +MAPE + P D+++ G+ L+++LT PY
Sbjct: 186 TIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 51/233 (21%), Positives = 98/233 (42%), Gaps = 50/233 (21%)
Query: 137 AIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY 195
A+K L K + +N + E I+ + ++ VV+ + NL V +++ G +
Sbjct: 30 AMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMM 89
Query: 196 DFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV- 254
L + + ++ + +A +++ + +H+ IHRD+K N+L+D +G +K+ DFG+
Sbjct: 90 SLLIRMEVFPEVLARFYIA-ELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLC 148
Query: 255 -----------------------------------------------ARVQAQSGVMTAE 267
A Q Q + +
Sbjct: 149 TGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSL 208
Query: 268 TGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320
GT ++APEV+ K Y D +S G+ L+E+L G+ P+ TP + + V+
Sbjct: 209 VGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVI 261
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 58.1 bits (140), Expect = 2e-09
Identities = 34/119 (28%), Positives = 62/119 (52%), Gaps = 11/119 (9%)
Query: 95 IEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGT-------YCSQEVAIKVLKPECVN 147
+++P D WE+ L + + SG++G + + T + +VA+K+LK +
Sbjct: 24 MQLPYDSA--WEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARS 81
Query: 148 TEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF 205
+E + E+ IM + H N+V +GACT+ + I+TE+ G + D+LH+ K F
Sbjct: 82 SEK-QALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTF 139
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 2e-09
Identities = 31/94 (32%), Positives = 57/94 (60%), Gaps = 7/94 (7%)
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA-RVQAQSGVMTA-ETGTYRWMAPEV 278
++ +HQ +HRD+K N+L+D+NG +++ADFG R+ A V + GT +++PE+
Sbjct: 115 IDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEI 174
Query: 279 IE-----HKPYDYKADVFSFGIALWELLTGELPY 307
++ Y + D +S G+ ++E+L GE P+
Sbjct: 175 LQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPF 208
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 3e-09
Identities = 30/95 (31%), Positives = 43/95 (45%), Gaps = 12/95 (12%)
Query: 213 VAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYR 272
V + + LH+ L T + L+ +G V A + Y
Sbjct: 22 VCLQCLGALRELHRQAKSGNILLTWDGLLKLDGSV-----------AFKTPEQSRPDPY- 69
Query: 273 WMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 307
+MAPEVI+ + Y KAD++S GI L+E L ELPY
Sbjct: 70 FMAPEVIQGQSYTEKADIYSLGITLYEALDYELPY 104
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|153172 cd04900, ACT_UUR-like_1, ACT domain family, ACT_UUR-like_1, includes the first of two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD and related domains | Back alignment and domain information |
|---|
Score = 52.1 bits (126), Expect = 5e-09
Identities = 21/48 (43%), Positives = 29/48 (60%), Gaps = 3/48 (6%)
Query: 14 LTSLLGEIGLNIQEAHAFSTVDGFSLDVFVV---DGWPYDETEDLKNV 58
+ L ++GLNI +A F+T DG++LD FVV DG P E E L +
Sbjct: 18 IAGALDQLGLNILDARIFTTRDGYALDTFVVLDPDGEPIGERERLARI 65
|
This ACT domain family, ACT_UUR-like_1, includes the first of two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD; including those enzymes similar to the GlnD found in enteric Escherichia coli and those found in photosynthetic, nitrogen-fixing bacterium Rhodospirillum rubrum. Also included in this CD is the N-terminal ACT domain of a yet characterized Arabidopsis/Oryza predicted tyrosine kinase. Members of this CD belong to the superfamily of ACT regulatory domains. Length = 73 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 1e-08
Identities = 37/120 (30%), Positives = 64/120 (53%), Gaps = 11/120 (9%)
Query: 95 IEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYC----SQ---EVAIKVLKPECVN 147
+++P D WE L + + SG++G + +GT SQ +VA+K+LKP +
Sbjct: 24 MQLPYDSR--WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARS 81
Query: 148 TEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQ 206
+E + E+ IM + H N+V +GACT+ + I+TE+ G + ++LHK + F
Sbjct: 82 SEK-QALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFL 140
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 6e-08
Identities = 42/184 (22%), Positives = 72/184 (39%), Gaps = 62/184 (33%)
Query: 181 NLCIVTEFMARGSI------YDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
L ++ E++ G + D +++ F + + +AID +H+ IHRD+
Sbjct: 75 YLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETI-LAID------SIHKLGYIHRDI 127
Query: 235 KTANLLMDENGVVKVADFGVA--------------------------------------- 255
K NLL+D G +K++DFG+
Sbjct: 128 KPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAET 187
Query: 256 -----RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL 310
R A S V GT ++APEV Y+ + D +S G+ ++E+L G P+
Sbjct: 188 WKRNRRALAYSTV-----GTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSD 242
Query: 311 TPLQ 314
P +
Sbjct: 243 NPQE 246
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 4e-07
Identities = 39/191 (20%), Positives = 86/191 (45%), Gaps = 18/191 (9%)
Query: 148 TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQL 207
+ + E+ + ++ H+N+++ N ++T+ +Y F++ + ++
Sbjct: 204 SRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQ-KYDFDLYSFMYDEAFDWKD 262
Query: 208 TSLLKVAIDVSK----GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA------RV 257
LLK + K + Y+H +IHRD+K N+ ++ +G + + DFG A R
Sbjct: 263 RPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKERE 322
Query: 258 QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGEL-PYAGLT--PLQ 314
G + GT +PE++ Y D++S G+ L ++L+ + P P +
Sbjct: 323 AFDYGWV----GTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK 378
Query: 315 AAVGVVQKVSI 325
+ ++ +S+
Sbjct: 379 QLLKIIDSLSV 389
|
Length = 501 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 4e-06
Identities = 32/110 (29%), Positives = 57/110 (51%), Gaps = 10/110 (9%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKG-------TYCSQEVAIKVLKPECVNTEMLKEFSQE 157
WE +LK+ + G++G + + T + VA+K+LK ++E + E
Sbjct: 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEH-RALMSE 60
Query: 158 VYIMRKI-RHKNVVQFIGACTRPPN-LCIVTEFMARGSIYDFLHKQKGVF 205
+ I+ I H NVV +GACT+P L ++ EF G++ ++L ++G F
Sbjct: 61 LKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEF 110
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 4e-06
Identities = 33/111 (29%), Positives = 55/111 (49%), Gaps = 12/111 (10%)
Query: 105 WEIDAKQLKIECKVASGSYGDL--------YKGTYCSQEVAIKVLKPECVNTEMLKEFSQ 156
WE +L++ + G++G + K + C VA+K+LK +E K
Sbjct: 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSC-NTVAVKMLKEGATASEH-KALMS 59
Query: 157 EVYIMRKI-RHKNVVQFIGACTRPPN-LCIVTEFMARGSIYDFLHKQKGVF 205
E+ I+ I H NVV +GACT+P L ++ EF G++ +FL ++ F
Sbjct: 60 ELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFF 110
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 2e-05
Identities = 29/111 (26%), Positives = 52/111 (46%), Gaps = 13/111 (11%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTE---MLKEF 154
WE +L + +G++G + + T + VA+K+LKP TE ++ E
Sbjct: 30 WEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSEL 89
Query: 155 SQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF 205
Y+ H N+V +GACT ++TE+ G + +FL +++ F
Sbjct: 90 KVLSYLGN---HINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSF 137
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 45.6 bits (108), Expect = 2e-05
Identities = 29/111 (26%), Positives = 55/111 (49%), Gaps = 9/111 (8%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFS 155
+ WE L+ + +G++G + + T VA+K+LK +T+ +
Sbjct: 31 EKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKAS-AHTDEREALM 89
Query: 156 QEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF 205
E+ I+ + +HKN+V +GACT + ++TE+ G + +FL K+ F
Sbjct: 90 SELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETF 140
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 3e-05
Identities = 32/114 (28%), Positives = 55/114 (48%), Gaps = 12/114 (10%)
Query: 105 WEIDAKQLKIECKVASGSYG--------DLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ 156
WE +LK+ + G++G + K C + VA+K+LK +E K
Sbjct: 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASC-RTVAVKMLKEGATASEY-KALMT 59
Query: 157 EVYIMRKI-RHKNVVQFIGACTRPPN-LCIVTEFMARGSIYDFLHKQKGVFQLT 208
E+ I+ I H NVV +GACT+P L ++ E+ G++ ++L ++ F
Sbjct: 60 ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPY 113
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 4e-05
Identities = 34/129 (26%), Positives = 57/129 (44%), Gaps = 20/129 (15%)
Query: 196 DFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDENGV-------- 246
D++ K G F L ++ ++Y H +++H DLK N+LM+ +
Sbjct: 220 DWIMKH-GPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNR 278
Query: 247 --------VKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALW 298
V++ D G + S T YR +PEV+ + Y D++S G ++
Sbjct: 279 ALPPDPCRVRICDLGGCCDERHSRTAIVSTRHYR--SPEVVLGLGWMYSTDMWSMGCIIY 336
Query: 299 ELLTGELPY 307
EL TG+L Y
Sbjct: 337 ELYTGKLLY 345
|
Length = 467 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 1e-04
Identities = 40/164 (24%), Positives = 71/164 (43%), Gaps = 17/164 (10%)
Query: 155 SQEVYIMRKIRHKNVVQFIGACTRP---PNL-CIVTEFMARGSIYDFL-HKQKGVF--QL 207
+Q+ +I++ +R + P PN+ C+ ++ S++ L H + G +
Sbjct: 17 TQQTFILKGLRKSSEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76
Query: 208 TSLLKV--------AIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA 259
+ L + A ++ ++ LH+ I+ RDL N+L+D+ G +++ F
Sbjct: 77 SKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVE 136
Query: 260 QSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTG 303
S A Y APEV D +S G L+ELLTG
Sbjct: 137 DSCDGEAVENMY--CAPEVGGISEETEACDWWSLGAILFELLTG 178
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (100), Expect = 2e-04
Identities = 27/70 (38%), Positives = 38/70 (54%), Gaps = 3/70 (4%)
Query: 187 EFMARGS-IYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG 245
EFM G I D + + K + + V V G+ LH+ I+HRD+K NLL+ +G
Sbjct: 289 EFMMAGKKIPDNMPQDKR--DINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDG 346
Query: 246 VVKVADFGVA 255
VK+ DFG A
Sbjct: 347 QVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 6e-04
Identities = 29/137 (21%), Positives = 52/137 (37%), Gaps = 48/137 (35%)
Query: 224 LHQNNIIHRDLKTANLLMDENGVVKVADFGVA-----------------------RVQAQ 260
+H+ IHRD+K N+L+D G +K++DFG++ R+ +
Sbjct: 117 VHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNR 176
Query: 261 SGVMT-------------------------AETGTYRWMAPEVIEHKPYDYKADVFSFGI 295
+ V + GT ++APE+ + Y + D +S G
Sbjct: 177 NSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236
Query: 296 ALWELLTGELPYAGLTP 312
++E L G P+
Sbjct: 237 IMFECLIGWPPFCSENS 253
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (94), Expect = 8e-04
Identities = 14/47 (29%), Positives = 28/47 (59%), Gaps = 1/47 (2%)
Query: 210 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR 256
L+++ ++ + + LH IIH DL T+N+++ + + DFG+A
Sbjct: 97 ELELSREIGRLVGKLHSAGIIHGDLTTSNMILSGGKIY-LIDFGLAE 142
|
Length = 211 |
| >gnl|CDD|153145 cd04873, ACT_UUR-ACR-like, ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD | Back alignment and domain information |
|---|
Score = 35.6 bits (83), Expect = 0.003
Identities = 16/55 (29%), Positives = 27/55 (49%), Gaps = 2/55 (3%)
Query: 13 ELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVV-DGWPYDETEDLKNVLAKEILKS 66
++T +L ++GLNI +A ST +LDVF V D + L + + +
Sbjct: 16 DITRVLADLGLNIHDAR-ISTTGERALDVFYVTDSDGRPLDPERIARLEEALEDA 69
|
This ACT domain family, ACT_UUR_ACR-like, includes the two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD; including those enzymes similar to the GlnD found in enteric Escherichia coli and those found in photosynthetic, nitrogen-fixing bacterium Rhodospirillum rubrum. Also included in this CD are the four ACT domains of a novel protein composed almost entirely of ACT domain repeats (the ACR protein) and like proteins. These ACR proteins, found in Arabidopsis and Oryza, are proposed to function as novel regulatory or sensor proteins in plants. This CD also includes the first of the two ACT domains that comprise the Glycine Cleavage System Transcriptional Repressor (GcvR) protein and related domains, as well as, the N-terminal ACT domain of a yet characterized Arabidopsis/Oryza predicted tyrosine kinase. Members of this CD belong to the superfamily of ACT regulatory domains. Length = 70 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 331 | |||
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.98 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.98 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.98 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.98 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.97 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.96 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.96 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.95 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.95 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.94 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.93 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.92 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.91 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.9 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.88 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.87 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.86 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.86 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.85 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.84 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.84 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.83 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.83 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.83 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.81 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.78 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.77 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.76 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.76 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.74 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.7 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.7 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.64 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.63 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.57 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.55 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.51 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.49 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.45 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.41 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.4 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.35 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.32 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.3 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.24 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.23 | |
| cd04928 | 68 | ACT_TyrKc Uncharacterized, N-terminal ACT domain o | 99.2 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.1 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.08 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 99.06 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 99.01 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 99.0 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.98 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.94 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.94 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.82 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.73 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.71 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 98.71 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.65 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.64 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.48 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.38 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 98.37 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.36 | |
| cd04900 | 73 | ACT_UUR-like_1 ACT domain family, ACT_UUR-like_1, | 98.36 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.28 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 98.28 | |
| cd04927 | 76 | ACT_ACR-like_2 Second ACT domain, of a novel type | 98.19 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 98.15 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.15 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 98.11 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 98.09 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.94 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.92 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.9 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.89 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.86 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.8 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.79 | |
| cd04925 | 74 | ACT_ACR_2 ACT domain-containing protein which is c | 97.78 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 97.69 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 97.5 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 97.46 | |
| PLN02236 | 344 | choline kinase | 97.43 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 97.32 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 97.29 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 97.18 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 97.12 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 97.07 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.96 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.84 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 96.77 | |
| PRK05092 | 931 | PII uridylyl-transferase; Provisional | 96.76 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 96.72 | |
| cd04926 | 72 | ACT_ACR_4 C-terminal ACT domain, of a novel type o | 96.68 | |
| TIGR01693 | 850 | UTase_glnD [Protein-PII] uridylyltransferase. This | 96.59 | |
| PRK00275 | 895 | glnD PII uridylyl-transferase; Provisional | 96.59 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 96.58 |
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-53 Score=393.26 Aligned_cols=231 Identities=48% Similarity=0.828 Sum_probs=215.0
Q ss_pred CCCCeeeecccCcceeeeeeecCceEEEEEEECCce-EEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEEC
Q 020085 100 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE-VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR 178 (331)
Q Consensus 100 ~~~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~-vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 178 (331)
.....|.|+.+++.+.+.+|+|+||+||+|.|.|+. ||||++.....+....+.|.+|+.+|++++|||||+|+|+|.+
T Consensus 31 ~~~~~~~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~ 110 (362)
T KOG0192|consen 31 DELPEEEIDPDELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTS 110 (362)
T ss_pred ccccceecChHHhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence 334668999999999999999999999999999998 9999999876666667899999999999999999999999999
Q ss_pred CC-CeEEEEeccCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCCCCEEEcCCC-cEEEeeecc
Q 020085 179 PP-NLCIVTEFMARGSIYDFLHK-QKGVFQLTSLLKVAIDVSKGMNYLHQNN-IIHRDLKTANLLMDENG-VVKVADFGV 254 (331)
Q Consensus 179 ~~-~~~lV~E~~~ggsL~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~-iiHrDlkp~NiLi~~~~-~vkl~DFg~ 254 (331)
+. .+++||||+++|+|.++++. .+..++...+++++.||++||+|||+++ ||||||||+|||++.++ ++||+|||+
T Consensus 111 ~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGl 190 (362)
T KOG0192|consen 111 PPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGL 190 (362)
T ss_pred CCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCcc
Confidence 88 79999999999999999988 4789999999999999999999999999 99999999999999998 999999999
Q ss_pred eeeecCC-CccccCCCCcccccchhcC--CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccccccccccc
Q 020085 255 ARVQAQS-GVMTAETGTYRWMAPEVIE--HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIHSIIL 330 (331)
Q Consensus 255 a~~~~~~-~~~~~~~gt~~y~aPE~~~--~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~p~~~~ 330 (331)
++..... ..++...||+.|||||++. ...|+.|+||||||++||||+||+.||.++.+.+++..++.++.||+++.
T Consensus 191 sr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~ 269 (362)
T KOG0192|consen 191 SREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIPK 269 (362)
T ss_pred ceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCCc
Confidence 9987765 4556689999999999999 66999999999999999999999999999999999999999999999874
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-51 Score=369.05 Aligned_cols=211 Identities=30% Similarity=0.566 Sum_probs=196.8
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~ 186 (331)
..+|.+.++||+|+||+||+|++ .+..||||.+.....+.+.++.+..|+.+|+.++|||||++++++..++.+|+||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 35799999999999999999988 5689999999888778888899999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC------CcEEEeeecceeeecC
Q 020085 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN------GVVKVADFGVARVQAQ 260 (331)
Q Consensus 187 E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~------~~vkl~DFg~a~~~~~ 260 (331)
|||.||+|.+|++. ++.+++.++..++.||+.||++||+++||||||||.|||++.. -.+||+|||+|+....
T Consensus 89 EyC~gGDLs~yi~~-~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~ 167 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRR-RGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQP 167 (429)
T ss_pred EeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCc
Confidence 99999999999976 5689999999999999999999999999999999999999875 3589999999999888
Q ss_pred CCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccc
Q 020085 261 SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 261 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~ 320 (331)
.....+.+|++.|||||++....|+-|+|+||+|+++|++++|+.||+..++.+....+.
T Consensus 168 ~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~ 227 (429)
T KOG0595|consen 168 GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIK 227 (429)
T ss_pred hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHh
Confidence 777778899999999999999999999999999999999999999999999998877643
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-51 Score=382.63 Aligned_cols=221 Identities=37% Similarity=0.721 Sum_probs=200.8
Q ss_pred CCeeeecccCcceeeeeeecCceEEEEEEECCc-eEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCC
Q 020085 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (331)
Q Consensus 102 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 180 (331)
.+.|+|+.+.+++.+.||+|-||.||.|.|++. +||+|.++....+. +.|.+|+++|++|+|+|||+++++|..+.
T Consensus 198 ~d~wei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~---~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~ 274 (468)
T KOG0197|consen 198 RDPWEIPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSP---EAFLREAQIMKKLRHEKLVKLYGVCTKQE 274 (468)
T ss_pred cCCeeecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccCh---hHHHHHHHHHHhCcccCeEEEEEEEecCC
Confidence 567999999999999999999999999999886 99999999765443 67899999999999999999999999988
Q ss_pred CeEEEEeccCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeec
Q 020085 181 NLCIVTEFMARGSIYDFLHK-QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA 259 (331)
Q Consensus 181 ~~~lV~E~~~ggsL~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~ 259 (331)
.+|||||||+.|+|.++|.. .++.+...+.+.++.|||+||+||+++++|||||.++||||++++.+||+|||+|+...
T Consensus 275 piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~ 354 (468)
T KOG0197|consen 275 PIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIG 354 (468)
T ss_pred ceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccC
Confidence 99999999999999999987 46789999999999999999999999999999999999999999999999999999544
Q ss_pred CCCccccCC---CCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhcccccccccc
Q 020085 260 QSGVMTAET---GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIHS 327 (331)
Q Consensus 260 ~~~~~~~~~---gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p~ 327 (331)
.+. .+... -...|.|||.+....++.+||||||||+||||+| |+.||++++..+++.. +++|+|.+
T Consensus 355 d~~-Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~-le~GyRlp 424 (468)
T KOG0197|consen 355 DDE-YTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLEL-LERGYRLP 424 (468)
T ss_pred CCc-eeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHH-HhccCcCC
Confidence 433 33332 3579999999999999999999999999999999 9999999999998887 67788754
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-49 Score=354.50 Aligned_cols=217 Identities=28% Similarity=0.481 Sum_probs=197.5
Q ss_pred eecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCe
Q 020085 106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL 182 (331)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 182 (331)
.+..++|++.+.||+|+||+||+++. +++.+|+|+++..... ....+....|..||.+++||+||+++..|++...+
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kL 100 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKL 100 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeE
Confidence 35678999999999999999999876 6789999999876543 34678899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC
Q 020085 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262 (331)
Q Consensus 183 ~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~ 262 (331)
|+|+||+.||.|..+|++ .+.|++..+..++.+|+.||.|||++|||||||||+|||+|.+|+++|+|||+++.....+
T Consensus 101 ylVld~~~GGeLf~hL~~-eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~ 179 (357)
T KOG0598|consen 101 YLVLDYLNGGELFYHLQR-EGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG 179 (357)
T ss_pred EEEEeccCCccHHHHHHh-cCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCC
Confidence 999999999999999965 6889999999999999999999999999999999999999999999999999998655544
Q ss_pred -ccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccccc
Q 020085 263 -VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKV 323 (331)
Q Consensus 263 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~ 323 (331)
.....+||+.|||||++.+.+|+..+|.||+|+++|||++|.+||.+.+..+.+.++++..
T Consensus 180 ~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k 241 (357)
T KOG0598|consen 180 DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGK 241 (357)
T ss_pred CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCc
Confidence 3445699999999999999999999999999999999999999999999999999977544
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-48 Score=342.57 Aligned_cols=222 Identities=31% Similarity=0.498 Sum_probs=199.8
Q ss_pred eeecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCC-
Q 020085 105 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN- 181 (331)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~- 181 (331)
..+..++++..+.||+|+.|+||++.+ +++.+|+|++... .++...+++.+|++++++++||+||+++|+|..+..
T Consensus 74 ~~i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~-~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~ 152 (364)
T KOG0581|consen 74 NGISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN-IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEE 152 (364)
T ss_pred cccCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc-CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCce
Confidence 345667899999999999999999998 4789999999433 467778899999999999999999999999999985
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEEcCCCcEEEeeecceeeecC
Q 020085 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (331)
Q Consensus 182 ~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~ 260 (331)
.+|+||||+||||.+++.. .+.+++..+.+++.++++||.|||+ .+||||||||+|||++..|.|||||||.++....
T Consensus 153 isI~mEYMDgGSLd~~~k~-~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvn 231 (364)
T KOG0581|consen 153 ISICMEYMDGGSLDDILKR-VGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVN 231 (364)
T ss_pred EEeehhhcCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhh
Confidence 9999999999999999965 4789999999999999999999995 9999999999999999999999999999987666
Q ss_pred CCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCC-----CHHHHHhccccccccccccc
Q 020085 261 SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL-----TPLQAAVGVVQKVSIHSIIL 330 (331)
Q Consensus 261 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~-----~~~~~~~~~~~~~~~p~~~~ 330 (331)
+ .....+||..|||||++.+..|+.++||||||.+++|+.+|+.||... .+.+....|+ .+..|.+|.
T Consensus 232 S-~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv-~~ppP~lP~ 304 (364)
T KOG0581|consen 232 S-IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIV-DEPPPRLPE 304 (364)
T ss_pred h-hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHh-cCCCCCCCc
Confidence 5 446778999999999999999999999999999999999999999874 7788777766 577777764
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-49 Score=337.61 Aligned_cols=221 Identities=25% Similarity=0.464 Sum_probs=197.9
Q ss_pred cccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEe-EEECCCC-eE
Q 020085 108 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG-ACTRPPN-LC 183 (331)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~-~~~~~~~-~~ 183 (331)
...+|++.++||.|+||+||+++. +|..+|.|.++.+..+....+....|+.+|++++|||||++++ .+.++.. ++
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evln 96 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLN 96 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhH
Confidence 356899999999999999999976 7899999999988888888899999999999999999999998 5544444 99
Q ss_pred EEEeccCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh--CC--cccCCCCCCCEEEcCCCcEEEeeeccee
Q 020085 184 IVTEFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLHQ--NN--IIHRDLKTANLLMDENGVVKVADFGVAR 256 (331)
Q Consensus 184 lV~E~~~ggsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~--~~--iiHrDlkp~NiLi~~~~~vkl~DFg~a~ 256 (331)
||||++.+|+|...+.. ++..+++..+++++.|++.||..+|. .. |+||||||+||+++.+|.+||+|||+++
T Consensus 97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r 176 (375)
T KOG0591|consen 97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR 176 (375)
T ss_pred HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence 99999999999998843 45789999999999999999999998 44 9999999999999999999999999999
Q ss_pred eecCCCc-cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccccccccccc
Q 020085 257 VQAQSGV-MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIHSII 329 (331)
Q Consensus 257 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~p~~~ 329 (331)
+...... .....|||.||+||++...+|+++|||||+||++|||+.-++||.+.+-.+.-.++. +|..|++|
T Consensus 177 ~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~-qgd~~~~p 249 (375)
T KOG0591|consen 177 FLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIE-QGDYPPLP 249 (375)
T ss_pred HhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHH-cCCCCCCc
Confidence 7766543 345689999999999999999999999999999999999999999998888888855 57777766
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-47 Score=356.56 Aligned_cols=226 Identities=37% Similarity=0.738 Sum_probs=203.0
Q ss_pred CCCeeeecccCcceeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCC
Q 020085 101 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (331)
Q Consensus 101 ~~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 180 (331)
....|+|..++..+..+||+|+||+||+|.|.| +||||+++.+..+++..+.|++|+.++++-+|.||+-|.|+|.+++
T Consensus 383 s~~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG-dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~ 461 (678)
T KOG0193|consen 383 SLEEWEIPPEEVLLGERIGSGSFGTVYRGRWHG-DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP 461 (678)
T ss_pred cccccccCHHHhhccceeccccccceeeccccc-ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence 347899999999999999999999999999988 6999999999888999999999999999999999999999999887
Q ss_pred CeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecC
Q 020085 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (331)
Q Consensus 181 ~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~ 260 (331)
. .||+.+|+|-+|+.+++..+.+|.+.+.+.|+.||++||.|||.++|||||||..||++.+++.|||.|||++.....
T Consensus 462 ~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~ 540 (678)
T KOG0193|consen 462 L-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTR 540 (678)
T ss_pred e-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeee
Confidence 6 999999999999999999899999999999999999999999999999999999999999999999999999964432
Q ss_pred ---CCccccCCCCcccccchhcC---CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccccccccc
Q 020085 261 ---SGVMTAETGTYRWMAPEVIE---HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIHSI 328 (331)
Q Consensus 261 ---~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~p~~ 328 (331)
........|...|||||+++ ..+|++.+|||||||++|||++|.+||...+..|.+..+-+...+|..
T Consensus 541 w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~ 614 (678)
T KOG0193|consen 541 WSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDL 614 (678)
T ss_pred eccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccc
Confidence 23344567889999999985 458999999999999999999999999977777777775443345543
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-46 Score=323.79 Aligned_cols=215 Identities=27% Similarity=0.475 Sum_probs=197.4
Q ss_pred ecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeE
Q 020085 107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183 (331)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 183 (331)
...++|++.+.||.|+||+|.+++. .+.-+|+|+++.+.. ....++...+|..+|+.+.||+++++.+.|.+.+++|
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~ly 120 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLY 120 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEE
Confidence 3466899999999999999999887 578899999986532 4456677899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCc
Q 020085 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV 263 (331)
Q Consensus 184 lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~ 263 (331)
+||||++||.|..++++ .++|+++.++.++.||+.|++|||+++|++|||||+|||+|.+|.+||+|||+|+.....
T Consensus 121 mvmeyv~GGElFS~Lrk-~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-- 197 (355)
T KOG0616|consen 121 MVMEYVPGGELFSYLRK-SGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-- 197 (355)
T ss_pred EEEeccCCccHHHHHHh-cCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc--
Confidence 99999999999999965 678999999999999999999999999999999999999999999999999999987654
Q ss_pred cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccccc
Q 020085 264 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVS 324 (331)
Q Consensus 264 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~ 324 (331)
..+-||||.|+|||++..++|..++|.||||+++|||+.|.+||.+.++.+.+.+|+....
T Consensus 198 T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v 258 (355)
T KOG0616|consen 198 TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKV 258 (355)
T ss_pred EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcc
Confidence 5667999999999999999999999999999999999999999999999999999886443
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-46 Score=347.81 Aligned_cols=216 Identities=27% Similarity=0.438 Sum_probs=197.0
Q ss_pred cccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEE
Q 020085 108 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI 184 (331)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~l 184 (331)
....|+..+.||+|||+.+|++++ +|+.||+|++..... .....+...+|++|.++++|||||+++++|++..+.||
T Consensus 16 ~~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYi 95 (592)
T KOG0575|consen 16 RSKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYI 95 (592)
T ss_pred CcceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEE
Confidence 346899999999999999999987 789999999975432 44556789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC-Cc
Q 020085 185 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GV 263 (331)
Q Consensus 185 V~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~-~~ 263 (331)
|.|.|+.++|..++. +++.+++++++.++.||+.||.|||+++|+|||||..|++++++.+|||+|||+|...... ..
T Consensus 96 vLELC~~~sL~el~K-rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Er 174 (592)
T KOG0575|consen 96 VLELCHRGSLMELLK-RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGER 174 (592)
T ss_pred EEEecCCccHHHHHH-hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccc
Confidence 999999999999986 6789999999999999999999999999999999999999999999999999999877644 55
Q ss_pred cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccccc
Q 020085 264 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVS 324 (331)
Q Consensus 264 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~ 324 (331)
..+-||||.|.|||++.....+..+||||+||+||-||.|++||...+-.+.+..++..-+
T Consensus 175 k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y 235 (592)
T KOG0575|consen 175 KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEY 235 (592)
T ss_pred cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCc
Confidence 6678999999999999999999999999999999999999999999888888888766555
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-47 Score=341.59 Aligned_cols=219 Identities=24% Similarity=0.378 Sum_probs=189.1
Q ss_pred cccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCH-----HHHHHHHHHHHHHHhcCCCcceeEEeEEECCC
Q 020085 108 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNT-----EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (331)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~-----~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 180 (331)
-.+.|.+.+.||+|+||.|-+|.. +++.||||+++...... .-.....+|+++|++++|||||+++++|+.+.
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 356789999999999999999976 67999999998653322 11233579999999999999999999999999
Q ss_pred CeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC---CcEEEeeecceee
Q 020085 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN---GVVKVADFGVARV 257 (331)
Q Consensus 181 ~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~---~~vkl~DFg~a~~ 257 (331)
..||||||++||.|.+++-. ++.+.+.....++.|++.|+.|||++||+||||||+|||+..+ -.+||+|||+|+.
T Consensus 250 s~YmVlE~v~GGeLfd~vv~-nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~ 328 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVA-NKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKV 328 (475)
T ss_pred ceEEEEEEecCccHHHHHHh-ccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccchhhc
Confidence 99999999999999999965 5778888889999999999999999999999999999999876 6799999999999
Q ss_pred ecCCCccccCCCCcccccchhcCCCCC---CChhhHHHHHHHHHHHHcCCCCCCCCCHHH-HHhccccccccccc
Q 020085 258 QAQSGVMTAETGTYRWMAPEVIEHKPY---DYKADVFSFGIALWELLTGELPYAGLTPLQ-AAVGVVQKVSIHSI 328 (331)
Q Consensus 258 ~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~Di~SlG~il~ell~g~~Pf~~~~~~~-~~~~~~~~~~~p~~ 328 (331)
......+.+.||||.|.|||++.++.+ ..+.|+||+||+||-+++|.+||.+..... +..+ +-+|..+..
T Consensus 329 ~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQ-I~~G~y~f~ 402 (475)
T KOG0615|consen 329 SGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQ-ILKGRYAFG 402 (475)
T ss_pred cccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHH-HhcCccccc
Confidence 988888999999999999999976543 347899999999999999999999875555 5555 445665544
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-45 Score=337.76 Aligned_cols=219 Identities=26% Similarity=0.432 Sum_probs=200.3
Q ss_pred cccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECC--CCeE
Q 020085 108 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--PNLC 183 (331)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~--~~~~ 183 (331)
..+.|+.+++||+|.||.||+|++ +|+.||+|.++.+...+.......+||.||++++||||+++.+..+.. ..+|
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siY 194 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIY 194 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEE
Confidence 457899999999999999999998 678899999998877777788899999999999999999999988776 6899
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC-
Q 020085 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG- 262 (331)
Q Consensus 184 lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~- 262 (331)
+|+|||+. +|.-++....-.|+++++..++.||+.||+|+|.+||+|||||.+|||||++|.+||+|||+|++.....
T Consensus 195 lVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~ 273 (560)
T KOG0600|consen 195 LVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGS 273 (560)
T ss_pred EEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCC
Confidence 99999998 9999997766789999999999999999999999999999999999999999999999999999766543
Q ss_pred -ccccCCCCcccccchhcCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccccccccc
Q 020085 263 -VMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIHS 327 (331)
Q Consensus 263 -~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~p~ 327 (331)
.++....|..|.|||.+.+. .|+.+.|+||.||||.||++|++.|.+.+.++....|.+-...|+
T Consensus 274 ~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~ 340 (560)
T KOG0600|consen 274 APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPT 340 (560)
T ss_pred cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCC
Confidence 57788899999999998765 799999999999999999999999999999999888887777664
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-44 Score=323.92 Aligned_cols=222 Identities=34% Similarity=0.555 Sum_probs=197.6
Q ss_pred CeeeecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCC
Q 020085 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (331)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 180 (331)
..|.++.++|++.+.||.|..++||+|++ .++.||||++..+..+.+ .+.+.+|+..|+.++||||++++..|..+.
T Consensus 19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~ 97 (516)
T KOG0582|consen 19 KEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDS 97 (516)
T ss_pred ccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecc
Confidence 45788899999999999999999999988 678999999998876665 789999999999999999999999999999
Q ss_pred CeEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeec
Q 020085 181 NLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA 259 (331)
Q Consensus 181 ~~~lV~E~~~ggsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~ 259 (331)
.+|+||.||.+||+.+++... ...+++..+..+++++++||.|||++|.||||+|+.||||+.+|.|||+|||.+-...
T Consensus 98 ~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~ 177 (516)
T KOG0582|consen 98 ELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLF 177 (516)
T ss_pred eeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeec
Confidence 999999999999999999664 4569999999999999999999999999999999999999999999999999875443
Q ss_pred CCC-cc----ccCCCCcccccchhcC--CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccccccc
Q 020085 260 QSG-VM----TAETGTYRWMAPEVIE--HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIH 326 (331)
Q Consensus 260 ~~~-~~----~~~~gt~~y~aPE~~~--~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~p 326 (331)
.++ .. ....||+.|||||++. ...|+.|+|||||||+..||.+|..||..+.|+++...-++ +..|
T Consensus 178 ~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLq-n~pp 250 (516)
T KOG0582|consen 178 DSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQ-NDPP 250 (516)
T ss_pred ccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhc-CCCC
Confidence 332 21 3347999999999964 45799999999999999999999999999999999888664 4444
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-45 Score=337.37 Aligned_cols=215 Identities=26% Similarity=0.462 Sum_probs=190.1
Q ss_pred ecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhc-CCCcceeEEeEEECCCCe
Q 020085 107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNL 182 (331)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~ 182 (331)
-...+|++++.||+|+|++|++|+. .++.||||++...... +..++-...|-.+|.+| .||.|++++..|+++..+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 3567999999999999999999987 6789999999755432 23345678899999999 799999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC
Q 020085 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262 (331)
Q Consensus 183 ~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~ 262 (331)
|+|+||+++|+|.++|++ -+.|++..++.++.||+.|++|||++|||||||||+|||+++|++++|.|||.|+......
T Consensus 150 YFvLe~A~nGdll~~i~K-~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~ 228 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKK-YGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQ 228 (604)
T ss_pred EEEEEecCCCcHHHHHHH-hCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhh
Confidence 999999999999999976 5899999999999999999999999999999999999999999999999999998554321
Q ss_pred c--------------cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccc
Q 020085 263 V--------------MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK 322 (331)
Q Consensus 263 ~--------------~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~ 322 (331)
. ....+||-.|.+||++.....++.+|+|+|||+||+|+.|++||.+.+..-.-.+|+..
T Consensus 229 ~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l 302 (604)
T KOG0592|consen 229 KSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQAL 302 (604)
T ss_pred ccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHh
Confidence 1 13357999999999999999999999999999999999999999999887776666543
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=332.94 Aligned_cols=216 Identities=23% Similarity=0.378 Sum_probs=191.9
Q ss_pred eecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCe
Q 020085 106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL 182 (331)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 182 (331)
.+..++|+++++||+|+||.||+++. +|..+|+|+++.... ..+.++....|-.+|...++|+||+++.+|++..++
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~L 216 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYL 216 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCee
Confidence 45788999999999999999999976 789999999986543 445678899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecC--
Q 020085 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-- 260 (331)
Q Consensus 183 ~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~-- 260 (331)
||||||++||++..+|.+ .+.+++..+..++.+++-|++.+|+.|+|||||||+|+|||..|++||+|||++.....
T Consensus 217 YLiMEylPGGD~mTLL~~-~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~ 295 (550)
T KOG0605|consen 217 YLIMEYLPGGDMMTLLMR-KDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKH 295 (550)
T ss_pred EEEEEecCCccHHHHHHh-cCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhh
Confidence 999999999999999965 78999999999999999999999999999999999999999999999999999841110
Q ss_pred -------------------C--Cc-----c--------------------ccCCCCcccccchhcCCCCCCChhhHHHHH
Q 020085 261 -------------------S--GV-----M--------------------TAETGTYRWMAPEVIEHKPYDYKADVFSFG 294 (331)
Q Consensus 261 -------------------~--~~-----~--------------------~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG 294 (331)
. .. . ....|||.|||||++.+..|+..+|.||||
T Consensus 296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG 375 (550)
T KOG0605|consen 296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLG 375 (550)
T ss_pred hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHH
Confidence 0 00 0 012499999999999999999999999999
Q ss_pred HHHHHHHcCCCCCCCCCHHHHHhccccc
Q 020085 295 IALWELLTGELPYAGLTPLQAAVGVVQK 322 (331)
Q Consensus 295 ~il~ell~g~~Pf~~~~~~~~~~~~~~~ 322 (331)
||+||||.|.+||.+.+|.+...+++.-
T Consensus 376 ~ImyEmLvGyPPF~s~tp~~T~rkI~nw 403 (550)
T KOG0605|consen 376 CIMYEMLVGYPPFCSETPQETYRKIVNW 403 (550)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 9999999999999999999998887643
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-45 Score=338.17 Aligned_cols=217 Identities=32% Similarity=0.580 Sum_probs=198.5
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEe
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E 187 (331)
++|.+.+.||+|+||.||||+. +.+.||+|.+.+...++...+.+.+|++|+++++||||+.+++.|+...++|+|+|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 4788999999999999999976 56889999998877788888999999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCc-ccc
Q 020085 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV-MTA 266 (331)
Q Consensus 188 ~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~-~~~ 266 (331)
|+.| +|+.++.. .+.++++.+..++.|+..||.|||+++|+|||+||.|||++.+|.+|++|||+|+....... .+.
T Consensus 82 ~a~g-~L~~il~~-d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vlts 159 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ-DGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTS 159 (808)
T ss_pred hhhh-hHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeeee
Confidence 9988 99999954 78999999999999999999999999999999999999999999999999999997765433 334
Q ss_pred CCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccccccccc
Q 020085 267 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIHSI 328 (331)
Q Consensus 267 ~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~p~~ 328 (331)
-.|||.|||||...+.+|+..+|+||+||++||+..|++||-...-.+.+..|+...-+|+.
T Consensus 160 ikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p~ 221 (808)
T KOG0597|consen 160 IKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPPS 221 (808)
T ss_pred ccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCcc
Confidence 46999999999999999999999999999999999999999999999988888776666553
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-44 Score=332.05 Aligned_cols=213 Identities=28% Similarity=0.554 Sum_probs=191.7
Q ss_pred ecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC---HHHHHHHHHHHHHHHhcC-CCcceeEEeEEECCC
Q 020085 107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN---TEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPP 180 (331)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~---~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~ 180 (331)
.....|.+.+.||+|+||+|+.|.. .+..||+|++...... ....+.+.+|+.++++++ ||||++++.++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 4466899999999999999999987 6799999988765221 134456778999999999 999999999999999
Q ss_pred CeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC-CcEEEeeecceeee-
Q 020085 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQ- 258 (331)
Q Consensus 181 ~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~-~~vkl~DFg~a~~~- 258 (331)
.+++||||+.||+|++++.+ .+++.+..+..++.|++.|++|+|++||+||||||+|||++.+ +++||+|||++...
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~ 172 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP 172 (370)
T ss_pred eEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC
Confidence 99999999999999999987 8899999999999999999999999999999999999999999 99999999999887
Q ss_pred cCCCccccCCCCcccccchhcCCCC-CC-ChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccc
Q 020085 259 AQSGVMTAETGTYRWMAPEVIEHKP-YD-YKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 259 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~ 320 (331)
.........+||+.|+|||++.+.. |+ .++||||+|++||.|++|+.||++.+.......+.
T Consensus 173 ~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~ 236 (370)
T KOG0583|consen 173 GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIR 236 (370)
T ss_pred CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHh
Confidence 4556677889999999999999988 86 78999999999999999999999988777777743
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-45 Score=315.57 Aligned_cols=210 Identities=29% Similarity=0.421 Sum_probs=189.6
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEe
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E 187 (331)
+.|+...++|+|+||.||+++. +|+.||||++.....++...+-.++|+++|++++|+|+|.++.+|.....+++|+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 4688889999999999999987 68999999998776667777789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeec-CCCcccc
Q 020085 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA-QSGVMTA 266 (331)
Q Consensus 188 ~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~-~~~~~~~ 266 (331)
|++. ++.+-+.......+...+..++.|+++|+.|+|++++|||||||+||||+.+|.+||||||+|+... .+...+.
T Consensus 82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTD 160 (396)
T KOG0593|consen 82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTD 160 (396)
T ss_pred ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhhh
Confidence 9988 6666676667788999999999999999999999999999999999999999999999999999776 5556677
Q ss_pred CCCCcccccchhcCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccc
Q 020085 267 ETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 267 ~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~ 320 (331)
...|..|.|||.+.+ .+|....||||+||++.||++|.+.|++.+..+..-.+.
T Consensus 161 YVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ 215 (396)
T KOG0593|consen 161 YVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIR 215 (396)
T ss_pred hhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHH
Confidence 889999999999877 789999999999999999999999999988777655533
|
|
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=337.48 Aligned_cols=228 Identities=33% Similarity=0.622 Sum_probs=203.9
Q ss_pred CeeeecccCcceeeeeeecCceEEEEEEECC-----ce-EEEEEecCC-CCCHHHHHHHHHHHHHHHhcCCCcceeEEeE
Q 020085 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCS-----QE-VAIKVLKPE-CVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175 (331)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~-vavK~~~~~-~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 175 (331)
+.|++..++..+.++||+|+||.||+|+..- .. ||||..+.+ ....+...+|.+|+++|++++|||||+++|+
T Consensus 150 ~~Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGV 229 (474)
T KOG0194|consen 150 QKWELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGV 229 (474)
T ss_pred cccEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence 4599999999999999999999999998722 23 899999863 3567888999999999999999999999999
Q ss_pred EECCCCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecce
Q 020085 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA 255 (331)
Q Consensus 176 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a 255 (331)
+.....+++|||+|.||+|.++|.+..+.++..+..+++.+.+.||+|||++++|||||.++|+|++.++.+||+|||++
T Consensus 230 a~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs 309 (474)
T KOG0194|consen 230 AVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLS 309 (474)
T ss_pred EcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccc
Confidence 99999999999999999999999887778999999999999999999999999999999999999999999999999998
Q ss_pred eeecCCCccc-cCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhccccccccccccc
Q 020085 256 RVQAQSGVMT-AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIHSIIL 330 (331)
Q Consensus 256 ~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p~~~~ 330 (331)
+....-.... ...-..+|+|||.+....|+.++|||||||++||+++ |..||++++..++...++..++|.+++.
T Consensus 310 ~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~ 386 (474)
T KOG0194|consen 310 RAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIPS 386 (474)
T ss_pred cCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCCC
Confidence 7654211111 1123579999999999999999999999999999999 8899999999999999989999988763
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=301.77 Aligned_cols=217 Identities=25% Similarity=0.422 Sum_probs=196.2
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEe
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E 187 (331)
++|...+++|+|.||.||+|++ +|+.||||.++.....+.......+|++.|+.++|+||+.++++|.....+.+|+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 4788899999999999999998 67999999999876655556778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCc-ccc
Q 020085 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV-MTA 266 (331)
Q Consensus 188 ~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~-~~~ 266 (331)
||+. +|...+....-.++..++..++.++++|++|||++.|+||||||.|+||+.+|.+||+|||+|+....... .+.
T Consensus 82 fm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~ 160 (318)
T KOG0659|consen 82 FMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTH 160 (318)
T ss_pred eccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCccccc
Confidence 9987 99999988888999999999999999999999999999999999999999999999999999997765543 334
Q ss_pred CCCCcccccchhcC-CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccccccccc
Q 020085 267 ETGTYRWMAPEVIE-HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIHS 327 (331)
Q Consensus 267 ~~gt~~y~aPE~~~-~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~p~ 327 (331)
...|..|.|||.+- .+.|....|+||.||++.||+-|.+-|++.+..+....+.+--..|.
T Consensus 161 ~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~ 222 (318)
T KOG0659|consen 161 QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPT 222 (318)
T ss_pred ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCC
Confidence 47899999999875 45799999999999999999999999999999998888877666664
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=334.72 Aligned_cols=212 Identities=30% Similarity=0.508 Sum_probs=195.3
Q ss_pred CcceeeeeeecCceEEEEEEE--CCceEEEEEecCC-CCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEe
Q 020085 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPE-CVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E 187 (331)
-|++++.||.|+.|.|..|++ +|+.+|||++... .........+.+|+-||+.+.|||++++++++++..++|+|.|
T Consensus 13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlE 92 (786)
T KOG0588|consen 13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLE 92 (786)
T ss_pred ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEE
Confidence 578899999999999999988 7899999999766 3344455678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCccccC
Q 020085 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE 267 (331)
Q Consensus 188 ~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~~~~ 267 (331)
|++||.|++++-. ++++++.++.+++.||+.|+.|+|..+|+||||||+|+|++..+++||+|||+|.....+.-..+.
T Consensus 93 yv~gGELFdylv~-kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklLeTS 171 (786)
T KOG0588|consen 93 YVPGGELFDYLVR-KGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLLETS 171 (786)
T ss_pred ecCCchhHHHHHh-hCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCcccccc
Confidence 9999999999965 789999999999999999999999999999999999999999999999999999988888778889
Q ss_pred CCCcccccchhcCCCCCC-ChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccccc
Q 020085 268 TGTYRWMAPEVIEHKPYD-YKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVS 324 (331)
Q Consensus 268 ~gt~~y~aPE~~~~~~~~-~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~ 324 (331)
||+|.|.|||++.|.+|+ .++||||+|||||.||+|++||++.+....+.+ |++|.
T Consensus 172 CGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlK-V~~G~ 228 (786)
T KOG0588|consen 172 CGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLK-VQRGV 228 (786)
T ss_pred CCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHH-HHcCc
Confidence 999999999999999996 789999999999999999999999888888877 55664
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-43 Score=318.71 Aligned_cols=220 Identities=28% Similarity=0.469 Sum_probs=189.7
Q ss_pred ccCcceeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCC--CeEE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP--NLCI 184 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~--~~~l 184 (331)
..++...+.||+|+||.||++++. |...|||...... ....+.+.+|+.+|++++|||||+++|...... .+++
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~--~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i 93 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED--SPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI 93 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeeccc--chhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence 456888999999999999999985 6899999987652 222677899999999999999999999754444 5999
Q ss_pred EEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC-CCcEEEeeecceeeecC---
Q 020085 185 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE-NGVVKVADFGVARVQAQ--- 260 (331)
Q Consensus 185 V~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~-~~~vkl~DFg~a~~~~~--- 260 (331)
.|||+++|||.+++.+..+.++++.+.+++.||++||+|||++||+||||||+|||++. ++.+||+|||.++....
T Consensus 94 ~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~ 173 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT 173 (313)
T ss_pred eeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence 99999999999999876668999999999999999999999999999999999999999 79999999999976653
Q ss_pred -CCccccCCCCcccccchhcCCC-CCCChhhHHHHHHHHHHHHcCCCCCCC-CCHHHHHhccccccccccccc
Q 020085 261 -SGVMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAG-LTPLQAAVGVVQKVSIHSIIL 330 (331)
Q Consensus 261 -~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~ell~g~~Pf~~-~~~~~~~~~~~~~~~~p~~~~ 330 (331)
........||+.|||||++.+. ...+++|||||||++.||+||+.||.. ..+.++...+...+..|.||-
T Consensus 174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~~P~ip~ 246 (313)
T KOG0198|consen 174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDSLPEIPD 246 (313)
T ss_pred cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCCCCCCCc
Confidence 2223456799999999999853 334599999999999999999999998 678888888887777777763
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=334.62 Aligned_cols=225 Identities=34% Similarity=0.640 Sum_probs=203.0
Q ss_pred cccCCCCCCeeeecccCcceeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEe
Q 020085 95 IEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174 (331)
Q Consensus 95 ~~~~~~~~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~ 174 (331)
.++..+..+.|+|+-+...-++-||+|+.|-||+|+..++.||||.++. .-..+|+-|++|+||||+.|.|
T Consensus 109 ~e~k~qq~e~WeiPFe~IsELeWlGSGaQGAVF~Grl~netVAVKKV~e---------lkETdIKHLRkLkH~NII~FkG 179 (904)
T KOG4721|consen 109 TEHKQQQEELWEIPFEEISELEWLGSGAQGAVFLGRLHNETVAVKKVRE---------LKETDIKHLRKLKHPNIITFKG 179 (904)
T ss_pred eehhhhhhhhccCCHHHhhhhhhhccCcccceeeeeccCceehhHHHhh---------hhhhhHHHHHhccCcceeeEee
Confidence 4556667788999999999999999999999999999999999999762 2235788899999999999999
Q ss_pred EEECCCCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecc
Q 020085 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV 254 (331)
Q Consensus 175 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~ 254 (331)
+|+..+.+|||||||..|-|+..|.. ..+++...+..|..+||.||.|||.+.|||||||.-||||..+..|||+|||-
T Consensus 180 VCtqsPcyCIiMEfCa~GqL~~VLka-~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGT 258 (904)
T KOG4721|consen 180 VCTQSPCYCIIMEFCAQGQLYEVLKA-GRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGT 258 (904)
T ss_pred eecCCceeEEeeeccccccHHHHHhc-cCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccc
Confidence 99999999999999999999999965 56889999999999999999999999999999999999999999999999999
Q ss_pred eeeecCCCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccccccccccc
Q 020085 255 ARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIHSII 329 (331)
Q Consensus 255 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~p~~~ 329 (331)
++.......+...+||..|||||++...+.+.|.||||||++|||||||..||.+.....++.+|-.+-..-++|
T Consensus 259 S~e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~LpvP 333 (904)
T KOG4721|consen 259 SKELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLPVP 333 (904)
T ss_pred hHhhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcccccCc
Confidence 987776666677899999999999999999999999999999999999999999998888888865555444444
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=324.89 Aligned_cols=211 Identities=25% Similarity=0.402 Sum_probs=184.7
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEE
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~ 186 (331)
++|++.+.||+|+||+||++.. .++.||+|+++.... .......+.+|+.++++++||||+++++.+.+...+|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 4789999999999999999987 568999999975322 2334567888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC----
Q 020085 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG---- 262 (331)
Q Consensus 187 E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~---- 262 (331)
||++||+|.+++.+ .+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~ 159 (363)
T cd05628 81 EFLPGGDMMTLLMK-KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEF 159 (363)
T ss_pred cCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccccc
Confidence 99999999999965 5678999999999999999999999999999999999999999999999999986432110
Q ss_pred --------------------------------ccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 020085 263 --------------------------------VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL 310 (331)
Q Consensus 263 --------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~ 310 (331)
.....+||+.|+|||++.+..++.++|+|||||++|||++|+.||.+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~ 239 (363)
T cd05628 160 YRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (363)
T ss_pred cccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCC
Confidence 012346999999999999999999999999999999999999999998
Q ss_pred CHHHHHhcccc
Q 020085 311 TPLQAAVGVVQ 321 (331)
Q Consensus 311 ~~~~~~~~~~~ 321 (331)
++.+....+..
T Consensus 240 ~~~~~~~~i~~ 250 (363)
T cd05628 240 TPQETYKKVMN 250 (363)
T ss_pred CHHHHHHHHHc
Confidence 88887776554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-44 Score=325.51 Aligned_cols=218 Identities=24% Similarity=0.403 Sum_probs=198.9
Q ss_pred cccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCcceeEEeEEECCC-CeE
Q 020085 108 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPP-NLC 183 (331)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~-~~~ 183 (331)
..++|.+.++||.|.||.||+|+. .++.||||.++......+. ..-.+|+..|++++ ||||+++.+++.+.. .++
T Consensus 8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee-~~nLREvksL~kln~hpniikL~Evi~d~~~~L~ 86 (538)
T KOG0661|consen 8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEE-CMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY 86 (538)
T ss_pred HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHH-HHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence 356899999999999999999986 6788999999877655432 34678999999999 999999999998877 899
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCc
Q 020085 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV 263 (331)
Q Consensus 184 lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~ 263 (331)
+|||||+. +|++++..++..|++..+..|+.||++||+|+|++|++|||+||+|||+..+..+||+|||+||.......
T Consensus 87 fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpP 165 (538)
T KOG0661|consen 87 FVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPP 165 (538)
T ss_pred eeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCCC
Confidence 99999988 99999999889999999999999999999999999999999999999999899999999999999988888
Q ss_pred cccCCCCcccccchhc-CCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccccccccc
Q 020085 264 MTAETGTYRWMAPEVI-EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIHS 327 (331)
Q Consensus 264 ~~~~~gt~~y~aPE~~-~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~p~ 327 (331)
.+..+.|..|.|||++ ...-|+.+.|+||+||+++|+.+-++.|++.+..+.+.+|.+-.+.|.
T Consensus 166 YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~ 230 (538)
T KOG0661|consen 166 YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPD 230 (538)
T ss_pred cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCc
Confidence 8999999999999997 566799999999999999999999999999999999988887655553
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=327.81 Aligned_cols=218 Identities=28% Similarity=0.454 Sum_probs=195.0
Q ss_pred eeecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcC-CCcceeEEeEEECCC
Q 020085 105 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPP 180 (331)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~ 180 (331)
..+..++|.+.++||+|+||+|+++.. +++.+|||+++++.. ..+.++..+.|.+|++..+ ||.+++++.+|+.+.
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 356788999999999999999999988 457899999987754 5567788999999998885 999999999999999
Q ss_pred CeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeec-
Q 020085 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA- 259 (331)
Q Consensus 181 ~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~- 259 (331)
++|+||||+.||++..+ .+.+.|++..+..++..++.||.|||++||||||||.+|||+|.+|++||+|||+++...
T Consensus 443 ~l~fvmey~~Ggdm~~~--~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 443 HLFFVMEYVAGGDLMHH--IHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG 520 (694)
T ss_pred eEEEEEEecCCCcEEEE--EecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCC
Confidence 99999999999994433 345889999999999999999999999999999999999999999999999999999765
Q ss_pred CCCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccccc
Q 020085 260 QSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVS 324 (331)
Q Consensus 260 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~ 324 (331)
.....++.+|||.|||||++.+..|+...|.||||++|||||.|..||++.+..+.-..++-...
T Consensus 521 ~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~ 585 (694)
T KOG0694|consen 521 QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEV 585 (694)
T ss_pred CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCC
Confidence 45556678999999999999999999999999999999999999999999888887777665443
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=323.38 Aligned_cols=202 Identities=34% Similarity=0.613 Sum_probs=180.0
Q ss_pred ecccCcceeeeeeecCceEEEEEEECC-ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCC-eEE
Q 020085 107 IDAKQLKIECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN-LCI 184 (331)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~-~~l 184 (331)
-..++|.-.+.||+|+||.||+|...+ +.||||.++...... ..+|.+|+.++.+++|||+|+++|+|.+.+. .++
T Consensus 72 ~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~--~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~L 149 (361)
T KOG1187|consen 72 KATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG--EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLL 149 (361)
T ss_pred HHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc--hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEE
Confidence 345788888999999999999999865 899999888664332 3569999999999999999999999999884 999
Q ss_pred EEeccCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCCCCEEEcCCCcEEEeeecceeeecC
Q 020085 185 VTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGMNYLHQN---NIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (331)
Q Consensus 185 V~E~~~ggsL~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~ 260 (331)
|+|||+.|+|.++|+.... .+++..+++|+.++|+||+|||+. .||||||||+|||+|++..+||+|||+|+..+.
T Consensus 150 VYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~ 229 (361)
T KOG1187|consen 150 VYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPE 229 (361)
T ss_pred EEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCc
Confidence 9999999999999988766 899999999999999999999985 399999999999999999999999999977665
Q ss_pred -CCccccC-CCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 020085 261 -SGVMTAE-TGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL 310 (331)
Q Consensus 261 -~~~~~~~-~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~ 310 (331)
....... .||.+|+|||++.....+.|+||||||++|.|+++|+.|.+..
T Consensus 230 ~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~ 281 (361)
T KOG1187|consen 230 GDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQS 281 (361)
T ss_pred cccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCC
Confidence 3333333 8999999999999999999999999999999999999888753
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-43 Score=315.26 Aligned_cols=216 Identities=25% Similarity=0.509 Sum_probs=199.6
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV 185 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV 185 (331)
.-+|++.+.||+|.||.|-+++. .|+.||||.++.+.. +....-.+.+|++||..++||||++++.+|++.+.+.||
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv 131 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV 131 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence 45799999999999999999986 689999999987654 344567799999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCccc
Q 020085 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT 265 (331)
Q Consensus 186 ~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~~ 265 (331)
|||..+|.|+||+.. ++.+++..+..+++||..|+.|+|+++++|||||.+|||+|.|+++||+|||++....+....+
T Consensus 132 MEYaS~GeLYDYiSe-r~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfLq 210 (668)
T KOG0611|consen 132 MEYASGGELYDYISE-RGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFLQ 210 (668)
T ss_pred EEecCCccHHHHHHH-hccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhccccHHH
Confidence 999999999999976 6789999999999999999999999999999999999999999999999999999988888888
Q ss_pred cCCCCcccccchhcCCCCC-CChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccccccc
Q 020085 266 AETGTYRWMAPEVIEHKPY-DYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSI 325 (331)
Q Consensus 266 ~~~gt~~y~aPE~~~~~~~-~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~ 325 (331)
+.||+|.|.+||++++.+| .+..|-||||++||-|+.|.+||++......+.++.+..+|
T Consensus 211 TFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYr 271 (668)
T KOG0611|consen 211 TFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYR 271 (668)
T ss_pred HhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhccccc
Confidence 9999999999999999999 47899999999999999999999999998888887665554
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=317.16 Aligned_cols=221 Identities=32% Similarity=0.609 Sum_probs=182.7
Q ss_pred eeecccCcceeeeeeecCceEEEEEEE-------CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCcceeEEeEE
Q 020085 105 WEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGAC 176 (331)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~ 176 (331)
|+++.++|++.++||+|+||.||+|.+ .++.||+|+++... .......+.+|+.+++++ +||||++++++|
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (338)
T cd05102 2 WEFPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA-TASEHKALMSELKILIHIGNHLNVVNLLGAC 80 (338)
T ss_pred cccchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc-chHHHHHHHHHHHHHHHhccCcceeeEEeEe
Confidence 788999999999999999999999975 23579999997543 334456799999999999 899999999988
Q ss_pred ECCC-CeEEEEeccCCCCHHHHHHhcC-----------------------------------------------------
Q 020085 177 TRPP-NLCIVTEFMARGSIYDFLHKQK----------------------------------------------------- 202 (331)
Q Consensus 177 ~~~~-~~~lV~E~~~ggsL~~~l~~~~----------------------------------------------------- 202 (331)
.... .+++||||+++|+|.+++....
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (338)
T cd05102 81 TKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPP 160 (338)
T ss_pred cCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccc
Confidence 7644 5899999999999999996532
Q ss_pred --------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCc---cccCCCCc
Q 020085 203 --------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV---MTAETGTY 271 (331)
Q Consensus 203 --------~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~ 271 (331)
..+++..+..++.||++||+|||++||+||||||+|||++.++.+||+|||+++....... .....+++
T Consensus 161 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~ 240 (338)
T cd05102 161 QETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240 (338)
T ss_pred hhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence 2367788899999999999999999999999999999999999999999999975433211 11233567
Q ss_pred ccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhccccccccc
Q 020085 272 RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIH 326 (331)
Q Consensus 272 ~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p 326 (331)
.|+|||++.+..++.++||||||+++|||++ |..||++....+.....+..+.++
T Consensus 241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~ 296 (338)
T cd05102 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM 296 (338)
T ss_pred cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCC
Confidence 8999999999999999999999999999997 999999865544444444445443
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=320.17 Aligned_cols=211 Identities=23% Similarity=0.392 Sum_probs=184.2
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEE
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~ 186 (331)
++|++.+.||+|+||+||+++. .++.||||+++.... .......+.+|+.+++.++||||+++++++..+..+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 4789999999999999999988 578999999975321 2344567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC----
Q 020085 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG---- 262 (331)
Q Consensus 187 E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~---- 262 (331)
||++||+|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||+++......
T Consensus 81 E~~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~ 159 (364)
T cd05599 81 EYLPGGDMMTLLMK-KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEF 159 (364)
T ss_pred CCCCCcHHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccccccc
Confidence 99999999999965 4678999999999999999999999999999999999999999999999999986432211
Q ss_pred -----------------------------------ccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCC
Q 020085 263 -----------------------------------VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 307 (331)
Q Consensus 263 -----------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf 307 (331)
......||+.|+|||++.+..++.++|||||||++|||++|..||
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf 239 (364)
T cd05599 160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPF 239 (364)
T ss_pred cccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCC
Confidence 001235899999999999999999999999999999999999999
Q ss_pred CCCCHHHHHhcccc
Q 020085 308 AGLTPLQAAVGVVQ 321 (331)
Q Consensus 308 ~~~~~~~~~~~~~~ 321 (331)
.+.++.+....+..
T Consensus 240 ~~~~~~~~~~~i~~ 253 (364)
T cd05599 240 CSDNPQETYRKIIN 253 (364)
T ss_pred CCCCHHHHHHHHHc
Confidence 99988877766543
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=320.12 Aligned_cols=217 Identities=23% Similarity=0.361 Sum_probs=186.5
Q ss_pred eeecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCC
Q 020085 105 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN 181 (331)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 181 (331)
.++..++|++.+.||+|+||.||++.+ .++.+|+|+++... ........+.+|+.+++.++||||+++++++..+..
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 456678999999999999999999988 56889999986422 123334568899999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC
Q 020085 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261 (331)
Q Consensus 182 ~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~ 261 (331)
+++||||++||+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~ 195 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 195 (371)
T ss_pred EEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcC
Confidence 9999999999999999864 45888999999999999999999999999999999999999999999999999865443
Q ss_pred Cc--cccCCCCcccccchhcCCCC----CCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccccc
Q 020085 262 GV--MTAETGTYRWMAPEVIEHKP----YDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKV 323 (331)
Q Consensus 262 ~~--~~~~~gt~~y~aPE~~~~~~----~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~ 323 (331)
.. .....||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+.......+....
T Consensus 196 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~ 263 (371)
T cd05622 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK 263 (371)
T ss_pred CcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Confidence 22 23456999999999986543 7899999999999999999999999988877777665443
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=320.39 Aligned_cols=209 Identities=24% Similarity=0.400 Sum_probs=181.5
Q ss_pred CcceeeeeeecCceEEEEEEE--CCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEe
Q 020085 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E 187 (331)
.|++.+.||+|+||+||+|++ .++.||+|+++... .+......+.+|+.++++++||||+++++++.+...+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 688999999999999999988 56789999997543 234456779999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC------
Q 020085 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS------ 261 (331)
Q Consensus 188 ~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~------ 261 (331)
|++||+|.+++.. .+.+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~ 160 (381)
T cd05626 82 YIPGGDMMSLLIR-MEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY 160 (381)
T ss_pred cCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence 9999999999965 467899999999999999999999999999999999999999999999999987532100
Q ss_pred ------------------------------------------CccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHH
Q 020085 262 ------------------------------------------GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWE 299 (331)
Q Consensus 262 ------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~e 299 (331)
.......||+.|+|||++.+..++.++|||||||++||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~e 240 (381)
T cd05626 161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFE 240 (381)
T ss_pred cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHH
Confidence 00112368999999999999999999999999999999
Q ss_pred HHcCCCCCCCCCHHHHHhccc
Q 020085 300 LLTGELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 300 ll~g~~Pf~~~~~~~~~~~~~ 320 (331)
|++|+.||...++.+...++.
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~ 261 (381)
T cd05626 241 MLVGQPPFLAPTPTETQLKVI 261 (381)
T ss_pred HHhCCCCCcCCCHHHHHHHHH
Confidence 999999999888776665544
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=321.05 Aligned_cols=210 Identities=20% Similarity=0.346 Sum_probs=181.7
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEE
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~ 186 (331)
++|.+.++||+|+||.||++.. .++.||||++..... ..+..+.+.+|+.++++++||||+++++++.+...+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 3789999999999999999987 678999999864321 3345567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC----
Q 020085 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG---- 262 (331)
Q Consensus 187 E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~---- 262 (331)
||++||+|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||+++......
T Consensus 81 E~~~gg~L~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~ 159 (377)
T cd05629 81 EFLPGGDLMTMLIK-YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAY 159 (377)
T ss_pred eCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence 99999999999965 4678999999999999999999999999999999999999999999999999985321100
Q ss_pred --------------------------------------------ccccCCCCcccccchhcCCCCCCChhhHHHHHHHHH
Q 020085 263 --------------------------------------------VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALW 298 (331)
Q Consensus 263 --------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ 298 (331)
......||+.|+|||++.+..++.++|||||||++|
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ 239 (377)
T cd05629 160 YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMF 239 (377)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhh
Confidence 001235899999999999999999999999999999
Q ss_pred HHHcCCCCCCCCCHHHHHhccc
Q 020085 299 ELLTGELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 299 ell~g~~Pf~~~~~~~~~~~~~ 320 (331)
||++|..||...++.+....+.
T Consensus 240 elltG~~Pf~~~~~~~~~~~i~ 261 (377)
T cd05629 240 ECLIGWPPFCSENSHETYRKII 261 (377)
T ss_pred hhhcCCCCCCCCCHHHHHHHHH
Confidence 9999999999888776665544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-41 Score=314.98 Aligned_cols=214 Identities=27% Similarity=0.434 Sum_probs=188.0
Q ss_pred eeecccCcceeeeeeecCceEEEEEEECC---ceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCC
Q 020085 105 WEIDAKQLKIECKVASGSYGDLYKGTYCS---QEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (331)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~---~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 180 (331)
..+..++|++.+.||+|+||.||+|.+.+ ..||+|+++.... .....+.+.+|+.+++.++||||+++++++....
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~ 104 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDES 104 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCC
Confidence 45677899999999999999999998633 5799999864322 2334567889999999999999999999999999
Q ss_pred CeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecC
Q 020085 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (331)
Q Consensus 181 ~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~ 260 (331)
..|+||||+++|+|.+++.. .+.+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||+++....
T Consensus 105 ~~~lv~Ey~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 105 YLYLVLEFVIGGEFFTFLRR-NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 99999999999999999965 45789999999999999999999999999999999999999999999999999986543
Q ss_pred CCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 261 SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 261 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
. .....||+.|+|||++.+..++.++|+|||||++|||++|+.||.+.++......+.+
T Consensus 184 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~ 242 (340)
T PTZ00426 184 R--TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILE 242 (340)
T ss_pred C--cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhc
Confidence 2 2345789999999999998899999999999999999999999999888776666543
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=320.02 Aligned_cols=210 Identities=24% Similarity=0.411 Sum_probs=182.1
Q ss_pred CcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEe
Q 020085 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E 187 (331)
.|.+.++||+|+||+||+|.. .++.||+|+++.... .......+.+|+.++++++||||+++++.+..+..+|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 588999999999999999987 568899999875322 23445678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC------
Q 020085 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS------ 261 (331)
Q Consensus 188 ~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~------ 261 (331)
|+++|+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~ 160 (382)
T cd05625 82 YIPGGDMMSLLIR-MGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160 (382)
T ss_pred CCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence 9999999999965 467899999999999999999999999999999999999999999999999997421100
Q ss_pred ------------------------------------------CccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHH
Q 020085 262 ------------------------------------------GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWE 299 (331)
Q Consensus 262 ------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~e 299 (331)
.......||+.|+|||++.+..++.++|||||||++||
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~e 240 (382)
T cd05625 161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 240 (382)
T ss_pred ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHH
Confidence 00012358999999999999999999999999999999
Q ss_pred HHcCCCCCCCCCHHHHHhcccc
Q 020085 300 LLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 300 ll~g~~Pf~~~~~~~~~~~~~~ 321 (331)
|++|+.||...++.+....+..
T Consensus 241 lltG~~Pf~~~~~~~~~~~i~~ 262 (382)
T cd05625 241 MLVGQPPFLAQTPLETQMKVIN 262 (382)
T ss_pred HHhCCCCCCCCCHHHHHHHHHc
Confidence 9999999999888877766554
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=313.42 Aligned_cols=210 Identities=27% Similarity=0.455 Sum_probs=186.6
Q ss_pred cccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEE
Q 020085 108 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI 184 (331)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~l 184 (331)
..++|.+.+.||+|+||.||++++ .++.||+|+++.... .....+.+.+|+.++++++||||+++++++..++..|+
T Consensus 16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 95 (329)
T PTZ00263 16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYF 95 (329)
T ss_pred CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEE
Confidence 357899999999999999999988 468899999975422 22345678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCcc
Q 020085 185 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM 264 (331)
Q Consensus 185 V~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~ 264 (331)
||||+++|+|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 96 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-- 172 (329)
T PTZ00263 96 LLEFVVGGELFTHLRK-AGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT-- 172 (329)
T ss_pred EEcCCCCChHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc--
Confidence 9999999999999965 4678999999999999999999999999999999999999999999999999998654332
Q ss_pred ccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccc
Q 020085 265 TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 265 ~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~ 320 (331)
....||+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.++.+....+.
T Consensus 173 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~ 228 (329)
T PTZ00263 173 FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKIL 228 (329)
T ss_pred ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHh
Confidence 34578999999999999999999999999999999999999999988887776644
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=301.84 Aligned_cols=218 Identities=28% Similarity=0.431 Sum_probs=192.6
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECC--CCeEE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--PNLCI 184 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~--~~~~l 184 (331)
.++|+...+|++|+||.||+|++ +++.||+|.++.+.......-.-.+|+.+|.+.+|||||.+-.+.... +.+||
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 46899999999999999999998 568899999998754433344578999999999999999998877543 46999
Q ss_pred EEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC-Cc
Q 020085 185 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GV 263 (331)
Q Consensus 185 V~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~-~~ 263 (331)
||||++. +|..++.+.+.+|...++..+..|+++|++|||.+.|+||||||+|+|++..|.+|++|||+|+..... ..
T Consensus 155 VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~ 233 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKP 233 (419)
T ss_pred eHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCccc
Confidence 9999998 999999988889999999999999999999999999999999999999999999999999999977654 34
Q ss_pred cccCCCCcccccchhcCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccccccccc
Q 020085 264 MTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIHS 327 (331)
Q Consensus 264 ~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~p~ 327 (331)
++.-..|..|.|||.+.+ ..|+...|+||+|||+.||+++++-|++.+..+...++.+.-..|.
T Consensus 234 ~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPt 298 (419)
T KOG0663|consen 234 YTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPS 298 (419)
T ss_pred CcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCc
Confidence 667788999999999865 4799999999999999999999999999988888888777666553
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=308.00 Aligned_cols=209 Identities=24% Similarity=0.426 Sum_probs=184.5
Q ss_pred cCcceeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEE
Q 020085 110 KQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~ 186 (331)
++|++.+.||+|+||.||++... ++.||+|+++.... .....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 47899999999999999999984 78999999975422 2234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCcccc
Q 020085 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 266 (331)
Q Consensus 187 E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~~~ 266 (331)
||+++|+|.+++.. .+.+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||+++..... ...
T Consensus 81 e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--~~~ 157 (291)
T cd05612 81 EYVPGGELFSYLRN-SGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--TWT 157 (291)
T ss_pred eCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--ccc
Confidence 99999999999965 467899999999999999999999999999999999999999999999999999765432 234
Q ss_pred CCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 267 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 267 ~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
..|++.|+|||++.+..++.++|||||||++|+|++|+.||.+.++.+....+..
T Consensus 158 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~ 212 (291)
T cd05612 158 LCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILA 212 (291)
T ss_pred ccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 5689999999999999999999999999999999999999999888776666443
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=318.15 Aligned_cols=219 Identities=23% Similarity=0.363 Sum_probs=187.1
Q ss_pred eecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCe
Q 020085 106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL 182 (331)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 182 (331)
.+..++|++.+.||+|+||.||++++ .++.+|+|+++.... .......+.+|+.+++.++||||+++++++..+..+
T Consensus 39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEE
Confidence 44567899999999999999999998 467899999864321 223345688999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC
Q 020085 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262 (331)
Q Consensus 183 ~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~ 262 (331)
|+||||++||+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||+++++.+||+|||+++......
T Consensus 119 ~lv~Ey~~gg~L~~~l~~--~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~ 196 (370)
T cd05621 119 YMVMEYMPGGDLVNLMSN--YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG 196 (370)
T ss_pred EEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCC
Confidence 999999999999999954 358899999999999999999999999999999999999999999999999998654332
Q ss_pred c--cccCCCCcccccchhcCCCC----CCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccccccc
Q 020085 263 V--MTAETGTYRWMAPEVIEHKP----YDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIH 326 (331)
Q Consensus 263 ~--~~~~~gt~~y~aPE~~~~~~----~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~p 326 (331)
. .....||+.|+|||++.+.. ++.++|+||+||++|||++|+.||...+......+++.....+
T Consensus 197 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~ 266 (370)
T cd05621 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSL 266 (370)
T ss_pred ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccc
Confidence 2 23456999999999997543 7889999999999999999999999988877777766544333
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=303.65 Aligned_cols=224 Identities=22% Similarity=0.418 Sum_probs=192.4
Q ss_pred CeeeecccCccee--eeeeecCceEEEEEEECCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhcCCCcceeEEeEEEC-
Q 020085 103 DVWEIDAKQLKIE--CKVASGSYGDLYKGTYCSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTR- 178 (331)
Q Consensus 103 ~~~~i~~~~~~~~--~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~- 178 (331)
+...|+.+++... ..||+|++|.||+|.++++.||||+++..... ....+.|.+|+.+|++++||||+++++++.+
T Consensus 11 ~~~~i~~~~i~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~ 90 (283)
T PHA02988 11 DIKCIESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDI 90 (283)
T ss_pred cceecCHHHcCCCCCeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEec
Confidence 3455666666665 68999999999999999999999999865433 3345788999999999999999999999876
Q ss_pred ---CCCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEEcCCCcEEEeeecc
Q 020085 179 ---PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENGVVKVADFGV 254 (331)
Q Consensus 179 ---~~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~iiHrDlkp~NiLi~~~~~vkl~DFg~ 254 (331)
...+++||||+++|+|.+++.+ ...++......++.|++.||.|||+ .+++||||||+||++++++.+||+|||+
T Consensus 91 ~~~~~~~~lv~Ey~~~g~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~ 169 (283)
T PHA02988 91 VDDLPRLSLILEYCTRGYLREVLDK-EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGL 169 (283)
T ss_pred ccCCCceEEEEEeCCCCcHHHHHhh-CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccch
Confidence 4568999999999999999976 4578899999999999999999998 4999999999999999999999999999
Q ss_pred eeeecCCCccccCCCCcccccchhcCC--CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccccccccccc
Q 020085 255 ARVQAQSGVMTAETGTYRWMAPEVIEH--KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIHSII 329 (331)
Q Consensus 255 a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~p~~~ 329 (331)
++..... .....+++.|+|||.+.+ ..++.++|||||||++|||++|+.||.+.++.+....++.++.+|.++
T Consensus 170 ~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~ 244 (283)
T PHA02988 170 EKILSSP--PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLP 244 (283)
T ss_pred Hhhhccc--cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC
Confidence 8754332 234568899999999976 689999999999999999999999999999888888777777776654
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=312.67 Aligned_cols=217 Identities=20% Similarity=0.352 Sum_probs=186.9
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEE
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~ 186 (331)
++|++.++||+|+||+||+++. .++.||+|+++... ........+.+|..+++.++|+||+++++++...+..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4799999999999999999987 46789999987432 12334456888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCcc--
Q 020085 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM-- 264 (331)
Q Consensus 187 E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~-- 264 (331)
||++||+|.+++......+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++........
T Consensus 81 Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~ 160 (331)
T cd05624 81 DYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQS 160 (331)
T ss_pred eCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceee
Confidence 999999999999876678899999999999999999999999999999999999999999999999999765443222
Q ss_pred ccCCCCcccccchhcCC-----CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccccccc
Q 020085 265 TAETGTYRWMAPEVIEH-----KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIH 326 (331)
Q Consensus 265 ~~~~gt~~y~aPE~~~~-----~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~p 326 (331)
....|++.|+|||++.+ ..++.++|+||||+++|||++|+.||...++.+....+.....++
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~ 227 (331)
T cd05624 161 SVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERF 227 (331)
T ss_pred ccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcc
Confidence 23468999999999875 467889999999999999999999999888877777665544443
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-41 Score=312.34 Aligned_cols=206 Identities=27% Similarity=0.470 Sum_probs=183.2
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEE
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~ 186 (331)
++|++.++||+|+||.||+|++ .++.||+|+++.... ..+....+.+|+.+++.++||||+++++++......|+||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 3789999999999999999998 468999999975432 2234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCcccc
Q 020085 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 266 (331)
Q Consensus 187 E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~~~ 266 (331)
||++||+|.+++.. .+.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++.... ....
T Consensus 81 e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--~~~~ 157 (333)
T cd05600 81 EYVPGGDFRTLLNN-LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--YANS 157 (333)
T ss_pred eCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--ccCC
Confidence 99999999999965 46789999999999999999999999999999999999999999999999999975543 2344
Q ss_pred CCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhc
Q 020085 267 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVG 318 (331)
Q Consensus 267 ~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~ 318 (331)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...++.+....
T Consensus 158 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~ 209 (333)
T cd05600 158 VVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWEN 209 (333)
T ss_pred cccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHH
Confidence 5789999999999999999999999999999999999999998887665544
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=303.40 Aligned_cols=202 Identities=23% Similarity=0.407 Sum_probs=177.7
Q ss_pred CcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEe
Q 020085 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E 187 (331)
.|+..+.||+|+||+||++.. +++.||+|++...... ......+.+|+.++++++|+||+++++++...+..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 377889999999999999987 5789999998754322 2234567899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCcccc
Q 020085 188 FMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 266 (331)
Q Consensus 188 ~~~ggsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~~~ 266 (331)
|+++|+|.+++... ...+++..+..++.|++.||+|||++|++||||||+|||+++++.++|+|||++...........
T Consensus 81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05631 81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRG 160 (285)
T ss_pred ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeecC
Confidence 99999999888653 34689999999999999999999999999999999999999999999999999987654444445
Q ss_pred CCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH
Q 020085 267 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTP 312 (331)
Q Consensus 267 ~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~ 312 (331)
..|++.|+|||++.+..++.++|||||||++|||++|+.||...+.
T Consensus 161 ~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~ 206 (285)
T cd05631 161 RVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKE 206 (285)
T ss_pred CCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCc
Confidence 6789999999999999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-41 Score=310.16 Aligned_cols=213 Identities=21% Similarity=0.369 Sum_probs=183.8
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEE
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~ 186 (331)
++|++.+.||+|+||+||+++. .++.||+|+++... ......+.+.+|+.+++.++|+||+++++++..+..+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 4799999999999999999987 46899999987422 22334566889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCc--c
Q 020085 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV--M 264 (331)
Q Consensus 187 E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~--~ 264 (331)
||++||+|.+++.+....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ .
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 160 (331)
T cd05597 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQS 160 (331)
T ss_pred ecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccc
Confidence 99999999999976667899999999999999999999999999999999999999999999999999876543322 1
Q ss_pred ccCCCCcccccchhcCC-----CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccc
Q 020085 265 TAETGTYRWMAPEVIEH-----KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK 322 (331)
Q Consensus 265 ~~~~gt~~y~aPE~~~~-----~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~ 322 (331)
....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+...
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~ 223 (331)
T cd05597 161 NVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNH 223 (331)
T ss_pred cceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcC
Confidence 23468999999999863 45788999999999999999999999988877766665543
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=318.21 Aligned_cols=210 Identities=23% Similarity=0.394 Sum_probs=180.4
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEE
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~ 186 (331)
++|++.++||+|+||.||+++. .++.||+|++..... .......+.+|+.++++++||||+++++.+..++.+|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 3799999999999999999987 468999999864321 2233466889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC-----
Q 020085 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS----- 261 (331)
Q Consensus 187 E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~----- 261 (331)
||+++|+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++......
T Consensus 81 E~~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~ 159 (376)
T cd05598 81 DYIPGGDMMSLLIR-LGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY 159 (376)
T ss_pred eCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccc
Confidence 99999999999965 467889999999999999999999999999999999999999999999999997421100
Q ss_pred ---------------------------------------CccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc
Q 020085 262 ---------------------------------------GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT 302 (331)
Q Consensus 262 ---------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~ 302 (331)
.......||+.|+|||++.+..++.++|||||||++|||++
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~ 239 (376)
T cd05598 160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLV 239 (376)
T ss_pred cccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhh
Confidence 00112368999999999999999999999999999999999
Q ss_pred CCCCCCCCCHHHHHhccc
Q 020085 303 GELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 303 g~~Pf~~~~~~~~~~~~~ 320 (331)
|+.||...++.+....+.
T Consensus 240 G~~Pf~~~~~~~~~~~i~ 257 (376)
T cd05598 240 GQPPFLADTPAETQLKVI 257 (376)
T ss_pred CCCCCCCCCHHHHHHHHh
Confidence 999999988776655543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=315.50 Aligned_cols=211 Identities=24% Similarity=0.427 Sum_probs=186.8
Q ss_pred cCcceeeeeeecCceEEEEEEEC--CceEEEEEecCCCCC-HHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEE
Q 020085 110 KQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~ 186 (331)
++|.+.+.||+|+||+||++++. ++.||+|+++..... ......+.+|+.+++.++||||+++++++.++...|+||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 47899999999999999999985 789999999754322 234567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC----
Q 020085 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG---- 262 (331)
Q Consensus 187 E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~---- 262 (331)
||+++++|.+++... +.+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+++......
T Consensus 81 e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~ 159 (350)
T cd05573 81 EYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREY 159 (350)
T ss_pred cCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccc
Confidence 999999999999764 789999999999999999999999999999999999999999999999999997554332
Q ss_pred --------------------------ccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 020085 263 --------------------------VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAA 316 (331)
Q Consensus 263 --------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~ 316 (331)
......||+.|+|||++.+..++.++|||||||++|||++|+.||...++.+..
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~ 239 (350)
T cd05573 160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETY 239 (350)
T ss_pred cccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHH
Confidence 223446899999999999999999999999999999999999999998887776
Q ss_pred hcccc
Q 020085 317 VGVVQ 321 (331)
Q Consensus 317 ~~~~~ 321 (331)
..+..
T Consensus 240 ~~i~~ 244 (350)
T cd05573 240 NKIIN 244 (350)
T ss_pred HHHhc
Confidence 66554
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-42 Score=331.73 Aligned_cols=222 Identities=31% Similarity=0.604 Sum_probs=195.5
Q ss_pred CCCeeeecccCcceeeeeeecCceEEEEEEECC-------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEE
Q 020085 101 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFI 173 (331)
Q Consensus 101 ~~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~ 173 (331)
+....+|...+.++.+.||+|.||+||+|...+ .-||||.+|... +.+...+|.+|+++++.++|||||+++
T Consensus 477 ~~~~~~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a-~~~~~~dF~REaeLla~l~H~nIVrLl 555 (774)
T KOG1026|consen 477 DLKVLEIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKA-ENQARQDFRREAELLAELQHPNIVRLL 555 (774)
T ss_pred ccceeEechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccc-cHHHHHHHHHHHHHHHhccCCCeEEEE
Confidence 456788999999999999999999999998643 569999999764 455778999999999999999999999
Q ss_pred eEEECCCCeEEEEeccCCCCHHHHHHhcC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEE
Q 020085 174 GACTRPPNLCIVTEFMARGSIYDFLHKQK-------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL 240 (331)
Q Consensus 174 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~-------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiL 240 (331)
|.|.+++.+|+|+|||..|+|.++|.... .+++..+.+.+|.|||.||+||-++.+|||||.++|+|
T Consensus 556 GVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCL 635 (774)
T KOG1026|consen 556 GVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCL 635 (774)
T ss_pred EEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhce
Confidence 99999999999999999999999996642 12778899999999999999999999999999999999
Q ss_pred EcCCCcEEEeeecceeeecCCCccccC---CCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHH
Q 020085 241 MDENGVVKVADFGVARVQAQSGVMTAE---TGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAA 316 (331)
Q Consensus 241 i~~~~~vkl~DFg~a~~~~~~~~~~~~---~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~ 316 (331)
|+++-.|||+|||+++..-........ .-..||||||.|....|+.+|||||||++|||+++ |+.||.++++.|++
T Consensus 636 Vge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVI 715 (774)
T KOG1026|consen 636 VGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVI 715 (774)
T ss_pred eccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHH
Confidence 999999999999999866554332222 23479999999999999999999999999999999 99999999998877
Q ss_pred hccccccc
Q 020085 317 VGVVQKVS 324 (331)
Q Consensus 317 ~~~~~~~~ 324 (331)
.- ++.|.
T Consensus 716 e~-i~~g~ 722 (774)
T KOG1026|consen 716 EC-IRAGQ 722 (774)
T ss_pred HH-HHcCC
Confidence 66 55554
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=317.29 Aligned_cols=214 Identities=31% Similarity=0.519 Sum_probs=191.2
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~ 186 (331)
...|..-.+||+|+.|.||.++. .++.||||.+....... .+-+.+|+.+|+..+|+|||++++.+...+.+|.||
T Consensus 272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~--keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVM 349 (550)
T KOG0578|consen 272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK--KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVM 349 (550)
T ss_pred hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc--hhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEE
Confidence 34678888999999999999987 56889999997654333 367899999999999999999999998889999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC-ccc
Q 020085 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMT 265 (331)
Q Consensus 187 E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~-~~~ 265 (331)
|||+||+|.|.+.. ..+++.++..++++++.||+|||.+||+|||||.+|||++.+|.+||+|||++....... ...
T Consensus 350 Eym~ggsLTDvVt~--~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~ 427 (550)
T KOG0578|consen 350 EYMEGGSLTDVVTK--TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRS 427 (550)
T ss_pred eecCCCchhhhhhc--ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCccc
Confidence 99999999999854 458999999999999999999999999999999999999999999999999987665543 556
Q ss_pred cCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccccccccc
Q 020085 266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIHS 327 (331)
Q Consensus 266 ~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~p~ 327 (331)
.-.|||.|||||++..+.|+++.||||||++.+||+.|.+||=..+|+++...+..+| +|+
T Consensus 428 TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng-~P~ 488 (550)
T KOG0578|consen 428 TMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPK 488 (550)
T ss_pred cccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcC-CCC
Confidence 7789999999999999999999999999999999999999999999999988866544 443
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=300.57 Aligned_cols=217 Identities=25% Similarity=0.428 Sum_probs=192.5
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCc-ceeEEeEEECCC-----
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN-VVQFIGACTRPP----- 180 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~n-iv~~~~~~~~~~----- 180 (331)
...|...++||+|+||+||+|+. +|+.||+|.++.+..++.......+|+.+|++++|+| |+.+++++....
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~ 89 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGI 89 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccccccc
Confidence 55688888999999999999987 6789999999876543334566789999999999999 999999998877
Q ss_pred -CeEEEEeccCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeeccee
Q 020085 181 -NLCIVTEFMARGSIYDFLHKQK---GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR 256 (331)
Q Consensus 181 -~~~lV~E~~~ggsL~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~ 256 (331)
.+++|+||++. +|..++.... ..++...+..++.||++||+|||+++|+||||||.||||+++|.+||+|||+|+
T Consensus 90 ~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAr 168 (323)
T KOG0594|consen 90 GKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLAR 168 (323)
T ss_pred ceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHH
Confidence 79999999977 9999997755 357888999999999999999999999999999999999999999999999998
Q ss_pred eec-CCCccccCCCCcccccchhcCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccccccc
Q 020085 257 VQA-QSGVMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIH 326 (331)
Q Consensus 257 ~~~-~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~p 326 (331)
... .....+.+.+|..|.|||++.+. .|+...||||+||++.||++++..|++.+..+....+-+.-..|
T Consensus 169 a~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP 240 (323)
T KOG0594|consen 169 AFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTP 240 (323)
T ss_pred HhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCC
Confidence 665 33446788899999999999776 79999999999999999999999999999988888887776666
|
|
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-41 Score=315.64 Aligned_cols=210 Identities=25% Similarity=0.406 Sum_probs=183.2
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEE
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~ 186 (331)
++|++.+.||+|+||.||++.. .++.||+|+++... ...+....+.+|+.++.+++||||+++++.+.....+|+||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 4789999999999999999987 57899999997432 12344567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC----
Q 020085 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG---- 262 (331)
Q Consensus 187 E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~---- 262 (331)
||++||+|.+++.+ .+.+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||+++......
T Consensus 81 E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~ 159 (360)
T cd05627 81 EFLPGGDMMTLLMK-KDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEF 159 (360)
T ss_pred eCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccccc
Confidence 99999999999965 4678999999999999999999999999999999999999999999999999986432110
Q ss_pred --------------------------------ccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 020085 263 --------------------------------VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL 310 (331)
Q Consensus 263 --------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~ 310 (331)
.....+||+.|+|||++.+..++.++|+|||||++|||++|+.||.+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~ 239 (360)
T cd05627 160 YRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239 (360)
T ss_pred ccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCC
Confidence 011346899999999999999999999999999999999999999998
Q ss_pred CHHHHHhccc
Q 020085 311 TPLQAAVGVV 320 (331)
Q Consensus 311 ~~~~~~~~~~ 320 (331)
++.+....+.
T Consensus 240 ~~~~~~~~i~ 249 (360)
T cd05627 240 TPQETYRKVM 249 (360)
T ss_pred CHHHHHHHHH
Confidence 8877766654
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=313.90 Aligned_cols=216 Identities=23% Similarity=0.369 Sum_probs=185.8
Q ss_pred eeecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCC
Q 020085 105 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN 181 (331)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 181 (331)
+.+..++|++.++||+|+||.||+++. .++.||+|+++.... .......+.+|+.+++.++||||+++++++..+..
T Consensus 38 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~ 117 (370)
T cd05596 38 LRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKY 117 (370)
T ss_pred CCCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCE
Confidence 456778999999999999999999987 568999999974322 22334557889999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC
Q 020085 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261 (331)
Q Consensus 182 ~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~ 261 (331)
.|+||||++||+|.+++.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 118 ~~lv~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~ 195 (370)
T cd05596 118 LYMVMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDAN 195 (370)
T ss_pred EEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCC
Confidence 9999999999999999864 45888999999999999999999999999999999999999999999999999765433
Q ss_pred Cc--cccCCCCcccccchhcCCC----CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccc
Q 020085 262 GV--MTAETGTYRWMAPEVIEHK----PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK 322 (331)
Q Consensus 262 ~~--~~~~~gt~~y~aPE~~~~~----~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~ 322 (331)
.. .....||+.|+|||++.+. .++.++|+|||||++|||++|+.||.+.+.......+...
T Consensus 196 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~ 262 (370)
T cd05596 196 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDH 262 (370)
T ss_pred CcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcC
Confidence 22 2345699999999998653 4789999999999999999999999998887776666543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=309.20 Aligned_cols=204 Identities=24% Similarity=0.455 Sum_probs=177.8
Q ss_pred eeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEeccCCC
Q 020085 116 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARG 192 (331)
Q Consensus 116 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~~~gg 192 (331)
+.||+|+||.||+++. .++.||+|+++.... .......+.+|+.++++++||||+++++++.....+|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999987 578999999985432 2344567889999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC-CccccCCCCc
Q 020085 193 SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTAETGTY 271 (331)
Q Consensus 193 sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~-~~~~~~~gt~ 271 (331)
+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..... .......||+
T Consensus 81 ~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~ 159 (323)
T cd05571 81 ELFFHLSR-ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP 159 (323)
T ss_pred cHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCc
Confidence 99999965 567899999999999999999999999999999999999999999999999998754322 2233456999
Q ss_pred ccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccc
Q 020085 272 RWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 272 ~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~ 320 (331)
.|+|||++.+..++.++|||||||++|||++|+.||...+.......+.
T Consensus 160 ~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~ 208 (323)
T cd05571 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL 208 (323)
T ss_pred cccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHH
Confidence 9999999999999999999999999999999999998877666555433
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=300.69 Aligned_cols=211 Identities=25% Similarity=0.434 Sum_probs=181.6
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~ 186 (331)
.++|.+.++||+|+||.||+|.. +++.||+|+++.... ......+.+|+.++++++||||+++++++......++||
T Consensus 4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (288)
T cd07871 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF 82 (288)
T ss_pred cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc-CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 45799999999999999999987 568899999975432 222356788999999999999999999999998999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC-ccc
Q 020085 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMT 265 (331)
Q Consensus 187 E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~-~~~ 265 (331)
||+.+ +|.+++......++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... ...
T Consensus 83 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~ 161 (288)
T cd07871 83 EYLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYS 161 (288)
T ss_pred eCCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCcccc
Confidence 99986 9999987766678999999999999999999999999999999999999999999999999997543322 223
Q ss_pred cCCCCcccccchhcCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 266 AETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 266 ~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
...+++.|+|||.+.+ ..++.++|+||+||++|+|++|+.||.+.+..+....+.+
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 218 (288)
T cd07871 162 NEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFR 218 (288)
T ss_pred CceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 4568999999999865 5689999999999999999999999999887776655443
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=296.53 Aligned_cols=220 Identities=28% Similarity=0.537 Sum_probs=187.9
Q ss_pred ecccCcceeeeeeecCceEEEEEEEC-----CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCC
Q 020085 107 IDAKQLKIECKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN 181 (331)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 181 (331)
|+..+|++.+.||+|+||.||+|.+. +..||+|.++... +......+.+|+.++++++||||+++++++..+..
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 80 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC-SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNT 80 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCC
Confidence 56788999999999999999999763 4689999998653 34445779999999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC
Q 020085 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261 (331)
Q Consensus 182 ~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~ 261 (331)
.++||||+++|+|.+++....+.+++..++.++.|++.||+|||++|++||||||+||+++.++.++++|||.+......
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~ 160 (266)
T cd05064 81 MMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE 160 (266)
T ss_pred cEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence 99999999999999999776678899999999999999999999999999999999999999999999999987643322
Q ss_pred Cccc--cCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhccccccccccc
Q 020085 262 GVMT--AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIHSI 328 (331)
Q Consensus 262 ~~~~--~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p~~ 328 (331)
.... ...++..|+|||.+.+..++.++|||||||++||+++ |+.||.+.++.+....+ .++.+++.
T Consensus 161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~-~~~~~~~~ 229 (266)
T cd05064 161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAV-EDGFRLPA 229 (266)
T ss_pred chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH-HCCCCCCC
Confidence 1111 2234678999999999999999999999999999775 99999998887766653 44555443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=309.11 Aligned_cols=216 Identities=21% Similarity=0.362 Sum_probs=185.5
Q ss_pred cCcceeeeeeecCceEEEEEEEC--CceEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEE
Q 020085 110 KQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~ 186 (331)
++|++.++||+|+||.||++... ++.+|+|++.... ........+.+|+.+++.++|+||+++++++.....+++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 47899999999999999999884 5789999986422 12233456888999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCc--c
Q 020085 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV--M 264 (331)
Q Consensus 187 E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~--~ 264 (331)
||+++|+|.+++.+....+++..+..++.|++.||+|||++||+||||||+|||++.++.++|+|||++........ .
T Consensus 81 ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~ 160 (332)
T cd05623 81 DYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQS 160 (332)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCccee
Confidence 99999999999987667899999999999999999999999999999999999999999999999999875433222 2
Q ss_pred ccCCCCcccccchhcC-----CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccccccc
Q 020085 265 TAETGTYRWMAPEVIE-----HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSI 325 (331)
Q Consensus 265 ~~~~gt~~y~aPE~~~-----~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~ 325 (331)
....||+.|+|||++. ...++.++|+|||||++|||++|+.||...++.+....+.....+
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~ 226 (332)
T cd05623 161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER 226 (332)
T ss_pred cccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCcc
Confidence 2356899999999985 346889999999999999999999999998888877776554433
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=306.63 Aligned_cols=204 Identities=23% Similarity=0.460 Sum_probs=177.7
Q ss_pred eeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEeccCCC
Q 020085 116 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARG 192 (331)
Q Consensus 116 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~~~gg 192 (331)
+.||+|+||.||++.. .++.||+|+++.... .......+.+|+.++++++||||+++++++.....+|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4699999999999987 578999999975432 2334567888999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecC-CCccccCCCCc
Q 020085 193 SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAETGTY 271 (331)
Q Consensus 193 sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~-~~~~~~~~gt~ 271 (331)
+|.+++.. .+.+++..+..++.||+.||+|||++|++||||||+|||++.++.+||+|||+++.... ........||+
T Consensus 81 ~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~ 159 (323)
T cd05595 81 ELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP 159 (323)
T ss_pred cHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCc
Confidence 99998865 46789999999999999999999999999999999999999999999999999875322 22233456899
Q ss_pred ccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccc
Q 020085 272 RWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 272 ~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~ 320 (331)
.|+|||++.+..++.++|+|||||++|||++|+.||...+..+....+.
T Consensus 160 ~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~ 208 (323)
T cd05595 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL 208 (323)
T ss_pred CcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHh
Confidence 9999999999999999999999999999999999998887766655544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=302.10 Aligned_cols=210 Identities=28% Similarity=0.479 Sum_probs=183.0
Q ss_pred CcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCC-----CeE
Q 020085 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP-----NLC 183 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~-----~~~ 183 (331)
.|.-.+.+|+|+||.||+|.. .++.||||..-.+. +--.+|+.+|+.++|||||+++.+|.... .+.
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~------r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~ln 98 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDK------RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLN 98 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCC------CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHH
Confidence 567788999999999999987 45899999986553 23457999999999999999998885322 457
Q ss_pred EEEeccCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC-CcEEEeeecceeeec
Q 020085 184 IVTEFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQA 259 (331)
Q Consensus 184 lV~E~~~ggsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~-~~vkl~DFg~a~~~~ 259 (331)
+|||||+. +|+++++. .+..++.-.+.-+..||++||.|||+.||+||||||.|+|+|.+ |.+||||||+|+...
T Consensus 99 lVleymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~ 177 (364)
T KOG0658|consen 99 LVLEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLV 177 (364)
T ss_pred HHHHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeec
Confidence 89999987 99999864 25678888899999999999999999999999999999999987 899999999999888
Q ss_pred CCCccccCCCCcccccchhcCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccccccccc
Q 020085 260 QSGVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIHS 327 (331)
Q Consensus 260 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~p~ 327 (331)
.+........|..|.|||.+-+ ..|+.+.||||.||++.||+.|++-|++.+..+.++.+++--..|+
T Consensus 178 ~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt 246 (364)
T KOG0658|consen 178 KGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPT 246 (364)
T ss_pred cCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCC
Confidence 8777788889999999999865 5799999999999999999999999999999988888887666654
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-41 Score=309.62 Aligned_cols=212 Identities=24% Similarity=0.395 Sum_probs=185.4
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEE
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~ 186 (331)
++|.+.+.||+|+||+||++.. .++.||+|+++.... ..+..+.+.+|+.+++.++||||+++++++......++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 4789999999999999999987 578999999986432 2334567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCc--c
Q 020085 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV--M 264 (331)
Q Consensus 187 E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~--~ 264 (331)
||+++|+|.+++....+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++....... .
T Consensus 81 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~ 160 (330)
T cd05601 81 EYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNS 160 (330)
T ss_pred CCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCceee
Confidence 99999999999987667899999999999999999999999999999999999999999999999999976544322 2
Q ss_pred ccCCCCcccccchhcC------CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 265 TAETGTYRWMAPEVIE------HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 265 ~~~~gt~~y~aPE~~~------~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
....||+.|+|||++. ...++.++|||||||++|||++|+.||...+..+...++..
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~ 223 (330)
T cd05601 161 KLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMN 223 (330)
T ss_pred ecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHc
Confidence 2346899999999986 45678999999999999999999999998887776666543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=310.70 Aligned_cols=224 Identities=31% Similarity=0.589 Sum_probs=187.9
Q ss_pred CCeeeecccCcceeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCcceeEE
Q 020085 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFI 173 (331)
Q Consensus 102 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~ 173 (331)
.+.|.++.++|++.+.||+|+||.||++++. +..||+|+++... ..+....+.+|+.+++.+ +||||++++
T Consensus 30 ~~~~~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~~h~nIv~~~ 108 (374)
T cd05106 30 NEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA-HTDEREALMSELKILSHLGQHKNIVNLL 108 (374)
T ss_pred cccccccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC-CHHHHHHHHHHHHHHHhhccCCceeeEe
Confidence 3568899999999999999999999998752 2479999998654 334456789999999999 899999999
Q ss_pred eEEECCCCeEEEEeccCCCCHHHHHHhcC---------------------------------------------------
Q 020085 174 GACTRPPNLCIVTEFMARGSIYDFLHKQK--------------------------------------------------- 202 (331)
Q Consensus 174 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~--------------------------------------------------- 202 (331)
++|......++||||+++|+|.+++....
T Consensus 109 ~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (374)
T cd05106 109 GACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVS 188 (374)
T ss_pred eEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcc
Confidence 99999999999999999999999986431
Q ss_pred ------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCcc
Q 020085 203 ------------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM 264 (331)
Q Consensus 203 ------------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~ 264 (331)
..+++..+.+++.|+++||+|||++|++||||||+|||+++++.++|+|||+++........
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~ 268 (374)
T cd05106 189 SSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNY 268 (374)
T ss_pred ccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcce
Confidence 24677889999999999999999999999999999999999999999999999765433221
Q ss_pred c---cCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhccccccccc
Q 020085 265 T---AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIH 326 (331)
Q Consensus 265 ~---~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p 326 (331)
. ...+++.|+|||++.+..++.++|||||||++|||++ |+.||+.....+...+++..+.++
T Consensus 269 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~ 334 (374)
T cd05106 269 VVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQM 334 (374)
T ss_pred eeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCc
Confidence 1 1234568999999998899999999999999999997 999998876655555555555444
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=304.22 Aligned_cols=203 Identities=23% Similarity=0.425 Sum_probs=177.9
Q ss_pred eeecCceEEEEEEE--CCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEeccCCCCH
Q 020085 118 VASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI 194 (331)
Q Consensus 118 lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~~~ggsL 194 (331)
||+|+||.||++++ .++.||+|+++... ........+.+|+.++++++||||+++++++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 69999999999998 46789999987532 2334456788999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC-CccccCCCCccc
Q 020085 195 YDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTAETGTYRW 273 (331)
Q Consensus 195 ~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~-~~~~~~~gt~~y 273 (331)
.+++.. .+.+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||+++..... .......||+.|
T Consensus 81 ~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y 159 (312)
T cd05585 81 FHHLQR-EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEY 159 (312)
T ss_pred HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCccc
Confidence 999965 567899999999999999999999999999999999999999999999999999754332 223345689999
Q ss_pred ccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 274 MAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 274 ~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+.+
T Consensus 160 ~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~ 207 (312)
T cd05585 160 LAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQ 207 (312)
T ss_pred CCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHc
Confidence 999999999999999999999999999999999998887776666443
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=299.81 Aligned_cols=203 Identities=26% Similarity=0.468 Sum_probs=175.9
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~ 186 (331)
.++|++.++||+|+||.||+|+. +++.||+|+++..... .....+.+|+.+++.++||||+++++++..+...++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEE-GTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVF 82 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEecccccc-ccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEE
Confidence 46899999999999999999998 5788999999754322 22345778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC-Cccc
Q 020085 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMT 265 (331)
Q Consensus 187 E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~-~~~~ 265 (331)
||+. ++|.+++....+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++..... ....
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 161 (303)
T cd07869 83 EYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYS 161 (303)
T ss_pred ECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCC
Confidence 9996 5898888776678999999999999999999999999999999999999999999999999998754322 2234
Q ss_pred cCCCCcccccchhcCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH
Q 020085 266 AETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPL 313 (331)
Q Consensus 266 ~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~ 313 (331)
...+++.|+|||++.+ ..++.++|+||+||++|+|++|+.||.+....
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 210 (303)
T cd07869 162 NEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDI 210 (303)
T ss_pred CCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccH
Confidence 4568999999999865 45889999999999999999999999886543
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=310.64 Aligned_cols=224 Identities=29% Similarity=0.563 Sum_probs=188.9
Q ss_pred CeeeecccCcceeeeeeecCceEEEEEEE-------CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCcceeEEe
Q 020085 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIG 174 (331)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~ 174 (331)
..|.++.++|++.++||+|+||+||+|++ .+..||+|+++.... ....+.+.+|+.+++.+ +||||+++++
T Consensus 28 ~~~~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~~Ei~il~~l~~HpnIv~l~~ 106 (375)
T cd05104 28 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAH-LTEREALMSELKVLSYLGNHINIVNLLG 106 (375)
T ss_pred cccccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcC-cHHHHHHHHHHHHHHHhcCCcceeeeee
Confidence 45888899999999999999999999974 235799999986542 33456789999999999 8999999999
Q ss_pred EEECCCCeEEEEeccCCCCHHHHHHhcC----------------------------------------------------
Q 020085 175 ACTRPPNLCIVTEFMARGSIYDFLHKQK---------------------------------------------------- 202 (331)
Q Consensus 175 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------------------------------------------------- 202 (331)
+|......++||||+++|+|.+++....
T Consensus 107 ~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 186 (375)
T cd05104 107 ACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKR 186 (375)
T ss_pred eeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccc
Confidence 9999999999999999999999986532
Q ss_pred ----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecC
Q 020085 203 ----------------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (331)
Q Consensus 203 ----------------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~ 260 (331)
..+++..+..++.||++||.|||++|++||||||+|||++.++.+||+|||+++....
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 187 RSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRN 266 (375)
T ss_pred cccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccC
Confidence 1467788899999999999999999999999999999999999999999999976543
Q ss_pred CCccc---cCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhcccccccccc
Q 020085 261 SGVMT---AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIHS 327 (331)
Q Consensus 261 ~~~~~---~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p~ 327 (331)
..... ...++..|+|||.+.+..++.++||||||+++|||++ |..||..........+.+..+.++.
T Consensus 267 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~ 337 (375)
T cd05104 267 DSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRML 337 (375)
T ss_pred cccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCC
Confidence 32211 2234568999999999999999999999999999998 8999998776665666666665543
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-40 Score=303.22 Aligned_cols=210 Identities=25% Similarity=0.435 Sum_probs=181.1
Q ss_pred CcceeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-CHHHHHHHHHHHHHHHhc-CCCcceeEEeEEECCCCeEEEE
Q 020085 111 QLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~lV~ 186 (331)
+|.+.+.||+|+||.||++... ++.||+|+++.... .....+.+..|..+++.+ +|++|+++++++...+.+++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 5889999999999999999884 57899999985432 223345677788888877 4799999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC-Cccc
Q 020085 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMT 265 (331)
Q Consensus 187 E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~-~~~~ 265 (331)
||+++|+|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+|||+++++.+||+|||+++..... ....
T Consensus 81 E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~ 159 (323)
T cd05616 81 EYVNGGDLMYQIQQ-VGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTK 159 (323)
T ss_pred cCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCccc
Confidence 99999999999865 467899999999999999999999999999999999999999999999999999754322 2233
Q ss_pred cCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 266 ~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
...||+.|+|||++.+..++.++|+|||||++|||++|+.||.+.++.+....+..
T Consensus 160 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~ 215 (323)
T cd05616 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 215 (323)
T ss_pred cCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 45789999999999999999999999999999999999999999888776666543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=302.70 Aligned_cols=209 Identities=24% Similarity=0.437 Sum_probs=180.7
Q ss_pred CcceeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCC-CcceeEEeEEECCCCeEEEE
Q 020085 111 QLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRH-KNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l~h-~niv~~~~~~~~~~~~~lV~ 186 (331)
+|++.+.||+|+||.||+|.+. ++.||+|+++.... .....+.+..|..+++.++| ++|+++++++...+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 5889999999999999999884 56899999975432 23345678889999999976 56888999999989999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeec-CCCccc
Q 020085 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA-QSGVMT 265 (331)
Q Consensus 187 E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~-~~~~~~ 265 (331)
||+++|+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||+++... ......
T Consensus 81 E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~ 159 (324)
T cd05587 81 EYVNGGDLMYHIQQ-VGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR 159 (324)
T ss_pred cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCcee
Confidence 99999999999865 4678999999999999999999999999999999999999999999999999987432 222233
Q ss_pred cCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccc
Q 020085 266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 266 ~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~ 320 (331)
...||+.|+|||++.+..++.++|+||+||++|||++|+.||.+.+..+....+.
T Consensus 160 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~ 214 (324)
T cd05587 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM 214 (324)
T ss_pred eecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 4568999999999999999999999999999999999999999888777666644
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=297.12 Aligned_cols=211 Identities=26% Similarity=0.475 Sum_probs=179.0
Q ss_pred cCcceeeeeeecCceEEEEEEE---CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc---CCCcceeEEeEEE-----C
Q 020085 110 KQLKIECKVASGSYGDLYKGTY---CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI---RHKNVVQFIGACT-----R 178 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l---~h~niv~~~~~~~-----~ 178 (331)
++|++.+.||+|+||+||+|.+ .++.||+|+++...........+.+|+.+++.+ +||||++++++|. .
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 3789999999999999999987 357799999876543333344566787777766 6999999999885 2
Q ss_pred CCCeEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceee
Q 020085 179 PPNLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV 257 (331)
Q Consensus 179 ~~~~~lV~E~~~ggsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~ 257 (331)
...+++||||+.+ +|.+++... ...+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||+++.
T Consensus 81 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~ 159 (290)
T cd07862 81 ETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 159 (290)
T ss_pred CCcEEEEEccCCC-CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEe
Confidence 4568999999975 999998654 34589999999999999999999999999999999999999999999999999987
Q ss_pred ecCCCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 258 QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 258 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
...........|++.|+|||.+.+..++.++|||||||++|||++|++||.+.+..+....++.
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~ 223 (290)
T cd07862 160 YSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD 223 (290)
T ss_pred ccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHH
Confidence 6554444456789999999999988999999999999999999999999999888777666553
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=304.71 Aligned_cols=203 Identities=24% Similarity=0.469 Sum_probs=177.5
Q ss_pred eeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEeccCCC
Q 020085 116 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARG 192 (331)
Q Consensus 116 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~~~gg 192 (331)
+.||+|+||.||++.. .++.||+|+++.... .......+.+|+.+++.++||||+++++++.....+|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999987 578999999975432 2344567889999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecC-CCccccCCCCc
Q 020085 193 SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAETGTY 271 (331)
Q Consensus 193 sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~-~~~~~~~~gt~ 271 (331)
+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.... ........||+
T Consensus 81 ~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~ 159 (328)
T cd05593 81 ELFFHLSR-ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTP 159 (328)
T ss_pred CHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCc
Confidence 99998865 46789999999999999999999999999999999999999999999999999875332 22233456899
Q ss_pred ccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcc
Q 020085 272 RWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGV 319 (331)
Q Consensus 272 ~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~ 319 (331)
.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+
T Consensus 160 ~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~ 207 (328)
T cd05593 160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 207 (328)
T ss_pred CccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHh
Confidence 999999999999999999999999999999999999888776655543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=332.37 Aligned_cols=221 Identities=34% Similarity=0.635 Sum_probs=193.1
Q ss_pred eeecccCcceeeeeeecCceEEEEEEECC---c----eEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEE
Q 020085 105 WEIDAKQLKIECKVASGSYGDLYKGTYCS---Q----EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177 (331)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~---~----~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 177 (331)
-+++.+...+.+.||+|.||.||.|++.+ . .||||.++... +.....+|.+|..+|+.++|||||+++|+|-
T Consensus 687 p~v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~-~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l 765 (1025)
T KOG1095|consen 687 PEVPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLS-SEQEVSDFLKEALLMSKFDHPNIVSLIGVCL 765 (1025)
T ss_pred ccCChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCcceeeEEEeec
Confidence 34678899999999999999999999843 2 38999988654 5667889999999999999999999999999
Q ss_pred CCCCeEEEEeccCCCCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEee
Q 020085 178 RPPNLCIVTEFMARGSIYDFLHKQ------KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 251 (331)
Q Consensus 178 ~~~~~~lV~E~~~ggsL~~~l~~~------~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~D 251 (331)
+....+|++|||+||+|..+|++. ...++...++.++.|||+|+.||+++++|||||.++|+|+++...+||+|
T Consensus 766 ~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaD 845 (1025)
T KOG1095|consen 766 DSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIAD 845 (1025)
T ss_pred CCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcc
Confidence 999999999999999999999887 56789999999999999999999999999999999999999999999999
Q ss_pred ecceeeecCCCccc--cC-CCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhcccccccccc
Q 020085 252 FGVARVQAQSGVMT--AE-TGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIHS 327 (331)
Q Consensus 252 Fg~a~~~~~~~~~~--~~-~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p~ 327 (331)
||+|+-........ .+ .-..+|||||.+....++.|+||||||+++||+++ |..||++.++.+...-+++.| |-+
T Consensus 846 FGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-RL~ 924 (1025)
T KOG1095|consen 846 FGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-RLD 924 (1025)
T ss_pred cchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-ccC
Confidence 99998433332211 11 12369999999999999999999999999999999 999999999999888766555 543
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=304.04 Aligned_cols=214 Identities=29% Similarity=0.487 Sum_probs=180.5
Q ss_pred cccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCH------------HHHHHHHHHHHHHHhcCCCcceeEE
Q 020085 108 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNT------------EMLKEFSQEVYIMRKIRHKNVVQFI 173 (331)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~------------~~~~~~~~E~~il~~l~h~niv~~~ 173 (331)
-.++|++.+.||+|.||.|.+|+. .++.||||++....... .-.+...+|+.+|++++|||||+++
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 356899999999999999999988 67899999997443211 1135789999999999999999999
Q ss_pred eEEECC--CCeEEEEeccCCCCHHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEe
Q 020085 174 GACTRP--PNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250 (331)
Q Consensus 174 ~~~~~~--~~~~lV~E~~~ggsL~~~l~~~~~~-~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~ 250 (331)
.+..+. +.+|||+|||..|.+...= .... +.+.+++.+++++..||+|||.+|||||||||+|+|++++|++||+
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p--~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~VKIs 252 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCP--PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTVKIS 252 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCC--CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcEEee
Confidence 988764 5799999999998876542 2233 8999999999999999999999999999999999999999999999
Q ss_pred eecceeeecCCC------ccccCCCCcccccchhcCCC---CC-CChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccc
Q 020085 251 DFGVARVQAQSG------VMTAETGTYRWMAPEVIEHK---PY-DYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 251 DFg~a~~~~~~~------~~~~~~gt~~y~aPE~~~~~---~~-~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~ 320 (331)
|||.+....++. ......|||-|+|||...+. .+ +.+.||||+|++||.|+.|+.||-+...++...+|+
T Consensus 253 DFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIv 332 (576)
T KOG0585|consen 253 DFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIV 332 (576)
T ss_pred ccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHh
Confidence 999998664332 22345799999999998652 23 578899999999999999999999999999888887
Q ss_pred ccc
Q 020085 321 QKV 323 (331)
Q Consensus 321 ~~~ 323 (331)
..-
T Consensus 333 n~p 335 (576)
T KOG0585|consen 333 NDP 335 (576)
T ss_pred cCc
Confidence 543
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-42 Score=309.32 Aligned_cols=208 Identities=33% Similarity=0.554 Sum_probs=186.0
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~ 186 (331)
...|...+.||+|+||.||+|.+ .++.||+|++..+. ..+..+++.+|+.+|.+++++||.++++.+..+..++++|
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~-~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiM 90 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE-AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIM 90 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhh-cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHH
Confidence 34677779999999999999998 57899999998765 3445788999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCc-cc
Q 020085 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV-MT 265 (331)
Q Consensus 187 E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~-~~ 265 (331)
||+.||++.+.+.. .+.+.+..+..++++++.|+.|||..+.+|||||++|||+..+|.+||+|||++-....... ..
T Consensus 91 ey~~gGsv~~lL~~-~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~ 169 (467)
T KOG0201|consen 91 EYCGGGSVLDLLKS-GNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRK 169 (467)
T ss_pred HHhcCcchhhhhcc-CCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhccc
Confidence 99999999999954 45558888899999999999999999999999999999999999999999999976554432 35
Q ss_pred cCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhc
Q 020085 266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVG 318 (331)
Q Consensus 266 ~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~ 318 (331)
...|||.|||||++.+..|+.++||||||++.+||++|.+||.++.|+.+..-
T Consensus 170 tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlfl 222 (467)
T KOG0201|consen 170 TFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFL 222 (467)
T ss_pred cccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEe
Confidence 67899999999999999999999999999999999999999999999665554
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=296.41 Aligned_cols=208 Identities=26% Similarity=0.409 Sum_probs=180.4
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEe
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E 187 (331)
++|++.+.||+|+||.||++++ .++.||+|+++.........+.+.+|+.++++++||||+++++++..++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 3689999999999999999998 46789999998665444556778899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC--ccc
Q 020085 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG--VMT 265 (331)
Q Consensus 188 ~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~--~~~ 265 (331)
|++++.+..+. .....+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 159 (287)
T cd07848 81 YVEKNMLELLE-EMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYT 159 (287)
T ss_pred cCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccccc
Confidence 99987665544 445678999999999999999999999999999999999999999999999999997654322 223
Q ss_pred cCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhc
Q 020085 266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVG 318 (331)
Q Consensus 266 ~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~ 318 (331)
...|++.|+|||++.+..++.++|+|||||++|||++|++||++.+..+....
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~ 212 (287)
T cd07848 160 EYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFT 212 (287)
T ss_pred ccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 34689999999999998999999999999999999999999998776554433
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-41 Score=310.15 Aligned_cols=219 Identities=25% Similarity=0.450 Sum_probs=199.5
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCC-eEEE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN-LCIV 185 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~-~~lV 185 (331)
.++|..++++|+|+||.++..+. .++.+++|.+.....+....+...+|+.++++++|||||.+.+.|..++. +|||
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 35799999999999999987665 56789999999888777777889999999999999999999999998888 9999
Q ss_pred EeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC-c
Q 020085 186 TEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-V 263 (331)
Q Consensus 186 ~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~-~ 263 (331)
|+|++||++.+.+.+++ ..++++.+..++.|++.|+.|||+++|.|||||+.||+++.++.|+|.|||+|+...... .
T Consensus 83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~ 162 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSL 162 (426)
T ss_pred EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchhh
Confidence 99999999999998877 678999999999999999999999999999999999999999999999999999877665 5
Q ss_pred cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccccccccc
Q 020085 264 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIHSI 328 (331)
Q Consensus 264 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~p~~ 328 (331)
.....||+.||+||.+.+.+|..|+|||||||++|||++-+++|...+....+.++.+ +..+++
T Consensus 163 a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~-~~~~Pl 226 (426)
T KOG0589|consen 163 ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINR-GLYSPL 226 (426)
T ss_pred hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhh-ccCCCC
Confidence 5567899999999999999999999999999999999999999999999998888775 434433
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=302.93 Aligned_cols=204 Identities=27% Similarity=0.474 Sum_probs=176.5
Q ss_pred eeeeecCceEEEEEEE-----CCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEec
Q 020085 116 CKVASGSYGDLYKGTY-----CSQEVAIKVLKPECV--NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF 188 (331)
Q Consensus 116 ~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~ 188 (331)
+.||+|+||.||+++. .++.||+|+++.... +......+.+|+.++++++||||+++++++..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6799999999999875 467899999975321 223345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC-ccccC
Q 020085 189 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAE 267 (331)
Q Consensus 189 ~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~-~~~~~ 267 (331)
+++++|.+++.. .+.+.+..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++...... .....
T Consensus 82 ~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 160 (323)
T cd05584 82 LSGGELFMHLER-EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTF 160 (323)
T ss_pred CCCchHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCccccc
Confidence 999999999965 5678889999999999999999999999999999999999999999999999987543322 22345
Q ss_pred CCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccc
Q 020085 268 TGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 268 ~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~ 320 (331)
.|++.|+|||++.+..++.++||||||+++|||++|+.||...+..+....+.
T Consensus 161 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~ 213 (323)
T cd05584 161 CGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKIL 213 (323)
T ss_pred CCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 68999999999999889999999999999999999999999988776655543
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-40 Score=302.01 Aligned_cols=207 Identities=29% Similarity=0.497 Sum_probs=177.5
Q ss_pred cceeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHH---HhcCCCcceeEEeEEECCCCeEEE
Q 020085 112 LKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIM---RKIRHKNVVQFIGACTRPPNLCIV 185 (331)
Q Consensus 112 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~il---~~l~h~niv~~~~~~~~~~~~~lV 185 (331)
|++.+.||+|+||.||++.+ .++.||||+++.... .....+.+.+|+.++ +.++||||+++++++......|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 67899999999999999987 568999999975421 223345677776665 456799999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC-Ccc
Q 020085 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVM 264 (331)
Q Consensus 186 ~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~-~~~ 264 (331)
|||+++++|..++. .+.+++..+..++.|++.||.|||++|++||||||+||++++++.+||+|||+++..... ...
T Consensus 81 ~E~~~~~~L~~~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~ 158 (324)
T cd05589 81 MEYAAGGDLMMHIH--TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT 158 (324)
T ss_pred EcCCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCcc
Confidence 99999999998885 357899999999999999999999999999999999999999999999999998753322 223
Q ss_pred ccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccc
Q 020085 265 TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 265 ~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~ 320 (331)
....|++.|+|||.+.+..++.++|+|||||++|||++|+.||.+.+..+....+.
T Consensus 159 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~ 214 (324)
T cd05589 159 STFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIV 214 (324)
T ss_pred cccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 34568999999999999999999999999999999999999999988777666544
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-40 Score=294.94 Aligned_cols=220 Identities=25% Similarity=0.380 Sum_probs=193.3
Q ss_pred CeeeecccCcceeeeeeecCceEEEEEEECC--ceEEEEEecCCCCC-HHHHHHHHHHHHHHHhcCCCcceeEEeEEECC
Q 020085 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP 179 (331)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~--~~vavK~~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 179 (331)
....+..++|++.+.||+|.-|+||++...+ ..+|+|++..+... .+...+...|.+||+.++||.++.++..|+.+
T Consensus 70 ~~~~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~ 149 (459)
T KOG0610|consen 70 KDGSLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETD 149 (459)
T ss_pred CCCccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecc
Confidence 3456778899999999999999999999866 78999999766443 45567788899999999999999999999999
Q ss_pred CCeEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeee
Q 020085 180 PNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (331)
Q Consensus 180 ~~~~lV~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~ 258 (331)
...|++||||+||+|+.+.+++. +.|+++.++.++.+++-||+|||-.|||+|||||+||||.++|+|.|+||.++...
T Consensus 150 ~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 150 KYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred ceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccC
Confidence 99999999999999999998875 57999999999999999999999999999999999999999999999999987321
Q ss_pred cC---------------------------------CCc------------------------cccCCCCcccccchhcCC
Q 020085 259 AQ---------------------------------SGV------------------------MTAETGTYRWMAPEVIEH 281 (331)
Q Consensus 259 ~~---------------------------------~~~------------------------~~~~~gt~~y~aPE~~~~ 281 (331)
.. ... ....+||-.|.|||++.+
T Consensus 230 ~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G 309 (459)
T KOG0610|consen 230 PVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRG 309 (459)
T ss_pred CCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeec
Confidence 00 000 011248889999999999
Q ss_pred CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccc
Q 020085 282 KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK 322 (331)
Q Consensus 282 ~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~ 322 (331)
...+.+.|.|+|||++|||+.|+.||.+.+..+....|+.+
T Consensus 310 ~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~ 350 (459)
T KOG0610|consen 310 EGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQ 350 (459)
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcC
Confidence 99999999999999999999999999999999999998843
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=300.54 Aligned_cols=202 Identities=25% Similarity=0.417 Sum_probs=172.3
Q ss_pred CcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCC-----CeE
Q 020085 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP-----NLC 183 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~-----~~~ 183 (331)
+|++.++||+|+||.||+|.. .++.||||+++...........+.+|+.++++++||||+++++++.... .+|
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 588999999999999999987 5789999998754333344567889999999999999999999885432 479
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC-
Q 020085 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG- 262 (331)
Q Consensus 184 lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~- 262 (331)
+||||+. ++|.+++.. ...+++..+..++.||++||.|||++|++||||||+|||++.++.+||+|||+++......
T Consensus 81 lv~e~~~-~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 158 (338)
T cd07859 81 VVFELME-SDLHQVIKA-NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP 158 (338)
T ss_pred EEEecCC-CCHHHHHHh-cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence 9999996 599998865 4578999999999999999999999999999999999999999999999999997543221
Q ss_pred ---ccccCCCCcccccchhcCC--CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHH
Q 020085 263 ---VMTAETGTYRWMAPEVIEH--KPYDYKADVFSFGIALWELLTGELPYAGLTPLQ 314 (331)
Q Consensus 263 ---~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~ 314 (331)
......|++.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+...
T Consensus 159 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~ 215 (338)
T cd07859 159 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH 215 (338)
T ss_pred ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHH
Confidence 1133468999999999865 678999999999999999999999998876544
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=303.62 Aligned_cols=209 Identities=25% Similarity=0.385 Sum_probs=180.3
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCC------
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP------ 180 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~------ 180 (331)
.++|++.+.||+|+||.||++.+ .++.||+|+++....+......+.+|+.+++.++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 99 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ 99 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence 46899999999999999999987 5789999999866545555677889999999999999999999886543
Q ss_pred CeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecC
Q 020085 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (331)
Q Consensus 181 ~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~ 260 (331)
..|+||||+.+ +|.+.+. ..++...+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 100 ~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 175 (359)
T cd07876 100 DVYLVMELMDA-NLCQVIH---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT 175 (359)
T ss_pred eeEEEEeCCCc-CHHHHHh---ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence 47999999976 6777663 3478889999999999999999999999999999999999999999999999976554
Q ss_pred CCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 261 SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 261 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
........+|+.|+|||.+.+..++.++|||||||++|+|++|+.||.+.+.......+.+
T Consensus 176 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~ 236 (359)
T cd07876 176 NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIE 236 (359)
T ss_pred CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 4444556789999999999999999999999999999999999999998876655444433
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=300.76 Aligned_cols=205 Identities=23% Similarity=0.385 Sum_probs=177.5
Q ss_pred eeeeecCceEEEEEEEC--CceEEEEEecCCCC-CHHHHHHHHHHHHHHHhc-CCCcceeEEeEEECCCCeEEEEeccCC
Q 020085 116 CKVASGSYGDLYKGTYC--SQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMAR 191 (331)
Q Consensus 116 ~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~lV~E~~~g 191 (331)
+.||+|+||.||+|+.. ++.||+|+++.... ..+..+.+..|..+++.+ +||||+++++++.....+|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999884 57899999975432 233456678899999876 799999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC-CccccCCCC
Q 020085 192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTAETGT 270 (331)
Q Consensus 192 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~-~~~~~~~gt 270 (331)
|+|.+++.. ...+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||+++..... .......||
T Consensus 81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt 159 (321)
T cd05591 81 GDLMFQIQR-SRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGT 159 (321)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccC
Confidence 999999865 467899999999999999999999999999999999999999999999999998754322 223345689
Q ss_pred cccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 271 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 271 ~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
+.|+|||++.+..++.++|+|||||++|||++|+.||...++.+....+..
T Consensus 160 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~ 210 (321)
T cd05591 160 PDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILH 210 (321)
T ss_pred ccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 999999999999999999999999999999999999999888777666543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=300.42 Aligned_cols=204 Identities=25% Similarity=0.419 Sum_probs=177.1
Q ss_pred eeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhc-CCCcceeEEeEEECCCCeEEEEeccCC
Q 020085 116 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMAR 191 (331)
Q Consensus 116 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~lV~E~~~g 191 (331)
+.||+|+||.||++.. .++.||+|+++.... .....+.+..|..+++.+ +||||+++++++.....+|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999987 467899999975422 233456778888888876 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecC-CCccccCCCC
Q 020085 192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAETGT 270 (331)
Q Consensus 192 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~-~~~~~~~~gt 270 (331)
|+|.+++.. ...+++..+..++.|++.||+|||++|++||||||+|||++.++.++|+|||+++.... ........||
T Consensus 81 g~L~~~i~~-~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt 159 (320)
T cd05590 81 GDLMFHIQK-SRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGT 159 (320)
T ss_pred chHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccC
Confidence 999999865 46789999999999999999999999999999999999999999999999999875432 2233445789
Q ss_pred cccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccc
Q 020085 271 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 271 ~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~ 320 (331)
+.|+|||++.+..++.++|+|||||++|+|++|+.||...+..+....+.
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~ 209 (320)
T cd05590 160 PDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL 209 (320)
T ss_pred ccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHh
Confidence 99999999999999999999999999999999999999988877666644
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=282.49 Aligned_cols=213 Identities=24% Similarity=0.435 Sum_probs=190.9
Q ss_pred cccCcceeeeeeecCceEEEEEEEC--CceEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEE
Q 020085 108 DAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI 184 (331)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~l 184 (331)
..++|++++.||+|-||.||.|+.. +-.||+|++.... ........+.+|++|-..++||||++++++|.++...|+
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 3568999999999999999999984 4679999986432 223345678999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCc
Q 020085 185 VTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV 263 (331)
Q Consensus 185 V~E~~~ggsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~ 263 (331)
++||..+|+++..|..+ ...+++.....+..|++.|+.|+|.++||||||||+|+|++.+|.+|++|||-+...+ .+.
T Consensus 100 ilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-~~k 178 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SNK 178 (281)
T ss_pred EEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC-CCC
Confidence 99999999999999754 3569999999999999999999999999999999999999999999999999997665 556
Q ss_pred cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 264 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 264 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
..+-|||..|.+||..++..++...|+|++|++.||++.|.+||...+..+.+.++.+
T Consensus 179 R~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k 236 (281)
T KOG0580|consen 179 RKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRK 236 (281)
T ss_pred ceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHH
Confidence 6778999999999999999999999999999999999999999999988777777553
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=299.26 Aligned_cols=203 Identities=26% Similarity=0.465 Sum_probs=173.8
Q ss_pred eeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhc-CCCcceeEEeEEECCCCeEEEEeccCC
Q 020085 116 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMAR 191 (331)
Q Consensus 116 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~lV~E~~~g 191 (331)
+.||+|+||.||+|++ +++.||+|+++.... .....+.+..|..++... +||||+++++++.....+++||||++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999988 457899999985432 223345566677777654 799999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC-CccccCCCC
Q 020085 192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTAETGT 270 (331)
Q Consensus 192 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~-~~~~~~~gt 270 (331)
|+|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++..... .......||
T Consensus 81 g~L~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt 159 (316)
T cd05592 81 GDLMFHIQS-SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGT 159 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCC
Confidence 999999865 467899999999999999999999999999999999999999999999999999754322 223345789
Q ss_pred cccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcc
Q 020085 271 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGV 319 (331)
Q Consensus 271 ~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~ 319 (331)
+.|+|||.+.+..++.++|+|||||++|||++|+.||.+.+..+....+
T Consensus 160 ~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i 208 (316)
T cd05592 160 PDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSI 208 (316)
T ss_pred ccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 9999999999999999999999999999999999999998877666554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-39 Score=294.48 Aligned_cols=211 Identities=33% Similarity=0.611 Sum_probs=178.4
Q ss_pred ecccCcceeeeeeecCceEEEEEEEC------------------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCc
Q 020085 107 IDAKQLKIECKVASGSYGDLYKGTYC------------------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN 168 (331)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~~------------------~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~n 168 (331)
+..++|.+.++||+|+||.||++.+. +..||+|+++... .......+.+|+.++++++|||
T Consensus 2 ~~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~n 80 (304)
T cd05096 2 FPRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA-NKNARNDFLKEVKILSRLKDPN 80 (304)
T ss_pred CchhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC-CHHHHHHHHHHHHHHhhcCCCC
Confidence 35678999999999999999999752 2369999998653 3445678999999999999999
Q ss_pred ceeEEeEEECCCCeEEEEeccCCCCHHHHHHhcC------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 020085 169 VVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK------------------GVFQLTSLLKVAIDVSKGMNYLHQNNII 230 (331)
Q Consensus 169 iv~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~------------------~~~~~~~~~~i~~qi~~~l~~LH~~~ii 230 (331)
|+++++++......++||||+++|+|.+++.... ..+++..+..++.||+.||.|||+.|++
T Consensus 81 iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~iv 160 (304)
T cd05096 81 IIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFV 160 (304)
T ss_pred eeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 9999999999999999999999999999986532 2357788899999999999999999999
Q ss_pred cCCCCCCCEEEcCCCcEEEeeecceeeecCCCc---cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc--CCC
Q 020085 231 HRDLKTANLLMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT--GEL 305 (331)
Q Consensus 231 HrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~--g~~ 305 (331)
||||||+|||++.++.+||+|||+++....... .....++..|+|||.+.+..++.++||||||+++|||++ +..
T Consensus 161 H~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~ 240 (304)
T cd05096 161 HRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQ 240 (304)
T ss_pred ccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCC
Confidence 999999999999999999999999975433221 122345788999999988889999999999999999986 678
Q ss_pred CCCCCCHHHHHhc
Q 020085 306 PYAGLTPLQAAVG 318 (331)
Q Consensus 306 Pf~~~~~~~~~~~ 318 (331)
||...++.+....
T Consensus 241 p~~~~~~~~~~~~ 253 (304)
T cd05096 241 PYGELTDEQVIEN 253 (304)
T ss_pred CCCcCCHHHHHHH
Confidence 9988776655443
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=297.70 Aligned_cols=206 Identities=26% Similarity=0.428 Sum_probs=182.5
Q ss_pred ecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEE
Q 020085 107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI 184 (331)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~l 184 (331)
+..++|++.+.||+|+||.||++++ .+..+|+|+++... .......+.+|++++++++||||+++++++..++..++
T Consensus 2 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (331)
T cd06649 2 LKDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (331)
T ss_pred CCcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 5578999999999999999999998 46789999998653 34556789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCc
Q 020085 185 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV 263 (331)
Q Consensus 185 V~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~ 263 (331)
||||+++++|.+++.. ...+++..+..++.|++.||.|||++ +++||||||+||+++.++.++|+|||+++..... .
T Consensus 81 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~ 158 (331)
T cd06649 81 CMEHMDGGSLDQVLKE-AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-M 158 (331)
T ss_pred EeecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc-c
Confidence 9999999999999965 45689999999999999999999986 6999999999999999999999999998755432 2
Q ss_pred cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 020085 264 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQA 315 (331)
Q Consensus 264 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~ 315 (331)
.....|++.|+|||++.+..++.++|+|||||++|||++|+.||......+.
T Consensus 159 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~ 210 (331)
T cd06649 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKEL 210 (331)
T ss_pred cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 3345689999999999999999999999999999999999999987665443
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=286.63 Aligned_cols=216 Identities=33% Similarity=0.615 Sum_probs=185.8
Q ss_pred ecccCcceeeeeeecCceEEEEEEECC-ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEE
Q 020085 107 IDAKQLKIECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV 185 (331)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV 185 (331)
++.++|++.+.||+|+||.||++.+.. ..+|+|.++..... ...+.+|+.++++++||||+++++++......++|
T Consensus 1 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 77 (256)
T cd05114 1 INPSELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS---EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIV 77 (256)
T ss_pred CCHHHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc---HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEE
Confidence 356789999999999999999998854 58999998755333 35788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCcc-
Q 020085 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM- 264 (331)
Q Consensus 186 ~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~- 264 (331)
|||+++|+|.+++....+.+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||.++........
T Consensus 78 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 78 TEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred EEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 9999999999999766667899999999999999999999999999999999999999999999999998754332221
Q ss_pred -ccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhccccccccc
Q 020085 265 -TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIH 326 (331)
Q Consensus 265 -~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p 326 (331)
....++..|+|||.+.+..++.++|+||||+++|||++ |+.||...+..+....+. ++.++
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~-~~~~~ 220 (256)
T cd05114 158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMIS-RGFRL 220 (256)
T ss_pred cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH-CCCCC
Confidence 12234568999999998899999999999999999999 999999988887777644 34443
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=302.34 Aligned_cols=202 Identities=24% Similarity=0.460 Sum_probs=175.8
Q ss_pred eeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEeccCCC
Q 020085 116 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARG 192 (331)
Q Consensus 116 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~~~gg 192 (331)
+.||+|+||.||++.. .++.||+|+++.... .......+.+|+.+++.++||||+++++++.....+|+||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999987 578999999975432 2334567788999999999999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEEcCCCcEEEeeecceeeecC-CCccccCCCC
Q 020085 193 SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAETGT 270 (331)
Q Consensus 193 sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~-~~~~~~~~gt 270 (331)
+|.+++.. ...+++..+..++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+++.... ........||
T Consensus 81 ~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt 159 (325)
T cd05594 81 ELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGT 159 (325)
T ss_pred cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCC
Confidence 99998865 4578999999999999999999997 7999999999999999999999999999875432 2223345699
Q ss_pred cccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhc
Q 020085 271 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVG 318 (331)
Q Consensus 271 ~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~ 318 (331)
+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~ 207 (325)
T cd05594 160 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFEL 207 (325)
T ss_pred cccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHH
Confidence 999999999999999999999999999999999999988776655444
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-40 Score=310.24 Aligned_cols=210 Identities=29% Similarity=0.465 Sum_probs=187.1
Q ss_pred CcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-C-----CcceeEEeEEECCCCe
Q 020085 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-H-----KNVVQFIGACTRPPNL 182 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~-h-----~niv~~~~~~~~~~~~ 182 (331)
+|.+.+.||+|+||.|.+|.+ +++.||||+++.. ....++...|+.+|..++ | -|+|+++++|...+++
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~---k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hl 263 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK---KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHL 263 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC---hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccce
Confidence 789999999999999999998 5789999999964 556677888999999997 4 4899999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC--cEEEeeecceeeec
Q 020085 183 CIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG--VVKVADFGVARVQA 259 (331)
Q Consensus 183 ~lV~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~--~vkl~DFg~a~~~~ 259 (331)
|||+|.+.- +|++++..++ ..++...++.++.||+.||.+||+.||||+||||+|||+.+-+ .|||+|||++....
T Consensus 264 ciVfELL~~-NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~ 342 (586)
T KOG0667|consen 264 CIVFELLST-NLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFES 342 (586)
T ss_pred eeeehhhhh-hHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccC
Confidence 999999966 9999997754 5699999999999999999999999999999999999997644 69999999998776
Q ss_pred CCCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccccccc
Q 020085 260 QSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIH 326 (331)
Q Consensus 260 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~p 326 (331)
+.-. ....+..|.|||++.+.+|+.+.|+||||||+.||++|.+.|++.+..+....|++--..|
T Consensus 343 q~vy--tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~P 407 (586)
T KOG0667|consen 343 QRVY--TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLP 407 (586)
T ss_pred Ccce--eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCC
Confidence 6433 6788999999999999999999999999999999999999999999888887777643333
|
|
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=298.39 Aligned_cols=210 Identities=25% Similarity=0.456 Sum_probs=180.4
Q ss_pred CcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcC-CCcceeEEeEEECCCCeEEEE
Q 020085 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~~~~lV~ 186 (331)
+|.+.+.||+|+||+||++.. +++.||+|+++.... .....+.+..|..+++.+. |++|+++++++...+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 467889999999999999987 578899999975422 2334566888999998886 578888999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC-ccc
Q 020085 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMT 265 (331)
Q Consensus 187 E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~-~~~ 265 (331)
||++||+|.+++.. .+.+++..+..++.|++.||+|||++|++||||||+|||++.++.++|+|||+++...... ...
T Consensus 81 Ey~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~ 159 (323)
T cd05615 81 EYVNGGDLMYHIQQ-VGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTR 159 (323)
T ss_pred cCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCcccc
Confidence 99999999999865 4679999999999999999999999999999999999999999999999999987543222 223
Q ss_pred cCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 266 ~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
...||+.|+|||++.+..++.++|+||+||++|||++|+.||.+.++.+....+.+
T Consensus 160 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~ 215 (323)
T cd05615 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIME 215 (323)
T ss_pred CccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 44689999999999999999999999999999999999999999888776666543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=303.30 Aligned_cols=204 Identities=27% Similarity=0.450 Sum_probs=178.5
Q ss_pred eeeeecCceEEEEEEE-----CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEeccC
Q 020085 116 CKVASGSYGDLYKGTY-----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMA 190 (331)
Q Consensus 116 ~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~~~ 190 (331)
+.||+|+||.||++.. .++.||+|+++...........+.+|+.++++++||||+++++++..+..+|+||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999998865 46889999998643333344567889999999999999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC-CccccCCC
Q 020085 191 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTAETG 269 (331)
Q Consensus 191 ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~-~~~~~~~g 269 (331)
+|+|.+++.+ ...+++..+..++.||++||+|||++|++||||||+||+++.++.++|+|||+++..... .......|
T Consensus 82 ~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g 160 (318)
T cd05582 82 GGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCG 160 (318)
T ss_pred CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecccC
Confidence 9999999965 467899999999999999999999999999999999999999999999999998765433 22334568
Q ss_pred CcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccc
Q 020085 270 TYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 270 t~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~ 320 (331)
++.|+|||.+.+..++.++|||||||++|||++|+.||...++.+....+.
T Consensus 161 ~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~ 211 (318)
T cd05582 161 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMIL 211 (318)
T ss_pred ChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHH
Confidence 999999999999899999999999999999999999999988777666544
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=311.34 Aligned_cols=215 Identities=27% Similarity=0.399 Sum_probs=186.4
Q ss_pred eecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCC---
Q 020085 106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP--- 180 (331)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~--- 180 (331)
+...++|.+.+.||+|+||+||+++. .++.||||+++....+......+.+|+.++..++|+|+++++..+....
T Consensus 28 ~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 28 KEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccC
Confidence 44567999999999999999999987 6789999999877666666778999999999999999999988775432
Q ss_pred -----CeEEEEeccCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeee
Q 020085 181 -----NLCIVTEFMARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADF 252 (331)
Q Consensus 181 -----~~~lV~E~~~ggsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DF 252 (331)
.+++||||+++|+|.+++... ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+||
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DF 187 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDF 187 (496)
T ss_pred cccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEec
Confidence 268999999999999998653 356899999999999999999999999999999999999999999999999
Q ss_pred cceeeecCC---CccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccc
Q 020085 253 GVARVQAQS---GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 253 g~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~ 320 (331)
|+++..... .......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+.
T Consensus 188 Gls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~ 258 (496)
T PTZ00283 188 GFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTL 258 (496)
T ss_pred ccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh
Confidence 999765432 12234568999999999999999999999999999999999999999988776665544
|
|
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=310.47 Aligned_cols=210 Identities=24% Similarity=0.405 Sum_probs=175.4
Q ss_pred eecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECC----
Q 020085 106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP---- 179 (331)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~---- 179 (331)
.....+|++.++||+|+||.||+|.. .++.||||++.... ....+|+.+++.++||||+++++++...
T Consensus 62 ~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~ 135 (440)
T PTZ00036 62 RSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP------QYKNRELLIMKNLNHINIIFLKDYYYTECFKK 135 (440)
T ss_pred cCcCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHhcCCCCCcceeeeEeeccccc
Confidence 34567899999999999999999987 56899999886432 2345799999999999999998876322
Q ss_pred ----CCeEEEEeccCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC-cEEEee
Q 020085 180 ----PNLCIVTEFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG-VVKVAD 251 (331)
Q Consensus 180 ----~~~~lV~E~~~ggsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~-~vkl~D 251 (331)
..+++||||+++ +|.+++.. ....+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|
T Consensus 136 ~~~~~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~D 214 (440)
T PTZ00036 136 NEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCD 214 (440)
T ss_pred CCCceEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeec
Confidence 246799999986 78777643 346789999999999999999999999999999999999999665 699999
Q ss_pred ecceeeecCCCccccCCCCcccccchhcCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccc
Q 020085 252 FGVARVQAQSGVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK 322 (331)
Q Consensus 252 Fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~ 322 (331)
||+++............||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.++.+....+++.
T Consensus 215 FGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~ 286 (440)
T PTZ00036 215 FGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQV 286 (440)
T ss_pred cccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHH
Confidence 999986655444455678999999999865 46899999999999999999999999998877766665543
|
|
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-39 Score=304.00 Aligned_cols=224 Identities=31% Similarity=0.583 Sum_probs=187.9
Q ss_pred CeeeecccCcceeeeeeecCceEEEEEEECC-------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCcceeEEe
Q 020085 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIG 174 (331)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~ 174 (331)
..|+++.++|.+.+.||+|+||.||+|++.+ ..||||+++... .....+.+.+|+.++++++ ||||+++++
T Consensus 30 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~ 108 (400)
T cd05105 30 SRWEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA-RSSEKQALMSELKIMTHLGPHLNIVNLLG 108 (400)
T ss_pred CceeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC-ChHHHHHHHHHHHHHHhcCCCCCeeeEEE
Confidence 5689999999999999999999999998632 359999997653 3344567999999999996 999999999
Q ss_pred EEECCCCeEEEEeccCCCCHHHHHHhcC----------------------------------------------------
Q 020085 175 ACTRPPNLCIVTEFMARGSIYDFLHKQK---------------------------------------------------- 202 (331)
Q Consensus 175 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------------------------------------------------- 202 (331)
+|......|+||||+++|+|.+++..+.
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 188 (400)
T cd05105 109 ACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQY 188 (400)
T ss_pred EEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhccccccccccccccccc
Confidence 9999999999999999999999986531
Q ss_pred -------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 020085 203 -------------------------------------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANL 239 (331)
Q Consensus 203 -------------------------------------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Ni 239 (331)
..+++..+..++.|+++||+|||+++++||||||+||
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Ni 268 (400)
T cd05105 189 VPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNV 268 (400)
T ss_pred chhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhE
Confidence 2367778889999999999999999999999999999
Q ss_pred EEcCCCcEEEeeecceeeecCCCcc---ccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHH
Q 020085 240 LMDENGVVKVADFGVARVQAQSGVM---TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQA 315 (331)
Q Consensus 240 Li~~~~~vkl~DFg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~ 315 (331)
|++.++.+||+|||+++........ ....+++.|+|||.+.+..++.++||||||+++|||++ |..||+.......
T Consensus 269 ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~ 348 (400)
T cd05105 269 LLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST 348 (400)
T ss_pred EEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH
Confidence 9999999999999999765432221 22345678999999998899999999999999999997 9999988765554
Q ss_pred Hhcccccccccc
Q 020085 316 AVGVVQKVSIHS 327 (331)
Q Consensus 316 ~~~~~~~~~~p~ 327 (331)
....+..+.++.
T Consensus 349 ~~~~~~~~~~~~ 360 (400)
T cd05105 349 FYNKIKSGYRMA 360 (400)
T ss_pred HHHHHhcCCCCC
Confidence 444455555543
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=310.59 Aligned_cols=310 Identities=26% Similarity=0.451 Sum_probs=243.9
Q ss_pred HHHHHHHH--HHHHHHhh--hCCCeeeeeeeecCCCceeeEEEecCCCCCchHHHHHHHHHHHHhhcccCCCCCCCCCCC
Q 020085 5 CWVLMKVG--ELTSLLGE--IGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEILKSKDQSCSKRQPALGV 80 (331)
Q Consensus 5 ~~~~~~~~--~~~~~~~~--~~~~i~~~~~~~t~~~~~~~~~vv~gw~~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~ 80 (331)
.|+|-||+ ||....++ -.||++-+..|+-+-.-.|+-. |...-....|.+++.+....-+..++.++--.-..
T Consensus 10 ~wLleLLr~aqL~qf~s~lr~~lnvrr~~hf~yVk~eDLl~I---GMgRp~qRRLrea~kkm~~~~k~kswvkKvf~ga~ 86 (1039)
T KOG0199|consen 10 DWLLELLRKAQLDQFISQLRFLLNVRRFDHFSYVKDEDLLEI---GMGRPQQRRLREAIKKMSREMKNKSWVKKVFIGAD 86 (1039)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHhccCchhhhhhcchhhhhhh---ccCcHHHHHHHHHHHHhhhhccccchHHHHhccCC
Confidence 59998886 46655554 3578888888887665556555 78888888888888776544333333322111111
Q ss_pred CCCccccccCCCCccccCCCCCCeeeecccCcceeeeeeecCceEEEEEEECC-----ceEEEEEecCCCCCHHHHHHHH
Q 020085 81 PMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS-----QEVAIKVLKPECVNTEMLKEFS 155 (331)
Q Consensus 81 p~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~ 155 (331)
|.+.+.. .+ . ...+....--|..++.++.++||+|+||.|++|.|+. -.||||+++.+..+. ...+|.
T Consensus 87 p~h~~~t-~~----~-~~p~~~lkclIpee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~-~mddfl 159 (1039)
T KOG0199|consen 87 PSHPAQT-NS----V-ANPSIDLKCLIPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA-IMDDFL 159 (1039)
T ss_pred ccccccc-cC----C-CCcCCCcceeccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch-hHHHHH
Confidence 1111110 00 0 1112334466888899999999999999999999943 358999999886554 578999
Q ss_pred HHHHHHHhcCCCcceeEEeEEECCCCeEEEEeccCCCCHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Q 020085 156 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK-QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234 (331)
Q Consensus 156 ~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDl 234 (331)
+|+.+|.+++|||++++||...+ ..+.+|||.+++|||.+.|++ .+..|....+..++.||+.||.||..+++|||||
T Consensus 160 rEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDL 238 (1039)
T KOG0199|consen 160 REASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDL 238 (1039)
T ss_pred HHHHHHHhccCcceeEEeeeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhh
Confidence 99999999999999999999887 678999999999999999988 4577888999999999999999999999999999
Q ss_pred CCCCEEEcCCCcEEEeeecceeeecCCCccccC----CCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCC
Q 020085 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAE----TGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAG 309 (331)
Q Consensus 235 kp~NiLi~~~~~vkl~DFg~a~~~~~~~~~~~~----~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~ 309 (331)
.++|+|+-....|||+|||+.+.......+... --..-|+|||.+++..++.++|+|+||+++|||++ |..||.+
T Consensus 239 AARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G 318 (1039)
T KOG0199|consen 239 AARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVG 318 (1039)
T ss_pred hhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCC
Confidence 999999999999999999999977665443322 23568999999999999999999999999999999 8999999
Q ss_pred CCHHHHHhccccccccc
Q 020085 310 LTPLQAAVGVVQKVSIH 326 (331)
Q Consensus 310 ~~~~~~~~~~~~~~~~p 326 (331)
....++...+- +|.|-
T Consensus 319 ~~g~qIL~~iD-~~erL 334 (1039)
T KOG0199|consen 319 CRGIQILKNID-AGERL 334 (1039)
T ss_pred CCHHHHHHhcc-ccccC
Confidence 99999888844 66653
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=300.24 Aligned_cols=204 Identities=25% Similarity=0.453 Sum_probs=173.8
Q ss_pred eeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHH-HHHhcCCCcceeEEeEEECCCCeEEEEeccCC
Q 020085 116 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVY-IMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 191 (331)
Q Consensus 116 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~-il~~l~h~niv~~~~~~~~~~~~~lV~E~~~g 191 (331)
+.||+|+||+||++.+ .++.||+|++..... .......+..|.. +++.++||||+++++.+......++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4699999999999998 578999999975422 1222344555544 56789999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecC-CCccccCCCC
Q 020085 192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAETGT 270 (331)
Q Consensus 192 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~-~~~~~~~~gt 270 (331)
|+|.+++.. ++.+++..+..++.||++||+|||++||+||||||+|||++.++.+||+|||+++.... ........||
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (323)
T cd05575 81 GELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGT 159 (323)
T ss_pred CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCC
Confidence 999999865 56789999999999999999999999999999999999999999999999999875322 2223345689
Q ss_pred cccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccc
Q 020085 271 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 271 ~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~ 320 (331)
+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+.
T Consensus 160 ~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~ 209 (323)
T cd05575 160 PEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNIL 209 (323)
T ss_pred hhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHH
Confidence 99999999999999999999999999999999999999988777666544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=302.26 Aligned_cols=210 Identities=26% Similarity=0.388 Sum_probs=183.1
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECC------C
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP------P 180 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~------~ 180 (331)
.++|++.+.||+|+||.||++.+ .++.||||+++....+......+.+|+.+++.++||||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 46899999999999999999987 568899999986654555567788999999999999999999987543 3
Q ss_pred CeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecC
Q 020085 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (331)
Q Consensus 181 ~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~ 260 (331)
..|+||||+++ +|.+.+. ..++...+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++....
T Consensus 103 ~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 178 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 178 (364)
T ss_pred eEEEEEeCCCC-CHHHHHH---hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence 57999999976 7887774 3478889999999999999999999999999999999999999999999999987655
Q ss_pred CCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccc
Q 020085 261 SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK 322 (331)
Q Consensus 261 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~ 322 (331)
........+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+++.
T Consensus 179 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~ 240 (364)
T cd07875 179 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQ 240 (364)
T ss_pred CCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 44445567899999999999999999999999999999999999999998887776665543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=291.39 Aligned_cols=202 Identities=23% Similarity=0.415 Sum_probs=177.6
Q ss_pred CcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEe
Q 020085 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E 187 (331)
.|++.+.||+|+||+||++.. +++.||+|+++..... ......+.+|+.++++++||||+++++.+..+...++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 378899999999999999987 5789999999754322 2234567889999999999999999999999899999999
Q ss_pred ccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCcccc
Q 020085 188 FMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 266 (331)
Q Consensus 188 ~~~ggsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~~~ 266 (331)
|+++|+|.+++... ...+++..+..++.|++.||.|||++|++||||||+||++++++.++|+|||+++..........
T Consensus 81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05605 81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRG 160 (285)
T ss_pred ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcccc
Confidence 99999999988654 35689999999999999999999999999999999999999999999999999987544433344
Q ss_pred CCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH
Q 020085 267 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTP 312 (331)
Q Consensus 267 ~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~ 312 (331)
..|++.|+|||.+.+..++.++|+||+|+++|||++|+.||.+.+.
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~ 206 (285)
T cd05605 161 RVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE 206 (285)
T ss_pred ccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCch
Confidence 5789999999999999999999999999999999999999987654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=299.75 Aligned_cols=204 Identities=25% Similarity=0.459 Sum_probs=172.4
Q ss_pred eeeeecCceEEEEEEE--CCceEEEEEecCCCCC-HHHHHHHHHHH-HHHHhcCCCcceeEEeEEECCCCeEEEEeccCC
Q 020085 116 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEV-YIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 191 (331)
Q Consensus 116 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~-~il~~l~h~niv~~~~~~~~~~~~~lV~E~~~g 191 (331)
+.||+|+||+||++++ .++.||+|+++..... ......+..|. .+++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 4699999999999988 4578999999753211 12223444444 457888999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecC-CCccccCCCC
Q 020085 192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAETGT 270 (331)
Q Consensus 192 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~-~~~~~~~~gt 270 (331)
|+|.+++.. .+.+.+..+..++.||++||+|||++||+||||||+|||++.++.+||+|||+++.... ........||
T Consensus 81 ~~L~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt 159 (325)
T cd05602 81 GELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGT 159 (325)
T ss_pred CcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCC
Confidence 999999965 46788899999999999999999999999999999999999999999999999875322 2233445699
Q ss_pred cccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccc
Q 020085 271 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 271 ~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~ 320 (331)
+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~ 209 (325)
T cd05602 160 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL 209 (325)
T ss_pred ccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 99999999999999999999999999999999999999988877666544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=288.63 Aligned_cols=215 Identities=35% Similarity=0.648 Sum_probs=183.9
Q ss_pred ceeeeeeecCceEEEEEEEC------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEE
Q 020085 113 KIECKVASGSYGDLYKGTYC------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 113 ~~~~~lg~G~~g~Vy~~~~~------~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~ 186 (331)
++.+.||.|+||.||+|++. +..|+||+++.. ...+..+.|.+|++.+++++||||++++|+|......++|+
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~ 80 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS-SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM 80 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT-SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc-cccccceeeeecccccccccccccccccccccccccccccc
Confidence 46789999999999999998 578999999764 34555788999999999999999999999999888899999
Q ss_pred eccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCc--
Q 020085 187 EFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV-- 263 (331)
Q Consensus 187 E~~~ggsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~-- 263 (331)
||+++|+|.+++... ...++...+..++.|+++||.|||+++++|++|+++||+++.++.+||+|||+++.......
T Consensus 81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~ 160 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK 160 (259)
T ss_dssp E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999999886 57899999999999999999999999999999999999999999999999999986632211
Q ss_pred -cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhcccccccccccc
Q 020085 264 -MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIHSII 329 (331)
Q Consensus 264 -~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p~~~ 329 (331)
.........|+|||.+....++.++||||||+++||+++ |+.||...+..+....+ .++.++.++
T Consensus 161 ~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~-~~~~~~~~~ 227 (259)
T PF07714_consen 161 NDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKL-KQGQRLPIP 227 (259)
T ss_dssp ESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHH-HTTEETTSB
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccccceec
Confidence 123346789999999988889999999999999999999 78999999888877665 667776554
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=299.97 Aligned_cols=204 Identities=27% Similarity=0.456 Sum_probs=174.2
Q ss_pred eeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHH-HHHhcCCCcceeEEeEEECCCCeEEEEeccCC
Q 020085 116 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVY-IMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 191 (331)
Q Consensus 116 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~-il~~l~h~niv~~~~~~~~~~~~~lV~E~~~g 191 (331)
+.||+|+||+||++.. .++.+|+|+++.... +......+..|.. +++.++||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999987 578999999975422 2233345555554 56778999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecC-CCccccCCCC
Q 020085 192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAETGT 270 (331)
Q Consensus 192 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~-~~~~~~~~gt 270 (331)
|+|.+++.. .+.+++..+..++.||+.||+|||++|++||||||+|||++.++.+||+|||+++.... ........|+
T Consensus 81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt 159 (325)
T cd05604 81 GELFFHLQR-ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGT 159 (325)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCC
Confidence 999998865 56789999999999999999999999999999999999999999999999999875322 2223445689
Q ss_pred cccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccc
Q 020085 271 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 271 ~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~ 320 (331)
+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+.
T Consensus 160 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~ 209 (325)
T cd05604 160 PEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNIL 209 (325)
T ss_pred hhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHH
Confidence 99999999999999999999999999999999999999888777665544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=298.63 Aligned_cols=204 Identities=25% Similarity=0.441 Sum_probs=173.1
Q ss_pred eeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHH-HHHHhcCCCcceeEEeEEECCCCeEEEEeccCC
Q 020085 116 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEV-YIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 191 (331)
Q Consensus 116 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~-~il~~l~h~niv~~~~~~~~~~~~~lV~E~~~g 191 (331)
+.||+|+||.||++++ .++.||+|++..... .......+.+|. .+++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999998 568899999875422 122234455555 467889999999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecC-CCccccCCCC
Q 020085 192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAETGT 270 (331)
Q Consensus 192 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~-~~~~~~~~gt 270 (331)
++|.+.+.. ...+++..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||+++.... ........||
T Consensus 81 ~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (321)
T cd05603 81 GELFFHLQR-ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGT 159 (321)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCC
Confidence 999998865 56788999999999999999999999999999999999999999999999999875322 2223345689
Q ss_pred cccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccc
Q 020085 271 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 271 ~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~ 320 (331)
+.|+|||.+.+..++.++|+|||||++|||++|+.||...+..+....+.
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~ 209 (321)
T cd05603 160 PEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNIL 209 (321)
T ss_pred cccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHh
Confidence 99999999999999999999999999999999999999887766666544
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=290.01 Aligned_cols=220 Identities=25% Similarity=0.419 Sum_probs=189.8
Q ss_pred eeeecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEEC---
Q 020085 104 VWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR--- 178 (331)
Q Consensus 104 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~--- 178 (331)
.|++.. .|...+.||+|+||.|..+.+ +++.||||.+.....+.-..++..+|+.+|+.++|+||+.+.+.+..
T Consensus 17 ~~~i~~-~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~ 95 (359)
T KOG0660|consen 17 LFEIPR-YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSR 95 (359)
T ss_pred EEeccc-eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccc
Confidence 344433 566689999999999999987 67899999998666666778889999999999999999999998865
Q ss_pred --CCCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeeccee
Q 020085 179 --PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR 256 (331)
Q Consensus 179 --~~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~ 256 (331)
-...|+|+|+|+. +|...++. +..++...+..++.|+++||.|+|+.||+||||||.|++++.+..+|++|||+|+
T Consensus 96 ~~f~DvYiV~elMet-DL~~iik~-~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 96 DKFNDVYLVFELMET-DLHQIIKS-QQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLAR 173 (359)
T ss_pred cccceeEEehhHHhh-HHHHHHHc-CccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEecccccee
Confidence 2358999999955 99999865 4559999999999999999999999999999999999999999999999999999
Q ss_pred eecC---CCccccCCCCcccccchhc-CCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccccccc
Q 020085 257 VQAQ---SGVMTAETGTYRWMAPEVI-EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIH 326 (331)
Q Consensus 257 ~~~~---~~~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~p 326 (331)
.... ...++....|..|.|||++ ....|+.+.||||.||||.||++|++-|++.+.......+.+--..|
T Consensus 174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP 247 (359)
T KOG0660|consen 174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTP 247 (359)
T ss_pred eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCC
Confidence 8763 5667888899999999987 56689999999999999999999999999987777666655444433
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=293.72 Aligned_cols=218 Identities=30% Similarity=0.595 Sum_probs=183.6
Q ss_pred ecccCcceeeeeeecCceEEEEEEE--CCc----eEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCC
Q 020085 107 IDAKQLKIECKVASGSYGDLYKGTY--CSQ----EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (331)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 180 (331)
+...+|++.+.||+|+||.||+|++ .++ .||+|+++... .....+++.+|+.+++.++||||++++++|...
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~- 81 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 81 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-
Confidence 4567899999999999999999986 333 48999987542 344567899999999999999999999999765
Q ss_pred CeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecC
Q 020085 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (331)
Q Consensus 181 ~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~ 260 (331)
..++++||+++|+|.+++......++...+.+++.|++.||+|||++|++||||||+|||++.++.+||+|||+++....
T Consensus 82 ~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~ 161 (316)
T cd05108 82 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 161 (316)
T ss_pred CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccC
Confidence 57899999999999999987667789999999999999999999999999999999999999999999999999986543
Q ss_pred CCcc---ccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhcccccccccc
Q 020085 261 SGVM---TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIHS 327 (331)
Q Consensus 261 ~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p~ 327 (331)
.... ....++..|+|||.+.+..++.++||||||+++|||++ |+.||.+....+.. .+++++.+++
T Consensus 162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~-~~~~~~~~~~ 231 (316)
T cd05108 162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKGERLP 231 (316)
T ss_pred CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH-HHHhCCCCCC
Confidence 3221 12234678999999999999999999999999999998 99999987766543 4455555543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-39 Score=300.06 Aligned_cols=208 Identities=25% Similarity=0.373 Sum_probs=180.9
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECC------C
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP------P 180 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~------~ 180 (331)
.++|++.+.||+|+||.||++.+ .++.||+|+++....+......+.+|+.+++.++||||+++++++... .
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 95 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ 95 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence 46899999999999999999987 578899999987655555667888999999999999999999988643 2
Q ss_pred CeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecC
Q 020085 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (331)
Q Consensus 181 ~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~ 260 (331)
..++||||+++ +|.+.+. ..++...+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 96 ~~~lv~e~~~~-~l~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~ 171 (355)
T cd07874 96 DVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 171 (355)
T ss_pred eeEEEhhhhcc-cHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccCCC
Confidence 47999999976 7777764 3478889999999999999999999999999999999999999999999999987655
Q ss_pred CCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccc
Q 020085 261 SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 261 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~ 320 (331)
........+|+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+..+....++
T Consensus 172 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~ 231 (355)
T cd07874 172 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 231 (355)
T ss_pred ccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 544455678999999999999999999999999999999999999999887666554443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=299.13 Aligned_cols=193 Identities=24% Similarity=0.448 Sum_probs=170.1
Q ss_pred eeeeecCceEEEEEEE--CCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhc-CCCcceeEEeEEECCCCeEEEEeccCC
Q 020085 116 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMAR 191 (331)
Q Consensus 116 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~lV~E~~~g 191 (331)
+.||+|+||.||++++ .++.||+|+++..... ....+.+..|..+++++ +||||+++++++.....+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4699999999999988 5688999999865332 33456688999999998 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecC-CCccccCCCC
Q 020085 192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAETGT 270 (331)
Q Consensus 192 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~-~~~~~~~~gt 270 (331)
|+|.+++.. .+.+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+++.... ........||
T Consensus 81 g~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt 159 (329)
T cd05588 81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGT 159 (329)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCC
Confidence 999998865 46799999999999999999999999999999999999999999999999999874322 2233445789
Q ss_pred cccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCC
Q 020085 271 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAG 309 (331)
Q Consensus 271 ~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~ 309 (331)
+.|+|||++.+..++.++|+|||||++|+|++|+.||..
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 160 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred ccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence 999999999999999999999999999999999999963
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=308.89 Aligned_cols=210 Identities=22% Similarity=0.357 Sum_probs=182.2
Q ss_pred ccCcceeeeeeecCceEEEEEEEC---CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTYC---SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV 185 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV 185 (331)
...|.+.+.||+|++|.||++... ++.||+|.+... .......+.+|+.+++.++||||++++++|..++.+|+|
T Consensus 66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~--~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv 143 (478)
T PTZ00267 66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN--DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLI 143 (478)
T ss_pred ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEE
Confidence 345999999999999999999763 567888876543 344456788899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC
Q 020085 186 TEFMARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262 (331)
Q Consensus 186 ~E~~~ggsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~ 262 (331)
|||++||+|.+++... ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 144 ~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 144 MEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred EECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 9999999999988542 4568899999999999999999999999999999999999999999999999998654432
Q ss_pred c---cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccc
Q 020085 263 V---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 263 ~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~ 320 (331)
. ....+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..+....+.
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~ 284 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVL 284 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 1 234468999999999999999999999999999999999999999888777666544
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=317.91 Aligned_cols=223 Identities=33% Similarity=0.584 Sum_probs=199.8
Q ss_pred eeecccCcceeeeeeecCceEEEEEEEC--C---ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECC
Q 020085 105 WEIDAKQLKIECKVASGSYGDLYKGTYC--S---QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP 179 (331)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~--~---~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 179 (331)
.||+....++.++||.|.||.|++|+.+ | ..||||.+|... .+....+|+.|+.||-+.+||||+++.|+.++.
T Consensus 624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy-tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks 702 (996)
T KOG0196|consen 624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKS 702 (996)
T ss_pred hhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc-cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecC
Confidence 5789999999999999999999999873 3 569999999764 566678999999999999999999999999999
Q ss_pred CCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeec
Q 020085 180 PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA 259 (331)
Q Consensus 180 ~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~ 259 (331)
...+||+|||++|+|+.+|+++.+.|+..++..+++.|+.||.||-+.|+|||||.++|||++.+-.+|++|||+++...
T Consensus 703 ~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvle 782 (996)
T KOG0196|consen 703 KPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 782 (996)
T ss_pred ceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecc
Confidence 99999999999999999999999999999999999999999999999999999999999999999999999999999765
Q ss_pred CCCc--cccCCC--CcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhcccccccccccc
Q 020085 260 QSGV--MTAETG--TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIHSII 329 (331)
Q Consensus 260 ~~~~--~~~~~g--t~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p~~~ 329 (331)
.... .+..-| ..+|.|||.+.+++++.++|||||||+|||.++ |..||=++++-+++.+ +++|+|-+=|
T Consensus 783 dd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIka-Ie~gyRLPpP 856 (996)
T KOG0196|consen 783 DDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKA-IEQGYRLPPP 856 (996)
T ss_pred cCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHH-HHhccCCCCC
Confidence 4431 112212 379999999999999999999999999999888 9999999999998888 5568875544
|
|
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=284.68 Aligned_cols=217 Identities=35% Similarity=0.691 Sum_probs=187.1
Q ss_pred eeecccCcceeeeeeecCceEEEEEEE-CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeE
Q 020085 105 WEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183 (331)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 183 (331)
|.|+.++|++.++||+|+||.||+|.. .++.||+|.++.... ..+.+.+|+.++++++|+||+++++.+......+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05072 1 WEIPRESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM---SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIY 77 (261)
T ss_pred CcCchHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch---hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcE
Confidence 778899999999999999999999987 457799999876432 3467899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC
Q 020085 184 IVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262 (331)
Q Consensus 184 lV~E~~~ggsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~ 262 (331)
++|||+++++|.+++... ...++...+..++.|++.|++|||+++++||||||+||+++.++.++|+|||.++......
T Consensus 78 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 78 IITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred EEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 999999999999999764 3568889999999999999999999999999999999999999999999999998654432
Q ss_pred cc--ccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhcccccccc
Q 020085 263 VM--TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSI 325 (331)
Q Consensus 263 ~~--~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~ 325 (331)
.. ....++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...++.+....+ .++.+
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~-~~~~~ 222 (261)
T cd05072 158 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSAL-QRGYR 222 (261)
T ss_pred eeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHH-HcCCC
Confidence 21 12235678999999998889999999999999999998 99999988777665553 33443
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=301.52 Aligned_cols=227 Identities=31% Similarity=0.563 Sum_probs=191.5
Q ss_pred CCeeeecccCcceeeeeeecCceEEEEEEECC-------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCcceeEE
Q 020085 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFI 173 (331)
Q Consensus 102 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~ 173 (331)
...|+++.++|.+.++||+|+||.||+|++.+ +.||+|+++... .......+.+|+.+++++. ||||++++
T Consensus 29 ~~~~~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~~E~~~l~~l~~H~niv~~~ 107 (401)
T cd05107 29 DSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA-RSSEKQALMSELKIMSHLGPHLNIVNLL 107 (401)
T ss_pred CCcceecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC-ChhHHHHHHHHHHHHHhcCCCCCeEEEE
Confidence 34599999999999999999999999998643 579999998653 2333457899999999997 99999999
Q ss_pred eEEECCCCeEEEEeccCCCCHHHHHHhcC---------------------------------------------------
Q 020085 174 GACTRPPNLCIVTEFMARGSIYDFLHKQK--------------------------------------------------- 202 (331)
Q Consensus 174 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~--------------------------------------------------- 202 (331)
++|......++||||+++|+|.++++..+
T Consensus 108 ~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 187 (401)
T cd05107 108 GACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESA 187 (401)
T ss_pred EEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCcccc
Confidence 99999999999999999999999996532
Q ss_pred ----------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCC
Q 020085 203 ----------------------------------------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKT 236 (331)
Q Consensus 203 ----------------------------------------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp 236 (331)
..++...+..++.|++.||+|||+++++||||||
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp 267 (401)
T cd05107 188 DYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAA 267 (401)
T ss_pred CccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCc
Confidence 1356667888999999999999999999999999
Q ss_pred CCEEEcCCCcEEEeeecceeeecCCCc---cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCH
Q 020085 237 ANLLMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTP 312 (331)
Q Consensus 237 ~NiLi~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~ 312 (331)
+|||+++++.++|+|||+++....... .....+++.|+|||.+.+..++.++|+||||+++|||++ |..||+....
T Consensus 268 ~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~ 347 (401)
T cd05107 268 RNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPM 347 (401)
T ss_pred ceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCc
Confidence 999999999999999999976433221 122346788999999998889999999999999999998 8999998777
Q ss_pred HHHHhcccccccccccc
Q 020085 313 LQAAVGVVQKVSIHSII 329 (331)
Q Consensus 313 ~~~~~~~~~~~~~p~~~ 329 (331)
.+.....+.++.++.++
T Consensus 348 ~~~~~~~~~~~~~~~~p 364 (401)
T cd05107 348 NEQFYNAIKRGYRMAKP 364 (401)
T ss_pred hHHHHHHHHcCCCCCCC
Confidence 67666666667666543
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=304.20 Aligned_cols=223 Identities=26% Similarity=0.463 Sum_probs=205.0
Q ss_pred ecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEE
Q 020085 107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI 184 (331)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~l 184 (331)
.....|.+.+.||+|.|++|.++++ ++..||||++.....+....+.+.+|+++|..++|||||+++.+...+..+|+
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lyl 132 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYL 132 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEE
Confidence 3355799999999999999999987 68899999999887787777779999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCcc
Q 020085 185 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM 264 (331)
Q Consensus 185 V~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~ 264 (331)
||||..+|.+++++.+ .+...+..+..++.|+.+|++|||+++|+|||||++|+|++.+.++||+|||++.+.......
T Consensus 133 V~eya~~ge~~~yl~~-~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~l 211 (596)
T KOG0586|consen 133 VMEYASGGELFDYLVK-HGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLML 211 (596)
T ss_pred EEEeccCchhHHHHHh-cccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecccccc
Confidence 9999999999999976 566677999999999999999999999999999999999999999999999999998887777
Q ss_pred ccCCCCcccccchhcCCCCCC-ChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccccccccccc
Q 020085 265 TAETGTYRWMAPEVIEHKPYD-YKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIHSIIL 330 (331)
Q Consensus 265 ~~~~gt~~y~aPE~~~~~~~~-~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~p~~~~ 330 (331)
...+|++.|.|||++.+..|+ +.+|+||+|+++|-|++|.+||++.+-.+....+++..+|-++.+
T Consensus 212 qt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~~m 278 (596)
T KOG0586|consen 212 QTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPFYM 278 (596)
T ss_pred cccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeeccccee
Confidence 888999999999999999884 889999999999999999999999998888888888777766654
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=294.33 Aligned_cols=202 Identities=26% Similarity=0.441 Sum_probs=173.3
Q ss_pred eeeeecCceEEEEEEEC--CceEEEEEecCCCC-CHHHHHHHHHHHHHHHhc-CCCcceeEEeEEECCCCeEEEEeccCC
Q 020085 116 CKVASGSYGDLYKGTYC--SQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMAR 191 (331)
Q Consensus 116 ~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~lV~E~~~g 191 (331)
+.||+|+||+||+|++. ++.||+|+++.... .......+..|..+++.. +||||+++++++.....+++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 46999999999999984 57899999986432 122345567788888764 899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecC-CCccccCCCC
Q 020085 192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAETGT 270 (331)
Q Consensus 192 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~-~~~~~~~~gt 270 (331)
|+|.+++.. ...+++..+..++.|++.||+|||++|++||||||+|||++.++.++|+|||+++.... ........||
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (316)
T cd05619 81 GDLMFHIQS-CHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGT 159 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCC
Confidence 999999965 46789999999999999999999999999999999999999999999999999875322 2223345689
Q ss_pred cccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhc
Q 020085 271 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVG 318 (331)
Q Consensus 271 ~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~ 318 (331)
+.|+|||++.+..++.++|+|||||++|||++|+.||.+.++.+....
T Consensus 160 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~ 207 (316)
T cd05619 160 PDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQS 207 (316)
T ss_pred ccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 999999999999999999999999999999999999998887665554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=287.15 Aligned_cols=220 Identities=30% Similarity=0.623 Sum_probs=186.7
Q ss_pred ecccCcceeeeeeecCceEEEEEEECC-------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECC
Q 020085 107 IDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP 179 (331)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 179 (331)
++.++|++.+.||+|+||.||+|...+ ..||+|.++... .......+.+|+.++++++||||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~ 80 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA-EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE 80 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC-CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC
Confidence 455689999999999999999998743 469999987543 345567799999999999999999999999998
Q ss_pred CCeEEEEeccCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC
Q 020085 180 PNLCIVTEFMARGSIYDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN 244 (331)
Q Consensus 180 ~~~~lV~E~~~ggsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~ 244 (331)
...+++|||+++++|.+++.... ..+++..++.++.|++.||.|||++|++|+||||+||+++++
T Consensus 81 ~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~ 160 (283)
T cd05048 81 QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEG 160 (283)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCC
Confidence 89999999999999999996532 457888999999999999999999999999999999999999
Q ss_pred CcEEEeeecceeeecCCC---ccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhccc
Q 020085 245 GVVKVADFGVARVQAQSG---VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 245 ~~vkl~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~ 320 (331)
+.++|+|||+++...... ......+++.|+|||.+.+..++.++|+|||||++|||++ |..||.+.++.+.... +
T Consensus 161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~-i 239 (283)
T cd05048 161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEM-I 239 (283)
T ss_pred CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-H
Confidence 999999999997653322 1223456788999999988889999999999999999998 9999998888776555 4
Q ss_pred cccccccc
Q 020085 321 QKVSIHSI 328 (331)
Q Consensus 321 ~~~~~p~~ 328 (331)
.++.++.+
T Consensus 240 ~~~~~~~~ 247 (283)
T cd05048 240 RSRQLLPC 247 (283)
T ss_pred HcCCcCCC
Confidence 45555543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=280.31 Aligned_cols=218 Identities=25% Similarity=0.438 Sum_probs=190.7
Q ss_pred CcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEec
Q 020085 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF 188 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~ 188 (331)
+|.+.+.||+|++|.||+++. +++.|++|.++...........+.+|+.++++++|||++++++++......++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 478899999999999999988 578999999986655566678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC-cccc
Q 020085 189 MARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTA 266 (331)
Q Consensus 189 ~~ggsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~-~~~~ 266 (331)
+++++|.+++... ...++...+..++.|++.||.|||++|++|+||+|+||++++++.++|+|||+++...... ....
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~ 160 (256)
T cd08529 81 AENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT 160 (256)
T ss_pred CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhhc
Confidence 9999999999775 4678899999999999999999999999999999999999999999999999987654432 2233
Q ss_pred CCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccccccccccc
Q 020085 267 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIHSII 329 (331)
Q Consensus 267 ~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~p~~~ 329 (331)
..+++.|+|||++.+..++.++|+||||+++|+|++|+.||...++.+....+. ++.+|+++
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~~~ 222 (256)
T cd08529 161 IVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKII-RGVFPPVS 222 (256)
T ss_pred cccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-cCCCCCCc
Confidence 468899999999999999999999999999999999999999888777666644 45555543
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=282.79 Aligned_cols=217 Identities=33% Similarity=0.615 Sum_probs=185.5
Q ss_pred ecccCcceeeeeeecCceEEEEEEECC-ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEE
Q 020085 107 IDAKQLKIECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV 185 (331)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV 185 (331)
|+.++|++.+.||+|+||.||++.+.+ ..+|+|.++..... ...+.+|+.++++++||||+++++++......++|
T Consensus 1 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05113 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS---EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIV 77 (256)
T ss_pred CChHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc---HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEE
Confidence 356789999999999999999998865 46999998755333 35689999999999999999999999988899999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCcc-
Q 020085 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM- 264 (331)
Q Consensus 186 ~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~- 264 (331)
|||+.+++|.+++......+++..++.++.|++.|+.|||++|++|+||||+||+++.++.+||+|||.++........
T Consensus 78 ~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 78 TEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred EEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 9999999999999765567899999999999999999999999999999999999999999999999998765433221
Q ss_pred -ccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhcccccccccc
Q 020085 265 -TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIHS 327 (331)
Q Consensus 265 -~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p~ 327 (331)
....++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...++.+....+. ++.++.
T Consensus 158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~ 221 (256)
T cd05113 158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVS-QGLRLY 221 (256)
T ss_pred cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHh-cCCCCC
Confidence 12235678999999988889999999999999999998 999999888776666644 455443
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=299.74 Aligned_cols=209 Identities=26% Similarity=0.421 Sum_probs=179.7
Q ss_pred CcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCC-----CeE
Q 020085 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP-----NLC 183 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~-----~~~ 183 (331)
+|++.++||+|+||.||++.+ .++.||+|++.....+....+.+.+|+.+++.++||||+++++++.... ..|
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 478899999999999999986 5789999998765444455678899999999999999999999998776 789
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC--
Q 020085 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-- 261 (331)
Q Consensus 184 lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~-- 261 (331)
+||||+.+ +|.+.+.. ...+++..+..++.||+.||+|||++|++||||||+|||++.++.+||+|||+++.....
T Consensus 81 lv~e~~~~-~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~ 158 (372)
T cd07853 81 VVTELMQS-DLHKIIVS-PQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES 158 (372)
T ss_pred EEeecccc-CHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc
Confidence 99999975 88888754 467899999999999999999999999999999999999999999999999999865432
Q ss_pred CccccCCCCcccccchhcCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 262 GVMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 262 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
.......+++.|+|||.+.+. .++.++||||+||++|||++|+.||.+.++.+....+.+
T Consensus 159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~ 219 (372)
T cd07853 159 KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITD 219 (372)
T ss_pred ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 223345678999999998764 579999999999999999999999999887766555443
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-39 Score=294.77 Aligned_cols=202 Identities=26% Similarity=0.444 Sum_probs=173.3
Q ss_pred eeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhc-CCCcceeEEeEEECCCCeEEEEeccCC
Q 020085 116 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMAR 191 (331)
Q Consensus 116 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~lV~E~~~g 191 (331)
+.||+|+||.||++++ +++.||+|+++.... .......+..|..+++.. +||||+++++++...+.+|+||||+.+
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 4699999999999988 567899999975422 122345667788888754 899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecC-CCccccCCCC
Q 020085 192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAETGT 270 (331)
Q Consensus 192 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~-~~~~~~~~gt 270 (331)
|+|.+++.. ++.+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||+++.... ........||
T Consensus 81 g~L~~~i~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (316)
T cd05620 81 GDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGT 159 (316)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCC
Confidence 999999865 46789999999999999999999999999999999999999999999999999874322 2223445789
Q ss_pred cccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhc
Q 020085 271 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVG 318 (331)
Q Consensus 271 ~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~ 318 (331)
+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~ 207 (316)
T cd05620 160 PDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFES 207 (316)
T ss_pred cCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 999999999999999999999999999999999999998877665544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-39 Score=297.34 Aligned_cols=198 Identities=24% Similarity=0.416 Sum_probs=171.4
Q ss_pred CcceeeeeeecCceEEEEEEE-----CCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhcC-CCcceeEEeEEECCCCe
Q 020085 111 QLKIECKVASGSYGDLYKGTY-----CSQEVAIKVLKPECV--NTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNL 182 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~--~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~~~ 182 (331)
+|++.+.||+|+||.||+++. .++.||+|+++.... .....+.+.+|+.+++.++ ||||+++++++..+..+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 488999999999999999876 468899999974321 2234466888999999995 89999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC
Q 020085 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262 (331)
Q Consensus 183 ~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~ 262 (331)
++||||+++|+|.+++.. +..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 81 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~ 159 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ-RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE 159 (332)
T ss_pred EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccC
Confidence 999999999999999965 4678999999999999999999999999999999999999999999999999987543221
Q ss_pred --ccccCCCCcccccchhcCCC-CCCChhhHHHHHHHHHHHHcCCCCCCC
Q 020085 263 --VMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAG 309 (331)
Q Consensus 263 --~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~ell~g~~Pf~~ 309 (331)
......||+.|+|||++.+. .++.++|||||||++|||++|+.||..
T Consensus 160 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 209 (332)
T cd05614 160 KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTL 209 (332)
T ss_pred CCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCC
Confidence 22245689999999999765 478999999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=285.52 Aligned_cols=215 Identities=29% Similarity=0.563 Sum_probs=182.2
Q ss_pred eeecccCcceeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEE
Q 020085 105 WEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177 (331)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 177 (331)
|++..++|++.+.||+|+||.||+|.+. +..||+|+++... ......++.+|+.+++.++||||+++++++.
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~ 79 (277)
T cd05062 1 WEVAREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred CcccHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 6778899999999999999999998764 3569999986543 2334567899999999999999999999999
Q ss_pred CCCCeEEEEeccCCCCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEE
Q 020085 178 RPPNLCIVTEFMARGSIYDFLHKQK---------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVK 248 (331)
Q Consensus 178 ~~~~~~lV~E~~~ggsL~~~l~~~~---------~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vk 248 (331)
.....++||||+++++|.+++.... ..++...+..++.|+++|++|||+.|++||||||+||++++++.++
T Consensus 80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~ 159 (277)
T cd05062 80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK 159 (277)
T ss_pred CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEE
Confidence 9899999999999999999996532 2356778899999999999999999999999999999999999999
Q ss_pred EeeecceeeecCCCcc---ccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhccc
Q 020085 249 VADFGVARVQAQSGVM---TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 249 l~DFg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~ 320 (331)
|+|||+++........ ....+++.|+|||.+.+..++.++|+||||+++|||++ |..||.+.++.+....+.
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~ 235 (277)
T cd05062 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVM 235 (277)
T ss_pred ECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999998754332211 12345778999999998899999999999999999999 789999888766655543
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=292.55 Aligned_cols=207 Identities=35% Similarity=0.588 Sum_probs=187.3
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~ 186 (331)
..-|.+..+||+|+||.||++.+ .|+.+|||.+..+ ..++++.+|+.||++++.|++|+++|.+.....+||||
T Consensus 32 EEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVM 107 (502)
T KOG0574|consen 32 EEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVM 107 (502)
T ss_pred HHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeeh
Confidence 34577889999999999999976 6899999998754 23578999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC-Cccc
Q 020085 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMT 265 (331)
Q Consensus 187 E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~-~~~~ 265 (331)
|||..||+.|.++.++.++.+..+..++.+.++||+|||...-||||||+.|||++.+|..||+|||.|...... ....
T Consensus 108 EYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRN 187 (502)
T KOG0574|consen 108 EYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRN 187 (502)
T ss_pred hhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhC
Confidence 999999999999999999999999999999999999999999999999999999999999999999999644332 2234
Q ss_pred cCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcc
Q 020085 266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGV 319 (331)
Q Consensus 266 ~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~ 319 (331)
.-.|||.|||||++..-.|+.++||||||++-.||..|++||.+..|..++.-+
T Consensus 188 TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMI 241 (502)
T KOG0574|consen 188 TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMI 241 (502)
T ss_pred ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEec
Confidence 557999999999999999999999999999999999999999999999887654
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=293.87 Aligned_cols=204 Identities=25% Similarity=0.453 Sum_probs=176.2
Q ss_pred eeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhc-CCCcceeEEeEEECCCCeEEEEeccCC
Q 020085 116 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMAR 191 (331)
Q Consensus 116 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~lV~E~~~g 191 (331)
+.||+|+||+||++.+ +++.||+|+++.... .......+..|..+++.+ +||||+++++++.....+|+||||++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4699999999999988 467899999975422 233456678899999888 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC-CccccCCCC
Q 020085 192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTAETGT 270 (331)
Q Consensus 192 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~-~~~~~~~gt 270 (331)
|+|.+++.. .+.+++..+..++.|++.||.|||++|++||||||+||++++++.++|+|||+++..... .......|+
T Consensus 81 ~~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~ 159 (318)
T cd05570 81 GDLMFHIQR-SGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGT 159 (318)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecC
Confidence 999999865 457999999999999999999999999999999999999999999999999998753322 222334689
Q ss_pred cccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccc
Q 020085 271 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 271 ~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~ 320 (331)
+.|+|||++.+..++.++|+|||||++|+|++|+.||.+.+..+....+.
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~ 209 (318)
T cd05570 160 PDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSIL 209 (318)
T ss_pred ccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHH
Confidence 99999999999999999999999999999999999999887776655543
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=283.16 Aligned_cols=220 Identities=36% Similarity=0.675 Sum_probs=187.5
Q ss_pred eeecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCe
Q 020085 105 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL 182 (331)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 182 (331)
|+++..+|.+.++||+|+||.||+|.+ .++.||+|+++... .....+.+|+.++++++||||+++++++..+..+
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 77 (263)
T cd05052 1 WEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPF 77 (263)
T ss_pred CCCchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc---hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCc
Confidence 678888999999999999999999987 47889999987542 2346789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC
Q 020085 183 CIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261 (331)
Q Consensus 183 ~lV~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~ 261 (331)
+++|||+++++|.+++.... ..+++..++.++.|+++||+|||++|++||||||+||++++++.+||+|||+++.....
T Consensus 78 ~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 78 YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred EEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence 99999999999999996543 46889999999999999999999999999999999999999999999999999765433
Q ss_pred Cccc--cCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhccccccccccc
Q 020085 262 GVMT--AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIHSI 328 (331)
Q Consensus 262 ~~~~--~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p~~ 328 (331)
.... ....++.|+|||.+.+..++.++|+||||+++|||++ |..||++.+..+.... ...+.++++
T Consensus 158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~-~~~~~~~~~ 226 (263)
T cd05052 158 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-LEKGYRMER 226 (263)
T ss_pred eeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-HHCCCCCCC
Confidence 2111 1234568999999999999999999999999999998 9999998776655444 444555443
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=295.11 Aligned_cols=193 Identities=23% Similarity=0.433 Sum_probs=169.8
Q ss_pred eeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhc-CCCcceeEEeEEECCCCeEEEEeccCC
Q 020085 116 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMAR 191 (331)
Q Consensus 116 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~lV~E~~~g 191 (331)
+.||+|+||.||++.. .++.||+|+++.... .....+.+.+|+.+++++ +||||+++++++.....+|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4699999999999987 568899999986532 234456788999999888 599999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecC-CCccccCCCC
Q 020085 192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTAETGT 270 (331)
Q Consensus 192 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~-~~~~~~~~gt 270 (331)
|+|.+++.. .+.+++..+..++.||+.||+|||++|++||||||+|||++.++.+||+|||+++.... .......+||
T Consensus 81 ~~L~~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt 159 (327)
T cd05617 81 GDLMFHMQR-QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGT 159 (327)
T ss_pred CcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCC
Confidence 999998865 46799999999999999999999999999999999999999999999999999875322 2233445799
Q ss_pred cccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCC
Q 020085 271 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAG 309 (331)
Q Consensus 271 ~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~ 309 (331)
+.|+|||.+.+..++.++|+|||||++|||++|+.||..
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~ 198 (327)
T cd05617 160 PNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 198 (327)
T ss_pred cccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCc
Confidence 999999999999999999999999999999999999953
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=296.23 Aligned_cols=221 Identities=32% Similarity=0.595 Sum_probs=182.8
Q ss_pred eeecccCcceeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCcceeEEeEE
Q 020085 105 WEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGAC 176 (331)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~ 176 (331)
|+++.++|++.+.||+|+||.||+|... ++.||+|+++... .......+.+|+.+++++ +||||++++++|
T Consensus 2 ~~~~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~ 80 (337)
T cd05054 2 WEFPRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA-TASEYKALMTELKILIHIGHHLNVVNLLGAC 80 (337)
T ss_pred cccCHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC-CHHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence 8899999999999999999999999642 3679999997543 334456788999999999 799999999988
Q ss_pred EC-CCCeEEEEeccCCCCHHHHHHhcC-----------------------------------------------------
Q 020085 177 TR-PPNLCIVTEFMARGSIYDFLHKQK----------------------------------------------------- 202 (331)
Q Consensus 177 ~~-~~~~~lV~E~~~ggsL~~~l~~~~----------------------------------------------------- 202 (331)
.. +..+++++||+++++|.+++....
T Consensus 81 ~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (337)
T cd05054 81 TKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDE 160 (337)
T ss_pred ecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccch
Confidence 64 456889999999999999986432
Q ss_pred -------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCc---cccCCCCcc
Q 020085 203 -------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV---MTAETGTYR 272 (331)
Q Consensus 203 -------~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~ 272 (331)
..+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||+++....... .....++..
T Consensus 161 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~ 240 (337)
T cd05054 161 EGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLK 240 (337)
T ss_pred hhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcc
Confidence 2578889999999999999999999999999999999999999999999999976533221 122335678
Q ss_pred cccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhccccccccc
Q 020085 273 WMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIH 326 (331)
Q Consensus 273 y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p 326 (331)
|+|||++.+..++.++|||||||++|||++ |..||.+..+.+......+++.++
T Consensus 241 y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~ 295 (337)
T cd05054 241 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM 295 (337)
T ss_pred ccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCC
Confidence 999999999999999999999999999998 999998765544444444444443
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=293.89 Aligned_cols=205 Identities=27% Similarity=0.466 Sum_probs=180.5
Q ss_pred eecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeE
Q 020085 106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183 (331)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 183 (331)
++..++|++.++||+|+||.||++.+ .+..+|+|+++... .......+.+|++++++++||||++++++|..++..+
T Consensus 1 ~l~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (333)
T cd06650 1 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 79 (333)
T ss_pred CcchhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEE
Confidence 35678999999999999999999998 46789999987653 3445577999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC
Q 020085 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262 (331)
Q Consensus 184 lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~ 262 (331)
+||||+++++|.+++.. .+.+++..+..++.|++.||.|||+. +++||||||+|||++.++.+||+|||++......
T Consensus 80 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~- 157 (333)
T cd06650 80 ICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (333)
T ss_pred EEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence 99999999999999965 45688999999999999999999975 7999999999999999999999999998654332
Q ss_pred ccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH
Q 020085 263 VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPL 313 (331)
Q Consensus 263 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~ 313 (331)
......++..|+|||.+.+..++.++|+|||||++|+|++|+.||......
T Consensus 158 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~ 208 (333)
T cd06650 158 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAK 208 (333)
T ss_pred ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchh
Confidence 223346899999999999989999999999999999999999999876543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-39 Score=296.67 Aligned_cols=192 Identities=24% Similarity=0.455 Sum_probs=168.6
Q ss_pred eeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhc-CCCcceeEEeEEECCCCeEEEEeccCC
Q 020085 116 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMAR 191 (331)
Q Consensus 116 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~lV~E~~~g 191 (331)
+.||+|+||+||+++. .++.||+|+++.... .......+.+|+.++.++ +||||+++++++......++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4699999999999987 467899999986532 234456688899988877 799999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC-CccccCCCC
Q 020085 192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTAETGT 270 (331)
Q Consensus 192 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~-~~~~~~~gt 270 (331)
|+|.+++.. .+.+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+++..... .......||
T Consensus 81 ~~L~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt 159 (329)
T cd05618 81 GDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGT 159 (329)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCC
Confidence 999998865 467899999999999999999999999999999999999999999999999998753322 223345689
Q ss_pred cccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCC
Q 020085 271 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYA 308 (331)
Q Consensus 271 ~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~ 308 (331)
+.|+|||++.+..++.++|+|||||++|||++|+.||.
T Consensus 160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~ 197 (329)
T cd05618 160 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 197 (329)
T ss_pred ccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCc
Confidence 99999999999999999999999999999999999995
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=287.43 Aligned_cols=194 Identities=25% Similarity=0.435 Sum_probs=168.8
Q ss_pred eeecCceEEEEEEE--CCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEeccCCCCH
Q 020085 118 VASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI 194 (331)
Q Consensus 118 lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~~~ggsL 194 (331)
||+|+||+||++.+ +++.||+|++...... ....+.+..|+.++++++||||+++.+++......++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999987 5789999998754322 22345678899999999999999999999999999999999999999
Q ss_pred HHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCc-cccCCCC
Q 020085 195 YDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV-MTAETGT 270 (331)
Q Consensus 195 ~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~-~~~~~gt 270 (331)
.+++.. ....+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||.+........ .....|+
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~ 160 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGT 160 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCC
Confidence 988754 235689999999999999999999999999999999999999999999999999976543322 2334689
Q ss_pred cccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC
Q 020085 271 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLT 311 (331)
Q Consensus 271 ~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~ 311 (331)
+.|+|||.+.+..++.++|+||||+++|||++|+.||....
T Consensus 161 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~ 201 (280)
T cd05608 161 PGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARG 201 (280)
T ss_pred cCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=281.93 Aligned_cols=218 Identities=33% Similarity=0.586 Sum_probs=186.6
Q ss_pred ecccCcceeeeeeecCceEEEEEEEC-----CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCC
Q 020085 107 IDAKQLKIECKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN 181 (331)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 181 (331)
|+.++|++.+.||+|+||.||+|.+. ...||+|+++... .......|.+|+.++++++||||+++++.+.....
T Consensus 1 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (266)
T cd05033 1 IDPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS-SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRP 79 (266)
T ss_pred CChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCc
Confidence 35678999999999999999999873 3479999987653 34456778999999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC
Q 020085 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261 (331)
Q Consensus 182 ~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~ 261 (331)
.+++|||+++++|.+++....+.++...+..++.|++.|++|||++|++|+||||+||++++++.++|+|||+++.....
T Consensus 80 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 159 (266)
T cd05033 80 VMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS 159 (266)
T ss_pred eEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence 99999999999999999876678999999999999999999999999999999999999999999999999999866421
Q ss_pred -Cccc--cCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhccccccccc
Q 020085 262 -GVMT--AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIH 326 (331)
Q Consensus 262 -~~~~--~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p 326 (331)
.... ...++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+. ++.++
T Consensus 160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~ 227 (266)
T cd05033 160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVE-DGYRL 227 (266)
T ss_pred ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHH-cCCCC
Confidence 1111 2234578999999999999999999999999999998 999998888777665543 44443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=290.40 Aligned_cols=210 Identities=23% Similarity=0.434 Sum_probs=179.6
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~ 186 (331)
.++|.+.++||+|+||.||+|++ .++.||+|.++.... ......+.+|+.++++++||||+++++++..++..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 83 (309)
T cd07872 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF 83 (309)
T ss_pred CCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc-CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence 46799999999999999999987 567899999875532 222346778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC-ccc
Q 020085 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMT 265 (331)
Q Consensus 187 E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~-~~~ 265 (331)
||+++ +|.+++......++...+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++...... ...
T Consensus 84 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~ 162 (309)
T cd07872 84 EYLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYS 162 (309)
T ss_pred eCCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCccccc
Confidence 99986 8999887766678999999999999999999999999999999999999999999999999997543322 223
Q ss_pred cCCCCcccccchhcCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccc
Q 020085 266 AETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 266 ~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~ 320 (331)
...+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.+..+....+.
T Consensus 163 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~ 218 (309)
T cd07872 163 NEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIF 218 (309)
T ss_pred cccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 4567899999999864 568999999999999999999999999887665544433
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=281.21 Aligned_cols=216 Identities=36% Similarity=0.672 Sum_probs=184.7
Q ss_pred eeecccCcceeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEE-CCCCeE
Q 020085 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT-RPPNLC 183 (331)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~-~~~~~~ 183 (331)
|.++.++|++.+.||+|+||.||++...+..+|+|..+... ..+.+.+|+.++++++|+|++++++++. .....+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 76 (256)
T cd05082 1 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 76 (256)
T ss_pred CCccHHhCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCCc----hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceE
Confidence 66788899999999999999999999999999999987542 2457899999999999999999999764 456789
Q ss_pred EEEeccCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC
Q 020085 184 IVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262 (331)
Q Consensus 184 lV~E~~~ggsL~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~ 262 (331)
+++||+++++|.+++.+... .+++..+..++.|++.||+|||++|++||||||+||++++++.+||+|||+++......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 77 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred EEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence 99999999999999976443 48889999999999999999999999999999999999999999999999987543322
Q ss_pred ccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhcccccccccc
Q 020085 263 VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIHS 327 (331)
Q Consensus 263 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p~ 327 (331)
....++..|+|||++.+..++.++|+||||+++|+|++ |+.||...+..+.... ++++..+.
T Consensus 157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~-~~~~~~~~ 219 (256)
T cd05082 157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-VEKGYKMD 219 (256)
T ss_pred --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HhcCCCCC
Confidence 23345678999999999899999999999999999997 9999998777665554 33444443
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=281.62 Aligned_cols=218 Identities=33% Similarity=0.614 Sum_probs=185.0
Q ss_pred ecccCcceeeeeeecCceEEEEEEECC-ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEE
Q 020085 107 IDAKQLKIECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV 185 (331)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV 185 (331)
|+..+|.+.+.||+|+||.||++.+.+ ..+|+|+++...... ..+.+|+.++++++||||+++++++......++|
T Consensus 1 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 77 (256)
T cd05059 1 IDPSELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSE---DDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIV 77 (256)
T ss_pred CChHHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCCH---HHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEE
Confidence 346679999999999999999998854 579999987543332 4688899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCccc
Q 020085 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT 265 (331)
Q Consensus 186 ~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~~ 265 (331)
|||+++++|.+++......+++..+..++.|++.|+.|||++|++||||||+||++++++.+||+|||.++.........
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 78 TEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred EecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 99999999999997766678999999999999999999999999999999999999999999999999987654322111
Q ss_pred --cCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhccccccccccc
Q 020085 266 --AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIHSI 328 (331)
Q Consensus 266 --~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p~~ 328 (331)
...++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...++.+....+ ..+.+++.
T Consensus 158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~-~~~~~~~~ 222 (256)
T cd05059 158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESV-SAGYRLYR 222 (256)
T ss_pred cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHH-HcCCcCCC
Confidence 1223458999999998899999999999999999999 89999988877766653 34544443
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-38 Score=285.89 Aligned_cols=203 Identities=24% Similarity=0.408 Sum_probs=178.1
Q ss_pred cceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEec
Q 020085 112 LKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF 188 (331)
Q Consensus 112 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~ 188 (331)
|+..+.||+|+||+||++.+ +++.+|+|+++..... ......+.+|+.++++++|+|++.+.+++..++..+++|||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 67788999999999999988 5789999998754332 23345678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCccccC
Q 020085 189 MARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE 267 (331)
Q Consensus 189 ~~ggsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~~~~ 267 (331)
+++++|.+++... ...+++..+..++.|++.||.|||+.||+||||||+||++++++.++|+|||++............
T Consensus 82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~ 161 (285)
T cd05632 82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGR 161 (285)
T ss_pred ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcccCC
Confidence 9999999988654 346999999999999999999999999999999999999999999999999999765443333455
Q ss_pred CCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHH
Q 020085 268 TGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ 314 (331)
Q Consensus 268 ~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~ 314 (331)
.|+..|+|||.+.+..++.++|+||||+++|+|++|+.||....+..
T Consensus 162 ~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~ 208 (285)
T cd05632 162 VGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKV 208 (285)
T ss_pred CCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 78999999999998899999999999999999999999998876543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-38 Score=281.14 Aligned_cols=213 Identities=38% Similarity=0.675 Sum_probs=185.3
Q ss_pred eeecccCcceeeeeeecCceEEEEEEE-CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeE
Q 020085 105 WEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183 (331)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 183 (331)
|+++.++|++.++||+|++|.||+|.+ .++.||+|.++..... .+.+.+|+.++++++|||++++++++...+..+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05068 1 WEIDRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD---PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIY 77 (261)
T ss_pred CccchhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCccc---HHHHHHHHHHHHHCCCCCccceeEEEecCCCee
Confidence 678888999999999999999999987 4568999999865332 356889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC
Q 020085 184 IVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262 (331)
Q Consensus 184 lV~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~ 262 (331)
++|||+++++|.+++.... ..++...+..++.|++.|+.+||++|++||||||+||++++++.++|+|||+++......
T Consensus 78 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05068 78 IVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDI 157 (261)
T ss_pred eeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCc
Confidence 9999999999999996643 468999999999999999999999999999999999999999999999999998765332
Q ss_pred ccc--cCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhccc
Q 020085 263 VMT--AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 263 ~~~--~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~ 320 (331)
... ....+..|+|||.+.+..++.++|+||||+++|||++ |+.||.+.++.+....+.
T Consensus 158 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~ 218 (261)
T cd05068 158 YEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD 218 (261)
T ss_pred ccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 111 1122458999999998899999999999999999999 999999988877766644
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=303.40 Aligned_cols=224 Identities=28% Similarity=0.603 Sum_probs=201.0
Q ss_pred CeeeecccCcceeeeeeecCceEEEEEEECCc------eEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEE
Q 020085 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC 176 (331)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~~------~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 176 (331)
...+|......+.++||.|-||.||+|.|..- -||||..|.+... +..+.|++|..+|++++||||++++|+|
T Consensus 382 rnyel~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~-d~tekflqEa~iMrnfdHphIikLIGv~ 460 (974)
T KOG4257|consen 382 RNYELRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTP-DDTEKFLQEASIMRNFDHPHIIKLIGVC 460 (974)
T ss_pred CcceeehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCCh-hhHHHHHHHHHHHHhCCCcchhheeeee
Confidence 35677777778888999999999999998542 4999999987643 4478899999999999999999999999
Q ss_pred ECCCCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeeccee
Q 020085 177 TRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR 256 (331)
Q Consensus 177 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~ 256 (331)
.+. ..|||||.++-|.|..|+..++..++...+..++.||+.||.|||+++++||||.++|||+....-+||+|||+++
T Consensus 461 ~e~-P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR 539 (974)
T KOG4257|consen 461 VEQ-PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSR 539 (974)
T ss_pred ecc-ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhh
Confidence 876 5899999999999999999988999999999999999999999999999999999999999999999999999999
Q ss_pred eecCCCccccCCC--CcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhcccccccccccc
Q 020085 257 VQAQSGVMTAETG--TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIHSII 329 (331)
Q Consensus 257 ~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p~~~ 329 (331)
............| ...|||||.++.+.++.++|||.||+.+||++. |..||.+..+-+++.. +++|.|++.|
T Consensus 540 ~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~-iEnGeRlP~P 614 (974)
T KOG4257|consen 540 YLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGH-IENGERLPCP 614 (974)
T ss_pred hccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEE-ecCCCCCCCC
Confidence 8887766555554 468999999999999999999999999999998 9999999998887666 7789998875
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=304.71 Aligned_cols=220 Identities=38% Similarity=0.707 Sum_probs=198.3
Q ss_pred CeeeecccCcceeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCC
Q 020085 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (331)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 180 (331)
+.|+++..+.....+||-|.||.||.|.|. .-.||||.++.+ ...+++|+.|+.+|+.++|||+|+++|+|+.+.
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED---tMeveEFLkEAAvMKeikHpNLVqLLGVCT~Ep 336 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED---TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEP 336 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc---chhHHHHHHHHHHHHhhcCccHHHHhhhhccCC
Confidence 779999999999999999999999999995 467999999865 345689999999999999999999999999999
Q ss_pred CeEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeec
Q 020085 181 NLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA 259 (331)
Q Consensus 181 ~~~lV~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~ 259 (331)
.+|||+|||..|+|.+||...+ ..++.-.+++++.||+.||+||..+++|||||.++|+|+.++..+|++|||+++++.
T Consensus 337 PFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMt 416 (1157)
T KOG4278|consen 337 PFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMT 416 (1157)
T ss_pred CeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhc
Confidence 9999999999999999997754 456777888999999999999999999999999999999999999999999999876
Q ss_pred CCCccccCCC---CcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhcccccccccc
Q 020085 260 QSGVMTAETG---TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIHS 327 (331)
Q Consensus 260 ~~~~~~~~~g---t~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p~ 327 (331)
... .+...| ...|.|||-+....++.|+|||+||++|||+.| |-.||++...-|++.- +++|+|..
T Consensus 417 gDT-YTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~L-LEkgyRM~ 486 (1157)
T KOG4278|consen 417 GDT-YTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGL-LEKGYRMD 486 (1157)
T ss_pred CCc-eecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHH-Hhcccccc
Confidence 643 333333 568999999999999999999999999999999 9999999988887766 78898864
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=283.02 Aligned_cols=223 Identities=29% Similarity=0.547 Sum_probs=189.1
Q ss_pred eeecccCcceeeeeeecCceEEEEEEECC-------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEE
Q 020085 105 WEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177 (331)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 177 (331)
|+++.++|.+.+.||+|+||.||+|...+ ..||+|.+.... .......+.+|+.+++.++||||+++++++.
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~ 79 (277)
T cd05032 1 WELPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA-SMRERIEFLNEASVMKEFNCHHVVRLLGVVS 79 (277)
T ss_pred CccchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc-CHHHHHHHHHHHHHHHhCCCCceeEEEEEEc
Confidence 67889999999999999999999998743 679999987543 3344567889999999999999999999999
Q ss_pred CCCCeEEEEeccCCCCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEE
Q 020085 178 RPPNLCIVTEFMARGSIYDFLHKQK---------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVK 248 (331)
Q Consensus 178 ~~~~~~lV~E~~~ggsL~~~l~~~~---------~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vk 248 (331)
.....++||||+++++|.+++.... ..+++..+..++.|++.|+.|||++|++||||||+||+++.++.++
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~k 159 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVK 159 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEE
Confidence 9999999999999999999996532 2467888999999999999999999999999999999999999999
Q ss_pred EeeecceeeecCCCc---cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhccccccc
Q 020085 249 VADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVS 324 (331)
Q Consensus 249 l~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~ 324 (331)
|+|||+++....... .....++..|+|||.+.+..++.++|+||||+++||+++ |+.||...++.+....+. .+.
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~-~~~ 238 (277)
T cd05032 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI-DGG 238 (277)
T ss_pred ECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHh-cCC
Confidence 999999875443321 123346789999999988889999999999999999998 999999888777666544 555
Q ss_pred ccccc
Q 020085 325 IHSII 329 (331)
Q Consensus 325 ~p~~~ 329 (331)
++.++
T Consensus 239 ~~~~~ 243 (277)
T cd05032 239 HLDLP 243 (277)
T ss_pred CCCCC
Confidence 55443
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=287.05 Aligned_cols=224 Identities=30% Similarity=0.599 Sum_probs=187.3
Q ss_pred CeeeecccCcceeeeeeecCceEEEEEEECC---------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCcceeE
Q 020085 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCS---------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQF 172 (331)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~---------~~vavK~~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~ 172 (331)
..|++..++|.+.+.||+|+||.||++.+.+ ..+|+|+++... .......+.+|+.+++.+ +||||+++
T Consensus 11 ~~~~~~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~~h~~i~~~ 89 (307)
T cd05098 11 PRWEVPRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINL 89 (307)
T ss_pred CcceeehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC-ChHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence 3588889999999999999999999997632 469999998653 334456788999999999 79999999
Q ss_pred EeEEECCCCeEEEEeccCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 020085 173 IGACTRPPNLCIVTEFMARGSIYDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 237 (331)
Q Consensus 173 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~ 237 (331)
++++......++||||+++|+|.+++.... ..++...++.++.|++.||+|||++|++||||||+
T Consensus 90 ~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~ 169 (307)
T cd05098 90 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAAR 169 (307)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHH
Confidence 999999999999999999999999997642 24788899999999999999999999999999999
Q ss_pred CEEEcCCCcEEEeeecceeeecCCCc---cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHH
Q 020085 238 NLLMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPL 313 (331)
Q Consensus 238 NiLi~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~ 313 (331)
||+++.++.++|+|||.++....... .....+++.|+|||.+.+..++.++|+||||+++|||++ |+.||...+..
T Consensus 170 Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~ 249 (307)
T cd05098 170 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 249 (307)
T ss_pred heEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence 99999999999999999875433211 112234578999999998889999999999999999998 89999887665
Q ss_pred HHHhccccccccccc
Q 020085 314 QAAVGVVQKVSIHSI 328 (331)
Q Consensus 314 ~~~~~~~~~~~~p~~ 328 (331)
+.... +..+.++++
T Consensus 250 ~~~~~-~~~~~~~~~ 263 (307)
T cd05098 250 ELFKL-LKEGHRMDK 263 (307)
T ss_pred HHHHH-HHcCCCCCC
Confidence 54433 555655544
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=279.45 Aligned_cols=218 Identities=29% Similarity=0.486 Sum_probs=186.8
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCH---HHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEE
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNT---EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI 184 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~---~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~l 184 (331)
+.|++.+.||+|++|.||++.. .++.+|+|.++...... .....+.+|+.++++++||||+++++++..+...++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 4688999999999999999976 57899999987543222 234678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCcc
Q 020085 185 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM 264 (331)
Q Consensus 185 V~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~ 264 (331)
|+||+++++|.+++.. .+.+++..+..++.|++.|+.|||+.|++||||+|+||++++++.++|+|||.++........
T Consensus 82 v~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~ 160 (263)
T cd06625 82 FMEYMPGGSVKDQLKA-YGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS 160 (263)
T ss_pred EEEECCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccccc
Confidence 9999999999999865 456889999999999999999999999999999999999999999999999998754332111
Q ss_pred ----ccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccccccccc
Q 020085 265 ----TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIHSI 328 (331)
Q Consensus 265 ----~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~p~~ 328 (331)
....++..|+|||.+.+..++.++|+||||+++|||++|+.||...++.....++.....++++
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 228 (263)
T cd06625 161 GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQL 228 (263)
T ss_pred cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCCCC
Confidence 2345788999999999988999999999999999999999999988887776665555555544
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=295.18 Aligned_cols=212 Identities=28% Similarity=0.514 Sum_probs=191.2
Q ss_pred cccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhcC-CCcceeEEeEEECCCCeE
Q 020085 108 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLC 183 (331)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~~~~ 183 (331)
....|.+.+.||+|.||.||+++. +|+.+|+|+++..... ......+.+|+.+|+++. ||||+++.++++....++
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 355799999999999999999988 5789999999765432 234578999999999998 999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC----CcEEEeeecceeeec
Q 020085 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN----GVVKVADFGVARVQA 259 (331)
Q Consensus 184 lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~----~~vkl~DFg~a~~~~ 259 (331)
+|||++.||.|.+.+... .+++..+..++.|++.++.|||+.|++|||+||+|+|+... +.++++|||++....
T Consensus 113 lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~ 190 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIK 190 (382)
T ss_pred EEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEcc
Confidence 999999999999999776 39999999999999999999999999999999999999643 479999999999888
Q ss_pred CCCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 260 QSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 260 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
........+||+.|+|||++...+|+..+|+||+|+++|.|++|.+||.+.+..+....+.+
T Consensus 191 ~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~ 252 (382)
T KOG0032|consen 191 PGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILR 252 (382)
T ss_pred CCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHc
Confidence 76677788999999999999999999999999999999999999999999988777776554
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-39 Score=264.27 Aligned_cols=222 Identities=30% Similarity=0.478 Sum_probs=191.9
Q ss_pred eeecccCcceeeeeeecCceEEEEEE--ECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCcceeEEeEEECCCC
Q 020085 105 WEIDAKQLKIECKVASGSYGDLYKGT--YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPN 181 (331)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~ 181 (331)
++++.+++.-+..||+|+||.|-+-+ +.|+..|+|.++... +....++...|+.+-.+. .+|.+|.|+|+..+...
T Consensus 41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv-n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd 119 (282)
T KOG0984|consen 41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV-NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD 119 (282)
T ss_pred cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc-ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc
Confidence 78889999999999999999976554 588999999998765 455567778888876555 68999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCCEEEcCCCcEEEeeecceee
Q 020085 182 LCIVTEFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDENGVVKVADFGVARV 257 (331)
Q Consensus 182 ~~lV~E~~~ggsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~-~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~ 257 (331)
.+|.||.|.- ||..+..+ +.+.+++..+-+++..+.+||.|||++ .+||||+||+|||++.+|++|+||||.+..
T Consensus 120 vwIcME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~ 198 (282)
T KOG0984|consen 120 VWICMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGY 198 (282)
T ss_pred EEEeHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEccccccee
Confidence 9999999976 88777543 467899999999999999999999975 899999999999999999999999999987
Q ss_pred ecCCCccccCCCCcccccchhcC----CCCCCChhhHHHHHHHHHHHHcCCCCCCCC-CHHHHHhcccccccccccc
Q 020085 258 QAQSGVMTAETGTYRWMAPEVIE----HKPYDYKADVFSFGIALWELLTGELPYAGL-TPLQAAVGVVQKVSIHSII 329 (331)
Q Consensus 258 ~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~Di~SlG~il~ell~g~~Pf~~~-~~~~~~~~~~~~~~~p~~~ 329 (331)
...+-..+...|...|||||.++ ...|+.++||||||+++.||.+++.||+.. +|++...++|+ --.|.++
T Consensus 199 L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe-ep~P~Lp 274 (282)
T KOG0984|consen 199 LVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE-EPSPQLP 274 (282)
T ss_pred ehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc-CCCCCCc
Confidence 77666666788999999999984 447999999999999999999999999985 99999999774 5556554
|
|
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=283.16 Aligned_cols=218 Identities=30% Similarity=0.574 Sum_probs=182.4
Q ss_pred ecccCcceeeeeeecCceEEEEEEE------CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCC
Q 020085 107 IDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (331)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 180 (331)
++.++|++.++||+|+||+||+|.. .++.+|+|.++... .......+.+|+.++++++||||+++++++....
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 80 (283)
T cd05090 2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDIN-NPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQ 80 (283)
T ss_pred CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCC
Confidence 4457899999999999999999985 34689999998543 3445577999999999999999999999999999
Q ss_pred CeEEEEeccCCCCHHHHHHhcC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC
Q 020085 181 NLCIVTEFMARGSIYDFLHKQK----------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN 244 (331)
Q Consensus 181 ~~~lV~E~~~ggsL~~~l~~~~----------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~ 244 (331)
..|+||||+++++|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||+++++
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~ 160 (283)
T cd05090 81 PVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQ 160 (283)
T ss_pred ceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCC
Confidence 9999999999999999985431 246788899999999999999999999999999999999999
Q ss_pred CcEEEeeecceeeecCCC---ccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhccc
Q 020085 245 GVVKVADFGVARVQAQSG---VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 245 ~~vkl~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~ 320 (331)
+.+||+|||+++...... ......++..|+|||.+.+..++.++|+||||+++|||++ |..||.+.++...... +
T Consensus 161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~-~ 239 (283)
T cd05090 161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEM-V 239 (283)
T ss_pred CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-H
Confidence 999999999997553321 1223345678999999988889999999999999999998 9999988776554443 4
Q ss_pred cccccc
Q 020085 321 QKVSIH 326 (331)
Q Consensus 321 ~~~~~p 326 (331)
+.+..+
T Consensus 240 ~~~~~~ 245 (283)
T cd05090 240 RKRQLL 245 (283)
T ss_pred HcCCcC
Confidence 444433
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=277.78 Aligned_cols=216 Identities=38% Similarity=0.692 Sum_probs=187.9
Q ss_pred eeecccCcceeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEE
Q 020085 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI 184 (331)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~l 184 (331)
|.++.++|++.+.||+|+||.||++...++.||+|.++.... ..+.+.+|+.++++++|+|++++++++......++
T Consensus 1 ~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 77 (256)
T cd05039 1 WAINSKELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDST---AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYI 77 (256)
T ss_pred CccChhhccceeeeecCCCceEEEEEecCcEEEEEEeccchh---HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEE
Confidence 567788999999999999999999999999999999986532 45779999999999999999999999998889999
Q ss_pred EEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCc
Q 020085 185 VTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV 263 (331)
Q Consensus 185 V~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~ 263 (331)
||||+++++|.+++.... ..+++..+..++.|++.|+.|||++|++|+||||+||+++.++.++|+|||.++......
T Consensus 78 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~- 156 (256)
T cd05039 78 VTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ- 156 (256)
T ss_pred EEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc-
Confidence 999999999999997643 368999999999999999999999999999999999999999999999999997653322
Q ss_pred cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhccccccccc
Q 020085 264 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIH 326 (331)
Q Consensus 264 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p 326 (331)
.....+..|+|||.+....++.++|+||||+++|++++ |..||...+..+.... +.++.++
T Consensus 157 -~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~-~~~~~~~ 218 (256)
T cd05039 157 -DSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPH-VEKGYRM 218 (256)
T ss_pred -ccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH-HhcCCCC
Confidence 23345668999999988889999999999999999997 9999998877665444 3344443
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=283.66 Aligned_cols=193 Identities=24% Similarity=0.457 Sum_probs=168.7
Q ss_pred eeecCceEEEEEEE--CCceEEEEEecCCCCCH-HHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEeccCCCCH
Q 020085 118 VASGSYGDLYKGTY--CSQEVAIKVLKPECVNT-EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI 194 (331)
Q Consensus 118 lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~-~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~~~ggsL 194 (331)
||+|+||.||++.. .++.||+|.++...... .....+..|++++++++||||+++++.+..+...++||||++|++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999987 57899999987533221 2234566799999999999999999999999999999999999999
Q ss_pred HHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCccccCCCCccc
Q 020085 195 YDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRW 273 (331)
Q Consensus 195 ~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~~~~~gt~~y 273 (331)
.+++.... ..+++..+..++.|++.||+|||+.|++||||||+||++++++.++|+|||++.............++..|
T Consensus 81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y 160 (277)
T cd05607 81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGY 160 (277)
T ss_pred HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCCCc
Confidence 98886533 45888999999999999999999999999999999999999999999999999766554444456789999
Q ss_pred ccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 020085 274 MAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL 310 (331)
Q Consensus 274 ~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~ 310 (331)
+|||++.+..++.++|+||+||++|||++|+.||...
T Consensus 161 ~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~ 197 (277)
T cd05607 161 MAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDH 197 (277)
T ss_pred cCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999888999999999999999999999999764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=278.60 Aligned_cols=210 Identities=28% Similarity=0.545 Sum_probs=178.5
Q ss_pred eeeecCceEEEEEEE----CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEeccCCC
Q 020085 117 KVASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARG 192 (331)
Q Consensus 117 ~lg~G~~g~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~~~gg 192 (331)
+||+|+||.||+|.+ .++.+|+|+++....+....+.+.+|+.+++.++||||+++++++.. ...++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCC
Confidence 689999999999975 45789999998766566667889999999999999999999998864 4679999999999
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCcc----ccCC
Q 020085 193 SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM----TAET 268 (331)
Q Consensus 193 sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~----~~~~ 268 (331)
+|.+++.. ...+++..+..++.|++.|++|||++|++||||||.||++++++.++|+|||.++........ ....
T Consensus 81 ~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~ 159 (257)
T cd05116 81 PLNKFLQK-NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGK 159 (257)
T ss_pred cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCC
Confidence 99999965 457899999999999999999999999999999999999999999999999999765433221 1223
Q ss_pred CCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhcccccccccccc
Q 020085 269 GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIHSII 329 (331)
Q Consensus 269 gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p~~~ 329 (331)
+++.|+|||.+....++.++|+||||+++|||++ |+.||...+..+.... ++++.+|+++
T Consensus 160 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~-i~~~~~~~~~ 220 (257)
T cd05116 160 WPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQM-IESGERMECP 220 (257)
T ss_pred CCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHCCCCCCCC
Confidence 4579999999988889999999999999999998 9999998877655444 5566666554
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=278.60 Aligned_cols=210 Identities=30% Similarity=0.563 Sum_probs=177.3
Q ss_pred eeeecCceEEEEEEEC----CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEeccCCC
Q 020085 117 KVASGSYGDLYKGTYC----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARG 192 (331)
Q Consensus 117 ~lg~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~~~gg 192 (331)
.||+|+||.||+|.+. +..||+|+++... .....+.+.+|+.++++++||||+++++++.. +..++||||++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~ 79 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN-EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGG 79 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc-ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCC
Confidence 4899999999999763 3469999997653 34455779999999999999999999998864 5789999999999
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCc----cccCC
Q 020085 193 SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV----MTAET 268 (331)
Q Consensus 193 sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~----~~~~~ 268 (331)
+|.+++......+++..+.+++.|++.||.|||++|++||||||+||+++.++.+||+|||+++....... .....
T Consensus 80 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 159 (257)
T cd05115 80 PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGK 159 (257)
T ss_pred CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCC
Confidence 99999977677899999999999999999999999999999999999999999999999999875433211 11223
Q ss_pred CCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhcccccccccccc
Q 020085 269 GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIHSII 329 (331)
Q Consensus 269 gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p~~~ 329 (331)
+++.|+|||.+.+..++.++|+||||+++||+++ |+.||...++.+.... +.++.++.++
T Consensus 160 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~ 220 (257)
T cd05115 160 WPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSF-IEQGKRLDCP 220 (257)
T ss_pred CCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHH-HHCCCCCCCC
Confidence 3578999999988889999999999999999996 9999999887776544 5566666543
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=280.99 Aligned_cols=218 Identities=31% Similarity=0.593 Sum_probs=183.2
Q ss_pred ecccCcceeeeeeecCceEEEEEEE--CCc----eEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCC
Q 020085 107 IDAKQLKIECKVASGSYGDLYKGTY--CSQ----EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (331)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 180 (331)
+..++|++.++||+|+||+||+|++ +++ .||+|+++... .......+.+|+.+++.++||||+++++++...
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~- 81 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT-SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS- 81 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC-CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-
Confidence 4567899999999999999999987 333 48999987543 444567899999999999999999999998754
Q ss_pred CeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecC
Q 020085 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (331)
Q Consensus 181 ~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~ 260 (331)
..++++||+++|+|.+++....+.+++..+..++.|++.||+|||++|++||||||+||++++++.+||+|||+++....
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~ 161 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI 161 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence 57899999999999999977667899999999999999999999999999999999999999999999999999986543
Q ss_pred CCcc---ccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhcccccccccc
Q 020085 261 SGVM---TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIHS 327 (331)
Q Consensus 261 ~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p~ 327 (331)
.... ....+++.|+|||.+.+..++.++|||||||++|||++ |..||....+..... .++.+.+++
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~-~~~~~~~~~ 231 (279)
T cd05109 162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPD-LLEKGERLP 231 (279)
T ss_pred ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH-HHHCCCcCC
Confidence 3221 12234678999999998899999999999999999998 999998877655443 344555443
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=284.34 Aligned_cols=217 Identities=32% Similarity=0.555 Sum_probs=180.2
Q ss_pred ccCcceeeeeeecCceEEEEEEEC--C--ceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCcceeEEeEEECCCCeE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTYC--S--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLC 183 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~~--~--~~vavK~~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~ 183 (331)
+++|++.+.||+|+||.||+|... + ..+++|.++... .....+.+.+|+.+++++ +||||+++++++......+
T Consensus 1 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 1 WEDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFA-SENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred CccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccC-CHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 368999999999999999999873 2 247888887432 344457789999999999 7999999999999989999
Q ss_pred EEEeccCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEE
Q 020085 184 IVTEFMARGSIYDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVK 248 (331)
Q Consensus 184 lV~E~~~ggsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vk 248 (331)
+++||+++++|.+++.... ..+++..++.++.|++.|++|||++|++||||||+|||++.++.+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 9999999999999996532 3478899999999999999999999999999999999999999999
Q ss_pred EeeecceeeecCCCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhcccccccccc
Q 020085 249 VADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIHS 327 (331)
Q Consensus 249 l~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p~ 327 (331)
|+|||++..............+..|+|||.+.+..++.++|||||||++|||++ |..||...++.+....+. ++.+++
T Consensus 160 l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~-~~~~~~ 238 (297)
T cd05089 160 IADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLP-QGYRME 238 (297)
T ss_pred ECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh-cCCCCC
Confidence 999999864322211222233567999999998899999999999999999997 999999988877665543 344443
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=281.49 Aligned_cols=219 Identities=27% Similarity=0.578 Sum_probs=182.1
Q ss_pred ecccCcceeeeeeecCceEEEEEEE--CCc----eEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCC
Q 020085 107 IDAKQLKIECKVASGSYGDLYKGTY--CSQ----EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (331)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 180 (331)
+..++|++.+.||+|+||+||+|.+ .++ .+++|.+.... ......++..|+.++++++||||+++++++.. .
T Consensus 4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~ 81 (279)
T cd05111 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS-GRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-A 81 (279)
T ss_pred CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc-chHHHHHHHHHHHHHhcCCCCCcceEEEEECC-C
Confidence 3456899999999999999999988 344 47888875432 23445678889999999999999999998754 5
Q ss_pred CeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecC
Q 020085 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (331)
Q Consensus 181 ~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~ 260 (331)
..++++||+++|+|.+++....+.+++..+..++.|++.||+|||++|++||||||+||++++++.+||+|||.++....
T Consensus 82 ~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~ 161 (279)
T cd05111 82 SLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP 161 (279)
T ss_pred ccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence 67899999999999999987677899999999999999999999999999999999999999999999999999986543
Q ss_pred CCc---cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhccccccccccc
Q 020085 261 SGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIHSI 328 (331)
Q Consensus 261 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p~~ 328 (331)
... .....++..|+|||.+.+..++.++|+||||+++||+++ |+.||.+..+... ...++++.++..
T Consensus 162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~~ 232 (279)
T cd05111 162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV-PDLLEKGERLAQ 232 (279)
T ss_pred CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHHCCCcCCC
Confidence 221 122346678999999998899999999999999999998 9999998876553 344556666543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=284.32 Aligned_cols=207 Identities=25% Similarity=0.451 Sum_probs=173.5
Q ss_pred CcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc---CCCcceeEEeEEEC-----CC
Q 020085 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI---RHKNVVQFIGACTR-----PP 180 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l---~h~niv~~~~~~~~-----~~ 180 (331)
+|.+.+.||+|+||+||+|.+ +++.||+|.++...........+.+|+.+++.+ +||||+++++++.. ..
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 488999999999999999988 568899999876433332233456677777665 69999999998864 23
Q ss_pred CeEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeec
Q 020085 181 NLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA 259 (331)
Q Consensus 181 ~~~lV~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~ 259 (331)
..+++|||+.+ +|.+++.... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+++...
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~ 159 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS 159 (288)
T ss_pred eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcccccc
Confidence 58999999986 8999886643 458999999999999999999999999999999999999999999999999998665
Q ss_pred CCCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhc
Q 020085 260 QSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVG 318 (331)
Q Consensus 260 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~ 318 (331)
.........++..|+|||++.+..++.++||||+||++|+|++|++||.+.+..+...+
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~ 218 (288)
T cd07863 160 CQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGK 218 (288)
T ss_pred CcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHH
Confidence 44444455689999999999988999999999999999999999999988766554444
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=283.62 Aligned_cols=201 Identities=24% Similarity=0.429 Sum_probs=176.1
Q ss_pred CcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEe
Q 020085 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E 187 (331)
.|+..+.||+|+||+||++.+ .++.||+|.+...... ......+.+|+.++++++|+|++++++.+...+..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 367788999999999999988 5689999998754322 2334567889999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCcccc
Q 020085 188 FMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 266 (331)
Q Consensus 188 ~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~~~ 266 (331)
|++|++|.+++.... ..+++..+..++.|++.||.|||+.|++||||||+||++++++.++|+|||++...........
T Consensus 81 ~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 160 (285)
T cd05630 81 LMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKG 160 (285)
T ss_pred ecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccccC
Confidence 999999999985533 4689999999999999999999999999999999999999999999999999976554433344
Q ss_pred CCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC
Q 020085 267 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLT 311 (331)
Q Consensus 267 ~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~ 311 (331)
..|+..|+|||.+.+..++.++|+||+|+++|+|++|+.||....
T Consensus 161 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~ 205 (285)
T cd05630 161 RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 205 (285)
T ss_pred CCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence 578999999999999999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=279.70 Aligned_cols=219 Identities=33% Similarity=0.580 Sum_probs=185.5
Q ss_pred ecccCcceeeeeeecCceEEEEEEEC-----CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCC
Q 020085 107 IDAKQLKIECKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN 181 (331)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 181 (331)
|+..+|++.+.||+|+||.||+|... +..+|+|.++... .....+.+.+|+.++++++||||+++++++..+..
T Consensus 1 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 79 (267)
T cd05066 1 IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKP 79 (267)
T ss_pred CCHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCc
Confidence 35678999999999999999999862 2369999987654 34446789999999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC
Q 020085 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261 (331)
Q Consensus 182 ~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~ 261 (331)
.++||||+++++|.+++....+.++...+..++.|++.|++|||++|++||||||+||+++.++.++|+|||.++.....
T Consensus 80 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd05066 80 VMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD 159 (267)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence 99999999999999999876677899999999999999999999999999999999999999999999999999765432
Q ss_pred Cc--c--ccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhcccccccccc
Q 020085 262 GV--M--TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIHS 327 (331)
Q Consensus 262 ~~--~--~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p~ 327 (331)
.. . ....++..|+|||.+.+..++.++|+||||+++||+++ |+.||....+.+....+. ++.+++
T Consensus 160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~-~~~~~~ 229 (267)
T cd05066 160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIE-EGYRLP 229 (267)
T ss_pred cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHh-CCCcCC
Confidence 21 1 11223568999999998899999999999999999887 999999888776666543 444443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=278.52 Aligned_cols=211 Identities=38% Similarity=0.689 Sum_probs=180.9
Q ss_pred eeecccCcceeeeeeecCceEEEEEEECC-ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeE
Q 020085 105 WEIDAKQLKIECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183 (331)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 183 (331)
|+++..+|.+.++||+|+||.||+|++.+ ..||+|+++...... +.+.+|+.++++++||||+++++.+.. ...+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~~---~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (262)
T cd05071 1 WEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIY 76 (262)
T ss_pred CCCChHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccCH---HHHHHHHHHHHhCCCCCcceEEEEECC-CCcE
Confidence 67788899999999999999999998744 579999998654332 568899999999999999999998754 5689
Q ss_pred EEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC
Q 020085 184 IVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262 (331)
Q Consensus 184 lV~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~ 262 (331)
+||||+++|+|.+++.... ..+++..+..++.|+++||+|||+++++||||||+||++++++.++|+|||.++......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 77 IVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred EEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 9999999999999997543 457889999999999999999999999999999999999999999999999997654432
Q ss_pred ccc--cCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhcc
Q 020085 263 VMT--AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGV 319 (331)
Q Consensus 263 ~~~--~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~ 319 (331)
... ...++..|+|||...+..++.++|+||||+++|+|++ |+.||.+.++.+....+
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~ 216 (262)
T cd05071 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQV 216 (262)
T ss_pred cccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHH
Confidence 211 2335678999999988889999999999999999999 89999988777665553
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-38 Score=297.22 Aligned_cols=193 Identities=27% Similarity=0.420 Sum_probs=169.4
Q ss_pred eecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeE
Q 020085 106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183 (331)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 183 (331)
.+....|++.+.||+|+||.||++.+ .++.||+|.... ..+.+|+.++++++||||+++++++......+
T Consensus 88 ~~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 159 (391)
T PHA03212 88 GIEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--------GGTATEAHILRAINHPSIIQLKGTFTYNKFTC 159 (391)
T ss_pred ccccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeE
Confidence 34567899999999999999999988 568899997542 34678999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC--
Q 020085 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-- 261 (331)
Q Consensus 184 lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~-- 261 (331)
+|+|++. ++|.+++.. ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 160 lv~e~~~-~~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~ 237 (391)
T PHA03212 160 LILPRYK-TDLYCYLAA-KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINA 237 (391)
T ss_pred EEEecCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccc
Confidence 9999996 589998865 457899999999999999999999999999999999999999999999999999653221
Q ss_pred CccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCC
Q 020085 262 GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYA 308 (331)
Q Consensus 262 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~ 308 (331)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||-
T Consensus 238 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~ 284 (391)
T PHA03212 238 NKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLF 284 (391)
T ss_pred cccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcC
Confidence 22234579999999999999999999999999999999999997764
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=280.27 Aligned_cols=199 Identities=36% Similarity=0.638 Sum_probs=177.9
Q ss_pred cceeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEecc
Q 020085 112 LKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFM 189 (331)
Q Consensus 112 ~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~~ 189 (331)
|++.+.||+|+||+||++... ++.+|+|++..............+|+.++++++||||+++++++......++|||++
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 788999999999999999995 457999999877544444445567999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeee-cCCCccccCC
Q 020085 190 ARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ-AQSGVMTAET 268 (331)
Q Consensus 190 ~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~-~~~~~~~~~~ 268 (331)
.+++|.+++. ....++...+..++.|+++||++||++|++|+||||+||++++++.++|+|||.+... ..........
T Consensus 81 ~~~~L~~~l~-~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 159 (260)
T PF00069_consen 81 PGGSLQDYLQ-KNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFV 159 (260)
T ss_dssp TTEBHHHHHH-HHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSS
T ss_pred cccccccccc-ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999997 3567899999999999999999999999999999999999999999999999999763 3333445667
Q ss_pred CCcccccchhcC-CCCCCChhhHHHHHHHHHHHHcCCCCCCCCC
Q 020085 269 GTYRWMAPEVIE-HKPYDYKADVFSFGIALWELLTGELPYAGLT 311 (331)
Q Consensus 269 gt~~y~aPE~~~-~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~ 311 (331)
+++.|+|||.+. +..++.++|+||+|+++|+|++|..||....
T Consensus 160 ~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~ 203 (260)
T PF00069_consen 160 GTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESN 203 (260)
T ss_dssp SSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccc
Confidence 899999999998 8889999999999999999999999999873
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=286.00 Aligned_cols=223 Identities=30% Similarity=0.604 Sum_probs=187.0
Q ss_pred CeeeecccCcceeeeeeecCceEEEEEEEC---------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCcceeE
Q 020085 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYC---------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQF 172 (331)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~ 172 (331)
..|.+..++|.+.++||+|+||.||+++.. ...+|+|+++... .......+.+|+.+++++ +||||+++
T Consensus 5 ~~~~~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~ 83 (314)
T cd05099 5 PKWEFPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA-TDKDLADLISEMELMKLIGKHKNIINL 83 (314)
T ss_pred ccccccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC-ChHHHHHHHHHHHHHHhccCCCCeeeE
Confidence 458888999999999999999999999752 3469999988543 344567789999999999 69999999
Q ss_pred EeEEECCCCeEEEEeccCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 020085 173 IGACTRPPNLCIVTEFMARGSIYDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 237 (331)
Q Consensus 173 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~ 237 (331)
+++|......+++|||+++|+|.+++.... ..++...+..++.|++.||.|||++|++||||||+
T Consensus 84 ~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~ 163 (314)
T cd05099 84 LGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAAR 163 (314)
T ss_pred EEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccce
Confidence 999999889999999999999999996532 34788899999999999999999999999999999
Q ss_pred CEEEcCCCcEEEeeecceeeecCCCc---cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHH
Q 020085 238 NLLMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPL 313 (331)
Q Consensus 238 NiLi~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~ 313 (331)
||++++++.+||+|||.++....... .....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||...++.
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~ 243 (314)
T cd05099 164 NVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE 243 (314)
T ss_pred eEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999975543211 112234568999999998899999999999999999999 89999988776
Q ss_pred HHHhcccccccccc
Q 020085 314 QAAVGVVQKVSIHS 327 (331)
Q Consensus 314 ~~~~~~~~~~~~p~ 327 (331)
+.... ...+.++.
T Consensus 244 ~~~~~-~~~~~~~~ 256 (314)
T cd05099 244 ELFKL-LREGHRMD 256 (314)
T ss_pred HHHHH-HHcCCCCC
Confidence 65554 33454443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=286.05 Aligned_cols=218 Identities=32% Similarity=0.575 Sum_probs=180.8
Q ss_pred ecccCcceeeeeeecCceEEEEEEEC--Cc--eEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCcceeEEeEEECCCC
Q 020085 107 IDAKQLKIECKVASGSYGDLYKGTYC--SQ--EVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPN 181 (331)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~--~vavK~~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~ 181 (331)
+..++|++.+.||+|+||.||+|.+. +. .+|+|.++... .......+.+|+.+++++ +||||+++++++..++.
T Consensus 4 ~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~ 82 (303)
T cd05088 4 LEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY 82 (303)
T ss_pred cchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC-CHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCC
Confidence 45678999999999999999999873 43 45777766432 345567889999999999 89999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCc
Q 020085 182 LCIVTEFMARGSIYDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV 246 (331)
Q Consensus 182 ~~lV~E~~~ggsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~ 246 (331)
.++||||+++++|.+++.... ..+++..++.++.|++.|++|||++|++||||||+|||++.++.
T Consensus 83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~ 162 (303)
T cd05088 83 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYV 162 (303)
T ss_pred ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCc
Confidence 999999999999999996532 25788999999999999999999999999999999999999999
Q ss_pred EEEeeecceeeecCCCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhcccccccc
Q 020085 247 VKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSI 325 (331)
Q Consensus 247 vkl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~ 325 (331)
++|+|||+++.............+..|+|||.+.+..++.++||||||+++|||++ |..||...+..+....+ ..+.+
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~-~~~~~ 241 (303)
T cd05088 163 AKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL-PQGYR 241 (303)
T ss_pred EEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHH-hcCCc
Confidence 99999999864322212222334678999999988889999999999999999998 99999887776655543 33444
Q ss_pred c
Q 020085 326 H 326 (331)
Q Consensus 326 p 326 (331)
+
T Consensus 242 ~ 242 (303)
T cd05088 242 L 242 (303)
T ss_pred C
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=279.14 Aligned_cols=214 Identities=21% Similarity=0.411 Sum_probs=191.4
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~ 186 (331)
.++|.+-+.||+|.|+.||++.. +|+.+|+|++..........+++.+|++|-+.++|||||++.+........|+|+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 56899999999999999998865 6889999998766555556788999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC---CCcEEEeeecceeeecCCCc
Q 020085 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE---NGVVKVADFGVARVQAQSGV 263 (331)
Q Consensus 187 E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~---~~~vkl~DFg~a~~~~~~~~ 263 (331)
|+|.|++|..-+-. +..+++..+....+||+++|+|+|.+||+|||+||+|+++-. ..-+||+|||+|........
T Consensus 90 e~m~G~dl~~eIV~-R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~ 168 (355)
T KOG0033|consen 90 DLVTGGELFEDIVA-REFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEA 168 (355)
T ss_pred ecccchHHHHHHHH-HHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCccc
Confidence 99999999877755 367888999999999999999999999999999999999953 34699999999998876555
Q ss_pred cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccccc
Q 020085 264 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKV 323 (331)
Q Consensus 264 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~ 323 (331)
.....|||.|||||++...+|+..+|||+.|++||-|+.|.+||-+.+....+.++.+..
T Consensus 169 ~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~ 228 (355)
T KOG0033|consen 169 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGA 228 (355)
T ss_pred cccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccc
Confidence 667789999999999999999999999999999999999999999999988888877643
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=290.61 Aligned_cols=198 Identities=30% Similarity=0.503 Sum_probs=169.7
Q ss_pred eecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeE
Q 020085 106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183 (331)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 183 (331)
....++|+..++||+|+||.||++++ .++.||||++.... .......+.+|+.+++.++|+||+++++++.....++
T Consensus 70 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 148 (353)
T PLN00034 70 AKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH-EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQ 148 (353)
T ss_pred CCCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC-cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEE
Confidence 34467889999999999999999988 47899999997543 3445677999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC-
Q 020085 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG- 262 (331)
Q Consensus 184 lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~- 262 (331)
+||||+++++|.+. ...++..+..++.||+.||+|||++|++||||||+|||+++++.+||+|||+++......
T Consensus 149 lv~e~~~~~~L~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 149 VLLEFMDGGSLEGT-----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred EEEecCCCCccccc-----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 99999999998653 234677888999999999999999999999999999999999999999999998654332
Q ss_pred ccccCCCCcccccchhcCC-----CCCCChhhHHHHHHHHHHHHcCCCCCCC
Q 020085 263 VMTAETGTYRWMAPEVIEH-----KPYDYKADVFSFGIALWELLTGELPYAG 309 (331)
Q Consensus 263 ~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~SlG~il~ell~g~~Pf~~ 309 (331)
......||..|+|||.+.. ...+.++|||||||++|||++|+.||..
T Consensus 224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~ 275 (353)
T PLN00034 224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV 275 (353)
T ss_pred cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 2234578999999999843 2345689999999999999999999974
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-37 Score=277.25 Aligned_cols=218 Identities=33% Similarity=0.617 Sum_probs=185.3
Q ss_pred eeecccCcceeeeeeecCceEEEEEEE-CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeE
Q 020085 105 WEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183 (331)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 183 (331)
|+|..++|++.++||+|+||.||+|.. .++.||+|.++....+ ...+.+|+.++++++|||++++++.+. ....+
T Consensus 1 ~~~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05067 1 WEVPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS---PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIY 76 (260)
T ss_pred CccchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc---HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcE
Confidence 678899999999999999999999987 5688999999865443 357889999999999999999999875 45689
Q ss_pred EEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC
Q 020085 184 IVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262 (331)
Q Consensus 184 lV~E~~~ggsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~ 262 (331)
++|||+.+++|.+++... ...++...+..++.|++.||+|||+.|++||||||+||++++++.++|+|||.+.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05067 77 IITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCC
Confidence 999999999999998654 3468889999999999999999999999999999999999999999999999997655322
Q ss_pred cc--ccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhcccccccccc
Q 020085 263 VM--TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIHS 327 (331)
Q Consensus 263 ~~--~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p~ 327 (331)
.. ....++..|+|||.+....++.++|+||||+++||+++ |+.||.+.++.+....+ .++.+++
T Consensus 157 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~-~~~~~~~ 223 (260)
T cd05067 157 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNL-ERGYRMP 223 (260)
T ss_pred cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHH-HcCCCCC
Confidence 21 12345678999999998889999999999999999999 99999988876665553 3344433
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=276.28 Aligned_cols=211 Identities=35% Similarity=0.558 Sum_probs=185.2
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~ 186 (331)
.++|++.++||+|+||.||++.. .++.+|+|+++... ....+.+.+|+.++++++||||+++++++.....+|++|
T Consensus 2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP--GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc--hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 46899999999999999999987 46789999998653 234578999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC-ccc
Q 020085 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMT 265 (331)
Q Consensus 187 E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~-~~~ 265 (331)
||+++++|.+++......+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus 80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 159 (262)
T cd06613 80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRK 159 (262)
T ss_pred eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhccc
Confidence 9999999999997765789999999999999999999999999999999999999999999999999987554322 223
Q ss_pred cCCCCcccccchhcCCC---CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 266 AETGTYRWMAPEVIEHK---PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 266 ~~~gt~~y~aPE~~~~~---~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
...++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...++.+......+
T Consensus 160 ~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~ 218 (262)
T cd06613 160 SFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISK 218 (262)
T ss_pred cccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 45678899999999776 889999999999999999999999998877766555433
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=276.94 Aligned_cols=212 Identities=37% Similarity=0.671 Sum_probs=182.9
Q ss_pred eeecccCcceeeeeeecCceEEEEEEE-CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeE
Q 020085 105 WEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183 (331)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 183 (331)
|++..++|++.++||+|+||.||++.. .+..+|+|.++...... +.+.+|+.++++++|||++++++++. ....+
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~~---~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~ 76 (260)
T cd05070 1 WEIPRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP---ESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIY 76 (260)
T ss_pred CCCchHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCCH---HHHHHHHHHHHhcCCCceEEEEeEEC-CCCcE
Confidence 678889999999999999999999987 45689999998754433 56889999999999999999999875 45689
Q ss_pred EEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC
Q 020085 184 IVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262 (331)
Q Consensus 184 lV~E~~~ggsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~ 262 (331)
++|||+++++|.+++... ...+++..+..++.|++.|+.|||++|++||||||+||++++++.++|+|||.+.......
T Consensus 77 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05070 77 IVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcc
Confidence 999999999999999764 3468999999999999999999999999999999999999999999999999997654432
Q ss_pred cc--ccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhccc
Q 020085 263 VM--TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 263 ~~--~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~ 320 (331)
.. ....++..|+|||.+.+..++.++|+||||+++|+|++ |..||.+.+..+....+.
T Consensus 157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~ 217 (260)
T cd05070 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVE 217 (260)
T ss_pred cccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 11 12234568999999988889999999999999999999 899999988877666644
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=315.10 Aligned_cols=219 Identities=22% Similarity=0.442 Sum_probs=183.8
Q ss_pred eeecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEEC--CC
Q 020085 105 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR--PP 180 (331)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~--~~ 180 (331)
.+...++|.+.++||+|+||+||++++ .++.+|+|+++...........+..|+.++++++||||++++++|.. ..
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~ 87 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQ 87 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCC
Confidence 345567999999999999999999988 45789999998766566667889999999999999999999998854 34
Q ss_pred CeEEEEeccCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC-------CcccCCCCCCCEEEcCC------
Q 020085 181 NLCIVTEFMARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLHQN-------NIIHRDLKTANLLMDEN------ 244 (331)
Q Consensus 181 ~~~lV~E~~~ggsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~-------~iiHrDlkp~NiLi~~~------ 244 (331)
.+||||||+++|+|.++|... .+.+++..++.++.||+.||.|||+. +|+||||||+|||++.+
T Consensus 88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~ 167 (1021)
T PTZ00266 88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK 167 (1021)
T ss_pred EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence 689999999999999999653 35799999999999999999999984 49999999999999642
Q ss_pred -----------CcEEEeeecceeeecCCCccccCCCCcccccchhcCC--CCCCChhhHHHHHHHHHHHHcCCCCCCCCC
Q 020085 245 -----------GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEH--KPYDYKADVFSFGIALWELLTGELPYAGLT 311 (331)
Q Consensus 245 -----------~~vkl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~SlG~il~ell~g~~Pf~~~~ 311 (331)
+.+||+|||+++............||+.|+|||++.+ ..++.++|||||||+||||++|+.||....
T Consensus 168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 168 ITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred ccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 3589999999986654444445579999999999854 458899999999999999999999998776
Q ss_pred HHHHHhcccccc
Q 020085 312 PLQAAVGVVQKV 323 (331)
Q Consensus 312 ~~~~~~~~~~~~ 323 (331)
........+..+
T Consensus 248 ~~~qli~~lk~~ 259 (1021)
T PTZ00266 248 NFSQLISELKRG 259 (1021)
T ss_pred cHHHHHHHHhcC
Confidence 655555544443
|
|
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-37 Score=284.13 Aligned_cols=222 Identities=31% Similarity=0.606 Sum_probs=187.0
Q ss_pred eeeecccCcceeeeeeecCceEEEEEEE-------CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCcceeEEeE
Q 020085 104 VWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGA 175 (331)
Q Consensus 104 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~ 175 (331)
.|.+..++|.+.+.||+|+||.||++++ .+..+|+|+++... .....+.+.+|+.+++++ +||||++++++
T Consensus 29 ~~~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 107 (302)
T cd05055 29 KWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA-HSSEREALMSELKIMSHLGNHENIVNLLGA 107 (302)
T ss_pred cccccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC-ChHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence 4778889999999999999999999975 23479999987553 234456799999999999 79999999999
Q ss_pred EECCCCeEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecc
Q 020085 176 CTRPPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV 254 (331)
Q Consensus 176 ~~~~~~~~lV~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~ 254 (331)
+...+..+++|||+.+|+|.+++.... ..+++..+..++.|++.|++|||+++++|+||||+||+++.++.++++|||.
T Consensus 108 ~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 108 CTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred EecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcc
Confidence 999999999999999999999997643 3489999999999999999999999999999999999999999999999999
Q ss_pred eeeecCCCc---cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhccccccccc
Q 020085 255 ARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIH 326 (331)
Q Consensus 255 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p 326 (331)
++....... .....++..|+|||.+.+..++.++||||+|+++|||++ |+.||...+..+........+.++
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~ 263 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRM 263 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcC
Confidence 975543221 112245678999999999899999999999999999998 999998876655444444444443
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=276.46 Aligned_cols=217 Identities=30% Similarity=0.497 Sum_probs=181.8
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCC---CHHHHHHHHHHHHHHHhcCCCcceeEEeEEECC--CCe
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV---NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--PNL 182 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~---~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~--~~~ 182 (331)
.+|++.+.||+|+||.||++.. +++.||+|.+..... .....+.+.+|+.++++++||||+++++++.+. ..+
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 5789999999999999999987 568899998864321 233457889999999999999999999988663 457
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC-
Q 020085 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS- 261 (331)
Q Consensus 183 ~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~- 261 (331)
+++|||+++++|.+++.. ...+++..+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||.++.....
T Consensus 82 ~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~ 160 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS-YGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC 160 (265)
T ss_pred EEEEEecCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccccc
Confidence 899999999999999865 356788999999999999999999999999999999999999999999999998754321
Q ss_pred ---CccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccccccccc
Q 020085 262 ---GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIHS 327 (331)
Q Consensus 262 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~p~ 327 (331)
.......++..|+|||.+.+..++.++|+||||+++|+|++|+.||....+.....+.......|.
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~ 229 (265)
T cd06652 161 LSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPV 229 (265)
T ss_pred ccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCCCC
Confidence 122334688899999999888899999999999999999999999988776666655444443443
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=281.00 Aligned_cols=218 Identities=30% Similarity=0.603 Sum_probs=184.8
Q ss_pred ecccCcceeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECC
Q 020085 107 IDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP 179 (331)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 179 (331)
+..++|.+.+.||+|+||.||+|+.. ++.||+|+++... ..+....+.+|++++++++||||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 80 (280)
T cd05049 2 VQRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA-SNDARKDFEREAELLTNFQHENIVKFYGVCTEG 80 (280)
T ss_pred CChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC-CHHHHHHHHHHHHHHHhcCCCCchheeeEEecC
Confidence 34668999999999999999999763 3679999998653 333557899999999999999999999999999
Q ss_pred CCeEEEEeccCCCCHHHHHHhcC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCc
Q 020085 180 PNLCIVTEFMARGSIYDFLHKQK-------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV 246 (331)
Q Consensus 180 ~~~~lV~E~~~ggsL~~~l~~~~-------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~ 246 (331)
...++||||+++++|.+++.... ..+++..+..++.|++.|+.|||++|++||||||+||+++.++.
T Consensus 81 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~ 160 (280)
T cd05049 81 DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLV 160 (280)
T ss_pred CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCe
Confidence 99999999999999999996532 34788899999999999999999999999999999999999999
Q ss_pred EEEeeecceeeecCCCc---cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhccccc
Q 020085 247 VKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQK 322 (331)
Q Consensus 247 vkl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~ 322 (331)
++|+|||+++....... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...+..+....+. .
T Consensus 161 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~-~ 239 (280)
T cd05049 161 VKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECIT-Q 239 (280)
T ss_pred EEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-c
Confidence 99999999975433221 123345788999999999999999999999999999998 999998887776665533 4
Q ss_pred cccc
Q 020085 323 VSIH 326 (331)
Q Consensus 323 ~~~p 326 (331)
+..+
T Consensus 240 ~~~~ 243 (280)
T cd05049 240 GRLL 243 (280)
T ss_pred CCcC
Confidence 4433
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=280.85 Aligned_cols=215 Identities=28% Similarity=0.546 Sum_probs=181.7
Q ss_pred eeecccCcceeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEE
Q 020085 105 WEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177 (331)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 177 (331)
|+++.++|++.++||+|+||.||+|... +..||+|.++... .......+.+|+.+++.++||||+++++++.
T Consensus 1 ~~~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~ 79 (288)
T cd05061 1 WEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA-SLRERIEFLNEASVMKGFTCHHVVRLLGVVS 79 (288)
T ss_pred CcccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence 7889999999999999999999998753 3479999987543 2333456889999999999999999999999
Q ss_pred CCCCeEEEEeccCCCCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEE
Q 020085 178 RPPNLCIVTEFMARGSIYDFLHKQK---------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVK 248 (331)
Q Consensus 178 ~~~~~~lV~E~~~ggsL~~~l~~~~---------~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vk 248 (331)
.....++||||+++|+|.+++.... ...+...+..++.|++.||.|||++|++||||||+||+++.++.++
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~ 159 (288)
T cd05061 80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVK 159 (288)
T ss_pred CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEE
Confidence 9999999999999999999996532 2345678889999999999999999999999999999999999999
Q ss_pred EeeecceeeecCCCc---cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhccc
Q 020085 249 VADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 249 l~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~ 320 (331)
|+|||+++....... .....++..|+|||.+.+..++.++|+|||||++|||++ |..||.+....+....++
T Consensus 160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~ 235 (288)
T cd05061 160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVM 235 (288)
T ss_pred ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 999999875433221 112234678999999998889999999999999999998 799999887776555443
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=280.78 Aligned_cols=217 Identities=28% Similarity=0.548 Sum_probs=184.3
Q ss_pred ecccCcceeeeeeecCceEEEEEEE-------CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECC
Q 020085 107 IDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP 179 (331)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 179 (331)
|+..+|.+.+.||+|+||.||++.. .+..+|+|.++.. .......+.+|+.++++++||||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (288)
T cd05093 2 IKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVCVEG 79 (288)
T ss_pred CchHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC
Confidence 5678899999999999999999974 2345899988754 344567799999999999999999999999999
Q ss_pred CCeEEEEeccCCCCHHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcE
Q 020085 180 PNLCIVTEFMARGSIYDFLHKQK------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVV 247 (331)
Q Consensus 180 ~~~~lV~E~~~ggsL~~~l~~~~------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~v 247 (331)
...++||||+++++|.+++.... ..+++..+..++.|++.||+|||++|++||||||+||++++++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~ 159 (288)
T cd05093 80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLV 159 (288)
T ss_pred CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcE
Confidence 99999999999999999996532 248999999999999999999999999999999999999999999
Q ss_pred EEeeecceeeecCCCc---cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhcccccc
Q 020085 248 KVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKV 323 (331)
Q Consensus 248 kl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~ 323 (331)
+|+|||.++....... .....+++.|+|||.+.+..++.++|+||||+++|+|++ |+.||...++.+....+. ++
T Consensus 160 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~-~~ 238 (288)
T cd05093 160 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT-QG 238 (288)
T ss_pred EeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cC
Confidence 9999999975533221 122335678999999999999999999999999999998 999999888777665543 44
Q ss_pred ccc
Q 020085 324 SIH 326 (331)
Q Consensus 324 ~~p 326 (331)
..+
T Consensus 239 ~~~ 241 (288)
T cd05093 239 RVL 241 (288)
T ss_pred CcC
Confidence 443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=275.68 Aligned_cols=213 Identities=39% Similarity=0.704 Sum_probs=185.3
Q ss_pred eeecccCcceeeeeeecCceEEEEEEEC-CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeE
Q 020085 105 WEIDAKQLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183 (331)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 183 (331)
|+++.++|.+.++||+|+||.||++... ++.+|+|.++..... .+++.+|+.++++++|||++++++++......+
T Consensus 1 ~~~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 77 (261)
T cd05034 1 WEIPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS---PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIY 77 (261)
T ss_pred CccchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC---HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceE
Confidence 6788999999999999999999999874 477999999865433 357889999999999999999999999888999
Q ss_pred EEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC
Q 020085 184 IVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262 (331)
Q Consensus 184 lV~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~ 262 (331)
+||||+++++|.+++.... ..++...+..++.|++.|+.|||++|++|+||||+||++++++.++|+|||.++......
T Consensus 78 ~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~ 157 (261)
T cd05034 78 IVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDE 157 (261)
T ss_pred EEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchh
Confidence 9999999999999997643 468999999999999999999999999999999999999999999999999987654321
Q ss_pred c--cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhccc
Q 020085 263 V--MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 263 ~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~ 320 (331)
. ......+..|+|||.+.+..++.++|+||||+++|++++ |+.||.+.++......+.
T Consensus 158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~ 218 (261)
T cd05034 158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVE 218 (261)
T ss_pred hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 1 112234568999999998889999999999999999998 999999888776666644
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=290.55 Aligned_cols=222 Identities=32% Similarity=0.609 Sum_probs=182.2
Q ss_pred eeecccCcceeeeeeecCceEEEEEEE-------CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCcceeEEeEE
Q 020085 105 WEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGAC 176 (331)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~ 176 (331)
|+.+.++|++.+.||+|+||+||+|.+ .++.||||+++... ..+....+.+|+.+++++ +||||++++++|
T Consensus 2 ~~~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~ 80 (343)
T cd05103 2 WEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGAC 80 (343)
T ss_pred cccchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC-ChHHHHHHHHHHHHHHhccCCccHhhhccee
Confidence 788889999999999999999999974 35789999997653 234456788999999999 689999999988
Q ss_pred ECC-CCeEEEEeccCCCCHHHHHHhcC-----------------------------------------------------
Q 020085 177 TRP-PNLCIVTEFMARGSIYDFLHKQK----------------------------------------------------- 202 (331)
Q Consensus 177 ~~~-~~~~lV~E~~~ggsL~~~l~~~~----------------------------------------------------- 202 (331)
... ...+++|||+++|+|.+++....
T Consensus 81 ~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (343)
T cd05103 81 TKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSD 160 (343)
T ss_pred ecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCcccc
Confidence 654 46899999999999999986532
Q ss_pred -------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCc---ccc
Q 020085 203 -------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV---MTA 266 (331)
Q Consensus 203 -------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~---~~~ 266 (331)
..++...+..++.|+++||+|||++|++||||||+||++++++.++|+|||+++....... ...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 240 (343)
T cd05103 161 VEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240 (343)
T ss_pred chhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence 2357778889999999999999999999999999999999999999999999875433211 112
Q ss_pred CCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhcccccccccc
Q 020085 267 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIHS 327 (331)
Q Consensus 267 ~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p~ 327 (331)
..+++.|+|||.+.+..++.++|+||||+++|+|++ |..||+.....+.....+.++.++.
T Consensus 241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 302 (343)
T cd05103 241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR 302 (343)
T ss_pred CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCC
Confidence 234678999999988899999999999999999997 9999988655444444455555543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=274.75 Aligned_cols=202 Identities=31% Similarity=0.616 Sum_probs=174.0
Q ss_pred eeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEeccCCCC
Q 020085 116 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGS 193 (331)
Q Consensus 116 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~~~ggs 193 (331)
+.||+|+||.||+|+. .++.+|+|.++... ..+....+.+|+.++++++||||++++++|......++||||+++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 79 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL-PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence 4699999999999987 67889999987543 45556789999999999999999999999999999999999999999
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCcc---ccCCCC
Q 020085 194 IYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM---TAETGT 270 (331)
Q Consensus 194 L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~---~~~~gt 270 (331)
|.+++......+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||.++........ .....+
T Consensus 80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 159 (252)
T cd05084 80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIP 159 (252)
T ss_pred HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCc
Confidence 99999765667899999999999999999999999999999999999999999999999998754322111 111234
Q ss_pred cccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhc
Q 020085 271 YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVG 318 (331)
Q Consensus 271 ~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~ 318 (331)
..|+|||.+.+..++.++|+||||+++|||++ |..||...++.+....
T Consensus 160 ~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~ 208 (252)
T cd05084 160 VKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREA 208 (252)
T ss_pred eeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHH
Confidence 57999999998889999999999999999998 9999988877655444
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=281.31 Aligned_cols=215 Identities=32% Similarity=0.517 Sum_probs=186.2
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~ 186 (331)
.++|.+.++||+|+||.||++.+ +++.+|+|+++.. .....+.+.+|+.++++++|||++++++.+..+...++||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE--SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI 81 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEe
Confidence 46799999999999999999987 4688999998754 3455678999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC-Cccc
Q 020085 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMT 265 (331)
Q Consensus 187 E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~-~~~~ 265 (331)
||+++++|.+++......+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+...... ....
T Consensus 82 e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~ 161 (280)
T cd06611 82 EFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRD 161 (280)
T ss_pred eccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccccc
Confidence 999999999999776678999999999999999999999999999999999999999999999999988654322 1223
Q ss_pred cCCCCcccccchhcC-----CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccccccc
Q 020085 266 AETGTYRWMAPEVIE-----HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIH 326 (331)
Q Consensus 266 ~~~gt~~y~aPE~~~-----~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~p 326 (331)
...+++.|+|||.+. ...++.++|+||||+++|+|++|+.||....+.+....+ +++..|
T Consensus 162 ~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~-~~~~~~ 226 (280)
T cd06611 162 TFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKI-LKSEPP 226 (280)
T ss_pred eeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHH-hcCCCC
Confidence 346889999999974 345788999999999999999999999998887766653 445444
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-38 Score=282.39 Aligned_cols=214 Identities=26% Similarity=0.546 Sum_probs=182.4
Q ss_pred ecccCcceeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECC
Q 020085 107 IDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP 179 (331)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 179 (331)
++..+|++.++||+|+||.||+|... ++.||+|+++... .....+.+.+|+.+++.++||||+++++++...
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~ 80 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA-EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKE 80 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC-CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCC
Confidence 55678999999999999999999863 3679999998553 334456789999999999999999999999999
Q ss_pred CCeEEEEeccCCCCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC
Q 020085 180 PNLCIVTEFMARGSIYDFLHKQ---------------KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN 244 (331)
Q Consensus 180 ~~~~lV~E~~~ggsL~~~l~~~---------------~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~ 244 (331)
...++++||+.+++|.+++... +..+++..+..++.|++.||+|||++|++||||||+||+++++
T Consensus 81 ~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~ 160 (283)
T cd05091 81 QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDK 160 (283)
T ss_pred CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCC
Confidence 9999999999999999998532 2347888899999999999999999999999999999999999
Q ss_pred CcEEEeeecceeeecCCCc---cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhccc
Q 020085 245 GVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 245 ~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~ 320 (331)
+.+||+|||+++....... .....+++.|+|||.+.+..++.++||||||+++|||++ |..||.+.++.+....+.
T Consensus 161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~ 240 (283)
T cd05091 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR 240 (283)
T ss_pred CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence 9999999999875433221 122345789999999988889999999999999999998 889999988877666644
Q ss_pred c
Q 020085 321 Q 321 (331)
Q Consensus 321 ~ 321 (331)
+
T Consensus 241 ~ 241 (283)
T cd05091 241 N 241 (283)
T ss_pred c
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=282.57 Aligned_cols=221 Identities=30% Similarity=0.608 Sum_probs=186.3
Q ss_pred eeeecccCcceeeeeeecCceEEEEEEEC---------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCcceeEE
Q 020085 104 VWEIDAKQLKIECKVASGSYGDLYKGTYC---------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFI 173 (331)
Q Consensus 104 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~ 173 (331)
.|++..++|.+.+.||+|+||.||++++. +..||+|.++... .......+.+|+.+++.+ +||||++++
T Consensus 9 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~ 87 (304)
T cd05101 9 RWEFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLL 87 (304)
T ss_pred cccccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc-chHHHHHHHHHHHHHHhhccCCCchhee
Confidence 37888999999999999999999999752 2469999987543 344457799999999999 899999999
Q ss_pred eEEECCCCeEEEEeccCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 020085 174 GACTRPPNLCIVTEFMARGSIYDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTAN 238 (331)
Q Consensus 174 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~N 238 (331)
+++......+++|||+++|+|.+++.... ..++...+..++.|+++||.|||++|++||||||+|
T Consensus 88 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~N 167 (304)
T cd05101 88 GACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARN 167 (304)
T ss_pred EEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccce
Confidence 99999999999999999999999997642 246778899999999999999999999999999999
Q ss_pred EEEcCCCcEEEeeecceeeecCCCc---cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHH
Q 020085 239 LLMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQ 314 (331)
Q Consensus 239 iLi~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~ 314 (331)
|+++.++.++|+|||.++....... .....+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+
T Consensus 168 ili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~ 247 (304)
T cd05101 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE 247 (304)
T ss_pred EEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH
Confidence 9999999999999999976543221 122345678999999988889999999999999999998 899999887766
Q ss_pred HHhccccccccc
Q 020085 315 AAVGVVQKVSIH 326 (331)
Q Consensus 315 ~~~~~~~~~~~p 326 (331)
.... +..+.++
T Consensus 248 ~~~~-~~~~~~~ 258 (304)
T cd05101 248 LFKL-LKEGHRM 258 (304)
T ss_pred HHHH-HHcCCcC
Confidence 5554 3444443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=277.79 Aligned_cols=211 Identities=31% Similarity=0.522 Sum_probs=180.9
Q ss_pred cccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEE
Q 020085 108 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV 185 (331)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV 185 (331)
..++|++.+.||+|+||.||+|+. .++.||+|+++.... .....+.+|+.++++++||||+++++.+......++|
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~--~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv 84 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPG--DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC 84 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCcc--chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence 356899999999999999999987 568899999975432 2335688899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC-cc
Q 020085 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VM 264 (331)
Q Consensus 186 ~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~-~~ 264 (331)
|||+++++|.+++.. .+.+++..+..++.|++.|+.|||+.|++|||++|+||+++.++.++|+|||+++...... ..
T Consensus 85 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd06646 85 MEYCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKR 163 (267)
T ss_pred EeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccccccc
Confidence 999999999999865 4678999999999999999999999999999999999999999999999999997654322 22
Q ss_pred ccCCCCcccccchhcC---CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 265 TAETGTYRWMAPEVIE---HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 265 ~~~~gt~~y~aPE~~~---~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
....+++.|+|||.+. ...++.++|+||||+++|||++|+.||....+.+....+.+
T Consensus 164 ~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~ 223 (267)
T cd06646 164 KSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSK 223 (267)
T ss_pred CccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeec
Confidence 3456889999999984 34578899999999999999999999987777665554433
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=311.82 Aligned_cols=203 Identities=23% Similarity=0.427 Sum_probs=175.2
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEE
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~ 186 (331)
++|.+.++||+|+||.||+|.+ +++.||+|+++.... +....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 4799999999999999999987 478999999976533 3344567999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhc----------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeeccee
Q 020085 187 EFMARGSIYDFLHKQ----------KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR 256 (331)
Q Consensus 187 E~~~ggsL~~~l~~~----------~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~ 256 (331)
||++||+|.+++... ....+...++.++.||++||+|||++||+||||||+||+++.++.++|+|||+++
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk 161 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI 161 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcce
Confidence 999999999998642 1234566788999999999999999999999999999999999999999999997
Q ss_pred eecCCC-------------------ccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH
Q 020085 257 VQAQSG-------------------VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTP 312 (331)
Q Consensus 257 ~~~~~~-------------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~ 312 (331)
...... ......||+.|+|||.+.+..++.++|||||||++|||++|+.||.....
T Consensus 162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~ 236 (932)
T PRK13184 162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG 236 (932)
T ss_pred ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcch
Confidence 652110 01123589999999999999999999999999999999999999987544
|
|
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-38 Score=291.13 Aligned_cols=210 Identities=25% Similarity=0.457 Sum_probs=178.0
Q ss_pred eeeecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECC--
Q 020085 104 VWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP-- 179 (331)
Q Consensus 104 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~-- 179 (331)
.|++ .++|.+.+.||+|+||+||++.+ .++.||||+++...........+.+|+.++++++||||+++++++...
T Consensus 10 ~~~~-~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07878 10 VWEV-PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATS 88 (343)
T ss_pred Hhhh-hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccc
Confidence 3444 36799999999999999999987 567899999986543444456788999999999999999999987543
Q ss_pred ----CCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecce
Q 020085 180 ----PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA 255 (331)
Q Consensus 180 ----~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a 255 (331)
...|+++|++ +++|.+++. ...+++..+..++.|++.||+|||++||+||||||+||++++++.+||+|||++
T Consensus 89 ~~~~~~~~~~~~~~-~~~l~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~ 165 (343)
T cd07878 89 IENFNEVYLVTNLM-GADLNNIVK--CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLA 165 (343)
T ss_pred ccccCcEEEEeecC-CCCHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccc
Confidence 3478999988 669988874 356899999999999999999999999999999999999999999999999999
Q ss_pred eeecCCCccccCCCCcccccchhcCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcc
Q 020085 256 RVQAQSGVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGV 319 (331)
Q Consensus 256 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~ 319 (331)
+..... .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+
T Consensus 166 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~ 228 (343)
T cd07878 166 RQADDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRI 228 (343)
T ss_pred eecCCC--cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 865432 344578999999999876 57899999999999999999999999987766655443
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=280.40 Aligned_cols=208 Identities=28% Similarity=0.486 Sum_probs=183.8
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEE
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~ 186 (331)
++|.+.+.||+|+||.||++.+ .++.+|+|+++.... .......+.+|++++++++||||+++++.+..+...++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 4789999999999999999988 568999999875432 2334567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCcccc
Q 020085 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 266 (331)
Q Consensus 187 E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~~~ 266 (331)
||+++++|.+++.. .+.+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||+++..... ...
T Consensus 81 e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--~~~ 157 (290)
T cd05580 81 EYVPGGELFSHLRK-SGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--TYT 157 (290)
T ss_pred ecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--CCC
Confidence 99999999999966 467899999999999999999999999999999999999999999999999999765443 334
Q ss_pred CCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccc
Q 020085 267 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 267 ~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~ 320 (331)
..+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...++.+....+.
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 211 (290)
T cd05580 158 LCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL 211 (290)
T ss_pred CCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Confidence 568899999999988888999999999999999999999999888766555544
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=293.81 Aligned_cols=201 Identities=23% Similarity=0.414 Sum_probs=169.8
Q ss_pred eeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhc---CCCcceeEEeEEECCCCeEEEEeccCC
Q 020085 118 VASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKI---RHKNVVQFIGACTRPPNLCIVTEFMAR 191 (331)
Q Consensus 118 lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l---~h~niv~~~~~~~~~~~~~lV~E~~~g 191 (331)
||+|+||+||+|+. .++.||+|++..... .......+..|..+++.. +||||+++++.+......|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 69999999999987 478999999864321 222334556677777665 699999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC-CccccCCCC
Q 020085 192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTAETGT 270 (331)
Q Consensus 192 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~-~~~~~~~gt 270 (331)
|+|.+++.. .+.+++..+..++.||++||+|||++||+||||||+|||++.++.++|+|||+++..... .......||
T Consensus 81 g~L~~~l~~-~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt 159 (330)
T cd05586 81 GELFWHLQK-EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGT 159 (330)
T ss_pred ChHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCC
Confidence 999999865 567899999999999999999999999999999999999999999999999998753322 223345689
Q ss_pred cccccchhcCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcc
Q 020085 271 YRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGV 319 (331)
Q Consensus 271 ~~y~aPE~~~~~-~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~ 319 (331)
+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+....+
T Consensus 160 ~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i 209 (330)
T cd05586 160 TEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNI 209 (330)
T ss_pred ccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHH
Confidence 999999998654 5899999999999999999999999988777665553
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=280.34 Aligned_cols=212 Identities=30% Similarity=0.516 Sum_probs=184.1
Q ss_pred eecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeE
Q 020085 106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183 (331)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 183 (331)
-.+.+.|++.++||+|+||.||+|.. .++.+++|+++.. +....+.+.+|+.+++.++|||++++++.+..+...+
T Consensus 8 ~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~ 85 (292)
T cd06644 8 LDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLW 85 (292)
T ss_pred cCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEE
Confidence 34457899999999999999999987 4688999998754 4555678999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC-C
Q 020085 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-G 262 (331)
Q Consensus 184 lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~-~ 262 (331)
+||||+++++|..++.+....+++..+..++.|++.++.|||+.|++||||||+||+++.++.++|+|||.+...... .
T Consensus 86 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~ 165 (292)
T cd06644 86 IMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ 165 (292)
T ss_pred EEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccccc
Confidence 999999999999988766677899999999999999999999999999999999999999999999999998654322 2
Q ss_pred ccccCCCCcccccchhcC-----CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcc
Q 020085 263 VMTAETGTYRWMAPEVIE-----HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGV 319 (331)
Q Consensus 263 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~ 319 (331)
......+++.|+|||.+. ...++.++|+||||+++|||++|+.||...++.+...++
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~ 227 (292)
T cd06644 166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI 227 (292)
T ss_pred ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHH
Confidence 223446889999999984 445788999999999999999999999888777666553
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-37 Score=276.56 Aligned_cols=215 Identities=29% Similarity=0.543 Sum_probs=180.9
Q ss_pred cceeeeeeecCceEEEEEEEC-----CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCC-----
Q 020085 112 LKIECKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN----- 181 (331)
Q Consensus 112 ~~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~----- 181 (331)
|++.+.||+|+||.||+|... +..||+|+++.+.........+.+|+..++.++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 567899999999999999863 2679999998766566667789999999999999999999998866554
Q ss_pred -eEEEEeccCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecce
Q 020085 182 -LCIVTEFMARGSIYDFLHKQ-----KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA 255 (331)
Q Consensus 182 -~~lV~E~~~ggsL~~~l~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a 255 (331)
.++++||+++|+|.+++... ...+++..+..++.|++.||+|||++|++||||||+||++++++.+||+|||++
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~ 160 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS 160 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence 79999999999999998543 236888999999999999999999999999999999999999999999999999
Q ss_pred eeecCCCcc---ccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhcccccccccc
Q 020085 256 RVQAQSGVM---TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIHS 327 (331)
Q Consensus 256 ~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p~ 327 (331)
+........ .....+..|+|||.+.+..++.++||||||+++|||++ |..||.+.++.+....+ .++..+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~-~~~~~~~ 235 (273)
T cd05035 161 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYL-RHGNRLK 235 (273)
T ss_pred eeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-HcCCCCC
Confidence 865443221 12235678999999988899999999999999999999 89999988877766553 3344443
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=276.95 Aligned_cols=211 Identities=33% Similarity=0.606 Sum_probs=181.4
Q ss_pred cccCcceeeeeeecCceEEEEEEEC--C---ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCe
Q 020085 108 DAKQLKIECKVASGSYGDLYKGTYC--S---QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL 182 (331)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~---~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 182 (331)
+..+|++.+.||+|+||.||+|... + ..||+|+++... +......|..|+.++++++||||+++.+++..+...
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 80 (269)
T cd05065 2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPV 80 (269)
T ss_pred ChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCce
Confidence 3557899999999999999999873 2 359999987653 455567899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC
Q 020085 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262 (331)
Q Consensus 183 ~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~ 262 (331)
++||||+++++|.+++....+.++...++.++.|++.|++|||++|++|+||||+||+++.++.++|+|||+++......
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~ 160 (269)
T cd05065 81 MIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDT 160 (269)
T ss_pred EEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCc
Confidence 99999999999999997766778999999999999999999999999999999999999999999999999987543322
Q ss_pred cc---ccCC---CCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhcc
Q 020085 263 VM---TAET---GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGV 319 (331)
Q Consensus 263 ~~---~~~~---gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~ 319 (331)
.. .... .+..|+|||.+.+..++.++|+||||+++||+++ |..||......+....+
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i 224 (269)
T cd05065 161 SDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAI 224 (269)
T ss_pred cccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHH
Confidence 11 1111 2457999999999999999999999999999887 99999988777665554
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=272.67 Aligned_cols=211 Identities=24% Similarity=0.454 Sum_probs=186.6
Q ss_pred CcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEec
Q 020085 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF 188 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~ 188 (331)
+|++.+.||+|+||.||.++. .++.+++|.+.....+......+.+|+.++++++|+||+++++++......+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 588999999999998887765 678899999876655666677899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC-cccc
Q 020085 189 MARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTA 266 (331)
Q Consensus 189 ~~ggsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~-~~~~ 266 (331)
+++++|.+++... ...++...+..++.|+++++.|||+.|++|+||+|+||++++++.+||+|||.++...... ....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~ 160 (256)
T cd08221 81 ANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET 160 (256)
T ss_pred cCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccccccc
Confidence 9999999999765 3568999999999999999999999999999999999999999999999999998654433 2334
Q ss_pred CCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 267 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 267 ~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
..+++.|+|||.+.+..++.++|+||||+++|+|++|..||...++.+....+..
T Consensus 161 ~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~ 215 (256)
T cd08221 161 VVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQ 215 (256)
T ss_pred cCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc
Confidence 5689999999999888899999999999999999999999998887776666543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=273.83 Aligned_cols=215 Identities=27% Similarity=0.460 Sum_probs=185.4
Q ss_pred CcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEec
Q 020085 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF 188 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~ 188 (331)
+|++.++||+|+||.||++.+ .++.+|+|.++... .....+.+.+|+.+++.++|||++++++.+..+..++++|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEY 79 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc-chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEee
Confidence 578899999999999999987 57889999987543 234457788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCc-ccc
Q 020085 189 MARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV-MTA 266 (331)
Q Consensus 189 ~~ggsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~-~~~ 266 (331)
+++++|.+++... ...+++..+..++.|++.||.|||++|++|+||||+||++++++.++++|||.++....... ...
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (255)
T cd08219 80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT 159 (255)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccccccc
Confidence 9999999998654 34688999999999999999999999999999999999999999999999999976544322 233
Q ss_pred CCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccccccccc
Q 020085 267 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIHS 327 (331)
Q Consensus 267 ~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~p~ 327 (331)
..+++.|+|||++.+..++.++|+||||+++|+|++|+.||...+.......+ .++.+++
T Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~ 219 (255)
T cd08219 160 YVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKV-CQGSYKP 219 (255)
T ss_pred ccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHH-hcCCCCC
Confidence 56889999999999989999999999999999999999999988776665553 3454443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=274.36 Aligned_cols=217 Identities=37% Similarity=0.656 Sum_probs=182.9
Q ss_pred eeecccCcceeeeeeecCceEEEEEEECC-ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeE
Q 020085 105 WEIDAKQLKIECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183 (331)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 183 (331)
|++..++|.+.++||+|++|.||++.+.+ ..+|+|.+...... .+.+.+|+.++++++|||++++++++.. ...+
T Consensus 1 ~~~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (260)
T cd05069 1 WEIPRESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMM---PEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIY 76 (260)
T ss_pred CcCChHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCcc---HHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcE
Confidence 67778889999999999999999998854 57999998754322 3568899999999999999999988754 5689
Q ss_pred EEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC
Q 020085 184 IVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262 (331)
Q Consensus 184 lV~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~ 262 (331)
++|||+.+++|.+++.... ..+++..+..++.|++.||+|||+.|++|+||||+||++++++.++|+|||.++......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 77 IVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 9999999999999997643 457889999999999999999999999999999999999999999999999997654332
Q ss_pred cc--ccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhccccccccc
Q 020085 263 VM--TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIH 326 (331)
Q Consensus 263 ~~--~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p 326 (331)
.. ....++..|+|||.+.+..++.++|+||||+++|||++ |+.||.+.++.+....+. ++.++
T Consensus 157 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~-~~~~~ 222 (260)
T cd05069 157 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVE-RGYRM 222 (260)
T ss_pred ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-cCCCC
Confidence 11 12235678999999998889999999999999999999 999999988777665543 34433
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=281.13 Aligned_cols=223 Identities=32% Similarity=0.605 Sum_probs=188.1
Q ss_pred CeeeecccCcceeeeeeecCceEEEEEEECC-------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCcceeEEe
Q 020085 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIG 174 (331)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~ 174 (331)
..|+++.++|++.+.||+|+||.||++...+ ..+|+|+++... .......+.+|+.+++++ +||||+++++
T Consensus 5 ~~~~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 83 (293)
T cd05053 5 PEWELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINLLG 83 (293)
T ss_pred cccccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC-CHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 3488899999999999999999999998642 579999988653 334456789999999999 7999999999
Q ss_pred EEECCCCeEEEEeccCCCCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 020085 175 ACTRPPNLCIVTEFMARGSIYDFLHKQ---------------KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANL 239 (331)
Q Consensus 175 ~~~~~~~~~lV~E~~~ggsL~~~l~~~---------------~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Ni 239 (331)
++..+..++++|||+++|+|.+++... ...+++..++.++.|++.|++|||++|++||||||+||
T Consensus 84 ~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Ni 163 (293)
T cd05053 84 VCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNV 163 (293)
T ss_pred EEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeE
Confidence 999999999999999999999999642 24688899999999999999999999999999999999
Q ss_pred EEcCCCcEEEeeecceeeecCCCc---cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHH
Q 020085 240 LMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQA 315 (331)
Q Consensus 240 Li~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~ 315 (331)
+++.++.++|+|||.++....... .....++..|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+.
T Consensus 164 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~ 243 (293)
T cd05053 164 LVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEEL 243 (293)
T ss_pred EEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHH
Confidence 999999999999999976543221 122234578999999998899999999999999999998 9999998877665
Q ss_pred Hhcccccccccc
Q 020085 316 AVGVVQKVSIHS 327 (331)
Q Consensus 316 ~~~~~~~~~~p~ 327 (331)
... ...+.++.
T Consensus 244 ~~~-~~~~~~~~ 254 (293)
T cd05053 244 FKL-LKEGYRME 254 (293)
T ss_pred HHH-HHcCCcCC
Confidence 554 33444444
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=304.14 Aligned_cols=217 Identities=31% Similarity=0.534 Sum_probs=191.7
Q ss_pred cCcceeeeeeecCceEEEEEEECC--ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEe
Q 020085 110 KQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E 187 (331)
+.|.|+..||.|+||.||++.... --.|-|++... +.+.++++.-|+.||..++||+||+++++|...+.++|..|
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk--seEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliE 109 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK--SEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIE 109 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc--chhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEe
Confidence 456677789999999999998754 33577877644 56778999999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecC-CCcccc
Q 020085 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVMTA 266 (331)
Q Consensus 188 ~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~-~~~~~~ 266 (331)
||.||-+..++-.-...++++++..++.|++.||.|||+++|||||||+.|||++-+|.++|+|||.+-.... ......
T Consensus 110 FC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDs 189 (1187)
T KOG0579|consen 110 FCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDS 189 (1187)
T ss_pred ecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhhcc
Confidence 9999999999988888999999999999999999999999999999999999999999999999998743322 223456
Q ss_pred CCCCcccccchhc-----CCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccccccccccc
Q 020085 267 ETGTYRWMAPEVI-----EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIHSII 329 (331)
Q Consensus 267 ~~gt~~y~aPE~~-----~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~p~~~ 329 (331)
..|||.|||||+. ...+|+.++|||||||+|.||..+.+|...++|+.++.+ +++...|+++
T Consensus 190 FIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllK-iaKSePPTLl 256 (1187)
T KOG0579|consen 190 FIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK-IAKSEPPTLL 256 (1187)
T ss_pred ccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHH-HhhcCCCccc
Confidence 7899999999996 467899999999999999999999999999999999999 5577777764
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=297.34 Aligned_cols=207 Identities=23% Similarity=0.418 Sum_probs=171.7
Q ss_pred eecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCC------CcceeEEeEEE
Q 020085 106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH------KNVVQFIGACT 177 (331)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h------~niv~~~~~~~ 177 (331)
++..++|++.++||+|+||+||+|.+ .++.||||+++.. ......+..|+.+++.++| ++++++++++.
T Consensus 125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~ 201 (467)
T PTZ00284 125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV---PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ 201 (467)
T ss_pred ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc---hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence 44567899999999999999999987 5678999999743 2233456678888877754 45888988887
Q ss_pred CC-CCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEEcCCC----------
Q 020085 178 RP-PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENG---------- 245 (331)
Q Consensus 178 ~~-~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~iiHrDlkp~NiLi~~~~---------- 245 (331)
.. ..+|+|||++ |++|.+++.+ .+.+++..+..++.||+.||+|||+ .||+||||||+|||++.++
T Consensus 202 ~~~~~~~iv~~~~-g~~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~ 279 (467)
T PTZ00284 202 NETGHMCIVMPKY-GPCLLDWIMK-HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRA 279 (467)
T ss_pred cCCceEEEEEecc-CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccc
Confidence 54 4689999988 6699998865 4679999999999999999999998 5999999999999998766
Q ss_pred ------cEEEeeecceeeecCCCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcc
Q 020085 246 ------VVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGV 319 (331)
Q Consensus 246 ------~vkl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~ 319 (331)
.+||+|||.+..... ......||+.|+|||++.+..|+.++|||||||++|||++|+.||++.+..+....+
T Consensus 280 ~~~~~~~vkl~DfG~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i 357 (467)
T PTZ00284 280 LPPDPCRVRICDLGGCCDERH--SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLM 357 (467)
T ss_pred cCCCCceEEECCCCccccCcc--ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 499999998764322 234567899999999999999999999999999999999999999988776655443
|
|
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-37 Score=277.07 Aligned_cols=217 Identities=32% Similarity=0.606 Sum_probs=184.2
Q ss_pred ecccCcceeeeeeecCceEEEEEEEC--C----ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCC
Q 020085 107 IDAKQLKIECKVASGSYGDLYKGTYC--S----QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (331)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~~--~----~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 180 (331)
+...+|++.+.||+|+||.||+|.+. + ..+|+|.++... .......+.+|+.++++++|||+++++++|.. .
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~ 81 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET-SPKANKEILDEAYVMASVDHPHVVRLLGICLS-S 81 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-C
Confidence 45678999999999999999999863 3 258999887654 34455779999999999999999999999987 7
Q ss_pred CeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecC
Q 020085 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (331)
Q Consensus 181 ~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~ 260 (331)
..++||||+++|+|.+++......+++..+..++.|++.|++|||++|++||||||+||+++.++.++|+|||.++....
T Consensus 82 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~ 161 (279)
T cd05057 82 QVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV 161 (279)
T ss_pred ceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence 89999999999999999987777799999999999999999999999999999999999999999999999999976543
Q ss_pred CCccc---cCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhccccccccc
Q 020085 261 SGVMT---AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIH 326 (331)
Q Consensus 261 ~~~~~---~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p 326 (331)
..... ...++..|+|||.+....++.++|+||||+++||+++ |+.||...++.+.... +.++..+
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~-~~~~~~~ 230 (279)
T cd05057 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDL-LEKGERL 230 (279)
T ss_pred cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH-HhCCCCC
Confidence 32211 1223568999999988889999999999999999998 9999999877665544 3344433
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=275.66 Aligned_cols=215 Identities=28% Similarity=0.535 Sum_probs=178.6
Q ss_pred cceeeeeeecCceEEEEEEECC----ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECC------CC
Q 020085 112 LKIECKVASGSYGDLYKGTYCS----QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP------PN 181 (331)
Q Consensus 112 ~~~~~~lg~G~~g~Vy~~~~~~----~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~------~~ 181 (331)
+.+.++||+|+||.||+|.+.. ..+|+|.++.........+.+.+|+.+++.++||||+++++.+... ..
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 80 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS 80 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence 3567899999999999998743 2599999987655666678899999999999999999999987432 24
Q ss_pred eEEEEeccCCCCHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeeccee
Q 020085 182 LCIVTEFMARGSIYDFLHKQ-----KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR 256 (331)
Q Consensus 182 ~~lV~E~~~ggsL~~~l~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~ 256 (331)
.+++|||+.+|+|.+++... ...+++..+..++.|++.||+|||++||+||||||+|||+++++.++|+|||+++
T Consensus 81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 160 (272)
T cd05075 81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK 160 (272)
T ss_pred cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence 68999999999999987432 2457899999999999999999999999999999999999999999999999998
Q ss_pred eecCCCc---cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhcccccccccc
Q 020085 257 VQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIHS 327 (331)
Q Consensus 257 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p~ 327 (331)
....... .....+++.|+|||.+.+..++.++|+||||+++|||++ |+.||....+.+.... ++++.++.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~-~~~~~~~~ 234 (272)
T cd05075 161 KIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDY-LRQGNRLK 234 (272)
T ss_pred ccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-HHcCCCCC
Confidence 6543321 122345678999999999999999999999999999999 8999998877766555 44454443
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=278.36 Aligned_cols=207 Identities=27% Similarity=0.441 Sum_probs=177.0
Q ss_pred CcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEec
Q 020085 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF 188 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~ 188 (331)
+|++.+.||+|++|.||+|+. +++.||+|+++....+......+.+|+.++++++|||++++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 588999999999999999987 578999999876543443456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC-Cccc
Q 020085 189 MARGSIYDFLHKQK--GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMT 265 (331)
Q Consensus 189 ~~ggsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~-~~~~ 265 (331)
++ ++|.+++.... ..+++..+..++.|+++||.|||++|++||||+|+||+++.++.++|+|||++...... ....
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYT 159 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCccccc
Confidence 98 48988886533 56899999999999999999999999999999999999999999999999998754332 2223
Q ss_pred cCCCCcccccchhcCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhc
Q 020085 266 AETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVG 318 (331)
Q Consensus 266 ~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~ 318 (331)
...+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.+.......
T Consensus 160 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~ 213 (285)
T cd07861 160 HEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFR 213 (285)
T ss_pred CCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence 4467899999998865 4578999999999999999999999988766554443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=274.73 Aligned_cols=201 Identities=25% Similarity=0.510 Sum_probs=176.0
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCC-CCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEE
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPE-CVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~ 186 (331)
++|++.+.||+|+||.||+|+. .++.||||.++.. ..+......+.+|+.+++.++|||++++++++...+..++++
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 5789999999999999999987 6789999988653 234455667899999999999999999999999888999999
Q ss_pred eccCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCc
Q 020085 187 EFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV 263 (331)
Q Consensus 187 E~~~ggsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~ 263 (331)
||+++++|.+++.. ....+++..+..++.|+++||+|||++|++|+||||+||+++.++.++|+|||.+........
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~ 161 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhH
Confidence 99999999998853 234578899999999999999999999999999999999999999999999999876543322
Q ss_pred -cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 020085 264 -MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL 310 (331)
Q Consensus 264 -~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~ 310 (331)
.....+++.|+|||.+.+..++.++|+||||+++|||++|+.||...
T Consensus 162 ~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~ 209 (267)
T cd08228 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccc
Confidence 22346888999999998888999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=281.55 Aligned_cols=206 Identities=25% Similarity=0.453 Sum_probs=177.1
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~ 186 (331)
.++|.+.++||+|+||.||+|++ .++.||+|.++.... ......+.+|+.++++++||||+++++++..+...++||
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 83 (301)
T cd07873 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 83 (301)
T ss_pred ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc-cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence 45799999999999999999987 468899999875432 222346778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC-ccc
Q 020085 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMT 265 (331)
Q Consensus 187 E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~-~~~ 265 (331)
||+.+ +|.+++......+++..+..++.|+++||+|||++|++|+||||+||+++.++.++|+|||+++...... ...
T Consensus 84 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 162 (301)
T cd07873 84 EYLDK-DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYS 162 (301)
T ss_pred ecccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCccc
Confidence 99975 9999997766778999999999999999999999999999999999999999999999999987543222 223
Q ss_pred cCCCCcccccchhcCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 020085 266 AETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAA 316 (331)
Q Consensus 266 ~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~ 316 (331)
...+++.|+|||.+.+ ..++.++||||||+++|+|++|++||...+..+..
T Consensus 163 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~ 214 (301)
T cd07873 163 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQL 214 (301)
T ss_pred ccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 4457899999999865 45788999999999999999999999987765444
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=284.44 Aligned_cols=224 Identities=30% Similarity=0.599 Sum_probs=187.4
Q ss_pred CeeeecccCcceeeeeeecCceEEEEEEECC---------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCcceeE
Q 020085 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCS---------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQF 172 (331)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~---------~~vavK~~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~ 172 (331)
..|++...+|.+.+.||+|+||.||++++.+ ..||+|+++... .....+.+.+|+.+++++ +||||+++
T Consensus 5 ~~~~~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~ 83 (334)
T cd05100 5 PKWELSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDA-TDKDLSDLVSEMEMMKMIGKHKNIINL 83 (334)
T ss_pred cccccCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEccccc-CHHHHHHHHHHHHHHHhhcCCCCeeee
Confidence 4589999999999999999999999997521 368999887542 344567899999999999 79999999
Q ss_pred EeEEECCCCeEEEEeccCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 020085 173 IGACTRPPNLCIVTEFMARGSIYDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 237 (331)
Q Consensus 173 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~ 237 (331)
+++|......++++||+++|+|.+++.... ..++...+..++.|++.||+|||++|++||||||+
T Consensus 84 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~ 163 (334)
T cd05100 84 LGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAAR 163 (334)
T ss_pred eEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccc
Confidence 999999999999999999999999996532 24677888999999999999999999999999999
Q ss_pred CEEEcCCCcEEEeeecceeeecCCCc---cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHH
Q 020085 238 NLLMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPL 313 (331)
Q Consensus 238 NiLi~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~ 313 (331)
||+++.++.+||+|||+++....... .....++..|+|||++.+..++.++||||||+++|||++ |..||.+.+..
T Consensus 164 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 243 (334)
T cd05100 164 NVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 243 (334)
T ss_pred eEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 99999999999999999976543221 122234568999999999999999999999999999998 89999988776
Q ss_pred HHHhccccccccccc
Q 020085 314 QAAVGVVQKVSIHSI 328 (331)
Q Consensus 314 ~~~~~~~~~~~~p~~ 328 (331)
+.... +..+.++++
T Consensus 244 ~~~~~-~~~~~~~~~ 257 (334)
T cd05100 244 ELFKL-LKEGHRMDK 257 (334)
T ss_pred HHHHH-HHcCCCCCC
Confidence 65554 334444443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-37 Score=278.66 Aligned_cols=218 Identities=29% Similarity=0.567 Sum_probs=183.8
Q ss_pred ecccCcceeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECC
Q 020085 107 IDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP 179 (331)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 179 (331)
+...+|.+.+.||+|+||.||++.+. +..+++|.++... ....+.+.+|+.++++++||||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (291)
T cd05094 2 IKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT--LAARKDFQREAELLTNLQHEHIVKFYGVCGDG 79 (291)
T ss_pred CchHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc--HHHHHHHHHHHHHHhcCCCCCcceEEEEEccC
Confidence 34567999999999999999999752 3458999987542 34456789999999999999999999999999
Q ss_pred CCeEEEEeccCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC
Q 020085 180 PNLCIVTEFMARGSIYDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN 244 (331)
Q Consensus 180 ~~~~lV~E~~~ggsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~ 244 (331)
...++||||+++++|.+++.... +.+++..++.++.||+.|++|||++|++||||||+||+++.+
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~ 159 (291)
T cd05094 80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGAN 159 (291)
T ss_pred CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccC
Confidence 99999999999999999996532 347889999999999999999999999999999999999999
Q ss_pred CcEEEeeecceeeecCCCc---cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhccc
Q 020085 245 GVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 245 ~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~ 320 (331)
+.++|+|||+++....... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||...++.+....+
T Consensus 160 ~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~- 238 (291)
T cd05094 160 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI- 238 (291)
T ss_pred CcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH-
Confidence 9999999999975443221 123346788999999999999999999999999999998 99999888887765553
Q ss_pred ccccccc
Q 020085 321 QKVSIHS 327 (331)
Q Consensus 321 ~~~~~p~ 327 (331)
..+.++.
T Consensus 239 ~~~~~~~ 245 (291)
T cd05094 239 TQGRVLE 245 (291)
T ss_pred hCCCCCC
Confidence 3454443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=276.17 Aligned_cols=220 Identities=34% Similarity=0.628 Sum_probs=187.3
Q ss_pred eecccCcceeeeeeecCceEEEEEEEC-CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEE
Q 020085 106 EIDAKQLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI 184 (331)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~l 184 (331)
+-...+|++.++||+|+||.||+|.+. ++.+|+|+++... ......+.+|+.+++.++||||+++++++......++
T Consensus 2 ~~~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l 79 (261)
T cd05148 2 ERPREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD--LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYI 79 (261)
T ss_pred cCcHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc--hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEE
Confidence 445668999999999999999999884 5789999987553 3335678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCc
Q 020085 185 VTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV 263 (331)
Q Consensus 185 V~E~~~ggsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~ 263 (331)
||||+++++|.+++... ...++...+..++.|++.|+.|||++|++|+||+|+||++++++.++|+|||.+........
T Consensus 80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~ 159 (261)
T cd05148 80 ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY 159 (261)
T ss_pred EEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence 99999999999999764 34689999999999999999999999999999999999999999999999999976543221
Q ss_pred -cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhccccccccccc
Q 020085 264 -MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIHSI 328 (331)
Q Consensus 264 -~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p~~ 328 (331)
.....+++.|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+....+. .+.+++.
T Consensus 160 ~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~~ 225 (261)
T cd05148 160 LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT-AGYRMPC 225 (261)
T ss_pred cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH-hCCcCCC
Confidence 123345678999999988899999999999999999998 899999888777666544 4555443
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-37 Score=276.62 Aligned_cols=217 Identities=29% Similarity=0.557 Sum_probs=183.5
Q ss_pred ecccCcceeeeeeecCceEEEEEEE-------CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECC
Q 020085 107 IDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP 179 (331)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 179 (331)
++.++|.+.++||+|+||.||++.. .+..+|+|.++.. .......+.+|+.+++.++||||+++++++...
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~ 79 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTVLQHQHIVRFYGVCTEG 79 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC--CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC
Confidence 5678899999999999999999864 3457899987744 345567899999999999999999999999999
Q ss_pred CCeEEEEeccCCCCHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC
Q 020085 180 PNLCIVTEFMARGSIYDFLHKQK--------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG 245 (331)
Q Consensus 180 ~~~~lV~E~~~ggsL~~~l~~~~--------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~ 245 (331)
...+++|||+++++|.+++.... ..+++..++.++.|++.|++|||++|++||||||+||++++++
T Consensus 80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~ 159 (280)
T cd05092 80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGL 159 (280)
T ss_pred CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCC
Confidence 99999999999999999997543 2478899999999999999999999999999999999999999
Q ss_pred cEEEeeecceeeecCCCc---cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhcccc
Q 020085 246 VVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 246 ~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~ 321 (331)
.++|+|||+++....... .....+++.|+|||.+.+..++.++|+|||||++|||++ |++||...++.+....+.
T Consensus 160 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~- 238 (280)
T cd05092 160 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT- 238 (280)
T ss_pred CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHH-
Confidence 999999999975533221 112234678999999999999999999999999999998 999998887776665543
Q ss_pred ccccc
Q 020085 322 KVSIH 326 (331)
Q Consensus 322 ~~~~p 326 (331)
++..+
T Consensus 239 ~~~~~ 243 (280)
T cd05092 239 QGREL 243 (280)
T ss_pred cCccC
Confidence 34333
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=273.91 Aligned_cols=213 Identities=31% Similarity=0.590 Sum_probs=182.9
Q ss_pred ecccCcceeeeeeecCceEEEEEEEC--Cc---eEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCC
Q 020085 107 IDAKQLKIECKVASGSYGDLYKGTYC--SQ---EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN 181 (331)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~---~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 181 (331)
|..++|...+.||+|+||.||+|+.. ++ .+|+|.++... .....+.+.+|+.++++++|||++++.+++.....
T Consensus 2 i~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (268)
T cd05063 2 IHPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY-TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKP 80 (268)
T ss_pred CChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCC
Confidence 55678999999999999999999873 32 69999987553 34445779999999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC
Q 020085 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261 (331)
Q Consensus 182 ~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~ 261 (331)
.++||||+++++|.+++....+.+++..+..++.|++.|++|||+.|++||||||+||+++.++.++++|||++......
T Consensus 81 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 160 (268)
T cd05063 81 AMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD 160 (268)
T ss_pred cEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence 99999999999999999776678899999999999999999999999999999999999999999999999998755432
Q ss_pred Cccc----cCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhccc
Q 020085 262 GVMT----AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 262 ~~~~----~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~ 320 (331)
.... ....++.|+|||.+.+..++.++|+||||+++|||++ |+.||...+..+....+.
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~ 224 (268)
T cd05063 161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAIN 224 (268)
T ss_pred cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHh
Confidence 2111 1123457999999998889999999999999999997 999998888776666644
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=274.15 Aligned_cols=219 Identities=29% Similarity=0.565 Sum_probs=184.2
Q ss_pred eecccCcceeeeeeecCceEEEEEEECC-----ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCC
Q 020085 106 EIDAKQLKIECKVASGSYGDLYKGTYCS-----QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (331)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 180 (331)
++..++|.+.+.||+|+||.||+|.+.+ ..||||..+... .....+.+.+|+.++++++||||+++++++.. .
T Consensus 2 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~ 79 (270)
T cd05056 2 EIQREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT-SPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-N 79 (270)
T ss_pred eechhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-C
Confidence 4567789999999999999999998743 368999887553 34456789999999999999999999998876 4
Q ss_pred CeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecC
Q 020085 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (331)
Q Consensus 181 ~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~ 260 (331)
..++||||+++++|.+++......++...+..++.|++.|++|||+.|++|+||||+||+++.++.++|+|||+++....
T Consensus 80 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 80 PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred CcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeeccc
Confidence 57899999999999999977666789999999999999999999999999999999999999999999999999976544
Q ss_pred CCcc--ccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhcccccccccc
Q 020085 261 SGVM--TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIHS 327 (331)
Q Consensus 261 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p~ 327 (331)
.... +...++..|+|||.+....++.++|+||||+++||+++ |..||...+..+.... +.++.++.
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~-~~~~~~~~ 228 (270)
T cd05056 160 ESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGR-IENGERLP 228 (270)
T ss_pred ccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH-HHcCCcCC
Confidence 3221 12234568999999988889999999999999999996 9999998887766655 33455444
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-38 Score=304.34 Aligned_cols=213 Identities=25% Similarity=0.442 Sum_probs=181.9
Q ss_pred CCCeeeecccCcceeeeeeecCceEEEEEEEC-C-ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCcceeEEeEE-
Q 020085 101 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYC-S-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGAC- 176 (331)
Q Consensus 101 ~~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-~-~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~- 176 (331)
.+..++|..-++++.+.|.+|||+.||.++.. + ..||+|++-.. +....+...+|+.+|++|. |+|||.+++..
T Consensus 28 ~G~~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~--de~~L~~v~~EI~~MK~L~gh~nIV~yidss~ 105 (738)
T KOG1989|consen 28 VGQTFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN--DEEALNAVKREIDIMKLLSGHKNIVSYIDSSA 105 (738)
T ss_pred CceEEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC--CHHHHHHHHHHHHHHHHhcCCCceeeEecccc
Confidence 34678999999999999999999999999983 3 79999998654 6778899999999999997 99999999933
Q ss_pred ECC------CCeEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCCEEEcCCCcE
Q 020085 177 TRP------PNLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNN--IIHRDLKTANLLMDENGVV 247 (331)
Q Consensus 177 ~~~------~~~~lV~E~~~ggsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~NiLi~~~~~v 247 (331)
... -.+.|.||||.||+|-|+++++ ...|++.++++|+.|+++|+.+||... |||||||-+||||..+|..
T Consensus 106 ~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~ 185 (738)
T KOG1989|consen 106 INRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNY 185 (738)
T ss_pred ccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCE
Confidence 211 2478899999999999999764 345999999999999999999999987 9999999999999999999
Q ss_pred EEeeecceeeecCCCcc----------ccCCCCcccccchhc---CCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHH
Q 020085 248 KVADFGVARVQAQSGVM----------TAETGTYRWMAPEVI---EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ 314 (331)
Q Consensus 248 kl~DFg~a~~~~~~~~~----------~~~~gt~~y~aPE~~---~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~ 314 (331)
||||||.|.-....... ....-|+.|.|||++ .+.+.+.|+|||+|||+||.|+....||+....+.
T Consensus 186 KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la 265 (738)
T KOG1989|consen 186 KLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA 265 (738)
T ss_pred EeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee
Confidence 99999999644332211 122368999999997 57789999999999999999999999999875554
Q ss_pred H
Q 020085 315 A 315 (331)
Q Consensus 315 ~ 315 (331)
+
T Consensus 266 I 266 (738)
T KOG1989|consen 266 I 266 (738)
T ss_pred E
Confidence 4
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=286.72 Aligned_cols=216 Identities=26% Similarity=0.455 Sum_probs=190.4
Q ss_pred eecccCcceeeeeeecCceEEEEEEECC--ceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcC-CCcceeEEeEEECCCC
Q 020085 106 EIDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPN 181 (331)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~~~--~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~~ 181 (331)
.|...+|.++.+||+|+||.|.++...| +.+|||+++.+.. +++.++--+.|.++|+... -|.+++++.+|+.-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 6788899999999999999999998865 5699999998754 3334555667888888764 6899999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC
Q 020085 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261 (331)
Q Consensus 182 ~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~ 261 (331)
+|+||||+.||+|--.+++ -+.+.++.+..++.+|+-||-+||++|||+||||.+|||++.+|++||+|||+++..--.
T Consensus 425 LyFVMEyvnGGDLMyhiQQ-~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~ 503 (683)
T KOG0696|consen 425 LYFVMEYVNGGDLMYHIQQ-VGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD 503 (683)
T ss_pred eeeEEEEecCchhhhHHHH-hcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccC
Confidence 9999999999999988854 689999999999999999999999999999999999999999999999999999865544
Q ss_pred Cc-cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccc
Q 020085 262 GV-MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK 322 (331)
Q Consensus 262 ~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~ 322 (331)
+. ..+.+|||.|+|||++...+|....|.||+|++||||+.|++||++....+....+.++
T Consensus 504 ~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~eh 565 (683)
T KOG0696|consen 504 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEH 565 (683)
T ss_pred CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc
Confidence 43 34568999999999999999999999999999999999999999999887776665543
|
|
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=271.13 Aligned_cols=208 Identities=35% Similarity=0.688 Sum_probs=181.0
Q ss_pred cccCcceeeeeeecCceEEEEEEEC-CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEE
Q 020085 108 DAKQLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~ 186 (331)
+..+|.+.+.||+|+||.||++.+. ++.+|+|+++...... ..+.+|++++++++|||++++++++......++||
T Consensus 2 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~~---~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd05112 2 HPSELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE---EDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVF 78 (256)
T ss_pred ChhHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCCH---HHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEE
Confidence 4668999999999999999999884 7889999987654433 46889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCc--c
Q 020085 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV--M 264 (331)
Q Consensus 187 E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~--~ 264 (331)
||+++++|.+++....+.+++..+..++.|++.+++|||+.|++|+||||+||+++.++.++|+|||.++....... .
T Consensus 79 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (256)
T cd05112 79 EFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS 158 (256)
T ss_pred EcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence 99999999999977667789999999999999999999999999999999999999999999999999875543221 1
Q ss_pred ccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhc
Q 020085 265 TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVG 318 (331)
Q Consensus 265 ~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~ 318 (331)
....++..|+|||.+.+..++.++|+||||+++|||++ |..||......+....
T Consensus 159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~ 213 (256)
T cd05112 159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVET 213 (256)
T ss_pred CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHH
Confidence 12234578999999998889999999999999999998 9999988776555544
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=276.25 Aligned_cols=211 Identities=33% Similarity=0.604 Sum_probs=177.5
Q ss_pred ecccCcceeeeeeecCceEEEEEEECC-------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECC
Q 020085 107 IDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP 179 (331)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 179 (331)
+..++|.+.+.||+|++|.||+|.+.+ ..||+|..+... .......|.+|+.++++++|+||+++++++...
T Consensus 3 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (277)
T cd05036 3 VPRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC-SEQDESDFLMEALIMSKFNHQNIVRLIGVSFER 81 (277)
T ss_pred CCHHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC
Confidence 456789999999999999999998843 678999876443 344456799999999999999999999999988
Q ss_pred CCeEEEEeccCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC---cEEEe
Q 020085 180 PNLCIVTEFMARGSIYDFLHKQK------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG---VVKVA 250 (331)
Q Consensus 180 ~~~~lV~E~~~ggsL~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~---~vkl~ 250 (331)
...++||||++|++|.+++.... ..+++..+++++.||+.|++|||+++++||||||+||+++.++ .+||+
T Consensus 82 ~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 82 LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEec
Confidence 89999999999999999996643 2588899999999999999999999999999999999998765 59999
Q ss_pred eecceeeecCCCcc---ccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhc
Q 020085 251 DFGVARVQAQSGVM---TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVG 318 (331)
Q Consensus 251 DFg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~ 318 (331)
|||+++........ .....+..|+|||++.+..++.++|||||||++|||++ |+.||+..++.+....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~ 233 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEF 233 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH
Confidence 99999765332211 12223568999999998889999999999999999997 9999998776655443
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=272.38 Aligned_cols=210 Identities=36% Similarity=0.683 Sum_probs=181.2
Q ss_pred eeecccCcceeeeeeecCceEEEEEEE-CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeE
Q 020085 105 WEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183 (331)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 183 (331)
|++..++|++.++||+|+||.||++.+ .+..+|+|.++.. ......+.+|+.++++++|+||+++.+.+.. ...+
T Consensus 1 ~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~ 76 (260)
T cd05073 1 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG---SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIY 76 (260)
T ss_pred CcccccceeEEeEecCccceEEEEEEecCCccEEEEecCCC---hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeE
Confidence 788899999999999999999999987 4467999998754 2334678899999999999999999999887 6789
Q ss_pred EEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC
Q 020085 184 IVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262 (331)
Q Consensus 184 lV~E~~~ggsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~ 262 (331)
++|||+++++|.+++... ...++...+..++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||.+.......
T Consensus 77 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~ 156 (260)
T cd05073 77 IITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE 156 (260)
T ss_pred EEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence 999999999999999764 3457888999999999999999999999999999999999999999999999997654322
Q ss_pred c--cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhc
Q 020085 263 V--MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVG 318 (331)
Q Consensus 263 ~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~ 318 (331)
. .....++..|+|||.+.+..++.++|+||||+++|++++ |+.||...+..+....
T Consensus 157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~ 215 (260)
T cd05073 157 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA 215 (260)
T ss_pred cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 1 122345678999999998889999999999999999998 9999998877665544
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=292.66 Aligned_cols=216 Identities=30% Similarity=0.570 Sum_probs=188.7
Q ss_pred CCeeeecccCcceeeeeeecCceEEEEEEECC-ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCC
Q 020085 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (331)
Q Consensus 102 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 180 (331)
....+++.+.+.+.++||+|-||.|.++.-.+ ..||||+++.+. +.+..++|.+|+++|.+++||||+.++|+|..++
T Consensus 530 ~al~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a-~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De 608 (807)
T KOG1094|consen 530 PALVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDA-TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDD 608 (807)
T ss_pred cchhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCccc-chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCC
Confidence 34567889999999999999999999999876 899999999875 4555789999999999999999999999999999
Q ss_pred CeEEEEeccCCCCHHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeec
Q 020085 181 NLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA 259 (331)
Q Consensus 181 ~~~lV~E~~~ggsL~~~l~~~~~~-~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~ 259 (331)
.+|+|+|||+.|+|.+++..+..+ .......+++.||+.||+||.+.+++|||+.++|+|++.++++||+|||+++..-
T Consensus 609 PicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ly 688 (807)
T KOG1094|consen 609 PLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLY 688 (807)
T ss_pred chHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccc
Confidence 999999999999999999776433 3556677899999999999999999999999999999999999999999998443
Q ss_pred CCCccc---cCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc--CCCCCCCCCHHHHHhc
Q 020085 260 QSGVMT---AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT--GELPYAGLTPLQAAVG 318 (331)
Q Consensus 260 ~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~--g~~Pf~~~~~~~~~~~ 318 (331)
...... ...-..+|||+|.+...+++.++|+|+||+++||+++ ...||..++..+....
T Consensus 689 sg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven 752 (807)
T KOG1094|consen 689 SGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVEN 752 (807)
T ss_pred cCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHh
Confidence 322211 1223579999999999999999999999999999766 7899999998887654
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=289.10 Aligned_cols=216 Identities=23% Similarity=0.406 Sum_probs=197.5
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~ 186 (331)
..-|.+.+.||+|.|+.|-++++ +|..||||++.....+.-....+.+|++.|+.++|||||++|.+......+|+|+
T Consensus 17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEE
Confidence 34688999999999999999876 8999999999888777777788999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEc-CCCcEEEeeecceeeecCCCccc
Q 020085 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD-ENGVVKVADFGVARVQAQSGVMT 265 (331)
Q Consensus 187 E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~-~~~~vkl~DFg~a~~~~~~~~~~ 265 (331)
|.-.+|+|+||+.+....+.+..+.+++.||+.|+.|+|+..++||||||+|+.+. +-|-+||.|||++....++...+
T Consensus 97 ELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~ 176 (864)
T KOG4717|consen 97 ELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLT 176 (864)
T ss_pred EecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcchhh
Confidence 99999999999999888999999999999999999999999999999999998876 46889999999998888888888
Q ss_pred cCCCCcccccchhcCCCCCC-ChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccccc
Q 020085 266 AETGTYRWMAPEVIEHKPYD-YKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVS 324 (331)
Q Consensus 266 ~~~gt~~y~aPE~~~~~~~~-~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~ 324 (331)
..||+.-|.|||++.+..|+ ++.||||||+|||-|++|++||..-+.-+..-.++...+
T Consensus 177 TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKY 236 (864)
T KOG4717|consen 177 TSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKY 236 (864)
T ss_pred cccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccc
Confidence 99999999999999999997 678999999999999999999988877776666555444
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=275.94 Aligned_cols=214 Identities=34% Similarity=0.544 Sum_probs=185.9
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEe
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E 187 (331)
++|++.+.||.|++|.||+|.. +++.+|+|+++... .......+.+|+.+++.++|||++++++++..+...++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE-AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc-cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 3688899999999999999987 56889999997653 23445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC-Ccccc
Q 020085 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTA 266 (331)
Q Consensus 188 ~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~-~~~~~ 266 (331)
|+++++|.+++... .+++..+..++.|++.|+.|||+.+++|+||+|+||++++++.++|+|||+++..... .....
T Consensus 80 ~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~ 157 (274)
T cd06609 80 YCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT 157 (274)
T ss_pred eeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccccccc
Confidence 99999999999653 7899999999999999999999999999999999999999999999999999876543 23344
Q ss_pred CCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccccccccc
Q 020085 267 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIHS 327 (331)
Q Consensus 267 ~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~p~ 327 (331)
..+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...++.+.... +.++..|.
T Consensus 158 ~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~-~~~~~~~~ 217 (274)
T cd06609 158 FVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFL-IPKNNPPS 217 (274)
T ss_pred ccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHH-hhhcCCCC
Confidence 5688899999999988899999999999999999999999988777665544 33444444
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-37 Score=275.94 Aligned_cols=208 Identities=34% Similarity=0.555 Sum_probs=179.6
Q ss_pred cccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEE
Q 020085 108 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV 185 (331)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV 185 (331)
+.++|++.++||+|+||.||+++. .++.||+|+++... ......+.+|+.+++.++||||+++++.+......++|
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv 84 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP--GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC 84 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc--hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence 346899999999999999999987 57899999987653 23345688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC-Ccc
Q 020085 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVM 264 (331)
Q Consensus 186 ~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~-~~~ 264 (331)
|||+++++|.+++.. .+.+++..+..++.|++.|+.|||+.|++|+||||+||+++.++.++|+|||++...... ...
T Consensus 85 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~ 163 (267)
T cd06645 85 MEFCGGGSLQDIYHV-TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKR 163 (267)
T ss_pred EeccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCccccc
Confidence 999999999999865 567899999999999999999999999999999999999999999999999998755432 122
Q ss_pred ccCCCCcccccchhcC---CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhc
Q 020085 265 TAETGTYRWMAPEVIE---HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVG 318 (331)
Q Consensus 265 ~~~~gt~~y~aPE~~~---~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~ 318 (331)
....|++.|+|||.+. ...++.++|+|||||++|+|++|+.||....+......
T Consensus 164 ~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~ 220 (267)
T cd06645 164 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFL 220 (267)
T ss_pred ccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHh
Confidence 3457899999999974 45688999999999999999999999977666554444
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=318.23 Aligned_cols=224 Identities=23% Similarity=0.345 Sum_probs=197.3
Q ss_pred eeecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCC
Q 020085 105 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN 181 (331)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 181 (331)
..+..++|.+.+.||+|+||.|..++. +++.||+|+++.-.. ......-|..|-.+|.--+.+-|++++.+|+++.+
T Consensus 70 lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~ 149 (1317)
T KOG0612|consen 70 LRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERY 149 (1317)
T ss_pred HhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccc
Confidence 456789999999999999999999887 568899999975322 12334669999999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC
Q 020085 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261 (331)
Q Consensus 182 ~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~ 261 (331)
+|+|||||+||+|..++.+.. ++++..+..++..|..||+-||+.|+|||||||+|||+|..|++||+|||.+-.....
T Consensus 150 LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~d 228 (1317)
T KOG0612|consen 150 LYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD 228 (1317)
T ss_pred eEEEEecccCchHHHHHhhcC-CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCC
Confidence 999999999999999997754 8999999999999999999999999999999999999999999999999998665544
Q ss_pred C--ccccCCCCcccccchhcC----C-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccccccccccc
Q 020085 262 G--VMTAETGTYRWMAPEVIE----H-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIHSII 329 (331)
Q Consensus 262 ~--~~~~~~gt~~y~aPE~~~----~-~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~p~~~ 329 (331)
+ .....+|||.|++||++. + +.|++.+|.||+||++|||+.|..||...+..+.+-+|+.......||
T Consensus 229 G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP 303 (1317)
T KOG0612|consen 229 GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFP 303 (1317)
T ss_pred CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCC
Confidence 3 335668999999999984 3 568999999999999999999999999999999999988876666665
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-37 Score=273.30 Aligned_cols=217 Identities=32% Similarity=0.604 Sum_probs=183.7
Q ss_pred CcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC-------HHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCC
Q 020085 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-------TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN 181 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-------~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 181 (331)
+|.+.+.||+|++|.||+|.+ .++.+|+|.+...... ....+.+.+|+.++++++||||+++++++.....
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 367788999999999999987 5688999988754322 1234678899999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC
Q 020085 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261 (331)
Q Consensus 182 ~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~ 261 (331)
.+++|||+++++|.+++.. .+.++...+..++.|++.|++|||++|++||||+|+||++++++.++|+|||.++.....
T Consensus 81 ~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN-YGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEAN 159 (267)
T ss_pred cEEEEEecCCCCHHHHHHh-ccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccccc
Confidence 9999999999999999965 467889999999999999999999999999999999999999999999999998755422
Q ss_pred Cc-------cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccccccccccc
Q 020085 262 GV-------MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIHSII 329 (331)
Q Consensus 262 ~~-------~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~p~~~ 329 (331)
.. .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+.+..+ ..+.+|.++
T Consensus 160 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~ 233 (267)
T cd06628 160 SLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKI-GENASPEIP 233 (267)
T ss_pred cccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHH-hccCCCcCC
Confidence 11 11235788999999999888999999999999999999999999988777666553 335555543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=271.70 Aligned_cols=210 Identities=38% Similarity=0.672 Sum_probs=183.1
Q ss_pred eeeeecCceEEEEEEEC-----CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEeccC
Q 020085 116 CKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMA 190 (331)
Q Consensus 116 ~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~~~ 190 (331)
+.||+|+||.||++... +..+|+|+++...... ..+.+.+|+.+++.++|+|++++++++......++||||++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 79 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE-ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYME 79 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh-HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEecc
Confidence 46999999999999885 7789999998765333 46789999999999999999999999999999999999999
Q ss_pred CCCHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC
Q 020085 191 RGSIYDFLHKQ--------KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262 (331)
Q Consensus 191 ggsL~~~l~~~--------~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~ 262 (331)
+++|.+++... ...+++..+..++.|+++|++|||++|++|+||+|+||++++++.++|+|||.++......
T Consensus 80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~ 159 (262)
T cd00192 80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD 159 (262)
T ss_pred CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccccccc
Confidence 99999999775 4779999999999999999999999999999999999999999999999999998665432
Q ss_pred ---ccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhcccccccccc
Q 020085 263 ---VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIHS 327 (331)
Q Consensus 263 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p~ 327 (331)
......+++.|+|||.+....++.++|+||+|+++|+|++ |..||...++.+....+. ++.++.
T Consensus 160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~-~~~~~~ 227 (262)
T cd00192 160 YYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLR-KGYRLP 227 (262)
T ss_pred ccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH-cCCCCC
Confidence 1233457889999999988889999999999999999999 699999988777666644 344443
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=269.68 Aligned_cols=210 Identities=36% Similarity=0.620 Sum_probs=178.7
Q ss_pred eeeeecCceEEEEEEE-CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEeccCCCCH
Q 020085 116 CKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI 194 (331)
Q Consensus 116 ~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~~~ggsL 194 (331)
+.||+|+||.||+|.. .++.+|+|+++... ..+....+.+|+.++++++||||+++++.+......++||||+++++|
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 79 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDL-PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF 79 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcC-CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence 3689999999999987 45789999987653 344456789999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCcc--ccCCCCcc
Q 020085 195 YDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM--TAETGTYR 272 (331)
Q Consensus 195 ~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~--~~~~gt~~ 272 (331)
.+++......+++..+..++.|++.+|.|||++|++||||+|+||+++.++.++|+|||++......... ....+++.
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~ 159 (250)
T cd05085 80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK 159 (250)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCccc
Confidence 9999776667899999999999999999999999999999999999999999999999998754332211 12234567
Q ss_pred cccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhcccccccccc
Q 020085 273 WMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIHS 327 (331)
Q Consensus 273 y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p~ 327 (331)
|+|||.+.+..++.++|+||||+++|++++ |..||...+..+.... +.++.++.
T Consensus 160 y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~-~~~~~~~~ 214 (250)
T cd05085 160 WTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQ-VEKGYRMS 214 (250)
T ss_pred ccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHH-HHcCCCCC
Confidence 999999998889999999999999999998 9999998877766555 34455543
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=272.58 Aligned_cols=218 Identities=29% Similarity=0.503 Sum_probs=184.2
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCC---CCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECC--CCe
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC---VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--PNL 182 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~--~~~ 182 (331)
.+|.+.+.||+|+||.||+++. +++.||+|++.... ........+.+|+.++++++||||+++++++... ..+
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 4789999999999999999986 57899999875432 1234556899999999999999999999998764 458
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC-
Q 020085 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS- 261 (331)
Q Consensus 183 ~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~- 261 (331)
++++||+++++|.+++.. .+.+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||+++.....
T Consensus 82 ~~v~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~ 160 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA-YGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTIC 160 (264)
T ss_pred EEEEEeCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccccc
Confidence 899999999999999865 356889999999999999999999999999999999999999999999999999754321
Q ss_pred ---CccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccccccccc
Q 020085 262 ---GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIHSI 328 (331)
Q Consensus 262 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~p~~ 328 (331)
.......++..|+|||.+.+..++.++|+||||+++|+|++|+.||......+...++.....+|.+
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 230 (264)
T cd06653 161 MSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPML 230 (264)
T ss_pred ccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCCCCCC
Confidence 1122346889999999999888999999999999999999999999988877777665544445544
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-37 Score=273.09 Aligned_cols=207 Identities=32% Similarity=0.584 Sum_probs=178.9
Q ss_pred CcceeeeeeecCceEEEEEEE-CCceEEEEEecCCCCC----HHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEE
Q 020085 111 QLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVN----TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV 185 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~----~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV 185 (331)
+|++.+.||+|+||.||+|.. .++.+|+|.++..... ......+.+|+.++++++|+||+++++++......+++
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 478889999999999999987 6788999998754322 23346688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC----
Q 020085 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS---- 261 (331)
Q Consensus 186 ~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~---- 261 (331)
+||+++++|.+++.+ .+.+++..+..++.|++.||+|||+.|++|+||+|+||++++++.++|+|||.++.....
T Consensus 81 ~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~ 159 (265)
T cd06631 81 MEFVPGGSISSILNR-FGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159 (265)
T ss_pred EecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccc
Confidence 999999999999965 457889999999999999999999999999999999999999999999999998754221
Q ss_pred ---CccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhc
Q 020085 262 ---GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVG 318 (331)
Q Consensus 262 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~ 318 (331)
.......++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+.......
T Consensus 160 ~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~ 219 (265)
T cd06631 160 THSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFY 219 (265)
T ss_pred cccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHH
Confidence 112234588999999999998899999999999999999999999998776655444
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=269.35 Aligned_cols=216 Identities=25% Similarity=0.447 Sum_probs=183.6
Q ss_pred CcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEEC-CCCeEEEEe
Q 020085 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR-PPNLCIVTE 187 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~-~~~~~lV~E 187 (331)
.|++.+.||+|++|.||++.. .++.+|+|.++.........+.+.+|+.++++++|||++++++.+.. +..++++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 488999999999999999987 56889999997665555666788999999999999999999998764 445799999
Q ss_pred ccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC-ccc
Q 020085 188 FMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMT 265 (331)
Q Consensus 188 ~~~ggsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~-~~~ 265 (331)
|+++++|.+++... ...+++..+..++.|++.|+++||++|++||||+|+||+++.++.++|+|||++....... ...
T Consensus 81 ~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~ 160 (257)
T cd08223 81 FCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAS 160 (257)
T ss_pred ccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCccc
Confidence 99999999999764 3468999999999999999999999999999999999999999999999999997654322 223
Q ss_pred cCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccccccccc
Q 020085 266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIHS 327 (331)
Q Consensus 266 ~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~p~ 327 (331)
...+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+......... .+..|+
T Consensus 161 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~-~~~~~~ 221 (257)
T cd08223 161 TLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRII-EGKLPP 221 (257)
T ss_pred cccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH-hcCCCC
Confidence 4468899999999999999999999999999999999999999877665544432 344443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=276.17 Aligned_cols=210 Identities=24% Similarity=0.460 Sum_probs=188.9
Q ss_pred eeecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCC
Q 020085 105 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN 181 (331)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 181 (331)
-.+.-++|..++.||+|.||+|-+++. .++.+|+|+++.+.. ..+.+..-..|-++|+..+||.+..+...|+..+.
T Consensus 163 ~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~dr 242 (516)
T KOG0690|consen 163 NKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDR 242 (516)
T ss_pred ceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCce
Confidence 345678899999999999999999876 678999999998754 44566778889999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecC-
Q 020085 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ- 260 (331)
Q Consensus 182 ~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~- 260 (331)
+|+||||..||.|+-+|.. ...|++...+.+..+|+.||.|||+++||+||+|.+|+|+|+||++||.|||+++....
T Consensus 243 lCFVMeyanGGeLf~HLsr-er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~ 321 (516)
T KOG0690|consen 243 LCFVMEYANGGELFFHLSR-ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY 321 (516)
T ss_pred EEEEEEEccCceEeeehhh-hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccc
Confidence 9999999999999999855 67899999999999999999999999999999999999999999999999999986544
Q ss_pred CCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 020085 261 SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQA 315 (331)
Q Consensus 261 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~ 315 (331)
...+...||||.|+|||++....|..+.|.|.+|+++|||++|++||.+......
T Consensus 322 g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kL 376 (516)
T KOG0690|consen 322 GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKL 376 (516)
T ss_pred cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHH
Confidence 3456678999999999999999999999999999999999999999988655433
|
|
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=272.71 Aligned_cols=215 Identities=33% Similarity=0.682 Sum_probs=182.9
Q ss_pred eeecccCcceeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEE
Q 020085 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI 184 (331)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~l 184 (331)
|-+..++|++.+.||+|+||.||++...++.+|+|+++... ....+.+|+.++++++|||++++++++... ..++
T Consensus 1 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~ 75 (254)
T cd05083 1 WLLNLQKLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYI 75 (254)
T ss_pred CcccHHHceeeeeeccCCCCceEecccCCCceEEEeecCcc----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEE
Confidence 44566789999999999999999999999999999987542 235788999999999999999999998764 5799
Q ss_pred EEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCc
Q 020085 185 VTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV 263 (331)
Q Consensus 185 V~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~ 263 (331)
+|||+.+++|.+++.... ..++...+..++.|++.|+.|||++|++||||||+||+++.++.++|+|||.++.....
T Consensus 76 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-- 153 (254)
T cd05083 76 VMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-- 153 (254)
T ss_pred EEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc--
Confidence 999999999999997643 45889999999999999999999999999999999999999999999999998754332
Q ss_pred cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhcccccccccc
Q 020085 264 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIHS 327 (331)
Q Consensus 264 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p~ 327 (331)
......+..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+.... ..++.+++
T Consensus 154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~-~~~~~~~~ 217 (254)
T cd05083 154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKEC-VEKGYRME 217 (254)
T ss_pred CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHH-HhCCCCCC
Confidence 122334578999999998899999999999999999998 9999998887665554 33454443
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=276.08 Aligned_cols=209 Identities=26% Similarity=0.446 Sum_probs=183.2
Q ss_pred CcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEec
Q 020085 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF 188 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~ 188 (331)
+|++.+.||+|++|.||+|++ .++.||+|+++...........+.+|+.++++++|||++++++++..+...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 588999999999999999987 578999999987655455567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC--cccc
Q 020085 189 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG--VMTA 266 (331)
Q Consensus 189 ~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~--~~~~ 266 (331)
+ +++|.+++......+++..+..++.|++++|+|||+.|++|+||||+||+++.++.++|+|||.+....... ....
T Consensus 81 ~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 159 (286)
T cd07832 81 M-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSH 159 (286)
T ss_pred c-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCcccc
Confidence 9 999999997766789999999999999999999999999999999999999999999999999997655432 1334
Q ss_pred CCCCcccccchhcCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccc
Q 020085 267 ETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 267 ~~gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~ 320 (331)
..++..|+|||.+.+. .++.++||||+|+++|||++|++||.+.++......+.
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~ 214 (286)
T cd07832 160 QVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVF 214 (286)
T ss_pred ccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHH
Confidence 5688999999998654 56899999999999999999999998877665554433
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=275.66 Aligned_cols=208 Identities=34% Similarity=0.555 Sum_probs=180.6
Q ss_pred CcceeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEec
Q 020085 111 QLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF 188 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~ 188 (331)
.|++.++||+|+||.||++.+. +..+++|.+... .....+.+.+|+.+++.++|||++++++.+......++|+||
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~ 83 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK--SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF 83 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC--CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence 4688899999999999999984 577899988654 345567889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC-CccccC
Q 020085 189 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTAE 267 (331)
Q Consensus 189 ~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~-~~~~~~ 267 (331)
+++++|.+++......+++..+..++.|+++||.|||+.|++||||||+||+++.++.++|+|||++...... ......
T Consensus 84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~ 163 (282)
T cd06643 84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF 163 (282)
T ss_pred cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccccccccc
Confidence 9999999988766678999999999999999999999999999999999999999999999999998654332 122344
Q ss_pred CCCcccccchhcC-----CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccc
Q 020085 268 TGTYRWMAPEVIE-----HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 268 ~gt~~y~aPE~~~-----~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~ 320 (331)
.+++.|+|||++. +..++.++|+|||||++|||++|+.||...++.+....+.
T Consensus 164 ~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~ 221 (282)
T cd06643 164 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIA 221 (282)
T ss_pred cccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHh
Confidence 6889999999983 4567889999999999999999999999988877666643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=276.72 Aligned_cols=214 Identities=29% Similarity=0.562 Sum_probs=178.9
Q ss_pred CcceeeeeeecCceEEEEEEECC-------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeE
Q 020085 111 QLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 183 (331)
+|.+.+.||+|+||.||+|.... ..+|+|.++... .......+.+|+.+++.++||||+++++.|......+
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 79 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA-SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLL 79 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC-CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcE
Confidence 47788999999999999998632 468999887553 3344577999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEE
Q 020085 184 IVTEFMARGSIYDFLHKQK-----------------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL 240 (331)
Q Consensus 184 lV~E~~~ggsL~~~l~~~~-----------------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiL 240 (331)
+++||+.+++|.+++.... ..++...++.++.|++.|++|||++|++||||||+||+
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nil 159 (290)
T cd05045 80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVL 159 (290)
T ss_pred EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEE
Confidence 9999999999999986421 34778899999999999999999999999999999999
Q ss_pred EcCCCcEEEeeecceeeecCCCc---cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHH
Q 020085 241 MDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAA 316 (331)
Q Consensus 241 i~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~ 316 (331)
+++++.++|+|||+++....... .....++..|+|||.+.+..++.++||||||+++|||++ |..||++..+.+..
T Consensus 160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~ 239 (290)
T cd05045 160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLF 239 (290)
T ss_pred EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence 99999999999999975433221 122345678999999988889999999999999999998 99999988776644
Q ss_pred hccccccccc
Q 020085 317 VGVVQKVSIH 326 (331)
Q Consensus 317 ~~~~~~~~~p 326 (331)
.. +.++.++
T Consensus 240 ~~-~~~~~~~ 248 (290)
T cd05045 240 NL-LKTGYRM 248 (290)
T ss_pred HH-HhCCCCC
Confidence 43 4444444
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-37 Score=276.18 Aligned_cols=207 Identities=27% Similarity=0.424 Sum_probs=178.2
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEe
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E 187 (331)
++|++.+.||+|++|.||+++. .++.||+|++..........+.+.+|+.++++++|||++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 4688999999999999999988 47899999987543333334568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC-cccc
Q 020085 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTA 266 (331)
Q Consensus 188 ~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~-~~~~ 266 (331)
|+++++|..++.. ...+++..+..++.|++.+|+|||+.|++||||||+||+++.++.++|+|||++....... ....
T Consensus 81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (286)
T cd07847 81 YCDHTVLNELEKN-PRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD 159 (286)
T ss_pred ccCccHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccccC
Confidence 9999888877643 4578999999999999999999999999999999999999999999999999998665433 2234
Q ss_pred CCCCcccccchhcCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHh
Q 020085 267 ETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAV 317 (331)
Q Consensus 267 ~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~ 317 (331)
..++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.++.+...
T Consensus 160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~ 211 (286)
T cd07847 160 YVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLY 211 (286)
T ss_pred cccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 457889999999865 557899999999999999999999999877655443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=272.30 Aligned_cols=219 Identities=29% Similarity=0.480 Sum_probs=183.8
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCC---CHHHHHHHHHHHHHHHhcCCCcceeEEeEEECC--CCe
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV---NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--PNL 182 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~---~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~--~~~ 182 (331)
.+|...+.||+|+||.||++.. .++.||+|+++.... .......+.+|+.++++++||||+++++.+... ..+
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 3688899999999999999987 578999999865432 234456789999999999999999999988653 568
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC-
Q 020085 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS- 261 (331)
Q Consensus 183 ~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~- 261 (331)
++++||+++++|.+++.. .+.++......++.|++.||+|||+.+++||||+|+||+++.++.++|+|||+++.....
T Consensus 82 ~l~~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~ 160 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA-YGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC 160 (266)
T ss_pred EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccc
Confidence 899999999999999965 356889999999999999999999999999999999999999999999999998754321
Q ss_pred ---CccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccccccccccc
Q 020085 262 ---GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIHSII 329 (331)
Q Consensus 262 ---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~p~~~ 329 (331)
.......++..|+|||.+.+..++.++|+|||||++|||++|+.||....+.+........+..|.++
T Consensus 161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 231 (266)
T cd06651 161 MSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLP 231 (266)
T ss_pred ccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCCCCCc
Confidence 11123457889999999998889999999999999999999999999887777666555445555543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=282.70 Aligned_cols=205 Identities=22% Similarity=0.420 Sum_probs=173.6
Q ss_pred eeeeeeec--CceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEecc
Q 020085 114 IECKVASG--SYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFM 189 (331)
Q Consensus 114 ~~~~lg~G--~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~~ 189 (331)
+.++||+| +|++||+++. +++.||+|+++.........+.+.+|+.+++.++||||++++++|..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 56789999 7899999987 5789999999876555566677888999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCc-----
Q 020085 190 ARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV----- 263 (331)
Q Consensus 190 ~ggsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~----- 263 (331)
++|+|.+++... ...+++..+..++.|++.||+|||++|++||||||+||+++.++.++++||+.+......+.
T Consensus 82 ~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 161 (327)
T cd08227 82 AYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVV 161 (327)
T ss_pred CCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccccc
Confidence 999999999654 34589999999999999999999999999999999999999999999999986543221110
Q ss_pred ---cccCCCCcccccchhcCC--CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhc
Q 020085 264 ---MTAETGTYRWMAPEVIEH--KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVG 318 (331)
Q Consensus 264 ---~~~~~gt~~y~aPE~~~~--~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~ 318 (331)
.....++..|+|||++.+ ..++.++|||||||++|||++|+.||......+....
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 221 (327)
T cd08227 162 HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLE 221 (327)
T ss_pred ccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHH
Confidence 112346778999999976 4689999999999999999999999998766554444
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=270.73 Aligned_cols=206 Identities=34% Similarity=0.576 Sum_probs=183.7
Q ss_pred ccCcceeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~ 186 (331)
.++|++.++||+|+||.||++... ++.+++|.++... ..+.+.+|+.++++++|||++++++.+......|+++
T Consensus 2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE----DLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHH----HHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 468999999999999999999984 5889999987542 2578999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC-ccc
Q 020085 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMT 265 (331)
Q Consensus 187 E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~-~~~ 265 (331)
||+++++|.+++......+++..+..++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~ 157 (256)
T cd06612 78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRN 157 (256)
T ss_pred ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCccccc
Confidence 9999999999997767789999999999999999999999999999999999999999999999999987654432 223
Q ss_pred cCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhc
Q 020085 266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVG 318 (331)
Q Consensus 266 ~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~ 318 (331)
...++..|+|||.+.+..++.++|+||||+++|+|++|+.||....+.+....
T Consensus 158 ~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~ 210 (256)
T cd06612 158 TVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM 210 (256)
T ss_pred cccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhh
Confidence 34578899999999999999999999999999999999999998877665544
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=273.37 Aligned_cols=207 Identities=30% Similarity=0.530 Sum_probs=170.2
Q ss_pred eeeeecCceEEEEEEE-C---CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEeccCC
Q 020085 116 CKVASGSYGDLYKGTY-C---SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 191 (331)
Q Consensus 116 ~~lg~G~~g~Vy~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~~~g 191 (331)
++||+|+||.||+|.. . ...+|+|.++... .......+.+|+.+++.++||||+++++.+......++||||+++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA-TPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL 79 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC-ChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence 3689999999999975 2 2468888776443 344456789999999999999999999999999999999999999
Q ss_pred CCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCc---c
Q 020085 192 GSIYDFLHKQKG----VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV---M 264 (331)
Q Consensus 192 gsL~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~---~ 264 (331)
|+|.+++..... ..++..+..++.|++.|++|||++|++||||||+||+++.++.+||+|||+++....... .
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~ 159 (269)
T cd05042 80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITK 159 (269)
T ss_pred CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheecc
Confidence 999999976432 345778889999999999999999999999999999999999999999999865433211 1
Q ss_pred ccCCCCcccccchhcC-------CCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhcccccc
Q 020085 265 TAETGTYRWMAPEVIE-------HKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKV 323 (331)
Q Consensus 265 ~~~~gt~~y~aPE~~~-------~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~ 323 (331)
....+++.|+|||++. ...++.++|+|||||++|||++ |..||...++.+....+++.+
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~ 226 (269)
T cd05042 160 DCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQ 226 (269)
T ss_pred CCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhcc
Confidence 2234567899999974 3456889999999999999999 889999988877666655443
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=269.65 Aligned_cols=210 Identities=23% Similarity=0.428 Sum_probs=184.9
Q ss_pred CcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEec
Q 020085 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF 188 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~ 188 (331)
+|.+.+.||+|+||.||++.. .++.+|+|.+.....+......+.+|+.++++++|||++++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 488899999999999999877 578899999987655566678899999999999999999999999988999999999
Q ss_pred cCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC-cEEEeeecceeeecCCCcccc
Q 020085 189 MARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG-VVKVADFGVARVQAQSGVMTA 266 (331)
Q Consensus 189 ~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~-~vkl~DFg~a~~~~~~~~~~~ 266 (331)
+++++|.+++.... ..+++..+..++.|++++++|||++|++|+||+|+||++++++ .++|+|||.+...........
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~ 160 (256)
T cd08220 81 APGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYT 160 (256)
T ss_pred CCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccccc
Confidence 99999999997653 4589999999999999999999999999999999999998654 689999999987655444444
Q ss_pred CCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccc
Q 020085 267 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 267 ~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~ 320 (331)
..++..|+|||.+.+..++.++|+||||+++|+|++|+.||...++...+..+.
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~ 214 (256)
T cd08220 161 VVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIM 214 (256)
T ss_pred cccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHH
Confidence 568899999999998889999999999999999999999999887766665544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=268.97 Aligned_cols=217 Identities=33% Similarity=0.560 Sum_probs=185.9
Q ss_pred CcceeeeeeecCceEEEEEEE--CCceEEEEEecCCC---CCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEE
Q 020085 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC---VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV 185 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV 185 (331)
+|+..+.||+|++|.||+|.. +++.|++|.+.... ...+..+.+.+|+.+++.++|||++++++++......+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 367778999999999999987 57899999986532 1234567899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCccc
Q 020085 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT 265 (331)
Q Consensus 186 ~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~~ 265 (331)
+||+++++|.+++.. .+.+++..+..++.|+++|+.|||+.|++|+||+|+||+++.++.+||+|||.+..........
T Consensus 81 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~ 159 (258)
T cd06632 81 LELVPGGSLAKLLKK-YGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAK 159 (258)
T ss_pred EEecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccccccc
Confidence 999999999999965 4568899999999999999999999999999999999999999999999999987655444344
Q ss_pred cCCCCcccccchhcCCCC-CCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccccccccc
Q 020085 266 AETGTYRWMAPEVIEHKP-YDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIHSI 328 (331)
Q Consensus 266 ~~~gt~~y~aPE~~~~~~-~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~p~~ 328 (331)
...+++.|+|||.+.... ++.++|+||||+++|+|++|+.||....+.+....+...+.+|.+
T Consensus 160 ~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 223 (258)
T cd06632 160 SFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELPPI 223 (258)
T ss_pred ccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcccCCCc
Confidence 566889999999997776 899999999999999999999999888776666554443444443
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=277.83 Aligned_cols=201 Identities=26% Similarity=0.443 Sum_probs=177.2
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEe
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E 187 (331)
++|++.++||+|+||.||++.+ ++..+|+|.++... .......+.+|++++++++||||++++++|..++.+++|||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI-KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 3689999999999999999987 46789999987543 34456678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCcccc
Q 020085 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 266 (331)
Q Consensus 188 ~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~~~ 266 (331)
|+++++|.+++.+ .+.+++..+..++.|+++||.|||+ .+++|+||||+||+++.++.++|+|||++...... ....
T Consensus 80 y~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~~~~ 157 (308)
T cd06615 80 HMDGGSLDQVLKK-AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANS 157 (308)
T ss_pred ccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc-cccc
Confidence 9999999999965 4678999999999999999999997 59999999999999999999999999998754332 2234
Q ss_pred CCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH
Q 020085 267 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPL 313 (331)
Q Consensus 267 ~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~ 313 (331)
..++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+..
T Consensus 158 ~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~ 204 (308)
T cd06615 158 FVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAK 204 (308)
T ss_pred CCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchh
Confidence 56889999999998888999999999999999999999999765543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=274.31 Aligned_cols=201 Identities=24% Similarity=0.443 Sum_probs=180.6
Q ss_pred CcceeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEe
Q 020085 111 QLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E 187 (331)
+|++.++||+|+||.||++... ++.||+|++..... .....+.+.+|++++++++||||+++++.+..+...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4889999999999999999884 78999999975433 23456789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCccccC
Q 020085 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE 267 (331)
Q Consensus 188 ~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~~~~ 267 (331)
|+.|++|.+++... ..+++..+..++.|+++||.|||++|++|+||+|+||++++++.++|+|||.+............
T Consensus 81 ~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 159 (258)
T cd05578 81 LLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTST 159 (258)
T ss_pred CCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcccccc
Confidence 99999999999664 68899999999999999999999999999999999999999999999999999766554444556
Q ss_pred CCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH
Q 020085 268 TGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTP 312 (331)
Q Consensus 268 ~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~ 312 (331)
.++..|+|||.+.+..++.++|+||||+++|+|++|+.||...+.
T Consensus 160 ~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 204 (258)
T cd05578 160 SGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSR 204 (258)
T ss_pred CCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCc
Confidence 788999999999888899999999999999999999999998763
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=278.09 Aligned_cols=212 Identities=24% Similarity=0.391 Sum_probs=183.1
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCH-HHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEE
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNT-EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~-~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~ 186 (331)
++|++.+.||+|++|.||++.. .++.+|+|.+....... ...+.+.+|+.+++.++||||+++++.+......|+||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 4689999999999999999988 46899999998654432 45677999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCc--
Q 020085 187 EFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV-- 263 (331)
Q Consensus 187 E~~~ggsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~-- 263 (331)
||+.|++|.+++... ...+++..+..++.|+++||+|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus 81 e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 160 (316)
T cd05574 81 DYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPV 160 (316)
T ss_pred EecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccccc
Confidence 999999999998754 35789999999999999999999999999999999999999999999999999864322110
Q ss_pred ----------------------------cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 020085 264 ----------------------------MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQA 315 (331)
Q Consensus 264 ----------------------------~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~ 315 (331)
.....|+..|+|||.+.+..++.++||||||+++|+|++|+.||.+.+..+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~ 240 (316)
T cd05574 161 SKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET 240 (316)
T ss_pred ccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHH
Confidence 0122578899999999988899999999999999999999999998877666
Q ss_pred Hhcccc
Q 020085 316 AVGVVQ 321 (331)
Q Consensus 316 ~~~~~~ 321 (331)
...+.+
T Consensus 241 ~~~~~~ 246 (316)
T cd05574 241 FSNILK 246 (316)
T ss_pred HHHHhc
Confidence 655443
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=274.37 Aligned_cols=207 Identities=34% Similarity=0.526 Sum_probs=171.8
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHH-HHhcCCCcceeEEeEEECCCCeEEEE
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYI-MRKIRHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~i-l~~l~h~niv~~~~~~~~~~~~~lV~ 186 (331)
++|.+.+.||+|+||.||++.+ +++.||+|+++....... ...+..|+.+ ++..+|||++++++++..+...+++|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQE-QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 4789999999999999999988 578999999986543333 3445556554 66678999999999999999999999
Q ss_pred eccCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC
Q 020085 187 EFMARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262 (331)
Q Consensus 187 E~~~ggsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~-~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~ 262 (331)
||+++ +|.+++... ...+++..+..++.|++.||+|||++ +++||||||+||+++.++.+||+|||.++......
T Consensus 80 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 158 (283)
T cd06617 80 EVMDT-SLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV 158 (283)
T ss_pred hhhcc-cHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence 99974 888887542 35689999999999999999999997 99999999999999999999999999997654433
Q ss_pred ccccCCCCcccccchhcCC----CCCCChhhHHHHHHHHHHHHcCCCCCCCC-CHHHHHhc
Q 020085 263 VMTAETGTYRWMAPEVIEH----KPYDYKADVFSFGIALWELLTGELPYAGL-TPLQAAVG 318 (331)
Q Consensus 263 ~~~~~~gt~~y~aPE~~~~----~~~~~~~Di~SlG~il~ell~g~~Pf~~~-~~~~~~~~ 318 (331)
..+...++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||... ++.+....
T Consensus 159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 219 (283)
T cd06617 159 AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQ 219 (283)
T ss_pred ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHH
Confidence 3344568899999999864 45788999999999999999999999764 33444444
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=275.21 Aligned_cols=217 Identities=31% Similarity=0.588 Sum_probs=182.5
Q ss_pred ecccCcceeeeeeecCceEEEEEEE-------CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECC
Q 020085 107 IDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP 179 (331)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 179 (331)
++.++|++.+.||+|+||.||++.. .+..||+|+++... .......+.+|+.++++++||||+++++++..+
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~ 80 (288)
T cd05050 2 YPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDHPNIVKLLGVCAVG 80 (288)
T ss_pred CChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc-CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence 4567899999999999999999986 34789999987543 344567799999999999999999999999999
Q ss_pred CCeEEEEeccCCCCHHHHHHhcC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 020085 180 PNLCIVTEFMARGSIYDFLHKQK---------------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTAN 238 (331)
Q Consensus 180 ~~~~lV~E~~~ggsL~~~l~~~~---------------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~N 238 (331)
...++++||+++|+|.+++.... ..+++..++.++.|++.||+|||++|++||||||+|
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~n 160 (288)
T cd05050 81 KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRN 160 (288)
T ss_pred CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhh
Confidence 99999999999999999996532 246778889999999999999999999999999999
Q ss_pred EEEcCCCcEEEeeecceeeecCCCc---cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHH
Q 020085 239 LLMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQ 314 (331)
Q Consensus 239 iLi~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~ 314 (331)
|+++.++.++|+|||.++....... ......+..|+|||.+.+..++.++|+|||||++|||++ |..||.+.++.+
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~ 240 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEE 240 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 9999999999999999875432211 122334678999999998899999999999999999998 889998887766
Q ss_pred HHhcccccccc
Q 020085 315 AAVGVVQKVSI 325 (331)
Q Consensus 315 ~~~~~~~~~~~ 325 (331)
.... +.++..
T Consensus 241 ~~~~-~~~~~~ 250 (288)
T cd05050 241 VIYY-VRDGNV 250 (288)
T ss_pred HHHH-HhcCCC
Confidence 5554 334443
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=287.50 Aligned_cols=195 Identities=25% Similarity=0.444 Sum_probs=170.6
Q ss_pred ecccCcceeeeeeecCceEEEEEEEC----CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCe
Q 020085 107 IDAKQLKIECKVASGSYGDLYKGTYC----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL 182 (331)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 182 (331)
+...+|.+.+.||+|+||.||++... ++.||+|.+... ..+.+|+.++++++||||+++++++......
T Consensus 89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~ 161 (392)
T PHA03207 89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-------KTPGREIDILKTISHRAIINLIHAYRWKSTV 161 (392)
T ss_pred hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-------ccHHHHHHHHHhcCCCCccceeeeEeeCCEE
Confidence 34568999999999999999999763 367999988643 2356799999999999999999999998999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC
Q 020085 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262 (331)
Q Consensus 183 ~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~ 262 (331)
|++||++. ++|.+++. ..+.+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||+++......
T Consensus 162 ~lv~e~~~-~~l~~~l~-~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 162 CMVMPKYK-CDLFTYVD-RSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred EEEehhcC-CCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 99999996 48999883 45789999999999999999999999999999999999999999999999999997544322
Q ss_pred c---cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 020085 263 V---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL 310 (331)
Q Consensus 263 ~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~ 310 (331)
. .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.
T Consensus 240 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~ 290 (392)
T PHA03207 240 DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGK 290 (392)
T ss_pred ccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 1 12346899999999999999999999999999999999999999664
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=273.15 Aligned_cols=219 Identities=26% Similarity=0.500 Sum_probs=185.1
Q ss_pred eecccCcceeeeeeecCceEEEEEEEC------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEEC-
Q 020085 106 EIDAKQLKIECKVASGSYGDLYKGTYC------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR- 178 (331)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~- 178 (331)
.++.++|++.+.||+|+||.||+|.+. +..|++|+++.. ........+.+|+.++++++||||+++++++..
T Consensus 2 ~~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~-~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~ 80 (280)
T cd05043 2 AISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH-ASEIQVTLLLQESCLLYGLSHQNILPILHVCIED 80 (280)
T ss_pred ccchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC-CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC
Confidence 366789999999999999999999874 477999998754 345556789999999999999999999998766
Q ss_pred CCCeEEEEeccCCCCHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEee
Q 020085 179 PPNLCIVTEFMARGSIYDFLHKQK-------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 251 (331)
Q Consensus 179 ~~~~~lV~E~~~ggsL~~~l~~~~-------~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~D 251 (331)
+...++++||+++++|.+++.... ..+++..+..++.|++.||+|||+++++||||||+||++++++.+||+|
T Consensus 81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECC
Confidence 467899999999999999996532 4588999999999999999999999999999999999999999999999
Q ss_pred ecceeeecCCCc---cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhccccccccc
Q 020085 252 FGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIH 326 (331)
Q Consensus 252 Fg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p 326 (331)
||+++....... .....++..|+|||.+.+..++.++||||||+++||+++ |+.||...++.+.... +..+.++
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~-~~~~~~~ 238 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAY-LKDGYRL 238 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHH-HHcCCCC
Confidence 999975433221 122345678999999998899999999999999999999 9999999888776554 3345443
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=295.45 Aligned_cols=214 Identities=33% Similarity=0.511 Sum_probs=190.8
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEE
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~ 186 (331)
.-|.-++.||.|+||-||-+++ +.+.||||.+..... +.+...++.+|+..|++++|||++.+-|++-.+...|+||
T Consensus 26 klf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 26 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHH
Confidence 3466788999999999999988 568899999986543 4455678999999999999999999999999998999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCcccc
Q 020085 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 266 (331)
Q Consensus 187 E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~~~ 266 (331)
|||-| |-.|++.-.+.++.+..+..|..+.+.||+|||+.+.||||||+.|||+++.|.|||+|||.|....+. ..
T Consensus 106 EYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA---ns 181 (948)
T KOG0577|consen 106 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA---NS 181 (948)
T ss_pred HHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCch---hc
Confidence 99976 999999877889999999999999999999999999999999999999999999999999999876554 35
Q ss_pred CCCCcccccchhc---CCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccccccccc
Q 020085 267 ETGTYRWMAPEVI---EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIHSI 328 (331)
Q Consensus 267 ~~gt~~y~aPE~~---~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~p~~ 328 (331)
.+|||.|||||++ ..+.|+-++|||||||+..||...++|+-+++.+.+.-.|.+ -..|++
T Consensus 182 FvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQ-NesPtL 245 (948)
T KOG0577|consen 182 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-NESPTL 245 (948)
T ss_pred ccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHh-cCCCCC
Confidence 6899999999998 456899999999999999999999999999999999888765 444544
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=270.60 Aligned_cols=203 Identities=33% Similarity=0.632 Sum_probs=176.5
Q ss_pred eeeeecCceEEEEEEECC-----ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEeccC
Q 020085 116 CKVASGSYGDLYKGTYCS-----QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMA 190 (331)
Q Consensus 116 ~~lg~G~~g~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~~~ 190 (331)
+.||+|++|.||+|.+.. ..||+|.++..... ...+.+.+|+.++++++||||+++++.+.. ...++||||++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~ 78 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS-DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH-HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence 468999999999998732 36999999876543 567889999999999999999999999988 88999999999
Q ss_pred CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCc----cc
Q 020085 191 RGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV----MT 265 (331)
Q Consensus 191 ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~----~~ 265 (331)
+++|.+++.... ..+++..+..++.|++.||+|||++|++|+||+|+||+++.++.+||+|||+++....... ..
T Consensus 79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 158 (257)
T cd05040 79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEE 158 (257)
T ss_pred CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceeccc
Confidence 999999997755 5789999999999999999999999999999999999999999999999999976544211 11
Q ss_pred cCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhccc
Q 020085 266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 266 ~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~ 320 (331)
...++..|+|||.+.+..++.++|+||||+++|||++ |+.||...+..+....+.
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~ 214 (257)
T cd05040 159 HLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKID 214 (257)
T ss_pred CCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence 2346789999999999999999999999999999998 999999888877655544
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=274.46 Aligned_cols=194 Identities=32% Similarity=0.537 Sum_probs=171.8
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEe
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E 187 (331)
++|++.+.||+|+||.||+|.+ +++.||+|+++... .......+.+|+.++++++||||+++++.+......++|||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI-TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC-ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence 3688899999999999999987 67889999987543 34455779999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCccccC
Q 020085 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE 267 (331)
Q Consensus 188 ~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~~~~ 267 (331)
|+++++|..+ ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++...... .....
T Consensus 80 ~~~~~~l~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-~~~~~ 153 (279)
T cd06619 80 FMDGGSLDVY-----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-IAKTY 153 (279)
T ss_pred cCCCCChHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-cccCC
Confidence 9999999764 34678889999999999999999999999999999999999999999999999765432 23345
Q ss_pred CCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 020085 268 TGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL 310 (331)
Q Consensus 268 ~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~ 310 (331)
.++..|+|||.+.+..++.++|+||||+++|+|++|+.||...
T Consensus 154 ~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 196 (279)
T cd06619 154 VGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQI 196 (279)
T ss_pred CCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhh
Confidence 7899999999999889999999999999999999999999653
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=283.26 Aligned_cols=208 Identities=26% Similarity=0.398 Sum_probs=180.0
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECC------C
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP------P 180 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~------~ 180 (331)
.++|++.+.||+|+||.||++.. .++.||+|+++....+......+.+|+.++++++||||+++++++... .
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 94 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ 94 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence 46799999999999999999987 678999999876544555566788999999999999999999988643 3
Q ss_pred CeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecC
Q 020085 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (331)
Q Consensus 181 ~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~ 260 (331)
..|+||||+.+ +|.+.+... ++...+..++.|++.||+|||++|++||||||+||+++.++.++|+|||.++....
T Consensus 95 ~~~lv~e~~~~-~l~~~~~~~---l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 170 (353)
T cd07850 95 DVYLVMELMDA-NLCQVIQMD---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 170 (353)
T ss_pred cEEEEEeccCC-CHHHHHhhc---CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence 47999999965 898888542 88999999999999999999999999999999999999999999999999987655
Q ss_pred CCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccc
Q 020085 261 SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 261 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~ 320 (331)
........++..|+|||.+.+..++.++|+|||||++|+|++|+.||...+.......+.
T Consensus 171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~ 230 (353)
T cd07850 171 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKII 230 (353)
T ss_pred CCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 444445568899999999999999999999999999999999999999877665555443
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=276.01 Aligned_cols=206 Identities=30% Similarity=0.514 Sum_probs=179.7
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~ 186 (331)
..+|.+.+.||+|+||.||+|.. .++.+|+|.+...... ..+.+.+|+.+++.++|||++++++.+..+...|+||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~ 96 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc--hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence 35899999999999999999986 5789999998765432 2467889999999999999999999999989999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC-ccc
Q 020085 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMT 265 (331)
Q Consensus 187 E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~-~~~ 265 (331)
||+++++|.+++.. ..++...+..++.|++.|++|||+.|++||||||+||+++.++.++|+|||.+....... ...
T Consensus 97 e~~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 174 (296)
T cd06654 97 EYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174 (296)
T ss_pred cccCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccccccC
Confidence 99999999999854 457889999999999999999999999999999999999999999999999987543321 223
Q ss_pred cCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhc
Q 020085 266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVG 318 (331)
Q Consensus 266 ~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~ 318 (331)
...+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...++......
T Consensus 175 ~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~ 227 (296)
T cd06654 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL 227 (296)
T ss_pred cccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHH
Confidence 45688999999999988899999999999999999999999988777554443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-37 Score=287.45 Aligned_cols=193 Identities=24% Similarity=0.435 Sum_probs=169.2
Q ss_pred cccCcceeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEE
Q 020085 108 DAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV 185 (331)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV 185 (331)
....|++.+.||+|+||.||+|+.. ++.||+|+.... ....|+.++++++||||+++++++......++|
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 135 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV 135 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence 4457999999999999999999984 468999985432 235689999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCccc
Q 020085 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT 265 (331)
Q Consensus 186 ~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~~ 265 (331)
+|++.+ +|.+++......+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||.++.........
T Consensus 136 ~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 214 (357)
T PHA03209 136 LPHYSS-DLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFL 214 (357)
T ss_pred EEccCC-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCcccc
Confidence 999965 9999997777789999999999999999999999999999999999999999999999999997654433344
Q ss_pred cCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcC-CCCCCC
Q 020085 266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTG-ELPYAG 309 (331)
Q Consensus 266 ~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g-~~Pf~~ 309 (331)
...||+.|+|||++.+..++.++|||||||++|||+++ +.+|..
T Consensus 215 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~ 259 (357)
T PHA03209 215 GLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFED 259 (357)
T ss_pred cccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccC
Confidence 56789999999999999999999999999999999985 455544
|
|
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=276.46 Aligned_cols=211 Identities=30% Similarity=0.582 Sum_probs=178.3
Q ss_pred ecccCcceeeeeeecCceEEEEEEECC----------------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcce
Q 020085 107 IDAKQLKIECKVASGSYGDLYKGTYCS----------------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170 (331)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~~~----------------~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv 170 (331)
+..++|++.++||+|+||.||+++..+ ..||+|.++... .......+.+|++++++++|||++
T Consensus 2 ~~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~ 80 (295)
T cd05097 2 FPRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV-TKTARNDFLKEIKIMSRLKNPNII 80 (295)
T ss_pred CchHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCcC
Confidence 456789999999999999999987632 248999998653 445567799999999999999999
Q ss_pred eEEeEEECCCCeEEEEeccCCCCHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 020085 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQK-----------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANL 239 (331)
Q Consensus 171 ~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~-----------~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Ni 239 (331)
++++++......++||||+.+++|.+++.... ..+++..++.++.|++.|+.|||++|++||||||+||
T Consensus 81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni 160 (295)
T cd05097 81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC 160 (295)
T ss_pred eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence 99999999999999999999999999986532 1367888999999999999999999999999999999
Q ss_pred EEcCCCcEEEeeecceeeecCCCc---cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc--CCCCCCCCCHHH
Q 020085 240 LMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT--GELPYAGLTPLQ 314 (331)
Q Consensus 240 Li~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~--g~~Pf~~~~~~~ 314 (331)
++++++.+||+|||+++....... .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 999999999999999875433221 112234678999999988889999999999999999988 678998877666
Q ss_pred HHhc
Q 020085 315 AAVG 318 (331)
Q Consensus 315 ~~~~ 318 (331)
....
T Consensus 241 ~~~~ 244 (295)
T cd05097 241 VIEN 244 (295)
T ss_pred HHHH
Confidence 5444
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=268.27 Aligned_cols=217 Identities=25% Similarity=0.441 Sum_probs=185.7
Q ss_pred CcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEEC--CCCeEEEE
Q 020085 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR--PPNLCIVT 186 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~--~~~~~lV~ 186 (331)
+|++.+.||+|+||.||++.. .++.+|+|+++.........+.+.+|+.++++++|||++++++.+.. ....+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 478899999999999999987 56889999998765566667789999999999999999999998754 34579999
Q ss_pred eccCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHH-----hCCcccCCCCCCCEEEcCCCcEEEeeecceeee
Q 020085 187 EFMARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLH-----QNNIIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (331)
Q Consensus 187 E~~~ggsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH-----~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~ 258 (331)
||+++++|.+++... ...+++..++.++.|+++|+.||| +.+++|+||+|+||++++++.++|+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999999654 467899999999999999999999 899999999999999999999999999999866
Q ss_pred cCCCc-cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccccccccc
Q 020085 259 AQSGV-MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIHSI 328 (331)
Q Consensus 259 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~p~~ 328 (331)
..... .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+.... +.++..|.+
T Consensus 161 ~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~ 230 (265)
T cd08217 161 GHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASK-IKEGKFRRI 230 (265)
T ss_pred cCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHH-HhcCCCCCC
Confidence 54432 3345689999999999988899999999999999999999999998775554443 445554443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=268.84 Aligned_cols=199 Identities=27% Similarity=0.535 Sum_probs=176.9
Q ss_pred CcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEec
Q 020085 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF 188 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~ 188 (331)
+|++.+.||+|+||.||++.. .++.+|+|+++.........+.+.+|+.++++++|+||+++++.+......++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 488899999999999999987 578999999987655555678899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCccc---
Q 020085 189 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT--- 265 (331)
Q Consensus 189 ~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~~--- 265 (331)
+++++|.+++.. ...+++..+..++.|++.|+.|||+.|++|+||+|+||++++++.++|+|||++..........
T Consensus 81 ~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~ 159 (264)
T cd06626 81 CSGGTLEELLEH-GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE 159 (264)
T ss_pred CCCCcHHHHHhh-cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence 999999999965 4567889999999999999999999999999999999999999999999999987654432211
Q ss_pred --cCCCCcccccchhcCCCC---CCChhhHHHHHHHHHHHHcCCCCCCCC
Q 020085 266 --AETGTYRWMAPEVIEHKP---YDYKADVFSFGIALWELLTGELPYAGL 310 (331)
Q Consensus 266 --~~~gt~~y~aPE~~~~~~---~~~~~Di~SlG~il~ell~g~~Pf~~~ 310 (331)
...+++.|+|||.+.+.. ++.++|+||||+++|++++|+.||...
T Consensus 160 ~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~ 209 (264)
T cd06626 160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209 (264)
T ss_pred ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCC
Confidence 245788999999997766 889999999999999999999999766
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-38 Score=298.43 Aligned_cols=197 Identities=28% Similarity=0.555 Sum_probs=173.3
Q ss_pred ceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCC------CeEE
Q 020085 113 KIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP------NLCI 184 (331)
Q Consensus 113 ~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~------~~~l 184 (331)
...+.||+|+||.||+|+. .|+.||||.++... +..-.+.-.+|+++|++++|||||++.++-+... ...+
T Consensus 16 ~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~-~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 16 EMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES-SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eehhhhcCCccceeeeecccccccchhHHhhhhhc-ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 3455899999999999986 68999999998754 3334577889999999999999999998765433 4689
Q ss_pred EEeccCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC--CC--cEEEeeecceeee
Q 020085 185 VTEFMARGSIYDFLHKQ--KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE--NG--VVKVADFGVARVQ 258 (331)
Q Consensus 185 V~E~~~ggsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~--~~--~vkl~DFg~a~~~ 258 (331)
|||||.||||+..+... ...+++..++.++.+++.||.|||++||+||||||.||++-. +| .-||+|||.|+..
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel 174 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAREL 174 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccC
Confidence 99999999999999764 357999999999999999999999999999999999999853 34 3799999999999
Q ss_pred cCCCccccCCCCcccccchhcC-CCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 020085 259 AQSGVMTAETGTYRWMAPEVIE-HKPYDYKADVFSFGIALWELLTGELPYAGL 310 (331)
Q Consensus 259 ~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~SlG~il~ell~g~~Pf~~~ 310 (331)
+++...+.-.||..|.+||... .+.|+...|.|||||++|++.||..||...
T Consensus 175 ~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~ 227 (732)
T KOG4250|consen 175 DDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPF 227 (732)
T ss_pred CCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcC
Confidence 9888888889999999999998 588999999999999999999999999653
|
|
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=273.98 Aligned_cols=210 Identities=34% Similarity=0.604 Sum_probs=179.8
Q ss_pred cccCcceeeeeeecCceEEEEEEECC------------------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcc
Q 020085 108 DAKQLKIECKVASGSYGDLYKGTYCS------------------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNV 169 (331)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~~~------------------~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~ni 169 (331)
..++|++.++||+|+||.||++.... ..||+|.++... .....+.+.+|+.++++++|||+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA-SDNAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhcCCCCE
Confidence 45689999999999999999987632 458999988654 34556789999999999999999
Q ss_pred eeEEeEEECCCCeEEEEeccCCCCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 020085 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK----------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANL 239 (331)
Q Consensus 170 v~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~----------~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Ni 239 (331)
+++++++..++..+++||++.+++|.+++.... ..+++..++.++.|++.||+|||++|++||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni 161 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC 161 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence 999999999999999999999999999996643 2688999999999999999999999999999999999
Q ss_pred EEcCCCcEEEeeecceeeecCCCc---cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc--CCCCCCCCCHHH
Q 020085 240 LMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT--GELPYAGLTPLQ 314 (331)
Q Consensus 240 Li~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~--g~~Pf~~~~~~~ 314 (331)
+++.++.++|+|||.++....... .....+++.|+|||.+.+..++.++||||||+++|||++ +..||...+..+
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ 241 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH
Confidence 999999999999999875433221 123345778999999988889999999999999999998 788998877666
Q ss_pred HHhc
Q 020085 315 AAVG 318 (331)
Q Consensus 315 ~~~~ 318 (331)
....
T Consensus 242 ~~~~ 245 (296)
T cd05051 242 VIEN 245 (296)
T ss_pred HHHH
Confidence 5444
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=267.53 Aligned_cols=216 Identities=24% Similarity=0.453 Sum_probs=186.9
Q ss_pred CcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEec
Q 020085 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF 188 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~ 188 (331)
+|++.+.||+|+||.+|+++. .++.||+|.++...........+.+|+.++++++||||+++++++...+..++|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 588999999999999999887 578999999876544555567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCcc-cc
Q 020085 189 MARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM-TA 266 (331)
Q Consensus 189 ~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~-~~ 266 (331)
+.+++|.+++.... ..+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++++|||.+......... ..
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~ 160 (256)
T cd08218 81 CEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART 160 (256)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhhh
Confidence 99999999997643 46789999999999999999999999999999999999999999999999999765443221 23
Q ss_pred CCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccccccccc
Q 020085 267 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIHS 327 (331)
Q Consensus 267 ~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~p~ 327 (331)
..+++.|+|||.+.+..++.++|+||||+++|+|++|+.||....+.+....+. .+..|+
T Consensus 161 ~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~-~~~~~~ 220 (256)
T cd08218 161 CIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKII-RGSYPP 220 (256)
T ss_pred ccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHh-cCCCCC
Confidence 357889999999998889999999999999999999999999887777666644 344443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=268.80 Aligned_cols=201 Identities=25% Similarity=0.491 Sum_probs=176.4
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEE
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~ 186 (331)
++|++.+.||+|+||.||+|.. .++.||+|.++.... +......+.+|+.++++++|+|++++++.+...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 5799999999999999999998 578999999875332 3344678999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC-
Q 020085 187 EFMARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG- 262 (331)
Q Consensus 187 E~~~ggsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~- 262 (331)
||+++++|.+++... ...++...+..++.|+++|+.|||+.|++||||+|+||+++.++.++|+|||.++......
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~ 161 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc
Confidence 999999999998642 3558899999999999999999999999999999999999999999999999987654322
Q ss_pred ccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 020085 263 VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL 310 (331)
Q Consensus 263 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~ 310 (331)
......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...
T Consensus 162 ~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 209 (267)
T cd08224 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccC
Confidence 223346888999999999989999999999999999999999999553
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=268.42 Aligned_cols=201 Identities=31% Similarity=0.590 Sum_probs=171.5
Q ss_pred eeeeecCceEEEEEEECC-----ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEeccC
Q 020085 116 CKVASGSYGDLYKGTYCS-----QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMA 190 (331)
Q Consensus 116 ~~lg~G~~g~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~~~ 190 (331)
++||+|+||.||+|.+.. ..+|+|.++..... ...+.+.+|+.+++.++|||++++++++. ....++||||++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~ 78 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA-AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAP 78 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCC
Confidence 479999999999998732 57999999866543 44577999999999999999999999876 456899999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCccc----c
Q 020085 191 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT----A 266 (331)
Q Consensus 191 ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~~----~ 266 (331)
+++|.+++... ..+++..+..++.|++.|++|||+.+++|+||||+||+++.++.++|+|||.++......... .
T Consensus 79 ~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~ 157 (257)
T cd05060 79 LGPLLKYLKKR-REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA 157 (257)
T ss_pred CCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccC
Confidence 99999999764 478999999999999999999999999999999999999999999999999997654432211 1
Q ss_pred CCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhcc
Q 020085 267 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGV 319 (331)
Q Consensus 267 ~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~ 319 (331)
..++..|+|||.+.+..++.++|+||||+++|+|++ |..||...++.+....+
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~ 211 (257)
T cd05060 158 GRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAML 211 (257)
T ss_pred ccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH
Confidence 123468999999999999999999999999999998 99999988876655543
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=277.40 Aligned_cols=213 Identities=25% Similarity=0.443 Sum_probs=181.3
Q ss_pred cccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECC--CCeE
Q 020085 108 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--PNLC 183 (331)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~--~~~~ 183 (331)
..++|++.+.||+|+||.||+|.+ .++.||+|+++...........+.+|+.++++++|+|++++++++... +..+
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 456899999999999999999988 578999999975543333334567899999999999999999998754 4689
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC-C
Q 020085 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-G 262 (331)
Q Consensus 184 lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~-~ 262 (331)
+||||+.+ +|.+++......+++..+..++.|+++|+.|||+.|++||||||+||++++++.++|+|||.++..... .
T Consensus 85 lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~ 163 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK 163 (309)
T ss_pred EEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCccC
Confidence 99999975 899998766678999999999999999999999999999999999999999999999999999865433 2
Q ss_pred ccccCCCCcccccchhcCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 263 VMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 263 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
......++..|+|||.+.+ ..++.++|+||||+++|||++|+.||.+.++.+....+.+
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~ 223 (309)
T cd07845 164 PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQ 223 (309)
T ss_pred CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 2233446788999999865 5678999999999999999999999999988877666544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=276.19 Aligned_cols=202 Identities=25% Similarity=0.438 Sum_probs=173.0
Q ss_pred CcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEec
Q 020085 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF 188 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~ 188 (331)
+|++.+.||+|+||.||++++ .|+.+|+|+++...........+.+|+.++++++||||+++++++......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 478899999999999999998 578999999976543333445678899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC-CccccC
Q 020085 189 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTAE 267 (331)
Q Consensus 189 ~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~-~~~~~~ 267 (331)
+++ +|.+++....+.+++..+..++.||++||.|||++|++||||||+||+++.++.++|+|||+++..... ......
T Consensus 81 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~ 159 (284)
T cd07839 81 CDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAE 159 (284)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCCC
Confidence 975 898888766678999999999999999999999999999999999999999999999999998754332 222345
Q ss_pred CCCcccccchhcCCC-CCCChhhHHHHHHHHHHHHcCCCCC-CCCCHH
Q 020085 268 TGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPY-AGLTPL 313 (331)
Q Consensus 268 ~gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~ell~g~~Pf-~~~~~~ 313 (331)
.+++.|+|||.+.+. .++.++|+||||+++|+|++|..|| ++.+..
T Consensus 160 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~ 207 (284)
T cd07839 160 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD 207 (284)
T ss_pred ccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH
Confidence 678999999998664 5789999999999999999988774 544433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=271.05 Aligned_cols=202 Identities=34% Similarity=0.610 Sum_probs=169.5
Q ss_pred eeeeecCceEEEEEEECC--c--eEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCcceeEEeEEECCCCeEEEEeccC
Q 020085 116 CKVASGSYGDLYKGTYCS--Q--EVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMA 190 (331)
Q Consensus 116 ~~lg~G~~g~Vy~~~~~~--~--~vavK~~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~lV~E~~~ 190 (331)
+.||+|+||.||+|+..+ . .+|+|.++... .....+.+.+|+.+++++ +||||+++++++......++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~ 79 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP 79 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccC-CHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence 368999999999998743 3 46888887432 344556889999999999 79999999999999999999999999
Q ss_pred CCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecce
Q 020085 191 RGSIYDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA 255 (331)
Q Consensus 191 ggsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a 255 (331)
+|+|.+++.... ..+++..+..++.|++.|++|||++|++||||||+||++++++.+||+|||++
T Consensus 80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~ 159 (270)
T cd05047 80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 159 (270)
T ss_pred CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCc
Confidence 999999996532 24788999999999999999999999999999999999999999999999998
Q ss_pred eeecCCCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhc
Q 020085 256 RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVG 318 (331)
Q Consensus 256 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~ 318 (331)
..............+..|+|||.+.+..++.++|+||||+++|||++ |..||.+.+..+....
T Consensus 160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~ 223 (270)
T cd05047 160 RGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK 223 (270)
T ss_pred cccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHH
Confidence 63322111222234567999999998899999999999999999997 9999988776665544
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=276.10 Aligned_cols=210 Identities=26% Similarity=0.416 Sum_probs=180.9
Q ss_pred ccCcceeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECC--CCeEE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--PNLCI 184 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~--~~~~l 184 (331)
.++|++.+.||+|+||.||+|++. ++.+|+|.++...........+.+|+.++++++||||+++++++... ...|+
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 357999999999999999999984 68899999986544444445678899999999999999999998776 78999
Q ss_pred EEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC-Cc
Q 020085 185 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GV 263 (331)
Q Consensus 185 V~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~-~~ 263 (331)
||||+.+ +|.+++......+++..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||.++..... ..
T Consensus 84 v~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 162 (293)
T cd07843 84 VMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP 162 (293)
T ss_pred EehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCccc
Confidence 9999985 999998776667999999999999999999999999999999999999999999999999999865543 22
Q ss_pred cccCCCCcccccchhcCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcc
Q 020085 264 MTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGV 319 (331)
Q Consensus 264 ~~~~~gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~ 319 (331)
.....+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||...++.+...++
T Consensus 163 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~ 219 (293)
T cd07843 163 YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKI 219 (293)
T ss_pred cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 3345678899999998654 4689999999999999999999999988776655543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=284.39 Aligned_cols=218 Identities=22% Similarity=0.372 Sum_probs=188.1
Q ss_pred CCeeeecccCcceeeeeeecCceEEEEEEEC-CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCcceeEEeEEECC
Q 020085 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRP 179 (331)
Q Consensus 102 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~ 179 (331)
...+.++...|+++++||+||.+.||++... .+.||+|.+.....+...+..|.+|+..|.+++ |.+|++++++-..+
T Consensus 353 ~~~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d 432 (677)
T KOG0596|consen 353 NEIIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTD 432 (677)
T ss_pred CeeEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccC
Confidence 3567889999999999999999999999885 467899988877778888999999999999995 89999999999999
Q ss_pred CCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeec
Q 020085 180 PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA 259 (331)
Q Consensus 180 ~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~ 259 (331)
+.+||||||=+. +|..+|.+.....+...+..+..|++.|+.++|+.||||.||||+|+|+- .|.+||+|||.|....
T Consensus 433 ~~lYmvmE~Gd~-DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 433 GYLYMVMECGDI-DLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQ 510 (677)
T ss_pred ceEEEEeecccc-cHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccC
Confidence 999999998755 99999988766666668899999999999999999999999999999995 6899999999998766
Q ss_pred CCCc---cccCCCCcccccchhcCCC-----------CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 260 QSGV---MTAETGTYRWMAPEVIEHK-----------PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 260 ~~~~---~~~~~gt~~y~aPE~~~~~-----------~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
.... ....+||+.||+||.+... ..++++||||||||||+|+.|+.||.......+....+.
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~ 586 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAIT 586 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhc
Confidence 5432 3456899999999998432 246789999999999999999999998765555444443
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=270.65 Aligned_cols=202 Identities=27% Similarity=0.488 Sum_probs=167.9
Q ss_pred eeeeecCceEEEEEEECC----ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEeccCC
Q 020085 116 CKVASGSYGDLYKGTYCS----QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 191 (331)
Q Consensus 116 ~~lg~G~~g~Vy~~~~~~----~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~~~g 191 (331)
+.||+|+||.||+|...+ ..+|+|.++.... ......+.+|+.++++++||||+++++++......++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 79 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSAS-VQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL 79 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCC-hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence 368999999999998633 5699999876542 33345789999999999999999999999998899999999999
Q ss_pred CCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCc---c
Q 020085 192 GSIYDFLHKQK----GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV---M 264 (331)
Q Consensus 192 gsL~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~---~ 264 (331)
|+|.+++.... ...+...+..++.|++.|++|||++|++||||||+||+++.++.++|+|||.++....... .
T Consensus 80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~ 159 (269)
T cd05087 80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTP 159 (269)
T ss_pred CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecC
Confidence 99999996532 2456677889999999999999999999999999999999999999999999875433221 1
Q ss_pred ccCCCCcccccchhcCCC-------CCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhc
Q 020085 265 TAETGTYRWMAPEVIEHK-------PYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVG 318 (331)
Q Consensus 265 ~~~~gt~~y~aPE~~~~~-------~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~ 318 (331)
....+++.|+|||++.+. .++.++|+||||+++|||++ |+.||+..++.+....
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~ 221 (269)
T cd05087 160 DQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTY 221 (269)
T ss_pred CCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHH
Confidence 223467889999998642 35789999999999999996 9999998877665443
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=270.95 Aligned_cols=215 Identities=33% Similarity=0.585 Sum_probs=184.3
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEe
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E 187 (331)
..|+..++||+|+||.||+|.+ .++.||+|+++... .......+.+|+.++++++||||+++++++..+...++|||
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME 82 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc-cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence 3577889999999999999987 56889999987543 23446789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCc-ccc
Q 020085 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV-MTA 266 (331)
Q Consensus 188 ~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~-~~~ 266 (331)
|++|++|.+++.. +.++...+..++.|++.|++|||+++++|+||+|+||+++.++.++++|||++........ ...
T Consensus 83 ~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06640 83 YLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred cCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcccccc
Confidence 9999999999854 5688899999999999999999999999999999999999999999999999976543321 223
Q ss_pred CCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccccccccc
Q 020085 267 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIHSI 328 (331)
Q Consensus 267 ~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~p~~ 328 (331)
..++..|+|||.+.+..++.++|+||||+++|||++|+.||...++...... +..+..|.+
T Consensus 161 ~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~-~~~~~~~~~ 221 (277)
T cd06640 161 FVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFL-IPKNNPPTL 221 (277)
T ss_pred ccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhh-hhcCCCCCC
Confidence 4578899999999988899999999999999999999999998877765554 334444443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=268.77 Aligned_cols=202 Identities=29% Similarity=0.474 Sum_probs=178.2
Q ss_pred eeecCceEEEEEEEC--CceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEeccCCCCH
Q 020085 118 VASGSYGDLYKGTYC--SQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI 194 (331)
Q Consensus 118 lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~~~ggsL 194 (331)
||.|++|.||+++.. ++.+|+|++..... .....+.+.+|+.++++++||||+++++.+..+...++++||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999996 78999999975433 234557799999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCccccCCCCcccc
Q 020085 195 YDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWM 274 (331)
Q Consensus 195 ~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~~~~~gt~~y~ 274 (331)
.+++.+ ...++...+..++.|++.||+|||++|++|+||+|+||+++.++.++|+|||.++............+++.|+
T Consensus 81 ~~~l~~-~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~ 159 (262)
T cd05572 81 WTILRD-RGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYV 159 (262)
T ss_pred HHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcCcc
Confidence 999965 4568999999999999999999999999999999999999999999999999998665543334456889999
Q ss_pred cchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC--HHHHHhccc
Q 020085 275 APEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLT--PLQAAVGVV 320 (331)
Q Consensus 275 aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~--~~~~~~~~~ 320 (331)
+||.+.+..++.++|+||+|+++|+|++|+.||.... +.+....+.
T Consensus 160 ~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 207 (262)
T cd05572 160 APEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDIL 207 (262)
T ss_pred ChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHh
Confidence 9999988889999999999999999999999998877 666665544
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=267.34 Aligned_cols=211 Identities=25% Similarity=0.438 Sum_probs=186.1
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCC------CCHHHHHHHHHHHHHHHhc-CCCcceeEEeEEECCC
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC------VNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPP 180 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~ 180 (331)
..|.-.+.+|.|..++|.++.. .|+.+|+|++.... .-.+..++-.+|+.||+++ .||+|+++.+.++.+.
T Consensus 17 ~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~s 96 (411)
T KOG0599|consen 17 AKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDA 96 (411)
T ss_pred hhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcc
Confidence 3567778899999999998866 67899999985321 1234566788899999998 5999999999999999
Q ss_pred CeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecC
Q 020085 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (331)
Q Consensus 181 ~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~ 260 (331)
.+++|+|.|+.|.|.|+|.. .-.+++....+++.|+.+|++|||.++|+||||||+|||++++.+++|+|||+++....
T Consensus 97 F~FlVFdl~prGELFDyLts-~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~ 175 (411)
T KOG0599|consen 97 FVFLVFDLMPRGELFDYLTS-KVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEP 175 (411)
T ss_pred hhhhhhhhcccchHHHHhhh-heeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccCC
Confidence 99999999999999999965 56789999999999999999999999999999999999999999999999999998888
Q ss_pred CCccccCCCCcccccchhcC------CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 261 SGVMTAETGTYRWMAPEVIE------HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 261 ~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
+.....-||||+|.|||.+. +..|+...|+||+|++||.|+.|.+||-....+-+..-+.+
T Consensus 176 GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~Ime 242 (411)
T KOG0599|consen 176 GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIME 242 (411)
T ss_pred chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHh
Confidence 88888889999999999984 45788999999999999999999999988777776666554
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=269.17 Aligned_cols=211 Identities=35% Similarity=0.585 Sum_probs=183.5
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEe
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E 187 (331)
++|++.+.||.|+||+||+|.. .+..+|+|+++...... ....+.+|+.+++.++|+|++++++.+......++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 79 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT-SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP 79 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch-HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence 4789999999999999999987 56789999997654333 56789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCcc-
Q 020085 188 FMARGSIYDFLHKQ--KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM- 264 (331)
Q Consensus 188 ~~~ggsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~- 264 (331)
++++++|.+++... ...+++..+..++.|++.|++|||+.|++||||+|+||++++++.++|+|||++.........
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~ 159 (267)
T cd06610 80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT 159 (267)
T ss_pred ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc
Confidence 99999999999764 246899999999999999999999999999999999999999999999999998654433221
Q ss_pred ----ccCCCCcccccchhcCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 265 ----TAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 265 ----~~~~gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
....++..|+|||.+... .++.++|+||||+++|+|++|+.||...++.+...+..+
T Consensus 160 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~ 221 (267)
T cd06610 160 RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQ 221 (267)
T ss_pred ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhc
Confidence 233588999999998766 789999999999999999999999998887766665443
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=270.96 Aligned_cols=201 Identities=25% Similarity=0.499 Sum_probs=176.0
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEE
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~ 186 (331)
++|++.+.||+|++|.||++.. .++.+|||.++... .+......+.+|+.+++.++||||+++++++..+...+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 4788999999999999999986 67899999886432 23445568899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCc
Q 020085 187 EFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV 263 (331)
Q Consensus 187 E~~~ggsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~ 263 (331)
||+++++|.+++.. ....+++..++.++.|+++|+.|||++|++|+||||+||+++.++.++|+|||.+........
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT 161 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc
Confidence 99999999998864 245689999999999999999999999999999999999999999999999999875543221
Q ss_pred -cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 020085 264 -MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL 310 (331)
Q Consensus 264 -~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~ 310 (331)
.....++..|+|||.+.+..++.++|+||||+++|+|++|..||.+.
T Consensus 162 ~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 209 (267)
T cd08229 162 AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccc
Confidence 23346889999999999889999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=274.33 Aligned_cols=208 Identities=27% Similarity=0.413 Sum_probs=178.4
Q ss_pred CcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC---HHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEE
Q 020085 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN---TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV 185 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~---~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV 185 (331)
+|++.+.||+|++|.||+|.+ .++.||+|.++..... ......+.+|+.++++++|+||+++++++......++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 478889999999999999987 4689999999865433 33445678899999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC-cc
Q 020085 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VM 264 (331)
Q Consensus 186 ~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~-~~ 264 (331)
|||+ +++|.+++......+++..+..++.||++||.|||++|++|+||+|+||+++.++.++|+|||+++...... ..
T Consensus 81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (298)
T cd07841 81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKM 159 (298)
T ss_pred Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccc
Confidence 9999 889999997644479999999999999999999999999999999999999999999999999998665432 22
Q ss_pred ccCCCCcccccchhcCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcc
Q 020085 265 TAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGV 319 (331)
Q Consensus 265 ~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~ 319 (331)
....+++.|+|||.+.+ ..++.++|+|||||++|||++|.+||.+.++......+
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~ 215 (298)
T cd07841 160 THQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKI 215 (298)
T ss_pred cccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHH
Confidence 33456889999999854 56789999999999999999999999887765544443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=292.36 Aligned_cols=215 Identities=28% Similarity=0.449 Sum_probs=198.6
Q ss_pred eecccCcceeeeeeecCceEEEEEEECCce--EEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCe
Q 020085 106 EIDAKQLKIECKVASGSYGDLYKGTYCSQE--VAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL 182 (331)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~--vavK~~~~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 182 (331)
++...+++.+..||-|+||.|=+....++. +|+|+++... .+....+....|-.||..++.|.||++|..|.++...
T Consensus 416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyv 495 (732)
T KOG0614|consen 416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYV 495 (732)
T ss_pred ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhh
Confidence 345678888999999999999999987766 8999997553 3556678899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC
Q 020085 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262 (331)
Q Consensus 183 ~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~ 262 (331)
|+.||-|-||.|...+.. ++.|+..++..++..+++|++|||++|||+|||||+|++++.+|.+||.|||+|+....+.
T Consensus 496 YmLmEaClGGElWTiLrd-Rg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~ 574 (732)
T KOG0614|consen 496 YMLMEACLGGELWTILRD-RGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR 574 (732)
T ss_pred hhhHHhhcCchhhhhhhh-cCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence 999999999999999965 6899999999999999999999999999999999999999999999999999999999888
Q ss_pred ccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 263 VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 263 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
...+.+|||.|.|||++.++..+.++|.||||+++|||++|++||.+.+|+..+..++.
T Consensus 575 KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILk 633 (732)
T KOG0614|consen 575 KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILK 633 (732)
T ss_pred ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHh
Confidence 88899999999999999999999999999999999999999999999999888877664
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-36 Score=274.97 Aligned_cols=217 Identities=31% Similarity=0.618 Sum_probs=180.2
Q ss_pred ecccCcceeeeeeecCceEEEEEEE--CCc----eEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCC
Q 020085 107 IDAKQLKIECKVASGSYGDLYKGTY--CSQ----EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (331)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 180 (331)
+...+|+..+.||+|+||.||+|.+ .+. .+|+|.++... .......+.+|+.+++.++||||+++++.|...
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~- 81 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT-GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP- 81 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-
Confidence 4566889999999999999999987 343 57999887553 334445789999999999999999999998754
Q ss_pred CeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecC
Q 020085 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (331)
Q Consensus 181 ~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~ 260 (331)
..++++||+++|+|.+++......++...+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++....
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~ 161 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG 161 (303)
T ss_pred CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccC
Confidence 56799999999999999977666789999999999999999999999999999999999999999999999999986543
Q ss_pred CCc---cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhccccccccc
Q 020085 261 SGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIH 326 (331)
Q Consensus 261 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p 326 (331)
... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||.+....+. ...++++.++
T Consensus 162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~-~~~~~~~~~~ 230 (303)
T cd05110 162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI-PDLLEKGERL 230 (303)
T ss_pred cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHHHCCCCC
Confidence 222 122335678999999999999999999999999999997 9999988765443 3334455544
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=283.58 Aligned_cols=206 Identities=24% Similarity=0.417 Sum_probs=184.7
Q ss_pred eeecccCcceeeeeeecCceEEEEEE--ECCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCC
Q 020085 105 WEIDAKQLKIECKVASGSYGDLYKGT--YCSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN 181 (331)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~--~~~~~vavK~~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 181 (331)
+.+..+.|..-++||+|+||.||-++ .+|+-+|.|.+...... .......++|..||++++.+.||.+-.+|+..+.
T Consensus 180 qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~ 259 (591)
T KOG0986|consen 180 QPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDA 259 (591)
T ss_pred hhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCc
Confidence 34566788899999999999999765 47899999988543322 2234568889999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecC
Q 020085 182 LCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (331)
Q Consensus 182 ~~lV~E~~~ggsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~ 260 (331)
+|+|+..|+||+|.-+|.+. +..|+++.++.++.+|+-||++||+.+||+||+||+|||+|+.|+++|+|.|+|.....
T Consensus 260 LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 260 LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 99999999999999888664 35799999999999999999999999999999999999999999999999999998888
Q ss_pred CCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 020085 261 SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL 310 (331)
Q Consensus 261 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~ 310 (331)
........||.+|||||++.+..|+...|.||+||++|||+.|+.||...
T Consensus 340 g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~ 389 (591)
T KOG0986|consen 340 GKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQR 389 (591)
T ss_pred CCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhh
Confidence 77777889999999999999999999999999999999999999999764
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=273.56 Aligned_cols=210 Identities=27% Similarity=0.440 Sum_probs=179.8
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEE
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~ 186 (331)
++|++.+.||+|+||.||++.. .++.||+|.++.... .......+.+|+.+++.++||||+++++.+..+...++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 3688999999999999999987 457899999875532 2234567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC----
Q 020085 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG---- 262 (331)
Q Consensus 187 E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~---- 262 (331)
||++|++|.+++.. .+.+++..+..++.|++.|+.|||++|++||||||+||+++.++.++|+|||.++......
T Consensus 81 e~~~g~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~ 159 (305)
T cd05609 81 EYVEGGDCATLLKN-IGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL 159 (305)
T ss_pred ecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccc
Confidence 99999999999965 4678999999999999999999999999999999999999999999999999986321110
Q ss_pred ------------ccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccc
Q 020085 263 ------------VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 263 ------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~ 320 (331)
......++..|+|||.+.+..++.++|+||||+++|||++|..||.+.++.+......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~ 229 (305)
T cd05609 160 YEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI 229 (305)
T ss_pred cccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 0112346789999999988889999999999999999999999999887776655543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=272.96 Aligned_cols=201 Identities=27% Similarity=0.473 Sum_probs=173.1
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~ 186 (331)
.++|.+.+.||+|++|.||+|.. .++.||+|.++..... .....+.+|+.++++++||||+++++++......++||
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEE-GAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF 82 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEeccccc-CCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence 36799999999999999999987 5788999998754322 12245678999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC-ccc
Q 020085 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMT 265 (331)
Q Consensus 187 E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~-~~~ 265 (331)
||+.+ +|.+++......+++..+..++.|+++||.|||++|++||||||+||+++.++.++|+|||.++...... ...
T Consensus 83 e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 161 (291)
T cd07844 83 EYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYS 161 (291)
T ss_pred ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCcccc
Confidence 99986 9999997766788999999999999999999999999999999999999999999999999987543221 122
Q ss_pred cCCCCcccccchhcCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCC
Q 020085 266 AETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLT 311 (331)
Q Consensus 266 ~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~ell~g~~Pf~~~~ 311 (331)
...++..|+|||.+.+ ..++.++|+||+|+++|+|++|+.||...+
T Consensus 162 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 208 (291)
T cd07844 162 NEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST 208 (291)
T ss_pred ccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 3356889999999865 568899999999999999999999997765
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=273.83 Aligned_cols=206 Identities=31% Similarity=0.515 Sum_probs=180.0
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~ 186 (331)
..+|.+.+.||+|+||.||++.. .++.||+|.+...... ..+.+.+|+.+++.++|||++++++.+..+...++||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~ 95 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP--KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 95 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc--hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEee
Confidence 35899999999999999999986 6789999999754322 3466889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC-ccc
Q 020085 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMT 265 (331)
Q Consensus 187 E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~-~~~ 265 (331)
||+++++|.+++.+ ..++...+..++.|++.+|.|||+.|++||||||+||+++.++.++|+|||.+....... ...
T Consensus 96 e~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~ 173 (297)
T cd06656 96 EYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 173 (297)
T ss_pred cccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcC
Confidence 99999999999854 457889999999999999999999999999999999999999999999999987654332 223
Q ss_pred cCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhc
Q 020085 266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVG 318 (331)
Q Consensus 266 ~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~ 318 (331)
...+++.|+|||.+.+..++.++|+||||+++|++++|+.||...++.+....
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~ 226 (297)
T cd06656 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL 226 (297)
T ss_pred cccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee
Confidence 44688999999999998899999999999999999999999988766554444
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=266.72 Aligned_cols=209 Identities=31% Similarity=0.554 Sum_probs=172.4
Q ss_pred eeeeecCceEEEEEEEC-----CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEE-CCCCeEEEEecc
Q 020085 116 CKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT-RPPNLCIVTEFM 189 (331)
Q Consensus 116 ~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~-~~~~~~lV~E~~ 189 (331)
+.||+|+||.||+|.+. ...+|+|.+.... .....+.+.+|+.+++.++|||++++++++. .++..+++|||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~ 79 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRIT-DLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM 79 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccC-CHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence 36899999999999862 2469999986432 3445678899999999999999999999875 455689999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC-----cc
Q 020085 190 ARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-----VM 264 (331)
Q Consensus 190 ~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~-----~~ 264 (331)
.+++|.+++.......+...+..++.|+++|++|||+.+++||||||+|||+++++.+||+|||+++...... ..
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 159 (262)
T cd05058 80 KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNH 159 (262)
T ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeeccc
Confidence 9999999997766667788889999999999999999999999999999999999999999999987543221 11
Q ss_pred ccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhccccccccc
Q 020085 265 TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIH 326 (331)
Q Consensus 265 ~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p 326 (331)
....+++.|+|||.+.+..++.++||||||+++|||++ |.+||...++.+....+ ..+.++
T Consensus 160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~-~~~~~~ 221 (262)
T cd05058 160 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYL-LQGRRL 221 (262)
T ss_pred ccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH-hcCCCC
Confidence 12345678999999988899999999999999999999 57889888877766553 344443
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=271.03 Aligned_cols=199 Identities=32% Similarity=0.596 Sum_probs=170.6
Q ss_pred ccCcceeeeeeecCceEEEEEEE------CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEEC--CC
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR--PP 180 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~--~~ 180 (331)
..+|++.+.||+|+||.||++.+ .++.||+|.++.. .....+.+.+|+.++++++||||+++++++.. ..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS--TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 45889999999999999999875 3678999998754 34556789999999999999999999998754 34
Q ss_pred CeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecC
Q 020085 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (331)
Q Consensus 181 ~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~ 260 (331)
.+++|+||+++++|.+++......+++..+..++.|++.||+|||++|++||||||+||++++++.++|+|||+++....
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~ 160 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ 160 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence 68999999999999999976666789999999999999999999999999999999999999999999999999986544
Q ss_pred CCcc----ccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCC
Q 020085 261 SGVM----TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAG 309 (331)
Q Consensus 261 ~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~ 309 (331)
.... ....++..|+|||.+.+..++.++|+||||+++|||++|..|+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~ 213 (284)
T cd05081 161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCS 213 (284)
T ss_pred CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCC
Confidence 3221 112234569999999988999999999999999999998777644
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=265.36 Aligned_cols=215 Identities=39% Similarity=0.698 Sum_probs=183.6
Q ss_pred cceeeeeeecCceEEEEEEECC------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEE
Q 020085 112 LKIECKVASGSYGDLYKGTYCS------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV 185 (331)
Q Consensus 112 ~~~~~~lg~G~~g~Vy~~~~~~------~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV 185 (331)
+.+.+.||.|+||.||++.+.. ..+|+|+++... .....+.+.+|+.++++++|+|++++++.+......+++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i 79 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA-DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIV 79 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC-ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEE
Confidence 3567899999999999999854 779999997654 233567899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCcc
Q 020085 186 TEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM 264 (331)
Q Consensus 186 ~E~~~ggsL~~~l~~~~~~-~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~ 264 (331)
|||+++++|.+++...... +++..+..++.|++.|+++||+.|++|+||+|+||+++.++.++|+|||.++........
T Consensus 80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (258)
T smart00219 80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY 159 (258)
T ss_pred EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence 9999999999999765444 899999999999999999999999999999999999999999999999999766543222
Q ss_pred c--cCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhccccccccccc
Q 020085 265 T--AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIHSI 328 (331)
Q Consensus 265 ~--~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p~~ 328 (331)
. ...+++.|+|||.+....++.++|+||+|+++|+|++ |..||...+..+.... +.++.++++
T Consensus 160 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~-~~~~~~~~~ 225 (258)
T smart00219 160 KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEY-LKKGYRLPK 225 (258)
T ss_pred ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HhcCCCCCC
Confidence 1 2236789999999988889999999999999999998 8999998777766655 334555543
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=272.85 Aligned_cols=228 Identities=27% Similarity=0.429 Sum_probs=191.7
Q ss_pred CCCCeeeecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHH-hcCCCcceeEEeEE
Q 020085 100 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMR-KIRHKNVVQFIGAC 176 (331)
Q Consensus 100 ~~~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~-~l~h~niv~~~~~~ 176 (331)
+....|+...++++-+..||.|+||+|++-.+ .|+..|||.++.... .....+++.|..... +-+.||||+|+|++
T Consensus 54 ~~~~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~ 132 (361)
T KOG1006|consen 54 DDAHLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGAL 132 (361)
T ss_pred CcccccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhh
Confidence 34567888899999999999999999999877 678999999987653 445667777777654 44789999999999
Q ss_pred ECCCCeEEEEeccCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEEcCCCcEEEee
Q 020085 177 TRPPNLCIVTEFMARGSIYDFLHK----QKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENGVVKVAD 251 (331)
Q Consensus 177 ~~~~~~~lV~E~~~ggsL~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~LH~-~~iiHrDlkp~NiLi~~~~~vkl~D 251 (331)
..++..||.||.|.- ||..+... ++..++++-+-.+..-..+||+||-+ ..|||||+||+|||++..|.+||||
T Consensus 133 F~EGdcWiCMELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCD 211 (361)
T KOG1006|consen 133 FSEGDCWICMELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCD 211 (361)
T ss_pred hcCCceeeeHHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeec
Confidence 999999999999965 77655422 35678999888999999999999996 5899999999999999999999999
Q ss_pred ecceeeecCCCccccCCCCcccccchhcC--CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccccccccccc
Q 020085 252 FGVARVQAQSGVMTAETGTYRWMAPEVIE--HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIHSII 329 (331)
Q Consensus 252 Fg~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~p~~~ 329 (331)
||.+.....+-..+...|...|||||.+. ...|+.+||+||||++|||+.||+.||.+.+..-....+|..|..|.+.
T Consensus 212 FGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~ 291 (361)
T KOG1006|consen 212 FGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILL 291 (361)
T ss_pred ccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeec
Confidence 99997666666667788999999999995 4469999999999999999999999999987655555556678777654
|
|
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=273.40 Aligned_cols=209 Identities=31% Similarity=0.578 Sum_probs=176.4
Q ss_pred cccCcceeeeeeecCceEEEEEEEC------------------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcc
Q 020085 108 DAKQLKIECKVASGSYGDLYKGTYC------------------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNV 169 (331)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~~------------------~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~ni 169 (331)
+.++|++.++||+|+||.||++.+. +..+|+|+++... .......+.+|+.+++.++||||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 3 PRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA-NKNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred ChhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCc
Confidence 4567999999999999999998542 2358999987553 34456789999999999999999
Q ss_pred eeEEeEEECCCCeEEEEeccCCCCHHHHHHhcC----------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 020085 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK----------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANL 239 (331)
Q Consensus 170 v~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~----------~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Ni 239 (331)
+++++++...+..++||||+.+++|.+++.... ..+++..+..++.|++.|++|||++|++||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 999999999999999999999999999996632 2366778999999999999999999999999999999
Q ss_pred EEcCCCcEEEeeecceeeecCCCc---cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc--CCCCCCCCCHHH
Q 020085 240 LMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT--GELPYAGLTPLQ 314 (331)
Q Consensus 240 Li~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~--g~~Pf~~~~~~~ 314 (331)
+++.++.++|+|||+++....... .....+++.|+|||...+..++.++|+|||||++|||++ |..||...++.+
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 999999999999999875433221 112234678999999888889999999999999999998 789998877766
Q ss_pred HHh
Q 020085 315 AAV 317 (331)
Q Consensus 315 ~~~ 317 (331)
...
T Consensus 242 ~~~ 244 (296)
T cd05095 242 VIE 244 (296)
T ss_pred HHH
Confidence 544
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=271.05 Aligned_cols=197 Identities=32% Similarity=0.591 Sum_probs=168.3
Q ss_pred CcceeeeeeecCceEEEEEEE------CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECC--CCe
Q 020085 111 QLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--PNL 182 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~--~~~ 182 (331)
.|++.+.||+|+||+||++.+ .++.||+|+++... .......+.+|+.++++++||||+++++++... ...
T Consensus 5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 5 YLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC-GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred hceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence 348999999999999988764 45689999998653 233456788999999999999999999988653 358
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC
Q 020085 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262 (331)
Q Consensus 183 ~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~ 262 (331)
+++|||+++++|.+++.. ..+++..++.++.|++.|++|||++|++||||||+||++++++.++|+|||+++......
T Consensus 84 ~lv~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~ 161 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 161 (283)
T ss_pred EEEecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCcc
Confidence 999999999999999965 458999999999999999999999999999999999999999999999999997654322
Q ss_pred c----cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 020085 263 V----MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL 310 (331)
Q Consensus 263 ~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~ 310 (331)
. .....++..|+|||.+.+..++.++||||||+++|||++|..||...
T Consensus 162 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 213 (283)
T cd05080 162 EYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSP 213 (283)
T ss_pred hhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCC
Confidence 1 11234567799999998888999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=277.03 Aligned_cols=191 Identities=26% Similarity=0.472 Sum_probs=159.4
Q ss_pred eeeeeecCceEEEEEEE----CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEEC--CCCeEEEEec
Q 020085 115 ECKVASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR--PPNLCIVTEF 188 (331)
Q Consensus 115 ~~~lg~G~~g~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~--~~~~~lV~E~ 188 (331)
.++||+|+||+||+|+. .++.+|+|.++..... ..+.+|+.++++++||||+++++++.. +...+++|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDY 81 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc----HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEec
Confidence 46899999999999986 3478999999755322 356789999999999999999998854 4568999999
Q ss_pred cCCCCHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEE----cCCCcEEEeeeccee
Q 020085 189 MARGSIYDFLHKQ--------KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM----DENGVVKVADFGVAR 256 (331)
Q Consensus 189 ~~ggsL~~~l~~~--------~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi----~~~~~vkl~DFg~a~ 256 (331)
+.+ +|.+++... ...+++..+..++.|++.||+|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07868 82 AEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred cCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCcee
Confidence 865 888887532 1258889999999999999999999999999999999999 456789999999998
Q ss_pred eecCCC----ccccCCCCcccccchhcCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 020085 257 VQAQSG----VMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGL 310 (331)
Q Consensus 257 ~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~ell~g~~Pf~~~ 310 (331)
...... ......+|+.|+|||++.+ ..++.++|+||+||++|+|++|++||...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 654322 2234568999999999876 45899999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=269.17 Aligned_cols=208 Identities=33% Similarity=0.584 Sum_probs=175.6
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCcceeEEeEEECC------
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRP------ 179 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~------ 179 (331)
...|.+.+.||+|+||.||+|.. .++.||+|+++.... ....+.+|+.+++++ +|||++++++++...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD---EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCc---cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 34688899999999999999987 568899999875432 235688899999998 699999999998653
Q ss_pred CCeEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeee
Q 020085 180 PNLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (331)
Q Consensus 180 ~~~~lV~E~~~ggsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~ 258 (331)
..++++|||+.+++|.+++... ...+++..+..++.|++.|++|||+++++||||||+||++++++.++|+|||+++..
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~ 161 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 161 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceec
Confidence 3589999999999999999764 356899999999999999999999999999999999999999999999999998765
Q ss_pred cCC-CccccCCCCcccccchhcC-----CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcc
Q 020085 259 AQS-GVMTAETGTYRWMAPEVIE-----HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGV 319 (331)
Q Consensus 259 ~~~-~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~ 319 (331)
... .......|++.|+|||++. +..++.++|+||||+++|||++|+.||....+.......
T Consensus 162 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~ 228 (272)
T cd06637 162 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLI 228 (272)
T ss_pred ccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH
Confidence 432 2233456889999999985 346888999999999999999999999887766655443
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=272.63 Aligned_cols=202 Identities=29% Similarity=0.492 Sum_probs=174.8
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEe
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E 187 (331)
++|++.+.||+|+||.||++.+ .++.||+|.++... +......+.+|+.++++++||||+++++.+...+..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL-DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc-CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 4688999999999999999998 47899999987543 34445789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCcc
Q 020085 188 FMARGSIYDFLHKQ--KGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM 264 (331)
Q Consensus 188 ~~~ggsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~-~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~ 264 (331)
|+++++|.+++... ...+++..+..++.|++.||.|||+ .|++||||||+||+++.++.++|+|||.++..... ..
T Consensus 80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~~ 158 (286)
T cd06622 80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-LA 158 (286)
T ss_pred ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-cc
Confidence 99999999998653 2478999999999999999999996 59999999999999999999999999998754332 22
Q ss_pred ccCCCCcccccchhcCCC------CCCChhhHHHHHHHHHHHHcCCCCCCCCCHH
Q 020085 265 TAETGTYRWMAPEVIEHK------PYDYKADVFSFGIALWELLTGELPYAGLTPL 313 (331)
Q Consensus 265 ~~~~gt~~y~aPE~~~~~------~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~ 313 (331)
....+++.|+|||.+.+. .++.++|+|||||++|+|++|+.||...+..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 213 (286)
T cd06622 159 KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYA 213 (286)
T ss_pred ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchh
Confidence 344678899999998544 3578999999999999999999999765443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-36 Score=268.43 Aligned_cols=194 Identities=28% Similarity=0.552 Sum_probs=165.8
Q ss_pred eeeeecCceEEEEEEECC--------------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCC
Q 020085 116 CKVASGSYGDLYKGTYCS--------------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN 181 (331)
Q Consensus 116 ~~lg~G~~g~Vy~~~~~~--------------~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 181 (331)
+.||+|+||.||+|+... ..+++|++... ..+....+.+|+.+++.++||||+++++++..+..
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~ 78 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS--HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE 78 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh--hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence 368999999999998532 25899987754 23445678999999999999999999999999889
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCc-------EEEeeecc
Q 020085 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV-------VKVADFGV 254 (331)
Q Consensus 182 ~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~-------vkl~DFg~ 254 (331)
.++||||+++++|..++......+++..+..++.||++||+|||++|++||||||+|||++.++. ++++|||.
T Consensus 79 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~ 158 (262)
T cd05077 79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGI 158 (262)
T ss_pred CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCC
Confidence 99999999999999998776678999999999999999999999999999999999999987664 89999999
Q ss_pred eeeecCCCccccCCCCcccccchhcC-CCCCCChhhHHHHHHHHHHHH-cCCCCCCCCCHHH
Q 020085 255 ARVQAQSGVMTAETGTYRWMAPEVIE-HKPYDYKADVFSFGIALWELL-TGELPYAGLTPLQ 314 (331)
Q Consensus 255 a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~SlG~il~ell-~g~~Pf~~~~~~~ 314 (331)
+...... ....++..|+|||.+. +..++.++||||||+++|||+ .|..||......+
T Consensus 159 ~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~ 217 (262)
T cd05077 159 PITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE 217 (262)
T ss_pred CccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH
Confidence 8654322 2345788999999986 567899999999999999998 5899998765443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=264.14 Aligned_cols=202 Identities=35% Similarity=0.674 Sum_probs=175.1
Q ss_pred eeeeecCceEEEEEEEC-CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEeccCCCCH
Q 020085 116 CKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI 194 (331)
Q Consensus 116 ~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~~~ggsL 194 (331)
++||+|+||.||++... ++.||+|+++..... +....+.+|+.++++++||||+++++++......++||||+.+++|
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l 79 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP-DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSL 79 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcH
Confidence 46999999999999875 799999998765433 4557899999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCcc---ccCCCCc
Q 020085 195 YDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM---TAETGTY 271 (331)
Q Consensus 195 ~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~---~~~~gt~ 271 (331)
.+++......++...+..++.+++.+++|||++|++||||+|+||+++.++.++|+|||.++........ .....+.
T Consensus 80 ~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~ 159 (251)
T cd05041 80 LTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPI 159 (251)
T ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCccee
Confidence 9999776667889999999999999999999999999999999999999999999999999755422111 1122356
Q ss_pred ccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhc
Q 020085 272 RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVG 318 (331)
Q Consensus 272 ~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~ 318 (331)
.|+|||.+.+..++.++|+||||+++|||++ |..||....+......
T Consensus 160 ~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~ 207 (251)
T cd05041 160 KWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRER 207 (251)
T ss_pred ccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHH
Confidence 7999999988889999999999999999999 8999998876554444
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=271.64 Aligned_cols=206 Identities=30% Similarity=0.520 Sum_probs=180.4
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~ 186 (331)
..+|.+.+.||.|++|.||+|.. .++.||+|.+..... ...+.+.+|+.+++.++|||++++++.+......++|+
T Consensus 18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 95 (296)
T cd06655 18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQ--PKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM 95 (296)
T ss_pred cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccC--chHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence 35799999999999999999986 678999999875432 23467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC-ccc
Q 020085 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMT 265 (331)
Q Consensus 187 E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~-~~~ 265 (331)
||+++++|.+++.. ..+++..+..++.|++.|++|||++|++||||+|+||+++.++.++|+|||++....... ...
T Consensus 96 e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~ 173 (296)
T cd06655 96 EYLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRS 173 (296)
T ss_pred EecCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCC
Confidence 99999999999854 468999999999999999999999999999999999999999999999999987543322 123
Q ss_pred cCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhc
Q 020085 266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVG 318 (331)
Q Consensus 266 ~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~ 318 (331)
...++..|+|||.+.+..++.++|+||||+++|+|++|+.||...++.+....
T Consensus 174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~ 226 (296)
T cd06655 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL 226 (296)
T ss_pred CcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 34688999999999988899999999999999999999999998887665544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=289.61 Aligned_cols=190 Identities=24% Similarity=0.368 Sum_probs=167.0
Q ss_pred ccCcceeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~ 186 (331)
...|.+.+.||+|+||.||++.+. ++.||||.... ..+.+|++++++++||||+++++++..+...++||
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~ 239 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVL 239 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 457999999999999999999984 57899996432 24568999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCc---
Q 020085 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV--- 263 (331)
Q Consensus 187 E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~--- 263 (331)
|++. ++|.+++......+++..++.++.|++.||.|||++||+||||||+|||++.++.++|+|||+++.......
T Consensus 240 e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 318 (461)
T PHA03211 240 PKYR-SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPF 318 (461)
T ss_pred EccC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccccc
Confidence 9996 599999877666899999999999999999999999999999999999999999999999999976543221
Q ss_pred cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCC
Q 020085 264 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 307 (331)
Q Consensus 264 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf 307 (331)
.....||+.|+|||++.+..++.++|||||||++|||++|..|+
T Consensus 319 ~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~l 362 (461)
T PHA03211 319 HYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASL 362 (461)
T ss_pred ccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCc
Confidence 12346899999999999999999999999999999999987543
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=268.98 Aligned_cols=209 Identities=32% Similarity=0.510 Sum_probs=176.2
Q ss_pred ecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCcceeEEeEEE-----C
Q 020085 107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACT-----R 178 (331)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~-----~ 178 (331)
...++|++.+.||+|+||.||++.. .++.+|+|+++... .....+.+|+.+++++ +|||++++++++. .
T Consensus 15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~---~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 91 (286)
T cd06638 15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH---DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN 91 (286)
T ss_pred CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc---chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence 3567899999999999999999987 56889999987532 2235678899999999 6999999999874 3
Q ss_pred CCCeEEEEeccCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecce
Q 020085 179 PPNLCIVTEFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA 255 (331)
Q Consensus 179 ~~~~~lV~E~~~ggsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a 255 (331)
++..++||||+++++|.+++.. ....+++..+..++.|+++|+.|||+.+++||||||+||+++.++.++|+|||++
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~ 171 (286)
T cd06638 92 GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVS 171 (286)
T ss_pred CCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCce
Confidence 4568999999999999998753 2356888999999999999999999999999999999999999999999999998
Q ss_pred eeecCCC-ccccCCCCcccccchhcCC-----CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhc
Q 020085 256 RVQAQSG-VMTAETGTYRWMAPEVIEH-----KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVG 318 (331)
Q Consensus 256 ~~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~ 318 (331)
+...... ......|++.|+|||.+.. ..++.++|+||+||++|||++|+.||....+.+....
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~ 240 (286)
T cd06638 172 AQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFK 240 (286)
T ss_pred eecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhh
Confidence 7654322 2233468999999999853 4578899999999999999999999998877666554
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-36 Score=270.95 Aligned_cols=202 Identities=26% Similarity=0.446 Sum_probs=172.2
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~ 186 (331)
.++|.+.+.||+|+||.||+|.. +++.||+|+++.... ......+.+|+.+++.++|+||+++++++..+...|+|+
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE-EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc-CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 35799999999999999999987 578999999875432 222345778999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC-ccc
Q 020085 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMT 265 (331)
Q Consensus 187 E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~-~~~ 265 (331)
||+. ++|.+++......+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||+++...... ...
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 161 (291)
T cd07870 83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYS 161 (291)
T ss_pred eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCC
Confidence 9996 58888776655678888999999999999999999999999999999999999999999999987543322 223
Q ss_pred cCCCCcccccchhcCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCH
Q 020085 266 AETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTP 312 (331)
Q Consensus 266 ~~~gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~ell~g~~Pf~~~~~ 312 (331)
...+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||...+.
T Consensus 162 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~ 209 (291)
T cd07870 162 SEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSD 209 (291)
T ss_pred CccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchh
Confidence 34578999999998754 578899999999999999999999987643
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=264.01 Aligned_cols=223 Identities=30% Similarity=0.483 Sum_probs=189.3
Q ss_pred eeeecccCcceeeeeeecCceEEEEEEECC--ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCcceeEEeEEECCC
Q 020085 104 VWEIDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPP 180 (331)
Q Consensus 104 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~ 180 (331)
....+.++++++..||+|+.|+|+++++.+ ...|||.+.... +.+..++++..+.++.... +|+||+.+|+|..+.
T Consensus 86 r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~-Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~ 164 (391)
T KOG0983|consen 86 RYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTG-NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNT 164 (391)
T ss_pred ccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccC-CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCc
Confidence 344556778888999999999999999855 889999998765 4555677777777776654 899999999999999
Q ss_pred CeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEEcCCCcEEEeeecceeeec
Q 020085 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENGVVKVADFGVARVQA 259 (331)
Q Consensus 181 ~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~ 259 (331)
..++.||.|.- -+..++..-.+++++..+-++...+++||.||-+ +||+|||+||+|||+|+.|++||||||.+.+..
T Consensus 165 dV~IcMelMs~-C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlv 243 (391)
T KOG0983|consen 165 DVFICMELMST-CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLV 243 (391)
T ss_pred hHHHHHHHHHH-HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceee
Confidence 99999999954 5666666667889999999999999999999996 589999999999999999999999999998887
Q ss_pred CCCccccCCCCcccccchhcC---CCCCCChhhHHHHHHHHHHHHcCCCCCCCC-CHHHHHhcccccccccccc
Q 020085 260 QSGVMTAETGTYRWMAPEVIE---HKPYDYKADVFSFGIALWELLTGELPYAGL-TPLQAAVGVVQKVSIHSII 329 (331)
Q Consensus 260 ~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~SlG~il~ell~g~~Pf~~~-~~~~~~~~~~~~~~~p~~~ 329 (331)
.+...+...|.+.|||||.+. ...|+.++||||||++++||.||+.||++. +.+++...+.. -..|.++
T Consensus 244 dSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln-~ePP~L~ 316 (391)
T KOG0983|consen 244 DSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLN-EEPPLLP 316 (391)
T ss_pred cccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHh-cCCCCCC
Confidence 777778888999999999995 447999999999999999999999999985 56676666554 5556554
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=298.81 Aligned_cols=225 Identities=32% Similarity=0.640 Sum_probs=197.3
Q ss_pred eeeecccCcceeeeeeecCceEEEEEEEC---------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCcceeEE
Q 020085 104 VWEIDAKQLKIECKVASGSYGDLYKGTYC---------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFI 173 (331)
Q Consensus 104 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~ 173 (331)
.|+++.+++++.+.+|+|.||.|++|... ...||||.++..... ...+.+..|+.+|+.+. ||||+.++
T Consensus 290 ~~e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~ll 368 (609)
T KOG0200|consen 290 KWEIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLL 368 (609)
T ss_pred ceeechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhhe
Confidence 79999999999999999999999999742 356999999977655 66788999999999995 99999999
Q ss_pred eEEECCCCeEEEEeccCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 020085 174 GACTRPPNLCIVTEFMARGSIYDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTAN 238 (331)
Q Consensus 174 ~~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~N 238 (331)
|+|+++..+++|+||+..|+|.+++...+ ..++...++.++.||+.||+||++.+++||||.++|
T Consensus 369 G~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRN 448 (609)
T KOG0200|consen 369 GACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARN 448 (609)
T ss_pred eeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhh
Confidence 99999999999999999999999998766 348889999999999999999999999999999999
Q ss_pred EEEcCCCcEEEeeecceeeecCCCccccC--CC--CcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHH
Q 020085 239 LLMDENGVVKVADFGVARVQAQSGVMTAE--TG--TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPL 313 (331)
Q Consensus 239 iLi~~~~~vkl~DFg~a~~~~~~~~~~~~--~g--t~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~ 313 (331)
||+.++..+|++|||+|+........... .+ ..+|||||.+....|+.++||||||++|||+++ |..||++..+.
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~ 528 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT 528 (609)
T ss_pred EEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH
Confidence 99999999999999999966554443322 22 357999999999999999999999999999999 89999997734
Q ss_pred HHHhcccccccccccc
Q 020085 314 QAAVGVVQKVSIHSII 329 (331)
Q Consensus 314 ~~~~~~~~~~~~p~~~ 329 (331)
+...+-++.|+|++-|
T Consensus 529 ~~l~~~l~~G~r~~~P 544 (609)
T KOG0200|consen 529 EELLEFLKEGNRMEQP 544 (609)
T ss_pred HHHHHHHhcCCCCCCC
Confidence 4445568899997765
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=267.32 Aligned_cols=209 Identities=29% Similarity=0.521 Sum_probs=177.6
Q ss_pred CcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCC--------CHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCC
Q 020085 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV--------NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--------~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 180 (331)
+|.+.+.||+|+||.||+|.. +++.+|+|.++.... .....+.+.+|+.++++++|||++++++++....
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 477888999999999999976 578999998864211 1123456889999999999999999999999999
Q ss_pred CeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecC
Q 020085 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (331)
Q Consensus 181 ~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~ 260 (331)
..++||||+++++|.+++... +.++...+..++.|++.|+.|||++|++||||+|+||+++.++.++++|||.++....
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 160 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDD 160 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccccc
Confidence 999999999999999999664 6789999999999999999999999999999999999999999999999999875432
Q ss_pred CC---ccccCCCCcccccchhcCCCC--CCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccc
Q 020085 261 SG---VMTAETGTYRWMAPEVIEHKP--YDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 261 ~~---~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~ 320 (331)
.. ......++..|+|||.+.... ++.++|+||||+++|++++|..||......+......
T Consensus 161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 225 (272)
T cd06629 161 IYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLG 225 (272)
T ss_pred cccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhh
Confidence 21 122345788999999987654 7899999999999999999999998877766555533
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-36 Score=270.38 Aligned_cols=198 Identities=31% Similarity=0.573 Sum_probs=170.8
Q ss_pred ccCcceeeeeeecCceEEEEEEE------CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECC--C
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--P 180 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~--~ 180 (331)
.+.|++.+.||+|+||.||++++ .+..||+|.++... .......+.+|+.++++++|||++++.+++... .
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (284)
T cd05079 3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 81 (284)
T ss_pred hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc-cHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence 45678999999999999999875 46789999987653 344457899999999999999999999998775 5
Q ss_pred CeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecC
Q 020085 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (331)
Q Consensus 181 ~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~ 260 (331)
..++||||++|++|.+++......+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||+++....
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET 161 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence 68999999999999999976556789999999999999999999999999999999999999999999999999976543
Q ss_pred CCc----cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCC
Q 020085 261 SGV----MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 307 (331)
Q Consensus 261 ~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf 307 (331)
... .....++..|+|||.+.+..++.++|+||||+++|||++++.|+
T Consensus 162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~ 212 (284)
T cd05079 162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSE 212 (284)
T ss_pred CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCC
Confidence 221 12234667899999998888999999999999999999987664
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-37 Score=292.32 Aligned_cols=211 Identities=30% Similarity=0.523 Sum_probs=178.9
Q ss_pred eeeecCceEEEEEEECC--ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEeccCCCCH
Q 020085 117 KVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI 194 (331)
Q Consensus 117 ~lg~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~~~ggsL 194 (331)
+||+|.||+||-|++.. ...|||-+... +....+-+.+|+.+-+.++|.|||+++|.|.+++.+-|.||.++||||
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpek--dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSL 659 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEK--DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSL 659 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccc--cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcH
Confidence 79999999999999855 45788877533 444566789999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCC--CHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC-CCcEEEeeecceeeecCCCc-cccCCCC
Q 020085 195 YDFLHKQKGVF--QLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE-NGVVKVADFGVARVQAQSGV-MTAETGT 270 (331)
Q Consensus 195 ~~~l~~~~~~~--~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~-~~~vkl~DFg~a~~~~~~~~-~~~~~gt 270 (331)
.+++...=+++ ++.++..+..||++||.|||++.|+|||||-+|+||+. .|.+||+|||-++....-.. ..+.+||
T Consensus 660 SsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTGT 739 (1226)
T KOG4279|consen 660 SSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGT 739 (1226)
T ss_pred HHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccccccc
Confidence 99998876777 78899999999999999999999999999999999974 78999999999986655433 3466899
Q ss_pred cccccchhcCCC--CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccc-ccccccccc
Q 020085 271 YRWMAPEVIEHK--PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV-QKVSIHSII 329 (331)
Q Consensus 271 ~~y~aPE~~~~~--~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~-~~~~~p~~~ 329 (331)
..|||||++.++ .|..++|||||||++.||.||++||-.+...+++.=.| -=...|+||
T Consensus 740 LQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP~iP 801 (1226)
T KOG4279|consen 740 LQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHPPIP 801 (1226)
T ss_pred hhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhcceecCCCCc
Confidence 999999999765 68999999999999999999999998886655554322 122345554
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-36 Score=269.23 Aligned_cols=194 Identities=26% Similarity=0.496 Sum_probs=164.5
Q ss_pred eeeecCceEEEEEEEC--------------------------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcce
Q 020085 117 KVASGSYGDLYKGTYC--------------------------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170 (331)
Q Consensus 117 ~lg~G~~g~Vy~~~~~--------------------------~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv 170 (331)
.||+|+||.||+|... ...||+|+++... .+....+.+|+.++++++||||+
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~~~~~~~~l~h~niv 79 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH--RDIALAFFETASLMSQVSHIHLA 79 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH--HHHHHHHHHHHHHHhcCCCCCee
Confidence 6999999999998741 1348999987542 34456789999999999999999
Q ss_pred eEEeEEECCCCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC-----
Q 020085 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG----- 245 (331)
Q Consensus 171 ~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~----- 245 (331)
+++++|..+...++||||+++|+|..++....+.+++..+..++.|+++||+|||++|++||||||+||+++.++
T Consensus 80 ~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~ 159 (274)
T cd05076 80 FVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGT 159 (274)
T ss_pred eEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCc
Confidence 999999999999999999999999999977667889999999999999999999999999999999999998654
Q ss_pred --cEEEeeecceeeecCCCccccCCCCcccccchhcCC-CCCCChhhHHHHHHHHHHHH-cCCCCCCCCCHHHH
Q 020085 246 --VVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELL-TGELPYAGLTPLQA 315 (331)
Q Consensus 246 --~vkl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~ell-~g~~Pf~~~~~~~~ 315 (331)
.++++|||.+...... ....++..|+|||.+.+ ..++.++|+||||+++||++ +|+.||...++.+.
T Consensus 160 ~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~ 230 (274)
T cd05076 160 SPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK 230 (274)
T ss_pred cceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence 3899999988543221 23357788999998865 56899999999999999985 69999988766543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=270.29 Aligned_cols=210 Identities=23% Similarity=0.387 Sum_probs=176.1
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCcceeEEeEEECCCC-----
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPN----- 181 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~~----- 181 (331)
++|++.+.||+|+||.||+|.+ +++.||+|+.+...........+.+|+.++++++ ||||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 4689999999999999999987 5789999998765433334467888999999995 6999999999876655
Q ss_pred eEEEEeccCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC-CCcEEEeeeccee
Q 020085 182 LCIVTEFMARGSIYDFLHKQK----GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE-NGVVKVADFGVAR 256 (331)
Q Consensus 182 ~~lV~E~~~ggsL~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~-~~~vkl~DFg~a~ 256 (331)
.|+||||+++ +|.+++.... ..+++..+..++.||+.||.|||++|++||||+|+||+++. ++.++|+|||.++
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~ 159 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence 8999999986 8988886532 35799999999999999999999999999999999999998 8899999999987
Q ss_pred eecCC-CccccCCCCcccccchhcCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccc
Q 020085 257 VQAQS-GVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 257 ~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~ 320 (331)
..... .......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.++.+....+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~ 225 (295)
T cd07837 160 AFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIF 225 (295)
T ss_pred ecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 54332 22233457889999998864 467899999999999999999999999887776655443
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=270.84 Aligned_cols=205 Identities=30% Similarity=0.466 Sum_probs=176.7
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEe
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E 187 (331)
++|++.++||+|+||.||+|.+ .++.||+|++..........+.+.+|+.+++.++||||+++++++..+...++|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 3688999999999999999998 46899999987654444445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC-cccc
Q 020085 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTA 266 (331)
Q Consensus 188 ~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~-~~~~ 266 (331)
|+++++|.++... ...+++..+..++.|++.||.|||+.|++|+||+|+||++++++.++|+|||++....... ....
T Consensus 81 ~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (286)
T cd07846 81 FVDHTVLDDLEKY-PNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD 159 (286)
T ss_pred cCCccHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCc
Confidence 9999888887654 4568999999999999999999999999999999999999999999999999987654332 2233
Q ss_pred CCCCcccccchhcCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 020085 267 ETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQA 315 (331)
Q Consensus 267 ~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~ 315 (331)
..++..|+|||++.+ ..++.++|+||||+++|||++|++||...+..+.
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~ 209 (286)
T cd07846 160 YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQ 209 (286)
T ss_pred ccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHH
Confidence 467889999999865 4578899999999999999999999987665443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=261.92 Aligned_cols=211 Identities=28% Similarity=0.554 Sum_probs=188.0
Q ss_pred CcceeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEec
Q 020085 111 QLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF 188 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~ 188 (331)
+|++.+.||+|+||.||++.+. ++.+|+|++............+.+|++++++++|||++++.+.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 5788999999999999999985 78999999987665556677899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC-cc
Q 020085 189 MARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VM 264 (331)
Q Consensus 189 ~~ggsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~-~~ 264 (331)
+++++|.+++... ...++...+..++.|++.||.|||++|++|+||+|+||++++++.++|+|||.+....... ..
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~ 160 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA 160 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCccee
Confidence 9999999999775 3789999999999999999999999999999999999999999999999999997655443 22
Q ss_pred ccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 265 TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 265 ~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
....+++.|+|||.+.+..++.++|+||+|+++|+|++|+.||...++.+......+
T Consensus 161 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~ 217 (258)
T cd08215 161 KTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILK 217 (258)
T ss_pred cceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhc
Confidence 334688999999999988899999999999999999999999998887776666443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-36 Score=268.97 Aligned_cols=199 Identities=33% Similarity=0.519 Sum_probs=177.6
Q ss_pred cCcceeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEe
Q 020085 110 KQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E 187 (331)
++|++.+.||+|++|.||++... ++.+|+|.+..... ......+.+|+.++++++||||+++++.+..+...++++|
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEIN-EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccC-hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence 36788899999999999999985 78899999876542 3456778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCcccc
Q 020085 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 266 (331)
Q Consensus 188 ~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~~~ 266 (331)
|+++++|.+++......+++..+..++.|++.+++|||+ .|++|+||+|+||++++++.++|+|||.+......... .
T Consensus 80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~-~ 158 (265)
T cd06605 80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK-T 158 (265)
T ss_pred ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh-c
Confidence 999999999997765789999999999999999999999 99999999999999999999999999998655332222 2
Q ss_pred CCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 020085 267 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL 310 (331)
Q Consensus 267 ~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~ 310 (331)
..++..|+|||.+.+..++.++|+||||+++|+|++|+.||...
T Consensus 159 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 159 FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred ccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 67889999999999999999999999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-36 Score=270.25 Aligned_cols=206 Identities=29% Similarity=0.445 Sum_probs=178.5
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEe
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E 187 (331)
++|++.+.||+|+||.||+|.+ .++.||+|+++....+......+.+|++++++++|+||+++++.+..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 3689999999999999999988 46889999987654444455789999999999999999999999999889999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC--ccc
Q 020085 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG--VMT 265 (331)
Q Consensus 188 ~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~--~~~ 265 (331)
|++++.+..+. .....++...+..++.|++.|+.|||++|++|+||+|+||++++++.++|+|||.+....... ...
T Consensus 81 ~~~~~~l~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~ 159 (288)
T cd07833 81 YVERTLLELLE-ASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT 159 (288)
T ss_pred cCCCCHHHHHH-hcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccccc
Confidence 99986666555 445668999999999999999999999999999999999999999999999999987655443 233
Q ss_pred cCCCCcccccchhcCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 020085 266 AETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAA 316 (331)
Q Consensus 266 ~~~gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~ 316 (331)
...++..|+|||++... .++.++|+||||+++|+|++|+.||.+.+..+..
T Consensus 160 ~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~ 211 (288)
T cd07833 160 DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQL 211 (288)
T ss_pred CcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 45678899999999877 8899999999999999999999999876655433
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-35 Score=260.01 Aligned_cols=209 Identities=32% Similarity=0.544 Sum_probs=185.0
Q ss_pred CcceeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECC--CCeEEEE
Q 020085 111 QLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--PNLCIVT 186 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~--~~~~lV~ 186 (331)
+|++.+.||+|++|.||+|... ++.+++|+++.........+.+.+|+.++++++||||+++++.+... ...++++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 4778899999999999999985 78999999987655556678899999999999999999999999888 7899999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCc---
Q 020085 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV--- 263 (331)
Q Consensus 187 E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~--- 263 (331)
||+++++|.+++... ..+++..+..++.|++.++.|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus 81 e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 159 (260)
T cd06606 81 EYVSGGSLSSLLKKF-GKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG 159 (260)
T ss_pred EecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence 999999999999764 4889999999999999999999999999999999999999999999999999987665543
Q ss_pred cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC-HHHHHhccc
Q 020085 264 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLT-PLQAAVGVV 320 (331)
Q Consensus 264 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~-~~~~~~~~~ 320 (331)
.....++..|+|||.+.....+.++|+||||+++|+|++|..||.... +.+......
T Consensus 160 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 217 (260)
T cd06606 160 TGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIG 217 (260)
T ss_pred ccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhcc
Confidence 345678899999999988889999999999999999999999998865 444444433
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=263.58 Aligned_cols=200 Identities=33% Similarity=0.523 Sum_probs=178.9
Q ss_pred cCcceeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEe
Q 020085 110 KQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E 187 (331)
++|++.+.||+|++|.||+++.. ++.|++|++...... .....+.+|+.++++++|||++++++++......++|+|
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE-EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch-HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence 36888999999999999999884 789999999866432 456789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCccc-
Q 020085 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT- 265 (331)
Q Consensus 188 ~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~~- 265 (331)
|+++++|.+++.. ...+++..+..++.|++++++|||+ .|++|+||+|+||+++.++.++|+|||.+..........
T Consensus 80 ~~~~~~L~~~l~~-~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~ 158 (264)
T cd06623 80 YMDGGSLADLLKK-VGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN 158 (264)
T ss_pred ecCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCccc
Confidence 9999999999965 3778999999999999999999999 999999999999999999999999999998665433222
Q ss_pred cCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC
Q 020085 266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLT 311 (331)
Q Consensus 266 ~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~ 311 (331)
...++..|+|||.+....++.++|+||||+++|+|++|+.||....
T Consensus 159 ~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 204 (264)
T cd06623 159 TFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPG 204 (264)
T ss_pred ceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 3457889999999999899999999999999999999999998873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=270.28 Aligned_cols=206 Identities=34% Similarity=0.615 Sum_probs=178.6
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEe
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E 187 (331)
+.|+..+.||+|+||.||+|.+ .++.||+|.++... .....+.+.+|+.++++++||||+++++.+..+...++|||
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME 82 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc-chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence 3577888999999999999987 56789999987543 23445789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCc-ccc
Q 020085 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV-MTA 266 (331)
Q Consensus 188 ~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~-~~~ 266 (331)
|+++++|.+++.. +.+++..+..++.|++.|+.|||++|++|+||+|+||++++++.++|+|||++........ ...
T Consensus 83 ~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~ 160 (277)
T cd06642 83 YLGGGSALDLLKP--GPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT 160 (277)
T ss_pred ccCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhhc
Confidence 9999999999853 5688999999999999999999999999999999999999999999999999875543221 223
Q ss_pred CCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhc
Q 020085 267 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVG 318 (331)
Q Consensus 267 ~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~ 318 (331)
..++..|+|||.+.+..++.++|+||||+++|||++|+.||....+......
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~ 212 (277)
T cd06642 161 FVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFL 212 (277)
T ss_pred ccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhh
Confidence 4578899999999998999999999999999999999999987766554443
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=266.75 Aligned_cols=204 Identities=25% Similarity=0.402 Sum_probs=173.6
Q ss_pred cceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCcceeEEeEEECC--CCeEEEE
Q 020085 112 LKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRP--PNLCIVT 186 (331)
Q Consensus 112 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~--~~~~lV~ 186 (331)
|++.++||+|+||.||++.. +++.||+|+++....+... ....+|+.+++++. |||++++++++..+ +..++||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~-~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~ 79 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQ-VNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVF 79 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchh-hhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEE
Confidence 67889999999999999987 5788999998765333322 34457888898885 99999999999877 8899999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCcccc
Q 020085 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 266 (331)
Q Consensus 187 E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~~~ 266 (331)
||+++ +|.+.+......+++..+..++.|++.||+|||+.|++||||+|+||+++. +.++|+|||.++..........
T Consensus 80 e~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~~ 157 (282)
T cd07831 80 ELMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYTE 157 (282)
T ss_pred ecCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCCcCC
Confidence 99975 898888776678899999999999999999999999999999999999999 9999999999986654444444
Q ss_pred CCCCcccccchhcC-CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhc
Q 020085 267 ETGTYRWMAPEVIE-HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVG 318 (331)
Q Consensus 267 ~~gt~~y~aPE~~~-~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~ 318 (331)
..+++.|+|||.+. +..++.++|+|||||++|||++|+.||++.++.+....
T Consensus 158 ~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~ 210 (282)
T cd07831 158 YISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAK 210 (282)
T ss_pred CCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHH
Confidence 56789999999864 45578899999999999999999999998877654443
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=264.02 Aligned_cols=204 Identities=29% Similarity=0.521 Sum_probs=172.8
Q ss_pred eecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeE
Q 020085 106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183 (331)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 183 (331)
+++.+.......||+|+||.||+|++ ++..||+|.++... ....+.+.+|+.++++++|+||+++++++..++..+
T Consensus 4 ~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 81 (268)
T cd06624 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERD--SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFK 81 (268)
T ss_pred ccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCC--HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEE
Confidence 34455555667899999999999987 45789999887542 344568999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCC--CHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC-CCcEEEeeecceeeecC
Q 020085 184 IVTEFMARGSIYDFLHKQKGVF--QLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE-NGVVKVADFGVARVQAQ 260 (331)
Q Consensus 184 lV~E~~~ggsL~~~l~~~~~~~--~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~-~~~vkl~DFg~a~~~~~ 260 (331)
+|+||+++++|.+++......+ +...+..++.|++.|++|||++|++||||||+||+++. ++.++|+|||.+.....
T Consensus 82 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 161 (268)
T cd06624 82 IFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161 (268)
T ss_pred EEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence 9999999999999997654555 78889999999999999999999999999999999986 67999999999875433
Q ss_pred CC-ccccCCCCcccccchhcCCC--CCCChhhHHHHHHHHHHHHcCCCCCCCCC
Q 020085 261 SG-VMTAETGTYRWMAPEVIEHK--PYDYKADVFSFGIALWELLTGELPYAGLT 311 (331)
Q Consensus 261 ~~-~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~SlG~il~ell~g~~Pf~~~~ 311 (331)
.. ......+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||....
T Consensus 162 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~ 215 (268)
T cd06624 162 INPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELG 215 (268)
T ss_pred CCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcccc
Confidence 22 22334678999999998654 47899999999999999999999997653
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=271.58 Aligned_cols=203 Identities=32% Similarity=0.509 Sum_probs=178.8
Q ss_pred ecccCcceeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEE
Q 020085 107 IDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI 184 (331)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~l 184 (331)
+..++|++.+.||+|+||+||++.+. ++.||+|++.... .....+.+.+|+.+++.++||||+++++.+.....+++
T Consensus 2 l~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 80 (284)
T cd06620 2 LRNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA-KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICM 80 (284)
T ss_pred ccHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC-cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEE
Confidence 45678999999999999999999884 7899999987543 34446789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCc
Q 020085 185 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV 263 (331)
Q Consensus 185 V~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~ 263 (331)
||||+++++|.+++.. .+.++...+..++.+++.++.|||+ .+++||||+|+||++++++.++|+|||++.......
T Consensus 81 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~- 158 (284)
T cd06620 81 CMEFMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI- 158 (284)
T ss_pred EEecCCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc-
Confidence 9999999999999865 4678999999999999999999997 699999999999999999999999999986543221
Q ss_pred cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH
Q 020085 264 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTP 312 (331)
Q Consensus 264 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~ 312 (331)
.....++..|+|||++.+..++.++|+|||||++|++++|+.||.....
T Consensus 159 ~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~ 207 (284)
T cd06620 159 ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNI 207 (284)
T ss_pred cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccch
Confidence 2234689999999999888899999999999999999999999987554
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=265.66 Aligned_cols=200 Identities=29% Similarity=0.537 Sum_probs=173.4
Q ss_pred CcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCC----CHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEE
Q 020085 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV----NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI 184 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~----~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~l 184 (331)
+|+..+.||+|++|.||++.. +++.+|+|+++.... .....+.+.+|+.++++++|||++++++++...+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999986 678999999875432 12345789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC-cEEEeeecceeeecCCCc
Q 020085 185 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG-VVKVADFGVARVQAQSGV 263 (331)
Q Consensus 185 V~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~-~vkl~DFg~a~~~~~~~~ 263 (331)
|+||+++++|.+++.. .+.+++..+..++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||.+........
T Consensus 81 v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~ 159 (268)
T cd06630 81 FVEWMAGGSVSHLLSK-YGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT 159 (268)
T ss_pred EEeccCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccc
Confidence 9999999999999965 45789999999999999999999999999999999999998776 599999999876543211
Q ss_pred -----cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC
Q 020085 264 -----MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLT 311 (331)
Q Consensus 264 -----~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~ 311 (331)
.....++..|+|||.+.+..++.++|+||+|+++|+|++|..||....
T Consensus 160 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 212 (268)
T cd06630 160 GAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEK 212 (268)
T ss_pred cCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 122357889999999988889999999999999999999999997543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=269.24 Aligned_cols=209 Identities=24% Similarity=0.439 Sum_probs=178.2
Q ss_pred cceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEecc
Q 020085 112 LKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFM 189 (331)
Q Consensus 112 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~~ 189 (331)
|++.+.||.|++|.||+|.+ +++.||+|+++...........+.+|+.++++++|||++++++++......+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 56788999999999999987 5789999999765434444467889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC-CccccC
Q 020085 190 ARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTAE 267 (331)
Q Consensus 190 ~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~-~~~~~~ 267 (331)
+ ++|.+++.... ..+++..+..++.|+++||+|||+++++||||+|+||+++.++.++|+|||.++..... ......
T Consensus 81 ~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~ 159 (283)
T cd07835 81 D-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHE 159 (283)
T ss_pred C-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCcc
Confidence 6 59999986643 46899999999999999999999999999999999999999999999999998754322 122334
Q ss_pred CCCcccccchhcCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 268 TGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 268 ~gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
.+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||...++......+.+
T Consensus 160 ~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 214 (283)
T cd07835 160 VVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFR 214 (283)
T ss_pred ccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 568899999988654 578999999999999999999999998877665555444
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=269.87 Aligned_cols=210 Identities=24% Similarity=0.442 Sum_probs=178.0
Q ss_pred CcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEec
Q 020085 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF 188 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~ 188 (331)
+|++.+.||+|++|.||+|++ +++.||||.++...........+.+|++++++++||||+++++++......++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 478899999999999999987 578999999876544444446788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC-cccc
Q 020085 189 MARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTA 266 (331)
Q Consensus 189 ~~ggsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~-~~~~ 266 (331)
+. ++|.+++... ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||+++...... ....
T Consensus 81 ~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~ 159 (284)
T cd07860 81 LH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 159 (284)
T ss_pred cc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcccccc
Confidence 96 5899988654 3568999999999999999999999999999999999999999999999999987543321 2233
Q ss_pred CCCCcccccchhcCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 267 ETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 267 ~~gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
..+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||...+......++.+
T Consensus 160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~ 215 (284)
T cd07860 160 EVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 215 (284)
T ss_pred ccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence 4568899999988654 468899999999999999999999988776555544443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-35 Score=265.50 Aligned_cols=213 Identities=34% Similarity=0.579 Sum_probs=182.6
Q ss_pred CcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEec
Q 020085 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF 188 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~ 188 (331)
-|++.++||+|+||.||+|.. .++.+|+|+..... .......+.+|+.++++++||||+++++++..+...++||||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 83 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 83 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc-chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence 477888999999999999986 56889999987543 234456789999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC-ccccC
Q 020085 189 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAE 267 (331)
Q Consensus 189 ~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~-~~~~~ 267 (331)
+++++|.+++.. ..++...+..++.|++.++.+||++|++|+||+|+||+++.++.++|+|||++....... .....
T Consensus 84 ~~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~ 161 (277)
T cd06641 84 LGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF 161 (277)
T ss_pred CCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhccc
Confidence 999999999853 568899999999999999999999999999999999999999999999999987554322 12234
Q ss_pred CCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccccccccc
Q 020085 268 TGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIHS 327 (331)
Q Consensus 268 ~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~p~ 327 (331)
.++..|+|||.+.+..++.++|+||||+++|+|++|..||...++...... +..+.+|.
T Consensus 162 ~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~ 220 (277)
T cd06641 162 VGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFL-IPKNNPPT 220 (277)
T ss_pred cCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHH-HhcCCCCC
Confidence 678899999999888899999999999999999999999998877665555 33444443
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-36 Score=265.46 Aligned_cols=192 Identities=28% Similarity=0.519 Sum_probs=165.3
Q ss_pred eeeeecCceEEEEEEECCc------------eEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeE
Q 020085 116 CKVASGSYGDLYKGTYCSQ------------EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183 (331)
Q Consensus 116 ~~lg~G~~g~Vy~~~~~~~------------~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 183 (331)
+.||+|+||.||+|..... .+++|+++..... ...+.+|+.++++++||||+++++++.. ...+
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~ 76 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD---SLAFFETASLMSQLSHKHLVKLYGVCVR-DENI 76 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh---HHHHHHHHHHHHcCCCcchhheeeEEec-CCcE
Confidence 4689999999999998543 3788887654311 5788999999999999999999999988 7789
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC-------cEEEeeeccee
Q 020085 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG-------VVKVADFGVAR 256 (331)
Q Consensus 184 lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~-------~vkl~DFg~a~ 256 (331)
+||||+++|+|.+++......++...+..++.|++.||+|||++|++||||||+||+++.++ .++|+|||+++
T Consensus 77 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~ 156 (259)
T cd05037 77 MVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI 156 (259)
T ss_pred EEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccc
Confidence 99999999999999977655789999999999999999999999999999999999999888 79999999997
Q ss_pred eecCCCccccCCCCcccccchhcCCC--CCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHH
Q 020085 257 VQAQSGVMTAETGTYRWMAPEVIEHK--PYDYKADVFSFGIALWELLT-GELPYAGLTPLQ 314 (331)
Q Consensus 257 ~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~ 314 (331)
.... .....++..|+|||.+.+. .++.++|+||||+++|+|++ |..||...++.+
T Consensus 157 ~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~ 214 (259)
T cd05037 157 TVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE 214 (259)
T ss_pred cccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh
Confidence 6543 2234567789999999876 78999999999999999999 688898775433
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=272.84 Aligned_cols=191 Identities=26% Similarity=0.477 Sum_probs=158.8
Q ss_pred eeeeeecCceEEEEEEEC----CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEEC--CCCeEEEEec
Q 020085 115 ECKVASGSYGDLYKGTYC----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR--PPNLCIVTEF 188 (331)
Q Consensus 115 ~~~lg~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~--~~~~~lV~E~ 188 (331)
.++||+|+||.||+|+.. +..||+|.++..... ..+.+|+.++++++||||+++++++.. +...++|+||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~ 81 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS----MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY 81 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCc----HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEee
Confidence 368999999999999863 367999998754322 357789999999999999999998853 4568999999
Q ss_pred cCCCCHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEE----cCCCcEEEeeeccee
Q 020085 189 MARGSIYDFLHKQ--------KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM----DENGVVKVADFGVAR 256 (331)
Q Consensus 189 ~~ggsL~~~l~~~--------~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi----~~~~~vkl~DFg~a~ 256 (331)
+.+ +|.+++... ...+++..+..++.|++.||.|||+.|++||||||+||++ +.++.+||+|||+++
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 82 AEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred eCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 876 888877432 1357888999999999999999999999999999999999 566789999999998
Q ss_pred eecCCC----ccccCCCCcccccchhcCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 020085 257 VQAQSG----VMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGL 310 (331)
Q Consensus 257 ~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~ell~g~~Pf~~~ 310 (331)
...... ......+|+.|+|||.+.+ ..++.++|||||||++|||++|++||...
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 654322 1233467899999999876 45899999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=267.07 Aligned_cols=207 Identities=28% Similarity=0.466 Sum_probs=178.7
Q ss_pred cceeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECC--CCeEEEEe
Q 020085 112 LKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--PNLCIVTE 187 (331)
Q Consensus 112 ~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~--~~~~lV~E 187 (331)
|++.++||+|++|.||+|... ++.+|+|+++...........+.+|+.++++++|||++++++++... ...++|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 678899999999999999884 58999999986643344456788999999999999999999999887 78999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC--ccc
Q 020085 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG--VMT 265 (331)
Q Consensus 188 ~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~--~~~ 265 (331)
|+++ +|.+++......+++..++.++.|+++||+|||+.|++|+||+|+||++++++.++|+|||.+....... ..+
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~ 159 (287)
T cd07840 81 YMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYT 159 (287)
T ss_pred cccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCccccc
Confidence 9975 9999987655689999999999999999999999999999999999999999999999999998665443 233
Q ss_pred cCCCCcccccchhcCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcc
Q 020085 266 AETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGV 319 (331)
Q Consensus 266 ~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~ 319 (331)
...++..|+|||.+.+ ..++.++|+||||+++|||++|+.||...+.......+
T Consensus 160 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~ 214 (287)
T cd07840 160 NRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKI 214 (287)
T ss_pred ccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 4457889999998754 46789999999999999999999999988766554443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=268.16 Aligned_cols=209 Identities=23% Similarity=0.415 Sum_probs=175.8
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEe
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E 187 (331)
++|++.++||+|++|.||+|.+ +++.||+|.++....+....+.+.+|+.++++++||||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 4789999999999999999987 46889999987654444445678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC-CCcEEEeeecceeeecCC-Ccc
Q 020085 188 FMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE-NGVVKVADFGVARVQAQS-GVM 264 (331)
Q Consensus 188 ~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~-~~~vkl~DFg~a~~~~~~-~~~ 264 (331)
|+++ +|.+++.... ..+++..+..++.||+.||+|||++|++|+||+|+||+++. ++.+||+|||++...... ...
T Consensus 82 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~ 160 (294)
T PLN00009 82 YLDL-DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTF 160 (294)
T ss_pred cccc-cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcccc
Confidence 9965 8888875533 33678888999999999999999999999999999999985 557999999999754332 122
Q ss_pred ccCCCCcccccchhcCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcc
Q 020085 265 TAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGV 319 (331)
Q Consensus 265 ~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~ 319 (331)
....+++.|+|||.+.+ ..++.++|+||+|+++|+|++|+.||...++.+...++
T Consensus 161 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~ 216 (294)
T PLN00009 161 THEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKI 216 (294)
T ss_pred ccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 33457889999999865 46789999999999999999999999988776665543
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=265.49 Aligned_cols=210 Identities=27% Similarity=0.516 Sum_probs=178.8
Q ss_pred cccCcceeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCC
Q 020085 108 DAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (331)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 180 (331)
+.++|++.+.||+|+||.||+|+.. .+.+++|.+.... .......+.+|++++++++||||+++++++....
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 81 (275)
T cd05046 3 PRSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK-DENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE 81 (275)
T ss_pred ChHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc-chHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence 4568999999999999999999863 3579999886543 2335678999999999999999999999999988
Q ss_pred CeEEEEeccCCCCHHHHHHhcC--------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeee
Q 020085 181 NLCIVTEFMARGSIYDFLHKQK--------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADF 252 (331)
Q Consensus 181 ~~~lV~E~~~ggsL~~~l~~~~--------~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DF 252 (331)
..++||||+++++|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++++||
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999999997543 15899999999999999999999999999999999999999999999999
Q ss_pred cceeeecCCC--ccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhc
Q 020085 253 GVARVQAQSG--VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVG 318 (331)
Q Consensus 253 g~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~ 318 (331)
|+++...... ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~ 230 (275)
T cd05046 162 SLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNR 230 (275)
T ss_pred ccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHH
Confidence 9986443221 1223345678999999988888999999999999999999 8899988766655444
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=274.33 Aligned_cols=217 Identities=31% Similarity=0.509 Sum_probs=181.7
Q ss_pred ecccCcceeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc--CCCcceeEEeEEECCC----
Q 020085 107 IDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI--RHKNVVQFIGACTRPP---- 180 (331)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l--~h~niv~~~~~~~~~~---- 180 (331)
.+.+.+.+.+.||+|.||.||+|...++.||||++.. ...+.|..|-+|.+.. +|+||++|+++-....
T Consensus 207 ~~l~pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp~-----~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ 281 (534)
T KOG3653|consen 207 LELDPLQLLELIGRGRFGCVWKAQLDNRLVAVKIFPE-----QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRM 281 (534)
T ss_pred ccCCchhhHHHhhcCccceeehhhccCceeEEEecCH-----HHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccc
Confidence 3456778889999999999999999999999999974 3456788888888765 7999999999876655
Q ss_pred CeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---------CCcccCCCCCCCEEEcCCCcEEEee
Q 020085 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ---------NNIIHRDLKTANLLMDENGVVKVAD 251 (331)
Q Consensus 181 ~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~---------~~iiHrDlkp~NiLi~~~~~vkl~D 251 (331)
.++||+||.+.|||.+||.. ..+++....+++..+++||+|||+ ..|+|||||..|||+.+|++..|+|
T Consensus 282 eywLVt~fh~kGsL~dyL~~--ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaD 359 (534)
T KOG3653|consen 282 EYWLVTEFHPKGSLCDYLKA--NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIAD 359 (534)
T ss_pred ceeEEeeeccCCcHHHHHHh--ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeec
Confidence 79999999999999999954 678999999999999999999995 2599999999999999999999999
Q ss_pred ecceeeecCC---CccccCCCCcccccchhcCCCC-CC-----ChhhHHHHHHHHHHHHcCC------------CCCC--
Q 020085 252 FGVARVQAQS---GVMTAETGTYRWMAPEVIEHKP-YD-----YKADVFSFGIALWELLTGE------------LPYA-- 308 (331)
Q Consensus 252 Fg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~Di~SlG~il~ell~g~------------~Pf~-- 308 (331)
||+|...... +......||.+|||||++++.. +. .+.||||+|.+||||++.- +||.
T Consensus 360 FGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~e 439 (534)
T KOG3653|consen 360 FGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAE 439 (534)
T ss_pred cceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHH
Confidence 9999765532 2334578999999999997653 22 3689999999999999852 2443
Q ss_pred ---CCCHHHHHhccccccccccccc
Q 020085 309 ---GLTPLQAAVGVVQKVSIHSIIL 330 (331)
Q Consensus 309 ---~~~~~~~~~~~~~~~~~p~~~~ 330 (331)
..+-.++..-+|++..||.|+-
T Consensus 440 vG~hPt~e~mq~~VV~kK~RP~~p~ 464 (534)
T KOG3653|consen 440 VGNHPTLEEMQELVVRKKQRPKIPD 464 (534)
T ss_pred hcCCCCHHHHHHHHHhhccCCCChh
Confidence 1244667777899999999874
|
|
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=266.23 Aligned_cols=209 Identities=31% Similarity=0.512 Sum_probs=176.6
Q ss_pred cccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCcceeEEeEEECC-----
Q 020085 108 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRP----- 179 (331)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~----- 179 (331)
..++|.+.+.||+|+||.||++.. .++.+|+|++.... .....+.+|+.+++++ +|||++++++++...
T Consensus 20 ~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 96 (291)
T cd06639 20 PTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS---DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG 96 (291)
T ss_pred CCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc---cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence 357899999999999999999987 57889999987542 2235677899999999 799999999998653
Q ss_pred CCeEEEEeccCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeeccee
Q 020085 180 PNLCIVTEFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR 256 (331)
Q Consensus 180 ~~~~lV~E~~~ggsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~ 256 (331)
...++||||+++++|.+++.. ....+++..++.++.|++.||+|||+.|++||||||+||++++++.++|+|||.++
T Consensus 97 ~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~ 176 (291)
T cd06639 97 GQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSA 176 (291)
T ss_pred CeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccch
Confidence 358999999999999998854 24578999999999999999999999999999999999999999999999999987
Q ss_pred eecCCC-ccccCCCCcccccchhcCCC-----CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcc
Q 020085 257 VQAQSG-VMTAETGTYRWMAPEVIEHK-----PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGV 319 (331)
Q Consensus 257 ~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~ 319 (331)
...... ......++..|+|||.+... .++.++|+||||+++|||++|+.||....+.+....+
T Consensus 177 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~ 245 (291)
T cd06639 177 QLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKI 245 (291)
T ss_pred hcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHH
Confidence 544322 22334688999999998543 3688999999999999999999999998877666553
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=265.02 Aligned_cols=205 Identities=31% Similarity=0.592 Sum_probs=177.8
Q ss_pred CcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC---CCcceeEEeEEECCCCeEEE
Q 020085 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR---HKNVVQFIGACTRPPNLCIV 185 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~---h~niv~~~~~~~~~~~~~lV 185 (331)
.|++.+.||+|+||.||+|.+ .++.||+|.++... .......+.+|+.++++++ |||++++++++......++|
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv 80 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT-PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWII 80 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC-CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEE
Confidence 578889999999999999997 57899999987543 2334567889999999997 99999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC-cc
Q 020085 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VM 264 (331)
Q Consensus 186 ~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~-~~ 264 (331)
|||+++++|.+++.. +.+++..+..++.|++.+|.|||+.|++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus 81 ~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~ 158 (277)
T cd06917 81 MEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKR 158 (277)
T ss_pred EecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcccc
Confidence 999999999999854 478999999999999999999999999999999999999999999999999997654432 22
Q ss_pred ccCCCCcccccchhcCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhc
Q 020085 265 TAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVG 318 (331)
Q Consensus 265 ~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~ 318 (331)
....|+..|+|||.+.+ ..++.++|+||||+++|+|++|..||...++......
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~ 213 (277)
T cd06917 159 STFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML 213 (277)
T ss_pred ccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhc
Confidence 34468899999999864 4578999999999999999999999998877665543
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=261.97 Aligned_cols=216 Identities=29% Similarity=0.524 Sum_probs=187.4
Q ss_pred CcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEec
Q 020085 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF 188 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~ 188 (331)
+|++.++||+|+||.||++.. +++.+|+|.++...........+.+|+.++++++||||+++++.+......++|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 478899999999999999987 568899999987655555567788999999999999999999999988999999999
Q ss_pred cCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCccc
Q 020085 189 MARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT 265 (331)
Q Consensus 189 ~~ggsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~~ 265 (331)
+++++|.+++... ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||+++..... ...
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-~~~ 159 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-MAK 159 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-Ccc
Confidence 9999999998652 356889999999999999999999999999999999999999999999999999766554 333
Q ss_pred cCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccccccccc
Q 020085 266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIHSI 328 (331)
Q Consensus 266 ~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~p~~ 328 (331)
...+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+....+ ..+..|++
T Consensus 160 ~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~ 221 (256)
T cd08530 160 TQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKV-QRGKYPPI 221 (256)
T ss_pred cccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-hcCCCCCC
Confidence 456889999999999999999999999999999999999999988876655543 34444443
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=266.15 Aligned_cols=203 Identities=36% Similarity=0.642 Sum_probs=171.9
Q ss_pred eeeeecCceEEEEEEECC--------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEe
Q 020085 116 CKVASGSYGDLYKGTYCS--------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (331)
Q Consensus 116 ~~lg~G~~g~Vy~~~~~~--------~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E 187 (331)
+.||+|+||.||+|+... +.+|+|.+.... .......+.+|+.+++.++||||+++++++......++|||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME 79 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc-chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence 368999999999998743 569999886542 22345678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhc------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC-----cEEEeeeccee
Q 020085 188 FMARGSIYDFLHKQ------KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG-----VVKVADFGVAR 256 (331)
Q Consensus 188 ~~~ggsL~~~l~~~------~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~-----~vkl~DFg~a~ 256 (331)
|+++++|.+++... ...+++..+..++.|++.|+.|||+++++|+||+|+||+++.++ .++++|||+++
T Consensus 80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~ 159 (269)
T cd05044 80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159 (269)
T ss_pred ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccc
Confidence 99999999999653 23478899999999999999999999999999999999999888 89999999987
Q ss_pred eecCCCc---cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhcc
Q 020085 257 VQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGV 319 (331)
Q Consensus 257 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~ 319 (331)
....... .....++..|+|||.+.+..++.++||||||+++|||++ |+.||+..++.+....+
T Consensus 160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~ 226 (269)
T cd05044 160 DIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHV 226 (269)
T ss_pred ccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHH
Confidence 5433211 112345688999999998899999999999999999998 99999988877765553
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=268.49 Aligned_cols=214 Identities=29% Similarity=0.484 Sum_probs=179.2
Q ss_pred CeeeecccCcceeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCcceeEEeEEECC
Q 020085 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRP 179 (331)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~ 179 (331)
..|.++.++|++.+.||+|+||.||++.+. ++.||||.++.... ......+.+|+.++.+. +||||++++++|...
T Consensus 8 ~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~ 86 (296)
T cd06618 8 QKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN-KEENKRILMDLDVVLKSHDCPYIVKCYGYFITD 86 (296)
T ss_pred eeccCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC-hHHHHHHHHHHHHHHhccCCCchHhhheeeecC
Confidence 457788899999999999999999999986 88999999975532 23345566777766666 499999999999999
Q ss_pred CCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEEcCCCcEEEeeecceeee
Q 020085 180 PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (331)
Q Consensus 180 ~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~ 258 (331)
...+++|||+.+ ++.+++....+.+++..+..++.|+++||.|||+ .|++||||+|+||++++++.++|+|||.+...
T Consensus 87 ~~~~~v~e~~~~-~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~ 165 (296)
T cd06618 87 SDVFICMELMST-CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRL 165 (296)
T ss_pred CeEEEEeeccCc-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhc
Confidence 999999999865 8888876656788999999999999999999997 59999999999999999999999999998765
Q ss_pred cCCCccccCCCCcccccchhcCCC----CCCChhhHHHHHHHHHHHHcCCCCCCCCCH-HHHHhc
Q 020085 259 AQSGVMTAETGTYRWMAPEVIEHK----PYDYKADVFSFGIALWELLTGELPYAGLTP-LQAAVG 318 (331)
Q Consensus 259 ~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~Di~SlG~il~ell~g~~Pf~~~~~-~~~~~~ 318 (331)
..........+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||..... .+....
T Consensus 166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~ 230 (296)
T cd06618 166 VDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTK 230 (296)
T ss_pred cCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHH
Confidence 544444445678899999998655 378999999999999999999999976433 344433
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=258.05 Aligned_cols=206 Identities=39% Similarity=0.682 Sum_probs=183.4
Q ss_pred CcceeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEec
Q 020085 111 QLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF 188 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~ 188 (331)
+|.+.+.||+|++|.||++... ++.+++|+++.... .....+.+|+.++++++|||++++++.+..+...++++||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~ 78 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK--EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF 78 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch--hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence 4788899999999999999984 78899999986543 3457899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCccccCC
Q 020085 189 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET 268 (331)
Q Consensus 189 ~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~~~~~ 268 (331)
+++++|.+++......+++..+..++.|++.++.+||++|++|+||+|+||++++++.++|+|||.+.............
T Consensus 79 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 158 (253)
T cd05122 79 CSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV 158 (253)
T ss_pred CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccccccee
Confidence 99999999997765689999999999999999999999999999999999999999999999999997665543234556
Q ss_pred CCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhc
Q 020085 269 GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVG 318 (331)
Q Consensus 269 gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~ 318 (331)
++..|+|||.+.+..++.++|+||||+++|+|++|+.||...++.+....
T Consensus 159 ~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~ 208 (253)
T cd05122 159 GTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFK 208 (253)
T ss_pred cCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHH
Confidence 88999999999888899999999999999999999999998866555444
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=269.60 Aligned_cols=206 Identities=28% Similarity=0.456 Sum_probs=173.3
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCC------
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP------ 180 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~------ 180 (331)
.++|++.++||+|+||.||++.. +++.||||++............+.+|+.++++++||||++++++|....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 45799999999999999999987 5789999998754333333345678999999999999999999986654
Q ss_pred --CeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeee
Q 020085 181 --NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (331)
Q Consensus 181 --~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~ 258 (331)
..++||||+.+ +|.+++......+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+...
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 169 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAF 169 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcccc
Confidence 35999999975 899888776668999999999999999999999999999999999999999999999999999755
Q ss_pred cCCCc-----cccCCCCcccccchhcCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 020085 259 AQSGV-----MTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQA 315 (331)
Q Consensus 259 ~~~~~-----~~~~~gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~ 315 (331)
..... .....++..|+|||.+.+. .++.++|+||||+++|||++|..||.+.++...
T Consensus 170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~ 232 (310)
T cd07865 170 SLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQ 232 (310)
T ss_pred cCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 33221 1234567899999988654 478899999999999999999999988766543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=266.36 Aligned_cols=208 Identities=25% Similarity=0.488 Sum_probs=176.7
Q ss_pred CcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEec
Q 020085 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF 188 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~ 188 (331)
+|++.++||+|++|.||+|+. +++.||||+++.... ......+.+|+.++++++||||+++++++...+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 79 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE-EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEY 79 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc-ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEec
Confidence 588999999999999999998 578899999976532 22235677899999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC-ccc
Q 020085 189 MARGSIYDFLHKQK--GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMT 265 (331)
Q Consensus 189 ~~ggsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~-~~~ 265 (331)
+++ +|.+++.... ..+++..+..++.|++.||+|||+.|++||||+|+||++++++.++|+|||.++...... ...
T Consensus 80 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~ 158 (284)
T cd07836 80 MDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFS 158 (284)
T ss_pred CCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccccc
Confidence 986 8998886543 568999999999999999999999999999999999999999999999999987543321 223
Q ss_pred cCCCCcccccchhcCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccc
Q 020085 266 AETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 266 ~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~ 320 (331)
...+++.|++||.+.+ ..++.++|+||||+++|+|++|+.||.+.+..+...++.
T Consensus 159 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~ 214 (284)
T cd07836 159 NEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIF 214 (284)
T ss_pred cccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Confidence 4457889999999865 457899999999999999999999999877665544433
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=267.41 Aligned_cols=205 Identities=32% Similarity=0.496 Sum_probs=177.8
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEE
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~ 186 (331)
..|.+.+.||+|+||.||+|.. .++.||+|+++... ...+....+.+|+.+++.++|||++++.++|......++|+
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 4688999999999999999987 57899999986442 23445567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCcccc
Q 020085 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 266 (331)
Q Consensus 187 E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~~~ 266 (331)
||+.| ++.+++......+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++...... ..
T Consensus 95 e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~---~~ 170 (307)
T cd06607 95 EYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA---NS 170 (307)
T ss_pred HhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC---CC
Confidence 99975 888887665677999999999999999999999999999999999999999999999999998765432 23
Q ss_pred CCCCcccccchhcC---CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhc
Q 020085 267 ETGTYRWMAPEVIE---HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVG 318 (331)
Q Consensus 267 ~~gt~~y~aPE~~~---~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~ 318 (331)
..+++.|+|||.+. ...++.++||||||+++|||++|+.||.+.++......
T Consensus 171 ~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~ 225 (307)
T cd06607 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH 225 (307)
T ss_pred ccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHH
Confidence 46788999999874 45688999999999999999999999988776665444
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=269.90 Aligned_cols=213 Identities=25% Similarity=0.415 Sum_probs=179.2
Q ss_pred ecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCC----
Q 020085 107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP---- 180 (331)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~---- 180 (331)
...++|++.+.||+|+||.||+|.. .++.||+|+++...........+.+|+.++++++|||++++++++....
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 3456899999999999999999998 4688999999765433333456788999999999999999999987654
Q ss_pred ------CeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecc
Q 020085 181 ------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV 254 (331)
Q Consensus 181 ------~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~ 254 (331)
.+++|+||+++ ++.+.+......+++..+..++.|++.||.|||+.|++|+||+|+||++++++.+||+|||.
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~ 162 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGL 162 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccc
Confidence 78999999987 88888866566799999999999999999999999999999999999999999999999999
Q ss_pred eeeecCCCc--cccCCCCcccccchhcCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccc
Q 020085 255 ARVQAQSGV--MTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 255 a~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~ 320 (331)
+........ .....++..|+|||.+.+ ..++.++||||||+++|+|++|++||...+..+....+.
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~ 231 (302)
T cd07864 163 ARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELIS 231 (302)
T ss_pred cccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 976544321 123346788999998864 457899999999999999999999999877766554433
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=263.04 Aligned_cols=204 Identities=25% Similarity=0.491 Sum_probs=166.6
Q ss_pred eeeecCceEEEEEEE-CC---ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEeccCCC
Q 020085 117 KVASGSYGDLYKGTY-CS---QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARG 192 (331)
Q Consensus 117 ~lg~G~~g~Vy~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~~~gg 192 (331)
+||+|+||+||++.. .+ ..+++|.++... .....+.+.+|+.+++.++||||+++++.|......++||||+++|
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA-SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC-ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 699999999999975 33 245667665432 2344678999999999999999999999999999999999999999
Q ss_pred CHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC---cccc
Q 020085 193 SIYDFLHKQK---GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG---VMTA 266 (331)
Q Consensus 193 sL~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~---~~~~ 266 (331)
+|.+++.+.. ...+...+..++.|++.||+|||+++++||||||+|||++.++.++|+|||++....... ....
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~ 160 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDD 160 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcccC
Confidence 9999997642 345667788999999999999999999999999999999999999999999986432211 1223
Q ss_pred CCCCcccccchhcCC-------CCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhcccc
Q 020085 267 ETGTYRWMAPEVIEH-------KPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 267 ~~gt~~y~aPE~~~~-------~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~ 321 (331)
..++..|+|||++.. ..++.++|+||||+++|||++ |..||...++.+....+..
T Consensus 161 ~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~ 223 (268)
T cd05086 161 KCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIK 223 (268)
T ss_pred CcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence 467889999999743 245789999999999999997 6789988887766665443
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=257.29 Aligned_cols=209 Identities=36% Similarity=0.613 Sum_probs=185.4
Q ss_pred CcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEec
Q 020085 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF 188 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~ 188 (331)
+|++.+.||+|++|.||+++. .++.|++|.+............+.+|++++++++|||++++++++..+...+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 478899999999999999987 568899999987765556678899999999999999999999999998999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCc-cccC
Q 020085 189 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV-MTAE 267 (331)
Q Consensus 189 ~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~-~~~~ 267 (331)
+++++|.+++... +.+++..+..++.|++.++.+||++|++||||+|+||+++.++.++|+|||.+........ ....
T Consensus 81 ~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~ 159 (254)
T cd06627 81 AENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASV 159 (254)
T ss_pred CCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccccccc
Confidence 9999999999654 6789999999999999999999999999999999999999999999999999986654332 2344
Q ss_pred CCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccc
Q 020085 268 TGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 268 ~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~ 320 (331)
.++..|+|||...+..++.++|+||+|+++|+|++|+.||...++........
T Consensus 160 ~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~ 212 (254)
T cd06627 160 VGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV 212 (254)
T ss_pred ccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh
Confidence 67899999999988888999999999999999999999998887766665544
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=266.46 Aligned_cols=194 Identities=26% Similarity=0.442 Sum_probs=169.6
Q ss_pred eeecCceEEEEEEE--CCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEeccCCCCH
Q 020085 118 VASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI 194 (331)
Q Consensus 118 lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~~~ggsL 194 (331)
||+|+||+||++.. +++.+|+|++...... ......+..|+.++++++|||++++++.+...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999976 5789999998754322 22345678899999999999999999999999999999999999999
Q ss_pred HHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCccccCCCCccc
Q 020085 195 YDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRW 273 (331)
Q Consensus 195 ~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~~~~~gt~~y 273 (331)
.+++.... ..+++..+..++.|++.|+.|||++|++||||+|+||++++++.++|+|||.+.............++..|
T Consensus 81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y 160 (277)
T cd05577 81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGY 160 (277)
T ss_pred HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCCCc
Confidence 99997643 36899999999999999999999999999999999999999999999999998765443333455678899
Q ss_pred ccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC
Q 020085 274 MAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLT 311 (331)
Q Consensus 274 ~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~ 311 (331)
+|||.+.+..++.++|+||||+++|+|++|+.||....
T Consensus 161 ~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 198 (277)
T cd05577 161 MAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRK 198 (277)
T ss_pred CCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCc
Confidence 99999988889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=267.81 Aligned_cols=201 Identities=32% Similarity=0.514 Sum_probs=170.7
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCcceeEEeEEECCCCeEEE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCIV 185 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~~~~lV 185 (331)
.++|...+.||+|+||.||++.+ .++.+|+|.+...... .....+.+|+.++.++. ||||+++++++..+...+++
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~ 81 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE-KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC 81 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh-HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence 45777888999999999999988 5689999998754322 44567899999999996 99999999999998899999
Q ss_pred EeccCCCCHHHHH---Hh-cCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCCEEEcCCCcEEEeeecceeeecC
Q 020085 186 TEFMARGSIYDFL---HK-QKGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (331)
Q Consensus 186 ~E~~~ggsL~~~l---~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~-~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~ 260 (331)
|||+.. ++.++. .. ....+++..+..++.|++.||+|||+. |++||||||+||+++.++.++|+|||+++....
T Consensus 82 ~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 82 MELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred EecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 999875 655543 22 246789999999999999999999974 999999999999999999999999999875544
Q ss_pred CCccccCCCCcccccchhcCCC---CCCChhhHHHHHHHHHHHHcCCCCCCCCC
Q 020085 261 SGVMTAETGTYRWMAPEVIEHK---PYDYKADVFSFGIALWELLTGELPYAGLT 311 (331)
Q Consensus 261 ~~~~~~~~gt~~y~aPE~~~~~---~~~~~~Di~SlG~il~ell~g~~Pf~~~~ 311 (331)
........++..|+|||.+.+. .++.++|+||||+++|+|++|+.||....
T Consensus 161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 214 (288)
T cd06616 161 SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN 214 (288)
T ss_pred CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcc
Confidence 4333445688999999999766 68999999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=270.61 Aligned_cols=205 Identities=31% Similarity=0.523 Sum_probs=177.2
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEe
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E 187 (331)
+.|.....||+|+||.||++.. .++.||||.++.. .....+.+.+|+.+++.++|||++++++.+...+..++|||
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e 99 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR--KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVME 99 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc--hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEe
Confidence 3455567899999999999987 5788999998653 23445678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC-cccc
Q 020085 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTA 266 (331)
Q Consensus 188 ~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~-~~~~ 266 (331)
|+++++|.+++.. +.+++..+..++.||+.||+|||++|++||||||+||++++++.++|+|||++....... ....
T Consensus 100 ~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~ 177 (292)
T cd06658 100 FLEGGALTDIVTH--TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS 177 (292)
T ss_pred CCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCce
Confidence 9999999998843 468899999999999999999999999999999999999999999999999986543221 2233
Q ss_pred CCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhc
Q 020085 267 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVG 318 (331)
Q Consensus 267 ~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~ 318 (331)
..++..|+|||.+.+..++.++|+||||+++|||++|+.||....+.+....
T Consensus 178 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~ 229 (292)
T cd06658 178 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR 229 (292)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 4688999999999988899999999999999999999999998877665443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=263.24 Aligned_cols=211 Identities=25% Similarity=0.496 Sum_probs=181.1
Q ss_pred CcceeeeeeecCceEEEEEEEC---CceEEEEEecCCC--------CCHHHHHHHHHHHHHHHh-cCCCcceeEEeEEEC
Q 020085 111 QLKIECKVASGSYGDLYKGTYC---SQEVAIKVLKPEC--------VNTEMLKEFSQEVYIMRK-IRHKNVVQFIGACTR 178 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~~---~~~vavK~~~~~~--------~~~~~~~~~~~E~~il~~-l~h~niv~~~~~~~~ 178 (331)
.|++.+.||+|+||.||++... ++.+|+|.++... .......++.+|+.++++ ++||||+++++.+..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 4788899999999999999984 4789999886432 233455678889998875 799999999999999
Q ss_pred CCCeEEEEeccCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEEcCCCcEEEeeecc
Q 020085 179 PPNLCIVTEFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENGVVKVADFGV 254 (331)
Q Consensus 179 ~~~~~lV~E~~~ggsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~-~~iiHrDlkp~NiLi~~~~~vkl~DFg~ 254 (331)
.+..+++|||+++++|.+++.. ....+++..++.++.|++.+|.|||+ .|++|+||+|+||+++.++.++|+|||.
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~ 160 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL 160 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence 9999999999999999998743 34578999999999999999999996 7899999999999999999999999999
Q ss_pred eeeecCCCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 255 ARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 255 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
+.............++..|+|||.+.+..++.++|+||||+++|+|++|+.||...........+..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~ 227 (269)
T cd08528 161 AKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVE 227 (269)
T ss_pred eeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhh
Confidence 9876554444556789999999999988899999999999999999999999988777666655443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-35 Score=262.62 Aligned_cols=209 Identities=32% Similarity=0.528 Sum_probs=177.7
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCcceeEEeEEECCC-----
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPP----- 180 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~----- 180 (331)
.++|++.+.||+|++|.||+|.. .++.+++|+++... .....+.+|+.+++++ +||||+++++++....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE---DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 56899999999999999999998 45789999987653 2346789999999999 6999999999997654
Q ss_pred -CeEEEEeccCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeeccee
Q 020085 181 -NLCIVTEFMARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR 256 (331)
Q Consensus 181 -~~~lV~E~~~ggsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~ 256 (331)
.+++||||+++++|.+++... +..+++..+..++.|++.||.|||+.|++|+||+|+||++++++.++|+|||.+.
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~ 161 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA 161 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccce
Confidence 489999999999999998653 3678999999999999999999999999999999999999999999999999987
Q ss_pred eecCCC-ccccCCCCcccccchhcCC-----CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccc
Q 020085 257 VQAQSG-VMTAETGTYRWMAPEVIEH-----KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 257 ~~~~~~-~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~ 320 (331)
...... ......++..|+|||.+.. ..++.++|+||||+++|+|++|+.||....+.....++.
T Consensus 162 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 231 (275)
T cd06608 162 QLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIP 231 (275)
T ss_pred ecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhh
Confidence 654322 2234568899999998753 356789999999999999999999998877666655543
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=261.62 Aligned_cols=210 Identities=28% Similarity=0.526 Sum_probs=181.1
Q ss_pred CcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEec
Q 020085 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF 188 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~ 188 (331)
+|.+.+.||+|+||.||++.. .+..+|+|.+.....+....+.+.+|+.+++.++|+|++++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 478899999999999999988 568899999876543344456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCc-EEEeeecceeeecCCCcc-c
Q 020085 189 MARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV-VKVADFGVARVQAQSGVM-T 265 (331)
Q Consensus 189 ~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~-vkl~DFg~a~~~~~~~~~-~ 265 (331)
+++++|.+++.... ..+++..+..++.|+++|+.|||+.+++|+||+|+||++++++. ++|+|||.+......... .
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~ 160 (257)
T cd08225 81 CDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAY 160 (257)
T ss_pred CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCccccc
Confidence 99999999996643 35789999999999999999999999999999999999998864 699999998765433221 2
Q ss_pred cCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccc
Q 020085 266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 266 ~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~ 320 (331)
...|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...++.+......
T Consensus 161 ~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 215 (257)
T cd08225 161 TCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKIC 215 (257)
T ss_pred ccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHh
Confidence 3458899999999988889999999999999999999999999887766665543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=268.33 Aligned_cols=206 Identities=31% Similarity=0.524 Sum_probs=179.2
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~ 186 (331)
.++|++.+.||+|+||.||++.. +++.||+|.+.... ....+.+.+|+.++++++|||++++++.+......++|+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~ 95 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ--QPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVM 95 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc--chHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEE
Confidence 46899999999999999999986 56889999986442 233467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC-ccc
Q 020085 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMT 265 (331)
Q Consensus 187 E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~-~~~ 265 (331)
||+++++|.+++.+ ..++...+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus 96 e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~ 173 (293)
T cd06647 96 EYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 173 (293)
T ss_pred ecCCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccccc
Confidence 99999999999864 457888999999999999999999999999999999999999999999999886544322 223
Q ss_pred cCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhc
Q 020085 266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVG 318 (331)
Q Consensus 266 ~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~ 318 (331)
...+++.|+|||.+.+..++.++|+||||+++|++++|+.||...++.+....
T Consensus 174 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~ 226 (293)
T cd06647 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL 226 (293)
T ss_pred cccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee
Confidence 34688899999999888899999999999999999999999998777655443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=255.40 Aligned_cols=207 Identities=22% Similarity=0.374 Sum_probs=178.3
Q ss_pred CCeeeecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECC
Q 020085 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP 179 (331)
Q Consensus 102 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 179 (331)
.....|+.++|.+.+.+|+|||+-||.++. +++.||+|.+.-.. .+..+..++|++..++++|||++++++++..+
T Consensus 13 ~~tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~--~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~ 90 (302)
T KOG2345|consen 13 RGTVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHS--QEDIEEALREIDNHRKFNSPNVLRLVDHQLRE 90 (302)
T ss_pred CCcEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeeccc--hHHHHHHHHHHHHHHhhCCcchHHHHHHHHHh
Confidence 345679999999999999999999998875 67889999987653 55678899999999999999999999877544
Q ss_pred C-----CeEEEEeccCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCCEEEcCCCcEEE
Q 020085 180 P-----NLCIVTEFMARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLHQNN--IIHRDLKTANLLMDENGVVKV 249 (331)
Q Consensus 180 ~-----~~~lV~E~~~ggsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~NiLi~~~~~vkl 249 (331)
. ..||+++|...|||.+.+... ...+++.+++.++.++++||++||+.. ++||||||+|||+.+++.+++
T Consensus 91 ~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl 170 (302)
T KOG2345|consen 91 EKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVL 170 (302)
T ss_pred hccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEE
Confidence 3 389999999999999998664 247899999999999999999999998 999999999999999999999
Q ss_pred eeecceeeecCCC----------ccccCCCCcccccchhcC---CCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 020085 250 ADFGVARVQAQSG----------VMTAETGTYRWMAPEVIE---HKPYDYKADVFSFGIALWELLTGELPYAGL 310 (331)
Q Consensus 250 ~DFg~a~~~~~~~----------~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~SlG~il~ell~g~~Pf~~~ 310 (331)
.|||.++...-.- ....+..|..|.|||.+. +...+.++|||||||+||+|+.|..||+..
T Consensus 171 ~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~ 244 (302)
T KOG2345|consen 171 MDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERI 244 (302)
T ss_pred EeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHH
Confidence 9999986433211 123456899999999985 456789999999999999999999999753
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=266.07 Aligned_cols=201 Identities=30% Similarity=0.593 Sum_probs=175.0
Q ss_pred ccCcceeeeeeecCceEEEEEEEC------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEEC--CC
Q 020085 109 AKQLKIECKVASGSYGDLYKGTYC------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR--PP 180 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~--~~ 180 (331)
.++|++.+.||+|+||.||++++. ++.+|+|+++..... .....+.+|+.+++.++||||+++++++.. ..
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~ 81 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE-QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR 81 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch-HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence 457888999999999999999863 578999999866433 456789999999999999999999999877 55
Q ss_pred CeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecC
Q 020085 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (331)
Q Consensus 181 ~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~ 260 (331)
..+++|||+++++|.+++......++...+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||.+.....
T Consensus 82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 161 (284)
T cd05038 82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPE 161 (284)
T ss_pred ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEccccccccccc
Confidence 78999999999999999987666799999999999999999999999999999999999999999999999999986653
Q ss_pred CCcc----ccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 020085 261 SGVM----TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL 310 (331)
Q Consensus 261 ~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~ 310 (331)
.... ....++..|+|||.+.+..++.++|+||||+++|||++|+.||...
T Consensus 162 ~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 215 (284)
T cd05038 162 DKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSP 215 (284)
T ss_pred CCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccc
Confidence 2211 1223456799999998888999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=269.92 Aligned_cols=214 Identities=30% Similarity=0.608 Sum_probs=176.7
Q ss_pred ccCcceeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc--CCCcceeEEeEEECCC----Ce
Q 020085 109 AKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI--RHKNVVQFIGACTRPP----NL 182 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l--~h~niv~~~~~~~~~~----~~ 182 (331)
.++..+.+.||+|.||.||+|.|+|+.||||++.... .+...+|.+|++.+ +|+||+.|+++=..+. .+
T Consensus 210 arqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srd-----E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQL 284 (513)
T KOG2052|consen 210 ARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRD-----ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQL 284 (513)
T ss_pred hheeEEEEEecCccccceeeccccCCceEEEEecccc-----hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEE
Confidence 5678899999999999999999999999999997542 25677888888764 9999999998765443 48
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CcccCCCCCCCEEEcCCCcEEEeeecc
Q 020085 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN--------NIIHRDLKTANLLMDENGVVKVADFGV 254 (331)
Q Consensus 183 ~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~--------~iiHrDlkp~NiLi~~~~~vkl~DFg~ 254 (331)
++|++|.+.|||+|||.. ..++....++++..++.||++||.. .|.|||||..|||+.++|...|+|+|+
T Consensus 285 wLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL 362 (513)
T KOG2052|consen 285 WLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 362 (513)
T ss_pred EEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence 999999999999999964 6789999999999999999999942 499999999999999999999999999
Q ss_pred eeeecCCC-----ccccCCCCcccccchhcCCCC----C--CChhhHHHHHHHHHHHHcC----------CCCCCCCCH-
Q 020085 255 ARVQAQSG-----VMTAETGTYRWMAPEVIEHKP----Y--DYKADVFSFGIALWELLTG----------ELPYAGLTP- 312 (331)
Q Consensus 255 a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~----~--~~~~Di~SlG~il~ell~g----------~~Pf~~~~~- 312 (331)
|-...... .....+||.+|||||++...- + -..+||||||.++||+... ++||.+..|
T Consensus 363 Av~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~ 442 (513)
T KOG2052|consen 363 AVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPS 442 (513)
T ss_pred eEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCC
Confidence 97665542 235678999999999985432 1 1469999999999998752 679877533
Q ss_pred ----HHHHhcccccccccccc
Q 020085 313 ----LQAAVGVVQKVSIHSII 329 (331)
Q Consensus 313 ----~~~~~~~~~~~~~p~~~ 329 (331)
.++..=+..+..||.+|
T Consensus 443 DPs~eeMrkVVCv~~~RP~ip 463 (513)
T KOG2052|consen 443 DPSFEEMRKVVCVQKLRPNIP 463 (513)
T ss_pred CCCHHHHhcceeecccCCCCC
Confidence 44444455677888886
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-35 Score=264.76 Aligned_cols=210 Identities=26% Similarity=0.449 Sum_probs=183.2
Q ss_pred cceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEecc
Q 020085 112 LKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFM 189 (331)
Q Consensus 112 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~~ 189 (331)
|++.+.||+|++|.||++.. .++.+++|.++...........+.+|+.++++++||||+++++++..+...++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 56788999999999999987 5788999999876545445678889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC-ccccCC
Q 020085 190 ARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAET 268 (331)
Q Consensus 190 ~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~-~~~~~~ 268 (331)
++ +|.+++......+++..+..++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||.+....... ......
T Consensus 81 ~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~ 159 (283)
T cd05118 81 DT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYV 159 (283)
T ss_pred CC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCcc
Confidence 76 9999887766789999999999999999999999999999999999999999999999999997665443 223345
Q ss_pred CCcccccchhcCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccc
Q 020085 269 GTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK 322 (331)
Q Consensus 269 gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~ 322 (331)
++..|+|||.+.+. .++.++|+||||+++|+|++|+.||+..+..+....+.+.
T Consensus 160 ~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~ 214 (283)
T cd05118 160 VTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRT 214 (283)
T ss_pred CcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 78899999998776 7899999999999999999999999988877665554443
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=264.47 Aligned_cols=197 Identities=26% Similarity=0.460 Sum_probs=168.7
Q ss_pred Ccce-eeeeeecCceEEEEEE--ECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCcceeEEeEEECCCCeEEEE
Q 020085 111 QLKI-ECKVASGSYGDLYKGT--YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 111 ~~~~-~~~lg~G~~g~Vy~~~--~~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~~~~lV~ 186 (331)
-|++ .+.||+|+|+.|--+. .++..||||++.... .....+..+|++++.+.+ |+||++++++|+++..+|+||
T Consensus 78 ~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~--gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVf 155 (463)
T KOG0607|consen 78 MYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQP--GHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVF 155 (463)
T ss_pred HHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCC--chHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEE
Confidence 4555 3589999999998765 488999999998763 334578899999999995 999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCc---EEEeeecceeeecCC--
Q 020085 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV---VKVADFGVARVQAQS-- 261 (331)
Q Consensus 187 E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~---vkl~DFg~a~~~~~~-- 261 (331)
|.|.||+|...+++ +..|++.++.++..+|+.||.+||.+||.|||+||+|||-..-+. +||+||.+..-....
T Consensus 156 EKm~GGplLshI~~-~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~ 234 (463)
T KOG0607|consen 156 EKMRGGPLLSHIQK-RKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNND 234 (463)
T ss_pred ecccCchHHHHHHH-hhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCC
Confidence 99999999999976 567999999999999999999999999999999999999976553 899999997533221
Q ss_pred ------CccccCCCCcccccchhcC-----CCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 020085 262 ------GVMTAETGTYRWMAPEVIE-----HKPYDYKADVFSFGIALWELLTGELPYAGL 310 (331)
Q Consensus 262 ------~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~SlG~il~ell~g~~Pf~~~ 310 (331)
......+|+..|||||+.. ...|+.++|.||||+++|-||+|.+||.+.
T Consensus 235 ~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~ 294 (463)
T KOG0607|consen 235 CSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGH 294 (463)
T ss_pred CCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCc
Confidence 1223457889999999863 346899999999999999999999999775
|
|
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-35 Score=265.20 Aligned_cols=209 Identities=34% Similarity=0.539 Sum_probs=183.1
Q ss_pred ccCcceeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~ 186 (331)
.+.|.+.+.||+|++|.||++.+. ++.+++|+++.... ..+.+.+|+.++++++|+|++++++.+......++++
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ---NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch---hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 456888899999999999999985 78999999986532 4567889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC-ccc
Q 020085 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMT 265 (331)
Q Consensus 187 E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~-~~~ 265 (331)
||+++++|.+++......++...+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....... ...
T Consensus 95 e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~ 174 (286)
T cd06614 95 EYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRN 174 (286)
T ss_pred eccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhc
Confidence 9999999999997754489999999999999999999999999999999999999999999999999886443321 122
Q ss_pred cCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccc
Q 020085 266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 266 ~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~ 320 (331)
...+++.|+|||.+.+..++.++|+||||+++|+|++|+.||....+......+.
T Consensus 175 ~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~ 229 (286)
T cd06614 175 SVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLIT 229 (286)
T ss_pred cccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 3357889999999998889999999999999999999999999888776655543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=270.02 Aligned_cols=205 Identities=30% Similarity=0.496 Sum_probs=177.0
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEe
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E 187 (331)
..|....+||+|+||.||++.. .++.||+|+++.... ...+.+.+|+.+++.++|||++++++.+..+...++|+|
T Consensus 21 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e 98 (297)
T cd06659 21 SLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ--QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLME 98 (297)
T ss_pred hhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc--chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEe
Confidence 3455566899999999999987 578999999865432 234668899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC-cccc
Q 020085 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTA 266 (331)
Q Consensus 188 ~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~-~~~~ 266 (331)
|+++++|.+++.. ..+++..+..++.|++.||+|||++|++||||+|+||+++.++.++|+|||++....... ....
T Consensus 99 ~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~ 176 (297)
T cd06659 99 FLQGGALTDIVSQ--TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS 176 (297)
T ss_pred cCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccc
Confidence 9999999998743 568899999999999999999999999999999999999999999999999986443321 2234
Q ss_pred CCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhc
Q 020085 267 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVG 318 (331)
Q Consensus 267 ~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~ 318 (331)
..++..|+|||.+.+..++.++|+||||+++|||++|+.||....+.+....
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~ 228 (297)
T cd06659 177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKR 228 (297)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 5688999999999988899999999999999999999999988777665554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=262.87 Aligned_cols=208 Identities=25% Similarity=0.457 Sum_probs=177.9
Q ss_pred cceeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhc---CCCcceeEEeEEECCCC-----
Q 020085 112 LKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI---RHKNVVQFIGACTRPPN----- 181 (331)
Q Consensus 112 ~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l---~h~niv~~~~~~~~~~~----- 181 (331)
|++.+.||+|+||.||++++. ++.||+|+++...........+.+|+.+++++ +|||++++++++.....
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 678899999999999999984 68999999986544443445677788877766 59999999999987776
Q ss_pred eEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecC
Q 020085 182 LCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (331)
Q Consensus 182 ~~lV~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~ 260 (331)
.+++|||+.+ +|.+++.... ..+++..+..++.|+++||.|||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~ 159 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF 159 (287)
T ss_pred eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccC
Confidence 9999999975 8999886643 3689999999999999999999999999999999999999999999999999977654
Q ss_pred CCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccc
Q 020085 261 SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 261 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~ 320 (331)
........++..|+|||.+.+..++.++|+||||+++|+|++|++||...+..+....+.
T Consensus 160 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~ 219 (287)
T cd07838 160 EMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIF 219 (287)
T ss_pred CcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHH
Confidence 443344457889999999998899999999999999999999999999888766555443
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=269.77 Aligned_cols=212 Identities=26% Similarity=0.457 Sum_probs=175.5
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCC------
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP------ 180 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~------ 180 (331)
.++|.+.++||+|+||.||++++ .++.+|+|++............+.+|+.++++++||||+++++.+....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 46899999999999999999998 4688999998654333323346778999999999999999998775433
Q ss_pred --CeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeee
Q 020085 181 --NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (331)
Q Consensus 181 --~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~ 258 (331)
.+++|+||+.+ +|.+.+......+++..+..++.|+++||+|||++|++|+||||+||++++++.++|+|||+++..
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 165 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPY 165 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchhc
Confidence 46999999976 788888666678999999999999999999999999999999999999999999999999999754
Q ss_pred cCCCc------------cccCCCCcccccchhcCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 259 AQSGV------------MTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 259 ~~~~~------------~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
..... .+...+++.|+|||.+.+ ..++.++|+||||+++|||++|++||.+.++......+..
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~ 241 (311)
T cd07866 166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK 241 (311)
T ss_pred cCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 33211 122346788999998765 4588999999999999999999999998877665554443
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-35 Score=261.79 Aligned_cols=208 Identities=30% Similarity=0.567 Sum_probs=174.5
Q ss_pred cceeeeeeecCceEEEEEEE-----CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCC------
Q 020085 112 LKIECKVASGSYGDLYKGTY-----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP------ 180 (331)
Q Consensus 112 ~~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~------ 180 (331)
|++.+.||+|+||.||+|.+ .++.+|||+++....+....+++.+|+.++++++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 56788999999999999975 2578999999877666666778999999999999999999999886532
Q ss_pred CeEEEEeccCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecce
Q 020085 181 NLCIVTEFMARGSIYDFLHKQK-----GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA 255 (331)
Q Consensus 181 ~~~lV~E~~~ggsL~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a 255 (331)
..++++||+.+|+|.+++.... ..++...+..++.|++.|++|||++|++||||||+||+++.++.++|+|||.+
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~ 160 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS 160 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence 2478999999999998875321 24788899999999999999999999999999999999999999999999998
Q ss_pred eeecCCCc---cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhcc
Q 020085 256 RVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGV 319 (331)
Q Consensus 256 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~ 319 (331)
+....... .....+++.|++||.+....++.++||||||+++|+|++ |+.||...+..+....+
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~ 228 (273)
T cd05074 161 KKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYL 228 (273)
T ss_pred ccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHH
Confidence 75533221 122345678999999998899999999999999999999 89999988776555443
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=263.07 Aligned_cols=204 Identities=31% Similarity=0.515 Sum_probs=177.4
Q ss_pred CcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEec
Q 020085 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF 188 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~ 188 (331)
.|.-.+.||+|++|.||++.. .++.+++|+++.. .....+.+.+|+.+++.++|||++++++++...+..++++||
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~--~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~ 97 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR--KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEF 97 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc--chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEec
Confidence 455567999999999999986 5688999998643 233346688999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC-ccccC
Q 020085 189 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAE 267 (331)
Q Consensus 189 ~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~-~~~~~ 267 (331)
+.+++|.+++.. +.++...+..++.|++.|++|||++|++||||+|+||+++.++.++|+|||.+....... .....
T Consensus 98 ~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~ 175 (285)
T cd06648 98 LEGGALTDIVTH--TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSL 175 (285)
T ss_pred cCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccc
Confidence 999999999865 568899999999999999999999999999999999999999999999999886443321 12234
Q ss_pred CCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhc
Q 020085 268 TGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVG 318 (331)
Q Consensus 268 ~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~ 318 (331)
.+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...++.+....
T Consensus 176 ~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~ 226 (285)
T cd06648 176 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKR 226 (285)
T ss_pred cCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHH
Confidence 688999999999888899999999999999999999999988887776655
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=263.76 Aligned_cols=207 Identities=33% Similarity=0.592 Sum_probs=174.7
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCcceeEEeEEEC------C
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTR------P 179 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~------~ 179 (331)
...|++.+.||+|+||.||+|.+ .++.+|+|++... ......+..|+.+++++ +|||++++++++.. .
T Consensus 15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~---~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 91 (282)
T cd06636 15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT---EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHD 91 (282)
T ss_pred hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC---hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCC
Confidence 45789999999999999999998 5688999998653 23346688899999998 69999999998853 3
Q ss_pred CCeEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeee
Q 020085 180 PNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (331)
Q Consensus 180 ~~~~lV~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~ 258 (331)
...+++|||+++|+|.+++.... ..+++..+..++.|++.|+.|||+.|++|+||+|+||++++++.++|+|||++...
T Consensus 92 ~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~ 171 (282)
T cd06636 92 DQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQL 171 (282)
T ss_pred CEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhh
Confidence 56899999999999999996643 45888889999999999999999999999999999999999999999999998754
Q ss_pred cCC-CccccCCCCcccccchhcC-----CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhc
Q 020085 259 AQS-GVMTAETGTYRWMAPEVIE-----HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVG 318 (331)
Q Consensus 259 ~~~-~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~ 318 (331)
... .......+++.|+|||.+. +..++.++|+||||+++|||++|+.||....+.+....
T Consensus 172 ~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~ 237 (282)
T cd06636 172 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFL 237 (282)
T ss_pred hccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhh
Confidence 322 1223456889999999985 35688899999999999999999999988776665544
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-35 Score=266.42 Aligned_cols=206 Identities=18% Similarity=0.281 Sum_probs=160.4
Q ss_pred eeeecccCcceeeeeeecCceEEEEEEECC-----ceEEEEEecCCCCCHHH---------HHHHHHHHHHHHhcCCCcc
Q 020085 104 VWEIDAKQLKIECKVASGSYGDLYKGTYCS-----QEVAIKVLKPECVNTEM---------LKEFSQEVYIMRKIRHKNV 169 (331)
Q Consensus 104 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~vavK~~~~~~~~~~~---------~~~~~~E~~il~~l~h~ni 169 (331)
..++..++|++.++||+|+||.||+|...+ ..+|+|+.......... ......+...++.++|+|+
T Consensus 6 ~~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i 85 (294)
T PHA02882 6 LIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGI 85 (294)
T ss_pred eeccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCC
Confidence 345677899999999999999999998744 35677765433211100 0112233445566789999
Q ss_pred eeEEeEEECCC----CeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC
Q 020085 170 VQFIGACTRPP----NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG 245 (331)
Q Consensus 170 v~~~~~~~~~~----~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~ 245 (331)
+++++++.... ..++++|++.. ++.+.+.. ....++..+..++.|+++||+|||+++++||||||+|||++.++
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~ 163 (294)
T PHA02882 86 PKYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKR-IKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNN 163 (294)
T ss_pred CcEEEeeeEecCCceEEEEEEehhcc-CHHHHHHh-hccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCC
Confidence 99998765443 34678887754 77777644 34467888999999999999999999999999999999999999
Q ss_pred cEEEeeecceeeecCCC--------ccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC
Q 020085 246 VVKVADFGVARVQAQSG--------VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLT 311 (331)
Q Consensus 246 ~vkl~DFg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~ 311 (331)
.++|+|||+++...... ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+
T Consensus 164 ~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~ 237 (294)
T PHA02882 164 RGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFG 237 (294)
T ss_pred cEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccc
Confidence 99999999997653221 1123468999999999999999999999999999999999999998773
|
|
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-35 Score=264.32 Aligned_cols=195 Identities=25% Similarity=0.482 Sum_probs=165.7
Q ss_pred eeeeecCceEEEEEEEC---------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEE
Q 020085 116 CKVASGSYGDLYKGTYC---------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 116 ~~lg~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~ 186 (331)
+.||+|+||.||+|... ...+|+|.+... .....+.+.+|+.+++.++|||++++++++..+...++||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 78 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS--HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ 78 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcch--hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence 36999999999999763 234888887643 2344567899999999999999999999999988999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCc--------EEEeeecceeee
Q 020085 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV--------VKVADFGVARVQ 258 (331)
Q Consensus 187 E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~--------vkl~DFg~a~~~ 258 (331)
||+++|+|.+++......+++..+..++.||+.||+|||++|++||||||+||+++.++. ++++|||.+...
T Consensus 79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~ 158 (258)
T cd05078 79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITV 158 (258)
T ss_pred ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccccc
Confidence 999999999999776667899999999999999999999999999999999999987765 699999988654
Q ss_pred cCCCccccCCCCcccccchhcCC-CCCCChhhHHHHHHHHHHHHcC-CCCCCCCCHHHH
Q 020085 259 AQSGVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTG-ELPYAGLTPLQA 315 (331)
Q Consensus 259 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~ell~g-~~Pf~~~~~~~~ 315 (331)
... ....++..|+|||.+.+ ..++.++|+||||+++|||++| ..||...++...
T Consensus 159 ~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~ 214 (258)
T cd05078 159 LPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK 214 (258)
T ss_pred CCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH
Confidence 322 23467889999999976 4579999999999999999998 578877766543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=279.56 Aligned_cols=201 Identities=26% Similarity=0.468 Sum_probs=180.3
Q ss_pred eeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEeccCCC
Q 020085 115 ECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARG 192 (331)
Q Consensus 115 ~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~~~gg 192 (331)
.+.||+|.||+||-|++ +|+.||||++.+..........+.+|+.||+++.||.||.+...|+..+..+.|||.+.|.
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GD 648 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGD 648 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcch
Confidence 56899999999998876 7899999999877666666688999999999999999999999999999999999999874
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC---cEEEeeecceeeecCCCccccCCC
Q 020085 193 SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG---VVKVADFGVARVQAQSGVMTAETG 269 (331)
Q Consensus 193 sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~---~vkl~DFg~a~~~~~~~~~~~~~g 269 (331)
=|.=+|...++.+++..-..++.||+.||.|||-+||+|.||||+|||+.... ++||||||+|+..........-.|
T Consensus 649 MLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVG 728 (888)
T KOG4236|consen 649 MLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVG 728 (888)
T ss_pred HHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhcC
Confidence 45555555678999998899999999999999999999999999999997654 699999999999988887778899
Q ss_pred CcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 020085 270 TYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQA 315 (331)
Q Consensus 270 t~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~ 315 (331)
||.|+|||++..+.|...-|+||.|+++|--++|..||..-.....
T Consensus 729 TPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdInd 774 (888)
T KOG4236|consen 729 TPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIND 774 (888)
T ss_pred CccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhH
Confidence 9999999999999999999999999999999999999987544433
|
|
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=286.04 Aligned_cols=200 Identities=18% Similarity=0.355 Sum_probs=160.7
Q ss_pred ccCcceeeeeeecCceEEEEEEECC---ceEEEEEe---------------cCCCCCHHHHHHHHHHHHHHHhcCCCcce
Q 020085 109 AKQLKIECKVASGSYGDLYKGTYCS---QEVAIKVL---------------KPECVNTEMLKEFSQEVYIMRKIRHKNVV 170 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~~~---~~vavK~~---------------~~~~~~~~~~~~~~~E~~il~~l~h~niv 170 (331)
.++|++.++||+|+||+||++.... ...+.|.+ +...........+.+|+.++++++||||+
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv 226 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL 226 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence 4689999999999999999987532 11222211 11111233456788999999999999999
Q ss_pred eEEeEEECCCCeEEEEeccCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCc
Q 020085 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQK----GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV 246 (331)
Q Consensus 171 ~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~ 246 (331)
++++++...+..|+|+|++.+ +|.+++.... .......+..++.||+.||+|||++||+||||||+|||++.++.
T Consensus 227 ~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~~~~~ 305 (501)
T PHA03210 227 KIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGK 305 (501)
T ss_pred cEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence 999999999999999999865 8888775432 22345677889999999999999999999999999999999999
Q ss_pred EEEeeecceeeecCCCc--cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCC-CCCC
Q 020085 247 VKVADFGVARVQAQSGV--MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGEL-PYAG 309 (331)
Q Consensus 247 vkl~DFg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~-Pf~~ 309 (331)
+||+|||+++....... .....||+.|+|||++.+..++.++|||||||++|||++|.. ||..
T Consensus 306 vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~ 371 (501)
T PHA03210 306 IVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGD 371 (501)
T ss_pred EEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccC
Confidence 99999999986544322 223568999999999999999999999999999999999874 5543
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=265.93 Aligned_cols=208 Identities=32% Similarity=0.510 Sum_probs=179.6
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEE
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~ 186 (331)
..|+..+.||+|+||.||++.. .+..+|+|+++... ...+....+.+|+.++++++|||++++++++..+...++||
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 104 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVM 104 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEE
Confidence 4588899999999999999987 56889999987542 23445567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCcccc
Q 020085 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 266 (331)
Q Consensus 187 E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~~~ 266 (331)
||+.| +|.+.+......+++..+..++.|++.|+.|||++|++||||+|+||+++.++.++|+|||++..... ...
T Consensus 105 e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~---~~~ 180 (317)
T cd06635 105 EYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP---ANS 180 (317)
T ss_pred eCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC---ccc
Confidence 99975 88888876667799999999999999999999999999999999999999999999999999865432 234
Q ss_pred CCCCcccccchhcC---CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 267 ETGTYRWMAPEVIE---HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 267 ~~gt~~y~aPE~~~---~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
..+++.|+|||.+. ...++.++|+||||+++|+|++|+.||...........+..
T Consensus 181 ~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~ 238 (317)
T cd06635 181 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 238 (317)
T ss_pred ccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh
Confidence 56889999999973 45688999999999999999999999988777666655443
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-35 Score=273.37 Aligned_cols=205 Identities=25% Similarity=0.409 Sum_probs=174.2
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEEC----CCCeE
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR----PPNLC 183 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~----~~~~~ 183 (331)
++|++.+.||+|+||.||++.. +++.||+|+++...........+.+|+.++++++||||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 6899999999999999999987 57899999998654344455678889999999999999999988753 34689
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCc
Q 020085 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV 263 (331)
Q Consensus 184 lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~ 263 (331)
+||||+. ++|.+++.. .+.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++.......
T Consensus 85 lv~e~~~-~~l~~~~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 162 (334)
T cd07855 85 VVMDLME-SDLHHIIHS-DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPT 162 (334)
T ss_pred EEEehhh-hhHHHHhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCc
Confidence 9999996 589998865 45689999999999999999999999999999999999999999999999999976543221
Q ss_pred -----cccCCCCcccccchhcCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 020085 264 -----MTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAA 316 (331)
Q Consensus 264 -----~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~ 316 (331)
.....++..|+|||.+.+ ..++.++|+||||+++|||++|+.||.+.+.....
T Consensus 163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~ 221 (334)
T cd07855 163 EHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQL 221 (334)
T ss_pred CCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHH
Confidence 123468889999999865 46889999999999999999999999887665443
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=262.68 Aligned_cols=192 Identities=29% Similarity=0.464 Sum_probs=160.8
Q ss_pred eeeecCceEEEEEEE--CCceEEEEEecCCCCCH-HHHHHHHHHHHHHHh---cCCCcceeEEeEEECCCCeEEEEeccC
Q 020085 117 KVASGSYGDLYKGTY--CSQEVAIKVLKPECVNT-EMLKEFSQEVYIMRK---IRHKNVVQFIGACTRPPNLCIVTEFMA 190 (331)
Q Consensus 117 ~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~-~~~~~~~~E~~il~~---l~h~niv~~~~~~~~~~~~~lV~E~~~ 190 (331)
.||+|+||.||++.. +++.+|+|.++...... .....+.+|..+++. .+|||++.+++.+...+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999987 56899999987543322 222334455544443 479999999999999889999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCccccCCCC
Q 020085 191 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT 270 (331)
Q Consensus 191 ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~~~~~gt 270 (331)
+++|.+++.. .+.+++..+..++.|++.||+|||++|++||||||+||++++++.++|+|||++...... ......|+
T Consensus 81 ~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~-~~~~~~~~ 158 (279)
T cd05633 81 GGDLHYHLSQ-HGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASVGT 158 (279)
T ss_pred CCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceecccc-CccCcCCC
Confidence 9999999865 467999999999999999999999999999999999999999999999999998654332 22345689
Q ss_pred cccccchhcC-CCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 020085 271 YRWMAPEVIE-HKPYDYKADVFSFGIALWELLTGELPYAGL 310 (331)
Q Consensus 271 ~~y~aPE~~~-~~~~~~~~Di~SlG~il~ell~g~~Pf~~~ 310 (331)
..|+|||.+. +..++.++|+||+||++|+|++|..||...
T Consensus 159 ~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~ 199 (279)
T cd05633 159 HGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (279)
T ss_pred cCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCC
Confidence 9999999986 466899999999999999999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-36 Score=243.92 Aligned_cols=215 Identities=24% Similarity=0.422 Sum_probs=191.2
Q ss_pred CcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEec
Q 020085 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF 188 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~ 188 (331)
+|.-.++||+|.||+||+|+. .++.||+|.++.+..++.......+|+-+++.++|.|||++++....+..+.+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 566778999999999999986 568899999998776666677889999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC-ccccC
Q 020085 189 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAE 267 (331)
Q Consensus 189 ~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~-~~~~~ 267 (331)
+.. +|..+....++.++.+.+..++.|+++|+.++|++++.|||+||.|+||+.+|.+|++|||+++...-.- -.+.+
T Consensus 83 cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcysae 161 (292)
T KOG0662|consen 83 CDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAE 161 (292)
T ss_pred hhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeece
Confidence 976 9999998889999999999999999999999999999999999999999999999999999998665443 45677
Q ss_pred CCCcccccchhcCC-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhccccccccc
Q 020085 268 TGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIH 326 (331)
Q Consensus 268 ~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p 326 (331)
..|..|.+|.++-+ +.|+...|+||-||++.|+.. |++.|++..-.+...++.+....|
T Consensus 162 vvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p 222 (292)
T KOG0662|consen 162 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP 222 (292)
T ss_pred eeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCC
Confidence 88999999999865 468999999999999999998 888899998888777776655544
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-35 Score=269.80 Aligned_cols=201 Identities=27% Similarity=0.489 Sum_probs=169.8
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCC-----C
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP-----N 181 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~-----~ 181 (331)
.++|++.+.||+|+||.||+|.+ +++.||+|+++... .......+.+|+.++++++||||+++++++.... .
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 82 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFE-HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND 82 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence 35899999999999999999987 57899999987532 2334567889999999999999999999876543 4
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC
Q 020085 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261 (331)
Q Consensus 182 ~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~ 261 (331)
.++++||+.+ +|.+++. ...+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||+++.....
T Consensus 83 ~~lv~e~~~~-~l~~~~~--~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~ 159 (336)
T cd07849 83 VYIVQELMET-DLYKLIK--TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE 159 (336)
T ss_pred EEEEehhccc-CHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence 7999999975 8888874 356899999999999999999999999999999999999999999999999998765432
Q ss_pred Cc----cccCCCCcccccchhcCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH
Q 020085 262 GV----MTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPL 313 (331)
Q Consensus 262 ~~----~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~ 313 (331)
.. .....+++.|+|||.+.+ ..++.++|+||+|+++|+|++|+.||.+.+..
T Consensus 160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~ 216 (336)
T cd07849 160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYL 216 (336)
T ss_pred ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 21 123467899999998754 56899999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=269.83 Aligned_cols=207 Identities=26% Similarity=0.436 Sum_probs=174.9
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECC------C
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP------P 180 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~------~ 180 (331)
.++|.+.+.||+|+||.||++.. +++.||+|+++....+....+.+.+|+.++++++||||+++++++... .
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 95 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccc
Confidence 36799999999999999999986 578999999986543444456788999999999999999999988543 3
Q ss_pred CeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecC
Q 020085 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (331)
Q Consensus 181 ~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~ 260 (331)
..+++++++ +++|.+++.. ..+++..+..++.|+++||.|||+.|++||||||+||++++++.++|+|||+++....
T Consensus 96 ~~~lv~~~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~ 172 (345)
T cd07877 96 DVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD 172 (345)
T ss_pred cEEEEehhc-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccccc
Confidence 478888887 6799888753 4689999999999999999999999999999999999999999999999999875433
Q ss_pred CCccccCCCCcccccchhcCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccc
Q 020085 261 SGVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 261 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~ 320 (331)
. .....++..|+|||.+.+ ..++.++|+|||||++|+|++|+.||...+.......++
T Consensus 173 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~ 231 (345)
T cd07877 173 E--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 231 (345)
T ss_pred c--ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 2 234567889999999865 568899999999999999999999998877665544433
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=270.98 Aligned_cols=210 Identities=26% Similarity=0.424 Sum_probs=182.5
Q ss_pred CcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCC-----CeE
Q 020085 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP-----NLC 183 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~-----~~~ 183 (331)
+|++.+.||+|++|.||+++. .++.+|+|++..........+.+.+|+.++++++||||+++++++.... ..|
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 488999999999999999997 4689999999865433455678999999999999999999999987765 789
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC-
Q 020085 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG- 262 (331)
Q Consensus 184 lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~- 262 (331)
++|||+++ +|.+++.. ...+++..+..++.|++.||+|||++|++||||||.||+++.++.++|+|||.+.......
T Consensus 81 lv~e~~~~-~l~~~l~~-~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~ 158 (330)
T cd07834 81 IVTELMET-DLHKVIKS-PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED 158 (330)
T ss_pred EEecchhh-hHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence 99999985 89998865 4589999999999999999999999999999999999999999999999999998765543
Q ss_pred ---ccccCCCCcccccchhcCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccc
Q 020085 263 ---VMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK 322 (331)
Q Consensus 263 ---~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~ 322 (331)
......++..|+|||.+.+. .++.++|+||||+++|+|++|++||...+..+....+...
T Consensus 159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 222 (330)
T cd07834 159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEV 222 (330)
T ss_pred ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHh
Confidence 23445678899999999877 8899999999999999999999999988877666555443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-35 Score=267.09 Aligned_cols=207 Identities=24% Similarity=0.407 Sum_probs=177.2
Q ss_pred cceeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEeccCC
Q 020085 112 LKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 191 (331)
Q Consensus 112 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~~~g 191 (331)
+.+.+.+|.|+++.|+++..+++.||+|+++....+....+.+.+|+.++++++||||+++++++......+++|||+++
T Consensus 4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~ 83 (314)
T cd08216 4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAY 83 (314)
T ss_pred hhhhHhhcCCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCC
Confidence 45666777778888888888899999999987655566678899999999999999999999999999999999999999
Q ss_pred CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCc-------
Q 020085 192 GSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV------- 263 (331)
Q Consensus 192 gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~------- 263 (331)
++|.+++... ...+++..+..++.|+++||+|||++||+||||||+||+++.++.++++|||.+........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~ 163 (314)
T cd08216 84 GSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD 163 (314)
T ss_pred CCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccccc
Confidence 9999999764 35688999999999999999999999999999999999999999999999998864432211
Q ss_pred -cccCCCCcccccchhcCC--CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhc
Q 020085 264 -MTAETGTYRWMAPEVIEH--KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVG 318 (331)
Q Consensus 264 -~~~~~gt~~y~aPE~~~~--~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~ 318 (331)
.....++..|+|||++.+ ..++.++|+||||+++|||++|+.||....+......
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~ 221 (314)
T cd08216 164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLE 221 (314)
T ss_pred ccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 123356778999999876 3588999999999999999999999998766655444
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=260.84 Aligned_cols=199 Identities=31% Similarity=0.495 Sum_probs=172.5
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECC--CCeEEE
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--PNLCIV 185 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~--~~~~lV 185 (331)
++|...++||.|++|.||++.. .++.+|+|++.... .......+.+|++++++++||||++++++|... ..+++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP-NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC-chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 3688899999999999999998 56889999997553 234557799999999999999999999988653 368999
Q ss_pred EeccCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC
Q 020085 186 TEFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262 (331)
Q Consensus 186 ~E~~~ggsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~ 262 (331)
|||+++++|.+++.. ....++...+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL 159 (287)
T ss_pred EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence 999999999988753 24568889999999999999999999999999999999999999999999999986543322
Q ss_pred ccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 020085 263 VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL 310 (331)
Q Consensus 263 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~ 310 (331)
.....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...
T Consensus 160 -~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 160 -AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred -cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 22345788999999999999999999999999999999999999865
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=257.87 Aligned_cols=200 Identities=28% Similarity=0.391 Sum_probs=169.4
Q ss_pred eeeeecCceEEEEEEE--CCceEEEEEecCCCCC-HHHHHHHHHHHHHH-HhcCCCcceeEEeEEECCCCeEEEEeccCC
Q 020085 116 CKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIM-RKIRHKNVVQFIGACTRPPNLCIVTEFMAR 191 (331)
Q Consensus 116 ~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~il-~~l~h~niv~~~~~~~~~~~~~lV~E~~~g 191 (331)
+.||+|+||.||+|.. .++.||+|+++..... ......+..|..++ ...+|||++++++++..+...++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5699999999999988 5789999998754321 22233445555544 445899999999999999999999999999
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCccccCCCCc
Q 020085 192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY 271 (331)
Q Consensus 192 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~~~~~gt~ 271 (331)
++|.+++.. .+.+++..+..++.|++.||.|||+.|++||||+|+||++++++.++|+|||+++.... .....+++
T Consensus 82 ~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~ 157 (260)
T cd05611 82 GDCASLIKT-LGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NKKFVGTP 157 (260)
T ss_pred CCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc---cccCCCCc
Confidence 999999965 45789999999999999999999999999999999999999999999999999875433 22345788
Q ss_pred ccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcc
Q 020085 272 RWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGV 319 (331)
Q Consensus 272 ~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~ 319 (331)
.|+|||.+.+..++.++|+||||+++|+|++|..||...++.+....+
T Consensus 158 ~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~ 205 (260)
T cd05611 158 DYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNI 205 (260)
T ss_pred CccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 999999998888999999999999999999999999988877655543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=259.49 Aligned_cols=202 Identities=29% Similarity=0.461 Sum_probs=176.0
Q ss_pred eeecCceEEEEEEEC--CceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEeccCCCCH
Q 020085 118 VASGSYGDLYKGTYC--SQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI 194 (331)
Q Consensus 118 lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~~~ggsL 194 (331)
||+|+||.||++.+. ++.+++|+++.... .....+.+.+|+.++++++||||+++++.+......|+++||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999984 78999999976533 234567799999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC---------ccc
Q 020085 195 YDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG---------VMT 265 (331)
Q Consensus 195 ~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~---------~~~ 265 (331)
.+++... +.+++..+..++.|++.||+|||++|++|+||+|+||++++++.++|+|||++....... ...
T Consensus 81 ~~~l~~~-~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~ 159 (265)
T cd05579 81 ASLLENV-GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDK 159 (265)
T ss_pred HHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccccc
Confidence 9999764 478999999999999999999999999999999999999999999999999987543321 122
Q ss_pred cCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccc
Q 020085 266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 266 ~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~ 320 (331)
...++..|+|||.+....++.++|+||||+++|++++|+.||....+.+....+.
T Consensus 160 ~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~ 214 (265)
T cd05579 160 RIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNIL 214 (265)
T ss_pred CcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh
Confidence 3457889999999988889999999999999999999999999888777665544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-34 Score=268.62 Aligned_cols=209 Identities=28% Similarity=0.467 Sum_probs=177.1
Q ss_pred eeeecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCC-
Q 020085 104 VWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP- 180 (331)
Q Consensus 104 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~- 180 (331)
.|.+ .++|++.+.||+|+||.||++.. .++.||||+++...........+.+|+.++++++||||+++++++....
T Consensus 10 ~~~~-~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07880 10 IWEV-PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLS 88 (343)
T ss_pred hhcc-ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcc
Confidence 4554 45699999999999999999987 5788999998765444445567889999999999999999999987654
Q ss_pred -----CeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecce
Q 020085 181 -----NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA 255 (331)
Q Consensus 181 -----~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a 255 (331)
.+++||||+ +++|.+++.. ..+++..+..++.|+++||+|||+.|++||||||+||+++.++.++|+|||++
T Consensus 89 ~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~ 165 (343)
T cd07880 89 LDRFHDFYLVMPFM-GTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA 165 (343)
T ss_pred ccccceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccc
Confidence 358999998 6799988853 56899999999999999999999999999999999999999999999999999
Q ss_pred eeecCCCccccCCCCcccccchhcCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhc
Q 020085 256 RVQAQSGVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVG 318 (331)
Q Consensus 256 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~ 318 (331)
...... .....+++.|+|||.+.+ ..++.++|+||||+++|++++|+.||...+.......
T Consensus 166 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~ 227 (343)
T cd07880 166 RQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLME 227 (343)
T ss_pred cccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 755432 233467889999999876 4588999999999999999999999998776555444
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=263.68 Aligned_cols=198 Identities=24% Similarity=0.421 Sum_probs=169.9
Q ss_pred CcceeeeeeecCceEEEEEEE-----CCceEEEEEecCCCCC--HHHHHHHHHHHHHHHhc-CCCcceeEEeEEECCCCe
Q 020085 111 QLKIECKVASGSYGDLYKGTY-----CSQEVAIKVLKPECVN--TEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNL 182 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~--~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~ 182 (331)
+|++.+.||+|+||.||++.. +++.||+|+++..... ....+.+.+|+.+++++ +|+||+++++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 478899999999999999886 5788999999754221 22346688899999999 589999999999998899
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC
Q 020085 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262 (331)
Q Consensus 183 ~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~ 262 (331)
++||||+++++|.+++.. ...+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||+++......
T Consensus 81 ~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 159 (290)
T cd05613 81 HLILDYINGGELFTHLSQ-RERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE 159 (290)
T ss_pred EEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceeccccc
Confidence 999999999999999965 4678899999999999999999999999999999999999999999999999987653322
Q ss_pred --ccccCCCCcccccchhcCCC--CCCChhhHHHHHHHHHHHHcCCCCCCC
Q 020085 263 --VMTAETGTYRWMAPEVIEHK--PYDYKADVFSFGIALWELLTGELPYAG 309 (331)
Q Consensus 263 --~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~SlG~il~ell~g~~Pf~~ 309 (331)
......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||..
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~ 210 (290)
T cd05613 160 VERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV 210 (290)
T ss_pred ccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCc
Confidence 12234588999999998653 467899999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-36 Score=260.08 Aligned_cols=202 Identities=27% Similarity=0.428 Sum_probs=173.2
Q ss_pred cCccee-eeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCcceeEEeEEEC----CCC
Q 020085 110 KQLKIE-CKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTR----PPN 181 (331)
Q Consensus 110 ~~~~~~-~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~----~~~ 181 (331)
++|.+. ++||-|-.|.|..+.. +++.+|+|++... ....+|+++--.. .|||||.+++++.+ ...
T Consensus 61 edY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 61 EDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred hhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 456654 5899999999998876 6789999998743 3456777765444 69999999998854 346
Q ss_pred eEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC---CCcEEEeeecceee
Q 020085 182 LCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE---NGVVKVADFGVARV 257 (331)
Q Consensus 182 ~~lV~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~---~~~vkl~DFg~a~~ 257 (331)
+.+|||+|+||.|++.+..+. ..|++.++..|+.||+.|+.|||+.+|.||||||+|+|... |..+||+|||+|+.
T Consensus 134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~ 213 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKE 213 (400)
T ss_pred eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccc
Confidence 889999999999999997753 46999999999999999999999999999999999999974 45799999999998
Q ss_pred ecCCCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhc
Q 020085 258 QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVG 318 (331)
Q Consensus 258 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~ 318 (331)
..........+.||.|.|||++....|+..+|+||+|+++|-|++|.+||-......+..+
T Consensus 214 t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispg 274 (400)
T KOG0604|consen 214 TQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPG 274 (400)
T ss_pred cCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChh
Confidence 8877778888999999999999999999999999999999999999999987654443333
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=267.89 Aligned_cols=205 Identities=25% Similarity=0.445 Sum_probs=171.8
Q ss_pred eeeeec--CceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEeccCC
Q 020085 116 CKVASG--SYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMAR 191 (331)
Q Consensus 116 ~~lg~G--~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~~~g 191 (331)
..||+| +||+||++.+ .++.||+|+++......+..+.+.+|+.+++.++||||++++++|..+...++|+||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 456666 9999999988 689999999987665666678899999999999999999999999999999999999999
Q ss_pred CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCc-------
Q 020085 192 GSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV------- 263 (331)
Q Consensus 192 gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~------- 263 (331)
++|.+++.... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++++||+.+........
T Consensus 84 ~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (328)
T cd08226 84 GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYD 163 (328)
T ss_pred CCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccccccc
Confidence 99999986542 4588999999999999999999999999999999999999999999999986532211110
Q ss_pred -cccCCCCcccccchhcCCC--CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccc
Q 020085 264 -MTAETGTYRWMAPEVIEHK--PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 264 -~~~~~gt~~y~aPE~~~~~--~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~ 320 (331)
.....++..|+|||++.+. .++.++|+|||||++|+|++|+.||......+......
T Consensus 164 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~ 223 (328)
T cd08226 164 FPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKL 223 (328)
T ss_pred ccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHh
Confidence 1112346679999999763 57899999999999999999999999887666554433
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=260.41 Aligned_cols=192 Identities=28% Similarity=0.446 Sum_probs=160.8
Q ss_pred eeeecCceEEEEEEE--CCceEEEEEecCCCCCH-HHHHHHHHHHH---HHHhcCCCcceeEEeEEECCCCeEEEEeccC
Q 020085 117 KVASGSYGDLYKGTY--CSQEVAIKVLKPECVNT-EMLKEFSQEVY---IMRKIRHKNVVQFIGACTRPPNLCIVTEFMA 190 (331)
Q Consensus 117 ~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~-~~~~~~~~E~~---il~~l~h~niv~~~~~~~~~~~~~lV~E~~~ 190 (331)
.||+|+||.||++.. .++.||+|++....... .....+..|.. .++..+||||+++++++...+..++||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999876 57899999987543321 11223444444 3444579999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCccccCCCC
Q 020085 191 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT 270 (331)
Q Consensus 191 ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~~~~~gt 270 (331)
|++|.+++.. .+.+++..+..++.|+++|++|||+.+++||||||+||+++.++.++|+|||++...... ......|+
T Consensus 81 g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~ 158 (278)
T cd05606 81 GGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASVGT 158 (278)
T ss_pred CCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc-CCcCcCCC
Confidence 9999998865 567999999999999999999999999999999999999999999999999998754332 22345789
Q ss_pred cccccchhcCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 020085 271 YRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGL 310 (331)
Q Consensus 271 ~~y~aPE~~~~-~~~~~~~Di~SlG~il~ell~g~~Pf~~~ 310 (331)
..|+|||.+.+ ..++.++|+||+|+++|+|++|+.||...
T Consensus 159 ~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~ 199 (278)
T cd05606 159 HGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (278)
T ss_pred cCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence 99999999874 46899999999999999999999999876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=269.72 Aligned_cols=202 Identities=26% Similarity=0.412 Sum_probs=172.6
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECC-----CCe
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP-----PNL 182 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~-----~~~ 182 (331)
++|++.+.||+|+||+||+++. +++.||||.++...........+.+|+.+++.++||||+++++++... ...
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~ 84 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV 84 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence 4799999999999999999987 578999999876433333456678899999999999999999987644 248
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC-
Q 020085 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS- 261 (331)
Q Consensus 183 ~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~- 261 (331)
|+|+||+. ++|.+++.. .+.+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||+++.....
T Consensus 85 ~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~ 162 (337)
T cd07858 85 YIVYELMD-TDLHQIIRS-SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG 162 (337)
T ss_pred EEEEeCCC-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc
Confidence 99999996 589998865 467999999999999999999999999999999999999999999999999999765443
Q ss_pred CccccCCCCcccccchhcCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH
Q 020085 262 GVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPL 313 (331)
Q Consensus 262 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~ 313 (331)
.......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+.+..
T Consensus 163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 215 (337)
T cd07858 163 DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYV 215 (337)
T ss_pred ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChH
Confidence 22344568899999998864 46899999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=269.98 Aligned_cols=211 Identities=27% Similarity=0.461 Sum_probs=176.7
Q ss_pred CeeeecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCC
Q 020085 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (331)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 180 (331)
..|++. ++|.+.+.||+|+||.||+|.+ +++.||+|+++...........+.+|+.++++++||||+++++++....
T Consensus 9 ~~~~~~-~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~ 87 (342)
T cd07879 9 TVWELP-ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAV 87 (342)
T ss_pred hhhccc-cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccc
Confidence 456664 4799999999999999999986 5789999998765434444566889999999999999999999886543
Q ss_pred ------CeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecc
Q 020085 181 ------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV 254 (331)
Q Consensus 181 ------~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~ 254 (331)
.+++|+||+.. +|.++. ...+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||+
T Consensus 88 ~~~~~~~~~lv~e~~~~-~l~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~ 163 (342)
T cd07879 88 SGDEFQDFYLVMPYMQT-DLQKIM---GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGL 163 (342)
T ss_pred cCCCCceEEEEeccccc-CHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCC
Confidence 46999999975 777765 34689999999999999999999999999999999999999999999999999
Q ss_pred eeeecCCCccccCCCCcccccchhcCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccc
Q 020085 255 ARVQAQSGVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 255 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~ 320 (331)
++.... ......+++.|+|||.+.+ ..++.++|+||||+++|||++|+.||.+.+.......+.
T Consensus 164 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~ 228 (342)
T cd07879 164 ARHADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQIL 228 (342)
T ss_pred CcCCCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 875432 2234467889999999866 468899999999999999999999999887665554433
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=261.44 Aligned_cols=205 Identities=27% Similarity=0.439 Sum_probs=175.9
Q ss_pred cceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCcceeEEeEEECCCCeEEEEec
Q 020085 112 LKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCIVTEF 188 (331)
Q Consensus 112 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~~~~lV~E~ 188 (331)
|.+.+.||+|++|+||+|.. .++.||||.+.......+ .....+|+..+++++ |||++++++++..+...++||||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~ 79 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWE-ECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEY 79 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchh-HHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEec
Confidence 67889999999999999998 468899999875533222 234567899999999 99999999999999999999999
Q ss_pred cCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCccccC
Q 020085 189 MARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE 267 (331)
Q Consensus 189 ~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~~~~ 267 (331)
+ +|+|.+++.... ..+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||.++...........
T Consensus 80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~ 158 (283)
T cd07830 80 M-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDY 158 (283)
T ss_pred C-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCCC
Confidence 9 779999987654 57899999999999999999999999999999999999999999999999999876554444556
Q ss_pred CCCcccccchhcC-CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhc
Q 020085 268 TGTYRWMAPEVIE-HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVG 318 (331)
Q Consensus 268 ~gt~~y~aPE~~~-~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~ 318 (331)
.++..|+|||.+. ...++.++|+||||+++|+|++|++||+..+.......
T Consensus 159 ~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~ 210 (283)
T cd07830 159 VSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYK 210 (283)
T ss_pred CCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHH
Confidence 6889999999874 45678999999999999999999999988776554443
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=265.74 Aligned_cols=200 Identities=27% Similarity=0.458 Sum_probs=168.3
Q ss_pred CcceeeeeeecCceEEEEEEE----CCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECC--CCeE
Q 020085 111 QLKIECKVASGSYGDLYKGTY----CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--PNLC 183 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~----~~~~vavK~~~~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~--~~~~ 183 (331)
.|.+.++||+|+||.||+|.. .++.||+|.++... ........+.+|+.++++++||||+++++++... ..++
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 478899999999999999998 45899999998643 1122345678899999999999999999999887 7899
Q ss_pred EEEeccCCCCHHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC----CCcEEEeeecce
Q 020085 184 IVTEFMARGSIYDFLHKQ----KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE----NGVVKVADFGVA 255 (331)
Q Consensus 184 lV~E~~~ggsL~~~l~~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~----~~~vkl~DFg~a 255 (331)
+||||+++ +|.+.+... ...+++..+..++.|++.||+|||+++++||||||+||+++. ++.+||+|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999976 777776432 136889999999999999999999999999999999999999 899999999998
Q ss_pred eeecCCCc----cccCCCCcccccchhcCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCC
Q 020085 256 RVQAQSGV----MTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLT 311 (331)
Q Consensus 256 ~~~~~~~~----~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~ell~g~~Pf~~~~ 311 (331)
+....... .....+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 220 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE 220 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCc
Confidence 76543222 123356889999998865 468899999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-35 Score=269.92 Aligned_cols=209 Identities=25% Similarity=0.448 Sum_probs=174.8
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCcceeEEeEEECC--CCeE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRP--PNLC 183 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~--~~~~ 183 (331)
.++|.+.+.||+|+||.||+|.+ .++.+|+|.+.....+......+.+|+.+++++ +||||++++++|... ...+
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~ 85 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY 85 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence 45799999999999999999987 568899999865433444456678899999999 999999999988643 3589
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC-
Q 020085 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG- 262 (331)
Q Consensus 184 lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~- 262 (331)
+||||+.+ +|.+++... .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||.++......
T Consensus 86 lv~e~~~~-~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~ 162 (337)
T cd07852 86 LVFEYMET-DLHAVIRAN--ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE 162 (337)
T ss_pred EEeccccc-CHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccc
Confidence 99999975 999988653 77888999999999999999999999999999999999999999999999987554322
Q ss_pred -----ccccCCCCcccccchhcCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccc
Q 020085 263 -----VMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 263 -----~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~ 320 (331)
......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||.+..+.+...++.
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~ 226 (337)
T cd07852 163 NPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKII 226 (337)
T ss_pred cccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 1123457889999998754 567899999999999999999999998877665544433
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=261.30 Aligned_cols=208 Identities=25% Similarity=0.472 Sum_probs=180.0
Q ss_pred cceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEecc
Q 020085 112 LKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFM 189 (331)
Q Consensus 112 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~~ 189 (331)
|++.+.||+|++|.||+|+. +++.+|+|+++.........+.+.+|+.++++++|||++++++++......++|+||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 56778899999999999988 4789999999876434444567889999999999999999999999989999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC-ccccCC
Q 020085 190 ARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAET 268 (331)
Q Consensus 190 ~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~-~~~~~~ 268 (331)
++ +|.+++......+++..+..++.|++.||.|||++|++||||+|+||++++++.++|+|||.++...... ......
T Consensus 81 ~~-~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 159 (282)
T cd07829 81 DM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEV 159 (282)
T ss_pred Cc-CHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCccc
Confidence 85 9999997755679999999999999999999999999999999999999999999999999987654432 233445
Q ss_pred CCcccccchhcCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccc
Q 020085 269 GTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 269 gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~ 320 (331)
++..|+|||.+.+. .++.++|+||||+++||+++|+.||...+.......+.
T Consensus 160 ~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~ 212 (282)
T cd07829 160 VTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIF 212 (282)
T ss_pred cCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH
Confidence 67889999998766 78999999999999999999999999887666555443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=265.00 Aligned_cols=201 Identities=25% Similarity=0.445 Sum_probs=171.4
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEEC-CCCeEEE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR-PPNLCIV 185 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~-~~~~~lV 185 (331)
.++|.+.+.||.|+||.||++.. +++.||+|++..........+.+.+|+.++++++|||++++.+++.. ....+++
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv 88 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFV 88 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEE
Confidence 45699999999999999999986 57889999986544334445678899999999999999999998865 5578999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCccc
Q 020085 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT 265 (331)
Q Consensus 186 ~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~~ 265 (331)
+||+ +++|.+++.. ..++...+..++.|+++||.|||++|++||||+|+||++++++.++|+|||.+...... ..
T Consensus 89 ~e~~-~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~--~~ 163 (328)
T cd07856 89 TELL-GTDLHRLLTS--RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ--MT 163 (328)
T ss_pred eehh-ccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCCC--cC
Confidence 9998 4589988853 46788889999999999999999999999999999999999999999999998754322 23
Q ss_pred cCCCCcccccchhcCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHH
Q 020085 266 AETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQ 314 (331)
Q Consensus 266 ~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~ 314 (331)
...++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||+...+..
T Consensus 164 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~ 213 (328)
T cd07856 164 GYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVN 213 (328)
T ss_pred CCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 3467889999999765 578999999999999999999999998876543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=281.66 Aligned_cols=214 Identities=29% Similarity=0.491 Sum_probs=179.8
Q ss_pred cCcceeeeeeecCceEEEEEEEC--CceEEEEEecC--CCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCC--eE
Q 020085 110 KQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKP--ECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN--LC 183 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~--~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~--~~ 183 (331)
+-.++..+||+|+|-+||+|.+. |-.||=--++. -..+.+..++|..|+.+|+.|+||||++|+.++.+..+ +.
T Consensus 40 Ry~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in 119 (632)
T KOG0584|consen 40 RYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTIN 119 (632)
T ss_pred ceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceee
Confidence 34577889999999999999884 44444222221 11245667899999999999999999999999987665 88
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCCCCEEEcC-CCcEEEeeecceeeecC
Q 020085 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN--NIIHRDLKTANLLMDE-NGVVKVADFGVARVQAQ 260 (331)
Q Consensus 184 lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~--~iiHrDlkp~NiLi~~-~~~vkl~DFg~a~~~~~ 260 (331)
+|+|.+..|+|..|+.+ .+..+...+..|++||++||.|||++ -|||||||.+||+|+. -|.|||+|+|+|.....
T Consensus 120 ~iTEL~TSGtLr~Y~kk-~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~ 198 (632)
T KOG0584|consen 120 FITELFTSGTLREYRKK-HRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK 198 (632)
T ss_pred eeeecccCCcHHHHHHH-hccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence 99999999999999966 56788999999999999999999987 4999999999999975 57999999999987766
Q ss_pred CCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCC-CCCHHHHHhcccccccccc
Q 020085 261 SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYA-GLTPLQAAVGVVQKVSIHS 327 (331)
Q Consensus 261 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~-~~~~~~~~~~~~~~~~~p~ 327 (331)
+... .-.|||.|||||+.. ..|+...||||||+.|.||+|+..||. +.++-|++.+|. .|..|.
T Consensus 199 s~ak-svIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~-SGiKP~ 263 (632)
T KOG0584|consen 199 SHAK-SVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVT-SGIKPA 263 (632)
T ss_pred cccc-eeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHH-cCCCHH
Confidence 5332 268999999999998 779999999999999999999999995 468999999966 466553
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=265.96 Aligned_cols=208 Identities=25% Similarity=0.431 Sum_probs=173.4
Q ss_pred Cc-ceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHH------------HHHHHHHHHHHHHhcCCCcceeEEeE
Q 020085 111 QL-KIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTE------------MLKEFSQEVYIMRKIRHKNVVQFIGA 175 (331)
Q Consensus 111 ~~-~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~------------~~~~~~~E~~il~~l~h~niv~~~~~ 175 (331)
+| .+.+.||+|+||.||++.+ .++.||+|+++....... ....+.+|+.++++++||||++++++
T Consensus 9 ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 88 (335)
T PTZ00024 9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDV 88 (335)
T ss_pred chhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEE
Confidence 44 4567899999999999986 578999999875432210 01247789999999999999999999
Q ss_pred EECCCCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecce
Q 020085 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA 255 (331)
Q Consensus 176 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a 255 (331)
+...+..++||||+.+ +|.+++.. ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+
T Consensus 89 ~~~~~~~~lv~e~~~~-~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~dfg~~ 166 (335)
T PTZ00024 89 YVEGDFINLVMDIMAS-DLKKVVDR-KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLA 166 (335)
T ss_pred EecCCcEEEEEecccc-CHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCccce
Confidence 9999999999999975 99999854 567899999999999999999999999999999999999999999999999999
Q ss_pred eeecCC---------------CccccCCCCcccccchhcCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcc
Q 020085 256 RVQAQS---------------GVMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGV 319 (331)
Q Consensus 256 ~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~ 319 (331)
+..... .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||.+.++.+....+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i 246 (335)
T PTZ00024 167 RRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRI 246 (335)
T ss_pred eecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 755411 112233467889999998664 4689999999999999999999999988876655544
Q ss_pred c
Q 020085 320 V 320 (331)
Q Consensus 320 ~ 320 (331)
.
T Consensus 247 ~ 247 (335)
T PTZ00024 247 F 247 (335)
T ss_pred H
Confidence 3
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-34 Score=257.19 Aligned_cols=191 Identities=24% Similarity=0.457 Sum_probs=162.1
Q ss_pred cCcceeeee--eecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCcceeEEeEEECCCCeEE
Q 020085 110 KQLKIECKV--ASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCI 184 (331)
Q Consensus 110 ~~~~~~~~l--g~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~l 184 (331)
++|.+.+.+ |+|+||.||++.. +++.+|+|+++....... |+...+.+ +|||++++++.+...+..++
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-------e~~~~~~~~~h~~iv~~~~~~~~~~~~~i 86 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-------EPMVHQLMKDNPNFIKLYYSVTTLKGHVL 86 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-------hHHHHHHhhcCCCEEEEEEEEecCCeeEE
Confidence 355666655 9999999999986 568899999875432221 22222222 69999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC-cEEEeeecceeeecCCCc
Q 020085 185 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG-VVKVADFGVARVQAQSGV 263 (331)
Q Consensus 185 V~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~-~vkl~DFg~a~~~~~~~~ 263 (331)
||||+++++|.+++... ..+++..+..++.|+++|+.|||+.|++||||+|+||+++.++ .++|+|||.++.....
T Consensus 87 v~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~-- 163 (267)
T PHA03390 87 IMDYIKDGDLFDLLKKE-GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP-- 163 (267)
T ss_pred EEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC--
Confidence 99999999999999664 4889999999999999999999999999999999999999998 9999999998765433
Q ss_pred cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC
Q 020085 264 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLT 311 (331)
Q Consensus 264 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~ 311 (331)
....++..|+|||.+.+..++.++|+||+|+++|+|++|+.||....
T Consensus 164 -~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~ 210 (267)
T PHA03390 164 -SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDE 210 (267)
T ss_pred -ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 23468899999999999999999999999999999999999998654
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=260.11 Aligned_cols=205 Identities=31% Similarity=0.499 Sum_probs=176.7
Q ss_pred cceeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEec
Q 020085 112 LKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF 188 (331)
Q Consensus 112 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~ 188 (331)
|...++||+|+||.||+|+. .++.|++|++..... .......+.+|+.+++.++|||++++++++......++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 66678899999999999987 678999999875432 334456788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCccccCC
Q 020085 189 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET 268 (331)
Q Consensus 189 ~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~~~~~ 268 (331)
+.+ ++.+++......+++..+..++.|++.++.|||++|++|+||+|+||+++.++.++|+|||++..... .....
T Consensus 103 ~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~---~~~~~ 178 (313)
T cd06633 103 CLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP---ANSFV 178 (313)
T ss_pred CCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC---CCCcc
Confidence 965 88888876667889999999999999999999999999999999999999999999999999864322 23456
Q ss_pred CCcccccchhcC---CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccc
Q 020085 269 GTYRWMAPEVIE---HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 269 gt~~y~aPE~~~---~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~ 320 (331)
++..|+|||.+. ...++.++|+||||+++|+|++|..||...++......+.
T Consensus 179 ~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~ 233 (313)
T cd06633 179 GTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA 233 (313)
T ss_pred ccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 889999999984 4568899999999999999999999998887766655543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-34 Score=260.57 Aligned_cols=203 Identities=31% Similarity=0.498 Sum_probs=174.8
Q ss_pred cceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEecc
Q 020085 112 LKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFM 189 (331)
Q Consensus 112 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~~ 189 (331)
|....+||+|+||.||++.. +++.||+|.+... .......+.+|+.+++.++|+|++++++.+...+..++||||+
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 99 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR--KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 99 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc--chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecC
Confidence 34456899999999999987 5789999998643 2334567899999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC-ccccCC
Q 020085 190 ARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAET 268 (331)
Q Consensus 190 ~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~-~~~~~~ 268 (331)
++++|.+++.. ..+++..+..++.|++.+++|||+.|++|+||+|+||++++++.++|+|||++....... ......
T Consensus 100 ~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 177 (292)
T cd06657 100 EGGALTDIVTH--TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLV 177 (292)
T ss_pred CCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccccccccc
Confidence 99999998743 468899999999999999999999999999999999999999999999999987554322 223356
Q ss_pred CCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhc
Q 020085 269 GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVG 318 (331)
Q Consensus 269 gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~ 318 (331)
+++.|+|||.+.+..++.++|+||+|+++|+|++|+.||......+....
T Consensus 178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~ 227 (292)
T cd06657 178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKM 227 (292)
T ss_pred cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 88999999999888899999999999999999999999988766654433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=263.59 Aligned_cols=206 Identities=24% Similarity=0.372 Sum_probs=170.7
Q ss_pred CcceeeeeeecCceEEEEEEEC----CceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCcceeEEeEEECC----CC
Q 020085 111 QLKIECKVASGSYGDLYKGTYC----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRP----PN 181 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~----~~ 181 (331)
+|++.+.||+|+||.||++.+. ++.||+|+++.........+.+.+|+.+++++ +||||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4788999999999999999985 56899999875443344456788999999999 599999999875432 35
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC
Q 020085 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261 (331)
Q Consensus 182 ~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~ 261 (331)
.++++|++. ++|.+++.. ...+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||.++.....
T Consensus 81 ~~~~~e~~~-~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~ 158 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS-GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158 (332)
T ss_pred EEEEEeccc-CCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccc
Confidence 788999986 599998854 567899999999999999999999999999999999999999999999999999754432
Q ss_pred Cc-----cccCCCCcccccchhcCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhc
Q 020085 262 GV-----MTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVG 318 (331)
Q Consensus 262 ~~-----~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~ 318 (331)
.. .....|++.|+|||.+.+ ..++.++|+||+|+++|+|++|++||...........
T Consensus 159 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~ 221 (332)
T cd07857 159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQ 221 (332)
T ss_pred cccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHH
Confidence 11 223468899999998765 5789999999999999999999999988765544443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-34 Score=257.83 Aligned_cols=210 Identities=24% Similarity=0.476 Sum_probs=181.4
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcC-CCcceeEEeEEECCCCeEEE
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCIV 185 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~~~~lV 185 (331)
++|.+.+.||+|+||.||++.. +++.||+|++..... .....+.+.+|..++++++ ||||+++++.+..+...++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 4789999999999999999988 678999999975432 3344567889999999998 99999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCc--
Q 020085 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV-- 263 (331)
Q Consensus 186 ~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~-- 263 (331)
||++++++|.+++.+ .+.+++..+..++.|++.||.+||++|++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~e~~~~~~L~~~l~~-~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~ 159 (280)
T cd05581 81 LEYAPNGELLQYIRK-YGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE 159 (280)
T ss_pred EcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccc
Confidence 999999999999966 45799999999999999999999999999999999999999999999999999875433221
Q ss_pred -------------------cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccc
Q 020085 264 -------------------MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 264 -------------------~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~ 320 (331)
.....++..|+|||.+....++.++|+||||++++++++|+.||...+..+....+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 235 (280)
T cd05581 160 SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL 235 (280)
T ss_pred cCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH
Confidence 112346789999999988889999999999999999999999999887655544433
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=303.45 Aligned_cols=217 Identities=27% Similarity=0.417 Sum_probs=185.7
Q ss_pred cceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEecc
Q 020085 112 LKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFM 189 (331)
Q Consensus 112 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~~ 189 (331)
+.-...||.|.||.||-|.. +|...|+|-++.............+|..++..++|||+|+++|+-...+..+|.||||
T Consensus 1237 Wqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC 1316 (1509)
T KOG4645|consen 1237 WQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYC 1316 (1509)
T ss_pred eccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHh
Confidence 44566899999999999976 6788999998876555556677889999999999999999999999999999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC-----cc
Q 020085 190 ARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-----VM 264 (331)
Q Consensus 190 ~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~-----~~ 264 (331)
+||+|.+.+.. .+..++-....+..|++.|+.|||+.|||||||||+||+++.+|.+|++|||.|....... ..
T Consensus 1317 ~~GsLa~ll~~-gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el 1395 (1509)
T KOG4645|consen 1317 EGGSLASLLEH-GRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGEL 1395 (1509)
T ss_pred ccCcHHHHHHh-cchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHH
Confidence 99999999854 4455666777889999999999999999999999999999999999999999998765543 12
Q ss_pred ccCCCCcccccchhcCCC---CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccccccccccc
Q 020085 265 TAETGTYRWMAPEVIEHK---PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIHSII 329 (331)
Q Consensus 265 ~~~~gt~~y~aPE~~~~~---~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~p~~~ 329 (331)
....||+-|||||++.+. .-..++||||+||++.||.||+.||..+...=++.=-|.-|..|++|
T Consensus 1396 ~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P 1463 (1509)
T KOG4645|consen 1396 QSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIP 1463 (1509)
T ss_pred HhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCc
Confidence 234699999999999654 45678999999999999999999999986655555557789999987
|
|
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-33 Score=259.64 Aligned_cols=206 Identities=34% Similarity=0.526 Sum_probs=177.0
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV 185 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV 185 (331)
...|...+.||+|+||.||+|+. .++.+|+|.+.... ........+.+|+.+++.++|+|++++++++......++|
T Consensus 14 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEE
Confidence 34588889999999999999987 56889999987532 2344456788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCccc
Q 020085 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT 265 (331)
Q Consensus 186 ~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~~ 265 (331)
+||+. |++.+.+......+++..+..++.|++.|+.|||+++++||||+|+||+++.++.++|+|||++...... .
T Consensus 94 ~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~---~ 169 (308)
T cd06634 94 MEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---N 169 (308)
T ss_pred EEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc---c
Confidence 99997 5888888666677899999999999999999999999999999999999999999999999998765432 3
Q ss_pred cCCCCcccccchhcC---CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhc
Q 020085 266 AETGTYRWMAPEVIE---HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVG 318 (331)
Q Consensus 266 ~~~gt~~y~aPE~~~---~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~ 318 (331)
...+++.|+|||.+. ...++.++||||||+++|+|++|+.||...+..+....
T Consensus 170 ~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~ 225 (308)
T cd06634 170 XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH 225 (308)
T ss_pred cccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHH
Confidence 456889999999974 45678899999999999999999999988776655544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-34 Score=266.49 Aligned_cols=210 Identities=27% Similarity=0.475 Sum_probs=178.0
Q ss_pred eeeecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCC
Q 020085 104 VWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN 181 (331)
Q Consensus 104 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 181 (331)
.|++ .++|.+.+.||+|++|.||+|.. .++.||+|+++....+......+.+|+.++++++|||++++.+++.....
T Consensus 10 ~~~~-~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 88 (343)
T cd07851 10 VWEV-PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASS 88 (343)
T ss_pred eecc-cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccc
Confidence 3444 44799999999999999999988 46889999987654444455678889999999999999999987765544
Q ss_pred ------eEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecce
Q 020085 182 ------LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA 255 (331)
Q Consensus 182 ------~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a 255 (331)
.++|+||+ +++|.+++.. ..+++..+..++.|+++|+.|||+.|++||||+|+||++++++.++|+|||.+
T Consensus 89 ~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~ 165 (343)
T cd07851 89 LEDFQDVYLVTHLM-GADLNNIVKC--QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA 165 (343)
T ss_pred ccccccEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccc
Confidence 89999998 5699999854 56899999999999999999999999999999999999999999999999999
Q ss_pred eeecCCCccccCCCCcccccchhcCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcc
Q 020085 256 RVQAQSGVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGV 319 (331)
Q Consensus 256 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~ 319 (331)
...... .....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||++.++.+....+
T Consensus 166 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i 228 (343)
T cd07851 166 RHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRI 228 (343)
T ss_pred cccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 755432 334467889999999855 46789999999999999999999999988776655443
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=273.44 Aligned_cols=213 Identities=24% Similarity=0.415 Sum_probs=184.3
Q ss_pred eecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCC-CCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCe
Q 020085 106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPE-CVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL 182 (331)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~-~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 182 (331)
.++.+.|..++.||-|+||+|.+++. +...||+|.++.. ....+.+.....|-.||..-+.+-||+++..|.+.+++
T Consensus 625 KMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnL 704 (1034)
T KOG0608|consen 625 KMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNL 704 (1034)
T ss_pred hccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCce
Confidence 35677888999999999999999876 4467999998653 34556677788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceee---ec
Q 020085 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV---QA 259 (331)
Q Consensus 183 ~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~---~~ 259 (331)
|+||+|++||++-.+|.+ -+.|++..++.++.++..|+++.|+.|+|||||||+|||||.+|+|||.|||++.- ..
T Consensus 705 YFVMdYIPGGDmMSLLIr-mgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTH 783 (1034)
T KOG0608|consen 705 YFVMDYIPGGDMMSLLIR-MGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 783 (1034)
T ss_pred EEEEeccCCccHHHHHHH-hccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecc
Confidence 999999999999999865 68899999999999999999999999999999999999999999999999999841 00
Q ss_pred -----CCCc-----------------------------------cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHH
Q 020085 260 -----QSGV-----------------------------------MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWE 299 (331)
Q Consensus 260 -----~~~~-----------------------------------~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~e 299 (331)
+.+. .....||+.|+|||++....|+..+|.||.|+||||
T Consensus 784 dskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~e 863 (1034)
T KOG0608|consen 784 DSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYE 863 (1034)
T ss_pred ccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHH
Confidence 0000 011248999999999999999999999999999999
Q ss_pred HHcCCCCCCCCCHHHHHhcc
Q 020085 300 LLTGELPYAGLTPLQAAVGV 319 (331)
Q Consensus 300 ll~g~~Pf~~~~~~~~~~~~ 319 (331)
|+.|++||-..+|.+...++
T Consensus 864 m~~g~~pf~~~tp~~tq~kv 883 (1034)
T KOG0608|consen 864 MLVGQPPFLADTPGETQYKV 883 (1034)
T ss_pred HhhCCCCccCCCCCcceeee
Confidence 99999999998887765554
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=282.14 Aligned_cols=216 Identities=32% Similarity=0.597 Sum_probs=187.8
Q ss_pred cccCcceeeeeeecCceEEEEEEE--CC----ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCC
Q 020085 108 DAKQLKIECKVASGSYGDLYKGTY--CS----QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN 181 (331)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~----~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 181 (331)
...+++..++||+|+||+||+|.| .+ -+||||++.... ....-.++..|+.+|.+++|||+++++++|..+.
T Consensus 694 kEtelkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t-~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~- 771 (1177)
T KOG1025|consen 694 KETELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFT-SPKASIELLDEALRMASLDHPNLLRLLGVCMLST- 771 (1177)
T ss_pred hhhhhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccC-CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-
Confidence 344677788999999999999988 33 469999987543 4445578999999999999999999999998765
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC
Q 020085 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261 (331)
Q Consensus 182 ~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~ 261 (331)
+.||++||++|+|.|+++..++.+.....+.|..||++||.|||.++++||||.++|+|+.+-..+|+.|||+++.....
T Consensus 772 ~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d 851 (1177)
T KOG1025|consen 772 LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPD 851 (1177)
T ss_pred HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcc
Confidence 88999999999999999999999999999999999999999999999999999999999999999999999999876654
Q ss_pred Ccc-ccCCC--CcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhccccccccc
Q 020085 262 GVM-TAETG--TYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIH 326 (331)
Q Consensus 262 ~~~-~~~~g--t~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p 326 (331)
... ....| .+.|||-|.+....|++++||||||+++||++| |..||.++...+ +....++|.|-
T Consensus 852 ~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~e-I~dlle~geRL 919 (1177)
T KOG1025|consen 852 EKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEE-IPDLLEKGERL 919 (1177)
T ss_pred cccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHH-hhHHHhccccC
Confidence 432 22333 479999999999999999999999999999999 999999986665 45557788773
|
|
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=249.68 Aligned_cols=203 Identities=29% Similarity=0.453 Sum_probs=176.9
Q ss_pred eeecCceEEEEEEEC--CceEEEEEecCCCCC-HHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEeccCCCCH
Q 020085 118 VASGSYGDLYKGTYC--SQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSI 194 (331)
Q Consensus 118 lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~~~ggsL 194 (331)
||+|+||.||++... ++.+|+|+++..... ......+..|+.++++++|||++++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999884 789999998765332 23566889999999999999999999999999999999999999999
Q ss_pred HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC-CccccCCCCccc
Q 020085 195 YDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTAETGTYRW 273 (331)
Q Consensus 195 ~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~-~~~~~~~gt~~y 273 (331)
.+++... ..+++..+..++.|++.|+.|||+.+++|+||+|+||+++.++.++|+|||.+...... .......++..|
T Consensus 81 ~~~l~~~-~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ 159 (250)
T cd05123 81 FSHLSKE-GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEY 159 (250)
T ss_pred HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCccc
Confidence 9999653 46899999999999999999999999999999999999999999999999999765443 223345678899
Q ss_pred ccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 274 MAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 274 ~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
+|||.+.+...+.++|+||||+++|++++|+.||......+....+.+
T Consensus 160 ~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~ 207 (250)
T cd05123 160 LAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK 207 (250)
T ss_pred cChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc
Confidence 999999888889999999999999999999999988876555555443
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=251.85 Aligned_cols=216 Identities=28% Similarity=0.469 Sum_probs=178.3
Q ss_pred CcceeeeeeecCceEEEEEEEC--CceEEEEEecCCC---CCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEE
Q 020085 111 QLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPEC---VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV 185 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~---~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV 185 (331)
+|.+.++||+|+||.||++.+. +..+++|+++... ........+..|+.++++++|||++++++++......++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 4888999999999999999874 3557777766422 1222345677899999999999999999999988899999
Q ss_pred EeccCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC
Q 020085 186 TEFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262 (331)
Q Consensus 186 ~E~~~ggsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~ 262 (331)
+||+++++|.+++.. ....+++..+..++.|+++|+.|||++|++|+||+|+||+++. +.++|+|||.++......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~ 159 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC 159 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence 999999999998864 2457899999999999999999999999999999999999975 679999999987654332
Q ss_pred -ccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccccccccc
Q 020085 263 -VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIHSI 328 (331)
Q Consensus 263 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~p~~ 328 (331)
......+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+...... .+..|.+
T Consensus 160 ~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~-~~~~~~~ 225 (260)
T cd08222 160 DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIV-EGPTPSL 225 (260)
T ss_pred ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH-cCCCCCC
Confidence 2234567899999999988889999999999999999999999998877766655533 3444443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=281.02 Aligned_cols=147 Identities=28% Similarity=0.506 Sum_probs=133.7
Q ss_pred ccCcceeeeeeecCceEEEEEEEC--CceEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV 185 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV 185 (331)
.++|.+.++||+|+||.||+|.+. ++.||||+++... .+......+.+|+.+++.++||||+++++.+......|+|
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lV 82 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLV 82 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEE
Confidence 457999999999999999999985 7899999997543 3445567899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeeccee
Q 020085 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR 256 (331)
Q Consensus 186 ~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~ 256 (331)
|||+.|++|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.++.++|+|||+++
T Consensus 83 mEy~~g~~L~~li~~-~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 83 MEYLIGGDVKSLLHI-YGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 999999999999965 4578899999999999999999999999999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=255.40 Aligned_cols=198 Identities=25% Similarity=0.416 Sum_probs=169.4
Q ss_pred CcceeeeeeecCceEEEEEEE-----CCceEEEEEecCCCCC--HHHHHHHHHHHHHHHhc-CCCcceeEEeEEECCCCe
Q 020085 111 QLKIECKVASGSYGDLYKGTY-----CSQEVAIKVLKPECVN--TEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNL 182 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~--~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~ 182 (331)
+|++.+.||+|++|.||+++. .++.||||+++..... ......+.+|+.+++++ +||||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 478899999999999999875 3578999998743221 22345688999999999 599999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC
Q 020085 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262 (331)
Q Consensus 183 ~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~ 262 (331)
++||||+.+++|.+++.. ...+++..+..++.|++++|.|||+.|++||||+|+||+++.++.++|+|||+++......
T Consensus 81 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 159 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ-REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE 159 (288)
T ss_pred EEEEecCCCCcHHHHHhh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccccc
Confidence 999999999999999865 4578899999999999999999999999999999999999999999999999987544332
Q ss_pred c--cccCCCCcccccchhcCCCC--CCChhhHHHHHHHHHHHHcCCCCCCC
Q 020085 263 V--MTAETGTYRWMAPEVIEHKP--YDYKADVFSFGIALWELLTGELPYAG 309 (331)
Q Consensus 263 ~--~~~~~gt~~y~aPE~~~~~~--~~~~~Di~SlG~il~ell~g~~Pf~~ 309 (331)
. .....++..|+|||.+.+.. .+.++|+||||+++|+|++|..||..
T Consensus 160 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 210 (288)
T cd05583 160 EERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTV 210 (288)
T ss_pred ccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCccc
Confidence 1 12235789999999987654 78899999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=262.18 Aligned_cols=206 Identities=24% Similarity=0.420 Sum_probs=171.1
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECC-------
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP------- 179 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~------- 179 (331)
..+|.+.+.||.|+||.||+|.. +++.||+|.+..... ...+.+.+|+.++++++||||+++++.+...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~--~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP--QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC--chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 36899999999999999999987 578999999875532 3346788999999999999999999766543
Q ss_pred -------CCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC-CCcEEEee
Q 020085 180 -------PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE-NGVVKVAD 251 (331)
Q Consensus 180 -------~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~-~~~vkl~D 251 (331)
...|+||||+.+ +|.+++.. +.+++..+..++.||++||+|||+.|++||||||+||+++. ++.++++|
T Consensus 82 ~~~~~~~~~~~lv~e~~~~-~L~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~d 158 (342)
T cd07854 82 VGSLTELNSVYIVQEYMET-DLANVLEQ--GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGD 158 (342)
T ss_pred cccccccceEEEEeecccc-cHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECC
Confidence 357899999975 99988853 46899999999999999999999999999999999999974 56789999
Q ss_pred ecceeeecCCC----ccccCCCCcccccchhcCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcc
Q 020085 252 FGVARVQAQSG----VMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGV 319 (331)
Q Consensus 252 Fg~a~~~~~~~----~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~ 319 (331)
||.++...... ......++..|+|||.+.. ..++.++|+|||||++|+|++|+.||.+.++.+.....
T Consensus 159 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~ 231 (342)
T cd07854 159 FGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLI 231 (342)
T ss_pred cccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 99997543221 1123457889999998754 56889999999999999999999999988776655543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=239.31 Aligned_cols=217 Identities=31% Similarity=0.515 Sum_probs=187.6
Q ss_pred cceeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEecc
Q 020085 112 LKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFM 189 (331)
Q Consensus 112 ~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~~ 189 (331)
|.+.+.||+|++|.||++... ++.+|+|.+...... ...+.+.+|+..+++++|+|++++++.+......++++|++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 79 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE-KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYC 79 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch-HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEecc
Confidence 567889999999999999984 589999999865433 24678999999999999999999999999989999999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC--ccccC
Q 020085 190 ARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG--VMTAE 267 (331)
Q Consensus 190 ~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~--~~~~~ 267 (331)
++++|.+++......+++..+..++.+++.++.+||+.+++|+|++|.||+++.++.++|+|||.+....... .....
T Consensus 80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 159 (225)
T smart00221 80 EGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTV 159 (225)
T ss_pred CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccce
Confidence 9999999997654338899999999999999999999999999999999999999999999999998765543 33345
Q ss_pred CCCcccccchhc-CCCCCCChhhHHHHHHHHHHHHcCCCCCCC-CCHHHHHhcccccccccccc
Q 020085 268 TGTYRWMAPEVI-EHKPYDYKADVFSFGIALWELLTGELPYAG-LTPLQAAVGVVQKVSIHSII 329 (331)
Q Consensus 268 ~gt~~y~aPE~~-~~~~~~~~~Di~SlG~il~ell~g~~Pf~~-~~~~~~~~~~~~~~~~p~~~ 329 (331)
.++..|++||.+ ....++.++|+||||+++++|++|+.||+. .++...+.+...+|..+.++
T Consensus 160 ~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 223 (225)
T smart00221 160 KGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVPLLWE 223 (225)
T ss_pred eccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCccccc
Confidence 678899999998 777888899999999999999999999988 67776666667677655543
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=254.94 Aligned_cols=201 Identities=26% Similarity=0.422 Sum_probs=170.5
Q ss_pred ccCcceeeeeeecCceEEEEEEEC------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEEC-CCC
Q 020085 109 AKQLKIECKVASGSYGDLYKGTYC------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR-PPN 181 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~-~~~ 181 (331)
...|+....||+|.||.||++... .+.+|||.++.+......-....+|+.++|.++|||++.+..++-. +..
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 457999999999999999999442 2479999998764333334567889999999999999999998866 778
Q ss_pred eEEEEeccCCCCHHHHHHhcC----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC----CcEEEeeec
Q 020085 182 LCIVTEFMARGSIYDFLHKQK----GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN----GVVKVADFG 253 (331)
Q Consensus 182 ~~lV~E~~~ggsL~~~l~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~----~~vkl~DFg 253 (331)
.++++||.+. +|..+++..+ ..++...+..++.||+.|+.|||++.|+||||||+|||+..+ |.|||+|||
T Consensus 103 v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlG 181 (438)
T KOG0666|consen 103 VWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLG 181 (438)
T ss_pred EEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeeccc
Confidence 9999999988 9999886542 468889999999999999999999999999999999999887 899999999
Q ss_pred ceeeecCCCcc----ccCCCCcccccchhcCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 020085 254 VARVQAQSGVM----TAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGL 310 (331)
Q Consensus 254 ~a~~~~~~~~~----~~~~gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~ell~g~~Pf~~~ 310 (331)
+++.....-.. ..-..|..|.|||.+.+. .|+.+.|+||.|||+.||++.++.|.+.
T Consensus 182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred HHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 99876553221 223468899999998765 6999999999999999999999998764
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-34 Score=286.46 Aligned_cols=215 Identities=27% Similarity=0.458 Sum_probs=173.9
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECC--------
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP-------- 179 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~-------- 179 (331)
.+|+..+.||+||||.||+++. +|+.||||++.... +........+|+..|++++|||||+++.++.+.
T Consensus 479 ~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~-s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e 557 (1351)
T KOG1035|consen 479 NDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA-SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE 557 (1351)
T ss_pred hhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch-HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence 4677888999999999999987 79999999998765 566778899999999999999999987654211
Q ss_pred --------------------------------------------------------------------------------
Q 020085 180 -------------------------------------------------------------------------------- 179 (331)
Q Consensus 180 -------------------------------------------------------------------------------- 179 (331)
T Consensus 558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e 637 (1351)
T KOG1035|consen 558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE 637 (1351)
T ss_pred ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence
Q ss_pred -------------------------------CCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 020085 180 -------------------------------PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNN 228 (331)
Q Consensus 180 -------------------------------~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ 228 (331)
..+||-||||+.-.+.+++..+...-....+++++++|+.||.|+|+.|
T Consensus 638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g 717 (1351)
T KOG1035|consen 638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG 717 (1351)
T ss_pred CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc
Confidence 0268999999997777777553322257889999999999999999999
Q ss_pred cccCCCCCCCEEEcCCCcEEEeeecceeeec-------------------CCCccccCCCCcccccchhcCCC---CCCC
Q 020085 229 IIHRDLKTANLLMDENGVVKVADFGVARVQA-------------------QSGVMTAETGTYRWMAPEVIEHK---PYDY 286 (331)
Q Consensus 229 iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~~---~~~~ 286 (331)
+|||||||.||++++++.|||+|||+|+... ..+..+...||.-|+|||++.+. .|+.
T Consensus 718 iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~ 797 (1351)
T KOG1035|consen 718 IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNS 797 (1351)
T ss_pred eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccc
Confidence 9999999999999999999999999997411 11244666899999999999655 4999
Q ss_pred hhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccccccccc
Q 020085 287 KADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIHSI 328 (331)
Q Consensus 287 ~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~p~~ 328 (331)
|+|+|||||+|+||+. ||........+....++|..|.-
T Consensus 798 KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~ 836 (1351)
T KOG1035|consen 798 KIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEP 836 (1351)
T ss_pred hhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCC
Confidence 9999999999999986 57654433334444666666643
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-34 Score=249.83 Aligned_cols=206 Identities=22% Similarity=0.405 Sum_probs=183.0
Q ss_pred CeeeecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHH-HHHHHHHHHHHHHhc-CCCcceeEEeEEEC
Q 020085 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTE-MLKEFSQEVYIMRKI-RHKNVVQFIGACTR 178 (331)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~-~~~~~~~E~~il~~l-~h~niv~~~~~~~~ 178 (331)
..|.+..++|.+.++||+|+|++|.+++. +.+.+|+|+++.+..+++ .+.=.+.|..+..+. +||.+|.+..+|+.
T Consensus 243 ~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt 322 (593)
T KOG0695|consen 243 ISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT 322 (593)
T ss_pred cccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc
Confidence 45778889999999999999999999887 557899999998765543 344466677777655 79999999999999
Q ss_pred CCCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeee
Q 020085 179 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (331)
Q Consensus 179 ~~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~ 258 (331)
+..+++|.||++||+|--.+++ ..+++++.+..+..+|+.||.|||++|||+||||.+|+|++.+|++||.|+|+++..
T Consensus 323 esrlffvieyv~ggdlmfhmqr-qrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~ 401 (593)
T KOG0695|consen 323 ESRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEG 401 (593)
T ss_pred cceEEEEEEEecCcceeeehhh-hhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcC
Confidence 9999999999999999888865 467999999999999999999999999999999999999999999999999999876
Q ss_pred cCCCc-cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCC
Q 020085 259 AQSGV-MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAG 309 (331)
Q Consensus 259 ~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~ 309 (331)
...+. .++.+|||.|.|||++.+..|....|.|+||++++||+.|+.||+-
T Consensus 402 l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdi 453 (593)
T KOG0695|consen 402 LGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDI 453 (593)
T ss_pred CCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcce
Confidence 65554 4567999999999999999999999999999999999999999963
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=267.44 Aligned_cols=210 Identities=33% Similarity=0.572 Sum_probs=182.6
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCcceeEEeEEEC-----CC
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTR-----PP 180 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~-----~~ 180 (331)
.+-+++.+.||.|.+|.||+++. .++.+|+|++.+....+ ++...|.++|+.. .|||++.++|++.. ++
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~d---eEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D 94 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEE---EEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD 94 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcccc---HHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence 45677899999999999998865 78999999998765333 5666788999887 58999999998853 45
Q ss_pred CeEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeec
Q 020085 181 NLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA 259 (331)
Q Consensus 181 ~~~lV~E~~~ggsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~ 259 (331)
.+|+|||||.|||.-|++.+- ...+.+..+..|++.++.|+.+||++.++|||+|-.|||++.++.|||+|||++....
T Consensus 95 qLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQld 174 (953)
T KOG0587|consen 95 QLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD 174 (953)
T ss_pred eEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeee
Confidence 799999999999999998664 4578899999999999999999999999999999999999999999999999986544
Q ss_pred C-CCccccCCCCcccccchhcCC-----CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 260 Q-SGVMTAETGTYRWMAPEVIEH-----KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 260 ~-~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
. .+...+.+|||.|||||++.. ..|+.++|+||||++-.||-.|.+|+-++.|..+...+-+
T Consensus 175 sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpR 242 (953)
T KOG0587|consen 175 STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR 242 (953)
T ss_pred cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCC
Confidence 3 344566789999999999853 3578899999999999999999999999999999988764
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=241.36 Aligned_cols=179 Identities=22% Similarity=0.266 Sum_probs=154.6
Q ss_pred cCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEeccCCCCHHHHH
Q 020085 121 GSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL 198 (331)
Q Consensus 121 G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~~~ggsL~~~l 198 (331)
|.+|.||++.+ +++.+|+|.++... .+.+|...+....||||+++++.+......++||||++||+|.+++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 76 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHI 76 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHH
Confidence 88999999988 67889999997542 2334555555667999999999999999999999999999999998
Q ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCccccCCCCcccccchh
Q 020085 199 HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278 (331)
Q Consensus 199 ~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~ 278 (331)
.+ ...+++..+..++.|+++||+|||++|++||||||+||+++.++.++++|||.+...... .....++..|+|||.
T Consensus 77 ~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~ 153 (237)
T cd05576 77 SK-FLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--CDGEAVENMYCAPEV 153 (237)
T ss_pred HH-hcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc--cccCCcCccccCCcc
Confidence 65 356899999999999999999999999999999999999999999999999987654332 233456778999999
Q ss_pred cCCCCCCChhhHHHHHHHHHHHHcCCCCCCC
Q 020085 279 IEHKPYDYKADVFSFGIALWELLTGELPYAG 309 (331)
Q Consensus 279 ~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~ 309 (331)
+.+..++.++|+||+|+++|||++|+.||..
T Consensus 154 ~~~~~~~~~~DvwslG~il~el~~g~~~~~~ 184 (237)
T cd05576 154 GGISEETEACDWWSLGAILFELLTGKTLVEC 184 (237)
T ss_pred cCCCCCCchhhHHHHHHHHHHHHHCcchhhc
Confidence 9888899999999999999999999988764
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-33 Score=248.78 Aligned_cols=201 Identities=26% Similarity=0.391 Sum_probs=173.0
Q ss_pred cccCcceeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCC--C----cceeEEeEEECC
Q 020085 108 DAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH--K----NVVQFIGACTRP 179 (331)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h--~----niv~~~~~~~~~ 179 (331)
-..+|.+.+.+|+|.||.|-++.+. +..||||+++.- ....+..+-|+++|+++.+ | -++++.++|...
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V---~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr 163 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV---DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR 163 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH---HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence 3678999999999999999999874 578999999843 3445667889999999953 3 378888889999
Q ss_pred CCeEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC---------------
Q 020085 180 PNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE--------------- 243 (331)
Q Consensus 180 ~~~~lV~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~--------------- 243 (331)
++.|||+|.+ |-|+++++..++ .+++...+..++.|+++++++||+.+++|.||||+|||+.+
T Consensus 164 ghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~ 242 (415)
T KOG0671|consen 164 GHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCF 242 (415)
T ss_pred CceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccce
Confidence 9999999988 559999997643 57999999999999999999999999999999999999942
Q ss_pred -----CCcEEEeeecceeeecCCCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHH
Q 020085 244 -----NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ 314 (331)
Q Consensus 244 -----~~~vkl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~ 314 (331)
+-.|+++|||.|+...+.. +.-..|..|.|||++.+-+++.++||||+||||+|+.+|...|..-...+
T Consensus 243 ~r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 243 IRPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred eccCCCcceEEEecCCcceeccCc--ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 2359999999998766543 45578999999999999999999999999999999999999998776555
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-33 Score=261.45 Aligned_cols=205 Identities=22% Similarity=0.382 Sum_probs=172.0
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCcceeEEeEEECCCCeEEE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIV 185 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~lV 185 (331)
.++|.+...+|.|+|+.|-.+.. +++..++|++.... .+..+|+.++... +||||+++.+.+.+..+.|+|
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v 394 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLV 394 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc------cccccccchhhhhcCCCcceeecceecCCceeeee
Confidence 67899999999999999999877 56889999998652 2334566555544 699999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEE-cCCCcEEEeeecceeeecCCCcc
Q 020085 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM-DENGVVKVADFGVARVQAQSGVM 264 (331)
Q Consensus 186 ~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi-~~~~~vkl~DFg~a~~~~~~~~~ 264 (331)
||.+.|+-+.+.+.... .+. ..+..|+.+|+.|+.|||.+|++||||||+|||+ +..|+++|+|||.++..... .
T Consensus 395 ~e~l~g~ell~ri~~~~-~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--~ 470 (612)
T KOG0603|consen 395 MELLDGGELLRRIRSKP-EFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--C 470 (612)
T ss_pred ehhccccHHHHHHHhcc-hhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--h
Confidence 99999998888885532 223 7788899999999999999999999999999999 68999999999999876654 3
Q ss_pred ccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccccc
Q 020085 265 TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKV 323 (331)
Q Consensus 265 ~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~ 323 (331)
...+-|..|.|||++....|+.++|+||||++||+||+|+.||..-..-..+...++.|
T Consensus 471 ~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~ 529 (612)
T KOG0603|consen 471 DTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMP 529 (612)
T ss_pred cccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCC
Confidence 45567889999999999999999999999999999999999998765443444434433
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-32 Score=284.10 Aligned_cols=185 Identities=25% Similarity=0.417 Sum_probs=158.7
Q ss_pred CcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEec
Q 020085 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF 188 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~ 188 (331)
.++..+.||+|+||.||+|.. .+..||||.++.... ....|++++++++||||++++++|..+...++||||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey 764 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEY 764 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeC
Confidence 466678999999999999986 678999999874321 123458889999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCccc
Q 020085 189 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH---QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT 265 (331)
Q Consensus 189 ~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~~ 265 (331)
+++|+|.++++ .+++..+.+++.|+++||+||| +.+++|||+||+||+++.++..++. |+....... ..
T Consensus 765 ~~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~---~~ 836 (968)
T PLN00113 765 IEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT---DT 836 (968)
T ss_pred CCCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc---CC
Confidence 99999999995 3788999999999999999999 6799999999999999998887775 665543222 12
Q ss_pred cCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCC
Q 020085 266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAG 309 (331)
Q Consensus 266 ~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~ 309 (331)
...+++.|+|||++.+..++.++|||||||++|||++|+.||+.
T Consensus 837 ~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~ 880 (968)
T PLN00113 837 KCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADA 880 (968)
T ss_pred CccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCc
Confidence 34678999999999999999999999999999999999999854
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-34 Score=244.90 Aligned_cols=214 Identities=27% Similarity=0.444 Sum_probs=181.1
Q ss_pred eecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEEC-----
Q 020085 106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR----- 178 (331)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~----- 178 (331)
-+..+.|.-..+||+|.||.||+|+. .++.||+|+.-.+...+.......+|+.+|+.++|+|++.++..|..
T Consensus 13 ~~~~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~ 92 (376)
T KOG0669|consen 13 CDEVSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPT 92 (376)
T ss_pred eecchHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCc
Confidence 34567788889999999999999876 56789998765443333344567899999999999999999988743
Q ss_pred ---CCCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecce
Q 020085 179 ---PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA 255 (331)
Q Consensus 179 ---~~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a 255 (331)
...+|+|+.+|+. +|.-++.+..-.++..++.+++.++..||.|+|++.|+|||+||+|+||+.+|.+||+|||++
T Consensus 93 ~r~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGla 171 (376)
T KOG0669|consen 93 NRDRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLA 171 (376)
T ss_pred ccccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccc
Confidence 2348999999988 999999887788999999999999999999999999999999999999999999999999999
Q ss_pred eeecCC-----CccccCCCCcccccchhcCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccc
Q 020085 256 RVQAQS-----GVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 256 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~ 320 (331)
+....+ ...+.+..|..|.+||.+.+ +.|+++.|+|.-||++.||+++.+-+.+.+..+....+-
T Consensus 172 r~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is 242 (376)
T KOG0669|consen 172 RAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLIS 242 (376)
T ss_pred cceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHH
Confidence 754432 23456677999999999865 579999999999999999999999999988777665543
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-34 Score=246.02 Aligned_cols=215 Identities=25% Similarity=0.423 Sum_probs=183.0
Q ss_pred CcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCC-----CeE
Q 020085 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP-----NLC 183 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~-----~~~ 183 (331)
+.+..+.||.|+||.||..++ +|+.||+|.+..-..+--.-+.+.+|+.+|...+|.|++..+++..... .+|
T Consensus 54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 344567899999999999998 6899999998755444455678999999999999999999888765432 368
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecC--C
Q 020085 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ--S 261 (331)
Q Consensus 184 lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~--~ 261 (331)
.++|.|.. +|..++-. ...++.+.+.-++.||++||.|||+.||.||||||.|+|++.|..+||+|||+++.... .
T Consensus 134 V~TELmQS-DLHKIIVS-PQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~ 211 (449)
T KOG0664|consen 134 VLTELMQS-DLHKIIVS-PQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDR 211 (449)
T ss_pred HHHHHHHh-hhhheecc-CCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhhh
Confidence 89999876 88887754 46788899999999999999999999999999999999999999999999999986554 3
Q ss_pred CccccCCCCcccccchhcCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccccccccc
Q 020085 262 GVMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIHS 327 (331)
Q Consensus 262 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~p~ 327 (331)
..++.+..|..|.|||++.+. .|+.+.||||.||++.|++-.+..|...+|.|...-+..-...|.
T Consensus 212 ~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs 278 (449)
T KOG0664|consen 212 LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPS 278 (449)
T ss_pred hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCc
Confidence 467788889999999999764 689999999999999999999999999999888776665555554
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.5e-31 Score=256.38 Aligned_cols=205 Identities=23% Similarity=0.354 Sum_probs=156.3
Q ss_pred eeeecccCcceeeeeeecCceEEEEEEE------------------CCceEEEEEecCCCCCHHHHH-------------
Q 020085 104 VWEIDAKQLKIECKVASGSYGDLYKGTY------------------CSQEVAIKVLKPECVNTEMLK------------- 152 (331)
Q Consensus 104 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~------------------~~~~vavK~~~~~~~~~~~~~------------- 152 (331)
......++|++.++||+|+||+||+|.. .++.||||.++.... ...+
T Consensus 139 ~~r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~--~~~~~fl~e~~~~~~~~ 216 (507)
T PLN03224 139 NSRWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQ--GVRQDFLKTGTLAKGSA 216 (507)
T ss_pred CCCccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccch--hhHHHHHhhhhhhhccc
Confidence 3455788999999999999999999964 345799999875421 1122
Q ss_pred -HHHHHHHHHHhcCCCcc-----eeEEeEEEC--------CCCeEEEEeccCCCCHHHHHHhcCC---------------
Q 020085 153 -EFSQEVYIMRKIRHKNV-----VQFIGACTR--------PPNLCIVTEFMARGSIYDFLHKQKG--------------- 203 (331)
Q Consensus 153 -~~~~E~~il~~l~h~ni-----v~~~~~~~~--------~~~~~lV~E~~~ggsL~~~l~~~~~--------------- 203 (331)
.+..|+.++.+++|.++ ++++++|.. .+..++|+||+++++|.++++...+
T Consensus 217 e~~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~ 296 (507)
T PLN03224 217 ETGMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKK 296 (507)
T ss_pred chhHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCc
Confidence 23446777777766544 677777653 3468999999999999999865321
Q ss_pred --------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCccc--cCCCCccc
Q 020085 204 --------VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT--AETGTYRW 273 (331)
Q Consensus 204 --------~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~~--~~~gt~~y 273 (331)
.+++..+..++.|++.+|.|||+.+++||||||+|||++.++.+||+|||+++......... ...+++.|
T Consensus 297 l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y 376 (507)
T PLN03224 297 IPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRY 376 (507)
T ss_pred hhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcce
Confidence 23456788899999999999999999999999999999999999999999997544332222 22347899
Q ss_pred ccchhcCCCC--------------------C--CChhhHHHHHHHHHHHHcCCC-CCCCC
Q 020085 274 MAPEVIEHKP--------------------Y--DYKADVFSFGIALWELLTGEL-PYAGL 310 (331)
Q Consensus 274 ~aPE~~~~~~--------------------~--~~~~Di~SlG~il~ell~g~~-Pf~~~ 310 (331)
+|||.+.... | ..+.|+||+||++|+|++|.. ||...
T Consensus 377 ~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~ 436 (507)
T PLN03224 377 SPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANI 436 (507)
T ss_pred eChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccch
Confidence 9999975432 1 134699999999999999875 88654
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=6e-33 Score=258.83 Aligned_cols=199 Identities=27% Similarity=0.433 Sum_probs=173.4
Q ss_pred ccCcceeeeeeecCceEEEEEEECC--ceEEEEEecCCCCC------HHHHHHHHHHHHHHHhcC---CCcceeEEeEEE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVN------TEMLKEFSQEVYIMRKIR---HKNVVQFIGACT 177 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~~~--~~vavK~~~~~~~~------~~~~~~~~~E~~il~~l~---h~niv~~~~~~~ 177 (331)
..+|...+++|+|+||.|+.+.++. ..|+||.+.+++.- +..+-..-.|++||..++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 3568999999999999999999954 67999998765431 112234667999999997 999999999999
Q ss_pred CCCCeEEEEeccC-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeeccee
Q 020085 178 RPPNLCIVTEFMA-RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR 256 (331)
Q Consensus 178 ~~~~~~lV~E~~~-ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~ 256 (331)
+++++||+||-.. |-+|++++.. +..+++..+..|+.|++.|+++||+.||||||||-+|+.++.+|-+||+|||.|.
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~-kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa 718 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEF-KPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAA 718 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhc-cCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchh
Confidence 9999999999864 4499999954 6789999999999999999999999999999999999999999999999999996
Q ss_pred eecCCCccccCCCCcccccchhcCCCCCC-ChhhHHHHHHHHHHHHcCCCCCCC
Q 020085 257 VQAQSGVMTAETGTYRWMAPEVIEHKPYD-YKADVFSFGIALWELLTGELPYAG 309 (331)
Q Consensus 257 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~SlG~il~ell~g~~Pf~~ 309 (331)
.. .++......||..|.|||++.+.+|- ...|||++|++||.++....||-+
T Consensus 719 ~~-ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 719 YT-KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred hh-cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 54 44566778999999999999999985 557999999999999999999865
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=230.03 Aligned_cols=201 Identities=36% Similarity=0.596 Sum_probs=173.3
Q ss_pred CceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEeccCCCCHHHHHH
Q 020085 122 SYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLH 199 (331)
Q Consensus 122 ~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~~~ggsL~~~l~ 199 (331)
+||.||+|.+. ++.+|+|++........ .+.+.+|+..+++++|+|++++++.+......++++||+++++|.+++.
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~ 79 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK-RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK 79 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH-HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence 58999999984 58999999986543322 5789999999999999999999999998889999999999999999986
Q ss_pred hcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCccccCCCCcccccchhc
Q 020085 200 KQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVI 279 (331)
Q Consensus 200 ~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~ 279 (331)
... .++...+..++.+++.++.+||+.+++|+||+|+||++++++.++++|||.+.............+++.|++||.+
T Consensus 80 ~~~-~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~ 158 (244)
T smart00220 80 KRG-RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVL 158 (244)
T ss_pred hcc-CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHHHH
Confidence 643 3889999999999999999999999999999999999999999999999999877665455566789999999999
Q ss_pred CCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccccc
Q 020085 280 EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVS 324 (331)
Q Consensus 280 ~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~ 324 (331)
.+..++.++|+||||++++++++|..||......+.......++.
T Consensus 159 ~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~ 203 (244)
T smart00220 159 LGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPK 203 (244)
T ss_pred ccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccC
Confidence 988899999999999999999999999988434343444344333
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-32 Score=247.75 Aligned_cols=206 Identities=22% Similarity=0.413 Sum_probs=171.6
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-----CHHHHHHHHHHHHHHHhcCCCcceeEEeEEEC-CC
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-----NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR-PP 180 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-----~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~-~~ 180 (331)
.++|-++..||+|+|+.||++.+ ..+.||+|+-..... ..+..+...+|..|-+.++||.||+++++|.- ..
T Consensus 462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence 45688889999999999999987 457799999754322 22345668899999999999999999999964 45
Q ss_pred CeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--CcccCCCCCCCEEEcC---CCcEEEeeecce
Q 020085 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN--NIIHRDLKTANLLMDE---NGVVKVADFGVA 255 (331)
Q Consensus 181 ~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~--~iiHrDlkp~NiLi~~---~~~vkl~DFg~a 255 (331)
.+|-|+||++|-+|.-||. ++..+++..+..|+.||+.||.||.+. .|||-||||.|||+-+ .|.+||.|||++
T Consensus 542 sFCTVLEYceGNDLDFYLK-QhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLS 620 (775)
T KOG1151|consen 542 SFCTVLEYCEGNDLDFYLK-QHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLS 620 (775)
T ss_pred cceeeeeecCCCchhHHHH-hhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeecchh
Confidence 6899999999999998885 467899999999999999999999976 5999999999999954 467999999999
Q ss_pred eeecCCCcc--------ccCCCCcccccchhcC----CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 020085 256 RVQAQSGVM--------TAETGTYRWMAPEVIE----HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQA 315 (331)
Q Consensus 256 ~~~~~~~~~--------~~~~gt~~y~aPE~~~----~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~ 315 (331)
+.....+.. +...||+.|++||.+. ....+.+.||||.|+++|..+.|+.||...-.-+.
T Consensus 621 KIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd 692 (775)
T KOG1151|consen 621 KIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD 692 (775)
T ss_pred hhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH
Confidence 877654322 3456999999999873 33578899999999999999999999987644433
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=224.41 Aligned_cols=204 Identities=21% Similarity=0.437 Sum_probs=174.5
Q ss_pred cccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCcceeEEeEEECCC--Ce
Q 020085 108 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPP--NL 182 (331)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~--~~ 182 (331)
..++|++.+++|+|.|+.||.|.. +.+.++||++++-. .+.+.+|+.||+.+. ||||+++++...++. ..
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk-----kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK-----KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH-----HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 567999999999999999999985 67899999998642 467899999999997 999999999987653 47
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC-cEEEeeecceeeecCC
Q 020085 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG-VVKVADFGVARVQAQS 261 (331)
Q Consensus 183 ~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~-~vkl~DFg~a~~~~~~ 261 (331)
.+|+||+++.+...+. ..++...+..++.++++||.|+|+.||+|||+||.|++||... .++|+|+|+|.+....
T Consensus 111 aLiFE~v~n~Dfk~ly----~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~ 186 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLY----PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG 186 (338)
T ss_pred hhHhhhhccccHHHHh----hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence 8999999987777665 4577888999999999999999999999999999999999755 5999999999988887
Q ss_pred CccccCCCCcccccchhcC-CCCCCChhhHHHHHHHHHHHHcCCCCC-CCCCHHHHHhccc
Q 020085 262 GVMTAETGTYRWMAPEVIE-HKPYDYKADVFSFGIALWELLTGELPY-AGLTPLQAAVGVV 320 (331)
Q Consensus 262 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~SlG~il~ell~g~~Pf-~~~~~~~~~~~~~ 320 (331)
....-+..+..|--||.+- .+.|+..-|+|||||+|..|+..+-|| .+.++.+..+++.
T Consensus 187 ~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIa 247 (338)
T KOG0668|consen 187 KEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIA 247 (338)
T ss_pred ceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHH
Confidence 7777777888889999984 556899999999999999999988775 5555555555544
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=256.80 Aligned_cols=196 Identities=28% Similarity=0.468 Sum_probs=162.9
Q ss_pred cceeeeeeecCceE-EEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCcceeEEeEEECCCCeEEEEecc
Q 020085 112 LKIECKVASGSYGD-LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCIVTEFM 189 (331)
Q Consensus 112 ~~~~~~lg~G~~g~-Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~~~~lV~E~~ 189 (331)
+.-.+.+|.|+.|+ ||+|.+.++.||||.+-.+ ......+|+..|+..+ ||||+++++.-.++...||..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e-----~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEE-----FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeCCceehHHHHhhH-----hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh
Confidence 44456789999987 8999999999999998644 3456788999999985 999999999888889999999999
Q ss_pred CCCCHHHHHHhcCCC--CCH-HHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC---CC--cEEEeeecceeeecCC
Q 020085 190 ARGSIYDFLHKQKGV--FQL-TSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE---NG--VVKVADFGVARVQAQS 261 (331)
Q Consensus 190 ~ggsL~~~l~~~~~~--~~~-~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~---~~--~vkl~DFg~a~~~~~~ 261 (331)
.. +|.+++...... ... ...+.+..|+++|+++||+.+||||||||.||||.. ++ .++|+|||+++.....
T Consensus 586 ~~-sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~ 664 (903)
T KOG1027|consen 586 AC-SLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG 664 (903)
T ss_pred hh-hHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence 88 999999763111 111 345788999999999999999999999999999986 33 6999999999866543
Q ss_pred C----ccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHH
Q 020085 262 G----VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPL 313 (331)
Q Consensus 262 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~ 313 (331)
. ......||.+|+|||++....-+.+.||||+||++|+.++ |++||.+.-..
T Consensus 665 ~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R 721 (903)
T KOG1027|consen 665 KSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLER 721 (903)
T ss_pred cchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHh
Confidence 2 2344579999999999988888889999999999999999 49999975433
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-31 Score=233.84 Aligned_cols=214 Identities=24% Similarity=0.363 Sum_probs=188.1
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCC------
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP------ 180 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~------ 180 (331)
..+|.-.+.+|.|.- .|-.+-+ .+++||+|.+.....+....+...+|..++..++|+||++++.+++-..
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~ 94 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ 94 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence 457888888999988 5666554 6799999998777666666788899999999999999999999997654
Q ss_pred CeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecC
Q 020085 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (331)
Q Consensus 181 ~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~ 260 (331)
..|+|||+|.. +|...+. ..++-.++..++.|++.|+.|||+.||+||||||+||++..++.+||.|||+|+....
T Consensus 95 e~y~v~e~m~~-nl~~vi~---~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~ 170 (369)
T KOG0665|consen 95 EVYLVMELMDA-NLCQVIL---MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDT 170 (369)
T ss_pred hHHHHHHhhhh-HHHHHHH---HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcccCc
Confidence 47999999976 9999886 3467788999999999999999999999999999999999999999999999987776
Q ss_pred CCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccccccccc
Q 020085 261 SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIHS 327 (331)
Q Consensus 261 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~p~ 327 (331)
.-.++....|..|.|||++.+..|...+||||+||++.||++|+..|++....+..-++++.-..|.
T Consensus 171 ~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd 237 (369)
T KOG0665|consen 171 DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPD 237 (369)
T ss_pred ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCC
Confidence 6677888999999999999888899999999999999999999999999999988888887666553
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=246.87 Aligned_cols=216 Identities=25% Similarity=0.395 Sum_probs=183.7
Q ss_pred eecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCC------CcceeEEeEEE
Q 020085 106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH------KNVVQFIGACT 177 (331)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h------~niv~~~~~~~ 177 (331)
++....|.+..-.|+|-|++|.+|.+ .++.||||+++.. +-..+.=+.|++||++|+. -++++++..|.
T Consensus 428 E~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN---E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~ 504 (752)
T KOG0670|consen 428 ELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN---EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFK 504 (752)
T ss_pred hhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc---hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhh
Confidence 34567889999999999999999988 5789999999853 4445667789999999952 47899999999
Q ss_pred CCCCeEEEEeccCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC-cEEEeeecc
Q 020085 178 RPPNLCIVTEFMARGSIYDFLHKQK--GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG-VVKVADFGV 254 (331)
Q Consensus 178 ~~~~~~lV~E~~~ggsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~-~vkl~DFg~ 254 (331)
..+++|||+|-+.- +|.++|.+-. -.+....+..++.|+.-||..|-+.||+|.||||.||||++.. .+||||||.
T Consensus 505 hknHLClVFE~Lsl-NLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGS 583 (752)
T KOG0670|consen 505 HKNHLCLVFEPLSL-NLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGS 583 (752)
T ss_pred hcceeEEEehhhhc-hHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcc
Confidence 99999999999865 9999997643 4577788999999999999999999999999999999999865 689999999
Q ss_pred eeeecCCCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccc-cccccc
Q 020085 255 ARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV-QKVSIH 326 (331)
Q Consensus 255 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~-~~~~~p 326 (331)
|...... ..+.+..+..|.|||++.+.+|+...|+||.||+||||.||+..|++.++-++..-.+ -+|..|
T Consensus 584 A~~~~en-eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p 655 (752)
T KOG0670|consen 584 ASFASEN-EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFP 655 (752)
T ss_pred ccccccc-cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCc
Confidence 9876554 3456667889999999999999999999999999999999999999988777665433 355555
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-30 Score=252.75 Aligned_cols=198 Identities=17% Similarity=0.283 Sum_probs=143.1
Q ss_pred eecccCcceeeeeeecCceEEEEEEEC------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeE----
Q 020085 106 EIDAKQLKIECKVASGSYGDLYKGTYC------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA---- 175 (331)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~---- 175 (331)
....++|.+.++||+|+||.||+|++. +..||+|.++..... +....| .++...+.++..++..
T Consensus 128 ~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~----e~~~~e--~l~~~~~~~~~~~~~~~~~~ 201 (566)
T PLN03225 128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAV----EIWMNE--RVRRACPNSCADFVYGFLEP 201 (566)
T ss_pred CCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchh----HHHHHH--HHHhhchhhHHHHHHhhhcc
Confidence 446779999999999999999999984 578999998643211 111111 1112222222222211
Q ss_pred --EECCCCeEEEEeccCCCCHHHHHHhcCCCC-------------------CHHHHHHHHHHHHHHHHHHHhCCcccCCC
Q 020085 176 --CTRPPNLCIVTEFMARGSIYDFLHKQKGVF-------------------QLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234 (331)
Q Consensus 176 --~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~-------------------~~~~~~~i~~qi~~~l~~LH~~~iiHrDl 234 (331)
+......++|+||+.+++|.+++....... ....+..++.|++.||+|||++||+||||
T Consensus 202 ~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDL 281 (566)
T PLN03225 202 VSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDV 281 (566)
T ss_pred cccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcC
Confidence 245667999999999999999986543211 12345679999999999999999999999
Q ss_pred CCCCEEEcC-CCcEEEeeecceeeecCC--CccccCCCCcccccchhcCCC----------------------CCCChhh
Q 020085 235 KTANLLMDE-NGVVKVADFGVARVQAQS--GVMTAETGTYRWMAPEVIEHK----------------------PYDYKAD 289 (331)
Q Consensus 235 kp~NiLi~~-~~~vkl~DFg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~D 289 (331)
||+|||++. ++.+||+|||+++..... .......+++.|+|||.+... .++.++|
T Consensus 282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 999999986 579999999999754332 223345789999999976322 2345679
Q ss_pred HHHHHHHHHHHHcCCCCCCC
Q 020085 290 VFSFGIALWELLTGELPYAG 309 (331)
Q Consensus 290 i~SlG~il~ell~g~~Pf~~ 309 (331)
||||||+||||+++..|++.
T Consensus 362 VwSlGviL~el~~~~~~~~~ 381 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDS 381 (566)
T ss_pred cHHHHHHHHHHHhCcCCCch
Confidence 99999999999998777653
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-29 Score=226.55 Aligned_cols=221 Identities=24% Similarity=0.468 Sum_probs=183.8
Q ss_pred eeecccCcceeeeeeecCceEEEEEEECC-------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEE
Q 020085 105 WEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177 (331)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 177 (331)
..+...++.+...+-+|.||+||+|.|.. +.|-+|.++... ++-.+..+.+|.-.+..+.|||+.++.+++.
T Consensus 279 l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A-S~iQv~~~L~es~lly~~sH~nll~V~~V~i 357 (563)
T KOG1024|consen 279 LTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA-SQIQVNLLLQESMLLYGASHPNLLSVLGVSI 357 (563)
T ss_pred hhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc-cHHHHHHHHHHHHHHhcCcCCCccceeEEEe
Confidence 33445667777889999999999996643 457788887553 5556788999999999999999999999875
Q ss_pred C-CCCeEEEEeccCCCCHHHHHHhcC-------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEE
Q 020085 178 R-PPNLCIVTEFMARGSIYDFLHKQK-------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKV 249 (331)
Q Consensus 178 ~-~~~~~lV~E~~~ggsL~~~l~~~~-------~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl 249 (331)
+ ....+.++.++.-|+|..++...+ ..++..++..++.|++.||+|||+.|+||.||.++|.+|++.-++||
T Consensus 358 e~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkl 437 (563)
T KOG1024|consen 358 EDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKL 437 (563)
T ss_pred eccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEe
Confidence 4 445778899999999999997322 34666788899999999999999999999999999999999999999
Q ss_pred eeecceeeecCCCc---cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhcccccccc
Q 020085 250 ADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSI 325 (331)
Q Consensus 250 ~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~ 325 (331)
+|=.+++-.-+... -..+....+||+||.+.+..|+.++|+||||++||||+| |+.||....|.++..- +.+|+|
T Consensus 438 tDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~y-lkdGyR 516 (563)
T KOG1024|consen 438 TDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHY-LKDGYR 516 (563)
T ss_pred ccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHH-Hhccce
Confidence 99999974433222 234456789999999999999999999999999999999 9999999999998766 667887
Q ss_pred cc
Q 020085 326 HS 327 (331)
Q Consensus 326 p~ 327 (331)
-.
T Consensus 517 la 518 (563)
T KOG1024|consen 517 LA 518 (563)
T ss_pred ec
Confidence 54
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-31 Score=248.13 Aligned_cols=217 Identities=32% Similarity=0.497 Sum_probs=190.4
Q ss_pred cccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEE
Q 020085 108 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV 185 (331)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV 185 (331)
+.++|.+..++|+|.||.|||+++ .++..|+|+++.+..+ ......+|+-+++..+||||+.++|.+-....+++.
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~d--d~~~iqqei~~~~dc~h~nivay~gsylr~dklwic 90 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGD--DFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC 90 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCc--cccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence 356899999999999999999988 6789999999977533 356788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecC-CCcc
Q 020085 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVM 264 (331)
Q Consensus 186 ~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~-~~~~ 264 (331)
|||+.||+|.+..+- .+++++.++..+.++.+++++|||+.|-+|||||-.|||+++.|.+|++|||.+-.... -...
T Consensus 91 MEycgggslQdiy~~-TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Kr 169 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKR 169 (829)
T ss_pred EEecCCCcccceeee-cccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhh
Confidence 999999999998754 68999999999999999999999999999999999999999999999999999753332 1223
Q ss_pred ccCCCCcccccchhc---CCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccccccccc
Q 020085 265 TAETGTYRWMAPEVI---EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIHS 327 (331)
Q Consensus 265 ~~~~gt~~y~aPE~~---~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~p~ 327 (331)
-...||+.|||||+- ....|...+|+|++|++-.|+-.-++|--++.|.++..-+-.-+..|+
T Consensus 170 ksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp 235 (829)
T KOG0576|consen 170 KSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPP 235 (829)
T ss_pred hcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCC
Confidence 456799999999986 456799999999999999999999999988999999887776666554
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.9e-28 Score=204.89 Aligned_cols=182 Identities=36% Similarity=0.688 Sum_probs=161.5
Q ss_pred eeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEeccCCCCHH
Q 020085 118 VASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY 195 (331)
Q Consensus 118 lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~~~ggsL~ 195 (331)
||+|++|.||++... ++.+++|++....... ....+.+|+..++.++|++++++++++......++++|++.|++|.
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~ 79 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS-LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLK 79 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh-HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence 689999999999996 8999999998664322 3467999999999999999999999999988999999999999999
Q ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC-CCcEEEeeecceeeecCCC-ccccCCCCccc
Q 020085 196 DFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE-NGVVKVADFGVARVQAQSG-VMTAETGTYRW 273 (331)
Q Consensus 196 ~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~-~~~vkl~DFg~a~~~~~~~-~~~~~~gt~~y 273 (331)
+++......++...+..++.++++++.+||+.|++|+||+|.||+++. ++.++|+|||.+....... ......+...|
T Consensus 80 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~ 159 (215)
T cd00180 80 DLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAY 159 (215)
T ss_pred HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCc
Confidence 999765457899999999999999999999999999999999999999 8999999999998665442 23345678899
Q ss_pred ccchhcCCC-CCCChhhHHHHHHHHHHH
Q 020085 274 MAPEVIEHK-PYDYKADVFSFGIALWEL 300 (331)
Q Consensus 274 ~aPE~~~~~-~~~~~~Di~SlG~il~el 300 (331)
++||.+... .++.++|+|++|++++++
T Consensus 160 ~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 160 MAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred cChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 999999877 888999999999999998
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=208.34 Aligned_cols=213 Identities=25% Similarity=0.343 Sum_probs=180.8
Q ss_pred eecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCC-CcceeEEeEEECCCCe
Q 020085 106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH-KNVVQFIGACTRPPNL 182 (331)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h-~niv~~~~~~~~~~~~ 182 (331)
.|-...|+++++||+|+||.+|.|.. .|..||||+-+.....+ .+..|..+.+.+++ ..|..+..+..+...-
T Consensus 11 ~iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hp----qL~yEskvY~iL~~g~GiP~i~~y~~e~~yn 86 (341)
T KOG1163|consen 11 LIVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHP----QLLYESKVYRILQGGVGIPHIRHYGTEKDYN 86 (341)
T ss_pred heeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCc----chhHHHHHHHHhccCCCCchhhhhccccccc
Confidence 45678999999999999999999987 78999999987654433 56778999999986 7888888888888889
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC---CcEEEeeecceeeec
Q 020085 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN---GVVKVADFGVARVQA 259 (331)
Q Consensus 183 ~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~---~~vkl~DFg~a~~~~ 259 (331)
.+||+.+ |.||.+++.-....++..+++-++-|++.-++|+|.+++|||||||+|+|++-+ ..+.++|||+|+...
T Consensus 87 vlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred eeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhc
Confidence 9999988 779999998878899999999999999999999999999999999999999754 469999999997543
Q ss_pred CCC--------ccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH---HHHHhcccccc
Q 020085 260 QSG--------VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTP---LQAAVGVVQKV 323 (331)
Q Consensus 260 ~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~---~~~~~~~~~~~ 323 (331)
... ....-+||.+|.+-....+...+.+.|+-|+|.+|.++.-|.+||.++.+ .|.+..+.++.
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK 240 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKK 240 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhh
Confidence 321 12344799999999999888899999999999999999999999998744 55666655543
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.2e-28 Score=221.26 Aligned_cols=130 Identities=23% Similarity=0.442 Sum_probs=112.2
Q ss_pred cccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-----C---CcceeEEeEEE
Q 020085 108 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-----H---KNVVQFIGACT 177 (331)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~-----h---~niv~~~~~~~ 177 (331)
...+|.+.++||.|.|++||++.+ ..+.||+|+.+.. ....+....||.+|++++ | ..||++++.|.
T Consensus 76 ~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA---qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fk 152 (590)
T KOG1290|consen 76 NGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA---QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFK 152 (590)
T ss_pred cCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh---hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccce
Confidence 457899999999999999999988 4578999999965 445577889999999984 3 46999999996
Q ss_pred C----CCCeEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEE
Q 020085 178 R----PPNLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLM 241 (331)
Q Consensus 178 ~----~~~~~lV~E~~~ggsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~-~~iiHrDlkp~NiLi 241 (331)
. +.++|||+|++ |.+|..+|... ...++...+.+|+.|++.||.|||+ .||||.||||+|||+
T Consensus 153 hsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 153 HSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLL 221 (590)
T ss_pred ecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeee
Confidence 4 45799999999 55898888664 3679999999999999999999996 699999999999999
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.4e-27 Score=216.66 Aligned_cols=199 Identities=26% Similarity=0.379 Sum_probs=166.4
Q ss_pred CcceeeeeeecCceEEEEEEECC---ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCC----CcceeEEeEE-ECCCCe
Q 020085 111 QLKIECKVASGSYGDLYKGTYCS---QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH----KNVVQFIGAC-TRPPNL 182 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h----~niv~~~~~~-~~~~~~ 182 (331)
.|++.++||+|+||.||++.... ..+|+|+......... ..+..|..++..+.. +++.++++.. ..+...
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~--~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~ 96 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP--SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFN 96 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC--ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCcee
Confidence 89999999999999999999855 3699998875432211 257778888888862 6899999988 477788
Q ss_pred EEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC-----CcEEEeeeccee
Q 020085 183 CIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN-----GVVKVADFGVAR 256 (331)
Q Consensus 183 ~lV~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~-----~~vkl~DFg~a~ 256 (331)
++||+.+ |.+|.++..... +.++..++.+++.|++.+|++||+.|++||||||+|++++.. ..+.|.|||+++
T Consensus 97 ~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar 175 (322)
T KOG1164|consen 97 FIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR 175 (322)
T ss_pred EEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence 9999987 679999886554 789999999999999999999999999999999999999865 359999999998
Q ss_pred --eec-CCC-------c-cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH
Q 020085 257 --VQA-QSG-------V-MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTP 312 (331)
Q Consensus 257 --~~~-~~~-------~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~ 312 (331)
... ..+ . .....||.+|+++....+...+++.|+||+++++.+++.|..||.+...
T Consensus 176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~ 242 (322)
T KOG1164|consen 176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEM 242 (322)
T ss_pred cccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccc
Confidence 321 111 0 1233499999999999999999999999999999999999999988764
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=206.25 Aligned_cols=219 Identities=30% Similarity=0.589 Sum_probs=188.8
Q ss_pred eeecccCcceeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEE
Q 020085 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI 184 (331)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~l 184 (331)
..|+-.++.+..+|.+...|..|+|+|.|.+++.|+++-.......-++|..|.-.|+-..||||+.++++|..++++.+
T Consensus 185 ~gid~~~lnl~tkl~e~hsgelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~ 264 (448)
T KOG0195|consen 185 TGIDVSSLNLITKLAESHSGELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVI 264 (448)
T ss_pred cCcchhhhhhhhhhccCCCcccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceE
Confidence 45677888899999999999999999999999999999777777777899999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC-c-ccCCCCCCCEEEcCCCcEEEe--eecceeeec
Q 020085 185 VTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGMNYLHQNN-I-IHRDLKTANLLMDENGVVKVA--DFGVARVQA 259 (331)
Q Consensus 185 V~E~~~ggsL~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~-i-iHrDlkp~NiLi~~~~~vkl~--DFg~a~~~~ 259 (331)
+..||+.|||+..++.+.+ ..+..++.+++.++++||+|||+.. + .---|+...++||++-+.+|+ |--++..
T Consensus 265 isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq-- 342 (448)
T KOG0195|consen 265 ISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ-- 342 (448)
T ss_pred eeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee--
Confidence 9999999999999988653 4667899999999999999999864 3 334788999999999876654 4333311
Q ss_pred CCCccccCCCCcccccchhcCCCCCC---ChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccccccccccc
Q 020085 260 QSGVMTAETGTYRWMAPEVIEHKPYD---YKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIHSII 329 (331)
Q Consensus 260 ~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~p~~~ 329 (331)
.....-.|.||+||.+..++.+ .++|+|||++++||+.|...||.+++|.+.-.++.-.|.|+.||
T Consensus 343 ----e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~ip 411 (448)
T KOG0195|consen 343 ----EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHIP 411 (448)
T ss_pred ----ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccCC
Confidence 1223456899999999877654 57899999999999999999999999999999999999999987
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3e-26 Score=202.09 Aligned_cols=212 Identities=20% Similarity=0.328 Sum_probs=179.7
Q ss_pred eecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCcceeEEeEEECCCCe
Q 020085 106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNL 182 (331)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~~~ 182 (331)
.+-.-+|+++++||+|+||.+|.|+. +++.||||.-..... .-++.-|.+..+.|. .++|.+.+.+..++.+-
T Consensus 24 ~~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~----APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~N 99 (449)
T KOG1165|consen 24 LMVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE----APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYN 99 (449)
T ss_pred eEecccceeccccccCcceeeecccccccCceEEEEeccccCC----cchHHHHHHHHHHHcCCCCCCceeeeccccchh
Confidence 45677999999999999999999985 899999998654321 235667888888885 69999999888888888
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC-----CcEEEeeecceee
Q 020085 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN-----GVVKVADFGVARV 257 (331)
Q Consensus 183 ~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~-----~~vkl~DFg~a~~ 257 (331)
.+|+|.+ |.||.|++.-....|+..++..+|.|++.-++|+|++.+|+|||||+|+||+.- +.|.++|||+|+.
T Consensus 100 iLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~ 178 (449)
T KOG1165|consen 100 ILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKE 178 (449)
T ss_pred hhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhh
Confidence 8999988 679999987777899999999999999999999999999999999999999743 3699999999986
Q ss_pred ecCCC--------ccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCC---CHHHHHhccccc
Q 020085 258 QAQSG--------VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL---TPLQAAVGVVQK 322 (331)
Q Consensus 258 ~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~---~~~~~~~~~~~~ 322 (331)
..... ..-..+||.+||+-.-..++..+.+.|+-|||-++.+.|-|.+||.++ +..+.+.+|-++
T Consensus 179 YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~ 254 (449)
T KOG1165|consen 179 YRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGET 254 (449)
T ss_pred hcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccc
Confidence 54432 122347999999999999999999999999999999999999999886 667777765543
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.9e-28 Score=208.68 Aligned_cols=194 Identities=21% Similarity=0.364 Sum_probs=156.4
Q ss_pred ccCcceeeeeeecCceEEEEEEECC--ceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCcceeEEe-EEECCCCeEE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIG-ACTRPPNLCI 184 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~-~~~~~~~~~l 184 (331)
.+.|.+.+.+|+|.||.+-++.+++ +.+++|.+..+.. ..++|.+|..---.| .|.||+..++ +|+..+.+++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~t---t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF 99 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQT---TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVF 99 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchh---hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEE
Confidence 4689999999999999999999854 7899999876533 346788887654444 4899998776 5677778899
Q ss_pred EEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC--CCcEEEeeecceeeecCCC
Q 020085 185 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE--NGVVKVADFGVARVQAQSG 262 (331)
Q Consensus 185 V~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~--~~~vkl~DFg~a~~~~~~~ 262 (331)
++||++.|+|.+-+.. ..+.+....+++.|+++|++|+|+++++|||||.+||||.. ...+||+|||.++..+..-
T Consensus 100 ~qE~aP~gdL~snv~~--~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV 177 (378)
T KOG1345|consen 100 VQEFAPRGDLRSNVEA--AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTV 177 (378)
T ss_pred eeccCccchhhhhcCc--ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCcee
Confidence 9999999999987743 56788888999999999999999999999999999999954 3379999999987554321
Q ss_pred ccccCCCCcccccchhcCCC-----CCCChhhHHHHHHHHHHHHcCCCCCCC
Q 020085 263 VMTAETGTYRWMAPEVIEHK-----PYDYKADVFSFGIALWELLTGELPYAG 309 (331)
Q Consensus 263 ~~~~~~gt~~y~aPE~~~~~-----~~~~~~Di~SlG~il~ell~g~~Pf~~ 309 (331)
.. ...+..|.+||..... ..++.+|+|.|||++|.+++|+.||..
T Consensus 178 ~~--~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQk 227 (378)
T KOG1345|consen 178 KY--LEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQK 227 (378)
T ss_pred hh--hhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchh
Confidence 11 1234568899986322 346789999999999999999999964
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-26 Score=213.53 Aligned_cols=164 Identities=18% Similarity=0.205 Sum_probs=128.5
Q ss_pred ecccCcceeeeeeecCceEEEEEEE---CCceEEEEEecCCCC---CHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCC
Q 020085 107 IDAKQLKIECKVASGSYGDLYKGTY---CSQEVAIKVLKPECV---NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (331)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~~---~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 180 (331)
.-.+.|.+.+.||+|+||+||+|.+ .++.+|||++..... .......|.+|+++|++++|+|++..+..+ .
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---~ 91 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---G 91 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---C
Confidence 4466899999999999999999987 456789998764321 233456799999999999999998533322 3
Q ss_pred CeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC-CCCCEEEcCCCcEEEeeecceeeec
Q 020085 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL-KTANLLMDENGVVKVADFGVARVQA 259 (331)
Q Consensus 181 ~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDl-kp~NiLi~~~~~vkl~DFg~a~~~~ 259 (331)
..|+||||++|++|... ...+ ...++.|++++|.|||++||+|||| ||+|||++.++.++|+|||+|+...
T Consensus 92 ~~~LVmE~~~G~~L~~~--~~~~------~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~ 163 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLA--RPHG------DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFR 163 (365)
T ss_pred CcEEEEEccCCCCHHHh--Cccc------hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecc
Confidence 57999999999999732 1111 1467889999999999999999999 9999999999999999999998665
Q ss_pred CCCcc---------ccCCCCcccccchhcCC
Q 020085 260 QSGVM---------TAETGTYRWMAPEVIEH 281 (331)
Q Consensus 260 ~~~~~---------~~~~gt~~y~aPE~~~~ 281 (331)
..+.. +...+++.|+|||.+..
T Consensus 164 ~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 164 RRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred cCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 44311 23357788999999853
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.1e-24 Score=195.47 Aligned_cols=200 Identities=34% Similarity=0.581 Sum_probs=175.3
Q ss_pred cceeeeeeecCceEEEEEEECCceEEEEEecCCCCCHH-HHHHHHHHHHHHHhcCCC-cceeEEeEEECCCCeEEEEecc
Q 020085 112 LKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTE-MLKEFSQEVYIMRKIRHK-NVVQFIGACTRPPNLCIVTEFM 189 (331)
Q Consensus 112 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~-~~~~~~~E~~il~~l~h~-niv~~~~~~~~~~~~~lV~E~~ 189 (331)
|.+.+.||.|+||.||++.+. ..+++|.+........ ....+.+|+.+++.+.|+ +++++.+.+......+++++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~ 80 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecC
Confidence 678889999999999999988 8899999987655443 578899999999999988 7999999997777789999999
Q ss_pred CCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC-cEEEeeecceeeecCCC----
Q 020085 190 ARGSIYDFLHKQK--GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG-VVKVADFGVARVQAQSG---- 262 (331)
Q Consensus 190 ~ggsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~-~vkl~DFg~a~~~~~~~---- 262 (331)
.++++.+++.... ..+.......+..|++.++.|+|+.+++|||+||+||+++..+ .++++|||.++......
T Consensus 81 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~ 160 (384)
T COG0515 81 DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSS 160 (384)
T ss_pred CCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcccc
Confidence 9999997775533 2789999999999999999999999999999999999999998 79999999997554432
Q ss_pred ---ccccCCCCcccccchhcCC---CCCCChhhHHHHHHHHHHHHcCCCCCCCCCH
Q 020085 263 ---VMTAETGTYRWMAPEVIEH---KPYDYKADVFSFGIALWELLTGELPYAGLTP 312 (331)
Q Consensus 263 ---~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~ 312 (331)
......++..|+|||.+.+ ..+....|+||+|++++++++|..||.....
T Consensus 161 ~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~ 216 (384)
T COG0515 161 IPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKN 216 (384)
T ss_pred ccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 2356679999999999987 5788999999999999999999999888763
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.8e-26 Score=207.89 Aligned_cols=193 Identities=24% Similarity=0.401 Sum_probs=160.8
Q ss_pred ccCcceeeeeeecCceEEEEEEE-----CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCcceeEEeEEECCCCe
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY-----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNL 182 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~~~ 182 (331)
...|...++||+|+|++||+++. ..+.||+|.+..... ......|+++|..+. +.||+++.+++..++..
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~----p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v 110 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSS----PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQV 110 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccC----chHHHHHHHHHHHhccchhhhcchhhhccCCee
Confidence 34788999999999999999976 346799999875431 256889999999995 89999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC-CCcEEEeeecceeeec--
Q 020085 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE-NGVVKVADFGVARVQA-- 259 (331)
Q Consensus 183 ~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~-~~~vkl~DFg~a~~~~-- 259 (331)
++|+||++.....+++.. ++...+..++..++.||.++|.+||||||+||.|+|.+. -+.-.|+|||+|....
T Consensus 111 ~ivlp~~~H~~f~~l~~~----l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~ 186 (418)
T KOG1167|consen 111 AIVLPYFEHDRFRDLYRS----LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGY 186 (418)
T ss_pred EEEecccCccCHHHHHhc----CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhh
Confidence 999999999999998743 568899999999999999999999999999999999985 4568999999995110
Q ss_pred ---------------C-CC---------------------------ccccCCCCcccccchhcCC-CCCCChhhHHHHHH
Q 020085 260 ---------------Q-SG---------------------------VMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGI 295 (331)
Q Consensus 260 ---------------~-~~---------------------------~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~ 295 (331)
. .+ ......||++|.|||++.. ...+.+.||||.|+
T Consensus 187 ~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GV 266 (418)
T KOG1167|consen 187 QQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGV 266 (418)
T ss_pred hhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccc
Confidence 0 00 0012248999999999854 45688999999999
Q ss_pred HHHHHHcCCCCCCC
Q 020085 296 ALWELLTGELPYAG 309 (331)
Q Consensus 296 il~ell~g~~Pf~~ 309 (331)
++.-+++++.||-.
T Consensus 267 I~Lslls~~~PFf~ 280 (418)
T KOG1167|consen 267 ILLSLLSRRYPFFK 280 (418)
T ss_pred eeehhhcccccccc
Confidence 99999999999743
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.2e-26 Score=232.49 Aligned_cols=146 Identities=15% Similarity=0.208 Sum_probs=116.0
Q ss_pred cCC-CcceeEEeEE-------ECCCCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Q 020085 164 IRH-KNVVQFIGAC-------TRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 235 (331)
Q Consensus 164 l~h-~niv~~~~~~-------~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlk 235 (331)
++| +||++++++| .....++.++|++. ++|.+++......+++..+..++.||++||+|||++||+|||||
T Consensus 29 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlK 107 (793)
T PLN00181 29 LSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECED-VSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVR 107 (793)
T ss_pred hhHHHHHHHhhcccCCccccccccchhhhhhccCC-ccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCC
Confidence 455 5778888877 23346788899884 59999997666679999999999999999999999999999999
Q ss_pred CCCEEEcCC-------------------CcEEEeeecceeeecCC-----------------CccccCCCCcccccchhc
Q 020085 236 TANLLMDEN-------------------GVVKVADFGVARVQAQS-----------------GVMTAETGTYRWMAPEVI 279 (331)
Q Consensus 236 p~NiLi~~~-------------------~~vkl~DFg~a~~~~~~-----------------~~~~~~~gt~~y~aPE~~ 279 (331)
|+|||++.. +.+|++|||+++..... .......||+.|||||++
T Consensus 108 P~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~ 187 (793)
T PLN00181 108 PSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEED 187 (793)
T ss_pred chhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhh
Confidence 999999654 45566666666532110 001123578899999999
Q ss_pred CCCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 020085 280 EHKPYDYKADVFSFGIALWELLTGELPYAGL 310 (331)
Q Consensus 280 ~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~ 310 (331)
.+..|+.++|||||||+||||++|..|+...
T Consensus 188 ~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~ 218 (793)
T PLN00181 188 NGSSSNCASDVYRLGVLLFELFCPVSSREEK 218 (793)
T ss_pred ccCCCCchhhhhhHHHHHHHHhhCCCchhhH
Confidence 9999999999999999999999999988753
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.1e-24 Score=189.03 Aligned_cols=174 Identities=16% Similarity=0.221 Sum_probs=136.9
Q ss_pred ecccCcceeeeeeecCceEEEEEEECCceEEEEEecCCCCCHH-HHHH------HHHHHHHHHhcCCCcceeEEeEEECC
Q 020085 107 IDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTE-MLKE------FSQEVYIMRKIRHKNVVQFIGACTRP 179 (331)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~-~~~~------~~~E~~il~~l~h~niv~~~~~~~~~ 179 (331)
+-..+|++.+.+|.|+||.||+....+..+|+|++++.....+ .... +.+|+..+++++||+|..+.+++...
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 3467999999999999999999887888999999987654332 2223 57899999999999999998875432
Q ss_pred --------CCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEee
Q 020085 180 --------PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 251 (331)
Q Consensus 180 --------~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~D 251 (331)
...+++|||++|.+|.++.. +++ ....+++.++..+|+.|++|||++|+||+++++| ++|+|
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-----~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~liD 177 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-----ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRIID 177 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-----ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEEEE
Confidence 35789999999999988742 222 2456999999999999999999999999999999 99999
Q ss_pred ecceeeecCCCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHH
Q 020085 252 FGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELL 301 (331)
Q Consensus 252 Fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell 301 (331)
||..+........ ........|+.++|+||||+++..+.
T Consensus 178 fg~~~~~~e~~a~-----------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 178 LSGKRCTAQRKAK-----------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CCCcccccchhhH-----------HHHHHHhHhcccccccceeEeehHHH
Confidence 9988644221111 11334556778999999999987543
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.8e-24 Score=183.51 Aligned_cols=140 Identities=17% Similarity=0.200 Sum_probs=109.3
Q ss_pred eeeeeecCceEEEEEEE-CCceEEEEEecCCCCCHHH------------------------HHHHHHHHHHHHhcCCCcc
Q 020085 115 ECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEM------------------------LKEFSQEVYIMRKIRHKNV 169 (331)
Q Consensus 115 ~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~------------------------~~~~~~E~~il~~l~h~ni 169 (331)
...||+|++|+||+|.. +|+.||||+++........ .....+|+.+++++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 46799999999999987 5899999999865321110 1123459999999987776
Q ss_pred eeEEeEEECCCCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH-HhCCcccCCCCCCCEEEcCCCcEE
Q 020085 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL-HQNNIIHRDLKTANLLMDENGVVK 248 (331)
Q Consensus 170 v~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~L-H~~~iiHrDlkp~NiLi~~~~~vk 248 (331)
......... ..+|||||++|+++...... ...++...+..++.|++.+|.++ |+.||+||||||+|||++ ++.++
T Consensus 82 ~~p~~~~~~--~~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~ 157 (190)
T cd05147 82 PCPEPILLK--SHVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLY 157 (190)
T ss_pred CCCcEEEec--CCEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEE
Confidence 443322222 23899999999877655433 46789999999999999999999 799999999999999998 57899
Q ss_pred Eeeecceeee
Q 020085 249 VADFGVARVQ 258 (331)
Q Consensus 249 l~DFg~a~~~ 258 (331)
|+|||+|...
T Consensus 158 LiDFG~a~~~ 167 (190)
T cd05147 158 IIDVSQSVEH 167 (190)
T ss_pred EEEccccccC
Confidence 9999999744
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=177.19 Aligned_cols=110 Identities=30% Similarity=0.478 Sum_probs=99.1
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCccccCCCCc
Q 020085 192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY 271 (331)
Q Consensus 192 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~~~~~gt~ 271 (331)
|+|.+++...+..+++..++.++.|+++||.|||+++ ||+|||++.++.+++ ||.++..... ...|++
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~----~~~g~~ 68 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE----QSRVDP 68 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc----cCCCcc
Confidence 6999999876677999999999999999999999998 999999999999999 9999866543 236899
Q ss_pred ccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH
Q 020085 272 RWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPL 313 (331)
Q Consensus 272 ~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~ 313 (331)
.|||||++.+..++.++|||||||++|||++|+.||......
T Consensus 69 ~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~ 110 (176)
T smart00750 69 YFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEEREL 110 (176)
T ss_pred cccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchh
Confidence 999999999999999999999999999999999999876543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.4e-23 Score=175.31 Aligned_cols=142 Identities=17% Similarity=0.193 Sum_probs=111.8
Q ss_pred eeeeeecCceEEEEEEE-CCceEEEEEecCCCCC----------------------HH--HHHHHHHHHHHHHhcCCCcc
Q 020085 115 ECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVN----------------------TE--MLKEFSQEVYIMRKIRHKNV 169 (331)
Q Consensus 115 ~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~----------------------~~--~~~~~~~E~~il~~l~h~ni 169 (331)
...||+|++|.||+|.. +|+.||||+++..... .. ....+..|...++++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 56899999999999987 5899999999865321 00 11234678999999999987
Q ss_pred eeEEeEEECCCCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEEcCCCcEE
Q 020085 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENGVVK 248 (331)
Q Consensus 170 v~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~iiHrDlkp~NiLi~~~~~vk 248 (331)
.....+... ..++||||++|+++...... ...++...+..++.|++.++.++|+ .||+||||||+||+++ ++.++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~-~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~ 157 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLK-DVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPY 157 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhh-hccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEE
Confidence 544433332 24899999999865443222 3567888999999999999999999 9999999999999998 88999
Q ss_pred EeeecceeeecC
Q 020085 249 VADFGVARVQAQ 260 (331)
Q Consensus 249 l~DFg~a~~~~~ 260 (331)
|+|||+++....
T Consensus 158 liDFG~a~~~~~ 169 (190)
T cd05145 158 IIDVSQAVELDH 169 (190)
T ss_pred EEEcccceecCC
Confidence 999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-22 Score=173.05 Aligned_cols=185 Identities=15% Similarity=0.143 Sum_probs=142.4
Q ss_pred ceeeeeeecCceEEEEEEECCceEEEEEecCCCCCHH--HHHHHHHHHHHHHhcC-CCcceeEEeEEECCCCeEEEEecc
Q 020085 113 KIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTE--MLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCIVTEFM 189 (331)
Q Consensus 113 ~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~--~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~~~~lV~E~~ 189 (331)
.+...|++|+||+||.+...+.+++.+.++....-.. ....+.+|+++|+++. |+++++++++ ...+++|||+
T Consensus 5 ~~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred ccceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 3567899999999999888889999888875533211 1235889999999996 5889999886 3469999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC-CCCCEEEcCCCcEEEeeecceeeecCCCcc----
Q 020085 190 ARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL-KTANLLMDENGVVKVADFGVARVQAQSGVM---- 264 (331)
Q Consensus 190 ~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDl-kp~NiLi~~~~~vkl~DFg~a~~~~~~~~~---- 264 (331)
.|.+|.+.+.. + ...++.|++.++.++|++||+|||| ||+|||++.++.++|+|||++......+..
T Consensus 81 ~G~~L~~~~~~--~------~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L 152 (218)
T PRK12274 81 AGAAMYQRPPR--G------DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLL 152 (218)
T ss_pred cCccHHhhhhh--h------hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHH
Confidence 99998765421 1 1357789999999999999999999 799999999999999999999865543320
Q ss_pred ----------ccCCCCcccccchhcCCC-CCC-ChhhHHHHHHHHHHHHcCCCCCCC
Q 020085 265 ----------TAETGTYRWMAPEVIEHK-PYD-YKADVFSFGIALWELLTGELPYAG 309 (331)
Q Consensus 265 ----------~~~~gt~~y~aPE~~~~~-~~~-~~~Di~SlG~il~ell~g~~Pf~~ 309 (331)
.-...++.+++|+...-- ..+ .+.+.++.|+-+|.++|+..|+-+
T Consensus 153 ~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 153 AREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 011257778888765322 223 567888999999999999888643
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.3e-22 Score=202.65 Aligned_cols=198 Identities=22% Similarity=0.358 Sum_probs=164.3
Q ss_pred CCeeeecccCcceeeeeeecCceEEEEEEE-CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC---CCcceeEEeEEE
Q 020085 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR---HKNVVQFIGACT 177 (331)
Q Consensus 102 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~---h~niv~~~~~~~ 177 (331)
....++....|.|.+.||+|+||.||+|+. +|+.||+|+-++....+ |.--.+++.+|+ -+.|..+..+..
T Consensus 690 ~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE-----fYI~~q~~~RLk~~~~~~~~~~~~a~~ 764 (974)
T KOG1166|consen 690 NTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE-----FYICLQVMERLKPQMLPSIMHISSAHV 764 (974)
T ss_pred cceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee-----eeehHHHHHhhchhhhcchHHHHHHHc
Confidence 456788899999999999999999999987 67899999999875432 222233444444 245555666666
Q ss_pred CCCCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC-------CCcEEEe
Q 020085 178 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE-------NGVVKVA 250 (331)
Q Consensus 178 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~-------~~~vkl~ 250 (331)
-.+..++|+||.+.|+|.++++ ..+.+++..+..+..|+++.++.||..+|||+||||+|+|+.. +..++|+
T Consensus 765 ~~~~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lI 843 (974)
T KOG1166|consen 765 FQNASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLI 843 (974)
T ss_pred cCCcceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEE
Confidence 6667799999999999999997 4678899999999999999999999999999999999999953 3359999
Q ss_pred eeccee---eecCCCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCC
Q 020085 251 DFGVAR---VQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGEL 305 (331)
Q Consensus 251 DFg~a~---~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~ 305 (331)
|||.+. ...........++|-.+-++|+..+++++..+|.|.++.+++-||.|+.
T Consensus 844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 999984 4444445667788999999999999999999999999999999999963
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-23 Score=198.77 Aligned_cols=187 Identities=28% Similarity=0.457 Sum_probs=159.9
Q ss_pred eeeecCceEEEEEE-----ECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCcceeEEeEEECCCCeEEEEeccC
Q 020085 117 KVASGSYGDLYKGT-----YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCIVTEFMA 190 (331)
Q Consensus 117 ~lg~G~~g~Vy~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~~~~lV~E~~~ 190 (331)
.+|+|+||.|++++ +.+.-+|+|++++.............|..++..++ ||.++++..+++.+...++++++..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 37899999999653 45677999998765432222225667888888887 9999999999999999999999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCccccCCCC
Q 020085 191 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT 270 (331)
Q Consensus 191 ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~~~~~gt 270 (331)
||.|...+.+ ...+.+.....+...++-+++++|+.+++|||+|++||+++.+|++++.|||.++....... .+||
T Consensus 81 gg~lft~l~~-~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~---~cgt 156 (612)
T KOG0603|consen 81 GGDLFTRLSK-EVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI---ACGT 156 (612)
T ss_pred cchhhhcccc-CCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhh---cccc
Confidence 9999988854 46677777888888999999999999999999999999999999999999999986554322 2999
Q ss_pred cccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCC
Q 020085 271 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAG 309 (331)
Q Consensus 271 ~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~ 309 (331)
+.|||||+++ ....++|.||||++++||++|..||..
T Consensus 157 ~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 157 YEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred hhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 9999999998 567899999999999999999999998
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.4e-21 Score=166.36 Aligned_cols=138 Identities=17% Similarity=0.249 Sum_probs=106.6
Q ss_pred ceeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-----CCCcceeEEeEEECCC---CeE-
Q 020085 113 KIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-----RHKNVVQFIGACTRPP---NLC- 183 (331)
Q Consensus 113 ~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l-----~h~niv~~~~~~~~~~---~~~- 183 (331)
.-.+.||+|+||.||....... .+||+...... ...+.+.+|+.+++++ +||||++++|++.++. ..+
T Consensus 5 ~~~~~LG~G~~~~Vy~hp~~~~-k~IKv~~~~~~--~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~ 81 (210)
T PRK10345 5 SEQSPLGTGRHRKCYAHPEDAQ-RCIKIVYHRGD--GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYD 81 (210)
T ss_pred CCcceecCCCceEEEECCCCcC-eEEEEEecccc--chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEE
Confidence 3456899999999997333333 47998876432 2346799999999999 5799999999998764 333
Q ss_pred EEEec--cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHH-HHHHhCCcccCCCCCCCEEEcCC----CcEEEee-ecce
Q 020085 184 IVTEF--MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM-NYLHQNNIIHRDLKTANLLMDEN----GVVKVAD-FGVA 255 (331)
Q Consensus 184 lV~E~--~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l-~~LH~~~iiHrDlkp~NiLi~~~----~~vkl~D-Fg~a 255 (331)
+|+|| +.+|+|.+++.+ +.+++. ..++.|++.++ +|||+++|+||||||+|||++.+ +.++|+| ||..
T Consensus 82 ~I~e~~G~~~~tL~~~l~~--~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~ 157 (210)
T PRK10345 82 VIADFDGKPSITLTEFAEQ--CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGES 157 (210)
T ss_pred EEecCCCCcchhHHHHHHc--ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCCc
Confidence 78999 557899999954 345555 35677888777 99999999999999999999743 3799999 6655
Q ss_pred ee
Q 020085 256 RV 257 (331)
Q Consensus 256 ~~ 257 (331)
..
T Consensus 158 ~~ 159 (210)
T PRK10345 158 TF 159 (210)
T ss_pred ce
Confidence 44
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.1e-20 Score=163.78 Aligned_cols=137 Identities=23% Similarity=0.393 Sum_probs=116.8
Q ss_pred eeeeecCceEEEEEEECCceEEEEEecCCCCCHH------HHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEecc
Q 020085 116 CKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTE------MLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFM 189 (331)
Q Consensus 116 ~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~------~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~~ 189 (331)
+.||+|++|.||+|.+.+..+++|+..+...... ....+.+|+.+++.++|+++.....++......+++|||+
T Consensus 2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 81 (211)
T PRK14879 2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI 81 (211)
T ss_pred cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence 5799999999999999999999998775433211 2245788999999999999887777776777889999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeee
Q 020085 190 ARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (331)
Q Consensus 190 ~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~ 258 (331)
+|++|.+++.... . ....++.+++.+|.++|+.|++|+|++|.||+++ ++.++|+|||.++..
T Consensus 82 ~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~ 144 (211)
T PRK14879 82 EGEPLKDLINSNG----M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEFS 144 (211)
T ss_pred CCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence 9999999985432 1 7788999999999999999999999999999999 789999999998753
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.2e-20 Score=162.11 Aligned_cols=133 Identities=20% Similarity=0.356 Sum_probs=109.5
Q ss_pred eeeecCceEEEEEEECCceEEEEEecCCCCC-H-----HHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEeccC
Q 020085 117 KVASGSYGDLYKGTYCSQEVAIKVLKPECVN-T-----EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMA 190 (331)
Q Consensus 117 ~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~-~-----~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~~~ 190 (331)
.||+|+||.||+|.+.+..+++|+....... . .....+.+|+.+++.++|+++.....++......++||||++
T Consensus 1 ~ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~ 80 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIE 80 (199)
T ss_pred CCCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEEC
Confidence 3799999999999999999999997643221 1 123567889999999998876555555555667799999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeee
Q 020085 191 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (331)
Q Consensus 191 ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~ 258 (331)
|++|.+.+..... .++.+++.+|.+||+.|++|+|++|.||+++ ++.++++|||.++..
T Consensus 81 g~~l~~~~~~~~~--------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 81 GKPLKDVIEEGND--------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CccHHHHHhhcHH--------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9999998754211 7899999999999999999999999999999 889999999998754
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.3e-20 Score=168.41 Aligned_cols=201 Identities=19% Similarity=0.335 Sum_probs=134.4
Q ss_pred cCcceeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCC----------CcceeEEeEE
Q 020085 110 KQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRH----------KNVVQFIGAC 176 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l~h----------~niv~~~~~~ 176 (331)
..+...+.||.|+++.||.+++. ++++|+|+...... .....+.+.+|......+.+ -.++-.++..
T Consensus 12 r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~ 91 (288)
T PF14531_consen 12 RTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLL 91 (288)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEE
T ss_pred eEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEE
Confidence 35677889999999999999994 59999999864432 22356677777655555322 1222222222
Q ss_pred E---------CCC--------CeEEEEeccCCCCHHHHHHh---cCCC---CCHHHHHHHHHHHHHHHHHHHhCCcccCC
Q 020085 177 T---------RPP--------NLCIVTEFMARGSIYDFLHK---QKGV---FQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233 (331)
Q Consensus 177 ~---------~~~--------~~~lV~E~~~ggsL~~~l~~---~~~~---~~~~~~~~i~~qi~~~l~~LH~~~iiHrD 233 (331)
. ... +.+++|+-+.+ +|.+++.. .... ........+..|+++.+++||..|++|+|
T Consensus 92 ~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~-dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgd 170 (288)
T PF14531_consen 92 RIPGKPPFFERGPGQSIYWVLNRFLLMPRAQG-DLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGD 170 (288)
T ss_dssp EETTS-SEEEECETTEEEEEESEEEEEE--SE-EHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST
T ss_pred EEcCCCcceecCCCCccceeehhhhccchhhh-cHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecc
Confidence 1 111 45788888866 88887532 2211 22233456678999999999999999999
Q ss_pred CCCCCEEEcCCCcEEEeeecceeeecCCCccccCCCCcccccchhcCC--------CCCCChhhHHHHHHHHHHHHcCCC
Q 020085 234 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEH--------KPYDYKADVFSFGIALWELLTGEL 305 (331)
Q Consensus 234 lkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~SlG~il~ell~g~~ 305 (331)
|+|+|++++++|.++|+||+........... ...+..|.+||.... -.++.+.|.|+||+++|.|+||..
T Consensus 171 i~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l 248 (288)
T PF14531_consen 171 IKPENFLLDQDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL 248 (288)
T ss_dssp -SGGGEEE-TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred cceeeEEEcCCCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence 9999999999999999999988765543221 445578999998643 257889999999999999999999
Q ss_pred CCCCCCHH
Q 020085 306 PYAGLTPL 313 (331)
Q Consensus 306 Pf~~~~~~ 313 (331)
||+...+.
T Consensus 249 Pf~~~~~~ 256 (288)
T PF14531_consen 249 PFGLSSPE 256 (288)
T ss_dssp STCCCGGG
T ss_pred CCCCCCcc
Confidence 99976543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.2e-21 Score=193.15 Aligned_cols=197 Identities=25% Similarity=0.400 Sum_probs=156.7
Q ss_pred ceeeeeeecCceEEEEEEE--CCceEEEEEec----CCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEE
Q 020085 113 KIECKVASGSYGDLYKGTY--CSQEVAIKVLK----PECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 113 ~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~----~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~ 186 (331)
+....+|.|++|.|+.... ..+..+.|..+ +..........+..|.-+-..+.|||++..+..+.+.....-.|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 5678999999998877654 22334444332 22222223333677888888899999988877666655555559
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC----
Q 020085 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG---- 262 (331)
Q Consensus 187 E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~---- 262 (331)
||+++ +|+.++.. .+.++...+-.++.|++.|++|+|..|+.|||+|++|+++..+|.+|++|||.+.......
T Consensus 401 E~~~~-Dlf~~~~~-~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~ 478 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMS-NGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNI 478 (601)
T ss_pred hcccH-HHHHHHhc-ccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCcchhh
Confidence 99999 99999854 4578889999999999999999999999999999999999999999999999997554332
Q ss_pred -ccccCCCCcccccchhcCCCCCCCh-hhHHHHHHHHHHHHcCCCCCCCCC
Q 020085 263 -VMTAETGTYRWMAPEVIEHKPYDYK-ADVFSFGIALWELLTGELPYAGLT 311 (331)
Q Consensus 263 -~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~SlG~il~ell~g~~Pf~~~~ 311 (331)
.....+|+..|+|||.+.+..|+++ .||||.|++++.|.+|+.||..-.
T Consensus 479 ~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~ 529 (601)
T KOG0590|consen 479 HESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAK 529 (601)
T ss_pred hhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCcccccc
Confidence 2345578999999999999999865 799999999999999999997643
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.5e-20 Score=163.55 Aligned_cols=146 Identities=16% Similarity=0.178 Sum_probs=113.9
Q ss_pred ccCcceeeeeeecCceEEEEEE---ECCceEEEEEecCCCCC--------------------H--HHHHHHHHHHHHHHh
Q 020085 109 AKQLKIECKVASGSYGDLYKGT---YCSQEVAIKVLKPECVN--------------------T--EMLKEFSQEVYIMRK 163 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~---~~~~~vavK~~~~~~~~--------------------~--~~~~~~~~E~~il~~ 163 (331)
...|++.+.||+|++|.||+|. ..|+.||+|+++..... . .....+..|+.++++
T Consensus 27 ~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~ 106 (237)
T smart00090 27 GILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR 106 (237)
T ss_pred CchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 3468899999999999999998 36899999999754211 0 012346789999999
Q ss_pred cCCC--cceeEEeEEECCCCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC-cccCCCCCCCEE
Q 020085 164 IRHK--NVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNN-IIHRDLKTANLL 240 (331)
Q Consensus 164 l~h~--niv~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-iiHrDlkp~NiL 240 (331)
+.+. .+.++++. ...++||||++|++|...... ...+....+..++.|++.++.+||+.| ++||||||+||+
T Consensus 107 L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIl 181 (237)
T smart00090 107 LYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLK-DVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNIL 181 (237)
T ss_pred HHhcCCCCCeeeEe----cCceEEEEEecCCcccccccc-cCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEE
Confidence 9753 34444442 235899999999888766532 345566677899999999999999999 999999999999
Q ss_pred EcCCCcEEEeeecceeeecC
Q 020085 241 MDENGVVKVADFGVARVQAQ 260 (331)
Q Consensus 241 i~~~~~vkl~DFg~a~~~~~ 260 (331)
++ ++.++|+|||.+.....
T Consensus 182 i~-~~~i~LiDFg~a~~~~~ 200 (237)
T smart00090 182 VH-DGKVVIIDVSQSVELDH 200 (237)
T ss_pred EE-CCCEEEEEChhhhccCC
Confidence 99 88999999999875443
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.7e-20 Score=180.41 Aligned_cols=138 Identities=21% Similarity=0.315 Sum_probs=115.7
Q ss_pred cceeeeeeecCceEEEEEEECCceEEEEEecCCCCC------HHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEE
Q 020085 112 LKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVN------TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV 185 (331)
Q Consensus 112 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~------~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV 185 (331)
|...+.||+|+||+||+|.+.+..+++|+....... ....+.+.+|++++++++|++++....++......++|
T Consensus 335 ~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv 414 (535)
T PRK09605 335 KIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIV 414 (535)
T ss_pred cCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEE
Confidence 456889999999999999998887777764322111 11235688999999999999999888777777788999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeec
Q 020085 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA 259 (331)
Q Consensus 186 ~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~ 259 (331)
|||++|++|.+++. ....++.+++++|.+||+.|++|||+||+|||+ .++.++|+|||+++...
T Consensus 415 ~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~~ 478 (535)
T PRK09605 415 MEYIGGKDLKDVLE---------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYSD 478 (535)
T ss_pred EEecCCCcHHHHHH---------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcccccCC
Confidence 99999999999885 346789999999999999999999999999999 67899999999997643
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=3e-21 Score=192.23 Aligned_cols=195 Identities=17% Similarity=0.267 Sum_probs=155.5
Q ss_pred CcceeeeeeecCceEEEEEEECCceEEEEEecCCC--CCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEec
Q 020085 111 QLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPEC--VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF 188 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~ 188 (331)
++...+.||++.|=+|.+|++....|+||++-... .+-....+..+|++ ....++||.+.+...-......|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 78889999999999999999988889999985443 22233344444555 5556899999998887777888999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeec----CCCc-
Q 020085 189 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA----QSGV- 263 (331)
Q Consensus 189 ~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~----~~~~- 263 (331)
... +|+|.+.. +.-+..-+...|+.|++.|+..+|+.||+|+|||.+||||+.-+.+.|+||..-+..- .++.
T Consensus 103 vkh-nLyDRlST-RPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf 180 (1431)
T KOG1240|consen 103 VKH-NLYDRLST-RPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADF 180 (1431)
T ss_pred Hhh-hhhhhhcc-chHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcccc
Confidence 977 99999965 4556777888999999999999999999999999999999999999999999875321 1111
Q ss_pred ---cccCCCCcccccchhcCCC----------C-CCChhhHHHHHHHHHHHHc-CCCCCC
Q 020085 264 ---MTAETGTYRWMAPEVIEHK----------P-YDYKADVFSFGIALWELLT-GELPYA 308 (331)
Q Consensus 264 ---~~~~~gt~~y~aPE~~~~~----------~-~~~~~Di~SlG~il~ell~-g~~Pf~ 308 (331)
..+...-..|.|||++... + .+++-||||+||++.||++ |++||.
T Consensus 181 ~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~ 240 (1431)
T KOG1240|consen 181 TFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT 240 (1431)
T ss_pred eEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence 1122234589999998431 2 5678999999999999999 899986
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.4e-19 Score=155.64 Aligned_cols=138 Identities=16% Similarity=0.170 Sum_probs=109.1
Q ss_pred CcceeeeeeecCceEEEEEEE-CCceEEEEEecCCCCCH--------------------HHHHHHHHHHHHHHhcCCC--
Q 020085 111 QLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNT--------------------EMLKEFSQEVYIMRKIRHK-- 167 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~--------------------~~~~~~~~E~~il~~l~h~-- 167 (331)
.|.+.+.||+|+||.||++.. .++.||||+++...... .....+..|..++..+.|+
T Consensus 16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 95 (198)
T cd05144 16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF 95 (198)
T ss_pred hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence 377789999999999999988 58999999976543110 0112367889999999877
Q ss_pred cceeEEeEEECCCCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcE
Q 020085 168 NVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVV 247 (331)
Q Consensus 168 niv~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~v 247 (331)
.++..++. ...++||||++|++|.+.... .....++.+++.++.++|+.|++||||+|+||++++++.+
T Consensus 96 ~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~-------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~ 164 (198)
T cd05144 96 PVPKPIDW----NRHAVVMEYIDGVELYRVRVL-------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKI 164 (198)
T ss_pred CCCceeec----CCceEEEEEeCCcchhhcccc-------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcE
Confidence 44445442 345899999999998775421 3456788999999999999999999999999999999999
Q ss_pred EEeeecceeeec
Q 020085 248 KVADFGVARVQA 259 (331)
Q Consensus 248 kl~DFg~a~~~~ 259 (331)
+|+|||.+....
T Consensus 165 ~liDfg~~~~~~ 176 (198)
T cd05144 165 YIIDWPQMVSTD 176 (198)
T ss_pred EEEECCccccCC
Confidence 999999996443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=4.5e-19 Score=160.28 Aligned_cols=221 Identities=20% Similarity=0.324 Sum_probs=151.1
Q ss_pred eecccCcceeeeeeecCceEEEEEEECC-------------------------------------ceEEEEEecC---CC
Q 020085 106 EIDAKQLKIECKVASGSYGDLYKGTYCS-------------------------------------QEVAIKVLKP---EC 145 (331)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-------------------------------------~~vavK~~~~---~~ 145 (331)
....++|+++..||+|....||.++... -+.|||.+-. +.
T Consensus 153 kFtiddyeiG~~igkGC~AaVY~A~~~~dg~~le~~~~t~~~pgf~p~ts~p~e~~q~~~p~~~aFPLAiKmMfN~~~~s 232 (598)
T KOG4158|consen 153 KFTIDDYEIGEFIGKGCNAAVYSARLANDGSDLESSGNTHYGPGFNPVTSIPAEIPQVSKPAQKAFPLAIKMMFNFEHDS 232 (598)
T ss_pred ccchhhhcccchhhccchhhhhhhhcCCCcccccccCCCCcCCCcCCCcCCcccCCcccCccccccchHHHHhcccccCC
Confidence 3446789999999999999999764211 0246665421 11
Q ss_pred CCHHHHHHHHHHHH------H--------HHh--------cCCCcceeEEeEEECC------------------------
Q 020085 146 VNTEMLKEFSQEVY------I--------MRK--------IRHKNVVQFIGACTRP------------------------ 179 (331)
Q Consensus 146 ~~~~~~~~~~~E~~------i--------l~~--------l~h~niv~~~~~~~~~------------------------ 179 (331)
.+....+..-+|.- . .+. -+|||||++.++|.++
T Consensus 233 ~~~~iL~sM~~ElvPa~~~a~~~e~~~~t~R~l~nqtvhLa~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~ 312 (598)
T KOG4158|consen 233 GDAHILKSMGNELVPAPNAAKLLEGQMGTFRPLPNQTVHLAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGA 312 (598)
T ss_pred chHHHHHHhhhhccCcchhhhhcccccceeeeCCCCCcccCCCCCEEeehhhhhhhhccCCchhhhCcccccceeccccc
Confidence 12233344444321 1 111 1599999999887542
Q ss_pred ---CCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEc--CCC--cEEEeee
Q 020085 180 ---PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD--ENG--VVKVADF 252 (331)
Q Consensus 180 ---~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~--~~~--~vkl~DF 252 (331)
..+|+||..+.. +|.+++..+ ..+.....-++.|+++|+.|||++||.|||+|.+|||+. +|+ .+.++||
T Consensus 313 g~~~tlylvMkrY~~-tLr~yl~~~--~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDF 389 (598)
T KOG4158|consen 313 GEPKTLYLVMKRYRQ-TLREYLWTR--HRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADF 389 (598)
T ss_pred CCCceEEEehhcchh-hHHHHHhcC--CCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEccc
Confidence 248999999987 999999654 346667778899999999999999999999999999994 344 5899999
Q ss_pred cceeeecCC-------CccccCCCCcccccchhcCCCCC------CChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcc
Q 020085 253 GVARVQAQS-------GVMTAETGTYRWMAPEVIEHKPY------DYKADVFSFGIALWELLTGELPYAGLTPLQAAVGV 319 (331)
Q Consensus 253 g~a~~~~~~-------~~~~~~~gt~~y~aPE~~~~~~~------~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~ 319 (331)
|.+-..... +.....-|.-.-||||+....+- -.++|.|+.|.+-||++....||-+....-.-...
T Consensus 390 GCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~ 469 (598)
T KOG4158|consen 390 GCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRT 469 (598)
T ss_pred ceeeeccccccccccccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhh
Confidence 987432221 12223346678899999854321 25899999999999999999999773222212222
Q ss_pred cccccccccc
Q 020085 320 VQKVSIHSII 329 (331)
Q Consensus 320 ~~~~~~p~~~ 329 (331)
.|+...|.++
T Consensus 470 Yqe~qLPalp 479 (598)
T KOG4158|consen 470 YQESQLPALP 479 (598)
T ss_pred hhhhhCCCCc
Confidence 4445555544
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.7e-18 Score=145.97 Aligned_cols=138 Identities=20% Similarity=0.258 Sum_probs=99.7
Q ss_pred eeeeeecCceEEEEEEEC-CceEEEEEecCCCCCHHHHHHH----------------------HHHHHHHHhcCCC--cc
Q 020085 115 ECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEF----------------------SQEVYIMRKIRHK--NV 169 (331)
Q Consensus 115 ~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~----------------------~~E~~il~~l~h~--ni 169 (331)
.+.||+|+||+||+|... ++.||||+++...........+ ..|...+.++.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 467999999999999885 8999999988653322211111 3566666666543 24
Q ss_pred eeEEeEEECCCCeEEEEeccCCCCHHH-HHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEEcCCCcE
Q 020085 170 VQFIGACTRPPNLCIVTEFMARGSIYD-FLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENGVV 247 (331)
Q Consensus 170 v~~~~~~~~~~~~~lV~E~~~ggsL~~-~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~iiHrDlkp~NiLi~~~~~v 247 (331)
.+.++. ...++||||++++.+.. .+..... ...+..++.+++.++.++|. .|++|+||||+||+++ ++.+
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~---~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~ 153 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRL---LEDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKV 153 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhhh---cccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcE
Confidence 444443 24589999999954321 1111111 15678899999999999999 9999999999999999 8999
Q ss_pred EEeeecceeeecC
Q 020085 248 KVADFGVARVQAQ 260 (331)
Q Consensus 248 kl~DFg~a~~~~~ 260 (331)
+++|||.+.....
T Consensus 154 ~liDfg~a~~~~~ 166 (187)
T cd05119 154 YIIDVPQAVEIDH 166 (187)
T ss_pred EEEECcccccccC
Confidence 9999999965443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.2e-17 Score=147.59 Aligned_cols=138 Identities=13% Similarity=0.140 Sum_probs=108.3
Q ss_pred eeeee-ecCceEEEEEEECCceEEEEEecCCCC-----------CHHHHHHHHHHHHHHHhcCCCcc--eeEEeEEECCC
Q 020085 115 ECKVA-SGSYGDLYKGTYCSQEVAIKVLKPECV-----------NTEMLKEFSQEVYIMRKIRHKNV--VQFIGACTRPP 180 (331)
Q Consensus 115 ~~~lg-~G~~g~Vy~~~~~~~~vavK~~~~~~~-----------~~~~~~~~~~E~~il~~l~h~ni--v~~~~~~~~~~ 180 (331)
...|| .|+.|+||.....+..+++|.++.... +......+.+|+.++++++|+++ ++.+++.....
T Consensus 36 ~~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred CceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 34687 899999999998899999998864221 11223568889999999998775 67777643322
Q ss_pred -C---eEEEEeccCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecce
Q 020085 181 -N---LCIVTEFMAR-GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA 255 (331)
Q Consensus 181 -~---~~lV~E~~~g-gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a 255 (331)
. .++|||+++| .+|.+++.. ..++.. .+.+++.++.+||++||+||||||+|||++.++.++|+|||.+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~ 189 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE--APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRG 189 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc--CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCc
Confidence 2 3599999997 699998854 345544 3568999999999999999999999999999999999999998
Q ss_pred eee
Q 020085 256 RVQ 258 (331)
Q Consensus 256 ~~~ 258 (331)
+..
T Consensus 190 ~~~ 192 (239)
T PRK01723 190 ELR 192 (239)
T ss_pred ccC
Confidence 753
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.76 E-value=8.8e-18 Score=136.47 Aligned_cols=132 Identities=15% Similarity=0.181 Sum_probs=114.3
Q ss_pred eeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCC--CcceeEEeEEECCCCeEEEEeccCC
Q 020085 114 IECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH--KNVVQFIGACTRPPNLCIVTEFMAR 191 (331)
Q Consensus 114 ~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h--~niv~~~~~~~~~~~~~lV~E~~~g 191 (331)
+.+.||+|.++.||+++..++.+++|..+.... ...+.+|+.+++.++| .++++++.+....+..++++||++|
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g 77 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEG 77 (155)
T ss_pred cceecccccccceEEEEecCCeEEEEecCCCCc----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCC
Confidence 457899999999999999889999999876532 4578899999999976 5899999988887889999999998
Q ss_pred CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCCCCEEEcCCCcEEEeeecceee
Q 020085 192 GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN---NIIHRDLKTANLLMDENGVVKVADFGVARV 257 (331)
Q Consensus 192 gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~ 257 (331)
+++..+ +......++.++++++.++|.. +++|+|++|+||++++++.++++|||.++.
T Consensus 78 ~~~~~~--------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 78 ETLDEV--------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred eecccC--------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 777654 4456677899999999999984 799999999999999989999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.8e-18 Score=170.97 Aligned_cols=173 Identities=31% Similarity=0.476 Sum_probs=130.3
Q ss_pred ccCcceeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~ 186 (331)
.++|..++.|..|+||-||..++. .+++|+|+-+.. ...+. ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq~----lilRn------ilt~a~npfvv---------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQN----LILRN------ILTFAGNPFVV---------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcccccc----hhhhc------cccccCCccee----------------
Confidence 457888999999999999999775 688999663321 01110 22222333333
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC----
Q 020085 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG---- 262 (331)
Q Consensus 187 E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~---- 262 (331)
|+....+.. -++++... +.+++|||+.||+|||+||+|++|+.-|++|+.|||+.+......
T Consensus 136 -----gDc~tllk~-~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl 201 (1205)
T KOG0606|consen 136 -----GDCATLLKN-IGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNL 201 (1205)
T ss_pred -----chhhhhccc-CCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchh
Confidence 455555532 34444332 778999999999999999999999999999999999986432211
Q ss_pred ------------ccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 263 ------------VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 263 ------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
....-+||+.|.|||++..+.|....|.|++|+++||.+-|..||.+.+|.+....++.
T Consensus 202 ~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~vis 272 (1205)
T KOG0606|consen 202 KEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS 272 (1205)
T ss_pred hhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhh
Confidence 00123799999999999999999999999999999999999999999999987776653
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.70 E-value=3.8e-18 Score=159.58 Aligned_cols=140 Identities=26% Similarity=0.474 Sum_probs=118.2
Q ss_pred CeEEEEeccCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeee
Q 020085 181 NLCIVTEFMARGSIYDFLHKQ--KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (331)
Q Consensus 181 ~~~lV~E~~~ggsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~ 258 (331)
++||.|+++...+|.+++..+ ....+......++.|++.+++| +|.+|+|+||.||+...+.++||.|||+....
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts~ 406 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTSQ 406 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheeec
Confidence 589999999999999999643 2456677889999999999999 99999999999999999999999999998766
Q ss_pred cCCC-------ccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhcccccccccc
Q 020085 259 AQSG-------VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIHS 327 (331)
Q Consensus 259 ~~~~-------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p~ 327 (331)
.... .++...||..||+||.+.+..|+.++||||||++|+|++. =..+|.. .+....++.|..|+
T Consensus 407 ~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er----~~t~~d~r~g~ip~ 479 (516)
T KOG1033|consen 407 DKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFER----IATLTDIRDGIIPP 479 (516)
T ss_pred ccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHH----HHhhhhhhcCCCCh
Confidence 5544 5677789999999999999999999999999999999998 3444443 33444466777774
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=2.3e-17 Score=156.54 Aligned_cols=149 Identities=32% Similarity=0.584 Sum_probs=127.4
Q ss_pred HHhcCCCcceeEEeEEECCCCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCc-ccCCCCCCCE
Q 020085 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI-IHRDLKTANL 239 (331)
Q Consensus 161 l~~l~h~niv~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i-iHrDlkp~Ni 239 (331)
|+.+.|.|+.+|+|.+.+++..++|.+|+..|+|.|.+....-.++.-....+..+|++||.|||+..| .|+.+++.|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 457889999999999999999999999999999999998766677777888899999999999998765 9999999999
Q ss_pred EEcCCCcEEEeeecceeeecCC---CccccCCCCcccccchhcCCCC-------CCChhhHHHHHHHHHHHHcCCCCCCC
Q 020085 240 LMDENGVVKVADFGVARVQAQS---GVMTAETGTYRWMAPEVIEHKP-------YDYKADVFSFGIALWELLTGELPYAG 309 (331)
Q Consensus 240 Li~~~~~vkl~DFg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~-------~~~~~Di~SlG~il~ell~g~~Pf~~ 309 (331)
+++....+|++|||+....... ...........|.|||.+.... .+.++|+||||++++|+++.+.||+.
T Consensus 81 lvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~ 160 (484)
T KOG1023|consen 81 LVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDL 160 (484)
T ss_pred eeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccc
Confidence 9999999999999998765431 1112223457899999986541 46779999999999999999999987
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.9e-15 Score=144.67 Aligned_cols=142 Identities=18% Similarity=0.287 Sum_probs=100.5
Q ss_pred eeeeecCceEEEEEEE-CCceEEEEEecCCCCCH----------------------------HHH----------HHHHH
Q 020085 116 CKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNT----------------------------EML----------KEFSQ 156 (331)
Q Consensus 116 ~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~----------------------------~~~----------~~~~~ 156 (331)
+.||+|++|.||+|+. +|+.||||+.++..... +.. -+|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 5799999999999998 68999999998753110 000 12555
Q ss_pred HHHHHHhcC----CCcceeEEeEE-ECCCCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHH-HHHHHHhCCcc
Q 020085 157 EVYIMRKIR----HKNVVQFIGAC-TRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK-GMNYLHQNNII 230 (331)
Q Consensus 157 E~~il~~l~----h~niv~~~~~~-~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~-~l~~LH~~~ii 230 (331)
|...+.+++ |.+-+.+-..+ ......++||||++|++|.++........+ ...++.+++. .+..+|..|++
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~~ 279 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGFF 279 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCce
Confidence 666666653 22222222222 223456899999999999988754322222 3446666665 47889999999
Q ss_pred cCCCCCCCEEEcCCCcEEEeeecceeeecC
Q 020085 231 HRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (331)
Q Consensus 231 HrDlkp~NiLi~~~~~vkl~DFg~a~~~~~ 260 (331)
|+|++|.||++++++.++++|||++.....
T Consensus 280 H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 280 HADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred eCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 999999999999999999999999976553
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.63 E-value=2.5e-17 Score=162.69 Aligned_cols=203 Identities=28% Similarity=0.465 Sum_probs=167.7
Q ss_pred ccCcceeeeeeecCceEEEEEEE---CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCcceeEEeEEECCCCeEE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY---CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCI 184 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~~~~l 184 (331)
...|.+.+.||+|+|+.|-.... ....+|+|.+...............|..+-+.+. |+|++.+++.....+..++
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 45678888899999999987655 3345677776654434445566667888888887 9999999999999999999
Q ss_pred EEeccCCCCHHHHH-HhcCCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCCCCEEEcCCC-cEEEeeecceeeecC-
Q 020085 185 VTEFMARGSIYDFL-HKQKGVFQLTSLLKVAIDVSKGMNYLH-QNNIIHRDLKTANLLMDENG-VVKVADFGVARVQAQ- 260 (331)
Q Consensus 185 V~E~~~ggsL~~~l-~~~~~~~~~~~~~~i~~qi~~~l~~LH-~~~iiHrDlkp~NiLi~~~~-~vkl~DFg~a~~~~~- 260 (331)
++++..|+++.+.+ +......+...+-.++.|+..++.|+| ..++.|||+||+|.+++..+ .++++|||+|.....
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~ 178 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK 178 (601)
T ss_pred ccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccccc
Confidence 99999999999988 443336677788899999999999999 99999999999999999999 999999999976555
Q ss_pred CC---ccccCCC-CcccccchhcCCCCC-CChhhHHHHHHHHHHHHcCCCCCCCCC
Q 020085 261 SG---VMTAETG-TYRWMAPEVIEHKPY-DYKADVFSFGIALWELLTGELPYAGLT 311 (331)
Q Consensus 261 ~~---~~~~~~g-t~~y~aPE~~~~~~~-~~~~Di~SlG~il~ell~g~~Pf~~~~ 311 (331)
.+ .....+| ++.|+|||...+..+ .+..|+||.|+++.-+++|..||....
T Consensus 179 ~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~ 234 (601)
T KOG0590|consen 179 NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPS 234 (601)
T ss_pred CCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccc
Confidence 22 2334578 999999999987544 577899999999999999999997653
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.57 E-value=1.4e-14 Score=120.93 Aligned_cols=128 Identities=16% Similarity=0.204 Sum_probs=98.3
Q ss_pred eeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcc-eeEEeEEECCCCeEEEEeccCCCC
Q 020085 115 ECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNV-VQFIGACTRPPNLCIVTEFMARGS 193 (331)
Q Consensus 115 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~ni-v~~~~~~~~~~~~~lV~E~~~ggs 193 (331)
.+.++.|.++.||+++..++.+++|+...... ....+.+|+.+++.+.+.++ ++++.... ...++||||++|.+
T Consensus 3 ~~~l~~G~~~~vy~~~~~~~~~~lK~~~~~~~---~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~ 77 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVANKKYVVRIPGNGTE---LLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSE 77 (170)
T ss_pred eeecCCcccCceEEEEECCeEEEEEeCCCCcc---cccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCc
Confidence 35789999999999999999999999865421 12346789999998865444 44554433 24589999999988
Q ss_pred HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCc-----ccCCCCCCCEEEcCCCcEEEeeecceee
Q 020085 194 IYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI-----IHRDLKTANLLMDENGVVKVADFGVARV 257 (331)
Q Consensus 194 L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i-----iHrDlkp~NiLi~~~~~vkl~DFg~a~~ 257 (331)
+.+.- . .....+.++++++..||+.++ +|+|++|.||+++ ++.++++||+.+..
T Consensus 78 l~~~~------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 78 LLTED------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred ccccc------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 76430 1 112456789999999999885 9999999999998 67899999999864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.55 E-value=1.4e-14 Score=140.80 Aligned_cols=148 Identities=17% Similarity=0.229 Sum_probs=92.9
Q ss_pred cCcceeeeeeecCceEEEEEEE-C-CceEEEEEecCCCCC----------------------------H----HHHHH--
Q 020085 110 KQLKIECKVASGSYGDLYKGTY-C-SQEVAIKVLKPECVN----------------------------T----EMLKE-- 153 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~-~-~~~vavK~~~~~~~~----------------------------~----~~~~~-- 153 (331)
.+|.. +.||+|++|.||+|+. . |+.||||+.++.... . +..+.
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 34655 7899999999999998 3 899999999865310 0 11111
Q ss_pred ----HHHHHHHHHhcC----CCcceeEEeEE-ECCCCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Q 020085 154 ----FSQEVYIMRKIR----HKNVVQFIGAC-TRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 224 (331)
Q Consensus 154 ----~~~E~~il~~l~----h~niv~~~~~~-~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~L 224 (331)
+.+|+..+.+++ +.+.+.+-..+ ......++||||++|+++.++-.-.....+...+.....+ .-+..+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~--~~~~Qi 276 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVE--VFFTQV 276 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHH--HHHHHH
Confidence 344444444442 22222222222 1133567999999999998753211222222222211111 123445
Q ss_pred HhCCcccCCCCCCCEEEcCCC----cEEEeeecceeeecC
Q 020085 225 HQNNIIHRDLKTANLLMDENG----VVKVADFGVARVQAQ 260 (331)
Q Consensus 225 H~~~iiHrDlkp~NiLi~~~~----~vkl~DFg~a~~~~~ 260 (331)
...|++|+|+||.||+++.+| .++++|||++...+.
T Consensus 277 f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 579999999999999999988 999999999976544
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.51 E-value=2.1e-13 Score=116.04 Aligned_cols=137 Identities=18% Similarity=0.209 Sum_probs=100.0
Q ss_pred eeeeecCceEEEEEEEC--------CceEEEEEecCCCC-----------C---------HHHHHHH----HHHHHHHHh
Q 020085 116 CKVASGSYGDLYKGTYC--------SQEVAIKVLKPECV-----------N---------TEMLKEF----SQEVYIMRK 163 (331)
Q Consensus 116 ~~lg~G~~g~Vy~~~~~--------~~~vavK~~~~~~~-----------~---------~~~~~~~----~~E~~il~~ 163 (331)
..||.|--+.||.|... +..+|||+.+.... + ....+.+ .+|...|++
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 47899999999999764 36899999873211 0 0112233 389999999
Q ss_pred cCC--CcceeEEeEEECCCCeEEEEeccCCCCHHH-HHHhcCCCCCHHHHHHHHHHHHHHHHHH-HhCCcccCCCCCCCE
Q 020085 164 IRH--KNVVQFIGACTRPPNLCIVTEFMARGSIYD-FLHKQKGVFQLTSLLKVAIDVSKGMNYL-HQNNIIHRDLKTANL 239 (331)
Q Consensus 164 l~h--~niv~~~~~~~~~~~~~lV~E~~~ggsL~~-~l~~~~~~~~~~~~~~i~~qi~~~l~~L-H~~~iiHrDlkp~Ni 239 (331)
+.. -++++.+++ ...++||||+.+..+.. .+. ...++...+..+..+++.+|..| |+.|++|+||++.||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk--d~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NI 156 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK--DAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNM 156 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh--ccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 853 456666654 35689999998754422 221 22345566778889999999998 899999999999999
Q ss_pred EEcCCCcEEEeeecceeeec
Q 020085 240 LMDENGVVKVADFGVARVQA 259 (331)
Q Consensus 240 Li~~~~~vkl~DFg~a~~~~ 259 (331)
+++ ++.+.++|||.+....
T Consensus 157 L~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 157 LWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred EEE-CCcEEEEECCCceeCC
Confidence 997 5689999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.49 E-value=6.6e-13 Score=109.89 Aligned_cols=134 Identities=22% Similarity=0.299 Sum_probs=102.6
Q ss_pred eeeeecCceEEEEEEECCceEEEEEecCCCC-CH----H-HHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEecc
Q 020085 116 CKVASGSYGDLYKGTYCSQEVAIKVLKPECV-NT----E-MLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFM 189 (331)
Q Consensus 116 ~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~-~~----~-~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~~ 189 (331)
..+++|+-+.+|.+.+.|.++.+|.-.+... .+ . ....-.+|+.++++++--.|...+-+..+.....|+|||+
T Consensus 2 ~~i~~GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I 81 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYI 81 (204)
T ss_pred chhhCCcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEe
Confidence 3578999999999999888888886543322 22 1 1244677999999987656555555566777888999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeee
Q 020085 190 ARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (331)
Q Consensus 190 ~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~ 258 (331)
+|..|.+.+... . ..++..+=..+.-||..||+|+||.++||++..++ +.++|||++...
T Consensus 82 ~G~~lkd~l~~~----~----~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s 141 (204)
T COG3642 82 EGELLKDALEEA----R----PDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS 141 (204)
T ss_pred CChhHHHHHHhc----c----hHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence 999999999654 2 34555555666779999999999999999997655 999999999743
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.45 E-value=2e-12 Score=106.66 Aligned_cols=145 Identities=22% Similarity=0.277 Sum_probs=109.0
Q ss_pred eeeeeeecCceEEEEEEECCceEEEEEecCCCC-----CHH-HHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEe
Q 020085 114 IECKVASGSYGDLYKGTYCSQEVAIKVLKPECV-----NTE-MLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (331)
Q Consensus 114 ~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~-----~~~-~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E 187 (331)
....+.||+-+.|+++.+.|+...||.-.+... +.. ...+..+|+++|.+++--.|.--.-++.+...-+|+||
T Consensus 11 ~l~likQGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME 90 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYME 90 (229)
T ss_pred cceeeeccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEE
Confidence 456789999999999999999988886543322 222 23567889999999875455443334555556789999
Q ss_pred ccCC-CCHHHHHHhcCCC-CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC---cEEEeeecceeee
Q 020085 188 FMAR-GSIYDFLHKQKGV-FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG---VVKVADFGVARVQ 258 (331)
Q Consensus 188 ~~~g-gsL~~~l~~~~~~-~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~---~vkl~DFg~a~~~ 258 (331)
|++| .++.+++...-.. ........++.+|=+.+.-||.+++||+||..+||++..++ .+.++|||++...
T Consensus 91 ~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 91 FIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred eccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 9987 4788888665333 23333477888888999999999999999999999998766 3589999998643
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.41 E-value=4.2e-12 Score=122.55 Aligned_cols=162 Identities=17% Similarity=0.268 Sum_probs=124.6
Q ss_pred CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEeccCCCCHHHHHHhcCCCCCHHHHH
Q 020085 132 CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLL 211 (331)
Q Consensus 132 ~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~ 211 (331)
.+.+|.|.+.+.... .......+-++-|+.++||||++++..++.++.+|+|+|.+. .|..++.+.. .....
T Consensus 36 ~~~~vsVF~~~~~~~--~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~----~~~v~ 107 (690)
T KOG1243|consen 36 DGGPVSVFVYKRSNG--EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG----KEEVC 107 (690)
T ss_pred cCCceEEEEEeCCCc--hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH----HHHHH
Confidence 567888888876532 334556777888999999999999999999999999999985 7887875533 45566
Q ss_pred HHHHHHHHHHHHHH-hCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCcc-ccCCCCcccccchhcCCCCCCChhh
Q 020085 212 KVAIDVSKGMNYLH-QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM-TAETGTYRWMAPEVIEHKPYDYKAD 289 (331)
Q Consensus 212 ~i~~qi~~~l~~LH-~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~D 289 (331)
.-+.||+.||.+|| +.+++|++++...|++++.|..||++|.++........+ ....---.|..|+.+.... ...|
T Consensus 108 ~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s~--~s~D 185 (690)
T KOG1243|consen 108 LGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPSE--WSID 185 (690)
T ss_pred HHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCccc--cchh
Confidence 67889999999998 578999999999999999999999999998655443320 0111112345566553332 4569
Q ss_pred HHHHHHHHHHHHcC
Q 020085 290 VFSFGIALWELLTG 303 (331)
Q Consensus 290 i~SlG~il~ell~g 303 (331)
.|-|||+++|++.|
T Consensus 186 ~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 186 SWGLGCLIEELFNG 199 (690)
T ss_pred hhhHHHHHHHHhCc
Confidence 99999999999999
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.40 E-value=2.6e-13 Score=129.40 Aligned_cols=196 Identities=25% Similarity=0.323 Sum_probs=157.1
Q ss_pred cCcceeeeeee--cCceEEEEEEE----CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCcceeEEeEEECCCCe
Q 020085 110 KQLKIECKVAS--GSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNL 182 (331)
Q Consensus 110 ~~~~~~~~lg~--G~~g~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~~~ 182 (331)
..+.+.+.+|. |.+|.||.++. .+..+|+|.-+........-..-.+|....+.++ |+|.++....+...+..
T Consensus 114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~l 193 (524)
T KOG0601|consen 114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGIL 193 (524)
T ss_pred hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcc
Confidence 34567788999 99999998765 5678999985533322222233345565666664 89999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHH----HHHHHHhCCcccCCCCCCCEEEcCC-CcEEEeeecceee
Q 020085 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK----GMNYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARV 257 (331)
Q Consensus 183 ~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~----~l~~LH~~~iiHrDlkp~NiLi~~~-~~vkl~DFg~a~~ 257 (331)
++-+|.+. .+|.++.+.....++...++..+.+... |+.++|..+++|-|+||+||++..+ ...++.|||+...
T Consensus 194 fiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~ 272 (524)
T KOG0601|consen 194 FIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSK 272 (524)
T ss_pred eeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcceeEE
Confidence 99999985 6999998887777888999999999999 9999999999999999999999999 8899999999976
Q ss_pred ecCCCcc------ccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCC
Q 020085 258 QAQSGVM------TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 307 (331)
Q Consensus 258 ~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf 307 (331)
....... ...-+...|++||..++. ++..+|+||+|.++.+..++..+.
T Consensus 273 i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l-~~~~~di~sl~ev~l~~~l~~~~~ 327 (524)
T KOG0601|consen 273 ISDGNFSSVFKVSKRPEGDCIYAAKELLNGL-ATFASDIFSLGEVILEAILGSHLP 327 (524)
T ss_pred ccCCccccceeeeecCCCCceEeChhhhccc-cchHhhhcchhhhhHhhHhhcccc
Confidence 6554321 112578899999998654 688999999999999998875443
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.35 E-value=6e-12 Score=109.33 Aligned_cols=140 Identities=18% Similarity=0.259 Sum_probs=106.6
Q ss_pred eeeeecCceEEEEEEECC-ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCC--CcceeEEeEEECCC---CeEEEEecc
Q 020085 116 CKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH--KNVVQFIGACTRPP---NLCIVTEFM 189 (331)
Q Consensus 116 ~~lg~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h--~niv~~~~~~~~~~---~~~lV~E~~ 189 (331)
+.|+.|.++.||+++..+ +.+++|+....... .....+.+|..+++.+++ .++.+++.+..... ..++||||+
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~-~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i 82 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL-PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV 82 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccC-cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence 568999999999998865 89999997654321 124578899999999975 34677777765532 568999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------------
Q 020085 190 ARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ------------------------------------------- 226 (331)
Q Consensus 190 ~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~------------------------------------------- 226 (331)
+|.++.+.+.. ..++......++.+++++|..||+
T Consensus 83 ~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (223)
T cd05154 83 DGRVLRDRLLR--PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERL 160 (223)
T ss_pred CCEecCCCCCC--CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHH
Confidence 99888775521 345666667777777777777773
Q ss_pred -------------CCcccCCCCCCCEEEcC--CCcEEEeeecceeee
Q 020085 227 -------------NNIIHRDLKTANLLMDE--NGVVKVADFGVARVQ 258 (331)
Q Consensus 227 -------------~~iiHrDlkp~NiLi~~--~~~vkl~DFg~a~~~ 258 (331)
..++|+|++|.||+++. ++.+.++||+.+...
T Consensus 161 ~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 161 LRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred HHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 23589999999999998 677899999998643
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.32 E-value=6.7e-11 Score=105.99 Aligned_cols=135 Identities=16% Similarity=0.125 Sum_probs=99.5
Q ss_pred CceEEEEEEECCceEEEEEecCCCCCHHHHH----------HHHHHHHHHHhcCCCcc--eeEEeEEEC-----CCCeEE
Q 020085 122 SYGDLYKGTYCSQEVAIKVLKPECVNTEMLK----------EFSQEVYIMRKIRHKNV--VQFIGACTR-----PPNLCI 184 (331)
Q Consensus 122 ~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~----------~~~~E~~il~~l~h~ni--v~~~~~~~~-----~~~~~l 184 (331)
....|++....|+.+.||........ ...+ .+.+|...+.++...+| ++.+++... ....++
T Consensus 34 ~~rrvvr~~~~g~~~~vKr~~~~~~~-~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~L 112 (268)
T PRK15123 34 EGRRTLRFELAGKSYFLKWHRGTGWG-EIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFI 112 (268)
T ss_pred CCceEEEEEECCEEEEEEEecCCcHH-HHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEE
Confidence 33457788888999999987543311 1111 47789998888854333 334444432 224789
Q ss_pred EEeccCCC-CHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC-------CCcEEEeeecce
Q 020085 185 VTEFMARG-SIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE-------NGVVKVADFGVA 255 (331)
Q Consensus 185 V~E~~~gg-sL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~-------~~~vkl~DFg~a 255 (331)
|||++++. +|.+++... ....+......++.+++..+..||+.||+|+|+++.|||++. +..+.++||+.+
T Consensus 113 Vte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~ 192 (268)
T PRK15123 113 ITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRA 192 (268)
T ss_pred EEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCcc
Confidence 99999986 899998532 344566677889999999999999999999999999999985 467999999998
Q ss_pred ee
Q 020085 256 RV 257 (331)
Q Consensus 256 ~~ 257 (331)
+.
T Consensus 193 ~~ 194 (268)
T PRK15123 193 QI 194 (268)
T ss_pred cc
Confidence 64
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.30 E-value=9.1e-13 Score=132.17 Aligned_cols=214 Identities=23% Similarity=0.296 Sum_probs=157.3
Q ss_pred eecccCcceeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCe
Q 020085 106 EIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL 182 (331)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 182 (331)
....+.+.+.+.+-+|+++.++.++-. +...++|+.+.... .....+....+-.++-..++|.++.....+......
T Consensus 800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~ 879 (1205)
T KOG0606|consen 800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPL 879 (1205)
T ss_pred cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCc
Confidence 445667888889999999999977653 33445554432210 011112233333333333457777666666667789
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecC--
Q 020085 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-- 260 (331)
Q Consensus 183 ~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~-- 260 (331)
+++++|..+++|...++.. +..+..-.......+..+.+|||...+.|||++|.|+++..++..++.||+......-
T Consensus 880 ~L~~~~~~~~~~~Skl~~~-~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~ 958 (1205)
T KOG0606|consen 880 PLVGHYLNGGDLPSKLHNS-GCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIP 958 (1205)
T ss_pred chhhHHhccCCchhhhhcC-CCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccccccccc
Confidence 9999999999999999764 4455555666777888999999999999999999999999999999999984321100
Q ss_pred -------------------C-----------CccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 020085 261 -------------------S-----------GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL 310 (331)
Q Consensus 261 -------------------~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~ 310 (331)
. .......+|+.|.+||...+......+|.|+.|++++|.++|.+||...
T Consensus 959 p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen 959 PTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred CcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCc
Confidence 0 0011234899999999999999999999999999999999999999999
Q ss_pred CHHHHHhccc
Q 020085 311 TPLQAAVGVV 320 (331)
Q Consensus 311 ~~~~~~~~~~ 320 (331)
++-+....+.
T Consensus 1039 tpq~~f~ni~ 1048 (1205)
T KOG0606|consen 1039 TPQQIFENIL 1048 (1205)
T ss_pred chhhhhhccc
Confidence 9988876654
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.24 E-value=4.6e-12 Score=120.87 Aligned_cols=195 Identities=22% Similarity=0.208 Sum_probs=152.3
Q ss_pred cccCcceeeeeeecCceEEEEEEE---CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCcceeEEeEEECCCCeE
Q 020085 108 DAKQLKIECKVASGSYGDLYKGTY---CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLC 183 (331)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~~~~ 183 (331)
...++..+..||.|.|+.|++... .+..|++|-+............-..|+.+...+. |.+++.....+..-+..|
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 456788999999999999998765 3577899988766544433344556777777774 889999888888888889
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC-CcEEEeeecceeeecCCC
Q 020085 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSG 262 (331)
Q Consensus 184 lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~-~~vkl~DFg~a~~~~~~~ 262 (331)
+-.||++++++...+ .-...+.+...+++..|++.++.++|+..++|+|++|+||++..+ +..++.|||........
T Consensus 343 ip~e~~~~~s~~l~~-~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~- 420 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRS-VTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS- 420 (524)
T ss_pred CchhhhcCcchhhhh-HHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccccee-
Confidence 999999999877666 224567788899999999999999999999999999999999886 77899999998642221
Q ss_pred ccccCCCCcccc--cchhcCCCCCCChhhHHHHHHHHHHHHcCCC
Q 020085 263 VMTAETGTYRWM--APEVIEHKPYDYKADVFSFGIALWELLTGEL 305 (331)
Q Consensus 263 ~~~~~~gt~~y~--aPE~~~~~~~~~~~Di~SlG~il~ell~g~~ 305 (331)
.....+.-+++ +++..+...+..+.|+||||..+.+..++.+
T Consensus 421 -~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ 464 (524)
T KOG0601|consen 421 -SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSP 464 (524)
T ss_pred -cccccccccccccchhhccccccccccccccccccccccccCcc
Confidence 11222333444 5666677788899999999999999999763
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.23 E-value=1e-10 Score=99.17 Aligned_cols=127 Identities=20% Similarity=0.255 Sum_probs=83.0
Q ss_pred EEEEEEE-CCceEEEEEecCCCC-----------------------CH-HHHHHHHHHHHHHHhcCCC--cceeEEeEEE
Q 020085 125 DLYKGTY-CSQEVAIKVLKPECV-----------------------NT-EMLKEFSQEVYIMRKIRHK--NVVQFIGACT 177 (331)
Q Consensus 125 ~Vy~~~~-~~~~vavK~~~~~~~-----------------------~~-~~~~~~~~E~~il~~l~h~--niv~~~~~~~ 177 (331)
.||.|.. .+..+|+|+.+.... .. -......+|.+.|.++..- ++++.+++-
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899987 678999999873211 11 1234578899999999765 466666542
Q ss_pred CCCCeEEEEeccC--CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH-HHhCCcccCCCCCCCEEEcCCCcEEEeeecc
Q 020085 178 RPPNLCIVTEFMA--RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNY-LHQNNIIHRDLKTANLLMDENGVVKVADFGV 254 (331)
Q Consensus 178 ~~~~~~lV~E~~~--ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~-LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~ 254 (331)
..++||||++ |..+..+.... ++......++.+++..+.. +|+.|++|+||++.||+++++ .+.++|||.
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~---~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q 152 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD---LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ 152 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG---GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred ---CCEEEEEecCCCccchhhHHhcc---ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence 3479999999 65555543221 1133455677777775555 579999999999999999887 999999999
Q ss_pred eeeec
Q 020085 255 ARVQA 259 (331)
Q Consensus 255 a~~~~ 259 (331)
+....
T Consensus 153 av~~~ 157 (188)
T PF01163_consen 153 AVDSS 157 (188)
T ss_dssp EEETT
T ss_pred ceecC
Confidence 86543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >cd04928 ACT_TyrKc Uncharacterized, N-terminal ACT domain of an Arabidopsis/Oryza predicted tyrosine kinase and other related ACT domains | Back alignment and domain information |
|---|
Probab=99.20 E-value=5.7e-11 Score=82.65 Aligned_cols=55 Identities=58% Similarity=0.925 Sum_probs=52.3
Q ss_pred HHHHHHHHHHhhhCCCeeeeeeeecCCCceeeEEEecCCCCCchHHHHHHHHHHH
Q 020085 9 MKVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEI 63 (331)
Q Consensus 9 ~~~~~~~~~~~~~~~~i~~~~~~~t~~~~~~~~~vv~gw~~~~~~~l~~~l~~~~ 63 (331)
.++++++.+|+..||||++|.+|+|.|||.||+|+|.+|..+++++|..++.+++
T Consensus 13 gLFa~iag~L~~~~LnI~~A~i~tt~dG~~LDtF~V~d~~~~~~~~~~~~~~~~~ 67 (68)
T cd04928 13 KLLSQLSSLLGDLGLNIAEAHAFSTDDGLALDIFVVTGWKRGETAALGHALQKEI 67 (68)
T ss_pred chHHHHHHHHHHCCCceEEEEEEEcCCCeEEEEEEEecCCccchHHHHHHHHHhh
Confidence 3789999999999999999999999999999999999999999999999998764
|
This CD includes a novel, yet uncharacterized, N-terminal ACT domain of an Arabidopsis/Oryza predicted tyrosine kinase and other related ACT domains. Members of this CD belong to the superfamily of ACT regulatory domains. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.10 E-value=2e-09 Score=99.29 Aligned_cols=191 Identities=17% Similarity=0.228 Sum_probs=135.0
Q ss_pred ceeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCccee--------EEeEEECCCCeE
Q 020085 113 KIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQ--------FIGACTRPPNLC 183 (331)
Q Consensus 113 ~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~--------~~~~~~~~~~~~ 183 (331)
...+.||+|+-+.+|-.-.-+. -+-|++.... .. .-.+.+..|... .||-+-. ++|. ..+....
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~d-~VAKIYh~Pp--pa---~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~-~~~~~iG 86 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVRD-QVAKIYHAPP--PA---AQAQKVAELAATPDAPLLNYRVAWPQATLHGG-RRGKVIG 86 (637)
T ss_pred CCCccccCCccceeeecchhhc-hhheeecCCC--ch---HHHHHHHHhccCCCCcchhhhhcccHHHhhCC-CccceeE
Confidence 4567899999999995432222 3446654332 11 112233344443 4553322 1111 1122367
Q ss_pred EEEeccCCC-CHHHHHHhc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceee
Q 020085 184 IVTEFMARG-SIYDFLHKQ-----KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV 257 (331)
Q Consensus 184 lV~E~~~gg-sL~~~l~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~ 257 (331)
+.|..+.|. ....+++.. .....++.+++.++.++.+.+-||+.|.+-+|++++|+|+.+++.+.|.|=..-..
T Consensus 87 flmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 87 FLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred EecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceee
Confidence 888888775 333333221 23477889999999999999999999999999999999999999999999777666
Q ss_pred ecCCCccccCCCCcccccchhcC-----CCCCCChhhHHHHHHHHHHHHcC-CCCCCCC
Q 020085 258 QAQSGVMTAETGTYRWMAPEVIE-----HKPYDYKADVFSFGIALWELLTG-ELPYAGL 310 (331)
Q Consensus 258 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~SlG~il~ell~g-~~Pf~~~ 310 (331)
...+.......|...|.+||... +-.-+...|.|.||+++++++.| ++||.+.
T Consensus 167 ~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI 225 (637)
T COG4248 167 NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI 225 (637)
T ss_pred ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence 66666677788999999999864 34556789999999999999995 9999875
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.1e-09 Score=94.72 Aligned_cols=107 Identities=17% Similarity=0.272 Sum_probs=83.7
Q ss_pred HHHHHHHHHHHhcCCCc--ceeEEeEEECCC----CeEEEEeccCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Q 020085 152 KEFSQEVYIMRKIRHKN--VVQFIGACTRPP----NLCIVTEFMARG-SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 224 (331)
Q Consensus 152 ~~~~~E~~il~~l~h~n--iv~~~~~~~~~~----~~~lV~E~~~gg-sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~L 224 (331)
....+|...+..+.... +++.+++..... ..++|||++++. +|.+++..... .+......++.++++.+.-|
T Consensus 56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~~~i~~l 134 (206)
T PF06293_consen 56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALARLIAKL 134 (206)
T ss_pred hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHHHHHHHH
Confidence 45778888887775322 344555554422 358999999984 89999865322 56677788999999999999
Q ss_pred HhCCcccCCCCCCCEEEcCCC---cEEEeeecceeeec
Q 020085 225 HQNNIIHRDLKTANLLMDENG---VVKVADFGVARVQA 259 (331)
Q Consensus 225 H~~~iiHrDlkp~NiLi~~~~---~vkl~DFg~a~~~~ 259 (331)
|++||+|+|+++.|||++.++ .+.++||+.++...
T Consensus 135 H~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 135 HDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 999999999999999999887 89999999987543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=1.2e-09 Score=95.78 Aligned_cols=137 Identities=18% Similarity=0.230 Sum_probs=102.6
Q ss_pred cceeeeeeecCceEEEEEEE-CCceEEEEEecCCCC------------------C--HHHHHHHHHHHHHHHhcCCC--c
Q 020085 112 LKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECV------------------N--TEMLKEFSQEVYIMRKIRHK--N 168 (331)
Q Consensus 112 ~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~------------------~--~~~~~~~~~E~~il~~l~h~--n 168 (331)
..++.+||-|--+.||.|.+ .|.++|||.-+.... + .-......+|.++|+++... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 46778999999999999998 589999998653321 1 11234577899999998654 6
Q ss_pred ceeEEeEEECCCCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEE
Q 020085 169 VVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVK 248 (331)
Q Consensus 169 iv~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vk 248 (331)
+++.++. +...+|||+++|-.|...- ++....-.++..|+.-+.-+-..|++|+|+++-||++++||.+.
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~ 242 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLR------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIV 242 (304)
T ss_pred CCCcccc----ccceeeeehcccceeeccc------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEE
Confidence 6766653 3568999999997665532 12333445555666666666699999999999999999999999
Q ss_pred Eeeecceeee
Q 020085 249 VADFGVARVQ 258 (331)
Q Consensus 249 l~DFg~a~~~ 258 (331)
++||-.+...
T Consensus 243 vIDwPQ~v~~ 252 (304)
T COG0478 243 VIDWPQAVPI 252 (304)
T ss_pred EEeCcccccC
Confidence 9999987543
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.01 E-value=9.9e-09 Score=87.86 Aligned_cols=140 Identities=14% Similarity=0.076 Sum_probs=103.7
Q ss_pred eeecCceEEEEEEECCceEEEEEecCCCC----CHHHHHHHHHHHHHHHhcCC--CcceeEEeEEECC----CCeEEEEe
Q 020085 118 VASGSYGDLYKGTYCSQEVAIKVLKPECV----NTEMLKEFSQEVYIMRKIRH--KNVVQFIGACTRP----PNLCIVTE 187 (331)
Q Consensus 118 lg~G~~g~Vy~~~~~~~~vavK~~~~~~~----~~~~~~~~~~E~~il~~l~h--~niv~~~~~~~~~----~~~~lV~E 187 (331)
-|.||-+-|++-.+.|+.+-+|.-..... .+.....|.+|...++++.. -.+++.+.+.... ...+||+|
T Consensus 26 ~~rgG~SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe 105 (216)
T PRK09902 26 YRRNGMSGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTE 105 (216)
T ss_pred cCCCCcceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEE
Confidence 35688888999888888888887651110 02234679999999999853 2244554222221 13689999
Q ss_pred ccCC-CCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCc--EEEeeecceee
Q 020085 188 FMAR-GSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV--VKVADFGVARV 257 (331)
Q Consensus 188 ~~~g-gsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~--vkl~DFg~a~~ 257 (331)
-+.| .+|.+++.+.. .+.+......+..++++++.-||+.|+.|+|+.+.||+++.+|. ++++||.-++.
T Consensus 106 ~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 106 DMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred eCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 8864 38998885432 34566777889999999999999999999999999999987777 99999998864
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.00 E-value=2.7e-09 Score=103.37 Aligned_cols=143 Identities=18% Similarity=0.244 Sum_probs=97.2
Q ss_pred eeeeecCceEEEEEEEC-CceEEEEEecCCCCCH----------------------------HH----------HHHHHH
Q 020085 116 CKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNT----------------------------EM----------LKEFSQ 156 (331)
Q Consensus 116 ~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~----------------------------~~----------~~~~~~ 156 (331)
..|+.+|-|.||+|+.. |+.||||+.++..... +. .-++.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 57999999999999996 8999999988653110 00 112445
Q ss_pred HHHHHHhcC-----CCcceeEEeEEECCCCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 020085 157 EVYIMRKIR-----HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIH 231 (331)
Q Consensus 157 E~~il~~l~-----h~niv~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiH 231 (331)
|...+.+++ .|++.--.-+++....-.++|||++|-.+.+........++...+.....++ -+..+=..|++|
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~--f~~q~~~dgffH 288 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRA--FLRQLLRDGFFH 288 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHH--HHHHHHhcCccc
Confidence 555555553 2333222222333445689999999999988854434555644433333222 244555689999
Q ss_pred CCCCCCCEEEcCCCcEEEeeecceeeecC
Q 020085 232 RDLKTANLLMDENGVVKVADFGVARVQAQ 260 (331)
Q Consensus 232 rDlkp~NiLi~~~~~vkl~DFg~a~~~~~ 260 (331)
.|.+|.||+++.+|.+.+.|||+......
T Consensus 289 aDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 289 ADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred cCCCccceEEecCCcEEEEcCcceecCCH
Confidence 99999999999999999999999875544
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.98 E-value=6.5e-09 Score=98.12 Aligned_cols=165 Identities=18% Similarity=0.249 Sum_probs=126.0
Q ss_pred CceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEE----CCCCeEEEEeccCC-CCH
Q 020085 122 SYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT----RPPNLCIVTEFMAR-GSI 194 (331)
Q Consensus 122 ~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~----~~~~~~lV~E~~~g-gsL 194 (331)
-..+.|+++. +|..|++|+++.... ........-+++++++.|+|+|+|..++. .+..+++|++|+++ ++|
T Consensus 288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~--~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 288 FSITTYKATSNVDGNAYVLKRLHGDRD--QSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred ccceeEeeeeccCCceeeeeeeccccc--cCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 3467889876 789999999943321 11123345577899999999999998876 34568999999986 478
Q ss_pred HHHHHhc--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecC
Q 020085 195 YDFLHKQ--------------KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (331)
Q Consensus 195 ~~~l~~~--------------~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~ 260 (331)
+++.... +...++..+|.++.|+..||.++|+.|+..+-|.+.+|+++.+.+++|+..|.......
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 8876332 22467889999999999999999999999999999999999988999998888765543
Q ss_pred CCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCC
Q 020085 261 SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGE 304 (331)
Q Consensus 261 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~ 304 (331)
... +-++. ..+-|.=.||.++..|.||.
T Consensus 446 d~~-------------~~le~---~Qq~D~~~lG~ll~aLAt~~ 473 (655)
T KOG3741|consen 446 DPT-------------EPLES---QQQNDLRDLGLLLLALATGT 473 (655)
T ss_pred CCC-------------cchhH---HhhhhHHHHHHHHHHHhhcc
Confidence 320 11111 23578889999999999984
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.94 E-value=2.1e-08 Score=86.18 Aligned_cols=141 Identities=18% Similarity=0.220 Sum_probs=96.7
Q ss_pred ecccCcceeeeeeecCceEEEEEEECCceEEEEEecCCCCCHH-HHHH------HHHHHHHHHhcC---CCcceeEEeEE
Q 020085 107 IDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTE-MLKE------FSQEVYIMRKIR---HKNVVQFIGAC 176 (331)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~-~~~~------~~~E~~il~~l~---h~niv~~~~~~ 176 (331)
+...+|++.+.+.......|.+-...++.+.+|..+......+ .... ..+++..+.+++ -.....++.+.
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 3466888889998888888999899999999999886542221 1111 223333333332 23333333333
Q ss_pred EC-----CCCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEee
Q 020085 177 TR-----PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 251 (331)
Q Consensus 177 ~~-----~~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~D 251 (331)
.. ....+++|||++|..|.+... +++ .++..+.+++..||+.|+.|+|.+|.|+++++++ ++++|
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID 177 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED-----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIID 177 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh-----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEE
Confidence 22 234678999999988877542 222 2456677889999999999999999999998655 99999
Q ss_pred ecceee
Q 020085 252 FGVARV 257 (331)
Q Consensus 252 Fg~a~~ 257 (331)
|+..+.
T Consensus 178 ~~~k~~ 183 (229)
T PF06176_consen 178 TQGKRM 183 (229)
T ss_pred Cccccc
Confidence 987753
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.94 E-value=1.5e-09 Score=97.03 Aligned_cols=146 Identities=23% Similarity=0.411 Sum_probs=113.0
Q ss_pred HHhcCCCcceeEEeEEECC-----CCeEEEEeccCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC--Ccc
Q 020085 161 MRKIRHKNVVQFIGACTRP-----PNLCIVTEFMARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLHQN--NII 230 (331)
Q Consensus 161 l~~l~h~niv~~~~~~~~~-----~~~~lV~E~~~ggsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~--~ii 230 (331)
+-++.|.|+|+++.++.+. ....+++|||..|++..+|++. ...+......+|+-||+.||.|||+. -++
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppii 200 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPII 200 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccc
Confidence 3445799999999988653 3578999999999999999664 24577778889999999999999986 599
Q ss_pred cCCCCCCCEEEcCCCcEEEeeecceeeecC-----CCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCC
Q 020085 231 HRDLKTANLLMDENGVVKVADFGVARVQAQ-----SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGEL 305 (331)
Q Consensus 231 HrDlkp~NiLi~~~~~vkl~DFg~a~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~ 305 (331)
|+++..+.|++..+|-+|+.--.-...... .......++-++|.+||.=.....+-++|||+||....+|..+..
T Consensus 201 hgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEi 280 (458)
T KOG1266|consen 201 HGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEI 280 (458)
T ss_pred cCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhee
Confidence 999999999999999888763222211111 111233457789999998666666778999999999999988765
Q ss_pred C
Q 020085 306 P 306 (331)
Q Consensus 306 P 306 (331)
-
T Consensus 281 q 281 (458)
T KOG1266|consen 281 Q 281 (458)
T ss_pred c
Confidence 4
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.82 E-value=6.4e-08 Score=84.88 Aligned_cols=137 Identities=16% Similarity=0.238 Sum_probs=87.3
Q ss_pred eeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCc--ceeEEeEEECCCCeEEEEeccCCCC
Q 020085 116 CKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN--VVQFIGACTRPPNLCIVTEFMARGS 193 (331)
Q Consensus 116 ~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~n--iv~~~~~~~~~~~~~lV~E~~~ggs 193 (331)
..||+|..+.||+. .+..+++|...... .. ....+|.++++.+..-. +.+.++++...+...+|||+++|.+
T Consensus 7 ~~i~~G~t~~~y~~--~~~~~VlR~~~~~~-~~---~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 7 TQTGEGGNGESYTH--KTGKWMLKLYNPGF-DK---ETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred eeecCCCCcceeEe--cCCCEEEEeCCCCC-CH---HHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 57999999999984 36678889987543 22 34678999999886433 4677877777777899999999963
Q ss_pred -HHHH---------------------HHhcC-CCCCHHHHH-HHHHH----------HHH-HHHHHH----hCCcccCCC
Q 020085 194 -IYDF---------------------LHKQK-GVFQLTSLL-KVAID----------VSK-GMNYLH----QNNIIHRDL 234 (331)
Q Consensus 194 -L~~~---------------------l~~~~-~~~~~~~~~-~i~~q----------i~~-~l~~LH----~~~iiHrDl 234 (331)
+... +|... ...+..... ++..+ +.+ ..++|. ...++|+|+
T Consensus 81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~ 160 (226)
T TIGR02172 81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDF 160 (226)
T ss_pred chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCC
Confidence 2111 11110 111111111 11101 111 122222 124789999
Q ss_pred CCCCEEEcCCCcEEEeeecceeeec
Q 020085 235 KTANLLMDENGVVKVADFGVARVQA 259 (331)
Q Consensus 235 kp~NiLi~~~~~vkl~DFg~a~~~~ 259 (331)
.|.||++++++ +.++||+.+...+
T Consensus 161 ~~~Nii~~~~~-~~iIDwe~a~~Gd 184 (226)
T TIGR02172 161 QIGNLITSGKG-TYWIDLGDFGYGN 184 (226)
T ss_pred CCCcEEEcCCC-cEEEechhcCcCC
Confidence 99999999888 9999999986443
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.73 E-value=9.4e-08 Score=92.61 Aligned_cols=141 Identities=16% Similarity=0.249 Sum_probs=95.9
Q ss_pred eeeeecCceEEEEEEE-CCceEEEEEecCCCCCH-----------------------------HH------HHHHHHHHH
Q 020085 116 CKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNT-----------------------------EM------LKEFSQEVY 159 (331)
Q Consensus 116 ~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~-----------------------------~~------~~~~~~E~~ 159 (331)
+.||..+.|.||+|+. .|+.||||+.+++.... +. .-+|.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 5799999999999987 67889999988653211 00 112555555
Q ss_pred HHHhc----CCCc------ceeEEeEEECCCCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 020085 160 IMRKI----RHKN------VVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229 (331)
Q Consensus 160 il~~l----~h~n------iv~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i 229 (331)
-..+. .|-+ |++++-.+ .....++||||+|..+.|.-.-.+..++...+..-+.+.. .+.+=..|+
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~--~~qIf~~Gf 322 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAY--LEQIFKTGF 322 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHH--HHHHHhcCC
Confidence 55444 3444 44444333 2356899999999977776544455677665554444432 233445789
Q ss_pred ccCCCCCCCEEEcC----CCcEEEeeecceeeecC
Q 020085 230 IHRDLKTANLLMDE----NGVVKVADFGVARVQAQ 260 (331)
Q Consensus 230 iHrDlkp~NiLi~~----~~~vkl~DFg~a~~~~~ 260 (331)
+|+|-+|.||+++. ++.+.+.|||+......
T Consensus 323 fHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 323 FHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred ccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 99999999999994 56899999999875543
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.71 E-value=2.7e-07 Score=80.45 Aligned_cols=140 Identities=19% Similarity=0.276 Sum_probs=86.3
Q ss_pred eeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCC--cceeEEeEEEC---CCCeEEEEecc
Q 020085 115 ECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHK--NVVQFIGACTR---PPNLCIVTEFM 189 (331)
Q Consensus 115 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~--niv~~~~~~~~---~~~~~lV~E~~ 189 (331)
++.++.|..+.||+.+..+..+++|+.... .....+.+|..+++.+... .+.+++..+.. ....+++|+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~~~~vlK~~~~~----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i 77 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDDGRYVLKFYRPP----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYI 77 (239)
T ss_dssp EEEEEESSSSEEEEEEETTSEEEEEEESSH----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEE
T ss_pred CccCCCCCeeeEEEEEECCcEEEEEEeCCC----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEe
Confidence 467999999999999998899999997643 3456788899999888533 35566664422 23468999999
Q ss_pred CCCCHHH----------------HH---HhcC---CCCCHHH---------HHHH------------HHHHHH-HHHHHH
Q 020085 190 ARGSIYD----------------FL---HKQK---GVFQLTS---------LLKV------------AIDVSK-GMNYLH 225 (331)
Q Consensus 190 ~ggsL~~----------------~l---~~~~---~~~~~~~---------~~~i------------~~qi~~-~l~~LH 225 (331)
+|.++.. .+ +... ..+.... .... ...+.. .++.++
T Consensus 78 ~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 157 (239)
T PF01636_consen 78 PGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELE 157 (239)
T ss_dssp SSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHH
Confidence 9987777 11 1110 1111000 0000 111222 233333
Q ss_pred h-------CCcccCCCCCCCEEEc-CCCcEEEeeecceeee
Q 020085 226 Q-------NNIIHRDLKTANLLMD-ENGVVKVADFGVARVQ 258 (331)
Q Consensus 226 ~-------~~iiHrDlkp~NiLi~-~~~~vkl~DFg~a~~~ 258 (331)
+ ..++|+|+.|.||+++ +++.+-|+||+.+...
T Consensus 158 ~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~~ 198 (239)
T PF01636_consen 158 ALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGWG 198 (239)
T ss_dssp HHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EEE
T ss_pred hhhccCCCcEEEEeccccccceeeeccceeEEEecccceEC
Confidence 2 4599999999999999 6666789999998654
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.71 E-value=1.3e-07 Score=78.09 Aligned_cols=139 Identities=19% Similarity=0.219 Sum_probs=100.7
Q ss_pred ccCcceeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcc-eeEEeEEECCCCeEEEEe
Q 020085 109 AKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNV-VQFIGACTRPPNLCIVTE 187 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~ni-v~~~~~~~~~~~~~lV~E 187 (331)
.......+.||+|.+|.||+|.|.+..+|+|+-+.+. ....+..|+++|..++-.++ .+++.+-. -++.||
T Consensus 21 ~~~~~v~~~L~KG~~s~Vyl~~~~~~~~a~Kvrr~ds----~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me 92 (201)
T COG2112 21 KYELRVEKELAKGTTSVVYLGEWRGGEVALKVRRRDS----PRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRME 92 (201)
T ss_pred chhhhhhhhhhcccccEEEEeeccCceEEEEEecCCc----chhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhh
Confidence 4455667889999999999999999999999988653 23678899999999986554 44554433 246699
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCC-CCEEEcCCCcEEEeeecceeeecCCCc
Q 020085 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKT-ANLLMDENGVVKVADFGVARVQAQSGV 263 (331)
Q Consensus 188 ~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp-~NiLi~~~~~vkl~DFg~a~~~~~~~~ 263 (331)
|+.|.+|.+.-... +..++ ..+++.---|-..||-|..|+- ...++.+++.+.|+||..|+....+..
T Consensus 93 ~i~G~~L~~~~~~~----~rk~l----~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k~~p~N 161 (201)
T COG2112 93 YIDGRPLGKLEIGG----DRKHL----LRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFKKKPRN 161 (201)
T ss_pred hhcCcchhhhhhcc----cHHHH----HHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhccCCch
Confidence 99998888765321 33333 3445555567788999999974 444444555999999999986655443
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.65 E-value=4.1e-07 Score=80.55 Aligned_cols=137 Identities=16% Similarity=0.132 Sum_probs=86.8
Q ss_pred eeeecCc-eEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCcceeEEeEEECCCCeEEEEeccCCCCH
Q 020085 117 KVASGSY-GDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCIVTEFMARGSI 194 (331)
Q Consensus 117 ~lg~G~~-g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~~~~lV~E~~~ggsL 194 (331)
.|..|.+ ..||+....+..+.+|+..... .....+|+.+++.+. +--+.+++++...++..++|||+++|.++
T Consensus 5 ~~~~g~~~~~v~~~~~~~~~~~vk~~~~~~-----~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l 79 (244)
T cd05150 5 RVTEGQSGATVYRLDGKNPGLYLKIAPSGP-----TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPA 79 (244)
T ss_pred ecCCCCCcCeEEEEcCCCCcEEEEecCCCc-----ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccH
Confidence 3444555 7899998877888999876542 235667888888884 34466778777766678999999999877
Q ss_pred HHHH-------------------HhcCC---CCCHH--HHHHHHH--------------------HHHHHHHHHH-----
Q 020085 195 YDFL-------------------HKQKG---VFQLT--SLLKVAI--------------------DVSKGMNYLH----- 225 (331)
Q Consensus 195 ~~~l-------------------~~~~~---~~~~~--~~~~i~~--------------------qi~~~l~~LH----- 225 (331)
.... +.... ++... ....... .+......|-
T Consensus 80 ~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 159 (244)
T cd05150 80 AALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPA 159 (244)
T ss_pred hHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCC
Confidence 6432 11100 11100 0000000 0111122221
Q ss_pred --hCCcccCCCCCCCEEEcCCCcEEEeeecceeee
Q 020085 226 --QNNIIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (331)
Q Consensus 226 --~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~ 258 (331)
...++|+|+.|.|||+++++.+.|+||+.+...
T Consensus 160 ~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~g 194 (244)
T cd05150 160 EEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGVA 194 (244)
T ss_pred cCceEEECCCCCCccEEEeCCcEEEEEEccccccc
Confidence 234899999999999999888899999988543
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.64 E-value=4.4e-07 Score=79.07 Aligned_cols=136 Identities=20% Similarity=0.210 Sum_probs=92.9
Q ss_pred eeeecCceEEEEEEE-CCceEEEEEecCCCCCHHH--------------------H--HHHHHHHHHHHhcC--CCccee
Q 020085 117 KVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEM--------------------L--KEFSQEVYIMRKIR--HKNVVQ 171 (331)
Q Consensus 117 ~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~--------------------~--~~~~~E~~il~~l~--h~niv~ 171 (331)
.|.+|--+.||+|.. .+..+|+|+++.....-.. + .=..+|..-|+++. +=.+++
T Consensus 55 ~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~ 134 (268)
T COG1718 55 CISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPE 134 (268)
T ss_pred eecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCC
Confidence 777888899999876 5889999999854221111 1 11344666666663 334455
Q ss_pred EEeEEECCCCeEEEEeccCCCC-HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEEcCCCcEEE
Q 020085 172 FIGACTRPPNLCIVTEFMARGS-IYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENGVVKV 249 (331)
Q Consensus 172 ~~~~~~~~~~~~lV~E~~~ggs-L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~iiHrDlkp~NiLi~~~~~vkl 249 (331)
-+++. +-.+||||+.... -.-.|. .-.+....+..+..++++.|.-|-. .++||+||+.=|||+. ++.+.+
T Consensus 135 Pi~~~----~nVLvMEfIg~~g~pAP~Lk--Dv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~i 207 (268)
T COG1718 135 PIAFR----NNVLVMEFIGDDGLPAPRLK--DVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYI 207 (268)
T ss_pred ceeec----CCeEEEEeccCCCCCCCCcc--cCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEE
Confidence 55543 3479999996531 111111 1123333677788889999888887 8999999999999999 889999
Q ss_pred eeecceeeec
Q 020085 250 ADFGVARVQA 259 (331)
Q Consensus 250 ~DFg~a~~~~ 259 (331)
+|||.|....
T Consensus 208 ID~~QaV~~~ 217 (268)
T COG1718 208 IDVSQAVTID 217 (268)
T ss_pred EECccccccC
Confidence 9999986544
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.48 E-value=4.5e-06 Score=71.44 Aligned_cols=136 Identities=20% Similarity=0.363 Sum_probs=97.0
Q ss_pred eeeeeecCceEEEEEEECCceEEEEEecCCC--------------CCHHHHHHHHHHHHHHHhcC------CCcceeEEe
Q 020085 115 ECKVASGSYGDLYKGTYCSQEVAIKVLKPEC--------------VNTEMLKEFSQEVYIMRKIR------HKNVVQFIG 174 (331)
Q Consensus 115 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~--------------~~~~~~~~~~~E~~il~~l~------h~niv~~~~ 174 (331)
...||+|+.-.||.-- .....+||+.++.. ......++..+|+.-...+. +.+|.+++|
T Consensus 6 ~~~i~~G~~R~cy~HP-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G 84 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHP-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFYG 84 (199)
T ss_pred CcccccCCCceEEECC-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEeE
Confidence 4579999999888743 34567899988765 01112355666666665555 789999999
Q ss_pred EEECCCCeEEEEeccCC------CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC---
Q 020085 175 ACTRPPNLCIVTEFMAR------GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG--- 245 (331)
Q Consensus 175 ~~~~~~~~~lV~E~~~g------gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~--- 245 (331)
..+.+.-..+|+|.+.. .+|.+++.. +.++. .+.+ .+-+-.+||-+++|+.+|++|.||++..++
T Consensus 85 ~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~--~~~~~-~~~~---~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~ 158 (199)
T PF10707_consen 85 FVETNLGLGLVVELIRDADGNISPTLEDYLKE--GGLTE-ELRQ---ALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGE 158 (199)
T ss_pred EEecCCceEEEEEEEECCCCCcCccHHHHHHc--CCccH-HHHH---HHHHHHHHHHHcCCeecCCCcccEEEEecCCCc
Confidence 99999889999998754 278888843 44554 3333 334456788999999999999999997543
Q ss_pred -cEEEee-ecceee
Q 020085 246 -VVKVAD-FGVARV 257 (331)
Q Consensus 246 -~vkl~D-Fg~a~~ 257 (331)
.+.|+| ||....
T Consensus 159 ~~lvlIDG~G~~~~ 172 (199)
T PF10707_consen 159 FRLVLIDGLGEKEL 172 (199)
T ss_pred eEEEEEeCCCCccc
Confidence 578887 666543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.38 E-value=1.1e-05 Score=68.79 Aligned_cols=128 Identities=20% Similarity=0.285 Sum_probs=92.3
Q ss_pred ccCcceeeeeeecCc-eEEEEEEECCceEEEEEecC---CCC-------C--H-------HHHHHHHHHHHHHHhcC---
Q 020085 109 AKQLKIECKVASGSY-GDLYKGTYCSQEVAIKVLKP---ECV-------N--T-------EMLKEFSQEVYIMRKIR--- 165 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~-g~Vy~~~~~~~~vavK~~~~---~~~-------~--~-------~~~~~~~~E~~il~~l~--- 165 (331)
..+++.++.||.|.- |.||++...|+.+|+|+.+. ... . . ....-|..|-+...+++
T Consensus 36 ~~~I~flefLg~g~~~~~V~kv~I~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 36 GDDIEFLEFLGHGSHDGYVFKVEIDGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CCcEeeeeecCCCCceeEEEEEEECCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 378999999999999 99999999999999999331 110 0 0 12345788888877775
Q ss_pred CCcc--eeEEeEEECC------------------CCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Q 020085 166 HKNV--VQFIGACTRP------------------PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 225 (331)
Q Consensus 166 h~ni--v~~~~~~~~~------------------~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH 225 (331)
+.++ |+++|+..-. ....||-||++... .+... -+.+|.+-|..+|
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~----------~~~~~----~~~~~~~dl~~~~ 181 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP----------PLQIR----DIPQMLRDLKILH 181 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc----------ccchh----HHHHHHHHHHHHH
Confidence 4555 8999887321 12467888776533 22333 3446666788899
Q ss_pred hCCcccCCCCCCCEEEcCCCcEEEeeecce
Q 020085 226 QNNIIHRDLKTANLLMDENGVVKVADFGVA 255 (331)
Q Consensus 226 ~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a 255 (331)
+.||+-+|+++.|..=+ +|+|||.+
T Consensus 182 k~gI~~~Dv~~~ny~~G-----~lvDfs~~ 206 (207)
T PF13095_consen 182 KLGIVPRDVKPRNYRGG-----KLVDFSSS 206 (207)
T ss_pred HCCeeeccCccccccCC-----EEEecccC
Confidence 99999999999998722 89999975
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=98.37 E-value=5.6e-06 Score=85.96 Aligned_cols=144 Identities=15% Similarity=0.277 Sum_probs=91.6
Q ss_pred eeeeeecCceEEEEEEECC----ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCcc--eeEEeEEECC---CCeEE
Q 020085 115 ECKVASGSYGDLYKGTYCS----QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNV--VQFIGACTRP---PNLCI 184 (331)
Q Consensus 115 ~~~lg~G~~g~Vy~~~~~~----~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~-h~ni--v~~~~~~~~~---~~~~l 184 (331)
.+.++.|.++.+|+.+..+ ..+++|+....... .....+.+|..+++.+. |+++ ++++.+|.+. +..|+
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~-~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~fl 121 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLL-QSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFY 121 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccC-ccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceE
Confidence 4678999999999887754 46788876543211 12346889999999995 6665 7888888764 35789
Q ss_pred EEeccCCCCHHH--------------------H---HHhcCC-C--C---------CHHHHHHHHHH-------------
Q 020085 185 VTEFMARGSIYD--------------------F---LHKQKG-V--F---------QLTSLLKVAID------------- 216 (331)
Q Consensus 185 V~E~~~ggsL~~--------------------~---l~~~~~-~--~---------~~~~~~~i~~q------------- 216 (331)
||||++|..+.+ . ||.... . + ...++.++..+
T Consensus 122 VME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~ 201 (822)
T PLN02876 122 IMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRN 201 (822)
T ss_pred EEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCC
Confidence 999999864321 1 111110 0 0 01122222111
Q ss_pred --HHHHHHHHHh-----------CCcccCCCCCCCEEEcCC-C-cEEEeeecceeeec
Q 020085 217 --VSKGMNYLHQ-----------NNIIHRDLKTANLLMDEN-G-VVKVADFGVARVQA 259 (331)
Q Consensus 217 --i~~~l~~LH~-----------~~iiHrDlkp~NiLi~~~-~-~vkl~DFg~a~~~~ 259 (331)
+.+.+++|.. ..++|+|+++.|++++.+ + .+-|+||+++...+
T Consensus 202 ~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~Gd 259 (822)
T PLN02876 202 PKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGN 259 (822)
T ss_pred hhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCC
Confidence 2234566642 249999999999999853 3 36799999986543
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.36 E-value=5.8e-08 Score=93.90 Aligned_cols=186 Identities=19% Similarity=0.182 Sum_probs=135.7
Q ss_pred CcceeeeeeecCceEEEEEEECCc-eEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCc-ceeEEeEEECCCCeEEEEec
Q 020085 111 QLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN-VVQFIGACTRPPNLCIVTEF 188 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~n-iv~~~~~~~~~~~~~lV~E~ 188 (331)
-+..-+-+++|+++.++|.+...+ ....+.+... ....-++++|.+++||| .+..++-++.+...++++++
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-------l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i 315 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-------LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRI 315 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhheeceeeccc-------hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhh
Confidence 355667789999999999876442 2334444322 34556788999999999 77777778888889999999
Q ss_pred cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCccccC
Q 020085 189 MARG-SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE 267 (331)
Q Consensus 189 ~~gg-sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~~~~ 267 (331)
+.++ +...-.....-.+...+...+.+.-+++++++|+.-=+|+| ||+..+ +..+..||+..............
T Consensus 316 ~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~~~t~ 390 (829)
T KOG0576|consen 316 CSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTMKPRTA 390 (829)
T ss_pred hcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCcccccccC
Confidence 9887 32222211112233344555666777899999998778998 777654 78899999998765554445566
Q ss_pred CCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCC
Q 020085 268 TGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYA 308 (331)
Q Consensus 268 ~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~ 308 (331)
.+++.|+|||+.....++...|.|++|.--.++.-|-+|-.
T Consensus 391 ~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 391 IGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred CCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 79999999999999999999999999986666666666543
|
|
| >cd04900 ACT_UUR-like_1 ACT domain family, ACT_UUR-like_1, includes the first of two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD and related domains | Back alignment and domain information |
|---|
Probab=98.36 E-value=2.4e-06 Score=60.97 Aligned_cols=55 Identities=27% Similarity=0.416 Sum_probs=44.2
Q ss_pred HHHHHHHHHHhhhCCCeeeeeeeecCCCceeeEEEecCCCCCc--hHHHHHHHHHHH
Q 020085 9 MKVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDE--TEDLKNVLAKEI 63 (331)
Q Consensus 9 ~~~~~~~~~~~~~~~~i~~~~~~~t~~~~~~~~~vv~gw~~~~--~~~l~~~l~~~~ 63 (331)
.+|++++.+|++.|+||..|.+|++.||+.+|+|.|..+.... .++....+++.+
T Consensus 13 gLl~~i~~~l~~~~l~I~~A~i~T~~~~~v~D~F~v~~~~~~~~~~~~~~~~l~~~L 69 (73)
T cd04900 13 GLFARIAGALDQLGLNILDARIFTTRDGYALDTFVVLDPDGEPIGERERLARIREAL 69 (73)
T ss_pred CHHHHHHHHHHHCCCCeEEeEEEEeCCCeEEEEEEEECCCCCCCChHHHHHHHHHHH
Confidence 4789999999999999999999999999999999997665543 234445555554
|
This ACT domain family, ACT_UUR-like_1, includes the first of two C-terminal ACT domains of the bacterial signal-transducing uridylyltransferase /uridylyl-removing (UUR) enzyme, GlnD; including those enzymes similar to the GlnD found in enteric Escherichia coli and those found in photosynthetic, nitrogen-fixing bacterium Rhodospirillum rubrum. Also included in this CD is the N-terminal ACT domain of a yet characterized Arabidopsis/Oryza predicted tyrosine kinase. Members of this CD belong to the superfamily of ACT regulatory domains. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.28 E-value=1.5e-07 Score=91.77 Aligned_cols=96 Identities=21% Similarity=0.383 Sum_probs=76.4
Q ss_pred HHHHHHHHHHHh-CCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCc----------cccCCCCcccccchhcCCCC
Q 020085 215 IDVSKGMNYLHQ-NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV----------MTAETGTYRWMAPEVIEHKP 283 (331)
Q Consensus 215 ~qi~~~l~~LH~-~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~ 283 (331)
.+.+.|+.|+|+ .++||++|.|++|.++.++..|++.|+++........ .........|.|||.+.+..
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~ 185 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT 185 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence 344589999997 5899999999999999999999999998754333111 11122456899999999988
Q ss_pred CCChhhHHHHHHHHHHHH-cCCCCCCCC
Q 020085 284 YDYKADVFSFGIALWELL-TGELPYAGL 310 (331)
Q Consensus 284 ~~~~~Di~SlG~il~ell-~g~~Pf~~~ 310 (331)
-+.++|+||+|+++|.+. .|+.-+...
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~ 213 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAAN 213 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhcc
Confidence 899999999999999999 466666554
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=98.28 E-value=4.9e-06 Score=73.29 Aligned_cols=73 Identities=11% Similarity=0.147 Sum_probs=46.3
Q ss_pred eeeeecCce-EEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCC---cceeEEeEEECC---CCeEEEEec
Q 020085 116 CKVASGSYG-DLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHK---NVVQFIGACTRP---PNLCIVTEF 188 (331)
Q Consensus 116 ~~lg~G~~g-~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~---niv~~~~~~~~~---~~~~lV~E~ 188 (331)
+.++.|+.. .||+. +..+++|+.+... ....+.+|.++++.+... -+.+.++..... ...+++|++
T Consensus 3 ~~~~~gG~~n~vy~~---~~~~VlR~~~~~~----~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~ 75 (235)
T cd05155 3 EPVDSGGTDNATFRL---GDDMSVRLPSAAG----YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRW 75 (235)
T ss_pred eeccCCCcccceEEc---CCceEEEcCCccc----hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEe
Confidence 457766666 48875 3467788755421 234788899999888532 344455443332 234889999
Q ss_pred cCCCCHH
Q 020085 189 MARGSIY 195 (331)
Q Consensus 189 ~~ggsL~ 195 (331)
++|.++.
T Consensus 76 i~G~~l~ 82 (235)
T cd05155 76 LEGETAT 82 (235)
T ss_pred ecCCCCC
Confidence 9997663
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd04927 ACT_ACR-like_2 Second ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein) | Back alignment and domain information |
|---|
Probab=98.19 E-value=9e-06 Score=58.42 Aligned_cols=55 Identities=22% Similarity=0.241 Sum_probs=43.2
Q ss_pred HHHHHHHHHhhhCCCeeeeeeeecCCCceeeEEEecCCCCC-chHHHHHHHHHHHH
Q 020085 10 KVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYD-ETEDLKNVLAKEIL 64 (331)
Q Consensus 10 ~~~~~~~~~~~~~~~i~~~~~~~t~~~~~~~~~vv~gw~~~-~~~~l~~~l~~~~~ 64 (331)
||++++.+|++.|+||..|++++|.+|+.+|+|.|...... ..++....+.+.+.
T Consensus 13 Lfa~i~~~l~~~~l~I~~A~I~Tt~~~~v~D~F~V~d~~~~~~~~~~~~~l~~~L~ 68 (76)
T cd04927 13 LLHDVTEVLYELELTIERVKVSTTPDGRVLDLFFITDARELLHTKKRREETYDYLR 68 (76)
T ss_pred HHHHHHHHHHHCCCeEEEEEEEECCCCEEEEEEEEeCCCCCCCCHHHHHHHHHHHH
Confidence 78999999999999999999999999999999999665544 22333444444443
|
This CD includes the second ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) have been described, however, the ACR-like sequences in this CD are distinct from those characterized. This CD includes the Oryza sativa ACR-like protein (Os05g0113000) encoded on chromosome 5 and the Arabidopsis thaliana predicted gene product, At2g39570. Members of this CD belong to the superfamily of ACT regulatory domains. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.15 E-value=6.1e-05 Score=68.86 Aligned_cols=78 Identities=10% Similarity=0.025 Sum_probs=58.9
Q ss_pred ceeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCC---CcceeEEeEEECC---CCeEEEE
Q 020085 113 KIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH---KNVVQFIGACTRP---PNLCIVT 186 (331)
Q Consensus 113 ~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h---~niv~~~~~~~~~---~~~~lV~ 186 (331)
.-.+.||.|..+.||+....+..+.+|..+... . ...+..|...|+.+.. -.++++++.|... +..++||
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~~~~~~k~~~~~~-~---~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm 92 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQGNPMPLMARSFS-T---PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL 92 (297)
T ss_pred heeeecCCccceeEEEEEcCCCCEEEEEecccc-c---chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence 335679999999999988766678888865311 1 2578899999998853 3678888887543 5689999
Q ss_pred eccCCCCH
Q 020085 187 EFMARGSI 194 (331)
Q Consensus 187 E~~~ggsL 194 (331)
|+++|+++
T Consensus 93 E~i~G~~~ 100 (297)
T PRK10593 93 ERLRGVSV 100 (297)
T ss_pred eccCCEec
Confidence 99998754
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.15 E-value=7.2e-06 Score=69.72 Aligned_cols=100 Identities=19% Similarity=0.337 Sum_probs=80.2
Q ss_pred HHHHHHHHhcCC-CcceeEEeEEECCCCeEEEEeccCCCCHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHh---CC
Q 020085 155 SQEVYIMRKIRH-KNVVQFIGACTRPPNLCIVTEFMARGSIYDFLH--KQKGVFQLTSLLKVAIDVSKGMNYLHQ---NN 228 (331)
Q Consensus 155 ~~E~~il~~l~h-~niv~~~~~~~~~~~~~lV~E~~~ggsL~~~l~--~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ 228 (331)
..|.-+++.+++ +++++++|+|-+ ++|+||...+++..... .+-...++..+.+++.++++.+++|+. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 457888898976 799999999943 78999998776643200 011245789999999999999999997 35
Q ss_pred cccCCCCCCCEEEcCCCcEEEeeecceeee
Q 020085 229 IIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (331)
Q Consensus 229 iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~ 258 (331)
+.-.|++++|+-++++|.+|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 777899999999999999999999987543
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=98.11 E-value=3.6e-05 Score=67.61 Aligned_cols=136 Identities=18% Similarity=0.222 Sum_probs=81.3
Q ss_pred eeeeeecCceEEEEEEEC---CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCC-CcceeEEeEEECCCCeEEEEeccC
Q 020085 115 ECKVASGSYGDLYKGTYC---SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH-KNVVQFIGACTRPPNLCIVTEFMA 190 (331)
Q Consensus 115 ~~~lg~G~~g~Vy~~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h-~niv~~~~~~~~~~~~~lV~E~~~ 190 (331)
.+.|..|-...+|+.... ++.|++|+...... ..-...+|..+++.+.. .-.+++++.+. + .++|||++
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~---~~~d~~~E~~~~~~l~~~gl~P~v~~~~~-~---~~l~e~i~ 75 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE---LIIDRERELRIHKLLSKHGLAPKLYATFQ-N---GLIYEFIP 75 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc---ceecHHHHHHHHHHHHhCCCCCeEEEEeC-C---cEEEEeeC
Confidence 356788889999998875 57899998764321 11223478888888853 33445554432 2 48999999
Q ss_pred CCCHHHH-----------------HHhcCCCC----------CH-HHHHHHHH----------------------HHHHH
Q 020085 191 RGSIYDF-----------------LHKQKGVF----------QL-TSLLKVAI----------------------DVSKG 220 (331)
Q Consensus 191 ggsL~~~-----------------l~~~~~~~----------~~-~~~~~i~~----------------------qi~~~ 220 (331)
|.++... +|...... .. ..+..+.. .+.+.
T Consensus 76 G~~l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 155 (235)
T cd05157 76 GRTLEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDE 155 (235)
T ss_pred CCcCCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHH
Confidence 8765211 11111111 11 12112211 11111
Q ss_pred HHHH----H----hCCcccCCCCCCCEEEcC-CCcEEEeeecceee
Q 020085 221 MNYL----H----QNNIIHRDLKTANLLMDE-NGVVKVADFGVARV 257 (331)
Q Consensus 221 l~~L----H----~~~iiHrDlkp~NiLi~~-~~~vkl~DFg~a~~ 257 (331)
+..| . ..+++|+|+.+.|||+++ ++.+.++||..|..
T Consensus 156 ~~~l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 156 ISWLKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHHHHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 1222 1 136899999999999998 57899999998864
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=98.09 E-value=1.8e-05 Score=70.60 Aligned_cols=137 Identities=15% Similarity=0.181 Sum_probs=81.6
Q ss_pred eeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcc-eeEEeEEECCCCeEEEEeccCCCCHH
Q 020085 117 KVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNV-VQFIGACTRPPNLCIVTEFMARGSIY 195 (331)
Q Consensus 117 ~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~ni-v~~~~~~~~~~~~~lV~E~~~ggsL~ 195 (331)
.+..|-.+.+|+.+..++.+++|+..... ....-...+|..+++.+....+ .+++..+. -++|+||++|..+.
T Consensus 3 ~~~~G~tn~~y~~~~~~~~~vlR~~~~~~--~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~ 76 (256)
T TIGR02721 3 TLSGGLTNRSWRIEHPGISFVWRPQSPVC--KALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVIT 76 (256)
T ss_pred cCCCcCcCCeEEEEeCCccEEEeeCCccc--ccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccc
Confidence 35568888999998888899999865431 1110135678888888864333 44454432 37899999987643
Q ss_pred H--------------H---HHhcC---CCCCHH-HHHHHHHHH---------HHHHHHHHh--------CCcccCCCCCC
Q 020085 196 D--------------F---LHKQK---GVFQLT-SLLKVAIDV---------SKGMNYLHQ--------NNIIHRDLKTA 237 (331)
Q Consensus 196 ~--------------~---l~~~~---~~~~~~-~~~~i~~qi---------~~~l~~LH~--------~~iiHrDlkp~ 237 (331)
. . +|... .+++.. .+..+..++ ...+..+-. ..++|+|+.|.
T Consensus 77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~ 156 (256)
T TIGR02721 77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY 156 (256)
T ss_pred cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence 2 1 12111 111211 111221111 111222222 25899999999
Q ss_pred CEEEcCCCcEEEeeecceeeecC
Q 020085 238 NLLMDENGVVKVADFGVARVQAQ 260 (331)
Q Consensus 238 NiLi~~~~~vkl~DFg~a~~~~~ 260 (331)
||++++++ +.++||..+.....
T Consensus 157 Nil~~~~~-~~lIDwE~a~~gdp 178 (256)
T TIGR02721 157 NLVVTPQG-LKLIDWEYASDGDI 178 (256)
T ss_pred cEEEeCCC-CEEEeccccCcCCH
Confidence 99999877 78999999865443
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.94 E-value=1.1e-05 Score=72.93 Aligned_cols=135 Identities=16% Similarity=0.189 Sum_probs=94.7
Q ss_pred CcceeeeeeecCceEEEEEEEC-CceEEEEEecCCCCCH------------------H--HHHHHHHHHHHHHhcC-CC-
Q 020085 111 QLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNT------------------E--MLKEFSQEVYIMRKIR-HK- 167 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~------------------~--~~~~~~~E~~il~~l~-h~- 167 (331)
-+.+++.||-|--+.||.+.+. |++.++|.-+....+- - ..-...+|..-|+.+. |.
T Consensus 93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 3567889999999999999884 8999999765332111 1 1123566777787774 22
Q ss_pred cceeEEeEEECCCCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcE
Q 020085 168 NVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVV 247 (331)
Q Consensus 168 niv~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~v 247 (331)
-+++.+++ ...|+|||++.|-.|...-+- .+.++ +...+..-+--|.++|+||+|++-=||++++++.+
T Consensus 173 pVPkpiD~----~RH~Vvmelv~g~Pl~~v~~v----~d~~~---ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i 241 (465)
T KOG2268|consen 173 PVPKPIDH----NRHCVVMELVDGYPLRQVRHV----EDPPT---LYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKI 241 (465)
T ss_pred CCCCcccc----cceeeHHHhhcccceeeeeec----CChHH---HHHHHHHHHHHHHHcCceecccchheeEEecCCCE
Confidence 23444443 356899999999887765322 22333 33344444566888999999999999999999999
Q ss_pred EEeeeccee
Q 020085 248 KVADFGVAR 256 (331)
Q Consensus 248 kl~DFg~a~ 256 (331)
+++||-...
T Consensus 242 ~vIDFPQmv 250 (465)
T KOG2268|consen 242 VVIDFPQMV 250 (465)
T ss_pred EEeechHhh
Confidence 999998753
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.92 E-value=0.00022 Score=64.86 Aligned_cols=139 Identities=17% Similarity=0.177 Sum_probs=85.7
Q ss_pred eeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCc--ceeEEeE------EECCCCeEEEE
Q 020085 115 ECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN--VVQFIGA------CTRPPNLCIVT 186 (331)
Q Consensus 115 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~n--iv~~~~~------~~~~~~~~lV~ 186 (331)
.+.+..|....+|+....+..+++|+.... +. .....|+.+++.+.+.+ +++++.. ....+..++|+
T Consensus 19 i~~i~~G~~n~~y~v~~~~~~~vLr~~~~~--~~---~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~ 93 (296)
T cd05153 19 FEGISAGIENTNYFVTTDSGRYVLTLFEKV--SA---EELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALV 93 (296)
T ss_pred eecccCccccceEEEEeCCCcEEEEEcCCC--Ch---HhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEE
Confidence 456778888899998877788999998652 22 34666777777774322 4444431 12234568999
Q ss_pred eccCCCCHHH-----------H---HHhcCCCC----------CHHHH--H--------HHHHHHHHHHHHHHh------
Q 020085 187 EFMARGSIYD-----------F---LHKQKGVF----------QLTSL--L--------KVAIDVSKGMNYLHQ------ 226 (331)
Q Consensus 187 E~~~ggsL~~-----------~---l~~~~~~~----------~~~~~--~--------~i~~qi~~~l~~LH~------ 226 (331)
+|++|..+.. . +|.....+ .+... . .....+..++.++.+
T Consensus 94 ~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~ 173 (296)
T cd05153 94 EFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDL 173 (296)
T ss_pred EeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcC
Confidence 9999876421 0 11110000 00000 0 011112334445443
Q ss_pred -CCcccCCCCCCCEEEcCCCcEEEeeecceeee
Q 020085 227 -NNIIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (331)
Q Consensus 227 -~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~ 258 (331)
.+++|+|+.|.|+++++++.+.|+||+.+...
T Consensus 174 ~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~g 206 (296)
T cd05153 174 PRGVIHADLFRDNVLFDGDELSGVIDFYFACTD 206 (296)
T ss_pred CCcCCccCcCcccEEEeCCceEEEeehhhhcCc
Confidence 47999999999999999887899999998643
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.90 E-value=3.8e-06 Score=88.53 Aligned_cols=187 Identities=10% Similarity=0.059 Sum_probs=133.3
Q ss_pred eEEEEEEECC---ceEEEEEecCC---CCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEEC--CCCeEEEEeccCCCCHH
Q 020085 124 GDLYKGTYCS---QEVAIKVLKPE---CVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR--PPNLCIVTEFMARGSIY 195 (331)
Q Consensus 124 g~Vy~~~~~~---~~vavK~~~~~---~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~--~~~~~lV~E~~~ggsL~ 195 (331)
+.-+++.+-+ .-+.+|+.+.- ...+...+....|...++...|+++.....-... +...+.+++++.+|.+.
T Consensus 1240 ~~~~R~k~Lr~kid~Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f 1319 (2724)
T KOG1826|consen 1240 HFHFRNKWLRSKIDWFKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLF 1319 (2724)
T ss_pred ceeeccchHhhhhceeEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHH
Confidence 3445666532 23466666532 2233445556667777777889988776654422 33468999999999999
Q ss_pred HHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhC-----CcccCCCCCCCEEEcCCCcEEEeeeccee-eecCCCcccc
Q 020085 196 DFLHKQKG---VFQLTSLLKVAIDVSKGMNYLHQN-----NIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTA 266 (331)
Q Consensus 196 ~~l~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~-----~iiHrDlkp~NiLi~~~~~vkl~DFg~a~-~~~~~~~~~~ 266 (331)
+.+-+... ......+.....+......-.|+. -.+|+++|+.|.+|..+..+++.++|+.+ ..+.......
T Consensus 1320 ~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl 1399 (2724)
T KOG1826|consen 1320 SIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGL 1399 (2724)
T ss_pred HHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhh
Confidence 99976533 233333444444434445554532 26899999999999999999999999998 4444445556
Q ss_pred CCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 020085 267 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL 310 (331)
Q Consensus 267 ~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~ 310 (331)
..+++.|++|++.++-.++.++|+|+.|+-+|+...|..||...
T Consensus 1400 ~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi~f 1443 (2724)
T KOG1826|consen 1400 ELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFIFF 1443 (2724)
T ss_pred hhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHHHH
Confidence 67889999999999999999999999999999999998888653
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.89 E-value=0.00043 Score=63.73 Aligned_cols=138 Identities=17% Similarity=0.215 Sum_probs=77.2
Q ss_pred eeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCc--ceeEEe------EEECCCCeEEEE
Q 020085 115 ECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN--VVQFIG------ACTRPPNLCIVT 186 (331)
Q Consensus 115 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~n--iv~~~~------~~~~~~~~~lV~ 186 (331)
.+.++.|....+|+....+..+++|+.. . ...+ ....|..+++.+...+ +.+.+. +....+..++++
T Consensus 27 ~~~l~~G~~n~~y~v~t~~g~~vLK~~~-~-~~~~---~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~ 101 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQGEYVLTLFE-R-LTAE---DLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIV 101 (319)
T ss_pred cchhccccccceEEEEeCCCcEEEEEec-c-CChH---HhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEE
Confidence 3457778888999988777789999986 2 2222 2334555555553111 333332 112244578999
Q ss_pred eccCCCCHH-----------HHH---HhcCCCC--------CH---HHHH-H-----------HHHH-HHHHHHHHH---
Q 020085 187 EFMARGSIY-----------DFL---HKQKGVF--------QL---TSLL-K-----------VAID-VSKGMNYLH--- 225 (331)
Q Consensus 187 E~~~ggsL~-----------~~l---~~~~~~~--------~~---~~~~-~-----------i~~q-i~~~l~~LH--- 225 (331)
||++|..+. +.+ |.....+ .. .... + ...+ +...++.+.
T Consensus 102 ~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~ 181 (319)
T PRK05231 102 TFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAA 181 (319)
T ss_pred EecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccc
Confidence 999997431 111 1111111 10 0100 0 1111 111223332
Q ss_pred ----hCCcccCCCCCCCEEEcCCCcEEEeeecceee
Q 020085 226 ----QNNIIHRDLKTANLLMDENGVVKVADFGVARV 257 (331)
Q Consensus 226 ----~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~ 257 (331)
..+++|+|+.|.||+++.+...-++||+.+..
T Consensus 182 ~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 182 WPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 24899999999999999776678999999854
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.86 E-value=0.00026 Score=64.95 Aligned_cols=140 Identities=21% Similarity=0.273 Sum_probs=83.7
Q ss_pred eeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCc--ceeEEeEE------ECCCCeEEE
Q 020085 114 IECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN--VVQFIGAC------TRPPNLCIV 185 (331)
Q Consensus 114 ~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~n--iv~~~~~~------~~~~~~~lV 185 (331)
..+.++.|....+|+....+..+++|+.+... .. .....|..+++.+.... +++++... ...+..+++
T Consensus 26 ~i~~~~~G~~n~~y~v~t~~~~~vLK~~~~~~-~~---~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l 101 (307)
T TIGR00938 26 SLKGIAEGVENSNYLLTTDVGRYILTLYEKRV-KA---EELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACL 101 (307)
T ss_pred eccccCCccccceEEEEeCCCcEEEEEecCCC-CH---HHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEE
Confidence 35567778778999987767788999876532 22 23445667777664222 34444321 123457899
Q ss_pred EeccCCCCHH-----------HH---HHhcCCCC--------CHHH---HH------------HHHHHHHHHHHHHHh--
Q 020085 186 TEFMARGSIY-----------DF---LHKQKGVF--------QLTS---LL------------KVAIDVSKGMNYLHQ-- 226 (331)
Q Consensus 186 ~E~~~ggsL~-----------~~---l~~~~~~~--------~~~~---~~------------~i~~qi~~~l~~LH~-- 226 (331)
+||++|.++. .. +|.....+ .... .. .....+.+.++++..
T Consensus 102 ~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~ 181 (307)
T TIGR00938 102 VEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFW 181 (307)
T ss_pred EEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhh
Confidence 9999985431 11 12111111 0010 00 011123344555542
Q ss_pred -----CCcccCCCCCCCEEEcCCCcEEEeeecceee
Q 020085 227 -----NNIIHRDLKTANLLMDENGVVKVADFGVARV 257 (331)
Q Consensus 227 -----~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~ 257 (331)
.+++|+|+++.|+++++++...|+||+.+..
T Consensus 182 ~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 182 PRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred hhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 6899999999999999988778999999853
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00067 Score=64.28 Aligned_cols=75 Identities=12% Similarity=0.060 Sum_probs=52.8
Q ss_pred eeeeecCceEEEEEEECC--ceEEEEEecCCCC----C-HHHHHHHHHHHHHHHhcC---CCcceeEEeEEECCCCeEEE
Q 020085 116 CKVASGSYGDLYKGTYCS--QEVAIKVLKPECV----N-TEMLKEFSQEVYIMRKIR---HKNVVQFIGACTRPPNLCIV 185 (331)
Q Consensus 116 ~~lg~G~~g~Vy~~~~~~--~~vavK~~~~~~~----~-~~~~~~~~~E~~il~~l~---h~niv~~~~~~~~~~~~~lV 185 (331)
+.||.|.+..||+.+..+ +.+.||.-.+... . .-..+.+..|.+.|+.+. ..++++++.+ +....++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 468999999999998855 3899998543211 0 123456777888888863 2456777765 33457899
Q ss_pred EeccCCC
Q 020085 186 TEFMARG 192 (331)
Q Consensus 186 ~E~~~gg 192 (331)
||++++.
T Consensus 110 ME~L~~~ 116 (401)
T PRK09550 110 MEDLSDH 116 (401)
T ss_pred EecCCCc
Confidence 9999864
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.79 E-value=0.00018 Score=65.82 Aligned_cols=137 Identities=19% Similarity=0.294 Sum_probs=82.7
Q ss_pred eeeeecCceEEEEEEEC--------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCc-ceeEEeEEECCCCeEEEE
Q 020085 116 CKVASGSYGDLYKGTYC--------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN-VVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 116 ~~lg~G~~g~Vy~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~n-iv~~~~~~~~~~~~~lV~ 186 (331)
+.+..|-...+|+.+.. ++.+++|+..... .......+|..+++.+.... ..++++.+.. .+|+
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~ 76 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV---ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIE 76 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC---cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchh
Confidence 45667778889988764 3789999976542 11234567888888875322 3455655532 3689
Q ss_pred eccCCCCHHHH-----------------HHhcCCCC------CHHHHH----H--------------------------H
Q 020085 187 EFMARGSIYDF-----------------LHKQKGVF------QLTSLL----K--------------------------V 213 (331)
Q Consensus 187 E~~~ggsL~~~-----------------l~~~~~~~------~~~~~~----~--------------------------i 213 (331)
||++|..+... +|...... ....+. . .
T Consensus 77 e~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 156 (302)
T cd05156 77 EFIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLF 156 (302)
T ss_pred heeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHH
Confidence 99998765321 11111111 001110 0 1
Q ss_pred HHHHHHHHHHHHh---------CCcccCCCCCCCEEEcCC----CcEEEeeecceeeec
Q 020085 214 AIDVSKGMNYLHQ---------NNIIHRDLKTANLLMDEN----GVVKVADFGVARVQA 259 (331)
Q Consensus 214 ~~qi~~~l~~LH~---------~~iiHrDlkp~NiLi~~~----~~vkl~DFg~a~~~~ 259 (331)
..++.+.+..+-. ..++|+|+.+.||+++++ +.+.++||..+....
T Consensus 157 ~~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~~~ 215 (302)
T cd05156 157 LEDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASYNY 215 (302)
T ss_pred HHHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCCCC
Confidence 1122223334432 358999999999999985 889999999986443
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >cd04925 ACT_ACR_2 ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein) | Back alignment and domain information |
|---|
Probab=97.78 E-value=6.1e-05 Score=53.76 Aligned_cols=37 Identities=27% Similarity=0.307 Sum_probs=33.5
Q ss_pred HHHHHHHHHHhhhCCCeeeeeeeecCCCceeeEEEecC
Q 020085 9 MKVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDG 46 (331)
Q Consensus 9 ~~~~~~~~~~~~~~~~i~~~~~~~t~~~~~~~~~vv~g 46 (331)
.+|+.++.+|++.|+||.+|+++ |.+|+.+|+|.|..
T Consensus 12 gLl~~i~~~l~~~~lnI~~A~i~-t~~~~~~d~f~V~d 48 (74)
T cd04925 12 GLLSEVFAVLADLHCNVVEARAW-THNGRLACVIYVRD 48 (74)
T ss_pred CHHHHHHHHHHHCCCcEEEEEEE-EECCEEEEEEEEEc
Confidence 37899999999999999999999 55999999999853
|
This CD includes the second ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products have been described (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) and are represented in this CD. Members of this CD belong to the superfamily of ACT regulatory domains. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00048 Score=63.64 Aligned_cols=140 Identities=21% Similarity=0.298 Sum_probs=94.7
Q ss_pred eeeeeeecCceEEEEEEE-CCceEEEEEecCCCC----------------------CH-HHHHH-HHHHHHHHHhcCCCc
Q 020085 114 IECKVASGSYGDLYKGTY-CSQEVAIKVLKPECV----------------------NT-EMLKE-FSQEVYIMRKIRHKN 168 (331)
Q Consensus 114 ~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~----------------------~~-~~~~~-~~~E~~il~~l~h~n 168 (331)
+..+|..|--+.||.++. .|..+|||+++.... ++ ..++. ...|++-|.+++...
T Consensus 148 inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 148 INGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred cccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 445788899999999987 678899999873210 11 11221 345777788776544
Q ss_pred ceeEEeEEECCCCeEEEEeccCCCCH-HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEEcCCCc
Q 020085 169 VVQFIGACTRPPNLCIVTEFMARGSI-YDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENGV 246 (331)
Q Consensus 169 iv~~~~~~~~~~~~~lV~E~~~ggsL-~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~iiHrDlkp~NiLi~~~~~ 246 (331)
|...--+... ...|||+|+.+-.. .-.| ..-.++...+..+..|++.-|.-|-+ .++||.||+--|+|+. +|.
T Consensus 228 IP~PePIlLk--~hVLVM~FlGrdgw~aPkL--Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Lyh-dG~ 302 (520)
T KOG2270|consen 228 IPCPEPILLK--NHVLVMEFLGRDGWAAPKL--KDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLYH-DGK 302 (520)
T ss_pred CCCCCceeee--cceEeeeeccCCCCcCccc--ccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheEE-CCE
Confidence 4322111111 35799999964221 1111 12456777888888898888887765 6999999999999995 678
Q ss_pred EEEeeecceeee
Q 020085 247 VKVADFGVARVQ 258 (331)
Q Consensus 247 vkl~DFg~a~~~ 258 (331)
+.++|.+.+-..
T Consensus 303 lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 303 LYIIDVSQSVEH 314 (520)
T ss_pred EEEEEccccccC
Confidence 999999987543
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.50 E-value=0.0014 Score=60.13 Aligned_cols=147 Identities=18% Similarity=0.287 Sum_probs=89.3
Q ss_pred eeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCC--CcceeEEeEEECCC--CeEEEEecc
Q 020085 114 IECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH--KNVVQFIGACTRPP--NLCIVTEFM 189 (331)
Q Consensus 114 ~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h--~niv~~~~~~~~~~--~~~lV~E~~ 189 (331)
+.+.+..|..-.+|.....++++++. ..+............+|..+++.+.- --+...++.|..+. ..+.||+|+
T Consensus 29 ~v~~~~~G~sn~t~~~~~~~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~v 107 (321)
T COG3173 29 IVEEISGGWSNDTFRLGDTGQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWV 107 (321)
T ss_pred eeeeccCCcccceEEEecCCceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEe
Confidence 33444445555567666668888888 33323344556677888888888753 23344566776655 679999999
Q ss_pred CCCCHHH------------------HHHhcC----------C---CCCHHHHHHHHHHH--------------HHHHHHH
Q 020085 190 ARGSIYD------------------FLHKQK----------G---VFQLTSLLKVAIDV--------------SKGMNYL 224 (331)
Q Consensus 190 ~ggsL~~------------------~l~~~~----------~---~~~~~~~~~i~~qi--------------~~~l~~L 224 (331)
+|..+.+ +|..-+ + .....++.++..+. .....+|
T Consensus 108 eGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl 187 (321)
T COG3173 108 EGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWL 187 (321)
T ss_pred cceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHH
Confidence 9842221 111100 0 00111111222111 2234555
Q ss_pred HhC--------CcccCCCCCCCEEEcCCCcEEEeeecceeeecCC
Q 020085 225 HQN--------NIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261 (331)
Q Consensus 225 H~~--------~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~ 261 (331)
+.+ .++|+|+++.|+++++++-+=|+||+.+...++.
T Consensus 188 ~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP~ 232 (321)
T COG3173 188 EANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLGDPL 232 (321)
T ss_pred HhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccCCcH
Confidence 543 3699999999999999999999999999766554
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=97.46 E-value=0.00069 Score=70.50 Aligned_cols=187 Identities=19% Similarity=0.261 Sum_probs=131.4
Q ss_pred eeecCceEEEEEEECC------ceEEEEEe--cCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCC----eEEE
Q 020085 118 VASGSYGDLYKGTYCS------QEVAIKVL--KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN----LCIV 185 (331)
Q Consensus 118 lg~G~~g~Vy~~~~~~------~~vavK~~--~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~----~~lV 185 (331)
+..-.+|+++...+.. +++-++.- +... ..........|...+.+..|+|++.+..+..+... ..+.
T Consensus 186 ls~~~~~~l~l~k~~~~~qs~~~~~~~s~~~~~~~~-~k~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~ 264 (1351)
T KOG1035|consen 186 LSHLTQGTLLLVKWVEQAQSLSEPIEISHDYESTPC-GKKEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVL 264 (1351)
T ss_pred eccccCceEEEEehhhhHHhhcCcccccCcccCccc-hHHHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHH
Confidence 4455667777766522 22222211 1111 11233445557777888899999999988765443 2345
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC---CEEEcCCCcEEEe--eecceeeecC
Q 020085 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA---NLLMDENGVVKVA--DFGVARVQAQ 260 (331)
Q Consensus 186 ~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~---NiLi~~~~~vkl~--DFg~a~~~~~ 260 (331)
.|++..-++.+.+.. -+.++....+.+..++.+|+.|+|+....|.-+..+ +--++.++.+... ||+..+....
T Consensus 265 ~~~~s~~~~~~~~q~-v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d 343 (1351)
T KOG1035|consen 265 QEICSKVELRSLLQS-VGSIPLETLRILHQKLLEGLAYLHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPD 343 (1351)
T ss_pred HhhcCccchHHHHhh-ccccCHHHHHHHHHHHhhhHHHHHHhccceeEEecccccccccCccceeecchhhhcccccCCC
Confidence 677888888888754 577889999999999999999999997766666655 5555666777777 9998887666
Q ss_pred CCccccCCCCcccccchhcCCCCCCCh--hhHHHHHHHHHHHHcCCCC
Q 020085 261 SGVMTAETGTYRWMAPEVIEHKPYDYK--ADVFSFGIALWELLTGELP 306 (331)
Q Consensus 261 ~~~~~~~~gt~~y~aPE~~~~~~~~~~--~Di~SlG~il~ell~g~~P 306 (331)
.........+..+-+||......++.+ .|+|.+|..+..+..|..+
T Consensus 344 ~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i 391 (1351)
T KOG1035|consen 344 NEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDI 391 (1351)
T ss_pred cccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcc
Confidence 655556666778888998877766544 7999999999999887544
|
|
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.0014 Score=61.16 Aligned_cols=138 Identities=13% Similarity=0.235 Sum_probs=81.5
Q ss_pred eeeeecCceEEEEEEEC------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcc-eeEEeEEECCCCeEEEEec
Q 020085 116 CKVASGSYGDLYKGTYC------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNV-VQFIGACTRPPNLCIVTEF 188 (331)
Q Consensus 116 ~~lg~G~~g~Vy~~~~~------~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~ni-v~~~~~~~~~~~~~lV~E~ 188 (331)
+.+..|-...+|+.... ++.|.+|+..... ... -...+|..+++.+...++ .++++.+.. ..|+||
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t--~~~-idR~~E~~~~~~l~~~gl~P~~~~~~~~----g~v~ef 114 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV--ELF-FDRDDEIRTFECMSRHGQGPRLLGRFPN----GRVEEF 114 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC--Cee-echHHHHHHHHHHHHcCCCCceEEEECC----ceEEEe
Confidence 35555888899998752 2678999876542 222 223678888888864333 455665533 268999
Q ss_pred cCCCCHHHH-----------------HHhcCCC----CC-HHHHHHHHHHH-----------------HHHHHHHH----
Q 020085 189 MARGSIYDF-----------------LHKQKGV----FQ-LTSLLKVAIDV-----------------SKGMNYLH---- 225 (331)
Q Consensus 189 ~~ggsL~~~-----------------l~~~~~~----~~-~~~~~~i~~qi-----------------~~~l~~LH---- 225 (331)
+++.++... +|....+ .. ...+.++..++ ...+..|.
T Consensus 115 i~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~ 194 (344)
T PLN02236 115 IHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELS 194 (344)
T ss_pred eCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhc
Confidence 988765321 1211111 11 12222322111 11122222
Q ss_pred ----hCCcccCCCCCCCEEEcC-CCcEEEeeecceeeecC
Q 020085 226 ----QNNIIHRDLKTANLLMDE-NGVVKVADFGVARVQAQ 260 (331)
Q Consensus 226 ----~~~iiHrDlkp~NiLi~~-~~~vkl~DFg~a~~~~~ 260 (331)
...++|+|+++.||++++ ++.+.++||..+.....
T Consensus 195 ~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~~~~ 234 (344)
T PLN02236 195 GDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASYNPV 234 (344)
T ss_pred ccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccccch
Confidence 235899999999999986 46899999999975443
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=97.32 E-value=0.0034 Score=57.45 Aligned_cols=30 Identities=27% Similarity=0.476 Sum_probs=26.2
Q ss_pred CCcccCCCCCCCEEEcCCCcEEEeeecceee
Q 020085 227 NNIIHRDLKTANLLMDENGVVKVADFGVARV 257 (331)
Q Consensus 227 ~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~ 257 (331)
.+++|+|+.+.||+++. +.+.|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 57899999999999987 6789999997753
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0065 Score=57.60 Aligned_cols=82 Identities=15% Similarity=0.008 Sum_probs=55.0
Q ss_pred eeeeeecCceEEEEEEECCceEEEEEecCCCC--C---HHHHHHHHHHHHHHHhcC---CCcceeEEeEEECCCCeEEEE
Q 020085 115 ECKVASGSYGDLYKGTYCSQEVAIKVLKPECV--N---TEMLKEFSQEVYIMRKIR---HKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 115 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~--~---~~~~~~~~~E~~il~~l~---h~niv~~~~~~~~~~~~~lV~ 186 (331)
.+.||.|....||+.+..++.++||.-.+... . +....+-..|...|+.+. ..++++++.++.+ ..+++|
T Consensus 37 ~~eiggGn~N~VyrV~~~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vlvM 114 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSSSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALIGM 114 (418)
T ss_pred EEEcCCCceeeEEEEEcCCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEEEE
Confidence 55789999999999988777899998652211 0 012334445567776654 2478888888774 458899
Q ss_pred eccCC--CCHHHHH
Q 020085 187 EFMAR--GSIYDFL 198 (331)
Q Consensus 187 E~~~g--gsL~~~l 198 (331)
|++++ ..+.+.+
T Consensus 115 E~L~~~~~ilr~~L 128 (418)
T PLN02756 115 RYLEPPHIILRKGL 128 (418)
T ss_pred eecCCcceehhhhh
Confidence 99977 2444443
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=97.18 E-value=0.0033 Score=58.36 Aligned_cols=143 Identities=16% Similarity=0.276 Sum_probs=82.1
Q ss_pred cCcceeeeeeecCceEEEEEEECC-----ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcc-eeEEeEEECCCCeE
Q 020085 110 KQLKIECKVASGSYGDLYKGTYCS-----QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNV-VQFIGACTRPPNLC 183 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~ni-v~~~~~~~~~~~~~ 183 (331)
++.++. .|..|-...+|+....+ ..|.+|+..... . ..-...+|..+++.+...++ +++++++. . .
T Consensus 15 ~~i~i~-~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t--~-~~IdR~~E~~il~~l~~~gl~P~~l~~~~-~---G 86 (330)
T PLN02421 15 SDFSVE-RISGGITNLLLKVSVKEENGNEVSVTVRLFGPNT--D-YVIDRERELQAIKYLSAAGFGAKLLGVFG-N---G 86 (330)
T ss_pred CceEEE-EeCCcccceEEEEEecCCCCCCceEEEEEecCCc--C-eEechHHHHHHHHHHHhcCCCCceeEEeC-C---c
Confidence 344444 44448888899887644 278999876532 1 12234678888888865444 45565553 2 2
Q ss_pred EEEeccCCCCHHH--------------H---HHhcCCC----CC-HHHHHHHHHHH----------------------HH
Q 020085 184 IVTEFMARGSIYD--------------F---LHKQKGV----FQ-LTSLLKVAIDV----------------------SK 219 (331)
Q Consensus 184 lV~E~~~ggsL~~--------------~---l~~~~~~----~~-~~~~~~i~~qi----------------------~~ 219 (331)
+|.+|++|..|.. . +|....+ ++ ...+..+..++ ..
T Consensus 87 ~i~~fi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 166 (330)
T PLN02421 87 MIQSFINARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRD 166 (330)
T ss_pred EeehhhcCCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHH
Confidence 5899998765421 0 1211101 11 12222222221 11
Q ss_pred HHHHHH----hC----CcccCCCCCCCEEEcC-CCcEEEeeecceeeecC
Q 020085 220 GMNYLH----QN----NIIHRDLKTANLLMDE-NGVVKVADFGVARVQAQ 260 (331)
Q Consensus 220 ~l~~LH----~~----~iiHrDlkp~NiLi~~-~~~vkl~DFg~a~~~~~ 260 (331)
-+..+. .. -++|.|+.+.|||+++ ++.++++||..|.....
T Consensus 167 ~~~~l~~~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~nd~ 216 (330)
T PLN02421 167 EIVELKEITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSYSYR 216 (330)
T ss_pred HHHHHHHHhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCCCcc
Confidence 122222 11 2799999999999975 57899999999965443
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=97.12 E-value=0.0053 Score=55.51 Aligned_cols=33 Identities=27% Similarity=0.509 Sum_probs=27.0
Q ss_pred CcccCCCCCCCEEEcCCCc-EEEeeecceeeecC
Q 020085 228 NIIHRDLKTANLLMDENGV-VKVADFGVARVQAQ 260 (331)
Q Consensus 228 ~iiHrDlkp~NiLi~~~~~-vkl~DFg~a~~~~~ 260 (331)
.++|+|++|.||++++++. .-|+||+.+...+.
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iGDP 219 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVGDP 219 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhcccCCH
Confidence 4899999999999997555 56999999875543
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=97.07 E-value=0.0034 Score=57.01 Aligned_cols=75 Identities=16% Similarity=0.139 Sum_probs=49.6
Q ss_pred ceeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC---CCcceeEEeEEECCCCeEEEEecc
Q 020085 113 KIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR---HKNVVQFIGACTRPPNLCIVTEFM 189 (331)
Q Consensus 113 ~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~---h~niv~~~~~~~~~~~~~lV~E~~ 189 (331)
+-.+.++.|....+|+.+..++.+.||+-.... ...|..|..-|+.+. .-.+++.+++....+..++||||+
T Consensus 20 ~~~~~v~GG~i~~a~~~~~~~~~~FvK~~~~~~-----~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l 94 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLDTDGGSYFVKVNSESG-----RDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFL 94 (288)
T ss_dssp -EEEEE--SSSSEEEEEETTS-EEEEEEEEGGG-----CCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE--
T ss_pred eeeEecCCCChhheEEEECCCccEEEEecChhh-----HHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEee
Confidence 335678889999999999888999999976321 246788888888884 355778888887777779999999
Q ss_pred CCC
Q 020085 190 ARG 192 (331)
Q Consensus 190 ~gg 192 (331)
+.+
T Consensus 95 ~~~ 97 (288)
T PF03881_consen 95 EMG 97 (288)
T ss_dssp ---
T ss_pred cCC
Confidence 876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.96 E-value=0.023 Score=52.18 Aligned_cols=32 Identities=22% Similarity=0.297 Sum_probs=28.9
Q ss_pred CcccCCCCCCCEEEcCCCcEEEeeecceeeec
Q 020085 228 NIIHRDLKTANLLMDENGVVKVADFGVARVQA 259 (331)
Q Consensus 228 ~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~ 259 (331)
+++|+|+.+.|++++.++.+.++||..+....
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~d~ 228 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASFAS 228 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhcccCC
Confidence 79999999999999999999999999986443
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.84 E-value=0.0088 Score=55.76 Aligned_cols=80 Identities=13% Similarity=-0.011 Sum_probs=49.3
Q ss_pred eeeecCceEEEEEEECC--ceEEEEEecCCCC-----CHHHHHHHHHHHHHHHhcC--CC-cceeEEeEEECCCCeEEEE
Q 020085 117 KVASGSYGDLYKGTYCS--QEVAIKVLKPECV-----NTEMLKEFSQEVYIMRKIR--HK-NVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 117 ~lg~G~~g~Vy~~~~~~--~~vavK~~~~~~~-----~~~~~~~~~~E~~il~~l~--h~-niv~~~~~~~~~~~~~lV~ 186 (331)
.||.|....||++...+ +.++||.-.+... .+-..++..-|...|+... .| .+++++. .++....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~--~D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH--FDTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE--EccccceehH
Confidence 57899999999998754 5799997532110 1122345557778887664 35 4444543 3344567999
Q ss_pred eccCCC-CHHHHH
Q 020085 187 EFMARG-SIYDFL 198 (331)
Q Consensus 187 E~~~gg-sL~~~l 198 (331)
|+++.. .|...|
T Consensus 80 EdL~~~~ilR~~L 92 (370)
T TIGR01767 80 EDLSHHKIARKGL 92 (370)
T ss_pred hhCccchHHHHHH
Confidence 999543 344444
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=96.77 E-value=0.003 Score=54.53 Aligned_cols=32 Identities=34% Similarity=0.580 Sum_probs=22.8
Q ss_pred CcccCCCCCCCEEE-cCCCcEEEeeecceeeec
Q 020085 228 NIIHRDLKTANLLM-DENGVVKVADFGVARVQA 259 (331)
Q Consensus 228 ~iiHrDlkp~NiLi-~~~~~vkl~DFg~a~~~~ 259 (331)
.++|.|+.|.||++ +.++.++++||..|....
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~n~ 176 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGYND 176 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EEEE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhhcc
Confidence 58999999999999 889999999999997543
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK05092 PII uridylyl-transferase; Provisional | Back alignment and domain information |
|---|
Probab=96.76 E-value=0.0037 Score=65.96 Aligned_cols=55 Identities=27% Similarity=0.386 Sum_probs=43.7
Q ss_pred HHHHHHHHHHhhhCCCeeeeeeeecCCCceeeEEEe---cCCCCCc---hHHHHHHHHHHH
Q 020085 9 MKVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVV---DGWPYDE---TEDLKNVLAKEI 63 (331)
Q Consensus 9 ~~~~~~~~~~~~~~~~i~~~~~~~t~~~~~~~~~vv---~gw~~~~---~~~l~~~l~~~~ 63 (331)
.+|++++.+|+..|+||.+|++|+|.||+.+|+|.| +|.+..+ .+.+++.|...+
T Consensus 744 GLfa~i~~~L~~~glnI~~A~I~t~~dg~alD~F~V~~~~g~~~~~~~~~~~l~~~L~~~l 804 (931)
T PRK05092 744 GLFSRIAGACAAAGANIVDARIFTTTDGRALDTFWIQDAFGRDEDEPRRLARLAKAIEDAL 804 (931)
T ss_pred cHHHHHHHHHHHCCCcEEEEEEEEecCCeEEEEEEEECCCCCCCCCHHHHHHHHHHHHHHH
Confidence 378999999999999999999999999999999999 6654332 444555555444
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=96.72 E-value=0.012 Score=55.49 Aligned_cols=82 Identities=11% Similarity=-0.005 Sum_probs=52.4
Q ss_pred eeeeeecCceEEEEEEEC--CceEEEEEecCCC----CCHHHHHHHHHHHHHHHhcC--CC-cceeEEeEEECCCCeEEE
Q 020085 115 ECKVASGSYGDLYKGTYC--SQEVAIKVLKPEC----VNTEMLKEFSQEVYIMRKIR--HK-NVVQFIGACTRPPNLCIV 185 (331)
Q Consensus 115 ~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~~~~~~E~~il~~l~--h~-niv~~~~~~~~~~~~~lV 185 (331)
.+.||.|.-..||++... ++.++||.-.+.. ..+-..++..-|...|+... .| .+++++. .++....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~--~D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL--FDSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE--ECcHHhhHH
Confidence 456899999999999974 5789999743211 11223456677888888764 35 4555553 344456789
Q ss_pred EeccCCC-CHHHHH
Q 020085 186 TEFMARG-SIYDFL 198 (331)
Q Consensus 186 ~E~~~gg-sL~~~l 198 (331)
||+++.. .|++.|
T Consensus 112 MEdL~~~~ilR~~L 125 (409)
T PRK12396 112 MEDLSDHTILRTAL 125 (409)
T ss_pred HHhCcccHHHHHHH
Confidence 9998643 344444
|
|
| >cd04926 ACT_ACR_4 C-terminal ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein) | Back alignment and domain information |
|---|
Probab=96.68 E-value=0.0092 Score=42.16 Aligned_cols=40 Identities=20% Similarity=0.328 Sum_probs=34.5
Q ss_pred HHHHHHHHHhhhCCCeeeeeeeecCCCceeeEEEecCCCCC
Q 020085 10 KVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYD 50 (331)
Q Consensus 10 ~~~~~~~~~~~~~~~i~~~~~~~t~~~~~~~~~vv~gw~~~ 50 (331)
+|.+++.+|++.|+||..|.+|++ +|+.+|+|.|......
T Consensus 14 ll~~i~~~l~~~~lnI~sa~i~t~-~~~~~d~f~v~~~~~~ 53 (72)
T cd04926 14 LLSDVTRVFRENGLTVTRAEISTQ-GDMAVNVFYVTDANGN 53 (72)
T ss_pred HHHHHHHHHHHCCcEEEEEEEecC-CCeEEEEEEEECCCCC
Confidence 689999999999999999999855 8899999998654444
|
This CD includes the C-terminal ACT domain, of a novel type of ACT domain-containing protein which is composed almost entirely of four ACT domain repeats (the "ACR" protein). ACR proteins, found only in Arabidopsis and Oryza, as yet, are proposed to function as novel regulatory or sensor proteins in plants. Nine ACR gene products have been described (ACR1-8 in Arabidopsis and OsARC1-9 in Oryza) and are represented in this CD. Members of this CD belong to the superfamily of ACT regulatory domains. |
| >TIGR01693 UTase_glnD [Protein-PII] uridylyltransferase | Back alignment and domain information |
|---|
Probab=96.59 E-value=0.0071 Score=63.31 Aligned_cols=56 Identities=23% Similarity=0.309 Sum_probs=44.1
Q ss_pred HHHHHHHHHHhhhCCCeeeeeeeecCCCceeeEEEecCCCCCc------hHHHHHHHHHHHH
Q 020085 9 MKVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDE------TEDLKNVLAKEIL 64 (331)
Q Consensus 9 ~~~~~~~~~~~~~~~~i~~~~~~~t~~~~~~~~~vv~gw~~~~------~~~l~~~l~~~~~ 64 (331)
.+|++++.+|+..||||..|++|+|.||+.+|+|.|....... .+.+++.|.+.+.
T Consensus 680 gLla~i~~~L~~~~l~I~~A~I~tt~~g~~lD~F~V~~~~g~~~~~~~~~~~i~~~L~~~L~ 741 (850)
T TIGR01693 680 GLFAKVAGALAMLSLSVHDAQVNTTKDGVALDTFVVQDLFGSPPAAERVFQELLQGLVDVLA 741 (850)
T ss_pred cHHHHHHHHHHHCCCeEEEEEEEEecCCEEEEEEEEECCCCCCCCcHHHHHHHHHHHHHHHc
Confidence 3789999999999999999999999999999999996554432 2334555555553
|
This model describes GlnD, the uridylyltransferase/uridylyl-removing enzyme for the nitrogen regulatory protein PII. Not all homologs of PII share the property of uridylyltransferase modification on the characteristic Tyr residue (see Prosite pattern PS00496 and document PDOC00439), but the modification site is preserved in the PII homolog of all species with a member of this family. |
| >PRK00275 glnD PII uridylyl-transferase; Provisional | Back alignment and domain information |
|---|
Probab=96.59 E-value=0.006 Score=63.91 Aligned_cols=43 Identities=19% Similarity=0.298 Sum_probs=38.4
Q ss_pred HHHHHHHHHHhhhCCCeeeeeeeecCCCceeeEEEecCCCCCc
Q 020085 9 MKVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDE 51 (331)
Q Consensus 9 ~~~~~~~~~~~~~~~~i~~~~~~~t~~~~~~~~~vv~gw~~~~ 51 (331)
.+++.++.+|+..||||.+|.+|+|.|||.+|+|+|-......
T Consensus 716 gLFa~i~g~L~~~~lnI~~A~I~Tt~dg~alD~F~V~d~~g~~ 758 (895)
T PRK00275 716 DFFAATVAAMDQLNLNIHDARIITSSSQFTLDTYIVLDDDGEP 758 (895)
T ss_pred cHHHHHHHHHHHCCCeEEEEEEEEcCCCeEEEEEEEeCCCCCC
Confidence 3788999999999999999999999999999999997655443
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=96.58 E-value=0.07 Score=56.93 Aligned_cols=30 Identities=33% Similarity=0.591 Sum_probs=26.0
Q ss_pred CCcccCCCCCCCEEEcCCC--cEE-Eeeeccee
Q 020085 227 NNIIHRDLKTANLLMDENG--VVK-VADFGVAR 256 (331)
Q Consensus 227 ~~iiHrDlkp~NiLi~~~~--~vk-l~DFg~a~ 256 (331)
.++||+|+++.|||++.++ .+. |+|||-+.
T Consensus 203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~ 235 (1013)
T PRK06148 203 AQVIHNDANDYNILVDADDGERISGLIDFGDAV 235 (1013)
T ss_pred cceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence 5799999999999999875 555 99999984
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 331 | ||||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 3e-52 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-52 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 7e-46 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-45 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 9e-45 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-44 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-44 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 4e-44 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 6e-44 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 7e-44 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-43 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-43 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-43 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-43 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 1e-42 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-42 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-39 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 5e-39 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-39 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-39 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 1e-38 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-38 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 2e-38 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 2e-38 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-38 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-38 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 2e-38 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-38 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 2e-38 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-38 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-38 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 3e-38 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 3e-38 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-38 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 3e-38 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 3e-38 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 3e-38 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 3e-38 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 3e-38 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 4e-38 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-38 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-38 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 7e-38 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 8e-38 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-37 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-37 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 1e-37 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-37 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 1e-37 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 1e-37 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 1e-37 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 1e-37 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-37 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-37 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 2e-37 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-37 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 2e-37 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 2e-37 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-37 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-37 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 7e-37 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 7e-37 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 7e-37 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 1e-36 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-36 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-36 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-36 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 4e-36 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 5e-36 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 7e-36 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 1e-35 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-35 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-35 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 7e-35 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 7e-35 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 8e-35 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 8e-35 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 8e-35 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-34 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 1e-34 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-34 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-34 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 2e-34 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 9e-33 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 1e-32 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-32 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-32 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 1e-32 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-32 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-32 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-32 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-32 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-32 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-32 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-32 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-32 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 3e-32 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-31 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-31 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-31 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-31 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 4e-31 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 5e-31 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-31 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 5e-31 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 1e-30 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 4e-30 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-30 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 5e-30 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-30 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 1e-29 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-29 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-29 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 1e-29 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-29 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 2e-29 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 3e-29 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-29 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-29 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 3e-29 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-29 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 4e-29 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 4e-29 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 4e-29 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-29 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 5e-29 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-29 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 7e-29 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 7e-29 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 7e-29 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 7e-29 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 7e-29 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-29 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-29 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 8e-29 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 8e-29 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 8e-29 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 9e-29 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 9e-29 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 1e-28 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 1e-28 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-28 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-28 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-28 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-28 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-28 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-28 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-28 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-28 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-28 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-28 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-28 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-28 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-28 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-28 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 6e-28 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 6e-28 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 6e-28 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-28 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 7e-28 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 8e-28 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-27 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-27 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 3e-27 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 3e-27 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 3e-27 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 3e-27 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 4e-27 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 4e-27 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 4e-27 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 4e-27 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 4e-27 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 4e-27 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 4e-27 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 4e-27 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 4e-27 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 4e-27 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 4e-27 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-27 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 7e-27 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 8e-27 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 8e-27 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 8e-27 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 8e-27 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 8e-27 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 8e-27 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 9e-27 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 1e-26 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-26 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-26 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-26 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-26 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-26 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-26 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-26 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-26 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-26 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-26 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 2e-26 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-26 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 2e-26 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-26 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-26 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-26 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 3e-26 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-26 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-26 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-26 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-26 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 3e-26 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-26 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 4e-26 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-26 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-26 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-26 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 4e-26 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-26 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 4e-26 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 4e-26 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-26 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 5e-26 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-26 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 7e-26 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-26 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 9e-26 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 9e-26 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-25 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 1e-25 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-25 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 1e-25 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-25 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-25 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-25 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-25 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-25 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-25 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-25 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-25 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-25 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-25 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-25 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-25 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 4e-25 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 5e-25 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 5e-25 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 7e-25 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 7e-25 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-25 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-25 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 8e-25 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 8e-25 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 9e-25 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 9e-25 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 9e-25 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-24 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 1e-24 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 1e-24 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 1e-24 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 3e-24 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 3e-24 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-24 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 3e-24 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 3e-24 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-24 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-24 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-24 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-24 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-24 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-24 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-24 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-24 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 4e-24 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 4e-24 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-24 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 4e-24 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 5e-24 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 5e-24 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 6e-24 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 6e-24 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 6e-24 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 6e-24 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 6e-24 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 6e-24 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 7e-24 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 7e-24 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 7e-24 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 7e-24 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 7e-24 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 7e-24 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 7e-24 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 8e-24 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 9e-24 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 9e-24 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 1e-23 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-23 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-23 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-23 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-23 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-23 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-23 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-23 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 1e-23 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-23 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-23 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-23 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-23 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-23 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-23 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-23 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-23 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-23 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-23 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-23 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 2e-23 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-23 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-23 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-23 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-23 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-23 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-23 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-23 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 3e-23 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-23 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 4e-23 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-23 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 4e-23 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 4e-23 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-23 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 6e-23 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 6e-23 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-23 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 6e-23 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-23 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 7e-23 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 7e-23 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 8e-23 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 9e-23 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-22 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-22 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-22 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 1e-22 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 1e-22 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 1e-22 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 1e-22 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-22 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 2e-22 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-22 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 2e-22 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 2e-22 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-22 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 2e-22 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 2e-22 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-22 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-22 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-22 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-22 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-22 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-22 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 3e-22 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-22 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 4e-22 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 4e-22 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-22 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-22 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 5e-22 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 5e-22 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 5e-22 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 5e-22 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-22 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 5e-22 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-22 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 7e-22 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 7e-22 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 7e-22 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 8e-22 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 9e-22 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 9e-22 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 9e-22 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-21 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 1e-21 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-21 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-21 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-21 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-21 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-21 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-21 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-21 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-21 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 2e-21 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-21 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 2e-21 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-21 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-21 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-21 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-21 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 2e-21 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 2e-21 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 2e-21 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-21 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 2e-21 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-21 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-21 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-21 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-21 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 3e-21 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 3e-21 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 4e-21 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-21 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 7e-21 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 8e-21 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-20 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-20 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-20 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-20 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 1e-20 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 1e-20 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-20 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 3e-20 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-20 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-20 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-20 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-20 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 4e-20 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 5e-20 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 5e-20 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 5e-20 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 5e-20 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 6e-20 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 6e-20 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 6e-20 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 7e-20 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 8e-20 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 8e-20 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 9e-20 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 9e-20 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 1e-19 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-19 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-19 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-19 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-19 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-19 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-19 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-19 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-19 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 1e-19 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-19 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-19 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-19 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-19 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-19 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-19 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-19 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-19 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 2e-19 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-19 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-19 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-19 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-19 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-19 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-19 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-19 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 3e-19 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 3e-19 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 3e-19 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 3e-19 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-19 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-19 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-19 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 4e-19 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 4e-19 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 4e-19 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 5e-19 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-19 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 5e-19 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 6e-19 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-19 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 7e-19 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 7e-19 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 7e-19 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 8e-19 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 8e-19 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 8e-19 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 8e-19 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 9e-19 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 9e-19 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-18 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-18 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 1e-18 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-18 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-18 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-18 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-18 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-18 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-18 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-18 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 2e-18 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-18 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-18 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-18 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 3e-18 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-18 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 3e-18 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 3e-18 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 5e-18 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-18 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 5e-18 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 5e-18 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-18 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 7e-18 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 7e-18 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-18 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-18 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 7e-18 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 8e-18 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 9e-18 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-17 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-17 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-17 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-17 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-17 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-17 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 1e-17 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-17 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-17 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 1e-17 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 1e-17 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-17 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-17 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-17 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-17 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-17 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-17 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-17 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-17 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-17 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 4e-17 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 5e-17 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 5e-17 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 5e-17 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 5e-17 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 5e-17 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 6e-17 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 6e-17 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 6e-17 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 6e-17 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 6e-17 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 6e-17 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 6e-17 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 6e-17 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 7e-17 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 7e-17 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 7e-17 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 7e-17 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 7e-17 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 7e-17 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 7e-17 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 7e-17 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 7e-17 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 8e-17 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 8e-17 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 9e-17 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-16 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 1e-16 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 1e-16 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-16 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-16 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-16 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 1e-16 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 1e-16 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-16 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-16 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-16 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-16 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 2e-16 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-16 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 2e-16 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 2e-16 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 2e-16 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-16 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 2e-16 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-16 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 2e-16 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 2e-16 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 2e-16 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 2e-16 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-16 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-16 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-16 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-16 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-16 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-16 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-16 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 3e-16 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-16 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-16 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-16 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 3e-16 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 3e-16 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 3e-16 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-16 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 4e-16 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-16 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-16 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 4e-16 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 5e-16 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 5e-16 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 5e-16 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 5e-16 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 5e-16 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 6e-16 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 6e-16 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 6e-16 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-16 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 6e-16 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 6e-16 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 6e-16 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 6e-16 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-16 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 6e-16 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 6e-16 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 6e-16 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 6e-16 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-16 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-16 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 7e-16 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 7e-16 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 7e-16 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 7e-16 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 7e-16 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 7e-16 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 7e-16 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 8e-16 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-16 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 8e-16 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 8e-16 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 8e-16 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 8e-16 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 8e-16 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-16 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 8e-16 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-16 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 8e-16 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 8e-16 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 9e-16 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 9e-16 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 9e-16 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 9e-16 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 9e-16 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 9e-16 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 9e-16 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 9e-16 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 9e-16 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 1e-15 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 1e-15 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 1e-15 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 1e-15 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-15 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 1e-15 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-15 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-15 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-15 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-15 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-15 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-15 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 1e-15 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 1e-15 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 1e-15 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 1e-15 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-15 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 2e-15 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 2e-15 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 2e-15 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-15 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-15 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 2e-15 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-15 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 2e-15 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-15 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 3e-15 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 3e-15 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 3e-15 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 3e-15 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-15 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-15 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 3e-15 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-15 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-15 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 4e-15 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-15 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 5e-15 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-15 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 5e-15 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 5e-15 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-15 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 5e-15 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 5e-15 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 5e-15 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 5e-15 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 6e-15 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 6e-15 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 7e-15 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 7e-15 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 7e-15 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 8e-15 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 8e-15 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 8e-15 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 8e-15 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 8e-15 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 8e-15 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-15 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-15 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 9e-15 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 9e-15 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-14 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-14 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-14 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-14 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-14 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-14 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-14 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-14 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-14 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-14 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-14 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-14 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-14 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-14 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-14 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-14 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-14 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-14 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-14 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-14 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-14 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-14 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-14 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-14 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-14 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-14 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-14 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-14 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-14 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-14 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 1e-14 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-14 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-14 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-14 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-14 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 2e-14 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 3e-14 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 3e-14 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 3e-14 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 3e-14 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-14 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-14 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 3e-14 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 3e-14 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-14 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-14 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-14 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-14 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-14 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 4e-14 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 4e-14 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 4e-14 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 4e-14 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 4e-14 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 4e-14 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-14 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 5e-14 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-14 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-14 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 5e-14 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-14 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-14 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 6e-14 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 6e-14 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 6e-14 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 6e-14 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 6e-14 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 6e-14 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 6e-14 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 6e-14 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 7e-14 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-14 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 7e-14 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 7e-14 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 7e-14 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 7e-14 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 8e-14 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 8e-14 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 8e-14 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 8e-14 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 8e-14 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 8e-14 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 9e-14 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 9e-14 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 9e-14 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 9e-14 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 9e-14 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 9e-14 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 9e-14 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 9e-14 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 9e-14 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 9e-14 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 9e-14 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-13 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 1e-13 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-13 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-13 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-13 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-13 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-13 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-13 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 1e-13 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-13 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 1e-13 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-13 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 1e-13 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 1e-13 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-13 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-13 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 2e-13 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-13 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 2e-13 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 2e-13 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-13 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 2e-13 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 2e-13 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 2e-13 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 2e-13 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 2e-13 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-13 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 2e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-13 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 2e-13 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 2e-13 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 2e-13 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 2e-13 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-13 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 2e-13 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 2e-13 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-13 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 2e-13 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-13 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-13 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-13 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-13 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-13 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 2e-13 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 2e-13 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 2e-13 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-13 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-13 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-13 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-13 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-13 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-13 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-13 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 3e-13 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-13 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-13 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-13 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-13 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-13 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-13 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-13 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-13 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-13 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-13 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-13 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-13 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-13 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 3e-13 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-13 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 3e-13 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-13 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-13 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-13 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 3e-13 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-13 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-13 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-13 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-13 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-13 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 4e-13 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 4e-13 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-13 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 4e-13 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-13 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 4e-13 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 4e-13 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 4e-13 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 4e-13 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 4e-13 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 4e-13 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 4e-13 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 4e-13 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 4e-13 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 4e-13 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 4e-13 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-13 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 4e-13 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 4e-13 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-13 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-13 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 4e-13 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 5e-13 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 5e-13 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 5e-13 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 5e-13 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-13 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 6e-13 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-13 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 7e-13 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 7e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 8e-13 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 8e-13 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 1e-12 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-12 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 2e-12 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 2e-12 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 3e-12 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 3e-12 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 3e-12 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 5e-12 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-12 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 5e-12 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 5e-12 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 5e-12 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 5e-12 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 5e-12 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 5e-12 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 6e-12 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 6e-12 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 6e-12 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 6e-12 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 9e-12 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-11 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-11 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-11 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-11 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 2e-11 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 2e-11 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-11 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-11 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 2e-11 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 2e-11 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-11 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-11 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-11 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-11 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 2e-11 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 3e-11 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-11 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 3e-11 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 3e-11 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 3e-11 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 3e-11 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 3e-11 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 3e-11 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 3e-11 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 3e-11 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-11 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 3e-11 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 3e-11 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 3e-11 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 3e-11 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 3e-11 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 3e-11 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 3e-11 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 3e-11 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 3e-11 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 4e-11 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 5e-11 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 6e-11 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 6e-11 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 7e-11 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 7e-11 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 1e-10 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-10 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-10 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 2e-10 | ||
| 1ckj_A | 317 | Casein Kinase I Delta Truncation Mutant Containing | 2e-10 | ||
| 3uys_A | 296 | Crystal Structure Of Apo Human Ck1d Length = 296 | 2e-10 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 2e-10 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 3e-10 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 4e-10 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 4e-10 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 4e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 4e-10 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 4e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 4e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 4e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 5e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 5e-10 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-10 |
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317 | Back alignment and structure |
|
| >pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 379 bits (976), Expect = e-133
Identities = 102/244 (41%), Positives = 152/244 (62%), Gaps = 5/244 (2%)
Query: 84 SKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKP 143
S I ++ N D +I L I+ K+ +GS+G +++ + +VA+K+L
Sbjct: 11 SDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILME 70
Query: 144 ECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG 203
+ + E + EF +EV IM+++RH N+V F+GA T+PPNL IVTE+++RGS+Y LHK
Sbjct: 71 QDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGA 130
Query: 204 VFQLT--SLLKVAIDVSKGMNYLHQNN--IIHRDLKTANLLMDENGVVKVADFGVARVQA 259
QL L +A DV+KGMNYLH N I+HR+LK+ NLL+D+ VKV DFG++R++A
Sbjct: 131 REQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190
Query: 260 QSGV-MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVG 318
+ + + GT WMAPEV+ +P + K+DV+SFG+ LWEL T + P+ L P Q
Sbjct: 191 STFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAA 250
Query: 319 VVQK 322
V K
Sbjct: 251 VGFK 254
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 362 bits (932), Expect = e-126
Identities = 86/233 (36%), Positives = 140/233 (60%), Gaps = 8/233 (3%)
Query: 96 EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFS 155
D D WEI Q+ + ++ SGS+G +YKG + +VA+K+L + L+ F
Sbjct: 10 HGSRDAADDWEIPDGQITVGQRIGSGSFGTVYKGKWH-GDVAVKMLNVTAPTPQQLQAFK 68
Query: 156 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
EV ++RK RH N++ F+G T P L IVT++ S+Y LH + F++ L+ +A
Sbjct: 69 NEVGVLRKTRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIAR 127
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ---SGVMTAETGTYR 272
++GM+YLH +IIHRDLK+ N+ + E+ VK+ DFG+A +++ S +G+
Sbjct: 128 QTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 187
Query: 273 WMAPEVI---EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK 322
WMAPEVI + PY +++DV++FGI L+EL+TG+LPY+ + + +V +
Sbjct: 188 WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGR 240
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 348 bits (896), Expect = e-121
Identities = 80/232 (34%), Positives = 130/232 (56%), Gaps = 16/232 (6%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVN--TEMLKEFSQEVYIM 161
+ EID +L +E + G +G +Y+ + EVA+K + + ++ ++ QE +
Sbjct: 1 LLEIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLF 60
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
++H N++ G C + PNLC+V EF G + L ++ L+ A+ +++GM
Sbjct: 61 AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGKR--IPPDILVNWAVQIARGM 118
Query: 222 NYLHQNN---IIHRDLKTANLLMDE--------NGVVKVADFGVARVQAQSGVMTAETGT 270
NYLH IIHRDLK++N+L+ + N ++K+ DFG+AR ++ M+A G
Sbjct: 119 NYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA-AGA 177
Query: 271 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK 322
Y WMAPEVI + +DV+S+G+ LWELLTGE+P+ G+ L A GV
Sbjct: 178 YAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMN 229
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 348 bits (894), Expect = e-120
Identities = 74/247 (29%), Positives = 119/247 (48%), Gaps = 17/247 (6%)
Query: 90 SSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTE 149
S P + W+I +QL+I + G +G +Y G + EVAI+++ E N +
Sbjct: 13 SFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWH-GEVAIRLIDIERDNED 71
Query: 150 MLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTS 209
LK F +EV R+ RH+NVV F+GAC PP+L I+T ++Y + K V +
Sbjct: 72 QLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNK 131
Query: 210 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA------QSGV 263
++A ++ KGM YLH I+H+DLK+ N+ D NG V + DFG+ + +
Sbjct: 132 TRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDK 190
Query: 264 MTAETGTYRWMAPEVI---------EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ 314
+ + G +APE+I + P+ +DVF+ G +EL E P+
Sbjct: 191 LRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA 250
Query: 315 AAVGVVQ 321
+
Sbjct: 251 IIWQMGT 257
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 345 bits (888), Expect = e-120
Identities = 67/226 (29%), Positives = 120/226 (53%), Gaps = 12/226 (5%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI 164
ID KQL K+ G+L+KG + ++ +KVLK +T ++F++E +R
Sbjct: 5 SGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF 64
Query: 165 RHKNVVQFIGACTRPP--NLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGM 221
H NV+ +GAC PP + ++T +M GS+Y+ LH+ V + +K A+D+++GM
Sbjct: 65 SHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGM 124
Query: 222 NYLH--QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVI 279
+LH + I L + ++++DE+ +++ V W+APE +
Sbjct: 125 AFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF----QSPGRMYAPAWVAPEAL 180
Query: 280 EHKPYDY---KADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK 322
+ KP D AD++SF + LWEL+T E+P+A L+ ++ + V +
Sbjct: 181 QKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALE 226
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 343 bits (883), Expect = e-119
Identities = 68/233 (29%), Positives = 103/233 (44%), Gaps = 15/233 (6%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI 164
L + G +G K T+ + + + + E + F +EV +MR +
Sbjct: 5 RIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCL 64
Query: 165 RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 224
H NV++FIG + L +TE++ G++ + + + + A D++ GM YL
Sbjct: 65 EHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYL 124
Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA---------------QSGVMTAETG 269
H NIIHRDL + N L+ EN V VADFG+AR+ G
Sbjct: 125 HSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVG 184
Query: 270 TYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK 322
WMAPE+I + YD K DVFSFGI L E++ P G+ +
Sbjct: 185 NPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVR 237
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 332 bits (854), Expect = e-114
Identities = 67/243 (27%), Positives = 120/243 (49%), Gaps = 22/243 (9%)
Query: 98 PTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVN-----TEM 150
+ + + +++ E ++ G +G ++KG VAIK L E
Sbjct: 7 EFPKSRLPTLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEK 66
Query: 151 LKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSL 210
+EF +EV+IM + H N+V+ G PP +V EF+ G +Y L + + +
Sbjct: 67 FQEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVK 124
Query: 211 LKVAIDVSKGMNYLHQNN--IIHRDLKTANLLMDENG-----VVKVADFGVARVQAQSGV 263
L++ +D++ G+ Y+ N I+HRDL++ N+ + KVADFG+++ S
Sbjct: 125 LRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS-- 182
Query: 264 MTAETGTYRWMAPEVI--EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAV--GV 319
++ G ++WMAPE I E + Y KAD +SF + L+ +LTGE P+ + + +
Sbjct: 183 VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI 242
Query: 320 VQK 322
++
Sbjct: 243 REE 245
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 327 bits (840), Expect = e-112
Identities = 78/226 (34%), Positives = 120/226 (53%), Gaps = 15/226 (6%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRK 163
+ ID K++++E V G++G + K + +++VAIK ++ E K F E+ + +
Sbjct: 2 LHMIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE----SERKAFIVELRQLSR 57
Query: 164 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLT--SLLKVAIDVSKGM 221
+ H N+V+ GAC P +C+V E+ GS+Y+ LH + + T + + S+G+
Sbjct: 58 VNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGV 115
Query: 222 NYLHQ---NNIIHRDLKTANLLMDENG-VVKVADFGVARVQAQSGVMTAETGTYRWMAPE 277
YLH +IHRDLK NLL+ G V+K+ DFG A MT G+ WMAPE
Sbjct: 116 AYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--MTNNKGSAAWMAPE 173
Query: 278 VIEHKPYDYKADVFSFGIALWELLTGELPYAGL-TPLQAAVGVVQK 322
V E Y K DVFS+GI LWE++T P+ + P + V
Sbjct: 174 VFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHN 219
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 297 bits (761), Expect = e-100
Identities = 76/279 (27%), Positives = 127/279 (45%), Gaps = 40/279 (14%)
Query: 80 VPMHSKL--LIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVA 137
+P L LIE S + V AKQ+++ ++ G YG+++ G + ++VA
Sbjct: 5 IPPGESLRDLIEQSQSSGSGSGLPLLVQRTIAKQIQMVKQIGKGRYGEVWMGKWRGEKVA 64
Query: 138 IKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP----PNLCIVTEFMARGS 193
+KV +E E+Y +RH+N++ FI A + L ++T++ GS
Sbjct: 65 VKVFFTTEEA-SWFRE--TEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGS 121
Query: 194 IYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH--------QNNIIHRDLKTANLLMDENG 245
+YD+L S+LK+A G+ +LH + I HRDLK+ N+L+ +NG
Sbjct: 122 LYDYLKSTT--LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG 179
Query: 246 VVKVADFGVARVQAQSG-----VMTAETGTYRWMAPEVIE------HKPYDYKADVFSFG 294
+AD G+A GT R+M PEV++ H AD++SFG
Sbjct: 180 TCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFG 239
Query: 295 IALWELLTG----------ELPYAGLTPLQAAVGVVQKV 323
+ LWE+ +LPY L P + ++++
Sbjct: 240 LILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREI 278
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 291 bits (746), Expect = 3e-98
Identities = 63/248 (25%), Positives = 118/248 (47%), Gaps = 38/248 (15%)
Query: 109 AKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN 168
A+ + + V G YG++++G++ + VA+K+ +E E+Y +RH+N
Sbjct: 7 ARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSRDEK-SWFRE--TELYNTVMLRHEN 63
Query: 169 VVQFIGACTR----PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 224
++ FI + L ++T + GS+YD+L S L++ + ++ G+ +L
Sbjct: 64 ILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTT--LDTVSCLRIVLSIASGLAHL 121
Query: 225 H--------QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM-----TAETGTY 271
H + I HRDLK+ N+L+ +NG +AD G+A + +QS GT
Sbjct: 122 HIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTK 181
Query: 272 RWMAPEVIEHKP------YDYKADVFSFGIALWELLTG----------ELPYAGLTPLQA 315
R+MAPEV++ + D+++FG+ LWE+ + P+ + P
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDP 241
Query: 316 AVGVVQKV 323
+ ++KV
Sbjct: 242 SFEDMRKV 249
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 282 bits (724), Expect = 3e-94
Identities = 65/253 (25%), Positives = 123/253 (48%), Gaps = 38/253 (15%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRK 163
V A+ + ++ + G +G++++G + +EVA+K+ +E E+Y
Sbjct: 36 VQRTIARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSREER-SWFRE--AEIYQTVM 92
Query: 164 IRHKNVVQFIGACTR----PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
+RH+N++ FI A + L +V+++ GS++D+L++ + ++K+A+ +
Sbjct: 93 LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTAS 150
Query: 220 GMNYLHQN--------NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-----VMTA 266
G+ +LH I HRDLK+ N+L+ +NG +AD G+A +
Sbjct: 151 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 210
Query: 267 ETGTYRWMAPEVIE------HKPYDYKADVFSFGIALWELLTG----------ELPYAGL 310
GT R+MAPEV++ H +AD+++ G+ WE+ +LPY L
Sbjct: 211 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 270
Query: 311 TPLQAAVGVVQKV 323
P +V ++KV
Sbjct: 271 VPSDPSVEEMRKV 283
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 276 bits (708), Expect = 3e-92
Identities = 68/245 (27%), Positives = 120/245 (48%), Gaps = 32/245 (13%)
Query: 101 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYI 160
GT+ + L++ A G +G ++K ++ VA+K+ + + + EVY
Sbjct: 15 GTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQD---KQSWQNEYEVYS 71
Query: 161 MRKIRHKNVVQFIGACTRPPN----LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAID 216
+ ++H+N++QFIGA R + L ++T F +GS+ DFL V L +A
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAET 129
Query: 217 VSKGMNYLHQN----------NIIHRDLKTANLLMDENGVVKVADFGVARVQ---AQSGV 263
+++G+ YLH++ I HRD+K+ N+L+ N +ADFG+A +G
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGD 189
Query: 264 MTAETGTYRWMAPEVIEH-----KPYDYKADVFSFGIALWELLTGELPYAG-----LTPL 313
+ GT R+MAPEV+E + + D+++ G+ LWEL + G + P
Sbjct: 190 THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249
Query: 314 QAAVG 318
+ +G
Sbjct: 250 EEEIG 254
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 255 bits (654), Expect = 7e-84
Identities = 61/245 (24%), Positives = 105/245 (42%), Gaps = 38/245 (15%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI 164
+D LK+ + G YG +YKG+ + VA+KV + E + +Y + +
Sbjct: 8 PSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQ-NFINE--KNIYRVPLM 64
Query: 165 RHKNVVQFIGACTRPP-----NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
H N+ +FI R +V E+ GS+ +L S ++A V++
Sbjct: 65 EHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT--SDWVSSCRLAHSVTR 122
Query: 220 GMNYLH---------QNNIIHRDLKTANLLMDENGVVKVADFGVARVQA---------QS 261
G+ YLH + I HRDL + N+L+ +G ++DFG++ +
Sbjct: 123 GLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEED 182
Query: 262 GVMTAETGTYRWMAPEVIE-------HKPYDYKADVFSFGIALWELL---TGELPYAGLT 311
+E GT R+MAPEV+E + + D+++ G+ WE+ T P +
Sbjct: 183 NAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242
Query: 312 PLQAA 316
Q A
Sbjct: 243 EYQMA 247
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 242 bits (621), Expect = 3e-78
Identities = 71/229 (31%), Positives = 118/229 (51%), Gaps = 13/229 (5%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYI 160
D W ++ + L + ++ G++G+++ G + VA+K + ++ +F QE I
Sbjct: 107 DKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETL-PPDLKAKFLQEARI 165
Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 220
+++ H N+V+ IG CT+ + IV E + G FL + ++ +LL++ D + G
Sbjct: 166 LKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAG 225
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT----YRWMAP 276
M YL IHRDL N L+ E V+K++DFG++R GV A G +W AP
Sbjct: 226 MEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSRE-EADGVYAASGGLRQVPVKWTAP 284
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVS 324
E + + Y ++DV+SFGI LWE + G PY L+ Q + V
Sbjct: 285 EALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ----TREFVE 329
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 235 bits (601), Expect = 1e-76
Identities = 78/228 (34%), Positives = 123/228 (53%), Gaps = 19/228 (8%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMR 162
W ++ K+LK+ + G +GD+ G Y +VA+K +K + + F E +M
Sbjct: 14 SGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMT 69
Query: 163 KIRHKNVVQFIGACTR-PPNLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKG 220
++RH N+VQ +G L IVTE+MA+GS+ D+L + V LLK ++DV +
Sbjct: 70 QLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 129
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPE 277
M YL NN +HRDL N+L+ E+ V KV+DFG+ + + + + +W APE
Sbjct: 130 MEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEAS-----STQDTGKLPVKWTAPE 184
Query: 278 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVS 324
+ K + K+DV+SFGI LWE+ + G +PY + VV +V
Sbjct: 185 ALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD----VVPRVE 228
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 3e-76
Identities = 78/212 (36%), Positives = 125/212 (58%), Gaps = 9/212 (4%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIMRK 163
W ID +L ++ SG +G ++ G + ++ +VAIK ++ ++ E +F +E +M K
Sbjct: 3 WVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMK 59
Query: 164 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNY 223
+ H +VQ G C +C+VTEFM G + D+L Q+G+F +LL + +DV +GM Y
Sbjct: 60 LSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAY 119
Query: 224 LHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEVIE 280
L + +IHRDL N L+ EN V+KV+DFG+ R T+ TGT +W +PEV
Sbjct: 120 LEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF-VLDDQYTSSTGTKFPVKWASPEVFS 178
Query: 281 HKPYDYKADVFSFGIALWELLT-GELPYAGLT 311
Y K+DV+SFG+ +WE+ + G++PY +
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVFSEGKIPYENRS 210
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 234 bits (598), Expect = 6e-76
Identities = 73/214 (34%), Positives = 124/214 (57%), Gaps = 9/214 (4%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIM 161
WEID K L ++ +G +G + G + Q +VAIK++K ++ + EF +E +M
Sbjct: 17 GSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVM 73
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
+ H+ +VQ G CT+ + I+TE+MA G + ++L + + FQ LL++ DV + M
Sbjct: 74 MNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAM 133
Query: 222 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEV 278
YL +HRDL N L+++ GVVKV+DFG++R T+ G+ RW PEV
Sbjct: 134 EYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRY-VLDDEYTSSVGSKFPVRWSPPEV 192
Query: 279 IEHKPYDYKADVFSFGIALWELLT-GELPYAGLT 311
+ + + K+D+++FG+ +WE+ + G++PY T
Sbjct: 193 LMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFT 226
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 238 bits (609), Expect = 1e-75
Identities = 80/254 (31%), Positives = 126/254 (49%), Gaps = 19/254 (7%)
Query: 77 ALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEV 136
A G+ W ++ K+LK+ + G +GD+ G Y +V
Sbjct: 160 ADGLCTRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKV 219
Query: 137 AIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR-PPNLCIVTEFMARGSIY 195
A+K +K + + F E +M ++RH N+VQ +G L IVTE+MA+GS+
Sbjct: 220 AVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLV 275
Query: 196 DFLHKQKG-VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV 254
D+L + V LLK ++DV + M YL NN +HRDL N+L+ E+ V KV+DFG+
Sbjct: 276 DYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGL 335
Query: 255 ARVQAQSGVMTAETGT---YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGL 310
+ + + + +W APE + K + K+DV+SFGI LWE+ + G +PY +
Sbjct: 336 TKEAS-----STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 390
Query: 311 TPLQAAVGVVQKVS 324
VV +V
Sbjct: 391 PLKD----VVPRVE 400
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 232 bits (593), Expect = 3e-75
Identities = 73/236 (30%), Positives = 124/236 (52%), Gaps = 16/236 (6%)
Query: 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE-----VAIKVLKPECVNT-EMLKEFS 155
+ I K L++ K+ GS+G + +G + + VA+K LKP+ ++ E + +F
Sbjct: 10 SLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI 69
Query: 156 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
+EV M + H+N+++ G PP + +VTE GS+ D L K +G F L +L + A+
Sbjct: 70 REVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV 128
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGT---Y 271
V++GM YL IHRDL NLL+ +VK+ DFG+ R + + +
Sbjct: 129 QVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 188
Query: 272 RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIH 326
W APE ++ + + + +D + FG+ LWE+ T G+ P+ GL Q ++ K+
Sbjct: 189 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ----ILHKIDKE 240
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 2e-74
Identities = 74/225 (32%), Positives = 126/225 (56%), Gaps = 13/225 (5%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIMRK 163
E+ +++ + ++ SG +G + G + Q +VA+K++K ++ + EF QE M K
Sbjct: 3 MELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSED---EFFQEAQTMMK 59
Query: 164 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNY 223
+ H +V+F G C++ + IVTE+++ G + ++L + + LL++ DV +GM +
Sbjct: 60 LSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAF 119
Query: 224 LHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEVIE 280
L + IHRDL N L+D + VKV+DFG+ R + GT +W APEV
Sbjct: 120 LESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRY-VLDDQYVSSVGTKFPVKWSAPEVFH 178
Query: 281 HKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVS 324
+ Y K+DV++FGI +WE+ + G++PY T + VV KVS
Sbjct: 179 YFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE----VVLKVS 219
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 229 bits (587), Expect = 3e-74
Identities = 84/229 (36%), Positives = 129/229 (56%), Gaps = 15/229 (6%)
Query: 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE--VAIKVLKPECVNTEMLKEFSQEVY 159
D WE++ + ++ K+ G YG++Y+G + VA+K LK + + E EF +E
Sbjct: 5 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVE---EFLKEAA 61
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVS 218
+M++I+H N+VQ +G CTR P I+TEFM G++ D+L + LL +A +S
Sbjct: 62 VMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQIS 121
Query: 219 KGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMA 275
M YL + N IHRDL N L+ EN +VKVADFG++R+ TA G +W A
Sbjct: 122 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTA 180
Query: 276 PEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKV 323
PE + + + K+DV++FG+ LWE+ T G PY G+ Q V + +
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----VYELL 225
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 4e-74
Identities = 59/231 (25%), Positives = 111/231 (48%), Gaps = 14/231 (6%)
Query: 101 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFS 155
G + I + + + + G +G++Y+G Y + + VA+K K +C ++F
Sbjct: 3 GGPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNK-EKFM 61
Query: 156 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
E IM+ + H ++V+ IG P I+ E G + +L + K ++ +L+ ++
Sbjct: 62 SEAVIMKNLDHPHIVKLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSL 120
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RW 273
+ K M YL N +HRD+ N+L+ VK+ DFG++R A +W
Sbjct: 121 QICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKW 180
Query: 274 MAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKV 323
M+PE I + + +DV+ F + +WE+L+ G+ P+ L V+ +
Sbjct: 181 MSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD----VIGVL 227
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 5e-74
Identities = 77/228 (33%), Positives = 133/228 (58%), Gaps = 15/228 (6%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIM 161
D WE+ + LK+ ++ +G +G+++ G Y +VA+K LK ++ + F E +M
Sbjct: 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLM 62
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKG 220
++++H+ +V+ T+ P + I+TE+M GS+ DFL G + LL +A +++G
Sbjct: 63 KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPE 277
M ++ + N IHRDL+ AN+L+ + K+ADFG+AR+ + TA G +W APE
Sbjct: 122 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARL-IEDNEYTAREGAKFPIKWTAPE 180
Query: 278 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVS 324
I + + K+DV+SFGI L E++T G +PY G+T + V+Q +
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE----VIQNLE 224
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 234 bits (599), Expect = 1e-73
Identities = 85/241 (35%), Positives = 134/241 (55%), Gaps = 15/241 (6%)
Query: 91 SPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNT 148
+ I + D WE++ + ++ K+ G YG++Y+G + S VA+K LK +T
Sbjct: 201 NKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DT 257
Query: 149 EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG-VFQL 207
++EF +E +M++I+H N+VQ +G CTR P I+TEFM G++ D+L +
Sbjct: 258 MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA 317
Query: 208 TSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE 267
LL +A +S M YL + N IHR+L N L+ EN +VKVADFG++R+ TA
Sbjct: 318 VVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAH 376
Query: 268 TGT---YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKV 323
G +W APE + + + K+DV++FG+ LWE+ T G PY G+ Q V + +
Sbjct: 377 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----VYELL 432
Query: 324 S 324
Sbjct: 433 E 433
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 229 bits (585), Expect = 2e-73
Identities = 77/219 (35%), Positives = 111/219 (50%), Gaps = 11/219 (5%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQE 157
EI+A ++ IE + SG G++ G VAIK LK + ++F E
Sbjct: 42 FTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQ-RRDFLSE 100
Query: 158 VYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDV 217
IM + H N+++ G TR IVTE+M GS+ FL G F + L+ + V
Sbjct: 101 ASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGV 160
Query: 218 SKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGT---YRW 273
GM YL +HRDL N+L+D N V KV+DFG++R ++ TG RW
Sbjct: 161 GAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRW 220
Query: 274 MAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLT 311
APE I + + +DV+SFG+ +WE+L GE PY +T
Sbjct: 221 TAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMT 259
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 2e-73
Identities = 70/219 (31%), Positives = 113/219 (51%), Gaps = 10/219 (4%)
Query: 101 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFS 155
T +EI +++++ + G +GD+++G Y S E VAIK K + + ++F
Sbjct: 6 STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFL 64
Query: 156 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
QE MR+ H ++V+ IG T P + I+ E G + FL +K L SL+ A
Sbjct: 65 QEALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAY 123
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RW 273
+S + YL +HRD+ N+L+ N VK+ DFG++R S A G +W
Sbjct: 124 QLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKW 183
Query: 274 MAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLT 311
MAPE I + + +DV+ FG+ +WE+L G P+ G+
Sbjct: 184 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVK 222
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 228 bits (583), Expect = 3e-73
Identities = 73/252 (28%), Positives = 120/252 (47%), Gaps = 16/252 (6%)
Query: 73 KRQPALGVPMHSKLLIESSPNCIEIPTDGT--DVWEIDAKQLKIECKVASGSYGDLYKGT 130
+P L P EI + + + +G +G++YKG
Sbjct: 7 HHHHDYDIPTTENLYF--QGAMGSDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGM 64
Query: 131 Y------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI 184
VAIK LK + +F E IM + H N+++ G ++ + I
Sbjct: 65 LKTSSGKKEVPVAIKTLKAGYTEKQR-VDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123
Query: 185 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN 244
+TE+M G++ FL ++ G F + L+ + ++ GM YL N +HRDL N+L++ N
Sbjct: 124 ITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSN 183
Query: 245 GVVKVADFGVAR-VQAQSGVMTAETGT---YRWMAPEVIEHKPYDYKADVFSFGIALWEL 300
V KV+DFG++R ++ +G RW APE I ++ + +DV+SFGI +WE+
Sbjct: 184 LVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEV 243
Query: 301 LT-GELPYAGLT 311
+T GE PY L+
Sbjct: 244 MTYGERPYWELS 255
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 8e-73
Identities = 62/229 (27%), Positives = 115/229 (50%), Gaps = 16/229 (6%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEV 158
+L+ + SG +G ++KG + + V IKV++ + + + + +
Sbjct: 8 RIFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHM 66
Query: 159 YIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVS 218
+ + H ++V+ +G C L +VT+++ GS+ D + + +G LL + ++
Sbjct: 67 LAIGSLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIA 125
Query: 219 KGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMA 275
KGM YL ++ ++HR+L N+L+ V+VADFGVA + + +WMA
Sbjct: 126 KGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMA 185
Query: 276 PEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKV 323
E I Y +++DV+S+G+ +WEL+T G PYAGL + V +
Sbjct: 186 LESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE----VPDLL 230
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 226 bits (578), Expect = 2e-72
Identities = 57/232 (24%), Positives = 106/232 (45%), Gaps = 15/232 (6%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQ 156
D + + LK ++ G++G + Y VA+K L+ + ++F +
Sbjct: 16 DPTIFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSG--PDQQRDFQR 73
Query: 157 EVYIMRKIRHKNVVQFIGACTRP--PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVA 214
E+ I++ + +V++ G P +L +V E++ G + DFL + + + LL +
Sbjct: 74 EIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYS 133
Query: 215 IDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGT--- 270
+ KGM YL +HRDL N+L++ VK+ADFG+A+ +
Sbjct: 134 SQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP 193
Query: 271 YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQ 321
W APE + + ++DV+SFG+ L+EL T + + +G +
Sbjct: 194 IFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCER 245
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 2e-72
Identities = 65/219 (29%), Positives = 116/219 (52%), Gaps = 12/219 (5%)
Query: 103 DVWEIDAKQLKIECKV-ASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQE 157
+D K L +E K SG++G + KG Y + VA+K+LK E + + E E
Sbjct: 9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAE 68
Query: 158 VYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDV 217
+M+++ + +V+ IG C +V E G + +L + + + +++++ V
Sbjct: 69 ANVMQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQV 126
Query: 218 SKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGT---YRW 273
S GM YL ++N +HRDL N+L+ K++DFG+++ ++A A+T +W
Sbjct: 127 SMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 186
Query: 274 MAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLT 311
APE I + + K+DV+SFG+ +WE + G+ PY G+
Sbjct: 187 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK 225
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 224 bits (572), Expect = 1e-71
Identities = 68/227 (29%), Positives = 117/227 (51%), Gaps = 16/227 (7%)
Query: 107 IDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNTEMLKEFSQEVYI 160
+ + K + SG++G +YKG + + VAIK L+ KE E Y+
Sbjct: 12 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN-KEILDEAYV 70
Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 220
M + + +V + +G C + ++T+ M G + D++ + K LL + ++KG
Sbjct: 71 MASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 129
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTY--RWMAPE 277
MNYL ++HRDL N+L+ VK+ DFG+A+ + A+ AE G +WMA E
Sbjct: 130 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 189
Query: 278 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKV 323
I H+ Y +++DV+S+G+ +WEL+T G PY G+ + + +
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----ISSIL 232
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 225 bits (575), Expect = 2e-71
Identities = 70/219 (31%), Positives = 113/219 (51%), Gaps = 11/219 (5%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY-----CSQEVAIKVLKPECVNTEMLKEFSQE 157
E+DA + I+ V +G +G++ G VAIK LK + ++F E
Sbjct: 38 FAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ-RRDFLGE 96
Query: 158 VYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDV 217
IM + H N+++ G T+ + IVTE+M GS+ FL K F + L+ + +
Sbjct: 97 ASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGI 156
Query: 218 SKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGT---YRW 273
+ GM YL +HRDL N+L++ N V KV+DFG+ R ++ G RW
Sbjct: 157 ASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRW 216
Query: 274 MAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLT 311
+PE I ++ + +DV+S+GI LWE+++ GE PY ++
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 222 bits (568), Expect = 2e-71
Identities = 62/219 (28%), Positives = 114/219 (52%), Gaps = 12/219 (5%)
Query: 103 DVWEIDAKQLKI-ECKVASGSYGDLYKGTYCSQ----EVAIKVLKPECVNTEMLKEFSQE 157
+ L I + ++ G++G + +G Y + +VAIKVLK + +E +E
Sbjct: 2 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADT-EEMMRE 60
Query: 158 VYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDV 217
IM ++ + +V+ IG C L +V E G ++ FL ++ ++++ ++ V
Sbjct: 61 AQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQV 119
Query: 218 SKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGT---YRW 273
S GM YL + N +HRDL N+L+ K++DFG+++ + A TA + +W
Sbjct: 120 SMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKW 179
Query: 274 MAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLT 311
APE I + + ++DV+S+G+ +WE L+ G+ PY +
Sbjct: 180 YAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMK 218
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 3e-71
Identities = 62/239 (25%), Positives = 108/239 (45%), Gaps = 30/239 (12%)
Query: 101 GTDVWEIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEF 154
G+D + + + LK ++ G++G + Y + VA+K L+ L++F
Sbjct: 1 GSDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEH--LRDF 58
Query: 155 SQEVYIMRKIRHKNVVQFIGACTRPPN--LCIVTEFMARGSIYDFLHKQKGVFQLTSLLK 212
+E+ I++ ++H N+V++ G C L ++ E++ GS+ D+L K K LL+
Sbjct: 59 EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ 118
Query: 213 VAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGT- 270
+ KGM YL IHRDL T N+L++ VK+ DFG+ + + +
Sbjct: 119 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGE 178
Query: 271 --YRWMAPEVIEHKPYDYKADVFSFGIALWELLT----------------GELPYAGLT 311
W APE + + +DV+SFG+ L+EL T G +
Sbjct: 179 SPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMI 237
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 226 bits (578), Expect = 5e-71
Identities = 82/228 (35%), Positives = 135/228 (59%), Gaps = 15/228 (6%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
D WEI + LK+E K+ +G +G+++ TY +VA+K +KP + ++ F E +M
Sbjct: 181 DAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKP---GSMSVEAFLAEANVM 237
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKG 220
+ ++H +V+ T+ P + I+TEFMA+GS+ DFL +G L L+ + +++G
Sbjct: 238 KTLQHDKLVKLHAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEG 296
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPE 277
M ++ Q N IHRDL+ AN+L+ + V K+ADFG+ARV + TA G +W APE
Sbjct: 297 MAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARV-IEDNEYTAREGAKFPIKWTAPE 355
Query: 278 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVS 324
I + K+DV+SFGI L E++T G +PY G++ + V++ +
Sbjct: 356 AINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE----VIRALE 399
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 2e-70
Identities = 61/248 (24%), Positives = 108/248 (43%), Gaps = 30/248 (12%)
Query: 92 PNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPEC 145
+ + D + + + LK ++ G++G + Y + VA+K L+
Sbjct: 23 QGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHST 82
Query: 146 VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN--LCIVTEFMARGSIYDFLHKQKG 203
L++F +E+ I++ ++H N+V++ G C L ++ E++ GS+ D+L K K
Sbjct: 83 EEH--LRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE 140
Query: 204 VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSG 262
LL+ + KGM YL IHRDL T N+L++ VK+ DFG+ + +
Sbjct: 141 RIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 200
Query: 263 VMTAETGT---YRWMAPEVIEHKPYDYKADVFSFGIALWELLT----------------G 303
+ W APE + + +DV+SFG+ L+EL T G
Sbjct: 201 YYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIG 260
Query: 304 ELPYAGLT 311
+
Sbjct: 261 NDKQGQMI 268
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 226 bits (577), Expect = 6e-70
Identities = 89/228 (39%), Positives = 135/228 (59%), Gaps = 15/228 (6%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIM 161
D WEI + L++E K+ G +G+++ GT+ VAIK LKP T + F QE +M
Sbjct: 260 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP---GTMSPEAFLQEAQVM 316
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKG 220
+K+RH+ +VQ + P + IVTE+M++GS+ DFL + G +L L+ +A ++ G
Sbjct: 317 KKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 375
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPE 277
M Y+ + N +HRDL+ AN+L+ EN V KVADFG+AR+ + TA G +W APE
Sbjct: 376 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPE 434
Query: 278 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVS 324
+ + K+DV+SFGI L EL T G +PY G+ + V+ +V
Sbjct: 435 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQVE 478
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 9e-70
Identities = 66/234 (28%), Positives = 113/234 (48%), Gaps = 14/234 (5%)
Query: 98 PTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEML 151
P D + + LK + G +G + Y ++VA+K LKPE +
Sbjct: 9 PATEVDPTHFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHI 67
Query: 152 KEFSQEVYIMRKIRHKNVVQFIGACTRPPN--LCIVTEFMARGSIYDFLHKQKGVFQLTS 209
+ +E+ I+R + H+N+V++ G CT + ++ EF+ GS+ ++L K K L
Sbjct: 68 ADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQ 127
Query: 210 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAET 268
LK A+ + KGM+YL +HRDL N+L++ VK+ DFG+ + ++ T +
Sbjct: 128 QLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKD 187
Query: 269 GT---YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVG 318
W APE + + +DV+SFG+ L ELLT + + + +G
Sbjct: 188 DRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIG 241
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 2e-69
Identities = 78/285 (27%), Positives = 132/285 (46%), Gaps = 18/285 (6%)
Query: 47 WPYDETEDLKNVLAKEILKSKDQSCSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWE 106
P E E + K K S +++++ E +P+ +E
Sbjct: 331 RPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTY--TMPST--RDYE 386
Query: 107 IDAKQLKIECKVASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQEVYIM 161
I +++++ + G +GD+++G Y S E VAIK K + + ++F QE M
Sbjct: 387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT-SDSVREKFLQEALTM 445
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
R+ H ++V+ IG T P + I+ E G + FL +K L SL+ A +S +
Sbjct: 446 RQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTAL 504
Query: 222 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY--RWMAPEVI 279
YL +HRD+ N+L+ N VK+ DFG++R S A G +WMAPE I
Sbjct: 505 AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESI 564
Query: 280 EHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKV 323
+ + +DV+ FG+ +WE+L G P+ G+ V+ ++
Sbjct: 565 NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND----VIGRI 605
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 2e-69
Identities = 89/228 (39%), Positives = 135/228 (59%), Gaps = 15/228 (6%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-EVAIKVLKPECVNTEMLKEFSQEVYIM 161
D WEI + L++E K+ G +G+++ GT+ VAIK LKP T + F QE +M
Sbjct: 177 DAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKP---GTMSPEAFLQEAQVM 233
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKG 220
+K+RH+ +VQ + P + IVTE+M++GS+ DFL + G +L L+ +A ++ G
Sbjct: 234 KKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASG 292
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPE 277
M Y+ + N +HRDL+ AN+L+ EN V KVADFG+AR+ + TA G +W APE
Sbjct: 293 MAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTAPE 351
Query: 278 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVS 324
+ + K+DV+SFGI L EL T G +PY G+ + V+ +V
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----VLDQVE 395
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 2e-68
Identities = 57/242 (23%), Positives = 102/242 (42%), Gaps = 36/242 (14%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTY---------CSQEVAIKVLKPECVNTEMLKEFS 155
+I + L + G++ ++KG EV +KVL N + F
Sbjct: 3 HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYS--ESFF 60
Query: 156 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
+ +M K+ HK++V G C +V EF+ GS+ +L K K + L+VA
Sbjct: 61 EAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAK 120
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMD--------ENGVVKVADFGVARVQAQSGVMTAE 267
++ M++L +N +IH ++ N+L+ +K++D G++
Sbjct: 121 QLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT-------VLP 173
Query: 268 TGTY----RWMAPEVIEH-KPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQ 321
W+ PE IE+ K + D +SFG LWE+ + G+ P + L + +Q
Sbjct: 174 KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR----KLQ 229
Query: 322 KV 323
Sbjct: 230 FY 231
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 214 bits (548), Expect = 4e-68
Identities = 66/244 (27%), Positives = 113/244 (46%), Gaps = 16/244 (6%)
Query: 89 ESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLK 142
+ D + LK + G +G + Y + VA+K LK
Sbjct: 10 HHHGALEVLFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALK 69
Query: 143 PECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--PNLCIVTEFMARGSIYDFLHK 200
+ + + QE+ I+R + H++++++ G C +L +V E++ GS+ D+L +
Sbjct: 70 ADA-GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPR 128
Query: 201 QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQA 259
L LL A + +GM YLH + IHRDL N+L+D + +VK+ DFG+A+ V
Sbjct: 129 HS--IGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE 186
Query: 260 QSGVMTAETGT---YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQA 315
W APE ++ + Y +DV+SFG+ L+ELLT + + T
Sbjct: 187 GHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLE 246
Query: 316 AVGV 319
+G+
Sbjct: 247 LIGI 250
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 8e-68
Identities = 62/231 (26%), Positives = 108/231 (46%), Gaps = 19/231 (8%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY-----CSQEVAIKVLKPECVNTEMLKEFSQE 157
+ ID L + + G +G + +G S +VA+K +K + + ++EF E
Sbjct: 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSE 86
Query: 158 VYIMRKIRHKNVVQFIGACTR-----PPNLCIVTEFMARGSIYDFL-----HKQKGVFQL 207
M+ H NV++ +G C P ++ FM G ++ +L L
Sbjct: 87 AACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPL 146
Query: 208 TSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAE 267
+LLK +D++ GM YL N +HRDL N ++ ++ V VADFG+++
Sbjct: 147 QTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQG 206
Query: 268 TGT---YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQ 314
+W+A E + + Y K+DV++FG+ +WE+ T G PY G+ +
Sbjct: 207 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE 257
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 214 bits (546), Expect = 1e-67
Identities = 70/230 (30%), Positives = 118/230 (51%), Gaps = 15/230 (6%)
Query: 96 EIPTDGTDVWE-IDAKQLKIECKVASGSYGDLYKGTYCSQ------EVAIKVLKPECVNT 148
E P + + + K + SG++G +YKG + + VAIK L+
Sbjct: 2 EAPNQA--LLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPK 59
Query: 149 EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLT 208
KE E Y+M + + +V + +G C + ++T+ M G + D++ + K
Sbjct: 60 AN-KEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQ 117
Query: 209 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAE 267
LL + ++KGMNYL ++HRDL N+L+ VK+ DFG+A+ + A+ AE
Sbjct: 118 YLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAE 177
Query: 268 TGTY--RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQ 314
G +WMA E I H+ Y +++DV+S+G+ +WEL+T G PY G+ +
Sbjct: 178 GGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 5e-67
Identities = 61/232 (26%), Positives = 112/232 (48%), Gaps = 20/232 (8%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY-----CSQEVAIKVLKPECVNTEMLKEFSQE 157
+ I +Q + + G +G + + +VA+K+LK + + + ++EF +E
Sbjct: 16 EDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLRE 75
Query: 158 VYIMRKIRHKNVVQFIGACTR------PPNLCIVTEFMARGSIYDFL-----HKQKGVFQ 206
M++ H +V + +G R P ++ FM G ++ FL +
Sbjct: 76 AACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLP 135
Query: 207 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 266
L +L++ +D++ GM YL N IHRDL N ++ E+ V VADFG++R
Sbjct: 136 LQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQ 195
Query: 267 ETGT---YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQ 314
+ +W+A E + Y +DV++FG+ +WE++T G+ PYAG+ +
Sbjct: 196 GCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE 247
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 4e-66
Identities = 64/264 (24%), Positives = 123/264 (46%), Gaps = 19/264 (7%)
Query: 65 KSKDQSCSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKI--------EC 116
+ + P + + +D E+ K+L + +
Sbjct: 283 RIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADI 342
Query: 117 KVASGSYGDLYKGTYCSQ----EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQF 172
++ G++G + +G Y + +VAIKVLK +E +E IM ++ + +V+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK-ADTEEMMREAQIMHQLDNPYIVRL 401
Query: 173 IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHR 232
IG C L +V E G ++ FL ++ ++++ ++ VS GM YL + N +HR
Sbjct: 402 IGVCQAEA-LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHR 460
Query: 233 DLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGT---YRWMAPEVIEHKPYDYKA 288
+L N+L+ K++DFG+++ + A TA + +W APE I + + ++
Sbjct: 461 NLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRS 520
Query: 289 DVFSFGIALWELLT-GELPYAGLT 311
DV+S+G+ +WE L+ G+ PY +
Sbjct: 521 DVWSYGVTMWEALSYGQKPYKKMK 544
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 4e-66
Identities = 59/234 (25%), Positives = 111/234 (47%), Gaps = 27/234 (11%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQ 156
+ EI ++ ++ +G +YKG +Q VAIK LK + + +EF
Sbjct: 3 LKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRH 61
Query: 157 EVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL---------------HKQ 201
E + +++H NVV +G T+ L ++ + + G +++FL
Sbjct: 62 EAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTV 121
Query: 202 KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261
K + + + ++ GM YL ++++H+DL T N+L+ + VK++D G+ R +
Sbjct: 122 KSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAA 181
Query: 262 GVMTAETGTY---RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLT 311
+ RWMAPE I + + +D++S+G+ LWE+ + G PY G +
Sbjct: 182 DYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS 235
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 8e-66
Identities = 70/289 (24%), Positives = 118/289 (40%), Gaps = 15/289 (5%)
Query: 38 SLDVFVVDGWPYDETEDLKNVLAKEILKSKDQSCSKRQPALGVPMHSKLLIESSPNCIEI 97
+ + D + + ++ S+ G L +P ++
Sbjct: 19 ASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQA 78
Query: 98 PTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS-----QEVAIKVLKPECVNTEMLK 152
V + + + G +G +Y GT A+K L E+
Sbjct: 79 VQH--VVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEV-S 135
Query: 153 EFSQEVYIMRKIRHKNVVQFIGACTRP-PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLL 211
+F E IM+ H NV+ +G C R + +V +M G + +F+ + + L+
Sbjct: 136 QFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLI 195
Query: 212 KVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY 271
+ V+KGM +L +HRDL N ++DE VKVADFG+AR + T
Sbjct: 196 GFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTG 255
Query: 272 -----RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQ 314
+WMA E ++ + + K+DV+SFG+ LWEL+T G PY +
Sbjct: 256 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 304
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 8e-66
Identities = 65/223 (29%), Positives = 103/223 (46%), Gaps = 13/223 (5%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKGTYCS-----QEVAIKVLKPECVNTEMLKEFSQEV 158
V + + + G +G +Y GT A+K L + + +F E
Sbjct: 19 VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEG 77
Query: 159 YIMRKIRHKNVVQFIGACTRP-PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDV 217
IM+ H NV+ +G C R + +V +M G + +F+ + + L+ + V
Sbjct: 78 IIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 137
Query: 218 SKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY-----R 272
+KGM YL +HRDL N ++DE VKVADFG+AR + T +
Sbjct: 138 AKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 197
Query: 273 WMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQ 314
WMA E ++ + + K+DV+SFG+ LWEL+T G PY +
Sbjct: 198 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 240
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 8e-66
Identities = 67/238 (28%), Positives = 117/238 (49%), Gaps = 28/238 (11%)
Query: 100 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLK 152
G V I + + ++ ++ G++G ++ VA+K LK + K
Sbjct: 5 SGIHVQHIKRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAAR--K 62
Query: 153 EFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL-------------- 198
+F +E ++ ++H+++V+F G C L +V E+M G + FL
Sbjct: 63 DFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQ 122
Query: 199 -HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV 257
+ KG L+ +L +A ++ GM YL + +HRDL T N L+ N +VK+ DFG++R
Sbjct: 123 PRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRD 182
Query: 258 QAQSGVMTAETGTY---RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLT 311
+ T RWM PE I ++ + ++DV+SFG+ LWE+ T G+ P+ L+
Sbjct: 183 VYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS 240
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 208 bits (531), Expect = 9e-66
Identities = 64/224 (28%), Positives = 105/224 (46%), Gaps = 15/224 (6%)
Query: 105 WEI--DAKQLKIECKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQE 157
I + + + G +G +Y G Y + AIK L ++ + F +E
Sbjct: 14 VLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQV-EAFLRE 72
Query: 158 VYIMRKIRHKNVVQFIGACTRP-PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAID 216
+MR + H NV+ IG P ++ +M G + F+ + + L+ +
Sbjct: 73 GLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQ 132
Query: 217 VSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY----- 271
V++GM YL + +HRDL N ++DE+ VKVADFG+AR + + +
Sbjct: 133 VARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPV 192
Query: 272 RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQ 314
+W A E ++ + K+DV+SFG+ LWELLT G PY + P
Sbjct: 193 KWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD 236
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 3e-65
Identities = 68/258 (26%), Positives = 121/258 (46%), Gaps = 37/258 (14%)
Query: 91 SPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKP 143
S + +I D WE K L + + G +G + K T VA+K+LK
Sbjct: 6 SVDAFKILED--PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKE 63
Query: 144 ECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL----- 198
+E+ ++ E +++++ H +V++ GAC++ L ++ E+ GS+ FL
Sbjct: 64 NASPSEL-RDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRK 122
Query: 199 ------------------HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL 240
H + + L+ A +S+GM YL + ++HRDL N+L
Sbjct: 123 VGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNIL 182
Query: 241 MDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEVIEHKPYDYKADVFSFGIAL 297
+ E +K++DFG++R + + +WMA E + Y ++DV+SFG+ L
Sbjct: 183 VAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLL 242
Query: 298 WELLT-GELPYAGLTPLQ 314
WE++T G PY G+ P +
Sbjct: 243 WEIVTLGGNPYPGIPPER 260
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 207 bits (529), Expect = 4e-65
Identities = 74/279 (26%), Positives = 124/279 (44%), Gaps = 35/279 (12%)
Query: 70 SCSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKG 129
S S P G + I +P V I + + ++ ++ G++G ++
Sbjct: 5 SGSSLSPTEGKGSGLQGHIIENPQYFSDA----CVHHIKRRDIVLKWELGEGAFGKVFLA 60
Query: 130 TY-------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL 182
VA+K LK ++F +E ++ ++H+++V+F G CT L
Sbjct: 61 ECHNLLPEQDKMLVAVKALKEAS--ESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL 118
Query: 183 CIVTEFMARGSIYDFL--------------HKQKGVFQLTSLLKVAIDVSKGMNYLHQNN 228
+V E+M G + FL G L LL VA V+ GM YL +
Sbjct: 119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH 178
Query: 229 IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY---RWMAPEVIEHKPYD 285
+HRDL T N L+ + VVK+ DFG++R + T RWM PE I ++ +
Sbjct: 179 FVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFT 238
Query: 286 YKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKV 323
++DV+SFG+ LWE+ T G+ P+ L+ + + +
Sbjct: 239 TESDVWSFGVVLWEIFTYGKQPWYQLSNTE----AIDCI 273
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 206 bits (527), Expect = 5e-65
Identities = 71/249 (28%), Positives = 115/249 (46%), Gaps = 32/249 (12%)
Query: 93 NCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPEC 145
+ ++P D WE +L + +G++G + + T + VA+K+LKP
Sbjct: 8 DPTQLPYD--HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA 65
Query: 146 VNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL------ 198
TE + E+ ++ + H N+V +GACT ++TE+ G + +FL
Sbjct: 66 HLTER-EALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDS 124
Query: 199 -----------HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVV 247
+ L LL + V+KGM +L N IHRDL N+L+ +
Sbjct: 125 FICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT 184
Query: 248 KVADFGVARVQAQSGVMTAETGT---YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-G 303
K+ DFG+AR + +WMAPE I + Y +++DV+S+GI LWEL + G
Sbjct: 185 KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLG 244
Query: 304 ELPYAGLTP 312
PY G+
Sbjct: 245 SSPYPGMPV 253
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 8e-65
Identities = 63/232 (27%), Positives = 114/232 (49%), Gaps = 21/232 (9%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFS 155
D WE+ +++ + ++ GS+G +Y+G VAIK + + EF
Sbjct: 18 DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFL 76
Query: 156 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL---------HKQKGVFQ 206
E +M++ +VV+ +G ++ ++ E M RG + +L +
Sbjct: 77 NEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPS 136
Query: 207 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 266
L+ ++++A +++ GM YL+ N +HRDL N ++ E+ VK+ DFG+ R ++
Sbjct: 137 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRK 196
Query: 267 ETGTY---RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQ 314
RWM+PE ++ + +DV+SFG+ LWE+ T E PY GL+ Q
Sbjct: 197 GGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ 248
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 1e-64
Identities = 68/241 (28%), Positives = 112/241 (46%), Gaps = 25/241 (10%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFS 155
D+ E+ K + + + G++G++Y+G +VA+K L C + + +F
Sbjct: 23 DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFL 81
Query: 156 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL------HKQKGVFQLTS 209
E I+ K H+N+V+ IG + I+ E MA G + FL Q +
Sbjct: 82 MEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLD 141
Query: 210 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD---ENGVVKVADFGVARVQAQSGVMTA 266
LL VA D++ G YL +N+ IHRD+ N L+ V K+ DFG+AR ++
Sbjct: 142 LLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRK 201
Query: 267 ETGTY---RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQK 322
+WM PE + K D +SFG+ LWE+ + G +PY + + V++
Sbjct: 202 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE----VLEF 257
Query: 323 V 323
V
Sbjct: 258 V 258
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 1e-64
Identities = 71/236 (30%), Positives = 115/236 (48%), Gaps = 28/236 (11%)
Query: 100 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTYC----SQEVAIKVLKPECVNTEMLKEFS 155
D T +D +K + + G++G + K + AIK +K + ++F+
Sbjct: 15 DPTIYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDH-RDFA 73
Query: 156 QEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL---------------H 199
E+ ++ K+ H N++ +GAC L + E+ G++ DFL +
Sbjct: 74 GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 133
Query: 200 KQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA 259
LL A DV++GM+YL Q IHRDL N+L+ EN V K+ADFG++R
Sbjct: 134 STASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--- 190
Query: 260 QSGVMTAETGT---YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLT 311
V +T RWMA E + + Y +DV+S+G+ LWE+++ G PY G+T
Sbjct: 191 GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 246
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 4e-64
Identities = 69/248 (27%), Positives = 121/248 (48%), Gaps = 32/248 (12%)
Query: 96 EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYC---------SQEVAIKVLKPECV 146
E+P D WE +L + + G++G + + VA+K+LK +
Sbjct: 23 ELPED--PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA- 79
Query: 147 NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL------- 198
+ L + E+ +M+ I +HKN++ +GACT+ L ++ E+ ++G++ ++L
Sbjct: 80 TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 139
Query: 199 --------HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
+ L+ +++GM YL IHRDL N+L+ EN V+K+A
Sbjct: 140 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIA 199
Query: 251 DFGVARVQAQSGVMTAETGT---YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELP 306
DFG+AR T +WMAPE + + Y +++DV+SFG+ +WE+ T G P
Sbjct: 200 DFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259
Query: 307 YAGLTPLQ 314
Y G+ +
Sbjct: 260 YPGIPVEE 267
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 7e-64
Identities = 69/248 (27%), Positives = 120/248 (48%), Gaps = 32/248 (12%)
Query: 96 EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYC---------SQEVAIKVLKPECV 146
E+P D WE +L + + G +G + + VA+K+LK +
Sbjct: 69 ELPED--PKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA- 125
Query: 147 NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL------- 198
+ L + E+ +M+ I +HKN++ +GACT+ L ++ E+ ++G++ ++L
Sbjct: 126 TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPG 185
Query: 199 --------HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
+ L+ +++GM YL IHRDL N+L+ EN V+K+A
Sbjct: 186 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIA 245
Query: 251 DFGVARVQAQSGVMTAETGT---YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELP 306
DFG+AR T +WMAPE + + Y +++DV+SFG+ +WE+ T G P
Sbjct: 246 DFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305
Query: 307 YAGLTPLQ 314
Y G+ +
Sbjct: 306 YPGIPVEE 313
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 8e-64
Identities = 70/241 (29%), Positives = 115/241 (47%), Gaps = 25/241 (10%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFS 155
D+ E+ K + + + G++G++Y+G +VA+K L C + + +F
Sbjct: 64 DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFL 122
Query: 156 QEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK------QKGVFQLTS 209
E I+ K H+N+V+ IG + I+ E MA G + FL + Q +
Sbjct: 123 MEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLD 182
Query: 210 LLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG---VVKVADFGVARVQAQSGVMTA 266
LL VA D++ G YL +N+ IHRD+ N L+ G V K+ DFG+AR ++G
Sbjct: 183 LLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRK 242
Query: 267 ETGTY---RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQK 322
+WM PE + K D +SFG+ LWE+ + G +PY + + V++
Sbjct: 243 GGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE----VLEF 298
Query: 323 V 323
V
Sbjct: 299 V 299
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 205 bits (524), Expect = 1e-63
Identities = 72/272 (26%), Positives = 127/272 (46%), Gaps = 32/272 (11%)
Query: 72 SKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY 131
+ + + E+P D WE+ +L + + G++G +
Sbjct: 33 HHDYDIPTTENLYFQGMLAGVSEYELPED--PRWELPRDRLVLGKPLGEGAFGQVVLAEA 90
Query: 132 ---------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPN 181
+VA+K+LK + + L + E+ +M+ I +HKN++ +GACT+
Sbjct: 91 IGLDKDKPNRVTKVAVKMLKSDATEKD-LSDLISEMEMMKMIGKHKNIINLLGACTQDGP 149
Query: 182 LCIVTEFMARGSIYDFL---------------HKQKGVFQLTSLLKVAIDVSKGMNYLHQ 226
L ++ E+ ++G++ ++L H + L+ A V++GM YL
Sbjct: 150 LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS 209
Query: 227 NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEVIEHKP 283
IHRDL N+L+ E+ V+K+ADFG+AR T +WMAPE + +
Sbjct: 210 KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI 269
Query: 284 YDYKADVFSFGIALWELLT-GELPYAGLTPLQ 314
Y +++DV+SFG+ LWE+ T G PY G+ +
Sbjct: 270 YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE 301
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 2e-63
Identities = 68/243 (27%), Positives = 117/243 (48%), Gaps = 28/243 (11%)
Query: 93 NCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPEC 145
+ ++P + + WE L+ + +G++G + + T +VA+K+LK
Sbjct: 31 DPTQLPYN--EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA 88
Query: 146 VNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV 204
E + E+ IM + +H+N+V +GACT + ++TE+ G + +FL ++ V
Sbjct: 89 HADEK-EALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRV 147
Query: 205 FQ-------------LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVAD 251
+ LL + V++GM +L N IHRD+ N+L+ V K+ D
Sbjct: 148 LETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGD 207
Query: 252 FGVARVQAQSGVMTAETGT---YRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPY 307
FG+AR + +WMAPE I Y ++DV+S+GI LWE+ + G PY
Sbjct: 208 FGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPY 267
Query: 308 AGL 310
G+
Sbjct: 268 PGI 270
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 5e-63
Identities = 74/252 (29%), Positives = 116/252 (46%), Gaps = 30/252 (11%)
Query: 88 IESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKV 140
+ +C +P D WE +LK+ + G++G + + + VA+K+
Sbjct: 6 LPLDEHCERLPYD-ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKM 64
Query: 141 LKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPN-LCIVTEFMARGSIYDFL 198
LK + E+ I+ I H NVV +GACT+P L ++ EF G++ +L
Sbjct: 65 LKEGA-THSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 123
Query: 199 ---------------HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE 243
K L L+ + V+KGM +L IHRDL N+L+ E
Sbjct: 124 RSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 183
Query: 244 NGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEVIEHKPYDYKADVFSFGIALWEL 300
VVK+ DFG+AR + + +WMAPE I + Y ++DV+SFG+ LWE+
Sbjct: 184 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243
Query: 301 LT-GELPYAGLT 311
+ G PY G+
Sbjct: 244 FSLGASPYPGVK 255
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 9e-63
Identities = 72/256 (28%), Positives = 118/256 (46%), Gaps = 37/256 (14%)
Query: 91 SPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKP 143
+ E D WE + L+ + SG++G + T S +VA+K+LK
Sbjct: 28 YVDFREYEYD--LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKE 85
Query: 144 ECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK 202
+ ++E + E+ +M ++ H+N+V +GACT + ++ E+ G + ++L ++
Sbjct: 86 KADSSER-EALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKR 144
Query: 203 GVF--------------------QLTS--LLKVAIDVSKGMNYLHQNNIIHRDLKTANLL 240
F LT LL A V+KGM +L + +HRDL N+L
Sbjct: 145 EKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVL 204
Query: 241 MDENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEVIEHKPYDYKADVFSFGIAL 297
+ VVK+ DFG+AR +WMAPE + Y K+DV+S+GI L
Sbjct: 205 VTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILL 264
Query: 298 WELLT-GELPYAGLTP 312
WE+ + G PY G+
Sbjct: 265 WEIFSLGVNPYPGIPV 280
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 2e-61
Identities = 66/250 (26%), Positives = 113/250 (45%), Gaps = 35/250 (14%)
Query: 96 EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNT 148
+ E ++ + G++G +++ VA+K+LK E +
Sbjct: 33 LLLNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SA 91
Query: 149 EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL---------- 198
+M +F +E +M + + N+V+ +G C +C++ E+MA G + +FL
Sbjct: 92 DMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCS 151
Query: 199 -------------HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG 245
L +A V+ GM YL + +HRDL T N L+ EN
Sbjct: 152 LSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENM 211
Query: 246 VVKVADFGVARVQAQSGVMTAETGTY---RWMAPEVIEHKPYDYKADVFSFGIALWELLT 302
VVK+ADFG++R + A+ RWM PE I + Y ++DV+++G+ LWE+ +
Sbjct: 212 VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
Query: 303 -GELPYAGLT 311
G PY G+
Sbjct: 272 YGLQPYYGMA 281
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 4e-60
Identities = 74/227 (32%), Positives = 118/227 (51%), Gaps = 17/227 (7%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMR 162
W I+ +++ + SG+ + ++VAIK + E T + E +E+ M
Sbjct: 10 WSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTS-MDELLKEIQAMS 68
Query: 163 KIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL--HKQKGVFQLTSLLKVAI----- 215
+ H N+V + + L +V + ++ GS+ D + KG + L + I
Sbjct: 69 QCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILR 128
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET------G 269
+V +G+ YLH+N IHRD+K N+L+ E+G V++ADFGV+ A G +T G
Sbjct: 129 EVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188
Query: 270 TYRWMAPEVIE-HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQA 315
T WMAPEV+E + YD+KAD++SFGI EL TG PY P++
Sbjct: 189 TPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV 235
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 5e-60
Identities = 67/238 (28%), Positives = 114/238 (47%), Gaps = 14/238 (5%)
Query: 89 ESSPNCIEIPTDGTDVWEID--AKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPE 144
E + +I T + + LK + ++ GS+ +YKG T + EVA L+
Sbjct: 3 ERNQQQDDIEELETKAVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDR 62
Query: 145 CVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA----CTRPPNLCIVTEFMARGSIYDFLHK 200
+ + F +E +++ ++H N+V+F + + +VTE M G++ +L +
Sbjct: 63 KLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR 122
Query: 201 QKGVFQLTSLLKVAIDVSKGMNYLHQNN--IIHRDLKTANLLMD-ENGVVKVADFGVARV 257
V ++ L + KG+ +LH IIHRDLK N+ + G VK+ D G+A +
Sbjct: 123 F-KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 181
Query: 258 QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQA 315
+ S GT +MAPE+ E K YD DV++FG+ + E+ T E PY+
Sbjct: 182 KRASFAKA-VIGTPEFMAPEMYEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQ 237
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 190 bits (486), Expect = 6e-59
Identities = 77/238 (32%), Positives = 124/238 (52%), Gaps = 15/238 (6%)
Query: 82 MHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIK 139
M + P + D +++ K+ GS+G+++KG + VAIK
Sbjct: 1 MAHSPVQSGLPGMQNLKADPEELFTK-------LEKIGKGSFGEVFKGIDNRTQKVVAIK 53
Query: 140 VLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLH 199
++ E E +++ QE+ ++ + V ++ G+ + L I+ E++ GS D L
Sbjct: 54 IIDLEEAEDE-IEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLL- 111
Query: 200 KQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA 259
+ G T + + ++ KG++YLH IHRD+K AN+L+ E+G VK+ADFGVA Q
Sbjct: 112 -EPGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVA-GQL 169
Query: 260 QSGVMTAET--GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQA 315
+ T GT WMAPEVI+ YD KAD++S GI EL GE P++ L P++
Sbjct: 170 TDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKV 227
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 186 bits (475), Expect = 3e-57
Identities = 73/225 (32%), Positives = 115/225 (51%), Gaps = 16/225 (7%)
Query: 95 IEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLK 152
+ +V+++ K+ GSYG +YK + Q VAIK + E L+
Sbjct: 21 DSLTKQPEEVFDV-------LEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE----SDLQ 69
Query: 153 EFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLK 212
E +E+ IM++ +VV++ G+ + +L IV E+ GS+ D + + +
Sbjct: 70 EIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIAT 129
Query: 213 VAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GT 270
+ KG+ YLH IHRD+K N+L++ G K+ADFGVA Q + T GT
Sbjct: 130 ILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVA-GQLTDTMAKRNTVIGT 188
Query: 271 YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQA 315
WMAPEVI+ Y+ AD++S GI E+ G+ PYA + P++A
Sbjct: 189 PFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRA 233
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 1e-56
Identities = 57/207 (27%), Positives = 114/207 (55%), Gaps = 6/207 (2%)
Query: 120 SGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
GS+G T ++ IK + ++++ +E +EV ++ ++H N+VQ+ +
Sbjct: 34 EGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFE 93
Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKT 236
+L IV ++ G ++ ++ QKGV FQ +L + + + ++H I+HRD+K+
Sbjct: 94 ENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKS 153
Query: 237 ANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYDYKADVFSFG 294
N+ + ++G V++ DFG+ARV S V A GT +++PE+ E+KPY+ K+D+++ G
Sbjct: 154 QNIFLTKDGTVQLGDFGIARV-LNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALG 212
Query: 295 IALWELLTGELPYAGLTPLQAAVGVVQ 321
L+EL T + + + + ++
Sbjct: 213 CVLYELCTLKHAFEAGSMKNLVLKIIS 239
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 1e-56
Identities = 46/226 (20%), Positives = 93/226 (41%), Gaps = 15/226 (6%)
Query: 105 WEIDAKQLKIECKVASG--SYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYI 160
+ + ++ + G + Y + V ++ + E + EM+ E+++
Sbjct: 20 FLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHV 79
Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFL-HKQKGVFQLTSLLKVAIDVSK 219
+ H N+V + L +VT FMA GS D + ++ + V K
Sbjct: 80 SKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLK 139
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA--------RVQAQSGVMTAETGTY 271
++Y+H +HR +K +++L+ +G V ++ R +
Sbjct: 140 ALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL 199
Query: 272 RWMAPEVIEH--KPYDYKADVFSFGIALWELLTGELPYAGLTPLQA 315
W++PEV++ + YD K+D++S GI EL G +P+ + Q
Sbjct: 200 PWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM 245
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 9e-56
Identities = 64/210 (30%), Positives = 106/210 (50%), Gaps = 9/210 (4%)
Query: 110 KQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHK 167
K+ K+ G+ G +Y + QEVAI+ + + + E+ +MR+ ++
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ--QQPKKELIINEILVMRENKNP 77
Query: 168 NVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN 227
N+V ++ + L +V E++A GS+ D + + + V + + + +LH N
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSN 135
Query: 228 NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYD 285
+IHRD+K+ N+L+ +G VK+ DFG Q T GT WMAPEV+ K Y
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFC-AQITPEQSKRSTMVGTPYWMAPEVVTRKAYG 194
Query: 286 YKADVFSFGIALWELLTGELPYAGLTPLQA 315
K D++S GI E++ GE PY PL+A
Sbjct: 195 PKVDIWSLGIMAIEMIEGEPPYLNENPLRA 224
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 2e-55
Identities = 69/230 (30%), Positives = 114/230 (49%), Gaps = 19/230 (8%)
Query: 95 IEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLK 152
+ D +VWEI ++ G++G +YK A KV++ + + E L+
Sbjct: 11 VRRDLDPNEVWEI-------VGELGDGAFGKVYKAKNKETGALAAAKVIETK--SEEELE 61
Query: 153 EFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLK 212
++ E+ I+ H +V+ +GA L I+ EF G++ + + +
Sbjct: 62 DYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV 121
Query: 213 VAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GT 270
V + + +N+LH IIHRDLK N+LM G +++ADFGV+ + + ++ GT
Sbjct: 122 VCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVS-AKNLKTLQKRDSFIGT 180
Query: 271 YRWMAPEVIEH-----KPYDYKADVFSFGIALWELLTGELPYAGLTPLQA 315
WMAPEV+ PYDYKAD++S GI L E+ E P+ L P++
Sbjct: 181 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV 230
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 2e-55
Identities = 53/233 (22%), Positives = 90/233 (38%), Gaps = 6/233 (2%)
Query: 81 PMHSKLLIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAI 138
P E+S D + + + ++ GSYG+++K + A+
Sbjct: 28 PRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAV 87
Query: 139 KVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDF 197
K + EV K+ +H V+ A L + TE S+
Sbjct: 88 KRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTEL-CGPSLQQH 146
Query: 198 LHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV 257
+ D + +LH ++H D+K AN+ + G K+ DFG+
Sbjct: 147 CEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVE 206
Query: 258 QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTG-ELPYAG 309
+G + G R+MAPE+++ Y ADVFS G+ + E+ ELP+ G
Sbjct: 207 LGTAGAGEVQEGDPRYMAPELLQ-GSYGTAADVFSLGLTILEVACNMELPHGG 258
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 3e-55
Identities = 63/210 (30%), Positives = 104/210 (49%), Gaps = 9/210 (4%)
Query: 110 KQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHK 167
L K+ GS G + ++VA+K++ + + EV IMR +H
Sbjct: 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLR--KQQRRELLFNEVVIMRDYQHF 102
Query: 168 NVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN 227
NVV+ + L ++ EF+ G++ D + + + V V + + YLH
Sbjct: 103 NVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQ 160
Query: 228 NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYD 285
+IHRD+K+ ++L+ +G VK++DFG Q V ++ GT WMAPEVI Y
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFC-AQISKDVPKRKSLVGTPYWMAPEVISRSLYA 219
Query: 286 YKADVFSFGIALWELLTGELPYAGLTPLQA 315
+ D++S GI + E++ GE PY +P+QA
Sbjct: 220 TEVDIWSLGIMVIEMVDGEPPYFSDSPVQA 249
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 8e-55
Identities = 71/238 (29%), Positives = 117/238 (49%), Gaps = 16/238 (6%)
Query: 87 LIESSPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPE 144
+ S ++I + W+ A+ LK ++ G+YG + K + Q +A+K ++
Sbjct: 1 MSIESSGKLKISPE--QHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRST 58
Query: 145 CVNTEMLKEFSQEVYI-MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHK--- 200
V+ + K+ ++ + MR +VQF GA R + I E M+ S F
Sbjct: 59 -VDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYS 116
Query: 201 -QKGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDENGVVKVADFGVARVQ 258
V L K+ + K +N+L +N IIHRD+K +N+L+D +G +K+ DFG++
Sbjct: 117 VLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQL 176
Query: 259 AQSGVMTAETGTYRWMAPEVIE----HKPYDYKADVFSFGIALWELLTGELPYAGLTP 312
S T + G +MAPE I+ + YD ++DV+S GI L+EL TG PY
Sbjct: 177 VDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNS 234
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 1e-54
Identities = 51/205 (24%), Positives = 84/205 (40%), Gaps = 17/205 (8%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
GS+G++++ + A+K ++ E +E+ + +V GA
Sbjct: 68 RGSFGEVHRMKDKQTGFQCAVKKVRLEVFR-------VEELVACAGLSSPRIVPLYGAVR 120
Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 237
P + I E + GS+ + KQ G L +G+ YLH I+H D+K
Sbjct: 121 EGPWVNIFMELLEGGSLGQLI-KQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKAD 179
Query: 238 NLLMDENGV-VKVADFGVARVQAQSGVMTAET------GTYRWMAPEVIEHKPYDYKADV 290
N+L+ +G + DFG A G+ + GT MAPEV+ KP D K D+
Sbjct: 180 NVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDI 239
Query: 291 FSFGIALWELLTGELPYAGLTPLQA 315
+S + +L G P+
Sbjct: 240 WSSCCMMLHMLNGCHPWTQYFRGPL 264
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 1e-54
Identities = 68/209 (32%), Positives = 102/209 (48%), Gaps = 10/209 (4%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNT-EMLKEFSQEVYIMRKIRHKNV 169
++ GS+G +Y + VAIK + + E ++ +EV ++K+RH N
Sbjct: 57 SDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNT 116
Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
+Q+ G R +V E+ GS D L K Q + V +G+ YLH +N+
Sbjct: 117 IQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNM 175
Query: 230 IHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVI---EHKPYDY 286
IHRD+K N+L+ E G+VK+ DFG A + + GT WMAPEVI + YD
Sbjct: 176 IHRDVKAGNILLSEPGLVKLGDFGSA---SIMAPANSFVGTPYWMAPEVILAMDEGQYDG 232
Query: 287 KADVFSFGIALWELLTGELPYAGLTPLQA 315
K DV+S GI EL + P + + A
Sbjct: 233 KVDVWSLGITCIELAERKPPLFNMNAMSA 261
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 179 bits (455), Expect = 2e-54
Identities = 63/205 (30%), Positives = 112/205 (54%), Gaps = 10/205 (4%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
G+YG +Y G S +AIK + ++ + +E+ + + ++HKN+VQ++G+ +
Sbjct: 32 KGTYGIVYAGRDLSNQVRIAIKEIPER--DSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLT-SLLKV-AIDVSKGMNYLHQNNIIHRDLK 235
+ I E + GS+ L + G + + + +G+ YLH N I+HRD+K
Sbjct: 90 ENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIK 149
Query: 236 TANLLMD-ENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKP--YDYKADVF 291
N+L++ +GV+K++DFG + R+ + TGT ++MAPE+I+ P Y AD++
Sbjct: 150 GDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIW 209
Query: 292 SFGIALWELLTGELPYAGLTPLQAA 316
S G + E+ TG+ P+ L QAA
Sbjct: 210 SLGCTIIEMATGKPPFYELGEPQAA 234
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 3e-54
Identities = 58/220 (26%), Positives = 107/220 (48%), Gaps = 6/220 (2%)
Query: 96 EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKE 153
T V E+ + ++ +G+ G ++K ++ +A K++ E + + +
Sbjct: 19 AFLTQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQ 77
Query: 154 FSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKV 213
+E+ ++ + +V F GA + I E M GS+ L K+ G L KV
Sbjct: 78 IIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVL-KKAGRIPEQILGKV 136
Query: 214 AIDVSKGMNYLHQN-NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYR 272
+I V KG+ YL + I+HRD+K +N+L++ G +K+ DFGV+ S + GT
Sbjct: 137 SIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF-VGTRS 195
Query: 273 WMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTP 312
+M+PE ++ Y ++D++S G++L E+ G P
Sbjct: 196 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 235
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 7e-54
Identities = 55/213 (25%), Positives = 99/213 (46%), Gaps = 25/213 (11%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
K + SG +G ++K + + IK +K E +EV + K+ H N+V
Sbjct: 14 KEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAE------REVKALAKLDHVNIV 67
Query: 171 QFIGA----------------CTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKV 213
+ G ++ L I EF +G++ ++ K++G L++
Sbjct: 68 HYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL 127
Query: 214 AIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRW 273
++KG++Y+H +I+RDLK +N+ + + VK+ DFG+ G T GT R+
Sbjct: 128 FEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRY 187
Query: 274 MAPEVIEHKPYDYKADVFSFGIALWELLTGELP 306
M+PE I + Y + D+++ G+ L ELL
Sbjct: 188 MSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 3e-53
Identities = 62/216 (28%), Positives = 103/216 (47%), Gaps = 13/216 (6%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYI-MR 162
E+ A L+ ++ G+YG + K + Q +A+K ++ VN++ K ++ I MR
Sbjct: 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRAT-VNSQEQKRLLMDLDISMR 61
Query: 163 KIRHKNVVQFIGACTRPPNLCIVTEFMARGS---IYDFLHKQKGVFQLTSLLKVAIDVSK 219
+ V F GA R ++ I E M S Y + + L K+A+ + K
Sbjct: 62 TVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVK 120
Query: 220 GMNYLHQN-NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
+ +LH ++IHRD+K +N+L++ G VK+ DFG++ + G +MAPE
Sbjct: 121 ALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPER 180
Query: 279 IE----HKPYDYKADVFSFGIALWELLTGELPYAGL 310
I K Y K+D++S GI + EL PY
Sbjct: 181 INPELNQKGYSVKSDIWSLGITMIELAILRFPYDSW 216
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 4e-53
Identities = 45/197 (22%), Positives = 100/197 (50%), Gaps = 7/197 (3%)
Query: 120 SGSYGDLYKG--TYCSQEVAIKVLK-PECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC 176
G + ++Y+ VA+K ++ + ++ + + +E+ +++++ H NV+++ +
Sbjct: 42 RGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASF 101
Query: 177 TRPPNLCIVTEFMARGSIYDFLHKQK---GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
L IV E G + + K + ++ K + + + ++H ++HRD
Sbjct: 102 IEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRD 161
Query: 234 LKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFS 292
+K AN+ + GVVK+ D G+ R +++ + GT +M+PE I Y++K+D++S
Sbjct: 162 IKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWS 221
Query: 293 FGIALWELLTGELPYAG 309
G L+E+ + P+ G
Sbjct: 222 LGCLLYEMAALQSPFYG 238
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 174 bits (443), Expect = 2e-52
Identities = 59/223 (26%), Positives = 104/223 (46%), Gaps = 11/223 (4%)
Query: 99 TDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQ 156
T G ++ + L+ ++ SG+ G ++K + +A+K ++ N E K
Sbjct: 14 TIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRS-GNKEENKRILM 72
Query: 157 EVYI-MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
++ + ++ +VQ G ++ I E M + +G L K+ +
Sbjct: 73 DLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMG-TCAEKLKKRMQGPIPERILGKMTV 131
Query: 216 DVSKGMNYLH-QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWM 274
+ K + YL ++ +IHRD+K +N+L+DE G +K+ DFG++ G +M
Sbjct: 132 AIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYM 191
Query: 275 APEVIE-----HKPYDYKADVFSFGIALWELLTGELPYAGLTP 312
APE I+ YD +ADV+S GI+L EL TG+ PY
Sbjct: 192 APERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT 234
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 1e-51
Identities = 72/220 (32%), Positives = 115/220 (52%), Gaps = 21/220 (9%)
Query: 113 KIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNV 169
++ V +G+YG +YKG + Q AIKV+ V + +E QE+ +++K H+N+
Sbjct: 27 ELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD---VTGDEEEEIKQEINMLKKYSHHRNI 83
Query: 170 VQFIGA------CTRPPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMN 222
+ GA L +V EF GS+ D + K + + + ++ +G++
Sbjct: 84 ATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLS 143
Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIE 280
+LHQ+ +IHRD+K N+L+ EN VK+ DFGV+ Q V T GT WMAPEVI
Sbjct: 144 HLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA-QLDRTVGRRNTFIGTPYWMAPEVIA 202
Query: 281 HK-----PYDYKADVFSFGIALWELLTGELPYAGLTPLQA 315
YD+K+D++S GI E+ G P + P++A
Sbjct: 203 CDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA 242
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 6e-51
Identities = 46/229 (20%), Positives = 90/229 (39%), Gaps = 29/229 (12%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNV 169
K+ SG +G ++K AIK K + + +EVY + +H +V
Sbjct: 14 HELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHV 73
Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFL---HKQKGVFQLTSLLKVAIDVSKGMNYLHQ 226
V++ A ++ I E+ GS+ D + ++ F+ L + + V +G+ Y+H
Sbjct: 74 VRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS 133
Query: 227 NNIIHRDLKTANLLMDENGV-------------------VKVADFGVARVQAQSGVMTAE 267
+++H D+K +N+ + + K+ D G + E
Sbjct: 134 MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHV---TRISSPQVE 190
Query: 268 TGTYRWMAPEVI-EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQA 315
G R++A EV+ E+ + KAD+F+ + + E
Sbjct: 191 EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHE 239
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 167 bits (425), Expect = 9e-50
Identities = 49/229 (21%), Positives = 93/229 (40%), Gaps = 25/229 (10%)
Query: 101 GTDVWEIDAKQLKIECKVASGSYGDLY--KGTYCSQEVAIKVLKPECVNTEMLKEFSQEV 158
G V ID K K+ G + + +G + A+K + C + +E +E
Sbjct: 21 GHMVI-IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRIL--CHEQQDREEAQREA 77
Query: 159 YIMRKIRHKNVVQFIGACTRPPN----LCIVTEFMARGSIYDFL---HKQKGVFQLTSLL 211
+ R H N+++ + C R ++ F RG++++ + + +L
Sbjct: 78 DMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQIL 137
Query: 212 KVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ----------AQS 261
+ + + +G+ +H HRDLK N+L+ + G + D G
Sbjct: 138 WLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTL 197
Query: 262 GVMTAETGTYRWMAPEVIEHKPY---DYKADVFSFGIALWELLTGELPY 307
A+ T + APE+ + + D + DV+S G L+ ++ GE PY
Sbjct: 198 QDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPY 246
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 166 bits (424), Expect = 1e-49
Identities = 69/190 (36%), Positives = 112/190 (58%), Gaps = 8/190 (4%)
Query: 121 GSYGDLYKGTYCSQEVAIKVLKPECVNTEM--LKEFSQEVYIMRKIRHKNVVQFIGACTR 178
G +G +YKG + VA+K L T ++F QE+ +M K +H+N+V+ +G +
Sbjct: 42 GGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSD 101
Query: 179 PPNLCIVTEFMARGSIYDFLHKQKGVFQL--TSLLKVAIDVSKGMNYLHQNNIIHRDLKT 236
+LC+V +M GS+ D L G L K+A + G+N+LH+N+ IHRD+K+
Sbjct: 102 GDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKS 161
Query: 237 ANLLMDENGVVKVADFGVAR---VQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
AN+L+DE K++DFG+AR AQ+ + + GT +MAPE + + K+D++SF
Sbjct: 162 ANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRGEITP-KSDIYSF 220
Query: 294 GIALWELLTG 303
G+ L E++TG
Sbjct: 221 GVVLLEIITG 230
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 2e-48
Identities = 47/212 (22%), Positives = 93/212 (43%), Gaps = 30/212 (14%)
Query: 120 SGSYGDLYKGT--YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC- 176
G +G +++ AIK ++ ++ +EV + K+ H +V++ A
Sbjct: 15 RGGFGVVFEAKNKVDDCNYAIKRIRLP-NRELAREKVMREVKALAKLEHPGIVRYFNAWL 73
Query: 177 -----------TRPPNLCIVTEFMARGSIYDFLHKQKGVFQL--TSLLKVAIDVSKGMNY 223
+ L I + + ++ D+++ + + + + L + + +++ + +
Sbjct: 74 EKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEF 133
Query: 224 LHQNNIIHRDLKTANLLMDENGVVKVADFGVARV-------------QAQSGVMTAETGT 270
LH ++HRDLK +N+ + VVKV DFG+ T + GT
Sbjct: 134 LHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGT 193
Query: 271 YRWMAPEVIEHKPYDYKADVFSFGIALWELLT 302
+M+PE I Y +K D+FS G+ L+ELL
Sbjct: 194 KLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 163 bits (414), Expect = 3e-48
Identities = 55/215 (25%), Positives = 97/215 (45%), Gaps = 34/215 (15%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
G++G + K + AIK ++ E L EV ++ + H+ VV++ A
Sbjct: 16 QGAFGQVVKARNALDSRYYAIKKIR---HTEEKLSTILSEVMLLASLNHQYVVRYYAAWL 72
Query: 178 RPPN-------------LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 224
N L I E+ G++YD +H + Q ++ + + ++Y+
Sbjct: 73 ERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYI 132
Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVARV---------------QAQSGVMTAETG 269
H IIHRDLK N+ +DE+ VK+ DFG+A+ S +T+ G
Sbjct: 133 HSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIG 192
Query: 270 TYRWMAPEVIEHKP-YDYKADVFSFGIALWELLTG 303
T ++A EV++ Y+ K D++S GI +E++
Sbjct: 193 TAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 2e-47
Identities = 46/209 (22%), Positives = 94/209 (44%), Gaps = 20/209 (9%)
Query: 120 SGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN--VVQFIGAC 176
SG +++ Q AIK + E + + L + E+ + K++ + +++
Sbjct: 19 SGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 78
Query: 177 TRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKT 236
+ +V E + +L K+K ++ + ++ +HQ+ I+H DLK
Sbjct: 79 ITDQYIYMVMEC-GNIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKP 136
Query: 237 ANLLMDENGVVKVADFGVAR-VQAQSGVMTAET--GTYRWMAPEVIEHKP---------- 283
AN L+ +G++K+ DFG+A +Q + + ++ GT +M PE I+
Sbjct: 137 ANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKS 195
Query: 284 -YDYKADVFSFGIALWELLTGELPYAGLT 311
K+DV+S G L+ + G+ P+ +
Sbjct: 196 KISPKSDVWSLGCILYYMTYGKTPFQQII 224
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 160 bits (408), Expect = 4e-47
Identities = 59/197 (29%), Positives = 110/197 (55%), Gaps = 11/197 (5%)
Query: 115 ECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFI 173
+ + G +G +YKG +VA+K PE +++ ++EF E+ + RH ++V I
Sbjct: 44 KFLIGHGVFGKVYKGVLRDGAKVALKRRTPE--SSQGIEEFETEIETLSFCRHPHLVSLI 101
Query: 174 GACTRPPNLCIVTEFMARGSIYDFLH-KQKGVFQLT--SLLKVAIDVSKGMNYLHQNNII 230
G C + ++ ++M G++ L+ ++ L++ I ++G++YLH II
Sbjct: 102 GFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAII 161
Query: 231 HRDLKTANLLMDENGVVKVADFGVARVQAQSG---VMTAETGTYRWMAPE-VIEHKPYDY 286
HRD+K+ N+L+DEN V K+ DFG+++ + + T GT ++ PE I+ + +
Sbjct: 162 HRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTE- 220
Query: 287 KADVFSFGIALWELLTG 303
K+DV+SFG+ L+E+L
Sbjct: 221 KSDVYSFGVVLFEVLCA 237
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 5e-47
Identities = 45/209 (21%), Positives = 93/209 (44%), Gaps = 20/209 (9%)
Query: 120 SGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN--VVQFIGAC 176
SG +++ Q AIK + E + + L + E+ + K++ + +++
Sbjct: 66 SGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 125
Query: 177 TRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKT 236
+ +V E + +L K+K ++ + ++ +HQ+ I+H DLK
Sbjct: 126 ITDQYIYMVMEC-GNIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKP 183
Query: 237 ANLLMDENGVVKVADFGVAR-VQAQSGVMTAET--GTYRWMAPEVIEHKP---------- 283
AN L+ +G++K+ DFG+A +Q + + ++ G +M PE I+
Sbjct: 184 ANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKS 242
Query: 284 -YDYKADVFSFGIALWELLTGELPYAGLT 311
K+DV+S G L+ + G+ P+ +
Sbjct: 243 KISPKSDVWSLGCILYYMTYGKTPFQQII 271
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 1e-46
Identities = 46/209 (22%), Positives = 94/209 (44%), Gaps = 20/209 (9%)
Query: 120 SGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN--VVQFIGAC 176
SG +++ Q AIK + E + + L + E+ + K++ + +++
Sbjct: 38 SGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 97
Query: 177 TRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKT 236
+ +V E + +L K+K ++ + ++ +HQ+ I+H DLK
Sbjct: 98 ITDQYIYMVMEC-GNIDLNSWL-KKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKP 155
Query: 237 ANLLMDENGVVKVADFGVAR-VQAQSGVMTAET--GTYRWMAPEVIEHKP---------- 283
AN L+ +G++K+ DFG+A +Q + + ++ GT +M PE I+
Sbjct: 156 ANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKS 214
Query: 284 -YDYKADVFSFGIALWELLTGELPYAGLT 311
K+DV+S G L+ + G+ P+ +
Sbjct: 215 KISPKSDVWSLGCILYYMTYGKTPFQQII 243
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 1e-46
Identities = 54/209 (25%), Positives = 98/209 (46%), Gaps = 15/209 (7%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
+GSYG K S + + K L + + EV ++R+++H N+V++
Sbjct: 16 TGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRII 75
Query: 178 RPPN--LCIVTEFMARGSIYDFL--HKQKGV-FQLTSLLKVAIDVSKGMNYLHQ-----N 227
N L IV E+ G + + ++ +L+V ++ + H+ +
Sbjct: 76 DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGH 135
Query: 228 NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYD 285
++HRDLK AN+ +D VK+ DFG+AR+ A+T GT +M+PE + Y+
Sbjct: 136 TVLHRDLKPANVFLDGKQNVKLGDFGLARI-LNHDTSFAKTFVGTPYYMSPEQMNRMSYN 194
Query: 286 YKADVFSFGIALWELLTGELPYAGLTPLQ 314
K+D++S G L+EL P+ + +
Sbjct: 195 EKSDIWSLGCLLYELCALMPPFTAFSQKE 223
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 157 bits (399), Expect = 7e-46
Identities = 57/222 (25%), Positives = 98/222 (44%), Gaps = 19/222 (8%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA-- 175
G+ ++++G + AIKV + +E +++K+ HKN+V+
Sbjct: 19 QGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFAIEE 77
Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLT--SLLKVAIDVSKGMNYLHQNNIIHRD 233
T + ++ EF GS+Y L + + L L V DV GMN+L +N I+HR+
Sbjct: 78 ETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRN 137
Query: 234 LKTANLLM----DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE--------H 281
+K N++ D V K+ DFG AR + GT ++ P++ E
Sbjct: 138 IKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQ 197
Query: 282 KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKV 323
K Y D++S G+ + TG LP+ + V+ K+
Sbjct: 198 KKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 1e-44
Identities = 54/201 (26%), Positives = 92/201 (45%), Gaps = 26/201 (12%)
Query: 121 GSYGDLYKGTYCS--QEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
GS+ +Y+ EVAIK++ K M++ EV I +++H ++++
Sbjct: 22 GSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFE 81
Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGVF----------QLTSLLKVAIDVSKGMNYLHQN 227
+ +V E G + +L + F Q+ + GM YLH +
Sbjct: 82 DSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIIT----------GMLYLHSH 131
Query: 228 NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYD 285
I+HRDL +NLL+ N +K+ADFG+A Q + T GT +++PE+ +
Sbjct: 132 GILHRDLTLSNLLLTRNMNIKIADFGLA-TQLKMPHEKHYTLCGTPNYISPEIATRSAHG 190
Query: 286 YKADVFSFGIALWELLTGELP 306
++DV+S G + LL G P
Sbjct: 191 LESDVWSLGCMFYTLLIGRPP 211
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 2e-44
Identities = 57/222 (25%), Positives = 98/222 (44%), Gaps = 19/222 (8%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA-- 175
G+ ++++G + AIKV + +E +++K+ HKN+V+
Sbjct: 19 QGATANVFRGRHKKTGDLFAIKVFNNISFL-RPVDVQMREFEVLKKLNHKNIVKLFAIEE 77
Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLT--SLLKVAIDVSKGMNYLHQNNIIHRD 233
T + ++ EF GS+Y L + + L L V DV GMN+L +N I+HR+
Sbjct: 78 ETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRN 137
Query: 234 LKTANLLM----DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE--------H 281
+K N++ D V K+ DFG AR + GT ++ P++ E
Sbjct: 138 IKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQ 197
Query: 282 KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKV 323
K Y D++S G+ + TG LP+ + V+ K+
Sbjct: 198 KKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 158 bits (400), Expect = 1e-43
Identities = 55/203 (27%), Positives = 98/203 (48%), Gaps = 14/203 (6%)
Query: 120 SGSYGDLYKGT--YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFI---- 173
+G +G + + ++VAIK + E ++ + + + E+ IM+K+ H NVV
Sbjct: 24 TGGFGYVLRWIHQDTGEQVAIKQCRQE-LSPKNRERWCLEIQIMKKLNHPNVVSAREVPD 82
Query: 174 --GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLT--SLLKVAIDVSKGMNYLHQNNI 229
+ E+ G + +L++ + L + + D+S + YLH+N I
Sbjct: 83 GLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRI 142
Query: 230 IHRDLKTANLLMDENG---VVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDY 286
IHRDLK N+++ + K+ D G A+ Q + T GT +++APE++E K Y
Sbjct: 143 IHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTV 202
Query: 287 KADVFSFGIALWELLTGELPYAG 309
D +SFG +E +TG P+
Sbjct: 203 TVDYWSFGTLAFECITGFRPFLP 225
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 1e-43
Identities = 57/200 (28%), Positives = 97/200 (48%), Gaps = 25/200 (12%)
Query: 121 GSYGDLYKGT--YCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
G + ++ + + A K++ K + ++ S E+ I R + H++VV F G
Sbjct: 52 GGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE 111
Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGVF----------QLTSLLKVAIDVSKGMNYLHQN 227
+ +V E R S+ + LHK++ Q+ G YLH+N
Sbjct: 112 DNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVL----------GCQYLHRN 160
Query: 228 NIIHRDLKTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDY 286
+IHRDLK NL ++E+ VK+ DFG+A +V+ GT ++APEV+ K + +
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSF 220
Query: 287 KADVFSFGIALWELLTGELP 306
+ DV+S G ++ LL G+ P
Sbjct: 221 EVDVWSIGCIMYTLLVGKPP 240
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 3e-43
Identities = 57/200 (28%), Positives = 97/200 (48%), Gaps = 25/200 (12%)
Query: 121 GSYGDLYKGT--YCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
G + ++ + + A K++ K + ++ S E+ I R + H++VV F G
Sbjct: 26 GGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE 85
Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGVF----------QLTSLLKVAIDVSKGMNYLHQN 227
+ +V E R S+ + LHK++ Q+ G YLH+N
Sbjct: 86 DNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVL----------GCQYLHRN 134
Query: 228 NIIHRDLKTANLLMDENGVVKVADFGVA-RVQAQSGVMTAETGTYRWMAPEVIEHKPYDY 286
+IHRDLK NL ++E+ VK+ DFG+A +V+ GT ++APEV+ K + +
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSF 194
Query: 287 KADVFSFGIALWELLTGELP 306
+ DV+S G ++ LL G+ P
Sbjct: 195 EVDVWSIGCIMYTLLVGKPP 214
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 6e-43
Identities = 65/198 (32%), Positives = 101/198 (51%), Gaps = 10/198 (5%)
Query: 115 ECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFI 173
+ + G +G +YKG VA+K LK E +F EV ++ H+N+++
Sbjct: 35 KNILGRGGFGKVYKGRLADGTLVAVKRLKEER-TQGGELQFQTEVEMISMAVHRNLLRLR 93
Query: 174 GACTRPPNLCIVTEFMARGSIYDFLH-KQKGVFQLT--SLLKVAIDVSKGMNYLHQN--- 227
G C P +V +MA GS+ L + + L ++A+ ++G+ YLH +
Sbjct: 94 GFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDP 153
Query: 228 NIIHRDLKTANLLMDENGVVKVADFGVARVQ--AQSGVMTAETGTYRWMAPEVIEHKPYD 285
IIHRD+K AN+L+DE V DFG+A++ + V TA GT +APE +
Sbjct: 154 KIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSS 213
Query: 286 YKADVFSFGIALWELLTG 303
K DVF +G+ L EL+TG
Sbjct: 214 EKTDVFGYGVMLLELITG 231
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-42
Identities = 55/189 (29%), Positives = 98/189 (51%), Gaps = 5/189 (2%)
Query: 121 GSYGDLY--KGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
G +G++Y + +A+KVL K + + + +EV I +RH N+++ G
Sbjct: 20 GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 79
Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 237
+ ++ E+ G++Y L ++ F +++ ++Y H +IHRD+K
Sbjct: 80 DATRVYLILEYAPLGTVYREL-QKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPE 138
Query: 238 NLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIAL 297
NLL+ G +K+ADFG + V A S T GT ++ PE+IE + +D K D++S G+
Sbjct: 139 NLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLC 197
Query: 298 WELLTGELP 306
+E L G+ P
Sbjct: 198 YEFLVGKPP 206
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-42
Identities = 56/189 (29%), Positives = 96/189 (50%), Gaps = 5/189 (2%)
Query: 121 GSYGDLY--KGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
G +G++Y + +A+KVL K + + + +E+ I +RH N+++
Sbjct: 25 GKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH 84
Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 237
+ ++ EF RG +Y L ++ G F +++ ++Y H+ +IHRD+K
Sbjct: 85 DRKRIYLMLEFAPRGELYKEL-QKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPE 143
Query: 238 NLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIAL 297
NLLM G +K+ADFG + V A S GT ++ PE+IE K +D K D++ G+
Sbjct: 144 NLLMGYKGELKIADFGWS-VHAPSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLC 202
Query: 298 WELLTGELP 306
+E L G P
Sbjct: 203 YEFLVGMPP 211
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 7e-42
Identities = 51/212 (24%), Positives = 88/212 (41%), Gaps = 28/212 (13%)
Query: 121 GSYGDLYKGTYCSQEVAIKVLK---------------PECVNTEMLKEFSQEVYIMRKIR 165
G + + ++ A+K + + +F E+ I+ I+
Sbjct: 42 GKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK 101
Query: 166 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK------ 219
++ + G T + I+ E+M SI F V + I V K
Sbjct: 102 NEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEY-FFVLDKNYTCFIPIQVIKCIIKSV 160
Query: 220 --GMNYLH-QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAP 276
+Y+H + NI HRD+K +N+LMD+NG VK++DFG + + GTY +M P
Sbjct: 161 LNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGES-EYMVDKKIKGSRGTYEFMPP 219
Query: 277 EVIEHKP--YDYKADVFSFGIALWELLTGELP 306
E ++ K D++S GI L+ + +P
Sbjct: 220 EFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 1e-41
Identities = 40/227 (17%), Positives = 92/227 (40%), Gaps = 27/227 (11%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQEV 158
++ +K + + + G++ +Y+ T Q+ +KV KP E Q +
Sbjct: 61 QLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPW-EFYIGT-QLM 118
Query: 159 YIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK----GVFQLTSLLKVA 214
++ ++F A +V E + G++ + ++ K V ++ A
Sbjct: 119 ERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFA 178
Query: 215 IDVSKGMNYLHQNNIIHRDLKTANLLM-----------DENGVVKVADFGVA---RVQAQ 260
+ + + +H IIH D+K N ++ D + + + D G + ++ +
Sbjct: 179 MRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPK 238
Query: 261 SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 307
+ TA+ T + E++ +KP++Y+ D F ++ +L G
Sbjct: 239 GTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMK 285
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 2e-41
Identities = 49/211 (23%), Positives = 96/211 (45%), Gaps = 21/211 (9%)
Query: 120 SGSYGD-LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACT 177
G+ G +Y+G + +++VA+K + PEC +EV ++R+ H NV+++
Sbjct: 34 HGAEGTIVYRGMFDNRDVAVKRILPEC-----FSFADREVQLLRESDEHPNVIRYFCTEK 88
Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 237
I E A ++ +++ ++ + + + G+ +LH NI+HRDLK
Sbjct: 89 DRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPH 147
Query: 238 NLLMDENG-----VVKVADFGVARV----QAQSGVMTAETGTYRWMAPEVIE---HKPYD 285
N+L+ ++DFG+ + + + GT W+APE++ +
Sbjct: 148 NILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPT 207
Query: 286 YKADVFSFGIALWELLT-GELPYAGLTPLQA 315
Y D+FS G + +++ G P+ QA
Sbjct: 208 YTVDIFSAGCVFYYVISEGSHPFGKSLQRQA 238
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 1e-40
Identities = 60/245 (24%), Positives = 106/245 (43%), Gaps = 35/245 (14%)
Query: 101 GTDVWEIDAKQLKIECKVASGSYGDLY--KGTYCSQEVAIKVLKPECVNTEMLKEFSQEV 158
G V E+ +L++ +A G + +Y + +E A+K L E + QEV
Sbjct: 20 GQTV-ELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLL--SNEEEKNRAIIQEV 76
Query: 159 YIMRKIR-HKNVVQFIGACTRPPN--------LCIVTEFMARGSIYDFL--HKQKGVFQL 207
M+K+ H N+VQF A + ++TE +G + +FL + +G
Sbjct: 77 CFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTEL-CKGQLVEFLKKMESRGPLSC 135
Query: 208 TSLLKVAIDVSKGMNYLHQNN--IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT 265
++LK+ + + ++H+ IIHRDLK NLL+ G +K+ DFG A + +
Sbjct: 136 DTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYS 195
Query: 266 AET-------------GTYRWMAPEVIE---HKPYDYKADVFSFGIALWELLTGELPYAG 309
T + PE+I+ + P K D+++ G L+ L + P+
Sbjct: 196 WSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED 255
Query: 310 LTPLQ 314
L+
Sbjct: 256 GAKLR 260
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 2e-39
Identities = 57/209 (27%), Positives = 105/209 (50%), Gaps = 6/209 (2%)
Query: 113 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPE-CVNTEMLKEFSQEVYIMRKIRHKNV 169
KI K+ G +Y T + +VAIK + E LK F +EV+ ++ H+N+
Sbjct: 14 KIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNI 73
Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
V I +V E++ ++ +++ G + + + + G+ + H I
Sbjct: 74 VSMIDVDEEDDCYYLVMEYIEGPTLSEYIE-SHGPLSVDTAINFTNQILDGIKHAHDMRI 132
Query: 230 IHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYDYK 287
+HRD+K N+L+D N +K+ DFG+A+ +++ + GT ++ +PE + + D
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDEC 192
Query: 288 ADVFSFGIALWELLTGELPYAGLTPLQAA 316
D++S GI L+E+L GE P+ G T + A
Sbjct: 193 TDIYSIGIVLYEMLVGEPPFNGETAVSIA 221
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 1e-38
Identities = 63/215 (29%), Positives = 107/215 (49%), Gaps = 12/215 (5%)
Query: 113 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPE-CVNTEMLKEFSQEVYIMRKIRHKNV 169
++ + G +++ ++VA+KVL+ + + F +E + H +
Sbjct: 15 ELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAI 74
Query: 170 VQF--IGACTRPPNLC--IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 225
V G P IV E++ ++ D +H +G ++V D + +N+ H
Sbjct: 75 VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH-TEGPMTPKRAIEVIADACQALNFSH 133
Query: 226 QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET----GTYRWMAPEVIEH 281
QN IIHRD+K AN+++ VKV DFG+AR A SG +T GT ++++PE
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193
Query: 282 KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAA 316
D ++DV+S G L+E+LTGE P+ G +P+ A
Sbjct: 194 DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA 228
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 8e-38
Identities = 42/192 (21%), Positives = 81/192 (42%), Gaps = 15/192 (7%)
Query: 127 YKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186
++ + + + + S ++ M KN V + + L I
Sbjct: 81 WQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQM 140
Query: 187 EFMARGSIYDFLHKQKGVFQL--TSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN 244
+ + ++ D+++++ + L + I +++ + +LH ++HRDLK +N+ +
Sbjct: 141 QLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMD 200
Query: 245 GVVKVADFGVARV-------------QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVF 291
VVKV DFG+ T + GT +M+PE I Y +K D+F
Sbjct: 201 DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIF 260
Query: 292 SFGIALWELLTG 303
S G+ L+ELL
Sbjct: 261 SLGLILFELLYS 272
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 137 bits (345), Expect = 1e-37
Identities = 28/243 (11%), Positives = 77/243 (31%), Gaps = 38/243 (15%)
Query: 110 KQLKIECKVASGSYGDLYKGTYCS--QEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRH 166
++LK+ + G ++ ++ A+KV + L+ + + ++
Sbjct: 62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG 121
Query: 167 KNVVQFIGAC--------------------------TRPPNLCIVTEFMAR-----GSIY 195
++ + N ++ + S
Sbjct: 122 ESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTL 181
Query: 196 DFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA 255
DF++ +G + +L + + + L ++H NL + +G + + D
Sbjct: 182 DFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSAL 241
Query: 256 RVQAQSGVMTAETGTYRWMAPEVIEHK--PYDYKADVFSFGIALWELLTGELPYAGLTPL 313
G ++ TY E + + + + + G++++ + LP+ +TP
Sbjct: 242 WKVGTRGPASSVPVTY--APREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPG 299
Query: 314 QAA 316
Sbjct: 300 IKG 302
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 2e-37
Identities = 58/183 (31%), Positives = 95/183 (51%), Gaps = 20/183 (10%)
Query: 134 QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGS 193
+EVAIK++ +N L++ +EV IM+ + H N+V+ L ++ E+ + G
Sbjct: 41 REVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGE 100
Query: 194 IYDFLHKQKGV--------F-QLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN 244
++D+L + F Q+ S + Y HQ I+HRDLK NLL+D +
Sbjct: 101 VFDYLVAHGRMKEKEARSKFRQIVS----------AVQYCHQKRIVHRDLKAENLLLDAD 150
Query: 245 GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYD-YKADVFSFGIALWELLTG 303
+K+ADFG + G + A G + APE+ + K YD + DV+S G+ L+ L++G
Sbjct: 151 MNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 210
Query: 304 ELP 306
LP
Sbjct: 211 SLP 213
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 5e-37
Identities = 63/204 (30%), Positives = 107/204 (52%), Gaps = 7/204 (3%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
+ K+ SG+YG++ E AIK+++ V+T + +EV +++ + H N++
Sbjct: 40 QRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIM 99
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 230
+ N +V E G ++D + + F + V G+ YLH++NI+
Sbjct: 100 KLYDFFEDKRNYYLVMECYKGGELFDEI-IHRMKFNEVDAAVIIKQVLSGVTYLHKHNIV 158
Query: 231 HRDLKTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYK 287
HRDLK NLL+ +++ ++K+ DFG++ V M GT ++APEV+ K YD K
Sbjct: 159 HRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVL-RKKYDEK 217
Query: 288 ADVFSFGIALWELLTGELPYAGLT 311
DV+S G+ L+ LL G P+ G T
Sbjct: 218 CDVWSIGVILFILLAGYPPFGGQT 241
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-36
Identities = 49/207 (23%), Positives = 95/207 (45%), Gaps = 29/207 (14%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVL------KPECVNTEMLKEFSQEVYIMRKIRHKNVVQ 171
SG++G ++ +EV +K + + + L + + E+ I+ ++ H N+++
Sbjct: 34 SGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIK 93
Query: 172 FIGACTRPPNLCIVTEFMARGS-IYDFLHKQ--------KGVF-QLTSLLKVAIDVSKGM 221
+ +V E G ++ F+ + +F QL S A+
Sbjct: 94 VLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVS----AVG----- 144
Query: 222 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEH 281
YL +IIHRD+K N+++ E+ +K+ DFG A + + GT + APEV+
Sbjct: 145 -YLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMG 203
Query: 282 KPYD-YKADVFSFGIALWELLTGELPY 307
PY + +++S G+ L+ L+ E P+
Sbjct: 204 NPYRGPELEMWSLGVTLYTLVFEENPF 230
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-36
Identities = 60/202 (29%), Positives = 106/202 (52%), Gaps = 7/202 (3%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
I C + GS+G++ K QE A+KV+ + +EV +++K+ H N++
Sbjct: 25 NIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIM 84
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 230
+ + IV E G ++D + ++ F ++ V G+ Y+H++NI+
Sbjct: 85 KLFEILEDSSSFYIVGELYTGGELFDEI-IKRKRFSEHDAARIIKQVFSGITYMHKHNIV 143
Query: 231 HRDLKTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYK 287
HRDLK N+L+ +++ +K+ DFG++ Q+ M GT ++APEV+ YD K
Sbjct: 144 HRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGTYDEK 202
Query: 288 ADVFSFGIALWELLTGELPYAG 309
DV+S G+ L+ LL+G P+ G
Sbjct: 203 CDVWSAGVILYILLSGTPPFYG 224
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-36
Identities = 60/226 (26%), Positives = 99/226 (43%), Gaps = 50/226 (22%)
Query: 121 GSYGDLYKGT--YCSQEVAIKVL------------------------KPECVNTEMLKEF 154
GSYG + + A+KVL +++
Sbjct: 24 GSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQV 83
Query: 155 SQEVYIMRKIRHKNVVQF---IGACTRPPNLCIVTEFMARGSIYDFLHKQK-------GV 204
QE+ I++K+ H NVV+ + +L +V E + +G + + +
Sbjct: 84 YQEIAILKKLDHPNVVKLVEVLDDPNED-HLYMVFELVNQGPVMEVPTLKPLSEDQARFY 142
Query: 205 FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM 264
FQ D+ KG+ YLH IIHRD+K +NLL+ E+G +K+ADFGV+ S +
Sbjct: 143 FQ---------DLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDAL 193
Query: 265 TAET-GTYRWMAPEVI--EHKPYD-YKADVFSFGIALWELLTGELP 306
+ T GT +MAPE + K + DV++ G+ L+ + G+ P
Sbjct: 194 LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCP 239
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 135 bits (342), Expect = 3e-36
Identities = 58/205 (28%), Positives = 104/205 (50%), Gaps = 8/205 (3%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNV 169
K + + GS+G++ QE A+KV+ K + + +EV +++++ H N+
Sbjct: 29 KGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNI 88
Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
++ +V E G ++D + + F ++ V G+ Y+H+N I
Sbjct: 89 MKLYEFFEDKGYFYLVGEVYTGGELFDEI-ISRKRFSEVDAARIIRQVLSGITYMHKNKI 147
Query: 230 IHRDLKTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDY 286
+HRDLK NLL+ ++ +++ DFG++ S M + GT ++APEV+ H YD
Sbjct: 148 VHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVL-HGTYDE 206
Query: 287 KADVFSFGIALWELLTGELPYAGLT 311
K DV+S G+ L+ LL+G P+ G
Sbjct: 207 KCDVWSTGVILYILLSGCPPFNGAN 231
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 3e-36
Identities = 57/202 (28%), Positives = 99/202 (49%), Gaps = 26/202 (12%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
G+YG++ + VA+K++ + + + +E+ I + + H+NVV+F G
Sbjct: 17 EGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRR 75
Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGV--------F-QLTSLLKVAIDVSKGMNYLHQNN 228
+ E+ + G ++D + G+ F QL + G+ YLH
Sbjct: 76 EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA----------GVVYLHGIG 125
Query: 229 IIHRDLKTANLLMDENGVVKVADFG---VARVQAQSGVMTAETGTYRWMAPEVIEHKPYD 285
I HRD+K NLL+DE +K++DFG V R + ++ GT ++APE+++ + +
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 286 -YKADVFSFGIALWELLTGELP 306
DV+S GI L +L GELP
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELP 207
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 9e-36
Identities = 57/192 (29%), Positives = 101/192 (52%), Gaps = 7/192 (3%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
GS+G++ K QE A+KV+ + +EV +++K+ H N+++
Sbjct: 32 KGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE 91
Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 237
+ IV E G ++D + ++ F ++ V G+ Y+H++NI+HRDLK
Sbjct: 92 DSSSFYIVGELYTGGELFDEI-IKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPE 150
Query: 238 NLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 294
N+L+ +++ +K+ DFG++ Q+ M GT ++APEV+ YD K DV+S G
Sbjct: 151 NILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVL-RGTYDEKCDVWSAG 209
Query: 295 IALWELLTGELP 306
+ L+ LL+G P
Sbjct: 210 VILYILLSGTPP 221
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-35
Identities = 51/200 (25%), Positives = 108/200 (54%), Gaps = 23/200 (11%)
Query: 121 GSYGDLYKGTYCS--QEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
G++G + G + +VA+K+L + + + +++ + +E+ ++ RH ++++ +
Sbjct: 22 GTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIS 81
Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGV--------F-QLTSLLKVAIDVSKGMNYLHQNN 228
P + +V E+++ G ++D++ K V F Q+ S ++Y H++
Sbjct: 82 TPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILS----------AVDYCHRHM 131
Query: 229 IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYD-YK 287
++HRDLK N+L+D + K+ADFG++ + + + G+ + APEVI + Y +
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPE 191
Query: 288 ADVFSFGIALWELLTGELPY 307
D++S G+ L+ LL G LP+
Sbjct: 192 VDIWSCGVILYALLCGTLPF 211
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-35
Identities = 46/192 (23%), Positives = 93/192 (48%), Gaps = 6/192 (3%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
G++ + + + + E A K++ + ++ ++ +E I RK++H N+V+ +
Sbjct: 16 KGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 75
Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 237
+V + + G +++ + + + + + + Y H N I+HR+LK
Sbjct: 76 EESFHYLVFDLVTGGELFEDI-VAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPE 134
Query: 238 NLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 294
NLL+ + VK+ADFG+A S GT +++PEV++ PY D+++ G
Sbjct: 135 NLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACG 194
Query: 295 IALWELLTGELP 306
+ L+ LL G P
Sbjct: 195 VILYILLVGYPP 206
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-35
Identities = 57/202 (28%), Positives = 99/202 (49%), Gaps = 26/202 (12%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
G+YG++ + VA+K++ + + + +E+ I + + H+NVV+F G
Sbjct: 17 EGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRR 75
Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGV--------F-QLTSLLKVAIDVSKGMNYLHQNN 228
+ E+ + G ++D + G+ F QL + G+ YLH
Sbjct: 76 EGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA----------GVVYLHGIG 125
Query: 229 IIHRDLKTANLLMDENGVVKVADFG---VARVQAQSGVMTAETGTYRWMAPEVIEHKPYD 285
I HRD+K NLL+DE +K++DFG V R + ++ GT ++APE+++ + +
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 286 -YKADVFSFGIALWELLTGELP 306
DV+S GI L +L GELP
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELP 207
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 4e-35
Identities = 44/214 (20%), Positives = 85/214 (39%), Gaps = 7/214 (3%)
Query: 113 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKE-FSQEVYIMRKIRHKNV 169
++ V G GD+Y+ T + VA+K++ + + + +E +++ +V
Sbjct: 37 RLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHV 96
Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
V L + + + L +++G + + + ++ H
Sbjct: 97 VPIHDFGEIDGQLYVDMRLINGVDLAAML-RRQGPLAPPRAVAIVRQIGSALDAAHAAGA 155
Query: 230 IHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYDYK 287
HRD+K N+L+ + + DFG+A + GT +MAPE Y+
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYR 215
Query: 288 ADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321
AD+++ L+E LTG PY G L +
Sbjct: 216 ADIYALTCVLYECLTGSPPYQG-DQLSVMGAHIN 248
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 5e-35
Identities = 41/201 (20%), Positives = 89/201 (44%), Gaps = 7/201 (3%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
I + G +G +++ S + K +K + + ++K +E+ I+ RH+N++
Sbjct: 8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---KEISILNIARHRNIL 64
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 230
+ L ++ EF++ I++ ++ ++ V + + +LH +NI
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124
Query: 231 HRDLKTANLLM--DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKA 288
H D++ N++ + +K+ +FG AR + APEV +H
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTAT 184
Query: 289 DVFSFGIALWELLTGELPYAG 309
D++S G ++ LL+G P+
Sbjct: 185 DMWSLGTLVYVLLSGINPFLA 205
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 5e-35
Identities = 43/205 (20%), Positives = 104/205 (50%), Gaps = 14/205 (6%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNV 169
I ++ SG++G +++ + + K + P ++ +K E+ IM ++ H +
Sbjct: 54 DILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVK---NEISIMNQLHHPKL 110
Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF---QLTSLLKVAIDVSKGMNYLHQ 226
+ A + ++ EF++ G ++D + + ++ + ++ +G+ ++H+
Sbjct: 111 INLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMR---QACEGLKHMHE 167
Query: 227 NNIIHRDLKTANLLM--DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPY 284
++I+H D+K N++ + VK+ DFG+A ++ T T + APE+++ +P
Sbjct: 168 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPV 227
Query: 285 DYKADVFSFGIALWELLTGELPYAG 309
+ D+++ G+ + LL+G P+AG
Sbjct: 228 GFYTDMWAIGVLGYVLLSGLSPFAG 252
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 5e-35
Identities = 49/193 (25%), Positives = 91/193 (47%), Gaps = 11/193 (5%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC 176
GS+G++ A K + K + + K QE+ IM+ + H N+++
Sbjct: 19 RGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFK---QEIEIMKSLDHPNIIRLYETF 75
Query: 177 TRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKT 236
++ +V E G +++ + K VF+ + ++ DV + Y H+ N+ HRDLK
Sbjct: 76 EDNTDIYLVMELCTGGELFERV-VHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKP 134
Query: 237 ANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
N L + +K+ DFG+A +M + GT +++P+V+ Y + D +S
Sbjct: 135 ENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVL-EGLYGPECDEWSA 193
Query: 294 GIALWELLTGELP 306
G+ ++ LL G P
Sbjct: 194 GVMMYVLLCGYPP 206
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 8e-35
Identities = 56/193 (29%), Positives = 103/193 (53%), Gaps = 11/193 (5%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC 176
SG++ +++ + A+K + K L+ E+ +++KI+H+N+V
Sbjct: 19 SGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE---NEIAVLKKIKHENIVTLEDIY 75
Query: 177 TRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKT 236
+ +V + ++ G ++D + ++GV+ V V + YLH+N I+HRDLK
Sbjct: 76 ESTTHYYLVMQLVSGGELFDRI-LERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKP 134
Query: 237 ANLL---MDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
NLL +EN + + DFG+++++ Q+G+M+ GT ++APEV+ KPY D +S
Sbjct: 135 ENLLYLTPEENSKIMITDFGLSKME-QNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSI 193
Query: 294 GIALWELLTGELP 306
G+ + LL G P
Sbjct: 194 GVITYILLCGYPP 206
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 1e-34
Identities = 50/233 (21%), Positives = 97/233 (41%), Gaps = 42/233 (18%)
Query: 120 SGSYGDL-YKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACT 177
GS G + ++G++ + VA+K + + E+ ++ + H NV+++ + T
Sbjct: 25 YGSSGTVVFQGSFQGRPVAVKRMLIDFC-----DIALMEIKLLTESDDHPNVIRYYCSET 79
Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK-------GMNYLHQNNII 230
L I E ++ D + + K V L+ + G+ +LH II
Sbjct: 80 TDRFLYIALELCN-LNLQDLV-ESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKII 137
Query: 231 HRDLKTANLLMD-------------ENGVVKVADFGVARV-----QAQSGVMTAETGTYR 272
HRDLK N+L+ EN + ++DFG+ + + + +GT
Sbjct: 138 HRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSG 197
Query: 273 WMAPEVIE-------HKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAV 317
W APE++E + D+FS G + +L+ G+ P+ ++ +
Sbjct: 198 WRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESNI 250
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 2e-34
Identities = 58/202 (28%), Positives = 95/202 (47%), Gaps = 29/202 (14%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
SG++G + VA+K ++ E ++ +E+ R +RH N+V+F
Sbjct: 30 SGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ---REIINHRSLRHPNIVRFKEVIL 86
Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGVF----------QLTSLLKVAIDVSKGMNYLHQN 227
P +L I+ E+ + G +Y+ + G F QL S G++Y H
Sbjct: 87 TPTHLAIIMEYASGGELYERI-CNAGRFSEDEARFFFQQLLS----------GVSYCHSM 135
Query: 228 NIIHRDLKTANLLMDENGV--VKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYD 285
I HRDLK N L+D + +K+ DFG ++ + GT ++APEV+ + YD
Sbjct: 136 QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYD 195
Query: 286 -YKADVFSFGIALWELLTGELP 306
ADV+S G+ L+ +L G P
Sbjct: 196 GKIADVWSCGVTLYVMLVGAYP 217
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-34
Identities = 49/201 (24%), Positives = 95/201 (47%), Gaps = 16/201 (7%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVLK------PECVNTEMLKEFSQEVYIMRKIRHKNVVQ 171
SG+ G++ ++VAI+++ + E+ I++K+ H +++
Sbjct: 145 SGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIK 204
Query: 172 FIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIH 231
+ IV E M G ++D + + + + + YLH+N IIH
Sbjct: 205 IKNFFD-AEDYYIVLELMEGGELFDKV-VGNKRLKEATCKLYFYQMLLAVQYLHENGIIH 262
Query: 232 RDLKTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE---HKPYD 285
RDLK N+L+ +E+ ++K+ DFG +++ ++ +M GT ++APEV+ Y+
Sbjct: 263 RDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYN 322
Query: 286 YKADVFSFGIALWELLTGELP 306
D +S G+ L+ L+G P
Sbjct: 323 RAVDCWSLGVILFICLSGYPP 343
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 2e-34
Identities = 46/192 (23%), Positives = 93/192 (48%), Gaps = 6/192 (3%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
G++ + + + + E A K++ + ++ ++ +E I RK++H N+V+ +
Sbjct: 39 KGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQ 98
Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 237
+V + + G +++ + + + + + + Y H N I+HR+LK
Sbjct: 99 EESFHYLVFDLVTGGELFEDI-VAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPE 157
Query: 238 NLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 294
NLL+ + VK+ADFG+A S GT +++PEV++ PY D+++ G
Sbjct: 158 NLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACG 217
Query: 295 IALWELLTGELP 306
+ L+ LL G P
Sbjct: 218 VILYILLVGYPP 229
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 126 bits (320), Expect = 2e-34
Identities = 53/218 (24%), Positives = 98/218 (44%), Gaps = 19/218 (8%)
Query: 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVY 159
+ + + +K+L G + + + S QE A K LK + E E+
Sbjct: 27 NNFYILTSKEL------GRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIA 80
Query: 160 IMRKIRH-KNVVQFIGACTRPPNLCIVTEFMARGSIYDFL-HKQKGVF---QLTSLLKVA 214
++ + V+ + ++ E+ A G I+ + + + L+K
Sbjct: 81 VLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIK-- 138
Query: 215 IDVSKGMNYLHQNNIIHRDLKTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTY 271
+ +G+ YLHQNNI+H DLK N+L+ G +K+ DFG++R + + GT
Sbjct: 139 -QILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTP 197
Query: 272 RWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAG 309
++APE++ + P D+++ GI + LLT P+ G
Sbjct: 198 EYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVG 235
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 4e-34
Identities = 51/199 (25%), Positives = 109/199 (54%), Gaps = 23/199 (11%)
Query: 121 GSYGDLYKGTYCS--QEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
G++G + G + +VA+K+L + + + +++ + +E+ ++ RH ++++ +
Sbjct: 27 GTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIS 86
Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGV--------F-QLTSLLKVAIDVSKGMNYLHQNN 228
P ++ +V E+++ G ++D++ K + F Q+ S G++Y H++
Sbjct: 87 TPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS----------GVDYCHRHM 136
Query: 229 IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYD-YK 287
++HRDLK N+L+D + K+ADFG++ + + + G+ + APEVI + Y +
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPE 196
Query: 288 ADVFSFGIALWELLTGELP 306
D++S G+ L+ LL G LP
Sbjct: 197 VDIWSSGVILYALLCGTLP 215
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 5e-34
Identities = 52/202 (25%), Positives = 99/202 (49%), Gaps = 8/202 (3%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNV 169
I ++ +G++G +++ T + A K + P + E ++ +E+ M +RH +
Sbjct: 160 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVR---KEIQTMSVLRHPTL 216
Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
V A + ++ EFM+ G +++ + + ++ V KG+ ++H+NN
Sbjct: 217 VNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNY 276
Query: 230 IHRDLKTANLLM--DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYK 287
+H DLK N++ + +K+ DFG+ + TGT + APEV E KP Y
Sbjct: 277 VHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYY 336
Query: 288 ADVFSFGIALWELLTGELPYAG 309
D++S G+ + LL+G P+ G
Sbjct: 337 TDMWSVGVLSYILLSGLSPFGG 358
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 6e-34
Identities = 53/201 (26%), Positives = 95/201 (47%), Gaps = 16/201 (7%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVL-KPECVNTEML--KEFSQEVYIMRKIRHKNVVQFIG 174
G + + + Q+ A+K++ + ++ L ++ +E I ++H ++V+ +
Sbjct: 34 KGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLE 93
Query: 175 ACTRPPNLCIVTEFMARGSIYDFL-HKQKGVFQLTSLLKVAIDVSK----GMNYLHQNNI 229
+ L +V EFM + + + F + VA + + Y H NNI
Sbjct: 94 TYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSE--AVASHYMRQILEALRYCHDNNI 151
Query: 230 IHRDLKTANLLM---DENGVVKVADFGVAR-VQAQSGVMTAETGTYRWMAPEVIEHKPYD 285
IHRD+K +L+ + + VK+ FGVA + V GT +MAPEV++ +PY
Sbjct: 152 IHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYG 211
Query: 286 YKADVFSFGIALWELLTGELP 306
DV+ G+ L+ LL+G LP
Sbjct: 212 KPVDVWGCGVILFILLSGCLP 232
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 9e-34
Identities = 59/199 (29%), Positives = 106/199 (53%), Gaps = 24/199 (12%)
Query: 121 GSYGDLYKGTYCS--QEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
GS+G + T+ Q+VA+K + + ++M +E+ ++ +RH ++++ T
Sbjct: 20 GSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVIT 79
Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGV--------F-QLTSLLKVAIDVSKGMNYLHQNN 228
P ++ +V E+ A G ++D++ ++K + F Q+ + Y H++
Sbjct: 80 TPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIIC----------AIEYCHRHK 128
Query: 229 IIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYD-YK 287
I+HRDLK NLL+D+N VK+ADFG++ + + G+ + APEVI K Y +
Sbjct: 129 IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPE 188
Query: 288 ADVFSFGIALWELLTGELP 306
DV+S GI L+ +L G LP
Sbjct: 189 VDVWSCGIVLYVMLVGRLP 207
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-33
Identities = 56/210 (26%), Positives = 102/210 (48%), Gaps = 17/210 (8%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLK----PECVNTEMLKEFSQEVYIMRKIRH 166
++ ++ SG + + K +E A K +K +E +EV I+R+IRH
Sbjct: 8 EMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRH 67
Query: 167 KNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVF---QLTSLLKVAIDVSKGMNY 223
N++ ++ ++ E ++ G ++DFL +K + T LK + G++Y
Sbjct: 68 PNIITLHDIFENKTDVVLILELVSGGELFDFL-AEKESLTEDEATQFLK---QILDGVHY 123
Query: 224 LHQNNIIHRDLKTANLLM----DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVI 279
LH I H DLK N+++ N +K+ DFG+A GT ++APE++
Sbjct: 124 LHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIV 183
Query: 280 EHKPYDYKADVFSFGIALWELLTGELPYAG 309
++P +AD++S G+ + LL+G P+ G
Sbjct: 184 NYEPLGLEADMWSIGVITYILLSGASPFLG 213
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-33
Identities = 53/240 (22%), Positives = 93/240 (38%), Gaps = 53/240 (22%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVL---KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174
GSYG + AIK++ K +N + ++ EV +M+K+ H N+ +
Sbjct: 36 QGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYE 95
Query: 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLL----------------------- 211
+C+V E G + D L+ +
Sbjct: 96 VYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIH 155
Query: 212 ----------------KVAIDVSKGMNYLHQNNIIHRDLKTANLLM--DENGVVKVADFG 253
+ + ++YLH I HRD+K N L +++ +K+ DFG
Sbjct: 156 GFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFG 215
Query: 254 VARV-----QAQSGVMTAETGTYRWMAPEVIE--HKPYDYKADVFSFGIALWELLTGELP 306
+++ + MT + GT ++APEV+ ++ Y K D +S G+ L LL G +P
Sbjct: 216 LSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVP 275
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 2e-33
Identities = 53/200 (26%), Positives = 92/200 (46%), Gaps = 11/200 (5%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVLK----PECVNTEMLKEFSQEVYIMRKIRHKNVVQFI 173
SG + + K S E A K +K +E +EV I+R++ H N++
Sbjct: 22 SGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLH 81
Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
++ ++ E ++ G ++DFL QK + G+NYLH I H D
Sbjct: 82 DVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDGVNYLHTKKIAHFD 140
Query: 234 LKTANLLM----DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKAD 289
LK N+++ +K+ DFG+A GT ++APE++ ++P +AD
Sbjct: 141 LKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEAD 200
Query: 290 VFSFGIALWELLTGELPYAG 309
++S G+ + LL+G P+ G
Sbjct: 201 MWSIGVITYILLSGASPFLG 220
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-33
Identities = 54/200 (27%), Positives = 92/200 (46%), Gaps = 11/200 (5%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVLK----PECVNTEMLKEFSQEVYIMRKIRHKNVVQFI 173
SG + + K S E A K +K +E +EV I+R++ H NV+
Sbjct: 22 SGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLH 81
Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
++ ++ E ++ G ++DFL QK + G+NYLH I H D
Sbjct: 82 DVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDGVNYLHTKKIAHFD 140
Query: 234 LKTANLLM----DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKAD 289
LK N+++ +K+ DFG+A GT ++APE++ ++P +AD
Sbjct: 141 LKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEAD 200
Query: 290 VFSFGIALWELLTGELPYAG 309
++S G+ + LL+G P+ G
Sbjct: 201 MWSIGVITYILLSGASPFLG 220
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-33
Identities = 48/198 (24%), Positives = 94/198 (47%), Gaps = 10/198 (5%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
SG++GD++ S E IK + + +++ E+ +++ + H N+++
Sbjct: 32 SGAFGDVHLVEERSSGLERVIKTINKDRSQ-VPMEQIEAEIEVLKSLDHPNIIKIFEVFE 90
Query: 178 RPPNLCIVTEFMARGSIYDFL---HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
N+ IV E G + + + + + ++ + + Y H +++H+DL
Sbjct: 91 DYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDL 150
Query: 235 KTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVF 291
K N+L + +K+ DFG+A + T GT +MAPEV + +K D++
Sbjct: 151 KPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVF-KRDVTFKCDIW 209
Query: 292 SFGIALWELLTGELPYAG 309
S G+ ++ LLTG LP+ G
Sbjct: 210 SAGVVMYFLLTGCLPFTG 227
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 4e-33
Identities = 54/206 (26%), Positives = 101/206 (49%), Gaps = 18/206 (8%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVLK-----------PECVNTEMLKEFSQEVYIMRKIRH 166
SG+YG++ + E AIKV+K + +E E+ +++ + H
Sbjct: 46 SGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDH 105
Query: 167 KNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ 226
N+++ +VTEF G +++ + + F + + G+ YLH+
Sbjct: 106 PNIIKLFDVFEDKKYFYLVTEFYEGGELFEQI-INRHKFDECDAANIMKQILSGICYLHK 164
Query: 227 NNIIHRDLKTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKP 283
+NI+HRD+K N+L+ + +K+ DFG++ ++ + GT ++APEV+ K
Sbjct: 165 HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVL-KKK 223
Query: 284 YDYKADVFSFGIALWELLTGELPYAG 309
Y+ K DV+S G+ ++ LL G P+ G
Sbjct: 224 YNEKCDVWSCGVIMYILLCGYPPFGG 249
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-33
Identities = 42/193 (21%), Positives = 93/193 (48%), Gaps = 7/193 (3%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
G++ + + QE A ++ + ++ ++ +E I R ++H N+V+ + +
Sbjct: 21 KGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSIS 80
Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 237
+ ++ + + G +++ + + + + + + + HQ ++HR+LK
Sbjct: 81 EEGHHYLIFDLVTGGELFEDI-VAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPE 139
Query: 238 NLLM---DENGVVKVADFGVAR-VQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSF 293
NLL+ + VK+ADFG+A V+ + GT +++PEV+ PY D+++
Sbjct: 140 NLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWAC 199
Query: 294 GIALWELLTGELP 306
G+ L+ LL G P
Sbjct: 200 GVILYILLVGYPP 212
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 5e-33
Identities = 51/208 (24%), Positives = 96/208 (46%), Gaps = 17/208 (8%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVLK------PECVNTEMLKEFSQEVYIMRKIRHKNVVQ 171
SG+ G++ ++VAIK++ + E+ I++K+ H +++
Sbjct: 20 SGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIK 79
Query: 172 FIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIH 231
+ IV E M G ++D + + + + + YLH+N IIH
Sbjct: 80 IKNFFD-AEDYYIVLELMEGGELFDKV-VGNKRLKEATCKLYFYQMLLAVQYLHENGIIH 137
Query: 232 RDLKTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE---HKPYD 285
RDLK N+L+ +E+ ++K+ DFG +++ ++ +M GT ++APEV+ Y+
Sbjct: 138 RDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYN 197
Query: 286 YKADVFSFGIALWELLTGELP-YAGLTP 312
D +S G+ L+ L+G P T
Sbjct: 198 RAVDCWSLGVILFICLSGYPPFSEHRTQ 225
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 8e-33
Identities = 54/203 (26%), Positives = 98/203 (48%), Gaps = 17/203 (8%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVL---KPECVNTEMLKE-FSQEVYIMRKIRHKNVVQFI 173
SG + + K S + A K + + + + +E +EV I+++I+H NV+
Sbjct: 21 SGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLH 80
Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVF---QLTSLLKVAIDVSKGMNYLHQNNII 230
++ ++ E +A G ++DFL +K + T LK + G+ YLH I
Sbjct: 81 EVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLK---QILNGVYYLHSLQIA 136
Query: 231 HRDLKTANLLM----DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDY 286
H DLK N+++ +K+ DFG+A GT ++APE++ ++P
Sbjct: 137 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGL 196
Query: 287 KADVFSFGIALWELLTGELPYAG 309
+AD++S G+ + LL+G P+ G
Sbjct: 197 EADMWSIGVITYILLSGASPFLG 219
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 9e-33
Identities = 52/209 (24%), Positives = 93/209 (44%), Gaps = 33/209 (15%)
Query: 121 GSYGDLYKGTYCS--QEVAIKVLKPECVNT--EMLKEFSQEVYIMRKIRHKNVVQF---I 173
GSYG + + A+K+LK + + +E+ ++R++RHKNV+Q +
Sbjct: 16 GSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVL 75
Query: 174 GACTRPPNLCIVTEFMARGS--IYDFLHKQK-------GVF-QLTSLLKVAIDVSKGMNY 223
+ +V E+ G + D + +++ G F QL G+ Y
Sbjct: 76 YNEE-KQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLID----------GLEY 124
Query: 224 LHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ---AQSGVMTAETGTYRWMAPEVIE 280
LH I+H+D+K NLL+ G +K++ GVA A G+ + PE+
Sbjct: 125 LHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIAN 184
Query: 281 -HKPYD-YKADVFSFGIALWELLTGELPY 307
+ +K D++S G+ L+ + TG P+
Sbjct: 185 GLDTFSGFKVDIWSAGVTLYNITTGLYPF 213
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-32
Identities = 52/207 (25%), Positives = 96/207 (46%), Gaps = 31/207 (14%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVLKPECVNT----EMLKEFSQEVYIMRKIRHK--NVVQ 171
SG +G +Y G S VAIK ++ + ++ EV +++K+ V++
Sbjct: 53 SGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIR 112
Query: 172 FIGACTRPPNLCIVTEFMA-RGSIYDFLHKQ--------KGVF-QLTSLLKVAIDVSKGM 221
+ RP + ++ E ++DF+ ++ + F Q+ A+
Sbjct: 113 LLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE----AVR----- 163
Query: 222 NYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE 280
+ H ++HRD+K N+L+D N G +K+ DFG + + V T GT + PE I
Sbjct: 164 -HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL-KDTVYTDFDGTRVYSPPEWIR 221
Query: 281 HKPYD-YKADVFSFGIALWELLTGELP 306
+ Y A V+S GI L++++ G++P
Sbjct: 222 YHRYHGRSAAVWSLGILLYDMVCGDIP 248
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-32
Identities = 49/209 (23%), Positives = 87/209 (41%), Gaps = 33/209 (15%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVLKPECVNT----EMLKEFSQEVYIMRKIR----HKNV 169
G +G ++ G + +VAIKV+ V EV ++ K+ H V
Sbjct: 41 KGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGV 100
Query: 170 VQFIGACTRPPNLCIVTEFMARGS-IYDFLHKQ--------KGVF-QLTSLLKVAIDVSK 219
++ + +V E ++D++ ++ + F Q+ + AI
Sbjct: 101 IRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVA----AIQ--- 153
Query: 220 GMNYLHQNNIIHRDLKTANLLMD-ENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEV 278
+ H ++HRD+K N+L+D G K+ DFG + T GT + PE
Sbjct: 154 ---HCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL-HDEPYTDFDGTRVYSPPEW 209
Query: 279 IEHKPYD-YKADVFSFGIALWELLTGELP 306
I Y A V+S GI L++++ G++P
Sbjct: 210 ISRHQYHALPATVWSLGILLYDMVCGDIP 238
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 2e-32
Identities = 48/198 (24%), Positives = 97/198 (48%), Gaps = 14/198 (7%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC 176
G +G ++K + ++A K++ + E +K E+ +M ++ H N++Q A
Sbjct: 99 GGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVK---NEISVMNQLDHANLIQLYDAF 155
Query: 177 TRPPNLCIVTEFMARGSIYDFLHKQKGVF---QLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
++ +V E++ G ++D + + +K + +G+ ++HQ I+H D
Sbjct: 156 ESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMK---QICEGIRHMHQMYILHLD 212
Query: 234 LKTANLLM--DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVF 291
LK N+L + +K+ DFG+AR + GT ++APEV+ + + D++
Sbjct: 213 LKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMW 272
Query: 292 SFGIALWELLTGELPYAG 309
S G+ + LL+G P+ G
Sbjct: 273 SVGVIAYMLLSGLSPFLG 290
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 3e-32
Identities = 50/189 (26%), Positives = 97/189 (51%), Gaps = 10/189 (5%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177
G+ +Y+ + A+KVLK + V+ ++++ E+ ++ ++ H N+++
Sbjct: 63 RGATSIVYRCKQKGTQKPYALKVLK-KTVDKKIVR---TEIGVLLRLSHPNIIKLKEIFE 118
Query: 178 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 237
P + +V E + G ++D + +KG + + + + YLH+N I+HRDLK
Sbjct: 119 TPTEISLVLELVTGGELFDRI-VEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPE 177
Query: 238 NLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFG 294
NLL + +K+ADFG++++ +M GT + APE++ Y + D++S G
Sbjct: 178 NLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVG 237
Query: 295 IALWELLTG 303
I + LL G
Sbjct: 238 IITYILLCG 246
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 4e-32
Identities = 47/202 (23%), Positives = 101/202 (50%), Gaps = 16/202 (7%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVLK------PECVNTEMLKEFSQEVYIMRKIR-HKNVV 170
G + + + + E A+K+++ E+ + +E +I+R++ H +++
Sbjct: 104 RGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHII 163
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 230
I + + +V + M +G ++D+L +K + + + +++LH NNI+
Sbjct: 164 TLIDSYESSSFMFLVFDLMRKGELFDYL-TEKVALSEKETRSIMRSLLEAVSFLHANNIV 222
Query: 231 HRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE------HKPY 284
HRDLK N+L+D+N ++++DFG + + GT ++APE+++ H Y
Sbjct: 223 HRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGY 282
Query: 285 DYKADVFSFGIALWELLTGELP 306
+ D+++ G+ L+ LL G P
Sbjct: 283 GKEVDLWACGVILFTLLAGSPP 304
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 121 bits (304), Expect = 9e-32
Identities = 28/239 (11%), Positives = 72/239 (30%), Gaps = 49/239 (20%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIR----------- 165
+ T + + V E + +K+ +EV +R +R
Sbjct: 83 QEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVH 142
Query: 166 --------------HKNVVQFIGACTRPPNLCIVTEFM-ARGSIYDFLH------KQKGV 204
K +++ L + + ++ F
Sbjct: 143 LRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKS 202
Query: 205 FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM 264
+ L++ + V + + LH ++H L+ ++++D+ G V + F + G
Sbjct: 203 LVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV---RDGAR 259
Query: 265 TAETGTYRWMAPEVI-----------EHKPYDYKADVFSFGIALWELLTGELPYAGLTP 312
+ + + PE+ + D ++ G+ ++ + +LP
Sbjct: 260 VVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAA 318
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 9e-32
Identities = 46/200 (23%), Positives = 95/200 (47%), Gaps = 19/200 (9%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGAC 176
GS+ K + Q A+K ++ M +E+ ++ H N+V+
Sbjct: 21 EGSFSICRKCVHKKSNQAFAVK-----IISKRMEANTQKEITALKLCEGHPNIVKLHEVF 75
Query: 177 TRPPNLCIVTEFMARGSIYDFLHKQKGVF---QLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
+ +V E + G +++ + K+K F + + +++ + ++++H ++HRD
Sbjct: 76 HDQLHTFLVMELLNGGELFERI-KKKKHFSETEASYIMR---KLVSAVSHMHDVGVVHRD 131
Query: 234 LKTANLLM---DENGVVKVADFGVAR-VQAQSGVMTAETGTYRWMAPEVIEHKPYDYKAD 289
LK NLL ++N +K+ DFG AR + + T + APE++ YD D
Sbjct: 132 LKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCD 191
Query: 290 VFSFGIALWELLTGELPYAG 309
++S G+ L+ +L+G++P+
Sbjct: 192 LWSLGVILYTMLSGQVPFQS 211
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-31
Identities = 53/203 (26%), Positives = 98/203 (48%), Gaps = 17/203 (8%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVL---KPECVNTEMLKE----FSQEVYIMRKI-RHKNV 169
G + + + +E A+K++ + E ++E +EV I+RK+ H N+
Sbjct: 27 RGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNI 86
Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
+Q +V + M +G ++D+L +K K+ + + + LH+ NI
Sbjct: 87 IQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKIMRALLEVICALHKLNI 145
Query: 230 IHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE------HKP 283
+HRDLK N+L+D++ +K+ DFG + + GT ++APE+IE H
Sbjct: 146 VHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPG 205
Query: 284 YDYKADVFSFGIALWELLTGELP 306
Y + D++S G+ ++ LL G P
Sbjct: 206 YGKEVDMWSTGVIMYTLLAGSPP 228
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 5e-31
Identities = 51/195 (26%), Positives = 85/195 (43%), Gaps = 7/195 (3%)
Query: 122 SYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN 181
+G+L S+ K + K++ + + K R ++ + +
Sbjct: 110 KFGNLST-YLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFV 168
Query: 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM 241
+ + L+K L L+ + V+KGM +L IHRDL N+L+
Sbjct: 169 EEKSLSDVEEEEAPEDLYK--DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILL 226
Query: 242 DENGVVKVADFGVARVQAQSGVMTAETGT---YRWMAPEVIEHKPYDYKADVFSFGIALW 298
E VVK+ DFG+AR + + +WMAPE I + Y ++DV+SFG+ LW
Sbjct: 227 SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLW 286
Query: 299 ELLT-GELPYAGLTP 312
E+ + G PY G+
Sbjct: 287 EIFSLGASPYPGVKI 301
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 89.2 bits (221), Expect = 3e-20
Identities = 39/151 (25%), Positives = 67/151 (44%), Gaps = 16/151 (10%)
Query: 94 CIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECV 146
C +P D WE +LK+ + G++G + + + VA+K+LK
Sbjct: 7 CERLPYD-ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT 65
Query: 147 NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPN-LCIVTEFMARGSIYDFLHKQKGV 204
++E + E+ I+ I H NVV +GACT+P L ++ EF G++ +L ++
Sbjct: 66 HSEH-RALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNE 124
Query: 205 FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 235
F +G +Y+ I DLK
Sbjct: 125 FVPYKTKGA--RFRQGKDYV---GAIPVDLK 150
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 9e-31
Identities = 40/208 (19%), Positives = 78/208 (37%), Gaps = 17/208 (8%)
Query: 113 KIECKVASGSYGDLYKGT---YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNV 169
+++ +A G G +Y + V +K L + E E + ++ H ++
Sbjct: 83 EVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS-GDAEAQAMAMAERQFLAEVVHPSI 141
Query: 170 VQFI-----GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 224
VQ P IV E++ S+ + + +++ ++YL
Sbjct: 142 VQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK---GQKLPVAEAIAYLLEILPALSYL 198
Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPY 284
H +++ DLK N+++ E +K+ D G G + GT + APE++ P
Sbjct: 199 HSIGLVYNDLKPENIMLTEEQ-LKLIDLGAVSRINSFGYL---YGTPGFQAPEIVRTGPT 254
Query: 285 DYKADVFSFGIALWELLTGELPYAGLTP 312
D+++ G L L G
Sbjct: 255 V-ATDIYTVGRTLAALTLDLPTRNGRYV 281
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 1e-30
Identities = 61/199 (30%), Positives = 99/199 (49%), Gaps = 12/199 (6%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQ-EVYIMRKIRHKNV 169
+ V GSYG + K + VAIK + +M+K+ + E+ +++++RH+N+
Sbjct: 29 NLG-LVGEGSYGMVMKCRNKDTGRIVAIKKFLES-DDDKMVKKIAMREIKLLKQLRHENL 86
Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
V + C + +V EF+ +I D L + K + G+ + H +NI
Sbjct: 87 VNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNI 145
Query: 230 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGT--YRWMAPEVI-EHKPYD 285
IHRD+K N+L+ ++GVVK+ DFG AR A V E T YR APE++ Y
Sbjct: 146 IHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYR--APELLVGDVKYG 203
Query: 286 YKADVFSFGIALWELLTGE 304
DV++ G + E+ GE
Sbjct: 204 KAVDVWAIGCLVTEMFMGE 222
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 3e-30
Identities = 28/247 (11%), Positives = 78/247 (31%), Gaps = 44/247 (17%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIR----------- 165
+ T + + V E + +K+ +EV +R +R
Sbjct: 88 QEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVH 147
Query: 166 -----------HKNVVQFIGACTRPPNLCIVTEFM----ARGSIYDFLH------KQKGV 204
+ I ++ +++ F + ++ F
Sbjct: 148 LRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKS 207
Query: 205 FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM 264
+ L++ + V + + LH ++H L+ ++++D+ G V + F + +
Sbjct: 208 LVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR-DGASAV 266
Query: 265 TAETGTY---RWMAPEVIEHKP-----YDYKADVFSFGIALWELLTGELPYAGLTPLQAA 316
+ + A ++ + D ++ G+A++ + +LP L +
Sbjct: 267 SPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGS 326
Query: 317 VGVVQKV 323
+ +
Sbjct: 327 EWIFRSC 333
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 8e-30
Identities = 51/219 (23%), Positives = 99/219 (45%), Gaps = 27/219 (12%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGAC 176
G G + + + Q+ A+K+L + QEV + ++V +
Sbjct: 39 LGVNGKVLECFHRRTGQKCALKLLYDS-------PKARQEVDHHWQASGGPHIVCILDVY 91
Query: 177 ----TRPPNLCIVTEFMARGSIYDFLHKQKGVFQLT-----SLLKVAIDVSKGMNYLHQN 227
L I+ E M G ++ + + +G T +++ D+ + +LH +
Sbjct: 92 ENMHHGKRCLLIIMECMEGGELFSRIQE-RGDQAFTEREAAEIMR---DIGTAIQFLHSH 147
Query: 228 NIIHRDLKTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPY 284
NI HRD+K NLL +++ V+K+ DFG A+ + + T ++APEV+ + Y
Sbjct: 148 NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK-ETTQNALQTPCYTPYYVAPEVLGPEKY 206
Query: 285 DYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKV 323
D D++S G+ ++ LL G P+ T + G+ +++
Sbjct: 207 DKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRI 245
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-29
Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 25/205 (12%)
Query: 113 KIECKVASGSYGDLYKGTYCSQE-VAIKVLKPECVNTEMLKE---FS--QEVYIMRKIRH 166
+E K+ G+YG +YK E A+K ++ E E + +E+ I+++++H
Sbjct: 6 GLE-KIGEGTYGVVYKAQNNYGETFALKKIR-----LEKEDEGIPSTTIREISILKELKH 59
Query: 167 KNVVQFIGACTRPPNLCIVTEFMARGSIYD---FLHKQKGVFQLTSLLKVAIDVSKGMNY 223
N+V+ L +V E + D L +G + + + + G+ Y
Sbjct: 60 SNIVKLYDVIHTKKRLVLVFEHLD----QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAY 115
Query: 224 LHQNNIIHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGT--YRWMAPEVI- 279
H ++HRDLK NLL++ G +K+ADFG+AR T E T YR AP+V+
Sbjct: 116 CHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYR--APDVLM 173
Query: 280 EHKPYDYKADVFSFGIALWELLTGE 304
K Y D++S G E++ G
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 2e-29
Identities = 52/201 (25%), Positives = 103/201 (51%), Gaps = 21/201 (10%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRK-IRHKNVVQFIGAC 176
GSY + + + E A+K ++ ++E+ I+ + +H N++
Sbjct: 32 VGSYSVCKRCIHKATNMEFAVK-----IIDKSKRDP-TEEIEILLRYGQHPNIITLKDVY 85
Query: 177 TRPPNLCIVTEFMARGSIYDFLHKQKGVF---QLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
+ +VTE M G + D + + + F + +++L ++K + YLH ++HRD
Sbjct: 86 DDGKYVYVVTELMKGGELLDKILR-QKFFSEREASAVLF---TITKTVEYLHAQGVVHRD 141
Query: 234 LKTANLLM----DENGVVKVADFGVAR-VQAQSGVMTAETGTYRWMAPEVIEHKPYDYKA 288
LK +N+L +++ DFG A+ ++A++G++ T ++APEV+E + YD
Sbjct: 142 LKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAAC 201
Query: 289 DVFSFGIALWELLTGELPYAG 309
D++S G+ L+ +LTG P+A
Sbjct: 202 DIWSLGVLLYTMLTGYTPFAN 222
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 3e-29
Identities = 63/205 (30%), Positives = 102/205 (49%), Gaps = 25/205 (12%)
Query: 113 KIECKVASGSYGDLYKGTYCSQE-VAIKVLKPECVNTEMLKE---FS--QEVYIMRKIRH 166
K+E KV G+YG +YK VA+K ++ + E + +E+ +++++ H
Sbjct: 25 KLE-KVGEGTYGVVYKAKDSQGRIVALKRIR-----LDAEDEGIPSTAIREISLLKELHH 78
Query: 167 KNVVQFIGACTRPPNLCIVTEFMARGSIYD---FLHKQKGVFQLTSLLKVAIDVSKGMNY 223
N+V I L +V EFM D L + K Q + + + +G+ +
Sbjct: 79 PNIVSLIDVIHSERCLTLVFEFME----KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAH 134
Query: 224 LHQNNIIHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGT--YRWMAPEVI- 279
HQ+ I+HRDLK NLL++ +G +K+ADFG+AR T E T YR AP+V+
Sbjct: 135 CHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYR--APDVLM 192
Query: 280 EHKPYDYKADVFSFGIALWELLTGE 304
K Y D++S G E++TG+
Sbjct: 193 GSKKYSTSVDIWSIGCIFAEMITGK 217
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 5e-29
Identities = 50/184 (27%), Positives = 88/184 (47%), Gaps = 23/184 (12%)
Query: 137 AIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY 195
A+K + K +CV ++ +E+ IM+ + H +V + ++ +V + + G +
Sbjct: 44 AMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDL- 102
Query: 196 DFLH-KQKGVFQLTSLLKVAIDVSK--------GMNYLHQNNIIHRDLKTANLLMDENGV 246
H +Q F+ + K ++YL IIHRD+K N+L+DE+G
Sbjct: 103 -RYHLQQNVHFK--------EETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGH 153
Query: 247 VKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKP---YDYKADVFSFGIALWELLTG 303
V + DF +A + + +T GT +MAPE+ + Y + D +S G+ +ELL G
Sbjct: 154 VHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRG 213
Query: 304 ELPY 307
PY
Sbjct: 214 RRPY 217
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 5e-29
Identities = 55/199 (27%), Positives = 99/199 (49%), Gaps = 12/199 (6%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQ-EVYIMRKIRHKNV 169
KI K+ GSYG ++K Q VAIK + ++K+ + E+ ++++++H N+
Sbjct: 7 KIG-KIGEGSYGVVFKCRNRDTGQIVAIKKFLES-EDDPVIKKIALREIRMLKQLKHPNL 64
Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
V + R L +V E+ ++ L + + + + + +N+ H++N
Sbjct: 65 VNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNC 123
Query: 230 IHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGT--YRWMAPEVIEH-KPYD 285
IHRD+K N+L+ ++ V+K+ DFG AR+ S E T YR +PE++ Y
Sbjct: 124 IHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYR--SPELLVGDTQYG 181
Query: 286 YKADVFSFGIALWELLTGE 304
DV++ G ELL+G
Sbjct: 182 PPVDVWAIGCVFAELLSGV 200
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 9e-29
Identities = 58/209 (27%), Positives = 97/209 (46%), Gaps = 26/209 (12%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKE---FS--QEVYIMRKIR 165
K+E K+ G+YG ++K + VA+K ++ + E S +E+ ++++++
Sbjct: 6 KLE-KIGEGTYGTVFKAKNRETHEIVALKRVR-----LDDDDEGVPSSALREICLLKELK 59
Query: 166 HKNVVQFIGACTRPPNLCIVTEFMARGSIYD---FLHKQKGVFQLTSLLKVAIDVSKGMN 222
HKN+V+ L +V EF D + G + + KG+
Sbjct: 60 HKNIVRLHDVLHSDKKLTLVFEFCD----QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLG 115
Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGT--YRWMAPEVI 279
+ H N++HRDLK NLL++ NG +K+A+FG+AR +AE T YR P+V+
Sbjct: 116 FCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYR--PPDVL 173
Query: 280 -EHKPYDYKADVFSFGIALWELLTGELPY 307
K Y D++S G EL P
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPL 202
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-28
Identities = 59/212 (27%), Positives = 103/212 (48%), Gaps = 35/212 (16%)
Query: 113 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKE---FS--QEVYIMRKIR 165
K++ + G + +YK +Q VAIK +K + K+ + +E+ +++++
Sbjct: 14 KLD-FLGEGQFATVYKARDKNTNQIVAIKKIKLG--HRSEAKDGINRTALREIKLLQELS 70
Query: 166 HKNVVQFIGACTRPPNLCIVTEFM---------ARGSIYDFLHKQKGVFQLTSLLKVAID 216
H N++ + A N+ +V +FM + H + +
Sbjct: 71 HPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTL-------- 122
Query: 217 VSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGT--YRW 273
+G+ YLHQ+ I+HRDLK NLL+DENGV+K+ADFG+A+ + + T + T YR
Sbjct: 123 --QGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYR- 179
Query: 274 MAPEVIEH-KPYDYKADVFSFGIALWELLTGE 304
APE++ + Y D+++ G L ELL
Sbjct: 180 -APELLFGARMYGVGVDMWAVGCILAELLLRV 210
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-28
Identities = 51/220 (23%), Positives = 95/220 (43%), Gaps = 28/220 (12%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVL-KPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGA 175
G G + + ++ A+K+L +EV + + + ++V+ +
Sbjct: 72 LGINGKVLQIFNKRTQEKFALKMLQDCPKA--------RREVELHWRASQCPHIVRIVDV 123
Query: 176 C----TRPPNLCIVTEFMARGSIYDFLHKQKGVFQLT-----SLLKVAIDVSKGMNYLHQ 226
L IV E + G ++ + +G T ++K + + + YLH
Sbjct: 124 YENLYAGRKCLLIVMECLDGGELFSRIQ-DRGDQAFTEREASEIMK---SIGEAIQYLHS 179
Query: 227 NNIIHRDLKTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKP 283
NI HRD+K NLL N ++K+ DFG A+ +T T ++APEV+ +
Sbjct: 180 INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEK 239
Query: 284 YDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKV 323
YD D++S G+ ++ LL G P+ L + G+ ++
Sbjct: 240 YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI 279
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-28
Identities = 55/210 (26%), Positives = 99/210 (47%), Gaps = 35/210 (16%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPEC---VNTEMLKEFSQEVYIMRKIRHK 167
K++ K+ G+Y +YKG VA+K ++ E ++E S +++ ++H
Sbjct: 6 KLD-KLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVS----LLKDLKHA 60
Query: 168 NVVQFIGACTRPPNLCIVTEFM---------ARGSIYDFLHKQKGVFQLTSLLKVAIDVS 218
N+V +L +V E++ G+I + + + +FQL
Sbjct: 61 NIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLL---------- 110
Query: 219 KGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGT--YRWMA 275
+G+ Y H+ ++HRDLK NLL++E G +K+ADFG+AR + E T YR
Sbjct: 111 RGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYR--P 168
Query: 276 PEVI-EHKPYDYKADVFSFGIALWELLTGE 304
P+++ Y + D++ G +E+ TG
Sbjct: 169 PDILLGSTDYSTQIDMWGVGCIFYEMATGR 198
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-28
Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 24/210 (11%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGA 175
G++ + QE A+K++ K + +EV ++ + + H+NV++ I
Sbjct: 23 EGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVF---REVEMLYQCQGHRNVLELIEF 79
Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 235
+V E M GSI +HK + F V DV+ +++LH I HRDLK
Sbjct: 80 FEEEDRFYLVFEKMRGGSILSHIHK-RRHFNELEASVVVQDVASALDFLHNKGIAHRDLK 138
Query: 236 TANLLM---DENGVVKVADFGVARV--------QAQSGVMTAETGTYRWMAPEVIE---- 280
N+L ++ VK+ DF + + + G+ +MAPEV+E
Sbjct: 139 PENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSE 198
Query: 281 -HKPYDYKADVFSFGIALWELLTGELPYAG 309
YD + D++S G+ L+ LL+G P+ G
Sbjct: 199 EASIYDKRCDLWSLGVILYILLSGYPPFVG 228
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-28
Identities = 48/210 (22%), Positives = 92/210 (43%), Gaps = 27/210 (12%)
Query: 121 GSYGDLY----KGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
GS+ + T S+E AIK+L K + + ++E +M ++ H V+
Sbjct: 41 GSFSTVVLARELAT--SREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFT 98
Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK--------GMNYLHQN 227
L + G + ++ K G F ++ + YLH
Sbjct: 99 FQDDEKLYFGLSYAKNGELLKYIRKI-GSFD--------ETCTRFYTAEIVSALEYLHGK 149
Query: 228 NIIHRDLKTANLLMDENGVVKVADFGVA-RVQAQSGVMTAET--GTYRWMAPEVIEHKPY 284
IIHRDLK N+L++E+ +++ DFG A + +S A + GT ++++PE++ K
Sbjct: 150 GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSA 209
Query: 285 DYKADVFSFGIALWELLTGELPYAGLTPLQ 314
+D+++ G +++L+ G P+
Sbjct: 210 CKSSDLWALGCIIYQLVAGLPPFRAGNEYL 239
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 4e-28
Identities = 59/235 (25%), Positives = 101/235 (42%), Gaps = 46/235 (19%)
Query: 95 IEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKE 153
+ +DG + + + + +GS+G +++ S EVAIK + + K
Sbjct: 26 KVLASDGKTGEQREIAYTNCK-VIGNGSFGVVFQAKLVESDEVAIKKVLQD-------KR 77
Query: 154 F-SQEVYIMRKIRHKNVVQFIGACTRPPN-------LCIVTEFM------------ARGS 193
F ++E+ IMR ++H NVV + A L +V E++
Sbjct: 78 FKNRELQIMRIVKHPNVVD-LKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQ 136
Query: 194 IYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN-GVVKVADF 252
L + ++QL + + Y+H I HRD+K NLL+D GV+K+ DF
Sbjct: 137 TMPMLLIKLYMYQLL----------RSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDF 186
Query: 253 GVARVQAQSGVMTAE--TGTYRWMAPEVI-EHKPYDYKADVFSFGIALWELLTGE 304
G A++ + + YR APE+I Y D++S G + EL+ G+
Sbjct: 187 GSAKILIAGEPNVSYICSRYYR--APELIFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 4e-28
Identities = 45/234 (19%), Positives = 88/234 (37%), Gaps = 52/234 (22%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKGTYCS------QEVAIKVLKPECVNTEMLKEFSQ- 156
+ + + ++ ++SGSYG C+ VAIK + + + S
Sbjct: 17 LHAMQSPY-TVQRFISSGSYG-----AVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDS 70
Query: 157 --------EVYIMRKIRHKNVVQFIGACTRPPNLC------IVTEFM---------ARGS 193
E+ ++ H N++ + +VTE M +
Sbjct: 71 FLCKRVLREIRLLNHFHHPNILG-LRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRI 129
Query: 194 IYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFG 253
+ H Q ++ + G++ LH+ ++HRDL N+L+ +N + + DF
Sbjct: 130 VISPQHIQYFMYHIL----------LGLHVLHEAGVVHRDLHPGNILLADNNDITICDFN 179
Query: 254 VARVQAQSGVMTAETGT--YRWMAPEVI-EHKPYDYKADVFSFGIALWELLTGE 304
+AR T YR APE++ + K + D++S G + E+ +
Sbjct: 180 LAREDTADANKTHYVTHRWYR--APELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 6e-28
Identities = 54/240 (22%), Positives = 100/240 (41%), Gaps = 43/240 (17%)
Query: 95 IEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKG----TYCSQEVAIKVLKPECVNTEM 150
++ D CKV G+YG +YK ++ A+K ++ ++
Sbjct: 7 FKVKLSSERERVED-LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSA 65
Query: 151 LKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI--VTEFMARGSIYD---FLHKQKGVF 205
+E + ++R+++H NV+ + + + ++ +D + +
Sbjct: 66 CRE----IALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE----HDLWHIIKFHRASK 117
Query: 206 QLTSLLKVAIDVSK--------GMNYLHQNNIIHRDLKTANLLM----DENGVVKVADFG 253
+++ + K G++YLH N ++HRDLK AN+L+ E G VK+AD G
Sbjct: 118 ANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMG 177
Query: 254 VARV-QAQSGVMTAETGT-----YRWMAPEVI---EHKPYDYKADVFSFGIALWELLTGE 304
AR+ + + YR APE++ H Y D+++ G ELLT E
Sbjct: 178 FARLFNSPLKPLADLDPVVVTFWYR--APELLLGARH--YTKAIDIWAIGCIFAELLTSE 233
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 2e-27
Identities = 42/217 (19%), Positives = 93/217 (42%), Gaps = 31/217 (14%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIM 161
W + K+ G Y ++++ + ++V +K+LKP K+ +E+ I+
Sbjct: 31 EWGNQDDYQLVR-KLGRGKYSEVFEAINITNNEKVVVKILKPV-----KKKKIKREIKIL 84
Query: 162 RKIR-HKNVVQFIGACTRPPNLC---IVTEFMAR--GSIYDFL---HKQKGVFQLTSLLK 212
+R N++ P + + +Y L + ++++
Sbjct: 85 ENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEIL---- 140
Query: 213 VAIDVSKGMNYLHQNNIIHRDLKTANLLMD-ENGVVKVADFGVARVQAQSGVMTAETGTY 271
K ++Y H I+HRD+K N+++D E+ +++ D+G+A +
Sbjct: 141 ------KALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVAS- 193
Query: 272 RWM-APEVI-EHKPYDYKADVFSFGIALWELLTGELP 306
R+ PE++ +++ YDY D++S G L ++ + P
Sbjct: 194 RYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEP 230
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-27
Identities = 58/205 (28%), Positives = 106/205 (51%), Gaps = 20/205 (9%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPEC---VNTEMLKEFSQEVYIMRKIRHK 167
++E K+ +G+Y +YKG + VA+K +K + + ++E S +M++++H+
Sbjct: 9 QLE-KLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREIS----LMKELKHE 63
Query: 168 NVVQFIGACTRPPNLCIVTEFMA---RGSIYDFLHKQKGVFQLTSLLK-VAIDVSKGMNY 223
N+V+ L +V EFM + + +L+K + +G+ +
Sbjct: 64 NIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123
Query: 224 LHQNNIIHRDLKTANLLMDENGVVKVADFGVARV-QAQSGVMTAETGT--YRWMAPEVI- 279
H+N I+HRDLK NLL+++ G +K+ DFG+AR ++E T YR AP+V+
Sbjct: 124 CHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYR--APDVLM 181
Query: 280 EHKPYDYKADVFSFGIALWELLTGE 304
+ Y D++S G L E++TG+
Sbjct: 182 GSRTYSTSIDIWSCGCILAEMITGK 206
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 7e-27
Identities = 56/202 (27%), Positives = 99/202 (49%), Gaps = 23/202 (11%)
Query: 121 GSYGDLY----KGTYCSQEVAIKVLKPECV----NTEMLKEFSQEVYIMRKIRHKNVVQF 172
G +G+++ K T + A K L + + + E I+ K+ + +V
Sbjct: 196 GGFGEVFACQMKAT--GKLYACKKLNKKRLKKRKGYQGAM---VEKKILAKVHSRFIVSL 250
Query: 173 IGACTRPPNLCIVTEFMARGSIYDFLH-----KQKGVFQLTSLLKVAIDVSKGMNYLHQN 227
A +LC+V M G I H + FQ + + G+ +LHQ
Sbjct: 251 AYAFETKTDLCLVMTIMNGGDI--RYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR 308
Query: 228 NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYD 285
NII+RDLK N+L+D++G V+++D G+A V+ ++G + GT +MAPE++ + YD
Sbjct: 309 NIIYRDLKPENVLLDDDGNVRISDLGLA-VELKAGQTKTKGYAGTPGFMAPELLLGEEYD 367
Query: 286 YKADVFSFGIALWELLTGELPY 307
+ D F+ G+ L+E++ P+
Sbjct: 368 FSVDYFALGVTLYEMIAARGPF 389
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 9e-27
Identities = 61/218 (27%), Positives = 106/218 (48%), Gaps = 38/218 (17%)
Query: 113 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKE-F----SQEVYIMRKIR 165
K+ K+ G++G+++K Q+VA+K + E KE F +E+ I++ ++
Sbjct: 21 KLA-KIGQGTFGEVFKARHRKTGQKVALKKVL-----MENEKEGFPITALREIKILQLLK 74
Query: 166 HKNVVQFIGACT--------RPPNLCIVTEFMARGSIYD---FLHKQKGVFQLTSLLKVA 214
H+NVV I C ++ +V +F +D L F L+ + +V
Sbjct: 75 HENVVNLIEICRTKASPYNRCKGSIYLVFDFCE----HDLAGLLSNVLVKFTLSEIKRVM 130
Query: 215 IDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR-----VQAQSGVMTAETG 269
+ G+ Y+H+N I+HRD+K AN+L+ +GV+K+ADFG+AR +Q T
Sbjct: 131 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 190
Query: 270 T--YRWMAPEVI-EHKPYDYKADVFSFGIALWELLTGE 304
T YR PE++ + Y D++ G + E+ T
Sbjct: 191 TLWYR--PPELLLGERDYGPPIDLWGAGCIMAEMWTRS 226
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 1e-26
Identities = 54/218 (24%), Positives = 93/218 (42%), Gaps = 31/218 (14%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
+ + + + + SG+ G + + VAIK L N K +E+ +M
Sbjct: 57 TFTVLKR-YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLM 115
Query: 162 RKIRHKNVVQFIGACTRPPNLC------IVTEFMA-------RGSIYDFLHKQKGVFQLT 208
+ + HKN++ + T L +V E M + + ++Q+
Sbjct: 116 KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDH-ERMSYLLYQML 174
Query: 209 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET 268
G+ +LH IIHRDLK +N+++ + +K+ DFG+AR S +MT
Sbjct: 175 ----------CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV 224
Query: 269 GT--YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGE 304
T YR APEVI Y D++S G + E++ +
Sbjct: 225 VTRYYR--APEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-26
Identities = 64/218 (29%), Positives = 98/218 (44%), Gaps = 31/218 (14%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
WE+ A ++ V SG+YG + +VAIK L + K +E+ ++
Sbjct: 20 AWEVRAVYRDLQ-PVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLL 78
Query: 162 RKIRHKNVVQFIGACTRPPNLC------IVTEFMA-------RGSIYDFLHKQKGVFQLT 208
+ +RH+NV+ + T L +V FM + Q V+Q+
Sbjct: 79 KHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQML 138
Query: 209 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET 268
KG+ Y+H IIHRDLK NL ++E+ +K+ DFG+AR MT
Sbjct: 139 ----------KGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE--MTGYV 186
Query: 269 GTYRWM-APEVI-EHKPYDYKADVFSFGIALWELLTGE 304
T RW APEVI Y D++S G + E++TG+
Sbjct: 187 VT-RWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 52/202 (25%), Positives = 95/202 (47%), Gaps = 22/202 (10%)
Query: 121 GSYGDLY----KGTYCSQEVAIKVLKPECV----NTEMLKEFSQEVYIMRKIRHKNVVQF 172
G +G++ + T + A K L+ + + M E I+ K+ + VV
Sbjct: 195 GGFGEVCACQVRAT--GKMYACKKLEKKRIKKRKGEAMAL---NEKQILEKVNSRFVVSL 249
Query: 173 IGACTRPPNLCIVTEFMARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
A LC+V M G + H + F + A ++ G+ LH+ I
Sbjct: 250 AYAYETKDALCLVLTLMNGGDL--KFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERI 307
Query: 230 IHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYDYK 287
++RDLK N+L+D++G ++++D G+A V G GT +MAPEV++++ Y +
Sbjct: 308 VYRDLKPENILLDDHGHIRISDLGLA-VHVPEGQTIK-GRVGTVGYMAPEVVKNERYTFS 365
Query: 288 ADVFSFGIALWELLTGELPYAG 309
D ++ G L+E++ G+ P+
Sbjct: 366 PDWWALGCLLYEMIAGQSPFQQ 387
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 1e-26
Identities = 52/181 (28%), Positives = 90/181 (49%), Gaps = 8/181 (4%)
Query: 137 AIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY 195
A+K+L K + V + ++ E I++ + +V+ + NL +V E++A G ++
Sbjct: 70 AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF 129
Query: 196 DFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA 255
L + G F A + YLH ++I+RDLK NLL+D+ G ++V DFG A
Sbjct: 130 SHLRRI-GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 256 RVQAQSGVMTAET--GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPL 313
+ T GT +APE+I K Y+ D ++ G+ ++E+ G P+ P+
Sbjct: 189 KRVKG----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI 244
Query: 314 Q 314
Q
Sbjct: 245 Q 245
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-26
Identities = 51/205 (24%), Positives = 95/205 (46%), Gaps = 26/205 (12%)
Query: 121 GSYGDLY----KGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
G++G++ K + A+K+L K E + F +E ++ K + A
Sbjct: 85 GAFGEVAVVKLKNA--DKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYA 142
Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQL------TSLLKVAIDVSKGMNYLHQNNI 229
NL +V ++ G + L K + + + +AID +HQ +
Sbjct: 143 FQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAID------SVHQLHY 196
Query: 230 IHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKP---- 283
+HRD+K N+LMD NG +++ADFG + G + + GT +++PE+++
Sbjct: 197 VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKG 256
Query: 284 -YDYKADVFSFGIALWELLTGELPY 307
Y + D +S G+ ++E+L GE P+
Sbjct: 257 RYGPECDWWSLGVCMYEMLYGETPF 281
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-26
Identities = 55/217 (25%), Positives = 95/217 (43%), Gaps = 29/217 (13%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
+ + + ++ + SG+ G + + VAIK L N K +E+ +M
Sbjct: 20 TFTVLKRYQNLK-PIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLM 78
Query: 162 RKIRHKNVVQFIGACTRPPNLC------IVTEFMA-------RGSIYDFLHKQKGVFQLT 208
+ + HKN++ + T +L IV E M + + ++Q+
Sbjct: 79 KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDH-ERMSYLLYQML 137
Query: 209 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET 268
G+ +LH IIHRDLK +N+++ + +K+ DFG+AR S +MT
Sbjct: 138 ----------CGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV 187
Query: 269 GTYRWM-APEVIEHKPYDYKADVFSFGIALWELLTGE 304
T R+ APEVI Y D++S G + E++ G
Sbjct: 188 VT-RYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-26
Identities = 57/212 (26%), Positives = 95/212 (44%), Gaps = 28/212 (13%)
Query: 113 KIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQ----EVYIMRKIR- 165
+ ++ G+YG +YK + VA+K ++ EV ++R++
Sbjct: 13 PVA-EIGVGAYGTVYKARDPHSGHFVALKSVRVP-NGGGGGGGLPISTVREVALLRRLEA 70
Query: 166 --HKNVVQFIGACT-----RPPNLCIVTEFMARGSIYD---FLHKQKGVFQLTSLLK-VA 214
H NVV+ + C R + +V E + D +L K +K +
Sbjct: 71 FEHPNVVRLMDVCATSRTDREIKVTLVFEHVD----QDLRTYLDKAPPPGLPAETIKDLM 126
Query: 215 IDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGT--YR 272
+G+++LH N I+HRDLK N+L+ G VK+ADFG+AR+ + +T T YR
Sbjct: 127 RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYR 186
Query: 273 WMAPEVIEHKPYDYKADVFSFGIALWELLTGE 304
APEV+ Y D++S G E+ +
Sbjct: 187 --APEVLLQSTYATPVDMWSVGCIFAEMFRRK 216
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-26
Identities = 51/197 (25%), Positives = 93/197 (47%), Gaps = 13/197 (6%)
Query: 121 GSYGDL----YKGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
G++G + K T + A+K+L K + + + E +++ RH + A
Sbjct: 16 GTFGKVILVREKAT--GRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYA 73
Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDL 234
LC V E+ G + F H + VF ++ + YLH ++++RD+
Sbjct: 74 FQTHDRLCFVMEYANGGEL--FFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDI 131
Query: 235 KTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYDYKADVFS 292
K NL++D++G +K+ DFG+ + G T GT ++APEV+E Y D +
Sbjct: 132 KLENLMLDKDGHIKITDFGLCKEGISDGATMK-TFCGTPEYLAPEVLEDNDYGRAVDWWG 190
Query: 293 FGIALWELLTGELPYAG 309
G+ ++E++ G LP+
Sbjct: 191 LGVVMYEMMCGRLPFYN 207
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-26
Identities = 61/218 (27%), Positives = 103/218 (47%), Gaps = 31/218 (14%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYK--GTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
+WE+ + + V SG+YG + T VA+K L + K +E+ ++
Sbjct: 24 IWEVPERYQNLSP-VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLL 82
Query: 162 RKIRHKNVVQFIGACTRPPNLC------IVTEFMA-------RGSIYDFLHKQKGVFQLT 208
+ ++H+NV+ + T +L +VT M + H Q ++Q+
Sbjct: 83 KHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQIL 142
Query: 209 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET 268
+G+ Y+H +IIHRDLK +NL ++E+ +K+ DFG+AR + MT
Sbjct: 143 ----------RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH--TADEMTGYV 190
Query: 269 GTYRW-MAPEVI-EHKPYDYKADVFSFGIALWELLTGE 304
T RW APE++ Y+ D++S G + ELLTG
Sbjct: 191 AT-RWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-26
Identities = 62/267 (23%), Positives = 103/267 (38%), Gaps = 52/267 (19%)
Query: 67 KDQSCSKRQPALGVPMHSKLLIESSPNCIEIPTDGTDVWEIDAKQL---KIECKVASGSY 123
+ +QP+ S + T D Q + +GS+
Sbjct: 11 AESCKPVQQPS---AFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSF 67
Query: 124 GDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQ-EVYIMRKIRHKNVVQFIGACTRPP 180
G +Y+ C + VAIK + + K F E+ IMRK+ H N+V+ +
Sbjct: 68 GVVYQAKLCDSGELVAIKKVLQD-------KRFKNRELQIMRKLDHCNIVR-LRYFFYSS 119
Query: 181 N-------LCIVTEFM------------ARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
L +V +++ ++ + ++QL + +
Sbjct: 120 GEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLF----------RSL 169
Query: 222 NYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSGVMTAETGT--YRWMAPEV 278
Y+H I HRD+K NLL+D + V+K+ DFG A+ + + + YR APE+
Sbjct: 170 AYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR--APEL 227
Query: 279 I-EHKPYDYKADVFSFGIALWELLTGE 304
I Y DV+S G L ELL G+
Sbjct: 228 IFGATDYTSSIDVWSAGCVLAELLLGQ 254
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 5e-26
Identities = 53/218 (24%), Positives = 96/218 (44%), Gaps = 42/218 (19%)
Query: 113 KIECKVASGSYGDLYKGTYCS---QEVAIKVLKPECVNTE------------MLKEFSQE 157
+ ++ G+YG ++K + VA+K ++ + E +L+
Sbjct: 15 CVA-EIGEGAYGKVFKARDLKNGGRFVALKRVRVQ--TGEEGMPLSTIREVAVLRH---- 67
Query: 158 VYIMRKIRHKNVVQFI-----GACTRPPNLCIVTEFMARGSIYD---FLHKQKGVFQLTS 209
+ H NVV+ R L +V E + D +L K T
Sbjct: 68 ---LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD----QDLTTYLDKVPEPGVPTE 120
Query: 210 LLK-VAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET 268
+K + + +G+++LH + ++HRDLK N+L+ +G +K+ADFG+AR+ + +T+
Sbjct: 121 TIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV 180
Query: 269 GT--YRWMAPEVIEHKPYDYKADVFSFGIALWELLTGE 304
T YR APEV+ Y D++S G E+ +
Sbjct: 181 VTLWYR--APEVLLQSSYATPVDLWSVGCIFAEMFRRK 216
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 9e-26
Identities = 54/182 (29%), Positives = 86/182 (47%), Gaps = 19/182 (10%)
Query: 137 AIKVLKPECVNTEMLKEFSQEVYIM--RKI-------RHKNVVQFIGACTRPPNLCIVTE 187
A+K L + +K E + R + +V A P L + +
Sbjct: 218 AMKCLD-----KKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILD 272
Query: 188 FMARGSIYDFLH-KQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV 246
M G + H Q GVF + A ++ G+ ++H +++RDLK AN+L+DE+G
Sbjct: 273 LMNGGDL--HYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGH 330
Query: 247 VKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGEL 305
V+++D G+A A GT+ +MAPEV++ YD AD FS G L++LL G
Sbjct: 331 VRISDLGLA-CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 389
Query: 306 PY 307
P+
Sbjct: 390 PF 391
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 9e-26
Identities = 61/218 (27%), Positives = 98/218 (44%), Gaps = 32/218 (14%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
WE+ V SG+YG + ++VAIK L + K +E+ ++
Sbjct: 19 AWELPKT-YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLL 77
Query: 162 RKIRHKNVVQFIGACTRPPNLC------IVTEFMA-------RGSIYDFLHKQKGVFQLT 208
+ ++H+NV+ + T +L +V FM + Q V+Q+
Sbjct: 78 KHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEE-KIQYLVYQML 136
Query: 209 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET 268
KG+ Y+H ++HRDLK NL ++E+ +K+ DFG+AR MT
Sbjct: 137 ----------KGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE--MTGYV 184
Query: 269 GTYRW-MAPEVI-EHKPYDYKADVFSFGIALWELLTGE 304
T RW APEVI Y+ D++S G + E+LTG+
Sbjct: 185 VT-RWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-25
Identities = 52/215 (24%), Positives = 92/215 (42%), Gaps = 40/215 (18%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPEC----VNTEMLKEFSQEVYIMRKIRH 166
+I K+ G+YG++YK + VAIK ++ E V ++E S ++++++H
Sbjct: 38 RIT-KLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVS----LLKELQH 92
Query: 167 KNVVQFIGACTRPPNLCIVTEFMA--------RGSIYDFLHKQKGVFQLTSLLKVAIDVS 218
+N+++ L ++ E+ + + ++QL
Sbjct: 93 RNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLI---------- 142
Query: 219 KGMNYLHQNNIIHRDLKTANLLMD-----ENGVVKVADFGVARV-QAQSGVMTAETGT-- 270
G+N+ H +HRDLK NLL+ E V+K+ DFG+AR T E T
Sbjct: 143 NGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLW 202
Query: 271 YRWMAPEVI-EHKPYDYKADVFSFGIALWELLTGE 304
YR PE++ + Y D++S E+L
Sbjct: 203 YR--PPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-25
Identities = 53/184 (28%), Positives = 89/184 (48%), Gaps = 22/184 (11%)
Query: 137 AIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYD 196
A+KVLK + E I+ ++ H +V+ A L ++ +F+ G +
Sbjct: 56 AMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDL-- 113
Query: 197 FLHKQK-GVFQLTSLLKVAIDVSK--------GMNYLHQNNIIHRDLKTANLLMDENGVV 247
F K +F + K +++LH II+RDLK N+L+DE G +
Sbjct: 114 FTRLSKEVMFTE--------EDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHI 165
Query: 248 KVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGEL 305
K+ DFG+++ + GT +MAPEV+ + + AD +SFG+ ++E+LTG L
Sbjct: 166 KLTDFGLSKESIDHEKKAY-SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTL 224
Query: 306 PYAG 309
P+ G
Sbjct: 225 PFQG 228
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 58/224 (25%), Positives = 100/224 (44%), Gaps = 39/224 (17%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKP-ECVNTEMLKEFSQEVYI 160
V+++ + + G+YG + VAIK + P E + + +E+ I
Sbjct: 22 VFDVGPR-YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKI 78
Query: 161 MRKIRHKNVVQFIGACTRPPNLC------IVTEFMA-------RGSIYDFLHKQKGVFQL 207
+ + RH+N++ I R P + IV + M + H ++Q+
Sbjct: 79 LLRFRHENIIG-INDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQI 137
Query: 208 TSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGV 263
+G+ Y+H N++HRDLK +NLL++ +K+ DFG+ARV +G
Sbjct: 138 L----------RGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 187
Query: 264 MTAETGT--YRWMAPEVI-EHKPYDYKADVFSFGIALWELLTGE 304
+T T YR APE++ K Y D++S G L E+L+
Sbjct: 188 LTEYVATRWYR--APEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-25
Identities = 47/221 (21%), Positives = 104/221 (47%), Gaps = 39/221 (17%)
Query: 113 KIECKVASGSYG------DLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR- 165
+ K+ G + D+ T+ VA+K+++ + V TE ++ E+ +++++
Sbjct: 22 ILVRKLGWGHFSTVWLAKDMVNNTH----VAMKIVRGDKVYTEAAED---EIKLLQRVND 74
Query: 166 ----------HKNVVQFIGACT-RPPN---LCIVTEFMARGSIYDFLHKQKGV-FQLTSL 210
++++ + + PN + +V E + ++ + K + L +
Sbjct: 75 ADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYV 133
Query: 211 LKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDE------NGVVKVADFGVARVQAQSGV 263
+++ + G++Y+H+ IIH D+K N+LM+ +K+AD G A +
Sbjct: 134 KQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYT 193
Query: 264 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGE 304
+ +T YR +PEV+ P+ AD++S ++EL+TG+
Sbjct: 194 NSIQTREYR--SPEVLLGAPWGCGADIWSTACLIFELITGD 232
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 4e-25
Identities = 53/190 (27%), Positives = 93/190 (48%), Gaps = 26/190 (13%)
Query: 137 AIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY 195
A+KVL K V + ++ + E ++ + H +++ G + ++ +++ G +
Sbjct: 35 AMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGEL- 93
Query: 196 DFLHKQK-GVFQLTSLLKVAIDVSK--------GMNYLHQNNIIHRDLKTANLLMDENGV 246
F +K F V+K + YLH +II+RDLK N+L+D+NG
Sbjct: 94 -FSLLRKSQRF--------PNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGH 144
Query: 247 VKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGE 304
+K+ DFG A+ T GT ++APEV+ KPY+ D +SFGI ++E+L G
Sbjct: 145 IKITDFGFAKYVPD----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY 200
Query: 305 LPYAGLTPLQ 314
P+ ++
Sbjct: 201 TPFYDSNTMK 210
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 5e-25
Identities = 53/198 (26%), Positives = 96/198 (48%), Gaps = 14/198 (7%)
Query: 121 GSYGDLY----KGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
G++G + K T + A+K+L K V + + E +++ RH + +
Sbjct: 159 GTFGKVILVKEKAT--GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYS 216
Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLH-QNNIIHRD 233
LC V E+ G + F H + VF ++ ++YLH + N+++RD
Sbjct: 217 FQTHDRLCFVMEYANGGEL--FFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRD 274
Query: 234 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYDYKADVF 291
LK NL++D++G +K+ DFG+ + + G T GT ++APEV+E Y D +
Sbjct: 275 LKLENLMLDKDGHIKITDFGLCKEGIKDGATMK-TFCGTPEYLAPEVLEDNDYGRAVDWW 333
Query: 292 SFGIALWELLTGELPYAG 309
G+ ++E++ G LP+
Sbjct: 334 GLGVVMYEMMCGRLPFYN 351
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 5e-25
Identities = 44/207 (21%), Positives = 90/207 (43%), Gaps = 28/207 (13%)
Query: 121 GSYGDLY----KGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
G++ ++ K T Q A+K++ K + + + F +E ++ + + Q A
Sbjct: 72 GAFSEVAVVKMKQT--GQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFA 129
Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQL------TSLLKVAIDVSKGMNYLHQNNI 229
L +V E+ G + L K + + +AID +H+
Sbjct: 130 FQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAID------SVHRLGY 183
Query: 230 IHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIE------- 280
+HRD+K N+L+D G +++ADFG G + + GT +++PE+++
Sbjct: 184 VHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPG 243
Query: 281 HKPYDYKADVFSFGIALWELLTGELPY 307
Y + D ++ G+ +E+ G+ P+
Sbjct: 244 TGSYGPECDWWALGVFAYEMFYGQTPF 270
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 7e-25
Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 38/210 (18%)
Query: 121 GSYGDL----YKGTYCSQEVAIKVLK---------PECVNTEMLKEFSQEVYIMRKI--- 164
GS+G + KGT + A+K+LK EC E +++
Sbjct: 352 GSFGKVMLSERKGT--DELYAVKILKKDVVIQDDDVECTMVE------------KRVLAL 397
Query: 165 --RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGM 221
+ + Q L V E++ G + H Q+ G F+ + A +++ G+
Sbjct: 398 PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEPHAVFYAAEIAIGL 455
Query: 222 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVI 279
+L II+RDLK N+++D G +K+ADFG+ + GV T T GT ++APE+I
Sbjct: 456 FFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTK-TFCGTPDYIAPEII 514
Query: 280 EHKPYDYKADVFSFGIALWELLTGELPYAG 309
++PY D ++FG+ L+E+L G+ P+ G
Sbjct: 515 AYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 544
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 1e-24
Identities = 63/210 (30%), Positives = 93/210 (44%), Gaps = 38/210 (18%)
Query: 121 GSYGDLY----KGTYCSQEVAIKVLK---------PECVNTEMLKEFSQEVYIMRKI--- 164
GS+G + K T A+KVLK EC TE ++I
Sbjct: 34 GSFGKVMLARVKET--GDLYAVKVLKKDVILQDDDVECTMTE------------KRILSL 79
Query: 165 --RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGM 221
H + Q P L V EF+ G + H QK F A ++ +
Sbjct: 80 ARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDL--MFHIQKSRRFDEARARFYAAEIISAL 137
Query: 222 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVI 279
+LH II+RDLK N+L+D G K+ADFG+ + +GV TA T GT ++APE++
Sbjct: 138 MFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTA-TFCGTPDYIAPEIL 196
Query: 280 EHKPYDYKADVFSFGIALWELLTGELPYAG 309
+ Y D ++ G+ L+E+L G P+
Sbjct: 197 QEMLYGPAVDWWAMGVLLYEMLCGHAPFEA 226
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-24
Identities = 54/198 (27%), Positives = 94/198 (47%), Gaps = 15/198 (7%)
Query: 121 GSYGDLY----KGTYCSQEVAIKVL-KPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175
G++G++ K T + A+K+L K E + F +E IM VVQ A
Sbjct: 80 GAFGEVQLVRHKST--RKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYA 137
Query: 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 235
L +V E+M G + +V ++ +H IHRD+K
Sbjct: 138 FQDDRYLYMVMEYMPGGDL--VNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVK 195
Query: 236 TANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKP----YDYKAD 289
N+L+D++G +K+ADFG + G++ +T GT +++PEV++ + Y + D
Sbjct: 196 PDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECD 255
Query: 290 VFSFGIALWELLTGELPY 307
+S G+ L+E+L G+ P+
Sbjct: 256 WWSVGVFLYEMLVGDTPF 273
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-24
Identities = 56/210 (26%), Positives = 99/210 (47%), Gaps = 35/210 (16%)
Query: 121 GSYG-------DLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQ---EVYIMRKIRHKNVV 170
G YG T + A+KVLK + K+ + E I+ +++H +V
Sbjct: 28 GGYGKVFQVRKVTGANT--GKIFAMKVLKKAMI-VRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSK--------GM 221
I A L ++ E+++ G + F+ ++ G+F D + +
Sbjct: 85 DLIYAFQTGGKLYLILEYLSGGEL--FMQLEREGIFME--------DTACFYLAEISMAL 134
Query: 222 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVI 279
+LHQ II+RDLK N++++ G VK+ DFG+ + G +T T GT +MAPE++
Sbjct: 135 GHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVT-HTFCGTIEYMAPEIL 193
Query: 280 EHKPYDYKADVFSFGIALWELLTGELPYAG 309
++ D +S G ++++LTG P+ G
Sbjct: 194 MRSGHNRAVDWWSLGALMYDMLTGAPPFTG 223
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-24
Identities = 39/151 (25%), Positives = 75/151 (49%), Gaps = 6/151 (3%)
Query: 182 LCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL 240
L V E++ G + H Q+ + ++S +NYLH+ II+RDLK N+L
Sbjct: 85 LFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVL 142
Query: 241 MDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYDYKADVFSFGIALW 298
+D G +K+ D+G+ + + G T+ T GT ++APE++ + Y + D ++ G+ ++
Sbjct: 143 LDSEGHIKLTDYGMCKEGLRPGDTTS-TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMF 201
Query: 299 ELLTGELPYAGLTPLQAAVGVVQKVSIHSII 329
E++ G P+ + + I+
Sbjct: 202 EMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL 232
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-24
Identities = 39/151 (25%), Positives = 75/151 (49%), Gaps = 6/151 (3%)
Query: 182 LCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL 240
L V E++ G + H Q+ + ++S +NYLH+ II+RDLK N+L
Sbjct: 128 LFFVIEYVNGGDL--MFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVL 185
Query: 241 MDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYDYKADVFSFGIALW 298
+D G +K+ D+G+ + + G T+ T GT ++APE++ + Y + D ++ G+ ++
Sbjct: 186 LDSEGHIKLTDYGMCKEGLRPGDTTS-TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMF 244
Query: 299 ELLTGELPYAGLTPLQAAVGVVQKVSIHSII 329
E++ G P+ + + I+
Sbjct: 245 EMMAGRSPFDIVGSSDNPDQNTEDYLFQVIL 275
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 60/210 (28%), Positives = 101/210 (48%), Gaps = 38/210 (18%)
Query: 121 GSYGDL----YKGTYCSQEVAIKVLK---------PECVNTEMLKEFSQEVYIMRKI--- 164
GS+G + KGT + A+K+LK EC E +++
Sbjct: 31 GSFGKVMLSERKGT--DELYAVKILKKDVVIQDDDVECTMVE------------KRVLAL 76
Query: 165 --RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGM 221
+ + Q L V E++ G + H Q+ G F+ + A +++ G+
Sbjct: 77 PGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL--MYHIQQVGRFKEPHAVFYAAEIAIGL 134
Query: 222 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVI 279
+L II+RDLK N+++D G +K+ADFG+ + GV T T GT ++APE+I
Sbjct: 135 FFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTK-TFCGTPDYIAPEII 193
Query: 280 EHKPYDYKADVFSFGIALWELLTGELPYAG 309
++PY D ++FG+ L+E+L G+ P+ G
Sbjct: 194 AYQPYGKSVDWWAFGVLLYEMLAGQAPFEG 223
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 61/207 (29%), Positives = 98/207 (47%), Gaps = 32/207 (15%)
Query: 121 GSYGDL----YKGTYCSQEVAIKVLK---------PECVNTE--MLKEFSQEVYIMRKIR 165
GS+G + +K T +Q AIK LK EC E +L
Sbjct: 28 GSFGKVFLAEFKKT--NQFFAIKALKKDVVLMDDDVECTMVEKRVLS---------LAWE 76
Query: 166 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYL 224
H + NL V E++ G + H Q F L+ A ++ G+ +L
Sbjct: 77 HPFLTHMFCTFQTKENLFFVMEYLNGGDL--MYHIQSCHKFDLSRATFYAAEIILGLQFL 134
Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHK 282
H I++RDLK N+L+D++G +K+ADFG+ + T T GT ++APE++ +
Sbjct: 135 HSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN-TFCGTPDYIAPEILLGQ 193
Query: 283 PYDYKADVFSFGIALWELLTGELPYAG 309
Y++ D +SFG+ L+E+L G+ P+ G
Sbjct: 194 KYNHSVDWWSFGVLLYEMLIGQSPFHG 220
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-24
Identities = 54/222 (24%), Positives = 93/222 (41%), Gaps = 48/222 (21%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIK--VLKPECVNTEMLKEFSQEVYIMRKIRHKN 168
++E G++G + G S VAIK + P N E+ Q + + + H N
Sbjct: 26 QVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNREL-----QIMQDLAVLHHPN 80
Query: 169 VVQFIGACTRPPN--------LCIVTEFM------------ARGSIYDFLHKQKGVFQLT 208
+VQ + + L +V E++ R + + +FQL
Sbjct: 81 IVQ-LQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLI 139
Query: 209 SLLKVAIDVSKGMNYLHQN--NIIHRDLKTANLLMD-ENGVVKVADFGVARVQAQSGVMT 265
+ + LH N+ HRD+K N+L++ +G +K+ DFG A+ + S
Sbjct: 140 ----------RSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNV 189
Query: 266 AETGT--YRWMAPEVI-EHKPYDYKADVFSFGIALWELLTGE 304
A + YR APE+I ++ Y D++S G E++ GE
Sbjct: 190 AYICSRYYR--APELIFGNQHYTTAVDIWSVGCIFAEMMLGE 229
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 99.3 bits (248), Expect = 8e-24
Identities = 61/242 (25%), Positives = 108/242 (44%), Gaps = 29/242 (11%)
Query: 87 LIESSPNCIEIPTDGTDVWEIDAKQLKIEC----KV-ASGSYGDLY----KGTYCSQEVA 137
L+ ++P P+ ++ K KV GS+G + K A
Sbjct: 10 LMNANPAPPPAPSQQINLGPSSNPHAKPSDFHFLKVIGKGSFGKVLLARHKAE--EVFYA 67
Query: 138 IKVLKPECVNTEMLKEFSQEVYIM-------RKIRHKNVVQFIGACTRPPNLCIVTEFMA 190
+KVL+ + + + +E +IM + ++H +V + L V +++
Sbjct: 68 VKVLQ-----KKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYIN 122
Query: 191 RGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKV 249
G + F H Q+ F A +++ + YLH NI++RDLK N+L+D G + +
Sbjct: 123 GGEL--FYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVL 180
Query: 250 ADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPY 307
DFG+ + + T+ T GT ++APEV+ +PYD D + G L+E+L G P+
Sbjct: 181 TDFGLCKENIEHNSTTS-TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPF 239
Query: 308 AG 309
Sbjct: 240 YS 241
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 9e-24
Identities = 61/231 (26%), Positives = 99/231 (42%), Gaps = 46/231 (19%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKP-ECVNTEMLKEFSQEVYI 160
V+ I + +++ + G+YG + T+ + VAIK ++P + +E+ I
Sbjct: 6 VYNISSD-FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD--KPLFALRTLREIKI 62
Query: 161 MRKIRHKNVVQFIGACTRPPNLC------IVTEFMA-------RGSIYDFLHKQKGVFQL 207
++ +H+N++ I RP + I+ E M + H Q ++Q
Sbjct: 63 LKHFKHENIIT-IFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQT 121
Query: 208 TSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV---------- 257
+ + LH +N+IHRDLK +NLL++ N +KV DFG+AR+
Sbjct: 122 L----------RAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSE 171
Query: 258 -QAQSGVMTAETGT--YRWMAPEVI-EHKPYDYKADVFSFGIALWELLTGE 304
Q M T YR APEV+ Y DV+S G L EL
Sbjct: 172 PTGQQSGMVEFVATRWYR--APEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 5e-23
Identities = 59/204 (28%), Positives = 100/204 (49%), Gaps = 23/204 (11%)
Query: 120 SGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHK------N 168
GS+G + K Q VA+K+++ ++ ++E+ I+ +R + N
Sbjct: 107 KGSFGQVVK---AYDHKVHQHVALKMVRN---EKRFHRQAAEEIRILEHLRKQDKDNTMN 160
Query: 169 VVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKGMNYLHQN 227
V+ + T ++C+ E ++ ++Y+ + K K F L + K A + + ++ LH+N
Sbjct: 161 VIHMLENFTFRNHICMTFELLSM-NLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN 219
Query: 228 NIIHRDLKTANLLMDENG--VVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYD 285
IIH DLK N+L+ + G +KV DFG + + Q ++ YR APEVI Y
Sbjct: 220 RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRFYR--APEVILGARYG 277
Query: 286 YKADVFSFGIALWELLTGELPYAG 309
D++S G L ELLTG G
Sbjct: 278 MPIDMWSLGCILAELLTGYPLLPG 301
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 6e-23
Identities = 46/219 (21%), Positives = 88/219 (40%), Gaps = 47/219 (21%)
Query: 120 SGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGAC 176
G G + + ++ A+K+L+ + + EV + + + ++V+ +
Sbjct: 28 LGINGKVLQIFNKRTQEKFALKMLQ----DCPKARR---EVELHWRASQCPHIVRIVDVY 80
Query: 177 ----TRPPNLCIVTEFMARGSIYDFLHKQKGVFQLT-----SLLKVAIDVSKGMNYLHQN 227
L IV E + G ++ + + +G T ++K + + + YLH
Sbjct: 81 ENLYAGRKCLLIVMECLDGGELFSRI-QDRGDQAFTEREASEIMK---SIGEAIQYLHSI 136
Query: 228 NIIHRDLKTANLLM---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPY 284
NI HRD+K NLL N ++K+ DFG A E + Y
Sbjct: 137 NIAHRDVKPENLLYTSKRPNAILKLTDFG--------------------FAKETT-GEKY 175
Query: 285 DYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKV 323
D D++S G+ ++ LL G P+ L + G+ ++
Sbjct: 176 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI 214
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 94.4 bits (235), Expect = 1e-22
Identities = 23/214 (10%), Positives = 62/214 (28%), Gaps = 32/214 (14%)
Query: 114 IECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTE-MLKEFSQEVYIMRKIRHKNVV 170
+ ++ T ++VA+ + P+ V + +L+E + +I V
Sbjct: 35 LLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 230
+ + +V E++ GS+ + ++ ++ + H+ +
Sbjct: 95 RVLDVVHTRAGGLVVAEWIRGGSLQEVADTSPSPVGA---IRAMQSLAAAADAAHRAGVA 151
Query: 231 HRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADV 290
+ + + +G V +A + + D+
Sbjct: 152 LSIDHPSRVRVSIDGDVVLAYPATMP--------------------------DANPQDDI 185
Query: 291 FSFGIALWELLTGELPYAGLTPLQAAVGVVQKVS 324
G +L+ LL P + +
Sbjct: 186 RGIGASLYALLVNRWPLPEAGVRSGLAPAERDTA 219
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 3e-22
Identities = 54/232 (23%), Positives = 101/232 (43%), Gaps = 48/232 (20%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
+++ ++ + G G ++ C + VAIK + + + +K +E+ I+
Sbjct: 6 GFDLGSR-YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKII 62
Query: 162 RKIRHKNVVQFIGACTRPPNLC---------------IVTEFMA-------RGSIYDFLH 199
R++ H N+V+ + P IV E+M H
Sbjct: 63 RRLDHDNIVK-VFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEH 121
Query: 200 KQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD-ENGVVKVADFGVARV- 257
+ ++QL +G+ Y+H N++HRDLK ANL ++ E+ V+K+ DFG+AR+
Sbjct: 122 ARLFMYQLL----------RGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIM 171
Query: 258 ---QAQSGVMTAETGT--YRWMAPEVI-EHKPYDYKADVFSFGIALWELLTG 303
+ G ++ T YR +P ++ Y D+++ G E+LTG
Sbjct: 172 DPHYSHKGHLSEGLVTKWYR--SPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 221
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 95.7 bits (238), Expect = 3e-22
Identities = 58/251 (23%), Positives = 97/251 (38%), Gaps = 63/251 (25%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
W+I + +I + +GSYG + + + VAIK + + K +E+ I+
Sbjct: 48 DWQIPDR-YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAIL 106
Query: 162 RKIRHKNVVQFIGACTRPPNLC------IVTEFM---------ARGSIYDFLHKQKGVFQ 206
++ H +VV+ + P ++ +V E + + H + ++
Sbjct: 107 NRLNHDHVVK-VLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTEL-HIKTLLYN 164
Query: 207 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--------- 257
L G+ Y+H I+HRDLK AN L++++ VKV DFG+AR
Sbjct: 165 LL----------VGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNS 214
Query: 258 -------------------QAQSGVMTAETGT--YRWMAPEVI-EHKPYDYKADVFSFGI 295
+ +T T YR APE+I + Y DV+S G
Sbjct: 215 QLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYR--APELILLQENYTEAIDVWSIGC 272
Query: 296 ALWELLTGELP 306
ELL
Sbjct: 273 IFAELLNMIKE 283
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 5e-22
Identities = 56/245 (22%), Positives = 94/245 (38%), Gaps = 58/245 (23%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKG--TYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMR 162
+ I+ + GSYG +Y + VAIK + + K +E+ I+
Sbjct: 22 VHVPDN-YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILN 80
Query: 163 KIRHKNVVQFIGACTRPPNLC------IVTEFM---------ARGSIYDFLHKQKGVFQL 207
+++ +++ P +L IV E + + H + ++ L
Sbjct: 81 RLKSDYIIRLYDLI-IPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEE-HIKTILYNL 138
Query: 208 TSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV---------- 257
G N++H++ IIHRDLK AN L++++ VKV DFG+AR
Sbjct: 139 L----------LGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIV 188
Query: 258 -------------QAQSGVMTAETGT--YRWMAPEVI-EHKPYDYKADVFSFGIALWELL 301
+ +T+ T YR APE+I + Y D++S G ELL
Sbjct: 189 NDLEENEEPGPHNKNLKKQLTSHVVTRWYR--APELILLQENYTKSIDIWSTGCIFAELL 246
Query: 302 TGELP 306
Sbjct: 247 NMLQS 251
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 8e-22
Identities = 50/212 (23%), Positives = 88/212 (41%), Gaps = 35/212 (16%)
Query: 121 GSYG-------DLYKGTYCSQEVAIKVLKPECV--NTEMLKEFSQEVYIMRKIRHKN-VV 170
G+YG T + A+KVLK + + + E ++ IR +V
Sbjct: 65 GAYGKVFLVRKISGHDT--GKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLV 122
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSK--------GM 221
A L ++ +++ G + F H + F + +
Sbjct: 123 TLHYAFQTETKLHLILDYINGGEL--FTHLSQRERFTE--------HEVQIYVGEIVLAL 172
Query: 222 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVI 279
+LH+ II+RD+K N+L+D NG V + DFG+++ A GT +MAP+++
Sbjct: 173 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 232
Query: 280 EHKPYDYKADV--FSFGIALWELLTGELPYAG 309
+ V +S G+ ++ELLTG P+
Sbjct: 233 RGGDSGHDKAVDWWSLGVLMYELLTGASPFTV 264
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 92.9 bits (231), Expect = 2e-21
Identities = 47/257 (18%), Positives = 93/257 (36%), Gaps = 78/257 (30%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQ-EVYIMR 162
E +K+ + + +GS+G + + + A+K + + + E+ IM+
Sbjct: 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD-------PRYKNRELDIMK 55
Query: 163 KIRHKNVVQ--------------------------------FIGACTRPPN------LCI 184
+ H N+++ + N L +
Sbjct: 56 VLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNV 115
Query: 185 VTEFM-------------ARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIH 231
+ E++ + SI ++QL + + ++H I H
Sbjct: 116 IMEYVPDTLHKVLKSFIRSGRSIPM-NLISIYIYQLF----------RAVGFIHSLGICH 164
Query: 232 RDLKTANLLMD-ENGVVKVADFGVARVQAQSGVMTAETGT--YRWMAPEVI-EHKPYDYK 287
RD+K NLL++ ++ +K+ DFG A+ S A + YR APE++ Y
Sbjct: 165 RDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYR--APELMLGATEYTPS 222
Query: 288 ADVFSFGIALWELLTGE 304
D++S G EL+ G+
Sbjct: 223 IDLWSIGCVFGELILGK 239
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 3e-21
Identities = 59/242 (24%), Positives = 102/242 (42%), Gaps = 62/242 (25%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQE 157
+ K ++ K+ G+YG + VA+K + N+ + +E
Sbjct: 5 RHVLRK-YELVKKLGKGAYG-----IVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFRE 58
Query: 158 VYIMRKIR-HKNVVQFIGACTRPPN---LCIVTEFMA-------RGSIYDFLHKQKGVFQ 206
+ I+ ++ H+N+V + R N + +V ++M R +I + +HKQ V+Q
Sbjct: 59 IMILTELSGHENIVNLLNVL-RADNDRDVYLVFDYMETDLHAVIRANILEPVHKQYVVYQ 117
Query: 207 LTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--------- 257
L K + YLH ++HRD+K +N+L++ VKVADFG++R
Sbjct: 118 LI----------KVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTN 167
Query: 258 -------------QAQSGVMTAETGT--YRWMAPEVI-EHKPYDYKADVFSFGIALWELL 301
++T T YR APE++ Y D++S G L E+L
Sbjct: 168 NIPLSINENTENFDDDQPILTDYVATRWYR--APEILLGSTKYTKGIDMWSLGCILGEIL 225
Query: 302 TG 303
G
Sbjct: 226 CG 227
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 91.9 bits (228), Expect = 4e-21
Identities = 54/261 (20%), Positives = 94/261 (36%), Gaps = 79/261 (30%)
Query: 113 KIECKVASGSYG------DLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR- 165
+ K+ G + D+ + VA+KV+K TE + E+ +++ +R
Sbjct: 40 HVIRKLGWGHFSTVWLSWDIQGKKF----VAMKVVKSAEHYTETALD---EIRLLKSVRN 92
Query: 166 -------HKNVVQFIGACT-RPPN---LCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKV 213
+ VVQ + N +C+V E + + ++ K L + K+
Sbjct: 93 SDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKI 151
Query: 214 AIDVSKGMNYLH-QNNIIHRDLKTANLLM------------------------------- 241
V +G++YLH + IIH D+K N+L+
Sbjct: 152 IQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVS 211
Query: 242 ------------------DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKP 283
E VK+AD G A + +T YR + EV+
Sbjct: 212 TAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYR--SLEVLIGSG 269
Query: 284 YDYKADVFSFGIALWELLTGE 304
Y+ AD++S +EL TG+
Sbjct: 270 YNTPADIWSTACMAFELATGD 290
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 1e-20
Identities = 55/213 (25%), Positives = 93/213 (43%), Gaps = 25/213 (11%)
Query: 113 KIECKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH- 166
+I+ + GS+G + K + VAIK++K L + EV ++ +
Sbjct: 57 EIDSLIGKGSFGQVVK---AYDRVEQEWVAIKIIKN---KKAFLNQAQIEVRLLELMNKH 110
Query: 167 -----KNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKG 220
+V +LC+V E ++ ++YD L L K A +
Sbjct: 111 DTEMKYYIVHLKRHFMFRNHLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTA 169
Query: 221 MNYLHQN--NIIHRDLKTANLLM--DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAP 276
+ +L +IIH DLK N+L+ + +K+ DFG + Q ++ YR +P
Sbjct: 170 LLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQRIYQYIQSRFYR--SP 227
Query: 277 EVIEHKPYDYKADVFSFGIALWELLTGELPYAG 309
EV+ PYD D++S G L E+ TGE ++G
Sbjct: 228 EVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSG 260
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 1e-19
Identities = 47/210 (22%), Positives = 84/210 (40%), Gaps = 48/210 (22%)
Query: 134 QEVAIKVLKPECVNTEMLKEFSQ-EVYIMRKIRHK------NVVQFIGACTRPPNLCIVT 186
+VA+K+++ N +E ++ E+ +++KI+ K V ++CI
Sbjct: 46 SQVALKIIR----NVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAF 101
Query: 187 EFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG 245
E + + + ++FL + + L + +A + + +LH+N + H DLK N+L +
Sbjct: 102 ELLGK-NTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSE 160
Query: 246 V-------------------VKVADFGVARVQAQSGVMTAETGT-------YRWMAPEVI 279
++VADFG S E T YR PEVI
Sbjct: 161 FETLYNEHKSCEEKSVKNTSIRVADFG-------SATFDHEHHTTIVATRHYR--PPEVI 211
Query: 280 EHKPYDYKADVFSFGIALWELLTGELPYAG 309
+ DV+S G L+E G +
Sbjct: 212 LELGWAQPCDVWSIGCILFEYYRGFTLFQT 241
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 85.8 bits (213), Expect = 3e-19
Identities = 53/211 (25%), Positives = 86/211 (40%), Gaps = 48/211 (22%)
Query: 133 SQEVAIKVLKPECVNTEMLKEFSQ-EVYIMRKIRHK------NVVQFIGACTRPPNLCIV 185
+ VA+K++K N + E ++ E+ ++ + VQ + ++CIV
Sbjct: 40 GRHVAVKIVK----NVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIV 95
Query: 186 TEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN 244
E + S YDF+ + + F+L + K+A + K +N+LH N + H DLK N+L ++
Sbjct: 96 FELLGL-STYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQS 154
Query: 245 GV-------------------VKVADFGVARVQAQSGVMTAETGT-------YRWMAPEV 278
+KV DFG S E + YR APEV
Sbjct: 155 DYTEAYNPKIKRDERTLINPDIKVVDFG-------SATYDDEHHSTLVSTRHYR--APEV 205
Query: 279 IEHKPYDYKADVFSFGIALWELLTGELPYAG 309
I + DV+S G L E G +
Sbjct: 206 ILALGWSQPCDVWSIGCILIEYYLGFTVFPT 236
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 1e-18
Identities = 50/211 (23%), Positives = 93/211 (44%), Gaps = 55/211 (26%)
Query: 134 QEVAIKVLKPECVNTEMLKEFSQ-EVYIMRKIRH-----KNVVQFIGACTRPPNLCIVTE 187
+ A+KV++ N + ++ E I++KI++ N+V++ G ++C++ E
Sbjct: 61 KYYAVKVVR----NIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFE 116
Query: 188 FMARGSIYDFL--HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG 245
+ S+Y+ + + G F + + I++ K +NYL + ++ H DLK N+L+D+
Sbjct: 117 PLGP-SLYEIITRNNYNG-FHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPY 174
Query: 246 V-------------------------VKVADFGVARVQAQSGVMTAETGT-------YRW 273
+K+ DFG ++ YR
Sbjct: 175 FEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFG-------CATFKSDYHGSIINTRQYR- 226
Query: 274 MAPEVIEHKPYDYKADVFSFGIALWELLTGE 304
APEVI + +D +D++SFG L EL TG
Sbjct: 227 -APEVILNLGWDVSSDMWSFGCVLAELYTGS 256
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 2e-15
Identities = 62/217 (28%), Positives = 96/217 (44%), Gaps = 29/217 (13%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTE--MLKEFSQEVYIMRKIRH-K 167
++ K+ SGS+GD+Y GT + +EVAIK+ ECV T+ L E I + ++
Sbjct: 12 RLGRKIGSGSFGDIYLGTDIAAGEEVAIKL---ECVKTKHPQLH---IESKIYKMMQGGV 65
Query: 168 NVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN 227
+ +V E + S+ D + F L ++L +A + + Y+H
Sbjct: 66 GIPTIRWCGAEGDYNVMVMELLGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK 124
Query: 228 NIIHRDLKTANLLM---DENGVVKVADFGVAR--VQAQSGVMTAE------TGTYRWM-- 274
N IHRD+K N LM + +V + DFG+A+ A++ TGT R+
Sbjct: 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 184
Query: 275 -APEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL 310
IE D D+ S G L G LP+ GL
Sbjct: 185 NTHLGIEQSRRD---DLESLGYVLMYFNLGSLPWQGL 218
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 5e-15
Identities = 52/249 (20%), Positives = 100/249 (40%), Gaps = 36/249 (14%)
Query: 100 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQE 157
+G + +++ Q + K+ SG +G +Y ++ A V+K E L E
Sbjct: 27 EGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLF---SE 83
Query: 158 VYIMRKIRHKNVVQFIGACTRPPNLCIVT-----EFMARGSIYDF------------LHK 200
+ +++ K+ ++ + L I +G Y F +
Sbjct: 84 LKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISG 143
Query: 201 QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKV--ADFGVARVQ 258
Q G F+ +++L++ I + + Y+H+N +H D+K ANLL+ +V AD+G++
Sbjct: 144 QNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRY 203
Query: 259 AQSGVM--------TAETGTYRWMAPEVIEHKPYDY--KADVFSFGIALWELLTGELPYA 308
+G GT + + + HK ++DV G + L G+LP+
Sbjct: 204 CPNGNHKQYQENPRKGHNGTIEFTS--LDAHKGVALSRRSDVEILGYCMLRWLCGKLPWE 261
Query: 309 GLTPLQAAV 317
AV
Sbjct: 262 QNLKDPVAV 270
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 74.3 bits (182), Expect = 7e-15
Identities = 56/222 (25%), Positives = 93/222 (41%), Gaps = 39/222 (17%)
Query: 113 KIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTE--MLKEFSQEVYIMRKIR-HK 167
++ K+ SGS+G++Y GT ++EVAIK+ E V T+ L E I R ++
Sbjct: 10 RLGRKIGSGSFGEIYLGTNIQTNEEVAIKL---ENVKTKHPQLL---YESKIYRILQGGT 63
Query: 168 NVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN 227
+ +V + + S+ D + L ++L +A + + ++H
Sbjct: 64 GIPNVRWFGVEGDYNVLVMDLLGP-SLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSK 122
Query: 228 NIIHRDLKTANLLMDENG---VVKVADFGVARV-------------QAQSGVMTAETGTY 271
+ +HRD+K N LM V + DFG+A+ + ++ TGT
Sbjct: 123 SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNL-----TGTA 177
Query: 272 RWM---APEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL 310
R+ IE D D+ S G L L G LP+ GL
Sbjct: 178 RYASVNTHLGIEQSRRD---DLESLGYVLMYFLRGSLPWQGL 216
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 72.8 bits (179), Expect = 1e-14
Identities = 51/214 (23%), Positives = 92/214 (42%), Gaps = 21/214 (9%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH-KNV 169
++ K+ G++G+L G + VAIK+ E + + + E +++ +
Sbjct: 12 RVGKKIGCGNFGELRLGKNLYTNEYVAIKL---EPMKSRA-PQLHLEYRFYKQLGSGDGI 67
Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
Q +V E + S+ D F L ++L +AI + M Y+H N+
Sbjct: 68 PQVYYFGPCGKYNAMVLELLGP-SLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNL 126
Query: 230 IHRDLKTANLLMDENG-----VVKVADFGVAR--VQAQSG--VMTAE----TGTYRWMAP 276
I+RD+K N L+ G V+ + DF +A+ + ++ + E TGT R+M+
Sbjct: 127 IYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSI 186
Query: 277 EVIEHKPYDYKADVFSFGIALWELLTGELPYAGL 310
K + D+ + G L G LP+ GL
Sbjct: 187 NTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGL 220
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 4e-14
Identities = 41/214 (19%), Positives = 86/214 (40%), Gaps = 21/214 (9%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH-KNV 169
K+ ++ GS+G +++GT Q+VAIK E ++ + E + + +
Sbjct: 13 KVGRRIGEGSFGVIFEGTNLLNNQQVAIKF---EPRRSDA-PQLRDEYRTYKLLAGCTGI 68
Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
+ +V + + S+ D L F + ++ A + + +H+ ++
Sbjct: 69 PNVYYFGQEGLHNVLVIDLLGP-SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSL 127
Query: 230 IHRDLKTANLLMDENG-----VVKVADFGVAR--VQAQSGVMTAE------TGTYRWMAP 276
++RD+K N L+ ++ V DFG+ + + +GT R+M+
Sbjct: 128 VYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSI 187
Query: 277 EVIEHKPYDYKADVFSFGIALWELLTGELPYAGL 310
+ + D+ + G L G LP+ GL
Sbjct: 188 NTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 221
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 8e-13
Identities = 43/246 (17%), Positives = 89/246 (36%), Gaps = 41/246 (16%)
Query: 100 DGTDVWEIDAKQLKIECKVASGSYGDLYKGT----------YCSQEVAIKVLKPECVNTE 149
GT + + +Q K++ + G LY+ Q+ ++K+ + +
Sbjct: 32 TGTVLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKL---DAKDGR 88
Query: 150 MLKEFS-----------QEVYIMRKIRHKNVVQFIGACTRPPNL-CIVTEFMARGSIYDF 197
+ E + + + + +G +V + R S+
Sbjct: 89 LFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSLGR-SLQSA 147
Query: 198 LHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKV--ADFGV 254
L K V S+L+VA + + +LH+N +H ++ N+ +D +V A +G
Sbjct: 148 LDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGF 207
Query: 255 AR--------VQAQSGVMTAETGTYRWMAPEVIEHKPYDY--KADVFSFGIALWELLTGE 304
A V G + G +++ + HK ++D+ S G + + L G
Sbjct: 208 AFRYCPSGKHVAYVEGSRSPHEGDLEFIS--MDLHKGCGPSRRSDLQSLGYCMLKWLYGF 265
Query: 305 LPYAGL 310
LP+
Sbjct: 266 LPWTNC 271
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 3e-12
Identities = 42/243 (17%), Positives = 91/243 (37%), Gaps = 35/243 (14%)
Query: 100 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPEC--VNTEM 150
G + ++ A K+ + G +G +Y S +KV + + TE+
Sbjct: 25 VGEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTEL 84
Query: 151 --LKEFSQEVYIMRKIRHKNV-------VQFIGACTRPPNL--CIVTEFMARGSIYDFLH 199
+ ++ I + IR + + G + ++ + +
Sbjct: 85 KFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS-DLQKIYE 143
Query: 200 KQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKV--ADFGVARV 257
F ++L++++ + + Y+H++ +H D+K +NLL++ +V D+G+A
Sbjct: 144 ANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYR 203
Query: 258 QAQSGVMTAE--------TGTYRWMAPEVIEHKPYDY--KADVFSFGIALWELLTGELPY 307
GV A GT + + + H + D+ G + + LTG LP+
Sbjct: 204 YCPEGVHKAYAADPKRCHDGTIEFTS--IDAHNGVAPSRRGDLEILGYCMIQWLTGHLPW 261
Query: 308 AGL 310
Sbjct: 262 EDN 264
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 63.4 bits (153), Expect = 1e-11
Identities = 32/192 (16%), Positives = 65/192 (33%), Gaps = 48/192 (25%)
Query: 111 QLKIECKVASGSYGDLYKGTYCSQEVAIKVL---KPECVNTEM---LKEFSQEVYIMRKI 164
+L+ K+ G +G++++ VAIK++ P+ VN +E E+ I +++
Sbjct: 21 KLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKEL 80
Query: 165 ---------RHKNVVQFIGAC----TRPPNLC--------------------------IV 185
R + + + PP L IV
Sbjct: 81 SLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIV 140
Query: 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDEN 244
EF G D + + L + + ++ + + HRDL N+L+ +
Sbjct: 141 LEFEFGGI--DLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKT 198
Query: 245 GVVKVADFGVAR 256
+ K+ +
Sbjct: 199 SLKKLHYTLNGK 210
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.1 bits (103), Expect = 5e-05
Identities = 47/339 (13%), Positives = 92/339 (27%), Gaps = 92/339 (27%)
Query: 39 LDVFVVDGWPYDETEDLKNVLAKE----ILKSKDQSCSKRQPALGVPMHSKLLIESSPNC 94
D FV + D + K++L+KE I+ SKD G L+
Sbjct: 26 EDAFVDNFDCKDVQDMPKSILSKEEIDHIIMSKD-------AVSGTLRLFWTLLSKQEEM 78
Query: 95 IEIPTDGTDVWEID----AKQLKIECKVASG---SYGDLYKGTYCSQEVAIK--VLKPEC 145
++ + +V I+ +K E + S Y + Y +V K V + +
Sbjct: 79 VQKFVE--EVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQP 136
Query: 146 VNT--EMLKEFSQEVYI----MR---K-------IRHKNVVQF---------IGACTRPP 180
+ L E + + K V + C P
Sbjct: 137 YLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPE 196
Query: 181 -------NLC--IVTEFMARGSIYD--FLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
L I + +R L +L LLK
Sbjct: 197 TVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLK----------------- 239
Query: 230 IHRDLKTANLLMDE---NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDY 286
+ + L++ + ++ + T +++ H D+
Sbjct: 240 -SKPYENCLLVLLNVQNAKAWNAFNLS-CKIL----LTTRFKQVTDFLSAATTTHISLDH 293
Query: 287 KADVF----SFGI-ALW-ELLTGELPYAGLT--PLQAAV 317
+ + + + +LP LT P + ++
Sbjct: 294 HSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSI 332
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 43.7 bits (102), Expect = 6e-05
Identities = 53/296 (17%), Positives = 94/296 (31%), Gaps = 95/296 (32%)
Query: 6 WVLMKVGELTSLLGEIGLNIQEA----HAFSTVDGFSLDVFVVDG----------WPYDE 51
W + +LT+++ E LN+ E F L VF W
Sbjct: 347 WKHVNCDKLTTII-ESSLNVLEPAEYRKMF-----DRLSVFPPSAHIPTILLSLIWFDVI 400
Query: 52 TEDLKNVLAKEILKS------KDQSCS--------KRQPALGVPMHSKLLIESSPNCIEI 97
D+ V+ K S K+ + S K + +H ++ + I
Sbjct: 401 KSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIV-----DHYNI 455
Query: 98 PTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQE 157
P D ++ L D Y ++ LK + E + F
Sbjct: 456 P-KTFDSDDLIPPYL------------DQYFYSHIGHH-----LK-NIEHPERMTLFRM- 495
Query: 158 VY-----IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIY-DFLHKQKGVF-QLTSL 210
V+ + +KIRH + A N +F Y ++ + +L +
Sbjct: 496 VFLDFRFLEQKIRHDSTAW--NASGSILNTLQQLKF------YKPYICDNDPKYERLVNA 547
Query: 211 LKVAIDVSKGMNYLHQ--NNII---HRDL-KTANLLMDENGVVKVADFGVARVQAQ 260
+ +++L + N+I + DL + A LM E+ + F A Q Q
Sbjct: 548 I---------LDFLPKIEENLICSKYTDLLRIA--LMAEDEAI----FEEAHKQVQ 588
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 331 | |||
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.97 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.94 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.88 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.79 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.53 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.37 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.35 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.27 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 99.09 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.91 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.81 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.77 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.58 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.55 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.55 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.49 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 98.18 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 98.18 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 98.07 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.89 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.84 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.8 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.72 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 97.6 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.52 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.43 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.37 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 97.36 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 97.1 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.81 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 96.71 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.58 | |
| 1u8s_A | 192 | Glycine cleavage system transcriptional repressor, | 94.13 | |
| 2nyi_A | 195 | Unknown protein; protein structure initiative, PSI | 93.73 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 93.65 | |
| 1zpv_A | 91 | ACT domain protein; structural genomics, PSI, prot | 91.81 | |
| 1cja_A | 342 | Protein (actin-fragmin kinase); transferase; HET: | 90.56 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 88.82 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 85.61 | |
| 2f1f_A | 164 | Acetolactate synthase isozyme III small subunit; f | 85.37 | |
| 2ko1_A | 88 | CTR148A, GTP pyrophosphokinase; homodimer, alpha+b | 85.11 |
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-56 Score=408.84 Aligned_cols=224 Identities=39% Similarity=0.733 Sum_probs=195.0
Q ss_pred CCCeeeecccCcceeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCC
Q 020085 101 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (331)
Q Consensus 101 ~~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 180 (331)
....|+|+.+++.+.++||+|+||+||+|++.+ .||||+++....+.+..+.|.+|+.++++++|||||+++++|.+ +
T Consensus 27 ~~~~Wei~~~~l~l~~~iG~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~ 104 (307)
T 3omv_A 27 SSYYWEIEASEVMLSTRIGSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-D 104 (307)
T ss_dssp --CCCBCCTTSCCEEEECCCCSSSEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-S
T ss_pred CCcCcEEcHHHeEEeeEEeeCCCcEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-C
Confidence 345699999999999999999999999998765 69999998776677778899999999999999999999998865 5
Q ss_pred CeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecC
Q 020085 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (331)
Q Consensus 181 ~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~ 260 (331)
.+||||||++||+|.++++..++.+++..+..++.||++||+|||+++||||||||+|||+++++.+||+|||+|+....
T Consensus 105 ~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~ 184 (307)
T 3omv_A 105 NLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSR 184 (307)
T ss_dssp SCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC---
T ss_pred eEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceeccc
Confidence 68999999999999999988778899999999999999999999999999999999999999999999999999986543
Q ss_pred C---CccccCCCCcccccchhcCC---CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccccccc
Q 020085 261 S---GVMTAETGTYRWMAPEVIEH---KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIH 326 (331)
Q Consensus 261 ~---~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~p 326 (331)
. ......+||+.|||||++.+ .+|+.++|||||||+||||+||+.||.+.++.+....++.++.++
T Consensus 185 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~ 256 (307)
T 3omv_A 185 WSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYAS 256 (307)
T ss_dssp ---------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCC
T ss_pred CCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCC
Confidence 2 22345689999999999853 469999999999999999999999999988777666666666543
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-55 Score=402.01 Aligned_cols=223 Identities=28% Similarity=0.535 Sum_probs=196.4
Q ss_pred eeeecccCcceeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEE
Q 020085 104 VWEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC 176 (331)
Q Consensus 104 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 176 (331)
.++|+.++|.+.++||+|+||+||+|++. ++.||||+++.. +.+..++|.+|+.+|++++|||||+++|+|
T Consensus 7 ~~~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~~ 84 (299)
T 4asz_A 7 VQHIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA--SDNARKDFHREAELLTNLQHEHIVKFYGVC 84 (299)
T ss_dssp CCBCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred hcccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC--ChHHHHHHHHHHHHHHhCCCCCCccEEEEE
Confidence 35788899999999999999999999873 567999999864 466678899999999999999999999999
Q ss_pred ECCCCeEEEEeccCCCCHHHHHHhcC------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC
Q 020085 177 TRPPNLCIVTEFMARGSIYDFLHKQK------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN 244 (331)
Q Consensus 177 ~~~~~~~lV~E~~~ggsL~~~l~~~~------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~ 244 (331)
.+++.+||||||+++|+|.++++... ..+++..+..++.||++||+|||+++|+||||||+|||++++
T Consensus 85 ~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~ 164 (299)
T 4asz_A 85 VEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGEN 164 (299)
T ss_dssp CSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred eeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCC
Confidence 99999999999999999999997632 469999999999999999999999999999999999999999
Q ss_pred CcEEEeeecceeeecCCCcc---ccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhccc
Q 020085 245 GVVKVADFGVARVQAQSGVM---TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 245 ~~vkl~DFg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~ 320 (331)
+.+||+|||+|+........ ....||++|||||++.+..|+.++|||||||++|||+| |+.||.+.++.+.... +
T Consensus 165 ~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~-i 243 (299)
T 4asz_A 165 LLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIEC-I 243 (299)
T ss_dssp GCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH-H
T ss_pred CcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHH-H
Confidence 99999999999865443222 22358999999999999999999999999999999999 8999999999888777 4
Q ss_pred ccccccccc
Q 020085 321 QKVSIHSII 329 (331)
Q Consensus 321 ~~~~~p~~~ 329 (331)
.+|.+|++|
T Consensus 244 ~~~~~~~~p 252 (299)
T 4asz_A 244 TQGRVLQRP 252 (299)
T ss_dssp HHTCCCCCC
T ss_pred HcCCCCCCC
Confidence 568777765
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-55 Score=406.01 Aligned_cols=219 Identities=25% Similarity=0.453 Sum_probs=192.3
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~ 186 (331)
-++|++.++||+|+||+||+|++ +++.||||+++....+....+.+.+|+.+|++++|||||++++++.+++.+||||
T Consensus 23 me~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVm 102 (350)
T 4b9d_A 23 MEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVM 102 (350)
T ss_dssp CCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred ccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEE
Confidence 46899999999999999999998 4789999999887777777889999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC-cc
Q 020085 187 EFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VM 264 (331)
Q Consensus 187 E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~-~~ 264 (331)
||++||+|.+++..++ ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+...... ..
T Consensus 103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~ 182 (350)
T 4b9d_A 103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA 182 (350)
T ss_dssp ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHHH
T ss_pred eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCcccc
Confidence 9999999999997654 467999999999999999999999999999999999999999999999999998765432 23
Q ss_pred ccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccccccccc
Q 020085 265 TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIHSI 328 (331)
Q Consensus 265 ~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~p~~ 328 (331)
...+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+...+++ ++..|++
T Consensus 183 ~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~-~~~~~~~ 245 (350)
T 4b9d_A 183 RACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKII-SGSFPPV 245 (350)
T ss_dssp HHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH-HTCCCCC
T ss_pred cccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH-cCCCCCC
Confidence 34579999999999999999999999999999999999999999999998888865 4555544
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-54 Score=400.71 Aligned_cols=224 Identities=30% Similarity=0.535 Sum_probs=193.1
Q ss_pred CeeeecccCcceeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeE
Q 020085 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175 (331)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 175 (331)
..+.|+.+++.+.++||+|+||+||+|++. ++.||||+++.. +....++|.+|+.+|++++|||||+++|+
T Consensus 34 ~~~~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~--~~~~~~~f~~E~~il~~l~HpnIV~l~g~ 111 (329)
T 4aoj_A 34 CVHHIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA--SESARQDFQREAELLTMLQHQHIVRFFGV 111 (329)
T ss_dssp CSCBCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC--SHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred hhcccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence 346788899999999999999999999874 578999999854 46667889999999999999999999999
Q ss_pred EECCCCeEEEEeccCCCCHHHHHHhcC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEE
Q 020085 176 CTRPPNLCIVTEFMARGSIYDFLHKQK--------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM 241 (331)
Q Consensus 176 ~~~~~~~~lV~E~~~ggsL~~~l~~~~--------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi 241 (331)
|.+++.+||||||+++|+|.+++++.. +++++..++.++.|+++||+|||+++|+||||||+|||+
T Consensus 112 ~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl 191 (329)
T 4aoj_A 112 CTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLV 191 (329)
T ss_dssp ECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred EEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEE
Confidence 999999999999999999999997642 468999999999999999999999999999999999999
Q ss_pred cCCCcEEEeeecceeeecCCCc---cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHh
Q 020085 242 DENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAV 317 (331)
Q Consensus 242 ~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~ 317 (331)
++++.+||+|||+++....... .....||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.++.+...
T Consensus 192 ~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~ 271 (329)
T 4aoj_A 192 GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID 271 (329)
T ss_dssp ETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHH
T ss_pred CCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 9999999999999986543322 234568999999999999999999999999999999999 899999999988777
Q ss_pred cccccccccccc
Q 020085 318 GVVQKVSIHSII 329 (331)
Q Consensus 318 ~~~~~~~~p~~~ 329 (331)
. +.+|.+|++|
T Consensus 272 ~-i~~g~~~~~p 282 (329)
T 4aoj_A 272 C-ITQGRELERP 282 (329)
T ss_dssp H-HHHTCCCCCC
T ss_pred H-HHcCCCCCCc
Confidence 6 4567777765
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-55 Score=398.97 Aligned_cols=224 Identities=26% Similarity=0.539 Sum_probs=196.5
Q ss_pred eeeecccCcceeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEE
Q 020085 104 VWEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC 176 (331)
Q Consensus 104 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 176 (331)
.++|+.+++++.++||+|+||+||+|++. ++.||||+++... +....++|.+|+.++++++|||||+++|+|
T Consensus 20 ~~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~ 98 (308)
T 4gt4_A 20 LKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVV 98 (308)
T ss_dssp CCBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C-CC-CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc-ChHHHHHHHHHHHHHHhCCCCCCCCcceEE
Confidence 45788889999999999999999999873 4689999998653 334457899999999999999999999999
Q ss_pred ECCCCeEEEEeccCCCCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEE
Q 020085 177 TRPPNLCIVTEFMARGSIYDFLHKQ---------------KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM 241 (331)
Q Consensus 177 ~~~~~~~lV~E~~~ggsL~~~l~~~---------------~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi 241 (331)
.+++.++|||||+++|+|.++|... ...+++..+.+++.||++||+|||+++||||||||+|||+
T Consensus 99 ~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl 178 (308)
T 4gt4_A 99 TKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLV 178 (308)
T ss_dssp CSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred EECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEE
Confidence 9999999999999999999999653 2458999999999999999999999999999999999999
Q ss_pred cCCCcEEEeeecceeeecCCC---ccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHh
Q 020085 242 DENGVVKVADFGVARVQAQSG---VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAV 317 (331)
Q Consensus 242 ~~~~~vkl~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~ 317 (331)
++++.+||+|||+++...... ......||++|||||++.+..|+.++|||||||+||||+| |+.||.+.++.+...
T Consensus 179 ~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~ 258 (308)
T 4gt4_A 179 YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVE 258 (308)
T ss_dssp CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHH
T ss_pred CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 999999999999998654332 2334578999999999999999999999999999999999 899999999988776
Q ss_pred cccccccccccc
Q 020085 318 GVVQKVSIHSII 329 (331)
Q Consensus 318 ~~~~~~~~p~~~ 329 (331)
. +.++.+|++|
T Consensus 259 ~-i~~~~~~~~p 269 (308)
T 4gt4_A 259 M-IRNRQVLPCP 269 (308)
T ss_dssp H-HHTTCCCCCC
T ss_pred H-HHcCCCCCCc
Confidence 6 5567777665
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-54 Score=395.39 Aligned_cols=213 Identities=22% Similarity=0.405 Sum_probs=190.9
Q ss_pred cccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEE
Q 020085 108 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI 184 (331)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~l 184 (331)
..++|++.+.||+|+||+||+|++ +++.||||+++.... +.+..+.+.+|+++|++++|||||++++++.++..+||
T Consensus 30 ~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yi 109 (311)
T 4aw0_A 30 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 109 (311)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEE
Confidence 356899999999999999999998 578999999974321 12235679999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC--
Q 020085 185 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-- 262 (331)
Q Consensus 185 V~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~-- 262 (331)
||||++||+|.+++.+ .+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+......
T Consensus 110 vmEy~~gG~L~~~i~~-~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~ 188 (311)
T 4aw0_A 110 GLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 188 (311)
T ss_dssp EECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred EEecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence 9999999999999965 5689999999999999999999999999999999999999999999999999998764332
Q ss_pred -ccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 263 -VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 263 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
.....+||+.|||||++.+..|+.++||||+||++|||++|++||.+.+..+...+++.
T Consensus 189 ~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~ 248 (311)
T 4aw0_A 189 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIK 248 (311)
T ss_dssp CCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred ccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence 33456899999999999999999999999999999999999999999998888777654
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-55 Score=396.39 Aligned_cols=215 Identities=27% Similarity=0.444 Sum_probs=185.0
Q ss_pred eecccCcceeeeeeecCceEEEEEEE-----CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCC
Q 020085 106 EIDAKQLKIECKVASGSYGDLYKGTY-----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (331)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 180 (331)
.++.++|++.+.||+|+||+||+|+. .++.||||+++....+......+.+|+.+|++++|||||++++++.+++
T Consensus 20 ~~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~ 99 (304)
T 3ubd_A 20 KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEG 99 (304)
T ss_dssp CCCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETT
T ss_pred cCCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECC
Confidence 45678999999999999999999987 3578999999765433222346888999999999999999999999999
Q ss_pred CeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecC
Q 020085 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (331)
Q Consensus 181 ~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~ 260 (331)
.+|+||||++||+|.+++.+ .+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 100 ~~~ivmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~ 178 (304)
T 3ubd_A 100 KLYLILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID 178 (304)
T ss_dssp EEEEEECCCTTCEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred EEEEEEEcCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence 99999999999999999976 56899999999999999999999999999999999999999999999999999986543
Q ss_pred -CCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 261 -SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 261 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
.......+||+.|||||++.+..|+.++||||+||++|||++|+.||.+.+..+....+.+
T Consensus 179 ~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~ 240 (304)
T 3ubd_A 179 HEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK 240 (304)
T ss_dssp --CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHc
Confidence 3334566899999999999999999999999999999999999999999999888777654
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-53 Score=385.01 Aligned_cols=214 Identities=29% Similarity=0.513 Sum_probs=186.6
Q ss_pred CcceeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEEC----CCCeEE
Q 020085 111 QLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR----PPNLCI 184 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~----~~~~~l 184 (331)
-|++.++||+|+||+||+|.+. ++.||+|++.....+....+.|.+|+.+|++++|||||+++++|.. +..+||
T Consensus 27 ~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~l 106 (290)
T 3fpq_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred eEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEE
Confidence 3588899999999999999984 6789999998776677777889999999999999999999999864 345899
Q ss_pred EEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCCEEEc-CCCcEEEeeecceeeecCC
Q 020085 185 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNN--IIHRDLKTANLLMD-ENGVVKVADFGVARVQAQS 261 (331)
Q Consensus 185 V~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~NiLi~-~~~~vkl~DFg~a~~~~~~ 261 (331)
||||++||+|.+++.+ .+.+++..+..++.||+.||+|||++| |+||||||+|||++ ++|.+||+|||+|+....
T Consensus 107 vmEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~- 184 (290)
T 3fpq_A 107 VTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA- 184 (290)
T ss_dssp EEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT-
T ss_pred EEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC-
Confidence 9999999999999975 568999999999999999999999998 99999999999997 479999999999975443
Q ss_pred CccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccccccccc
Q 020085 262 GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIHS 327 (331)
Q Consensus 262 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~p~ 327 (331)
......+||+.|||||++.+ .|+.++|||||||++|||++|+.||.+.++.......+..+.+|.
T Consensus 185 ~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~~ 249 (290)
T 3fpq_A 185 SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA 249 (290)
T ss_dssp TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG
T ss_pred CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCCC
Confidence 33455689999999999875 599999999999999999999999988766555555566666553
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-53 Score=394.11 Aligned_cols=213 Identities=29% Similarity=0.451 Sum_probs=190.3
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~ 186 (331)
.+.|++.++||+|+||+||+|++ +|+.||||+++..... ..+.+.+|+.+|++++|||||+++++|.+++.+||||
T Consensus 73 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivm 150 (346)
T 4fih_A 73 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 150 (346)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS--SGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh--HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 45799999999999999999998 5789999999754322 2356889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC-Cccc
Q 020085 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMT 265 (331)
Q Consensus 187 E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~-~~~~ 265 (331)
||++||+|.+++.+ +.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+..... ....
T Consensus 151 Ey~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~ 228 (346)
T 4fih_A 151 EFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK 228 (346)
T ss_dssp CCCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBC
T ss_pred eCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCccc
Confidence 99999999999965 56999999999999999999999999999999999999999999999999999876544 3445
Q ss_pred cCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccccccc
Q 020085 266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIH 326 (331)
Q Consensus 266 ~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~p 326 (331)
..+||+.|||||++.+..|+.++|||||||++|||++|++||.+.++.+....+. ++..|
T Consensus 229 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~-~~~~~ 288 (346)
T 4fih_A 229 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR-DNLPP 288 (346)
T ss_dssp CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH-HSSCC
T ss_pred ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH-cCCCC
Confidence 6789999999999999999999999999999999999999999999988777644 34433
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-54 Score=398.06 Aligned_cols=227 Identities=31% Similarity=0.575 Sum_probs=199.5
Q ss_pred CCeeeecccCcceeeeeeecCceEEEEEEECC-------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCC-CcceeEE
Q 020085 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH-KNVVQFI 173 (331)
Q Consensus 102 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h-~niv~~~ 173 (331)
.+.|+|+.++|++.++||+|+||+||+|++.+ +.||||+++... .....+.|.+|+.+|++++| ||||+++
T Consensus 56 ~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~-~~~~~~~~~~E~~il~~l~hhpnIV~l~ 134 (353)
T 4ase_A 56 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLL 134 (353)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-ChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence 35699999999999999999999999999754 579999998654 44556789999999999976 9999999
Q ss_pred eEEECC-CCeEEEEeccCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 020085 174 GACTRP-PNLCIVTEFMARGSIYDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 237 (331)
Q Consensus 174 ~~~~~~-~~~~lV~E~~~ggsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~ 237 (331)
|+|.++ ..++||||||++|+|.++|+... ..+++..+..++.||++||+|||+++||||||||+
T Consensus 135 g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~ 214 (353)
T 4ase_A 135 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 214 (353)
T ss_dssp EEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCcc
Confidence 999764 56899999999999999997632 34889999999999999999999999999999999
Q ss_pred CEEEcCCCcEEEeeecceeeecCCCc---cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHH
Q 020085 238 NLLMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPL 313 (331)
Q Consensus 238 NiLi~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~ 313 (331)
|||+++++.+||+|||+|+....... .....||+.|||||++.+..|+.++|||||||+||||+| |+.||++.+..
T Consensus 215 NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~ 294 (353)
T 4ase_A 215 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 294 (353)
T ss_dssp GEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999986544332 223468999999999999999999999999999999998 99999998877
Q ss_pred HHHhcccccccccccc
Q 020085 314 QAAVGVVQKVSIHSII 329 (331)
Q Consensus 314 ~~~~~~~~~~~~p~~~ 329 (331)
+....++.+|.||++|
T Consensus 295 ~~~~~~i~~g~~~~~p 310 (353)
T 4ase_A 295 EEFCRRLKEGTRMRAP 310 (353)
T ss_dssp HHHHHHHHHTCCCCCC
T ss_pred HHHHHHHHcCCCCCCC
Confidence 7777778889888776
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-53 Score=378.83 Aligned_cols=209 Identities=24% Similarity=0.476 Sum_probs=171.9
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEE
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~ 186 (331)
++|++.+.||+|+||+||+|++ +++.||||+++..... .+..+.+.+|+.++++++|||||++++++..++.+|+||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 5799999999999999999987 5789999999765433 334567999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCcccc
Q 020085 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 266 (331)
Q Consensus 187 E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~~~ 266 (331)
||+ +|+|.+++.+ ++.+++..+..++.||+.||+|||++||+||||||+|||+++++.+||+|||+|+..........
T Consensus 93 Ey~-~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~ 170 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ-RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKT 170 (275)
T ss_dssp ECC-CEEHHHHHHH-SCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-----------
T ss_pred eCC-CCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCccCC
Confidence 999 6799999965 57899999999999999999999999999999999999999999999999999987766655667
Q ss_pred CCCCcccccchhcCCCCC-CChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccc
Q 020085 267 ETGTYRWMAPEVIEHKPY-DYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 267 ~~gt~~y~aPE~~~~~~~-~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~ 320 (331)
.+||+.|||||++.+..| +.++||||+||++|||++|+.||.+.+..+....+.
T Consensus 171 ~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~ 225 (275)
T 3hyh_A 171 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNIS 225 (275)
T ss_dssp ----CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred eeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 789999999999998887 579999999999999999999999988777666543
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-52 Score=394.98 Aligned_cols=213 Identities=29% Similarity=0.451 Sum_probs=190.4
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~ 186 (331)
.+.|++.++||+|+||.||+|++ +|+.||||+++..... ..+.+.+|+.+|++++|||||+++++|..++.+||||
T Consensus 150 ~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~--~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm 227 (423)
T 4fie_A 150 RSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ--RRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM 227 (423)
T ss_dssp GGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS--SGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence 35799999999999999999998 4789999999755322 2356889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC-Cccc
Q 020085 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMT 265 (331)
Q Consensus 187 E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~-~~~~ 265 (331)
|||+||+|.+++.. +.+++..+..++.||+.||+|||++|||||||||+|||++.+|.+||+|||+|+..... ....
T Consensus 228 Ey~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~ 305 (423)
T 4fie_A 228 EFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK 305 (423)
T ss_dssp ECCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBC
T ss_pred eCCCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCcccc
Confidence 99999999999964 56999999999999999999999999999999999999999999999999999876544 3445
Q ss_pred cCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccccccc
Q 020085 266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIH 326 (331)
Q Consensus 266 ~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~p 326 (331)
..+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.++.+....+. .+..|
T Consensus 306 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~-~~~~~ 365 (423)
T 4fie_A 306 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR-DNLPP 365 (423)
T ss_dssp CCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH-HSCCC
T ss_pred ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH-cCCCC
Confidence 6689999999999999999999999999999999999999999999988877654 34433
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-53 Score=387.68 Aligned_cols=208 Identities=24% Similarity=0.378 Sum_probs=181.6
Q ss_pred eecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeE
Q 020085 106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183 (331)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 183 (331)
....+.|++.++||+|+||+||+|++ +++.||||+++.+.. +.+|+.++++++|||||++++++.+++.+|
T Consensus 54 ~~~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ 126 (336)
T 4g3f_A 54 REEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-------RVEELVACAGLSSPRIVPLYGAVREGPWVN 126 (336)
T ss_dssp CBTTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-------CTHHHHTTTTCCCTTBCCEEEEEEETTEEE
T ss_pred hcchhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-------HHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 34556799999999999999999998 478999999986532 246999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC-cEEEeeecceeeecCCC
Q 020085 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG-VVKVADFGVARVQAQSG 262 (331)
Q Consensus 184 lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~-~vkl~DFg~a~~~~~~~ 262 (331)
|||||++||+|.+++.+ .+.+++..+..++.||+.||+|||++||+||||||+|||++.+| .+||+|||+|+......
T Consensus 127 ivmEy~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 127 IFMELLEGGSLGQLIKQ-MGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp EEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred EEEeccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 99999999999999965 46899999999999999999999999999999999999999988 69999999998765432
Q ss_pred c------cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 263 V------MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 263 ~------~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
. ....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+....+..
T Consensus 206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~ 270 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS 270 (336)
T ss_dssp --------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHH
T ss_pred cccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHc
Confidence 1 1224699999999999999999999999999999999999999998776665555443
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=369.18 Aligned_cols=214 Identities=23% Similarity=0.419 Sum_probs=169.7
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCC-------
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP------- 180 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~------- 180 (331)
++|++.+.||+|+||+||+|++ +++.||||+++... .....+.+.+|+.+|++++|||||++++++...+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~ 83 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP 83 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS-SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence 3699999999999999999998 47899999997553 4455678999999999999999999999986543
Q ss_pred -----CeEEEEeccCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeec
Q 020085 181 -----NLCIVTEFMARGSIYDFLHKQK--GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFG 253 (331)
Q Consensus 181 -----~~~lV~E~~~ggsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg 253 (331)
.+|+||||++||+|.+++.... ...+...++.++.||++||+|||++||+||||||+|||++.+|.+||+|||
T Consensus 84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFG 163 (299)
T 4g31_A 84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFG 163 (299)
T ss_dssp ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCc
Confidence 3799999999999999997643 234566788999999999999999999999999999999999999999999
Q ss_pred ceeeecCCC-------------ccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccc
Q 020085 254 VARVQAQSG-------------VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 254 ~a~~~~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~ 320 (331)
+|+...... ..+..+||+.|||||++.+..|+.++|||||||++|||++ ||............+
T Consensus 164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~ 240 (299)
T 4g31_A 164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDV 240 (299)
T ss_dssp CC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHH
T ss_pred cceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHH
Confidence 998654322 1234579999999999999999999999999999999996 887643332223334
Q ss_pred ccccccc
Q 020085 321 QKVSIHS 327 (331)
Q Consensus 321 ~~~~~p~ 327 (331)
+++..|+
T Consensus 241 ~~~~~p~ 247 (299)
T 4g31_A 241 RNLKFPP 247 (299)
T ss_dssp HTTCCCH
T ss_pred hcCCCCC
Confidence 4455553
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-50 Score=370.41 Aligned_cols=215 Identities=27% Similarity=0.496 Sum_probs=175.3
Q ss_pred cCcceeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCC----CeEEE
Q 020085 110 KQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP----NLCIV 185 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~----~~~lV 185 (331)
++|.+.++||+|+||+||+|+++|+.||||+++... .....+..|+..+.+++|||||+++++|.+++ .+|||
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~~---~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV 79 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV 79 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc---hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence 578999999999999999999999999999997542 21223345666667889999999999997654 47999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CcccCCCCCCCEEEcCCCcEEEeeecceee
Q 020085 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN--------NIIHRDLKTANLLMDENGVVKVADFGVARV 257 (331)
Q Consensus 186 ~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~--------~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~ 257 (331)
|||+++|+|.++++. ..+++..+.+++.|+++||+|||++ +|+||||||+|||++.++.+||+|||+|+.
T Consensus 80 ~Ey~~~gsL~~~l~~--~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~ 157 (303)
T 3hmm_A 80 SDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157 (303)
T ss_dssp EECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred ecCCCCCcHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence 999999999999965 4689999999999999999999987 999999999999999999999999999987
Q ss_pred ecCCCcc-----ccCCCCcccccchhcCCC------CCCChhhHHHHHHHHHHHHcCCCCC----------CCC-----C
Q 020085 258 QAQSGVM-----TAETGTYRWMAPEVIEHK------PYDYKADVFSFGIALWELLTGELPY----------AGL-----T 311 (331)
Q Consensus 258 ~~~~~~~-----~~~~gt~~y~aPE~~~~~------~~~~~~Di~SlG~il~ell~g~~Pf----------~~~-----~ 311 (331)
....... ....||+.|||||++.+. .++.++|||||||+||||+||..|| .+. .
T Consensus 158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~ 237 (303)
T 3hmm_A 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237 (303)
T ss_dssp EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence 6554322 234699999999999754 4678999999999999999997654 332 2
Q ss_pred HHHHHhcccccccccccc
Q 020085 312 PLQAAVGVVQKVSIHSII 329 (331)
Q Consensus 312 ~~~~~~~~~~~~~~p~~~ 329 (331)
..+....++.++.||.++
T Consensus 238 ~~~~~~~~~~~~~rp~~p 255 (303)
T 3hmm_A 238 VEEMRKVVCEQKLRPNIP 255 (303)
T ss_dssp HHHHHHHHTTSCCCCCCC
T ss_pred HHHHHHHHhcccCCCCCC
Confidence 234455556677788765
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-50 Score=377.73 Aligned_cols=216 Identities=24% Similarity=0.380 Sum_probs=188.8
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEEC------CC
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR------PP 180 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~------~~ 180 (331)
.++|++.++||+|+||+||+|++ +|+.||||+++.........+.+.+|+.+|++++|||||++++++.. ..
T Consensus 53 ~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~ 132 (398)
T 4b99_A 53 GDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK 132 (398)
T ss_dssp CSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred CCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence 35899999999999999999998 57899999998776666667889999999999999999999998754 35
Q ss_pred CeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecC
Q 020085 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (331)
Q Consensus 181 ~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~ 260 (331)
.+||||||++ |+|.+++.+ ++.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus 133 ~~~ivmE~~~-g~L~~~i~~-~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~ 210 (398)
T 4b99_A 133 SVYVVLDLME-SDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCT 210 (398)
T ss_dssp CEEEEEECCS-EEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC--
T ss_pred EEEEEEeCCC-CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeeccc
Confidence 7899999996 589999965 57899999999999999999999999999999999999999999999999999985533
Q ss_pred C-----CccccCCCCcccccchhcCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccccccc
Q 020085 261 S-----GVMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIH 326 (331)
Q Consensus 261 ~-----~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~p 326 (331)
. ......+||+.|||||++.+. .|+.++||||+||++|||++|++||.+.+..+....+.+....|
T Consensus 211 ~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p 282 (398)
T 4b99_A 211 SPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTP 282 (398)
T ss_dssp -----CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred CccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 2 234456899999999998775 56999999999999999999999999999888887776554444
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-48 Score=380.88 Aligned_cols=211 Identities=24% Similarity=0.414 Sum_probs=193.8
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEe
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E 187 (331)
++|++.+.||+|+||+||+|++ +|+.||+|+++.. .....+.+.+|+.+|+.++|||||++++++.++..+|||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~--~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E 234 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 234 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc--chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 5899999999999999999998 5789999999765 34445778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC--CcEEEeeecceeeecCCCccc
Q 020085 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN--GVVKVADFGVARVQAQSGVMT 265 (331)
Q Consensus 188 ~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~--~~vkl~DFg~a~~~~~~~~~~ 265 (331)
|++||+|.+++....+.+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.........
T Consensus 235 ~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~ 314 (573)
T 3uto_A 235 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK 314 (573)
T ss_dssp CCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEE
T ss_pred ecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCcee
Confidence 999999999997767789999999999999999999999999999999999999854 899999999999887766666
Q ss_pred cCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccc
Q 020085 266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK 322 (331)
Q Consensus 266 ~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~ 322 (331)
..+||+.|||||++.+..|+.++||||+||++|||++|+.||.+.+..+....+...
T Consensus 315 ~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~ 371 (573)
T 3uto_A 315 VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC 371 (573)
T ss_dssp EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTT
T ss_pred eeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhC
Confidence 778999999999999999999999999999999999999999999998887776543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=376.62 Aligned_cols=202 Identities=26% Similarity=0.429 Sum_probs=176.7
Q ss_pred ecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCC----CCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCC
Q 020085 107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC----VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (331)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~----~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 180 (331)
+..++|++.+.||+|+||+||+|+. +|+.||||+++... ...........++.+++.++|||||+++++|.+..
T Consensus 186 ~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~ 265 (689)
T 3v5w_A 186 LTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD 265 (689)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSS
T ss_pred CchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECC
Confidence 4567899999999999999999998 57899999996432 12222333444567777889999999999999999
Q ss_pred CeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecC
Q 020085 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (331)
Q Consensus 181 ~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~ 260 (331)
.+|+||||++||+|.+++.+ .+.+++..+..++.||+.||+|||++|||||||||+|||++.+|++||+|||+|+....
T Consensus 266 ~lylVmEy~~GGdL~~~l~~-~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~ 344 (689)
T 3v5w_A 266 KLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK 344 (689)
T ss_dssp EEEEEECCCCSCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred EEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCC
Confidence 99999999999999999976 57899999999999999999999999999999999999999999999999999987654
Q ss_pred CCccccCCCCcccccchhcC-CCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 020085 261 SGVMTAETGTYRWMAPEVIE-HKPYDYKADVFSFGIALWELLTGELPYAGL 310 (331)
Q Consensus 261 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~SlG~il~ell~g~~Pf~~~ 310 (331)
. .....+||+.|||||++. +..|+.++|+|||||++|||++|++||.+.
T Consensus 345 ~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~ 394 (689)
T 3v5w_A 345 K-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 394 (689)
T ss_dssp C-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGG
T ss_pred C-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 4 334568999999999996 468999999999999999999999999763
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=356.22 Aligned_cols=203 Identities=23% Similarity=0.404 Sum_probs=172.9
Q ss_pred ccCcceeeeeeecCceEEEEEEEC-----CceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCcceeEEeEEECCCCe
Q 020085 109 AKQLKIECKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNL 182 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~ 182 (331)
.+.|++.++||+|+||+||+|++. ++.||||++.... . ...+.+|+++|+.+ +||||+++++++...+.+
T Consensus 20 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-~---~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 20 SNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-H---PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-C---HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred cCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-C---HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 357999999999999999999862 5789999987543 1 24678899999998 699999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC-CcEEEeeecceeeecCC
Q 020085 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQS 261 (331)
Q Consensus 183 ~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~-~~vkl~DFg~a~~~~~~ 261 (331)
|+||||++||+|.+++. .+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.....
T Consensus 96 ~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~ 171 (361)
T 4f9c_A 96 VIAMPYLEHESFLDILN----SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDT 171 (361)
T ss_dssp EEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTC
T ss_pred EEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCc
Confidence 99999999999999983 48999999999999999999999999999999999999877 79999999999754332
Q ss_pred C-----------------------------ccccCCCCcccccchhcCCC-CCCChhhHHHHHHHHHHHHcCCCCCC-CC
Q 020085 262 G-----------------------------VMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYA-GL 310 (331)
Q Consensus 262 ~-----------------------------~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~ell~g~~Pf~-~~ 310 (331)
. ..+..+||+.|||||++.+. .|+.++||||+||++|||++|+.||. +.
T Consensus 172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~ 251 (361)
T 4f9c_A 172 KIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKAS 251 (361)
T ss_dssp SCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCC
Confidence 1 12345799999999999775 58999999999999999999999984 44
Q ss_pred CHHHHHhcc
Q 020085 311 TPLQAAVGV 319 (331)
Q Consensus 311 ~~~~~~~~~ 319 (331)
+..+....+
T Consensus 252 ~~~~~l~~I 260 (361)
T 4f9c_A 252 DDLTALAQI 260 (361)
T ss_dssp SHHHHHHHH
T ss_pred CHHHHHHHH
Confidence 555544443
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-45 Score=336.15 Aligned_cols=227 Identities=43% Similarity=0.729 Sum_probs=192.7
Q ss_pred CCeeeecccCcceeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCC
Q 020085 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN 181 (331)
Q Consensus 102 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 181 (331)
...+++..++|++.+.||+|+||+||+|++.++.||||+++.........+.+.+|+.++++++||||+++++++.....
T Consensus 29 ~~~~~i~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 108 (309)
T 3p86_A 29 GDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN 108 (309)
T ss_dssp ---CBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTC
T ss_pred cccccCChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCc
Confidence 45688999999999999999999999999999999999998877677777889999999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCCEEEcCCCcEEEeeecceee
Q 020085 182 LCIVTEFMARGSIYDFLHKQK--GVFQLTSLLKVAIDVSKGMNYLHQNN--IIHRDLKTANLLMDENGVVKVADFGVARV 257 (331)
Q Consensus 182 ~~lV~E~~~ggsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~NiLi~~~~~vkl~DFg~a~~ 257 (331)
.++||||+++|+|.+++.... ..+++..++.++.|++.||+|||++| |+||||||+||+++.++.+||+|||+++.
T Consensus 109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~ 188 (309)
T 3p86_A 109 LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL 188 (309)
T ss_dssp CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC----
T ss_pred eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCcc
Confidence 999999999999999997543 23899999999999999999999999 99999999999999999999999999975
Q ss_pred ecCCC-ccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccccccccc
Q 020085 258 QAQSG-VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIHSI 328 (331)
Q Consensus 258 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~p~~ 328 (331)
..... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.++.+....+.....++++
T Consensus 189 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~ 260 (309)
T 3p86_A 189 KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEI 260 (309)
T ss_dssp -------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCCC
T ss_pred ccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCC
Confidence 44332 233457899999999999999999999999999999999999999999988877776555555544
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-45 Score=337.09 Aligned_cols=214 Identities=28% Similarity=0.504 Sum_probs=195.2
Q ss_pred cccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEE
Q 020085 108 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV 185 (331)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV 185 (331)
..++|++.+.||+|+||.||+|++ +++.||||+++....+....+.+.+|+.+++.++||||+++++++......|+|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 92 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLI 92 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 356899999999999999999998 678999999987766777778899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCccc
Q 020085 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT 265 (331)
Q Consensus 186 ~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~~ 265 (331)
|||++||+|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus 93 ~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~ 171 (328)
T 3fe3_A 93 MEYASGGEVFDYLVA-HGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLD 171 (328)
T ss_dssp ECCCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGGG
T ss_pred EECCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCccc
Confidence 999999999999966 4679999999999999999999999999999999999999999999999999998766666667
Q ss_pred cCCCCcccccchhcCCCCCC-ChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccc
Q 020085 266 AETGTYRWMAPEVIEHKPYD-YKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK 322 (331)
Q Consensus 266 ~~~gt~~y~aPE~~~~~~~~-~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~ 322 (331)
..+||+.|+|||++.+..++ .++||||+||++|+|++|+.||.+.+..+....+.+.
T Consensus 172 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~ 229 (328)
T 3fe3_A 172 AFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG 229 (328)
T ss_dssp TTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred cccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence 77899999999999888875 7999999999999999999999999888877765543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=334.26 Aligned_cols=214 Identities=22% Similarity=0.442 Sum_probs=188.4
Q ss_pred ecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeE
Q 020085 107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183 (331)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 183 (331)
+..++|++.+.||+|+||+||+++. .++.||+|+++.... ..+....+.+|+.++++++||||+++++++.....+|
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~ 81 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEE
Confidence 4567899999999999999999998 478999999974321 1123467889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecC-CC
Q 020085 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SG 262 (331)
Q Consensus 184 lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~-~~ 262 (331)
+||||++||+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.... ..
T Consensus 82 lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~ 160 (337)
T 1o6l_A 82 FVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp EEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred EEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCC
Confidence 99999999999999965 46789999999999999999999999999999999999999999999999999986432 33
Q ss_pred ccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 263 VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 263 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
.....+||+.|+|||++.+..++.++|+|||||++|||++|+.||.+.+..+....+..
T Consensus 161 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~ 219 (337)
T 1o6l_A 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM 219 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 34556799999999999999999999999999999999999999999888776666543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-45 Score=348.50 Aligned_cols=221 Identities=21% Similarity=0.355 Sum_probs=192.1
Q ss_pred eeecccCcceeeeeeecCceEEEEEEEC--CceEEEEEecCCCCC-HHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCC
Q 020085 105 WEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN 181 (331)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 181 (331)
..+..++|++.++||+|+||+||++++. ++.||+|+++..... ......+.+|..+++.++||||++++++|.++..
T Consensus 69 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~ 148 (437)
T 4aw2_A 69 MRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNN 148 (437)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred ccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCE
Confidence 4566789999999999999999999984 588999999742110 0112338899999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC
Q 020085 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261 (331)
Q Consensus 182 ~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~ 261 (331)
+|+||||++||+|.+++.+..+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 149 ~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~ 228 (437)
T 4aw2_A 149 LYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 228 (437)
T ss_dssp EEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccC
Confidence 99999999999999999876788999999999999999999999999999999999999999999999999999766544
Q ss_pred Ccc--ccCCCCcccccchhcC-----CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccccccc
Q 020085 262 GVM--TAETGTYRWMAPEVIE-----HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSI 325 (331)
Q Consensus 262 ~~~--~~~~gt~~y~aPE~~~-----~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~ 325 (331)
... ...+||+.|+|||++. ...++.++|+|||||++|||++|+.||.+.+..+....++....+
T Consensus 229 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~ 299 (437)
T 4aw2_A 229 GTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER 299 (437)
T ss_dssp SCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH
T ss_pred CCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccc
Confidence 332 3457999999999986 567899999999999999999999999999998888887654433
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=319.74 Aligned_cols=221 Identities=33% Similarity=0.653 Sum_probs=194.0
Q ss_pred CCeeeecccCcceeeeeeecCceEEEEEEE-CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCC
Q 020085 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (331)
Q Consensus 102 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 180 (331)
...|.++.++|++.+.||+|+||.||++.+ .++.||+|+++...... +.+.+|+.++++++||||+++++++..+.
T Consensus 2 ~~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 78 (269)
T 4hcu_A 2 SGKWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQA 78 (269)
T ss_dssp ---CBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred CccEEeChhhceeeheecCCCccEEEEEEecCCCeEEEEEecccccCH---HHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 356899999999999999999999999998 67889999998765444 56889999999999999999999999999
Q ss_pred CeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecC
Q 020085 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (331)
Q Consensus 181 ~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~ 260 (331)
..++||||+++++|.+++....+.+++..+..++.|+++||+|||++|++||||||+||+++.++.+||+|||+++....
T Consensus 79 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 158 (269)
T 4hcu_A 79 PICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 158 (269)
T ss_dssp SEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred ceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccc
Confidence 99999999999999999987778899999999999999999999999999999999999999999999999999975543
Q ss_pred CC--ccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhccccccccc
Q 020085 261 SG--VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIH 326 (331)
Q Consensus 261 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p 326 (331)
.. ......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||...+..+....+. .+.++
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~-~~~~~ 226 (269)
T 4hcu_A 159 DQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRL 226 (269)
T ss_dssp HHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCC
T ss_pred cccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHh-cCccC
Confidence 22 1233456788999999999999999999999999999999 999999988887766643 34333
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-44 Score=334.28 Aligned_cols=225 Identities=29% Similarity=0.587 Sum_probs=194.2
Q ss_pred CeeeecccCcceeeeeeecCceEEEEEEEC---------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCcceeE
Q 020085 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYC---------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQF 172 (331)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~ 172 (331)
..|++..++|++.+.||+|+||.||+|++. +..||||+++... .....+.+.+|+.+++++ +||||+++
T Consensus 74 ~~~~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~~ 152 (370)
T 2psq_A 74 PKWEFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINL 152 (370)
T ss_dssp TTTBCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTC-BHHHHHHHHHHHHHHHHSCCCTTBCCE
T ss_pred ccccccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCc-CHHHHHHHHHHHHHHHHhcCCCCEeeE
Confidence 457888999999999999999999999873 2469999998653 455677899999999999 89999999
Q ss_pred EeEEECCCCeEEEEeccCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 020085 173 IGACTRPPNLCIVTEFMARGSIYDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 237 (331)
Q Consensus 173 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~ 237 (331)
+++|.....+|+||||+++|+|.+++.... ..++...++.++.||+.||+|||++||+||||||+
T Consensus 153 ~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~ 232 (370)
T 2psq_A 153 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR 232 (370)
T ss_dssp EEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred EEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchh
Confidence 999999999999999999999999997643 34789999999999999999999999999999999
Q ss_pred CEEEcCCCcEEEeeecceeeecCCC---ccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHH
Q 020085 238 NLLMDENGVVKVADFGVARVQAQSG---VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPL 313 (331)
Q Consensus 238 NiLi~~~~~vkl~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~ 313 (331)
|||++.++.+||+|||+++...... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..
T Consensus 233 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~ 312 (370)
T 2psq_A 233 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 312 (370)
T ss_dssp GEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred hEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 9999999999999999998654432 2233457889999999999999999999999999999999 99999988766
Q ss_pred HHHhcccccccccccc
Q 020085 314 QAAVGVVQKVSIHSII 329 (331)
Q Consensus 314 ~~~~~~~~~~~~p~~~ 329 (331)
+.... +..+.++.++
T Consensus 313 ~~~~~-~~~~~~~~~~ 327 (370)
T 2psq_A 313 ELFKL-LKEGHRMDKP 327 (370)
T ss_dssp GHHHH-HHTTCCCCCC
T ss_pred HHHHH-HhcCCCCCCC
Confidence 55444 4556665543
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=339.81 Aligned_cols=225 Identities=31% Similarity=0.580 Sum_probs=197.2
Q ss_pred CeeeecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCC
Q 020085 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (331)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 180 (331)
+.|+++.++|.+.+.||+|+||.||+|++ .++.||||+++.. ...+..+.|.+|+.++++++||||++++++|..+.
T Consensus 107 ~~~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~ 185 (377)
T 3cbl_A 107 DKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET-LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQ 185 (377)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT-SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred cccEEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc-CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCC
Confidence 46899999999999999999999999999 4789999999855 34555678999999999999999999999999999
Q ss_pred CeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecC
Q 020085 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (331)
Q Consensus 181 ~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~ 260 (331)
..++||||+++|+|.+++......+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||+++....
T Consensus 186 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 186 PIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp SCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred CcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 99999999999999999987666799999999999999999999999999999999999999999999999999986543
Q ss_pred CCccc---cCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhcccccccccccc
Q 020085 261 SGVMT---AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIHSII 329 (331)
Q Consensus 261 ~~~~~---~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p~~~ 329 (331)
..... ...+++.|+|||.+.+..++.++||||||+++|||++ |..||.+.+..+.... +.++.+++++
T Consensus 266 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~-~~~~~~~~~~ 337 (377)
T 3cbl_A 266 GVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREF-VEKGGRLPCP 337 (377)
T ss_dssp SEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHH-HHTTCCCCCC
T ss_pred CceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCCCCC
Confidence 32111 1234678999999998889999999999999999998 9999999988776555 5566665543
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=335.57 Aligned_cols=215 Identities=24% Similarity=0.396 Sum_probs=183.4
Q ss_pred eecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhc-CCCcceeEEeEEECCCC
Q 020085 106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPN 181 (331)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~ 181 (331)
.+..++|++.+.||+|+||+||++++ .++.||||+++.... .....+.+.+|..+++.+ +||||+++++++.....
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 98 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR 98 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence 45678999999999999999999998 468999999975321 122346688999999988 69999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC
Q 020085 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261 (331)
Q Consensus 182 ~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~ 261 (331)
+|+||||++||+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 99 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~ 177 (353)
T 3txo_A 99 LFFVMEFVNGGDLMFHIQK-SRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN 177 (353)
T ss_dssp EEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-
T ss_pred EEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccC
Confidence 9999999999999999966 467999999999999999999999999999999999999999999999999999754332
Q ss_pred -CccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 262 -GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 262 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
......+||+.|+|||++.+..++.++|+|||||++|||++|+.||.+.+..+....+..
T Consensus 178 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~ 238 (353)
T 3txo_A 178 GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN 238 (353)
T ss_dssp --------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence 233456799999999999999999999999999999999999999999998887777654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-44 Score=342.42 Aligned_cols=220 Identities=35% Similarity=0.651 Sum_probs=192.7
Q ss_pred CeeeecccCcceeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCC-C
Q 020085 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP-N 181 (331)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~-~ 181 (331)
..|+++.++|++.+.||+|+||.||+|.+.++.||||+++... ..+.|.+|+.++++++||||+++++++.... .
T Consensus 186 ~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 261 (450)
T 1k9a_A 186 SGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 261 (450)
T ss_dssp TTCBCCGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSC
T ss_pred cccccChHHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCc
Confidence 4589999999999999999999999999999999999998653 2367999999999999999999999987665 7
Q ss_pred eEEEEeccCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecC
Q 020085 182 LCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (331)
Q Consensus 182 ~~lV~E~~~ggsL~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~ 260 (331)
+++||||+++|+|.+++..... .++...++.++.|++.||+|||++|++||||||+|||++.++.+||+|||+++....
T Consensus 262 ~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 341 (450)
T 1k9a_A 262 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 341 (450)
T ss_dssp EEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccc
Confidence 9999999999999999977543 479999999999999999999999999999999999999999999999999985443
Q ss_pred CCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhcccccccccccc
Q 020085 261 SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIHSII 329 (331)
Q Consensus 261 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p~~~ 329 (331)
. .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||++.+..+.... +.+|.+++++
T Consensus 342 ~--~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~-i~~~~~~~~p 408 (450)
T 1k9a_A 342 T--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-VEKGYKMDAP 408 (450)
T ss_dssp -------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHH-HHTTCCCCCC
T ss_pred c--ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCCCCC
Confidence 2 223467889999999999999999999999999999998 9999999877776655 4567766554
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-43 Score=329.80 Aligned_cols=212 Identities=22% Similarity=0.419 Sum_probs=191.6
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~ 186 (331)
.++|.+.+.||+|+||.||++.+ .++.||+|+++.........+.+.+|+.++++++||||+++++++......|+||
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 107 (362)
T 2bdw_A 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 107 (362)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 45899999999999999999998 4789999999877666777788999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC---cEEEeeecceeeecCCCc
Q 020085 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG---VVKVADFGVARVQAQSGV 263 (331)
Q Consensus 187 E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~---~vkl~DFg~a~~~~~~~~ 263 (331)
||++||+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++.......
T Consensus 108 e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~ 186 (362)
T 2bdw_A 108 DLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 186 (362)
T ss_dssp CCCCSCBHHHHHTT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCS
T ss_pred ecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcc
Confidence 99999999999965 46789999999999999999999999999999999999998654 599999999987765555
Q ss_pred cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 264 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 264 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
.....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+..
T Consensus 187 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~ 244 (362)
T 2bdw_A 187 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA 244 (362)
T ss_dssp CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh
Confidence 5567899999999999999999999999999999999999999999888776666443
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=326.08 Aligned_cols=210 Identities=20% Similarity=0.330 Sum_probs=190.3
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~ 186 (331)
.++|.+.+.||+|+||.||++.+ .++.||+|+++.. ......+.+|+.+++.++||||+++++++......++||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 80 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK---GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC---THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC---cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEE
Confidence 46899999999999999999998 4688999999754 234467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC--CCcEEEeeecceeeecCCCcc
Q 020085 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE--NGVVKVADFGVARVQAQSGVM 264 (331)
Q Consensus 187 E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~--~~~vkl~DFg~a~~~~~~~~~ 264 (331)
||++||+|.+++......+++..+..++.|++.||.|||++||+||||||+|||++. ++.+||+|||+++........
T Consensus 81 e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~ 160 (321)
T 1tki_A 81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF 160 (321)
T ss_dssp CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE
T ss_pred EeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCcc
Confidence 999999999999776668999999999999999999999999999999999999987 789999999999887666555
Q ss_pred ccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 265 TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 265 ~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
....||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+..
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 217 (321)
T 1tki_A 161 RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMN 217 (321)
T ss_dssp EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH
T ss_pred ccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHc
Confidence 667799999999999998899999999999999999999999999888777766554
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=326.76 Aligned_cols=223 Identities=35% Similarity=0.560 Sum_probs=193.1
Q ss_pred eeeecccCcceeeeeeecCceEEEEEEEC-----CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEEC
Q 020085 104 VWEIDAKQLKIECKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR 178 (331)
Q Consensus 104 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 178 (331)
..++..++|++.+.||+|+||.||+|.+. +..||||+++... .....+.+.+|+.++++++||||+++++++..
T Consensus 43 ~~~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 121 (325)
T 3kul_A 43 TREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY-TERQRRDFLSEASIMGQFDHPNIIRLEGVVTR 121 (325)
T ss_dssp CCBCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG
T ss_pred ccccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe
Confidence 35788899999999999999999999983 3459999998653 45566789999999999999999999999999
Q ss_pred CCCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeee
Q 020085 179 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (331)
Q Consensus 179 ~~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~ 258 (331)
....++||||+++|+|.+++....+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~ 201 (325)
T 3kul_A 122 GRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201 (325)
T ss_dssp GGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred CCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccc
Confidence 99999999999999999999877778999999999999999999999999999999999999999999999999999865
Q ss_pred cCCCc----cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhccccccccccc
Q 020085 259 AQSGV----MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIHSI 328 (331)
Q Consensus 259 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p~~ 328 (331)
..... .....+|+.|+|||++.+..++.++||||||+++|||++ |+.||.+.+..+....+. .+.+++.
T Consensus 202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~-~~~~~~~ 275 (325)
T 3kul_A 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVE-EGYRLPA 275 (325)
T ss_dssp C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHH-TTCCCCC
T ss_pred ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHH-cCCCCCC
Confidence 44321 223346788999999998899999999999999999999 999999998888777644 4554443
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-44 Score=341.82 Aligned_cols=218 Identities=18% Similarity=0.319 Sum_probs=191.0
Q ss_pred eeecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCC
Q 020085 105 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN 181 (331)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 181 (331)
+.+..++|++.+.||+|+||+||+++. +++.||+|+++.... .....+.+.+|..+++.++||||+++++++.+...
T Consensus 56 ~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~ 135 (412)
T 2vd5_A 56 VRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENY 135 (412)
T ss_dssp HSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSE
T ss_pred ccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCE
Confidence 456678999999999999999999998 578999999974211 11123458899999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC
Q 020085 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261 (331)
Q Consensus 182 ~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~ 261 (331)
+|+||||++||+|.+++.+....+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 136 ~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~ 215 (412)
T 2vd5_A 136 LYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRAD 215 (412)
T ss_dssp EEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCC
Confidence 99999999999999999876668999999999999999999999999999999999999999999999999999876554
Q ss_pred Cc--cccCCCCcccccchhcC-------CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccc
Q 020085 262 GV--MTAETGTYRWMAPEVIE-------HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK 322 (331)
Q Consensus 262 ~~--~~~~~gt~~y~aPE~~~-------~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~ 322 (331)
.. ....+||+.|+|||++. ...++.++|+|||||++|||++|+.||.+.+..+....++..
T Consensus 216 ~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~ 285 (412)
T 2vd5_A 216 GTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHY 285 (412)
T ss_dssp SCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTH
T ss_pred CccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence 33 23457999999999986 457899999999999999999999999999988887776653
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-43 Score=330.04 Aligned_cols=212 Identities=25% Similarity=0.437 Sum_probs=189.6
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCH----HHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCe
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNT----EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL 182 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~----~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 182 (331)
.+.|++.+.||+|+||.||++++ +++.||+|+++...... ...+.+.+|+.++++++||||+++++++.....+
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 45799999999999999999998 47899999997653321 1246789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC----cEEEeeecceeee
Q 020085 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG----VVKVADFGVARVQ 258 (331)
Q Consensus 183 ~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~----~vkl~DFg~a~~~ 258 (331)
++||||++||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 91 ~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~ 169 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (361)
T ss_dssp EEEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred EEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence 999999999999999965 56899999999999999999999999999999999999998877 7999999999877
Q ss_pred cCCCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 259 AQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 259 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
..........||+.|+|||++.+..++.++|+||||+++|+|++|..||.+.+..+....+..
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~ 232 (361)
T 2yab_A 170 EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITA 232 (361)
T ss_dssp CTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHT
T ss_pred CCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 665555667899999999999999999999999999999999999999999888777666443
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=321.11 Aligned_cols=224 Identities=38% Similarity=0.769 Sum_probs=183.2
Q ss_pred CCCCeeeecccCcceeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECC
Q 020085 100 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP 179 (331)
Q Consensus 100 ~~~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 179 (331)
.+.+.++|..++|++.++||+|+||+||+|++.+ .||+|+++....+....+.+.+|+.++++++||||+++++++ ..
T Consensus 14 ~~~~~~ei~~~~y~~~~~lG~G~~g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~ 91 (289)
T 3og7_A 14 DAADDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TA 91 (289)
T ss_dssp ----CCBCCTTSCEEEEEEEECSSEEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CS
T ss_pred CCCCCCccCccceeeeeEecCCCCeEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cC
Confidence 4456789999999999999999999999998765 599999988777777788899999999999999999999965 45
Q ss_pred CCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeec
Q 020085 180 PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA 259 (331)
Q Consensus 180 ~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~ 259 (331)
...++||||+++++|.+++......+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||+++...
T Consensus 92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 171 (289)
T 3og7_A 92 PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKS 171 (289)
T ss_dssp SSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC------
T ss_pred CccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccc
Confidence 67899999999999999997777889999999999999999999999999999999999999999999999999997544
Q ss_pred C---CCccccCCCCcccccchhcC---CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccccccc
Q 020085 260 Q---SGVMTAETGTYRWMAPEVIE---HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSI 325 (331)
Q Consensus 260 ~---~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~ 325 (331)
. ........||+.|+|||.+. +..++.++||||||+++|+|++|+.||.+.+..+.....+.++..
T Consensus 172 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 243 (289)
T 3og7_A 172 RWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSL 243 (289)
T ss_dssp ------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSC
T ss_pred cccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhccccc
Confidence 3 22233456899999999986 667889999999999999999999999987766666665555543
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=315.97 Aligned_cols=221 Identities=31% Similarity=0.548 Sum_probs=197.9
Q ss_pred eeecccCcceeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECC--CCe
Q 020085 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--PNL 182 (331)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~--~~~ 182 (331)
++++.++|++.+.||+|+||.||+|++.++.||+|+++....+....+.+.+|+.++++++||||+++++++... ...
T Consensus 5 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (271)
T 3kmu_A 5 SGIDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHP 84 (271)
T ss_dssp CCCCGGGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSC
T ss_pred CCCCHHHhHHHHHhcCCCcceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCe
Confidence 567889999999999999999999999999999999998776777778899999999999999999999999877 778
Q ss_pred EEEEeccCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCCEEEcCCCcEEEeeecceeeec
Q 020085 183 CIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGMNYLHQNN--IIHRDLKTANLLMDENGVVKVADFGVARVQA 259 (331)
Q Consensus 183 ~lV~E~~~ggsL~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~ 259 (331)
++||||+++|+|.+++..... .+++..+..++.|+++||.|||++| ++||||||+||+++.++.++++|||++....
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~ 164 (271)
T 3kmu_A 85 TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ 164 (271)
T ss_dssp EEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS
T ss_pred EeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeec
Confidence 999999999999999976543 5899999999999999999999999 9999999999999999999999999875422
Q ss_pred CCCccccCCCCcccccchhcCCCCCCC---hhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccccccccccc
Q 020085 260 QSGVMTAETGTYRWMAPEVIEHKPYDY---KADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIHSII 329 (331)
Q Consensus 260 ~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~p~~~ 329 (331)
.....+|+.|+|||.+.+..++. ++||||||+++|||++|+.||.+.+..+....+...+.+|.++
T Consensus 165 ----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~ 233 (271)
T 3kmu_A 165 ----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIP 233 (271)
T ss_dssp ----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCCCC
T ss_pred ----ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCCCC
Confidence 23456899999999998765544 8999999999999999999999999988888877777777654
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=319.60 Aligned_cols=214 Identities=27% Similarity=0.477 Sum_probs=185.3
Q ss_pred ecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeE
Q 020085 107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183 (331)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 183 (331)
+-.++|++.+.||+|+||.||++++ .++.||+|++.... ......+.+.+|+.++++++||||+++++++..+...+
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 87 (294)
T 4eqm_A 8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYY 87 (294)
T ss_dssp CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEE
T ss_pred HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEE
Confidence 3467899999999999999999997 57899999986543 34566788999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC-
Q 020085 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG- 262 (331)
Q Consensus 184 lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~- 262 (331)
+||||++|++|.+++.. .+.+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+++......
T Consensus 88 lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 166 (294)
T 4eqm_A 88 LVMEYIEGPTLSEYIES-HGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL 166 (294)
T ss_dssp EEEECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred EEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence 99999999999999966 4679999999999999999999999999999999999999999999999999997554332
Q ss_pred -ccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 263 -VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 263 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.+.+..+......+
T Consensus 167 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~ 226 (294)
T 4eqm_A 167 TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQ 226 (294)
T ss_dssp --------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHS
T ss_pred cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhh
Confidence 22334689999999999999999999999999999999999999999988777666554
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=336.89 Aligned_cols=217 Identities=23% Similarity=0.359 Sum_probs=189.0
Q ss_pred eeecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCC
Q 020085 105 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN 181 (331)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 181 (331)
+.+..++|++.++||+|+||+||++++ .++.||+|+++.... .....+.+.+|+.+++.++||||++++++|.++..
T Consensus 64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 143 (410)
T 3v8s_A 64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 143 (410)
T ss_dssp HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence 456678999999999999999999998 468899999964210 00112347899999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC
Q 020085 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261 (331)
Q Consensus 182 ~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~ 261 (331)
+|+||||++||+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 144 ~~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~ 221 (410)
T 3v8s_A 144 LYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE 221 (410)
T ss_dssp EEEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccC
Confidence 9999999999999999965 46899999999999999999999999999999999999999999999999999876554
Q ss_pred Cc--cccCCCCcccccchhcCCCC----CCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccccc
Q 020085 262 GV--MTAETGTYRWMAPEVIEHKP----YDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKV 323 (331)
Q Consensus 262 ~~--~~~~~gt~~y~aPE~~~~~~----~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~ 323 (331)
.. ....+||+.|+|||++.+.. ++.++|+|||||++|||++|+.||.+.+..+....++...
T Consensus 222 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~ 289 (410)
T 3v8s_A 222 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHK 289 (410)
T ss_dssp SEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHH
T ss_pred CcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhcc
Confidence 32 23567999999999997665 7899999999999999999999999999888888776543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=325.48 Aligned_cols=213 Identities=27% Similarity=0.490 Sum_probs=188.7
Q ss_pred ecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeE
Q 020085 107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183 (331)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 183 (331)
+..++|++.+.||+|+||.||+++. +++.||+|+++..... ....+.+.+|..+++.++||||+++++++.+...+|
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~ 82 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIF 82 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEE
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEE
Confidence 3467899999999999999999998 5789999999743211 122456889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCc
Q 020085 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV 263 (331)
Q Consensus 184 lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~ 263 (331)
+||||++||+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 83 lv~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-- 159 (318)
T 1fot_A 83 MIMDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-- 159 (318)
T ss_dssp EEECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--
T ss_pred EEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc--
Confidence 99999999999999976 567999999999999999999999999999999999999999999999999999865432
Q ss_pred cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccc
Q 020085 264 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK 322 (331)
Q Consensus 264 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~ 322 (331)
....+||+.|+|||++.+..++.++|+|||||++|||++|+.||.+.+..+....+...
T Consensus 160 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~ 218 (318)
T 1fot_A 160 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA 218 (318)
T ss_dssp BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC
T ss_pred cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence 34567999999999999999999999999999999999999999998888777766543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-43 Score=319.73 Aligned_cols=209 Identities=30% Similarity=0.514 Sum_probs=186.4
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~ 186 (331)
.++|++.++||+|+||+||+|.+ .++.||+|++....... .+.+.+|+.++++++||||+++++++..++..++||
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 96 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH--HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEE
Confidence 46899999999999999999986 67899999997553322 356889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC-ccc
Q 020085 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMT 265 (331)
Q Consensus 187 E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~-~~~ 265 (331)
||++||+|.+++.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++...... ...
T Consensus 97 e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 174 (297)
T 3fxz_A 97 EYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS 174 (297)
T ss_dssp ECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred ECCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccC
Confidence 99999999999965 368999999999999999999999999999999999999999999999999997655433 334
Q ss_pred cCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 266 ~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
...||+.|+|||++.+..++.++||||||+++|||++|+.||.+.++.+....+..
T Consensus 175 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~ 230 (297)
T 3fxz_A 175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT 230 (297)
T ss_dssp CCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred CccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 56799999999999999999999999999999999999999999888777666443
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-43 Score=328.54 Aligned_cols=225 Identities=30% Similarity=0.591 Sum_probs=196.3
Q ss_pred CCeeeecccCcceeeeeeecCceEEEEEEECC---------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCccee
Q 020085 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCS---------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQ 171 (331)
Q Consensus 102 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~---------~~vavK~~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~ 171 (331)
...|++..++|.+.++||+|+||.||+|++.+ ..||+|+++... .....+.+.+|+.+++++ +||||++
T Consensus 61 ~~~~~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpnIv~ 139 (382)
T 3tt0_A 61 DPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIIN 139 (382)
T ss_dssp CTTTBCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CcccccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeecccc-CHHHHHHHHHHHHHHHHhcCCchhhh
Confidence 35589999999999999999999999999733 469999998663 455668899999999999 8999999
Q ss_pred EEeEEECCCCeEEEEeccCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCC
Q 020085 172 FIGACTRPPNLCIVTEFMARGSIYDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKT 236 (331)
Q Consensus 172 ~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp 236 (331)
++++|...+..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||++||+||||||
T Consensus 140 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp 219 (382)
T 3tt0_A 140 LLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAA 219 (382)
T ss_dssp EEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred heeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCc
Confidence 9999999999999999999999999997653 3589999999999999999999999999999999
Q ss_pred CCEEEcCCCcEEEeeecceeeecCCC---ccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCH
Q 020085 237 ANLLMDENGVVKVADFGVARVQAQSG---VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTP 312 (331)
Q Consensus 237 ~NiLi~~~~~vkl~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~ 312 (331)
+|||++.++.+||+|||+++...... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+.+.
T Consensus 220 ~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~ 299 (382)
T 3tt0_A 220 RNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 299 (382)
T ss_dssp GGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred ceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999999998654332 2334457889999999999999999999999999999999 9999999887
Q ss_pred HHHHhccccccccccc
Q 020085 313 LQAAVGVVQKVSIHSI 328 (331)
Q Consensus 313 ~~~~~~~~~~~~~p~~ 328 (331)
.+.... +..+.++..
T Consensus 300 ~~~~~~-~~~~~~~~~ 314 (382)
T 3tt0_A 300 EELFKL-LKEGHRMDK 314 (382)
T ss_dssp HHHHHH-HHTTCCCCC
T ss_pred HHHHHH-HHcCCCCCC
Confidence 776555 445555544
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=322.49 Aligned_cols=214 Identities=28% Similarity=0.435 Sum_probs=184.0
Q ss_pred eecccCcceeeeeeecCceEEEEEEE-CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEE
Q 020085 106 EIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI 184 (331)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~l 184 (331)
+.-.++|++.++||+|+||+||+|++ .++.||+|+++....+......+.+|+.++++++||||+++++++..+...++
T Consensus 17 q~l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 96 (311)
T 3niz_A 17 QGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTL 96 (311)
T ss_dssp ECSSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEE
T ss_pred cchHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEE
Confidence 34467899999999999999999998 67899999998665445456788999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC-Cc
Q 020085 185 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GV 263 (331)
Q Consensus 185 V~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~-~~ 263 (331)
||||+++ +|.+++......+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++..... ..
T Consensus 97 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~ 175 (311)
T 3niz_A 97 VFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRS 175 (311)
T ss_dssp EEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-
T ss_pred EEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCccc
Confidence 9999986 899998877778999999999999999999999999999999999999999999999999999876433 23
Q ss_pred cccCCCCcccccchhcCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccc
Q 020085 264 MTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 264 ~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~ 320 (331)
.....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||++.+..+....+.
T Consensus 176 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 233 (311)
T 3niz_A 176 YTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIF 233 (311)
T ss_dssp --CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHH
T ss_pred ccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 445678999999999876 568999999999999999999999999876655555443
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-43 Score=323.21 Aligned_cols=216 Identities=25% Similarity=0.453 Sum_probs=179.9
Q ss_pred eeecccCcceeeeeeecCceEEEEEEE-----CCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhcCCCcceeEEeEEE
Q 020085 105 WEIDAKQLKIECKVASGSYGDLYKGTY-----CSQEVAIKVLKPECV--NTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177 (331)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 177 (331)
..+..++|++.+.||+|+||.||+++. .++.||+|+++.... +......+.+|+.++++++||||+++++++.
T Consensus 12 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~ 91 (327)
T 3a62_A 12 EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQ 91 (327)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEE
T ss_pred CCCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEE
Confidence 356678999999999999999999987 568899999986532 2234466889999999999999999999999
Q ss_pred CCCCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceee
Q 020085 178 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV 257 (331)
Q Consensus 178 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~ 257 (331)
....+|+||||++|++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 92 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 92 TGGKLYLILEYLSGGELFMQLER-EGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp CSSCEEEEEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred cCCEEEEEEeCCCCCcHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 99999999999999999999965 46789999999999999999999999999999999999999999999999999975
Q ss_pred ecCC-CccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 258 QAQS-GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 258 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
.... .......||+.|+|||++.+..++.++|+||||+++|+|++|+.||.+.+..+....+.+
T Consensus 171 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~ 235 (327)
T 3a62_A 171 SIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK 235 (327)
T ss_dssp --------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh
Confidence 4332 223445799999999999999999999999999999999999999999888777666543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-43 Score=318.65 Aligned_cols=204 Identities=33% Similarity=0.517 Sum_probs=183.8
Q ss_pred eeecccCcceeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCe
Q 020085 105 WEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL 182 (331)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 182 (331)
+.+..++|.+.+.||+|+||+||++++. ++.||+|++... +....+.+.+|+.++++++||||+++++++..+...
T Consensus 5 ~~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 82 (310)
T 3s95_A 5 RIFRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF--DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRL 82 (310)
T ss_dssp EEECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEE
T ss_pred eeeChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCee
Confidence 4567889999999999999999999984 789999998653 566678899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC
Q 020085 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262 (331)
Q Consensus 183 ~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~ 262 (331)
++||||+++|+|.+++......+++..+..++.|+++||+|||++|++||||||+||+++.++.+||+|||+++......
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 162 (310)
T 3s95_A 83 NFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK 162 (310)
T ss_dssp EEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred EEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence 99999999999999998877889999999999999999999999999999999999999999999999999998654332
Q ss_pred cc---------------ccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 020085 263 VM---------------TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL 310 (331)
Q Consensus 263 ~~---------------~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~ 310 (331)
.. ....||+.|+|||.+.+..++.++||||||+++|||++|..||...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~ 225 (310)
T 3s95_A 163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDY 225 (310)
T ss_dssp -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTT
T ss_pred ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcch
Confidence 21 1446899999999999999999999999999999999999998764
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=316.72 Aligned_cols=221 Identities=32% Similarity=0.633 Sum_probs=191.8
Q ss_pred CCeeeecccCcceeeeeeecCceEEEEEEECC-ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCC
Q 020085 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (331)
Q Consensus 102 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 180 (331)
...|+++.++|++.+.||+|+||.||++.+.+ ..||+|+++...... +.+.+|+.++++++||||+++++++....
T Consensus 16 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 92 (283)
T 3gen_A 16 YGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQR 92 (283)
T ss_dssp CCTTBCCGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred CCCccCCHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCCH---HHHHHHHHHHhcCCCCCEeeEEEEEecCC
Confidence 35689999999999999999999999999865 589999998765443 56889999999999999999999999999
Q ss_pred CeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecC
Q 020085 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (331)
Q Consensus 181 ~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~ 260 (331)
..++||||+++++|.+++......+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++....
T Consensus 93 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 93 PIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp SEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred CeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 99999999999999999987667899999999999999999999999999999999999999999999999999975543
Q ss_pred CC--ccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhccccccccc
Q 020085 261 SG--VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIH 326 (331)
Q Consensus 261 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p 326 (331)
.. ......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||...+..+....+. ++.++
T Consensus 173 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~-~~~~~ 240 (283)
T 3gen_A 173 DEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA-QGLRL 240 (283)
T ss_dssp HHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-TTCCC
T ss_pred cccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHh-cccCC
Confidence 21 1223456788999999998899999999999999999998 999999998887777644 34433
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=330.54 Aligned_cols=215 Identities=23% Similarity=0.422 Sum_probs=187.1
Q ss_pred eecccCcceeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-CHHHHHHHHHHHHHHHhc-CCCcceeEEeEEECCCC
Q 020085 106 EIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPN 181 (331)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~ 181 (331)
.+..++|++.+.||+|+||.||++++. ++.||+|+++.... ..+..+.+..|..+++.+ +||||+++++++.....
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 95 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 95 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence 456789999999999999999999985 57899999975321 112346688899999988 79999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecC-
Q 020085 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ- 260 (331)
Q Consensus 182 ~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~- 260 (331)
+|+||||++||+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 96 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 174 (353)
T 2i0e_A 96 LYFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD 174 (353)
T ss_dssp EEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccC
Confidence 9999999999999999965 46799999999999999999999999999999999999999999999999999986432
Q ss_pred CCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 261 SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 261 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
.......+||+.|+|||++.+..++.++|+|||||++|||++|+.||.+.+..+....+..
T Consensus 175 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~ 235 (353)
T 2i0e_A 175 GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME 235 (353)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHh
Confidence 2334456799999999999999999999999999999999999999999888877776554
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=333.45 Aligned_cols=204 Identities=23% Similarity=0.427 Sum_probs=180.0
Q ss_pred eeecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhc-CCCcceeEEeEEECCC
Q 020085 105 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPP 180 (331)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~ 180 (331)
..+..++|++.++||+|+||+||+++. .++.||+|+++..... ....+.+.+|..+++++ +||||+++++++....
T Consensus 47 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~ 126 (396)
T 4dc2_A 47 SSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES 126 (396)
T ss_dssp --CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSS
T ss_pred cCCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECC
Confidence 456678999999999999999999998 4678999999865432 33445688999999887 8999999999999999
Q ss_pred CeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeec-
Q 020085 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA- 259 (331)
Q Consensus 181 ~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~- 259 (331)
.+|+||||++||+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++...
T Consensus 127 ~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 127 RLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEEEEEEcCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 99999999999999999976 4679999999999999999999999999999999999999999999999999998633
Q ss_pred CCCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCC
Q 020085 260 QSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAG 309 (331)
Q Consensus 260 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~ 309 (331)
........+||+.|+|||++.+..++.++|+|||||++|||++|+.||..
T Consensus 206 ~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~ 255 (396)
T 4dc2_A 206 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 255 (396)
T ss_dssp TTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTT
T ss_pred CCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcc
Confidence 33344566899999999999999999999999999999999999999964
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=333.32 Aligned_cols=205 Identities=24% Similarity=0.448 Sum_probs=183.5
Q ss_pred eeecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCC
Q 020085 105 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN 181 (331)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 181 (331)
..+..++|++.+.||+|+||.||++.+ .++.||+|+++.... .....+.+.+|+.++++++||||+++++++.....
T Consensus 10 ~~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~ 89 (384)
T 4fr4_A 10 EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEED 89 (384)
T ss_dssp CCCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSE
T ss_pred CCCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCE
Confidence 467788999999999999999999998 467899999864321 11234678899999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC
Q 020085 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261 (331)
Q Consensus 182 ~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~ 261 (331)
+|+||||+.||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.....
T Consensus 90 ~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 90 MFMVVDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp EEEEECCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred EEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 9999999999999999965 567999999999999999999999999999999999999999999999999999887766
Q ss_pred CccccCCCCcccccchhcCC---CCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 020085 262 GVMTAETGTYRWMAPEVIEH---KPYDYKADVFSFGIALWELLTGELPYAGL 310 (331)
Q Consensus 262 ~~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~SlG~il~ell~g~~Pf~~~ 310 (331)
......+||+.|+|||++.+ ..++.++|+|||||++|||++|+.||...
T Consensus 169 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~ 220 (384)
T 4fr4_A 169 TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIR 220 (384)
T ss_dssp CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCC
T ss_pred CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCC
Confidence 66677789999999999963 46899999999999999999999999753
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-43 Score=323.58 Aligned_cols=202 Identities=23% Similarity=0.433 Sum_probs=181.8
Q ss_pred ecccCcceeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-CHHHHHHHHHHHHHHHhc-CCCcceeEEeEEECCCCe
Q 020085 107 IDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNL 182 (331)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~ 182 (331)
+..++|++.+.||+|+||.||++++. ++.||+|+++.... .....+.+.+|..+++++ +||||+++++++.....+
T Consensus 6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~ 85 (345)
T 3a8x_A 6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRL 85 (345)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEE
Confidence 45678999999999999999999984 78899999986543 445667789999999988 899999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecC-C
Q 020085 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-S 261 (331)
Q Consensus 183 ~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~-~ 261 (331)
|+||||++||+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.... .
T Consensus 86 ~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~ 164 (345)
T 3a8x_A 86 FFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG 164 (345)
T ss_dssp EEEECCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT
T ss_pred EEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCC
Confidence 999999999999999965 46799999999999999999999999999999999999999999999999999986432 2
Q ss_pred CccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCC
Q 020085 262 GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAG 309 (331)
Q Consensus 262 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~ 309 (331)
......+||+.|+|||++.+..++.++|+|||||++|||++|+.||..
T Consensus 165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 165 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence 334556899999999999999999999999999999999999999975
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=327.65 Aligned_cols=214 Identities=25% Similarity=0.454 Sum_probs=185.9
Q ss_pred eecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhc-CCCcceeEEeEEECCCC
Q 020085 106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPN 181 (331)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~ 181 (331)
.+..++|.+.+.||+|+||.||+|++ .++.||||+++.... ..+..+.+..|..+++.+ +||||+++++++.....
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 45678999999999999999999998 478899999975321 111245678899999887 89999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecC-
Q 020085 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ- 260 (331)
Q Consensus 182 ~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~- 260 (331)
+|+||||++||+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 93 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 171 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 171 (345)
T ss_dssp EEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccC
Confidence 9999999999999999965 46799999999999999999999999999999999999999999999999999975432
Q ss_pred CCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccc
Q 020085 261 SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 261 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~ 320 (331)
.......+||+.|+|||++.+..++.++|+|||||++|||++|+.||.+.+..+....+.
T Consensus 172 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~ 231 (345)
T 1xjd_A 172 DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR 231 (345)
T ss_dssp TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 233455689999999999999999999999999999999999999999988877766644
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=312.04 Aligned_cols=214 Identities=31% Similarity=0.596 Sum_probs=190.9
Q ss_pred eeeecccCcceeeeeeecCceEEEEEEECC-ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCe
Q 020085 104 VWEIDAKQLKIECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL 182 (331)
Q Consensus 104 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 182 (331)
.+++..++|++.+.||+|+||.||++.+.+ ..||+|+++...... +.+.+|+.++++++||||+++++++......
T Consensus 2 ~~~l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (268)
T 3sxs_A 2 HMELKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE---DEFFQEAQTMMKLSHPKLVKFYGVCSKEYPI 78 (268)
T ss_dssp TTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSSSE
T ss_pred ceEechhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCcH---HHHHHHHHHHHhCCCCCEeeEEEEEccCCce
Confidence 367889999999999999999999999865 579999998765443 5688999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC
Q 020085 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262 (331)
Q Consensus 183 ~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~ 262 (331)
++||||+++++|.+++......+++..++.++.|++.||+|||++|++||||||+||+++.++.++|+|||+++......
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 79 YIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp EEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred EEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 99999999999999998766779999999999999999999999999999999999999999999999999998665443
Q ss_pred cc--ccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhccc
Q 020085 263 VM--TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 263 ~~--~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~ 320 (331)
.. ....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||...+..+....+.
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~ 219 (268)
T 3sxs_A 159 YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVS 219 (268)
T ss_dssp EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH
T ss_pred hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHH
Confidence 22 23346778999999998889999999999999999999 999999988877766643
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-43 Score=333.99 Aligned_cols=212 Identities=19% Similarity=0.362 Sum_probs=188.8
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~ 186 (331)
.++|++.+.||+|+||.||++.+ .++.+|+|+++.........+.+.+|+.++++++||||+++++++..+...|+||
T Consensus 10 ~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~ 89 (444)
T 3soa_A 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF 89 (444)
T ss_dssp HHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred cCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence 46899999999999999999988 5789999999877666666778999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEc---CCCcEEEeeecceeeecCCC-
Q 020085 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD---ENGVVKVADFGVARVQAQSG- 262 (331)
Q Consensus 187 E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~---~~~~vkl~DFg~a~~~~~~~- 262 (331)
||++||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++ +++.+||+|||+++......
T Consensus 90 E~~~gg~L~~~i~~-~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~ 168 (444)
T 3soa_A 90 DLVTGGELFEDIVA-REYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ 168 (444)
T ss_dssp CCCBCCBHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC
T ss_pred EeCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc
Confidence 99999999999976 46799999999999999999999999999999999999998 46789999999997655433
Q ss_pred ccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 263 VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 263 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
......||+.|+|||++.+..++.++||||+||++|+|++|..||.+.+..+....+..
T Consensus 169 ~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~ 227 (444)
T 3soa_A 169 AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKA 227 (444)
T ss_dssp BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh
Confidence 23456799999999999999999999999999999999999999999888777766543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-44 Score=341.17 Aligned_cols=217 Identities=23% Similarity=0.442 Sum_probs=180.4
Q ss_pred eeecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCC
Q 020085 105 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN 181 (331)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 181 (331)
+.+..++|++.+.||+|+||.||++.+ .++.||||+++.... .......+.+|+.++++++||||++++++|...+.
T Consensus 143 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~ 222 (446)
T 4ejn_A 143 HRVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDR 222 (446)
T ss_dssp -CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTE
T ss_pred cCCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCE
Confidence 456678999999999999999999998 578999999975421 23345678899999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEEcCCCcEEEeeecceeeecC
Q 020085 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (331)
Q Consensus 182 ~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~ 260 (331)
+|+||||+++|+|.+++.. .+.+++..+..++.||+.||+|||+ +||+||||||+|||++.++.+||+|||+++....
T Consensus 223 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 301 (446)
T 4ejn_A 223 LCFVMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 301 (446)
T ss_dssp EEEEECCCSSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred EEEEEeeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence 9999999999999999966 4679999999999999999999998 9999999999999999999999999999975332
Q ss_pred -CCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccc
Q 020085 261 -SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK 322 (331)
Q Consensus 261 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~ 322 (331)
........||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+...
T Consensus 302 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~ 364 (446)
T 4ejn_A 302 DGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME 364 (446)
T ss_dssp -----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred CCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhC
Confidence 23345568999999999999999999999999999999999999999998887776665543
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-43 Score=330.32 Aligned_cols=216 Identities=23% Similarity=0.435 Sum_probs=180.9
Q ss_pred eecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHH-HHhcCCCcceeEEeEEECCCC
Q 020085 106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYI-MRKIRHKNVVQFIGACTRPPN 181 (331)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~i-l~~l~h~niv~~~~~~~~~~~ 181 (331)
.+..++|++.+.||+|+||.||++++ .++.||+|+++.... .......+.+|..+ ++.++||||+++++++.....
T Consensus 34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~ 113 (373)
T 2r5t_A 34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK 113 (373)
T ss_dssp TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSE
T ss_pred CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE
Confidence 35577999999999999999999998 467899999976543 23344566777776 577899999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecC-
Q 020085 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ- 260 (331)
Q Consensus 182 ~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~- 260 (331)
+|+||||++||+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 114 ~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~ 192 (373)
T 2r5t_A 114 LYFVLDYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEH 192 (373)
T ss_dssp EEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC
T ss_pred EEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccC
Confidence 9999999999999999965 46789999999999999999999999999999999999999999999999999975332
Q ss_pred CCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccc
Q 020085 261 SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK 322 (331)
Q Consensus 261 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~ 322 (331)
.......+||+.|+|||++.+..++.++|+|||||++|||++|+.||.+.+..+....++..
T Consensus 193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~ 254 (373)
T 2r5t_A 193 NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNK 254 (373)
T ss_dssp CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHS
T ss_pred CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc
Confidence 33345568999999999999999999999999999999999999999998888877776543
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-43 Score=323.34 Aligned_cols=223 Identities=30% Similarity=0.565 Sum_probs=193.5
Q ss_pred eeeecccCcceeeeeeecCceEEEEEEECC-------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEE
Q 020085 104 VWEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC 176 (331)
Q Consensus 104 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 176 (331)
.+++..++|++.+.||+|+||.||+|++.+ +.||+|+++... ..+..+.+.+|+.++++++||||+++++++
T Consensus 41 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 41 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVC 119 (343)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred eeEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence 367788999999999999999999999864 789999998653 455677899999999999999999999999
Q ss_pred ECCCCeEEEEeccCCCCHHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Q 020085 177 TRPPNLCIVTEFMARGSIYDFLHKQK-----------------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233 (331)
Q Consensus 177 ~~~~~~~lV~E~~~ggsL~~~l~~~~-----------------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrD 233 (331)
......++||||+++|+|.+++.... ..+++..++.++.||++||.|||++||+|||
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~D 199 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 199 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCC
Confidence 99999999999999999999997642 5789999999999999999999999999999
Q ss_pred CCCCCEEEcCCCcEEEeeecceeeecCCC---ccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCC
Q 020085 234 LKTANLLMDENGVVKVADFGVARVQAQSG---VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAG 309 (331)
Q Consensus 234 lkp~NiLi~~~~~vkl~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~ 309 (331)
|||+||+++.++.+||+|||+++...... ......+|+.|+|||.+.+..++.++||||||+++|||++ |..||.+
T Consensus 200 lkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 279 (343)
T 1luf_A 200 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 279 (343)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred CCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCC
Confidence 99999999999999999999997543321 2234467899999999998899999999999999999999 9999999
Q ss_pred CCHHHHHhccccccccccc
Q 020085 310 LTPLQAAVGVVQKVSIHSI 328 (331)
Q Consensus 310 ~~~~~~~~~~~~~~~~p~~ 328 (331)
.+..+.... +.++.++.+
T Consensus 280 ~~~~~~~~~-~~~~~~~~~ 297 (343)
T 1luf_A 280 MAHEEVIYY-VRDGNILAC 297 (343)
T ss_dssp SCHHHHHHH-HHTTCCCCC
T ss_pred CChHHHHHH-HhCCCcCCC
Confidence 888776665 344555443
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=328.07 Aligned_cols=226 Identities=31% Similarity=0.587 Sum_probs=192.5
Q ss_pred CCeeeecccCcceeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCcceeEE
Q 020085 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFI 173 (331)
Q Consensus 102 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~ 173 (331)
...|++..++|++.+.||+|+||.||+|++. ++.||||+++... .....+.+.+|+.+++++ +||||++++
T Consensus 14 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hpniv~~~ 92 (359)
T 3vhe_A 14 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLL 92 (359)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred cccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcC-CHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence 4569999999999999999999999999853 3789999998653 445567899999999999 789999999
Q ss_pred eEEECCCC-eEEEEeccCCCCHHHHHHhcCC-------------------------------------------------
Q 020085 174 GACTRPPN-LCIVTEFMARGSIYDFLHKQKG------------------------------------------------- 203 (331)
Q Consensus 174 ~~~~~~~~-~~lV~E~~~ggsL~~~l~~~~~------------------------------------------------- 203 (331)
+++..... .++||||+++|+|.+++.....
T Consensus 93 ~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (359)
T 3vhe_A 93 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKS 172 (359)
T ss_dssp EEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------
T ss_pred eeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccc
Confidence 99987554 8999999999999999976432
Q ss_pred ----------------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC---cc
Q 020085 204 ----------------VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG---VM 264 (331)
Q Consensus 204 ----------------~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~---~~ 264 (331)
.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...... ..
T Consensus 173 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 252 (359)
T 3vhe_A 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 252 (359)
T ss_dssp -----------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC
T ss_pred cchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhc
Confidence 18899999999999999999999999999999999999999999999999997553322 22
Q ss_pred ccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhccccccccccc
Q 020085 265 TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIHSI 328 (331)
Q Consensus 265 ~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p~~ 328 (331)
....+|+.|+|||++.+..++.++||||||+++|||++ |+.||.+....+.....+..+.++.+
T Consensus 253 ~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~ 317 (359)
T 3vhe_A 253 GDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 317 (359)
T ss_dssp --CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCC
T ss_pred cccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCC
Confidence 33457889999999999999999999999999999998 99999987766655555655555544
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-43 Score=325.99 Aligned_cols=203 Identities=19% Similarity=0.359 Sum_probs=180.5
Q ss_pred CCeeeecccCcceeeeeeecCceEEEEEE-------ECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC---CCccee
Q 020085 102 TDVWEIDAKQLKIECKVASGSYGDLYKGT-------YCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR---HKNVVQ 171 (331)
Q Consensus 102 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~-------~~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~---h~niv~ 171 (331)
...+++..++|.+.+.||+|+||+||+|. ..++.||+|+++... ..++..|+.+++.++ |+||++
T Consensus 57 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~l~~~~~~~iv~ 131 (365)
T 3e7e_A 57 KTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN-----PWEFYIGTQLMERLKPSMQHMFMK 131 (365)
T ss_dssp SCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC-----HHHHHHHHHHHHHSCGGGGGGBCC
T ss_pred ceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC-----hhHHHHHHHHHHHhhhhhhhhhhh
Confidence 45688899999999999999999999993 367899999998652 346778888888886 899999
Q ss_pred EEeEEECCCCeEEEEeccCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC----
Q 020085 172 FIGACTRPPNLCIVTEFMARGSIYDFLHK----QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE---- 243 (331)
Q Consensus 172 ~~~~~~~~~~~~lV~E~~~ggsL~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~---- 243 (331)
+++++...+..++||||+++|+|.+++.. ....+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 132 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~ 211 (365)
T 3e7e_A 132 FYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLE 211 (365)
T ss_dssp EEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTC
T ss_pred hheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccC
Confidence 99999999999999999999999999975 3467999999999999999999999999999999999999998
Q ss_pred -------CCcEEEeeecceeeec---CCCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCC
Q 020085 244 -------NGVVKVADFGVARVQA---QSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAG 309 (331)
Q Consensus 244 -------~~~vkl~DFg~a~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~ 309 (331)
++.+||+|||+++... .........||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus 212 ~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~ 287 (365)
T 3e7e_A 212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVK 287 (365)
T ss_dssp C------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred ccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCcccc
Confidence 8999999999997543 23344566799999999999999999999999999999999999999854
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=317.98 Aligned_cols=211 Identities=25% Similarity=0.449 Sum_probs=182.5
Q ss_pred cCcceeeeeeecCceEEEEEEEC-CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEec
Q 020085 110 KQLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF 188 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~ 188 (331)
++|++.+.||+|+||+||+|++. ++.||+|+++....+....+.+.+|+.++++++||||+++++++..+...++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 57999999999999999999984 78999999976543333346788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC-CccccC
Q 020085 189 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTAE 267 (331)
Q Consensus 189 ~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~-~~~~~~ 267 (331)
+++ +|.+++....+.+++..+..++.|+++||+|||++||+||||||+||+++.++.+||+|||+++..... ......
T Consensus 82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 160 (288)
T 1ob3_A 82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE 160 (288)
T ss_dssp CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccccccccc
Confidence 987 999999877788999999999999999999999999999999999999999999999999999754432 223455
Q ss_pred CCCcccccchhcCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 268 TGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 268 ~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
.+|+.|+|||++.+ ..++.++||||||+++|||++|+.||.+.+..+....+.+
T Consensus 161 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~ 215 (288)
T 1ob3_A 161 IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFR 215 (288)
T ss_dssp -CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 78999999999976 4589999999999999999999999999888776666544
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-42 Score=314.34 Aligned_cols=211 Identities=24% Similarity=0.430 Sum_probs=185.3
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEe
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E 187 (331)
++|++.++||+|+||+||+|++ .++.||+|+++...........+.+|+.++++++||||+++++++..+...++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 5799999999999999999998 57889999998766566666789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC-Ccccc
Q 020085 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTA 266 (331)
Q Consensus 188 ~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~-~~~~~ 266 (331)
|+++ ++.+.+....+.+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++..... .....
T Consensus 82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 160 (292)
T 3o0g_A 82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA 160 (292)
T ss_dssp CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCCS
T ss_pred cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccccccC
Confidence 9986 777777676788999999999999999999999999999999999999999999999999999866433 23445
Q ss_pred CCCCcccccchhcCCCC-CCChhhHHHHHHHHHHHHcCCCC-CCCCCHHHHHhcccc
Q 020085 267 ETGTYRWMAPEVIEHKP-YDYKADVFSFGIALWELLTGELP-YAGLTPLQAAVGVVQ 321 (331)
Q Consensus 267 ~~gt~~y~aPE~~~~~~-~~~~~Di~SlG~il~ell~g~~P-f~~~~~~~~~~~~~~ 321 (331)
..+|+.|+|||++.+.. ++.++||||||+++|+|++|..| |.+.+..+....+.+
T Consensus 161 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~ 217 (292)
T 3o0g_A 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR 217 (292)
T ss_dssp CCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHH
T ss_pred CccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHH
Confidence 67899999999997765 89999999999999999987766 677776666665544
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=320.32 Aligned_cols=211 Identities=25% Similarity=0.424 Sum_probs=187.8
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCH----HHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCe
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNT----EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL 182 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~----~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 182 (331)
.+.|.+.+.||+|+||.||++++ .++.||+|+++...... ...+.+.+|+.++++++||||+++++++......
T Consensus 10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEE
Confidence 45799999999999999999998 47899999997543221 1246789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC----cEEEeeecceeee
Q 020085 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG----VVKVADFGVARVQ 258 (331)
Q Consensus 183 ~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~----~vkl~DFg~a~~~ 258 (331)
++||||+++++|.+++.. .+.+++..+..++.|++.||.|||++||+||||||+|||++.++ .+||+|||+++..
T Consensus 90 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~ 168 (326)
T 2y0a_A 90 ILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI 168 (326)
T ss_dssp EEEEECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeEC
Confidence 999999999999999965 56799999999999999999999999999999999999999888 7999999999877
Q ss_pred cCCCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccc
Q 020085 259 AQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 259 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~ 320 (331)
..........||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+..+....+.
T Consensus 169 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~ 230 (326)
T 2y0a_A 169 DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS 230 (326)
T ss_dssp CTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH
T ss_pred CCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHH
Confidence 65555566789999999999999999999999999999999999999999887766655543
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-43 Score=335.98 Aligned_cols=222 Identities=34% Similarity=0.653 Sum_probs=193.3
Q ss_pred CCeeeecccCcceeeeeeecCceEEEEEEEC-CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCC
Q 020085 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (331)
Q Consensus 102 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 180 (331)
.+.|+++.++|++.++||+|+||.||+|++. +..||||+++..... .+.|.+|+.++++++||||+++++++. ..
T Consensus 180 ~~~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~ 255 (454)
T 1qcf_A 180 KDAWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS---VEAFLAEANVMKTLQHDKLVKLHAVVT-KE 255 (454)
T ss_dssp TTCSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSBC---HHHHHHHHHHHTTCCCTTBCCEEEEEC-SS
T ss_pred ccceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCcc---HHHHHHHHHHHhhCCCCCEeeEEEEEe-CC
Confidence 4569999999999999999999999999995 678999999876433 468999999999999999999999987 56
Q ss_pred CeEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeec
Q 020085 181 NLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA 259 (331)
Q Consensus 181 ~~~lV~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~ 259 (331)
..++||||+++|+|.+++.... ..++...+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 256 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 335 (454)
T 1qcf_A 256 PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIE 335 (454)
T ss_dssp SCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred ccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence 7899999999999999997543 368899999999999999999999999999999999999999999999999997654
Q ss_pred CCCc--cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhccccccccccc
Q 020085 260 QSGV--MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIHSI 328 (331)
Q Consensus 260 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p~~ 328 (331)
.... .....+++.|+|||++....++.++||||||+++|||++ |+.||.+.+..+.... +.++.+++.
T Consensus 336 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~-i~~~~~~~~ 406 (454)
T 1qcf_A 336 DNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA-LERGYRMPR 406 (454)
T ss_dssp CHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH-HHHTCCCCC
T ss_pred CCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCCCC
Confidence 3211 123346789999999998999999999999999999999 9999999998887766 445666544
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-43 Score=313.86 Aligned_cols=222 Identities=29% Similarity=0.539 Sum_probs=180.8
Q ss_pred CeeeecccCcceeeeeeecCceEEEEEEEC-----CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEE
Q 020085 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177 (331)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 177 (331)
..+++..++|++.+.||+|+||.||+|.+. +..||+|+++... .....+.+.+|+.++++++||||+++++++.
T Consensus 8 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 86 (281)
T 1mp8_A 8 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT 86 (281)
T ss_dssp -CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred cceEEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCccceEEEEEc
Confidence 347888999999999999999999999884 3469999987643 4556678999999999999999999999985
Q ss_pred CCCCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceee
Q 020085 178 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV 257 (331)
Q Consensus 178 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~ 257 (331)
++..++||||+++++|.+++......+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+++.
T Consensus 87 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 165 (281)
T 1mp8_A 87 -ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165 (281)
T ss_dssp -SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------
T ss_pred -cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccc
Confidence 4578999999999999999987767899999999999999999999999999999999999999999999999999986
Q ss_pred ecCCCc--cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhcccccccccc
Q 020085 258 QAQSGV--MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIHS 327 (331)
Q Consensus 258 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p~ 327 (331)
...... .....+++.|+|||.+.+..++.++||||||+++|||++ |..||.+.+..+....+ .++.+++
T Consensus 166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i-~~~~~~~ 237 (281)
T 1mp8_A 166 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-ENGERLP 237 (281)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHH-HTTCCCC
T ss_pred cCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHH-HcCCCCC
Confidence 544322 223456789999999998999999999999999999997 99999988776655553 3444443
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=336.13 Aligned_cols=214 Identities=25% Similarity=0.367 Sum_probs=183.9
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCC------
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP------ 180 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~------ 180 (331)
.++|++.++||+|+||+||+|.+ .++.||||++.....+....+.+.+|+.+++.++||||+++++++....
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 56899999999999999999988 5789999999876556677788999999999999999999999997653
Q ss_pred CeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecC
Q 020085 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (331)
Q Consensus 181 ~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~ 260 (331)
..|+||||+++ +|.+.+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 141 ~~~lv~E~~~~-~l~~~~~---~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 216 (464)
T 3ttj_A 141 DVYLVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 216 (464)
T ss_dssp EEEEEEECCSE-EHHHHHT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred eEEEEEeCCCC-CHHHHHh---hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence 46999999987 5777763 3589999999999999999999999999999999999999999999999999987766
Q ss_pred CCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccccccc
Q 020085 261 SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIH 326 (331)
Q Consensus 261 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~p 326 (331)
....+...||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+....+++....|
T Consensus 217 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p 282 (464)
T 3ttj_A 217 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTP 282 (464)
T ss_dssp CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSC
T ss_pred CcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence 656667789999999999999999999999999999999999999999999888877776644433
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=327.92 Aligned_cols=221 Identities=32% Similarity=0.565 Sum_probs=182.5
Q ss_pred eeecccCcceeeeeeecCceEEEEEEEC-----CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECC
Q 020085 105 WEIDAKQLKIECKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP 179 (331)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 179 (331)
.+++.++|++.+.||+|+||.||+|++. +..||||+++... .....+.|.+|+.++++++||||+++++++...
T Consensus 40 ~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 118 (373)
T 2qol_A 40 KELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY-TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS 118 (373)
T ss_dssp CBCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS
T ss_pred hhcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC
Confidence 5678899999999999999999999874 5679999998653 455667899999999999999999999999999
Q ss_pred CCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeec
Q 020085 180 PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA 259 (331)
Q Consensus 180 ~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~ 259 (331)
...++||||+++|+|.+++......+++..+..++.|+++||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 119 ~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~ 198 (373)
T 2qol_A 119 KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLE 198 (373)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-------
T ss_pred CceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccc
Confidence 99999999999999999998766789999999999999999999999999999999999999999999999999998654
Q ss_pred CCCc----cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhcccccccccc
Q 020085 260 QSGV----MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIHS 327 (331)
Q Consensus 260 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p~ 327 (331)
.... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...+..+.... +..+.+++
T Consensus 199 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~-i~~~~~~~ 270 (373)
T 2qol_A 199 DDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKA-VDEGYRLP 270 (373)
T ss_dssp ---------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHH-HHTTEECC
T ss_pred cCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCCC
Confidence 4321 112235678999999999999999999999999999998 9999999888776665 33454443
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=326.76 Aligned_cols=211 Identities=20% Similarity=0.409 Sum_probs=189.5
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~ 186 (331)
.+.|++.+.||+|+||.||+|.+ .++.||+|+++... ......+.+|+.++++++||||+++++++......++||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~ 127 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 127 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEE
Confidence 36899999999999999999998 47889999997653 334567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC--CCcEEEeeecceeeecCCCcc
Q 020085 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE--NGVVKVADFGVARVQAQSGVM 264 (331)
Q Consensus 187 E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~--~~~vkl~DFg~a~~~~~~~~~ 264 (331)
||++||+|.+++......+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++........
T Consensus 128 E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~ 207 (387)
T 1kob_A 128 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV 207 (387)
T ss_dssp ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE
T ss_pred EcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCcce
Confidence 999999999999766668999999999999999999999999999999999999974 467999999999877665555
Q ss_pred ccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 265 TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 265 ~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+.+
T Consensus 208 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~ 264 (387)
T 1kob_A 208 KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKR 264 (387)
T ss_dssp EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHH
T ss_pred eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 566899999999999999999999999999999999999999999888776666443
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-43 Score=322.20 Aligned_cols=206 Identities=32% Similarity=0.526 Sum_probs=180.1
Q ss_pred CCCCeeeecccCcceeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECC
Q 020085 100 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP 179 (331)
Q Consensus 100 ~~~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 179 (331)
+++..+.++.++|++.++||+|+||+||+|++.++.||||+++.. ......+.+|+.++++++||||+++++++...
T Consensus 14 ~~~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~ 90 (322)
T 3soc_A 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQ---DKQSWQNEYEVYSLPGMKHENILQFIGAEKRG 90 (322)
T ss_dssp CCCCCEEETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEE
T ss_pred cCccccccchhhchhhheecccCceEEEEEEECCCEEEEEEeecC---chHHHHHHHHHHHHhcCCCCCchhhcceeccC
Confidence 455678899999999999999999999999999999999999754 23345566799999999999999999999875
Q ss_pred CC----eEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC----------CcccCCCCCCCEEEcCCC
Q 020085 180 PN----LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN----------NIIHRDLKTANLLMDENG 245 (331)
Q Consensus 180 ~~----~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~----------~iiHrDlkp~NiLi~~~~ 245 (331)
.. +++||||+++|+|.+++.. ..+++..+..++.|++.||+|||+. ||+||||||+|||++.++
T Consensus 91 ~~~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~ 168 (322)
T 3soc_A 91 TSVDVDLWLITAFHEKGSLSDFLKA--NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNL 168 (322)
T ss_dssp CSSSEEEEEEEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTC
T ss_pred CCCCceEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCC
Confidence 43 6999999999999999965 4589999999999999999999999 999999999999999999
Q ss_pred cEEEeeecceeeecCCCc---cccCCCCcccccchhcCCC-----CCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 020085 246 VVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHK-----PYDYKADVFSFGIALWELLTGELPYAGL 310 (331)
Q Consensus 246 ~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~-----~~~~~~Di~SlG~il~ell~g~~Pf~~~ 310 (331)
.+||+|||+++....... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+.
T Consensus 169 ~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~ 241 (322)
T 3soc_A 169 TACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP 241 (322)
T ss_dssp CEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSC
T ss_pred eEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCC
Confidence 999999999986654322 2335789999999999763 4567889999999999999999999753
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-43 Score=325.89 Aligned_cols=211 Identities=26% Similarity=0.415 Sum_probs=187.9
Q ss_pred cccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEE
Q 020085 108 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI 184 (331)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~l 184 (331)
..++|++.+.||+|+||.||++++ .++.||+|+++.... .....+.+.+|+.+++.++||||+++++++.....+|+
T Consensus 39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 118 (350)
T 1rdq_E 39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYM 118 (350)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEE
T ss_pred CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence 356899999999999999999998 478999999964321 11234678899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCcc
Q 020085 185 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM 264 (331)
Q Consensus 185 V~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~ 264 (331)
||||++||+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++..... .
T Consensus 119 v~e~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--~ 195 (350)
T 1rdq_E 119 VMEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--T 195 (350)
T ss_dssp EEECCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--B
T ss_pred EEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC--c
Confidence 9999999999999976 467999999999999999999999999999999999999999999999999999866443 3
Q ss_pred ccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 265 TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 265 ~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
...+||+.|+|||++.+..++.++|+|||||++|||++|+.||.+.++.+....+..
T Consensus 196 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~ 252 (350)
T 1rdq_E 196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVS 252 (350)
T ss_dssp CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHc
Confidence 455799999999999999999999999999999999999999999988887776554
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=326.27 Aligned_cols=216 Identities=21% Similarity=0.398 Sum_probs=191.0
Q ss_pred eeecccCcceeeeeeec--CceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCC
Q 020085 105 WEIDAKQLKIECKVASG--SYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (331)
Q Consensus 105 ~~i~~~~~~~~~~lg~G--~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 180 (331)
+..+.++|++.++||+| +||.||++++. ++.||||+++......+..+.+.+|+.++++++||||+++++++..+.
T Consensus 20 ~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~ 99 (389)
T 3gni_B 20 FLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN 99 (389)
T ss_dssp CCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETT
T ss_pred ccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECC
Confidence 44567899999999999 99999999984 789999999877667777788999999999999999999999999999
Q ss_pred CeEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeec
Q 020085 181 NLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA 259 (331)
Q Consensus 181 ~~~lV~E~~~ggsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~ 259 (331)
.+++||||+++|+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||.+....
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~ 179 (389)
T 3gni_B 100 ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMI 179 (389)
T ss_dssp EEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECE
T ss_pred EEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeec
Confidence 999999999999999999764 3679999999999999999999999999999999999999999999999999986443
Q ss_pred CCC--------ccccCCCCcccccchhcCC--CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccc
Q 020085 260 QSG--------VMTAETGTYRWMAPEVIEH--KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 260 ~~~--------~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~ 320 (331)
..+ ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+....++
T Consensus 180 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~ 250 (389)
T 3gni_B 180 SHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKL 250 (389)
T ss_dssp ETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-
T ss_pred cccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHh
Confidence 221 1223468999999999987 679999999999999999999999999887766666544
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=309.27 Aligned_cols=212 Identities=22% Similarity=0.416 Sum_probs=192.6
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~ 186 (331)
.++|++.+.||+|+||.||+|.+ .++.||+|+++....+....+.+.+|+.++++++||||+++++++..+...++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 46899999999999999999988 4789999999877667777788999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCc---EEEeeecceeeecCCCc
Q 020085 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV---VKVADFGVARVQAQSGV 263 (331)
Q Consensus 187 E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~---vkl~DFg~a~~~~~~~~ 263 (331)
||+++++|.+.+.. ...+++..+..++.|++.||+|||++|++||||||+||+++.++. +||+|||.+........
T Consensus 85 e~~~~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~ 163 (284)
T 3kk8_A 85 DLVTGGELFEDIVA-REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 163 (284)
T ss_dssp CCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB
T ss_pred ecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc
Confidence 99999999999866 467899999999999999999999999999999999999987665 99999999987776655
Q ss_pred cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 264 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 264 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
.....||+.|+|||.+.+..++.++||||||+++|+|++|+.||.+.+..+....+..
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~ 221 (284)
T 3kk8_A 164 WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA 221 (284)
T ss_dssp CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHh
Confidence 5667899999999999999999999999999999999999999999888777666543
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=332.92 Aligned_cols=223 Identities=37% Similarity=0.642 Sum_probs=190.1
Q ss_pred CCeeeecccCcceeeeeeecCceEEEEEEECC-ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCC
Q 020085 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (331)
Q Consensus 102 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 180 (331)
.+.|+++.++|++.++||+|+||.||+|++.+ ..||||+++..... .+.|.+|+.++++++||||+++++++.. .
T Consensus 176 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~ 251 (452)
T 1fmk_A 176 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 251 (452)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ccccccChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEcC-C
Confidence 45699999999999999999999999999965 67999999876544 3578999999999999999999999876 6
Q ss_pred CeEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeec
Q 020085 181 NLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA 259 (331)
Q Consensus 181 ~~~lV~E~~~ggsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~ 259 (331)
..++||||+++|+|.+++... ...+++..+..++.|++.||+|||++|++||||||+|||++.++.+||+|||+++...
T Consensus 252 ~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 331 (452)
T 1fmk_A 252 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 331 (452)
T ss_dssp SCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC---
T ss_pred ceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecC
Confidence 789999999999999999653 3568999999999999999999999999999999999999999999999999997654
Q ss_pred CCCc--cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhcccccccccccc
Q 020085 260 QSGV--MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIHSII 329 (331)
Q Consensus 260 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p~~~ 329 (331)
.... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.+.++.+.... +.++.+++.+
T Consensus 332 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~-i~~~~~~~~~ 403 (452)
T 1fmk_A 332 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ-VERGYRMPCP 403 (452)
T ss_dssp -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-HHTTCCCCCC
T ss_pred CCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCCCCC
Confidence 3221 123346789999999998999999999999999999999 9999999998887766 4466665543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-43 Score=324.06 Aligned_cols=225 Identities=30% Similarity=0.554 Sum_probs=191.3
Q ss_pred CeeeecccCcceeeeeeecCceEEEEEEE-------CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCcceeEEe
Q 020085 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIG 174 (331)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~ 174 (331)
..|+++.++|++.+.||+|+||.||+|++ .++.||+|+++... .....+.+.+|+.+++++ +||||+++++
T Consensus 38 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 116 (344)
T 1rjb_A 38 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLG 116 (344)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cCcccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc-CHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 45899999999999999999999999997 23579999998543 334457899999999999 8999999999
Q ss_pred EEECCCCeEEEEeccCCCCHHHHHHhcCC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCcccC
Q 020085 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKG----------------------VFQLTSLLKVAIDVSKGMNYLHQNNIIHR 232 (331)
Q Consensus 175 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~----------------------~~~~~~~~~i~~qi~~~l~~LH~~~iiHr 232 (331)
++...+..++||||+++|+|.+++..... .+++..++.++.||+.||+|||++||+||
T Consensus 117 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~ 196 (344)
T 1rjb_A 117 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 196 (344)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred EEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 99999999999999999999999976543 37889999999999999999999999999
Q ss_pred CCCCCCEEEcCCCcEEEeeecceeeecCCCc---cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCC
Q 020085 233 DLKTANLLMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYA 308 (331)
Q Consensus 233 Dlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~ 308 (331)
||||+||+++.++.+||+|||+++....... .....+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.
T Consensus 197 Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 276 (344)
T 1rjb_A 197 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 276 (344)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred CCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcc
Confidence 9999999999999999999999976543322 123346789999999998999999999999999999998 999999
Q ss_pred CCCHHHHHhccccccccccc
Q 020085 309 GLTPLQAAVGVVQKVSIHSI 328 (331)
Q Consensus 309 ~~~~~~~~~~~~~~~~~p~~ 328 (331)
+.+..+....+++.+.++..
T Consensus 277 ~~~~~~~~~~~~~~~~~~~~ 296 (344)
T 1rjb_A 277 GIPVDANFYKLIQNGFKMDQ 296 (344)
T ss_dssp TCCCSHHHHHHHHTTCCCCC
T ss_pred cCCcHHHHHHHHhcCCCCCC
Confidence 88766666666666665544
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-43 Score=320.23 Aligned_cols=217 Identities=29% Similarity=0.488 Sum_probs=183.0
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCC----
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN---- 181 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~---- 181 (331)
.++|++.+.||+|+||.||++++ .++.||||+++.... +......+.+|+.++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 56899999999999999999997 578999999987543 44566789999999999999999999999876544
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC
Q 020085 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261 (331)
Q Consensus 182 ~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~ 261 (331)
.|+||||++|++|.+++.. .+.+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+++.....
T Consensus 91 ~~lv~e~~~g~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 169 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 169 (311)
T ss_dssp EEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC------
T ss_pred cEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccccc
Confidence 3999999999999999975 467999999999999999999999999999999999999999999999999999765443
Q ss_pred Cc----cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccccccc
Q 020085 262 GV----MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIH 326 (331)
Q Consensus 262 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~p 326 (331)
.. .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.++.+......+....|
T Consensus 170 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~ 238 (311)
T 3ork_A 170 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIP 238 (311)
T ss_dssp ------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC
T ss_pred ccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCC
Confidence 21 223458999999999999999999999999999999999999999998888776666554433
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-42 Score=315.96 Aligned_cols=223 Identities=30% Similarity=0.582 Sum_probs=193.3
Q ss_pred CeeeecccCcceeeeeeecCceEEEEEEE-------CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCcceeEEe
Q 020085 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIG 174 (331)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~ 174 (331)
..|++..++|++.+.||+|+||.||+|++ .++.||+|+++... .....+.+.+|+.+++++ +||||+++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 94 (313)
T 1t46_A 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLG 94 (313)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cccccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch-hHHHHHHHHHHHHHHhhcccCCCeeeEEE
Confidence 55899999999999999999999999986 34789999998654 344567899999999999 8999999999
Q ss_pred EEECCCCeEEEEeccCCCCHHHHHHhcCC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 020085 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKG-----------------VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 237 (331)
Q Consensus 175 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~-----------------~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~ 237 (331)
++..++..++||||+++|+|.+++..... .+++..++.++.|++.||.|||++|++||||||+
T Consensus 95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~ 174 (313)
T 1t46_A 95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR 174 (313)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccc
Confidence 99999999999999999999999976543 4899999999999999999999999999999999
Q ss_pred CEEEcCCCcEEEeeecceeeecCCCc---cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHH
Q 020085 238 NLLMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPL 313 (331)
Q Consensus 238 NiLi~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~ 313 (331)
||+++.++.+||+|||+++....... .....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||.+....
T Consensus 175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 254 (313)
T 1t46_A 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (313)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch
Confidence 99999999999999999976554332 123346789999999999999999999999999999999 99999987665
Q ss_pred HHHhccccccccc
Q 020085 314 QAAVGVVQKVSIH 326 (331)
Q Consensus 314 ~~~~~~~~~~~~p 326 (331)
......+..+.++
T Consensus 255 ~~~~~~~~~~~~~ 267 (313)
T 1t46_A 255 SKFYKMIKEGFRM 267 (313)
T ss_dssp HHHHHHHHHTCCC
T ss_pred hHHHHHhccCCCC
Confidence 5555555555444
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-42 Score=310.17 Aligned_cols=221 Identities=36% Similarity=0.690 Sum_probs=181.9
Q ss_pred eeecccCcceeeeeeecCceEEEEEEECCceEEEEEecCCCCC--HHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCe
Q 020085 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVN--TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL 182 (331)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~--~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 182 (331)
.+++.++|++.+.||+|+||.||+|.+.++.||+|+++..... ....+.+.+|+.+++.++||||+++++++..++..
T Consensus 2 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (271)
T 3dtc_A 2 LEIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNL 81 (271)
T ss_dssp CBCCTTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--C
T ss_pred CccchhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCce
Confidence 3567889999999999999999999999999999998754322 23356789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCCCCEEEcC--------CCcEEEee
Q 020085 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNN---IIHRDLKTANLLMDE--------NGVVKVAD 251 (331)
Q Consensus 183 ~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~NiLi~~--------~~~vkl~D 251 (331)
++||||+++++|.+++. ...+++..+..++.|++.||.|||++| ++||||||+||+++. ++.+||+|
T Consensus 82 ~lv~e~~~~~~L~~~~~--~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D 159 (271)
T 3dtc_A 82 CLVMEFARGGPLNRVLS--GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD 159 (271)
T ss_dssp EEEEECCTTEEHHHHHT--SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred EEEEEcCCCCCHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence 99999999999999984 457899999999999999999999999 899999999999986 77899999
Q ss_pred ecceeeecCCCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccccccccc
Q 020085 252 FGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIHSI 328 (331)
Q Consensus 252 Fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~p~~ 328 (331)
||+++...... .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||.+.+..+....+.....++++
T Consensus 160 fg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 235 (271)
T 3dtc_A 160 FGLAREWHRTT-KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPI 235 (271)
T ss_dssp CCC--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCCC
T ss_pred CCccccccccc-ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCCC
Confidence 99997654432 23457899999999999999999999999999999999999999999888877776655555443
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=308.05 Aligned_cols=219 Identities=34% Similarity=0.663 Sum_probs=192.7
Q ss_pred eeeecccCcceeeeeeecCceEEEEEEE-CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCe
Q 020085 104 VWEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL 182 (331)
Q Consensus 104 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 182 (331)
.|.++.++|++.+.||+|+||.||++.+ .++.||+|+++...... +.+.+|+.++++++||||+++++++..+...
T Consensus 2 ~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~---~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 78 (267)
T 3t9t_A 2 KWVIDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPI 78 (267)
T ss_dssp -CBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBCH---HHHHHHHHHHHTCCCTTBCCEEEEECSSSSC
T ss_pred ceEEchhheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCCH---HHHHHHHHHHHhCCCCCEeeEEEEEccCCCe
Confidence 4889999999999999999999999998 56789999998765443 5788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC
Q 020085 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262 (331)
Q Consensus 183 ~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~ 262 (331)
++||||+++++|.+++....+.+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||+++......
T Consensus 79 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~ 158 (267)
T 3t9t_A 79 CLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 158 (267)
T ss_dssp EEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH
T ss_pred EEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccc
Confidence 99999999999999998877789999999999999999999999999999999999999999999999999997553321
Q ss_pred --ccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhccccccccc
Q 020085 263 --VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIH 326 (331)
Q Consensus 263 --~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p 326 (331)
......+++.|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+....+. .+.++
T Consensus 159 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~-~~~~~ 224 (267)
T 3t9t_A 159 YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-TGFRL 224 (267)
T ss_dssp HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHH-TTCCC
T ss_pred ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHh-cCCcC
Confidence 1223456789999999998899999999999999999999 899999988877666533 44443
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=325.33 Aligned_cols=223 Identities=30% Similarity=0.536 Sum_probs=191.1
Q ss_pred CeeeecccCcceeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeE
Q 020085 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175 (331)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 175 (331)
+.+++..++|++.++||+|+||+||+|++. ++.||||+++... .......+.+|+.++++++||||++++++
T Consensus 64 ~~~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~ 142 (367)
T 3l9p_A 64 DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGV 142 (367)
T ss_dssp GSCBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred chhhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEeccccc-ChhhHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 446788899999999999999999999853 4579999997543 45556779999999999999999999999
Q ss_pred EECCCCeEEEEeccCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC---c
Q 020085 176 CTRPPNLCIVTEFMARGSIYDFLHKQK------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG---V 246 (331)
Q Consensus 176 ~~~~~~~~lV~E~~~ggsL~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~---~ 246 (331)
+......++||||+++|+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+|||++.++ .
T Consensus 143 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~ 222 (367)
T 3l9p_A 143 SLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRV 222 (367)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCC
T ss_pred EecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCce
Confidence 999999999999999999999997653 4589999999999999999999999999999999999999555 5
Q ss_pred EEEeeecceeeecCC---CccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhccccc
Q 020085 247 VKVADFGVARVQAQS---GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQK 322 (331)
Q Consensus 247 vkl~DFg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~ 322 (331)
+||+|||+++..... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||...+..+....+. .
T Consensus 223 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~-~ 301 (367)
T 3l9p_A 223 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVT-S 301 (367)
T ss_dssp EEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHH-T
T ss_pred EEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-c
Confidence 999999999744322 12234467899999999999999999999999999999998 999999988877666644 4
Q ss_pred ccccc
Q 020085 323 VSIHS 327 (331)
Q Consensus 323 ~~~p~ 327 (331)
+.++.
T Consensus 302 ~~~~~ 306 (367)
T 3l9p_A 302 GGRMD 306 (367)
T ss_dssp TCCCC
T ss_pred CCCCC
Confidence 54443
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=322.20 Aligned_cols=211 Identities=22% Similarity=0.404 Sum_probs=183.2
Q ss_pred cCcce--eeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEE
Q 020085 110 KQLKI--ECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV 185 (331)
Q Consensus 110 ~~~~~--~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV 185 (331)
+.|.+ .+.||+|+||.||+|+. .++.||+|+++... ....+.+.+|+.++++++||||+++++++......++|
T Consensus 87 ~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 164 (373)
T 2x4f_A 87 SFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG--MKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLV 164 (373)
T ss_dssp GTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc--cccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEE
Confidence 34444 67899999999999998 57899999998653 34557899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEE--cCCCcEEEeeecceeeecCCCc
Q 020085 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM--DENGVVKVADFGVARVQAQSGV 263 (331)
Q Consensus 186 ~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi--~~~~~vkl~DFg~a~~~~~~~~ 263 (331)
|||+++++|.+++......+++..+..++.||++||+|||++||+||||||+|||+ +.++.+||+|||+++.......
T Consensus 165 ~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~ 244 (373)
T 2x4f_A 165 MEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK 244 (373)
T ss_dssp EECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB
T ss_pred EeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc
Confidence 99999999999997766779999999999999999999999999999999999999 5677899999999988766655
Q ss_pred cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccc
Q 020085 264 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK 322 (331)
Q Consensus 264 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~ 322 (331)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+...
T Consensus 245 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~ 303 (373)
T 2x4f_A 245 LKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILAC 303 (373)
T ss_dssp CCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT
T ss_pred cccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence 56667999999999999999999999999999999999999999998887777665543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-42 Score=324.54 Aligned_cols=215 Identities=23% Similarity=0.424 Sum_probs=177.9
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCcceeEEeEEECCC--CeE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPP--NLC 183 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~--~~~ 183 (331)
.++|++.+.||+|+||.||+|.+ .++.||||++.....+......+.+|+.+++++. ||||+++++++...+ .+|
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~ 87 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVY 87 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEE
Confidence 46899999999999999999987 5789999999876666777788999999999997 999999999997544 689
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecC---
Q 020085 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ--- 260 (331)
Q Consensus 184 lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~--- 260 (331)
+||||+++ +|.+++.. +.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 88 lv~e~~~~-~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~ 164 (388)
T 3oz6_A 88 LVFDYMET-DLHAVIRA--NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRR 164 (388)
T ss_dssp EEEECCSE-EHHHHHHH--TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCC
T ss_pred EEecccCc-CHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCccccccccccc
Confidence 99999985 99999865 5789999999999999999999999999999999999999999999999999986432
Q ss_pred -------------------CCccccCCCCcccccchhcCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccc
Q 020085 261 -------------------SGVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 261 -------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~ 320 (331)
....+...||+.|+|||++.+ ..++.++|||||||++|||++|++||++.+..+....+.
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~ 244 (388)
T 3oz6_A 165 VTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERII 244 (388)
T ss_dssp CCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred ccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 112334579999999999976 678999999999999999999999999999888877766
Q ss_pred cccccc
Q 020085 321 QKVSIH 326 (331)
Q Consensus 321 ~~~~~p 326 (331)
.....|
T Consensus 245 ~~~~~p 250 (388)
T 3oz6_A 245 GVIDFP 250 (388)
T ss_dssp HHHCCC
T ss_pred HhcCCC
Confidence 544443
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=309.99 Aligned_cols=223 Identities=27% Similarity=0.521 Sum_probs=193.2
Q ss_pred eeeecccCcceee-eeeecCceEEEEEEE----CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEEC
Q 020085 104 VWEIDAKQLKIEC-KVASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR 178 (331)
Q Consensus 104 ~~~i~~~~~~~~~-~lg~G~~g~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 178 (331)
.+.+..++|.+.+ .||+|+||.||+|.+ .+..||+|+++... .....+.+.+|+.++++++||||+++++++.
T Consensus 3 ~~~~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~- 80 (287)
T 1u59_A 3 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQ- 80 (287)
T ss_dssp CCBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE-
T ss_pred cccccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCcc-chhHHHHHHHHHHHHHhCCCCCEeEEEEEec-
Confidence 4678888999887 999999999999986 46789999998753 4556788999999999999999999999994
Q ss_pred CCCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeee
Q 020085 179 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (331)
Q Consensus 179 ~~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~ 258 (331)
.+..++||||+++++|.+++......+++..+..++.|+++||.|||++|++||||||+||+++.++.++|+|||+++..
T Consensus 81 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~ 160 (287)
T 1u59_A 81 AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKAL 160 (287)
T ss_dssp SSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred CCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeee
Confidence 45699999999999999999776778999999999999999999999999999999999999999999999999999876
Q ss_pred cCCCc----cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhcccccccccccc
Q 020085 259 AQSGV----MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIHSII 329 (331)
Q Consensus 259 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p~~~ 329 (331)
..... .....+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||...+..+.... +.++.++.++
T Consensus 161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~-i~~~~~~~~~ 235 (287)
T 1u59_A 161 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF-IEQGKRMECP 235 (287)
T ss_dssp TTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHH-HHTTCCCCCC
T ss_pred ccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHH-HhcCCcCCCC
Confidence 54322 123346889999999988889999999999999999998 9999999877666555 4456665543
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-42 Score=337.16 Aligned_cols=223 Identities=36% Similarity=0.673 Sum_probs=195.0
Q ss_pred CCeeeecccCcceeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECC
Q 020085 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP 179 (331)
Q Consensus 102 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 179 (331)
.+.|++..++|++.++||+|+||.||+|.+. +..||||+++..... .+.|.+|+.++++++||||++++++|...
T Consensus 212 ~~~~~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~l~~~~~~~ 288 (495)
T 1opk_A 212 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTRE 288 (495)
T ss_dssp SSCCBCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred ccccccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccc---hHHHHHHHHHHHhcCCCCEeeEEEEEecC
Confidence 3569999999999999999999999999995 688999999866433 46799999999999999999999999999
Q ss_pred CCeEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeee
Q 020085 180 PNLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (331)
Q Consensus 180 ~~~~lV~E~~~ggsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~ 258 (331)
..+++||||+++|+|.+++... ...+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 289 ~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~ 368 (495)
T 1opk_A 289 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLM 368 (495)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECC
T ss_pred CcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceec
Confidence 9999999999999999999764 356899999999999999999999999999999999999999999999999999876
Q ss_pred cCCCcc--ccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhccccccccccc
Q 020085 259 AQSGVM--TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIHSI 328 (331)
Q Consensus 259 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p~~ 328 (331)
...... ....+++.|+|||.+.+..++.++||||||+++|||++ |..||.+.+..+.... +.++.++..
T Consensus 369 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~-~~~~~~~~~ 440 (495)
T 1opk_A 369 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL-LEKDYRMER 440 (495)
T ss_dssp TTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH-HHTTCCCCC
T ss_pred cCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCCCC
Confidence 443221 22345689999999998899999999999999999999 9999999887665544 455665544
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-42 Score=312.48 Aligned_cols=204 Identities=23% Similarity=0.288 Sum_probs=175.4
Q ss_pred ecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCcceeEEeEEECCCCeE
Q 020085 107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLC 183 (331)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~ 183 (331)
+-.++|++.++||+|+||+||+|++ .++.||||++............+..|+..+.++ +||||++++++|..+...+
T Consensus 54 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~ 133 (311)
T 3p1a_A 54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILY 133 (311)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred hhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEE
Confidence 3457899999999999999999998 478999999987655555556666677666665 8999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCc
Q 020085 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV 263 (331)
Q Consensus 184 lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~ 263 (331)
+||||+ +++|.+++......+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 134 lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~ 212 (311)
T 3p1a_A 134 LQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA 212 (311)
T ss_dssp EEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred EEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCCC
Confidence 999999 5699999988777899999999999999999999999999999999999999999999999999987766655
Q ss_pred cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH
Q 020085 264 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTP 312 (331)
Q Consensus 264 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~ 312 (331)
.....||+.|+|||++.+ .++.++||||||+++|||++|..|+.....
T Consensus 213 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~ 260 (311)
T 3p1a_A 213 GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG 260 (311)
T ss_dssp --CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH
T ss_pred CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH
Confidence 566679999999999876 689999999999999999999766654433
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-42 Score=315.32 Aligned_cols=221 Identities=32% Similarity=0.559 Sum_probs=187.6
Q ss_pred eeecccCcceeeeeeecCceEEEEEEECC------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEEC
Q 020085 105 WEIDAKQLKIECKVASGSYGDLYKGTYCS------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR 178 (331)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 178 (331)
+++..++|.+.+.||+|+||.||+|.+.. ..||+|+++... .......+.+|+.++++++||||+++++++..
T Consensus 39 ~~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 117 (333)
T 1mqb_A 39 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK 117 (333)
T ss_dssp CBCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred ccCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec
Confidence 57889999999999999999999998743 359999998654 45556789999999999999999999999999
Q ss_pred CCCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeee
Q 020085 179 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (331)
Q Consensus 179 ~~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~ 258 (331)
....++||||+++++|.+++....+.+++..++.++.|+++||+|||++|++||||||+||+++.++.+||+|||+++..
T Consensus 118 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 197 (333)
T 1mqb_A 118 YKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 197 (333)
T ss_dssp SSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred CCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhh
Confidence 99999999999999999999877788999999999999999999999999999999999999999999999999999765
Q ss_pred cCCCc----cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhcccccccccc
Q 020085 259 AQSGV----MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIHS 327 (331)
Q Consensus 259 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p~ 327 (331)
..... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||...+..+....+ .++.+++
T Consensus 198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~-~~~~~~~ 270 (333)
T 1mqb_A 198 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI-NDGFRLP 270 (333)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH-HTTCCCC
T ss_pred ccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHH-HCCCcCC
Confidence 43321 122346789999999999999999999999999999999 99999998887766653 4454444
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=312.92 Aligned_cols=204 Identities=31% Similarity=0.585 Sum_probs=177.1
Q ss_pred eeecccCcceeeeeeecCceEEEEEEE------CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEEC
Q 020085 105 WEIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR 178 (331)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 178 (331)
.++..++|++.++||+|+||+||++++ .++.||||+++.. +....+.+.+|+.++++++||||+++++++..
T Consensus 5 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 82 (295)
T 3ugc_A 5 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS 82 (295)
T ss_dssp -CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECH
T ss_pred CcCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 467789999999999999999999985 5688999999854 45666789999999999999999999999854
Q ss_pred --CCCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeeccee
Q 020085 179 --PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR 256 (331)
Q Consensus 179 --~~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~ 256 (331)
...+++||||+++|+|.+++......+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+++
T Consensus 83 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~ 162 (295)
T 3ugc_A 83 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 162 (295)
T ss_dssp HHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC
T ss_pred CCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccc
Confidence 356899999999999999998876779999999999999999999999999999999999999999999999999998
Q ss_pred eecCCC----ccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 020085 257 VQAQSG----VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL 310 (331)
Q Consensus 257 ~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~ 310 (331)
...... ......++..|+|||.+.+..++.++||||||+++|||++|..||...
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~ 220 (295)
T 3ugc_A 163 VLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP 220 (295)
T ss_dssp -------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSH
T ss_pred cccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCC
Confidence 654432 122345677899999999999999999999999999999999998753
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=313.59 Aligned_cols=224 Identities=29% Similarity=0.557 Sum_probs=193.0
Q ss_pred CeeeecccCcceeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeE
Q 020085 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175 (331)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 175 (331)
..|++..++|.+.+.||+|+||.||++++. ++.||+|+++... .....+.+.+|+.++++++||||++++++
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~ 94 (314)
T 2ivs_A 16 PKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA-SPSELRDLLSEFNVLKQVNHPHVIKLYGA 94 (314)
T ss_dssp TTTBCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred cccccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCC-CHHHHHHHHHHHHHHhhCCCCceeeEEEE
Confidence 357888999999999999999999999872 3789999998553 45667889999999999999999999999
Q ss_pred EECCCCeEEEEeccCCCCHHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Q 020085 176 CTRPPNLCIVTEFMARGSIYDFLHKQK-----------------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHR 232 (331)
Q Consensus 176 ~~~~~~~~lV~E~~~ggsL~~~l~~~~-----------------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiHr 232 (331)
+......++||||+++++|.+++.... ..+++..++.++.|+++||.|||++|++||
T Consensus 95 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~ 174 (314)
T 2ivs_A 95 CSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHR 174 (314)
T ss_dssp ECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred EecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccc
Confidence 999999999999999999999997643 238899999999999999999999999999
Q ss_pred CCCCCCEEEcCCCcEEEeeecceeeecCCCc---cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCC
Q 020085 233 DLKTANLLMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYA 308 (331)
Q Consensus 233 Dlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~ 308 (331)
||||+||+++.++.+||+|||+++....... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.
T Consensus 175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 254 (314)
T 2ivs_A 175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 254 (314)
T ss_dssp CCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999986644322 223456789999999998889999999999999999999 999999
Q ss_pred CCCHHHHHhccccccccccc
Q 020085 309 GLTPLQAAVGVVQKVSIHSI 328 (331)
Q Consensus 309 ~~~~~~~~~~~~~~~~~p~~ 328 (331)
+.++.+.... +..+.++..
T Consensus 255 ~~~~~~~~~~-~~~~~~~~~ 273 (314)
T 2ivs_A 255 GIPPERLFNL-LKTGHRMER 273 (314)
T ss_dssp TCCGGGHHHH-HHTTCCCCC
T ss_pred CCCHHHHHHH-hhcCCcCCC
Confidence 8877655444 444544443
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-42 Score=315.04 Aligned_cols=224 Identities=29% Similarity=0.596 Sum_probs=193.5
Q ss_pred CeeeecccCcceeeeeeecCceEEEEEEEC---------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCcceeE
Q 020085 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYC---------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQF 172 (331)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~ 172 (331)
..|++..++|.+.+.||+|+||.||+|++. ++.||+|+++... .....+.+.+|+.+++++ +||||+++
T Consensus 28 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~ 106 (334)
T 2pvf_A 28 PKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA-TEKDLSDLVSEMEMMKMIGKHKNIINL 106 (334)
T ss_dssp TTTBCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCC-cHHHHHHHHHHHHHHHHhhcCCCEeeE
Confidence 458899999999999999999999999873 4679999998653 455677899999999999 89999999
Q ss_pred EeEEECCCCeEEEEeccCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 020085 173 IGACTRPPNLCIVTEFMARGSIYDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 237 (331)
Q Consensus 173 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~ 237 (331)
++++......++||||+++|+|.+++.... ..+++..++.++.|+++||.|||++|++||||||+
T Consensus 107 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~ 186 (334)
T 2pvf_A 107 LGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAAR 186 (334)
T ss_dssp EEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred EEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccc
Confidence 999999999999999999999999997643 24889999999999999999999999999999999
Q ss_pred CEEEcCCCcEEEeeecceeeecCCCc---cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHH
Q 020085 238 NLLMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPL 313 (331)
Q Consensus 238 NiLi~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~ 313 (331)
||+++.++.+||+|||+++....... .....+++.|+|||++.+..++.++||||||+++|+|++ |+.||.+.+..
T Consensus 187 NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 266 (334)
T 2pvf_A 187 NVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 266 (334)
T ss_dssp GEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred eEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHH
Confidence 99999999999999999986654322 233456789999999988889999999999999999999 99999998877
Q ss_pred HHHhccccccccccc
Q 020085 314 QAAVGVVQKVSIHSI 328 (331)
Q Consensus 314 ~~~~~~~~~~~~p~~ 328 (331)
+.... +.++.++.+
T Consensus 267 ~~~~~-~~~~~~~~~ 280 (334)
T 2pvf_A 267 ELFKL-LKEGHRMDK 280 (334)
T ss_dssp HHHHH-HHHTCCCCC
T ss_pred HHHHH-HhcCCCCCC
Confidence 65554 444555443
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-42 Score=320.04 Aligned_cols=212 Identities=26% Similarity=0.387 Sum_probs=178.2
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCC------
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP------ 180 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~------ 180 (331)
.++|++.+.||+|+||.||+|.+ .++.||||+++....+....+.+.+|+.+++.++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 46899999999999999999988 5788999999876666677788999999999999999999999997665
Q ss_pred CeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecC
Q 020085 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (331)
Q Consensus 181 ~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~ 260 (331)
..|+||||+++ +|.+++. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 104 ~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~ 179 (371)
T 2xrw_A 104 DVYIVMELMDA-NLCQVIQ---MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT 179 (371)
T ss_dssp EEEEEEECCSE-EHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred ceEEEEEcCCC-CHHHHHh---hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence 68999999986 8888884 3589999999999999999999999999999999999999999999999999987665
Q ss_pred CCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccccc
Q 020085 261 SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVS 324 (331)
Q Consensus 261 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~ 324 (331)
........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+++...
T Consensus 180 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~ 243 (371)
T 2xrw_A 180 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLG 243 (371)
T ss_dssp ----------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CC
T ss_pred ccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 5445567899999999999999999999999999999999999999999988887777665433
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=316.93 Aligned_cols=203 Identities=26% Similarity=0.459 Sum_probs=179.0
Q ss_pred ecccCcceeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCC--Ce
Q 020085 107 IDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP--NL 182 (331)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~--~~ 182 (331)
+..++|++.+.||+|+||+||+|++. ++.||||+++.... ....+.+.+|+.++++++||||+++++++.... ..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 84 (319)
T 4euu_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (319)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence 44678999999999999999999995 78999999975432 122467889999999999999999999998755 78
Q ss_pred EEEEeccCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEE----cCCCcEEEeeeccee
Q 020085 183 CIVTEFMARGSIYDFLHKQK--GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM----DENGVVKVADFGVAR 256 (331)
Q Consensus 183 ~lV~E~~~ggsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi----~~~~~vkl~DFg~a~ 256 (331)
++||||+++++|.+++.... ..+++..++.++.|++.||+|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~ 164 (319)
T 4euu_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (319)
T ss_dssp EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCE
T ss_pred EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCce
Confidence 99999999999999997643 338999999999999999999999999999999999999 778889999999998
Q ss_pred eecCCCccccCCCCcccccchhcC--------CCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 020085 257 VQAQSGVMTAETGTYRWMAPEVIE--------HKPYDYKADVFSFGIALWELLTGELPYAGL 310 (331)
Q Consensus 257 ~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~Di~SlG~il~ell~g~~Pf~~~ 310 (331)
............||+.|+|||++. +..++.++|||||||++|||++|+.||...
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 226 (319)
T 4euu_A 165 ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPF 226 (319)
T ss_dssp ECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECT
T ss_pred ecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 877666666678999999999985 578899999999999999999999999754
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=318.35 Aligned_cols=203 Identities=26% Similarity=0.457 Sum_probs=164.9
Q ss_pred ecccCcceeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEE
Q 020085 107 IDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI 184 (331)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~l 184 (331)
.-.+.|++.+.||+|+||.||+|++. ++.||||+++... ..+.+.+|+.++++++||||+++++++......++
T Consensus 50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 125 (349)
T 2w4o_A 50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISL 125 (349)
T ss_dssp CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC--------------CHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEE
Confidence 34568999999999999999999994 5789999998542 23568899999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC---CCcEEEeeecceeeecCC
Q 020085 185 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE---NGVVKVADFGVARVQAQS 261 (331)
Q Consensus 185 V~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~---~~~vkl~DFg~a~~~~~~ 261 (331)
||||+++++|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+|||++. ++.+||+|||+++.....
T Consensus 126 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 204 (349)
T 2w4o_A 126 VLELVTGGELFDRIVE-KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQ 204 (349)
T ss_dssp EECCCCSCBHHHHHTT-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------
T ss_pred EEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcc
Confidence 9999999999999965 467899999999999999999999999999999999999975 889999999999876555
Q ss_pred CccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHH
Q 020085 262 GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ 314 (331)
Q Consensus 262 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~ 314 (331)
.......||+.|+|||++.+..++.++|||||||++|||++|+.||......+
T Consensus 205 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~ 257 (349)
T 2w4o_A 205 VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ 257 (349)
T ss_dssp --------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH
T ss_pred cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH
Confidence 44556679999999999999999999999999999999999999998765544
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=316.08 Aligned_cols=211 Identities=27% Similarity=0.474 Sum_probs=169.9
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~ 186 (331)
.++|++.++||+|+||.||+|.+ .++.||+|+++... .....+.+.+|+.++++++||||+++++++..++..++||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 82 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS-EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF 82 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCS-TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc-ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence 45799999999999999999987 47899999997553 2222356889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC
Q 020085 187 EFMARGSIYDFLHKQK-----GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261 (331)
Q Consensus 187 E~~~ggsL~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~ 261 (331)
||+++ +|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 83 e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 161 (317)
T 2pmi_A 83 EFMDN-DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP 161 (317)
T ss_dssp ECCCC-BHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred EecCC-CHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence 99985 9999986542 45899999999999999999999999999999999999999999999999999865433
Q ss_pred -CccccCCCCcccccchhcCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 262 -GVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 262 -~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
.......+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+....+.+
T Consensus 162 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~ 223 (317)
T 2pmi_A 162 VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFD 223 (317)
T ss_dssp CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 23345678999999999976 4689999999999999999999999999888776665543
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-42 Score=312.71 Aligned_cols=219 Identities=29% Similarity=0.560 Sum_probs=191.4
Q ss_pred CCeeeecccCcceeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEe
Q 020085 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174 (331)
Q Consensus 102 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~ 174 (331)
.+.|++..++|++.+.||+|+||.||+|++. ++.||+|+++... .......+.+|+.++++++||||+++++
T Consensus 17 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~ 95 (322)
T 1p4o_A 17 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLG 95 (322)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred hhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence 3568999999999999999999999999864 5789999998553 4455677999999999999999999999
Q ss_pred EEECCCCeEEEEeccCCCCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC
Q 020085 175 ACTRPPNLCIVTEFMARGSIYDFLHKQK---------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG 245 (331)
Q Consensus 175 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~ 245 (331)
++......++||||+++|+|.+++.... ..+++..++.++.|++.||.|||++||+||||||+||+++.++
T Consensus 96 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~ 175 (322)
T 1p4o_A 96 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF 175 (322)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred EEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCC
Confidence 9999999999999999999999996532 4578999999999999999999999999999999999999999
Q ss_pred cEEEeeecceeeecCCCc---cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhcccc
Q 020085 246 VVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 246 ~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~ 321 (331)
.+||+|||+++....... .....+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||.+.+..+....+.+
T Consensus 176 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~ 255 (322)
T 1p4o_A 176 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 255 (322)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT
T ss_pred eEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHc
Confidence 999999999975543321 223356889999999999999999999999999999999 8999999888777666443
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-42 Score=315.71 Aligned_cols=217 Identities=28% Similarity=0.534 Sum_probs=172.7
Q ss_pred eeeecccCcceeeeeeecCceEEEEEEECCc-----eEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEEC
Q 020085 104 VWEIDAKQLKIECKVASGSYGDLYKGTYCSQ-----EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR 178 (331)
Q Consensus 104 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~~-----~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 178 (331)
.+.+..++|++.+.||+|+||.||+|++... .||||+++.........+.+.+|+.++++++||||+++++++..
T Consensus 17 ~~~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 96 (323)
T 3qup_A 17 DVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLR 96 (323)
T ss_dssp TTBCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEEC
T ss_pred hcccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeec
Confidence 3567888999999999999999999987432 79999998765555667889999999999999999999999987
Q ss_pred CCCe------EEEEeccCCCCHHHHHHhcC-----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcE
Q 020085 179 PPNL------CIVTEFMARGSIYDFLHKQK-----GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVV 247 (331)
Q Consensus 179 ~~~~------~lV~E~~~ggsL~~~l~~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~v 247 (331)
.... ++||||+++|+|.+++.... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+
T Consensus 97 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 97 SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCE
T ss_pred cccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCE
Confidence 7655 99999999999999996532 258999999999999999999999999999999999999999999
Q ss_pred EEeeecceeeecCCCc---cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhccc
Q 020085 248 KVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 248 kl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~ 320 (331)
||+|||+++....... .....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.+.+..+....+.
T Consensus 177 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~ 253 (323)
T 3qup_A 177 CVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLI 253 (323)
T ss_dssp EECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHH
T ss_pred EEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHh
Confidence 9999999976544322 223446789999999999999999999999999999999 999999988777666544
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-42 Score=321.04 Aligned_cols=202 Identities=26% Similarity=0.435 Sum_probs=176.9
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCC---CHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV---NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~---~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 183 (331)
.+.|++.+.||+|+||.||++++ +++.||||+++.... .....+.+.+|+.++++++||||+++++++..+..+|
T Consensus 23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 46899999999999999999998 478999999863210 1112467899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCc---EEEeeecceee
Q 020085 184 IVTEFMARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV---VKVADFGVARV 257 (331)
Q Consensus 184 lV~E~~~ggsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~---vkl~DFg~a~~ 257 (331)
+||||++|++|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||+++.
T Consensus 103 lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~ 182 (351)
T 3c0i_A 103 MVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQ 182 (351)
T ss_dssp EEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEE
T ss_pred EEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeE
Confidence 999999999999888653 245899999999999999999999999999999999999987654 99999999987
Q ss_pred ecCCCc-cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 020085 258 QAQSGV-MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL 310 (331)
Q Consensus 258 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~ 310 (331)
...... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.
T Consensus 183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~ 236 (351)
T 3c0i_A 183 LGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT 236 (351)
T ss_dssp CCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred ecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc
Confidence 655432 34567999999999999999999999999999999999999999874
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=315.55 Aligned_cols=224 Identities=29% Similarity=0.561 Sum_probs=192.5
Q ss_pred CeeeecccCcceeeeeeecCceEEEEEEECC-------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCcceeEEe
Q 020085 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIG 174 (331)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~ 174 (331)
..|++..++|++.+.||+|+||.||+|.+.+ +.||+|+++... .....+.+.+|+.+++++ +||||+++++
T Consensus 39 ~~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~ 117 (333)
T 2i1m_A 39 EKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA-HADEKEALMSELKIMSHLGQHENIVNLLG 117 (333)
T ss_dssp GGGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc-ChHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence 4689999999999999999999999999843 379999998654 445567899999999999 8999999999
Q ss_pred EEECCCCeEEEEeccCCCCHHHHHHhc-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEE
Q 020085 175 ACTRPPNLCIVTEFMARGSIYDFLHKQ-------------KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM 241 (331)
Q Consensus 175 ~~~~~~~~~lV~E~~~ggsL~~~l~~~-------------~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi 241 (331)
++......++||||+++|+|.+++... ...+++..++.++.|++.||+|||++||+||||||+||++
T Consensus 118 ~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~ 197 (333)
T 2i1m_A 118 ACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLL 197 (333)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEE
T ss_pred EEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEE
Confidence 999999999999999999999999653 2467999999999999999999999999999999999999
Q ss_pred cCCCcEEEeeecceeeecCCCc---cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHh
Q 020085 242 DENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAV 317 (331)
Q Consensus 242 ~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~ 317 (331)
+.++.+||+|||+++....... .....+|+.|+|||.+.+..++.++||||||+++|||++ |..||.+........
T Consensus 198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~ 277 (333)
T 2i1m_A 198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY 277 (333)
T ss_dssp EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH
T ss_pred CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHH
Confidence 9999999999999976543322 123346789999999998999999999999999999999 999999876655555
Q ss_pred cccccccccc
Q 020085 318 GVVQKVSIHS 327 (331)
Q Consensus 318 ~~~~~~~~p~ 327 (331)
..+..+.++.
T Consensus 278 ~~~~~~~~~~ 287 (333)
T 2i1m_A 278 KLVKDGYQMA 287 (333)
T ss_dssp HHHHHTCCCC
T ss_pred HHHhcCCCCC
Confidence 5555555443
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=309.99 Aligned_cols=209 Identities=24% Similarity=0.386 Sum_probs=180.8
Q ss_pred cCcceeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEe
Q 020085 110 KQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E 187 (331)
++|++.++||+|+||+||+|.+. ++.||+|++.....+....+.+.+|+.++++++||||+++++++......++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57999999999999999999984 7899999998776666667889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC-Ccccc
Q 020085 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTA 266 (331)
Q Consensus 188 ~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~-~~~~~ 266 (331)
|+++++|.+++.. .+.+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+++..... .....
T Consensus 83 ~~~~~~l~~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 161 (311)
T 4agu_A 83 YCDHTVLHELDRY-QRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDD 161 (311)
T ss_dssp CCSEEHHHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred eCCCchHHHHHhh-hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccCC
Confidence 9999999988754 567999999999999999999999999999999999999999999999999999876533 23345
Q ss_pred CCCCcccccchhcCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcc
Q 020085 267 ETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGV 319 (331)
Q Consensus 267 ~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~ 319 (331)
..+|+.|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.+..+....+
T Consensus 162 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 215 (311)
T 4agu_A 162 EVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLI 215 (311)
T ss_dssp ----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred CcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 678999999999865 67899999999999999999999999998877665543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-43 Score=322.60 Aligned_cols=204 Identities=28% Similarity=0.521 Sum_probs=179.9
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV 185 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV 185 (331)
.++|.+.+.||+|+||.||+|.+ .++.||+|+++..... .+....+.+|+.+++.++||||+++++++..+...++|
T Consensus 8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv 87 (336)
T 3h4j_B 8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMV 87 (336)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 46899999999999999999998 6789999998643211 11134688999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCccc
Q 020085 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT 265 (331)
Q Consensus 186 ~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~~ 265 (331)
|||+ +|+|.+++.. .+.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++.........
T Consensus 88 ~E~~-~g~l~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~~ 165 (336)
T 3h4j_B 88 IEYA-GGELFDYIVE-KKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLK 165 (336)
T ss_dssp ECCC-CEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTTC
T ss_pred EECC-CCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCcccc
Confidence 9999 6799999865 4679999999999999999999999999999999999999999999999999998766655566
Q ss_pred cCCCCcccccchhcCCCCC-CChhhHHHHHHHHHHHHcCCCCCCCCCHHH
Q 020085 266 AETGTYRWMAPEVIEHKPY-DYKADVFSFGIALWELLTGELPYAGLTPLQ 314 (331)
Q Consensus 266 ~~~gt~~y~aPE~~~~~~~-~~~~Di~SlG~il~ell~g~~Pf~~~~~~~ 314 (331)
..+||+.|+|||++.+..+ +.++||||||+++|+|++|+.||.+....+
T Consensus 166 ~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~ 215 (336)
T 3h4j_B 166 TSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPN 215 (336)
T ss_dssp CCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTT
T ss_pred cccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHH
Confidence 6789999999999988876 789999999999999999999998764433
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-42 Score=316.36 Aligned_cols=220 Identities=30% Similarity=0.573 Sum_probs=182.1
Q ss_pred eeecccCcceeeeeeecCceEEEEEEEC--Cc----eEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEEC
Q 020085 105 WEIDAKQLKIECKVASGSYGDLYKGTYC--SQ----EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR 178 (331)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~----~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 178 (331)
-.+..++|++.+.||+|+||+||+|++. ++ .||+|.++... .....+.+.+|+.++++++||||++++++|..
T Consensus 10 ~~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 88 (327)
T 3poz_A 10 RILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLT 88 (327)
T ss_dssp EECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC--------CHHHHHHHHHHHHHCCBTTBCCEEEEEES
T ss_pred hhcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec
Confidence 3466789999999999999999999873 33 36888876442 33445789999999999999999999999987
Q ss_pred CCCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeee
Q 020085 179 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (331)
Q Consensus 179 ~~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~ 258 (331)
+ ..++|+||+.+|+|.+++....+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 89 ~-~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~ 167 (327)
T 3poz_A 89 S-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 167 (327)
T ss_dssp S-SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHH
T ss_pred C-CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEc
Confidence 5 488999999999999999887788999999999999999999999999999999999999999999999999999765
Q ss_pred cCCCc---cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhcccccccccc
Q 020085 259 AQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIHS 327 (331)
Q Consensus 259 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p~ 327 (331)
..... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.+.+..+.... +.++.+++
T Consensus 168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~-~~~~~~~~ 239 (327)
T 3poz_A 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-LEKGERLP 239 (327)
T ss_dssp TTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH-HHTTCCCC
T ss_pred cCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHH-HHcCCCCC
Confidence 44322 223356889999999999999999999999999999999 9999998876655444 44454443
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=322.16 Aligned_cols=203 Identities=28% Similarity=0.466 Sum_probs=168.3
Q ss_pred eecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeE
Q 020085 106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183 (331)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 183 (331)
....++|++.+.||+|+||.||+++. .++.||+|+++...... +.+.+|+.++++++||||+++++++.....++
T Consensus 16 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~---~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 92 (361)
T 3uc3_A 16 MHDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID---ENVQREIINHRSLRHPNIVRFKEVILTPTHLA 92 (361)
T ss_dssp CCCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC---HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CCCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc---HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEE
Confidence 34567899999999999999999998 57899999997654332 46789999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCc--EEEeeecceeeecCC
Q 020085 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV--VKVADFGVARVQAQS 261 (331)
Q Consensus 184 lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~--vkl~DFg~a~~~~~~ 261 (331)
+||||+++|+|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+|||++.++. +||+|||+++.....
T Consensus 93 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~ 171 (361)
T 3uc3_A 93 IIMEYASGGELYERICN-AGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171 (361)
T ss_dssp EEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC------
T ss_pred EEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc
Confidence 99999999999999965 457999999999999999999999999999999999999987775 999999999855544
Q ss_pred CccccCCCCcccccchhcCCCCCCCh-hhHHHHHHHHHHHHcCCCCCCCCCH
Q 020085 262 GVMTAETGTYRWMAPEVIEHKPYDYK-ADVFSFGIALWELLTGELPYAGLTP 312 (331)
Q Consensus 262 ~~~~~~~gt~~y~aPE~~~~~~~~~~-~Di~SlG~il~ell~g~~Pf~~~~~ 312 (331)
.......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||.+.+.
T Consensus 172 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 223 (361)
T 3uc3_A 172 SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 223 (361)
T ss_dssp ---------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----
T ss_pred CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCcc
Confidence 44556679999999999988888765 8999999999999999999987543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=310.85 Aligned_cols=205 Identities=30% Similarity=0.472 Sum_probs=183.2
Q ss_pred CcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEec
Q 020085 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF 188 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~ 188 (331)
.|...++||+|+||.||+|+. .++.||||+++..... ..+.+.+|+.++++++||||+++++++......++||||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 123 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQ--RRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEF 123 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--SHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchh--HHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEec
Confidence 477788999999999999998 4789999999765432 246788999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC-ccccC
Q 020085 189 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAE 267 (331)
Q Consensus 189 ~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~-~~~~~ 267 (331)
+++++|.+++.. ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+++...... .....
T Consensus 124 ~~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~ 201 (321)
T 2c30_A 124 LQGGALTDIVSQ--VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL 201 (321)
T ss_dssp CCSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCC
T ss_pred CCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccc
Confidence 999999999853 568999999999999999999999999999999999999999999999999998665432 23455
Q ss_pred CCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcc
Q 020085 268 TGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGV 319 (331)
Q Consensus 268 ~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~ 319 (331)
.||+.|+|||++.+..++.++||||||+++|||++|+.||...++.+....+
T Consensus 202 ~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~ 253 (321)
T 2c30_A 202 VGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL 253 (321)
T ss_dssp CSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH
T ss_pred cCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 7999999999999999999999999999999999999999998887776653
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-42 Score=306.97 Aligned_cols=221 Identities=25% Similarity=0.527 Sum_probs=186.4
Q ss_pred CeeeecccCcceeeeeeecCceEEEEEEECC-----ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEE
Q 020085 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCS-----QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177 (331)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 177 (331)
..+.+..++|++.+.||+|+||.||+|.+.+ ..||+|+++... .....+.+.+|+.++++++||||+++++++.
T Consensus 5 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~ 83 (281)
T 3cc6_A 5 PQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC-TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE 83 (281)
T ss_dssp CCCSCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS-CHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC
T ss_pred ccceecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc-CchHHHHHHHHHHHHHhCCCCCcceEEEEEc
Confidence 3467888999999999999999999998743 349999998653 4555688999999999999999999999987
Q ss_pred CCCCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceee
Q 020085 178 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV 257 (331)
Q Consensus 178 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~ 257 (331)
.+ ..++||||+++++|.+++......+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++.
T Consensus 84 ~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 162 (281)
T 3cc6_A 84 EE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRY 162 (281)
T ss_dssp SS-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred CC-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCcc
Confidence 54 57899999999999999987777899999999999999999999999999999999999999999999999999975
Q ss_pred ecCCC--ccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhccccccccc
Q 020085 258 QAQSG--VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIH 326 (331)
Q Consensus 258 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p 326 (331)
..... ......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||...+..+.... +.++.++
T Consensus 163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~-~~~~~~~ 233 (281)
T 3cc6_A 163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGV-LEKGDRL 233 (281)
T ss_dssp C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHH-HHHTCCC
T ss_pred cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHH-HhcCCCC
Confidence 54332 1233456889999999998999999999999999999998 9999987766554443 3334433
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-42 Score=319.40 Aligned_cols=216 Identities=27% Similarity=0.441 Sum_probs=183.7
Q ss_pred CeeeecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCC
Q 020085 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (331)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 180 (331)
..|++ .++|++.+.||+|+||.||+|.+ .++.||||++.....+....+.+.+|+.++++++||||+++++++....
T Consensus 19 ~~~~~-~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~ 97 (367)
T 1cm8_A 19 TAWEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE 97 (367)
T ss_dssp SEECC-BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCS
T ss_pred ceeee-cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCC
Confidence 34555 46899999999999999999998 5789999999776656667788999999999999999999999997653
Q ss_pred ------CeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecc
Q 020085 181 ------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV 254 (331)
Q Consensus 181 ------~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~ 254 (331)
.+|+||||+ +++|.+++.. ..+++..+..++.||++||+|||++||+||||||+|||++.++.+||+|||+
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~ 174 (367)
T 1cm8_A 98 TLDDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL 174 (367)
T ss_dssp STTTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred ccccCceEEEEEecC-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeec
Confidence 469999999 7799999965 5689999999999999999999999999999999999999999999999999
Q ss_pred eeeecCCCccccCCCCcccccchhcCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccccc
Q 020085 255 ARVQAQSGVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVS 324 (331)
Q Consensus 255 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~ 324 (331)
++.... ..+...+|+.|+|||++.+ ..++.++||||+||++|||++|+.||.+.+..+....+.+...
T Consensus 175 a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g 243 (367)
T 1cm8_A 175 ARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 243 (367)
T ss_dssp CEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred cccccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcC
Confidence 987543 2455678999999999876 6899999999999999999999999999988777766655433
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=312.32 Aligned_cols=211 Identities=26% Similarity=0.441 Sum_probs=188.2
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCH----HHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCe
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNT----EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL 182 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~----~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 182 (331)
.+.|++.+.||+|+||.||++++ .++.||+|+++...... ...+.+.+|+.++++++||||+++++++......
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 46799999999999999999998 47899999997543221 1246789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC----cEEEeeecceeee
Q 020085 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG----VVKVADFGVARVQ 258 (331)
Q Consensus 183 ~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~----~vkl~DFg~a~~~ 258 (331)
++||||+++++|.+++.. .+.+++..+..++.|++.||+|||++|++||||||+||+++.++ .+||+|||+++..
T Consensus 91 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~ 169 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI 169 (321)
T ss_dssp EEEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEEC
T ss_pred EEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceec
Confidence 999999999999999965 56789999999999999999999999999999999999999888 7999999999877
Q ss_pred cCCCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccc
Q 020085 259 AQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 259 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~ 320 (331)
..........||+.|+|||.+.+..++.++||||||+++|+|++|+.||.+.+..+....+.
T Consensus 170 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~ 231 (321)
T 2a2a_A 170 EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANIT 231 (321)
T ss_dssp CTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH
T ss_pred CccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 66555556679999999999999999999999999999999999999999888776665543
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-42 Score=315.57 Aligned_cols=199 Identities=24% Similarity=0.384 Sum_probs=177.8
Q ss_pred ecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCcceeEEeEEECCCCeE
Q 020085 107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLC 183 (331)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~ 183 (331)
+..++|++.+.||+|+||+||+|++ .++.||||+++..... +.+.+|+.+++++ +||||+++++++......+
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~ 81 (330)
T 2izr_A 6 MVGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNA 81 (330)
T ss_dssp EETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEE
T ss_pred EEcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccE
Confidence 3457899999999999999999996 6789999999755322 3588999999999 8999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCc-----EEEeeecceeee
Q 020085 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV-----VKVADFGVARVQ 258 (331)
Q Consensus 184 lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~-----vkl~DFg~a~~~ 258 (331)
+||||+ +++|.+++....+.+++..+..++.|++.||+|||++||+||||||+|||++.++. +||+|||+++..
T Consensus 82 lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 82 MVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp EEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred EEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 999999 88999999876778999999999999999999999999999999999999999887 999999999865
Q ss_pred cCCCc--------cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 020085 259 AQSGV--------MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL 310 (331)
Q Consensus 259 ~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~ 310 (331)
..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~ 220 (330)
T 2izr_A 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGL 220 (330)
T ss_dssp BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccc
Confidence 44321 23557999999999999999999999999999999999999999884
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=303.94 Aligned_cols=209 Identities=25% Similarity=0.451 Sum_probs=186.7
Q ss_pred ccCcceeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~ 186 (331)
.++|++.+.||+|+||.||+|.+. +..+|+|++....... .+.+.+|+.++++++||||+++++++......++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~--~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED--VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM 85 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch--HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence 457999999999999999999984 4689999987543222 467899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEE---cCCCcEEEeeecceeeecCCCc
Q 020085 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM---DENGVVKVADFGVARVQAQSGV 263 (331)
Q Consensus 187 E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi---~~~~~vkl~DFg~a~~~~~~~~ 263 (331)
||+++++|.+++.. ...+++..+..++.|++.||+|||++|++||||||+||++ +.++.++|+|||++........
T Consensus 86 e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~ 164 (277)
T 3f3z_A 86 ELCTGGELFERVVH-KRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM 164 (277)
T ss_dssp ECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC
T ss_pred eccCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc
Confidence 99999999999866 4678999999999999999999999999999999999999 7888999999999987766666
Q ss_pred cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 264 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 264 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
.....+|+.|+|||.+.+. ++.++||||||+++|+|++|+.||...+..+....+.+
T Consensus 165 ~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 221 (277)
T 3f3z_A 165 MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIRE 221 (277)
T ss_dssp BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh
Confidence 6677899999999998765 89999999999999999999999999888777766443
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-42 Score=308.95 Aligned_cols=224 Identities=28% Similarity=0.532 Sum_probs=188.1
Q ss_pred CeeeecccCcceee-eeeecCceEEEEEEE----CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEE
Q 020085 103 DVWEIDAKQLKIEC-KVASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177 (331)
Q Consensus 103 ~~~~i~~~~~~~~~-~lg~G~~g~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 177 (331)
..+.++.++|.+.+ .||+|+||.||+|.+ .++.||||+++....+....+.+.+|+.++++++||||+++++++
T Consensus 9 ~~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~- 87 (291)
T 1xbb_A 9 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC- 87 (291)
T ss_dssp --CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-
T ss_pred ceeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-
Confidence 34677889999998 999999999999966 247899999987655555678899999999999999999999999
Q ss_pred CCCCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceee
Q 020085 178 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV 257 (331)
Q Consensus 178 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~ 257 (331)
..+..++||||+++++|.+++.. .+.+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||+++.
T Consensus 88 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 166 (291)
T 1xbb_A 88 EAESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKA 166 (291)
T ss_dssp ESSSEEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred CCCCcEEEEEeCCCCCHHHHHHh-CcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCccee
Confidence 45678999999999999999976 46799999999999999999999999999999999999999999999999999986
Q ss_pred ecCCCc----cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhcccccccccccc
Q 020085 258 QAQSGV----MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIHSII 329 (331)
Q Consensus 258 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p~~~ 329 (331)
...... .....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||.+.+..+.... +..+.++.++
T Consensus 167 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~-~~~~~~~~~~ 242 (291)
T 1xbb_A 167 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM-LEKGERMGCP 242 (291)
T ss_dssp CCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-HHTTCCCCCC
T ss_pred eccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH-HHcCCCCCCC
Confidence 654332 123346789999999988889999999999999999999 9999999888776555 4456665543
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=305.58 Aligned_cols=219 Identities=32% Similarity=0.622 Sum_probs=189.4
Q ss_pred CeeeecccCcceeeeeeecCceEEEEEEECC-ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCC
Q 020085 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN 181 (331)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 181 (331)
+.|++..++|++.+.||+|+||.||+|.+.+ +.||+|+++..... .+.+.+|+.++++++||||+++++++.. +.
T Consensus 6 ~~~~v~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~ 81 (279)
T 1qpc_A 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS---PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EP 81 (279)
T ss_dssp CTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred hhcccCHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCccc---HHHHHHHHHHHHhCCCcCcceEEEEEcC-CC
Confidence 5699999999999999999999999999864 58999999866433 3578899999999999999999998874 46
Q ss_pred eEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecC
Q 020085 182 LCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (331)
Q Consensus 182 ~~lV~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~ 260 (331)
.++||||+++++|.+++.... ..+++..+..++.|++.||+|||++|++||||||+||++++++.+||+|||+++....
T Consensus 82 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 161 (279)
T 1qpc_A 82 IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED 161 (279)
T ss_dssp CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccC
Confidence 899999999999999996532 3689999999999999999999999999999999999999999999999999987654
Q ss_pred CCcc--ccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhccccccccc
Q 020085 261 SGVM--TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIH 326 (331)
Q Consensus 261 ~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p 326 (331)
.... ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.+.+..+....+ .++.++
T Consensus 162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~-~~~~~~ 229 (279)
T 1qpc_A 162 NEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL-ERGYRM 229 (279)
T ss_dssp SCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHH-HTTCCC
T ss_pred cccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHH-hcccCC
Confidence 3322 23346789999999998889999999999999999999 99999998887766553 344443
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-42 Score=309.51 Aligned_cols=211 Identities=27% Similarity=0.442 Sum_probs=177.4
Q ss_pred ecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCH------------------------HHHHHHHHHHHH
Q 020085 107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNT------------------------EMLKEFSQEVYI 160 (331)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~------------------------~~~~~~~~E~~i 160 (331)
+..++|++.+.||+|+||.||+|++ .++.||||+++...... ...+.+.+|+.+
T Consensus 10 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~ 89 (298)
T 2zv2_A 10 VQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI 89 (298)
T ss_dssp CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHH
T ss_pred eeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHH
Confidence 3457899999999999999999987 57889999997543211 124568999999
Q ss_pred HHhcCCCcceeEEeEEEC--CCCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 020085 161 MRKIRHKNVVQFIGACTR--PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTAN 238 (331)
Q Consensus 161 l~~l~h~niv~~~~~~~~--~~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~N 238 (331)
+++++||||+++++++.. ....++||||+++++|.+++. ...+++..+..++.|++.||+|||++|++||||||+|
T Consensus 90 l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~N 167 (298)
T 2zv2_A 90 LKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSN 167 (298)
T ss_dssp HHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred HHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHH
Confidence 999999999999999986 567899999999999988653 4679999999999999999999999999999999999
Q ss_pred EEEcCCCcEEEeeecceeeecCCC-ccccCCCCcccccchhcCCCC---CCChhhHHHHHHHHHHHHcCCCCCCCCCHHH
Q 020085 239 LLMDENGVVKVADFGVARVQAQSG-VMTAETGTYRWMAPEVIEHKP---YDYKADVFSFGIALWELLTGELPYAGLTPLQ 314 (331)
Q Consensus 239 iLi~~~~~vkl~DFg~a~~~~~~~-~~~~~~gt~~y~aPE~~~~~~---~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~ 314 (331)
||++.++.+||+|||+++...... ......||+.|+|||.+.+.. ++.++||||||+++|+|++|+.||...+...
T Consensus 168 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~ 247 (298)
T 2zv2_A 168 LLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC 247 (298)
T ss_dssp EEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred EEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHH
Confidence 999999999999999998765432 334567999999999997765 3788999999999999999999999887766
Q ss_pred HHhcc
Q 020085 315 AAVGV 319 (331)
Q Consensus 315 ~~~~~ 319 (331)
....+
T Consensus 248 ~~~~~ 252 (298)
T 2zv2_A 248 LHSKI 252 (298)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 55543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=313.34 Aligned_cols=215 Identities=25% Similarity=0.441 Sum_probs=181.4
Q ss_pred ecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCC---CHHHHHHHHHHHHHHHhcC---CCcceeEEeEEEC
Q 020085 107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV---NTEMLKEFSQEVYIMRKIR---HKNVVQFIGACTR 178 (331)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~---~~~~~~~~~~E~~il~~l~---h~niv~~~~~~~~ 178 (331)
+..++|++.++||+|+||+||+|++ .++.||+|+++.... .......+.+|+.++++++ ||||++++++|..
T Consensus 6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~ 85 (308)
T 3g33_A 6 MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCAT 85 (308)
T ss_dssp ----CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEE
T ss_pred ccccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeec
Confidence 4467999999999999999999996 678999999874321 1111235667777777664 9999999999976
Q ss_pred CC-----CeEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeee
Q 020085 179 PP-----NLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADF 252 (331)
Q Consensus 179 ~~-----~~~lV~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DF 252 (331)
.. ..++||||+.+ +|.+++.... ..+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+||
T Consensus 86 ~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Df 164 (308)
T 3g33_A 86 SRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADF 164 (308)
T ss_dssp CCSSSEEEEEEEEECCCC-BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSC
T ss_pred cCCCCceeEEEEehhhhc-CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeC
Confidence 55 48999999975 9999997654 34999999999999999999999999999999999999999999999999
Q ss_pred cceeeecCCCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccc
Q 020085 253 GVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK 322 (331)
Q Consensus 253 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~ 322 (331)
|+++............||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.+.
T Consensus 165 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 234 (308)
T 3g33_A 165 GLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL 234 (308)
T ss_dssp SCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHH
T ss_pred ccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 9998766555556678999999999999999999999999999999999999999999888877776543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=314.94 Aligned_cols=214 Identities=22% Similarity=0.383 Sum_probs=180.6
Q ss_pred eeeecccCcceeeeeeecCceEEEEEEE-CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCC--CcceeEEeEEECCC
Q 020085 104 VWEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH--KNVVQFIGACTRPP 180 (331)
Q Consensus 104 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h--~niv~~~~~~~~~~ 180 (331)
...+..+.|++.+.||+|+||.||++.+ .++.||||+++....+....+.+.+|+.++++++| |||+++++++..+.
T Consensus 3 ~i~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~ 82 (343)
T 3dbq_A 3 CISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 82 (343)
T ss_dssp CEESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred eeeeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCC
Confidence 3567788999999999999999999987 56789999998776677777889999999999986 99999999999999
Q ss_pred CeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecC
Q 020085 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (331)
Q Consensus 181 ~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~ 260 (331)
..++|||+ .+++|.+++.. .+.+++..+..++.|++.||.|||++||+||||||+|||++ ++.+||+|||+++....
T Consensus 83 ~~~lv~e~-~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 83 YIYMVMEC-GNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EEEEEECC-CSEEHHHHHHH-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred EEEEEEeC-CCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 99999994 57799999976 56799999999999999999999999999999999999997 68899999999976543
Q ss_pred CC---ccccCCCCcccccchhcCC-----------CCCCChhhHHHHHHHHHHHHcCCCCCCCC-CHHHHHhccc
Q 020085 261 SG---VMTAETGTYRWMAPEVIEH-----------KPYDYKADVFSFGIALWELLTGELPYAGL-TPLQAAVGVV 320 (331)
Q Consensus 261 ~~---~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Di~SlG~il~ell~g~~Pf~~~-~~~~~~~~~~ 320 (331)
.. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||... ........++
T Consensus 160 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~ 234 (343)
T 3dbq_A 160 DTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII 234 (343)
T ss_dssp ----------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH
T ss_pred ccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHh
Confidence 32 2234579999999999864 67899999999999999999999999874 3334444433
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=307.29 Aligned_cols=216 Identities=30% Similarity=0.448 Sum_probs=172.5
Q ss_pred eeecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCe
Q 020085 105 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL 182 (331)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 182 (331)
+++..++|++.+.||+|+||+||++++ .++.||+|+++.........+.+.++...++.++||||+++++++..+...
T Consensus 2 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 2 MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV 81 (290)
T ss_dssp CCCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred CcccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence 567889999999999999999999998 678999999987654444455566666678889999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCCEEEcCCCcEEEeeecceeee
Q 020085 183 CIVTEFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (331)
Q Consensus 183 ~lV~E~~~ggsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~-~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~ 258 (331)
++||||+++ +|.+++.. ....+++..+..++.|++.||+|||++ |++||||||+||+++.++.+||+|||+++..
T Consensus 82 ~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 160 (290)
T 3fme_A 82 WICMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYL 160 (290)
T ss_dssp EEEEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC------
T ss_pred EEEEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccc
Confidence 999999986 88887754 357899999999999999999999998 9999999999999999999999999999876
Q ss_pred cCCCccccCCCCcccccchhc----CCCCCCChhhHHHHHHHHHHHHcCCCCCCC-CCHHHHHhcccc
Q 020085 259 AQSGVMTAETGTYRWMAPEVI----EHKPYDYKADVFSFGIALWELLTGELPYAG-LTPLQAAVGVVQ 321 (331)
Q Consensus 259 ~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Di~SlG~il~ell~g~~Pf~~-~~~~~~~~~~~~ 321 (331)
..........||+.|+|||.+ .+..++.++||||||+++|+|++|+.||.. ..+.+.......
T Consensus 161 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 228 (290)
T 3fme_A 161 VDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVE 228 (290)
T ss_dssp ---------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHH
T ss_pred cccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhc
Confidence 665555556799999999996 566789999999999999999999999987 355555554443
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-41 Score=312.73 Aligned_cols=210 Identities=25% Similarity=0.428 Sum_probs=185.9
Q ss_pred eeecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-----CCcceeEEeEEE
Q 020085 105 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-----HKNVVQFIGACT 177 (331)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~-----h~niv~~~~~~~ 177 (331)
..+-.++|++.++||+|+||+||+|++ .++.||||+++.. ....+.+..|+.+++.++ ||||+++++++.
T Consensus 30 g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~ 106 (360)
T 3llt_A 30 GMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI---KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFM 106 (360)
T ss_dssp TCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC---HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEE
T ss_pred ceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc---hhhhhhhHHHHHHHHHhcccCCCCCCeecccceee
Confidence 445578999999999999999999998 6788999999743 445567888999999996 999999999999
Q ss_pred CCCCeEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC-------------
Q 020085 178 RPPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE------------- 243 (331)
Q Consensus 178 ~~~~~~lV~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~------------- 243 (331)
..+..++||||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 107 ~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~ 185 (360)
T 3llt_A 107 YYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRV 185 (360)
T ss_dssp ETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECT
T ss_pred ECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhcc
Confidence 999999999999 889999997654 46999999999999999999999999999999999999975
Q ss_pred ------------CCcEEEeeecceeeecCCCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC
Q 020085 244 ------------NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLT 311 (331)
Q Consensus 244 ------------~~~vkl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~ 311 (331)
++.+||+|||+++..... .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+
T Consensus 186 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 263 (360)
T 3llt_A 186 TDGKKIQIYRTKSTGIKLIDFGCATFKSDY--HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHE 263 (360)
T ss_dssp TTCCEEEEEEESCCCEEECCCTTCEETTSC--CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cccccccccccCCCCEEEEeccCceecCCC--CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCc
Confidence 789999999999864432 345678999999999999999999999999999999999999999988
Q ss_pred HHHHHhccc
Q 020085 312 PLQAAVGVV 320 (331)
Q Consensus 312 ~~~~~~~~~ 320 (331)
..+....+.
T Consensus 264 ~~~~~~~~~ 272 (360)
T 3llt_A 264 HMEHLAMME 272 (360)
T ss_dssp HHHHHHHHH
T ss_pred HHHHHHHHH
Confidence 777665543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=316.37 Aligned_cols=211 Identities=24% Similarity=0.437 Sum_probs=177.9
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEe
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E 187 (331)
++|++.++||+|+||+||+|++ .++.||+|+++.... ......+.+|+.++++++||||+++++++......++|||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE-EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE 80 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC-------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc-cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence 5799999999999999999998 478899999975431 2222346679999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC-Ccccc
Q 020085 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTA 266 (331)
Q Consensus 188 ~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~-~~~~~ 266 (331)
|+++ +|.+++......+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++..... .....
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~ 159 (324)
T 3mtl_A 81 YLDK-DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN 159 (324)
T ss_dssp CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC---------
T ss_pred cccc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcccccc
Confidence 9985 999999887778999999999999999999999999999999999999999999999999999765432 23344
Q ss_pred CCCCcccccchhcCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccc
Q 020085 267 ETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK 322 (331)
Q Consensus 267 ~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~ 322 (331)
..+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+..+....+.+.
T Consensus 160 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~ 216 (324)
T 3mtl_A 160 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRI 216 (324)
T ss_dssp ---CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred ccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 578999999999876 57899999999999999999999999999888877766553
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-42 Score=334.86 Aligned_cols=222 Identities=37% Similarity=0.651 Sum_probs=193.4
Q ss_pred CCeeeecccCcceeeeeeecCceEEEEEEECC-ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCC
Q 020085 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (331)
Q Consensus 102 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 180 (331)
.+.|+|..++|++.++||+|+||.||+|++.+ ..||||+++..... .+.|.+|+.+|++++||||+++++++.+ .
T Consensus 259 ~~~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~---~~~~~~E~~~l~~l~hpniv~~~~~~~~-~ 334 (535)
T 2h8h_A 259 KDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-E 334 (535)
T ss_dssp TTCSBCCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC---HHHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred ccceecchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC---HHHHHHHHHHHHhCCCCCEeeEEEEEee-c
Confidence 45699999999999999999999999999965 67999999876544 3579999999999999999999999876 6
Q ss_pred CeEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeec
Q 020085 181 NLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA 259 (331)
Q Consensus 181 ~~~lV~E~~~ggsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~ 259 (331)
..++||||+++|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 335 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 414 (535)
T 2h8h_A 335 PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE 414 (535)
T ss_dssp SCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCC
T ss_pred cceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecC
Confidence 789999999999999999653 3568999999999999999999999999999999999999999999999999997554
Q ss_pred CCC--ccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhccccccccccc
Q 020085 260 QSG--VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIHSI 328 (331)
Q Consensus 260 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p~~ 328 (331)
... ......++..|+|||.+.+..++.++||||||+++|||++ |+.||.+.+..+.... +.++.++++
T Consensus 415 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~-i~~~~~~~~ 485 (535)
T 2h8h_A 415 DNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ-VERGYRMPC 485 (535)
T ss_dssp CHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHH-HHTTCCCCC
T ss_pred CCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCCCC
Confidence 321 1123346789999999998899999999999999999999 9999999988887666 445666544
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-42 Score=333.30 Aligned_cols=204 Identities=25% Similarity=0.418 Sum_probs=181.4
Q ss_pred ecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeE
Q 020085 107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183 (331)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 183 (331)
+..++|.+.+.||+|+||.||++++ +++.||+|+++..... ......+.+|+.++++++||||+++++++.....+|
T Consensus 182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 261 (543)
T 3c4z_A 182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLC 261 (543)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEE
Confidence 5568899999999999999999998 5789999999743211 122457889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecC
Q 020085 184 IVTEFMARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (331)
Q Consensus 184 lV~E~~~ggsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~ 260 (331)
+||||++||+|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++....
T Consensus 262 lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 262 LVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp EEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 999999999999999764 34699999999999999999999999999999999999999999999999999987654
Q ss_pred CCcc-ccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 020085 261 SGVM-TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL 310 (331)
Q Consensus 261 ~~~~-~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~ 310 (331)
.... ...+||+.|+|||++.+..++.++|+|||||++|||++|+.||.+.
T Consensus 342 ~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~ 392 (543)
T 3c4z_A 342 GQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRAR 392 (543)
T ss_dssp TCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCT
T ss_pred CCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCC
Confidence 4332 3458999999999999999999999999999999999999999875
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-42 Score=332.09 Aligned_cols=213 Identities=23% Similarity=0.507 Sum_probs=188.5
Q ss_pred ecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeE
Q 020085 107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183 (331)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 183 (331)
+..++|.+.+.||+|+||.||+|++ +++.||||+++..... .+....+.+|+.+++.++||||+++++++......+
T Consensus 13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~ 92 (476)
T 2y94_A 13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIF 92 (476)
T ss_dssp CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 4467899999999999999999998 4789999999743211 123467899999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCc
Q 020085 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV 263 (331)
Q Consensus 184 lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~ 263 (331)
+||||++||+|.+++.. ++.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus 93 lv~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~ 171 (476)
T 2y94_A 93 MVMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF 171 (476)
T ss_dssp EEEECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC
T ss_pred EEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccccc
Confidence 99999999999999964 56799999999999999999999999999999999999999999999999999988766555
Q ss_pred cccCCCCcccccchhcCCCCC-CChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccc
Q 020085 264 MTAETGTYRWMAPEVIEHKPY-DYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 264 ~~~~~gt~~y~aPE~~~~~~~-~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~ 320 (331)
....+||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+..+....+.
T Consensus 172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~ 229 (476)
T 2y94_A 172 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKIC 229 (476)
T ss_dssp BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHH
T ss_pred ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHh
Confidence 566789999999999988876 689999999999999999999999887666655544
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=314.55 Aligned_cols=209 Identities=34% Similarity=0.518 Sum_probs=185.7
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV 185 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV 185 (331)
.+.|++.+.||+|+||+||+|+. .++.||||+++.... +....+.+.+|+.++++++||||+++++++..+...++|
T Consensus 53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEE
Confidence 35699999999999999999997 578999999976543 344567899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCccc
Q 020085 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT 265 (331)
Q Consensus 186 ~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~~ 265 (331)
|||+.| +|.+++......+++..+..++.|+++||+|||++||+||||||+|||++.++.+||+|||+++..... .
T Consensus 133 ~e~~~g-~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~---~ 208 (348)
T 1u5q_A 133 MEYCLG-SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---N 208 (348)
T ss_dssp EECCSE-EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---C
T ss_pred EecCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC---C
Confidence 999985 899988776788999999999999999999999999999999999999999999999999999765432 3
Q ss_pred cCCCCcccccchhcC---CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 266 AETGTYRWMAPEVIE---HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 266 ~~~gt~~y~aPE~~~---~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
...||+.|+|||++. ...++.++|||||||++|||++|+.||.+.+..+....+.+
T Consensus 209 ~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~ 267 (348)
T 1u5q_A 209 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 267 (348)
T ss_dssp CCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred cccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh
Confidence 457999999999984 56789999999999999999999999999888877766554
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=332.63 Aligned_cols=211 Identities=30% Similarity=0.540 Sum_probs=183.9
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~ 186 (331)
.++|++.++||+|+||+||++++ .++.||||+++...........+.+|+.++++++||||+++++++.....+++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 46899999999999999999998 4789999998643222223467899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEc---CCCcEEEeeecceeeecCCCc
Q 020085 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD---ENGVVKVADFGVARVQAQSGV 263 (331)
Q Consensus 187 E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~---~~~~vkl~DFg~a~~~~~~~~ 263 (331)
||+.+|+|.+.+.. .+.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++.......
T Consensus 101 e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~ 179 (486)
T 3mwu_A 101 ELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK 179 (486)
T ss_dssp CCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC--
T ss_pred EcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCc
Confidence 99999999999866 46799999999999999999999999999999999999995 456799999999986665555
Q ss_pred cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 264 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 264 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
.....||+.|+|||++.+ .++.++||||+||++|+|++|+.||.+.+..+....+..
T Consensus 180 ~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 236 (486)
T 3mwu_A 180 MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET 236 (486)
T ss_dssp --CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 566789999999999976 499999999999999999999999999988887777554
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=314.98 Aligned_cols=213 Identities=23% Similarity=0.413 Sum_probs=176.6
Q ss_pred cccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEE
Q 020085 108 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV 185 (331)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV 185 (331)
..++|++.++||+|+||+||++.+ .++.||||+++.........+.+.+|+.++++++||||+++++++..+...++|
T Consensus 32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 111 (329)
T 3gbz_A 32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLI 111 (329)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEE
Confidence 356899999999999999999987 578999999987655555567788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEc-----CCCcEEEeeecceeeecC
Q 020085 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD-----ENGVVKVADFGVARVQAQ 260 (331)
Q Consensus 186 ~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~-----~~~~vkl~DFg~a~~~~~ 260 (331)
|||+++ +|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++....
T Consensus 112 ~e~~~~-~L~~~~~~-~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~ 189 (329)
T 3gbz_A 112 FEYAEN-DLKKYMDK-NPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI 189 (329)
T ss_dssp EECCSE-EHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-
T ss_pred EecCCC-CHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCC
Confidence 999986 99999966 45799999999999999999999999999999999999994 455699999999975543
Q ss_pred C-CccccCCCCcccccchhcCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccc
Q 020085 261 S-GVMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK 322 (331)
Q Consensus 261 ~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~ 322 (331)
. .......+|+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+....+.+.
T Consensus 190 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~ 253 (329)
T 3gbz_A 190 PIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEV 253 (329)
T ss_dssp ----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred cccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHH
Confidence 2 233455789999999999774 5899999999999999999999999999888877776654
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=330.45 Aligned_cols=211 Identities=30% Similarity=0.506 Sum_probs=182.6
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~ 186 (331)
.+.|++.++||+|+||+||+|++ .++.||+|+++...........+.+|+.++++++||||++++++|......|+||
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 115 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVM 115 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 34799999999999999999998 5688999999865443334567899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC---CcEEEeeecceeeecCCCc
Q 020085 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN---GVVKVADFGVARVQAQSGV 263 (331)
Q Consensus 187 E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~---~~vkl~DFg~a~~~~~~~~ 263 (331)
||+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+++.......
T Consensus 116 e~~~~g~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~ 194 (494)
T 3lij_A 116 ECYKGGELFDEIIH-RMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK 194 (494)
T ss_dssp ECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBC
T ss_pred ecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCcc
Confidence 99999999999865 4678999999999999999999999999999999999999764 4599999999988776666
Q ss_pred cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 264 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 264 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
.....||+.|+|||++. ..++.++||||+||++|+|++|..||.+.++.+....+..
T Consensus 195 ~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 251 (494)
T 3lij_A 195 MKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEK 251 (494)
T ss_dssp BCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred ccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 66778999999999986 4699999999999999999999999999988887776544
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-42 Score=315.80 Aligned_cols=202 Identities=26% Similarity=0.476 Sum_probs=175.3
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~ 186 (331)
.++|++.+.||+|+||.||+|.+ .++.||+|+++.... ....+.+.+|+.+++.++||||+++++++..+...++||
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 84 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 84 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc-cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence 35899999999999999999988 478999999975432 223467889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC---c
Q 020085 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG---V 263 (331)
Q Consensus 187 E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~---~ 263 (331)
||+++|+|.+++.. ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++...... .
T Consensus 85 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 163 (323)
T 3tki_A 85 EYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL 163 (323)
T ss_dssp ECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred EcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccc
Confidence 99999999999854 4579999999999999999999999999999999999999999999999999997654322 2
Q ss_pred cccCCCCcccccchhcCCCCC-CChhhHHHHHHHHHHHHcCCCCCCCCCH
Q 020085 264 MTAETGTYRWMAPEVIEHKPY-DYKADVFSFGIALWELLTGELPYAGLTP 312 (331)
Q Consensus 264 ~~~~~gt~~y~aPE~~~~~~~-~~~~Di~SlG~il~ell~g~~Pf~~~~~ 312 (331)
.....||+.|+|||++.+..+ +.++||||||+++|+|++|+.||.....
T Consensus 164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 213 (323)
T 3tki_A 164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213 (323)
T ss_dssp BCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCT
T ss_pred cCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCch
Confidence 335579999999999987765 7789999999999999999999987544
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=331.00 Aligned_cols=215 Identities=27% Similarity=0.468 Sum_probs=190.4
Q ss_pred ecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeE
Q 020085 107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183 (331)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 183 (331)
+-.++|++.+.||+|+||.||++++ .++.||||++...... ....+.+.+|+.++++++||||+++++++......+
T Consensus 23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 102 (484)
T 3nyv_A 23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFY 102 (484)
T ss_dssp CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEE
T ss_pred cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 3456899999999999999999998 5789999999654322 233567999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEE---cCCCcEEEeeecceeeecC
Q 020085 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM---DENGVVKVADFGVARVQAQ 260 (331)
Q Consensus 184 lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi---~~~~~vkl~DFg~a~~~~~ 260 (331)
+||||+.+|+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||+ +.++.+||+|||+++....
T Consensus 103 lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~ 181 (484)
T 3nyv_A 103 LVGEVYTGGELFDEIIS-RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181 (484)
T ss_dssp EEECCCCSCBHHHHHHT-CSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCC
T ss_pred EEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccc
Confidence 99999999999999965 5679999999999999999999999999999999999999 5678999999999987666
Q ss_pred CCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccccc
Q 020085 261 SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKV 323 (331)
Q Consensus 261 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~ 323 (331)
........||+.|+|||++.+ .++.++||||+||++|+|++|++||.+.++.+....+.+..
T Consensus 182 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~ 243 (484)
T 3nyv_A 182 SKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGK 243 (484)
T ss_dssp CCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred ccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC
Confidence 555566789999999999976 69999999999999999999999999999888877755443
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-42 Score=336.14 Aligned_cols=204 Identities=23% Similarity=0.425 Sum_probs=183.2
Q ss_pred ecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeE
Q 020085 107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183 (331)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 183 (331)
+..++|++.+.||+|+||.||++++ +++.||+|+++.... .......+.+|+.++++++||||+++++++.....+|
T Consensus 181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~ 260 (576)
T 2acx_A 181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALC 260 (576)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEE
Confidence 5678899999999999999999998 578999999964321 1112356889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC
Q 020085 184 IVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262 (331)
Q Consensus 184 lV~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~ 262 (331)
+||||++||+|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus 261 lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~ 340 (576)
T 2acx_A 261 LVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 340 (576)
T ss_dssp EEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred EEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCc
Confidence 9999999999999997643 359999999999999999999999999999999999999999999999999998776655
Q ss_pred ccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 020085 263 VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL 310 (331)
Q Consensus 263 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~ 310 (331)
.....+||+.|+|||++.+..++.++|+|||||++|||++|+.||...
T Consensus 341 ~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~ 388 (576)
T 2acx_A 341 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR 388 (576)
T ss_dssp CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCS
T ss_pred cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCccc
Confidence 556678999999999999999999999999999999999999999875
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=337.94 Aligned_cols=223 Identities=26% Similarity=0.517 Sum_probs=188.5
Q ss_pred eeeecccCcceee-eeeecCceEEEEEEEC----CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEEC
Q 020085 104 VWEIDAKQLKIEC-KVASGSYGDLYKGTYC----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR 178 (331)
Q Consensus 104 ~~~i~~~~~~~~~-~lg~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 178 (331)
.+.+..+++.+.+ +||+|+||.||+|.+. +..||||+++... .....+.+.+|+.+|++++||||++++++|..
T Consensus 329 ~~~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~ 407 (613)
T 2ozo_A 329 KLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA 407 (613)
T ss_dssp CSBCCTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCC-SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES
T ss_pred ceeccccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC-ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc
Confidence 4667777888777 8999999999999873 4569999998653 23345789999999999999999999999986
Q ss_pred CCCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeee
Q 020085 179 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (331)
Q Consensus 179 ~~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~ 258 (331)
+.+++||||+++|+|.+++......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 408 -~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~ 486 (613)
T 2ozo_A 408 -EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKAL 486 (613)
T ss_dssp -SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTC
T ss_pred -CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccc
Confidence 5699999999999999999777778999999999999999999999999999999999999999999999999999765
Q ss_pred cCCCc----cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhcccccccccccc
Q 020085 259 AQSGV----MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIHSII 329 (331)
Q Consensus 259 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p~~~ 329 (331)
..... .....+++.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+.... +.+|.+++++
T Consensus 487 ~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~-i~~~~~~~~p 561 (613)
T 2ozo_A 487 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF-IEQGKRMECP 561 (613)
T ss_dssp C--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHH-HHTTCCCCCC
T ss_pred cCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH-HHcCCCCCCC
Confidence 43221 122345689999999999999999999999999999998 9999999888776655 5567776654
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-42 Score=311.34 Aligned_cols=225 Identities=31% Similarity=0.583 Sum_probs=190.8
Q ss_pred CeeeecccCcceeeeeeecCceEEEEEEE-------CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCcceeEEe
Q 020085 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIG 174 (331)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~ 174 (331)
..|++..++|++.+.||+|+||.||+|.+ .++.||||+++... .....+.+.+|+.+++++ +||||+++++
T Consensus 20 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 98 (316)
T 2xir_A 20 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLLG 98 (316)
T ss_dssp HHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC-CcHHHHHHHHHHHHHHhcccCCCeeeEEE
Confidence 46888999999999999999999999985 33789999998653 455567899999999999 6899999999
Q ss_pred EEECCC-CeEEEEeccCCCCHHHHHHhcCCC---------------CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCC
Q 020085 175 ACTRPP-NLCIVTEFMARGSIYDFLHKQKGV---------------FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTAN 238 (331)
Q Consensus 175 ~~~~~~-~~~lV~E~~~ggsL~~~l~~~~~~---------------~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~N 238 (331)
++...+ .+++||||+++++|.+++...... +++..+..++.|+++||.|||++|++||||||+|
T Consensus 99 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~N 178 (316)
T 2xir_A 99 ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARN 178 (316)
T ss_dssp EECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred EEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccce
Confidence 987654 489999999999999999765432 7899999999999999999999999999999999
Q ss_pred EEEcCCCcEEEeeecceeeecCCCc---cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHH
Q 020085 239 LLMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQ 314 (331)
Q Consensus 239 iLi~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~ 314 (331)
|+++.++.+||+|||+++....... .....+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.+.+..+
T Consensus 179 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~ 258 (316)
T 2xir_A 179 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE 258 (316)
T ss_dssp EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred EEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhH
Confidence 9999999999999999976543322 223457889999999999999999999999999999998 999998876555
Q ss_pred HHhccccccccccc
Q 020085 315 AAVGVVQKVSIHSI 328 (331)
Q Consensus 315 ~~~~~~~~~~~p~~ 328 (331)
.....+..+.++.+
T Consensus 259 ~~~~~~~~~~~~~~ 272 (316)
T 2xir_A 259 EFCRRLKEGTRMRA 272 (316)
T ss_dssp HHHHHHHHTCCCCC
T ss_pred HHHHHhccCccCCC
Confidence 55554555554443
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-42 Score=307.97 Aligned_cols=213 Identities=38% Similarity=0.706 Sum_probs=188.7
Q ss_pred CeeeecccCcceeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCC
Q 020085 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (331)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 180 (331)
+.|++..++|++.+.||+|+||.||+|.+. ++.||+|+++... ...+.+.+|+.++++++||||+++++++..+.
T Consensus 6 ~~~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 82 (288)
T 3kfa_A 6 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT---MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP 82 (288)
T ss_dssp CTTBCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS---THHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred hcccccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 458999999999999999999999999995 7889999998653 23567899999999999999999999999999
Q ss_pred CeEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeec
Q 020085 181 NLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA 259 (331)
Q Consensus 181 ~~~lV~E~~~ggsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~ 259 (331)
..++||||+++++|.+++... ...+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||+++...
T Consensus 83 ~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 162 (288)
T 3kfa_A 83 PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT 162 (288)
T ss_dssp SEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSC
T ss_pred CEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceecc
Confidence 999999999999999999764 3568999999999999999999999999999999999999999999999999997654
Q ss_pred CCCc--cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhc
Q 020085 260 QSGV--MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVG 318 (331)
Q Consensus 260 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~ 318 (331)
.... .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....
T Consensus 163 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~ 224 (288)
T 3kfa_A 163 GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYEL 224 (288)
T ss_dssp SSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHH
T ss_pred CCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 4322 223346788999999998999999999999999999999 9999998776655544
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=343.80 Aligned_cols=218 Identities=23% Similarity=0.409 Sum_probs=188.5
Q ss_pred eeeecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhc-CCCcceeEEeEEECC
Q 020085 104 VWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRP 179 (331)
Q Consensus 104 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~ 179 (331)
...+..++|++.+.||+|+||.||++++ .++.||||+++.... .....+.+..|..+++.+ +||||+++++++...
T Consensus 335 ~~~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~ 414 (674)
T 3pfq_A 335 RDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM 414 (674)
T ss_dssp -----CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCS
T ss_pred cccccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeC
Confidence 3456778999999999999999999998 457899999974321 112345688899999987 699999999999999
Q ss_pred CCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeec
Q 020085 180 PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA 259 (331)
Q Consensus 180 ~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~ 259 (331)
..+|+||||++||+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 415 ~~~~lV~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~ 493 (674)
T 3pfq_A 415 DRLYFVMEYVNGGDLMYHIQQ-VGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI 493 (674)
T ss_dssp SEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECC
T ss_pred CEEEEEEeCcCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccc
Confidence 999999999999999999976 4679999999999999999999999999999999999999999999999999998643
Q ss_pred C-CCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccc
Q 020085 260 Q-SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK 322 (331)
Q Consensus 260 ~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~ 322 (331)
. .......+||+.|+|||++.+..|+.++|+||||+++|||++|+.||.+.+..+....+.+.
T Consensus 494 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~ 557 (674)
T 3pfq_A 494 WDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH 557 (674)
T ss_dssp CTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSS
T ss_pred cCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhC
Confidence 3 33345568999999999999999999999999999999999999999999988888776653
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=306.72 Aligned_cols=219 Identities=35% Similarity=0.657 Sum_probs=182.0
Q ss_pred CeeeecccCcceeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECC-CC
Q 020085 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP-PN 181 (331)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~-~~ 181 (331)
..|.++.++|++.+.||+|+||.||++++.++.||+|+++... ..+.+.+|+.++++++||||+++++++... ..
T Consensus 14 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 89 (278)
T 1byg_A 14 SGWALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGG 89 (278)
T ss_dssp -CCBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--C
T ss_pred ccccCChhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCc
Confidence 4588899999999999999999999999999999999998653 346789999999999999999999987554 47
Q ss_pred eEEEEeccCCCCHHHHHHhcCC-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecC
Q 020085 182 LCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (331)
Q Consensus 182 ~~lV~E~~~ggsL~~~l~~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~ 260 (331)
.++||||+++++|.+++..... .+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||+++....
T Consensus 90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 90 LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred eEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 8999999999999999976432 378999999999999999999999999999999999999999999999999975543
Q ss_pred CCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhccccccccccc
Q 020085 261 SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIHSI 328 (331)
Q Consensus 261 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p~~ 328 (331)
. .....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||...+..+.... +.++.++.+
T Consensus 170 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~-~~~~~~~~~ 235 (278)
T 1byg_A 170 T--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-VEKGYKMDA 235 (278)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH-HTTTCCCCC
T ss_pred c--ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HhcCCCCCC
Confidence 2 233467889999999999999999999999999999998 9999998776665544 334544443
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-41 Score=319.23 Aligned_cols=215 Identities=21% Similarity=0.356 Sum_probs=182.3
Q ss_pred eeecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEEC----
Q 020085 105 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR---- 178 (331)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~---- 178 (331)
++...++|++.+.||+|+||+||+|++ +++.||||++..+. ....+|+.+++.++||||+++++++..
T Consensus 2 l~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~------~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 75 (383)
T 3eb0_A 2 LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP------RYKNRELDIMKVLDHVNIIKLVDYFYTTGDE 75 (383)
T ss_dssp ----CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT------TSCCHHHHHHTTCCCTTBCCEEEEEEEC---
T ss_pred CccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc------chHHHHHHHHHHcCCCCccchhheeeecCcc
Confidence 345577999999999999999999988 67899999987553 223479999999999999999999843
Q ss_pred ----------------------------------CCCeEEEEeccCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHH
Q 020085 179 ----------------------------------PPNLCIVTEFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGM 221 (331)
Q Consensus 179 ----------------------------------~~~~~lV~E~~~ggsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l 221 (331)
...+++||||+++ +|.+.+.. ....+++..+..++.||++||
T Consensus 76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL 154 (383)
T 3eb0_A 76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAV 154 (383)
T ss_dssp ----------------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence 3348899999985 88777753 357899999999999999999
Q ss_pred HHHHhCCcccCCCCCCCEEEc-CCCcEEEeeecceeeecCCCccccCCCCcccccchhcCCC-CCCChhhHHHHHHHHHH
Q 020085 222 NYLHQNNIIHRDLKTANLLMD-ENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWE 299 (331)
Q Consensus 222 ~~LH~~~iiHrDlkp~NiLi~-~~~~vkl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~e 299 (331)
+|||++||+||||||+|||++ .++.+||+|||+++............+|+.|+|||.+.+. .++.++||||+||++||
T Consensus 155 ~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e 234 (383)
T 3eb0_A 155 GFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGE 234 (383)
T ss_dssp HHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHH
T ss_pred HHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHH
Confidence 999999999999999999998 6889999999999977666666677899999999998765 58999999999999999
Q ss_pred HHcCCCCCCCCCHHHHHhccccccccc
Q 020085 300 LLTGELPYAGLTPLQAAVGVVQKVSIH 326 (331)
Q Consensus 300 ll~g~~Pf~~~~~~~~~~~~~~~~~~p 326 (331)
|++|+.||.+.+..+....+++....|
T Consensus 235 ll~g~~pf~~~~~~~~~~~i~~~~g~p 261 (383)
T 3eb0_A 235 LILGKPLFSGETSIDQLVRIIQIMGTP 261 (383)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHHHCCC
T ss_pred HHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence 999999999999988888776644443
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=304.57 Aligned_cols=219 Identities=31% Similarity=0.587 Sum_probs=184.1
Q ss_pred eecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCH--HHH---HHHHHHHHHHHhcCCCcceeEEeEEEC
Q 020085 106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNT--EML---KEFSQEVYIMRKIRHKNVVQFIGACTR 178 (331)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~--~~~---~~~~~E~~il~~l~h~niv~~~~~~~~ 178 (331)
.+..++|++.+.||+|+||.||+|++ .++.||+|++....... ... +.+.+|+.++++++||||+++++++..
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (287)
T 4f0f_A 15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHN 94 (287)
T ss_dssp BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETT
T ss_pred hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecC
Confidence 45678999999999999999999998 57899999987543322 211 678999999999999999999999876
Q ss_pred CCCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCCEEEcCCCc-----EEEee
Q 020085 179 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNN--IIHRDLKTANLLMDENGV-----VKVAD 251 (331)
Q Consensus 179 ~~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~NiLi~~~~~-----vkl~D 251 (331)
.. ++||||+++|+|.+++......+++..+..++.|++.||+|||++| ++||||||+||+++.++. +||+|
T Consensus 95 ~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D 172 (287)
T 4f0f_A 95 PP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172 (287)
T ss_dssp TT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred CC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence 54 7999999999999999877778999999999999999999999999 999999999999988876 99999
Q ss_pred ecceeeecCCCccccCCCCcccccchhc--CCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH--HHHHhcccccccccc
Q 020085 252 FGVARVQAQSGVMTAETGTYRWMAPEVI--EHKPYDYKADVFSFGIALWELLTGELPYAGLTP--LQAAVGVVQKVSIHS 327 (331)
Q Consensus 252 Fg~a~~~~~~~~~~~~~gt~~y~aPE~~--~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~--~~~~~~~~~~~~~p~ 327 (331)
||+++.... ......||+.|+|||.+ ....++.++||||||+++|+|++|+.||...+. ......+...+.+|.
T Consensus 173 fg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~ 250 (287)
T 4f0f_A 173 FGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPT 250 (287)
T ss_dssp CTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCCC
T ss_pred CCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCCC
Confidence 999975433 34456799999999998 455678999999999999999999999987643 333444444455554
Q ss_pred c
Q 020085 328 I 328 (331)
Q Consensus 328 ~ 328 (331)
+
T Consensus 251 ~ 251 (287)
T 4f0f_A 251 I 251 (287)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-42 Score=316.60 Aligned_cols=220 Identities=28% Similarity=0.568 Sum_probs=182.6
Q ss_pred eecccCcceeeeeeecCceEEEEEEEC--Cce----EEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECC
Q 020085 106 EIDAKQLKIECKVASGSYGDLYKGTYC--SQE----VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP 179 (331)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~----vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 179 (331)
.+..++|++.+.||+|+||+||+|++. ++. ||+|++.... .......+.+|+.++++++||||+++++++. .
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~ 86 (325)
T 3kex_A 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS-GRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-G 86 (325)
T ss_dssp BCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT-SCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-B
T ss_pred hcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc-cHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-C
Confidence 355779999999999999999999984 333 8888876442 1222356788999999999999999999886 4
Q ss_pred CCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeec
Q 020085 180 PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA 259 (331)
Q Consensus 180 ~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~ 259 (331)
...++||||+.+|+|.+++...++.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 87 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 87 SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccC
Confidence 57899999999999999998766789999999999999999999999999999999999999999999999999998654
Q ss_pred CCC---ccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhccccccccccc
Q 020085 260 QSG---VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIHSI 328 (331)
Q Consensus 260 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p~~ 328 (331)
... ......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||.+.+..+.... +.++.++..
T Consensus 167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~-~~~~~~~~~ 238 (325)
T 3kex_A 167 PDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDL-LEKGERLAQ 238 (325)
T ss_dssp CCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHH-HHTTCBCCC
T ss_pred cccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHH-HHcCCCCCC
Confidence 332 2234457789999999998999999999999999999999 9999998876665444 444544433
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=325.22 Aligned_cols=204 Identities=27% Similarity=0.423 Sum_probs=164.3
Q ss_pred eeecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECC---
Q 020085 105 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP--- 179 (331)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~--- 179 (331)
|++ .++|++.+.||+|+||+||+|.+ .++.||||++.....+....+.+.+|+.+|++++||||+++++++...
T Consensus 49 ~~~-~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~ 127 (458)
T 3rp9_A 49 WQI-PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVE 127 (458)
T ss_dssp CCS-CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTT
T ss_pred Ccc-CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcc
Confidence 444 36899999999999999999987 578999999987666666778899999999999999999999998433
Q ss_pred --CCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceee
Q 020085 180 --PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV 257 (331)
Q Consensus 180 --~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~ 257 (331)
..+|+||||+. ++|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 128 ~~~~~~lv~e~~~-~~L~~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 128 KFDELYVVLEIAD-SDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp TCCCEEEEECCCS-EEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred cCceEEEEEeccc-cchhhhccc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchh
Confidence 56899999985 599999864 56799999999999999999999999999999999999999999999999999986
Q ss_pred ecCCC----------------------------ccccCCCCcccccchhc-CCCCCCChhhHHHHHHHHHHHHc------
Q 020085 258 QAQSG----------------------------VMTAETGTYRWMAPEVI-EHKPYDYKADVFSFGIALWELLT------ 302 (331)
Q Consensus 258 ~~~~~----------------------------~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~SlG~il~ell~------ 302 (331)
..... ..+..+||+.|+|||++ .+..|+.++|||||||++|||++
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~ 285 (458)
T 3rp9_A 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV 285 (458)
T ss_dssp TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccc
Confidence 54221 23445689999999986 56779999999999999999999
Q ss_pred -----CCCCCCCCC
Q 020085 303 -----GELPYAGLT 311 (331)
Q Consensus 303 -----g~~Pf~~~~ 311 (331)
|++||++.+
T Consensus 286 ~~~~~~~p~f~g~~ 299 (458)
T 3rp9_A 286 AYHADRGPLFPGSS 299 (458)
T ss_dssp SSGGGCCCSCC---
T ss_pred cccccccccCCCCc
Confidence 788887754
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-41 Score=317.62 Aligned_cols=214 Identities=26% Similarity=0.461 Sum_probs=171.0
Q ss_pred CeeeecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECC-
Q 020085 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP- 179 (331)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~- 179 (331)
..|++. ++|++.+.||+|+||.||+|.+ .++.||||+++....+....+.+.+|+.+++.++||||+++++++...
T Consensus 23 ~~~~~~-~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 101 (367)
T 2fst_X 23 TIWEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPAR 101 (367)
T ss_dssp EEEEEE-TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCS
T ss_pred cccCCC-CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence 456665 6899999999999999999987 578999999987665666778899999999999999999999999754
Q ss_pred -----CCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecc
Q 020085 180 -----PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV 254 (331)
Q Consensus 180 -----~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~ 254 (331)
...++|+|++ +++|.+++.. ..+++..+..++.||++||.|||++||+||||||+|||++.++.+||+|||+
T Consensus 102 ~~~~~~~~~lv~e~~-~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~ 178 (367)
T 2fst_X 102 SLEEFNDVYLVTHLM-GADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGL 178 (367)
T ss_dssp SGGGCCCCEEEEECC-CEECC-------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC---
T ss_pred ccccCCeEEEEeccc-CCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccc
Confidence 5689999999 6799998854 5799999999999999999999999999999999999999999999999999
Q ss_pred eeeecCCCccccCCCCcccccchhcCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccc
Q 020085 255 ARVQAQSGVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK 322 (331)
Q Consensus 255 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~ 322 (331)
++..... .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+....+.+.
T Consensus 179 a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~ 245 (367)
T 2fst_X 179 ARHTADE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 245 (367)
T ss_dssp --------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred ccccccc--CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 9865432 345678999999999876 67899999999999999999999999999887776665543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=314.63 Aligned_cols=212 Identities=26% Similarity=0.436 Sum_probs=184.1
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECC-------
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP------- 179 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~------- 179 (331)
.++|++.++||+|+||.||+|++ .++.||+|++............+.+|+.++++++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 95 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence 46899999999999999999998 578999999976654444446788999999999999999999998763
Q ss_pred -CCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeee
Q 020085 180 -PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (331)
Q Consensus 180 -~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~ 258 (331)
...++||||+++ +|.+.+......+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 96 ~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~ 174 (351)
T 3mi9_A 96 KGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 174 (351)
T ss_dssp -CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred CceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcccc
Confidence 458999999986 888888776778999999999999999999999999999999999999999999999999999865
Q ss_pred cC-----CCccccCCCCcccccchhcCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 259 AQ-----SGVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 259 ~~-----~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
.. ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+.+
T Consensus 175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~ 243 (351)
T 3mi9_A 175 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 243 (351)
T ss_dssp CCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 42 222345578999999999876 5689999999999999999999999999887776665543
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-41 Score=328.29 Aligned_cols=211 Identities=26% Similarity=0.499 Sum_probs=184.9
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCH-----------HHHHHHHHHHHHHHhcCCCcceeEEeE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNT-----------EMLKEFSQEVYIMRKIRHKNVVQFIGA 175 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~-----------~~~~~~~~E~~il~~l~h~niv~~~~~ 175 (331)
.++|.+.++||+|+||+||+|++ .++.||+|+++...... ...+.+.+|+.++++++||||++++++
T Consensus 35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~ 114 (504)
T 3q5i_A 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV 114 (504)
T ss_dssp GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence 56899999999999999999998 46889999997653221 234678999999999999999999999
Q ss_pred EECCCCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC---cEEEeee
Q 020085 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG---VVKVADF 252 (331)
Q Consensus 176 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~---~vkl~DF 252 (331)
+.....+|+||||++||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+||
T Consensus 115 ~~~~~~~~lv~e~~~gg~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Df 193 (504)
T 3q5i_A 115 FEDKKYFYLVTEFYEGGELFEQIIN-RHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDF 193 (504)
T ss_dssp EECSSEEEEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEEECCC
T ss_pred EEcCCEEEEEEecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEEEEEC
Confidence 9999999999999999999999966 46799999999999999999999999999999999999999876 6999999
Q ss_pred cceeeecCCCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 253 GVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 253 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
|+++............||+.|+|||++.+ .++.++||||+||++|+|++|..||.+.+..+....+..
T Consensus 194 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 261 (504)
T 3q5i_A 194 GLSSFFSKDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEK 261 (504)
T ss_dssp TTCEECCTTSCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCCEEcCCCCccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc
Confidence 99988776666667789999999999874 589999999999999999999999999988887776544
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=307.73 Aligned_cols=225 Identities=27% Similarity=0.486 Sum_probs=183.0
Q ss_pred CeeeecccCcceeeeeeecCceEEEEEEECC-----ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEE
Q 020085 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCS-----QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177 (331)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 177 (331)
..+.++.++|.+.+.||+|+||.||+|++.. +.||+|+++.........+.+.+|+.++++++||||+++++++.
T Consensus 27 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~ 106 (313)
T 3brb_A 27 EDVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCI 106 (313)
T ss_dssp TTTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred HhcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEe
Confidence 4577889999999999999999999998732 47999999877667777788999999999999999999999997
Q ss_pred CCC-----CeEEEEeccCCCCHHHHHHh-----cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcE
Q 020085 178 RPP-----NLCIVTEFMARGSIYDFLHK-----QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVV 247 (331)
Q Consensus 178 ~~~-----~~~lV~E~~~ggsL~~~l~~-----~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~v 247 (331)
... ..++||||+++++|.+++.. ....+++..++.++.|+++||.|||++|++||||||+||+++.++.+
T Consensus 107 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~ 186 (313)
T 3brb_A 107 EMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTV 186 (313)
T ss_dssp C-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCE
T ss_pred eccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcE
Confidence 754 35999999999999999853 23579999999999999999999999999999999999999999999
Q ss_pred EEeeecceeeecCCC---ccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhcccccc
Q 020085 248 KVADFGVARVQAQSG---VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKV 323 (331)
Q Consensus 248 kl~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~ 323 (331)
||+|||+++...... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||...+..+....+. .+
T Consensus 187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~-~~ 265 (313)
T 3brb_A 187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLL-HG 265 (313)
T ss_dssp EECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHH-TT
T ss_pred EEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHH-cC
Confidence 999999997654332 1233456889999999999999999999999999999999 899999887776655533 44
Q ss_pred ccccc
Q 020085 324 SIHSI 328 (331)
Q Consensus 324 ~~p~~ 328 (331)
.++.+
T Consensus 266 ~~~~~ 270 (313)
T 3brb_A 266 HRLKQ 270 (313)
T ss_dssp CCCCC
T ss_pred CCCCC
Confidence 44443
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=310.12 Aligned_cols=198 Identities=25% Similarity=0.439 Sum_probs=170.2
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCC------
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN------ 181 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~------ 181 (331)
++|++.+.||+|+||.||+|++ +++.||||+++... .....+.+.+|+.++++++||||++++++|.+...
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 84 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN-RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE 84 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS-TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC-chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence 5799999999999999999998 57899999997554 33345789999999999999999999999865432
Q ss_pred ---------------------------------------------------eEEEEeccCCCCHHHHHHhcC--CCCCHH
Q 020085 182 ---------------------------------------------------LCIVTEFMARGSIYDFLHKQK--GVFQLT 208 (331)
Q Consensus 182 ---------------------------------------------------~~lV~E~~~ggsL~~~l~~~~--~~~~~~ 208 (331)
.++||||+++++|.+++.... ...+..
T Consensus 85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~ 164 (332)
T 3qd2_B 85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG 164 (332)
T ss_dssp HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence 799999999999999997643 235566
Q ss_pred HHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC-------------ccccCCCCccccc
Q 020085 209 SLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-------------VMTAETGTYRWMA 275 (331)
Q Consensus 209 ~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~-------------~~~~~~gt~~y~a 275 (331)
.++.++.|++.||+|||++||+||||||+||+++.++.+||+|||+++...... ......||+.|+|
T Consensus 165 ~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 244 (332)
T 3qd2_B 165 VCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244 (332)
T ss_dssp HHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSC
T ss_pred HHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccC
Confidence 789999999999999999999999999999999999999999999998765432 2234569999999
Q ss_pred chhcCCCCCCChhhHHHHHHHHHHHHcCCCCCC
Q 020085 276 PEVIEHKPYDYKADVFSFGIALWELLTGELPYA 308 (331)
Q Consensus 276 PE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~ 308 (331)
||++.+..++.++||||||+++|||++|..|+.
T Consensus 245 PE~~~~~~~~~~~Di~slG~il~el~~~~~~~~ 277 (332)
T 3qd2_B 245 PEQIHGNNYSHKVDIFSLGLILFELLYSFSTQM 277 (332)
T ss_dssp HHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHH
T ss_pred hHHhcCCCCcchhhHHHHHHHHHHHHHcCCChh
Confidence 999999999999999999999999999887764
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-41 Score=317.12 Aligned_cols=215 Identities=21% Similarity=0.377 Sum_probs=181.7
Q ss_pred eeeecccCcceeeeeeecCceEEEEEEE-CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC--CCcceeEEeEEECCC
Q 020085 104 VWEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR--HKNVVQFIGACTRPP 180 (331)
Q Consensus 104 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~--h~niv~~~~~~~~~~ 180 (331)
...+..+.|++.+.||+|+||.||++.. .++.||||+++....+....+.+.+|+.++++++ ||||+++++++....
T Consensus 50 ~~~~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~ 129 (390)
T 2zmd_A 50 CISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 129 (390)
T ss_dssp CEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred cccccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCC
Confidence 4566778899999999999999999987 4688999999877667777888999999999997 599999999999999
Q ss_pred CeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecC
Q 020085 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (331)
Q Consensus 181 ~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~ 260 (331)
.+|+||| +.+++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||+++....
T Consensus 130 ~~~lv~E-~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~ 206 (390)
T 2zmd_A 130 YIYMVME-CGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 206 (390)
T ss_dssp EEEEEEE-CCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred EEEEEEe-cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence 9999999 567799999976 45789999999999999999999999999999999999995 68999999999986543
Q ss_pred CC---ccccCCCCcccccchhcCC-----------CCCCChhhHHHHHHHHHHHHcCCCCCCCC-CHHHHHhcccc
Q 020085 261 SG---VMTAETGTYRWMAPEVIEH-----------KPYDYKADVFSFGIALWELLTGELPYAGL-TPLQAAVGVVQ 321 (331)
Q Consensus 261 ~~---~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Di~SlG~il~ell~g~~Pf~~~-~~~~~~~~~~~ 321 (331)
.. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||... ........++.
T Consensus 207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~ 282 (390)
T 2zmd_A 207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID 282 (390)
T ss_dssp -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHC
T ss_pred CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhC
Confidence 32 2234579999999999865 46899999999999999999999999875 33444444443
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=301.84 Aligned_cols=210 Identities=25% Similarity=0.471 Sum_probs=182.2
Q ss_pred ccCcceeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCH----HHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCe
Q 020085 109 AKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNT----EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL 182 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~----~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 182 (331)
.++|++.+.||+|+||.||++++. ++.||+|+++...... ...+.+.+|+.++++++||||+++++++......
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeE
Confidence 357999999999999999999984 7899999997653321 1246789999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC----cEEEeeecceeee
Q 020085 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG----VVKVADFGVARVQ 258 (331)
Q Consensus 183 ~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~----~vkl~DFg~a~~~ 258 (331)
++||||+++++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+||+++.++ .++|+|||.++..
T Consensus 84 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~ 162 (283)
T 3bhy_A 84 VLILELVSGGELFDFLAE-KESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI 162 (283)
T ss_dssp EEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred EEEEeecCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence 999999999999999965 46789999999999999999999999999999999999999877 8999999999876
Q ss_pred cCCCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcc
Q 020085 259 AQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGV 319 (331)
Q Consensus 259 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~ 319 (331)
..........+++.|+|||.+.+..++.++|+||||+++|+|++|+.||.+.+..+....+
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~ 223 (283)
T 3bhy_A 163 EAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNI 223 (283)
T ss_dssp C--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred cCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHh
Confidence 6555555567999999999999999999999999999999999999999998776665543
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-42 Score=318.92 Aligned_cols=209 Identities=19% Similarity=0.322 Sum_probs=174.0
Q ss_pred CCCeeeecccCcceeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCCHHH---------HHHHHHHHHHHHhc
Q 020085 101 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEM---------LKEFSQEVYIMRKI 164 (331)
Q Consensus 101 ~~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~---------~~~~~~E~~il~~l 164 (331)
+....++..++|++.+.||+|+||.||+|.+. ++.||||+++........ ...+.+|+..++.+
T Consensus 26 g~~i~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l 105 (364)
T 3op5_A 26 GEIITDMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKL 105 (364)
T ss_dssp TCEEECTTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTC
T ss_pred CcEeeccCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhc
Confidence 33444567889999999999999999999883 368999998765311100 01234456667778
Q ss_pred CCCcceeEEeEEECC----CCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEE
Q 020085 165 RHKNVVQFIGACTRP----PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLL 240 (331)
Q Consensus 165 ~h~niv~~~~~~~~~----~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiL 240 (331)
+||||+++++++... ...++||||+ |++|.+++....+.+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 106 ~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nil 184 (364)
T 3op5_A 106 KYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLL 184 (364)
T ss_dssp SCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred cCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEE
Confidence 899999999998764 3489999999 89999999887688999999999999999999999999999999999999
Q ss_pred Ec--CCCcEEEeeecceeeecCCCcc--------ccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 020085 241 MD--ENGVVKVADFGVARVQAQSGVM--------TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL 310 (331)
Q Consensus 241 i~--~~~~vkl~DFg~a~~~~~~~~~--------~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~ 310 (331)
++ .++.+||+|||+++........ ....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.
T Consensus 185 l~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~ 264 (364)
T 3op5_A 185 LNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDN 264 (364)
T ss_dssp EESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred EecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 99 8899999999999865443211 2334999999999999999999999999999999999999999864
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=304.30 Aligned_cols=200 Identities=20% Similarity=0.331 Sum_probs=178.4
Q ss_pred eecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCcceeEEeEEECCCCe
Q 020085 106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNL 182 (331)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~ 182 (331)
.+..++|++.+.||+|+||.||+|.+ .++.||+|+++..... +.+.+|+.+++++ +|+|++++++++......
T Consensus 6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~ 81 (298)
T 1csn_A 6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHN 81 (298)
T ss_dssp CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEE
T ss_pred cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc----HHHHHHHHHHHHHhcCCCCCeEEeecCCCcee
Confidence 45678999999999999999999996 6789999998754322 4578899999999 799999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCc-----EEEeeecceee
Q 020085 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV-----VKVADFGVARV 257 (331)
Q Consensus 183 ~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~-----vkl~DFg~a~~ 257 (331)
++||||+ +++|.+++......+++..+..++.|++.||+|||++||+||||||+||+++.++. +||+|||+++.
T Consensus 82 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 82 VLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp EEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 9999999 88999999876677999999999999999999999999999999999999987776 99999999986
Q ss_pred ecCCCc--------cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 020085 258 QAQSGV--------MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL 310 (331)
Q Consensus 258 ~~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~ 310 (331)
...... .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 221 (298)
T 1csn_A 161 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 221 (298)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred cccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchh
Confidence 654322 23456899999999999999999999999999999999999999884
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-41 Score=309.59 Aligned_cols=216 Identities=26% Similarity=0.426 Sum_probs=186.1
Q ss_pred eeeecccCcceeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCC
Q 020085 104 VWEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN 181 (331)
Q Consensus 104 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 181 (331)
......++|++.+.||+|+||.||++++. ++.||+|++..........+.+.+|+.++++++||||+++++++.....
T Consensus 19 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 98 (331)
T 4aaa_A 19 LYFQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKR 98 (331)
T ss_dssp CCCBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTE
T ss_pred hhhhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCE
Confidence 34456779999999999999999999984 7899999998776666677789999999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC
Q 020085 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261 (331)
Q Consensus 182 ~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~ 261 (331)
.++||||+++++|.+++.. .+.+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+++.....
T Consensus 99 ~~lv~e~~~~~~l~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 177 (331)
T 4aaa_A 99 WYLVFEFVDHTILDDLELF-PNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP 177 (331)
T ss_dssp EEEEEECCSEEHHHHHHHS-TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred EEEEEecCCcchHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCC
Confidence 9999999999888887644 567999999999999999999999999999999999999999999999999999765432
Q ss_pred -CccccCCCCcccccchhcCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccc
Q 020085 262 -GVMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 262 -~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~ 320 (331)
.......+|+.|+|||.+.+. .++.++||||||+++|+|++|+.||.+.+..+....++
T Consensus 178 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 238 (331)
T 4aaa_A 178 GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIM 238 (331)
T ss_dssp ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred ccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Confidence 233456789999999999775 78999999999999999999999999988777665544
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=305.66 Aligned_cols=203 Identities=31% Similarity=0.561 Sum_probs=176.8
Q ss_pred eeecccCcceeeeeeecCceEEEEEEE------CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEEC
Q 020085 105 WEIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR 178 (331)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 178 (331)
..+..+.|++.+.||+|+||.||++++ .++.||+|+++... .....+.+.+|+.++++++||||+++++++..
T Consensus 16 ~~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~ 94 (302)
T 4e5w_A 16 THFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES-GGNHIADLKKEIEILRNLYHENIVKYKGICTE 94 (302)
T ss_dssp TBCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC
T ss_pred hhhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc-cchhHHHHHHHHHHHHhCCCCCeeeeeeEEec
Confidence 356677899999999999999999985 56889999998653 22335678999999999999999999999987
Q ss_pred C--CCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeeccee
Q 020085 179 P--PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR 256 (331)
Q Consensus 179 ~--~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~ 256 (331)
. ..+++||||+++++|.+++......+++..++.++.|++.||+|||++|++||||||+||+++.++.++|+|||+++
T Consensus 95 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~ 174 (302)
T 4e5w_A 95 DGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTK 174 (302)
T ss_dssp ---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCE
T ss_pred CCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccc
Confidence 6 66899999999999999997777889999999999999999999999999999999999999999999999999998
Q ss_pred eecCCCc----cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCC
Q 020085 257 VQAQSGV----MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYA 308 (331)
Q Consensus 257 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~ 308 (331)
....... .....+|..|+|||.+.+..++.++||||||+++|+|++|..|+.
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~ 230 (302)
T 4e5w_A 175 AIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDS 230 (302)
T ss_dssp ECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred cccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCc
Confidence 7654432 234457888999999999899999999999999999999998764
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=306.56 Aligned_cols=209 Identities=26% Similarity=0.468 Sum_probs=181.1
Q ss_pred eeecccCcceeeeeeecCceEEEEEEECC---------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeE
Q 020085 105 WEIDAKQLKIECKVASGSYGDLYKGTYCS---------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175 (331)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~---------~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 175 (331)
.++..++|.+.+.||+|+||+||+|.+.. ..||+|+++... ....+.+.+|+.++++++||||++++++
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 80 (289)
T 4fvq_A 3 HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH--RNYSESFFEAASMMSKLSHKHLVLNYGV 80 (289)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG--GGGHHHHHHHHHHHHTSCCTTBCCEEEE
T ss_pred EEechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEE
Confidence 35778899999999999999999998743 469999997543 3345779999999999999999999999
Q ss_pred EECCCCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCc--------E
Q 020085 176 CTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV--------V 247 (331)
Q Consensus 176 ~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~--------v 247 (331)
+..++..++||||+++|+|.+++......+++..+..++.|++.||.|||++|++||||||+|||++.++. +
T Consensus 81 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~ 160 (289)
T 4fvq_A 81 CVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFI 160 (289)
T ss_dssp ECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred EEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCccccccccee
Confidence 99999999999999999999999876666999999999999999999999999999999999999999887 9
Q ss_pred EEeeecceeeecCCCccccCCCCcccccchhcCC-CCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhc
Q 020085 248 KVADFGVARVQAQSGVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVG 318 (331)
Q Consensus 248 kl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~ 318 (331)
||+|||+++..... ....+++.|+|||.+.+ ..++.++||||||+++|||++ +.+||...........
T Consensus 161 kl~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~ 230 (289)
T 4fvq_A 161 KLSDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQF 230 (289)
T ss_dssp EECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH
T ss_pred eeccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHH
Confidence 99999998644322 23457889999999987 779999999999999999999 5677777666554433
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=310.35 Aligned_cols=221 Identities=32% Similarity=0.560 Sum_probs=185.5
Q ss_pred eecccCcceeeeeeecCceEEEEEEE--CCce--EEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCcceeEEeEEECCC
Q 020085 106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQE--VAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPP 180 (331)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~--vavK~~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~ 180 (331)
.++.++|++.+.||+|+||.||+|++ .+.. +|+|.++... .....+.+.+|+.+++++ +||||+++++++....
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~-~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 99 (327)
T 1fvr_A 21 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 99 (327)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred cccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeecccc-chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCC
Confidence 46678999999999999999999987 4454 5999987542 334456799999999999 8999999999999999
Q ss_pred CeEEEEeccCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC
Q 020085 181 NLCIVTEFMARGSIYDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG 245 (331)
Q Consensus 181 ~~~lV~E~~~ggsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~ 245 (331)
..++||||+++++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+||+++.++
T Consensus 100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~ 179 (327)
T 1fvr_A 100 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 179 (327)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred ceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCC
Confidence 9999999999999999997643 4789999999999999999999999999999999999999999
Q ss_pred cEEEeeecceeeecCCCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhccccccc
Q 020085 246 VVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVS 324 (331)
Q Consensus 246 ~vkl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~ 324 (331)
.+||+|||+++............+++.|+|||.+.+..++.++||||||+++|+|++ |+.||.+.+..+....+ ..+.
T Consensus 180 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~-~~~~ 258 (327)
T 1fvr_A 180 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL-PQGY 258 (327)
T ss_dssp CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG-GGTC
T ss_pred eEEEcccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHh-hcCC
Confidence 999999999975443333344567889999999998889999999999999999998 99999998887766664 3454
Q ss_pred cccc
Q 020085 325 IHSI 328 (331)
Q Consensus 325 ~p~~ 328 (331)
++..
T Consensus 259 ~~~~ 262 (327)
T 1fvr_A 259 RLEK 262 (327)
T ss_dssp CCCC
T ss_pred CCCC
Confidence 4443
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=304.03 Aligned_cols=208 Identities=23% Similarity=0.434 Sum_probs=176.9
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~ 186 (331)
.+.|.+.++||+|+||.||++++ .++.+|+|++...... ...+.+.+|+.++++++||||+++++++......++||
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 99 (285)
T 3is5_A 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ-VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM 99 (285)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC-SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc-hhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence 35899999999999999999998 4688999999765322 22467899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEE---cCCCcEEEeeecceeeecC
Q 020085 187 EFMARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM---DENGVVKVADFGVARVQAQ 260 (331)
Q Consensus 187 E~~~ggsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi---~~~~~vkl~DFg~a~~~~~ 260 (331)
||+++|+|.+++... ...+++..+..++.|++.||+|||++||+||||||+||++ +.++.+||+|||+++....
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~ 179 (285)
T 3is5_A 100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS 179 (285)
T ss_dssp CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC---
T ss_pred EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCC
Confidence 999999999998543 4679999999999999999999999999999999999999 4567899999999987665
Q ss_pred CCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhc
Q 020085 261 SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVG 318 (331)
Q Consensus 261 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~ 318 (331)
........||+.|+|||.+. ..++.++||||||+++|+|++|+.||.+.+..+....
T Consensus 180 ~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~ 236 (285)
T 3is5_A 180 DEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQK 236 (285)
T ss_dssp -------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred cccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhh
Confidence 55556677999999999986 4689999999999999999999999998877665544
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=314.30 Aligned_cols=216 Identities=27% Similarity=0.458 Sum_probs=181.1
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCC---CCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC---VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~---~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 183 (331)
.++|++.+.||+|+||.||+|.+ .++.||+|+++... .+....+.+.+|+.++++++||||+++++++......+
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence 46899999999999999999988 46789999986431 12344578999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhc---------------------------------------CCCCCHHHHHHHHHHHHHHHHHH
Q 020085 184 IVTEFMARGSIYDFLHKQ---------------------------------------KGVFQLTSLLKVAIDVSKGMNYL 224 (331)
Q Consensus 184 lV~E~~~ggsL~~~l~~~---------------------------------------~~~~~~~~~~~i~~qi~~~l~~L 224 (331)
+||||++||+|.+++... ...+++..+..++.|++.||+||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 999999999999998421 11235677889999999999999
Q ss_pred HhCCcccCCCCCCCEEEcCCC--cEEEeeecceeeecCCC-----ccccCCCCcccccchhcCC--CCCCChhhHHHHHH
Q 020085 225 HQNNIIHRDLKTANLLMDENG--VVKVADFGVARVQAQSG-----VMTAETGTYRWMAPEVIEH--KPYDYKADVFSFGI 295 (331)
Q Consensus 225 H~~~iiHrDlkp~NiLi~~~~--~vkl~DFg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~SlG~ 295 (331)
|++||+||||||+||+++.++ .+||+|||+++...... ......||+.|+|||++.+ ..++.++||||||+
T Consensus 185 H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~ 264 (345)
T 3hko_A 185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264 (345)
T ss_dssp HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHH
T ss_pred HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHH
Confidence 999999999999999998777 89999999998653321 2345579999999999965 67899999999999
Q ss_pred HHHHHHcCCCCCCCCCHHHHHhccccccc
Q 020085 296 ALWELLTGELPYAGLTPLQAAVGVVQKVS 324 (331)
Q Consensus 296 il~ell~g~~Pf~~~~~~~~~~~~~~~~~ 324 (331)
++|||++|+.||.+.+..+....+.....
T Consensus 265 il~el~~g~~pf~~~~~~~~~~~~~~~~~ 293 (345)
T 3hko_A 265 LLHLLLMGAVPFPGVNDADTISQVLNKKL 293 (345)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHCCC
T ss_pred HHHHHHHCCCCCCCCChHHHHHHHHhccc
Confidence 99999999999999988887777665444
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=300.93 Aligned_cols=218 Identities=30% Similarity=0.513 Sum_probs=186.3
Q ss_pred eecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEEC----C
Q 020085 106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR----P 179 (331)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~----~ 179 (331)
..+.+.|++.+.||+|+||.||+|.+ .+..||+|+++....+....+.+.+|+.++++++||||+++++++.. .
T Consensus 22 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~ 101 (290)
T 1t4h_A 22 SNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGK 101 (290)
T ss_dssp CTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSC
T ss_pred ccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCC
Confidence 34566799999999999999999998 45789999998776677778889999999999999999999998864 3
Q ss_pred CCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCCEEEc-CCCcEEEeeeccee
Q 020085 180 PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNN--IIHRDLKTANLLMD-ENGVVKVADFGVAR 256 (331)
Q Consensus 180 ~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~NiLi~-~~~~vkl~DFg~a~ 256 (331)
..+++||||+++++|.+++.. .+.+++..+..++.|++.||.|||++| ++||||||+||+++ .++.+||+|||++.
T Consensus 102 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~ 180 (290)
T 1t4h_A 102 KCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT 180 (290)
T ss_dssp EEEEEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGG
T ss_pred ceEEEEEEecCCCCHHHHHHH-ccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcc
Confidence 458999999999999999965 467899999999999999999999999 99999999999997 78999999999996
Q ss_pred eecCCCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccccccc
Q 020085 257 VQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIH 326 (331)
Q Consensus 257 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~p 326 (331)
..... ......||+.|+|||.+.+ .++.++||||||+++|+|++|+.||............+..+..|
T Consensus 181 ~~~~~-~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~ 248 (290)
T 1t4h_A 181 LKRAS-FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP 248 (290)
T ss_dssp GCCTT-SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC
T ss_pred ccccc-ccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCCc
Confidence 54433 3345579999999999874 58999999999999999999999998865544444444444443
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=317.68 Aligned_cols=196 Identities=24% Similarity=0.415 Sum_probs=164.0
Q ss_pred ccCccee-eeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHH-hcCCCcceeEEeEEEC----CC
Q 020085 109 AKQLKIE-CKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMR-KIRHKNVVQFIGACTR----PP 180 (331)
Q Consensus 109 ~~~~~~~-~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~-~l~h~niv~~~~~~~~----~~ 180 (331)
.++|.+. +.||+|+||+||++.+ +++.||||+++.. ..+.+|+.++. ..+||||+++++++.. ..
T Consensus 60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~ 132 (400)
T 1nxk_A 60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 132 (400)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCc
Confidence 3567776 7899999999999998 4788999999743 35678888874 4589999999998865 55
Q ss_pred CeEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC---CCcEEEeeeccee
Q 020085 181 NLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE---NGVVKVADFGVAR 256 (331)
Q Consensus 181 ~~~lV~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~---~~~vkl~DFg~a~ 256 (331)
.+|+||||++||+|.+++.... ..+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||+++
T Consensus 133 ~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~ 212 (400)
T 1nxk_A 133 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212 (400)
T ss_dssp EEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred EEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccccc
Confidence 7899999999999999997643 46999999999999999999999999999999999999998 7899999999998
Q ss_pred eecCCCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC
Q 020085 257 VQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLT 311 (331)
Q Consensus 257 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~ 311 (331)
...........+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+
T Consensus 213 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~ 267 (400)
T 1nxk_A 213 ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNH 267 (400)
T ss_dssp ECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCT
T ss_pred ccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCc
Confidence 7665555566789999999999999999999999999999999999999997754
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-41 Score=304.14 Aligned_cols=220 Identities=25% Similarity=0.415 Sum_probs=188.0
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEE--CCCCeEE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT--RPPNLCI 184 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~--~~~~~~l 184 (331)
.++|++.+.||+|+||.||++.+ .++.||+|+++....+....+.+.+|+.++++++||||+++++++. .....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 46899999999999999999998 5789999999877667777788999999999999999999999874 3567999
Q ss_pred EEeccCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCCCCEEEcCCCcEEEeeeccee
Q 020085 185 VTEFMARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLHQNN-----IIHRDLKTANLLMDENGVVKVADFGVAR 256 (331)
Q Consensus 185 V~E~~~ggsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~-----iiHrDlkp~NiLi~~~~~vkl~DFg~a~ 256 (331)
||||+++++|.+++... ...+++..++.++.|++.||+|||++| ++||||||+||+++.++.+||+|||.++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 99999999999999653 245899999999999999999999999 9999999999999999999999999997
Q ss_pred eecCCCc-cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccccccccccc
Q 020085 257 VQAQSGV-MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIHSII 329 (331)
Q Consensus 257 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~p~~~ 329 (331)
....... .....|++.|+|||.+.+..++.++||||||+++|+|++|+.||...+..+.... +..+.++.++
T Consensus 165 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~-i~~~~~~~~~ 237 (279)
T 2w5a_A 165 ILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGK-IREGKFRRIP 237 (279)
T ss_dssp HC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH-HHHTCCCCCC
T ss_pred eeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHH-HhhcccccCC
Confidence 5543321 2334689999999999998999999999999999999999999999887766555 4455555443
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-41 Score=306.47 Aligned_cols=214 Identities=35% Similarity=0.646 Sum_probs=176.0
Q ss_pred eecccCcceeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEE
Q 020085 106 EIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV 185 (331)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV 185 (331)
.++.++|++.+.||+|+||.||++++.++.||+|+++.. ...+.+.+|+.++++++||||+++++++.+ ..++|
T Consensus 4 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv 77 (307)
T 2eva_A 4 MIDYKEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLV 77 (307)
T ss_dssp BCCGGGEEEEEEEECCSSSEEEEEEETTEEEEEEECSST----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEE
T ss_pred cCCHhHeeeeeEeecCCCceEEEEEECCeeEEEEEecCh----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEE
Confidence 467889999999999999999999999999999999743 234679999999999999999999998864 57999
Q ss_pred EeccCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCCCCEEEcCCCc-EEEeeecceeeec
Q 020085 186 TEFMARGSIYDFLHKQKG--VFQLTSLLKVAIDVSKGMNYLHQ---NNIIHRDLKTANLLMDENGV-VKVADFGVARVQA 259 (331)
Q Consensus 186 ~E~~~ggsL~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~NiLi~~~~~-vkl~DFg~a~~~~ 259 (331)
|||+++|+|.+++..... .++...++.++.|+++||+|||+ +|++||||||+||+++.++. +||+|||+++...
T Consensus 78 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~ 157 (307)
T 2eva_A 78 MEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ 157 (307)
T ss_dssp EECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred EEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence 999999999999976432 47889999999999999999999 89999999999999998886 7999999997544
Q ss_pred CCCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC--HHHHHhccccccccccc
Q 020085 260 QSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLT--PLQAAVGVVQKVSIHSI 328 (331)
Q Consensus 260 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~--~~~~~~~~~~~~~~p~~ 328 (331)
.. .....||+.|+|||.+.+..++.++||||||+++|||++|+.||.... ..+.... +..+.+|++
T Consensus 158 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~ 225 (307)
T 2eva_A 158 TH--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWA-VHNGTRPPL 225 (307)
T ss_dssp ---------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHH-HHTTCCCCC
T ss_pred cc--cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHH-HhcCCCCCc
Confidence 32 234568999999999999999999999999999999999999998642 2332222 344555543
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=336.03 Aligned_cols=224 Identities=28% Similarity=0.533 Sum_probs=188.2
Q ss_pred CeeeecccCcceee-eeeecCceEEEEEEE----CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEE
Q 020085 103 DVWEIDAKQLKIEC-KVASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177 (331)
Q Consensus 103 ~~~~i~~~~~~~~~-~lg~G~~g~Vy~~~~----~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 177 (331)
..|.++...+.+.. +||+|+||.||+|.+ .++.||||+++....+....+++.+|+.++++++||||++++++|.
T Consensus 361 ~~~~~~~~~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~ 440 (635)
T 4fl3_A 361 KEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE 440 (635)
T ss_dssp SSSBCCGGGEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred ccccccchhccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence 34666666676654 899999999999976 3467999999876555556688999999999999999999999997
Q ss_pred CCCCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceee
Q 020085 178 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV 257 (331)
Q Consensus 178 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~ 257 (331)
. +..++||||+++|+|.+++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 441 ~-~~~~lv~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~ 518 (635)
T 4fl3_A 441 A-ESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKA 518 (635)
T ss_dssp S-SSEEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHH
T ss_pred c-CCEEEEEEccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccc
Confidence 5 468999999999999999965 56799999999999999999999999999999999999999999999999999975
Q ss_pred ecCCC----ccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhcccccccccccc
Q 020085 258 QAQSG----VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIHSII 329 (331)
Q Consensus 258 ~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p~~~ 329 (331)
..... ......+|+.|+|||++.+..++.++|||||||++|||++ |+.||.+.+..+.... +.++.++.++
T Consensus 519 ~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~-i~~~~~~~~p 594 (635)
T 4fl3_A 519 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM-LEKGERMGCP 594 (635)
T ss_dssp TTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-HHTTCCCCCC
T ss_pred cccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCCCCC
Confidence 54322 1233456789999999999999999999999999999998 9999999988776655 5567666554
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-41 Score=304.97 Aligned_cols=197 Identities=30% Similarity=0.607 Sum_probs=169.6
Q ss_pred ecccCcceeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHh--cCCCcceeEEeEEEC----CC
Q 020085 107 IDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRK--IRHKNVVQFIGACTR----PP 180 (331)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~--l~h~niv~~~~~~~~----~~ 180 (331)
+..++|++.+.||+|+||+||+|++.++.||||+++.. ....+.+|.+++.. ++||||+++++++.. ..
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~ 79 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSR-----DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSST 79 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGG-----GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEE
T ss_pred cccCcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccc-----cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCc
Confidence 44679999999999999999999999999999999753 23456667777776 789999999998654 24
Q ss_pred CeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------hCCcccCCCCCCCEEEcCCCcEEEeee
Q 020085 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH--------QNNIIHRDLKTANLLMDENGVVKVADF 252 (331)
Q Consensus 181 ~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH--------~~~iiHrDlkp~NiLi~~~~~vkl~DF 252 (331)
..++||||+++|+|.+++. ...+++..+..++.|++.||+||| ++||+||||||+|||++.++.+||+||
T Consensus 80 ~~~lv~e~~~~g~L~~~l~--~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df 157 (301)
T 3q4u_A 80 QLWLITHYHEMGSLYDYLQ--LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADL 157 (301)
T ss_dssp EEEEEECCCTTCBHHHHHT--TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred eeEEehhhccCCCHHHHHh--hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeC
Confidence 5899999999999999994 457899999999999999999999 999999999999999999999999999
Q ss_pred cceeeecCCCcc-----ccCCCCcccccchhcCCC------CCCChhhHHHHHHHHHHHHcC----------CCCCCCC
Q 020085 253 GVARVQAQSGVM-----TAETGTYRWMAPEVIEHK------PYDYKADVFSFGIALWELLTG----------ELPYAGL 310 (331)
Q Consensus 253 g~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~------~~~~~~Di~SlG~il~ell~g----------~~Pf~~~ 310 (331)
|+++........ ....||+.|+|||++.+. .++.++||||||+++|||++| +.||...
T Consensus 158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~ 236 (301)
T 3q4u_A 158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV 236 (301)
T ss_dssp TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence 999866544322 234799999999999876 445799999999999999999 8898653
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=311.56 Aligned_cols=205 Identities=29% Similarity=0.545 Sum_probs=180.2
Q ss_pred eecccCcceeeeeeecCceEEEEEEEC-CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEE
Q 020085 106 EIDAKQLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI 184 (331)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~l 184 (331)
+...++|++.+.||+|+||.||+|++. ++.||||++.... ....+.+.+|+.++++++||||+++++++...+..++
T Consensus 35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 112 (321)
T 2qkw_B 35 EEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES--SQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMIL 112 (321)
T ss_dssp CCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC--SSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEE
T ss_pred HHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEE
Confidence 335678999999999999999999984 7899999987653 2345789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC
Q 020085 185 VTEFMARGSIYDFLHKQK---GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261 (331)
Q Consensus 185 V~E~~~ggsL~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~ 261 (331)
||||+++|+|.+++.... ..+++..+..++.|+++||+|||++|++||||||+||+++.++.+||+|||+++.....
T Consensus 113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 192 (321)
T 2qkw_B 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTEL 192 (321)
T ss_dssp EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSS
T ss_pred EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 999999999999986543 35899999999999999999999999999999999999999999999999999864432
Q ss_pred C---ccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH
Q 020085 262 G---VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTP 312 (331)
Q Consensus 262 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~ 312 (331)
. ......||+.|+|||.+.+..++.++||||||+++|||++|+.||....+
T Consensus 193 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~ 246 (321)
T 2qkw_B 193 DQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLP 246 (321)
T ss_dssp SCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSS
T ss_pred cccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCc
Confidence 2 22334589999999999888999999999999999999999999976543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=299.54 Aligned_cols=211 Identities=24% Similarity=0.394 Sum_probs=187.3
Q ss_pred cccCcceeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEE
Q 020085 108 DAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI 184 (331)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~l 184 (331)
..++|.+.+.||+|+||.||++.+. ++.||+|++..... .....+.+.+|+.++++++||||+++++++...+..++
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 92 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 92 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEE
Confidence 3568999999999999999999984 67899999875532 44566789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC-Cc
Q 020085 185 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GV 263 (331)
Q Consensus 185 V~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~-~~ 263 (331)
||||+++++|.+++.. .+.+++..+..++.|+++||+|||++|++||||||+||+++.++.+||+|||.++..... ..
T Consensus 93 v~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~ 171 (294)
T 2rku_A 93 VLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 171 (294)
T ss_dssp EEECCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred EEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCccc
Confidence 9999999999998865 467899999999999999999999999999999999999999999999999999866533 23
Q ss_pred cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcc
Q 020085 264 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGV 319 (331)
Q Consensus 264 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~ 319 (331)
.....|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+....+
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 227 (294)
T 2rku_A 172 KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI 227 (294)
T ss_dssp BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 34457899999999999999999999999999999999999999988776655543
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=311.12 Aligned_cols=210 Identities=22% Similarity=0.446 Sum_probs=185.9
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCC--C----HHHHHHHHHHHHHHHhc-CCCcceeEEeEEECCC
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV--N----TEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPP 180 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~----~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~ 180 (331)
++|.+.+.||+|+||.||+|++ +|+.||||+++.... . ....+.+.+|+.+++++ +||||+++++++....
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 5799999999999999999998 478999999976532 1 12346788999999999 7999999999999999
Q ss_pred CeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecC
Q 020085 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (331)
Q Consensus 181 ~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~ 260 (331)
..++||||++|++|.+++.. ...+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.....
T Consensus 174 ~~~lv~e~~~g~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~ 252 (365)
T 2y7j_A 174 FMFLVFDLMRKGELFDYLTE-KVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP 252 (365)
T ss_dssp EEEEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCT
T ss_pred EEEEEEEeCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCC
Confidence 99999999999999999965 46799999999999999999999999999999999999999999999999999987766
Q ss_pred CCccccCCCCcccccchhcC------CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccc
Q 020085 261 SGVMTAETGTYRWMAPEVIE------HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 261 ~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~ 320 (331)
........||+.|+|||++. ...++.++||||||+++|+|++|+.||...+..+....+.
T Consensus 253 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~ 318 (365)
T 2y7j_A 253 GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIM 318 (365)
T ss_dssp TCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 55556678999999999985 3368899999999999999999999999888777665544
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-41 Score=308.21 Aligned_cols=226 Identities=31% Similarity=0.489 Sum_probs=166.7
Q ss_pred CCCeeeecccCcceeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHH-HHHhcCCCcceeEEeEEE
Q 020085 101 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVY-IMRKIRHKNVVQFIGACT 177 (331)
Q Consensus 101 ~~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~-il~~l~h~niv~~~~~~~ 177 (331)
....|.+..++|++.+.||+|+||.||++.+. ++.||||+++... .......+..|+. +++.++||||+++++++.
T Consensus 13 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~ 91 (327)
T 3aln_A 13 PEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV-DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALF 91 (327)
T ss_dssp CCEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC-CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEE
T ss_pred hHHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc-CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEE
Confidence 34678999999999999999999999999985 7899999998654 3344455566665 777889999999999999
Q ss_pred CCCCeEEEEeccCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCCEEEcCCCcEEEeee
Q 020085 178 RPPNLCIVTEFMARGSIYDFLHK----QKGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDENGVVKVADF 252 (331)
Q Consensus 178 ~~~~~~lV~E~~~ggsL~~~l~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~-~iiHrDlkp~NiLi~~~~~vkl~DF 252 (331)
.++..++||||+++ +|.+++.. ....+++..+..++.|++.||.|||++ |++||||||+||+++.++.+||+||
T Consensus 92 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Df 170 (327)
T 3aln_A 92 REGDCWICMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDF 170 (327)
T ss_dssp CSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCC
T ss_pred eCCceEEEEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccC
Confidence 99999999999986 88887753 256789999999999999999999999 9999999999999999999999999
Q ss_pred cceeeecCCCccccCCCCcccccchhc----CCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccccccccc
Q 020085 253 GVARVQAQSGVMTAETGTYRWMAPEVI----EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIHSI 328 (331)
Q Consensus 253 g~a~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~p~~ 328 (331)
|+++............||+.|+|||.+ .+..++.++||||||+++|+|++|+.||............+.++.+|.+
T Consensus 171 g~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 250 (327)
T 3aln_A 171 GISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQL 250 (327)
T ss_dssp SSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCC
T ss_pred CCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCC
Confidence 999866555444555799999999998 4667899999999999999999999999886544333333445555544
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-41 Score=312.51 Aligned_cols=213 Identities=28% Similarity=0.421 Sum_probs=180.2
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCH---HHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNT---EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~---~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 183 (331)
.++|++.+.||+|+||.||+|++ .++.||||+++...... ...+.+.+|+.++++++||||+++++++......+
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 88 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS 88 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCE
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceE
Confidence 56899999999999999999998 47899999997543221 22346889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC-C
Q 020085 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-G 262 (331)
Q Consensus 184 lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~-~ 262 (331)
+||||+++ +|.+++......+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++..... .
T Consensus 89 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~ 167 (346)
T 1ua2_A 89 LVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 167 (346)
T ss_dssp EEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred EEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCcc
Confidence 99999987 899999776678999999999999999999999999999999999999999999999999999765432 2
Q ss_pred ccccCCCCcccccchhcCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccc
Q 020085 263 VMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK 322 (331)
Q Consensus 263 ~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~ 322 (331)
......+|+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+.+.
T Consensus 168 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~ 228 (346)
T 1ua2_A 168 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFET 228 (346)
T ss_dssp CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH
Confidence 3445678999999999965 45899999999999999999999999999888877776654
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-40 Score=311.51 Aligned_cols=217 Identities=28% Similarity=0.476 Sum_probs=186.9
Q ss_pred CCeeeecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECC
Q 020085 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP 179 (331)
Q Consensus 102 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 179 (331)
...|++. ++|.+.+.||+|+||.||+|.+ .++.||||+++....+....+.+.+|+.++++++||||+++++++...
T Consensus 35 ~~~~~l~-~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~ 113 (371)
T 4exu_A 35 KTAWELP-KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPA 113 (371)
T ss_dssp TEEEEEE-TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSC
T ss_pred cceeccc-ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheecc
Confidence 3456665 5899999999999999999988 478999999987766677778899999999999999999999999877
Q ss_pred CCe------EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeec
Q 020085 180 PNL------CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFG 253 (331)
Q Consensus 180 ~~~------~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg 253 (331)
... ++||||+.+ +|.+++ ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||
T Consensus 114 ~~~~~~~~~~lv~e~~~~-~l~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg 189 (371)
T 4exu_A 114 SSLRNFYDFYLVMPFMQT-DLQKIM---GMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFG 189 (371)
T ss_dssp SSSTTCCCCEEEEECCCE-EHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTT
T ss_pred CCcccceeEEEEEccccc-cHHHHh---hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecC
Confidence 655 999999985 888887 3458999999999999999999999999999999999999999999999999
Q ss_pred ceeeecCCCccccCCCCcccccchhcCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccccccc
Q 020085 254 VARVQAQSGVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSI 325 (331)
Q Consensus 254 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~ 325 (331)
+++..... .....+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+..+....+.+....
T Consensus 190 ~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~ 260 (371)
T 4exu_A 190 LARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGV 260 (371)
T ss_dssp CC----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred cccccccC--cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence 99765432 345678999999999977 78999999999999999999999999999888877776654433
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-41 Score=307.53 Aligned_cols=203 Identities=27% Similarity=0.510 Sum_probs=180.3
Q ss_pred eecccCcceeeeeeecCceEEEEEEE------CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEE--
Q 020085 106 EIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT-- 177 (331)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~-- 177 (331)
-++.++|++.+.||+|+||.||++++ .++.||||+++.. .....+.+.+|+.++++++||||+++++++.
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~ 96 (327)
T 3lxl_A 19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS--GPDQQRDFQREIQILKALHSDFIVKYRGVSYGP 96 (327)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred hhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC--CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC
Confidence 35678999999999999999999985 4678999999865 4556678999999999999999999999886
Q ss_pred CCCCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceee
Q 020085 178 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV 257 (331)
Q Consensus 178 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~ 257 (331)
.....++||||+++++|.+++......+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||+++.
T Consensus 97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~ 176 (327)
T 3lxl_A 97 GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKL 176 (327)
T ss_dssp SSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEE
T ss_pred CCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEccccccee
Confidence 44568999999999999999987667799999999999999999999999999999999999999999999999999987
Q ss_pred ecCCCc----cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 020085 258 QAQSGV----MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL 310 (331)
Q Consensus 258 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~ 310 (331)
...... .....+|+.|+|||.+.+..++.++||||||+++|+|++|+.||...
T Consensus 177 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~ 233 (327)
T 3lxl_A 177 LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSP 233 (327)
T ss_dssp CCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred cccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccc
Confidence 654332 23345788899999999988999999999999999999999998653
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=305.85 Aligned_cols=211 Identities=24% Similarity=0.394 Sum_probs=187.4
Q ss_pred cccCcceeeeeeecCceEEEEEEEC--CceEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEE
Q 020085 108 DAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI 184 (331)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~l 184 (331)
..++|.+.+.||+|+||.||++.+. ++.||+|++.... ......+.+.+|+.++++++||||+++++++......++
T Consensus 39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 118 (335)
T 2owb_A 39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFV 118 (335)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEE
Confidence 3568999999999999999999984 6789999987543 244566789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC-Cc
Q 020085 185 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GV 263 (331)
Q Consensus 185 V~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~-~~ 263 (331)
||||+++++|.+++.. ...+++..+..++.|+++||+|||++||+||||||+||+++.++.+||+|||+++..... ..
T Consensus 119 v~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~ 197 (335)
T 2owb_A 119 VLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER 197 (335)
T ss_dssp EECCCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred EEecCCCCCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCccc
Confidence 9999999999999865 467899999999999999999999999999999999999999999999999999876533 23
Q ss_pred cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcc
Q 020085 264 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGV 319 (331)
Q Consensus 264 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~ 319 (331)
.....||+.|+|||.+.+..++.++||||||+++|+|++|+.||...+..+....+
T Consensus 198 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 253 (335)
T 2owb_A 198 KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI 253 (335)
T ss_dssp BCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH
T ss_pred ccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH
Confidence 34557899999999999999999999999999999999999999988776655543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=314.33 Aligned_cols=225 Identities=32% Similarity=0.590 Sum_probs=189.7
Q ss_pred CCCeeeecccCcceeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCC
Q 020085 101 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (331)
Q Consensus 101 ~~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 180 (331)
....|+++.++|++.+.||+|+||.||+|.+.+ .+|+|+++....+....+.+.+|+.++++++||||+++++++....
T Consensus 24 ~~~~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~ 102 (319)
T 2y4i_B 24 FLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPP 102 (319)
T ss_dssp CGGGSSSCCSCEECCCBCCCSSSSEEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSS
T ss_pred ccccccCCHHHeEEeeEeccCCceEEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCC
Confidence 346689999999999999999999999999876 5999999865444444466888999999999999999999999999
Q ss_pred CeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecC
Q 020085 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (331)
Q Consensus 181 ~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~ 260 (331)
..++||||+++++|.+++......+++..+..++.|++.||+|||++|++||||||+||+++ ++.++|+|||+++....
T Consensus 103 ~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~ 181 (319)
T 2y4i_B 103 HLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGV 181 (319)
T ss_dssp CEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC----
T ss_pred ceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccc
Confidence 99999999999999999977666799999999999999999999999999999999999998 68999999999864321
Q ss_pred ------CCccccCCCCcccccchhcCC---------CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccccccc
Q 020085 261 ------SGVMTAETGTYRWMAPEVIEH---------KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSI 325 (331)
Q Consensus 261 ------~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~ 325 (331)
........|++.|+|||.+.+ ..++.++||||||+++|||++|+.||...+..+....+ ..+.+
T Consensus 182 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~-~~~~~ 260 (319)
T 2y4i_B 182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM-GTGMK 260 (319)
T ss_dssp ------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHH-HTTCC
T ss_pred ccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh-ccCCC
Confidence 122234468999999999864 45789999999999999999999999998887766653 34555
Q ss_pred ccc
Q 020085 326 HSI 328 (331)
Q Consensus 326 p~~ 328 (331)
|.+
T Consensus 261 ~~~ 263 (319)
T 2y4i_B 261 PNL 263 (319)
T ss_dssp CCC
T ss_pred CCC
Confidence 543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=301.36 Aligned_cols=213 Identities=26% Similarity=0.453 Sum_probs=182.4
Q ss_pred eecccCcceeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCH-HHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCe
Q 020085 106 EIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNT-EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL 182 (331)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~-~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 182 (331)
+...++|++.+.||+|+||.||++.+. ++.||+|++....... .....+.+|+.++++++||||+++++++......
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 84 (279)
T 3fdn_A 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRV 84 (279)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEE
Confidence 345678999999999999999999984 5689999986432111 1245688999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC
Q 020085 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262 (331)
Q Consensus 183 ~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~ 262 (331)
++||||+++++|.+++.. ...+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||++......
T Consensus 85 ~lv~e~~~~~~l~~~l~~-~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~- 162 (279)
T 3fdn_A 85 YLILEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS- 162 (279)
T ss_dssp EEEECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC----
T ss_pred EEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc-
Confidence 999999999999999966 367899999999999999999999999999999999999999999999999998654433
Q ss_pred ccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccc
Q 020085 263 VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 263 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~ 320 (331)
......|++.|+|||.+.+..++.++||||||+++|+|++|+.||...+..+....+.
T Consensus 163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 220 (279)
T 3fdn_A 163 RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS 220 (279)
T ss_dssp -----CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHH
Confidence 2345578999999999999999999999999999999999999999988777665543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=303.90 Aligned_cols=210 Identities=25% Similarity=0.428 Sum_probs=160.8
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV 185 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV 185 (331)
.++|++.+.||+|+||.||+|++ .++.||+|+++..... ....+.+.+|+.++++++||||+++++++......++|
T Consensus 10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 89 (278)
T 3cok_A 10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLV 89 (278)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEE
T ss_pred cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEE
Confidence 45799999999999999999997 6789999999643211 11246789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC-cc
Q 020085 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VM 264 (331)
Q Consensus 186 ~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~-~~ 264 (331)
|||+++++|.+++......+++..+..++.|+++||+|||++|++||||||+||+++.++.++|+|||++....... ..
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~ 169 (278)
T 3cok_A 90 LEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH 169 (278)
T ss_dssp EECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC------
T ss_pred EecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCcc
Confidence 99999999999998766789999999999999999999999999999999999999999999999999998654322 22
Q ss_pred ccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhc
Q 020085 265 TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVG 318 (331)
Q Consensus 265 ~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~ 318 (331)
....||+.|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+....
T Consensus 170 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~ 223 (278)
T 3cok_A 170 YTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNK 223 (278)
T ss_dssp ----------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----
T ss_pred eeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHH
Confidence 345689999999999999999999999999999999999999987654444333
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-41 Score=309.65 Aligned_cols=219 Identities=30% Similarity=0.581 Sum_probs=180.1
Q ss_pred eecccCcceeeeeeecCceEEEEEEEC--Cce----EEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECC
Q 020085 106 EIDAKQLKIECKVASGSYGDLYKGTYC--SQE----VAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP 179 (331)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~----vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 179 (331)
.+..++|++.++||+|+||.||+|.+. ++. ||+|.++... .....+.+.+|+.++++++||||+++++++..+
T Consensus 11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~ 89 (327)
T 3lzb_A 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS 89 (327)
T ss_dssp ECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS-SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS
T ss_pred ccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc-CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC
Confidence 456789999999999999999999983 443 5778776443 223357789999999999999999999999876
Q ss_pred CCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeec
Q 020085 180 PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA 259 (331)
Q Consensus 180 ~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~ 259 (331)
..++|+|++.+|+|.+++....+.+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 90 -~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 90 -TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp -SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred -CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 4889999999999999998877889999999999999999999999999999999999999999999999999998654
Q ss_pred CCCc---cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhcccccccccc
Q 020085 260 QSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIHS 327 (331)
Q Consensus 260 ~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p~ 327 (331)
.... .....+|+.|+|||.+.+..++.++||||||+++|||++ |+.||.+.+..+.... +.++.+++
T Consensus 169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~-~~~~~~~~ 239 (327)
T 3lzb_A 169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI-LEKGERLP 239 (327)
T ss_dssp -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH-HHTTCCCC
T ss_pred CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHH-HHcCCCCC
Confidence 3322 223456789999999999999999999999999999999 9999998877665444 44454443
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=301.14 Aligned_cols=216 Identities=33% Similarity=0.574 Sum_probs=189.0
Q ss_pred cccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEE
Q 020085 108 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV 185 (331)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV 185 (331)
..+.|++.+.||+|+||.||+|++ .++.||+|+++..... ...+.+.+|+.++++++||||+++++++......++|
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 98 (303)
T 3a7i_A 20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAE-DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII 98 (303)
T ss_dssp GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCS-TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccH-HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEE
Confidence 356799999999999999999987 4789999999765432 3357899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC-cc
Q 020085 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VM 264 (331)
Q Consensus 186 ~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~-~~ 264 (331)
|||+++++|.+++.. +.+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++....... ..
T Consensus 99 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 176 (303)
T 3a7i_A 99 MEYLGGGSALDLLEP--GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR 176 (303)
T ss_dssp EECCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCB
T ss_pred EEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcccccc
Confidence 999999999999853 678999999999999999999999999999999999999999999999999998655432 23
Q ss_pred ccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccccccccc
Q 020085 265 TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIHS 327 (331)
Q Consensus 265 ~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~p~ 327 (331)
....|++.|+|||.+.+..++.++||||||+++|+|++|+.||....+.+....+ .++.+|.
T Consensus 177 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~ 238 (303)
T 3a7i_A 177 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLI-PKNNPPT 238 (303)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH-HHSCCCC
T ss_pred CccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHh-hcCCCCC
Confidence 4457899999999999999999999999999999999999999998887766553 3344443
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=316.49 Aligned_cols=194 Identities=26% Similarity=0.392 Sum_probs=169.3
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECC-----CC
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP-----PN 181 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~-----~~ 181 (331)
.++|.+.+.||+|+||.||+|++ .++.||||+++....+....+.+.+|+.++++++||||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 45899999999999999999998 468899999987666666778899999999999999999999999766 56
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC
Q 020085 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261 (331)
Q Consensus 182 ~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~ 261 (331)
.|+||||+.+ +|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 105 ~~lv~e~~~~-~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~ 182 (432)
T 3n9x_A 105 LYIVLEIADS-DLKKLFKT-PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE 182 (432)
T ss_dssp EEEEEECCSE-EHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC---
T ss_pred EEEEEecCCc-CHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccccccc
Confidence 9999999875 99999965 567999999999999999999999999999999999999999999999999999865433
Q ss_pred C-----------------------ccccCCCCcccccchhc-CCCCCCChhhHHHHHHHHHHHHcCC
Q 020085 262 G-----------------------VMTAETGTYRWMAPEVI-EHKPYDYKADVFSFGIALWELLTGE 304 (331)
Q Consensus 262 ~-----------------------~~~~~~gt~~y~aPE~~-~~~~~~~~~Di~SlG~il~ell~g~ 304 (331)
. ..+...||+.|+|||++ ....++.++|||||||++|||++|.
T Consensus 183 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~ 249 (432)
T 3n9x_A 183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNML 249 (432)
T ss_dssp ----------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTC
T ss_pred ccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcc
Confidence 2 23566799999999986 5667999999999999999999843
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=311.63 Aligned_cols=218 Identities=22% Similarity=0.354 Sum_probs=179.9
Q ss_pred cccCcceeeeeeecCceEEEEEEE-CCceEEEEEecCCCC---------CHHHHHHHHHHHHHHHhcCCCcceeEEeEEE
Q 020085 108 DAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECV---------NTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177 (331)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~---------~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 177 (331)
..++|.+.+.||+|+||.||+|.+ .++.||||++..... +....+.+.+|+.++++++||||+++++++.
T Consensus 20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 99 (362)
T 3pg1_A 20 MQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFV 99 (362)
T ss_dssp TTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEE
T ss_pred hccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEE
Confidence 457899999999999999999987 578899999864322 2344578999999999999999999999984
Q ss_pred C-----CCCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeee
Q 020085 178 R-----PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADF 252 (331)
Q Consensus 178 ~-----~~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DF 252 (331)
. ...+|+||||+.| +|.+++......+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+||
T Consensus 100 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Df 178 (362)
T 3pg1_A 100 HFEEPAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDF 178 (362)
T ss_dssp ECCTTTCCEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCT
T ss_pred eccCCCcceEEEEEccCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEEEEec
Confidence 3 3358999999985 999999877778999999999999999999999999999999999999999999999999
Q ss_pred cceeeecCCCccccCCCCcccccchhcCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccccccc
Q 020085 253 GVARVQAQSGVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIH 326 (331)
Q Consensus 253 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~p 326 (331)
|+++............+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+..+....+++....|
T Consensus 179 g~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~ 253 (362)
T 3pg1_A 179 NLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP 253 (362)
T ss_dssp TC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred CcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence 99986665555566789999999999876 678999999999999999999999999999888877776655444
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=314.00 Aligned_cols=201 Identities=24% Similarity=0.449 Sum_probs=179.5
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCH------HHHHHHHHHHHHHHhcCCCcceeEEeEEECCC
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNT------EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~------~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 180 (331)
.++|++.+.||+|+||.||+|.+ .++.||||+++...... .....+.+|+.++++++||||+++++++....
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSS
T ss_pred ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCC
Confidence 46899999999999999999987 57899999998654322 13346788999999999999999999999999
Q ss_pred CeEEEEeccCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeec
Q 020085 181 NLCIVTEFMARG-SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA 259 (331)
Q Consensus 181 ~~~lV~E~~~gg-sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~ 259 (331)
..++||||+.+| +|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 103 ~~~lv~e~~~~g~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~ 181 (335)
T 3dls_A 103 FFQLVMEKHGSGLDLFAFIDR-HPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLE 181 (335)
T ss_dssp EEEEEEECCTTSCBHHHHHHT-CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC
T ss_pred EEEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECC
Confidence 999999999776 99999965 5679999999999999999999999999999999999999999999999999998876
Q ss_pred CCCccccCCCCcccccchhcCCCCC-CChhhHHHHHHHHHHHHcCCCCCCCC
Q 020085 260 QSGVMTAETGTYRWMAPEVIEHKPY-DYKADVFSFGIALWELLTGELPYAGL 310 (331)
Q Consensus 260 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~SlG~il~ell~g~~Pf~~~ 310 (331)
.........||+.|+|||++.+..+ +.++||||||+++|+|++|+.||...
T Consensus 182 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 233 (335)
T 3dls_A 182 RGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCEL 233 (335)
T ss_dssp TTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSG
T ss_pred CCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhH
Confidence 6655566789999999999988877 78999999999999999999999763
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-41 Score=309.00 Aligned_cols=213 Identities=23% Similarity=0.417 Sum_probs=182.7
Q ss_pred ccCccee-eeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCcceeEEeEEECCCCeEE
Q 020085 109 AKQLKIE-CKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCI 184 (331)
Q Consensus 109 ~~~~~~~-~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~~~~l 184 (331)
.+.|.+. +.||+|+||.||+|.+. ++.||+|+++...........+.+|+.++++++ ||||+++++++......++
T Consensus 27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~l 106 (327)
T 3lm5_A 27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL 106 (327)
T ss_dssp HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEE
Confidence 4567776 89999999999999984 789999999865544444578999999999995 6999999999999999999
Q ss_pred EEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC---CCcEEEeeecceeeecC
Q 020085 185 VTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE---NGVVKVADFGVARVQAQ 260 (331)
Q Consensus 185 V~E~~~ggsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~---~~~vkl~DFg~a~~~~~ 260 (331)
||||+++|+|.+++... ...+++..+..++.|++.||+|||++||+||||||+||+++. ++.+||+|||+++....
T Consensus 107 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~ 186 (327)
T 3lm5_A 107 ILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH 186 (327)
T ss_dssp EEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC--
T ss_pred EEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCC
Confidence 99999999999998543 367999999999999999999999999999999999999998 78999999999987766
Q ss_pred CCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 261 SGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 261 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
........||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+..+....+.+
T Consensus 187 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 247 (327)
T 3lm5_A 187 ACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQ 247 (327)
T ss_dssp -------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred ccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHh
Confidence 5555566899999999999999999999999999999999999999999888776655443
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=302.13 Aligned_cols=202 Identities=19% Similarity=0.389 Sum_probs=177.6
Q ss_pred ecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCcceeEEeEEEC--CCC
Q 020085 107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTR--PPN 181 (331)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~--~~~ 181 (331)
...++|++.+.||+|+||.||+|++ .++.||+|+++... .+.+.+|+.++++++ ||||+++++++.. ...
T Consensus 33 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-----~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~ 107 (330)
T 3nsz_A 33 GNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRT 107 (330)
T ss_dssp EEGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCC
T ss_pred cCCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc-----hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCc
Confidence 3467899999999999999999987 57899999998542 357889999999997 9999999999987 667
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC-cEEEeeecceeeecC
Q 020085 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG-VVKVADFGVARVQAQ 260 (331)
Q Consensus 182 ~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~-~vkl~DFg~a~~~~~ 260 (331)
.++||||+++++|.+++. .+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++....
T Consensus 108 ~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 108 PALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp EEEEEECCCCCCHHHHGG----GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred eEEEEeccCchhHHHHHH----hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 899999999999999884 378999999999999999999999999999999999999777 899999999987766
Q ss_pred CCccccCCCCcccccchhcCC-CCCCChhhHHHHHHHHHHHHcCCCCCCC-CCHHHHHh
Q 020085 261 SGVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAG-LTPLQAAV 317 (331)
Q Consensus 261 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~ell~g~~Pf~~-~~~~~~~~ 317 (331)
........+++.|+|||.+.+ ..++.++|||||||++|+|++|+.||.. ....+...
T Consensus 184 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~ 242 (330)
T 3nsz_A 184 GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 242 (330)
T ss_dssp TCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHH
T ss_pred CCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHH
Confidence 666667789999999999876 6789999999999999999999999943 34444333
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-40 Score=301.07 Aligned_cols=210 Identities=33% Similarity=0.534 Sum_probs=180.7
Q ss_pred eeecccCcceeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCe
Q 020085 105 WEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL 182 (331)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 182 (331)
.....++|++.+.||+|+||.||+|.+. ++.||+|+++.... .+.+.+|+.++++++||||+++++++......
T Consensus 24 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 99 (314)
T 3com_A 24 TKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESD----LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDL 99 (314)
T ss_dssp ------CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSC----CHHHHHHHHHHHTCCCTTBCCEEEEEEETTEE
T ss_pred hhcchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHH----HHHHHHHHHHHHhCCCCCCccEEEEEEeCCEE
Confidence 3455778999999999999999999984 78999999986532 35688999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC
Q 020085 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262 (331)
Q Consensus 183 ~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~ 262 (331)
++||||+++++|.+++......+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||.+.......
T Consensus 100 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~ 179 (314)
T 3com_A 100 WIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM 179 (314)
T ss_dssp EEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred EEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence 99999999999999997667889999999999999999999999999999999999999999999999999997654432
Q ss_pred -ccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhc
Q 020085 263 -VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVG 318 (331)
Q Consensus 263 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~ 318 (331)
......|++.|+|||.+.+..++.++||||||+++|+|++|+.||....+.+....
T Consensus 180 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~ 236 (314)
T 3com_A 180 AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFM 236 (314)
T ss_dssp SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHH
T ss_pred cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence 23445789999999999999999999999999999999999999999887766554
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=305.83 Aligned_cols=223 Identities=30% Similarity=0.530 Sum_probs=186.3
Q ss_pred CeeeecccCcceeeeeeecCceEEEEEEE-------CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeE
Q 020085 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY-------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA 175 (331)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~-------~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~ 175 (331)
+..++..++|++.+.||+|+||.||+|++ .++.||||+++... .......+.+|+.++++++||||++++++
T Consensus 23 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~ 101 (327)
T 2yfx_A 23 DLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDELDFLMEALIISKFNHQNIVRCIGV 101 (327)
T ss_dssp GSCBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred hcccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEecccc-chhhHHHHHHHHHHHhhCCCCCCCeEEEE
Confidence 34577889999999999999999999984 35679999997543 45556789999999999999999999999
Q ss_pred EECCCCeEEEEeccCCCCHHHHHHhcC------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC---CCc
Q 020085 176 CTRPPNLCIVTEFMARGSIYDFLHKQK------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE---NGV 246 (331)
Q Consensus 176 ~~~~~~~~lV~E~~~ggsL~~~l~~~~------~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~---~~~ 246 (331)
+......++||||+++++|.+++.... ..+++..++.++.|++.||.|||++|++||||||+||+++. +..
T Consensus 102 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~ 181 (327)
T 2yfx_A 102 SLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRV 181 (327)
T ss_dssp ECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCC
T ss_pred EcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcce
Confidence 999999999999999999999997754 45889999999999999999999999999999999999984 446
Q ss_pred EEEeeecceeeecCCC---ccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhccccc
Q 020085 247 VKVADFGVARVQAQSG---VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQK 322 (331)
Q Consensus 247 vkl~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~ 322 (331)
++|+|||+++...... ......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||...+..+.... +..
T Consensus 182 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~-~~~ 260 (327)
T 2yfx_A 182 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEF-VTS 260 (327)
T ss_dssp EEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHH-HHT
T ss_pred EEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHH-Hhc
Confidence 9999999987443322 1223457889999999998899999999999999999998 9999999887766555 334
Q ss_pred ccccc
Q 020085 323 VSIHS 327 (331)
Q Consensus 323 ~~~p~ 327 (331)
+.++.
T Consensus 261 ~~~~~ 265 (327)
T 2yfx_A 261 GGRMD 265 (327)
T ss_dssp TCCCC
T ss_pred CCCCC
Confidence 44443
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-41 Score=311.29 Aligned_cols=208 Identities=27% Similarity=0.451 Sum_probs=184.7
Q ss_pred eeecccCcceeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCe
Q 020085 105 WEIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL 182 (331)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 182 (331)
.++..++|++.+.||+|+||.||++++. ++.||+|+++... .....+.+.+|+.++++++||||+++++++..+...
T Consensus 28 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 106 (360)
T 3eqc_A 28 GELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEI 106 (360)
T ss_dssp CCCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEE
T ss_pred cccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEecccc-CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEE
Confidence 3566789999999999999999999995 7899999998663 456678899999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCCEEEcCCCcEEEeeecceeeecCC
Q 020085 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261 (331)
Q Consensus 183 ~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~ 261 (331)
++||||+++++|.+++.. .+.+++..+..++.|++.||.|||+. ||+||||||+||+++.++.++|+|||+++.....
T Consensus 107 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 185 (360)
T 3eqc_A 107 SICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 185 (360)
T ss_dssp EEEECCCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred EEEEECCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc
Confidence 999999999999999966 45789999999999999999999996 9999999999999999999999999998644322
Q ss_pred CccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 020085 262 GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQA 315 (331)
Q Consensus 262 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~ 315 (331)
......||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..+.
T Consensus 186 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 238 (360)
T 3eqc_A 186 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL 238 (360)
T ss_dssp -C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHH
T ss_pred -cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 22345789999999999999999999999999999999999999998776554
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=306.76 Aligned_cols=190 Identities=24% Similarity=0.459 Sum_probs=151.8
Q ss_pred eeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCcceeEEeEEECCCCeEEEEeccCCC
Q 020085 116 CKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCIVTEFMARG 192 (331)
Q Consensus 116 ~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~~~~lV~E~~~gg 192 (331)
+.||+|+||.||++.+. ++.||||+++.. ....+.+|+.+++++. ||||+++++++.++...|+||||++||
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-----~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~ 91 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR-----MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGG 91 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEGG-----GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSC
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEChh-----hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCC
Confidence 78999999999999984 789999999743 2356788999999997 999999999999999999999999999
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC---cEEEeeecceeeecCCC-ccccCC
Q 020085 193 SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG---VVKVADFGVARVQAQSG-VMTAET 268 (331)
Q Consensus 193 sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~---~vkl~DFg~a~~~~~~~-~~~~~~ 268 (331)
+|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++...... ......
T Consensus 92 ~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 170 (325)
T 3kn6_A 92 ELFERIKK-KKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPC 170 (325)
T ss_dssp BHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC---------
T ss_pred cHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccC
Confidence 99999976 56799999999999999999999999999999999999998766 89999999998654432 334557
Q ss_pred CCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC
Q 020085 269 GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLT 311 (331)
Q Consensus 269 gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~ 311 (331)
+|+.|+|||++.+..++.++||||||+++|+|++|+.||...+
T Consensus 171 ~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 213 (325)
T 3kn6_A 171 FTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHD 213 (325)
T ss_dssp -------------CCCCHHHHHHHHHHHHHHHHHSSCTTC---
T ss_pred CCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCc
Confidence 8999999999999999999999999999999999999998743
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-41 Score=302.73 Aligned_cols=222 Identities=33% Similarity=0.625 Sum_probs=182.1
Q ss_pred eeecccCcceeeeeeecCceEEEEEEEC---Cc--eEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCcceeEEeEEEC
Q 020085 105 WEIDAKQLKIECKVASGSYGDLYKGTYC---SQ--EVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR 178 (331)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~---~~--~vavK~~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 178 (331)
..+..++|++.+.||+|+||.||+|++. ++ .||+|+++.... +....+.+.+|+.++++++||||+++++++..
T Consensus 13 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~ 92 (291)
T 1u46_A 13 CLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT 92 (291)
T ss_dssp EECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred cccchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc
Confidence 4667889999999999999999999863 22 589999986543 23456789999999999999999999999987
Q ss_pred CCCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeee
Q 020085 179 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (331)
Q Consensus 179 ~~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~ 258 (331)
+. .++||||+++++|.+++....+.+++..+..++.|+++||.|||++|++||||||+||+++.++.+||+|||+++..
T Consensus 93 ~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 93 PP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp SS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred CC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccc
Confidence 54 89999999999999999876678999999999999999999999999999999999999999999999999999876
Q ss_pred cCCCc----cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhcccccccccc
Q 020085 259 AQSGV----MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIHS 327 (331)
Q Consensus 259 ~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p~ 327 (331)
..... .....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||.+.+..+....+...+.+++
T Consensus 172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 245 (291)
T 1u46_A 172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 245 (291)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC
T ss_pred cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCC
Confidence 54332 123457788999999998889999999999999999999 9999999988887777665555444
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-40 Score=296.74 Aligned_cols=212 Identities=25% Similarity=0.407 Sum_probs=187.1
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCC---C----HHHHHHHHHHHHHHHhcC-CCcceeEEeEEEC
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV---N----TEMLKEFSQEVYIMRKIR-HKNVVQFIGACTR 178 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~---~----~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~ 178 (331)
.++|++.+.||+|+||.||+|++ .++.||||+++.... . ....+.+.+|+.+++++. ||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~ 95 (298)
T 1phk_A 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 95 (298)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence 56899999999999999999998 568999999975531 1 233567889999999996 9999999999999
Q ss_pred CCCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeee
Q 020085 179 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (331)
Q Consensus 179 ~~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~ 258 (331)
....++||||+++++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||.+...
T Consensus 96 ~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 174 (298)
T 1phk_A 96 NTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL 174 (298)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred CCeEEEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhhc
Confidence 9999999999999999999976 467899999999999999999999999999999999999999999999999999877
Q ss_pred cCCCccccCCCCcccccchhcC------CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 259 AQSGVMTAETGTYRWMAPEVIE------HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 259 ~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
..........+++.|+|||++. ...++.++||||||+++|+|++|+.||...+..+....+..
T Consensus 175 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 243 (298)
T 1phk_A 175 DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS 243 (298)
T ss_dssp CTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhc
Confidence 6655556677999999999984 55788999999999999999999999998887776655443
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-40 Score=301.08 Aligned_cols=210 Identities=30% Similarity=0.557 Sum_probs=179.4
Q ss_pred ccCcceeeeeeecCceEEEEEEECC-----ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEE-CCCCe
Q 020085 109 AKQLKIECKVASGSYGDLYKGTYCS-----QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT-RPPNL 182 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~-~~~~~ 182 (331)
...|++.+.||+|+||.||+|++.. ..+|+|.++... +....+.+.+|+.++++++||||+++++++. .+...
T Consensus 24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 102 (298)
T 3f66_A 24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSP 102 (298)
T ss_dssp GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCC
T ss_pred ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCC-CHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCce
Confidence 4578999999999999999998632 258999988643 4556678999999999999999999999864 45678
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC
Q 020085 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262 (331)
Q Consensus 183 ~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~ 262 (331)
++||||+++|+|.+++......++...+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+++......
T Consensus 103 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~ 182 (298)
T 3f66_A 103 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 182 (298)
T ss_dssp EEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGG
T ss_pred EEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccc
Confidence 99999999999999998767789999999999999999999999999999999999999999999999999997554322
Q ss_pred -----ccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhcc
Q 020085 263 -----VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGV 319 (331)
Q Consensus 263 -----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~ 319 (331)
......+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||...+..+....+
T Consensus 183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~ 245 (298)
T 3f66_A 183 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 245 (298)
T ss_dssp GCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHH
T ss_pred hhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH
Confidence 1233456789999999999999999999999999999999 67888887666555443
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=317.79 Aligned_cols=207 Identities=26% Similarity=0.388 Sum_probs=176.5
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECC------C
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP------P 180 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~------~ 180 (331)
..+|++.+.||+|+||.||+|++ .++.||||++.... ..+.+|+.++++++||||++++++|... .
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~------~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~ 126 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK------RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEV 126 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT------TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEE
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc------hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcce
Confidence 44799999999999999999998 57899999987542 2234799999999999999999988432 2
Q ss_pred CeEEEEeccCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC-CcEEEeeeccee
Q 020085 181 NLCIVTEFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVAR 256 (331)
Q Consensus 181 ~~~lV~E~~~ggsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~-~~vkl~DFg~a~ 256 (331)
.+++||||+++ +|.+.+.. ....+++..+..++.||++||+|||++||+||||||+|||++.+ +.+||+|||+++
T Consensus 127 ~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 127 YLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 37799999987 67666542 35789999999999999999999999999999999999999965 578999999998
Q ss_pred eecCCCccccCCCCcccccchhcCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccc
Q 020085 257 VQAQSGVMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK 322 (331)
Q Consensus 257 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~ 322 (331)
............+|+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+...++++.
T Consensus 206 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~ 272 (420)
T 1j1b_A 206 QLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKV 272 (420)
T ss_dssp ECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred hcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 76655555667899999999998764 7999999999999999999999999999887777666553
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=315.93 Aligned_cols=215 Identities=30% Similarity=0.534 Sum_probs=173.6
Q ss_pred cCcceeeeeeecCceEEEEEEEC--C---ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEEC-CCCeE
Q 020085 110 KQLKIECKVASGSYGDLYKGTYC--S---QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR-PPNLC 183 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~~--~---~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~-~~~~~ 183 (331)
..|++.+.||+|+||.||+|++. + ..||+|.++... +....+.+.+|+.++++++||||++++++|.. ++..+
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~ 167 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT-DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 167 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCS-CSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCE
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeE
Confidence 35788999999999999999873 2 358999987543 44556889999999999999999999998754 45789
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC-
Q 020085 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG- 262 (331)
Q Consensus 184 lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~- 262 (331)
+||||+++|+|.+++......+++..+..++.|+++||+|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 168 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~ 247 (373)
T 3c1x_A 168 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF 247 (373)
T ss_dssp EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred EEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccccc
Confidence 9999999999999998767788999999999999999999999999999999999999999999999999997553322
Q ss_pred ----ccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhccccccccc
Q 020085 263 ----VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIH 326 (331)
Q Consensus 263 ----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p 326 (331)
......+++.|+|||.+.+..++.++||||||+++|||++ |.+||...+..+....+ .++.++
T Consensus 248 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~-~~~~~~ 315 (373)
T 3c1x_A 248 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL-LQGRRL 315 (373)
T ss_dssp ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHH-HTTCCC
T ss_pred ccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHH-HcCCCC
Confidence 1233456789999999999999999999999999999999 78999887665554443 334443
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-40 Score=297.09 Aligned_cols=204 Identities=22% Similarity=0.360 Sum_probs=177.7
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCcceeEEeEEECCCCeEEE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIV 185 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~lV 185 (331)
.++|++.+.||+|+||.||+|.+ .++.||+|+++...........+.+|+..+.++ +||||+++++++..++..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 46899999999999999999998 479999999987655556667899999999999 899999999999999999999
Q ss_pred EeccCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC-----------------
Q 020085 186 TEFMARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG----------------- 245 (331)
Q Consensus 186 ~E~~~ggsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~----------------- 245 (331)
|||+++++|.+++... ...+++..+..++.|++.||+|||++||+||||||+||+++.++
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~ 169 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASN 169 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC--------------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCC
Confidence 9999999999999764 26789999999999999999999999999999999999998544
Q ss_pred --cEEEeeecceeeecCCCccccCCCCcccccchhcCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 020085 246 --VVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQA 315 (331)
Q Consensus 246 --~vkl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~ 315 (331)
.++|+|||.+...... ....||+.|+|||.+.+. .++.++||||||+++|+|++|.+|+......+.
T Consensus 170 ~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~ 239 (289)
T 1x8b_A 170 KVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWHE 239 (289)
T ss_dssp CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHHH
T ss_pred ceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHHH
Confidence 7999999999876543 234699999999999766 567899999999999999999988766544433
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-41 Score=311.07 Aligned_cols=203 Identities=26% Similarity=0.484 Sum_probs=175.5
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCcceeEEeEEECCCCeEEE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIV 185 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~lV 185 (331)
.++|++.+.||+|+||.||++.+ .++.||+|+++.... ...+|+.++.++ +||||+++++++.++...|+|
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv 94 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVV 94 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEE
Confidence 46799999999999999999998 478999999976542 244688888887 799999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC----CcEEEeeecceeeecCC
Q 020085 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN----GVVKVADFGVARVQAQS 261 (331)
Q Consensus 186 ~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~----~~vkl~DFg~a~~~~~~ 261 (331)
|||++||+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+.++ +.+||+|||+++.....
T Consensus 95 ~E~~~gg~L~~~i~~-~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~ 173 (342)
T 2qr7_A 95 TELMKGGELLDKILR-QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAE 173 (342)
T ss_dssp ECCCCSCBHHHHHHT-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCT
T ss_pred EeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCC
Confidence 999999999999965 5679999999999999999999999999999999999998543 35999999999865443
Q ss_pred -CccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCC---CCHHHHHhc
Q 020085 262 -GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAG---LTPLQAAVG 318 (331)
Q Consensus 262 -~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~---~~~~~~~~~ 318 (331)
......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+ .++.+....
T Consensus 174 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~ 234 (342)
T 2qr7_A 174 NGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILAR 234 (342)
T ss_dssp TCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHH
T ss_pred CCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHH
Confidence 334456789999999999888899999999999999999999999986 344444444
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=301.10 Aligned_cols=208 Identities=26% Similarity=0.487 Sum_probs=182.0
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~ 186 (331)
.++|.+.+.||+|+||.||++++ .++.||+|+++... ....+.+.+|+.++++++||||+++++++......++||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP--AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM 85 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC--------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc--ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence 45899999999999999999998 47899999998543 222356889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEE---cCCCcEEEeeecceeeecCCCc
Q 020085 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM---DENGVVKVADFGVARVQAQSGV 263 (331)
Q Consensus 187 E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi---~~~~~vkl~DFg~a~~~~~~~~ 263 (331)
||+++++|.+++.. .+.+++..+..++.|++.||.|||++|++||||||+||++ +.++.++|+|||+++..... .
T Consensus 86 e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-~ 163 (304)
T 2jam_A 86 QLVSGGELFDRILE-RGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-I 163 (304)
T ss_dssp CCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-T
T ss_pred EcCCCccHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-c
Confidence 99999999999965 4578999999999999999999999999999999999999 78889999999998754432 2
Q ss_pred cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccc
Q 020085 264 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 264 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~ 320 (331)
.....|++.|+|||.+.+..++.++||||||+++|+|++|+.||...+..+....+.
T Consensus 164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~ 220 (304)
T 2jam_A 164 MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIK 220 (304)
T ss_dssp THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 344568999999999999999999999999999999999999999988776665544
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-40 Score=302.21 Aligned_cols=206 Identities=20% Similarity=0.361 Sum_probs=172.4
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV 185 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV 185 (331)
.++|++.+.||+|+||.||++++ .++.||+|+++.... +....+.+.+|+.++++++||||+++++++..+...++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 56899999999999999999997 478899999976533 344567899999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC--c
Q 020085 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG--V 263 (331)
Q Consensus 186 ~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~--~ 263 (331)
|||+++++|.+++.. .+.+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++....... .
T Consensus 113 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~ 191 (309)
T 2h34_A 113 MRLINGVDLAAMLRR-QGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ 191 (309)
T ss_dssp EECCCCEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC-----------
T ss_pred EEecCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccccccc
Confidence 999999999999975 4678999999999999999999999999999999999999999999999999987654432 2
Q ss_pred cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHH
Q 020085 264 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQA 315 (331)
Q Consensus 264 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~ 315 (331)
.....+++.|+|||.+.+..++.++||||||+++|+|++|+.||...+....
T Consensus 192 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 243 (309)
T 2h34_A 192 LGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVM 243 (309)
T ss_dssp -----CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHH
T ss_pred ccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHH
Confidence 2345689999999999999999999999999999999999999998765533
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-40 Score=305.30 Aligned_cols=212 Identities=25% Similarity=0.470 Sum_probs=182.5
Q ss_pred ccCcceeeeeeecCceEEEEEEE---CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc---CCCcceeEEeEEE-----
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY---CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI---RHKNVVQFIGACT----- 177 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l---~h~niv~~~~~~~----- 177 (331)
.++|++.+.||+|+||.||+|++ .++.||+|+++...........+.+|+.+++.+ +||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 10 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred hhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 46899999999999999999998 357899999975433222223566778777776 8999999999987
Q ss_pred CCCCeEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeeccee
Q 020085 178 RPPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR 256 (331)
Q Consensus 178 ~~~~~~lV~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~ 256 (331)
.....++||||+.+ +|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++
T Consensus 90 ~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~ 168 (326)
T 1blx_A 90 RETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168 (326)
T ss_dssp SEEEEEEEEECCSC-BHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred CCceEEEEEecCCC-CHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccc
Confidence 55678999999984 9999997653 458999999999999999999999999999999999999999999999999998
Q ss_pred eecCCCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 257 VQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 257 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
............+|+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+..+....+++
T Consensus 169 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~ 233 (326)
T 1blx_A 169 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD 233 (326)
T ss_dssp CCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHH
Confidence 76554445566789999999999999999999999999999999999999999888777666554
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-41 Score=315.32 Aligned_cols=209 Identities=26% Similarity=0.405 Sum_probs=177.1
Q ss_pred cccCcceeeeeeecCceEEEEEEE-CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCC-----
Q 020085 108 DAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN----- 181 (331)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~----- 181 (331)
...+|++.+.||+|+||.||+|++ .+..+|+|++.... ....+|+.+++.++||||+++++++.....
T Consensus 38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~ 111 (394)
T 4e7w_A 38 REIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDK------RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEV 111 (394)
T ss_dssp EEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCT------TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCE
T ss_pred ccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCc------chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCce
Confidence 356799999999999999999998 45669999886442 122369999999999999999999854333
Q ss_pred -eEEEEeccCCCCHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEc-CCCcEEEeeeccee
Q 020085 182 -LCIVTEFMARGSIYDFLH---KQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD-ENGVVKVADFGVAR 256 (331)
Q Consensus 182 -~~lV~E~~~ggsL~~~l~---~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~-~~~~vkl~DFg~a~ 256 (331)
+++||||++++ +.+.+. .....+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||+++
T Consensus 112 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~ 190 (394)
T 4e7w_A 112 FLNLVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAK 190 (394)
T ss_dssp EEEEEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred EEEEEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcc
Confidence 88999999884 444332 2356899999999999999999999999999999999999999 79999999999998
Q ss_pred eecCCCccccCCCCcccccchhcCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccccc
Q 020085 257 VQAQSGVMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKV 323 (331)
Q Consensus 257 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~ 323 (331)
............+|+.|+|||++.+. .++.++|||||||++|||++|+.||.+.+..+....+++..
T Consensus 191 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~ 258 (394)
T 4e7w_A 191 ILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVL 258 (394)
T ss_dssp ECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHH
T ss_pred cccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 77666556677899999999998664 58999999999999999999999999998887777766543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-41 Score=321.52 Aligned_cols=201 Identities=24% Similarity=0.445 Sum_probs=165.0
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCC------CHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCC
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV------NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~------~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 180 (331)
.++|.+.+.||+|+||+||+|.+ .++.||||+++.... .......+.+|+.++++++||||+++++++..+
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~- 212 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE- 212 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESS-
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence 56899999999999999999998 468999999975421 122234588999999999999999999998654
Q ss_pred CeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC---cEEEeeecceee
Q 020085 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG---VVKVADFGVARV 257 (331)
Q Consensus 181 ~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~---~vkl~DFg~a~~ 257 (331)
..++||||+++|+|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+|||++.++ .+||+|||+++.
T Consensus 213 ~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~ 291 (419)
T 3i6u_A 213 DYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 291 (419)
T ss_dssp EEEEEEECCTTCBGGGGTSS-SCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTS
T ss_pred ceEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeeccccee
Confidence 58999999999999998854 56799999999999999999999999999999999999997544 599999999987
Q ss_pred ecCCCccccCCCCcccccchhcC---CCCCCChhhHHHHHHHHHHHHcCCCCCCCCC
Q 020085 258 QAQSGVMTAETGTYRWMAPEVIE---HKPYDYKADVFSFGIALWELLTGELPYAGLT 311 (331)
Q Consensus 258 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~ 311 (331)
...........||+.|+|||++. ...++.++||||||+++|+|++|+.||....
T Consensus 292 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~ 348 (419)
T 3i6u_A 292 LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 348 (419)
T ss_dssp CC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCS
T ss_pred cCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCc
Confidence 66655556678999999999985 3678899999999999999999999998753
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=298.32 Aligned_cols=213 Identities=26% Similarity=0.460 Sum_probs=185.9
Q ss_pred eecccCcceeeeeeecCceEEEEEEEC--CceEEEEEecCCCCC-HHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCe
Q 020085 106 EIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL 182 (331)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 182 (331)
.+..++|++.+.||+|+||.||+|++. ++.||+|++...... ......+.+|+.++++++||||+++++++......
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 89 (284)
T 2vgo_A 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRI 89 (284)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEE
Confidence 345678999999999999999999984 578999998643211 11235788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC
Q 020085 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262 (331)
Q Consensus 183 ~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~ 262 (331)
++||||+++++|.+++... +.+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++......
T Consensus 90 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~- 167 (284)
T 2vgo_A 90 YLMLEFAPRGELYKELQKH-GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL- 167 (284)
T ss_dssp EEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-
T ss_pred EEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc-
Confidence 9999999999999999763 57899999999999999999999999999999999999999999999999999765433
Q ss_pred ccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccc
Q 020085 263 VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 263 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~ 320 (331)
......|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+....+.
T Consensus 168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 225 (284)
T 2vgo_A 168 RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV 225 (284)
T ss_dssp CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHh
Confidence 2345678999999999999999999999999999999999999999887776655543
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-41 Score=310.57 Aligned_cols=205 Identities=31% Similarity=0.529 Sum_probs=179.3
Q ss_pred CeeeecccCcceeeeeeecCceEEEEEEE-CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCC
Q 020085 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN 181 (331)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 181 (331)
..+++..++|++.+.||+|+||.||+|+. .++.||||+++..... .....+.+|+.++++++||||+++++++.....
T Consensus 23 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 101 (326)
T 3uim_A 23 RELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQ-GGELQFQTEVEMISMAVHRNLLRLRGFCMTPTE 101 (326)
T ss_dssp HHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSC
T ss_pred HHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCc-hHHHHHHHHHHHHHhccCCCccceEEEEecCCc
Confidence 34567788999999999999999999987 5788999999865321 122368899999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCCCCEEEcCCCcEEEeeecce
Q 020085 182 LCIVTEFMARGSIYDFLHKQK---GVFQLTSLLKVAIDVSKGMNYLHQN---NIIHRDLKTANLLMDENGVVKVADFGVA 255 (331)
Q Consensus 182 ~~lV~E~~~ggsL~~~l~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~NiLi~~~~~vkl~DFg~a 255 (331)
.++||||+++|+|.+++.... ..+++..+..++.|++.||+|||++ |++||||||+|||++.++.+||+|||++
T Consensus 102 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~ 181 (326)
T 3uim_A 102 RLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLA 181 (326)
T ss_dssp CEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSC
T ss_pred eEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccc
Confidence 999999999999999997643 3489999999999999999999999 9999999999999999999999999999
Q ss_pred eeecCCC--ccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCC
Q 020085 256 RVQAQSG--VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYA 308 (331)
Q Consensus 256 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~ 308 (331)
+...... ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.
T Consensus 182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 236 (326)
T 3uim_A 182 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFD 236 (326)
T ss_dssp EECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred cccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccc
Confidence 8664332 2334459999999999988889999999999999999999999995
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-40 Score=313.72 Aligned_cols=212 Identities=27% Similarity=0.438 Sum_probs=185.7
Q ss_pred cccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc------CCCcceeEEeEEECC
Q 020085 108 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI------RHKNVVQFIGACTRP 179 (331)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l------~h~niv~~~~~~~~~ 179 (331)
...+|++.+.||+|+||+||+|.+ .++.||||+++.. ....+.+.+|+.+++.+ +|+||+++++++...
T Consensus 95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 171 (429)
T 3kvw_A 95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE---KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR 171 (429)
T ss_dssp ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc---cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence 356799999999999999999988 4689999999853 44556788899999887 567999999999999
Q ss_pred CCeEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCc--EEEeeeccee
Q 020085 180 PNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV--VKVADFGVAR 256 (331)
Q Consensus 180 ~~~~lV~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~--vkl~DFg~a~ 256 (331)
...++||||+. ++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||++.++. +||+|||+++
T Consensus 172 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~ 250 (429)
T 3kvw_A 172 NHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSC 250 (429)
T ss_dssp TEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCE
T ss_pred CeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccce
Confidence 99999999996 59999997654 45999999999999999999999999999999999999999987 9999999997
Q ss_pred eecCCCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccccccc
Q 020085 257 VQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSI 325 (331)
Q Consensus 257 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~ 325 (331)
..... .....||+.|+|||++.+..++.++|||||||++|||++|++||.+.+..+....+++....
T Consensus 251 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~ 317 (429)
T 3kvw_A 251 YEHQR--VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGM 317 (429)
T ss_dssp ETTCC--CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred ecCCc--ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence 65432 34567999999999999999999999999999999999999999999888777766654433
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-41 Score=305.79 Aligned_cols=214 Identities=33% Similarity=0.605 Sum_probs=165.6
Q ss_pred eeeecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCC
Q 020085 104 VWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN 181 (331)
Q Consensus 104 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 181 (331)
.|.+..++|++.+.||+|+||.||++.+ .++.||||+++.... ....+.+.+|+.++++++||||+++++++...+.
T Consensus 9 p~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 87 (303)
T 2vwi_A 9 PWSINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC-QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDE 87 (303)
T ss_dssp ----CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC-----------------CCCCCCCTTBCCEEEEEESSSC
T ss_pred ccccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc-chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCC
Confidence 3788899999999999999999999987 678999999875432 2345678899999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHh-------cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecc
Q 020085 182 LCIVTEFMARGSIYDFLHK-------QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV 254 (331)
Q Consensus 182 ~~lV~E~~~ggsL~~~l~~-------~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~ 254 (331)
.++||||+++++|.+++.. ..+.+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+
T Consensus 88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~ 167 (303)
T 2vwi_A 88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGV 167 (303)
T ss_dssp EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHH
T ss_pred cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccc
Confidence 9999999999999999864 245689999999999999999999999999999999999999999999999999
Q ss_pred eeeecCCC------ccccCCCCcccccchhcCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhc
Q 020085 255 ARVQAQSG------VMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVG 318 (331)
Q Consensus 255 a~~~~~~~------~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~ 318 (331)
+....... ......||+.|+|||.+.+ ..++.++||||||+++|+|++|+.||....+.+....
T Consensus 168 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~ 238 (303)
T 2vwi_A 168 SAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML 238 (303)
T ss_dssp HHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH
T ss_pred hheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHH
Confidence 86543321 1233468999999999875 5689999999999999999999999998776555443
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-40 Score=298.43 Aligned_cols=212 Identities=23% Similarity=0.499 Sum_probs=176.6
Q ss_pred eecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCe
Q 020085 106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL 182 (331)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 182 (331)
.+..++|.+.+.||+|+||.||+|.+ .++.||+|+++.... +.+..+.+.+|+.++++++||||+++++++......
T Consensus 7 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 86 (276)
T 2h6d_A 7 RVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDF 86 (276)
T ss_dssp CCEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEE
T ss_pred cceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeE
Confidence 45567999999999999999999998 478999999874321 112245788999999999999999999999999999
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC
Q 020085 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262 (331)
Q Consensus 183 ~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~ 262 (331)
++||||+++++|.+++.. .+.+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.......
T Consensus 87 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~ 165 (276)
T 2h6d_A 87 FMVMEYVSGGELFDYICK-HGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE 165 (276)
T ss_dssp EEEEECCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC--
T ss_pred EEEEeccCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCc
Confidence 999999999999999966 4578999999999999999999999999999999999999999999999999998765544
Q ss_pred ccccCCCCcccccchhcCCCCC-CChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhc
Q 020085 263 VMTAETGTYRWMAPEVIEHKPY-DYKADVFSFGIALWELLTGELPYAGLTPLQAAVG 318 (331)
Q Consensus 263 ~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~ 318 (331)
......+++.|+|||.+.+..+ +.++|+||||+++|+|++|+.||...+..+....
T Consensus 166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~ 222 (276)
T 2h6d_A 166 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKK 222 (276)
T ss_dssp -----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH
Confidence 4455678999999999988776 6899999999999999999999998877665544
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-41 Score=318.44 Aligned_cols=202 Identities=26% Similarity=0.457 Sum_probs=177.0
Q ss_pred ecccCcceeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCC--Ce
Q 020085 107 IDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP--NL 182 (331)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~--~~ 182 (331)
...++|.+.+.||+|+||+||+|++. ++.||||+++.... ....+.+.+|+.++++++||||+++++++.... ..
T Consensus 6 ~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~ 84 (396)
T 4eut_A 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF-LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK 84 (396)
T ss_dssp CSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG-GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc-cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence 44678999999999999999999985 78999999975432 122467789999999999999999999998755 68
Q ss_pred EEEEeccCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEE----cCCCcEEEeeeccee
Q 020085 183 CIVTEFMARGSIYDFLHKQK--GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM----DENGVVKVADFGVAR 256 (331)
Q Consensus 183 ~lV~E~~~ggsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi----~~~~~vkl~DFg~a~ 256 (331)
++||||+++|+|.+++.... ..+++..++.++.|++.||+|||++||+||||||+|||+ +.++.+||+|||+++
T Consensus 85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~ 164 (396)
T 4eut_A 85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR 164 (396)
T ss_dssp EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCE
T ss_pred EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCce
Confidence 99999999999999996643 338999999999999999999999999999999999999 777889999999998
Q ss_pred eecCCCccccCCCCcccccchhcCC--------CCCCChhhHHHHHHHHHHHHcCCCCCCC
Q 020085 257 VQAQSGVMTAETGTYRWMAPEVIEH--------KPYDYKADVFSFGIALWELLTGELPYAG 309 (331)
Q Consensus 257 ~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~Di~SlG~il~ell~g~~Pf~~ 309 (331)
............||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~ 225 (396)
T 4eut_A 165 ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225 (396)
T ss_dssp ECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEEC
T ss_pred EccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 7766655566789999999999865 5678899999999999999999999964
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-40 Score=298.36 Aligned_cols=203 Identities=24% Similarity=0.489 Sum_probs=168.7
Q ss_pred cccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCC-CCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEE
Q 020085 108 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI 184 (331)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~l 184 (331)
..++|++.+.||+|+||.||+|.. .++.||+|+++... .+......+.+|+.++++++||||+++++++...+..++
T Consensus 30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l 109 (310)
T 2wqm_A 30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNI 109 (310)
T ss_dssp SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEE
Confidence 356899999999999999999997 57899999998643 345667789999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC
Q 020085 185 VTEFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261 (331)
Q Consensus 185 V~E~~~ggsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~ 261 (331)
||||+++++|.+++.. ....+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||+++.....
T Consensus 110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~ 189 (310)
T 2wqm_A 110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK 189 (310)
T ss_dssp EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC---------
T ss_pred EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCC
Confidence 9999999999999864 3567899999999999999999999999999999999999999999999999999765433
Q ss_pred C-ccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 020085 262 G-VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL 310 (331)
Q Consensus 262 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~ 310 (331)
. ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||.+.
T Consensus 190 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 239 (310)
T 2wqm_A 190 TTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 239 (310)
T ss_dssp ---------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred CccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 2 223456899999999999999999999999999999999999999754
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=303.00 Aligned_cols=211 Identities=28% Similarity=0.488 Sum_probs=164.8
Q ss_pred CCeeeecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCcceeEEeEEE-
Q 020085 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACT- 177 (331)
Q Consensus 102 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~- 177 (331)
.+.+++...+|++.++||+|+||.||++++ .++.||+|++... .....+.+.+|+.+++++. ||||+++++++.
T Consensus 20 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~ 97 (337)
T 3ll6_A 20 GQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN--EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASI 97 (337)
T ss_dssp TCEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEE
T ss_pred cceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC--chHHHHHHHHHHHHHHHhccCCChhhccccccc
Confidence 456889999999999999999999999998 6789999998654 3555678999999999996 999999999984
Q ss_pred -------CCCCeEEEEeccCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCCEEEcCCCc
Q 020085 178 -------RPPNLCIVTEFMARGSIYDFLHK--QKGVFQLTSLLKVAIDVSKGMNYLHQNN--IIHRDLKTANLLMDENGV 246 (331)
Q Consensus 178 -------~~~~~~lV~E~~~ggsL~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~NiLi~~~~~ 246 (331)
....+++||||+. |+|.+++.. ..+.+++..++.++.||+.||.|||++| ++||||||+|||++.++.
T Consensus 98 ~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~ 176 (337)
T 3ll6_A 98 GKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGT 176 (337)
T ss_dssp CTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSC
T ss_pred cccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCC
Confidence 3344899999997 599998865 3567999999999999999999999999 999999999999999999
Q ss_pred EEEeeecceeeecCCCcc-------------ccCCCCcccccchhc---CCCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 020085 247 VKVADFGVARVQAQSGVM-------------TAETGTYRWMAPEVI---EHKPYDYKADVFSFGIALWELLTGELPYAGL 310 (331)
Q Consensus 247 vkl~DFg~a~~~~~~~~~-------------~~~~gt~~y~aPE~~---~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~ 310 (331)
+||+|||+++........ ....+|+.|+|||++ .+..++.++||||||+++|+|++|+.||...
T Consensus 177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 256 (337)
T 3ll6_A 177 IKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDG 256 (337)
T ss_dssp EEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred EEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcch
Confidence 999999999765443211 134589999999998 5677899999999999999999999999876
Q ss_pred CHHHH
Q 020085 311 TPLQA 315 (331)
Q Consensus 311 ~~~~~ 315 (331)
...+.
T Consensus 257 ~~~~~ 261 (337)
T 3ll6_A 257 AKLRI 261 (337)
T ss_dssp -----
T ss_pred hHHHh
Confidence 55443
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-41 Score=312.07 Aligned_cols=204 Identities=23% Similarity=0.408 Sum_probs=175.0
Q ss_pred eeecccCcceeeeeeecCceEEEEEEE-----CCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhc-CCCcceeEEeEE
Q 020085 105 WEIDAKQLKIECKVASGSYGDLYKGTY-----CSQEVAIKVLKPECV--NTEMLKEFSQEVYIMRKI-RHKNVVQFIGAC 176 (331)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~--~~~~~~~~~~E~~il~~l-~h~niv~~~~~~ 176 (331)
..+..++|++.+.||+|+||.||+++. .++.||||+++.... .....+.+.+|+.+++++ +||||+++++++
T Consensus 49 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 128 (355)
T 1vzo_A 49 EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF 128 (355)
T ss_dssp CCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred ccccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEE
Confidence 345668999999999999999999998 578999999875321 111234577899999999 699999999999
Q ss_pred ECCCCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeeccee
Q 020085 177 TRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR 256 (331)
Q Consensus 177 ~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~ 256 (331)
......++||||+++++|.+++.. ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||+++
T Consensus 129 ~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 129 QTETKLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EETTEEEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeCceEEEEeecCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 999999999999999999999976 4579999999999999999999999999999999999999999999999999998
Q ss_pred eecCCC--ccccCCCCcccccchhcCC--CCCCChhhHHHHHHHHHHHHcCCCCCCC
Q 020085 257 VQAQSG--VMTAETGTYRWMAPEVIEH--KPYDYKADVFSFGIALWELLTGELPYAG 309 (331)
Q Consensus 257 ~~~~~~--~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~SlG~il~ell~g~~Pf~~ 309 (331)
...... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||..
T Consensus 208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~ 264 (355)
T 1vzo_A 208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTV 264 (355)
T ss_dssp ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSC
T ss_pred ecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCcc
Confidence 654322 2234579999999999975 4578999999999999999999999974
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-40 Score=301.03 Aligned_cols=211 Identities=31% Similarity=0.536 Sum_probs=180.6
Q ss_pred cccCcceeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEE
Q 020085 108 DAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV 185 (331)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV 185 (331)
..+.|++.+.||+|+||.||+|++. ++.||+|+++... ....+.+.+|+.++++++||||+++++++......++|
T Consensus 17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 94 (302)
T 2j7t_A 17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS--EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM 94 (302)
T ss_dssp GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC--HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence 4568999999999999999999994 7889999997543 22356789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC-Ccc
Q 020085 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVM 264 (331)
Q Consensus 186 ~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~-~~~ 264 (331)
|||+++++|.+++......+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++...... ...
T Consensus 95 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~ 174 (302)
T 2j7t_A 95 IEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR 174 (302)
T ss_dssp EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC-
T ss_pred EEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccccccc
Confidence 9999999999999876778999999999999999999999999999999999999999999999999987532211 112
Q ss_pred ccCCCCcccccchhc-----CCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccc
Q 020085 265 TAETGTYRWMAPEVI-----EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 265 ~~~~gt~~y~aPE~~-----~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~ 320 (331)
....|++.|+|||.+ .+..++.++||||||+++|+|++|+.||...++.+....+.
T Consensus 175 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 235 (302)
T 2j7t_A 175 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIA 235 (302)
T ss_dssp ----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred ccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHh
Confidence 345689999999998 46778999999999999999999999999988877766644
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-40 Score=300.89 Aligned_cols=225 Identities=26% Similarity=0.444 Sum_probs=172.2
Q ss_pred CCCeeeecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEEC
Q 020085 101 GTDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR 178 (331)
Q Consensus 101 ~~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 178 (331)
+...+.+..++|++.+.||+|+||.||+|.+ .++.||||+++.........+.+.++..+++.++||||+++++++..
T Consensus 16 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~ 95 (318)
T 2dyl_A 16 GGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT 95 (318)
T ss_dssp SSSEEECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC
T ss_pred cchhhhhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec
Confidence 3456788889999999999999999999998 47899999998765444444556666677888999999999999999
Q ss_pred CCCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCCEEEcCCCcEEEeeecceee
Q 020085 179 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDENGVVKVADFGVARV 257 (331)
Q Consensus 179 ~~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~ 257 (331)
+...++||||+ ++.+..+.....+.+++..+..++.|++.||.|||++ |++||||||+||+++.++.+||+|||+++.
T Consensus 96 ~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~ 174 (318)
T 2dyl_A 96 NTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGR 174 (318)
T ss_dssp SSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC--
T ss_pred CCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchh
Confidence 99999999999 5567666655567899999999999999999999995 999999999999999999999999999976
Q ss_pred ecCCCccccCCCCcccccchhcC-----CCCCCChhhHHHHHHHHHHHHcCCCCCCCC-CHHHHHhcccccccccc
Q 020085 258 QAQSGVMTAETGTYRWMAPEVIE-----HKPYDYKADVFSFGIALWELLTGELPYAGL-TPLQAAVGVVQKVSIHS 327 (331)
Q Consensus 258 ~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~SlG~il~ell~g~~Pf~~~-~~~~~~~~~~~~~~~p~ 327 (331)
...........+++.|+|||.+. ...++.++||||||+++|+|++|+.||... +..+....+ .++.+|.
T Consensus 175 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~-~~~~~~~ 249 (318)
T 2dyl_A 175 LVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKV-LQEEPPL 249 (318)
T ss_dssp ------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHH-HHSCCCC
T ss_pred ccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHH-hccCCCC
Confidence 65544445567999999999994 557899999999999999999999999874 444444443 3344443
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-40 Score=300.49 Aligned_cols=212 Identities=33% Similarity=0.575 Sum_probs=177.2
Q ss_pred eecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCcceeEEeEEEC----
Q 020085 106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTR---- 178 (331)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~---- 178 (331)
....++|++.+.||+|+||.||+|++ .++.||+|+++..... .+.+.+|+.+++++ +||||+++++++..
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~---~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 96 (326)
T 2x7f_A 20 RDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE---EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPP 96 (326)
T ss_dssp CCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSST---THHHHHHHHHHHHHCCSTTBCCEEEEEEECC--
T ss_pred cCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCccc---HHHHHHHHHHHHhccCCCCeeeeeeEEeeccCc
Confidence 34577899999999999999999999 6789999999755332 35788999999999 79999999999976
Q ss_pred --CCCeEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecce
Q 020085 179 --PPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA 255 (331)
Q Consensus 179 --~~~~~lV~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a 255 (331)
....++||||+++++|.+++.... ..+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 176 (326)
T 2x7f_A 97 GMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS 176 (326)
T ss_dssp CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTT
T ss_pred cccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCc
Confidence 457899999999999999997643 57899999999999999999999999999999999999999999999999998
Q ss_pred eeecCC-CccccCCCCcccccchhcC-----CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccc
Q 020085 256 RVQAQS-GVMTAETGTYRWMAPEVIE-----HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 256 ~~~~~~-~~~~~~~gt~~y~aPE~~~-----~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~ 320 (331)
...... .......|++.|+|||++. +..++.++||||||+++|+|++|+.||...++.+....+.
T Consensus 177 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 247 (326)
T 2x7f_A 177 AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP 247 (326)
T ss_dssp C-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred eecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhh
Confidence 765432 2233456899999999986 5678999999999999999999999999988877666543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-40 Score=296.57 Aligned_cols=207 Identities=31% Similarity=0.575 Sum_probs=177.9
Q ss_pred CcceeeeeeecCceEEEEEEEC--Cc---eEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCe-EE
Q 020085 111 QLKIECKVASGSYGDLYKGTYC--SQ---EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL-CI 184 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~~--~~---~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~-~l 184 (331)
.|.+.+.||+|+||+||+|.+. ++ .+|+|+++... .....+.+.+|+.++++++||||+++++++...+.. ++
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 100 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT-EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHV 100 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCC-SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccc-cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEE
Confidence 4567799999999999999872 22 69999997543 455678899999999999999999999999776655 99
Q ss_pred EEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC--
Q 020085 185 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-- 262 (331)
Q Consensus 185 V~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~-- 262 (331)
||||+.+|+|.+++......+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+++......
T Consensus 101 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~ 180 (298)
T 3pls_A 101 LLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYY 180 (298)
T ss_dssp EECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGG
T ss_pred EEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCccc
Confidence 999999999999998767789999999999999999999999999999999999999999999999999997543321
Q ss_pred ---ccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhc
Q 020085 263 ---VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVG 318 (331)
Q Consensus 263 ---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~ 318 (331)
......+++.|+|||.+.+..++.++||||||+++|+|++ |.+||...++.+....
T Consensus 181 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~ 240 (298)
T 3pls_A 181 SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHF 240 (298)
T ss_dssp CSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHH
T ss_pred ccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHH
Confidence 2233457889999999999999999999999999999999 5667777766655444
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-41 Score=310.87 Aligned_cols=205 Identities=20% Similarity=0.314 Sum_probs=169.7
Q ss_pred CeeeecccCcceeeeeeecCceEEEEEEE-----CCceEEEEEecCCCCCHH---------HHHHHHHHHHHHHhcCCCc
Q 020085 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY-----CSQEVAIKVLKPECVNTE---------MLKEFSQEVYIMRKIRHKN 168 (331)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~~~~---------~~~~~~~E~~il~~l~h~n 168 (331)
...++..++|++.+.||+|+||.||+|.+ .+..+|+|+......... ....+.+|+.+++.++|||
T Consensus 30 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~n 109 (345)
T 2v62_A 30 VLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLG 109 (345)
T ss_dssp EEECTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCC
T ss_pred eeccccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccC
Confidence 33456678999999999999999999998 457899999976532111 1123667889999999999
Q ss_pred ceeEEeEEEC----CCCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC
Q 020085 169 VVQFIGACTR----PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN 244 (331)
Q Consensus 169 iv~~~~~~~~----~~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~ 244 (331)
|+++++++.. ....++||||+ +++|.+++... +.+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 110 i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~ 187 (345)
T 2v62_A 110 IPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN-GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYK 187 (345)
T ss_dssp CCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG-GBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESS
T ss_pred cceeecccccccCCCcEEEEEEecc-CCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccC
Confidence 9999999977 67899999999 88999999654 489999999999999999999999999999999999999988
Q ss_pred C--cEEEeeecceeeecCCC--------ccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCC
Q 020085 245 G--VVKVADFGVARVQAQSG--------VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAG 309 (331)
Q Consensus 245 ~--~vkl~DFg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~ 309 (331)
+ .+||+|||+++...... ......||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 188 ~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~ 262 (345)
T 2v62_A 188 NPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQ 262 (345)
T ss_dssp STTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred CCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 7 99999999998654322 12345789999999999999999999999999999999999999965
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-40 Score=306.10 Aligned_cols=201 Identities=24% Similarity=0.435 Sum_probs=171.6
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCC------CHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCC
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV------NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~------~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 180 (331)
.++|++.+.||+|+||.||+|.+ .++.||||+++.... .......+.+|+.++++++||||+++++++..+.
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 46899999999999999999998 468999999975432 1123345889999999999999999999987654
Q ss_pred CeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCc---EEEeeecceee
Q 020085 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV---VKVADFGVARV 257 (331)
Q Consensus 181 ~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~---vkl~DFg~a~~ 257 (331)
.++||||+++++|.+++.. ...+++..+..++.||+.||.|||++|++||||||+||+++.++. +||+|||+++.
T Consensus 89 -~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~ 166 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI 166 (322)
T ss_dssp -EEEEEECCTTEETHHHHST-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred -eEEEEecCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence 8999999999999999854 567999999999999999999999999999999999999987664 99999999987
Q ss_pred ecCCCccccCCCCcccccchhcC---CCCCCChhhHHHHHHHHHHHHcCCCCCCCCC
Q 020085 258 QAQSGVMTAETGTYRWMAPEVIE---HKPYDYKADVFSFGIALWELLTGELPYAGLT 311 (331)
Q Consensus 258 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~ 311 (331)
...........||+.|+|||++. ...++.++||||||+++|+|++|+.||....
T Consensus 167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 223 (322)
T 2ycf_A 167 LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR 223 (322)
T ss_dssp CCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTT
T ss_pred cccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 66544444557899999999973 5678999999999999999999999997653
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-40 Score=306.09 Aligned_cols=209 Identities=25% Similarity=0.429 Sum_probs=181.5
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECC-----CC
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP-----PN 181 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~-----~~ 181 (331)
.++|++.+.||+|+||.||++.+ .++.||||+++... .....+.+.+|+.++++++||||+++++++... ..
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 104 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 104 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEecccc-CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence 35899999999999999999988 46889999998543 455567899999999999999999999999654 36
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC
Q 020085 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261 (331)
Q Consensus 182 ~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~ 261 (331)
.++||||+.+ +|.+++.. +.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 105 ~~iv~e~~~~-~L~~~l~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~ 181 (364)
T 3qyz_A 105 VYIVQDLMET-DLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD 181 (364)
T ss_dssp EEEEEECCSE-EHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred EEEEEcccCc-CHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCC
Confidence 8999999986 99999865 46899999999999999999999999999999999999999999999999999866543
Q ss_pred Cc----cccCCCCcccccchhcC-CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 262 GV----MTAETGTYRWMAPEVIE-HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 262 ~~----~~~~~gt~~y~aPE~~~-~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
.. .....||+.|+|||++. ...++.++|||||||++|+|++|+.||.+.+..+....++.
T Consensus 182 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~ 246 (364)
T 3qyz_A 182 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 246 (364)
T ss_dssp GCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHH
T ss_pred CCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHH
Confidence 22 23457899999999864 55689999999999999999999999999887776666543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-40 Score=302.32 Aligned_cols=208 Identities=21% Similarity=0.355 Sum_probs=178.2
Q ss_pred CCCCeeeecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEE
Q 020085 100 DGTDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177 (331)
Q Consensus 100 ~~~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 177 (331)
...+.+.++.++|++.+.||+|+||.||++.. .++.||+|++... +....+.+.+|+.++++++||||+++++++.
T Consensus 19 ~~g~~~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~ 96 (317)
T 2buj_A 19 FQGHMVIIDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH--EQQDREEAQREADMHRLFNHPNILRLVAYCL 96 (317)
T ss_dssp EEEEEEEETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred ecccEEEECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC--CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEE
Confidence 34466888999999999999999999999997 6789999998654 4556678999999999999999999999986
Q ss_pred ----CCCCeEEEEeccCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEe
Q 020085 178 ----RPPNLCIVTEFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250 (331)
Q Consensus 178 ----~~~~~~lV~E~~~ggsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~ 250 (331)
.....++||||+++|+|.+++.. ....+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+
T Consensus 97 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~ 176 (317)
T 2buj_A 97 RERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLM 176 (317)
T ss_dssp EEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEEC
T ss_pred eccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEE
Confidence 34468999999999999999976 35679999999999999999999999999999999999999999999999
Q ss_pred eecceeeecCCCc----------cccCCCCcccccchhcCCCC---CCChhhHHHHHHHHHHHHcCCCCCCC
Q 020085 251 DFGVARVQAQSGV----------MTAETGTYRWMAPEVIEHKP---YDYKADVFSFGIALWELLTGELPYAG 309 (331)
Q Consensus 251 DFg~a~~~~~~~~----------~~~~~gt~~y~aPE~~~~~~---~~~~~Di~SlG~il~ell~g~~Pf~~ 309 (331)
|||+++....... .....||+.|+|||.+.+.. ++.++||||||+++|+|++|+.||..
T Consensus 177 dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 248 (317)
T 2buj_A 177 DLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248 (317)
T ss_dssp CCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred ecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence 9999875432111 12335799999999987554 68999999999999999999999954
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-40 Score=298.35 Aligned_cols=210 Identities=30% Similarity=0.538 Sum_probs=184.2
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~ 186 (331)
.++|++.+.||+|+||.||++++ .++.||+|+++.........+.+.+|+.++++++||||+++++++......++||
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 100 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence 46899999999999999999998 5789999999765443344577999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC---CcEEEeeecceeeecCCCc
Q 020085 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN---GVVKVADFGVARVQAQSGV 263 (331)
Q Consensus 187 E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~---~~vkl~DFg~a~~~~~~~~ 263 (331)
||+++++|.+++.. ...+++..+..++.|++.||.|||++|++||||||+||+++.+ +.+||+|||+++.......
T Consensus 101 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~ 179 (287)
T 2wei_A 101 ELYTGGELFDEIIK-RKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK 179 (287)
T ss_dssp CCCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS
T ss_pred EccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCc
Confidence 99999999999865 3578999999999999999999999999999999999999764 4699999999976555444
Q ss_pred cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccc
Q 020085 264 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 264 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~ 320 (331)
.....+++.|+|||.+.+. ++.++||||||+++|+|++|+.||.+.+..+....+.
T Consensus 180 ~~~~~~~~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 235 (287)
T 2wei_A 180 MKDRIGTAYYIAPEVLRGT-YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVE 235 (287)
T ss_dssp CSCHHHHHTTCCHHHHTTC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred cccccCcccccChHHhcCC-CCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 4445688999999998764 8999999999999999999999999988877666544
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=317.56 Aligned_cols=206 Identities=14% Similarity=0.226 Sum_probs=167.3
Q ss_pred eeecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCC-CCHHHHHHHHHHHH---HHHhcCCCcceeEE-----
Q 020085 105 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPEC-VNTEMLKEFSQEVY---IMRKIRHKNVVQFI----- 173 (331)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~-~~~~~~~~~~~E~~---il~~l~h~niv~~~----- 173 (331)
|....++|++.+.||+|+||+||+|++ .++.||||+++... ......+.+.+|+. ++++++||||++++
T Consensus 68 ~~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~ 147 (377)
T 3byv_A 68 LGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIF 147 (377)
T ss_dssp SSCCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCC
T ss_pred cCCCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhh
Confidence 334467899999999999999999996 58899999997542 23345678999994 55555799999998
Q ss_pred --eEEECCC-----------------CeEEEEeccCCCCHHHHHHhcCCCCC-------HHHHHHHHHHHHHHHHHHHhC
Q 020085 174 --GACTRPP-----------------NLCIVTEFMARGSIYDFLHKQKGVFQ-------LTSLLKVAIDVSKGMNYLHQN 227 (331)
Q Consensus 174 --~~~~~~~-----------------~~~lV~E~~~ggsL~~~l~~~~~~~~-------~~~~~~i~~qi~~~l~~LH~~ 227 (331)
+++..++ ..|+||||+ +|+|.+++... +.++ +..++.++.||+.||+|||++
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~-~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 225 (377)
T 3byv_A 148 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVL-LSHSSTHKSLVHHARLQLTLQVIRLLASLHHY 225 (377)
T ss_dssp CSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHH-HHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT
T ss_pred hhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhc-cccccccccccHHHHHHHHHHHHHHHHHHHhC
Confidence 6666553 389999999 56999999764 2233 478888999999999999999
Q ss_pred CcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCccccCCCCcccccchhcCCC-----------CCCChhhHHHHHHH
Q 020085 228 NIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHK-----------PYDYKADVFSFGIA 296 (331)
Q Consensus 228 ~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~Di~SlG~i 296 (331)
||+||||||+|||++.++.+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||+
T Consensus 226 ~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~--~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~i 302 (377)
T 3byv_A 226 GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA--RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLV 302 (377)
T ss_dssp TEECSCCCGGGEEECTTCCEEECCGGGCEETTC--EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHH
T ss_pred CeecCCCCHHHEEEcCCCCEEEEechhheecCC--cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHH
Confidence 999999999999999999999999999986433 3345567 999999999877 89999999999999
Q ss_pred HHHHHcCCCCCCCCCHHHH
Q 020085 297 LWELLTGELPYAGLTPLQA 315 (331)
Q Consensus 297 l~ell~g~~Pf~~~~~~~~ 315 (331)
+|||++|+.||.+.+..+.
T Consensus 303 l~elltg~~Pf~~~~~~~~ 321 (377)
T 3byv_A 303 IYWIWCADLPITKDAALGG 321 (377)
T ss_dssp HHHHHHSSCCC------CC
T ss_pred HHHHHHCCCCCcccccccc
Confidence 9999999999987665443
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=301.23 Aligned_cols=202 Identities=31% Similarity=0.564 Sum_probs=176.8
Q ss_pred eecccCcceeeeeeecCceEEEEEEE------CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECC
Q 020085 106 EIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP 179 (331)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 179 (331)
.++.+.|++.++||+|+||+||++.+ .++.||||+++... .....+.+.+|+.++++++||||+++++++...
T Consensus 27 ~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 105 (318)
T 3lxp_A 27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADA-GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA 105 (318)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred eecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEecccc-ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC
Confidence 34555569999999999999999876 56789999998663 455677899999999999999999999999874
Q ss_pred --CCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceee
Q 020085 180 --PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV 257 (331)
Q Consensus 180 --~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~ 257 (331)
..+++||||+++|+|.+++.. ..+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||+++.
T Consensus 106 ~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~ 183 (318)
T 3lxp_A 106 GAASLQLVMEYVPLGSLRDYLPR--HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKA 183 (318)
T ss_dssp TTTEEEEEECCCTTCBHHHHGGG--SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEE
T ss_pred CCceEEEEEecccCCcHHHHHhh--CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccc
Confidence 568999999999999999965 3589999999999999999999999999999999999999999999999999987
Q ss_pred ecCCCc----cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 020085 258 QAQSGV----MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL 310 (331)
Q Consensus 258 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~ 310 (331)
...... .....+++.|+|||.+.+..++.++||||||+++|+|++|+.||...
T Consensus 184 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~ 240 (318)
T 3lxp_A 184 VPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSP 240 (318)
T ss_dssp CCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred ccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCccccc
Confidence 655432 23345788899999999988999999999999999999999999764
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-41 Score=313.15 Aligned_cols=202 Identities=11% Similarity=0.187 Sum_probs=159.4
Q ss_pred cccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhc--CCCcceeEE-------eE
Q 020085 108 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKI--RHKNVVQFI-------GA 175 (331)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l--~h~niv~~~-------~~ 175 (331)
...+|++.+.||+|+||.||+|++ .++.||||+++.... .....+.+.+|+.+++.+ +||||++++ ++
T Consensus 60 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~ 139 (371)
T 3q60_A 60 GERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDA 139 (371)
T ss_dssp CEEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEE
T ss_pred CceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehh
Confidence 355699999999999999999997 578899999987654 334556778885555554 699988755 44
Q ss_pred EECC-----------------CCeEEEEeccCCCCHHHHHHhcCCCCCHHHH------HHHHHHHHHHHHHHHhCCcccC
Q 020085 176 CTRP-----------------PNLCIVTEFMARGSIYDFLHKQKGVFQLTSL------LKVAIDVSKGMNYLHQNNIIHR 232 (331)
Q Consensus 176 ~~~~-----------------~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~------~~i~~qi~~~l~~LH~~~iiHr 232 (331)
+..+ ..+|+||||++ |+|.+++......++...+ ..++.||++||+|||++||+||
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHr 218 (371)
T 3q60_A 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHG 218 (371)
T ss_dssp EEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred eecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccC
Confidence 4432 23799999999 7999999775445555555 6788999999999999999999
Q ss_pred CCCCCCEEEcCCCcEEEeeecceeeecCCCccccCCCCcccccchhcCC--CCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 020085 233 DLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEH--KPYDYKADVFSFGIALWELLTGELPYAGL 310 (331)
Q Consensus 233 Dlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~SlG~il~ell~g~~Pf~~~ 310 (331)
||||+|||++.++.+||+|||+++..... .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.
T Consensus 219 Dikp~NIll~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 296 (371)
T 3q60_A 219 HFTPDNLFIMPDGRLMLGDVSALWKVGTR--GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV 296 (371)
T ss_dssp TCSGGGEEECTTSCEEECCGGGEEETTCE--EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBC
T ss_pred cCCHHHEEECCCCCEEEEecceeeecCCC--ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 99999999999999999999999865432 224567799999999987 78999999999999999999999999887
Q ss_pred CH
Q 020085 311 TP 312 (331)
Q Consensus 311 ~~ 312 (331)
++
T Consensus 297 ~~ 298 (371)
T 3q60_A 297 TP 298 (371)
T ss_dssp CT
T ss_pred Cc
Confidence 43
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-40 Score=297.63 Aligned_cols=200 Identities=33% Similarity=0.542 Sum_probs=175.6
Q ss_pred CcceeeeeeecCceEEEEEEECCceEEEEEecCCC--CCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEec
Q 020085 111 QLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPEC--VNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF 188 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~--~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~ 188 (331)
.|...++||+|+||.||+|.+.++.||+|++.... ......+.+.+|+.++++++||||+++++++......++||||
T Consensus 32 ~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 111 (307)
T 2nru_A 32 ISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVY 111 (307)
T ss_dssp TTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred ccccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEe
Confidence 34556899999999999999999999999997542 2334567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCc---
Q 020085 189 MARGSIYDFLHKQ--KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV--- 263 (331)
Q Consensus 189 ~~ggsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~--- 263 (331)
+++++|.+++... ...+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||+++.......
T Consensus 112 ~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~ 191 (307)
T 2nru_A 112 MPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVM 191 (307)
T ss_dssp CTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEE
T ss_pred cCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeeccccccccccccccc
Confidence 9999999999643 35689999999999999999999999999999999999999999999999999986544321
Q ss_pred cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC
Q 020085 264 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLT 311 (331)
Q Consensus 264 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~ 311 (331)
.....||+.|+|||.+.+. ++.++||||||+++|+|++|+.||....
T Consensus 192 ~~~~~g~~~y~aPE~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~ 238 (307)
T 2nru_A 192 TSRIVGTTAYMAPEALRGE-ITPKSDIYSFGVVLLEIITGLPAVDEHR 238 (307)
T ss_dssp CSSCCSCGGGCCHHHHTTE-ECTHHHHHHHHHHHHHHHHCCCSBCTTB
T ss_pred ccccCCCcCcCChHHhcCC-CCccchhHHHHHHHHHHHHCCCCcccCc
Confidence 2234689999999998764 7899999999999999999999998754
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-40 Score=304.58 Aligned_cols=211 Identities=28% Similarity=0.482 Sum_probs=181.4
Q ss_pred eeeecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCC
Q 020085 104 VWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN 181 (331)
Q Consensus 104 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 181 (331)
.|++. ++|.+.+.||+|+||.||+|.+ .++.||||+++....+....+.+.+|+.++++++||||+++++++.....
T Consensus 19 ~~~l~-~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 97 (353)
T 3coi_A 19 AWELP-KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASS 97 (353)
T ss_dssp EEEEE-TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSS
T ss_pred ccccC-ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccc
Confidence 35553 5899999999999999999998 47899999998776666677889999999999999999999999987654
Q ss_pred ------eEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecce
Q 020085 182 ------LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVA 255 (331)
Q Consensus 182 ------~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a 255 (331)
+++||||+.+ +|.+++. ..+++..+..++.||+.||+|||++|++||||||+||+++.++.+||+|||++
T Consensus 98 ~~~~~~~~lv~e~~~~-~l~~~~~---~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~ 173 (353)
T 3coi_A 98 LRNFYDFYLVMPFMQT-DLQKIMG---LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLA 173 (353)
T ss_dssp GGGCCCCEEEEECCSE-EGGGTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCT
T ss_pred cccceeEEEEeccccC-CHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccc
Confidence 4999999985 8888773 45899999999999999999999999999999999999999999999999999
Q ss_pred eeecCCCccccCCCCcccccchhcCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 256 RVQAQSGVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 256 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
+..... .....+|+.|+|||.+.+ ..++.++||||||+++|+|++|+.||.+.+..+....+.+
T Consensus 174 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~ 238 (353)
T 3coi_A 174 RHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK 238 (353)
T ss_dssp TC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHH
T ss_pred cCCCCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 754432 344578999999999876 6789999999999999999999999999887776666544
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=326.61 Aligned_cols=223 Identities=29% Similarity=0.541 Sum_probs=190.3
Q ss_pred CeeeecccCcceeeeeeecCceEEEEEEEC-----CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEE
Q 020085 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYC-----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177 (331)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 177 (331)
..+++..++|++.+.||+|+||.||+|.+. +..||+|+++... .....+.+.+|+.++++++||||+++++++.
T Consensus 383 ~~~~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~ 461 (656)
T 2j0j_A 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVIT 461 (656)
T ss_dssp GGTBCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTT-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cccccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence 457788899999999999999999999984 2469999987543 4556678999999999999999999999985
Q ss_pred CCCCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceee
Q 020085 178 RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV 257 (331)
Q Consensus 178 ~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~ 257 (331)
+ +..++||||+++|+|.+++......+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 462 ~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~ 540 (656)
T 2j0j_A 462 E-NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 540 (656)
T ss_dssp S-SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred c-CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCee
Confidence 4 568999999999999999987667899999999999999999999999999999999999999999999999999986
Q ss_pred ecCCCc--cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhccccccccccc
Q 020085 258 QAQSGV--MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIHSI 328 (331)
Q Consensus 258 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p~~ 328 (331)
...... .....+++.|+|||.+.+..++.++||||||+++|||++ |..||.+.+..+....+ ..+.++++
T Consensus 541 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i-~~~~~~~~ 613 (656)
T 2j0j_A 541 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI-ENGERLPM 613 (656)
T ss_dssp CCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHH-HHTCCCCC
T ss_pred cCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH-HcCCCCCC
Confidence 544322 223456789999999998999999999999999999997 99999999888776664 34555544
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-39 Score=301.25 Aligned_cols=208 Identities=25% Similarity=0.390 Sum_probs=178.8
Q ss_pred ccCcceeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECC-----CC
Q 020085 109 AKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP-----PN 181 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~-----~~ 181 (331)
.++|++.+.||+|+||.||+|++. ++.||||+++... .......+.+|+.++++++||||+++++++... ..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 88 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFD-KPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNE 88 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccc-cchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccce
Confidence 568999999999999999999985 7899999997543 455567789999999999999999999988654 67
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC
Q 020085 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261 (331)
Q Consensus 182 ~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~ 261 (331)
.++||||+.+ +|.+++.. +.+++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||+++.....
T Consensus 89 ~~lv~e~~~~-~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~ 165 (353)
T 2b9h_A 89 VYIIQELMQT-DLHRVIST--QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165 (353)
T ss_dssp EEEEECCCSE-EHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred EEEEEeccCc-cHHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccccc
Confidence 8999999985 99999865 56899999999999999999999999999999999999999999999999999865432
Q ss_pred Cc-----------cccCCCCcccccchhcC-CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccc
Q 020085 262 GV-----------MTAETGTYRWMAPEVIE-HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 262 ~~-----------~~~~~gt~~y~aPE~~~-~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~ 320 (331)
.. .....||+.|+|||++. +..++.++||||||+++|+|++|+.||.+.+..+....+.
T Consensus 166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 236 (353)
T 2b9h_A 166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIF 236 (353)
T ss_dssp --------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred cccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Confidence 11 12346899999999875 4778999999999999999999999999988766555443
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=301.89 Aligned_cols=203 Identities=31% Similarity=0.584 Sum_probs=178.9
Q ss_pred eeecccCcceeeeeeecCceEEEEEEE------CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEEC
Q 020085 105 WEIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR 178 (331)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 178 (331)
..+..++|++.+.||+|+||.||++++ .++.||+|+++.. +....+.+.+|+.++++++||||+++++++..
T Consensus 36 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~ 113 (326)
T 2w1i_A 36 TQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS--TEEHLRDFEREIEILKSLQHDNIVKYKGVCYS 113 (326)
T ss_dssp -CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC--CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC
T ss_pred cccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEe
Confidence 456678999999999999999999985 5688999999864 34556789999999999999999999999866
Q ss_pred CC--CeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeeccee
Q 020085 179 PP--NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR 256 (331)
Q Consensus 179 ~~--~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~ 256 (331)
.. ..++||||+++++|.+++......+++..++.++.|+++||+|||++|++||||||+||+++.++.+||+|||+++
T Consensus 114 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~ 193 (326)
T 2w1i_A 114 AGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTK 193 (326)
T ss_dssp ----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCE
T ss_pred cCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchh
Confidence 44 7899999999999999998877789999999999999999999999999999999999999999999999999998
Q ss_pred eecCCCc----cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCC
Q 020085 257 VQAQSGV----MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAG 309 (331)
Q Consensus 257 ~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~ 309 (331)
....... .....++..|+|||.+.+..++.++||||||+++|||++|..||..
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~ 250 (326)
T 2w1i_A 194 VLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKS 250 (326)
T ss_dssp ECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGS
T ss_pred hccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCC
Confidence 7654432 1234567889999999988899999999999999999999999874
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-39 Score=297.46 Aligned_cols=206 Identities=26% Similarity=0.407 Sum_probs=181.3
Q ss_pred ecccCcceeeeeeecCceEEEEEEE---CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCc------ceeEEeEEE
Q 020085 107 IDAKQLKIECKVASGSYGDLYKGTY---CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN------VVQFIGACT 177 (331)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~n------iv~~~~~~~ 177 (331)
+-.++|++.+.||+|+||.||++.+ .++.||+|+++.. ....+.+.+|+.+++.++|++ ++++++++.
T Consensus 11 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~ 87 (339)
T 1z57_A 11 VLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV---DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE 87 (339)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEE
T ss_pred CccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC---CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccc
Confidence 3467999999999999999999987 4688999999753 445677899999999997654 999999999
Q ss_pred CCCCeEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC-------------
Q 020085 178 RPPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE------------- 243 (331)
Q Consensus 178 ~~~~~~lV~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~------------- 243 (331)
..+..++||||+ +++|.+++.... ..+++..+..++.|++.||+|||++||+||||||+|||++.
T Consensus 88 ~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 88 HHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp ETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred cCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccc
Confidence 999999999999 789999997654 36899999999999999999999999999999999999987
Q ss_pred ------CCcEEEeeecceeeecCCCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHh
Q 020085 244 ------NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAV 317 (331)
Q Consensus 244 ------~~~vkl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~ 317 (331)
++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||...+..+...
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 244 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLA 244 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHH
T ss_pred ccccccCCCceEeeCcccccCccc--cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 668999999999865432 345578999999999999999999999999999999999999999987766554
Q ss_pred c
Q 020085 318 G 318 (331)
Q Consensus 318 ~ 318 (331)
.
T Consensus 245 ~ 245 (339)
T 1z57_A 245 M 245 (339)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-40 Score=294.16 Aligned_cols=201 Identities=26% Similarity=0.479 Sum_probs=177.4
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEe
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E 187 (331)
++|++.+.||+|+||.||+|.+ .++.||+|+++.... ....+.+.+|+.++++++||||+++++++..+...++|||
T Consensus 7 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC-TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc-hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 5799999999999999999998 478999999975432 2345778999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC---cc
Q 020085 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG---VM 264 (331)
Q Consensus 188 ~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~---~~ 264 (331)
|+++++|.+++.. ...+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||.+....... ..
T Consensus 86 ~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 164 (276)
T 2yex_A 86 YCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 164 (276)
T ss_dssp CCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred ecCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcc
Confidence 9999999999854 4678999999999999999999999999999999999999999999999999997654322 23
Q ss_pred ccCCCCcccccchhcCCCCC-CChhhHHHHHHHHHHHHcCCCCCCCCCH
Q 020085 265 TAETGTYRWMAPEVIEHKPY-DYKADVFSFGIALWELLTGELPYAGLTP 312 (331)
Q Consensus 265 ~~~~gt~~y~aPE~~~~~~~-~~~~Di~SlG~il~ell~g~~Pf~~~~~ 312 (331)
....|++.|+|||.+.+..+ +.++|+||||+++|+|++|+.||.....
T Consensus 165 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 213 (276)
T 2yex_A 165 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213 (276)
T ss_dssp CCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCT
T ss_pred cCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch
Confidence 44578999999999987765 7899999999999999999999987543
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-40 Score=295.30 Aligned_cols=195 Identities=27% Similarity=0.467 Sum_probs=175.5
Q ss_pred ccCcceeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEEC--------
Q 020085 109 AKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR-------- 178 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~-------- 178 (331)
..+|++.+.||+|+||.||++.+. ++.||+|+++... +.+.+|+.++++++||||+++++++..
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 83 (284)
T 2a19_B 10 GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83 (284)
T ss_dssp HHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred ccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence 467999999999999999999984 7899999998653 357789999999999999999998854
Q ss_pred --------CCCeEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEE
Q 020085 179 --------PPNLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKV 249 (331)
Q Consensus 179 --------~~~~~lV~E~~~ggsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl 249 (331)
...+++||||+++++|.+++... ...+++..++.++.|++.||.|||++|++||||||+||+++.++.+||
T Consensus 84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl 163 (284)
T 2a19_B 84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKI 163 (284)
T ss_dssp -----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEE
T ss_pred cccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEE
Confidence 34589999999999999999764 367999999999999999999999999999999999999999999999
Q ss_pred eeecceeeecCCCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCC
Q 020085 250 ADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAG 309 (331)
Q Consensus 250 ~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~ 309 (331)
+|||+++............+++.|+|||.+.+..++.++||||||+++|+|++|..||..
T Consensus 164 ~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~ 223 (284)
T 2a19_B 164 GDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE 223 (284)
T ss_dssp CCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH
T ss_pred CcchhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh
Confidence 999999877665555667799999999999999999999999999999999999988753
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-39 Score=293.20 Aligned_cols=197 Identities=28% Similarity=0.421 Sum_probs=173.1
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEE-ECCCCeEEE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC-TRPPNLCIV 185 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~-~~~~~~~lV 185 (331)
.++|++.+.||+|+||.||+|++ .++.||+|++...... ..+.+|+.++++++|++++..+..+ ......++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEE
Confidence 46899999999999999999996 6789999998765433 3588999999999998876666655 566678999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEE---cCCCcEEEeeecceeeecCCC
Q 020085 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM---DENGVVKVADFGVARVQAQSG 262 (331)
Q Consensus 186 ~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi---~~~~~vkl~DFg~a~~~~~~~ 262 (331)
|||+ +++|.+++......+++..+..++.|++.||+|||++|++||||||+||++ +.++.+||+|||+++......
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~ 162 (296)
T 3uzp_A 84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccc
Confidence 9999 889999998767789999999999999999999999999999999999999 488999999999998665432
Q ss_pred c--------cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 020085 263 V--------MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL 310 (331)
Q Consensus 263 ~--------~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~ 310 (331)
. .....||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 218 (296)
T 3uzp_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL 218 (296)
T ss_dssp TCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred cccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCc
Confidence 2 23457899999999999999999999999999999999999999874
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-40 Score=300.02 Aligned_cols=200 Identities=29% Similarity=0.469 Sum_probs=169.3
Q ss_pred ccCccee-eeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCcceeEEeEEECCCCeEE
Q 020085 109 AKQLKIE-CKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCI 184 (331)
Q Consensus 109 ~~~~~~~-~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~l 184 (331)
.+.|.+. +.||+|+||+||++++ .++.||||+++.... ...+.+.+|+.+++++ +||||+++++++..++..++
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~l 88 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG--HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYL 88 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS--CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc--hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEE
Confidence 4578885 7899999999999987 578999999976532 2346788999999985 79999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCc---EEEeeecceeeecCC
Q 020085 185 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV---VKVADFGVARVQAQS 261 (331)
Q Consensus 185 V~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~---vkl~DFg~a~~~~~~ 261 (331)
||||+++++|.+++.. ...+++..+..++.|++.||+|||++||+||||||+||+++.++. +||+|||+++.....
T Consensus 89 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~ 167 (316)
T 2ac3_A 89 VFEKMRGGSILSHIHK-RRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167 (316)
T ss_dssp EEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred EEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence 9999999999999976 467899999999999999999999999999999999999998776 999999998754322
Q ss_pred C--------ccccCCCCcccccchhcCC-----CCCCChhhHHHHHHHHHHHHcCCCCCCCCC
Q 020085 262 G--------VMTAETGTYRWMAPEVIEH-----KPYDYKADVFSFGIALWELLTGELPYAGLT 311 (331)
Q Consensus 262 ~--------~~~~~~gt~~y~aPE~~~~-----~~~~~~~Di~SlG~il~ell~g~~Pf~~~~ 311 (331)
. ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+..
T Consensus 168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 230 (316)
T 2ac3_A 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRC 230 (316)
T ss_dssp --------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred CccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccc
Confidence 1 1223459999999999865 568899999999999999999999998754
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-39 Score=294.71 Aligned_cols=198 Identities=28% Similarity=0.414 Sum_probs=170.1
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEE-ECCCCeEEE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC-TRPPNLCIV 185 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~-~~~~~~~lV 185 (331)
.++|++.+.||+|+||.||+|++ .++.||||++..... ...+.+|+.+++.++|++++..+..+ ......++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv 83 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 83 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc----chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence 46899999999999999999996 678999999765432 23578899999999988877766655 566778999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEE---cCCCcEEEeeecceeeecCCC
Q 020085 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM---DENGVVKVADFGVARVQAQSG 262 (331)
Q Consensus 186 ~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi---~~~~~vkl~DFg~a~~~~~~~ 262 (331)
|||+ +++|.+++......+++..+..++.|++.||.|||++|++||||||+|||+ +.++.+||+|||+++......
T Consensus 84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~ 162 (296)
T 4hgt_A 84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR 162 (296)
T ss_dssp EECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcc
Confidence 9999 889999998767789999999999999999999999999999999999999 789999999999998665432
Q ss_pred c--------cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC
Q 020085 263 V--------MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLT 311 (331)
Q Consensus 263 ~--------~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~ 311 (331)
. .....||+.|+|||.+.+..++.++||||||+++|+|++|+.||.+.+
T Consensus 163 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 219 (296)
T 4hgt_A 163 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLK 219 (296)
T ss_dssp TCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred cCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccc
Confidence 2 224578999999999999999999999999999999999999998753
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-39 Score=300.12 Aligned_cols=215 Identities=28% Similarity=0.556 Sum_probs=180.8
Q ss_pred cccCcceeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHh--cCCCcceeEEeEEECCC----C
Q 020085 108 DAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRK--IRHKNVVQFIGACTRPP----N 181 (331)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~--l~h~niv~~~~~~~~~~----~ 181 (331)
-.++|.+.+.||+|+||.||+|++.++.||||+++.. ....+.+|.++++. ++||||+++++++.... .
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~-----~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~ 114 (342)
T 1b6c_B 40 IARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR-----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQ 114 (342)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGG-----GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCC
T ss_pred ccccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCch-----hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccce
Confidence 3578999999999999999999999999999999743 23567889999987 78999999999998876 7
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH--------hCCcccCCCCCCCEEEcCCCcEEEeeec
Q 020085 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH--------QNNIIHRDLKTANLLMDENGVVKVADFG 253 (331)
Q Consensus 182 ~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH--------~~~iiHrDlkp~NiLi~~~~~vkl~DFg 253 (331)
.++||||+++|+|.+++.+ ..+++..++.++.|++.||.||| ++|++||||||+||+++.++.+||+|||
T Consensus 115 ~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg 192 (342)
T 1b6c_B 115 LWLVSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 192 (342)
T ss_dssp EEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCT
T ss_pred eEEEEeecCCCcHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECC
Confidence 9999999999999999965 46899999999999999999999 8999999999999999999999999999
Q ss_pred ceeeecCCCc-----cccCCCCcccccchhcCCCC------CCChhhHHHHHHHHHHHHcC----------CCCCCCCC-
Q 020085 254 VARVQAQSGV-----MTAETGTYRWMAPEVIEHKP------YDYKADVFSFGIALWELLTG----------ELPYAGLT- 311 (331)
Q Consensus 254 ~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~------~~~~~Di~SlG~il~ell~g----------~~Pf~~~~- 311 (331)
+++....... .....||+.|+|||.+.+.. ++.++||||||+++|||++| +.||....
T Consensus 193 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~ 272 (342)
T 1b6c_B 193 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 272 (342)
T ss_dssp TCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred CceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCc
Confidence 9987655432 23457899999999997653 33689999999999999999 88997652
Q ss_pred ----HHHHHhcccccccccccc
Q 020085 312 ----PLQAAVGVVQKVSIHSII 329 (331)
Q Consensus 312 ----~~~~~~~~~~~~~~p~~~ 329 (331)
.......+..+..+|.++
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~ 294 (342)
T 1b6c_B 273 SDPSVEEMRKVVCEQKLRPNIP 294 (342)
T ss_dssp SSCCHHHHHHHHTTSCCCCCCC
T ss_pred CcccHHHHHHHHHHHHhCCCCc
Confidence 233333344455555543
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-39 Score=305.29 Aligned_cols=198 Identities=25% Similarity=0.396 Sum_probs=173.5
Q ss_pred cccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC--------CCcceeEEeEEE
Q 020085 108 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR--------HKNVVQFIGACT 177 (331)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~--------h~niv~~~~~~~ 177 (331)
-.++|++.++||+|+||+||+|++ .++.||||+++.. ....+.+.+|+.++++++ ||||+++++++.
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~ 111 (397)
T 1wak_A 35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA---EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK 111 (397)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC---CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence 367899999999999999999987 4788999999753 455678899999999995 788999999987
Q ss_pred ----CCCCeEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCCEEEcCCC------
Q 020085 178 ----RPPNLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDENG------ 245 (331)
Q Consensus 178 ----~~~~~~lV~E~~~ggsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~-~iiHrDlkp~NiLi~~~~------ 245 (331)
....+|+||||+ +++|.+.+... ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++
T Consensus 112 ~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~ 190 (397)
T 1wak_A 112 ISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRL 190 (397)
T ss_dssp EEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHH
T ss_pred ecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhh
Confidence 566799999999 55776666554 36799999999999999999999998 999999999999999776
Q ss_pred -------------------------------------------cEEEeeecceeeecCCCccccCCCCcccccchhcCCC
Q 020085 246 -------------------------------------------VVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHK 282 (331)
Q Consensus 246 -------------------------------------------~vkl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~ 282 (331)
.+||+|||+++..... .....||+.|+|||++.+.
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~~ 268 (397)
T 1wak_A 191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIGS 268 (397)
T ss_dssp HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHHTS
T ss_pred hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhhcCC
Confidence 7999999999876543 3456799999999999999
Q ss_pred CCCChhhHHHHHHHHHHHHcCCCCCCCCC
Q 020085 283 PYDYKADVFSFGIALWELLTGELPYAGLT 311 (331)
Q Consensus 283 ~~~~~~Di~SlG~il~ell~g~~Pf~~~~ 311 (331)
.++.++|||||||++|||++|+.||...+
T Consensus 269 ~~~~~~DiwslG~il~elltg~~pf~~~~ 297 (397)
T 1wak_A 269 GYNTPADIWSTACMAFELATGDYLFEPHS 297 (397)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred CCCcHHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 99999999999999999999999998654
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-39 Score=302.74 Aligned_cols=215 Identities=22% Similarity=0.303 Sum_probs=172.0
Q ss_pred eecccCcceeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCC--
Q 020085 106 EIDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN-- 181 (331)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~-- 181 (331)
....++|++.+.||+|+||.||+|++. ++.||||++...... ...+.+++..++.++||||+++++++.....
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~---~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 19 RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF---RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTC---CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred hhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccc---cHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence 445678999999999999999999984 789999998654322 2356678888899999999999999865333
Q ss_pred -----eEEEEeccCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCCCCEEEcC-CCcEEEe
Q 020085 182 -----LCIVTEFMARGSIYDFLHK---QKGVFQLTSLLKVAIDVSKGMNYLH--QNNIIHRDLKTANLLMDE-NGVVKVA 250 (331)
Q Consensus 182 -----~~lV~E~~~ggsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~LH--~~~iiHrDlkp~NiLi~~-~~~vkl~ 250 (331)
+++||||+++ +|.+.+.. ....+++..+..++.|++.||.||| ++||+||||||+|||++. ++.+||+
T Consensus 96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~ 174 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLC 174 (360)
T ss_dssp TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEEC
T ss_pred ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEe
Confidence 8899999987 55554432 4567899999999999999999999 999999999999999997 8999999
Q ss_pred eecceeeecCCCccccCCCCcccccchhcCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccccc
Q 020085 251 DFGVARVQAQSGVMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVS 324 (331)
Q Consensus 251 DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~ 324 (331)
|||+++............||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+++...
T Consensus 175 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~ 249 (360)
T 3e3p_A 175 DFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLG 249 (360)
T ss_dssp CCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred eCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcC
Confidence 99999877666556667899999999998654 489999999999999999999999999988888777665433
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-40 Score=306.59 Aligned_cols=201 Identities=19% Similarity=0.295 Sum_probs=174.5
Q ss_pred CeeeecccCcceeeeeeecCceEEEEEEEC----------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCccee-
Q 020085 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYC----------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQ- 171 (331)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~----------~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~- 171 (331)
.......++|.+.+.||+|+||.||+|++. ++.||+|+++.. +.+.+|+.++++++||||++
T Consensus 35 ~i~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-------~~~~~E~~~l~~l~h~niv~~ 107 (352)
T 2jii_A 35 VLTDKSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-------GRLFNEQNFFQRAAKPLQVNK 107 (352)
T ss_dssp EEECTTSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-------STHHHHHHHHHHHCCHHHHHH
T ss_pred eeecccCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-------chHHHHHHHHHHhcccchhhh
Confidence 334455789999999999999999999884 678999999754 36889999999999999988
Q ss_pred --------------EEeEEEC-CCCeEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Q 020085 172 --------------FIGACTR-PPNLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLK 235 (331)
Q Consensus 172 --------------~~~~~~~-~~~~~lV~E~~~ggsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlk 235 (331)
+++++.. +...++||||+ +++|.+++... ...+++..++.++.||+.||.|||++||+|||||
T Consensus 108 ~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dik 186 (352)
T 2jii_A 108 WKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVT 186 (352)
T ss_dssp HHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCC
T ss_pred hhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCC
Confidence 5677765 67789999999 88999999764 3679999999999999999999999999999999
Q ss_pred CCCEEEcCCC--cEEEeeecceeeecCCC--------ccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCC
Q 020085 236 TANLLMDENG--VVKVADFGVARVQAQSG--------VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGEL 305 (331)
Q Consensus 236 p~NiLi~~~~--~vkl~DFg~a~~~~~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~ 305 (331)
|+|||++.++ .+||+|||+++...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.
T Consensus 187 p~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~ 266 (352)
T 2jii_A 187 AENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFL 266 (352)
T ss_dssp GGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCC
T ss_pred HHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 9999999998 89999999997654322 1233478999999999999999999999999999999999999
Q ss_pred CCCCCC
Q 020085 306 PYAGLT 311 (331)
Q Consensus 306 Pf~~~~ 311 (331)
||....
T Consensus 267 pf~~~~ 272 (352)
T 2jii_A 267 PWTNCL 272 (352)
T ss_dssp TTGGGT
T ss_pred CcccCC
Confidence 998764
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-40 Score=303.75 Aligned_cols=196 Identities=30% Similarity=0.523 Sum_probs=162.8
Q ss_pred eeecccCcceeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHH--HHhcCCCcceeEEeEEEC----
Q 020085 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYI--MRKIRHKNVVQFIGACTR---- 178 (331)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~i--l~~l~h~niv~~~~~~~~---- 178 (331)
+.++.++|++.+.||+|+||.||+|++.++.||||+++... ...+..|..+ ++.++||||+++++.+..
T Consensus 8 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~ 82 (336)
T 3g2f_A 8 PSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN-----RQNFINEKNIYRVPLMEHDNIARFIVGDERVTAD 82 (336)
T ss_dssp -CCCTTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTT
T ss_pred CCcChHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccc-----hhhHHHHHHHHHHHhccCcchhhheecccccccC
Confidence 45778899999999999999999999999999999997542 2334445444 445899999999986532
Q ss_pred -CCCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---------CcccCCCCCCCEEEcCCCcEE
Q 020085 179 -PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN---------NIIHRDLKTANLLMDENGVVK 248 (331)
Q Consensus 179 -~~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---------~iiHrDlkp~NiLi~~~~~vk 248 (331)
...+++||||+++|+|.+++... ..++..+..++.|+++||+|||+. ||+||||||+|||++.++.+|
T Consensus 83 ~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~k 160 (336)
T 3g2f_A 83 GRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCV 160 (336)
T ss_dssp SCEEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEE
T ss_pred CCceEEEEEecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEE
Confidence 23578999999999999999653 458889999999999999999999 999999999999999999999
Q ss_pred EeeecceeeecCCC---------ccccCCCCcccccchhcCC-------CCCCChhhHHHHHHHHHHHHcCCCCC
Q 020085 249 VADFGVARVQAQSG---------VMTAETGTYRWMAPEVIEH-------KPYDYKADVFSFGIALWELLTGELPY 307 (331)
Q Consensus 249 l~DFg~a~~~~~~~---------~~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~SlG~il~ell~g~~Pf 307 (331)
|+|||+++...... ......||+.|+|||++.+ ..++.++|||||||++|||++|..||
T Consensus 161 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~ 235 (336)
T 3g2f_A 161 ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDL 235 (336)
T ss_dssp ECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGG
T ss_pred EeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcC
Confidence 99999998654321 1224469999999999976 45667899999999999999996654
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-39 Score=294.14 Aligned_cols=219 Identities=21% Similarity=0.370 Sum_probs=181.7
Q ss_pred CeeeecccCcceeeeeeecCceEEEEEEE-CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC--CCcceeEEeEEECC
Q 020085 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR--HKNVVQFIGACTRP 179 (331)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~--h~niv~~~~~~~~~ 179 (331)
+...+..++|++.+.||+|+||.||++.+ .++.||+|+++....+....+.+.+|+.++++++ ||||+++++++...
T Consensus 21 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~ 100 (313)
T 3cek_A 21 QSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD 100 (313)
T ss_dssp CEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS
T ss_pred eeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC
Confidence 45778889999999999999999999988 4688999999877667777888999999999997 49999999999999
Q ss_pred CCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeec
Q 020085 180 PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA 259 (331)
Q Consensus 180 ~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~ 259 (331)
...++||| +.+++|.+++.. ...+++..+..++.|+++||.|||++|++||||||+||+++ ++.+||+|||+++...
T Consensus 101 ~~~~lv~e-~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~ 177 (313)
T 3cek_A 101 QYIYMVME-CGNIDLNSWLKK-KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQ 177 (313)
T ss_dssp SEEEEEEC-CCSEEHHHHHHH-CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC--
T ss_pred CEEEEEEe-cCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeecccccccc
Confidence 99999999 567799999976 46789999999999999999999999999999999999996 5899999999997654
Q ss_pred CCC---ccccCCCCcccccchhcCC-----------CCCCChhhHHHHHHHHHHHHcCCCCCCCC-CHHHHHhccccccc
Q 020085 260 QSG---VMTAETGTYRWMAPEVIEH-----------KPYDYKADVFSFGIALWELLTGELPYAGL-TPLQAAVGVVQKVS 324 (331)
Q Consensus 260 ~~~---~~~~~~gt~~y~aPE~~~~-----------~~~~~~~Di~SlG~il~ell~g~~Pf~~~-~~~~~~~~~~~~~~ 324 (331)
... ......|++.|+|||.+.+ ..++.++||||||+++|+|++|+.||... ........+.....
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 257 (313)
T 3cek_A 178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNH 257 (313)
T ss_dssp ------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTS
T ss_pred CccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhccc
Confidence 322 1234568999999999875 47889999999999999999999999875 33344444333333
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-39 Score=296.73 Aligned_cols=196 Identities=34% Similarity=0.615 Sum_probs=167.0
Q ss_pred cccCcceeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc--CCCcceeEEeEEECC----CC
Q 020085 108 DAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI--RHKNVVQFIGACTRP----PN 181 (331)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l--~h~niv~~~~~~~~~----~~ 181 (331)
-.++|++.+.||+|+||.||+|++.++.||||++.... ...+..|.+++... +||||+++++++... ..
T Consensus 35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 109 (337)
T 3mdy_A 35 IAKQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTTE-----EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQ 109 (337)
T ss_dssp HHHHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGGG-----HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCE
T ss_pred cccceEEEeEeecCCCeEEEEEEECCceEEEEEEeccc-----cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCc
Confidence 35689999999999999999999999999999986432 23455566666554 899999999999876 67
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC--------CcccCCCCCCCEEEcCCCcEEEeeec
Q 020085 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN--------NIIHRDLKTANLLMDENGVVKVADFG 253 (331)
Q Consensus 182 ~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~--------~iiHrDlkp~NiLi~~~~~vkl~DFg 253 (331)
.++||||+++|+|.+++.. ..+++..++.++.|++.||+|||++ ||+||||||+|||++.++.+||+|||
T Consensus 110 ~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg 187 (337)
T 3mdy_A 110 LYLITDYHENGSLYDYLKS--TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLG 187 (337)
T ss_dssp EEEEECCCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCT
T ss_pred eEEEEeccCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCC
Confidence 9999999999999999965 4689999999999999999999998 99999999999999999999999999
Q ss_pred ceeeecCCCcc-----ccCCCCcccccchhcCCCCCCCh------hhHHHHHHHHHHHHcC----------CCCCCCC
Q 020085 254 VARVQAQSGVM-----TAETGTYRWMAPEVIEHKPYDYK------ADVFSFGIALWELLTG----------ELPYAGL 310 (331)
Q Consensus 254 ~a~~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~------~Di~SlG~il~ell~g----------~~Pf~~~ 310 (331)
+++........ ....||+.|+|||++.+..+..+ +|||||||++|||++| +.||...
T Consensus 188 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~ 265 (337)
T 3mdy_A 188 LAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL 265 (337)
T ss_dssp TCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred CceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence 99765443221 24579999999999988776665 9999999999999999 7788654
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=292.87 Aligned_cols=206 Identities=29% Similarity=0.524 Sum_probs=176.0
Q ss_pred eeeecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCC
Q 020085 104 VWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN 181 (331)
Q Consensus 104 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 181 (331)
.+.+..++|.....||+|+||.||+|.+ .++.||+|+++... ....+.+.+|+.+++.++||||+++++++.....
T Consensus 16 ~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~ 93 (295)
T 2clq_A 16 EYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD--SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGF 93 (295)
T ss_dssp CEEECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC--C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTE
T ss_pred cccccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc--hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCc
Confidence 3556667777778999999999999998 56789999997653 3345779999999999999999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcCC--CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC-CCcEEEeeecceeee
Q 020085 182 LCIVTEFMARGSIYDFLHKQKG--VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE-NGVVKVADFGVARVQ 258 (331)
Q Consensus 182 ~~lV~E~~~ggsL~~~l~~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~-~~~vkl~DFg~a~~~ 258 (331)
.++||||+++++|.+++....+ .+++..+..++.|++.||+|||++|++||||||+||+++. ++.+||+|||+++..
T Consensus 94 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~ 173 (295)
T 2clq_A 94 IKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRL 173 (295)
T ss_dssp EEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEES
T ss_pred EEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeeccccccc
Confidence 9999999999999999976533 4668899999999999999999999999999999999987 899999999999865
Q ss_pred cCCC-ccccCCCCcccccchhcCCCC--CCChhhHHHHHHHHHHHHcCCCCCCCCC
Q 020085 259 AQSG-VMTAETGTYRWMAPEVIEHKP--YDYKADVFSFGIALWELLTGELPYAGLT 311 (331)
Q Consensus 259 ~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~SlG~il~ell~g~~Pf~~~~ 311 (331)
.... ......|++.|+|||.+.+.. ++.++||||||+++|+|++|+.||....
T Consensus 174 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 229 (295)
T 2clq_A 174 AGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELG 229 (295)
T ss_dssp CC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGS
T ss_pred CCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCC
Confidence 4322 233457899999999997643 8899999999999999999999997653
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=307.49 Aligned_cols=211 Identities=25% Similarity=0.448 Sum_probs=183.5
Q ss_pred ecccCcceeeeeeecCceEEEEEEECCceEEEEEecCCCCCH---------------HHHHHHHHHHHHHHhcCCCccee
Q 020085 107 IDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNT---------------EMLKEFSQEVYIMRKIRHKNVVQ 171 (331)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~---------------~~~~~~~~E~~il~~l~h~niv~ 171 (331)
+..++|.+.+.||+|+||.||+|.+.++.||+|+++...... ...+.+.+|+.++++++||||++
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~ 107 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT 107 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred cccCceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence 446799999999999999999999999999999987432111 11267999999999999999999
Q ss_pred EEeEEECCCCeEEEEeccCCCCHHHH------HHhc-CCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEEcC
Q 020085 172 FIGACTRPPNLCIVTEFMARGSIYDF------LHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDE 243 (331)
Q Consensus 172 ~~~~~~~~~~~~lV~E~~~ggsL~~~------l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~-~~iiHrDlkp~NiLi~~ 243 (331)
+++++...+..++||||+++++|.++ +... ...+++..+..++.|++.||.|||+ +|++||||||+||+++.
T Consensus 108 ~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~~~ 187 (348)
T 2pml_X 108 CEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDK 187 (348)
T ss_dssp CSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEECT
T ss_pred EEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEEcC
Confidence 99999999999999999999999998 5442 4679999999999999999999999 99999999999999999
Q ss_pred CCcEEEeeecceeeecCCCccccCCCCcccccchhcCCC-CCCC-hhhHHHHHHHHHHHHcCCCCCCCCCH-HHHHhc
Q 020085 244 NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHK-PYDY-KADVFSFGIALWELLTGELPYAGLTP-LQAAVG 318 (331)
Q Consensus 244 ~~~vkl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~Di~SlG~il~ell~g~~Pf~~~~~-~~~~~~ 318 (331)
++.++|+|||.++..... ......+++.|+|||.+.+. .++. ++||||||+++|+|++|+.||...+. .+....
T Consensus 188 ~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 264 (348)
T 2pml_X 188 NGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNN 264 (348)
T ss_dssp TSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHH
T ss_pred CCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Confidence 999999999999876443 34556799999999999877 6666 99999999999999999999998766 444333
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-39 Score=294.33 Aligned_cols=207 Identities=25% Similarity=0.433 Sum_probs=172.9
Q ss_pred ccCcceeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEE---------
Q 020085 109 AKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT--------- 177 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~--------- 177 (331)
.++|++.+.||+|+||.||+|.+. ++.||+|+++.. +....+.+.+|+.++++++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 87 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT--DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDD 87 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC-
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC--ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccc
Confidence 568999999999999999999985 789999998754 4566788999999999999999999999874
Q ss_pred -----CCCCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEc-CCCcEEEee
Q 020085 178 -----RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD-ENGVVKVAD 251 (331)
Q Consensus 178 -----~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~-~~~~vkl~D 251 (331)
.....++||||+++ +|.+++. .+.+++..+..++.|++.||+|||++|++||||||+||+++ +++.+||+|
T Consensus 88 ~~~~~~~~~~~lv~e~~~~-~L~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~D 164 (320)
T 2i6l_A 88 VGSLTELNSVYIVQEYMET-DLANVLE--QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGD 164 (320)
T ss_dssp ---CCSCSEEEEEEECCSE-EHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECC
T ss_pred cccccccCceeEEeeccCC-CHHHHhh--cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEcc
Confidence 34578999999985 9999985 36789999999999999999999999999999999999997 567999999
Q ss_pred ecceeeecCC----CccccCCCCcccccchhcCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccc
Q 020085 252 FGVARVQAQS----GVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 252 Fg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~ 320 (331)
||+++..... .......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||.+.+..+....+.
T Consensus 165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~ 238 (320)
T 2i6l_A 165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLIL 238 (320)
T ss_dssp CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999765332 12234457899999998865 678999999999999999999999999988877666544
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-39 Score=302.26 Aligned_cols=210 Identities=26% Similarity=0.432 Sum_probs=183.4
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CC-----cceeEEeEEECCC
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HK-----NVVQFIGACTRPP 180 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~-h~-----niv~~~~~~~~~~ 180 (331)
.++|++.+.||+|+||+||+|.+ .++.||||+++.. ......+..|+.+++.++ |+ +|+++++++....
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~ 129 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK---KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRN 129 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS---HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETT
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc---HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCC
Confidence 57899999999999999999988 4688999999853 445677888999998885 44 4999999999999
Q ss_pred CeEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHH--hCCcccCCCCCCCEEEc--CCCcEEEeeecce
Q 020085 181 NLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLH--QNNIIHRDLKTANLLMD--ENGVVKVADFGVA 255 (331)
Q Consensus 181 ~~~lV~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH--~~~iiHrDlkp~NiLi~--~~~~vkl~DFg~a 255 (331)
..|+||||+.+ +|.+++.... ..+++..+..++.|++.||.||| +.||+||||||+|||++ .++.+||+|||++
T Consensus 130 ~~~lv~e~~~~-~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a 208 (382)
T 2vx3_A 130 HLCLVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208 (382)
T ss_dssp EEEEEEECCCC-BHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred ceEEEEecCCC-CHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCc
Confidence 99999999975 9999997754 56899999999999999999999 57999999999999995 4778999999999
Q ss_pred eeecCCCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccccc
Q 020085 256 RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVS 324 (331)
Q Consensus 256 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~ 324 (331)
+..... .....||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+++...
T Consensus 209 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~ 275 (382)
T 2vx3_A 209 CQLGQR--IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLG 275 (382)
T ss_dssp EETTCC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred eecccc--cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence 876432 3456799999999999999999999999999999999999999999988887777665433
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-39 Score=305.87 Aligned_cols=198 Identities=25% Similarity=0.460 Sum_probs=156.3
Q ss_pred cCcce-eeeeeecCceEEEEEEEC----CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEE--CCCCe
Q 020085 110 KQLKI-ECKVASGSYGDLYKGTYC----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT--RPPNL 182 (331)
Q Consensus 110 ~~~~~-~~~lg~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~--~~~~~ 182 (331)
+.|.+ .++||+|+||+||+|++. ++.||||+++..... ..+.+|+.++++++||||+++++++. .....
T Consensus 20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 95 (405)
T 3rgf_A 20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS----MSACREIALLRELKHPNVISLQKVFLSHADRKV 95 (405)
T ss_dssp HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEE
T ss_pred hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeE
Confidence 34665 558999999999999964 578999999865433 35788999999999999999999994 46679
Q ss_pred EEEEeccCCCCHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEE----cCCCcEEEe
Q 020085 183 CIVTEFMARGSIYDFLHKQ--------KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM----DENGVVKVA 250 (331)
Q Consensus 183 ~lV~E~~~ggsL~~~l~~~--------~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi----~~~~~vkl~ 250 (331)
++||||+.+ +|.+++... ...+++..+..++.||+.||+|||++||+||||||+|||+ +.++.+||+
T Consensus 96 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~ 174 (405)
T 3rgf_A 96 WLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA 174 (405)
T ss_dssp EEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEEC
T ss_pred EEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEE
Confidence 999999976 888887532 1248999999999999999999999999999999999999 678899999
Q ss_pred eecceeeecCC----CccccCCCCcccccchhcCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCH
Q 020085 251 DFGVARVQAQS----GVMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTP 312 (331)
Q Consensus 251 DFg~a~~~~~~----~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~ell~g~~Pf~~~~~ 312 (331)
|||+++..... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||.+...
T Consensus 175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 241 (405)
T 3rgf_A 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 241 (405)
T ss_dssp CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccc
Confidence 99999865432 223445789999999999874 589999999999999999999999976543
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=294.16 Aligned_cols=206 Identities=23% Similarity=0.407 Sum_probs=179.3
Q ss_pred cccCcceeeeeeecCceEEEEEEEC--C-ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCc------ceeEEeEEEC
Q 020085 108 DAKQLKIECKVASGSYGDLYKGTYC--S-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN------VVQFIGACTR 178 (331)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~~--~-~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~n------iv~~~~~~~~ 178 (331)
-.++|++.+.||+|+||.||++.+. + +.||+|+++.. ....+.+.+|+.++++++|++ ++.+++++..
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~ 93 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV---GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF 93 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc---ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence 3679999999999999999999983 3 68999999753 445677889999999998766 8999999999
Q ss_pred CCCeEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEE----------------
Q 020085 179 PPNLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM---------------- 241 (331)
Q Consensus 179 ~~~~~lV~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi---------------- 241 (331)
....++||||+ +++|.+++.... ..+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 94 ~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~ 172 (355)
T 2eu9_A 94 HGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCE 172 (355)
T ss_dssp TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCC
T ss_pred CCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeccccccccccccccc
Confidence 99999999999 557777776543 579999999999999999999999999999999999999
Q ss_pred ---cCCCcEEEeeecceeeecCCCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhc
Q 020085 242 ---DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVG 318 (331)
Q Consensus 242 ---~~~~~vkl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~ 318 (331)
+.++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||...+..+....
T Consensus 173 ~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~ 250 (355)
T 2eu9_A 173 EKSVKNTSIRVADFGSATFDHEH--HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVM 250 (355)
T ss_dssp EEEESCCCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ccccCCCcEEEeecCcccccccc--ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 66789999999999865432 3456799999999999999999999999999999999999999999877665544
Q ss_pred c
Q 020085 319 V 319 (331)
Q Consensus 319 ~ 319 (331)
+
T Consensus 251 ~ 251 (355)
T 2eu9_A 251 M 251 (355)
T ss_dssp H
T ss_pred H
Confidence 3
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-39 Score=291.78 Aligned_cols=209 Identities=23% Similarity=0.424 Sum_probs=175.5
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhcCCCcceeEEeEEE--CCCCe
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV--NTEMLKEFSQEVYIMRKIRHKNVVQFIGACT--RPPNL 182 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~~~~~~~~~E~~il~~l~h~niv~~~~~~~--~~~~~ 182 (331)
.++|++.+.||+|+||.||++.+ .++.||+|+++.... .....+.+.+|+.++++++||||+++++++. .....
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 35899999999999999999998 567899999975321 1123567999999999999999999999984 45579
Q ss_pred EEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC
Q 020085 183 CIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261 (331)
Q Consensus 183 ~lV~E~~~ggsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~ 261 (331)
++||||++++ |.+++... ...+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||.+......
T Consensus 84 ~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~ 162 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPF 162 (305)
T ss_dssp EEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTT
T ss_pred EEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCcc
Confidence 9999999986 77777553 467999999999999999999999999999999999999999999999999999865432
Q ss_pred ---CccccCCCCcccccchhcCCCC--CCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhc
Q 020085 262 ---GVMTAETGTYRWMAPEVIEHKP--YDYKADVFSFGIALWELLTGELPYAGLTPLQAAVG 318 (331)
Q Consensus 262 ---~~~~~~~gt~~y~aPE~~~~~~--~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~ 318 (331)
.......|++.|+|||++.+.. ++.++||||||+++|+|++|+.||.+.+..+....
T Consensus 163 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~ 224 (305)
T 2wtk_C 163 AADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFEN 224 (305)
T ss_dssp CSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHH
Confidence 2233556899999999997654 37899999999999999999999999877666554
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-39 Score=289.63 Aligned_cols=195 Identities=29% Similarity=0.531 Sum_probs=165.4
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEEC--------
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR-------- 178 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~-------- 178 (331)
.++|++.+.||+|+||.||+|++ .++.||||+++.. ....+.+.+|+.++++++||||+++++++..
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT---EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPM 81 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC--
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc---HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhh
Confidence 35799999999999999999997 5789999999643 4556789999999999999999999998854
Q ss_pred -----CCCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeec
Q 020085 179 -----PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFG 253 (331)
Q Consensus 179 -----~~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg 253 (331)
....++||||+++++|.+++......+++..++.++.|++.||+|||++|++||||||+||+++.++.+||+|||
T Consensus 82 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg 161 (303)
T 1zy4_A 82 TAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFG 161 (303)
T ss_dssp ----CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCC
T ss_pred cccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCc
Confidence 346899999999999999998766678899999999999999999999999999999999999999999999999
Q ss_pred ceeeecCC---------------CccccCCCCcccccchhcCCC-CCCChhhHHHHHHHHHHHHcCCCCCCC
Q 020085 254 VARVQAQS---------------GVMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAG 309 (331)
Q Consensus 254 ~a~~~~~~---------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~ell~g~~Pf~~ 309 (331)
+++..... .......|++.|+|||.+.+. .++.++||||||+++|+|++ ||..
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~ 230 (303)
T 1zy4_A 162 LAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFST 230 (303)
T ss_dssp CCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred chhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCC
Confidence 99754321 122345689999999999765 78999999999999999998 5553
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-38 Score=307.16 Aligned_cols=198 Identities=25% Similarity=0.394 Sum_probs=174.0
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCC-CcceeEEeEEECCCCeEEE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH-KNVVQFIGACTRPPNLCIV 185 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h-~niv~~~~~~~~~~~~~lV 185 (331)
.++|++.++||+|+||.||+|++ .++.||||+++..... ..+.+|+.+++.++| +++..+..++......++|
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lv 81 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLV 81 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEE
Confidence 56899999999999999999997 4789999998755432 357889999999987 5666666677778889999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEE---cCCCcEEEeeecceeeecCCC
Q 020085 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLM---DENGVVKVADFGVARVQAQSG 262 (331)
Q Consensus 186 ~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi---~~~~~vkl~DFg~a~~~~~~~ 262 (331)
|||+ +++|.+++......+++..++.++.||+.||+|||++||+||||||+|||+ +.++.+||+|||+++......
T Consensus 82 me~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~ 160 (483)
T 3sv0_A 82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTS 160 (483)
T ss_dssp EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTT
T ss_pred EECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCc
Confidence 9999 889999998767889999999999999999999999999999999999999 688999999999998765433
Q ss_pred cc--------ccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC
Q 020085 263 VM--------TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLT 311 (331)
Q Consensus 263 ~~--------~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~ 311 (331)
.. ....||+.|+|||.+.+..++.++|||||||+||||++|+.||.+..
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~ 217 (483)
T 3sv0_A 161 THQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLK 217 (483)
T ss_dssp TCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred cccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccc
Confidence 21 24579999999999999999999999999999999999999998754
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-39 Score=305.18 Aligned_cols=207 Identities=25% Similarity=0.456 Sum_probs=170.3
Q ss_pred CCeeeecccCcceeeeeeecCceE-EEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCcceeEEeEEECC
Q 020085 102 TDVWEIDAKQLKIECKVASGSYGD-LYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRP 179 (331)
Q Consensus 102 ~~~~~i~~~~~~~~~~lg~G~~g~-Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~ 179 (331)
...+.+...+|.+.+.||+|+||+ ||++...++.||||++..+.. ..+.+|+.+++++ +||||+++++++...
T Consensus 16 ~~~~~i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~-----~~~~~E~~~l~~l~~HpnIv~l~~~~~~~ 90 (432)
T 3p23_A 16 TSVVIVGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF-----SFADREVQLLRESDEHPNVIRYFCTEKDR 90 (432)
T ss_dssp --CEEETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE-----EECHHHHHHHHHSCCCTTBCCEEEEEEET
T ss_pred CCcEEEccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH-----HHHHHHHHHHHhccCCCCcCeEEEEEecC
Confidence 356788888999999999999998 566777899999999976532 2356899999999 799999999999999
Q ss_pred CCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC---CC--cEEEeeecc
Q 020085 180 PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE---NG--VVKVADFGV 254 (331)
Q Consensus 180 ~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~---~~--~vkl~DFg~ 254 (331)
...|+||||+.| +|.+++......+....+..++.||+.||+|||++||+||||||+|||++. ++ .+||+|||+
T Consensus 91 ~~~~lv~E~~~g-~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~ 169 (432)
T 3p23_A 91 QFQYIAIELCAA-TLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGL 169 (432)
T ss_dssp TEEEEEEECCSE-EHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTE
T ss_pred CEEEEEEECCCC-CHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccc
Confidence 999999999975 999999876666666677899999999999999999999999999999953 22 588999999
Q ss_pred eeeecCC----CccccCCCCcccccchhcC---CCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHH
Q 020085 255 ARVQAQS----GVMTAETGTYRWMAPEVIE---HKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQ 314 (331)
Q Consensus 255 a~~~~~~----~~~~~~~gt~~y~aPE~~~---~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~ 314 (331)
++..... .......||+.|+|||++. ...++.++|||||||++|||++ |..||......+
T Consensus 170 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~ 237 (432)
T 3p23_A 170 CKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ 237 (432)
T ss_dssp EECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH
T ss_pred eeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH
Confidence 9865433 2234457999999999997 4567889999999999999999 999997654443
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-38 Score=295.16 Aligned_cols=200 Identities=20% Similarity=0.378 Sum_probs=172.2
Q ss_pred eecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-----------CCcceeE
Q 020085 106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-----------HKNVVQF 172 (331)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~-----------h~niv~~ 172 (331)
.+..++|.+.+.||+|+||+||+|++ .++.||||+++.. ....+.+.+|+.++++++ ||||+++
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~ 91 (373)
T 1q8y_A 15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL 91 (373)
T ss_dssp EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC---ccchhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence 45678999999999999999999997 5789999999753 444567889999999886 8999999
Q ss_pred EeEEECCC----CeEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCCCCEEEcC---
Q 020085 173 IGACTRPP----NLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQN-NIIHRDLKTANLLMDE--- 243 (331)
Q Consensus 173 ~~~~~~~~----~~~lV~E~~~ggsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~-~iiHrDlkp~NiLi~~--- 243 (331)
++++.... .+++|||++ +++|.+++... ...+++..+..++.||+.||+|||++ ||+||||||+|||++.
T Consensus 92 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~ 170 (373)
T 1q8y_A 92 LDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDS 170 (373)
T ss_dssp CEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEET
T ss_pred HHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCC
Confidence 99987543 689999999 78999999764 35699999999999999999999998 9999999999999953
Q ss_pred ---CCcEEEeeecceeeecCCCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCC
Q 020085 244 ---NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLT 311 (331)
Q Consensus 244 ---~~~vkl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~ 311 (331)
++.+||+|||+++..... .....||+.|+|||++.+..++.++||||||+++|||++|+.||...+
T Consensus 171 ~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 171 PENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp TTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred CcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence 347999999999866543 345578999999999999999999999999999999999999998654
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-39 Score=293.23 Aligned_cols=205 Identities=25% Similarity=0.447 Sum_probs=176.0
Q ss_pred eeeecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCH----HHHHHHHHHHHHHHhcC--CCcceeEEeE
Q 020085 104 VWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNT----EMLKEFSQEVYIMRKIR--HKNVVQFIGA 175 (331)
Q Consensus 104 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~----~~~~~~~~E~~il~~l~--h~niv~~~~~ 175 (331)
..+.-.++|++.+.||+|+||.||+|.+ .++.||||+++...... ...+.+.+|+.++++++ ||||++++++
T Consensus 37 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~ 116 (320)
T 3a99_A 37 EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116 (320)
T ss_dssp ---CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEE
T ss_pred ccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEE
Confidence 3455678999999999999999999988 57899999997553221 11245778999999996 5999999999
Q ss_pred EECCCCeEEEEeccCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEc-CCCcEEEeeec
Q 020085 176 CTRPPNLCIVTEFMAR-GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD-ENGVVKVADFG 253 (331)
Q Consensus 176 ~~~~~~~~lV~E~~~g-gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~-~~~~vkl~DFg 253 (331)
+..+...++|+|++.+ ++|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+|||++ +++.+||+|||
T Consensus 117 ~~~~~~~~lv~e~~~~~~~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg 195 (320)
T 3a99_A 117 FERPDSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFG 195 (320)
T ss_dssp EECSSEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCT
T ss_pred EecCCcEEEEEEcCCCCccHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCc
Confidence 9999999999999986 899999966 46789999999999999999999999999999999999999 78999999999
Q ss_pred ceeeecCCCccccCCCCcccccchhcCCCCC-CChhhHHHHHHHHHHHHcCCCCCCCC
Q 020085 254 VARVQAQSGVMTAETGTYRWMAPEVIEHKPY-DYKADVFSFGIALWELLTGELPYAGL 310 (331)
Q Consensus 254 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~SlG~il~ell~g~~Pf~~~ 310 (331)
+++..... ......||+.|+|||++.+..+ +.++||||||+++|||++|+.||...
T Consensus 196 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 252 (320)
T 3a99_A 196 SGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 252 (320)
T ss_dssp TCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred cccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCCh
Confidence 99876543 3345679999999999977665 68899999999999999999999764
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-38 Score=290.52 Aligned_cols=204 Identities=24% Similarity=0.411 Sum_probs=167.3
Q ss_pred eeecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCH----HHHHHHHHHHHHHHhc----CCCcceeEEe
Q 020085 105 WEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNT----EMLKEFSQEVYIMRKI----RHKNVVQFIG 174 (331)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~----~~~~~~~~E~~il~~l----~h~niv~~~~ 174 (331)
.+.-.++|++.+.||+|+||.||+|.+ .++.||+|+++...... .....+.+|+.+++++ +||||+++++
T Consensus 26 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~ 105 (312)
T 2iwi_A 26 REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLD 105 (312)
T ss_dssp -------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEE
T ss_pred hhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEE
Confidence 455577899999999999999999988 57889999997654322 2234567799999999 8999999999
Q ss_pred EEECCCCeEEEEec-cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEc-CCCcEEEeee
Q 020085 175 ACTRPPNLCIVTEF-MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD-ENGVVKVADF 252 (331)
Q Consensus 175 ~~~~~~~~~lV~E~-~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~-~~~~vkl~DF 252 (331)
++......++|+|+ +.+++|.+++.. .+.+++..+..++.|++.||+|||++|++||||||+||+++ .++.+||+||
T Consensus 106 ~~~~~~~~~~v~e~~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~df 184 (312)
T 2iwi_A 106 WFETQEGFMLVLERPLPAQDLFDYITE-KGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDF 184 (312)
T ss_dssp EC-----CEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCC
T ss_pred EEecCCeEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEc
Confidence 99988899999999 789999999976 45799999999999999999999999999999999999999 8899999999
Q ss_pred cceeeecCCCccccCCCCcccccchhcCCCCCC-ChhhHHHHHHHHHHHHcCCCCCCCC
Q 020085 253 GVARVQAQSGVMTAETGTYRWMAPEVIEHKPYD-YKADVFSFGIALWELLTGELPYAGL 310 (331)
Q Consensus 253 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~Di~SlG~il~ell~g~~Pf~~~ 310 (331)
|+++..... ......|++.|+|||.+.+..+. .++||||||+++|+|++|+.||...
T Consensus 185 g~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 242 (312)
T 2iwi_A 185 GSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD 242 (312)
T ss_dssp SSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred chhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh
Confidence 999876543 34456789999999999776664 5899999999999999999999763
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-38 Score=291.81 Aligned_cols=199 Identities=24% Similarity=0.388 Sum_probs=146.3
Q ss_pred ccCcceee-eeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEEC----CCC
Q 020085 109 AKQLKIEC-KVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR----PPN 181 (331)
Q Consensus 109 ~~~~~~~~-~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~----~~~ 181 (331)
.++|.+.+ .||+|+||.||+|.+. ++.||||++... .. ...+....++.++||||+++++++.. ...
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~---~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~ 100 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS---PK---ARQEVDHHWQASGGPHIVCILDVYENMHHGKRC 100 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS---HH---HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc---HH---HHHHHHHHHHhcCCCChHHHHHHHhhccCCCce
Confidence 45788855 6999999999999985 789999999753 22 22223334567799999999999865 445
Q ss_pred eEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC---CCcEEEeeecceee
Q 020085 182 LCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE---NGVVKVADFGVARV 257 (331)
Q Consensus 182 ~~lV~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~---~~~vkl~DFg~a~~ 257 (331)
.++||||++||+|.+++.... ..+++..++.++.|++.||.|||++|++||||||+||+++. ++.+||+|||+++.
T Consensus 101 ~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~ 180 (336)
T 3fhr_A 101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKE 180 (336)
T ss_dssp EEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEecccccee
Confidence 899999999999999997653 46999999999999999999999999999999999999986 45599999999986
Q ss_pred ecCCCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHH
Q 020085 258 QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ 314 (331)
Q Consensus 258 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~ 314 (331)
.... ......+|+.|+|||++.+..++.++||||||+++|+|++|+.||...+...
T Consensus 181 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 236 (336)
T 3fhr_A 181 TTQN-ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQA 236 (336)
T ss_dssp C-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC-------
T ss_pred cccc-ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchh
Confidence 5543 3345678999999999988889999999999999999999999997765443
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=302.46 Aligned_cols=196 Identities=17% Similarity=0.275 Sum_probs=166.9
Q ss_pred ecccCcceeeeeeecCceEEEEEEECCceEEEEEecCCCC------CHHHHHHHHHHHHHHHhcC---------CCccee
Q 020085 107 IDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECV------NTEMLKEFSQEVYIMRKIR---------HKNVVQ 171 (331)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~------~~~~~~~~~~E~~il~~l~---------h~niv~ 171 (331)
+..++|++.++||+|+||+||+|+++++.||||+++.... .....+.+.+|+.+++.++ ||||++
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~ 96 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG 96 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred cccccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence 4567899999999999999999999999999999986532 2223467889999999886 777777
Q ss_pred EEeEEE------------------------------CCCCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Q 020085 172 FIGACT------------------------------RPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221 (331)
Q Consensus 172 ~~~~~~------------------------------~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l 221 (331)
+.+++. ....+|+||||+++|++.+.+.+ ..+++..+..++.||+.||
T Consensus 97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~--~~~~~~~~~~i~~qi~~aL 174 (336)
T 2vuw_A 97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT--KLSSLATAKSILHQLTASL 174 (336)
T ss_dssp EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT--TCCCHHHHHHHHHHHHHHH
T ss_pred hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh--cCCCHHHHHHHHHHHHHHH
Confidence 776542 26789999999999977776633 6789999999999999999
Q ss_pred HHHH-hCCcccCCCCCCCEEEcCCC--------------------cEEEeeecceeeecCCCccccCCCCcccccchhcC
Q 020085 222 NYLH-QNNIIHRDLKTANLLMDENG--------------------VVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE 280 (331)
Q Consensus 222 ~~LH-~~~iiHrDlkp~NiLi~~~~--------------------~vkl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~ 280 (331)
+||| ++||+||||||+|||++.++ .+||+|||+++..... ...||+.|+|||++.
T Consensus 175 ~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~ 250 (336)
T 2vuw_A 175 AVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFT 250 (336)
T ss_dssp HHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGC
T ss_pred HHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhc
Confidence 9999 99999999999999999987 8999999999876543 347999999999998
Q ss_pred CCCCCChhhHHHHHHH-HHHHHcCCCCCCC
Q 020085 281 HKPYDYKADVFSFGIA-LWELLTGELPYAG 309 (331)
Q Consensus 281 ~~~~~~~~Di~SlG~i-l~ell~g~~Pf~~ 309 (331)
+.. +.++||||++++ .+++++|..||.+
T Consensus 251 g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~ 279 (336)
T 2vuw_A 251 GDG-DYQFDIYRLMKKENNNRWGEYHPYSN 279 (336)
T ss_dssp CCS-SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred CCC-ccceehhhhhCCCCcccccccCCCcc
Confidence 776 899999998777 7778889999965
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-38 Score=313.95 Aligned_cols=204 Identities=26% Similarity=0.427 Sum_probs=178.9
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEEC------CC
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR------PP 180 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~------~~ 180 (331)
.++|++.++||+|+||.||+|.+ .++.||||+++... .....+.+.+|+.++++++||||+++++++.. ..
T Consensus 13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~-~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~ 91 (676)
T 3qa8_A 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQEL-SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND 91 (676)
T ss_dssp ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCC-CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccC-CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence 36899999999999999999987 57899999998653 55667789999999999999999999998765 66
Q ss_pred CeEEEEeccCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCc---EEEeeecce
Q 020085 181 NLCIVTEFMARGSIYDFLHKQK--GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGV---VKVADFGVA 255 (331)
Q Consensus 181 ~~~lV~E~~~ggsL~~~l~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~---vkl~DFg~a 255 (331)
..++||||++||+|.+++.... ..+++..+..++.|++.||+|||++||+||||||+||+++.++. ++|+|||.+
T Consensus 92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a 171 (676)
T 3qa8_A 92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA 171 (676)
T ss_dssp SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence 7899999999999999997643 36889999999999999999999999999999999999997765 999999999
Q ss_pred eeecCCCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH
Q 020085 256 RVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPL 313 (331)
Q Consensus 256 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~ 313 (331)
+............||+.|+|||.+.+..++.++||||||+++|+|++|+.||......
T Consensus 172 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~ 229 (676)
T 3qa8_A 172 KELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP 229 (676)
T ss_dssp CBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH
T ss_pred cccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch
Confidence 8776665556678999999999999999999999999999999999999999775433
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.6e-38 Score=314.22 Aligned_cols=194 Identities=21% Similarity=0.300 Sum_probs=169.2
Q ss_pred ecccCcceeeeeeecCceEEEEEEE---CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCC--
Q 020085 107 IDAKQLKIECKVASGSYGDLYKGTY---CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN-- 181 (331)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~---~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~-- 181 (331)
+-.++|++.+.||+|+||.||++.+ .++.||||++.... +......+.+|+.++++++||||+++++++.....
T Consensus 77 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 155 (681)
T 2pzi_A 77 IVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSG-DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHG 155 (681)
T ss_dssp EETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSC-CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTS
T ss_pred EeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccC-CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCC
Confidence 4457999999999999999999998 36889999987543 45566789999999999999999999999987665
Q ss_pred ---eEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeee
Q 020085 182 ---LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (331)
Q Consensus 182 ---~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~ 258 (331)
.|+||||++|++|.+++.. .+++..++.++.||++||.|||++||+||||||+|||++.+ .+||+|||+++..
T Consensus 156 ~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~ 231 (681)
T 2pzi_A 156 DPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRI 231 (681)
T ss_dssp CEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred CceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchhc
Confidence 7999999999999998743 78999999999999999999999999999999999999875 8999999999876
Q ss_pred cCCCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCC
Q 020085 259 AQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAG 309 (331)
Q Consensus 259 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~ 309 (331)
... ....||+.|+|||++.+.. +.++|||||||++|+|++|..||.+
T Consensus 232 ~~~---~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~ 278 (681)
T 2pzi_A 232 NSF---GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNG 278 (681)
T ss_dssp TCC---SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETT
T ss_pred ccC---CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcc
Confidence 543 4457999999999987654 8999999999999999999998865
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-37 Score=295.06 Aligned_cols=197 Identities=23% Similarity=0.402 Sum_probs=158.0
Q ss_pred cCcceeeeeeecCceEEE-EEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCcceeEEeEEECCCCeEEEEe
Q 020085 110 KQLKIECKVASGSYGDLY-KGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTE 187 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy-~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~lV~E 187 (331)
+.|.+.+.||+|+||+|| .+...++.||||++..+. .+.+.+|+.+++++ +||||+++++++..+...|+|||
T Consensus 15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~-----~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E 89 (434)
T 2rio_A 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF-----CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE 89 (434)
T ss_dssp SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH-----HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence 456667899999999996 445588999999987542 34678899999886 89999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCC------CCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC-------------CcEE
Q 020085 188 FMARGSIYDFLHKQKGV------FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN-------------GVVK 248 (331)
Q Consensus 188 ~~~ggsL~~~l~~~~~~------~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~-------------~~vk 248 (331)
|+.| +|.+++...... .++..++.++.||+.||+|||++||+||||||+|||++.+ +.+|
T Consensus 90 ~~~g-sL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 90 LCNL-NLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp CCSE-EHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred cCCC-CHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 9964 999999764321 1223457899999999999999999999999999999754 4899
Q ss_pred EeeecceeeecCCCc-----cccCCCCcccccchhcCC-------CCCCChhhHHHHHHHHHHHHc-CCCCCCCCCH
Q 020085 249 VADFGVARVQAQSGV-----MTAETGTYRWMAPEVIEH-------KPYDYKADVFSFGIALWELLT-GELPYAGLTP 312 (331)
Q Consensus 249 l~DFg~a~~~~~~~~-----~~~~~gt~~y~aPE~~~~-------~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~ 312 (331)
|+|||+++....... .....||+.|+|||++.+ ..++.++|||||||++|||++ |+.||.....
T Consensus 169 L~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 245 (434)
T 2rio_A 169 ISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245 (434)
T ss_dssp ECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred EcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence 999999987654321 234579999999999975 678999999999999999999 9999987543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-36 Score=274.93 Aligned_cols=178 Identities=13% Similarity=0.193 Sum_probs=157.6
Q ss_pred ecccCcceeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeE
Q 020085 107 IDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183 (331)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 183 (331)
+-.++|++.+.||+|+||.||+|++. ++.||||+++.... +.+..+.+.+|+.++++++||||+++++++..++..|
T Consensus 28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~ 107 (286)
T 3uqc_A 28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGL 107 (286)
T ss_dssp ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEE
Confidence 44578999999999999999999995 78999999987644 3556688999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCc
Q 020085 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV 263 (331)
Q Consensus 184 lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~ 263 (331)
+||||++|++|.+++.. + .....+.+++.|++.||+|||++||+||||||+|||++.+|.+||++++.
T Consensus 108 lv~e~~~g~~L~~~l~~--~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~~--------- 175 (286)
T 3uqc_A 108 VVAEWIRGGSLQEVADT--S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPAT--------- 175 (286)
T ss_dssp EEEECCCEEEHHHHHTT--C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCCC---------
T ss_pred EEEEecCCCCHHHHHhc--C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEeccc---------
Confidence 99999999999999943 2 35667889999999999999999999999999999999999999985433
Q ss_pred cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHH
Q 020085 264 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPL 313 (331)
Q Consensus 264 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~ 313 (331)
++ +++.++|||||||++|||++|+.||.+.+..
T Consensus 176 ----------~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~ 208 (286)
T 3uqc_A 176 ----------MP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVR 208 (286)
T ss_dssp ----------CT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBC
T ss_pred ----------cC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcc
Confidence 32 3788999999999999999999999987653
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-37 Score=292.45 Aligned_cols=206 Identities=16% Similarity=0.221 Sum_probs=160.9
Q ss_pred ecccCcceeeeeeecCceEEEEEEEC--CceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCC-Ccce---------e--
Q 020085 107 IDAKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRH-KNVV---------Q-- 171 (331)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l~h-~niv---------~-- 171 (331)
.....|+..+.||+|+||+||+|++. ++.||||+++.... .....+.+.+|+.+++.++| +|.. .
T Consensus 75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~ 154 (413)
T 3dzo_A 75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF 154 (413)
T ss_dssp SCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred CCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence 34567889999999999999999985 89999999984432 22345779999999999977 2211 1
Q ss_pred ----------EEeEEEC-----CCCeEEEEeccCCCCHHHHHHh------cCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 020085 172 ----------FIGACTR-----PPNLCIVTEFMARGSIYDFLHK------QKGVFQLTSLLKVAIDVSKGMNYLHQNNII 230 (331)
Q Consensus 172 ----------~~~~~~~-----~~~~~lV~E~~~ggsL~~~l~~------~~~~~~~~~~~~i~~qi~~~l~~LH~~~ii 230 (331)
+..++.. ...++++|+.+ +++|.+++.. ....+++..++.++.|+++||+|||++||+
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ii 233 (413)
T 3dzo_A 155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLV 233 (413)
T ss_dssp EEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 1111111 22467788876 4599999842 234577788999999999999999999999
Q ss_pred cCCCCCCCEEEcCCCcEEEeeecceeeecCCCccccCCCCcccccchhc----------CCCCCCChhhHHHHHHHHHHH
Q 020085 231 HRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVI----------EHKPYDYKADVFSFGIALWEL 300 (331)
Q Consensus 231 HrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~Di~SlG~il~el 300 (331)
||||||+|||++.++.+||+|||+++..... .....| +.|+|||++ ....++.++|||||||++|||
T Consensus 234 HrDiKp~NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~el 310 (413)
T 3dzo_A 234 HTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI 310 (413)
T ss_dssp CSCCCGGGEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHH
T ss_pred cCCcccceEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHH
Confidence 9999999999999999999999999865443 345567 999999999 666788999999999999999
Q ss_pred HcCCCCCCCCCHHHHH
Q 020085 301 LTGELPYAGLTPLQAA 316 (331)
Q Consensus 301 l~g~~Pf~~~~~~~~~ 316 (331)
++|+.||...++.+..
T Consensus 311 ltg~~Pf~~~~~~~~~ 326 (413)
T 3dzo_A 311 WCADLPNTDDAALGGS 326 (413)
T ss_dssp HHSSCCCCTTGGGSCS
T ss_pred HHCCCCCCCcchhhhH
Confidence 9999999887654433
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-35 Score=269.66 Aligned_cols=180 Identities=24% Similarity=0.426 Sum_probs=152.0
Q ss_pred ccCccee-eeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHH-HhcCCCcceeEEeEEEC----CC
Q 020085 109 AKQLKIE-CKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIM-RKIRHKNVVQFIGACTR----PP 180 (331)
Q Consensus 109 ~~~~~~~-~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il-~~l~h~niv~~~~~~~~----~~ 180 (331)
.++|.+. +.||+|+||.||++.+ .++.||+|+++.. ..+.+|+.++ +..+||||+++++++.. ..
T Consensus 16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~ 88 (299)
T 3m2w_A 16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 88 (299)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCc
Confidence 3467776 7899999999999998 5789999999743 4567888888 55689999999999876 66
Q ss_pred CeEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC---CCcEEEeeeccee
Q 020085 181 NLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE---NGVVKVADFGVAR 256 (331)
Q Consensus 181 ~~~lV~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~---~~~vkl~DFg~a~ 256 (331)
..++||||+++|+|.+++.... ..+++..+..++.|++.||.|||++|++||||||+||+++. ++.+||+|||++.
T Consensus 89 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~ 168 (299)
T 3m2w_A 89 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168 (299)
T ss_dssp EEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred eEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence 7899999999999999997753 47999999999999999999999999999999999999998 7889999999986
Q ss_pred eecCCCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 020085 257 VQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAA 316 (331)
Q Consensus 257 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~ 316 (331)
... +..++.++||||||+++|||++|+.||.+.+..+..
T Consensus 169 ~~~---------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~ 207 (299)
T 3m2w_A 169 ETT---------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAIS 207 (299)
T ss_dssp ECT---------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------
T ss_pred ccc---------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhh
Confidence 543 234678999999999999999999999877655543
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-34 Score=280.94 Aligned_cols=182 Identities=12% Similarity=0.127 Sum_probs=130.6
Q ss_pred eeeecCceEEEEEE--ECCceEEEEEecCCCC----C----HHHHHHHHHHHHHHHhc-CCCcceeEEeEEECCCCeEEE
Q 020085 117 KVASGSYGDLYKGT--YCSQEVAIKVLKPECV----N----TEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIV 185 (331)
Q Consensus 117 ~lg~G~~g~Vy~~~--~~~~~vavK~~~~~~~----~----~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~~~~lV 185 (331)
..+.|+.|.+..++ +.|+.+|+|++..+.. + ....++|.+|+++|+++ .|+||++++++++++..+|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 45667777666543 4789999999976532 1 23356799999999999 699999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC-Ccc
Q 020085 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVM 264 (331)
Q Consensus 186 ~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~-~~~ 264 (331)
|||++|++|.+++.. .++++.. +|+.||+.||+|+|++|||||||||+|||++.+|.+||+|||+|+..... ...
T Consensus 321 MEyv~G~~L~d~i~~-~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~ 396 (569)
T 4azs_A 321 MEKLPGRLLSDMLAA-GEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWP 396 (569)
T ss_dssp EECCCSEEHHHHHHT-TCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCS
T ss_pred EecCCCCcHHHHHHh-CCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCccc
Confidence 999999999999965 5667754 57899999999999999999999999999999999999999999865443 233
Q ss_pred ccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcC
Q 020085 265 TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTG 303 (331)
Q Consensus 265 ~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g 303 (331)
...+||+.|||||++.+. +..++|+||+|++++++.++
T Consensus 397 ~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~ 434 (569)
T 4azs_A 397 TNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQP 434 (569)
T ss_dssp HHHHHHHHHHHHHHC------------------CCCCTT
T ss_pred cCceechhhccHHHhCCC-CCCcccccccccchhhhccc
Confidence 456799999999999765 56789999999988776554
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.6e-31 Score=258.43 Aligned_cols=184 Identities=18% Similarity=0.224 Sum_probs=149.1
Q ss_pred eeeeeeecCceEEEEEEECCceEEEEEecCCCCCH------HHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEe
Q 020085 114 IECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNT------EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (331)
Q Consensus 114 ~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~------~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E 187 (331)
..+.||+|+||+||++++.++.+++|+........ ...+.+.+|+.++++++||||+++..++......|+|||
T Consensus 340 ~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE 419 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS 419 (540)
T ss_dssp --------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred CCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence 36689999999999999999999999876543221 124558999999999999999966666666777899999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCcc---
Q 020085 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVM--- 264 (331)
Q Consensus 188 ~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~--- 264 (331)
|++|++|.+++.. +..++.|++++|+|||++||+||||||+|||++. .+||+|||+++........
T Consensus 420 ~~~ggsL~~~l~~---------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~ 488 (540)
T 3en9_A 420 YINGKLAKDVIED---------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVD 488 (540)
T ss_dssp CCCSEEHHHHSTT---------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHH
T ss_pred CCCCCCHHHHHHH---------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccccc
Confidence 9999999999854 5689999999999999999999999999999998 9999999999876553221
Q ss_pred -----ccCCCCcccccchhcCC--CCCCChhhHHHHHHHHHHHHcCCCCCC
Q 020085 265 -----TAETGTYRWMAPEVIEH--KPYDYKADVFSFGIALWELLTGELPYA 308 (331)
Q Consensus 265 -----~~~~gt~~y~aPE~~~~--~~~~~~~Di~SlG~il~ell~g~~Pf~ 308 (331)
....||+.|||||++.. ..|+..+|+||..+-..+-..++.+|.
T Consensus 489 ~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 489 LIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp HHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred hhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 24568999999999977 668888999999999888888888774
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=7.3e-27 Score=210.59 Aligned_cols=146 Identities=14% Similarity=0.135 Sum_probs=117.2
Q ss_pred cCcceeeeeeecCceEEEEEEE-CCceEEEEEecCCCCCH----------------HHHHHHHHHHHHHHhcCCCcceeE
Q 020085 110 KQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNT----------------EMLKEFSQEVYIMRKIRHKNVVQF 172 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~----------------~~~~~~~~E~~il~~l~h~niv~~ 172 (331)
..|.+.+.||+|+||.||+|.+ .++.||+|+++....+. .....+.+|+.++++++ | +++
T Consensus 90 ~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v 166 (282)
T 1zar_A 90 KVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV 166 (282)
T ss_dssp SCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred eEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence 3456779999999999999999 57899999997543211 24567999999999999 4 555
Q ss_pred EeEEECCCCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeee
Q 020085 173 IGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADF 252 (331)
Q Consensus 173 ~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DF 252 (331)
.+++.. +..|+||||++|++|.+ +.. .....++.|++.||.|||++||+||||||+|||++ ++.+||+||
T Consensus 167 ~~~~~~-~~~~lvmE~~~g~~L~~-l~~-------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~DF 236 (282)
T 1zar_A 167 PKVYAW-EGNAVLMELIDAKELYR-VRV-------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDF 236 (282)
T ss_dssp CCEEEE-ETTEEEEECCCCEEGGG-CCC-------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECCC
T ss_pred CeEEec-cceEEEEEecCCCcHHH-cch-------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEEC
Confidence 555443 45799999999999998 521 22457999999999999999999999999999999 999999999
Q ss_pred cceeeecCCCccccCCCCcccccchhcC
Q 020085 253 GVARVQAQSGVMTAETGTYRWMAPEVIE 280 (331)
Q Consensus 253 g~a~~~~~~~~~~~~~gt~~y~aPE~~~ 280 (331)
|+++. +..++|||.+.
T Consensus 237 G~a~~------------~~~~~a~e~l~ 252 (282)
T 1zar_A 237 PQSVE------------VGEEGWREILE 252 (282)
T ss_dssp TTCEE------------TTSTTHHHHHH
T ss_pred CCCeE------------CCCCCHHHHHH
Confidence 99963 33467899874
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.2e-22 Score=180.67 Aligned_cols=138 Identities=14% Similarity=0.206 Sum_probs=108.7
Q ss_pred CcceeeeeeecCceEEEEEEE--CCce--EEEEEecCCCCCH----------------------HHHHHHHHHHHHHHhc
Q 020085 111 QLKIECKVASGSYGDLYKGTY--CSQE--VAIKVLKPECVNT----------------------EMLKEFSQEVYIMRKI 164 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~--vavK~~~~~~~~~----------------------~~~~~~~~E~~il~~l 164 (331)
-|.+.+.||+|+||.||+|.+ .|+. ||||+++...... .....+.+|+.+++++
T Consensus 48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l 127 (258)
T 1zth_A 48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA 127 (258)
T ss_dssp EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence 367889999999999999998 7888 9999986542111 1123688999999999
Q ss_pred CCCcc--eeEEeEEECCCCeEEEEeccCC-C----CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH-hCCcccCCCCC
Q 020085 165 RHKNV--VQFIGACTRPPNLCIVTEFMAR-G----SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH-QNNIIHRDLKT 236 (331)
Q Consensus 165 ~h~ni--v~~~~~~~~~~~~~lV~E~~~g-g----sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH-~~~iiHrDlkp 236 (331)
+|+++ +..++. ...++||||+.+ | +|.++... .++..+..++.|++.+|.||| +.||+||||||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp 199 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDVVENVKRLYQEAELVHADLSE 199 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence 88754 444442 256899999942 3 77776532 234467889999999999999 99999999999
Q ss_pred CCEEEcCCCcEEEeeecceeee
Q 020085 237 ANLLMDENGVVKVADFGVARVQ 258 (331)
Q Consensus 237 ~NiLi~~~~~vkl~DFg~a~~~ 258 (331)
+|||++. .++|+|||+|...
T Consensus 200 ~NILl~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 200 YNIMYID--KVYFIDMGQAVTL 219 (258)
T ss_dssp TSEEESS--SEEECCCTTCEET
T ss_pred HHEEEcC--cEEEEECcccccC
Confidence 9999988 9999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.79 E-value=2.5e-19 Score=166.83 Aligned_cols=137 Identities=13% Similarity=0.151 Sum_probs=100.8
Q ss_pred CcceeeeeeecCceEEEEEEE-CCceEEEEEecCCCCC---------------H-HH----HHHHHHHHHHHHhcCCCcc
Q 020085 111 QLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVN---------------T-EM----LKEFSQEVYIMRKIRHKNV 169 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~---------------~-~~----~~~~~~E~~il~~l~h~ni 169 (331)
-|.+.++||+|++|.||+|.. .|+.||||+++....+ . .. .-...+|...|.++.+.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 388999999999999999987 6789999998643111 0 00 0112456677777754443
Q ss_pred --eeEEeEEECCCCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC--
Q 020085 170 --VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG-- 245 (331)
Q Consensus 170 --v~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~-- 245 (331)
...++. . ..+|||||++|++|.++.. .+....++.|++.+|.+||+.|||||||||.|||++++|
T Consensus 176 ~vp~p~~~--~--~~~LVME~i~G~~L~~l~~-------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~ 244 (397)
T 4gyi_A 176 PVPEPIAQ--S--RHTIVMSLVDALPMRQVSS-------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDA 244 (397)
T ss_dssp SCCCEEEE--E--TTEEEEECCSCEEGGGCCC-------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECS
T ss_pred CCCeeeec--c--CceEEEEecCCccHhhhcc-------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCc
Confidence 222322 1 3479999999988866431 123456889999999999999999999999999999887
Q ss_pred --------cEEEeeecceeee
Q 020085 246 --------VVKVADFGVARVQ 258 (331)
Q Consensus 246 --------~vkl~DFg~a~~~ 258 (331)
.+.|+||+.+...
T Consensus 245 ~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 245 EDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp SCTTSEEEEEEECCCTTCEET
T ss_pred ccccccccceEEEEeCCcccC
Confidence 3899999988543
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.53 E-value=3.9e-14 Score=125.27 Aligned_cols=142 Identities=13% Similarity=0.060 Sum_probs=114.1
Q ss_pred cCcceeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCcceeEEeEEECCCCeEEEEec
Q 020085 110 KQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCIVTEF 188 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~~~~lV~E~ 188 (331)
..|.+...++.|+.+.||+....++.+++|+........ ...+.+|+.+++.+. +..++++++++...+..|+||||
T Consensus 14 ~~~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~--~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~ 91 (263)
T 3tm0_A 14 EKYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE 91 (263)
T ss_dssp TTSEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred ccceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCC--HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence 358888899999999999998888999999987532111 235888999999985 67788999999888889999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh------------------------------------------
Q 020085 189 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ------------------------------------------ 226 (331)
Q Consensus 189 ~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~------------------------------------------ 226 (331)
++|.+|.+.+.. ......++.++++++..||+
T Consensus 92 i~G~~l~~~~~~------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (263)
T 3tm0_A 92 ADGVLCSEEYED------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFK 165 (263)
T ss_dssp CSSEEHHHHCCT------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSS
T ss_pred cCCeehhhccCC------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCC
Confidence 999999876411 12234678899999999998
Q ss_pred -----------------CCcccCCCCCCCEEEcCCCcEEEeeecceeeec
Q 020085 227 -----------------NNIIHRDLKTANLLMDENGVVKVADFGVARVQA 259 (331)
Q Consensus 227 -----------------~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~ 259 (331)
..++|+|++|.||++++++.+.|+||+.+....
T Consensus 166 ~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~gd 215 (263)
T 3tm0_A 166 DPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRAD 215 (263)
T ss_dssp SHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEEEE
T ss_pred CHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcccCC
Confidence 448999999999999876667799999986543
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.37 E-value=1.7e-12 Score=113.98 Aligned_cols=135 Identities=11% Similarity=0.104 Sum_probs=99.9
Q ss_pred CcceeeeeeecCceEEEEEEEC-CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCc--ceeEEeEEECCCCeEEEEe
Q 020085 111 QLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN--VVQFIGACTRPPNLCIVTE 187 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~n--iv~~~~~~~~~~~~~lV~E 187 (331)
.+.+....+.|+.+.||+.... |+.+++|+..... ...+.+|+.+++.+.+.+ +.+++++...++..++|||
T Consensus 21 ~~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~~-----~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e 95 (264)
T 1nd4_A 21 GYDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA-----LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG 95 (264)
T ss_dssp TCEEEECSCTTSSCEEEEEECTTSCCEEEEEECSCT-----TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred CCceEecccCCCCceEEEEecCCCCeEEEEeCCccc-----chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence 3444444446667999999764 5779999987541 245778999999886544 5668888888778999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------------
Q 020085 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNN--------------------------------------- 228 (331)
Q Consensus 188 ~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--------------------------------------- 228 (331)
|++|.+|. ... .+ ...++.++++.+..||+..
T Consensus 96 ~i~G~~l~--~~~----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (264)
T 1nd4_A 96 EVPGQDLL--SSH----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLA 166 (264)
T ss_dssp CCSSEETT--TSC----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCC
T ss_pred ecCCcccC--cCc----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCcc
Confidence 99998884 211 12 2256677777788888643
Q ss_pred -------------------cccCCCCCCCEEEcCCCcEEEeeecceeeec
Q 020085 229 -------------------IIHRDLKTANLLMDENGVVKVADFGVARVQA 259 (331)
Q Consensus 229 -------------------iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~ 259 (331)
++|+|++|.||++++++.+.|+||+.+....
T Consensus 167 ~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g~ 216 (264)
T 1nd4_A 167 PAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVAD 216 (264)
T ss_dssp HHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEEE
T ss_pred HHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccCC
Confidence 9999999999999877667799999987543
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.35 E-value=3.6e-12 Score=117.99 Aligned_cols=141 Identities=13% Similarity=0.198 Sum_probs=108.8
Q ss_pred eeeeeecCceEEEEEEECCceEEEEEec--CCCCCHHHHHHHHHHHHHHHhcC--CCcceeEEeEEECC---CCeEEEEe
Q 020085 115 ECKVASGSYGDLYKGTYCSQEVAIKVLK--PECVNTEMLKEFSQEVYIMRKIR--HKNVVQFIGACTRP---PNLCIVTE 187 (331)
Q Consensus 115 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~--~~~~~~~~~~~~~~E~~il~~l~--h~niv~~~~~~~~~---~~~~lV~E 187 (331)
.+.++.|.++.||+.+..+..+++|+.. .... ......+.+|..+++.+. +..+++++.++.+. +..++|||
T Consensus 43 ~~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~-~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKL-LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEECCC-CCSCEEEEECSSCEEEEECCCC-----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEEcCCcccceEEEEEECCceEEEEeCCCCCCCC-CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 5678999999999999888899999876 4321 122356888999999997 45678899888776 34899999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------
Q 020085 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ----------------------------------------- 226 (331)
Q Consensus 188 ~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~----------------------------------------- 226 (331)
|++|..+.+.. -..++......++.++++.|..||+
T Consensus 122 ~v~G~~l~~~~---~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (359)
T 3dxp_A 122 FVSGRVLWDQS---LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMD 198 (359)
T ss_dssp CCCCBCCCCTT---CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHH
T ss_pred ecCCeecCCCc---cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHH
Confidence 99998775421 2346778888899999999999997
Q ss_pred -----------------CCcccCCCCCCCEEEcCCCc--EEEeeecceeeec
Q 020085 227 -----------------NNIIHRDLKTANLLMDENGV--VKVADFGVARVQA 259 (331)
Q Consensus 227 -----------------~~iiHrDlkp~NiLi~~~~~--vkl~DFg~a~~~~ 259 (331)
..++|+|+++.||+++.++. +.|+||+.+....
T Consensus 199 ~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g~ 250 (359)
T 3dxp_A 199 SLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLGH 250 (359)
T ss_dssp HHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEEC
T ss_pred HHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccCC
Confidence 36899999999999998753 6899999997644
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.27 E-value=1.1e-11 Score=112.20 Aligned_cols=183 Identities=16% Similarity=0.176 Sum_probs=124.2
Q ss_pred eeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCc--ceeEEeEEECCC---CeEEEEecc
Q 020085 116 CKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKN--VVQFIGACTRPP---NLCIVTEFM 189 (331)
Q Consensus 116 ~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~-h~n--iv~~~~~~~~~~---~~~lV~E~~ 189 (331)
+.++.|.+..||+.. ..+++|+... ......+.+|..+++.+. +.. +.+.+....... ..|+|||++
T Consensus 26 ~~~~~G~~n~v~~v~---~~~vlR~~~~----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i 98 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN---RDFIFKFPKH----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI 98 (304)
T ss_dssp CEEEECSSEEEEEST---TSEEEEEESS----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred EecCCCCcceEEEEC---CEEEEEecCC----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence 358999999999864 6799999753 244577899999999884 322 445555443333 348899999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------------
Q 020085 190 ARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ------------------------------------------- 226 (331)
Q Consensus 190 ~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~------------------------------------------- 226 (331)
+|.+|.+... ..++......++.++++.+..||+
T Consensus 99 ~G~~l~~~~~---~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 175 (304)
T 3sg8_A 99 KGVPLTPLLL---NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDD 175 (304)
T ss_dssp CCEECCHHHH---HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHH
T ss_pred CCeECCcccc---ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHH
Confidence 9988875432 245677777888888888888886
Q ss_pred ---------------CCcccCCCCCCCEEEcC--CCcEEEeeecceeeecCCCccccCCCCcccccchhc----CCCC-C
Q 020085 227 ---------------NNIIHRDLKTANLLMDE--NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVI----EHKP-Y 284 (331)
Q Consensus 227 ---------------~~iiHrDlkp~NiLi~~--~~~vkl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~----~~~~-~ 284 (331)
..++|+|++|.||++++ ++.+.++||+.+.................-..|+.. .... .
T Consensus 176 ~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~ 255 (304)
T 3sg8_A 176 FYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHK 255 (304)
T ss_dssp HHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCS
T ss_pred HHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCC
Confidence 13699999999999998 556889999999765443211111100000122221 1100 0
Q ss_pred ---------CChhhHHHHHHHHHHHHcCCCCCC
Q 020085 285 ---------DYKADVFSFGIALWELLTGELPYA 308 (331)
Q Consensus 285 ---------~~~~Di~SlG~il~ell~g~~Pf~ 308 (331)
....+.|+++.++|.+.+|..+|-
T Consensus 256 ~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 256 DIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp CHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred CcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 123689999999999999998874
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.91 E-value=3.9e-08 Score=88.89 Aligned_cols=137 Identities=15% Similarity=0.136 Sum_probs=97.5
Q ss_pred eeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCC---cceeEEeEEE-CCCCeEEEEeccC
Q 020085 115 ECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHK---NVVQFIGACT-RPPNLCIVTEFMA 190 (331)
Q Consensus 115 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~---niv~~~~~~~-~~~~~~lV~E~~~ 190 (331)
.+.++.|....||+. ++.+++|+-. .......+.+|..+|+.+.+. .+.+.+.++. ..+..++|||+++
T Consensus 24 v~~l~~G~~n~v~~v---g~~~VlR~~~----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~ 96 (306)
T 3tdw_A 24 VESLGEGFRNYAILV---NGDWVFRFPK----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQ 96 (306)
T ss_dssp EEEEEECSSEEEEEE---TTTEEEEEES----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCC
T ss_pred eeecCCCcceeEEEE---CCEEEEEecC----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccC
Confidence 345788999999987 7889999953 234557899999999999752 3566777664 4455789999999
Q ss_pred CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-------------------------------------------
Q 020085 191 RGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN------------------------------------------- 227 (331)
Q Consensus 191 ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~------------------------------------------- 227 (331)
|.++.+... ..++......++.++.+.|..||+.
T Consensus 97 G~~l~~~~~---~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 97 GQILGEDGM---AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp SEECHHHHH---TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred CeECchhhh---hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 988876321 1234444445555555555555532
Q ss_pred -----------------CcccCCCCCCCEEEcC---CCc-EEEeeecceeeecCC
Q 020085 228 -----------------NIIHRDLKTANLLMDE---NGV-VKVADFGVARVQAQS 261 (331)
Q Consensus 228 -----------------~iiHrDlkp~NiLi~~---~~~-vkl~DFg~a~~~~~~ 261 (331)
.++|+|++|.||+++. ++. +.|+||+.+......
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd~~ 228 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISDPD 228 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEECGG
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCCHH
Confidence 3589999999999987 455 589999998765543
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.77 E-value=1.4e-07 Score=83.19 Aligned_cols=134 Identities=16% Similarity=0.212 Sum_probs=96.0
Q ss_pred eeeecCce-EEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCcceeEEeEEECCCCeEEEEeccCCC
Q 020085 117 KVASGSYG-DLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCIVTEFMARG 192 (331)
Q Consensus 117 ~lg~G~~g-~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~~~~lV~E~~~gg 192 (331)
.+..|..| .||+... .+..+.+|+-... ....+.+|..+|+.+. +--+.++++++...+..++|||+++|.
T Consensus 31 ~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~-----~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~ 105 (272)
T 4gkh_A 31 RDNVGQSGATIYRLYGKPNAPELFLKHGKGS-----VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGK 105 (272)
T ss_dssp EEECSSSSCEEEEEECCTTCCCEEEEEEETH-----HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSE
T ss_pred EccCCCcCCeEEEEEecCCCeEEEEEECCCC-----CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCc
Confidence 44556555 6898765 3568999997643 3456888999999885 323677888888888899999999998
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---------------------------------------------
Q 020085 193 SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN--------------------------------------------- 227 (331)
Q Consensus 193 sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~--------------------------------------------- 227 (331)
++.+..... ......+..++...|..||+.
T Consensus 106 ~~~~~~~~~-----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 180 (272)
T 4gkh_A 106 TAFQVLEEY-----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVW 180 (272)
T ss_dssp EHHHHHHHC-----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHH
T ss_pred cccccccCC-----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHH
Confidence 887765331 112234455555556666532
Q ss_pred -------------CcccCCCCCCCEEEcCCCcEEEeeecceeeecC
Q 020085 228 -------------NIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (331)
Q Consensus 228 -------------~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~ 260 (331)
.++|+|+.+.||++++++.+-|+||+.+.....
T Consensus 181 ~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~gdp 226 (272)
T 4gkh_A 181 KEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIADR 226 (272)
T ss_dssp HHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEEET
T ss_pred HHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccCCH
Confidence 158999999999999877778999999976543
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.58 E-value=8e-08 Score=88.40 Aligned_cols=81 Identities=11% Similarity=-0.000 Sum_probs=55.5
Q ss_pred eeee-eecCceEEEEEEEC--------CceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCC---CcceeEEeEEECC--
Q 020085 115 ECKV-ASGSYGDLYKGTYC--------SQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRH---KNVVQFIGACTRP-- 179 (331)
Q Consensus 115 ~~~l-g~G~~g~Vy~~~~~--------~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l~h---~niv~~~~~~~~~-- 179 (331)
.+.| +.|....+|+.... ++.+++|+...... .......+.+|..+++.+.. -.+.+++.++...
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 4567 88889999988765 67899998764320 00001346778888888752 3467788877655
Q ss_pred -CCeEEEEeccCCCCHH
Q 020085 180 -PNLCIVTEFMARGSIY 195 (331)
Q Consensus 180 -~~~~lV~E~~~ggsL~ 195 (331)
+..++||||++|..+.
T Consensus 105 ~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp TSSCEEEEECCCCBCCC
T ss_pred cCCceEEEEecCCCChh
Confidence 3468999999987654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.55 E-value=6.6e-07 Score=81.31 Aligned_cols=138 Identities=15% Similarity=0.148 Sum_probs=81.0
Q ss_pred eeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-----CCcceeEE-e--EEECCCCeEEEEe
Q 020085 116 CKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-----HKNVVQFI-G--ACTRPPNLCIVTE 187 (331)
Q Consensus 116 ~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~-----h~niv~~~-~--~~~~~~~~~lV~E 187 (331)
+.|+.|..+.||+....+..+++|+.... . ..+..|..+++.+. .|.++... | +....+..+++|+
T Consensus 38 ~~l~gG~~n~~~~v~~~~~~~vlk~~~~~---~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~ 111 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSGAVCLKRIHRP---E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYD 111 (346)
T ss_dssp EECC----CEEEEEEETTEEEEEEEECSC---H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEE
T ss_pred eeccccccCcEEEEEeCCCCEEEEecCCC---H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEE
Confidence 45666788999999887778999999753 2 23334555555553 24433310 0 1123456789999
Q ss_pred ccCCCCHH--------------HHHHhcCCCC-------------CHHH-------------------------------
Q 020085 188 FMARGSIY--------------DFLHKQKGVF-------------QLTS------------------------------- 209 (331)
Q Consensus 188 ~~~ggsL~--------------~~l~~~~~~~-------------~~~~------------------------------- 209 (331)
|++|.++. ..+|.....+ .+..
T Consensus 112 ~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ 191 (346)
T 2q83_A 112 WIEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQE 191 (346)
T ss_dssp CCCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHH
T ss_pred eecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHH
Confidence 99986532 1122211101 1110
Q ss_pred HHHHHHHHHHHHHHHH-------------hCCcccCCCCCCCEEEcCCCcEEEeeecceeeec
Q 020085 210 LLKVAIDVSKGMNYLH-------------QNNIIHRDLKTANLLMDENGVVKVADFGVARVQA 259 (331)
Q Consensus 210 ~~~i~~qi~~~l~~LH-------------~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~ 259 (331)
+..+..++..++++|+ ...++|+|+++.||+++.++.+.|+||+.+....
T Consensus 192 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~g~ 254 (346)
T 2q83_A 192 IDGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSFDL 254 (346)
T ss_dssp HHHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEECC
T ss_pred HHHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcccCC
Confidence 1111122334566665 3679999999999999888899999999986543
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.49 E-value=8.3e-07 Score=82.89 Aligned_cols=76 Identities=11% Similarity=0.036 Sum_probs=49.4
Q ss_pred eeeeeecCceEEEEEEE--CCceEEEEEecCCCC--CH---HHHHHHHHHHHHHHhcCC--Cc-ceeEEeEEECCCCeEE
Q 020085 115 ECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV--NT---EMLKEFSQEVYIMRKIRH--KN-VVQFIGACTRPPNLCI 184 (331)
Q Consensus 115 ~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~--~~---~~~~~~~~E~~il~~l~h--~n-iv~~~~~~~~~~~~~l 184 (331)
.+.+|.|.++.||+++. .++.+++|...+... .. .....+..|..+++.+.. |. +.+++.+ . .+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~-d-~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS-D-TEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE-E-TTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE-c-CCccEE
Confidence 45789999999999954 568899998764321 00 012456778899988742 43 4455543 2 345689
Q ss_pred EEeccCCC
Q 020085 185 VTEFMARG 192 (331)
Q Consensus 185 V~E~~~gg 192 (331)
|||+++|.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999874
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=98.18 E-value=1.6e-05 Score=74.88 Aligned_cols=78 Identities=17% Similarity=0.211 Sum_probs=47.1
Q ss_pred HhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCccccCC--CCcccccchhcCCCCC---CChhhHHHHHHHHHH
Q 020085 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKPY---DYKADVFSFGIALWE 299 (331)
Q Consensus 225 H~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~---~~~~Di~SlG~il~e 299 (331)
+...++|+|++|.|||++.++ +.++||+.+............. -...|++|+......- ....++.+....+|+
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 308 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN 308 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence 356799999999999998877 9999999997655332111111 1134555555432111 123445566666666
Q ss_pred HHcC
Q 020085 300 LLTG 303 (331)
Q Consensus 300 ll~g 303 (331)
.+++
T Consensus 309 ~y~~ 312 (420)
T 2pyw_A 309 LFNK 312 (420)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 5554
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=98.18 E-value=1.5e-05 Score=72.03 Aligned_cols=75 Identities=16% Similarity=0.136 Sum_probs=61.4
Q ss_pred eeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC---CCcceeEEeEEECCCCeEEEEeccCC
Q 020085 115 ECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR---HKNVVQFIGACTRPPNLCIVTEFMAR 191 (331)
Q Consensus 115 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~---h~niv~~~~~~~~~~~~~lV~E~~~g 191 (331)
.+.|+.|....+|+.+..++.+++|+.... ....+..|...|+.+. ...+++.+..+...+..++||||++|
T Consensus 41 ~~~l~gG~~n~~y~v~~~~~~~vlK~~~~~-----~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G 115 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDEVQTVFVKINERS-----YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK 115 (312)
T ss_dssp EEEECCSSSSEEEEEESSSCEEEEEEEEGG-----GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred eEEeCCccceeeeEEEECCCeEEEEeCCcc-----cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence 457899999999999888889999997643 2456888999998884 35688888888877889999999999
Q ss_pred CCH
Q 020085 192 GSI 194 (331)
Q Consensus 192 gsL 194 (331)
..+
T Consensus 116 ~~~ 118 (312)
T 3jr1_A 116 SKN 118 (312)
T ss_dssp CCC
T ss_pred CCC
Confidence 754
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=98.07 E-value=1.8e-05 Score=70.85 Aligned_cols=136 Identities=15% Similarity=0.205 Sum_probs=78.2
Q ss_pred eeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcc-eeEEeEEECCCCeEEEEecc-CCC
Q 020085 115 ECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNV-VQFIGACTRPPNLCIVTEFM-ARG 192 (331)
Q Consensus 115 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~ni-v~~~~~~~~~~~~~lV~E~~-~gg 192 (331)
.+.|+.|....+|+. +.+++|+..... .......+|..+++.+...++ .++++.+ ...-++++||+ +|.
T Consensus 23 i~~l~gG~tN~~~~~----~~~vlR~~~~~~---~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~ 93 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA----GDLCLRIPGKGT---EEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQ 93 (301)
T ss_dssp CEEEESCSSEEEEEE----TTEEEEEECC-------CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCE
T ss_pred eeEcCCcccccccee----eeEEEECCCCCc---cceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCc
Confidence 678999999999998 779999987531 111123467777777743222 4566543 33457899999 664
Q ss_pred CHHH------------------HHHhcCCCC----CH-HHHHHHHH--------------HHHHHHHHHH----h----C
Q 020085 193 SIYD------------------FLHKQKGVF----QL-TSLLKVAI--------------DVSKGMNYLH----Q----N 227 (331)
Q Consensus 193 sL~~------------------~l~~~~~~~----~~-~~~~~i~~--------------qi~~~l~~LH----~----~ 227 (331)
++.. .+|.....+ .. ..+..+.. .+.+.+..+. . .
T Consensus 94 ~l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~ 173 (301)
T 3dxq_A 94 TMSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPL 173 (301)
T ss_dssp ECCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCC
T ss_pred cCCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCc
Confidence 4421 111111111 11 11111111 1111122111 1 2
Q ss_pred CcccCCCCCCCEEEcCCCcEEEeeecceeeecC
Q 020085 228 NIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (331)
Q Consensus 228 ~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~ 260 (331)
.++|+|+.+.||+ ..++.+.++||..+.....
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g~~ 205 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGMNDP 205 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEEECT
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccCCCH
Confidence 4899999999999 5677789999999876544
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.89 E-value=3.3e-05 Score=70.11 Aligned_cols=138 Identities=13% Similarity=0.130 Sum_probs=75.1
Q ss_pred eeeecCceE-EEEEEEC-CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCC--CcceeEEeEEECCCCeEEEEeccCCC
Q 020085 117 KVASGSYGD-LYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH--KNVVQFIGACTRPPNLCIVTEFMARG 192 (331)
Q Consensus 117 ~lg~G~~g~-Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h--~niv~~~~~~~~~~~~~lV~E~~~gg 192 (331)
.|+.|.... +|+.+.. ++.+++|...+... ..+..|+.+++.+.. -.+.+++.+....+ +++||++.+.
T Consensus 25 ~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~~-----~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~ 97 (333)
T 3csv_A 25 PLAGDASSRRYQRLRSPTGAKAVLMDWSPEEG-----GDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDA 97 (333)
T ss_dssp C--------CCEEEECTTCCEEEEEECCTTTT-----CCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSC
T ss_pred ECCCCCCCceEEEEEcCCCCeEEEEECCCCCC-----ccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCc
Confidence 455555444 6677664 67788877654320 233456666666642 23556666543333 7899999876
Q ss_pred CHHHHHHhcC-------------------------CCCCHHHHH-------H-H------------HHHHHHHHHHH---
Q 020085 193 SIYDFLHKQK-------------------------GVFQLTSLL-------K-V------------AIDVSKGMNYL--- 224 (331)
Q Consensus 193 sL~~~l~~~~-------------------------~~~~~~~~~-------~-i------------~~qi~~~l~~L--- 224 (331)
.+.+.+.... ..++..... . + ...+...++.+
T Consensus 98 ~l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~ 177 (333)
T 3csv_A 98 LFTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSA 177 (333)
T ss_dssp BHHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred chHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHh
Confidence 6655442210 112221111 0 0 00112223333
Q ss_pred ---HhCCcccCCCCCCCEEEcCC----CcEEEeeecceeeecCC
Q 020085 225 ---HQNNIIHRDLKTANLLMDEN----GVVKVADFGVARVQAQS 261 (331)
Q Consensus 225 ---H~~~iiHrDlkp~NiLi~~~----~~vkl~DFg~a~~~~~~ 261 (331)
+...++|+|+.+.||+++.+ +.+.|+||+.+......
T Consensus 178 ~~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~~~ 221 (333)
T 3csv_A 178 QLEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGHRA 221 (333)
T ss_dssp HCCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEECTT
T ss_pred cccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCCCH
Confidence 13479999999999999875 68999999999766543
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.84 E-value=0.0001 Score=66.32 Aligned_cols=140 Identities=11% Similarity=0.121 Sum_probs=81.2
Q ss_pred eeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCc--ceeEEeE------EECCCCeEEEE
Q 020085 115 ECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN--VVQFIGA------CTRPPNLCIVT 186 (331)
Q Consensus 115 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~n--iv~~~~~------~~~~~~~~lV~ 186 (331)
.+.|+.|....+|+....+..+++|+...... ...+..|..+++.+...+ +.+++.. ....+..++++
T Consensus 27 ~~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~~----~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~ 102 (322)
T 2ppq_A 27 YKGIAEGVENSNFLLHTTKDPLILTLYEKRVE----KNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALI 102 (322)
T ss_dssp EEEECC---EEEEEEEESSCCEEEEEECC-------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEE
T ss_pred eeccCCCcccceEEEEeCCccEEEEEeCCCCC----HHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEE
Confidence 45678888899999988777899999876311 134556777777664212 2333321 11234568999
Q ss_pred eccCCCCHHH--------------HHHhcCCC--------CCHHHHHH---------------HHHHHHHHHHHHHh---
Q 020085 187 EFMARGSIYD--------------FLHKQKGV--------FQLTSLLK---------------VAIDVSKGMNYLHQ--- 226 (331)
Q Consensus 187 E~~~ggsL~~--------------~l~~~~~~--------~~~~~~~~---------------i~~qi~~~l~~LH~--- 226 (331)
+|++|..+.. .++..... ........ +...+.+.++.+++
T Consensus 103 ~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~ 182 (322)
T 2ppq_A 103 SFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWP 182 (322)
T ss_dssp ECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCC
T ss_pred EeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCc
Confidence 9999864311 12221111 11110000 00123445556653
Q ss_pred ----CCcccCCCCCCCEEEcCCCcEEEeeecceeee
Q 020085 227 ----NNIIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (331)
Q Consensus 227 ----~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~ 258 (331)
.+++|+|+++.||++++++.+.++||+.+...
T Consensus 183 ~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~g 218 (322)
T 2ppq_A 183 KDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACND 218 (322)
T ss_dssp CSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred ccCCcccCCCCCCccCEEEeCCceEEEecchhccCc
Confidence 36999999999999998766689999988654
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.80 E-value=0.00015 Score=64.42 Aligned_cols=80 Identities=13% Similarity=0.113 Sum_probs=56.7
Q ss_pred cccCcceeeeeeecCceEEEEEEE-CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCC---CcceeEEeEEECCCCeE
Q 020085 108 DAKQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH---KNVVQFIGACTRPPNLC 183 (331)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h---~niv~~~~~~~~~~~~~ 183 (331)
...+..-.+.+|.|..+.||+.+. +|+.|.+|+........ ...|..|...|+.+.. --+++.++.. .-+
T Consensus 13 ~G~~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~--~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~ 86 (288)
T 3f7w_A 13 TGREVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPAL--DGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRT 86 (288)
T ss_dssp HCCCEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC--TTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTE
T ss_pred cCCCeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch--hhHHHHHHHHHHHHHhhCCCCcceEEecc----Cce
Confidence 344566678899999999999987 57899999876443221 2457789999998842 1245555542 247
Q ss_pred EEEeccCCCC
Q 020085 184 IVTEFMARGS 193 (331)
Q Consensus 184 lV~E~~~ggs 193 (331)
+||||++++.
T Consensus 87 lv~e~l~~~~ 96 (288)
T 3f7w_A 87 LAMEWVDERP 96 (288)
T ss_dssp EEEECCCCCC
T ss_pred EEEEeecccC
Confidence 8999998764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.72 E-value=0.00016 Score=68.15 Aligned_cols=71 Identities=11% Similarity=0.197 Sum_probs=49.4
Q ss_pred eeeeeecCceEEEEEEEC---------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcc-eeEEeEEECCCCeEE
Q 020085 115 ECKVASGSYGDLYKGTYC---------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNV-VQFIGACTRPPNLCI 184 (331)
Q Consensus 115 ~~~lg~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~ni-v~~~~~~~~~~~~~l 184 (331)
.+.|+.|....+|+.... ++.+.+|+..... . ...+..|..+++.+...++ +++++.+.+ .+
T Consensus 78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~-~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~ 149 (429)
T 1nw1_A 78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE-T---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GR 149 (429)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC-C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC-c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CE
Confidence 457888999999999874 4789999985421 1 1344578888888853333 567766542 38
Q ss_pred EEeccCCCC
Q 020085 185 VTEFMARGS 193 (331)
Q Consensus 185 V~E~~~ggs 193 (331)
|+||++|.+
T Consensus 150 v~e~l~G~~ 158 (429)
T 1nw1_A 150 LEEYIPSRP 158 (429)
T ss_dssp EECCCCEEE
T ss_pred EEEEeCCcc
Confidence 999998743
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=97.60 E-value=0.00011 Score=67.73 Aligned_cols=72 Identities=11% Similarity=0.145 Sum_probs=44.5
Q ss_pred eeeeeecCceEEEEEEECC----------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCc-ceeEEeEEECCCCeE
Q 020085 115 ECKVASGSYGDLYKGTYCS----------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN-VVQFIGACTRPPNLC 183 (331)
Q Consensus 115 ~~~lg~G~~g~Vy~~~~~~----------~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~n-iv~~~~~~~~~~~~~ 183 (331)
.+.++.|....+|+....+ +.+++|+..... ........|..+++.+...+ ..++++.. . -+
T Consensus 38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~---~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~ 110 (369)
T 3c5i_A 38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV---DELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GG 110 (369)
T ss_dssp EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG---GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TE
T ss_pred EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc---cceecHHHHHHHHHHHHhcCCCCceEEec--C--Cc
Confidence 3467788889999988754 688999876431 11112357888888775333 44666544 2 37
Q ss_pred EEEeccCCCC
Q 020085 184 IVTEFMARGS 193 (331)
Q Consensus 184 lV~E~~~ggs 193 (331)
+||||++|.+
T Consensus 111 ~v~e~i~G~~ 120 (369)
T 3c5i_A 111 RIEEWLYGDP 120 (369)
T ss_dssp EEEECCCSEE
T ss_pred EEEEEecCCc
Confidence 8999999854
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.52 E-value=0.00044 Score=64.10 Aligned_cols=137 Identities=12% Similarity=0.186 Sum_probs=82.5
Q ss_pred eeeeecCceEEEEEEEC---------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCcceeEEeEEECCCCeEEE
Q 020085 116 CKVASGSYGDLYKGTYC---------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCIV 185 (331)
Q Consensus 116 ~~lg~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~~~~lV 185 (331)
+.+..|-...+|+.+.. ++.+.+|+..... .....+.+|..+++.+. +.-..++++.+.+ .+|
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v 128 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAIL---QGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRL 128 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC------CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCcc---chHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccE
Confidence 45777888889998763 3689999863321 12345668999998885 3223667766643 399
Q ss_pred EeccCCCCHHH--------------H---HHhcCC----CCC--HHHHHHHHHHHHH-------------------HHHH
Q 020085 186 TEFMARGSIYD--------------F---LHKQKG----VFQ--LTSLLKVAIDVSK-------------------GMNY 223 (331)
Q Consensus 186 ~E~~~ggsL~~--------------~---l~~~~~----~~~--~~~~~~i~~qi~~-------------------~l~~ 223 (331)
|||++|.+|.. . +|.... ... ..++.++..++.. .++.
T Consensus 129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 208 (379)
T 3feg_A 129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN 208 (379)
T ss_dssp EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence 99999864421 1 122111 111 2445555544322 2333
Q ss_pred HH----h----CCcccCCCCCCCEEEcCC----CcEEEeeecceeeec
Q 020085 224 LH----Q----NNIIHRDLKTANLLMDEN----GVVKVADFGVARVQA 259 (331)
Q Consensus 224 LH----~----~~iiHrDlkp~NiLi~~~----~~vkl~DFg~a~~~~ 259 (331)
|. . ..++|+|+.+.||+++.+ +.+.++||..+....
T Consensus 209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~~~ 256 (379)
T 3feg_A 209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSYNY 256 (379)
T ss_dssp HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEEEE
T ss_pred HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCcCC
Confidence 33 2 258999999999999887 789999999997543
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.43 E-value=0.0019 Score=58.00 Aligned_cols=138 Identities=13% Similarity=0.120 Sum_probs=79.5
Q ss_pred eeeecCceEEEEEEE-CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCc--ceeEEeE-----EECCCCeEEEEec
Q 020085 117 KVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN--VVQFIGA-----CTRPPNLCIVTEF 188 (331)
Q Consensus 117 ~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~n--iv~~~~~-----~~~~~~~~lV~E~ 188 (331)
.++ |....||+... .|+.+++|+.++...+. ..+..|..+++.+.... +++++.. ....+..++++++
T Consensus 33 ~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~~~---~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~ 108 (328)
T 1zyl_A 33 PLN-SYENRVYQFQDEDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPS 108 (328)
T ss_dssp EEC-CSSSEEEEECCTTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEEC
T ss_pred eec-CcccceEEEEcCCCCEEEEEEcCCCCCCH---HHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEe
Confidence 455 77889998876 45689999998654333 34566777777774212 3444432 1123456789999
Q ss_pred cCCCCHH-----H------H---HHhc--C------CCCCHHHH----HHHH---------------HHHHHHHHHHH--
Q 020085 189 MARGSIY-----D------F---LHKQ--K------GVFQLTSL----LKVA---------------IDVSKGMNYLH-- 225 (331)
Q Consensus 189 ~~ggsL~-----~------~---l~~~--~------~~~~~~~~----~~i~---------------~qi~~~l~~LH-- 225 (331)
++|..+. . . +|.. . ...+.... ..++ ..+-..++.+.
T Consensus 109 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 188 (328)
T 1zyl_A 109 VGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAH 188 (328)
T ss_dssp CCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHH
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHH
Confidence 9885321 1 1 1211 0 11121111 0010 01111223332
Q ss_pred -----hCCcccCCCCCCCEEEcCCCcEEEeeecceeeecC
Q 020085 226 -----QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (331)
Q Consensus 226 -----~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~ 260 (331)
...++|+|+++.||+++ + .+.++||+.+.....
T Consensus 189 ~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g~~ 226 (328)
T 1zyl_A 189 WREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNGPA 226 (328)
T ss_dssp CCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEECT
T ss_pred hhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcCcH
Confidence 34589999999999998 4 899999998875543
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.37 E-value=0.0014 Score=62.29 Aligned_cols=73 Identities=19% Similarity=0.123 Sum_probs=48.5
Q ss_pred eeeeeecCceEEEEEEECC--ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcc-eeEEeEEECCCCeEEEEeccCC
Q 020085 115 ECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNV-VQFIGACTRPPNLCIVTEFMAR 191 (331)
Q Consensus 115 ~~~lg~G~~g~Vy~~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~ni-v~~~~~~~~~~~~~lV~E~~~g 191 (331)
.+.|+.|-...+|+....+ +.+++|+....... .-...+|..+++.+...++ +++++.+. + .+|+||++|
T Consensus 113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~---~idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G 185 (458)
T 2qg7_A 113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE---IINREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDG 185 (458)
T ss_dssp EEEECC--CEEEEEEEETTTTEEEEEEEECC-CCS---CSCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCS
T ss_pred EEEcCCCeEeEEEEEEECCCCceEEEEECCCChhh---hcCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCC
Confidence 4578889999999999876 88999998543210 0112578888988865444 56777663 1 369999998
Q ss_pred CCH
Q 020085 192 GSI 194 (331)
Q Consensus 192 gsL 194 (331)
.+|
T Consensus 186 ~~l 188 (458)
T 2qg7_A 186 YAL 188 (458)
T ss_dssp EEC
T ss_pred ccC
Confidence 543
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=97.36 E-value=0.00081 Score=61.23 Aligned_cols=34 Identities=15% Similarity=0.356 Sum_probs=29.8
Q ss_pred CCcccCCCCCCCEEEcCCCcEEEeeecceeeecC
Q 020085 227 NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (331)
Q Consensus 227 ~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~ 260 (331)
..++|+|+.+.||++++++.+.++||+.+.....
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~~~ 239 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLAPK 239 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEEECT
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeCCH
Confidence 4699999999999999888999999998876554
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.81 E-value=0.0078 Score=50.94 Aligned_cols=101 Identities=16% Similarity=0.114 Sum_probs=68.8
Q ss_pred CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCccccCCCCc
Q 020085 193 SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTY 271 (331)
Q Consensus 193 sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~~~~~gt~ 271 (331)
||.++|...+.++++++++.++.|.+++|.-+-. +.-..+=+.|..|++..+|.|.+.+ +.+. ....
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------~~~~ 101 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------AGEP 101 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-----------cccc
Confidence 8999999989999999999999999999877622 2212344457899999999987774 1111 1223
Q ss_pred ccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCC
Q 020085 272 RWMAPEVIEHKPYDYKADVFSFGIALWELLTGELP 306 (331)
Q Consensus 272 ~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~P 306 (331)
.+.|||... ...+.+.=|||||+++|.-+--..|
T Consensus 102 ~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~ 135 (229)
T 2yle_A 102 PPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK 135 (229)
T ss_dssp -----CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC
T ss_pred CCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC
Confidence 456787763 3446788899999999998874433
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=96.71 E-value=0.0027 Score=59.70 Aligned_cols=72 Identities=11% Similarity=0.146 Sum_probs=48.0
Q ss_pred eeeeeecCceEEEEEEEC---------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCcceeEEeEEECCCCeEE
Q 020085 115 ECKVASGSYGDLYKGTYC---------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCI 184 (331)
Q Consensus 115 ~~~lg~G~~g~Vy~~~~~---------~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~~~~l 184 (331)
.+.+..|-...+|+.... ++.+++++..... +..-...+|..+++.+. +.-..++++.+. -++
T Consensus 75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t---~~~idR~~E~~~l~~L~~~gi~P~l~~~~~----~~~ 147 (424)
T 3mes_A 75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV---GKFYDSKVELDVFRYLSNINIAPNIIADFP----EGR 147 (424)
T ss_dssp EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC----CCCCHHHHHHHHHHHHHTTSSCCEEEEET----TEE
T ss_pred EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc---chhcCHHHHHHHHHHHHhcCCCCCEEEEcC----CCE
Confidence 456777888999999876 6889999965431 11112356888888775 323455665432 278
Q ss_pred EEeccCCCC
Q 020085 185 VTEFMARGS 193 (331)
Q Consensus 185 V~E~~~ggs 193 (331)
|+||++|..
T Consensus 148 I~efI~G~~ 156 (424)
T 3mes_A 148 IEEFIDGEP 156 (424)
T ss_dssp EEECCCSEE
T ss_pred EEEEeCCcc
Confidence 999999865
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=95.58 E-value=0.071 Score=49.42 Aligned_cols=32 Identities=22% Similarity=0.396 Sum_probs=26.9
Q ss_pred cccCCCCCCCEEE------cCCCcEEEeeecceeeecC
Q 020085 229 IIHRDLKTANLLM------DENGVVKVADFGVARVQAQ 260 (331)
Q Consensus 229 iiHrDlkp~NiLi------~~~~~vkl~DFg~a~~~~~ 260 (331)
++|+|+.+.|||+ ++++.+.++||..|.....
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~n~~ 283 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSYNYR 283 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEEEEH
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccCCCc
Confidence 6799999999999 4567899999999976543
|
| >1u8s_A Glycine cleavage system transcriptional repressor, putative; structural genomics, protein structure initiative (PSI), domain swapping; 2.45A {Vibrio cholerae} SCOP: d.58.18.5 d.58.18.5 | Back alignment and structure |
|---|
Probab=94.13 E-value=0.056 Score=44.66 Aligned_cols=52 Identities=17% Similarity=0.247 Sum_probs=40.3
Q ss_pred HHHHHHHHHhhhCCCeeeeeeeecCCCceeeEEEecCCCCCchHHHHHHHHHHH
Q 020085 10 KVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEI 63 (331)
Q Consensus 10 ~~~~~~~~~~~~~~~i~~~~~~~t~~~~~~~~~vv~gw~~~~~~~l~~~l~~~~ 63 (331)
+++++|.+|++.|+||.++..|.+.++|.+ .++|++ +....+.|+..|.+..
T Consensus 19 iva~vt~~La~~g~NI~d~~~~~~~~~f~~-~~~v~~-~~~~~~~l~~~L~~~~ 70 (192)
T 1u8s_A 19 ICNEVVRLVTQAGCNIIDSRIAMFGKEFTL-LMLISG-SPSNITRVETTLPLLG 70 (192)
T ss_dssp HHHHHHHHHHHTTCEEEEEEEEEETTEEEE-EEEEEE-CHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHCCCCEEeeeeeecCCceEE-EEEEec-CCCCHHHHHHHHHHHH
Confidence 688999999999999999999999988888 666664 2234566666666543
|
| >2nyi_A Unknown protein; protein structure initiative, PSI, center for eukaryotic structural genomics, CESG, structural genomics; 1.80A {Galdieria sulphuraria} | Back alignment and structure |
|---|
Probab=93.73 E-value=0.072 Score=44.21 Aligned_cols=35 Identities=17% Similarity=0.302 Sum_probs=31.5
Q ss_pred HHHHHHHHHhhhCCCeeeeeeeecCCCceeeEEEec
Q 020085 10 KVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVD 45 (331)
Q Consensus 10 ~~~~~~~~~~~~~~~i~~~~~~~t~~~~~~~~~vv~ 45 (331)
+.++++..|++.|+||.+|..|.+.++|.+ .+.|+
T Consensus 18 iva~vs~~La~~g~NI~da~q~~~~~~f~m-~~~v~ 52 (195)
T 2nyi_A 18 IVHDFSWALKNISANVESSRMACLGGDFAM-IVLVS 52 (195)
T ss_dssp HHHHHHHHHHHTTCEEEEEEEEEETTEEEE-EEEEE
T ss_pred HHHHHHHHHHHCCCCEEEEEeEEECCeEEE-EEEEE
Confidence 678999999999999999999999999999 55554
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=93.65 E-value=0.0055 Score=58.24 Aligned_cols=61 Identities=11% Similarity=0.050 Sum_probs=17.3
Q ss_pred eeeeeeecCceEEEEEEECC--ceEEE------EEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEE
Q 020085 114 IECKVASGSYGDLYKGTYCS--QEVAI------KVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACT 177 (331)
Q Consensus 114 ~~~~lg~G~~g~Vy~~~~~~--~~vav------K~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 177 (331)
+.+++| ||.||+|.+.+ .+||+ |..+......+....+.+|..+++..+|||+++.+++..
T Consensus 146 l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~ 214 (463)
T 3cxl_A 146 IYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKV 214 (463)
T ss_dssp STTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEE
T ss_pred ccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEE
Confidence 445666 99999999965 57888 877765555555677899999999999999999987664
|
| >1zpv_A ACT domain protein; structural genomics, PSI, protein structure INIT midwest center for structural genomics, MCSG, unknown funct; 1.90A {Streptococcus pneumoniae} SCOP: d.58.18.7 | Back alignment and structure |
|---|
Probab=91.81 E-value=0.47 Score=33.57 Aligned_cols=53 Identities=19% Similarity=0.143 Sum_probs=42.3
Q ss_pred HHHHHHHHHhhhCCCeeeeeeeecCCCceeeEEEecCCCCCchHHHHHHHHHHH
Q 020085 10 KVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEI 63 (331)
Q Consensus 10 ~~~~~~~~~~~~~~~i~~~~~~~t~~~~~~~~~vv~gw~~~~~~~l~~~l~~~~ 63 (331)
+|+++|++|++.|.||.+.+.+.+. |...-.+.++.-..+..+++...|.+-.
T Consensus 18 ila~vt~~la~~~~NI~~i~~~~~~-~~~~~~i~v~~~~~~~l~~l~~~L~~~~ 70 (91)
T 1zpv_A 18 IVAGVSGKIAELGLNIDDISQTVLD-EYFTMMAVVSSDEKQDFTYLRNEFEAFG 70 (91)
T ss_dssp HHHHHHHHHHHTTCEEEEEEEEEET-TEEEEEEEEEESSCCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHcCCCEEEEEeEEEc-CEEEEEEEEEeCCCCCHHHHHHHHHHHH
Confidence 6889999999999999999998775 7766666666544567888888887643
|
| >1cja_A Protein (actin-fragmin kinase); transferase; HET: AMP; 2.90A {Physarum polycephalum} SCOP: d.144.1.3 | Back alignment and structure |
|---|
Probab=90.56 E-value=3.2 Score=37.20 Aligned_cols=144 Identities=13% Similarity=0.130 Sum_probs=80.3
Q ss_pred eeecccC---cceeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeE------
Q 020085 105 WEIDAKQ---LKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGA------ 175 (331)
Q Consensus 105 ~~i~~~~---~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~------ 175 (331)
-.|+++. ++.++..-.|+.|.++-.+ ++..+.||-.. .-..+-+..++...=.+.-|+..-+...
T Consensus 61 ~~i~w~~l~~v~~I~~s~~Gstgvff~~t-d~~~~VVK~s~-----~l~~E~l~s~LA~~LGlpiP~~Riv~~~~~E~~e 134 (342)
T 1cja_A 61 GDINWKNLQQFKGIERSEKGTEGLFFVET-ESGVFIVKRST-----NIESETFCSLLCMRLGLHAPKVRVVSSNSEEGTN 134 (342)
T ss_dssp TCCCTTCGGGEEEEEECCSTTSCEEEEEE-SSCEEEEECCT-----THHHHHHHHHHHHHHTCCCCCEEEEESSSHHHHH
T ss_pred cccccccccCeeEEEeccCCCCCeEEEEe-CCCEEEEeCcH-----HHHHHHHHHHHHHHhCCCCCCeeEEeeCcHHHHH
Confidence 4566666 6677777888766555544 78889999431 2233444555544444555553222211
Q ss_pred ----------------EECCCCeEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHH--HHHHHHHHhCC----ccc-
Q 020085 176 ----------------CTRPPNLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDV--SKGMNYLHQNN----IIH- 231 (331)
Q Consensus 176 ----------------~~~~~~~~lV~E~~~ggsL~~~l~~~-~~~~~~~~~~~i~~qi--~~~l~~LH~~~----iiH- 231 (331)
........++|+|.+|..|.+.-... ...+.... +.++ +-+++.+.+++ .+.
T Consensus 135 ~~~~L~~~~~~~~~l~~l~~~~~~l~meyv~G~~L~e~~~~~~~~~f~~~~----~k~LG~Ii~FDi~InN~DR~Pl~W~ 210 (342)
T 1cja_A 135 MLECLAAIDKSFRVITTLANQANILLMELVRGITLNKLTTTSAPEVLTKST----MQQLGSLMALDVIVNNSDRLPIAWT 210 (342)
T ss_dssp HHHHHHHHCSSSCHHHHHTTCSEEEEEECCCEEESTTCCSSSHHHHSCHHH----HHHHHHHHHHHHHHTCCSSSCSSSC
T ss_pred HHHHHHHhhhhhHHHHHhhcccceehhhhcCCCccccchhhhhhhhcCHHH----HHhhchhheehhhhcCCccCccccc
Confidence 00122466999999986655431110 01122222 2332 23567777653 111
Q ss_pred CCCCCCCEEEcCCCc-EEEeeecceeee
Q 020085 232 RDLKTANLLMDENGV-VKVADFGVARVQ 258 (331)
Q Consensus 232 rDlkp~NiLi~~~~~-vkl~DFg~a~~~ 258 (331)
.-=.+.|||+++++. +.++|-+.+...
T Consensus 211 n~GN~~NIL~~~~n~~~~~IDhn~af~~ 238 (342)
T 1cja_A 211 NEGNLDNIMLSERGATVVPIDSKIIPLD 238 (342)
T ss_dssp SCCCGGGEEEESBTTCEEECSCCCCCCC
T ss_pred CCCChhheEEeCCCCeEEEEcCCccccC
Confidence 235889999987655 899999988543
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=88.82 E-value=1.1 Score=37.50 Aligned_cols=115 Identities=10% Similarity=0.125 Sum_probs=74.7
Q ss_pred CCCcceeEEeEEECCCCeEEEEeccCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC
Q 020085 165 RHKNVVQFIGACTRPPNLCIVTEFMARG-SIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE 243 (331)
Q Consensus 165 ~h~niv~~~~~~~~~~~~~lV~E~~~gg-sL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~ 243 (331)
.||+++.. .+-...+.+.+.++.-+.+ ++.. + ...+....++++.+|+....+++. =+|--++|+|++++.
T Consensus 43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i----k~~~~~eKlr~l~ni~~l~~~~~~--r~tf~L~P~NL~f~~ 114 (215)
T 4ann_A 43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I----KSFTKNEKLRYLLNIKNLEEVNRT--RYTFVLAPDELFFTR 114 (215)
T ss_dssp CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G----GGSCHHHHHHHHHHGGGGGGGGGS--SEECCCSGGGEEECT
T ss_pred cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H----HhcCHHHHHHHHHHHHHHHHHhcC--ceEEEEecceEEEcC
Confidence 57888876 3445555566666654422 3333 2 346788889999999887744432 357789999999999
Q ss_pred CCcEEEeeecceeeecCCCccccCCCCcccccchhcCCCCCCChhh-HHHHHHHHHHHHcCCCCCCC
Q 020085 244 NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKAD-VFSFGIALWELLTGELPYAG 309 (331)
Q Consensus 244 ~~~vkl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~D-i~SlG~il~ell~g~~Pf~~ 309 (331)
++.+++.-.|+-... +|. .++ ..| .-.+=|++..++.++..|..
T Consensus 115 ~~~p~i~~RGik~~l----------------~P~-----~~~-ee~fL~qyKAliiall~~K~~Fe~ 159 (215)
T 4ann_A 115 DGLPIAKTRGLQNVV----------------DPL-----PVS-EAEFLTRYKALVICAFNEKQSFDA 159 (215)
T ss_dssp TSCEEESCCEETTTB----------------SCC-----CCC-HHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred CCCEEEEEccCccCC----------------CCC-----CCC-HHHHHHHHHHHHHHHHcCCCCHHH
Confidence 999999977764211 111 111 223 33577888888888888754
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=85.61 E-value=4 Score=34.22 Aligned_cols=115 Identities=11% Similarity=0.047 Sum_probs=73.1
Q ss_pred CCCcceeEEeEEECCCCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHH-HHHhCCcccCCCCCCCEEEcC
Q 020085 165 RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMN-YLHQNNIIHRDLKTANLLMDE 243 (331)
Q Consensus 165 ~h~niv~~~~~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~-~LH~~~iiHrDlkp~NiLi~~ 243 (331)
.||++ .. ..-..++.+.+.++--+++.=...+ ...+....++++.+|+.... ++ ..-+|--++|+|++++.
T Consensus 48 ~~~~f-~~-~I~~~eD~~~i~y~~~~~~~~f~~i----~~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~~ 119 (219)
T 4ano_A 48 VDPCI-VR-DIDVSEDEVKVVIKPPSSFLTFAAI----RKTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFNR 119 (219)
T ss_dssp SCSSS-EE-EEEECSSEEEEEEECCTTCEEHHHH----HTSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEECT
T ss_pred cCCCC-Ce-EEEEeCCEEEEEEEcCcccCcHHHH----HhcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEeC
Confidence 57888 32 2335566666767765444223333 24678888999999887555 33 34567789999999999
Q ss_pred CCcEEEeeecceeeecCCCccccCCCCcccccchhcCCCCCCChhhH-HHHHHHHHHHHcCCCCCCC
Q 020085 244 NGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADV-FSFGIALWELLTGELPYAG 309 (331)
Q Consensus 244 ~~~vkl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di-~SlG~il~ell~g~~Pf~~ 309 (331)
++.+++.-.|+-... +|..+ ...|. -++=|++..++.++..|..
T Consensus 120 ~~~p~i~hRGi~~~l----------------pP~e~------~ee~fl~qyKali~all~~K~~Fe~ 164 (219)
T 4ano_A 120 ALEPFFLHVGVKESL----------------PPDEW------DDERLLREVKATVLALTEGEYRFDE 164 (219)
T ss_dssp TCCEEESCCEETTTB----------------SSCSC------CHHHHHHHHHHHHHHHTTCSSCHHH
T ss_pred CCcEEEEEcCCcccC----------------CCCCC------CHHHHHHHHHHHHHHHHcCCCCHHH
Confidence 999999977764222 11111 11233 3466777777877777654
|
| >2f1f_A Acetolactate synthase isozyme III small subunit; ferredoxin fold, ACT domain, transferase; HET: P33 1PE; 1.75A {Escherichia coli} SCOP: d.58.18.6 d.58.18.6 | Back alignment and structure |
|---|
Probab=85.37 E-value=1.4 Score=35.26 Aligned_cols=51 Identities=22% Similarity=0.248 Sum_probs=40.0
Q ss_pred HHHHHHHHHhhhCCCeeeeeeeecCC-CceeeEEEecCCCCCchHHHHHHHHHHHHh
Q 020085 10 KVGELTSLLGEIGLNIQEAHAFSTVD-GFSLDVFVVDGWPYDETEDLKNVLAKEILK 65 (331)
Q Consensus 10 ~~~~~~~~~~~~~~~i~~~~~~~t~~-~~~~~~~vv~gw~~~~~~~l~~~l~~~~~~ 65 (331)
+|++++.++++-|.||.-..+..|.| |.+-=.++|++- +...+.+.+.+.+
T Consensus 16 vLarIt~lfs~rg~NI~Sl~v~~t~d~~~sriti~V~~d-----~~~leqI~kqL~K 67 (164)
T 2f1f_A 16 ALSRVIGLFSQRGYNIESLTVAPTDDPTLSRMTIQTVGD-----EKVLEQIEKQLHK 67 (164)
T ss_dssp HHHHHHHHHHTTTCCCSEEEEEECSCSSEEEEEEEEESC-----HHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHCCCCeeeceeeecCCCCEEEEEEEEecc-----HHHHHHHHHHHcC
Confidence 68999999999999999999998886 888888899832 3444445555544
|
| >2ko1_A CTR148A, GTP pyrophosphokinase; homodimer, alpha+beta, transferase, structural genomics, PSI-2, protein structure initiative; NMR {Chlorobaculum tepidum} PDB: 3ibw_A | Back alignment and structure |
|---|
Probab=85.11 E-value=0.95 Score=31.50 Aligned_cols=36 Identities=8% Similarity=0.033 Sum_probs=28.0
Q ss_pred HHHHHHHHHhhhCCCeeeeeeeecCCCceeeEEEecC
Q 020085 10 KVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDG 46 (331)
Q Consensus 10 ~~~~~~~~~~~~~~~i~~~~~~~t~~~~~~~~~vv~g 46 (331)
+|++++++|++.|.||.........+ ....++.++.
T Consensus 18 ~L~~I~~~la~~~inI~~i~~~~~~~-~~~~~i~v~~ 53 (88)
T 2ko1_A 18 MTNQITGVISKFDTNIRTIVLNAKDG-IFTCNLMIFV 53 (88)
T ss_dssp HHHHHHHHHTTSSSCEEEEEEEECSS-EEEEEEEEEE
T ss_pred HHHHHHHHHHHCCCCeEEEEEEEcCC-EEEEEEEEEE
Confidence 68999999999999999988876544 5555565553
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 331 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 1e-75 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-65 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 5e-63 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-61 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-61 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 2e-60 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 9e-60 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-59 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 4e-59 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 7e-59 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-58 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 5e-58 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 1e-57 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 1e-57 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-57 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 3e-57 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 4e-57 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 7e-57 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 9e-57 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 4e-56 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 3e-55 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 5e-55 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 5e-54 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 9e-54 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 1e-53 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-53 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-53 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-52 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 4e-52 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 6e-52 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 8e-51 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-50 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-50 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 9e-50 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-49 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 2e-49 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-49 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-49 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 3e-48 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 8e-48 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 7e-47 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 9e-47 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 1e-46 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 5e-46 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 7e-46 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 1e-44 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-44 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-44 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-43 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 5e-43 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 8e-43 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-42 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-42 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 7e-41 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 9e-41 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-40 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 3e-40 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 4e-38 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-37 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 6e-37 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 9e-36 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-28 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-18 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 232 bits (592), Expect = 1e-75
Identities = 86/226 (38%), Positives = 140/226 (61%), Gaps = 8/226 (3%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMR 162
D WEI Q+ + ++ SGS+G +YKG + +VA+K+L + L+ F EV ++R
Sbjct: 1 DDWEIPDGQITVGQRIGSGSFGTVYKGKW-HGDVAVKMLNVTAPTPQQLQAFKNEVGVLR 59
Query: 163 KIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMN 222
K RH N++ F+G T P L IVT++ S+Y LH + F++ L+ +A ++GM+
Sbjct: 60 KTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMD 118
Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ---SGVMTAETGTYRWMAPEVI 279
YLH +IIHRDLK+ N+ + E+ VK+ DFG+A V+++ S +G+ WMAPEVI
Sbjct: 119 YLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178
Query: 280 EHK---PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK 322
+ PY +++DV++FGI L+EL+TG+LPY+ + + +V +
Sbjct: 179 RMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR 224
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (521), Expect = 3e-65
Identities = 76/214 (35%), Positives = 119/214 (55%), Gaps = 9/214 (4%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI 164
W ++ K+LK+ + G +GD+ G Y +VA+K +K N + F E +M ++
Sbjct: 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIK----NDATAQAFLAEASVMTQL 57
Query: 165 RHKNVVQFIGACTRPPN-LCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMN 222
RH N+VQ +G L IVTE+MA+GS+ D+L + + V LLK ++DV + M
Sbjct: 58 RHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAME 117
Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHK 282
YL NN +HRDL N+L+ E+ V KV+DFG+ + + + +W APE + K
Sbjct: 118 YLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALREK 175
Query: 283 PYDYKADVFSFGIALWELLT-GELPYAGLTPLQA 315
+ K+DV+SFGI LWE+ + G +PY +
Sbjct: 176 KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV 209
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 201 bits (511), Expect = 5e-63
Identities = 56/207 (27%), Positives = 106/207 (51%), Gaps = 6/207 (2%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRK 163
E+ + ++ +G+ G ++K ++ +A K++ E + + + +E+ ++ +
Sbjct: 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE-IKPAIRNQIIRELQVLHE 60
Query: 164 IRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNY 223
+V F GA + I E M GS+ L K G L KV+I V KG+ Y
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTY 119
Query: 224 LHQ-NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHK 282
L + + I+HRD+K +N+L++ G +K+ DFGV+ Q + + GT +M+PE ++
Sbjct: 120 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG-QLIDSMANSFVGTRSYMSPERLQGT 178
Query: 283 PYDYKADVFSFGIALWELLTGELPYAG 309
Y ++D++S G++L E+ G P
Sbjct: 179 HYSVQSDIWSMGLSLVEMAVGRYPIPP 205
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (498), Expect = 2e-61
Identities = 74/236 (31%), Positives = 120/236 (50%), Gaps = 17/236 (7%)
Query: 95 IEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLK 152
+ + D WEI + + G++G +YK S A KV+ + + E L+
Sbjct: 4 VTRDLNPEDFWEIIGE-------LGDGAFGKVYKAQNKETSVLAAAKVIDTK--SEEELE 54
Query: 153 EFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLK 212
++ E+ I+ H N+V+ + A NL I+ EF A G++ + + + + +
Sbjct: 55 DYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQV 114
Query: 213 VAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAETGTY 271
V +NYLH N IIHRDLK N+L +G +K+ADFGV+ ++ + GT
Sbjct: 115 VCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTP 174
Query: 272 RWMAPEVI-----EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK 322
WMAPEV+ + +PYDYKADV+S GI L E+ E P+ L P++ + + +
Sbjct: 175 YWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKS 230
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (496), Expect = 2e-61
Identities = 57/213 (26%), Positives = 103/213 (48%), Gaps = 7/213 (3%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTE-MLKEFSQEVYIM 161
W ++ +I + G +G++Y +A+KVL + + + +EV I
Sbjct: 3 WALE--DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 60
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
+RH N+++ G + ++ E+ G++Y L K F +++ +
Sbjct: 61 SHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANAL 119
Query: 222 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEH 281
+Y H +IHRD+K NLL+ G +K+ADFG + A S T GT ++ PE+IE
Sbjct: 120 SYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTTLCGTLDYLPPEMIEG 178
Query: 282 KPYDYKADVFSFGIALWELLTGELPYAGLTPLQ 314
+ +D K D++S G+ +E L G+ P+ T +
Sbjct: 179 RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 211
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 2e-60
Identities = 86/224 (38%), Positives = 131/224 (58%), Gaps = 11/224 (4%)
Query: 98 PTDGT--DVWEIDAKQLKIECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEF 154
T G D WEI + L++E K+ G +G+++ GT+ VAIK LKP ++ E F
Sbjct: 3 QTQGLAKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE---AF 59
Query: 155 SQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKV 213
QE +M+K+RH+ +VQ + P + IVTE+M++GS+ DFL + G +L L+ +
Sbjct: 60 LQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDM 118
Query: 214 AIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSGVMTAETGTY 271
A ++ GM Y+ + N +HRDL+ AN+L+ EN V KVADFG+AR+ +
Sbjct: 119 AAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPI 178
Query: 272 RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQ 314
+W APE + + K+DV+SFGI L EL T G +PY G+ +
Sbjct: 179 KWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE 222
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 9e-60
Identities = 72/218 (33%), Positives = 127/218 (58%), Gaps = 9/218 (4%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIM 161
D WE+ + LK+ ++ +G +G+++ G Y +VA+K LK ++ + F E +M
Sbjct: 6 DEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD---AFLAEANLM 62
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGV-FQLTSLLKVAIDVSKG 220
++++H+ +V+ T+ P + I+TE+M GS+ DFL G+ + LL +A +++G
Sbjct: 63 KQLQHQRLVRLYAVVTQEP-IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV--QAQSGVMTAETGTYRWMAPEV 278
M ++ + N IHRDL+ AN+L+ + K+ADFG+AR+ + +W APE
Sbjct: 122 MAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 181
Query: 279 IEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQA 315
I + + K+DV+SFGI L E++T G +PY G+T +
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEV 219
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 190 bits (484), Expect = 4e-59
Identities = 68/212 (32%), Positives = 103/212 (48%), Gaps = 10/212 (4%)
Query: 117 KVASGSYGDLYKGTYCS--QEVAIKVLKPECVNT-EMLKEFSQEVYIMRKIRHKNVVQFI 173
++ GS+G +Y + VAIK + + E ++ +EV ++K+RH N +Q+
Sbjct: 22 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 174 GACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233
G R +V E+ + D L K Q + V +G+ YLH +N+IHRD
Sbjct: 82 GCYLREHTAWLVMEYCLGSA-SDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRD 140
Query: 234 LKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE---HKPYDYKADV 290
+K N+L+ E G+VK+ DFG A + A + GT WMAPEVI YD K DV
Sbjct: 141 VKAGNILLSEPGLVKLGDFGSASIMAPANSF---VGTPYWMAPEVILAMDEGQYDGKVDV 197
Query: 291 FSFGIALWELLTGELPYAGLTPLQAAVGVVQK 322
+S GI EL + P + + A + Q
Sbjct: 198 WSLGITCIELAERKPPLFNMNAMSALYHIAQN 229
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 4e-59
Identities = 70/219 (31%), Positives = 121/219 (55%), Gaps = 7/219 (3%)
Query: 107 IDAKQLKIECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR 165
ID K L ++ +G +G + G + +VAIK++K ++ + EF +E +M +
Sbjct: 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSED---EFIEEAKVMMNLS 57
Query: 166 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 225
H+ +VQ G CT+ + I+TE+MA G + ++L + + FQ LL++ DV + M YL
Sbjct: 58 HEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE 117
Query: 226 QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG--VMTAETGTYRWMAPEVIEHKP 283
+HRDL N L+++ GVVKV+DFG++R RW PEV+ +
Sbjct: 118 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSK 177
Query: 284 YDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQ 321
+ K+D+++FG+ +WE+ + G++PY T + A + Q
Sbjct: 178 FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 216
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (479), Expect = 7e-59
Identities = 65/225 (28%), Positives = 109/225 (48%), Gaps = 12/225 (5%)
Query: 107 IDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKI 164
D + LK + ++ GS+ +YKG EVA L+ + + F +E +++ +
Sbjct: 6 NDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL 65
Query: 165 RHKNVVQFIGAC----TRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 220
+H N+V+F + + +VTE M G++ +L + V ++ L + KG
Sbjct: 66 QHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKG 124
Query: 221 MNYLHQNN--IIHRDLKTAN-LLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPE 277
+ +LH IIHRDLK N + G VK+ D G+A ++ ++ A GT +MAPE
Sbjct: 125 LQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK-RASFAKAVIGTPEFMAPE 183
Query: 278 VIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK 322
+ E K YD DV++FG+ + E+ T E PY+ V
Sbjct: 184 MYEEK-YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS 227
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 189 bits (482), Expect = 2e-58
Identities = 50/206 (24%), Positives = 97/206 (47%), Gaps = 6/206 (2%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
I ++ +G++G +++ T + A K + + + +E+ M +RH +V
Sbjct: 29 DIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP--HESDKETVRKEIQTMSVLRHPTLV 86
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 230
A + ++ EFM+ G +++ + + ++ V KG+ ++H+NN +
Sbjct: 87 NLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYV 146
Query: 231 HRDLKTANLLM--DENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKA 288
H DLK N++ + +K+ DFG+ + TGT + APEV E KP Y
Sbjct: 147 HLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYT 206
Query: 289 DVFSFGIALWELLTGELPYAGLTPLQ 314
D++S G+ + LL+G P+ G +
Sbjct: 207 DMWSVGVLSYILLSGLSPFGGENDDE 232
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 5e-58
Identities = 63/218 (28%), Positives = 114/218 (52%), Gaps = 12/218 (5%)
Query: 107 IDAKQLKIECKV-ASGSYGDLYKGTY----CSQEVAIKVLKPECVNTEMLKEFSQEVYIM 161
+D K L +E K SG++G + KG Y + VA+K+LK E + + E E +M
Sbjct: 3 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM 62
Query: 162 RKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
+++ + +V+ IG C + +V E G + +L + + + +++++ VS GM
Sbjct: 63 QQLDNPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRH-VKDKNIIELVHQVSMGM 120
Query: 222 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETGTYRWMAPE 277
YL ++N +HRDL N+L+ K++DFG+++ + T +W APE
Sbjct: 121 KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180
Query: 278 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQ 314
I + + K+DV+SFG+ +WE + G+ PY G+ +
Sbjct: 181 CINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 218
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 1e-57
Identities = 62/216 (28%), Positives = 108/216 (50%), Gaps = 7/216 (3%)
Query: 110 KQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHK 167
K+ K+ G+ G +Y + QEVAI+ + + + E+ +MR+ ++
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ--QQPKKELIINEILVMRENKNP 77
Query: 168 NVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN 227
N+V ++ + L +V E++A GS+ D + + + V + + + +LH N
Sbjct: 78 NIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC--MDEGQIAAVCRECLQALEFLHSN 135
Query: 228 NIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTYRWMAPEVIEHKPYDY 286
+IHRD+K+ N+L+ +G VK+ DFG + + + GT WMAPEV+ K Y
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195
Query: 287 KADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK 322
K D++S GI E++ GE PY PL+A +
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN 231
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 1e-57
Identities = 61/227 (26%), Positives = 114/227 (50%), Gaps = 12/227 (5%)
Query: 105 WEIDAKQLKI-ECKVASGSYGDLYKGTYCS----QEVAIKVLKPECVNTEMLKEFSQEVY 159
+ L I + ++ G++G + +G Y +VAIKVLK +E +E
Sbjct: 3 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG-TEKADTEEMMREAQ 61
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
IM ++ + +V+ IG C + L +V E G ++ FL ++ ++++ ++ VS
Sbjct: 62 IMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSM 120
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETGTYRWMA 275
GM YL + N +HRDL N+L+ K++DFG+++ + +A +W A
Sbjct: 121 GMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA 180
Query: 276 PEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQ 321
PE I + + ++DV+S+G+ +WE L+ G+ PY + + + Q
Sbjct: 181 PECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQ 227
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 187 bits (476), Expect = 2e-57
Identities = 42/206 (20%), Positives = 99/206 (48%), Gaps = 6/206 (2%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
I ++ SG++G +++ + + K + E+ IM ++ H ++
Sbjct: 32 DILEELGSGAFGVVHRCVEKATGRVFVAKFINTP--YPLDKYTVKNEISIMNQLHHPKLI 89
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 230
A + ++ EF++ G ++D + + ++ +G+ ++H+++I+
Sbjct: 90 NLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIV 149
Query: 231 HRDLKTANLLMD--ENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKA 288
H D+K N++ + + VK+ DFG+A ++ T T + APE+++ +P +
Sbjct: 150 HLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYT 209
Query: 289 DVFSFGIALWELLTGELPYAGLTPLQ 314
D+++ G+ + LL+G P+AG L+
Sbjct: 210 DMWAIGVLGYVLLSGLSPFAGEDDLE 235
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 3e-57
Identities = 68/252 (26%), Positives = 115/252 (45%), Gaps = 35/252 (13%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKG-------TYCSQEVAIKVLKPECVNTEMLKEFSQE 157
WE + L+ + SG++G + T S +VA+K+LK + ++ + E
Sbjct: 32 WEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK-ADSSEREALMSE 90
Query: 158 VYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK-------------- 202
+ +M ++ H+N+V +GACT + ++ E+ G + ++L ++
Sbjct: 91 LKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQK 150
Query: 203 --------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV 254
V LL A V+KGM +L + +HRDL N+L+ VVK+ DFG+
Sbjct: 151 RLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGL 210
Query: 255 ARVQAQSGVMTAET---GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGL 310
AR +WMAPE + Y K+DV+S+GI LWE+ + G PY G+
Sbjct: 211 ARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270
Query: 311 TPLQAAVGVVQK 322
++Q
Sbjct: 271 PVDANFYKLIQN 282
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (466), Expect = 4e-57
Identities = 70/219 (31%), Positives = 115/219 (52%), Gaps = 6/219 (2%)
Query: 107 IDAKQLKIECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR 165
ID +L ++ SG +G ++ G + + +VAIK ++ ++ E +F +E +M K+
Sbjct: 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEE---DFIEEAEVMMKLS 58
Query: 166 HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 225
H +VQ G C +C+V EFM G + D+L Q+G+F +LL + +DV +GM YL
Sbjct: 59 HPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLE 118
Query: 226 QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPEVIEHKP 283
+ +IHRDL N L+ EN V+KV+DFG+ R ++ +W +PEV
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSR 178
Query: 284 YDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK 322
Y K+DV+SFG+ +WE+ + V +
Sbjct: 179 YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST 217
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 7e-57
Identities = 55/222 (24%), Positives = 104/222 (46%), Gaps = 13/222 (5%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
++ + +GSYG K S + + K L + + EV ++R+++H N+V
Sbjct: 7 EVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIV 66
Query: 171 QFIGACTRPPN--LCIVTEFMARGSIYDFLH---KQKGVFQLTSLLKVAIDVSKGMNYLH 225
++ N L IV E+ G + + K++ +L+V ++ + H
Sbjct: 67 RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECH 126
Query: 226 Q-----NNIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTYRWMAPEVI 279
+ + ++HRDLK AN+ +D VK+ DFG+AR + + A GT +M+PE +
Sbjct: 127 RRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQM 186
Query: 280 EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321
Y+ K+D++S G L+EL P+ + + A + +
Sbjct: 187 NRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE 228
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 183 bits (466), Expect = 9e-57
Identities = 78/225 (34%), Positives = 125/225 (55%), Gaps = 8/225 (3%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYI 160
D WE++ + ++ K+ G YG++Y+G + S VA+K LK +T ++EF +E +
Sbjct: 10 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKE---DTMEVEEFLKEAAV 66
Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLH-KQKGVFQLTSLLKVAIDVSK 219
M++I+H N+VQ +G CTR P I+TEFM G++ D+L + LL +A +S
Sbjct: 67 MKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISS 126
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG--VMTAETGTYRWMAPE 277
M YL + N IHRDL N L+ EN +VKVADFG++R+ +W APE
Sbjct: 127 AMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPE 186
Query: 278 VIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK 322
+ + + K+DV++FG+ LWE+ T + L +++K
Sbjct: 187 SLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 231
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 4e-56
Identities = 72/227 (31%), Positives = 121/227 (53%), Gaps = 12/227 (5%)
Query: 107 IDAKQLKIECKVASGSYGDLYKGTYCS-----QEVAIKVLKPECVNT-EMLKEFSQEVYI 160
I K L++ K+ GS+G + +G + + VA+K LKP+ ++ E + +F +EV
Sbjct: 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNA 64
Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 220
M + H+N+++ G PP + +VTE GS+ D L K +G F L +L + A+ V++G
Sbjct: 65 MHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 123
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETGTYRWMAP 276
M YL IHRDL NLL+ +VK+ DFG+ R + + W AP
Sbjct: 124 MGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183
Query: 277 EVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQK 322
E ++ + + + +D + FG+ LWE+ T G+ P+ GL Q + ++
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKE 230
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 180 bits (457), Expect = 3e-55
Identities = 75/229 (32%), Positives = 116/229 (50%), Gaps = 13/229 (5%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCS-----QEVAIKVLKPECVNTEMLKEFSQEVY 159
EID +KIE + +G +G++ G VAIK LK + ++F E
Sbjct: 21 KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG-YTEKQRRDFLSEAS 79
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
IM + H NV+ G T+ + I+TEFM GS+ FL + G F + L+ + ++
Sbjct: 80 IMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAA 139
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET------GTYRW 273
GM YL N +HRDL N+L++ N V KV+DFG++R T RW
Sbjct: 140 GMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRW 199
Query: 274 MAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQ 321
APE I+++ + +DV+S+GI +WE+++ GE PY +T + Q
Sbjct: 200 TAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ 248
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 5e-55
Identities = 54/206 (26%), Positives = 101/206 (49%), Gaps = 8/206 (3%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
+ + G+YG++ + VA+K++ + + + +E+ I + + H+NVV
Sbjct: 8 DLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK-RAVDCPENIKKEICINKMLNHENVV 66
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 230
+F G + E+ + G ++D + G + + G+ YLH I
Sbjct: 67 KFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG-MPEPDAQRFFHQLMAGVVYLHGIGIT 125
Query: 231 HRDLKTANLLMDENGVVKVADFGVARV---QAQSGVMTAETGTYRWMAPEVIEHKPYD-Y 286
HRD+K NLL+DE +K++DFG+A V + ++ GT ++APE+++ + +
Sbjct: 126 HRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 185
Query: 287 KADVFSFGIALWELLTGELPYAGLTP 312
DV+S GI L +L GELP+ +
Sbjct: 186 PVDVWSCGIVLTAMLAGELPWDQPSD 211
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (450), Expect = 5e-54
Identities = 43/206 (20%), Positives = 91/206 (44%), Gaps = 7/206 (3%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
I + G +G +++ S + K +K + + ++K +E+ I+ RH+N++
Sbjct: 8 MIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVK---KEISILNIARHRNIL 64
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 230
+ L ++ EF++ I++ ++ ++ V + + +LH +NI
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIG 124
Query: 231 HRDLKTANLLMD--ENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKA 288
H D++ N++ + +K+ +FG AR + APEV +H
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTAT 184
Query: 289 DVFSFGIALWELLTGELPYAGLTPLQ 314
D++S G ++ LL+G P+ T Q
Sbjct: 185 DMWSLGTLVYVLLSGINPFLAETNQQ 210
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (446), Expect = 9e-54
Identities = 47/208 (22%), Positives = 94/208 (45%), Gaps = 7/208 (3%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTE-MLKEFSQEVYIMRKIRHKNV 169
K + GS+ + + +E AIK+L+ + E + ++E +M ++ H
Sbjct: 11 KFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFF 70
Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
V+ L + G + ++ K G F T ++ + YLH I
Sbjct: 71 VKLYFTFQDDEKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALEYLHGKGI 129
Query: 230 IHRDLKTANLLMDENGVVKVADFGVARVQAQSG---VMTAETGTYRWMAPEVIEHKPYDY 286
IHRDLK N+L++E+ +++ DFG A+V + + GT ++++PE++ K
Sbjct: 130 IHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACK 189
Query: 287 KADVFSFGIALWELLTGELPYAGLTPLQ 314
+D+++ G +++L+ G P+
Sbjct: 190 SSDLWALGCIIYQLVAGLPPFRAGNEYL 217
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 1e-53
Identities = 65/228 (28%), Positives = 111/228 (48%), Gaps = 11/228 (4%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQEV 158
EI + + + +G +G++YKG VAIK LK + +F E
Sbjct: 2 TEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG-YTEKQRVDFLGEA 60
Query: 159 YIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVS 218
IM + H N+++ G ++ + I+TE+M G++ FL ++ G F + L+ + ++
Sbjct: 61 GIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA 120
Query: 219 KGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETGTYRWM 274
GM YL N +HRDL N+L++ N V KV+DFG++RV + + RW
Sbjct: 121 AGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180
Query: 275 APEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK 322
APE I ++ + +DV+SFGI +WE++T + +
Sbjct: 181 APEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIND 228
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (445), Expect = 2e-53
Identities = 70/230 (30%), Positives = 114/230 (49%), Gaps = 22/230 (9%)
Query: 106 EIDAKQLKIECKVASGSYGDLYKGTYCS----QEVAIKVLKPECVNTEMLKEFSQEVYIM 161
+D +K + + G++G + K + AIK +K + + ++F+ E+ ++
Sbjct: 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY-ASKDDHRDFAGELEVL 64
Query: 162 RKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQ---------------KGVF 205
K+ H N++ +GAC L + E+ G++ DFL K
Sbjct: 65 CKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 124
Query: 206 QLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT 265
LL A DV++GM+YL Q IHRDL N+L+ EN V K+ADFG++R Q T
Sbjct: 125 SSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKT 184
Query: 266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQ 314
RWMA E + + Y +DV+S+G+ LWE+++ G PY G+T +
Sbjct: 185 MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE 234
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 5e-53
Identities = 68/219 (31%), Positives = 111/219 (50%), Gaps = 10/219 (4%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQE-----VAIKVLKPECVNTEMLKEFSQEVY 159
+EI +++++ + G +GD+++G Y S E VAIK K C + + ++F QE
Sbjct: 2 YEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCK-NCTSDSVREKFLQEAL 60
Query: 160 IMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSK 219
MR+ H ++V+ IG T + I+ E G + FL +K L SL+ A +S
Sbjct: 61 TMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 119
Query: 220 GMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET--GTYRWMAPE 277
+ YL +HRD+ N+L+ N VK+ DFG++R S A +WMAPE
Sbjct: 120 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPE 179
Query: 278 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQA 315
I + + +DV+ FG+ +WE+L G P+ G+
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 218
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 173 bits (440), Expect = 1e-52
Identities = 69/259 (26%), Positives = 119/259 (45%), Gaps = 32/259 (12%)
Query: 93 NCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPEC 145
+ ++P D WE +L + +G++G + + T VA+K+LKP
Sbjct: 8 DPTQLPYD--HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS- 64
Query: 146 VNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK-- 202
+ + E+ ++ + H N+V +GACT ++TE+ G + +FL +++
Sbjct: 65 AHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDS 124
Query: 203 ---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVV 247
L LL + V+KGM +L N IHRDL N+L+ +
Sbjct: 125 FICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT 184
Query: 248 KVADFGVARVQAQSGVMTAET---GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-G 303
K+ DFG+AR + +WMAPE I + Y +++DV+S+GI LWEL + G
Sbjct: 185 KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLG 244
Query: 304 ELPYAGLTPLQAAVGVVQK 322
PY G+ ++++
Sbjct: 245 SSPYPGMPVDSKFYKMIKE 263
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 172 bits (436), Expect = 4e-52
Identities = 67/252 (26%), Positives = 114/252 (45%), Gaps = 35/252 (13%)
Query: 105 WEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQE 157
E ++ + G++G +++ VA+K+LK E + +M +F +E
Sbjct: 8 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE-ASADMQADFQRE 66
Query: 158 VYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG-------------- 203
+M + + N+V+ +G C +C++ E+MA G + +FL
Sbjct: 67 AALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTR 126
Query: 204 ---------VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV 254
L +A V+ GM YL + +HRDL T N L+ EN VVK+ADFG+
Sbjct: 127 ARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGL 186
Query: 255 ARVQAQSGVMTAET---GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGEL-PYAGL 310
+R + A+ RWM PE I + Y ++DV+++G+ LWE+ + L PY G+
Sbjct: 187 SRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM 246
Query: 311 TPLQAAVGVVQK 322
+ V
Sbjct: 247 AHEEVIYYVRDG 258
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 171 bits (435), Expect = 6e-52
Identities = 51/207 (24%), Positives = 102/207 (49%), Gaps = 7/207 (3%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
+ +G++ ++ + VAIK + + + + E+ ++ KI+H N+V
Sbjct: 12 DFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGK-EGSMENEIAVLHKIKHPNIV 70
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 230
+L ++ + ++ G ++D + + KG + ++ V + YLH I+
Sbjct: 71 ALDDIYESGGHLYLIMQLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDLGIV 129
Query: 231 HRDLKTANLL---MDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYK 287
HRDLK NLL +DE+ + ++DFG+++++ V++ GT ++APEV+ KPY
Sbjct: 130 HRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKA 189
Query: 288 ADVFSFGIALWELLTGELPYAGLTPLQ 314
D +S G+ + LL G P+ +
Sbjct: 190 VDCWSIGVIAYILLCGYPPFYDENDAK 216
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 8e-51
Identities = 53/207 (25%), Positives = 99/207 (47%), Gaps = 6/207 (2%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNT-EMLKEFSQEVYIM-RKIRHKN 168
+ + GS+G ++ + Q AIK LK + V + ++ E ++ H
Sbjct: 5 ILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPF 64
Query: 169 VVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNN 228
+ NL V E++ G + + F L+ A ++ G+ +LH
Sbjct: 65 LTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKG 123
Query: 229 IIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTYRWMAPEVIEHKPYDYK 287
I++RDLK N+L+D++G +K+ADFG+ + GT ++APE++ + Y++
Sbjct: 124 IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHS 183
Query: 288 ADVFSFGIALWELLTGELPYAGLTPLQ 314
D +SFG+ L+E+L G+ P+ G +
Sbjct: 184 VDWWSFGVLLYEMLIGQSPFHGQDEEE 210
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 1e-50
Identities = 66/252 (26%), Positives = 121/252 (48%), Gaps = 25/252 (9%)
Query: 91 SPNCIEIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKP 143
S + +P D WE+ +++ + ++ GS+G +Y+G VAIK +
Sbjct: 5 SAADVYVP----DEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE 60
Query: 144 ECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKG 203
+ EF E +M++ +VV+ +G ++ ++ E M RG + +L +
Sbjct: 61 A-ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRP 119
Query: 204 V---------FQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV 254
L+ ++++A +++ GM YL+ N +HRDL N ++ E+ VK+ DFG+
Sbjct: 120 AMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM 179
Query: 255 ARVQAQSG---VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTG-ELPYAGL 310
R ++ RWM+PE ++ + +DV+SFG+ LWE+ T E PY GL
Sbjct: 180 TRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGL 239
Query: 311 TPLQAAVGVVQK 322
+ Q V++
Sbjct: 240 SNEQVLRFVMEG 251
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 166 bits (422), Expect = 2e-50
Identities = 52/218 (23%), Positives = 102/218 (46%), Gaps = 17/218 (7%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNT-------EMLKEFSQEVYIMRK 163
+ + + G + + + +E A+K++ + E+ + +EV I+RK
Sbjct: 6 EPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRK 65
Query: 164 IR-HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMN 222
+ H N++Q +V + M +G ++D+L + K K+ + + +
Sbjct: 66 VSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVIC 124
Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIE-- 280
LH+ NI+HRDLK N+L+D++ +K+ DFG + + GT ++APE+IE
Sbjct: 125 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECS 184
Query: 281 ----HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ 314
H Y + D++S G+ ++ LL G P+ +
Sbjct: 185 MNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML 222
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 166 bits (421), Expect = 9e-50
Identities = 56/215 (26%), Positives = 106/215 (49%), Gaps = 6/215 (2%)
Query: 110 KQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPE-CVNTEMLKEFSQEVYIMRKIRH 166
+ +I + +GS+G ++ + A+KVLK E V + ++ + E ++ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 167 KNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ 226
+++ G + ++ +++ G L ++ F A +V + YLH
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYI-EGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 122
Query: 227 NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDY 286
+II+RDLK N+L+D+NG +K+ DFG A+ GT ++APEV+ KPY+
Sbjct: 123 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--TYTLCGTPDYIAPEVVSTKPYNK 180
Query: 287 KADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321
D +SFGI ++E+L G P+ ++ ++
Sbjct: 181 SIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN 215
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 1e-49
Identities = 67/231 (29%), Positives = 105/231 (45%), Gaps = 15/231 (6%)
Query: 105 WEIDAKQLKI--ECKVASGSYGDLYKGTYCS-----QEVAIKVLKPECVNTEMLKEFSQE 157
I L + + G +G +Y GT A+K L + + +F E
Sbjct: 20 VVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTE 78
Query: 158 VYIMRKIRHKNVVQFIGACTRPPN-LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAID 216
IM+ H NV+ +G C R +V +M G + +F+ + + L+ +
Sbjct: 79 GIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQ 138
Query: 217 VSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-----VMTAETGTY 271
V+KGM +L +HRDL N ++DE VKVADFG+AR T
Sbjct: 139 VAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 198
Query: 272 RWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQ 321
+WMA E ++ + + K+DV+SFG+ LWEL+T G PY + V ++Q
Sbjct: 199 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 249
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (419), Expect = 2e-49
Identities = 64/218 (29%), Positives = 113/218 (51%), Gaps = 12/218 (5%)
Query: 107 IDAKQLKIECKVASGSYGDLYKGTY------CSQEVAIKVLKPECVNTEMLKEFSQEVYI 160
+ + K + SG++G +YKG + VAIK L+ + + KE E Y+
Sbjct: 6 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA-TSPKANKEILDEAYV 64
Query: 161 MRKIRHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKG 220
M + + +V + +G C + ++T+ M G + D++ + K LL + ++KG
Sbjct: 65 MASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKG 123
Query: 221 MNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV---QAQSGVMTAETGTYRWMAPE 277
MNYL ++HRDL N+L+ VK+ DFG+A++ + + +WMA E
Sbjct: 124 MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALE 183
Query: 278 VIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQ 314
I H+ Y +++DV+S+G+ +WEL+T G PY G+ +
Sbjct: 184 SILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 221
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 2e-49
Identities = 57/229 (24%), Positives = 110/229 (48%), Gaps = 28/229 (12%)
Query: 109 AKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKN 168
A+ + ++ + G +G++++G + +EVA+K+ E E+Y +RH+N
Sbjct: 2 ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHEN 58
Query: 169 VVQFIGACTRP----PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 224
++ FI A + L +V+++ GS++D+L++ + ++K+A+ + G+ +L
Sbjct: 59 ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT--VTVEGMIKLALSTASGLAHL 116
Query: 225 HQ--------NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-----VMTAETGTY 271
H I HRDLK+ N+L+ +NG +AD G+A + GT
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
Query: 272 RWMAPEVIE------HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ 314
R+MAPEV++ H +AD+++ G+ WE+ Q
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ 225
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 3e-49
Identities = 69/248 (27%), Positives = 123/248 (49%), Gaps = 32/248 (12%)
Query: 96 EIPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS---------QEVAIKVLKPECV 146
E+P D WE+ +L + + G++G + +VA+K+LK +
Sbjct: 1 ELPED--PRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT 58
Query: 147 NTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQK--- 202
++ + E+ +M+ I +HKN++ +GACT+ L ++ E+ ++G++ ++L ++
Sbjct: 59 EKDL-SDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPG 117
Query: 203 ------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVA 250
L+ A V++GM YL IHRDL N+L+ E+ V+K+A
Sbjct: 118 LEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIA 177
Query: 251 DFGVARVQAQSGVMTA---ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELP 306
DFG+AR +WMAPE + + Y +++DV+SFG+ LWE+ T G P
Sbjct: 178 DFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 237
Query: 307 YAGLTPLQ 314
Y G+ +
Sbjct: 238 YPGVPVEE 245
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (409), Expect = 3e-48
Identities = 71/253 (28%), Positives = 118/253 (46%), Gaps = 28/253 (11%)
Query: 97 IPTDGTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTE 149
+P D WE +LK+ + G++G + + + VA+K+LK ++E
Sbjct: 1 LPYD-ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSE 59
Query: 150 MLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN-LCIVTEFMARGSIYDFLHKQ------- 201
S+ ++ H NVV +GACT+P L ++ EF G++ +L +
Sbjct: 60 HRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 119
Query: 202 --------KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFG 253
K L L+ + V+KGM +L IHRDL N+L+ E VVK+ DFG
Sbjct: 120 KVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFG 179
Query: 254 VARVQAQSGVMTAET---GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTG-ELPYAG 309
+AR + + +WMAPE I + Y ++DV+SFG+ LWE+ + PY G
Sbjct: 180 LARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 239
Query: 310 LTPLQAAVGVVQK 322
+ + +++
Sbjct: 240 VKIDEEFCRRLKE 252
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 160 bits (405), Expect = 8e-48
Identities = 63/221 (28%), Positives = 109/221 (49%), Gaps = 12/221 (5%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNV 169
++ + G +++ ++VA+KVL+ + + F +E + H +
Sbjct: 10 ELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAI 69
Query: 170 VQFIGAC----TRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLH 225
V P IV E++ ++ D +H + G ++V D + +N+ H
Sbjct: 70 VAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNFSH 128
Query: 226 QNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAET----GTYRWMAPEVIEH 281
QN IIHRD+K AN+++ VKV DFG+AR A SG +T GT ++++PE
Sbjct: 129 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 188
Query: 282 KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK 322
D ++DV+S G L+E+LTGE P+ G +P+ A V++
Sbjct: 189 DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVRE 229
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 7e-47
Identities = 52/212 (24%), Positives = 99/212 (46%), Gaps = 11/212 (5%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTE----MLKEFSQEVYIMRKIRH 166
++ SG + + K S + A K +K + ++ +EV I+++I+H
Sbjct: 13 DTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQH 72
Query: 167 KNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ 226
NV+ ++ ++ E +A G ++DF +K + + G+ YLH
Sbjct: 73 PNVITLHEVYENKTDVILILELVAGGELFDF-LAEKESLTEEEATEFLKQILNGVYYLHS 131
Query: 227 NNIIHRDLKTANLLMDENGV----VKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHK 282
I H DLK N+++ + V +K+ DFG+A GT ++APE++ ++
Sbjct: 132 LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE 191
Query: 283 PYDYKADVFSFGIALWELLTGELPYAGLTPLQ 314
P +AD++S G+ + LL+G P+ G T +
Sbjct: 192 PLGLEADMWSIGVITYILLSGASPFLGDTKQE 223
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 158 bits (399), Expect = 9e-47
Identities = 50/213 (23%), Positives = 100/213 (46%), Gaps = 11/213 (5%)
Query: 113 KIECKVASGSYGDLYKGTYCS---QEVAIKVLKPECVNTEMLKEFSQEVYIMRKI---RH 166
+ ++ G+YG ++K + VA+K ++ + M +EV ++R + H
Sbjct: 10 ECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEH 69
Query: 167 KNVVQFIGACTRPPN-----LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGM 221
NVV+ CT L +V E + + + ++ + + +G+
Sbjct: 70 PNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 129
Query: 222 NYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEH 281
++LH + ++HRDLK N+L+ +G +K+ADFG+AR+ + +T+ T + APEV+
Sbjct: 130 DFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ 189
Query: 282 KPYDYKADVFSFGIALWELLTGELPYAGLTPLQ 314
Y D++S G E+ + + G + +
Sbjct: 190 SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD 222
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 159 bits (403), Expect = 1e-46
Identities = 53/207 (25%), Positives = 96/207 (46%), Gaps = 9/207 (4%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTE----MLKEFSQEVYIMRKIRH 166
+ + G +G++Y + A+K L + + + + + ++
Sbjct: 7 SVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDC 66
Query: 167 KNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ 226
+V A P L + + M G ++ L + GVF + A ++ G+ ++H
Sbjct: 67 PFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHN 125
Query: 227 NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEH-KPYD 285
+++RDLK AN+L+DE+G V+++D G+A A GT+ +MAPEV++ YD
Sbjct: 126 RFVVYRDLKPANILLDEHGHVRISDLGLAC-DFSKKKPHASVGTHGYMAPEVLQKGVAYD 184
Query: 286 YKADVFSFGIALWELLTGELPYAGLTP 312
AD FS G L++LL G P+
Sbjct: 185 SSADWFSLGCMLFKLLRGHSPFRQHKT 211
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 5e-46
Identities = 58/209 (27%), Positives = 106/209 (50%), Gaps = 9/209 (4%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNT---EMLKEFSQEVYIMRKIRHK 167
K++ + G + +YK + Q VAIK +K + + + +E+ +++++ H
Sbjct: 2 KLD-FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 168 NVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN 227
N++ + A N+ +V +FM + + V + + + +G+ YLHQ+
Sbjct: 61 NIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH 119
Query: 228 NIIHRDLKTANLLMDENGVVKVADFGVAR-VQAQSGVMTAETGTYRWMAPEVI-EHKPYD 285
I+HRDLK NLL+DENGV+K+ADFG+A+ + + T + T + APE++ + Y
Sbjct: 120 WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYG 179
Query: 286 YKADVFSFGIALWELLTGELPYAGLTPLQ 314
D+++ G L ELL G + L
Sbjct: 180 VGVDMWAVGCILAELLLRVPFLPGDSDLD 208
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 7e-46
Identities = 49/226 (21%), Positives = 97/226 (42%), Gaps = 18/226 (7%)
Query: 114 IECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVV 170
+ G G + + ++ A+K+L+ + +EV + + + ++V
Sbjct: 16 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIV 68
Query: 171 QFIGAC----TRPPNLCIVTEFMARGSIYDFLHKQKG-VFQLTSLLKVAIDVSKGMNYLH 225
+ + L IV E + G ++ + + F ++ + + + YLH
Sbjct: 69 RIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 128
Query: 226 QNNIIHRDLKTANLLMD---ENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHK 282
NI HRD+K NLL N ++K+ DFG A+ +T T ++APEV+ +
Sbjct: 129 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPE 188
Query: 283 PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIHSI 328
YD D++S G+ ++ LL G P+ L + G+ ++ +
Sbjct: 189 KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQY 234
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 1e-44
Identities = 50/211 (23%), Positives = 95/211 (45%), Gaps = 11/211 (5%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNT----EMLKEFSQEVYIMRKIR- 165
++ + SG +G +Y G S VAIK ++ + ++ EV +++K+
Sbjct: 7 QVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSS 66
Query: 166 -HKNVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 224
V++ + RP + ++ E ++G Q V + + +
Sbjct: 67 GFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHC 126
Query: 225 HQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKP 283
H ++HRD+K N+L+D N G +K+ DFG + + V T GT + PE I +
Sbjct: 127 HNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHR 185
Query: 284 Y-DYKADVFSFGIALWELLTGELPYAGLTPL 313
Y A V+S GI L++++ G++P+ +
Sbjct: 186 YHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 216
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 3e-44
Identities = 47/206 (22%), Positives = 96/206 (46%), Gaps = 5/206 (2%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNT-EMLKEFSQEVYIMRKIRHKNV 169
+ G++G + + + A+K+L+ E + + + E +++ RH +
Sbjct: 8 DYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFL 67
Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
A LC V E+ G ++ L +++ F ++ + YLH ++
Sbjct: 68 TALKYAFQTHDRLCFVMEYANGGELFFHLSRERV-FTEERARFYGAEIVSALEYLHSRDV 126
Query: 230 IHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAETGTYRWMAPEVIEHKPYDYKA 288
++RD+K NL++D++G +K+ DFG+ + G M GT ++APEV+E Y
Sbjct: 127 VYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAV 186
Query: 289 DVFSFGIALWELLTGELPYAGLTPLQ 314
D + G+ ++E++ G LP+ +
Sbjct: 187 DWWGLGVVMYEMMCGRLPFYNQDHER 212
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 3e-44
Identities = 49/213 (23%), Positives = 97/213 (45%), Gaps = 4/213 (1%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
+ K+ G+YG +YK + VA+K ++ + + +E+ +++++ H N+V
Sbjct: 5 QKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIV 64
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 230
+ + L +V EF+ + L + + +G+ + H + ++
Sbjct: 65 KLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVL 124
Query: 231 HRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAETGTYRWMAPEVIEHKPY-DYKA 288
HRDLK NLL++ G +K+ADFG+AR T E T + APE++ Y
Sbjct: 125 HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAV 184
Query: 289 DVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321
D++S G E++T + G + + + +
Sbjct: 185 DIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 217
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 148 bits (373), Expect = 5e-43
Identities = 50/205 (24%), Positives = 93/205 (45%), Gaps = 4/205 (1%)
Query: 113 KIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQ 171
K+ G+YG +YK + A+K ++ E + + +E+ I+++++H N+V+
Sbjct: 5 HGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVK 64
Query: 172 FIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIH 231
L +V E + + L +G + + + + G+ Y H ++H
Sbjct: 65 LYDVIHTKKRLVLVFEHL-DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLH 123
Query: 232 RDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRW-MAPEVIE-HKPYDYKAD 289
RDLK NLL++ G +K+ADFG+AR W AP+V+ K Y D
Sbjct: 124 RDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTID 183
Query: 290 VFSFGIALWELLTGELPYAGLTPLQ 314
++S G E++ G + G++
Sbjct: 184 IWSVGCIFAEMVNGTPLFPGVSEAD 208
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (377), Expect = 5e-43
Identities = 55/223 (24%), Positives = 101/223 (45%), Gaps = 17/223 (7%)
Query: 104 VWEIDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIM 161
V+++ + + + G+YG + VAIK + P + + +E+ I+
Sbjct: 3 VFDVGPRYTNLS-YIGEGAYGMVCSAYDNVNKVRVAIKKISPF-EHQTYCQRTLREIKIL 60
Query: 162 RKIRHKNVVQFIGACTRP-----PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAID 216
+ RH+N++ P ++ +VT M +Y L Q +
Sbjct: 61 LRFRHENIIGINDIIRAPTIEQMKDVYLVTHLM-GADLYKLLKTQH--LSNDHICYFLYQ 117
Query: 217 VSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETGTYR 272
+ +G+ Y+H N++HRDLK +NLL++ +K+ DFG+ARV +G +T T
Sbjct: 118 ILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 177
Query: 273 WMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQ 314
+ APE++ + Y D++S G L E+L+ + G L
Sbjct: 178 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLD 220
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 147 bits (372), Expect = 8e-43
Identities = 51/208 (24%), Positives = 89/208 (42%), Gaps = 17/208 (8%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
++ K+ SGS+GD+Y GT + +EVAIK+ + + E I + ++ +
Sbjct: 10 RLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK----TKHPQLHIESKIYKMMQGGVGI 65
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 230
I C + ++ + S+ D + F L ++L +A + + Y+H N I
Sbjct: 66 PTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFI 125
Query: 231 HRDLKTANLLM---DENGVVKVADFGVARVQAQSGV--------MTAETGTYRWMAPEVI 279
HRD+K N LM + +V + DFG+A+ + TGT R+ +
Sbjct: 126 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH 185
Query: 280 EHKPYDYKADVFSFGIALWELLTGELPY 307
+ D+ S G L G LP+
Sbjct: 186 LGIEQSRRDDLESLGYVLMYFNLGSLPW 213
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 148 bits (373), Expect = 2e-42
Identities = 53/205 (25%), Positives = 96/205 (46%), Gaps = 6/205 (2%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPE-CVNTEMLKEFSQEVYIMRKIRHKNV 169
+ +GS+G + + A+K+L + V + ++ E I++ + +
Sbjct: 44 DRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFL 103
Query: 170 VQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNI 229
V+ + NL +V E++A G ++ L + G F A + YLH ++
Sbjct: 104 VKLEFSFKDNSNLYMVMEYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSLDL 162
Query: 230 IHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKAD 289
I+RDLK NLL+D+ G ++V DFG A+ GT +APE+I K Y+ D
Sbjct: 163 IYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWTLCGTPEALAPEIILSKGYNKAVD 220
Query: 290 VFSFGIALWELLTGELPYAGLTPLQ 314
++ G+ ++E+ G P+ P+Q
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQ 245
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (368), Expect = 6e-42
Identities = 57/225 (25%), Positives = 104/225 (46%), Gaps = 17/225 (7%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
+ K+ G++G+++K + Q+VA+K + E +E+ I++ ++H+NVV
Sbjct: 13 EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVV 72
Query: 171 QFIGACTRPP--------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMN 222
I C ++ +V +F L F L+ + +V + G+
Sbjct: 73 NLIEICRTKASPYNRCKGSIYLVFDFCEHDL-AGLLSNVLVKFTLSEIKRVMQMLLNGLY 131
Query: 223 YLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV-----QAQSGVMTAETGTYRWMAPE 277
Y+H+N I+HRD+K AN+L+ +GV+K+ADFG+AR +Q T T + PE
Sbjct: 132 YIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 191
Query: 278 VI-EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321
++ + Y D++ G + E+ T G T + Q
Sbjct: 192 LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 236
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 142 bits (359), Expect = 7e-41
Identities = 39/224 (17%), Positives = 83/224 (37%), Gaps = 19/224 (8%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
K+ ++ GS+G +++GT Q+VAIK + E + + +
Sbjct: 8 KVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR----SDAPQLRDEYRTYKLLAGCTGI 63
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 230
+ + ++ + S+ D L F + ++ A + + +H+ +++
Sbjct: 64 PNVYYFGQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLV 123
Query: 231 HRDLKTANLLMDE-----NGVVKVADFGVARV--------QAQSGVMTAETGTYRWMAPE 277
+RD+K N L+ ++ V DFG+ + +GT R+M+
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183
Query: 278 VIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321
+ + D+ + G L G LP+ GL +
Sbjct: 184 THLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYER 227
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 9e-41
Identities = 57/240 (23%), Positives = 105/240 (43%), Gaps = 22/240 (9%)
Query: 95 IEIPTDGTD-VWEIDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEML 151
+ P G D E+ K+ + +GS+G +Y+ C + VAIK + +
Sbjct: 7 VATPGQGPDRPQEVSYTDTKV---IGNGSFGVVYQAKLCDSGELVAIKKVLQD------K 57
Query: 152 KEFSQEVYIMRKIRHKNVVQFIGACTRP------PNLCIVTEFMARGSIYDFLH--KQKG 203
+ ++E+ IMRK+ H N+V+ L +V +++ H + K
Sbjct: 58 RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ 117
Query: 204 VFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG-VVKVADFGVARVQAQSG 262
+ + + + + Y+H I HRD+K NLL+D + V+K+ DFG A+ +
Sbjct: 118 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE 177
Query: 263 VMTAETGTYRWMAP-EVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321
+ + + AP + Y DV+S G L ELL G+ + G + + V +++
Sbjct: 178 PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 237
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 2e-40
Identities = 62/223 (27%), Positives = 99/223 (44%), Gaps = 15/223 (6%)
Query: 101 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEV 158
WE+ + V SG+YG + +VAIK L + K +E+
Sbjct: 10 TKTAWEVR-AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYREL 68
Query: 159 YIMRKIRHKNVVQFIGACTRPP------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLK 212
+++ +RH+NV+ + T + +V FM G+ L K +
Sbjct: 69 RLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMK-HEKLGEDRIQF 125
Query: 213 VAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYR 272
+ + KG+ Y+H IIHRDLK NL ++E+ +K+ DFG+AR MT T
Sbjct: 126 LVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE--MTGYVVTRW 183
Query: 273 WMAPEVI-EHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ 314
+ APEVI Y D++S G + E++TG+ + G L
Sbjct: 184 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD 226
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 3e-40
Identities = 52/199 (26%), Positives = 94/199 (47%), Gaps = 5/199 (2%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
+ K+ G+YG ++K + VA+K ++ + + + +E+ ++++++HKN+V
Sbjct: 5 EKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIV 64
Query: 171 QFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNII 230
+ L +V EF + F G + + KG+ + H N++
Sbjct: 65 RLHDVLHSDKKLTLVFEFCDQDLKKYF-DSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVL 123
Query: 231 HRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAETGTYRWMAPEVIE-HKPYDYKA 288
HRDLK NLL++ NG +K+A+FG+AR +AE T + P+V+ K Y
Sbjct: 124 HRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSI 183
Query: 289 DVFSFGIALWELLTGELPY 307
D++S G EL P
Sbjct: 184 DMWSAGCIFAELANAGRPL 202
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (343), Expect = 4e-38
Identities = 53/222 (23%), Positives = 97/222 (43%), Gaps = 13/222 (5%)
Query: 101 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEV 158
G + + K+ + + SG+ G + + VAIK L N K +E+
Sbjct: 9 GDSTFTVL-KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYREL 67
Query: 159 YIMRKIRHKNVVQFIGACTRPP------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLK 212
+M+ + HKN++ + T ++ +V E M + +
Sbjct: 68 VLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN----LCQVIQMELDHERMSY 123
Query: 213 VAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYR 272
+ + G+ +LH IIHRDLK +N+++ + +K+ DFG+AR S +MT T
Sbjct: 124 LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRY 183
Query: 273 WMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ 314
+ APEVI Y D++S G + E++ ++ + G +
Sbjct: 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYID 225
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (339), Expect = 1e-37
Identities = 49/219 (22%), Positives = 96/219 (43%), Gaps = 11/219 (5%)
Query: 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYI 160
+WE+ + + V SG+YG + VA+K L + K +E+ +
Sbjct: 12 TIWEVPER-YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 161 MRKIRHKNVVQFIGACTRPP-----NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
++ ++H+NV+ + T N + + + + + QK + +
Sbjct: 71 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQK--LTDDHVQFLIY 128
Query: 216 DVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTAETGTYRWMA 275
+ +G+ Y+H +IIHRDLK +NL ++E+ +K+ DFG+AR + +
Sbjct: 129 QILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR-HTDDEMTGYVATRWYRAP 187
Query: 276 PEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ 314
++ Y+ D++S G + ELLTG + G +
Sbjct: 188 EIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID 226
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (334), Expect = 6e-37
Identities = 49/223 (21%), Positives = 105/223 (47%), Gaps = 13/223 (5%)
Query: 113 KIECKVASGSYGDLYKGTYCS-----QEVAIKVLKPECV--NTEMLKEFSQEVYIMRKIR 165
++ + +G+YG ++ S + A+KVLK + + + E ++ IR
Sbjct: 27 ELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR 86
Query: 166 HK-NVVQFIGACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYL 224
+V A L ++ +++ G ++ L +++ F + ++ + +L
Sbjct: 87 QSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER-FTEHEVQIYVGEIVLALEHL 145
Query: 225 HQNNIIHRDLKTANLLMDENGVVKVADFGVAR--VQAQSGVMTAETGTYRWMAPEVIEHK 282
H+ II+RD+K N+L+D NG V + DFG+++ V ++ GT +MAP+++
Sbjct: 146 HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGG 205
Query: 283 PYDY--KADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKV 323
+ D +S G+ ++ELLTG P+ + + +++
Sbjct: 206 DSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI 248
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 129 bits (326), Expect = 9e-36
Identities = 41/222 (18%), Positives = 97/222 (43%), Gaps = 24/222 (10%)
Query: 101 GTDVWEIDAKQLK--------IECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEM 150
+ W+ ++ ++ + K+ G Y ++++ + ++V +K+LKP
Sbjct: 18 PREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV-----K 72
Query: 151 LKEFSQEVYIMRKIR-HKNVVQFIGACTRPPN--LCIVTEFMARGSIYDFLHKQKGVFQL 207
K+ +E+ I+ +R N++ P + +V E +
Sbjct: 73 KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT----LTD 128
Query: 208 TSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD-ENGVVKVADFGVARVQAQSGVMTA 266
+ ++ K ++Y H I+HRD+K N+++D E+ +++ D+G+A
Sbjct: 129 YDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV 188
Query: 267 ETGTYRWMAPEV-IEHKPYDYKADVFSFGIALWELLTGELPY 307
+ + PE+ ++++ YDY D++S G L ++ + P+
Sbjct: 189 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 230
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 111 bits (278), Expect = 1e-28
Identities = 41/241 (17%), Positives = 94/241 (39%), Gaps = 29/241 (12%)
Query: 113 KIECKVASGSYGDLYKGTYCS--QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVV 170
+ K+ G + ++ VA+K+++ + V TE E+ +++++ +
Sbjct: 16 ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTE---AAEDEIKLLQRVNDADNT 72
Query: 171 QFIGACTRPP---------------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAI 215
+ ++ +V E + + + L + +++
Sbjct: 73 KEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK 132
Query: 216 DVSKGMNYLH-QNNIIHRDLKTANLLMDENGV------VKVADFGVARVQAQSGVMTAET 268
+ G++Y+H + IIH D+K N+LM+ +K+AD G A + +
Sbjct: 133 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS--I 190
Query: 269 GTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIHSI 328
T + +PEV+ P+ AD++S ++EL+TG+ + I +
Sbjct: 191 QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL 250
Query: 329 I 329
+
Sbjct: 251 L 251
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 78.7 bits (193), Expect = 5e-18
Identities = 27/203 (13%), Positives = 62/203 (30%), Gaps = 36/203 (17%)
Query: 107 IDAKQLKIECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLK--------EFSQE 157
+DA I + G ++ E +K K + + +K FS
Sbjct: 1 VDA----IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVL 56
Query: 158 VYIMRKIRHKNVVQFIGACTRPP----NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKV 213
+ + + + G ++ E + +Y + +V
Sbjct: 57 AIRSARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRVRVENP--------DEV 108
Query: 214 AIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV----QAQSGVMTAETG 269
+ + + + I+H DL N+L+ E G + + DF + + +
Sbjct: 109 LDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWREILERDVRN 167
Query: 270 TYRWMAPEVIEHKPYDYKADVFS 292
+ + + Y + D+ S
Sbjct: 168 IITYFS------RTYRTEKDINS 184
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 331 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.94 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.8 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.29 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.01 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.33 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.24 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.86 | |
| d2f06a1 | 71 | Hypothetical protein BT0572 {Bacteroides thetaiota | 91.4 | |
| d1zpva1 | 83 | UPF0237 protein SP0238 {Streptococcus pneumoniae [ | 90.02 | |
| d1u8sa1 | 86 | putative transcriptional repressor VC2159 {Vibrio | 88.31 | |
| d1ygya3 | 78 | Phosphoglycerate dehydrogenase, regulatory (C-term | 86.21 | |
| d1sc6a3 | 84 | Phosphoglycerate dehydrogenase, regulatory (C-term | 85.26 | |
| d2f06a2 | 70 | Hypothetical protein BT0572 {Bacteroides thetaiota | 84.62 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-55 Score=389.97 Aligned_cols=222 Identities=38% Similarity=0.742 Sum_probs=193.7
Q ss_pred CeeeecccCcceeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCe
Q 020085 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNL 182 (331)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~ 182 (331)
++|+|+.++|++.++||+|+||+||+|++.+ .||||+++....+....+.|.+|+.++++++|||||++++++.. +.+
T Consensus 1 ddwei~~~~~~~~~~lG~G~fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~ 78 (276)
T d1uwha_ 1 DDWEIPDGQITVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQL 78 (276)
T ss_dssp CCCBCCTTCCCCCSEEEECSSCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSC
T ss_pred CCcccccccEEEEEEEeeCCCcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEE
Confidence 4699999999999999999999999998765 69999998776666677899999999999999999999998765 568
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC
Q 020085 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262 (331)
Q Consensus 183 ~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~ 262 (331)
++||||+++|+|.+++...+..+++..+..++.||++||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus 79 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 79 AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp EEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred EEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 99999999999999998777889999999999999999999999999999999999999999999999999997654322
Q ss_pred ---ccccCCCCcccccchhcCC---CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccccccc
Q 020085 263 ---VMTAETGTYRWMAPEVIEH---KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIH 326 (331)
Q Consensus 263 ---~~~~~~gt~~y~aPE~~~~---~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~p 326 (331)
......||+.|||||++.+ ..|+.++|||||||++|||+||+.||.+.++.+.....+.++.++
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~ 228 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLS 228 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCC
T ss_pred CcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCC
Confidence 2344579999999999864 358999999999999999999999999988777777767766654
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-52 Score=377.93 Aligned_cols=224 Identities=36% Similarity=0.679 Sum_probs=195.0
Q ss_pred CCeeeecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECC
Q 020085 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP 179 (331)
Q Consensus 102 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 179 (331)
.+.|+|+.++|++.++||+|+||+||+|++ .++.||||+++.+... .++|.+|+.+|++++|||||+++++|.++
T Consensus 9 ~~~wei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~ 85 (287)
T d1opja_ 9 YDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME---VEEFLKEAAVMKEIKHPNLVQLLGVCTRE 85 (287)
T ss_dssp CCTTBCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSC---HHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred CcccEecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccch---HHHHHHHHHHHHhCCCCCEecCCccEeeC
Confidence 356999999999999999999999999998 4788999999866443 35799999999999999999999999999
Q ss_pred CCeEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeee
Q 020085 180 PNLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (331)
Q Consensus 180 ~~~~lV~E~~~ggsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~ 258 (331)
+.+++||||+++|+|.+++... ...+++..+..++.||++||+|||++||+||||||+|||+++++.+||+|||+|+..
T Consensus 86 ~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~ 165 (287)
T d1opja_ 86 PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM 165 (287)
T ss_dssp SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTC
T ss_pred CeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeec
Confidence 9999999999999999999764 467899999999999999999999999999999999999999999999999999866
Q ss_pred cCCCcc--ccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCC-CCCCCCHHHHHhcccccccccccc
Q 020085 259 AQSGVM--TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGEL-PYAGLTPLQAAVGVVQKVSIHSII 329 (331)
Q Consensus 259 ~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~-Pf~~~~~~~~~~~~~~~~~~p~~~ 329 (331)
...... ....|++.|+|||++.+..|+.++|||||||++|||++|.. ||.+.+..+ ..+.++++.+|+++
T Consensus 166 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~-~~~~i~~~~~~~~~ 238 (287)
T d1opja_ 166 TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ-VYELLEKDYRMERP 238 (287)
T ss_dssp CSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-HHHHHHTTCCCCCC
T ss_pred CCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHH-HHHHHhcCCCCCCC
Confidence 543322 23357899999999999999999999999999999999655 555555555 44557778887765
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-52 Score=368.96 Aligned_cols=219 Identities=33% Similarity=0.632 Sum_probs=185.6
Q ss_pred ecccCcceeeeeeecCceEEEEEEEC-CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEE
Q 020085 107 IDAKQLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV 185 (331)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV 185 (331)
|+.++|++.++||+|+||+||+|.+. ++.||||+++...... ++|.+|+.++++++||||++++|+|..++..++|
T Consensus 2 idp~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~---~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv 78 (263)
T d1sm2a_ 2 IDPSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE---EDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLV 78 (263)
T ss_dssp BCCSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred CChHHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCcH---HHHHHHHHHHHhcCCCCcccccceeccCCceEEE
Confidence 57789999999999999999999994 5789999998765443 5799999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCc--
Q 020085 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV-- 263 (331)
Q Consensus 186 ~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~-- 263 (331)
|||+++|+|.+++......+++..++.++.|+++||+|||+++|+||||||+|||+++++.+||+|||+++.......
T Consensus 79 ~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~ 158 (263)
T d1sm2a_ 79 FEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS 158 (263)
T ss_dssp EECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred EEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence 999999999999988778899999999999999999999999999999999999999999999999999986554332
Q ss_pred cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhcccccccccccc
Q 020085 264 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIHSII 329 (331)
Q Consensus 264 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p~~~ 329 (331)
.....||+.|+|||++.+..|+.++|||||||++|||+| |++||...+..+.... +..+.++..+
T Consensus 159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~-i~~~~~~~~p 224 (263)
T d1sm2a_ 159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED-ISTGFRLYKP 224 (263)
T ss_dssp ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHH-HHHTCCCCCC
T ss_pred ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHH-HHhcCCCCCc
Confidence 233568999999999999999999999999999999999 6788888887776666 5567766654
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-52 Score=372.09 Aligned_cols=220 Identities=25% Similarity=0.419 Sum_probs=184.1
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEEC--CCCeEE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR--PPNLCI 184 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~--~~~~~l 184 (331)
.++|++.+.||+|+||+||+|++ +|+.||+|+++....++...+.+.+|++++++++||||+++++++.+ +..+|+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence 46899999999999999999998 47899999998877777777889999999999999999999999864 456899
Q ss_pred EEeccCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC-----cccCCCCCCCEEEcCCCcEEEeeeccee
Q 020085 185 VTEFMARGSIYDFLHKQ---KGVFQLTSLLKVAIDVSKGMNYLHQNN-----IIHRDLKTANLLMDENGVVKVADFGVAR 256 (331)
Q Consensus 185 V~E~~~ggsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~-----iiHrDlkp~NiLi~~~~~vkl~DFg~a~ 256 (331)
||||++||+|.+++.+. +..+++..++.++.||+.||+|||++| |+||||||+|||++.++.+||+|||+++
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence 99999999999998642 467999999999999999999999876 9999999999999999999999999998
Q ss_pred eecCCC-ccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccccccccccc
Q 020085 257 VQAQSG-VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIHSII 329 (331)
Q Consensus 257 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~p~~~ 329 (331)
...... ......||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+....+ ..+..+.++
T Consensus 163 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i-~~~~~~~~~ 235 (269)
T d2java1 163 ILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKI-REGKFRRIP 235 (269)
T ss_dssp HC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH-HHTCCCCCC
T ss_pred ecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHH-HcCCCCCCC
Confidence 654432 334567999999999999999999999999999999999999999999988877664 456665554
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-51 Score=374.16 Aligned_cols=222 Identities=33% Similarity=0.567 Sum_probs=186.4
Q ss_pred eecccCcceeeeeeecCceEEEEEEEC--C---ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCC
Q 020085 106 EIDAKQLKIECKVASGSYGDLYKGTYC--S---QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (331)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~~--~---~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 180 (331)
+++.++|++.+.||+|+||+||+|++. + ..||||.+.... +....+.|.+|+.+|++++|||||+++|+|..++
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~ 100 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY-TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKST 100 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSS
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECccc-CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCC
Confidence 567789999999999999999999984 2 248899887653 4556678999999999999999999999999999
Q ss_pred CeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecC
Q 020085 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (331)
Q Consensus 181 ~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~ 260 (331)
.+++||||+++|+|.+++....+.+++..+..++.||++||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 101 ~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 101 PVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp SCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccC
Confidence 99999999999999999988778899999999999999999999999999999999999999999999999999986544
Q ss_pred CCcc------ccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhcccccccccccc
Q 020085 261 SGVM------TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIHSII 329 (331)
Q Consensus 261 ~~~~------~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p~~~ 329 (331)
.... ....+|+.|||||.+.+..++.++|||||||++|||+| |+.||.+.++.+.... +.++.+|+.+
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~-i~~~~~~~~~ 255 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINA-IEQDYRLPPP 255 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-HHTTCCCCCC
T ss_pred CCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCCCCC
Confidence 3221 12357899999999999999999999999999999998 8999999998887766 4567776654
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-52 Score=369.52 Aligned_cols=211 Identities=26% Similarity=0.467 Sum_probs=188.2
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV 185 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV 185 (331)
.++|++.+.||+|+||+||+|++ +++.||+|+++..... ....+.+.+|+.++++++||||+++++++.++..+|+|
T Consensus 5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~iv 84 (263)
T d2j4za1 5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 84 (263)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEE
Confidence 35799999999999999999998 4688999998643211 12346788999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCccc
Q 020085 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT 265 (331)
Q Consensus 186 ~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~~ 265 (331)
|||++||+|.+++.+ .+.+++..+..++.||++||+|||++||+||||||+|||++.++.+||+|||+|+..... ...
T Consensus 85 mEy~~~g~L~~~l~~-~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~-~~~ 162 (263)
T d2j4za1 85 LEYAPLGTVYRELQK-LSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RRT 162 (263)
T ss_dssp EECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-CCE
T ss_pred EeecCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC-ccc
Confidence 999999999999975 467999999999999999999999999999999999999999999999999999766543 344
Q ss_pred cCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 266 ~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
...||+.|||||++.+..|+.++|||||||++|||++|+.||.+.++.+....+.+
T Consensus 163 ~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~ 218 (263)
T d2j4za1 163 TLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR 218 (263)
T ss_dssp ETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT
T ss_pred ccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 56799999999999999999999999999999999999999999988887776543
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-51 Score=370.69 Aligned_cols=222 Identities=27% Similarity=0.525 Sum_probs=195.2
Q ss_pred eeecccCcceee-eeeecCceEEEEEEEC----CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECC
Q 020085 105 WEIDAKQLKIEC-KVASGSYGDLYKGTYC----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP 179 (331)
Q Consensus 105 ~~i~~~~~~~~~-~lg~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 179 (331)
+.++.++|.+.+ +||+|+||+||+|.+. +..||||+++... +....++|.+|+.+|++++|||||+++++|..
T Consensus 3 l~l~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~- 80 (285)
T d1u59a_ 3 LFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT-EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA- 80 (285)
T ss_dssp CBCCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-
T ss_pred eeecccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhc-CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-
Confidence 557788899988 5999999999999873 3469999998653 55567889999999999999999999999975
Q ss_pred CCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeec
Q 020085 180 PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA 259 (331)
Q Consensus 180 ~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~ 259 (331)
+.+|+||||+++|+|.+++...+..+++..+..++.|+++||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 81 EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccc
Confidence 46899999999999999987777889999999999999999999999999999999999999999999999999998765
Q ss_pred CCCc----cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhcccccccccccc
Q 020085 260 QSGV----MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIHSII 329 (331)
Q Consensus 260 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p~~~ 329 (331)
.... .....||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.+..+.... +++|.+|+++
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~-i~~~~~~~~p 234 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAF-IEQGKRMECP 234 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHH-HHTTCCCCCC
T ss_pred ccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHH-HHcCCCCCCC
Confidence 4332 223468899999999999999999999999999999998 9999999887776655 6678888775
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-52 Score=375.25 Aligned_cols=215 Identities=33% Similarity=0.539 Sum_probs=190.1
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEe
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E 187 (331)
+.|++.++||+|+||+||+|++ +++.||||+++... .+..+.+.+|+.+|++++|||||++++++.+++.+++|||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE 89 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS--EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE 89 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS--SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence 4689999999999999999998 46889999997653 3345678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC-cccc
Q 020085 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTA 266 (331)
Q Consensus 188 ~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~-~~~~ 266 (331)
|++||+|.+++.+..+.+++..+..++.||++||.|||++||+||||||+|||++.++.+||+|||+|+...... ....
T Consensus 90 y~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~ 169 (288)
T d2jfla1 90 FCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS 169 (288)
T ss_dssp CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTC
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCcccccc
Confidence 999999999987777789999999999999999999999999999999999999999999999999997654332 2345
Q ss_pred CCCCcccccchhcC-----CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccccccccc
Q 020085 267 ETGTYRWMAPEVIE-----HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIHS 327 (331)
Q Consensus 267 ~~gt~~y~aPE~~~-----~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~p~ 327 (331)
..||+.|+|||++. ...|+.++|||||||++|||++|+.||.+.++.+...++. ++..|.
T Consensus 170 ~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~-~~~~~~ 234 (288)
T d2jfla1 170 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIA-KSEPPT 234 (288)
T ss_dssp CCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHH-HSCCCC
T ss_pred cccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHH-cCCCCC
Confidence 67999999999983 5678999999999999999999999999999888877755 444443
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-52 Score=369.89 Aligned_cols=223 Identities=31% Similarity=0.603 Sum_probs=193.9
Q ss_pred CCeeeecccCcceeeeeeecCceEEEEEEEC-CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCC
Q 020085 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (331)
Q Consensus 102 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 180 (331)
.+.|+|+.++|++.++||+|+||+||+|++. ++.||||+++...... +.|.+|+.++++++|||||++++++.+ +
T Consensus 5 ~~~wei~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~~---~~~~~E~~~l~~l~HpnIv~~~g~~~~-~ 80 (272)
T d1qpca_ 5 EDEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP---DAFLAEANLMKQLQHQRLVRLYAVVTQ-E 80 (272)
T ss_dssp TCTTBCCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECS-S
T ss_pred CCCeecCHHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcCCH---HHHHHHHHHHHhCCCCCEeEEEeeecc-C
Confidence 3569999999999999999999999999996 4689999998665443 579999999999999999999998865 5
Q ss_pred CeEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeec
Q 020085 181 NLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA 259 (331)
Q Consensus 181 ~~~lV~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~ 259 (331)
..++||||+++|+|.+++.... ..+++..++.++.||++||.|||++||+||||||+|||+++++.+||+|||+|+...
T Consensus 81 ~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~ 160 (272)
T d1qpca_ 81 PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE 160 (272)
T ss_dssp SCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECS
T ss_pred CeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEcc
Confidence 6799999999999999875543 368999999999999999999999999999999999999999999999999998765
Q ss_pred CCCc--cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhcccccccccccc
Q 020085 260 QSGV--MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIHSII 329 (331)
Q Consensus 260 ~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p~~~ 329 (331)
.... .....||+.|||||++.+..++.++|||||||++|||+| |++||...+..+.... +.++.+|.++
T Consensus 161 ~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~-i~~~~~~~~p 232 (272)
T d1qpca_ 161 DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN-LERGYRMVRP 232 (272)
T ss_dssp SSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-HHTTCCCCCC
T ss_pred CCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHH-HHhcCCCCCc
Confidence 5432 234568999999999998899999999999999999999 5677777777776655 5677777665
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-51 Score=371.15 Aligned_cols=210 Identities=30% Similarity=0.510 Sum_probs=188.8
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEe
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E 187 (331)
++|++.++||+|+||+||+|++ +|+.||||+++...... .+.+.+|+.++++++||||+++++++..++.+|+|||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~--~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 97 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK--KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVME 97 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC--HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH--HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEE
Confidence 4799999999999999999997 48899999997543222 3678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC-Ccccc
Q 020085 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMTA 266 (331)
Q Consensus 188 ~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~-~~~~~ 266 (331)
|++||+|.+++.+ +.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+..... .....
T Consensus 98 y~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~ 175 (293)
T d1yhwa1 98 YLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST 175 (293)
T ss_dssp CCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCC
T ss_pred ecCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccccccc
Confidence 9999999998864 46999999999999999999999999999999999999999999999999999876543 34456
Q ss_pred CCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccccc
Q 020085 267 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKV 323 (331)
Q Consensus 267 ~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~ 323 (331)
.+||+.|+|||++.+..|+.++|||||||++|+|++|+.||.+.++.+....+...+
T Consensus 176 ~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~ 232 (293)
T d1yhwa1 176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG 232 (293)
T ss_dssp CCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC
T ss_pred cccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCC
Confidence 679999999999999999999999999999999999999999999888777765443
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-52 Score=378.79 Aligned_cols=226 Identities=30% Similarity=0.548 Sum_probs=195.9
Q ss_pred CeeeecccCcceeeeeeecCceEEEEEEECC-------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCcceeEEe
Q 020085 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIG 174 (331)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~ 174 (331)
..|+|+.++|++.++||+|+||+||+|++.+ ..||+|++.... +......+.+|+.+++++ +|||||++++
T Consensus 30 ~kwei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~l~~ 108 (325)
T d1rjba_ 30 LKWEFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA-DSSEREALMSELKMMTQLGSHENIVNLLG 108 (325)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC-------CHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccCCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc-CHHHHHHHHHHHHHHHHhcCCCcEeEEEE
Confidence 4599999999999999999999999999843 259999987543 333456799999999998 8999999999
Q ss_pred EEECCCCeEEEEeccCCCCHHHHHHhcC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccC
Q 020085 175 ACTRPPNLCIVTEFMARGSIYDFLHKQK----------------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHR 232 (331)
Q Consensus 175 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~----------------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiHr 232 (331)
+|...+.+++||||+++|+|.+++..+. ..+++..++.++.|+++||+|||++||+||
T Consensus 109 ~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHR 188 (325)
T d1rjba_ 109 ACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHR 188 (325)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEET
T ss_pred EEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence 9999999999999999999999997653 247889999999999999999999999999
Q ss_pred CCCCCCEEEcCCCcEEEeeecceeeecCCCcc---ccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCC
Q 020085 233 DLKTANLLMDENGVVKVADFGVARVQAQSGVM---TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYA 308 (331)
Q Consensus 233 Dlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~ 308 (331)
||||+|||++.++.+||+|||+|+........ ....||+.|||||++.+..|+.++|||||||++|||++ |+.||.
T Consensus 189 DlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~ 268 (325)
T d1rjba_ 189 DLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYP 268 (325)
T ss_dssp TCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSST
T ss_pred cCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCC
Confidence 99999999999999999999999865544322 23457999999999999999999999999999999998 899999
Q ss_pred CCCHHHHHhcccccccccccc
Q 020085 309 GLTPLQAAVGVVQKVSIHSII 329 (331)
Q Consensus 309 ~~~~~~~~~~~~~~~~~p~~~ 329 (331)
+.+..+...++++++.+|+++
T Consensus 269 ~~~~~~~~~~~~~~~~~~~~p 289 (325)
T d1rjba_ 269 GIPVDANFYKLIQNGFKMDQP 289 (325)
T ss_dssp TCCCSHHHHHHHHTTCCCCCC
T ss_pred CCCHHHHHHHHHhcCCCCCCC
Confidence 988877788888888888765
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-51 Score=362.31 Aligned_cols=219 Identities=32% Similarity=0.605 Sum_probs=196.8
Q ss_pred ecccCcceeeeeeecCceEEEEEEEC-CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEE
Q 020085 107 IDAKQLKIECKVASGSYGDLYKGTYC-SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV 185 (331)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV 185 (331)
++.++|++.++||+|+||+||+|++. ++.||||+++....+. ++|.+|+.++++++||||++++|+|.+++.+++|
T Consensus 1 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~~---~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv 77 (258)
T d1k2pa_ 1 IDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE---DEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII 77 (258)
T ss_dssp CCCCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSCH---HHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEE
T ss_pred CChHHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCCH---HHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEE
Confidence 46789999999999999999999995 5689999998765543 5799999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCc--
Q 020085 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV-- 263 (331)
Q Consensus 186 ~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~-- 263 (331)
|||+++|+|.+++......+++..+.+++.|+++||+|||++||+||||||+|||+++++.+||+|||+++.......
T Consensus 78 ~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 157 (258)
T d1k2pa_ 78 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS 157 (258)
T ss_dssp EECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred EEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence 999999999999888788899999999999999999999999999999999999999999999999999986544332
Q ss_pred cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhcccccccccccc
Q 020085 264 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIHSII 329 (331)
Q Consensus 264 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p~~~ 329 (331)
.....+|+.|+|||.+.+..++.++|||||||++|||+| |+.||.+.+..+....+ .++.++..+
T Consensus 158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i-~~~~~~~~p 223 (258)
T d1k2pa_ 158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI-AQGLRLYRP 223 (258)
T ss_dssp CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH-HTTCCCCCC
T ss_pred ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHH-HhCCCCCCc
Confidence 234568999999999999999999999999999999998 89999999998877764 567777665
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-52 Score=372.39 Aligned_cols=213 Identities=22% Similarity=0.409 Sum_probs=187.0
Q ss_pred cccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEE
Q 020085 108 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCI 184 (331)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~l 184 (331)
..++|++.+.||+|+||+||+|++ +++.||||+++.... +....+.+.+|+.++++++||||+++++++.+++.+|+
T Consensus 6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 85 (288)
T d1uu3a_ 6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYF 85 (288)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEE
T ss_pred CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEE
Confidence 456899999999999999999998 478999999874321 12234679999999999999999999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC--
Q 020085 185 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-- 262 (331)
Q Consensus 185 V~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~-- 262 (331)
||||++||+|.+++.. .+.+++..+..++.|++.||+|||++||+||||||+|||+++++.+||+|||+|+......
T Consensus 86 vmEy~~gg~L~~~~~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~ 164 (288)
T d1uu3a_ 86 GLSYAKNGELLKYIRK-IGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ 164 (288)
T ss_dssp EECCCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred EEEccCCCCHHHhhhc-cCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence 9999999999999865 5689999999999999999999999999999999999999999999999999998765332
Q ss_pred -ccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 263 -VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 263 -~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
......||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.++.+...++.+
T Consensus 165 ~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~ 224 (288)
T d1uu3a_ 165 ARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK 224 (288)
T ss_dssp -----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHT
T ss_pred cccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHc
Confidence 23345799999999999999999999999999999999999999999998888777553
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-52 Score=370.26 Aligned_cols=201 Identities=26% Similarity=0.479 Sum_probs=176.2
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEe
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E 187 (331)
++|++.+.||+|+||+||+|++ +++.||||+++.... .+..+.+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA-VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC--------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEe
Confidence 4799999999999999999998 478999999976532 2334678999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC---cc
Q 020085 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG---VM 264 (331)
Q Consensus 188 ~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~---~~ 264 (331)
|++||+|.+++.. ++.+++..+..++.||++||+|||++||+||||||+|||+++++.+||+|||+|+...... ..
T Consensus 84 y~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~ 162 (271)
T d1nvra_ 84 YCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL 162 (271)
T ss_dssp CCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred ccCCCcHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCccccc
Confidence 9999999999954 5689999999999999999999999999999999999999999999999999998654332 23
Q ss_pred ccCCCCcccccchhcCCCCC-CChhhHHHHHHHHHHHHcCCCCCCCCCH
Q 020085 265 TAETGTYRWMAPEVIEHKPY-DYKADVFSFGIALWELLTGELPYAGLTP 312 (331)
Q Consensus 265 ~~~~gt~~y~aPE~~~~~~~-~~~~Di~SlG~il~ell~g~~Pf~~~~~ 312 (331)
...+||+.|||||++.+..+ +.++||||+||++|||++|+.||...+.
T Consensus 163 ~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~ 211 (271)
T d1nvra_ 163 NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 211 (271)
T ss_dssp CCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSST
T ss_pred cceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCCh
Confidence 45679999999999988876 5789999999999999999999977543
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-51 Score=363.99 Aligned_cols=216 Identities=30% Similarity=0.516 Sum_probs=185.8
Q ss_pred ccCcceeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEEC----CCCe
Q 020085 109 AKQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR----PPNL 182 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~----~~~~ 182 (331)
.+-|++.++||+|+||+||+|++. ++.||+|+++....+....+.+.+|+++|++++||||+++++++.. +..+
T Consensus 8 gry~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~ 87 (270)
T d1t4ha_ 8 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCI 87 (270)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEE
T ss_pred CCEEEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEE
Confidence 344688889999999999999984 6789999998776667777889999999999999999999999864 3458
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC--cccCCCCCCCEEEc-CCCcEEEeeecceeeec
Q 020085 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNN--IIHRDLKTANLLMD-ENGVVKVADFGVARVQA 259 (331)
Q Consensus 183 ~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--iiHrDlkp~NiLi~-~~~~vkl~DFg~a~~~~ 259 (331)
|+||||+++|+|.+++.+ .+.+++..+..++.||++||+|||++| |+||||||+|||++ +++.+||+|||+++...
T Consensus 88 ~ivmE~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~ 166 (270)
T d1t4ha_ 88 VLVTELMTSGTLKTYLKR-FKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR 166 (270)
T ss_dssp EEEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred EEEEeCCCCCcHHHHHhc-cccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence 999999999999999965 467999999999999999999999998 99999999999996 57899999999997644
Q ss_pred CCCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccccccccc
Q 020085 260 QSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIHS 327 (331)
Q Consensus 260 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~p~ 327 (331)
.. ......||+.|||||++.+ .++.++|||||||++|||++|+.||.+..+.....+.+..+.+|.
T Consensus 167 ~~-~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~~ 232 (270)
T d1t4ha_ 167 AS-FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPA 232 (270)
T ss_dssp TT-SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCCG
T ss_pred CC-ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCCc
Confidence 33 3345689999999999976 599999999999999999999999987765555555555565543
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.7e-51 Score=371.80 Aligned_cols=215 Identities=23% Similarity=0.447 Sum_probs=173.6
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~ 186 (331)
.+.|++.+.||+|+||+||+|++ +++.||||+++...... ....+.+|+.+|++++||||+++++++.+++.+|+||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~-~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG-KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC-----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhh-HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 35699999999999999999998 47889999997654332 3456889999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEc---CCCcEEEeeecceeeecCCCc
Q 020085 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD---ENGVVKVADFGVARVQAQSGV 263 (331)
Q Consensus 187 E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~---~~~~vkl~DFg~a~~~~~~~~ 263 (331)
||++||+|.+++.. ++.+++..+..++.||+.||+|||++||+||||||+|||+. +++.+||+|||+++.......
T Consensus 87 E~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~ 165 (307)
T d1a06a_ 87 QLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV 165 (307)
T ss_dssp CCCCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----------
T ss_pred eccCCCcHHHhhhc-ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCCe
Confidence 99999999999965 57899999999999999999999999999999999999995 578999999999987766655
Q ss_pred cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccccccc
Q 020085 264 MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSI 325 (331)
Q Consensus 264 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~ 325 (331)
....+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+....+.+....
T Consensus 166 ~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~ 227 (307)
T d1a06a_ 166 LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYE 227 (307)
T ss_dssp -------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCC
T ss_pred eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCC
Confidence 56678999999999999999999999999999999999999999999888877776654433
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-51 Score=366.82 Aligned_cols=220 Identities=29% Similarity=0.547 Sum_probs=185.9
Q ss_pred ecccCccee-eeeeecCceEEEEEEEC----CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCC
Q 020085 107 IDAKQLKIE-CKVASGSYGDLYKGTYC----SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN 181 (331)
Q Consensus 107 i~~~~~~~~-~~lg~G~~g~Vy~~~~~----~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 181 (331)
++.+.+.+. ++||+|+||+||+|.+. ++.||||+++....+....+.|.+|+.+|++++|||||+++++|.. +.
T Consensus 3 ld~~~~~le~k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~ 81 (277)
T d1xbba_ 3 LDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ES 81 (277)
T ss_dssp CCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SS
T ss_pred echhhCeecCCCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CC
Confidence 344455554 47999999999999873 3579999998765556667889999999999999999999999975 46
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC
Q 020085 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261 (331)
Q Consensus 182 ~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~ 261 (331)
.++||||+++|+|.+++.. ...+++..+..++.||++||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus 82 ~~lvmE~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~ 160 (277)
T d1xbba_ 82 WMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 160 (277)
T ss_dssp EEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred EEEEEEcCCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccc
Confidence 7999999999999999965 567999999999999999999999999999999999999999999999999999865443
Q ss_pred Cc----cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhcccccccccccc
Q 020085 262 GV----MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIHSII 329 (331)
Q Consensus 262 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p~~~ 329 (331)
.. .....||+.|||||.+.+..++.++|||||||++|||++ |+.||.+.+..+.... +++|.+|+++
T Consensus 161 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~-i~~~~~~~~p 232 (277)
T d1xbba_ 161 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM-LEKGERMGCP 232 (277)
T ss_dssp CSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-HHTTCCCCCC
T ss_pred ccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHH-HHcCCCCCCC
Confidence 22 123468999999999999999999999999999999998 8999999998876655 6678888775
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1e-50 Score=375.10 Aligned_cols=211 Identities=24% Similarity=0.411 Sum_probs=193.1
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEe
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E 187 (331)
++|++.+.||+|+||.||+|++ +|+.||||+++... ....+.+.+|+.+|++++|||||++++++.+++.+|+|||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~--~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE 103 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH--ESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE 103 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS--HHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc--hhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 5899999999999999999998 47899999997653 4445789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC--CCcEEEeeecceeeecCCCccc
Q 020085 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE--NGVVKVADFGVARVQAQSGVMT 265 (331)
Q Consensus 188 ~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~--~~~vkl~DFg~a~~~~~~~~~~ 265 (331)
|++||+|.+++....+.+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||+++.........
T Consensus 104 ~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~ 183 (350)
T d1koaa2 104 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK 183 (350)
T ss_dssp CCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEE
T ss_pred cCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccccc
Confidence 99999999999776778999999999999999999999999999999999999964 6789999999999877766666
Q ss_pred cCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccc
Q 020085 266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK 322 (331)
Q Consensus 266 ~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~ 322 (331)
...||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+....+...
T Consensus 184 ~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~ 240 (350)
T d1koaa2 184 VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC 240 (350)
T ss_dssp EECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred eecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Confidence 778999999999999999999999999999999999999999999988877776543
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-51 Score=376.10 Aligned_cols=204 Identities=27% Similarity=0.475 Sum_probs=182.5
Q ss_pred eecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeE
Q 020085 106 EIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183 (331)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 183 (331)
+|..++|++.++||+|+||+||+|++ +++.||+|+++... +....+.+.+|+.+|++++|||||+++++|.++..+|
T Consensus 2 el~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 2 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI-KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CCCGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC-CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEE
T ss_pred CCCccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 56788999999999999999999998 47899999998653 3444578999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC
Q 020085 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262 (331)
Q Consensus 184 lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~ 262 (331)
+||||++||+|.+++.+ .+.+++..+..++.|++.||.|||+ +||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 81 iVmEy~~gg~L~~~l~~-~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~- 158 (322)
T d1s9ja_ 81 ICMEHMDGGSLDQVLKK-AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 158 (322)
T ss_dssp EEEECCTTEEHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred EEEEcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC-
Confidence 99999999999999976 4679999999999999999999997 59999999999999999999999999999865432
Q ss_pred ccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCH
Q 020085 263 VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTP 312 (331)
Q Consensus 263 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~ 312 (331)
.....+||+.|+|||++.+..|+.++||||+||++|||++|+.||.+.+.
T Consensus 159 ~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~ 208 (322)
T d1s9ja_ 159 MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208 (322)
T ss_dssp TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCT
T ss_pred ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 23456899999999999999999999999999999999999999987543
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=2.1e-50 Score=373.31 Aligned_cols=210 Identities=20% Similarity=0.417 Sum_probs=192.6
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEe
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E 187 (331)
++|++.+.||+|+||+||+|++ +++.||||+++... ....+.+.+|+.+|++++||||+++++++.++..+|+|||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE 106 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY--PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE 106 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS--HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc--hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 5799999999999999999998 57899999997653 3345678899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEc--CCCcEEEeeecceeeecCCCccc
Q 020085 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMD--ENGVVKVADFGVARVQAQSGVMT 265 (331)
Q Consensus 188 ~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~--~~~~vkl~DFg~a~~~~~~~~~~ 265 (331)
|++||+|.+++......+++..+..++.||+.||+|||++||+||||||+|||++ .++.+||+|||+|+.........
T Consensus 107 ~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~ 186 (352)
T d1koba_ 107 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK 186 (352)
T ss_dssp CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEE
T ss_pred cCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCcee
Confidence 9999999999877667899999999999999999999999999999999999998 57899999999999887766666
Q ss_pred cCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 266 ~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
...||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+....+.+
T Consensus 187 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~ 242 (352)
T d1koba_ 187 VTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKR 242 (352)
T ss_dssp EECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHH
T ss_pred eccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 77899999999999999999999999999999999999999999998888777554
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-50 Score=362.79 Aligned_cols=222 Identities=31% Similarity=0.543 Sum_probs=188.5
Q ss_pred eecccCcceeeeeeecCceEEEEEEECC------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECC
Q 020085 106 EIDAKQLKIECKVASGSYGDLYKGTYCS------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP 179 (331)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~~~------~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 179 (331)
||++++|++.+.||+|+||+||+|.+.+ ..||||+++... +......|.+|+.++++++|||||+++|+|...
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~ 81 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY 81 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc-ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC
Confidence 6788899999999999999999998743 369999997654 455567899999999999999999999999999
Q ss_pred CCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeec
Q 020085 180 PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA 259 (331)
Q Consensus 180 ~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~ 259 (331)
...++||||+.++++.+++......+++..+..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++...
T Consensus 82 ~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 82 KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhccc
Confidence 99999999999999999998877889999999999999999999999999999999999999999999999999998654
Q ss_pred CCC----ccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcC-CCCCCCCCHHHHHhcccccccccccc
Q 020085 260 QSG----VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTG-ELPYAGLTPLQAAVGVVQKVSIHSII 329 (331)
Q Consensus 260 ~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g-~~Pf~~~~~~~~~~~~~~~~~~p~~~ 329 (331)
... ......||+.|||||++.+..++.++|||||||++|||++| .+||...+..+.... +..+.+|+++
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~-i~~~~~~~~~ 235 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKA-INDGFRLPTP 235 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-HHTTCCCCCC
T ss_pred CCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHH-HhccCCCCCc
Confidence 332 12234689999999999999999999999999999999995 566776777665554 6678888765
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-50 Score=362.17 Aligned_cols=223 Identities=29% Similarity=0.539 Sum_probs=187.0
Q ss_pred eeeecccCcceeeeeeecCceEEEEEEECC-----ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEEC
Q 020085 104 VWEIDAKQLKIECKVASGSYGDLYKGTYCS-----QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR 178 (331)
Q Consensus 104 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 178 (331)
+|+|+.++|++.+.||+|+||+||+|++.+ ..||||+++... .....+.|.+|+.++++++||||+++++++.+
T Consensus 1 ~~ei~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~ 79 (273)
T d1mp8a_ 1 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT-SDSVREKFLQEALTMRQFDHPHIVKLIGVITE 79 (273)
T ss_dssp CCBCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTT-SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred CCCcCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec
Confidence 489999999999999999999999998843 358888886543 45566789999999999999999999999964
Q ss_pred CCCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeee
Q 020085 179 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (331)
Q Consensus 179 ~~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~ 258 (331)
+.+++||||+++|+|.+++....+.+++..++.++.||++||.|||++|++||||||+||+++.++.+||+|||+++..
T Consensus 80 -~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 80 -NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp -SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred -CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheec
Confidence 6789999999999999998887888999999999999999999999999999999999999999999999999999865
Q ss_pred cCCC--ccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhcccccccccccc
Q 020085 259 AQSG--VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIHSII 329 (331)
Q Consensus 259 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p~~~ 329 (331)
.... ..+...||+.|+|||.+.+..++.++|||||||++|||++ |.+||.+.++.+.... +..+.+|+++
T Consensus 159 ~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~-i~~~~~~~~~ 231 (273)
T d1mp8a_ 159 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGR-IENGERLPMP 231 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHH-HHTTCCCCCC
T ss_pred cCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHH-HHcCCCCCCC
Confidence 4332 2334567999999999999999999999999999999998 8999999998887776 4567777664
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-50 Score=371.98 Aligned_cols=213 Identities=22% Similarity=0.445 Sum_probs=190.2
Q ss_pred ecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeE
Q 020085 107 IDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183 (331)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 183 (331)
|..++|++.+.||+|+||+||+|++ +++.||||+++.... +.+..+.+.+|+.+|++++||||+++++++.++..+|
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~ 81 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLC 81 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEE
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccc
Confidence 4567899999999999999999998 578999999974321 1223567889999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecC-CC
Q 020085 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SG 262 (331)
Q Consensus 184 lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~-~~ 262 (331)
+||||++||+|.+++.+ .+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.... ..
T Consensus 82 iv~ey~~gg~L~~~~~~-~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~ 160 (337)
T d1o6la_ 82 FVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA 160 (337)
T ss_dssp EEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC
T ss_pred cceeccCCCchhhhhhc-ccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCc
Confidence 99999999999999866 56789999999999999999999999999999999999999999999999999986544 33
Q ss_pred ccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccc
Q 020085 263 VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 263 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~ 320 (331)
.....+||+.|+|||++.+..|+.++|+||+||++|||++|++||.+.+..+....+.
T Consensus 161 ~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~ 218 (337)
T d1o6la_ 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL 218 (337)
T ss_dssp CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHh
Confidence 4455689999999999999999999999999999999999999999999887766644
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-50 Score=361.81 Aligned_cols=211 Identities=25% Similarity=0.424 Sum_probs=190.7
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCH----HHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeE
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNT----EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLC 183 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~----~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~ 183 (331)
+.|++.+.||+|+||+||+|++ +|+.||||+++...... ...+.+.+|+.+|++++|||||++++++.++..+|
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 5799999999999999999998 47899999997543221 23577999999999999999999999999999999
Q ss_pred EEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC----cEEEeeecceeeec
Q 020085 184 IVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG----VVKVADFGVARVQA 259 (331)
Q Consensus 184 lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~----~vkl~DFg~a~~~~ 259 (331)
+||||++||+|.+++.. ++.+++..+..++.|++.||+|||++||+||||||+|||++.++ .+|++|||+++...
T Consensus 90 iv~E~~~gg~L~~~i~~-~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~ 168 (293)
T d1jksa_ 90 LILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 168 (293)
T ss_dssp EEEECCCSCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECT
T ss_pred EEEEcCCCccccchhcc-ccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhhhhhcC
Confidence 99999999999999966 46799999999999999999999999999999999999998877 49999999999877
Q ss_pred CCCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 260 QSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 260 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+....+.+
T Consensus 169 ~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~ 230 (293)
T d1jksa_ 169 FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSA 230 (293)
T ss_dssp TSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHT
T ss_pred CCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHh
Confidence 66666677899999999999999999999999999999999999999999998887776554
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.3e-50 Score=363.82 Aligned_cols=213 Identities=32% Similarity=0.470 Sum_probs=188.0
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC-HHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEE
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-TEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~ 186 (331)
+.|+..++||+|+||+||+|++ +++.||||+++..... ....+.+.+|+.+|++++|||||++++++.+++.+|+||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEE
Confidence 3599999999999999999997 5688999999866543 445677999999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCcccc
Q 020085 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 266 (331)
Q Consensus 187 E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~~~ 266 (331)
||+.+|+|..++.. ++.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|+..... ..
T Consensus 95 E~~~~g~l~~~~~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~---~~ 170 (309)
T d1u5ra_ 95 EYCLGSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NS 170 (309)
T ss_dssp ECCSEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB---CC
T ss_pred EecCCCchHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCCC---Cc
Confidence 99999998776644 578999999999999999999999999999999999999999999999999999865432 34
Q ss_pred CCCCcccccchhcCC---CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccccccccc
Q 020085 267 ETGTYRWMAPEVIEH---KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIHS 327 (331)
Q Consensus 267 ~~gt~~y~aPE~~~~---~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~p~ 327 (331)
..||+.|||||++.+ ..|+.++|||||||++|||++|+.||.+.++.+....+.+ +..|.
T Consensus 171 ~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~-~~~~~ 233 (309)
T d1u5ra_ 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ-NESPA 233 (309)
T ss_dssp CCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH-SCCCC
T ss_pred cccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh-CCCCC
Confidence 679999999999853 4689999999999999999999999999999888887665 44443
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=3.7e-50 Score=366.59 Aligned_cols=210 Identities=27% Similarity=0.502 Sum_probs=188.5
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIV 185 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV 185 (331)
.++|++.++||+|+||+||+|++ +|+.||||+++.... .....+.+.+|+.++++++||||+++++++.+++.+|+|
T Consensus 3 l~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 82 (316)
T d1fota_ 3 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMI 82 (316)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEE
T ss_pred hhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeE
Confidence 35799999999999999999998 478999999974321 112346789999999999999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCccc
Q 020085 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMT 265 (331)
Q Consensus 186 ~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~~ 265 (331)
|||++||+|..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+..... ..
T Consensus 83 mE~~~gg~l~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--~~ 159 (316)
T d1fota_ 83 MDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--TY 159 (316)
T ss_dssp ECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--BC
T ss_pred eeecCCccccccccc-cccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc--cc
Confidence 999999999998865 567899999999999999999999999999999999999999999999999999876543 34
Q ss_pred cCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 266 ~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
..+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.++.+...++.+
T Consensus 160 ~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~ 215 (316)
T d1fota_ 160 TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN 215 (316)
T ss_dssp CCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH
T ss_pred cccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHc
Confidence 56899999999999999999999999999999999999999999999888777554
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-50 Score=360.25 Aligned_cols=224 Identities=36% Similarity=0.634 Sum_probs=187.7
Q ss_pred CCCeeeecccCcceeeeeeecCceEEEEEEECC-ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECC
Q 020085 101 GTDVWEIDAKQLKIECKVASGSYGDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP 179 (331)
Q Consensus 101 ~~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 179 (331)
..+.|+|+.++|++.+.||+|+||+||+|++.+ +.||||+++....+. +.|.+|+.++++++|||||+++++|.+
T Consensus 8 ~~~~~~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~~---~~~~~E~~~l~~l~h~nIv~~~g~~~~- 83 (285)
T d1fmka3 8 AKDAWEIPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP---EAFLQEAQVMKKLRHEKLVQLYAVVSE- 83 (285)
T ss_dssp STTCSBCCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSCH---HHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred CCcceEcCHHHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccCCH---HHHHHHHHHHHhcccCCEeEEEEEEec-
Confidence 346799999999999999999999999999954 679999998665443 579999999999999999999999865
Q ss_pred CCeEEEEeccCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeee
Q 020085 180 PNLCIVTEFMARGSIYDFLHKQ-KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (331)
Q Consensus 180 ~~~~lV~E~~~ggsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~ 258 (331)
+.+++||||+++|+|.+++... ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 84 ~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~ 163 (285)
T d1fmka3 84 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 163 (285)
T ss_dssp SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--
T ss_pred CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhc
Confidence 5689999999999999998654 357999999999999999999999999999999999999999999999999999865
Q ss_pred cCCC--ccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcC-CCCCCCCCHHHHHhcccccccccccc
Q 020085 259 AQSG--VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTG-ELPYAGLTPLQAAVGVVQKVSIHSII 329 (331)
Q Consensus 259 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g-~~Pf~~~~~~~~~~~~~~~~~~p~~~ 329 (331)
..+. ......||+.|+|||.+....++.++|||||||++|||++| ++||.+.+..+.... +.++.+++++
T Consensus 164 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~-i~~~~~~~~~ 236 (285)
T d1fmka3 164 EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ-VERGYRMPCP 236 (285)
T ss_dssp ------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH-HHTTCCCCCC
T ss_pred cCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHH-HHhcCCCCCC
Confidence 4332 23345689999999999999999999999999999999995 566676666665555 5567776654
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-50 Score=359.40 Aligned_cols=218 Identities=35% Similarity=0.662 Sum_probs=187.7
Q ss_pred eeecccCcceeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEEC-CCCeE
Q 020085 105 WEIDAKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR-PPNLC 183 (331)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~-~~~~~ 183 (331)
|+|+.++|++.++||+|+||.||+|++.++.||||+++.+. ..+.|.+|+.++++++||||++++|+|.+ .+.++
T Consensus 2 w~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~ 77 (262)
T d1byga_ 2 WALNMKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLY 77 (262)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCE
T ss_pred CccCHHHeEEeEEEecCCCeEEEEEEECCeEEEEEEECcHH----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEE
Confidence 89999999999999999999999999999999999997653 23678999999999999999999999865 45689
Q ss_pred EEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC
Q 020085 184 IVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG 262 (331)
Q Consensus 184 lV~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~ 262 (331)
+||||+++|+|.+++.+.. ..+++..+++++.||+.||.|||+++|+||||||+|||++.++.+|++|||+++.....
T Consensus 78 lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~- 156 (262)
T d1byga_ 78 IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST- 156 (262)
T ss_dssp EEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred EEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC-
Confidence 9999999999999997643 45899999999999999999999999999999999999999999999999999865443
Q ss_pred ccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhcccccccccccc
Q 020085 263 VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIHSII 329 (331)
Q Consensus 263 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p~~~ 329 (331)
.....+++.|+|||.+.+..++.++|||||||++|||+| |++||...+..+.... +.++.+|+++
T Consensus 157 -~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~-i~~~~~~~~~ 222 (262)
T d1byga_ 157 -QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR-VEKGYKMDAP 222 (262)
T ss_dssp ------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHH-HTTTCCCCCC
T ss_pred -CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHH-HHcCCCCCCC
Confidence 334568899999999999999999999999999999998 7999999888877766 5678888876
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4.5e-49 Score=353.10 Aligned_cols=218 Identities=29% Similarity=0.490 Sum_probs=186.0
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCC----
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN---- 181 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~---- 181 (331)
.++|++.+.||+|+||+||+|++ +++.||||+++.... +......+.+|+.++++++||||+++++++.....
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 45799999999999999999998 478999999987644 45566789999999999999999999999876443
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC
Q 020085 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261 (331)
Q Consensus 182 ~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~ 261 (331)
+|+||||++|++|.+++.. .+.+++..+..++.||++||+|||++||+||||||+|||++.++.++++|||.++.....
T Consensus 86 ~~lvmE~~~g~~L~~~~~~-~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~ 164 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS 164 (277)
T ss_dssp EEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC--
T ss_pred EEEEEECCCCCEehhhhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhccc
Confidence 8999999999999998865 467999999999999999999999999999999999999999999999999998754433
Q ss_pred C----ccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccccccccc
Q 020085 262 G----VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQKVSIHS 327 (331)
Q Consensus 262 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~p~ 327 (331)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||.+.++.+...++++.+..|+
T Consensus 165 ~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~ 234 (277)
T d1o6ya_ 165 GNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP 234 (277)
T ss_dssp --------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCG
T ss_pred cccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCC
Confidence 2 23445799999999999999999999999999999999999999999999998888777665543
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=1.7e-48 Score=349.08 Aligned_cols=212 Identities=25% Similarity=0.408 Sum_probs=189.6
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCC-------HHHHHHHHHHHHHHHhcC-CCcceeEEeEEECC
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVN-------TEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRP 179 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~-------~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~ 179 (331)
++|++.+.||+|+||+||+|++ +++.||||+++..... ....+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 6899999999999999999998 6789999999755322 123456889999999997 99999999999999
Q ss_pred CCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeec
Q 020085 180 PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA 259 (331)
Q Consensus 180 ~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~ 259 (331)
+..||||||++||+|.+++.. ++.+++..+..++.||++||+|||++||+||||||+|||++.++.+||+|||+++...
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 161 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLD 161 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred cceEEEEEcCCCchHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEcc
Confidence 999999999999999999976 5689999999999999999999999999999999999999999999999999999877
Q ss_pred CCCccccCCCCcccccchhcC------CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccc
Q 020085 260 QSGVMTAETGTYRWMAPEVIE------HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK 322 (331)
Q Consensus 260 ~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~ 322 (331)
.........||+.|+|||.+. ...++.++||||+||++|||++|+.||.+.++.+....+...
T Consensus 162 ~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~ 230 (277)
T d1phka_ 162 PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG 230 (277)
T ss_dssp TTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred CCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhC
Confidence 666666778999999999984 345789999999999999999999999999988877665543
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.9e-49 Score=366.71 Aligned_cols=210 Identities=26% Similarity=0.415 Sum_probs=188.8
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEE
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVT 186 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~ 186 (331)
++|++.++||+|+||+||+|++ +|+.||||+++.... +....+.+.+|+.+|++++||||+++++++......++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 5899999999999999999998 478999999864321 1123467899999999999999999999999999999999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCcccc
Q 020085 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGVMTA 266 (331)
Q Consensus 187 E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~~~~ 266 (331)
||+.||+|.+++.+ .+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+..... ...
T Consensus 121 e~~~~g~l~~~l~~-~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--~~~ 197 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRR-IGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TWT 197 (350)
T ss_dssp ECCTTCBHHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--BCC
T ss_pred ccccccchhhhHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--ccc
Confidence 99999999999966 467999999999999999999999999999999999999999999999999999876543 345
Q ss_pred CCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccc
Q 020085 267 ETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK 322 (331)
Q Consensus 267 ~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~ 322 (331)
..||+.|||||++.+..|+.++|||||||++|||++|+.||.+.++.+....+...
T Consensus 198 ~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~ 253 (350)
T d1rdqe_ 198 LCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG 253 (350)
T ss_dssp CEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred ccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcC
Confidence 67999999999999999999999999999999999999999999988887776543
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-49 Score=355.70 Aligned_cols=223 Identities=32% Similarity=0.599 Sum_probs=187.9
Q ss_pred eecccCcceeeeeeecCceEEEEEEECC-----ceEEEEEecCCCC-CHHHHHHHHHHHHHHHhcCCCcceeEEeEEECC
Q 020085 106 EIDAKQLKIECKVASGSYGDLYKGTYCS-----QEVAIKVLKPECV-NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP 179 (331)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-----~~vavK~~~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 179 (331)
-|+.++|++.+.||+|+||+||+|++.+ ..||||+++.... +.+..+.|.+|+.+|++++||||++++|+|.+
T Consensus 4 ~i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~- 82 (273)
T d1u46a_ 4 LIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT- 82 (273)
T ss_dssp ECCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred EEchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-
Confidence 3678899999999999999999998743 3689999976543 33456789999999999999999999999976
Q ss_pred CCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeec
Q 020085 180 PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQA 259 (331)
Q Consensus 180 ~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~ 259 (331)
+..++||||+++|++.+++..+.+.+++..+++++.||++||.|||++||+||||||+||+++.++.+||+|||+++...
T Consensus 83 ~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~ 162 (273)
T d1u46a_ 83 PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP 162 (273)
T ss_dssp SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence 47899999999999999998877889999999999999999999999999999999999999999999999999998765
Q ss_pred CCCcc----ccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhcccccccccccc
Q 020085 260 QSGVM----TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIHSII 329 (331)
Q Consensus 260 ~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p~~~ 329 (331)
..... ....+++.|+|||.+.+..++.++||||||+++|||++ |+.||.+.+..+....+.+.+.+|+.+
T Consensus 163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~~~ 237 (273)
T d1u46a_ 163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPRP 237 (273)
T ss_dssp C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCCCC
T ss_pred cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCCCc
Confidence 44322 23357889999999999999999999999999999998 899999999999999988888888764
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.3e-49 Score=358.79 Aligned_cols=209 Identities=20% Similarity=0.333 Sum_probs=189.7
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEe
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E 187 (331)
++|++.+.||+|+||+||+|.+ +++.||||+++... .....+.+|+.+|++++||||+++++++.++..+|+|||
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~---~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE 81 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG---TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE 81 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT---HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc---ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence 5799999999999999999998 47889999998653 223568899999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC--CcEEEeeecceeeecCCCccc
Q 020085 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN--GVVKVADFGVARVQAQSGVMT 265 (331)
Q Consensus 188 ~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~--~~vkl~DFg~a~~~~~~~~~~ 265 (331)
|++||+|.+++......+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+++.........
T Consensus 82 ~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~ 161 (321)
T d1tkia_ 82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFR 161 (321)
T ss_dssp CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEE
T ss_pred cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCccc
Confidence 999999999997766689999999999999999999999999999999999999854 479999999998776665566
Q ss_pred cCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 266 AETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 266 ~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
...+|+.|+|||.+.+..|+.++||||+||++|+|++|+.||.+.++.+....+.+
T Consensus 162 ~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~ 217 (321)
T d1tkia_ 162 LLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMN 217 (321)
T ss_dssp EEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH
T ss_pred ccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 67899999999999999999999999999999999999999999998887777654
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.5e-49 Score=356.20 Aligned_cols=224 Identities=29% Similarity=0.546 Sum_probs=195.9
Q ss_pred eeeecccCcceeeeeeecCceEEEEEEECC-------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEE
Q 020085 104 VWEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGAC 176 (331)
Q Consensus 104 ~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 176 (331)
.||++.++|++.++||+|+||+||+|++.+ +.||||+++... ..+..++|.+|+.++++++||||++++++|
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA-SADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhc-ChHHHHHHHHHHHHHHhcCCCCcccceeee
Confidence 377888899999999999999999999754 679999998653 556677899999999999999999999999
Q ss_pred ECCCCeEEEEeccCCCCHHHHHHhcC-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Q 020085 177 TRPPNLCIVTEFMARGSIYDFLHKQK-----------------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRD 233 (331)
Q Consensus 177 ~~~~~~~lV~E~~~ggsL~~~l~~~~-----------------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrD 233 (331)
......+++|||+++|+|.+++.... ..+++..++.++.|++.||+|||+++++|||
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrD 165 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRD 165 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSC
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeE
Confidence 99999999999999999999996532 2478889999999999999999999999999
Q ss_pred CCCCCEEEcCCCcEEEeeecceeeecCCC---ccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCC-CCCCC
Q 020085 234 LKTANLLMDENGVVKVADFGVARVQAQSG---VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGE-LPYAG 309 (331)
Q Consensus 234 lkp~NiLi~~~~~vkl~DFg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~-~Pf~~ 309 (331)
|||+|||++.++.+||+|||+++...... ......+++.|+|||.+.+..|+.++|||||||++|||++|. +||.+
T Consensus 166 lKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~ 245 (301)
T d1lufa_ 166 LATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 245 (301)
T ss_dssp CSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred EcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCC
Confidence 99999999999999999999997543322 223456889999999999999999999999999999999985 78999
Q ss_pred CCHHHHHhcccccccccccc
Q 020085 310 LTPLQAAVGVVQKVSIHSII 329 (331)
Q Consensus 310 ~~~~~~~~~~~~~~~~p~~~ 329 (331)
.++.+.... ++++.+|+++
T Consensus 246 ~~~~e~~~~-v~~~~~~~~p 264 (301)
T d1lufa_ 246 MAHEEVIYY-VRDGNILACP 264 (301)
T ss_dssp SCHHHHHHH-HHTTCCCCCC
T ss_pred CCHHHHHHH-HHcCCCCCCC
Confidence 999888777 6678888765
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-48 Score=353.54 Aligned_cols=223 Identities=30% Similarity=0.597 Sum_probs=192.2
Q ss_pred eeecccCcceeeeeeecCceEEEEEEECC---------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCcceeEEe
Q 020085 105 WEIDAKQLKIECKVASGSYGDLYKGTYCS---------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIG 174 (331)
Q Consensus 105 ~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~---------~~vavK~~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~ 174 (331)
|+|+.++|.+.+.||+|+||.||+|++.+ ..||||+++.+. ......++.+|...+.++ +|||||++++
T Consensus 8 ~~i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~e~~~l~~~~~HpnIv~~~~ 86 (299)
T d1fgka_ 8 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA-TEKDLSDLISEMEMMKMIGKHKNIINLLG 86 (299)
T ss_dssp TBCCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred CcccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc-ChHHHHHHHHHHHHHHHhcCCCeEEeccc
Confidence 99999999999999999999999998733 369999998764 445567889999999888 7999999999
Q ss_pred EEECCCCeEEEEeccCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCE
Q 020085 175 ACTRPPNLCIVTEFMARGSIYDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANL 239 (331)
Q Consensus 175 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Ni 239 (331)
+|.+++..++||||+++|+|.+++.... ..+++..++.++.||+.||+|||++||+||||||+||
T Consensus 87 ~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~Ni 166 (299)
T d1fgka_ 87 ACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNV 166 (299)
T ss_dssp EECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred ccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccce
Confidence 9999999999999999999999997643 3589999999999999999999999999999999999
Q ss_pred EEcCCCcEEEeeecceeeecCCCc---cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHH
Q 020085 240 LMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQA 315 (331)
Q Consensus 240 Li~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~ 315 (331)
|++.++.+||+|||+++....... .....+++.|+|||.+.+..|+.++||||||+++|||++ |++||.+.+..+.
T Consensus 167 Ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~ 246 (299)
T d1fgka_ 167 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 246 (299)
T ss_dssp EECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred eecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHH
Confidence 999999999999999986654332 234568999999999999999999999999999999998 7999999888776
Q ss_pred Hhcccccccccccc
Q 020085 316 AVGVVQKVSIHSII 329 (331)
Q Consensus 316 ~~~~~~~~~~p~~~ 329 (331)
... ++.+.+|+++
T Consensus 247 ~~~-i~~~~~~~~p 259 (299)
T d1fgka_ 247 FKL-LKEGHRMDKP 259 (299)
T ss_dssp HHH-HHTTCCCCCC
T ss_pred HHH-HHcCCCCCCC
Confidence 554 6678888775
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.7e-49 Score=357.87 Aligned_cols=220 Identities=30% Similarity=0.586 Sum_probs=186.5
Q ss_pred ecccCcceeeeeeecCceEEEEEEEC--Cc----eEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCC
Q 020085 107 IDAKQLKIECKVASGSYGDLYKGTYC--SQ----EVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (331)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~----~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 180 (331)
+..++|++.++||+|+||+||+|.+. ++ .||+|.++... +....+.|.+|+.++++++|||||+++++|.++
T Consensus 6 ~k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~- 83 (317)
T d1xkka_ 6 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT-SPKANKEILDEAYVMASVDNPHVCRLLGICLTS- 83 (317)
T ss_dssp CCTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC-----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-
T ss_pred CCHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-
Confidence 34568999999999999999999884 32 58999987543 333457899999999999999999999999875
Q ss_pred CeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecC
Q 020085 181 NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (331)
Q Consensus 181 ~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~ 260 (331)
..++++|++.+|+|.+++......+++..+++++.||++||+|||++||+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~ 163 (317)
T d1xkka_ 84 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA 163 (317)
T ss_dssp SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence 57889999999999999988888999999999999999999999999999999999999999999999999999986544
Q ss_pred CCc---cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHHHHHhcccccccccccc
Q 020085 261 SGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPLQAAVGVVQKVSIHSII 329 (331)
Q Consensus 261 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~~~~~~~~~~~~~p~~~ 329 (331)
... .....||+.|+|||.+.+..|+.++|||||||++|||+| |++||.+.+..+.. ..+++|.+|+.+
T Consensus 164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~-~~i~~~~~~~~p 235 (317)
T d1xkka_ 164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-SILEKGERLPQP 235 (317)
T ss_dssp TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHH-HHHHHTCCCCCC
T ss_pred ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHH-HHHHcCCCCCCC
Confidence 322 223458999999999999999999999999999999998 89999998777654 446778887665
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8e-49 Score=355.21 Aligned_cols=227 Identities=30% Similarity=0.562 Sum_probs=187.1
Q ss_pred CCeeeecccCcceeeeeeecCceEEEEEEECC-------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCcceeEE
Q 020085 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYCS-------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFI 173 (331)
Q Consensus 102 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~~-------~~vavK~~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~ 173 (331)
.+.|+|+.++|++.++||+|+||+||+|++.+ +.||||+++... .....+.+.+|..++.++ +|+||++++
T Consensus 5 ~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~-~~~~~~~~~~e~~~l~~~~~h~~iv~~~ 83 (299)
T d1ywna1 5 ASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA-THSEHRALMSELKILIHIGHHLNVVNLL 83 (299)
T ss_dssp HHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC-----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CccccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc-CcHHHHHHHHHHHHHHhhcCCCeEEEee
Confidence 35699999999999999999999999998732 579999997553 444567788888888877 589999999
Q ss_pred eEEECC-CCeEEEEeccCCCCHHHHHHhcC---------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 020085 174 GACTRP-PNLCIVTEFMARGSIYDFLHKQK---------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 237 (331)
Q Consensus 174 ~~~~~~-~~~~lV~E~~~ggsL~~~l~~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~ 237 (331)
+++... ..+++||||+++|+|.+++.... ..+++..+..++.||++||+|||++||+||||||+
T Consensus 84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~ 163 (299)
T d1ywna1 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR 163 (299)
T ss_dssp EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred eeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCcc
Confidence 998664 46899999999999999997542 34889999999999999999999999999999999
Q ss_pred CEEEcCCCcEEEeeecceeeecCCCc---cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcC-CCCCCCCCHH
Q 020085 238 NLLMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTG-ELPYAGLTPL 313 (331)
Q Consensus 238 NiLi~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g-~~Pf~~~~~~ 313 (331)
|||+++++.+||+|||+|+....... .....||+.|+|||++.+..++.++|||||||++|||++| .+||.+.+..
T Consensus 164 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~ 243 (299)
T d1ywna1 164 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243 (299)
T ss_dssp GEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred ceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999986544322 2345689999999999999999999999999999999996 6789988777
Q ss_pred HHHhcccccccccccc
Q 020085 314 QAAVGVVQKVSIHSII 329 (331)
Q Consensus 314 ~~~~~~~~~~~~p~~~ 329 (331)
+.....++++.+|+++
T Consensus 244 ~~~~~~~~~~~~~~~~ 259 (299)
T d1ywna1 244 EEFCRRLKEGTRMRAP 259 (299)
T ss_dssp HHHHHHHHHTCCCCCC
T ss_pred HHHHHHHhcCCCCCCC
Confidence 7777778888888765
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-48 Score=355.82 Aligned_cols=210 Identities=25% Similarity=0.458 Sum_probs=184.4
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCC-CHHHHHHHHHHHHHHH-hcCCCcceeEEeEEECCCCeEEE
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-NTEMLKEFSQEVYIMR-KIRHKNVVQFIGACTRPPNLCIV 185 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~il~-~l~h~niv~~~~~~~~~~~~~lV 185 (331)
++|.+.++||+|+||+||+|++ +++.||||+++.... ..+..+.+..|..++. .++||||+++++++.+++.+|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 5799999999999999999998 678999999974321 1122345666776654 68999999999999999999999
Q ss_pred EeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecC-CCcc
Q 020085 186 TEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ-SGVM 264 (331)
Q Consensus 186 ~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~-~~~~ 264 (331)
|||++||+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||+++++.+||+|||+++.... ....
T Consensus 82 mEy~~~g~L~~~i~~-~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~ 160 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKT 160 (320)
T ss_dssp EECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCB
T ss_pred EeecCCCcHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccccccc
Confidence 999999999999965 56789999999999999999999999999999999999999999999999999986543 3334
Q ss_pred ccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccc
Q 020085 265 TAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVV 320 (331)
Q Consensus 265 ~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~ 320 (331)
+...||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.++.+....+.
T Consensus 161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~ 216 (320)
T d1xjda_ 161 NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR 216 (320)
T ss_dssp CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred cccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 55689999999999999999999999999999999999999999999888777654
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-48 Score=351.28 Aligned_cols=226 Identities=28% Similarity=0.526 Sum_probs=198.3
Q ss_pred CCeeeecccCcceeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEe
Q 020085 102 TDVWEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIG 174 (331)
Q Consensus 102 ~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~ 174 (331)
.+.|+|+.++|.+.++||+|+||+||+|.+. ++.||||+++... .......|.+|+.++++++||||+++++
T Consensus 12 ~~~~ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~-~~~~~~~~~~E~~il~~l~h~nIv~~~~ 90 (308)
T d1p4oa_ 12 PDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIEFLNEASVMKEFNCHHVVRLLG 90 (308)
T ss_dssp CCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS-CHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred ccceeecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECccc-ChHHHHHHHHHHHHHHHcCCCCEeeeee
Confidence 3569999999999999999999999999874 3679999998653 5556678999999999999999999999
Q ss_pred EEECCCCeEEEEeccCCCCHHHHHHhcC---------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC
Q 020085 175 ACTRPPNLCIVTEFMARGSIYDFLHKQK---------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG 245 (331)
Q Consensus 175 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~---------~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~ 245 (331)
+|..+...++||||+++|+|.+++.... ..++...+..++.|+++||.|||+++|+||||||+|||++.++
T Consensus 91 ~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~ 170 (308)
T d1p4oa_ 91 VVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDF 170 (308)
T ss_dssp EECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTC
T ss_pred EEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCc
Confidence 9999999999999999999999986532 3468889999999999999999999999999999999999999
Q ss_pred cEEEeeecceeeecCCCc---cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcC-CCCCCCCCHHHHHhcccc
Q 020085 246 VVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTG-ELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 246 ~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g-~~Pf~~~~~~~~~~~~~~ 321 (331)
++||+|||+++....... .....+|+.|+|||.+.+..++.++||||||+++|||++| ++||.+.+..+....++
T Consensus 171 ~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~- 249 (308)
T d1p4oa_ 171 TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM- 249 (308)
T ss_dssp CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHH-
T ss_pred eEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHH-
Confidence 999999999985543322 2334689999999999999999999999999999999997 69999999988877744
Q ss_pred cccccccc
Q 020085 322 KVSIHSII 329 (331)
Q Consensus 322 ~~~~p~~~ 329 (331)
++.+|+++
T Consensus 250 ~~~~~~~p 257 (308)
T d1p4oa_ 250 EGGLLDKP 257 (308)
T ss_dssp TTCCCCCC
T ss_pred hCCCCCCc
Confidence 67777665
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-48 Score=349.96 Aligned_cols=226 Identities=30% Similarity=0.557 Sum_probs=200.0
Q ss_pred CeeeecccCcceeeeeeecCceEEEEEEEC-------CceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCcceeEEe
Q 020085 103 DVWEIDAKQLKIECKVASGSYGDLYKGTYC-------SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIG 174 (331)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~ 174 (331)
..|+|+.++|++.++||+|+||.||+|++. ++.||||+++... .......|.+|+.+++++ +|||||++++
T Consensus 16 ~~~~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~E~~~~~~l~~HpnIv~~~g 94 (311)
T d1t46a_ 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA-HLTEREALMSELKVLSYLGNHMNIVNLLG 94 (311)
T ss_dssp GGGBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccccCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc-CHHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 369999999999999999999999999873 2579999998664 455567899999999999 6999999999
Q ss_pred EEECCCCeEEEEeccCCCCHHHHHHhcC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCC
Q 020085 175 ACTRPPNLCIVTEFMARGSIYDFLHKQK-----------------GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTA 237 (331)
Q Consensus 175 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~-----------------~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~ 237 (331)
+|..+...++||||+++|+|.+++.... ..+++..+..++.||++||+|||++|++||||||+
T Consensus 95 ~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~ 174 (311)
T d1t46a_ 95 ACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAAR 174 (311)
T ss_dssp EECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred EEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccc
Confidence 9999999999999999999999997643 25889999999999999999999999999999999
Q ss_pred CEEEcCCCcEEEeeecceeeecCCCc---cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHc-CCCCCCCCCHH
Q 020085 238 NLLMDENGVVKVADFGVARVQAQSGV---MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLT-GELPYAGLTPL 313 (331)
Q Consensus 238 NiLi~~~~~vkl~DFg~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~-g~~Pf~~~~~~ 313 (331)
||+++.++.+|++|||.++....... .....||+.|+|||.+.+..++.++||||||+++|||++ |++||.+.+..
T Consensus 175 NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~ 254 (311)
T d1t46a_ 175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD 254 (311)
T ss_dssp GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred cccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999986654322 233468999999999999999999999999999999999 77888888887
Q ss_pred HHHhcccccccccccc
Q 020085 314 QAAVGVVQKVSIHSII 329 (331)
Q Consensus 314 ~~~~~~~~~~~~p~~~ 329 (331)
+.+.++++.+.+|..+
T Consensus 255 ~~~~~~i~~~~~~~~~ 270 (311)
T d1t46a_ 255 SKFYKMIKEGFRMLSP 270 (311)
T ss_dssp HHHHHHHHHTCCCCCC
T ss_pred HHHHHHHhcCCCCCCc
Confidence 8788888888888765
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.2e-48 Score=352.08 Aligned_cols=223 Identities=31% Similarity=0.540 Sum_probs=190.5
Q ss_pred eecccCcceeeeeeecCceEEEEEEEC--Cc--eEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCcceeEEeEEECCC
Q 020085 106 EIDAKQLKIECKVASGSYGDLYKGTYC--SQ--EVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTRPP 180 (331)
Q Consensus 106 ~i~~~~~~~~~~lg~G~~g~Vy~~~~~--~~--~vavK~~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~~~ 180 (331)
.|+.++|++.++||+|+||+||+|++. +. .||||.++... ..+..+.|.+|+.+|+++ +||||++++++|..++
T Consensus 6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~ 84 (309)
T d1fvra_ 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA-SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG 84 (309)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC-------CHHHHHHHHHTTCCCCTTBCCEEEEEEETT
T ss_pred ccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc-ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCC
Confidence 467899999999999999999999984 33 47888876443 334456899999999998 7999999999999999
Q ss_pred CeEEEEeccCCCCHHHHHHhc---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC
Q 020085 181 NLCIVTEFMARGSIYDFLHKQ---------------KGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG 245 (331)
Q Consensus 181 ~~~lV~E~~~ggsL~~~l~~~---------------~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~ 245 (331)
.+++||||+++|+|.++++.. ...+++..+..++.||++||.|||++||+||||||+|||++.++
T Consensus 85 ~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~ 164 (309)
T d1fvra_ 85 YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENY 164 (309)
T ss_dssp EEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGG
T ss_pred eeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCC
Confidence 999999999999999999653 35789999999999999999999999999999999999999999
Q ss_pred cEEEeeecceeeecCCCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcC-CCCCCCCCHHHHHhccccccc
Q 020085 246 VVKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTG-ELPYAGLTPLQAAVGVVQKVS 324 (331)
Q Consensus 246 ~vkl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g-~~Pf~~~~~~~~~~~~~~~~~ 324 (331)
.+||+|||+++............||+.|+|||.+.+..++.++|||||||++|||++| .+||.+.+..+.... +.++.
T Consensus 165 ~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~-i~~~~ 243 (309)
T d1fvra_ 165 VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEK-LPQGY 243 (309)
T ss_dssp CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH-GGGTC
T ss_pred ceEEccccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHH-HHhcC
Confidence 9999999999866655555566789999999999999999999999999999999996 578999998887777 45688
Q ss_pred cccccc
Q 020085 325 IHSIIL 330 (331)
Q Consensus 325 ~p~~~~ 330 (331)
+|+++.
T Consensus 244 ~~~~~~ 249 (309)
T d1fvra_ 244 RLEKPL 249 (309)
T ss_dssp CCCCCT
T ss_pred CCCCCc
Confidence 888753
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.3e-48 Score=348.40 Aligned_cols=211 Identities=24% Similarity=0.449 Sum_probs=180.1
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEe
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E 187 (331)
++|++.++||+|+||+||+|.+ +++.||||+++....+....+.+.+|++++++++||||+++++++..+..+|+|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 5899999999999999999998 47899999998665444456789999999999999999999999999999999999
Q ss_pred ccCCCCHHHHH-HhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC-Cccc
Q 020085 188 FMARGSIYDFL-HKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS-GVMT 265 (331)
Q Consensus 188 ~~~ggsL~~~l-~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~-~~~~ 265 (331)
|+.+ ++.+++ ......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||.|+..... ....
T Consensus 82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~ 160 (298)
T d1gz8a_ 82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT 160 (298)
T ss_dssp CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTT
T ss_pred ecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcccce
Confidence 9987 444444 444567999999999999999999999999999999999999999999999999999766543 3344
Q ss_pred cCCCCcccccchhcCCCC-CCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 266 AETGTYRWMAPEVIEHKP-YDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 266 ~~~gt~~y~aPE~~~~~~-~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
...||+.|+|||.+.... ++.++|+||+||++|+|++|+.||.+.+..+...++.+
T Consensus 161 ~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~ 217 (298)
T d1gz8a_ 161 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 217 (298)
T ss_dssp CCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred eecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHH
Confidence 557999999999987665 47899999999999999999999999888776665443
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.6e-47 Score=355.41 Aligned_cols=202 Identities=26% Similarity=0.432 Sum_probs=174.8
Q ss_pred cccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCC----CHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCC
Q 020085 108 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV----NTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPN 181 (331)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~----~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~ 181 (331)
..++|++.+.||+|+||+||+|++ +|+.||||+++.... .........+|+.+++.++|||||++++++..++.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence 356899999999999999999998 578999999864321 11122233345677777889999999999999999
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC
Q 020085 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261 (331)
Q Consensus 182 ~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~ 261 (331)
+|+||||++||+|.+++.+ ...+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+.....
T Consensus 82 ~~ivmE~~~gg~L~~~l~~-~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~ 160 (364)
T d1omwa3 82 LSFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 160 (364)
T ss_dssp EEEEECCCCSCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred EEEEEEecCCCcHHHHHHh-cccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence 9999999999999999966 467899999999999999999999999999999999999999999999999999876543
Q ss_pred CccccCCCCcccccchhcC-CCCCCChhhHHHHHHHHHHHHcCCCCCCCCC
Q 020085 262 GVMTAETGTYRWMAPEVIE-HKPYDYKADVFSFGIALWELLTGELPYAGLT 311 (331)
Q Consensus 262 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~ 311 (331)
......||+.|+|||++. +..|+.++|||||||++|||++|+.||.+.+
T Consensus 161 -~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~ 210 (364)
T d1omwa3 161 -KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 210 (364)
T ss_dssp -CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSC
T ss_pred -cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCC
Confidence 345568999999999996 4578999999999999999999999998754
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.5e-48 Score=354.41 Aligned_cols=199 Identities=25% Similarity=0.424 Sum_probs=174.9
Q ss_pred ccCcceee-eeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhc-CCCcceeEEeEEEC----CC
Q 020085 109 AKQLKIEC-KVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI-RHKNVVQFIGACTR----PP 180 (331)
Q Consensus 109 ~~~~~~~~-~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l-~h~niv~~~~~~~~----~~ 180 (331)
.++|++.. .||+|+||+||+|++ +++.||||+++.. ..+.+|+.++.++ +||||+++++++.+ +.
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~ 82 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 82 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCC
Confidence 35798875 599999999999998 5789999999743 4577899987654 89999999999865 45
Q ss_pred CeEEEEeccCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC---CCcEEEeeeccee
Q 020085 181 NLCIVTEFMARGSIYDFLHKQK-GVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE---NGVVKVADFGVAR 256 (331)
Q Consensus 181 ~~~lV~E~~~ggsL~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~---~~~vkl~DFg~a~ 256 (331)
.+|+||||++||+|.+++.+.. ..+++..+..++.||+.||+|||++||+||||||+|||++. ++.+||+|||+|+
T Consensus 83 ~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~ 162 (335)
T d2ozaa1 83 CLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162 (335)
T ss_dssp EEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred EEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceee
Confidence 6899999999999999997643 46999999999999999999999999999999999999985 5579999999999
Q ss_pred eecCCCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHH
Q 020085 257 VQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQ 314 (331)
Q Consensus 257 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~ 314 (331)
............||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+..+
T Consensus 163 ~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~ 220 (335)
T d2ozaa1 163 ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 220 (335)
T ss_dssp ECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-
T ss_pred eccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHH
Confidence 8777666677889999999999999999999999999999999999999998765433
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-47 Score=348.32 Aligned_cols=213 Identities=24% Similarity=0.424 Sum_probs=184.6
Q ss_pred ccCcceeeeeeecCceEEEEEEEC---CceEEEEEecCCCCCHHHHHHHHHHHHHHHhc---CCCcceeEEeEEEC----
Q 020085 109 AKQLKIECKVASGSYGDLYKGTYC---SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKI---RHKNVVQFIGACTR---- 178 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~~---~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l---~h~niv~~~~~~~~---- 178 (331)
.++|++.++||+|+||+||+|++. ++.||||+++...........+.+|+.+++.+ +||||++++++|..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 468999999999999999999983 45799999975543333334566788887766 79999999999853
Q ss_pred -CCCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceee
Q 020085 179 -PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARV 257 (331)
Q Consensus 179 -~~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~ 257 (331)
...++++|||+.++++..........+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++.
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~ 165 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI 165 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred cCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence 3468999999999777766666677899999999999999999999999999999999999999999999999999987
Q ss_pred ecCCCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 258 QAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 258 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
...........||+.|+|||++.+.+|+.++||||+||++|||++|+.||.+.++.+....+.+
T Consensus 166 ~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~ 229 (305)
T d1blxa_ 166 YSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD 229 (305)
T ss_dssp CCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred hcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence 7666666778899999999999999999999999999999999999999999998887766554
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-47 Score=345.23 Aligned_cols=208 Identities=27% Similarity=0.400 Sum_probs=176.0
Q ss_pred eeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCH---HHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEec
Q 020085 114 IECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNT---EMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF 188 (331)
Q Consensus 114 ~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~---~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~ 188 (331)
.++.||+|+||+||+|++ +++.||||+++...... ...+.+.+|+.++++++|||||++++++..++.+|+||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhh
Confidence 457899999999999997 57899999997553322 2245689999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC-ccccC
Q 020085 189 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTAE 267 (331)
Q Consensus 189 ~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~-~~~~~ 267 (331)
+.++++..+. ..+..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... .....
T Consensus 82 ~~~~~~~~~~-~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~ 160 (299)
T d1ua2a_ 82 METDLEVIIK-DNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ 160 (299)
T ss_dssp CSEEHHHHHT-TCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCS
T ss_pred hcchHHhhhh-hcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcccccce
Confidence 9987666554 456789999999999999999999999999999999999999999999999999997654432 33455
Q ss_pred CCCcccccchhcCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccc
Q 020085 268 TGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK 322 (331)
Q Consensus 268 ~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~ 322 (331)
.||+.|+|||++.. ..|+.++|||||||++|||++|++||.+.+..+....+.+.
T Consensus 161 ~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~ 216 (299)
T d1ua2a_ 161 VVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFET 216 (299)
T ss_dssp CCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred ecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHh
Confidence 79999999999864 56899999999999999999999999999988877765543
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3e-46 Score=339.91 Aligned_cols=215 Identities=29% Similarity=0.496 Sum_probs=179.8
Q ss_pred ceeeeeeecCceEEEEEEECC-----ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEEC-CCCeEEEE
Q 020085 113 KIECKVASGSYGDLYKGTYCS-----QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR-PPNLCIVT 186 (331)
Q Consensus 113 ~~~~~lg~G~~g~Vy~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~-~~~~~lV~ 186 (331)
.+.++||+|+||+||+|++.. ..||||+++.. .+....++|.+|+++|++++||||++++|+|.. +...++||
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 108 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI-TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVL 108 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC-CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc-cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEE
Confidence 346789999999999999843 25899999753 356667889999999999999999999999865 55789999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCc---
Q 020085 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV--- 263 (331)
Q Consensus 187 E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~--- 263 (331)
||+++|+|.+++......+++..+++++.|+++||.|||+.+|+||||||+|||+++++.+||+|||+++.......
T Consensus 109 E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~ 188 (311)
T d1r0pa_ 109 PYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188 (311)
T ss_dssp ECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred EEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence 99999999999988777888999999999999999999999999999999999999999999999999986543321
Q ss_pred --cccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCC-CCHHHHHhcccccccccccc
Q 020085 264 --MTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAG-LTPLQAAVGVVQKVSIHSII 329 (331)
Q Consensus 264 --~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~-~~~~~~~~~~~~~~~~p~~~ 329 (331)
.....||+.|+|||.+....++.++||||||+++|||++|+.||.. .+..+.... +.+|.+|..+
T Consensus 189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~-i~~g~~~~~p 256 (311)
T d1r0pa_ 189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVY-LLQGRRLLQP 256 (311)
T ss_dssp TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHH-HHTTCCCCCC
T ss_pred eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHH-HHcCCCCCCc
Confidence 2234589999999999999999999999999999999997666654 444444444 5567887664
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.9e-46 Score=336.11 Aligned_cols=211 Identities=24% Similarity=0.415 Sum_probs=181.3
Q ss_pred cCcceeeeeeecCceEEEEEEE-CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEec
Q 020085 110 KQLKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTEF 188 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E~ 188 (331)
++|++.++||+|+||+||+|++ .++.||||+++....+....+.+.+|+.+|++++||||+++++++..++..++++|+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5899999999999999999998 468999999987654444567899999999999999999999999999999999999
Q ss_pred cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCCc-cccC
Q 020085 189 MARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSGV-MTAE 267 (331)
Q Consensus 189 ~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~~-~~~~ 267 (331)
+.++.+..+. ...+.+++..+..++.||+.||+|||+.||+||||||+|||++.++.+|++|||.+........ ....
T Consensus 82 ~~~~~~~~~~-~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~ 160 (286)
T d1ob3a_ 82 LDQDLKKLLD-VCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHE 160 (286)
T ss_dssp CSEEHHHHHH-TSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC--------
T ss_pred ehhhhHHHHH-hhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcccccee
Confidence 9886555554 5568899999999999999999999999999999999999999999999999999976544322 3445
Q ss_pred CCCcccccchhcCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 268 TGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 268 ~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
.+++.|+|||.+.+ ..++.++||||+||++|||++|+.||.+.+..+...++.+
T Consensus 161 ~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~ 215 (286)
T d1ob3a_ 161 IVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFR 215 (286)
T ss_dssp -CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence 68999999999865 4579999999999999999999999999988777666543
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-45 Score=335.25 Aligned_cols=195 Identities=28% Similarity=0.549 Sum_probs=163.3
Q ss_pred ccCcceeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCC----CeEE
Q 020085 109 AKQLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP----NLCI 184 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~----~~~l 184 (331)
.++|.+.++||+|+||+||+|+++|+.||||+++... .....+..|+..+++++||||++++++|.... .+|+
T Consensus 2 ~~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 2 ARTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred CcEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 3578999999999999999999999999999997542 21122334555556789999999999997654 4899
Q ss_pred EEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh--------CCcccCCCCCCCEEEcCCCcEEEeeeccee
Q 020085 185 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ--------NNIIHRDLKTANLLMDENGVVKVADFGVAR 256 (331)
Q Consensus 185 V~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~--------~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~ 256 (331)
||||+++|+|.+++++ ..+++..+++++.|++.||+|||+ +||+||||||+|||++.++.+||+|||+++
T Consensus 79 v~Ey~~~g~L~~~l~~--~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~ 156 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNR--YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156 (303)
T ss_dssp EEECCTTCBHHHHHHH--CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred EEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccc
Confidence 9999999999999975 468999999999999999999996 699999999999999999999999999998
Q ss_pred eecCCCc-----cccCCCCcccccchhcCCCC------CCChhhHHHHHHHHHHHHcCCCCCC
Q 020085 257 VQAQSGV-----MTAETGTYRWMAPEVIEHKP------YDYKADVFSFGIALWELLTGELPYA 308 (331)
Q Consensus 257 ~~~~~~~-----~~~~~gt~~y~aPE~~~~~~------~~~~~Di~SlG~il~ell~g~~Pf~ 308 (331)
....... .....||+.|+|||++.+.. ++.++|||||||+||||++|..||.
T Consensus 157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~ 219 (303)
T d1vjya_ 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 219 (303)
T ss_dssp EEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTT
T ss_pred cccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCC
Confidence 7655432 23456999999999987543 5678999999999999999988763
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-46 Score=334.52 Aligned_cols=199 Identities=26% Similarity=0.474 Sum_probs=172.4
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCH----HHHHHHHHHHHHHHhcC--CCcceeEEeEEECCCC
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNT----EMLKEFSQEVYIMRKIR--HKNVVQFIGACTRPPN 181 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~----~~~~~~~~E~~il~~l~--h~niv~~~~~~~~~~~ 181 (331)
++|++.+.||+|+||+||+|++ +++.||||+++...... .....+.+|+.++++++ ||||+++++++..++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 5799999999999999999998 47899999987543221 11234678999999996 8999999999999999
Q ss_pred eEEEEeccCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCC-CcEEEeeecceeeec
Q 020085 182 LCIVTEFMAR-GSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDEN-GVVKVADFGVARVQA 259 (331)
Q Consensus 182 ~~lV~E~~~g-gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~-~~vkl~DFg~a~~~~ 259 (331)
.++||||+.+ +++.+++.. ++.+++..+..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+...
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~-~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~ 162 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK 162 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred EEEEEEeccCcchHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceecc
Confidence 9999999986 578888765 5689999999999999999999999999999999999999854 799999999998655
Q ss_pred CCCccccCCCCcccccchhcCCCCC-CChhhHHHHHHHHHHHHcCCCCCCCC
Q 020085 260 QSGVMTAETGTYRWMAPEVIEHKPY-DYKADVFSFGIALWELLTGELPYAGL 310 (331)
Q Consensus 260 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~Di~SlG~il~ell~g~~Pf~~~ 310 (331)
.. ..+...||+.|+|||++.+..+ +.++||||+||++|||++|+.||.+.
T Consensus 163 ~~-~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~ 213 (273)
T d1xwsa_ 163 DT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD 213 (273)
T ss_dssp SS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH
T ss_pred cc-cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc
Confidence 43 3456689999999999987765 57789999999999999999999864
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-45 Score=337.71 Aligned_cols=213 Identities=28% Similarity=0.449 Sum_probs=182.1
Q ss_pred CeeeecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCC
Q 020085 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (331)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 180 (331)
..|++ .++|++.++||+|+||+||+|++ +++.||||+++....+....+.+.+|+.+|++++|||||+++++|...+
T Consensus 12 ~~~~~-~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~ 90 (346)
T d1cm8a_ 12 TAWEV-RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDE 90 (346)
T ss_dssp SEECC-BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCS
T ss_pred ceeec-CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCc
Confidence 45776 56899999999999999999998 4789999999877667777788999999999999999999999997654
Q ss_pred ------CeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecc
Q 020085 181 ------NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV 254 (331)
Q Consensus 181 ------~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~ 254 (331)
.+|+||||+ +.+|..+... +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+|++|||.
T Consensus 91 ~~~~~~~~~lv~e~~-~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 91 TLDDFTDFYLVMPFM-GTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp STTTCCCCEEEEECC-SEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTT
T ss_pred cccccceEEEEEecc-cccHHHHHHh--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccc
Confidence 479999999 5588887743 5799999999999999999999999999999999999999999999999999
Q ss_pred eeeecCCCccccCCCCcccccchhcCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 255 ARVQAQSGVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 255 a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
++.... ..+...||+.|+|||++.+ ..++.++||||+||++|+|++|+.||.+.+..+....+.+
T Consensus 168 a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~ 233 (346)
T d1cm8a_ 168 ARQADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK 233 (346)
T ss_dssp CEECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred eeccCC--ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHh
Confidence 987654 3456789999999999865 4578999999999999999999999999888777665444
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-44 Score=332.85 Aligned_cols=215 Identities=24% Similarity=0.414 Sum_probs=178.3
Q ss_pred CeeeecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCC
Q 020085 103 DVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPP 180 (331)
Q Consensus 103 ~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~ 180 (331)
++|+|.. +|+++++||+|+||+||+|++ +++.||||+++... .....+.+.+|+.+|++++||||+++++++....
T Consensus 2 ~~~~i~~-rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~ 79 (345)
T d1pmea_ 2 QVFDVGP-RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE-HQTYCQRTLREIKILLRFRHENIIGINDIIRAPT 79 (345)
T ss_dssp CCCCCCT-TEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT-CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSS
T ss_pred CccCcCC-CeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc-ChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeecc
Confidence 3466655 599999999999999999998 58999999997543 4556678999999999999999999999996543
Q ss_pred ----CeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeeccee
Q 020085 181 ----NLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVAR 256 (331)
Q Consensus 181 ----~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~ 256 (331)
..+++++++.||+|.+++.. ..+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 80 ~~~~~~~~l~~~~~~g~L~~~l~~--~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~ 157 (345)
T d1pmea_ 80 IEQMKDVYLVTHLMGADLYKLLKT--QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLAR 157 (345)
T ss_dssp TTTCCCEEEEEECCCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred ccccceEEEEEeecCCchhhhhhc--CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCcee
Confidence 23445556678899999965 469999999999999999999999999999999999999999999999999998
Q ss_pred eecCCC----ccccCCCCcccccchhcC-CCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 257 VQAQSG----VMTAETGTYRWMAPEVIE-HKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 257 ~~~~~~----~~~~~~gt~~y~aPE~~~-~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
...... ......||+.|+|||++. ...++.++||||+||++|+|++|+.||.+.+..........
T Consensus 158 ~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~ 227 (345)
T d1pmea_ 158 VADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 227 (345)
T ss_dssp ECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred eccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhh
Confidence 654432 234456899999999984 45678999999999999999999999999887666555443
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1e-44 Score=335.21 Aligned_cols=205 Identities=26% Similarity=0.362 Sum_probs=175.7
Q ss_pred CcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEEC------CCCe
Q 020085 111 QLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR------PPNL 182 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~------~~~~ 182 (331)
+|+..++||+|+||+||+|++ +++.||||+++.+.. .+.+|+.+|++++||||++++++|.. ...+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~ 94 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 94 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEE
Confidence 699999999999999999999 578999999976532 23479999999999999999999853 2347
Q ss_pred EEEEeccCCCCHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC-cEEEeeecceeeec
Q 020085 183 CIVTEFMARGSIYDFLH--KQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG-VVKVADFGVARVQA 259 (331)
Q Consensus 183 ~lV~E~~~ggsL~~~l~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~-~vkl~DFg~a~~~~ 259 (331)
|+||||++++.+..+.. .....+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+++...
T Consensus 95 ~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~ 174 (350)
T d1q5ka_ 95 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV 174 (350)
T ss_dssp EEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECC
T ss_pred EEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhcc
Confidence 89999998754433332 2356799999999999999999999999999999999999999775 89999999998877
Q ss_pred CCCccccCCCCcccccchhcCC-CCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 260 QSGVMTAETGTYRWMAPEVIEH-KPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 260 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
.........||+.|+|||.+.+ ..|+.++||||+||++|||++|+.||...+..+....+++
T Consensus 175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~ 237 (350)
T d1q5ka_ 175 RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK 237 (350)
T ss_dssp TTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHH
T ss_pred CCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHH
Confidence 6666667789999999998764 5789999999999999999999999999888777666543
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-44 Score=328.79 Aligned_cols=212 Identities=26% Similarity=0.410 Sum_probs=177.4
Q ss_pred ccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEEC--------
Q 020085 109 AKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR-------- 178 (331)
Q Consensus 109 ~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~-------- 178 (331)
.++|++.++||+|+||+||+|++ +++.||||+++.+.........+.+|+.+|++++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence 47899999999999999999998 47899999987655444455778999999999999999999998855
Q ss_pred CCCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeee
Q 020085 179 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (331)
Q Consensus 179 ~~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~ 258 (331)
...+|+||||+.++.+... ......+++..+..++.|+++||.|||++||+||||||+|||++.++.+|++|||+++..
T Consensus 89 ~~~~~iv~e~~~~~~~~~~-~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~ 167 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLL-SNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 167 (318)
T ss_dssp --CEEEEEECCCEEHHHHH-TCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred CceEEEEEeccCCCccchh-hhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeec
Confidence 3468999999988655544 345678999999999999999999999999999999999999999999999999999755
Q ss_pred cCC-----CccccCCCCcccccchhcCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 259 AQS-----GVMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 259 ~~~-----~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
... .......||+.|+|||++.+. .|+.++||||+||++|||++|+.||.+.++.+....+.+
T Consensus 168 ~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~ 236 (318)
T d3blha1 168 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQ 236 (318)
T ss_dssp CC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred ccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHH
Confidence 432 122335699999999998754 689999999999999999999999999888776655443
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.4e-44 Score=323.76 Aligned_cols=198 Identities=20% Similarity=0.330 Sum_probs=173.9
Q ss_pred cccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCC-CcceeEEeEEECCCCeEE
Q 020085 108 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH-KNVVQFIGACTRPPNLCI 184 (331)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h-~niv~~~~~~~~~~~~~l 184 (331)
-.++|++.++||+|+||+||+|++ +++.||||+++..... ..+.+|+++++.++| +|++.+++++..+...++
T Consensus 3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~ 78 (293)
T d1csna_ 3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 78 (293)
T ss_dssp ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEE
Confidence 357899999999999999999998 4789999998654322 346788899999976 899999999999999999
Q ss_pred EEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC-----CCcEEEeeecceeeec
Q 020085 185 VTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE-----NGVVKVADFGVARVQA 259 (331)
Q Consensus 185 V~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~-----~~~vkl~DFg~a~~~~ 259 (331)
||||+ +++|.+++......++...+..++.|++.||+|||++||+||||||+|||++. ++.+||+|||+|+...
T Consensus 79 vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~ 157 (293)
T d1csna_ 79 VIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYR 157 (293)
T ss_dssp EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESB
T ss_pred EEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcc
Confidence 99998 67999999877778999999999999999999999999999999999999974 5789999999998654
Q ss_pred CCC--------ccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 020085 260 QSG--------VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL 310 (331)
Q Consensus 260 ~~~--------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~ 310 (331)
... ......||+.|||||++.+..++.++|||||||++|||++|+.||.+.
T Consensus 158 ~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~ 216 (293)
T d1csna_ 158 DPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 216 (293)
T ss_dssp CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred cCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCc
Confidence 321 122346999999999999999999999999999999999999999764
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-44 Score=331.13 Aligned_cols=208 Identities=25% Similarity=0.377 Sum_probs=173.2
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECC------CC
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRP------PN 181 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~------~~ 181 (331)
++|++.++||+|+||+||+|.+ +++.||||+++....+......+.+|+.++++++||||++++++|... ..
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 5799999999999999999998 479999999988776777778899999999999999999999999643 57
Q ss_pred eEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCC
Q 020085 182 LCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQS 261 (331)
Q Consensus 182 ~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~ 261 (331)
+|+||||+.++ +.+.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.++.++++|||+++.....
T Consensus 97 ~~iv~Ey~~~~-l~~~~---~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~ 172 (355)
T d2b1pa1 97 VYLVMELMDAN-LCQVI---QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS 172 (355)
T ss_dssp EEEEEECCSEE-HHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred eEEEEeccchH-HHHhh---hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccccc
Confidence 89999999774 55544 356899999999999999999999999999999999999999999999999999877776
Q ss_pred CccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhcccc
Q 020085 262 GVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQ 321 (331)
Q Consensus 262 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~ 321 (331)
.......+|+.|+|||++.+..++.++||||+||++|+|++|++||.+.+.......+.+
T Consensus 173 ~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~ 232 (355)
T d2b1pa1 173 FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE 232 (355)
T ss_dssp --------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHH
Confidence 666777899999999999999999999999999999999999999999887777666554
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-45 Score=334.37 Aligned_cols=207 Identities=23% Similarity=0.402 Sum_probs=177.2
Q ss_pred ecccCcceeeeeeecCceEEEEEEE-----CCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhcCC-CcceeEEeEEEC
Q 020085 107 IDAKQLKIECKVASGSYGDLYKGTY-----CSQEVAIKVLKPECV--NTEMLKEFSQEVYIMRKIRH-KNVVQFIGACTR 178 (331)
Q Consensus 107 i~~~~~~~~~~lg~G~~g~Vy~~~~-----~~~~vavK~~~~~~~--~~~~~~~~~~E~~il~~l~h-~niv~~~~~~~~ 178 (331)
+..++|++.++||+|+||+||+|.. +|+.||||+++.... +....+.+.+|+.++++++| |||+++++++.+
T Consensus 21 ~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~ 100 (322)
T d1vzoa_ 21 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT 100 (322)
T ss_dssp CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred cchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc
Confidence 3457899999999999999999987 367899999875422 12234568899999999977 899999999999
Q ss_pred CCCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeee
Q 020085 179 PPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQ 258 (331)
Q Consensus 179 ~~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~ 258 (331)
...++++|||+.+|+|.+++.. .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++..
T Consensus 101 ~~~~~~v~e~~~~~~L~~~i~~-~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~ 179 (322)
T d1vzoa_ 101 ETKLHLILDYINGGELFTHLSQ-RERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 179 (322)
T ss_dssp TTEEEEEECCCCSCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEEC
T ss_pred CCceeeeeecccccHHHHHHHh-cccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhh
Confidence 9999999999999999999976 456788999999999999999999999999999999999999999999999999865
Q ss_pred cCC--CccccCCCCcccccchhcCCC--CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHH
Q 020085 259 AQS--GVMTAETGTYRWMAPEVIEHK--PYDYKADVFSFGIALWELLTGELPYAGLTPLQ 314 (331)
Q Consensus 259 ~~~--~~~~~~~gt~~y~aPE~~~~~--~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~ 314 (331)
... .......|++.|+|||.+.+. .++.++|||||||+||||++|+.||.+.+..+
T Consensus 180 ~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~ 239 (322)
T d1vzoa_ 180 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN 239 (322)
T ss_dssp CGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC
T ss_pred cccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 432 233456799999999999654 46889999999999999999999998764433
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-44 Score=330.30 Aligned_cols=217 Identities=24% Similarity=0.416 Sum_probs=184.8
Q ss_pred CCCeeeecccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEEC
Q 020085 101 GTDVWEIDAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTR 178 (331)
Q Consensus 101 ~~~~~~i~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~ 178 (331)
+..+|++. ++|++.++||+|+||+||+|++ +++.||||+++....+....+.+.+|+.+|++++|||++++++++..
T Consensus 10 ~~~~~~~~-~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~ 88 (348)
T d2gfsa1 10 NKTIWEVP-ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP 88 (348)
T ss_dssp SSSEEEEE-TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECS
T ss_pred CCccccCC-CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence 34568884 6799999999999999999997 57899999998777677777889999999999999999999999864
Q ss_pred C-----CCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeec
Q 020085 179 P-----PNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFG 253 (331)
Q Consensus 179 ~-----~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg 253 (331)
. ...+++++++.||+|.+++.. +.+++..+..++.||+.||+|||++||+||||||+|||++.++.+|++|||
T Consensus 89 ~~~~~~~~~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg 166 (348)
T d2gfsa1 89 ARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFG 166 (348)
T ss_dssp CSSTTTCCCCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC-
T ss_pred ccccccCceEEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccc
Confidence 3 345677788889999999853 579999999999999999999999999999999999999999999999999
Q ss_pred ceeeecCCCccccCCCCcccccchhcCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHHhccccc
Q 020085 254 VARVQAQSGVMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLTPLQAAVGVVQK 322 (331)
Q Consensus 254 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~~~~~~~ 322 (331)
.+..... ......|++.|+|||.+.+. .++.++||||+||++|+|++|+.||.+.+.......+.+.
T Consensus 167 ~a~~~~~--~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~ 234 (348)
T d2gfsa1 167 LARHTDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL 234 (348)
T ss_dssp ---CCTG--GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred hhcccCc--ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence 9975543 33456789999999987665 4689999999999999999999999998887776665543
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-43 Score=318.91 Aligned_cols=208 Identities=25% Similarity=0.392 Sum_probs=181.8
Q ss_pred cCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcceeEEeEEECCCCeEEEEe
Q 020085 110 KQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQFIGACTRPPNLCIVTE 187 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~lV~E 187 (331)
++|++.++||+|+||+||+|++ +++.||||+++...........+.+|+.+|+.++||||+++++++......++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 5799999999999999999998 56889999998776566677889999999999999999999999999999999999
Q ss_pred ccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecceeeecCCC-cccc
Q 020085 188 FMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGVARVQAQSG-VMTA 266 (331)
Q Consensus 188 ~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~~~-~~~~ 266 (331)
++.+++|..++. ..+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||.++...... ....
T Consensus 82 ~~~~~~l~~~~~-~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~ 160 (292)
T d1unla_ 82 FCDQDLKKYFDS-CNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA 160 (292)
T ss_dssp CCSEEHHHHHHH-TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCS
T ss_pred eccccccccccc-cccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCcccee
Confidence 999988888775 46788999999999999999999999999999999999999999999999999998765543 3344
Q ss_pred CCCCcccccchhcCCCC-CCChhhHHHHHHHHHHHHcCCCCC-CCCCHHHHHhc
Q 020085 267 ETGTYRWMAPEVIEHKP-YDYKADVFSFGIALWELLTGELPY-AGLTPLQAAVG 318 (331)
Q Consensus 267 ~~gt~~y~aPE~~~~~~-~~~~~Di~SlG~il~ell~g~~Pf-~~~~~~~~~~~ 318 (331)
..+++.|+|||.+.... ++.++||||+||++|||++|+.|| .+.+..+....
T Consensus 161 ~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~ 214 (292)
T d1unla_ 161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKR 214 (292)
T ss_dssp CCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHH
T ss_pred eccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHH
Confidence 56788999999987654 689999999999999999998885 54454444433
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.5e-43 Score=320.40 Aligned_cols=202 Identities=26% Similarity=0.371 Sum_probs=168.7
Q ss_pred cCcceeeeeeecCceEEEEEEEC--CceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCccee-EEeEEECCCCeEEEE
Q 020085 110 KQLKIECKVASGSYGDLYKGTYC--SQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNVVQ-FIGACTRPPNLCIVT 186 (331)
Q Consensus 110 ~~~~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~niv~-~~~~~~~~~~~~lV~ 186 (331)
++|++.++||+|+||+||+|++. ++.||||+++..... .++..|++++++++|+|++. +.+++...+..++||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm 82 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence 47999999999999999999984 789999998765332 35788999999998766554 555567777889999
Q ss_pred eccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcC---CCcEEEeeecceeeecCCC-
Q 020085 187 EFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDE---NGVVKVADFGVARVQAQSG- 262 (331)
Q Consensus 187 E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~---~~~vkl~DFg~a~~~~~~~- 262 (331)
||+. +++.+.+......+++..+..++.|++.||+|||++||+||||||+|||++. +..++++|||+|+......
T Consensus 83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~ 161 (299)
T d1ckia_ 83 ELLG-PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 161 (299)
T ss_dssp ECCC-CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTT
T ss_pred EEcC-CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccccc
Confidence 9984 5888888777788999999999999999999999999999999999999864 4579999999998765432
Q ss_pred -------ccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCCCHHHHH
Q 020085 263 -------VMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGLTPLQAA 316 (331)
Q Consensus 263 -------~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~~~~~~~ 316 (331)
......||+.|||||.+.+..++.++|||||||++|||++|+.||......+..
T Consensus 162 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~ 222 (299)
T d1ckia_ 162 HQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR 222 (299)
T ss_dssp CCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-----
T ss_pred ccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHH
Confidence 123346999999999999999999999999999999999999999886654443
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=3.6e-43 Score=321.80 Aligned_cols=195 Identities=19% Similarity=0.392 Sum_probs=172.4
Q ss_pred cccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCcceeEEeEEEC--CCCe
Q 020085 108 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTR--PPNL 182 (331)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~--~~~~ 182 (331)
+.++|++.++||+|+||+||+|++ +++.||||+++... .+.+.+|+.+|++++ ||||+++++++.. ...+
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~-----~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK-----KKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC-----HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH-----HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCce
Confidence 346899999999999999999998 47899999998642 356889999999995 9999999999974 4569
Q ss_pred EEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCC-cEEEeeecceeeecCC
Q 020085 183 CIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENG-VVKVADFGVARVQAQS 261 (331)
Q Consensus 183 ~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~-~vkl~DFg~a~~~~~~ 261 (331)
++||||+.+++|..+. ..+++..+..++.||+.||+|||++||+||||||+|||++.++ .+||+|||+|+.....
T Consensus 108 ~~v~e~~~~~~L~~~~----~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~ 183 (328)
T d3bqca1 108 ALVFEHVNNTDFKQLY----QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG 183 (328)
T ss_dssp EEEEECCCSCBGGGTT----TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred eEEEeecCCCcHHHHh----cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCC
Confidence 9999999999987753 4689999999999999999999999999999999999998655 6999999999887766
Q ss_pred CccccCCCCcccccchhcCCC-CCCChhhHHHHHHHHHHHHcCCCCCCCCC
Q 020085 262 GVMTAETGTYRWMAPEVIEHK-PYDYKADVFSFGIALWELLTGELPYAGLT 311 (331)
Q Consensus 262 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~SlG~il~ell~g~~Pf~~~~ 311 (331)
.......+|+.|+|||.+.+. .++.++|+||+||++|||++|+.||....
T Consensus 184 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~ 234 (328)
T d3bqca1 184 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGH 234 (328)
T ss_dssp CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCc
Confidence 666777899999999998765 57999999999999999999999997653
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9.5e-37 Score=282.18 Aligned_cols=198 Identities=20% Similarity=0.363 Sum_probs=161.1
Q ss_pred cccCcceeeeeeecCceEEEEEEE--CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-----------CCcceeEEe
Q 020085 108 DAKQLKIECKVASGSYGDLYKGTY--CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-----------HKNVVQFIG 174 (331)
Q Consensus 108 ~~~~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~-----------h~niv~~~~ 174 (331)
...+|+++++||+|+||+||+|++ +|+.||||+++.+ ....+.+.+|+.+++.++ |+||+++++
T Consensus 11 ~~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~---~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~ 87 (362)
T d1q8ya_ 11 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD---KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLD 87 (362)
T ss_dssp TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC---HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCE
T ss_pred cCCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc---ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEE
Confidence 345699999999999999999998 5799999999854 334467888999998875 578999998
Q ss_pred EEECC--CCeEEEEeccCCCCH--HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh-CCcccCCCCCCCEEEcCCCc---
Q 020085 175 ACTRP--PNLCIVTEFMARGSI--YDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQ-NNIIHRDLKTANLLMDENGV--- 246 (331)
Q Consensus 175 ~~~~~--~~~~lV~E~~~ggsL--~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~iiHrDlkp~NiLi~~~~~--- 246 (331)
++... ...+++++++..+.. ..........+++..+..++.|++.||+|||+ .||+||||||+|||++.++.
T Consensus 88 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~ 167 (362)
T d1q8ya_ 88 HFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPEN 167 (362)
T ss_dssp EEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTT
T ss_pred EeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccc
Confidence 87543 345666666554432 22233345688999999999999999999998 89999999999999987653
Q ss_pred ---EEEeeecceeeecCCCccccCCCCcccccchhcCCCCCCChhhHHHHHHHHHHHHcCCCCCCCC
Q 020085 247 ---VKVADFGVARVQAQSGVMTAETGTYRWMAPEVIEHKPYDYKADVFSFGIALWELLTGELPYAGL 310 (331)
Q Consensus 247 ---vkl~DFg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~SlG~il~ell~g~~Pf~~~ 310 (331)
++++|||.+...... .....||+.|+|||++....++.++|+||+||++++|++|+.||...
T Consensus 168 ~~~~kl~dfg~s~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~ 232 (362)
T d1q8ya_ 168 LIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPD 232 (362)
T ss_dssp EEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---
T ss_pred cceeeEeecccccccccc--cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCC
Confidence 999999999865443 34567999999999999999999999999999999999999999764
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.94 E-value=5.7e-27 Score=197.18 Aligned_cols=164 Identities=15% Similarity=0.147 Sum_probs=121.1
Q ss_pred cceeeeeeecCceEEEEEEE-CCceEEEEEecCCCCC----------------HHHHHHHHHHHHHHHhcCCCcceeEEe
Q 020085 112 LKIECKVASGSYGDLYKGTY-CSQEVAIKVLKPECVN----------------TEMLKEFSQEVYIMRKIRHKNVVQFIG 174 (331)
Q Consensus 112 ~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~----------------~~~~~~~~~E~~il~~l~h~niv~~~~ 174 (331)
+.+.++||+|+||+||+|++ +|+.||||+++....+ ......+..|...+.++.|++++..++
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~ 81 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYA 81 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEE
T ss_pred chhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEE
Confidence 45789999999999999987 6789999998643211 111234567889999999999999886
Q ss_pred EEECCCCeEEEEeccCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCCCCEEEcCCCcEEEeeecc
Q 020085 175 ACTRPPNLCIVTEFMARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQNNIIHRDLKTANLLMDENGVVKVADFGV 254 (331)
Q Consensus 175 ~~~~~~~~~lV~E~~~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~NiLi~~~~~vkl~DFg~ 254 (331)
+. ..+++|||+++..+.+ ++...+..++.|++++++|||++||+||||||+|||++++ .++|+|||.
T Consensus 82 ~~----~~~lvme~~~~~~~~~--------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG~ 148 (191)
T d1zara2 82 WE----GNAVLMELIDAKELYR--------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFPQ 148 (191)
T ss_dssp EE----TTEEEEECCCCEEGGG--------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCTT
T ss_pred ec----CCEEEEEeeccccccc--------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECCC
Confidence 54 2379999999865533 3344467899999999999999999999999999999865 489999999
Q ss_pred eeeecCCCccccCCCCccccc------chhcCCCCCCChhhHHHHHHH
Q 020085 255 ARVQAQSGVMTAETGTYRWMA------PEVIEHKPYDYKADVFSFGIA 296 (331)
Q Consensus 255 a~~~~~~~~~~~~~gt~~y~a------PE~~~~~~~~~~~Di~SlG~i 296 (331)
|+....+... .|.. .+.+ .+.|+.++|+||..--
T Consensus 149 a~~~~~~~~~-------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~ 188 (191)
T d1zara2 149 SVEVGEEGWR-------EILERDVRNIITYF-SRTYRTEKDINSAIDR 188 (191)
T ss_dssp CEETTSTTHH-------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHH
T ss_pred cccCCCCCcH-------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHH
Confidence 9765433211 1111 1111 3567889999996543
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.80 E-value=1e-08 Score=88.03 Aligned_cols=141 Identities=12% Similarity=0.058 Sum_probs=96.9
Q ss_pred CcceeeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCcceeEEeEEECCCCeEEEEecc
Q 020085 111 QLKIECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPPNLCIVTEFM 189 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~~~~lV~E~~ 189 (331)
.|++.+..+.++.+.||+....++.+.+|+........ ...+.+|...++.+. +--+.+++.++..++..++||+++
T Consensus 15 ~~~~~~~~~G~s~~~v~rv~~~~~~~vlk~~~~~~~~~--~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l 92 (263)
T d1j7la_ 15 KYRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT--TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA 92 (263)
T ss_dssp TSEEEECSCCCSSSEEEEEECSSCEEEEEEECGGGTTS--TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred ceEEEEcCCCCCCCcEEEEEeCCCeEEEEEcCCCcccc--hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEec
Confidence 56666665556667899998888999999986542211 234677888888774 333677788888888899999999
Q ss_pred CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------------
Q 020085 190 ARGSIYDFLHKQKGVFQLTSLLKVAIDVSKGMNYLHQN------------------------------------------ 227 (331)
Q Consensus 190 ~ggsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~------------------------------------------ 227 (331)
+|.++.+..... .. ...++.++++.+..||+.
T Consensus 93 ~G~~~~~~~~~~---~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (263)
T d1j7la_ 93 DGVLCSEEYEDE---QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD 166 (263)
T ss_dssp SSEEHHHHTTTC---SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSS
T ss_pred cccccccccccc---cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchH
Confidence 998876543211 11 122333444444444421
Q ss_pred -----------------CcccCCCCCCCEEEcCCCcEEEeeecceeeec
Q 020085 228 -----------------NIIHRDLKTANLLMDENGVVKVADFGVARVQA 259 (331)
Q Consensus 228 -----------------~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~ 259 (331)
.++|+|+.|.||++++++.+-|+||+.+....
T Consensus 167 ~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~g~ 215 (263)
T d1j7la_ 167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGRAD 215 (263)
T ss_dssp HHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEEE
T ss_pred HHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcccCC
Confidence 25899999999999987767799999987543
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.29 E-value=1.5e-06 Score=73.61 Aligned_cols=138 Identities=11% Similarity=0.111 Sum_probs=84.7
Q ss_pred eeeecCc-eEEEEEEECC-ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCC--CcceeEEeEEECCCCeEEEEeccCCC
Q 020085 117 KVASGSY-GDLYKGTYCS-QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH--KNVVQFIGACTRPPNLCIVTEFMARG 192 (331)
Q Consensus 117 ~lg~G~~-g~Vy~~~~~~-~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h--~niv~~~~~~~~~~~~~lV~E~~~gg 192 (331)
.+..|.. +.||+.+..+ ..+.+|....... ..+..|...++.+.. --+.+++.++..++..++||++++|.
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~-----~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL-----NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ 91 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCTT-----SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCccCH-----hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecc
Confidence 4455554 6799988754 5688898775532 246677888877743 23677788888888899999999986
Q ss_pred CHHHH--------------HHhcC------CCC--CHHHHHHHHH--------------------HHHHHHHHHHhC---
Q 020085 193 SIYDF--------------LHKQK------GVF--QLTSLLKVAI--------------------DVSKGMNYLHQN--- 227 (331)
Q Consensus 193 sL~~~--------------l~~~~------~~~--~~~~~~~i~~--------------------qi~~~l~~LH~~--- 227 (331)
++.+. +.+-. ..+ .......-.. .....+..+.+.
T Consensus 92 ~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 171 (255)
T d1nd4a_ 92 DLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPD 171 (255)
T ss_dssp ETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCS
T ss_pred ccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCc
Confidence 54321 11100 000 0110000000 011223333332
Q ss_pred ----CcccCCCCCCCEEEcCCCcEEEeeecceeeec
Q 020085 228 ----NIIHRDLKTANLLMDENGVVKVADFGVARVQA 259 (331)
Q Consensus 228 ----~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~ 259 (331)
.++|+|+.|.|||+++++.+-|+||+.+....
T Consensus 172 ~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~g~ 207 (255)
T d1nd4a_ 172 GEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVAD 207 (255)
T ss_dssp SCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEEE
T ss_pred cCCceEEeCCCCCcceEEeCCceEEEEEchhcccCC
Confidence 26999999999999987777899999987543
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.01 E-value=1.8e-05 Score=71.58 Aligned_cols=77 Identities=12% Similarity=0.017 Sum_probs=47.9
Q ss_pred eeeeeecCceEEEEEEE--CCceEEEEEecCCCC-----CHHHHHHHHHHHHHHHhcC-C--CcceeEEeEEECCCCeEE
Q 020085 115 ECKVASGSYGDLYKGTY--CSQEVAIKVLKPECV-----NTEMLKEFSQEVYIMRKIR-H--KNVVQFIGACTRPPNLCI 184 (331)
Q Consensus 115 ~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~-----~~~~~~~~~~E~~il~~l~-h--~niv~~~~~~~~~~~~~l 184 (331)
.+.||.|....||+.+. .++.+++|.-.+... ......+...|...|+.+. + ..+++++.+. +...++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~d--~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYSD--TEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEEE--TTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEEc--CCCCEE
Confidence 34689999999999875 356899997543110 0111233456788887663 2 3456666543 345689
Q ss_pred EEeccCCCC
Q 020085 185 VTEFMARGS 193 (331)
Q Consensus 185 V~E~~~ggs 193 (331)
|||++.+..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999998754
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.33 E-value=0.0004 Score=62.43 Aligned_cols=75 Identities=15% Similarity=0.239 Sum_probs=49.9
Q ss_pred CcceeeeeeecCceEEEEEEECC---------ceEEEEEecCCCCCHHHHHHHHHHHHHHHhcC-CCcceeEEeEEECCC
Q 020085 111 QLKIECKVASGSYGDLYKGTYCS---------QEVAIKVLKPECVNTEMLKEFSQEVYIMRKIR-HKNVVQFIGACTRPP 180 (331)
Q Consensus 111 ~~~~~~~lg~G~~g~Vy~~~~~~---------~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~ 180 (331)
++++ ++|+.|-.-.+|+.+... +.|.+++.-.. .. .-...+|..+++.+. +.-..++++++.+
T Consensus 44 ~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~--~idr~~E~~i~~~ls~~gl~Pkll~~~~~-- 116 (395)
T d1nw1a_ 44 HLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ET--ESHLVAESVIFTLLSERHLGPKLYGIFSG-- 116 (395)
T ss_dssp GEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CC--HHHHHHHHHHHHHHHHTTSSSCEEEEETT--
T ss_pred ceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--ch--hhHHHHHHHHHHHHHhCCCCCeEEEEcCC--
Confidence 3443 568889999999988642 45777776522 11 124557888988885 4334577777643
Q ss_pred CeEEEEeccCCCCH
Q 020085 181 NLCIVTEFMARGSI 194 (331)
Q Consensus 181 ~~~lV~E~~~ggsL 194 (331)
.+|+||++|.++
T Consensus 117 --g~I~efi~g~~l 128 (395)
T d1nw1a_ 117 --GRLEEYIPSRPL 128 (395)
T ss_dssp --EEEECCCCEEEC
T ss_pred --ceEEEEeccccC
Confidence 689999988543
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.24 E-value=0.00085 Score=58.50 Aligned_cols=133 Identities=16% Similarity=0.195 Sum_probs=75.9
Q ss_pred ceEEEEEEE-CCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCCCcc-----eeEE--eEEECCCCeEEEEeccCCCCH
Q 020085 123 YGDLYKGTY-CSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRHKNV-----VQFI--GACTRPPNLCIVTEFMARGSI 194 (331)
Q Consensus 123 ~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h~ni-----v~~~--~~~~~~~~~~lV~E~~~ggsL 194 (331)
--.||+.+. +|+.+++|+.++...+. +++..|...+..+...++ +..- ..+...+..+.++++++|..+
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~~s~---~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~ 111 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPERWTA---DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQF 111 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTTSCH---HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEEC
T ss_pred cceeEEEEcCCCCEEEEEEeCCCCCCH---HHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCC
Confidence 357999886 67889999998876554 456678888877742222 1111 122334567889999987422
Q ss_pred -----HH------H---HHhc--------CCCCCHH----------------------HHHHHHHHHHHHHHHHH----h
Q 020085 195 -----YD------F---LHKQ--------KGVFQLT----------------------SLLKVAIDVSKGMNYLH----Q 226 (331)
Q Consensus 195 -----~~------~---l~~~--------~~~~~~~----------------------~~~~i~~qi~~~l~~LH----~ 226 (331)
.. . ++.. ....+.. .....+.++...+.-.- .
T Consensus 112 ~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p 191 (325)
T d1zyla1 112 EADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFT 191 (325)
T ss_dssp CSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSC
T ss_pred CCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCC
Confidence 11 1 1110 0111111 11122222222222211 1
Q ss_pred CCcccCCCCCCCEEEcCCCcEEEeeecceeeecC
Q 020085 227 NNIIHRDLKTANLLMDENGVVKVADFGVARVQAQ 260 (331)
Q Consensus 227 ~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~~~~ 260 (331)
.++||+|+.+.|||+++ + ..++||+-+.....
T Consensus 192 ~~liHgDlh~~NvL~~~-~-~~~IDFdd~~~g~~ 223 (325)
T d1zyla1 192 VLRLHGDCHAGNILWRD-G-PMFVDLDDARNGPA 223 (325)
T ss_dssp CEECCSSCSGGGEEESS-S-EEECCCTTCCEECT
T ss_pred ceeecCCCCcccEEEeC-C-ceEEechhcccCcH
Confidence 36899999999999974 3 45899999875443
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.86 E-value=0.001 Score=57.49 Aligned_cols=139 Identities=10% Similarity=0.058 Sum_probs=72.9
Q ss_pred eeeeeecCceEEEEEEECCceEEEEEecCCCCCHHHHHHHHHHHHHHHhcCC-----CcceeEEe---EEECCCCeEEEE
Q 020085 115 ECKVASGSYGDLYKGTYCSQEVAIKVLKPECVNTEMLKEFSQEVYIMRKIRH-----KNVVQFIG---ACTRPPNLCIVT 186 (331)
Q Consensus 115 ~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~il~~l~h-----~niv~~~~---~~~~~~~~~lV~ 186 (331)
.+.|..|---+.|+.+..+..+++|+..... +. .++..|..++..+.. |..+...+ ..........++
T Consensus 23 ~~~i~~G~~N~ny~v~t~~g~yVLri~~~~~-~~---~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~ 98 (316)
T d2ppqa1 23 YKGIAEGVENSNFLLHTTKDPLILTLYEKRV-EK---NDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALI 98 (316)
T ss_dssp EEEECC---EEEEEEEESSCCEEEEEECC----C---CHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEE
T ss_pred eecCCCCcccCeEEEEECCCcEEEEEcCCCC-CH---HHHHHHHHHHHhhhhccccccccceecCCCcceeeecccceee
Confidence 3456678778899998888889999986542 11 334456666666532 22222110 111123455566
Q ss_pred eccCCCCHH--------------HHHHhcCC--------CCCH------------------HHHHHHHHHHHHHHHHHH-
Q 020085 187 EFMARGSIY--------------DFLHKQKG--------VFQL------------------TSLLKVAIDVSKGMNYLH- 225 (331)
Q Consensus 187 E~~~ggsL~--------------~~l~~~~~--------~~~~------------------~~~~~i~~qi~~~l~~LH- 225 (331)
.+..|.... ..++.... .... ......+..+...+...+
T Consensus 99 ~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~ 178 (316)
T d2ppqa1 99 SFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWP 178 (316)
T ss_dssp ECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCC
T ss_pred eecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCc
Confidence 666553221 01111000 0000 011112222222222222
Q ss_pred ---hCCcccCCCCCCCEEEcCCCcEEEeeecceee
Q 020085 226 ---QNNIIHRDLKTANLLMDENGVVKVADFGVARV 257 (331)
Q Consensus 226 ---~~~iiHrDlkp~NiLi~~~~~vkl~DFg~a~~ 257 (331)
..|+||+|+.+.|++++.++..-++||+.+..
T Consensus 179 ~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 179 KDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp CSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccccccccCCcchhhhhcccccceeEeccccccc
Confidence 24799999999999999888889999999864
|
| >d2f06a1 d.58.18.11 (A:71-141) Hypothetical protein BT0572 {Bacteroides thetaiotaomicron [TaxId: 818]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: BT0572-like domain: Hypothetical protein BT0572 species: Bacteroides thetaiotaomicron [TaxId: 818]
Probab=91.40 E-value=0.29 Score=31.69 Aligned_cols=47 Identities=15% Similarity=0.198 Sum_probs=39.9
Q ss_pred HHHHHHHHHhhhCCCeeeeeeeecCCCceeeEEEecCCCCCchHHHHHHHHHH
Q 020085 10 KVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKE 62 (331)
Q Consensus 10 ~~~~~~~~~~~~~~~i~~~~~~~t~~~~~~~~~vv~gw~~~~~~~l~~~l~~~ 62 (331)
.|.+++++|++-|.||.=..+|.+. +++.-+|.|| +.+..++.|.+.
T Consensus 12 ~L~~v~~~L~~~~InI~~~y~~~~~-~~~~~vl~vd-----d~~~a~~~L~~~ 58 (71)
T d2f06a1 12 ALAKVLGFLSAEGVFIEYMYSFANN-NVANVVIRPS-----NMDKCIEVLKEK 58 (71)
T ss_dssp HHHHHHHHHHHTTCCEEEEEEEEET-TEEEEEEEES-----CHHHHHHHHHHT
T ss_pred HHHHHHHHHHHCCCCEEEEEEEcCC-CcEEEEEEEC-----CHHHHHHHHHHC
Confidence 4788999999999999999999986 6899999997 667777777653
|
| >d1zpva1 d.58.18.7 (A:1-83) UPF0237 protein SP0238 {Streptococcus pneumoniae [TaxId: 1313]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: SP0238-like domain: UPF0237 protein SP0238 species: Streptococcus pneumoniae [TaxId: 1313]
Probab=90.02 E-value=0.31 Score=32.48 Aligned_cols=52 Identities=21% Similarity=0.202 Sum_probs=38.6
Q ss_pred HHHHHHHHHhhhCCCeeeeeeeecCCCceeeEEEecCCCC-CchHHHHHHHHHHH
Q 020085 10 KVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPY-DETEDLKNVLAKEI 63 (331)
Q Consensus 10 ~~~~~~~~~~~~~~~i~~~~~~~t~~~~~~~~~vv~gw~~-~~~~~l~~~l~~~~ 63 (331)
+++.+|.+|++.|.||.|..-+...+-|.+. +.++ ++. ...++++..+.+-.
T Consensus 15 iVa~vt~~l~~~g~NI~d~~q~~~~~~f~~~-~~v~-~~~~~~~~~l~~~l~~la 67 (83)
T d1zpva1 15 IVAGVSGKIAELGLNIDDISQTVLDEYFTMM-AVVS-SDEKQDFTYLRNEFEAFG 67 (83)
T ss_dssp HHHHHHHHHHHTTCEEEEEEEEEETTEEEEE-EEEE-ESSCCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHCCCeEEEEEeEEeCCEEEEE-EEEE-EecCCCHHHHHHHHHHHH
Confidence 5788999999999999999988765555554 4455 443 35788888887643
|
| >d1u8sa1 d.58.18.5 (A:2-87) putative transcriptional repressor VC2159 {Vibrio cholerae [TaxId: 666]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: Glycine cleavage system transcriptional repressor domain: putative transcriptional repressor VC2159 species: Vibrio cholerae [TaxId: 666]
Probab=88.31 E-value=0.25 Score=33.29 Aligned_cols=52 Identities=12% Similarity=0.017 Sum_probs=37.2
Q ss_pred HHHHHHHHHhhhCCCeeeeeeeecCCCceeeEEEecCCCCCchHHHHHHHHHHH
Q 020085 10 KVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAKEI 63 (331)
Q Consensus 10 ~~~~~~~~~~~~~~~i~~~~~~~t~~~~~~~~~vv~gw~~~~~~~l~~~l~~~~ 63 (331)
+++++|.+|++.|.||.+..-+..- |...-++.|+ ++....++|+..|.+--
T Consensus 18 iva~vt~~l~~~g~NI~d~~~~~~~-~~~~~~~~v~-~~~~~~~~l~~~L~~l~ 69 (86)
T d1u8sa1 18 ICNEVVRLVTQAGCNIIDSRIAMFG-KEFTLLMLIS-GSPSNITRVETTLPLLG 69 (86)
T ss_dssp HHHHHHHHHHHTTCEEEEEEEEEET-TEEEEEEEEE-ECHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHCCCeEEEeEeEEEC-CeeEEEEEEE-cCcccHHHHHHHHHHHH
Confidence 5789999999999999999987654 4445555565 44445666776665543
|
| >d1ygya3 d.58.18.1 (A:452-529) Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain domain: Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=86.21 E-value=1.3 Score=28.90 Aligned_cols=49 Identities=24% Similarity=0.341 Sum_probs=37.8
Q ss_pred HHHHHHHHHhhhCCCeeeeeeeec-CCCceeeEEEecCCCCCchHHHHHHHHH
Q 020085 10 KVGELTSLLGEIGLNIQEAHAFST-VDGFSLDVFVVDGWPYDETEDLKNVLAK 61 (331)
Q Consensus 10 ~~~~~~~~~~~~~~~i~~~~~~~t-~~~~~~~~~vv~gw~~~~~~~l~~~l~~ 61 (331)
+|++++++|++-|.||...++..+ ..|++.-++.+|+=. .+++.+.|.+
T Consensus 16 vi~~I~~~l~~~~iNI~~m~~~~~~~g~~a~~vi~vD~~~---~~~vl~~I~~ 65 (78)
T d1ygya3 16 ALGKIGTLLGTAGVNIQAAQLSEDAEGPGATILLRLDQDV---PDDVRTAIAA 65 (78)
T ss_dssp HHHHHHHHHHHTTCCEEEEEEEECSSSSCEEEEEEESSCC---CHHHHHHHHH
T ss_pred HHHHHHHHHHhcCcChhhheeeecCCCCeEEEEEEcCCCc---cHHHHHHHHc
Confidence 588999999999999999999865 555788888888643 3555555544
|
| >d1sc6a3 d.58.18.1 (A:327-410) Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain domain: Phosphoglycerate dehydrogenase, regulatory (C-terminal) domain species: Escherichia coli [TaxId: 562]
Probab=85.26 E-value=0.53 Score=31.43 Aligned_cols=36 Identities=19% Similarity=0.317 Sum_probs=28.6
Q ss_pred HHHHHHHHHhhhCCCeeeeeeeecCC-CceeeEEEec
Q 020085 10 KVGELTSLLGEIGLNIQEAHAFSTVD-GFSLDVFVVD 45 (331)
Q Consensus 10 ~~~~~~~~~~~~~~~i~~~~~~~t~~-~~~~~~~vv~ 45 (331)
+|++++++|++-|+||.+-+.-++-+ ||.+=++-+|
T Consensus 24 vla~I~~~l~~~~iNI~~~~~~~~~~~~~a~~~i~~D 60 (84)
T d1sc6a3 24 VLTALNKIFAEQGVNIAAQYLQTSAQMGYVVIDIEAD 60 (84)
T ss_dssp HHHHHHHHHHHTTCEEEEEEEEECSSEEEEEEEEECC
T ss_pred HHHHHHHHHHHcCCCHHHhccccCCCCcEEEEEEECC
Confidence 58899999999999999999988776 5555444443
|
| >d2f06a2 d.58.18.11 (A:1-70) Hypothetical protein BT0572 {Bacteroides thetaiotaomicron [TaxId: 818]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Ferredoxin-like superfamily: ACT-like family: BT0572-like domain: Hypothetical protein BT0572 species: Bacteroides thetaiotaomicron [TaxId: 818]
Probab=84.62 E-value=2.2 Score=27.21 Aligned_cols=46 Identities=17% Similarity=0.291 Sum_probs=36.7
Q ss_pred HHHHHHHHHhhhCCCeeeeeeeecCCCceeeEEEecCCCCCchHHHHHHHHH
Q 020085 10 KVGELTSLLGEIGLNIQEAHAFSTVDGFSLDVFVVDGWPYDETEDLKNVLAK 61 (331)
Q Consensus 10 ~~~~~~~~~~~~~~~i~~~~~~~t~~~~~~~~~vv~gw~~~~~~~l~~~l~~ 61 (331)
.|.+++.+|++-|.||.=-.++.|.| +..-.++|| +++...+.|.+
T Consensus 16 ~L~~v~~~~~~~~inI~sl~v~~t~~-~~i~Riiv~-----~~e~a~~~L~~ 61 (70)
T d2f06a2 16 RLTEVTEVLAKENINLSALCIAENAD-FGILRGIVS-----DPDKAYKALKD 61 (70)
T ss_dssp HHHHHHHHHHHTTCCEEEEEEEECSS-CEEEEEEES-----CHHHHHHHHHH
T ss_pred HHHHHHHHHHHCCCCEEEEEEeecCC-CCEEEEEEC-----ChHHHHHHHHH
Confidence 58899999999999999888888765 677778887 56666666644
|